{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "9b8da175",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "3633\n",
      "{'_id': 'MED-10', 'title': 'Statin Use and Breast Cancer Survival: A Nationwide Cohort Study from Finland', 'text': 'Recent studies have suggested that statins, an established drug group in the prevention of cardiovascular mortality, could delay or prevent breast cancer recurrence but the effect on disease-specific mortality remains unclear. We evaluated risk of breast cancer death among statin users in a population-based cohort of breast cancer patients. The study cohort included all newly diagnosed breast cancer patients in Finland during 1995–2003 (31,236 cases), identified from the Finnish Cancer Registry. Information on statin use before and after the diagnosis was obtained from a national prescription database. We used the Cox proportional hazards regression method to estimate mortality among statin users with statin use as time-dependent variable. A total of 4,151 participants had used statins. During the median follow-up of 3.25 years after the diagnosis (range 0.08–9.0 years) 6,011 participants died, of which 3,619 (60.2%) was due to breast cancer. After adjustment for age, tumor characteristics, and treatment selection, both post-diagnostic and pre-diagnostic statin use were associated with lowered risk of breast cancer death (HR 0.46, 95% CI 0.38–0.55 and HR 0.54, 95% CI 0.44–0.67, respectively). The risk decrease by post-diagnostic statin use was likely affected by healthy adherer bias; that is, the greater likelihood of dying cancer patients to discontinue statin use as the association was not clearly dose-dependent and observed already at low-dose/short-term use. The dose- and time-dependence of the survival benefit among pre-diagnostic statin users suggests a possible causal effect that should be evaluated further in a clinical trial testing statins’ effect on survival in breast cancer patients.', 'metadata': {'url': 'http://www.ncbi.nlm.nih.gov/pubmed/25329299'}}\n"
     ]
    }
   ],
   "source": [
    "import json\n",
    "\n",
    "CORPUS_PATH = \"/home/guest/r12922050/GitHub/d2qplus/data/nfcorpus/corpus.jsonl\"\n",
    "with open(CORPUS_PATH, \"r\") as f:\n",
    "    corpus = [json.loads(line) for line in f]\n",
    "print(len(corpus))\n",
    "print(corpus[0])"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a8d8d29f",
   "metadata": {},
   "source": [
    "# Keyword Extraction using KeyBERT + TF-IDF"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "9496608e",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "No sentence-transformers model found with name allenai/scibert_scivocab_uncased. Creating a new one with mean pooling.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "# of results generated:3633\n"
     ]
    }
   ],
   "source": [
    "from keybert import KeyBERT\n",
    "from sentence_transformers import SentenceTransformer\n",
    "from sklearn.feature_extraction.text import TfidfVectorizer\n",
    "from tqdm import tqdm\n",
    "\n",
    "tfidf = TfidfVectorizer(\n",
    "    ngram_range=(1,3),      # or (1,1)/(2,2) depending on your n-gram needs\n",
    "    max_df=0.9,             # drop very frequent tokens\n",
    "    min_df=2,               # drop extremely rare tokens\n",
    "    stop_words=\"english\"\n",
    ")\n",
    "\n",
    "tfidf.fit([doc[\"title\"] + \" \" + doc[\"text\"] for doc in corpus])\n",
    "\n",
    "# mp_net = SentenceTransformer(\"sentence-transformers/all-mpnet-base-v2\", device=\"cuda:2\")\n",
    "sci_bert = SentenceTransformer(\"allenai/scibert_scivocab_uncased\", device=\"cuda:2\")\n",
    "\n",
    "\n",
    "kw_model = KeyBERT(model=sci_bert)\n",
    "\n",
    "extract_params = {\n",
    "    \"keyphrase_ngram_range\": (1, 3),  # unigrams + bigrams\n",
    "    \"stop_words\": \"english\",          # default English stop words\n",
    "    \"use_mmr\": True,                  # use Maximal Marginal Relevance to increase diversity\n",
    "    \"diversity\": 0.6,                 # diversity trade-off between relevance vs novelty\n",
    "    \"top_n\": 15,                       # extract up to 10 keyphrases per document\n",
    "    \"vectorizer\": tfidf,             # use the fitted TF-IDF vectorizer\n",
    "}\n",
    "\n",
    "all_texts = [doc[\"title\"] + \" \" + doc[\"text\"] for doc in corpus]\n",
    "results = kw_model.extract_keywords(all_texts, **extract_params)\n",
    "print(f\"# of results generated:{len(results)}\")\n",
    "\n",
    "doc_ids = [doc[\"doc_id\"] for doc in corpus]\n",
    "# zip doc_ids with results\n",
    "\n",
    "\n",
    "\n",
    "# save to jsonl\n",
    "import json\n",
    "OUTPUT_PATH = \"/home/guest/r12922050/GitHub/d2qplus/augmented-data/nfcorpus/keywords/scibert_1_3_gram.jsonl\"\n",
    "with open(OUTPUT_PATH, \"w\") as f:\n",
    "    for doc_id, keywords in keywords_per_doc.items():\n",
    "        f.write(json.dumps({\"doc_id\": doc_id, \"keywords\": keywords}) + \"\\n\")\n",
    "print(f\"saved keywords to {OUTPUT_PATH}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "f17e3de2",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "saved keywords to /home/guest/r12922050/GitHub/d2qplus/augmented-data/nfcorpus/keywords/scibert_1_3_gram.jsonl\n"
     ]
    }
   ],
   "source": [
    "OUTPUT_PATH = \"/home/guest/r12922050/GitHub/d2qplus/augmented-data/nfcorpus/keywords/scibert_1_3_gram.jsonl\"\n",
    "with open(OUTPUT_PATH, \"w\") as f:\n",
    "    for i in range(len(corpus)):\n",
    "        doc_id = corpus[i][\"_id\"]\n",
    "        title = corpus[i][\"title\"]\n",
    "        keywords = results[i]\n",
    "        f.write(json.dumps({\"doc_id\": doc_id, \"title\": title, \"keywords\": keywords}) + \"\\n\")\n",
    "print(f\"saved keywords to {OUTPUT_PATH}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "17a0bf8a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'_id': 'MED-10',\n",
       " 'title': 'Statin Use and Breast Cancer Survival: A Nationwide Cohort Study from Finland',\n",
       " 'text': 'Recent studies have suggested that statins, an established drug group in the prevention of cardiovascular mortality, could delay or prevent breast cancer recurrence but the effect on disease-specific mortality remains unclear. We evaluated risk of breast cancer death among statin users in a population-based cohort of breast cancer patients. The study cohort included all newly diagnosed breast cancer patients in Finland during 1995–2003 (31,236 cases), identified from the Finnish Cancer Registry. Information on statin use before and after the diagnosis was obtained from a national prescription database. We used the Cox proportional hazards regression method to estimate mortality among statin users with statin use as time-dependent variable. A total of 4,151 participants had used statins. During the median follow-up of 3.25 years after the diagnosis (range 0.08–9.0 years) 6,011 participants died, of which 3,619 (60.2%) was due to breast cancer. After adjustment for age, tumor characteristics, and treatment selection, both post-diagnostic and pre-diagnostic statin use were associated with lowered risk of breast cancer death (HR 0.46, 95% CI 0.38–0.55 and HR 0.54, 95% CI 0.44–0.67, respectively). The risk decrease by post-diagnostic statin use was likely affected by healthy adherer bias; that is, the greater likelihood of dying cancer patients to discontinue statin use as the association was not clearly dose-dependent and observed already at low-dose/short-term use. The dose- and time-dependence of the survival benefit among pre-diagnostic statin users suggests a possible causal effect that should be evaluated further in a clinical trial testing statins’ effect on survival in breast cancer patients.',\n",
       " 'metadata': {'url': 'http://www.ncbi.nlm.nih.gov/pubmed/25329299'}}"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "corpus[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "3d2d203b",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "3633 {'MED-10': [['possible causal effect', 0.5809], ['nationwide cohort study', 0.5649], ['discontinue statin use', 0.5625], ['cancer registry information', 0.5324], ['characteristics treatment selection', 0.5257], ['breast cancer', 0.5231], ['specific mortality', 0.518], ['tumor characteristics', 0.517], ['95 ci 44', 0.4994], ['clinical trial testing', 0.4993], ['patients finland', 0.4434], ['users population based', 0.4357], ['2003 31', 0.404], ['ci', 0.4002], ['54', 0.3239]]}\n"
     ]
    }
   ],
   "source": [
    "with open(f\"/home/guest/r12922050/GitHub/d2qplus/augmented-data/nfcorpus/keywords/scibert_1_3_gram.jsonl\", \"r\") as f:\n",
    "    corpus_keywords = [json.loads(line) for line in f]\n",
    "print(len(corpus_keywords), corpus_keywords[0])"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "216b2320",
   "metadata": {},
   "source": [
    "## Core keyword extraction\n",
    "\n",
    "> CCQGen\n",
    "\n",
    "Core phrases identification. From each document, we\n",
    "identify core phrases used to describe its concepts. These phrases\n",
    "offer fine-grained details not captured at the topic level. We note\n",
    "that not all phrases in the document are equally important. Core\n",
    "phrases should describe concepts strongly relevant to the document\n",
    "but not frequently covered by other documents with similar topics.\n",
    "For example, among documents about ‘recommender system’ topic,\n",
    "the phrase ‘user-item interaction’ is very commonly used, and less\n",
    "likely to represent the most important concepts of the document.\n",
    "\n",
    "所以我們也應該需要考慮 keywords relevant to this document but not frequently covered by other documents with similar topics. 而不是直接使用整個 topic 的 keyword list 來去 guide generation\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "cffdd45a",
   "metadata": {},
   "outputs": [],
   "source": [
    "DOC_TOPICS_PATH = \"/home/guest/r12922050/GitHub/d2qplus/augmented-data/CSFCube-1.1/topics/0609-pritamdeka_scibert-biobert-pos-keybert-mmr/doc_topics.jsonl\"\n",
    "TOPIC_INFO_PKL = \"/home/guest/r12922050/GitHub/d2qplus/augmented-data/CSFCube-1.1/topics/0609-pritamdeka_scibert-biobert-pos-keybert-mmr/topic_info_dataframe_enhanced.pkl\"\n",
    "CORPUS_PATH = \"/home/guest/r12922050/GitHub/d2qplus/data/CSFCube-1.1/corpus.jsonl\"\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "d5090c18",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "4207 {'doc_id': '16421850', 'topics': [{'topic_id': 89, 'weight': 0.25}, {'topic_id': 36, 'weight': 0.25}, {'topic_id': 72, 'weight': 0.25}, {'topic_id': 23, 'weight': 0.25}]}\n"
     ]
    }
   ],
   "source": [
    "import json\n",
    "with open(DOC_TOPICS_PATH, \"r\") as f:\n",
    "    doc_topics = [json.loads(line) for line in f]\n",
    "print(len(doc_topics), doc_topics[3])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "f8825a0b",
   "metadata": {},
   "outputs": [],
   "source": [
    "from bertopic import BERTopic\n",
    "from keybert import KeyBERT\n",
    "from sklearn.feature_extraction.text import CountVectorizer\n",
    "import numpy as np\n",
    "\n",
    "# Sample documents\n",
    "docs = [doc['text'] for doc in all_docs][:50]\n",
    "\n",
    "# Step 1: Use BERTopic to identify topics\n",
    "topic_model = BERTopic(calculate_probabilities=True, verbose=True)\n",
    "topics, probs = topic_model.fit_transform(docs)\n",
    "\n",
    "# Step 2: Group documents by topic\n",
    "topic_docs = {}\n",
    "for doc, topic in zip(docs, topics):\n",
    "    if topic not in topic_docs:\n",
    "        topic_docs[topic] = []\n",
    "    topic_docs[topic].append(doc)\n",
    "\n",
    "# Step 3: Initialize KeyBERT\n",
    "kw_model = KeyBERT()\n",
    "\n",
    "# Step 4: Extract topic-level keywords to understand the topic's general content\n",
    "topic_keywords = {}\n",
    "for topic, topic_doc_list in topic_docs.items():\n",
    "    if topic == -1:  # Skip outliers\n",
    "        continue\n",
    "    # Combine all documents in the topic to get topic-level keywords\n",
    "    combined_text = \" \".join(topic_doc_list)\n",
    "    topic_keywords[topic] = kw_model.extract_keywords(\n",
    "        combined_text,\n",
    "        keyphrase_ngram_range=(1, 2),\n",
    "        stop_words='english',\n",
    "        top_n=10\n",
    "    )\n",
    "\n",
    "# Step 5: Extract document-level keywords and filter based on topic context\n",
    "document_keywords = []\n",
    "for doc_idx, (doc, topic) in enumerate(zip(docs, topics)):\n",
    "    if topic == -1:  # Skip outliers\n",
    "        document_keywords.append((doc, []))\n",
    "        continue\n",
    "    \n",
    "    # Extract document-level keywords\n",
    "    doc_keywords = kw_model.extract_keywords(\n",
    "        doc,\n",
    "        keyphrase_ngram_range=(1, 2),\n",
    "        stop_words='english',\n",
    "        top_n=5,\n",
    "        use_mmr=True,\n",
    "        diversity=0.5\n",
    "    )\n",
    "    \n",
    "    # Get topic-level keywords for comparison\n",
    "    topic_kw = topic_keywords.get(topic, [])\n",
    "    topic_kw_set = set(kw[0] for kw in topic_kw)\n",
    "    \n",
    "    # Filter document keywords: keep only those that are not too common in the topic\n",
    "    filtered_keywords = []\n",
    "    for keyword, score in doc_keywords:\n",
    "        # Check if the keyword is in the top topic keywords (i.e., too common in the topic)\n",
    "        if keyword not in topic_kw_set:\n",
    "            filtered_keywords.append((keyword, score))\n",
    "        else:\n",
    "            # Optionally, reduce the score of common keywords instead of filtering them out\n",
    "            adjusted_score = score * 0.5  # Reduce score for common keywords\n",
    "            filtered_keywords.append((keyword, adjusted_score))\n",
    "    \n",
    "    # Sort by adjusted score and take top 5\n",
    "    filtered_keywords = sorted(filtered_keywords, key=lambda x: x[1], reverse=True)[:5]\n",
    "    document_keywords.append((doc, filtered_keywords))\n",
    "\n",
    "# Step 6: Output the results\n",
    "for doc, keywords in document_keywords:\n",
    "    print(f\"Document: {doc}\")\n",
    "    print(f\"Keywords: {keywords}\\n\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "dbbc23db",
   "metadata": {},
   "outputs": [],
   "source": [
    "import numpy as np\n",
    "import json\n",
    "from keybert import KeyBERT\n",
    "from rank_bm25 import BM25Okapi\n",
    "from sentence_transformers import SentenceTransformer\n",
    "from collections import defaultdict\n",
    "from tqdm import tqdm"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "7a08b4a0",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/home/guest/r12922050/miniconda3/envs/d2qplus/lib/python3.9/site-packages/tqdm/auto.py:21: TqdmWarning: IProgress not found. Please update jupyter and ipywidgets. See https://ipywidgets.readthedocs.io/en/stable/user_install.html\n",
      "  from .autonotebook import tqdm as notebook_tqdm\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Processing 4207 documents with 4207 topic assignments\n",
      "Grouping documents by topics...\n",
      "Creating BM25 models for each topic...\n",
      "Grouping documents by topics...\n",
      "Creating BM25 models for each topic...\n",
      "Extracting core phrases...\n",
      "Extracting core phrases...\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing documents: 100%|██████████| 4207/4207 [08:46<00:00,  7.99it/s]\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/home/guest/r12922050/miniconda3/envs/d2qplus/lib/python3.9/site-packages/tqdm/auto.py:21: TqdmWarning: IProgress not found. Please update jupyter and ipywidgets. See https://ipywidgets.readthedocs.io/en/stable/user_install.html\n",
      "  from .autonotebook import tqdm as notebook_tqdm\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Processing 4207 documents with 4207 topic assignments\n",
      "Grouping documents by topics...\n",
      "Creating BM25 models for each topic...\n",
      "Grouping documents by topics...\n",
      "Creating BM25 models for each topic...\n",
      "Extracting core phrases...\n",
      "Extracting core phrases...\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing documents: 100%|██████████| 4207/4207 [08:46<00:00,  7.99it/s]\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Core phrases saved to /home/guest/r12922050/GitHub/d2qplus/augmented-data/CSFCube-1.1/keywords/core_phrases_ccqgen.jsonl\n",
      "\n",
      "Example results:\n",
      "\n",
      "Document 7632414:\n",
      "  - 'endpoint projection type' (score: 47828.8412)\n",
      "  - 'parameterised mpi programs' (score: 44512.6552)\n",
      "  - 'dimensions parameterised protocols' (score: 26746.3935)\n",
      "  - 'pabble guarantee safety' (score: 18875.8686)\n",
      "  - 'protocols type checking' (score: 9923.5282)\n",
      "  - 'local protocols type' (score: 7771.4462)\n",
      "\n",
      "Document 143814895:\n",
      "  - 'stylistic variation archaeological' (score: 8.4367)\n",
      "  - 'distinction functional stylistic' (score: 8.4367)\n",
      "  - 'variation defined functional' (score: 7.3520)\n",
      "  - 'conclude case neutral' (score: 5.9623)\n",
      "  - 'simulation processes cultural' (score: 4.1694)\n",
      "  - 'suggested neutral models' (score: 4.1694)\n",
      "\n",
      "Document 62097085:\n",
      "  - 'education projects realized' (score: 26862.4643)\n",
      "  - 'higher education projects' (score: 24264.0732)\n",
      "  - 'innovative ideas lack' (score: 4767.3662)\n",
      "  - 'lack corresponding evaluation' (score: 2584.4696)\n",
      "  - 'realized create greater' (score: 2469.0400)\n",
      "  - 'create greater engagement' (score: 1292.6110)\n"
     ]
    }
   ],
   "source": [
    "import numpy as np\n",
    "import json\n",
    "from keybert import KeyBERT\n",
    "from rank_bm25 import BM25Okapi\n",
    "from sentence_transformers import SentenceTransformer\n",
    "from collections import defaultdict\n",
    "from tqdm import tqdm\n",
    "\n",
    "class CorePhraseExtractor:\n",
    "    \"\"\"\n",
    "    Extract core phrases using the CCQGen methodology with existing topic assignments.\n",
    "    Core phrases are relevant to the document but distinctive within its topic group.\n",
    "    \"\"\"\n",
    "    \n",
    "    def __init__(self, embedding_model=\"allenai/scibert_scivocab_uncased\", device=\"cuda:2\"):\n",
    "        \"\"\"Initialize the extractor with KeyBERT and embedding model.\"\"\"\n",
    "        embedder = SentenceTransformer(embedding_model, device=device)\n",
    "        self.kw_model = KeyBERT(model=embedder)\n",
    "        \n",
    "    def extract_core_phrases(self, corpus, doc_topics, \n",
    "                           top_n_candidates=20, \n",
    "                           selection_ratio=0.2,\n",
    "                           min_phrases_per_doc=1,\n",
    "                           max_phrases_per_doc=8,\n",
    "                           keyphrase_ngram_range=(1, 3),\n",
    "                           use_mmr=True,\n",
    "                           diversity=0.7):\n",
    "        \"\"\"\n",
    "        Extract core phrases for each document using the CCQGen distinctiveness score.\n",
    "        \n",
    "        Args:\n",
    "            corpus: List of documents with '_id' and 'text' keys\n",
    "            doc_topics: List of topic assignments with 'doc_id' and 'topics' keys\n",
    "            top_n_candidates: Number of candidate phrases to extract initially\n",
    "            selection_ratio: Ratio of candidates to select as core phrases (0.2 = top 20%)\n",
    "            min_phrases_per_doc: Minimum number of phrases per document\n",
    "            max_phrases_per_doc: Maximum number of phrases per document\n",
    "            keyphrase_ngram_range: N-gram range for phrase extraction\n",
    "            use_mmr: Use Maximal Marginal Relevance for diversity\n",
    "            diversity: Diversity parameter for MMR (higher = more diverse)\n",
    "        \"\"\"\n",
    "        \n",
    "        # Create document lookup\n",
    "        doc_lookup = {doc['_id']: doc for doc in corpus}\n",
    "        topic_assignment = {item['doc_id']: item['topics'] for item in doc_topics}\n",
    "        \n",
    "        # Group documents by their assigned topics (weighted by topic strength)\n",
    "        print(\"Grouping documents by topics...\")\n",
    "        topic_to_docs = self._group_docs_by_topics(topic_assignment)\n",
    "        \n",
    "        # Create BM25 models for each topic\n",
    "        print(\"Creating BM25 models for each topic...\")\n",
    "        topic_bm25_models = self._create_topic_bm25_models(topic_to_docs, doc_lookup)\n",
    "        \n",
    "        # Extract core phrases for each document\n",
    "        print(\"Extracting core phrases...\")\n",
    "        doc_core_phrases = {}\n",
    "        \n",
    "        for doc_item in tqdm(doc_topics, desc=\"Processing documents\"):\n",
    "            doc_id = doc_item['doc_id']\n",
    "            doc_topics_list = doc_item['topics']\n",
    "            \n",
    "            if doc_id not in doc_lookup:\n",
    "                continue\n",
    "                \n",
    "            doc_text = doc_lookup[doc_id]['text']\n",
    "            \n",
    "            # Extract candidate phrases with improved KeyBERT parameters\n",
    "            candidate_phrases = self.kw_model.extract_keywords(\n",
    "                doc_text,\n",
    "                keyphrase_ngram_range=keyphrase_ngram_range,\n",
    "                stop_words='english',\n",
    "                top_n=top_n_candidates,\n",
    "                use_mmr=use_mmr,\n",
    "                diversity=diversity,  # Higher diversity to avoid redundant phrases\n",
    "                use_maxsum=False,     # MMR is generally better than MaxSum\n",
    "                nr_candidates=top_n_candidates * 2  # More candidates for MMR to choose from\n",
    "            )\n",
    "            \n",
    "            if not candidate_phrases:\n",
    "                doc_core_phrases[doc_id] = []\n",
    "                continue\n",
    "            \n",
    "            # Calculate distinctiveness scores for each candidate\n",
    "            distinctive_phrases = self._calculate_distinctiveness_scores(\n",
    "                candidate_phrases, doc_id, doc_topics_list, \n",
    "                topic_to_docs, topic_bm25_models, doc_lookup\n",
    "            )\n",
    "            \n",
    "            # Select top phrases based on distinctiveness\n",
    "            num_to_select = max(\n",
    "                min_phrases_per_doc,\n",
    "                min(max_phrases_per_doc, int(len(distinctive_phrases) * selection_ratio))\n",
    "            )\n",
    "            \n",
    "            distinctive_phrases.sort(key=lambda x: x[1], reverse=True)\n",
    "            selected_phrases = distinctive_phrases[:num_to_select]\n",
    "            \n",
    "            doc_core_phrases[doc_id] = [\n",
    "                {\"phrase\": phrase, \"distinctiveness_score\": score} \n",
    "                for phrase, score in selected_phrases\n",
    "            ]\n",
    "        \n",
    "        return doc_core_phrases\n",
    "    \n",
    "    def _group_docs_by_topics(self, topic_assignment):\n",
    "        \"\"\"Group documents by their assigned topics, considering topic weights.\"\"\"\n",
    "        topic_to_docs = defaultdict(list)\n",
    "        \n",
    "        for doc_id, topics in topic_assignment.items():\n",
    "            for topic_info in topics:\n",
    "                topic_id = topic_info['topic_id']\n",
    "                weight = topic_info['weight']\n",
    "                topic_to_docs[topic_id].append({\n",
    "                    'doc_id': doc_id,\n",
    "                    'weight': weight\n",
    "                })\n",
    "        \n",
    "        return topic_to_docs\n",
    "    \n",
    "    def _create_topic_bm25_models(self, topic_to_docs, doc_lookup):\n",
    "        \"\"\"Create BM25 models for each topic.\"\"\"\n",
    "        topic_bm25_models = {}\n",
    "        \n",
    "        for topic_id, doc_list in topic_to_docs.items():\n",
    "            # Get document texts for this topic\n",
    "            docs_in_topic = []\n",
    "            for doc_info in doc_list:\n",
    "                doc_id = doc_info['doc_id']\n",
    "                if doc_id in doc_lookup:\n",
    "                    docs_in_topic.append(doc_lookup[doc_id]['text'])\n",
    "            \n",
    "            if len(docs_in_topic) > 1:  # Need at least 2 docs for BM25 comparison\n",
    "                # Tokenize documents for BM25\n",
    "                tokenized_corpus = [doc.lower().split() for doc in docs_in_topic]\n",
    "                topic_bm25_models[topic_id] = {\n",
    "                    'model': BM25Okapi(tokenized_corpus),\n",
    "                    'doc_ids': [doc_info['doc_id'] for doc_info in doc_list if doc_info['doc_id'] in doc_lookup]\n",
    "                }\n",
    "        \n",
    "        return topic_bm25_models\n",
    "    \n",
    "    def _calculate_distinctiveness_scores(self, candidate_phrases, current_doc_id, \n",
    "                                        doc_topics_list, topic_to_docs, \n",
    "                                        topic_bm25_models, doc_lookup):\n",
    "        \"\"\"Calculate distinctiveness scores using CCQGen methodology.\"\"\"\n",
    "        distinctive_phrases = []\n",
    "        \n",
    "        for phrase, relevance_score in candidate_phrases:\n",
    "            # Calculate distinctiveness across all topics this document belongs to\n",
    "            total_distinctiveness = 0.0\n",
    "            total_weight = 0.0\n",
    "            \n",
    "            for topic_info in doc_topics_list:\n",
    "                topic_id = topic_info['topic_id']\n",
    "                topic_weight = topic_info['weight']\n",
    "                \n",
    "                if topic_id not in topic_bm25_models:\n",
    "                    # If topic has insufficient docs for BM25, use relevance score only\n",
    "                    distinctiveness = relevance_score\n",
    "                else:\n",
    "                    bm25_info = topic_bm25_models[topic_id]\n",
    "                    bm25_model = bm25_info['model']\n",
    "                    topic_doc_ids = bm25_info['doc_ids']\n",
    "                    \n",
    "                    # Find current document's position in the topic\n",
    "                    try:\n",
    "                        current_doc_idx = topic_doc_ids.index(current_doc_id)\n",
    "                    except ValueError:\n",
    "                        # Document not found in topic (shouldn't happen)\n",
    "                        distinctiveness = relevance_score\n",
    "                        continue\n",
    "                    \n",
    "                    # Calculate BM25 scores for the phrase across all docs in topic\n",
    "                    tokenized_phrase = phrase.lower().split()\n",
    "                    all_scores = bm25_model.get_scores(tokenized_phrase)\n",
    "                    \n",
    "                    # Current document's BM25 score\n",
    "                    current_score = all_scores[current_doc_idx]\n",
    "                    \n",
    "                    # Sum of exp(BM25) for other documents in topic\n",
    "                    other_scores = np.concatenate([\n",
    "                        all_scores[:current_doc_idx], \n",
    "                        all_scores[current_doc_idx+1:]\n",
    "                    ])\n",
    "                    sum_exp_others = np.sum(np.exp(other_scores))\n",
    "                    \n",
    "                    # CCQGen distinctiveness formula\n",
    "                    distinctiveness = np.exp(current_score) / (1 + sum_exp_others)\n",
    "                \n",
    "                total_distinctiveness += distinctiveness * topic_weight\n",
    "                total_weight += topic_weight\n",
    "            \n",
    "            # Weight-averaged distinctiveness score\n",
    "            final_distinctiveness = total_distinctiveness / total_weight if total_weight > 0 else relevance_score\n",
    "            distinctive_phrases.append((phrase, final_distinctiveness))\n",
    "        \n",
    "        return distinctive_phrases\n",
    "\n",
    "# Usage example with your data\n",
    "def run_core_phrase_extraction():\n",
    "    \"\"\"Run core phrase extraction on your corpus and doc_topics data.\"\"\"\n",
    "    CORPUS_PATH = \"/home/guest/r12922050/GitHub/d2qplus/data/CSFCube-1.1/corpus.jsonl\"\n",
    "    DOC_TOPICS_PATH = \"/home/guest/r12922050/GitHub/d2qplus/augmented-data/CSFCube-1.1/topics/0609-pritamdeka_scibert-biobert-pos-keybert-mmr/doc_topics.jsonl\"\n",
    "\n",
    "    # Load your corpus\n",
    "    with open(CORPUS_PATH, \"r\") as f:\n",
    "        corpus = [json.loads(line) for line in f]\n",
    "    \n",
    "    with open(DOC_TOPICS_PATH, \"r\") as f:\n",
    "        doc_topics = [json.loads(line) for line in f]\n",
    "\n",
    "    print(f\"Processing {len(corpus)} documents with {len(doc_topics)} topic assignments\")\n",
    "    \n",
    "    # Initialize extractor\n",
    "    extractor = CorePhraseExtractor(\n",
    "        embedding_model=\"pritamdeka/S-Scibert-snli-multinli-stsb\",\n",
    "        device=\"cuda:1\"\n",
    "    )\n",
    "    \n",
    "    # Extract core phrases\n",
    "    core_phrases = extractor.extract_core_phrases(\n",
    "        corpus=corpus,\n",
    "        doc_topics=doc_topics,\n",
    "        top_n_candidates=50,      # More candidates for better selection\n",
    "        selection_ratio=0.25,     # Select top 25% most distinctive\n",
    "        min_phrases_per_doc=2,    # At least 2 phrases per document\n",
    "        max_phrases_per_doc=6,    # At most 6 phrases per document\n",
    "        keyphrase_ngram_range=(1, 3),\n",
    "        use_mmr=True,            # Use MMR for diversity\n",
    "        diversity=0.6            # Moderate diversity (0.0=no diversity, 1.0=max diversity)\n",
    "    )\n",
    "    \n",
    "    # Save results\n",
    "    output_path = \"/home/guest/r12922050/GitHub/d2qplus/augmented-data/CSFCube-1.1/keywords/core_phrases_ccqgen.jsonl\"\n",
    "    with open(output_path, \"w\") as f:\n",
    "        for doc_id, phrases in core_phrases.items():\n",
    "            f.write(json.dumps({\"doc_id\": doc_id, \"core_phrases\": phrases}) + \"\\n\")\n",
    "    \n",
    "    print(f\"Core phrases saved to {output_path}\")\n",
    "    \n",
    "    # Show some examples\n",
    "    print(\"\\nExample results:\")\n",
    "    for i, (doc_id, phrases) in enumerate(list(core_phrases.items())[:3]):\n",
    "        print(f\"\\nDocument {doc_id}:\")\n",
    "        for phrase_info in phrases:\n",
    "            print(f\"  - '{phrase_info['phrase']}' (score: {phrase_info['distinctiveness_score']:.4f})\")\n",
    "    \n",
    "    return core_phrases\n",
    "\n",
    "# Run the extraction\n",
    "core_phrases_results = run_core_phrase_extraction()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9defed16",
   "metadata": {},
   "source": [
    "## Core Phrase Extraction using CCQGen Methodology\n",
    "\n",
    "This implementation extracts **distinctive core phrases** for each document based on the CCQGen paper methodology. The goal is to identify phrases that are:\n",
    "1. **Relevant** to the document (high semantic similarity)\n",
    "2. **Distinctive** within the document's topic group (not commonly used by similar documents)\n",
    "\n",
    "### Key Components:\n",
    "\n",
    "**1. Topic-based Document Grouping**\n",
    "- Uses existing topic assignments (no need to re-run BERTopic)\n",
    "- Groups documents by shared topics, weighted by topic strength\n",
    "- Handles multi-topic documents through weighted averaging\n",
    "\n",
    "**2. BM25-based Distinctiveness Scoring**\n",
    "- For each candidate phrase, calculates BM25 relevance across topic group\n",
    "- Applies CCQGen formula: `exp(BM25_current) / (1 + sum(exp(BM25_others)))`\n",
    "- Higher scores = phrase is more distinctive to this document vs. topic peers\n",
    "\n",
    "**3. Enhanced KeyBERT Parameters**\n",
    "- `use_mmr=True` with `diversity=0.6` for non-redundant phrase selection\n",
    "- `nr_candidates=2x` gives MMR more options to choose diverse phrases\n",
    "- N-gram range (1,3) captures single words to 3-word phrases\n",
    "\n",
    "### Output Format:\n",
    "```json\n",
    "{\n",
    "  \"doc_id\": \"123\",\n",
    "  \"core_phrases\": [\n",
    "    {\"phrase\": \"neural architecture search\", \"distinctiveness_score\": 0.847},\n",
    "    {\"phrase\": \"automl\", \"distinctiveness_score\": 0.723}\n",
    "  ]\n",
    "}\n",
    "```\n",
    "\n",
    "**Why this matters:** Standard keyword extraction might return \"deep learning\" for all ML papers, but this approach finds phrases like \"federated learning\" or \"graph neural networks\" that are specific to individual documents within the ML topic."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "e3d723d3",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Document ID: 1177419\n",
      "Text: We present an architecture and an on-line learning algorithm and apply it to the problem of part-of-speech tagging. The architecture presented, SNOW, is a network of linear separators in the feature space, utilizing the Winnow update algorithm.Multiplicative weight-update algorithms such as Winnow have been shown to have exceptionally good behavior when applied to very high dimensional problems, and especially when the target concepts depend on only a small subset of the features in the feature space. In this paper we describe an architecture that utilizes this mistake-driven algorithm for multi-class prediction-selecting the part of speech of a word. The experimental analysis presented here provides more evidence to that these algorithms are suitable for natural language problems.The algorithm used is an on-line algorithm: every example is used by the algorithm only once, and is then discarded. This has significance in terms of efficiency, as well as quick adaptation to new contexts.We present an extensive experimental study of our algorithm under various conditions; in particular, it is shown that the algorithm performs comparably to the best known algorithms for POS.\n",
      "Core Phrases:\n",
      "  - 'architecture presented snow' (score: 0.4894)\n",
      "  - 'tagging architecture presented' (score: 0.4493)\n",
      "  - 'learning algorithm' (score: 0.4476)\n",
      "  - 'snow network linear' (score: 0.4209)\n",
      "  - 'algorithms suitable' (score: 0.4191)\n",
      "  - 'known algorithms pos' (score: 0.3874)\n",
      "\n",
      "\n",
      "Document ID: 2420674\n",
      "Text: Parallel texts (bitexts) have properties that distinguish them from other kinds of parallel data. First, most words translate to only one other word. Second, bitext correspondence is typically only partialmany words in each text have no clear equivalent in the other text. This article presents methods for biasing statistical translation models to reflect these properties. Evaluation with respect to independent human judgments has confirmed that translation models biased in this fashion are significantly more accurate than a baseline knowledge-free model. This article also shows how a statistical translation model can take advantage of preexisting knowledge that might be available about particular language pairs. Even the simplest kinds of language-specific knowledge, such as the distinction between content words and function words, are shown to reliably boost translation model performance on some tasks. Statistical models that reflect knowledge about the model domain combine the best of both the rationalist and empiricist paradigms.\n",
      "Core Phrases:\n",
      "  - 'distinguish kinds parallel' (score: 92.5002)\n",
      "  - 'bitext correspondence typically' (score: 40.9751)\n",
      "  - 'correspondence typically partialmany' (score: 40.9751)\n",
      "  - 'shown reliably boost' (score: 36.8001)\n",
      "  - 'clear equivalent text' (score: 35.4338)\n",
      "  - 'simplest kinds language' (score: 35.1979)\n",
      "\n",
      "\n",
      "Document ID: 10058082\n",
      "Text: We study the self-organization of the consonant inventories through a complex network approach. We observe that the distribution of occurrence as well as cooccurrence of the consonants across languages follow a power-law behavior. The co-occurrence network of consonants exhibits a high clustering coefficient. We propose four novel synthesis models for these networks (each of which is a refinement of the earlier) so as to successively match with higher accuracy (a) the above mentioned topological properties as well as (b) the linguistic property of feature economy exhibited by the consonant inventories. We conclude by arguing that a possible interpretation of this mechanism of network growth is the process of child language acquisition. Such models essentially increase our understanding of the structure of languages that is influenced by their evolutionary dynamics and this, in turn, can be extremely useful for building future NLP applications.\n",
      "Core Phrases:\n",
      "  - 'cooccurrence consonants languages' (score: 242.6805)\n",
      "  - 'economy exhibited consonant' (score: 110.8734)\n",
      "  - 'consonants exhibits high' (score: 110.7936)\n",
      "  - 'consonant inventories complex' (score: 78.1789)\n",
      "  - 'occurrence network consonants' (score: 77.4794)\n",
      "  - 'structure languages influenced' (score: 76.5033)\n",
      "\n",
      "\n",
      "Document ID: 2410895\n",
      "Text: BackgroundBioinformatics tools for automatic processing of biomedical literature are invaluable for both the design and interpretation of large-scale experiments. Many information extraction (IE) systems that incorporate natural language processing (NLP) techniques have thus been developed for use in the biomedical field. A key IE task in this field is the extraction of biomedical relations, such as protein-protein and gene-disease interactions. However, most biomedical relation extraction systems usually ignore adverbial and prepositional phrases and words identifying location, manner, timing, and condition, which are essential for describing biomedical relations. Semantic role labeling (SRL) is a natural language processing technique that identifies the semantic roles of these words or phrases in sentences and expresses them as predicate-argument structures. We construct a biomedical SRL system called BIOSMILE that uses a maximum entropy (ME) machine-learning model to extract biomedical relations. BIOSMILE is trained on BioProp, our semi-automatic, annotated biomedical proposition bank. Currently, we are focusing on 30 biomedical verbs that are frequently used or considered important for describing molecular events.ResultsTo evaluate the performance of BIOSMILE, we conducted two experiments to (1) compare the performance of SRL systems trained on newswire and biomedical corpora; and (2) examine the effects of using biomedical-specific features. The experimental results show that using BioProp improves the F-score of the SRL system by 21.45% over an SRL system that uses a newswire corpus. It is noteworthy that adding automatically generated template features improves the overall F-score by a further 0.52%. Specifically, ArgM-LOC, ArgM-MNR, and Arg2 achieve statistically significant performance improvements of 3.33%, 2.27%, and 1.44%, respectively.ConclusionWe demonstrate the necessity of using a biomedical proposition bank for training SRL systems in the biomedical domain. Besides the different characteristics of biomedical and newswire sentences, factors such as cross-domain framesets and verb usage variations also influence the performance of SRL systems. For argument classification, we find that NE (named entity) features indicating if the target node matches with NEs are not effective, since NEs may match with a node of the parsing tree that does not have semantic role labels in the training set. We therefore incorporate templates composed of specific words, NE types, and POS tags into the SRL system. As a result, the classification accuracy for adjunct arguments, which is especially important for biomedical SRL, is improved significantly.\n",
      "Core Phrases:\n",
      "  - 'biosmile uses maximum' (score: 58.6072)\n",
      "  - 'match node parsing' (score: 44.8193)\n",
      "  - 'incorporate templates composed' (score: 17.0622)\n",
      "  - '30 biomedical verbs' (score: 14.1012)\n",
      "  - 'prepositional phrases words' (score: 11.1328)\n",
      "  - 'especially important biomedical' (score: 9.7295)\n",
      "\n",
      "\n",
      "Document ID: 14688775\n",
      "Text: AbstractAutomatic sentiment classification has been extensively studied and applied in recent years. However, sentiment is expressed differently in different domains, and annotating corpora for every possible domain of interest is impractical. We investigate domain adaptation for sentiment classifiers, focusing on online reviews for different types of products. First, we extend to sentiment classification the recently-proposed structural correspondence learning (SCL) algorithm, reducing the relative error due to adaptation between domains by an average of 30% over the original SCL algorithm and 46% over a supervised baseline. Second, we identify a measure of domain similarity that correlates well with the potential for adaptation of a classifier from one domain to another. This measure could for instance be used to select a small set of domains to annotate whose trained classifiers would transfer well to many other domains.\n",
      "Core Phrases:\n",
      "  - 'reducing relative error' (score: 8920.3796)\n",
      "  - 'investigate domain adaptation' (score: 5713.4630)\n",
      "  - 'potential adaptation classifier' (score: 1279.0918)\n",
      "  - 'domains annotating corpora' (score: 407.6700)\n",
      "  - 'domain adaptation sentiment' (score: 391.7397)\n",
      "  - 'classification extensively studied' (score: 160.6423)\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "with open(\"/home/guest/r12922050/GitHub/d2qplus/augmented-data/CSFCube-1.1/keywords/core_phrases_ccqgen.jsonl\", \"r\") as f:\n",
    "    core_phrases = [json.loads(line) for line in f]\n",
    "\n",
    "CORPUS_PATH = \"/home/guest/r12922050/GitHub/d2qplus/data/CSFCube-1.1/corpus.jsonl\"\n",
    "with open(CORPUS_PATH, \"r\") as f:\n",
    "    corpus = [json.loads(line) for line in f]\n",
    "\n",
    "docid2text = {doc[\"_id\"]: doc[\"text\"] for doc in corpus}\n",
    "\n",
    "# random pick 5 objects in core_phrases\n",
    "import random\n",
    "random.seed(42)  # For reproducibility\n",
    "sampled_core_phrases = random.sample(core_phrases, 5)\n",
    "for item in sampled_core_phrases:\n",
    "    doc_id = item[\"doc_id\"]\n",
    "    phrases = item[\"core_phrases\"]\n",
    "    print(f\"Document ID: {doc_id}\")\n",
    "    print(f\"Text: {docid2text[doc_id]}\")  # Print first 200 chars of text\n",
    "    print(\"Core Phrases:\")\n",
    "    for phrase_info in phrases:\n",
    "        print(f\"  - '{phrase_info['phrase']}' (score: {phrase_info['distinctiveness_score']:.4f})\")\n",
    "    print(\"\\n\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "62361e27",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Initializing KeyBERT model...\n",
      "Loaded 3633 documents\n",
      "Extracting candidate keywords...\n",
      "Loaded 3633 documents\n",
      "Extracting candidate keywords...\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing documents: 100%|██████████| 3633/3633 [06:37<00:00,  9.14it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Saved candidate keywords to /home/guest/r12922050/GitHub/d2qplus/augmented-data/nfcorpus/keywords/candidate_keywords_scibert.pkl\n",
      "Total documents processed: 3633\n",
      "\n",
      "Example results:\n",
      "\n",
      "Document MED-10:\n",
      "  - 'statins effect' (score: 0.6204)\n",
      "  - 'death statin' (score: 0.4759)\n",
      "  - 'cardiovascular mortality' (score: 0.4394)\n",
      "  - 'breast cancer' (score: 0.3747)\n",
      "  - 'cancer adjustment' (score: 0.3045)\n",
      "\n",
      "Document MED-14:\n",
      "  - 'investigated statins' (score: 0.6421)\n",
      "  - 'mortality statin' (score: 0.5900)\n",
      "  - 'simvastatin prevent' (score: 0.5744)\n",
      "  - 'reduced mortality' (score: 0.4262)\n",
      "  - 'regression models' (score: 0.3913)\n",
      "\n",
      "Document MED-118:\n",
      "  - 'op concentrations' (score: 0.5007)\n",
      "  - 'octylphenol op' (score: 0.4318)\n",
      "  - 'women consumed' (score: 0.4056)\n",
      "  - 'including mothers' (score: 0.3853)\n",
      "  - 'higher op' (score: 0.3844)\n"
     ]
    }
   ],
   "source": [
    "import pickle\n",
    "import os\n",
    "from keybert import KeyBERT\n",
    "from sentence_transformers import SentenceTransformer\n",
    "import json\n",
    "from tqdm import tqdm\n",
    "\n",
    "# Initialize KeyBERT with SciBERT model\n",
    "print(\"Initializing KeyBERT model...\")\n",
    "embedder = SentenceTransformer(\"pritamdeka/S-Scibert-snli-multinli-stsb\", device=\"cuda:1\")\n",
    "kw_model = KeyBERT(model=embedder)\n",
    "\n",
    "# Load corpus\n",
    "CORPUS_PATH = \"/home/guest/r12922050/GitHub/d2qplus/data/nfcorpus/corpus.jsonl\"\n",
    "with open(CORPUS_PATH, \"r\") as f:\n",
    "    corpus = [json.loads(line) for line in f]\n",
    "\n",
    "print(f\"Loaded {len(corpus)} documents\")\n",
    "\n",
    "# Parameters for keyword extraction\n",
    "keyphrase_ngram_range = (1, 2)\n",
    "top_n_candidates = 50\n",
    "use_mmr = True\n",
    "diversity = 0.6\n",
    "\n",
    "# Extract candidate keywords for all documents\n",
    "candidate_keywords = {}\n",
    "print(\"Extracting candidate keywords...\")\n",
    "\n",
    "for doc in tqdm(corpus, desc=\"Processing documents\"):\n",
    "    doc_id = doc[\"_id\"]\n",
    "    doc_text = doc[\"text\"]\n",
    "    \n",
    "    # Extract candidate phrases\n",
    "    candidate_phrases = kw_model.extract_keywords(\n",
    "        doc_text,\n",
    "        keyphrase_ngram_range=keyphrase_ngram_range,\n",
    "        stop_words='english',\n",
    "        top_n=top_n_candidates,\n",
    "        use_mmr=use_mmr,\n",
    "        diversity=diversity,\n",
    "        use_maxsum=False,\n",
    "        nr_candidates=top_n_candidates * 2\n",
    "    )\n",
    "    \n",
    "    candidate_keywords[doc_id] = candidate_phrases\n",
    "\n",
    "# Save to pickle file\n",
    "output_dir = \"/home/guest/r12922050/GitHub/d2qplus/augmented-data/nfcorpus/keywords\"\n",
    "os.makedirs(output_dir, exist_ok=True)\n",
    "pickle_path = os.path.join(output_dir, \"candidate_keywords_scibert.pkl\")\n",
    "\n",
    "with open(pickle_path, \"wb\") as f:\n",
    "    pickle.dump(candidate_keywords, f)\n",
    "\n",
    "print(f\"Saved candidate keywords to {pickle_path}\")\n",
    "print(f\"Total documents processed: {len(candidate_keywords)}\")\n",
    "\n",
    "# Show example results\n",
    "print(\"\\nExample results:\")\n",
    "sample_doc_ids = list(candidate_keywords.keys())[:3]\n",
    "for doc_id in sample_doc_ids:\n",
    "    print(f\"\\nDocument {doc_id}:\")\n",
    "    keywords = candidate_keywords[doc_id][:5]  # Show top 5\n",
    "    for phrase, score in keywords:\n",
    "        print(f\"  - '{phrase}' (score: {score:.4f})\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "eb3ce7b6",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'MED-10': [('statins effect', 0.6204),\n",
       "  ('death statin', 0.4759),\n",
       "  ('cardiovascular mortality', 0.4394),\n",
       "  ('breast cancer', 0.3747),\n",
       "  ('cancer adjustment', 0.3045),\n",
       "  ('specific mortality', 0.2945),\n",
       "  ('mortality remains', 0.2903),\n",
       "  ('effect disease', 0.2817),\n",
       "  ('finland 1995', 0.2737),\n",
       "  ('based cohort', 0.273),\n",
       "  ('group prevention', 0.2649),\n",
       "  ('hazards regression', 0.2611),\n",
       "  ('patients study', 0.2466),\n",
       "  ('recurrence effect', 0.2428),\n",
       "  ('characteristics treatment', 0.2367),\n",
       "  ('possible causal', 0.2347),\n",
       "  ('1995 2003', 0.2238),\n",
       "  ('national prescription', 0.2102),\n",
       "  ('evaluated risk', 0.2092),\n",
       "  ('drug group', 0.204),\n",
       "  ('recent studies', 0.2023),\n",
       "  ('survival benefit', 0.2012),\n",
       "  ('participants died', 0.198),\n",
       "  ('95 ci', 0.1952),\n",
       "  ('remains unclear', 0.1867),\n",
       "  ('dose dependent', 0.1797),\n",
       "  ('adherer bias', 0.171),\n",
       "  ('used cox', 0.1568),\n",
       "  ('619 60', 0.1507),\n",
       "  ('151 participants', 0.1471),\n",
       "  ('236 cases', 0.1454),\n",
       "  ('newly diagnosed', 0.1359),\n",
       "  ('2003 31', 0.1309),\n",
       "  ('delay prevent', 0.1228),\n",
       "  ('median follow', 0.1223),\n",
       "  ('low dose', 0.1194),\n",
       "  ('time dependence', 0.1191),\n",
       "  ('association clearly', 0.118),\n",
       "  ('cases identified', 0.1101),\n",
       "  ('hr 54', 0.0967),\n",
       "  ('patients discontinue', 0.0889),\n",
       "  ('users suggests', 0.0815),\n",
       "  ('database used', 0.0723),\n",
       "  ('term use', 0.0515),\n",
       "  ('greater likelihood', 0.0487),\n",
       "  ('25 years', 0.0481),\n",
       "  ('67 respectively', -0.0113),\n",
       "  ('38', -0.0169),\n",
       "  ('08 years', -0.0461),\n",
       "  ('affected healthy', -0.0575)],\n",
       " 'MED-14': [('investigated statins', 0.6421),\n",
       "  ('mortality statin', 0.59),\n",
       "  ('simvastatin prevent', 0.5744),\n",
       "  ('reduced mortality', 0.4262),\n",
       "  ('regression models', 0.3913),\n",
       "  ('cancer reduced', 0.3739),\n",
       "  ('models investigated', 0.3026),\n",
       "  ('mortality data', 0.2964),\n",
       "  ('methods cohort', 0.2867),\n",
       "  ('breast cancer', 0.2839),\n",
       "  ('prescription records', 0.2766),\n",
       "  ('patients methods', 0.2736),\n",
       "  ('studies shown', 0.2662),\n",
       "  ('cancer registries', 0.2647),\n",
       "  ('associations weak', 0.2519),\n",
       "  ('hazard ratios', 0.2304),\n",
       "  ('animal models', 0.2191),\n",
       "  ('prevent growth', 0.205),\n",
       "  ('sensitivity analyses', 0.2021),\n",
       "  ('propensity score', 0.1811),\n",
       "  ('background preclinical', 0.1783),\n",
       "  ('approach results', 0.1754),\n",
       "  ('research datalink', 0.1667),\n",
       "  ('cell lines', 0.1648),\n",
       "  ('cohort 17', 0.1608),\n",
       "  ('practice research', 0.1495),\n",
       "  ('multiple imputation', 0.149),\n",
       "  ('data 2013', 0.1441),\n",
       "  ('control approach', 0.1414),\n",
       "  ('statistics', 0.1412),\n",
       "  ('04', 0.1398),\n",
       "  ('causes fully', 0.1331),\n",
       "  ('cox', 0.1326),\n",
       "  ('use diagnosis', 0.1322),\n",
       "  ('identifying 3694', 0.127),\n",
       "  ('1469 deaths', 0.1171),\n",
       "  ('associations marked', 0.1138),\n",
       "  ('attenuated', 0.0979),\n",
       "  ('uk clinical', 0.0973),\n",
       "  ('unadjusted adjusted', 0.0922),\n",
       "  ('users', 0.092),\n",
       "  ('95 confidence', 0.0901),\n",
       "  ('using time', 0.0732),\n",
       "  ('79 63', 0.0584),\n",
       "  ('including', 0.0479),\n",
       "  ('2009 identified', 0.039),\n",
       "  ('880', -0.0352),\n",
       "  ('large population', -0.0476),\n",
       "  ('office national', -0.063),\n",
       "  ('identified english', -0.0834)],\n",
       " 'MED-118': [('op concentrations', 0.5007),\n",
       "  ('octylphenol op', 0.4318),\n",
       "  ('women consumed', 0.4056),\n",
       "  ('including mothers', 0.3853),\n",
       "  ('higher op', 0.3844),\n",
       "  ('np concentration', 0.3842),\n",
       "  ('nonylphenol', 0.3532),\n",
       "  ('np op', 0.3163),\n",
       "  ('cooking oil', 0.3136),\n",
       "  ('women', 0.2996),\n",
       "  ('milk samples', 0.2889),\n",
       "  ('consumption nursing', 0.2722),\n",
       "  ('infants np', 0.272),\n",
       "  ('01 fish', 0.2479),\n",
       "  ('concentration significantly', 0.2354),\n",
       "  ('ng consumed', 0.2293),\n",
       "  ('oil beta', 0.2282),\n",
       "  ('bmi np', 0.2237),\n",
       "  ('01 processed', 0.2223),\n",
       "  ('significantly higher', 0.2213),\n",
       "  ('concentrations 98', 0.219),\n",
       "  ('samples examine', 0.2181),\n",
       "  ('processed fish', 0.2068),\n",
       "  ('exposure', 0.2042),\n",
       "  ('aims study', 0.2009),\n",
       "  ('exposure 2010', 0.2008),\n",
       "  ('associated consumption', 0.1983),\n",
       "  ('products factor', 0.1968),\n",
       "  ('pattern cooking', 0.1945),\n",
       "  ('related factors', 0.1906),\n",
       "  ('59 human', 0.1864),\n",
       "  ('factor analysis', 0.1817),\n",
       "  ('39 01', 0.1725),\n",
       "  ('38', 0.1721),\n",
       "  ('consumed median', 0.1675),\n",
       "  ('suggesting foods', 0.1529),\n",
       "  ('meat products', 0.1229),\n",
       "  ('05 determinations', 0.121),\n",
       "  ('determinations aid', 0.1054),\n",
       "  ('habits', 0.0973),\n",
       "  ('beta 62', 0.0951),\n",
       "  ('age body', 0.0907),\n",
       "  ('demographics', 0.0638),\n",
       "  ('strongly', 0.0591),\n",
       "  ('capsules', 0.0449),\n",
       "  ('protect', 0.0118),\n",
       "  ('order', -0.0028),\n",
       "  ('mass', -0.0159),\n",
       "  ('human', -0.0211),\n",
       "  ('elsevier rights', -0.0287)],\n",
       " 'MED-301': [('etiology epilepsy', 0.7017),\n",
       "  ('linked epileptogenesis', 0.6638),\n",
       "  ('epileptogenesis review', 0.6399),\n",
       "  ('epilepsy cases', 0.6117),\n",
       "  ('susceptibility seizures', 0.5847),\n",
       "  ('epileptogenesis mini', 0.5224),\n",
       "  ('seizures discusses', 0.5219),\n",
       "  ('seizures increased', 0.4835),\n",
       "  ('changes seizure', 0.482),\n",
       "  ('neurological diseases', 0.4386),\n",
       "  ('role etiology', 0.4322),\n",
       "  ('display epileptic', 0.418),\n",
       "  ('gene environment', 0.4064),\n",
       "  ('disorder common', 0.4047),\n",
       "  ('brain injury', 0.388),\n",
       "  ('mechanisms underlying', 0.3789),\n",
       "  ('neurotoxicant', 0.378),\n",
       "  ('diseases humans', 0.3761),\n",
       "  ('glutamatergic', 0.3646),\n",
       "  ('mutations ion', 0.3642),\n",
       "  ('animals seizures', 0.3564),\n",
       "  ('factors brain', 0.3497),\n",
       "  ('environmental chemicals', 0.3374),\n",
       "  ('susceptibility humans', 0.3348),\n",
       "  ('important risk', 0.3036),\n",
       "  ('induced changes', 0.2933),\n",
       "  ('developmental exposure', 0.2869),\n",
       "  ('mehg induced', 0.2786),\n",
       "  ('highlights effects', 0.2648),\n",
       "  ('unknown gene', 0.253),\n",
       "  ('review proposes', 0.2471),\n",
       "  ('injury linked', 0.2459),\n",
       "  ('channels receptors', 0.2424),\n",
       "  ('nervous', 0.2116),\n",
       "  ('cns patients', 0.2072),\n",
       "  ('disinhibition', 0.1843),\n",
       "  ('interactions', 0.1797),\n",
       "  ('cases remains', 0.1722),\n",
       "  ('gabaergic leading', 0.1691),\n",
       "  ('function potential', 0.1506),\n",
       "  ('targets primarily', 0.1326),\n",
       "  ('play critical', 0.1058),\n",
       "  ('acute chronic', 0.0882),\n",
       "  ('thought', 0.0675),\n",
       "  ('patients', 0.0576),\n",
       "  ('increased', 0.0535),\n",
       "  ('low level', 0.0533),\n",
       "  ('majority', -0.0144),\n",
       "  ('humans animals', -0.0152),\n",
       "  ('proposes preferential', -0.0661)],\n",
       " 'MED-306': [('cognitive processing', 0.5415),\n",
       "  ('latencies hrt', 0.4989),\n",
       "  ('processing latencies', 0.4918),\n",
       "  ('reaction time', 0.483),\n",
       "  ('test results', 0.4303),\n",
       "  ('different neuropsychological', 0.4219),\n",
       "  ('learning habituation', 0.361),\n",
       "  ('intervals confounder', 0.3361),\n",
       "  ('developmental', 0.3346),\n",
       "  ('cpt measure', 0.3276),\n",
       "  ('biomarkers prenatal', 0.3268),\n",
       "  ('findings suggest', 0.3129),\n",
       "  ('rt outcomes', 0.3099),\n",
       "  ('visual targets', 0.301),\n",
       "  ('hit reaction', 0.29),\n",
       "  ('methylmercury exposures', 0.2884),\n",
       "  ('measure neurotoxicity', 0.2855),\n",
       "  ('performance', 0.2854),\n",
       "  ('minute interval', 0.2767),\n",
       "  ('dysfunction', 0.2761),\n",
       "  ('initiation orientation', 0.273),\n",
       "  ('sustained attention', 0.2662),\n",
       "  ('possible measure', 0.2656),\n",
       "  ('adjustment regression', 0.2538),\n",
       "  ('exposure 41', 0.2489),\n",
       "  ('speed included', 0.2333),\n",
       "  ('examined association', 0.2219),\n",
       "  ('exposures did', 0.2187),\n",
       "  ('involve different', 0.2098),\n",
       "  ('included models', 0.2083),\n",
       "  ('particularly vulnerable', 0.2066),\n",
       "  ('presented 1000', 0.203),\n",
       "  ('frontal lobes', 0.1947),\n",
       "  ('39 pattern', 0.1841),\n",
       "  ('recorded', 0.1782),\n",
       "  ('associated increased', 0.1665),\n",
       "  ('domain particularly', 0.1663),\n",
       "  ('10 minutes', 0.1617),\n",
       "  ('64', 0.1613),\n",
       "  ('14 years', 0.1578),\n",
       "  ('overall average', 0.1516),\n",
       "  ('cohort members', 0.1451),\n",
       "  ('beta se', 0.1237),\n",
       "  ('tapping', 0.101),\n",
       "  ('18', 0.0991),\n",
       "  ('years', 0.0988),\n",
       "  ('06', 0.09),\n",
       "  ('unchanged', 0.0671),\n",
       "  ('dominant demand', 0.0097),\n",
       "  ('total 878', -0.0101)],\n",
       " 'MED-329': [('elevated phosphate', 0.5969),\n",
       "  ('vascular calcification', 0.5923),\n",
       "  ('ckd increased', 0.5836),\n",
       "  ('ckd mbd', 0.4826),\n",
       "  ('disease mineral', 0.4779),\n",
       "  ('dysregulated calcium', 0.4637),\n",
       "  ('cardiovascular changes', 0.4558),\n",
       "  ('chronic kidney', 0.4478),\n",
       "  ('calcium parathyroid', 0.4325),\n",
       "  ('raised mortality', 0.4265),\n",
       "  ('bone disease', 0.4193),\n",
       "  ('advanced renal', 0.4116),\n",
       "  ('disturbances fgf', 0.4104),\n",
       "  ('dialysis high', 0.4078),\n",
       "  ('arterial stiffness', 0.4037),\n",
       "  ('risk factor', 0.3749),\n",
       "  ('adverse vascular', 0.364),\n",
       "  ('complex chronic', 0.3535),\n",
       "  ('mortality vessels', 0.2964),\n",
       "  ('levels adverse', 0.28),\n",
       "  ('klotho raised', 0.2777),\n",
       "  ('effect increasing', 0.2716),\n",
       "  ('children dialysis', 0.2674),\n",
       "  ('epidemiological studies', 0.2673),\n",
       "  ('aging data', 0.2672),\n",
       "  ('failure dysregulated', 0.263),\n",
       "  ('disease', 0.2566),\n",
       "  ('associated premature', 0.2493),\n",
       "  ('levels contribute', 0.2329),\n",
       "  ('association raised', 0.231),\n",
       "  ('fibroblast growth', 0.2066),\n",
       "  ('effects maintaining', 0.2054),\n",
       "  ('000 fold', 0.2021),\n",
       "  ('significant independent', 0.1868),\n",
       "  ('develop extensive', 0.1854),\n",
       "  ('data suggest', 0.1833),\n",
       "  ('vasculature leading', 0.1832),\n",
       "  ('function high', 0.1823),\n",
       "  ('thickness', 0.1671),\n",
       "  ('maintaining serum', 0.1646),\n",
       "  ('excretion', 0.1608),\n",
       "  ('develop apoptosis', 0.1552),\n",
       "  ('binders', 0.1545),\n",
       "  ('conditions vitro', 0.1291),\n",
       "  ('improved survival', 0.1091),\n",
       "  ('patients demonstrate', 0.1068),\n",
       "  ('triggers release', 0.1004),\n",
       "  ('range reduces', 0.1003),\n",
       "  ('23 receptor', 0.0909),\n",
       "  ('subjects normal', 0.0404)],\n",
       " 'MED-330': [('hyperphosphatemia contribute', 0.6487),\n",
       "  ('dietary phosphorus', 0.527),\n",
       "  ('endothelial dysfunction', 0.4809),\n",
       "  ('cardiovascular risk', 0.4363),\n",
       "  ('increase cardiovascular', 0.432),\n",
       "  ('increased serum', 0.3804),\n",
       "  ('load increased', 0.3526),\n",
       "  ('determine postprandial', 0.3274),\n",
       "  ('synthase phosphorus', 0.3002),\n",
       "  ('high dietary', 0.2954),\n",
       "  ('phosphate transporters', 0.2676),\n",
       "  ('kidney', 0.2492),\n",
       "  ('endothelial cells', 0.2452),\n",
       "  ('mechanisms underlying', 0.2356),\n",
       "  ('morbidity mortality', 0.2276),\n",
       "  ('vasodilation rat', 0.2116),\n",
       "  ('phosphorylation', 0.1986),\n",
       "  ('influx sodium', 0.1946),\n",
       "  ('artery meals', 0.1944),\n",
       "  ('patients chronic', 0.1871),\n",
       "  ('dilation flow', 0.186),\n",
       "  ('study measured', 0.1755),\n",
       "  ('measured flow', 0.1742),\n",
       "  ('dysfunction investigated', 0.1674),\n",
       "  ('disease', 0.1612),\n",
       "  ('risk healthy', 0.1609),\n",
       "  ('acute effect', 0.1597),\n",
       "  ('production reactive', 0.1528),\n",
       "  ('inversely serum', 0.1494),\n",
       "  ('oxygen species', 0.1388),\n",
       "  ('decreased nitric', 0.1263),\n",
       "  ('understood determine', 0.1239),\n",
       "  ('loading inhibited', 0.1171),\n",
       "  ('level', 0.1097),\n",
       "  ('bovine aortic', 0.0915),\n",
       "  ('400', 0.0897),\n",
       "  ('contribute relationship', 0.0879),\n",
       "  ('species depended', 0.0857),\n",
       "  ('brachial', 0.0844),\n",
       "  ('vitro vivo', 0.0783),\n",
       "  ('11 healthy', 0.0763),\n",
       "  ('1200 mg', 0.0714),\n",
       "  ('exposing', 0.071),\n",
       "  ('taken findings', 0.0683),\n",
       "  ('significantly', 0.0444),\n",
       "  ('double', 0.0032),\n",
       "  ('men alternately', 0.0027),\n",
       "  ('containing', -0.0025),\n",
       "  ('completely understood', -0.005),\n",
       "  ('blind crossover', -0.0898)],\n",
       " 'MED-332': [('toxicity phosphorus', 0.6114),\n",
       "  ('increasing phosphorus', 0.5348),\n",
       "  ('regulation phosphate', 0.4899),\n",
       "  ('databases phosphorus', 0.4695),\n",
       "  ('inaccuracies nutrient', 0.4342),\n",
       "  ('impaired kidney', 0.4207),\n",
       "  ('bone loss', 0.3955),\n",
       "  ('impact increasing', 0.3819),\n",
       "  ('diet renal', 0.3771),\n",
       "  ('disordered mineral', 0.3743),\n",
       "  ('disrupt hormonal', 0.3639),\n",
       "  ('american diet', 0.3547),\n",
       "  ('exceeds nutrient', 0.3539),\n",
       "  ('parathyroid hormone', 0.3522),\n",
       "  ('osteoporosis systematically', 0.3437),\n",
       "  ('potential adverse', 0.3284),\n",
       "  ('associated cardiovascular', 0.3259),\n",
       "  ('disordered regulation', 0.3194),\n",
       "  ('intakes', 0.3082),\n",
       "  ('review explores', 0.3054),\n",
       "  ('failure cvd', 0.3042),\n",
       "  ('changes serum', 0.2983),\n",
       "  ('calcium vitamin', 0.2932),\n",
       "  ('design inaccuracies', 0.2849),\n",
       "  ('metabolism', 0.2662),\n",
       "  ('calcification', 0.2525),\n",
       "  ('tissue damage', 0.2507),\n",
       "  ('processed foods', 0.242),\n",
       "  ('regulation extracellular', 0.2372),\n",
       "  ('populations evidence', 0.2208),\n",
       "  ('disease', 0.2195),\n",
       "  ('population significantly', 0.2141),\n",
       "  ('variety mechanisms', 0.2054),\n",
       "  ('23 parathyroid', 0.2034),\n",
       "  ('loss large', 0.2031),\n",
       "  ('hormones high', 0.1866),\n",
       "  ('cumulative use', 0.1846),\n",
       "  ('needs', 0.1835),\n",
       "  ('composition databases', 0.1783),\n",
       "  ('increasingly studies', 0.1704),\n",
       "  ('underestimated national', 0.1589),\n",
       "  ('general population', 0.1538),\n",
       "  ('consumption highly', 0.1488),\n",
       "  ('risk healthy', 0.1457),\n",
       "  ('fibroblast growth', 0.1279),\n",
       "  ('highly processed', 0.1112),\n",
       "  ('excess linked', 0.1026),\n",
       "  ('nature', 0.0996),\n",
       "  ('intake mild', 0.0906),\n",
       "  ('especially restaurant', 0.0526)],\n",
       " 'MED-334': [('sources phosphorus', 0.6523),\n",
       "  ('absorbability foods', 0.4888),\n",
       "  ('plant foods', 0.4765),\n",
       "  ('foods methods', 0.4625),\n",
       "  ('digestible dp', 0.4527),\n",
       "  ('tp content', 0.4514),\n",
       "  ('absorbability differ', 0.4407),\n",
       "  ('foods lacking', 0.3849),\n",
       "  ('tp different', 0.3377),\n",
       "  ('phosphate leavening', 0.317),\n",
       "  ('cereal products', 0.312),\n",
       "  ('important sources', 0.2957),\n",
       "  ('objective plant', 0.2916),\n",
       "  ('lacking measurement', 0.2905),\n",
       "  ('analysis samples', 0.2472),\n",
       "  ('21 foods', 0.237),\n",
       "  ('38 tp', 0.233),\n",
       "  ('previous conclusions', 0.2171),\n",
       "  ('enzymatically principle', 0.2125),\n",
       "  ('legumes relatively', 0.21),\n",
       "  ('relatively poor', 0.2067),\n",
       "  ('current data', 0.2011),\n",
       "  ('proportion', 0.1989),\n",
       "  ('drinks plant', 0.1984),\n",
       "  ('contents selected', 0.1982),\n",
       "  ('alimentary canal', 0.1914),\n",
       "  ('highest tp', 0.179),\n",
       "  ('study measure', 0.1727),\n",
       "  ('measured inductively', 0.1502),\n",
       "  ('cola', 0.1415),\n",
       "  ('kidney foundation', 0.1339),\n",
       "  ('contain sodium', 0.1227),\n",
       "  ('vitro', 0.1132),\n",
       "  ('despite high', 0.1121),\n",
       "  ('sesame seeds', 0.1119),\n",
       "  ('100 13', 0.1033),\n",
       "  ('667 mg', 0.1006),\n",
       "  ('present industrial', 0.0971),\n",
       "  ('additives copyright', 0.0761),\n",
       "  ('coupled plasma', 0.0759),\n",
       "  ('2012 national', 0.061),\n",
       "  ('muffins contain', 0.0574),\n",
       "  ('brands', 0.039),\n",
       "  ('optical emission', 0.0357),\n",
       "  ('hull', 0.0331),\n",
       "  ('published elsevier', 0.0121),\n",
       "  ('rights reserved', 0.0006),\n",
       "  ('216', -0.0118),\n",
       "  ('high supports', -0.0164),\n",
       "  ('leavening agent', -0.0731)],\n",
       " 'MED-335': [('dietary phosphorus', 0.5974),\n",
       "  ('objective meat', 0.5227),\n",
       "  ('foods methods', 0.4539),\n",
       "  ('cheese meat', 0.4521),\n",
       "  ('dietary', 0.4329),\n",
       "  ('protein ratios', 0.42),\n",
       "  ('foods animal', 0.4149),\n",
       "  ('pork', 0.4148),\n",
       "  ('milk products', 0.4041),\n",
       "  ('unenhanced meats', 0.392),\n",
       "  ('contents sausages', 0.3805),\n",
       "  ('vitro digestible', 0.37),\n",
       "  ('dp contents', 0.3279),\n",
       "  ('better absorbability', 0.318),\n",
       "  ('beef', 0.2851),\n",
       "  ('important sources', 0.2844),\n",
       "  ('lower protein', 0.2798),\n",
       "  ('tp different', 0.2646),\n",
       "  ('additives common', 0.2641),\n",
       "  ('highest tp', 0.2409),\n",
       "  ('analysis results', 0.2338),\n",
       "  ('findings better', 0.2256),\n",
       "  ('sodium contents', 0.2247),\n",
       "  ('measure total', 0.219),\n",
       "  ('principle way', 0.2162),\n",
       "  ('chicken', 0.2114),\n",
       "  ('alimentary canal', 0.2074),\n",
       "  ('trout contained', 0.2),\n",
       "  ('plasma', 0.1983),\n",
       "  ('contents selected', 0.1896),\n",
       "  ('compare amounts', 0.1793),\n",
       "  ('2012 national', 0.167),\n",
       "  ('oes dp', 0.1648),\n",
       "  ('measured inductively', 0.16),\n",
       "  ('support previous', 0.1485),\n",
       "  ('animal origin', 0.1368),\n",
       "  ('kidney foundation', 0.1363),\n",
       "  ('processed hard', 0.1339),\n",
       "  ('high content', 0.1317),\n",
       "  ('reflect', 0.128),\n",
       "  ('brands', 0.1141),\n",
       "  ('better choices', 0.1133),\n",
       "  ('21', 0.0945),\n",
       "  ('published elsevier', 0.0924),\n",
       "  ('coupled', 0.0687),\n",
       "  ('example legumes', 0.0422),\n",
       "  ('patients based', 0.0393),\n",
       "  ('optical', 0.0362),\n",
       "  ('chronic', -0.0073),\n",
       "  ('copyright', -0.048)],\n",
       " 'MED-398': [('grapefruit drug', 0.7061),\n",
       "  ('consumption grapefruit', 0.6872),\n",
       "  ('grapefruit induced', 0.6646),\n",
       "  ('summary grapefruit', 0.6377),\n",
       "  ('grapefruit juice', 0.6287),\n",
       "  ('grapefruit virtue', 0.6181),\n",
       "  ('fatal grapefruit', 0.5902),\n",
       "  ('extent grapefruit', 0.5703),\n",
       "  ('drug interactions', 0.4988),\n",
       "  ('rich flavonoid', 0.3688),\n",
       "  ('cytochrome p450', 0.3544),\n",
       "  ('nutritive fruit', 0.3509),\n",
       "  ('cardiovascular disorders', 0.3309),\n",
       "  ('cyp3a4 metabolises', 0.3275),\n",
       "  ('juice associated', 0.3092),\n",
       "  ('interactions unique', 0.2784),\n",
       "  ('drug transporter', 0.2642),\n",
       "  ('disorders potentially', 0.2526),\n",
       "  ('unique cytochrome', 0.25),\n",
       "  ('metabolises', 0.2401),\n",
       "  ('shown consumption', 0.2155),\n",
       "  ('interactions cases', 0.2153),\n",
       "  ('tasty', 0.1938),\n",
       "  ('commonly prescribed', 0.193),\n",
       "  ('enjoyed globally', 0.1832),\n",
       "  ('intestines involved', 0.1465),\n",
       "  ('diabetes', 0.1461),\n",
       "  ('recently emerged', 0.1436),\n",
       "  ('impact', 0.1289),\n",
       "  ('proteins glycoprotein', 0.1111),\n",
       "  ('metabolises 60', 0.1082),\n",
       "  ('cases reported', 0.108),\n",
       "  ('content beneficial', 0.108),\n",
       "  ('subject reviewed', 0.1005),\n",
       "  ('biomedical evidence', 0.0881),\n",
       "  ('10 years', 0.0879),\n",
       "  ('summary', 0.0818),\n",
       "  ('clinical', 0.0813),\n",
       "  ('fatal', 0.0783),\n",
       "  ('organic', 0.0748),\n",
       "  ('settings fully', 0.072),\n",
       "  ('popular', 0.07),\n",
       "  ('enzyme', 0.0672),\n",
       "  ('explosive subject', 0.0654),\n",
       "  ('years shown', 0.0507),\n",
       "  ('virtue', 0.0454),\n",
       "  ('rich', 0.0379),\n",
       "  ('cation transporter', 0.0073),\n",
       "  ('determined probably', 0.0054),\n",
       "  ('management degenerative', -0.0323)],\n",
       " 'MED-557': [('factors dysmenorrhea', 0.7412),\n",
       "  ('menses negative', 0.5224),\n",
       "  ('smoking depression', 0.3838),\n",
       "  ('contraceptives depo', 0.3637),\n",
       "  ('include nulliparity', 0.3298),\n",
       "  ('heavy menstrual', 0.3293),\n",
       "  ('problem women', 0.3234),\n",
       "  ('pelvic ultrasonography', 0.2973),\n",
       "  ('nonsteroidal anti', 0.2939),\n",
       "  ('risk factors', 0.2915),\n",
       "  ('intravaginal use', 0.2779),\n",
       "  ('reproductive age', 0.2708),\n",
       "  ('drugs', 0.2613),\n",
       "  ('absence adolescent', 0.2484),\n",
       "  ('hysterectomy effectiveness', 0.2408),\n",
       "  ('empiric therapy', 0.2281),\n",
       "  ('secondary causes', 0.2254),\n",
       "  ('supplements low', 0.2252),\n",
       "  ('use oral', 0.2078),\n",
       "  ('danazol', 0.1983),\n",
       "  ('common problem', 0.1969),\n",
       "  ('patients presumptive', 0.1621),\n",
       "  ('herbal remedy', 0.1621),\n",
       "  ('nifedipine terbutaline', 0.16),\n",
       "  ('recurrent short', 0.157),\n",
       "  ('girls common', 0.1504),\n",
       "  ('women desire', 0.1342),\n",
       "  ('term school', 0.1275),\n",
       "  ('inflammatory', 0.1266),\n",
       "  ('medroxyprogesterone acetate', 0.126),\n",
       "  ('anti', 0.1257),\n",
       "  ('prolonged cycle', 0.1236),\n",
       "  ('vegetarian diet', 0.1196),\n",
       "  ('relief insufficient', 0.1138),\n",
       "  ('thiamine', 0.108),\n",
       "  ('remains uncontrolled', 0.0969),\n",
       "  ('history', 0.0854),\n",
       "  ('conceive', 0.0779),\n",
       "  ('acupuncture', 0.0758),\n",
       "  ('severe refractory', 0.0747),\n",
       "  ('safe alternatives', 0.0663),\n",
       "  ('surgical', 0.0619),\n",
       "  ('san', 0.0609),\n",
       "  ('leuprolide considered', 0.0253),\n",
       "  ('topical heat', 0.0253),\n",
       "  ('include transcutaneous', 0.0149),\n",
       "  ('japanese', 0.0044),\n",
       "  ('benefit use', 0.0022),\n",
       "  ('fish', -0.0255),\n",
       "  ('electric', -0.0677)],\n",
       " 'MED-666': [('surgery mastalgia', 0.5782),\n",
       "  ('mastalgia resistant', 0.5372),\n",
       "  ('life mastalgia', 0.4846),\n",
       "  ('treatment resistant', 0.3907),\n",
       "  ('mastectomy median', 0.3675),\n",
       "  ('affecting women', 0.365),\n",
       "  ('surgery retrospective', 0.3609),\n",
       "  ('severe treatment', 0.3301),\n",
       "  ('patients undergoing', 0.3289),\n",
       "  ('breast', 0.3258),\n",
       "  ('wound infections', 0.3128),\n",
       "  ('cases pain', 0.3018),\n",
       "  ('cyclical patients', 0.2902),\n",
       "  ('review medical', 0.2783),\n",
       "  ('possible complications', 0.2777),\n",
       "  ('medication', 0.2651),\n",
       "  ('undergoing quadrantectomy', 0.2557),\n",
       "  ('pain improved', 0.2553),\n",
       "  ('women stage', 0.2471),\n",
       "  ('postal questionnaire', 0.2178),\n",
       "  ('symptoms years', 0.2162),\n",
       "  ('aims', 0.2146),\n",
       "  ('used treat', 0.2083),\n",
       "  ('common condition', 0.1948),\n",
       "  ('minority patients', 0.1908),\n",
       "  ('contractures', 0.1893),\n",
       "  ('reproductive life', 0.1845),\n",
       "  ('hospital wales', 0.171),\n",
       "  ('dehiscence', 0.1668),\n",
       "  ('clinic 12', 0.1646),\n",
       "  ('16 years', 0.153),\n",
       "  ('patients informed', 0.1497),\n",
       "  ('inherent reconstructive', 0.1426),\n",
       "  ('included subcutaneous', 0.133),\n",
       "  ('developed capsular', 0.1196),\n",
       "  ('warned', 0.1054),\n",
       "  ('non cyclical', 0.1006),\n",
       "  ('median duration', 0.0962),\n",
       "  ('satisfaction following', 0.0957),\n",
       "  ('audit efficacy', 0.0892),\n",
       "  ('26 non', 0.0727),\n",
       "  ('records', 0.0395),\n",
       "  ('persisted', 0.0374),\n",
       "  ('1054 patients', 0.0373),\n",
       "  ('university', 0.0347),\n",
       "  ('undergone', 0.0342),\n",
       "  ('bilateral simple', -0.0002),\n",
       "  ('50', -0.007),\n",
       "  ('distributed', -0.0206),\n",
       "  ('1973', -0.0366)],\n",
       " 'MED-691': [('antiemetic effects', 0.5989),\n",
       "  ('vomiting physiological', 0.5585),\n",
       "  ('symptoms influenced', 0.479),\n",
       "  ('induced nausea', 0.4714),\n",
       "  ('medicines shown', 0.4273),\n",
       "  ('different emetogenic', 0.4217),\n",
       "  ('symptoms recur', 0.4102),\n",
       "  ('effects herbal', 0.3746),\n",
       "  ('agents ineffective', 0.3296),\n",
       "  ('physiological processes', 0.3226),\n",
       "  ('effects', 0.3093),\n",
       "  ('medicine', 0.3053),\n",
       "  ('life detrimental', 0.2894),\n",
       "  ('sickness prevent', 0.2883),\n",
       "  ('complex protective', 0.2674),\n",
       "  ('motion sickness', 0.2344),\n",
       "  ('chemotherapy induced', 0.2315),\n",
       "  ('especially prevention', 0.2205),\n",
       "  ('ineffective certain', 0.2098),\n",
       "  ('recur frequently', 0.1883),\n",
       "  ('various preclinical', 0.1862),\n",
       "  ('processes experienced', 0.1824),\n",
       "  ('significantly reduce', 0.1778),\n",
       "  ('various traditional', 0.1667),\n",
       "  ('agents', 0.1539),\n",
       "  ('health existing', 0.1531),\n",
       "  ('quality life', 0.1525),\n",
       "  ('stimuli conflicting', 0.1504),\n",
       "  ('conclusion current', 0.1401),\n",
       "  ('ginger possess', 0.1382),\n",
       "  ('need investigations', 0.1345),\n",
       "  ('prevent drawing', 0.1313),\n",
       "  ('summarizes results', 0.1191),\n",
       "  ('years various', 0.1151),\n",
       "  ('emphasize aspects', 0.1135),\n",
       "  ('plants studied', 0.1011),\n",
       "  ('published studies', 0.0928),\n",
       "  ('used broad', 0.0927),\n",
       "  ('review time', 0.0885),\n",
       "  ('effective', 0.0742),\n",
       "  ('commonly known', 0.0663),\n",
       "  ('2000 years', 0.0638),\n",
       "  ('address lacunae', 0.048),\n",
       "  ('experienced human', 0.045),\n",
       "  ('human stage', 0.0339),\n",
       "  ('zingiber', 0.0254),\n",
       "  ('clinics future', 0.0112),\n",
       "  ('response', -0.0113),\n",
       "  ('officinale', -0.0173),\n",
       "  ('expensive possess', -0.0636)],\n",
       " 'MED-692': [('rcts ginger', 0.6234),\n",
       "  ('ginger pnv', 0.5234),\n",
       "  ('ginger safe', 0.4884),\n",
       "  ('nausea vomiting', 0.3559),\n",
       "  ('herb increasingly', 0.3555),\n",
       "  ('world therapeutic', 0.332),\n",
       "  ('drug herb', 0.3251),\n",
       "  ('common indications', 0.3248),\n",
       "  ('cinahl cochrane', 0.3012),\n",
       "  ('indications pregnancy', 0.298),\n",
       "  ('duration treatment', 0.2962),\n",
       "  ('trials orally', 0.2934),\n",
       "  ('therapeutic', 0.2885),\n",
       "  ('orally administered', 0.2876),\n",
       "  ('adverse events', 0.2674),\n",
       "  ('midwives published', 0.2567),\n",
       "  ('increasingly used', 0.256),\n",
       "  ('potential drug', 0.2414),\n",
       "  ('western society', 0.2368),\n",
       "  ('treatment consequences', 0.2185),\n",
       "  ('rcts met', 0.2182),\n",
       "  ('future research', 0.1668),\n",
       "  ('placebo reducing', 0.1658),\n",
       "  ('pnv sourced', 0.1547),\n",
       "  ('safe effective', 0.1273),\n",
       "  ('evidence suggests', 0.1168),\n",
       "  ('methodological', 0.1164),\n",
       "  ('common', 0.1122),\n",
       "  ('important areas', 0.1072),\n",
       "  ('interactions important', 0.1067),\n",
       "  ('used', 0.0974),\n",
       "  ('research copyright', 0.0929),\n",
       "  ('reducing frequency', 0.085),\n",
       "  ('centuries', 0.0823),\n",
       "  ('objectives', 0.0742),\n",
       "  ('uncertainty regarding', 0.0696),\n",
       "  ('best available', 0.0642),\n",
       "  ('events generally', 0.0622),\n",
       "  ('medline trip', 0.0601),\n",
       "  ('2012', 0.0596),\n",
       "  ('rights', 0.0583),\n",
       "  ('generally mild', 0.0389),\n",
       "  ('appraisal skills', 0.0388),\n",
       "  ('agent', 0.001),\n",
       "  ('significantly', -0.0106),\n",
       "  ('australian college', -0.0129),\n",
       "  ('elsevier rights', -0.0207),\n",
       "  ('remains', -0.0255),\n",
       "  ('library', -0.0741),\n",
       "  ('casp', -0.0882)],\n",
       " 'MED-702': [('liraglutide search', 0.6812),\n",
       "  ('liraglutide monotherapies', 0.5665),\n",
       "  ('aim review', 0.4555),\n",
       "  ('clinical trials', 0.4486),\n",
       "  ('databases resources', 0.3925),\n",
       "  ('rosiglitazone resulted', 0.3823),\n",
       "  ('studies compared', 0.3689),\n",
       "  ('metformin plus', 0.3657),\n",
       "  ('years search', 0.3593),\n",
       "  ('combination therapies', 0.3495),\n",
       "  ('date embase', 0.3484),\n",
       "  ('efficacy long', 0.3456),\n",
       "  ('compared efficacy', 0.3452),\n",
       "  ('sitagliptin arm', 0.3451),\n",
       "  ('plus glimepiride', 0.3359),\n",
       "  ('method pubmed', 0.3279),\n",
       "  ('posted drug', 0.3263),\n",
       "  ('glycemic control', 0.322),\n",
       "  ('diabetes mellitus', 0.32),\n",
       "  ('website evaluated', 0.2726),\n",
       "  ('adverse events', 0.2605),\n",
       "  ('metformin failed', 0.2576),\n",
       "  ('results phase', 0.2414),\n",
       "  ('reduction hba1c', 0.24),\n",
       "  ('events gastrointestinal', 0.2316),\n",
       "  ('evidence durability', 0.2297),\n",
       "  ('glyburide', 0.224),\n",
       "  ('phase iii', 0.2124),\n",
       "  ('lack evidence', 0.2065),\n",
       "  ('systematically', 0.2021),\n",
       "  ('compared monotherapies', 0.1971),\n",
       "  ('doses', 0.1925),\n",
       "  ('mg reduction', 0.1842),\n",
       "  ('cancer reported', 0.1791),\n",
       "  ('regard outcomes', 0.1753),\n",
       "  ('constipation clinical', 0.1739),\n",
       "  ('safety appear', 0.1514),\n",
       "  ('appear limit', 0.147),\n",
       "  ('triple', 0.1464),\n",
       "  ('comparison mono', 0.129),\n",
       "  ('exenatide', 0.1144),\n",
       "  ('control patients', 0.113),\n",
       "  ('type', 0.1023),\n",
       "  ('pancreatitis cases', 0.0843),\n",
       "  ('resulted additional', 0.0812),\n",
       "  ('vomit', 0.0771),\n",
       "  ('arms respectively', 0.0432),\n",
       "  ('utility general', 0.0414),\n",
       "  ('common', 0.0228),\n",
       "  ('showed significantly', 0.0178)],\n",
       " 'MED-706': [('bioactive phenolic', 0.5413),\n",
       "  ('increase antioxidant', 0.4897),\n",
       "  ('compounds including', 0.4367),\n",
       "  ('rich anthocyanins', 0.4307),\n",
       "  ('extract hibiscus', 0.3934),\n",
       "  ('beneficial effects', 0.3789),\n",
       "  ('valuable traditional', 0.3614),\n",
       "  ('including hydroxycitric', 0.3614),\n",
       "  ('plants additional', 0.357),\n",
       "  ('herbal medicine', 0.3554),\n",
       "  ('chlorogenic acids', 0.3537),\n",
       "  ('diet supplementation', 0.3487),\n",
       "  ('human health', 0.3242),\n",
       "  ('acids using', 0.3003),\n",
       "  ('metabolic pathways', 0.2798),\n",
       "  ('vitro extract', 0.2758),\n",
       "  ('additional sources', 0.2596),\n",
       "  ('diseases advantage', 0.2399),\n",
       "  ('protection cultured', 0.2327),\n",
       "  ('significantly improve', 0.2319),\n",
       "  ('concentrations significantly', 0.2071),\n",
       "  ('cultured peripheral', 0.2013),\n",
       "  ('promotes production', 0.1903),\n",
       "  ('context aqueous', 0.1861),\n",
       "  ('modulation important', 0.1832),\n",
       "  ('hibiscus sabdariffa', 0.1816),\n",
       "  ('treatment chronic', 0.175),\n",
       "  ('ingestion acute', 0.1745),\n",
       "  ('important strategy', 0.168),\n",
       "  ('dose dependent', 0.1664),\n",
       "  ('rich', 0.156),\n",
       "  ('cells cellular', 0.1366),\n",
       "  ('effects confirmed', 0.1304),\n",
       "  ('alcohol toxicity', 0.1299),\n",
       "  ('conditions role', 0.1111),\n",
       "  ('patients', 0.1059),\n",
       "  ('value potential', 0.1051),\n",
       "  ('production inflammatory', 0.1001),\n",
       "  ('devoid caloric', 0.0998),\n",
       "  ('blood', 0.0898),\n",
       "  ('supernatants dose', 0.0679),\n",
       "  ('involve direct', 0.0664),\n",
       "  ('search', 0.0635),\n",
       "  ('human', 0.0623),\n",
       "  ('extract 10g', 0.0565),\n",
       "  ('gmbh rights', 0.0371),\n",
       "  ('instead', 0.0153),\n",
       "  ('mcp established', -0.02),\n",
       "  ('il decreases', -0.0225),\n",
       "  ('copyright 2009', -0.0304)],\n",
       " 'MED-707': [('study roselle', 0.4575),\n",
       "  ('roselle hibiscus', 0.4487),\n",
       "  ('uricosuric', 0.3553),\n",
       "  ('stone risk', 0.3253),\n",
       "  ('rs used', 0.2994),\n",
       "  ('study cup', 0.2986),\n",
       "  ('non renal', 0.2968),\n",
       "  ('stones non', 0.2812),\n",
       "  ('urinary samples', 0.2716),\n",
       "  ('hibiscus sabdariffa', 0.2629),\n",
       "  ('oxalate', 0.2609),\n",
       "  ('history renal', 0.2563),\n",
       "  ('tea dry', 0.2555),\n",
       "  ('serum parameters', 0.2472),\n",
       "  ('acid excretion', 0.2282),\n",
       "  ('drinking stopped', 0.2211),\n",
       "  ('risk factors', 0.2167),\n",
       "  ('subjects history', 0.2078),\n",
       "  ('model subjects', 0.1995),\n",
       "  ('washout period', 0.1951),\n",
       "  ('citrate groups', 0.1944),\n",
       "  ('used study', 0.1864),\n",
       "  ('groups intake', 0.1843),\n",
       "  ('compositions', 0.1706),\n",
       "  ('effect materials', 0.1706),\n",
       "  ('clearance significantly', 0.1682),\n",
       "  ('ns group', 0.1637),\n",
       "  ('materials methods', 0.1602),\n",
       "  ('various chemical', 0.1577),\n",
       "  ('24 urinary', 0.1543),\n",
       "  ('15 days', 0.137),\n",
       "  ('returned baseline', 0.1273),\n",
       "  ('observed data', 0.1263),\n",
       "  ('aim', 0.1225),\n",
       "  ('values groups', 0.1207),\n",
       "  ('clotted blood', 0.1069),\n",
       "  ('period changes', 0.1043),\n",
       "  ('changes clearly', 0.0944),\n",
       "  ('feua', 0.0943),\n",
       "  ('subject presented', 0.0922),\n",
       "  ('increased 01', 0.0854),\n",
       "  ('similar taking', 0.0757),\n",
       "  ('normal ranges', 0.069),\n",
       "  ('subjects twice', 0.0656),\n",
       "  ('control days', 0.0644),\n",
       "  ('individually', 0.0393),\n",
       "  ('exerting', 0.0274),\n",
       "  ('calyces provided', 0.0228),\n",
       "  ('daily morning', -0.0192),\n",
       "  ('evening', -0.0272)],\n",
       " 'MED-708': [('amines haa', 0.4583),\n",
       "  ('haa carcinogenic', 0.4169),\n",
       "  ('inhibiting haa', 0.3822),\n",
       "  ('marinades containing', 0.3408),\n",
       "  ('meat objective', 0.3189),\n",
       "  ('different haa', 0.3132),\n",
       "  ('hibiscus extract', 0.3124),\n",
       "  ('mutagenic', 0.2996),\n",
       "  ('marinated fried', 0.2903),\n",
       "  ('different concentrations', 0.2888),\n",
       "  ('heterocyclic', 0.2807),\n",
       "  ('tests marinated', 0.274),\n",
       "  ('fried beef', 0.2705),\n",
       "  ('aromatic', 0.2642),\n",
       "  ('hibiscus sabdariffa', 0.2481),\n",
       "  ('frying', 0.2278),\n",
       "  ('phenolic compounds', 0.2259),\n",
       "  ('patties analyzed', 0.1928),\n",
       "  ('inhibiting', 0.1914),\n",
       "  ('oil control', 0.182),\n",
       "  ('assay', 0.1678),\n",
       "  ('different 05', 0.1626),\n",
       "  ('antioxidant', 0.16),\n",
       "  ('15 different', 0.153),\n",
       "  ('extract compared', 0.1529),\n",
       "  ('meiqx reduced', 0.1516),\n",
       "  ('examine possibility', 0.1504),\n",
       "  ('norharmane', 0.1477),\n",
       "  ('low levels', 0.1437),\n",
       "  ('146', 0.1426),\n",
       "  ('hplc analysis', 0.1372),\n",
       "  ('195 microg', 0.1264),\n",
       "  ('ng phip', 0.1252),\n",
       "  ('significantly different', 0.1216),\n",
       "  ('49 97', 0.1181),\n",
       "  ('crust', 0.1079),\n",
       "  ('ranking tests', 0.1073),\n",
       "  ('assay folin', 0.1067),\n",
       "  ('control samples', 0.1039),\n",
       "  ('containing highest', 0.0996),\n",
       "  ('significantly', 0.0983),\n",
       "  ('formation', 0.0546),\n",
       "  ('02 06', 0.051),\n",
       "  ('micromol trolox', 0.0436),\n",
       "  ('equivalents', -0.0041),\n",
       "  ('100g', -0.0081),\n",
       "  ('compared sunflower', -0.0146),\n",
       "  ('40', -0.0171),\n",
       "  ('rights reserved', -0.0344),\n",
       "  ('2010 elsevier', -0.0605)],\n",
       " 'MED-709': [('extract aphrodisiac', 0.4281),\n",
       "  ('different doses', 0.4141),\n",
       "  ('calyx extract', 0.3898),\n",
       "  ('testes investigated', 0.3723),\n",
       "  ('hs calyx', 0.3235),\n",
       "  ('toxicity rats', 0.3071),\n",
       "  ('extract induces', 0.2957),\n",
       "  ('hibiscus sabdariffa', 0.2868),\n",
       "  ('effect hibiscus', 0.2758),\n",
       "  ('kg dose', 0.2696),\n",
       "  ('period animals', 0.2539),\n",
       "  ('evaluate pharmacological', 0.2501),\n",
       "  ('decrease epididymal', 0.2071),\n",
       "  ('test groups', 0.2027),\n",
       "  ('distortion tubules', 0.1978),\n",
       "  ('sub chronic', 0.1885),\n",
       "  ('aqueous hs', 0.1872),\n",
       "  ('investigated view', 0.1865),\n",
       "  ('water control', 0.1788),\n",
       "  ('drinking', 0.1725),\n",
       "  ('50 extracts', 0.1647),\n",
       "  ('15 30', 0.1635),\n",
       "  ('disintegration sperm', 0.1542),\n",
       "  ('exposure', 0.1533),\n",
       "  ('received different', 0.1521),\n",
       "  ('excised', 0.1511),\n",
       "  ('basis use', 0.149),\n",
       "  ('60 kg', 0.1489),\n",
       "  ('compared control', 0.1486),\n",
       "  ('processed histological', 0.1414),\n",
       "  ('basement membrane', 0.1376),\n",
       "  ('volume', 0.1358),\n",
       "  ('examination', 0.1261),\n",
       "  ('significant 05', 0.1175),\n",
       "  ('showed hyperplasia', 0.1093),\n",
       "  ('dissolved', 0.1008),\n",
       "  ('weights significant', 0.0969),\n",
       "  ('expiration treatment', 0.0948),\n",
       "  ('cells results', 0.0679),\n",
       "  ('free access', 0.0645),\n",
       "  ('recorded', 0.0609),\n",
       "  ('did', 0.0579),\n",
       "  ('week period', 0.057),\n",
       "  ('12 week', 0.0467),\n",
       "  ('organization', 0.0423),\n",
       "  ('thickening', 0.0368),\n",
       "  ('given equivalent', 0.0203),\n",
       "  ('normal epithelial', -0.0402),\n",
       "  ('hand showed', -0.0433),\n",
       "  ('ld', -0.0537)],\n",
       " 'MED-711': [('metabolic syndrome', 0.5657),\n",
       "  ('dyslipidemia strongly', 0.4777),\n",
       "  ('hypolipidemic properties', 0.4722),\n",
       "  ('obesity hypertension', 0.4421),\n",
       "  ('currently antihypertensive', 0.429),\n",
       "  ('mesy treated', 0.3851),\n",
       "  ('diabetes currently', 0.3784),\n",
       "  ('triglycerides', 0.3587),\n",
       "  ('hdl levels', 0.3245),\n",
       "  ('treatment diet', 0.3142),\n",
       "  ('marker insulin', 0.3068),\n",
       "  ('clinical trials', 0.2865),\n",
       "  ('treatment comprises', 0.2574),\n",
       "  ('reversible clinical', 0.2407),\n",
       "  ('hsep significantly', 0.2386),\n",
       "  ('hypotensive', 0.2302),\n",
       "  ('disease', 0.23),\n",
       "  ('heart', 0.2259),\n",
       "  ('aqueous hibiscus', 0.2066),\n",
       "  ('100 mg', 0.1887),\n",
       "  ('sabdariffa extracts', 0.1884),\n",
       "  ('extracts', 0.1829),\n",
       "  ('recognized preventive', 0.1806),\n",
       "  ('resistance', 0.1767),\n",
       "  ('stage evolution', 0.1728),\n",
       "  ('strongly associated', 0.1706),\n",
       "  ('administered capsules', 0.1669),\n",
       "  ('alt levels', 0.1621),\n",
       "  ('present study', 0.1492),\n",
       "  ('suggest use', 0.1462),\n",
       "  ('levels improved', 0.142),\n",
       "  ('urea', 0.1414),\n",
       "  ('absolute differences', 0.1371),\n",
       "  ('comprises', 0.1171),\n",
       "  ('blood determined', 0.116),\n",
       "  ('education program', 0.1022),\n",
       "  ('adjusted individually', 0.1009),\n",
       "  ('pre post', 0.0997),\n",
       "  ('profiles individuals', 0.0967),\n",
       "  ('design t1', 0.0841),\n",
       "  ('anova 02', 0.0824),\n",
       "  ('total daily', 0.077),\n",
       "  ('ratio means', 0.0706),\n",
       "  ('adult', 0.0676),\n",
       "  ('05', 0.0616),\n",
       "  ('improved tag', 0.052),\n",
       "  ('according ncep', 0.0495),\n",
       "  ('powder', 0.0394),\n",
       "  ('panel iii', 0.0342),\n",
       "  ('significantly reduced', 0.0234)],\n",
       " 'MED-712': [('rich extracts', 0.4773),\n",
       "  ('extracts hse', 0.4446),\n",
       "  ('tea effectively', 0.4251),\n",
       "  ('sabdariffa anthocyanins', 0.4134),\n",
       "  ('bioactive compounds', 0.3902),\n",
       "  ('hibiscus sabdariffa', 0.354),\n",
       "  ('sabdariffa rich', 0.2941),\n",
       "  ('potent chemopreventive', 0.2914),\n",
       "  ('folk medicines', 0.2862),\n",
       "  ('treatment hypertension', 0.2823),\n",
       "  ('hepatoprotection', 0.2686),\n",
       "  ('hse pursued', 0.2503),\n",
       "  ('flowers', 0.2375),\n",
       "  ('rat hpe', 0.2203),\n",
       "  ('phenolic', 0.2188),\n",
       "  ('protocatechuic acid', 0.1934),\n",
       "  ('effectively used', 0.1841),\n",
       "  ('droperoxide', 0.1825),\n",
       "  ('acids', 0.1785),\n",
       "  ('agents inhibit', 0.1722),\n",
       "  ('developed potent', 0.1712),\n",
       "  ('tert butyl', 0.1672),\n",
       "  ('rose', 0.1672),\n",
       "  ('traditional chinese', 0.1523),\n",
       "  ('aqueous', 0.1466),\n",
       "  ('chemicals different', 0.1423),\n",
       "  ('syndromes results', 0.136),\n",
       "  ('activities atherosclerosis', 0.1271),\n",
       "  ('exhibit activities', 0.1156),\n",
       "  ('cholesterol human', 0.114),\n",
       "  ('oxidative damage', 0.1046),\n",
       "  ('healthy foods', 0.1035),\n",
       "  ('rabbits fed', 0.101),\n",
       "  ('prepared dried', 0.0998),\n",
       "  ('streptozotocin induced', 0.0962),\n",
       "  ('possible mechanisms', 0.0934),\n",
       "  ('experimental hyperammonemia', 0.0862),\n",
       "  ('enzymes experimental', 0.0828),\n",
       "  ('especially leukemia', 0.0731),\n",
       "  ('linne', 0.0413),\n",
       "  ('primary hepatocytes', 0.039),\n",
       "  ('foam cell', 0.0389),\n",
       "  ('nephropathy studies', 0.0261),\n",
       "  ('studies clear', 0.0244),\n",
       "  ('pca shown', 0.0078),\n",
       "  ('agents natural', -0.0028),\n",
       "  ('smooth muscle', -0.012),\n",
       "  ('gastric cancer', -0.0154),\n",
       "  ('imply', -0.0547),\n",
       "  ('cell migration', -0.0572)],\n",
       " 'MED-713': [('diclofenac investigated', 0.5558),\n",
       "  ('excretion diclofenac', 0.5434),\n",
       "  ('diclofenac 300', 0.5294),\n",
       "  ('reduction diclofenac', 0.4969),\n",
       "  ('beverages drugs', 0.4177),\n",
       "  ('effect beverages', 0.3999),\n",
       "  ('sabdariffa excretion', 0.3917),\n",
       "  ('anthocyanins', 0.3814),\n",
       "  ('excreted administration', 0.3795),\n",
       "  ('plant beverages', 0.361),\n",
       "  ('administration beverage', 0.3382),\n",
       "  ('dried calyx', 0.3379),\n",
       "  ('water beverage', 0.337),\n",
       "  ('beverage reduction', 0.3337),\n",
       "  ('urine samples', 0.3244),\n",
       "  ('drugs', 0.311),\n",
       "  ('chromatographic method', 0.2991),\n",
       "  ('excreted wide', 0.2906),\n",
       "  ('administered daily', 0.2808),\n",
       "  ('beverage hibiscus', 0.2623),\n",
       "  ('flowers', 0.2549),\n",
       "  ('prepared dried', 0.241),\n",
       "  ('300 ml', 0.2122),\n",
       "  ('method used', 0.2114),\n",
       "  ('18 mg', 0.2035),\n",
       "  ('controlled study', 0.2014),\n",
       "  ('variability observed', 0.1906),\n",
       "  ('patients use', 0.184),\n",
       "  ('liquid', 0.1709),\n",
       "  ('water', 0.1578),\n",
       "  ('administered', 0.155),\n",
       "  ('collected', 0.1545),\n",
       "  ('hibiscus sabdariffa', 0.1533),\n",
       "  ('use plant', 0.1475),\n",
       "  ('days unpaired', 0.1466),\n",
       "  ('significant difference', 0.1205),\n",
       "  ('need counsel', 0.1198),\n",
       "  ('effect', 0.1195),\n",
       "  ('used analyse', 0.1046),\n",
       "  ('investigated', 0.0903),\n",
       "  ('control', 0.0769),\n",
       "  ('increasing need', 0.0763),\n",
       "  ('volunteers high', 0.0613),\n",
       "  ('healthy human', 0.052),\n",
       "  ('test', 0.0325),\n",
       "  ('mg', 0.0203),\n",
       "  ('human', -0.025),\n",
       "  ('05 increasing', -0.0251),\n",
       "  ('equivalent', -0.031),\n",
       "  ('tailed', -0.0944)],\n",
       " 'MED-714': [('intakes dri', 0.5407),\n",
       "  ('vitamin decade', 0.5257),\n",
       "  ('report dietary', 0.4947),\n",
       "  ('reference intakes', 0.4775),\n",
       "  ('area vitamin', 0.3878),\n",
       "  ('review provides', 0.3815),\n",
       "  ('decade release', 0.3467),\n",
       "  ('data requirements', 0.3373),\n",
       "  ('committee revise', 0.3348),\n",
       "  ('expanded knowledge', 0.3308),\n",
       "  ('underpinning comprehensive', 0.3289),\n",
       "  ('iom committee', 0.3144),\n",
       "  ('deliberations underpinning', 0.3027),\n",
       "  ('sustainable food', 0.2894),\n",
       "  ('recently published', 0.2722),\n",
       "  ('risk assessment', 0.2588),\n",
       "  ('including', 0.2555),\n",
       "  ('approaches present', 0.2537),\n",
       "  ('application intake', 0.2519),\n",
       "  ('health effects', 0.2515),\n",
       "  ('dose response', 0.2505),\n",
       "  ('framework used', 0.2443),\n",
       "  ('authoritative sources', 0.2416),\n",
       "  ('recommendations population', 0.2315),\n",
       "  ('number research', 0.2161),\n",
       "  ('american institute', 0.2121),\n",
       "  ('sources key', 0.2045),\n",
       "  ('areas need', 0.2044),\n",
       "  ('ca', 0.2008),\n",
       "  ('policy makers', 0.1976),\n",
       "  ('identified levels', 0.1975),\n",
       "  ('hugely expanded', 0.1842),\n",
       "  ('knowledge gaps', 0.1749),\n",
       "  ('funding institutions', 0.1716),\n",
       "  ('medicine', 0.1638),\n",
       "  ('major', 0.1584),\n",
       "  ('organising', 0.1252),\n",
       "  ('effects safe', 0.1064),\n",
       "  ('storage status', 0.105),\n",
       "  ('metabolism', 0.0992),\n",
       "  ('beneficial adverse', 0.0954),\n",
       "  ('benefited', 0.0873),\n",
       "  ('identified mapped', 0.0795),\n",
       "  ('north', 0.0779),\n",
       "  ('industry groups', 0.0699),\n",
       "  ('attention', 0.0544),\n",
       "  ('base', 0.0409),\n",
       "  ('largely persistence', 0.0237),\n",
       "  ('collate number', 0.011),\n",
       "  ('intense controversy', -0.007)],\n",
       " 'MED-716': [('vitamin skin', 0.6403),\n",
       "  ('vitamin receptor', 0.6218),\n",
       "  ('produced vitamin', 0.5418),\n",
       "  ('25 dihydroxyvitamin', 0.5365),\n",
       "  ('life vitamin', 0.5088),\n",
       "  ('produced skin', 0.419),\n",
       "  ('sunshine', 0.4134),\n",
       "  ('hormone produced', 0.4035),\n",
       "  ('kidneys biologically', 0.3956),\n",
       "  ('evolution sunlight', 0.3732),\n",
       "  ('phosphate absorption', 0.3134),\n",
       "  ('skeleton life', 0.2969),\n",
       "  ('interacts receptor', 0.2968),\n",
       "  ('calcium', 0.295),\n",
       "  ('diabetes heart', 0.281),\n",
       "  ('diet converted', 0.2646),\n",
       "  ('maximize health', 0.2624),\n",
       "  ('deficiency years', 0.2598),\n",
       "  ('osteoporosis increasing', 0.2402),\n",
       "  ('body', 0.2311),\n",
       "  ('supplementation 2000', 0.228),\n",
       "  ('biologically', 0.2252),\n",
       "  ('active form', 0.2108),\n",
       "  ('exposure', 0.1982),\n",
       "  ('sclerosis rheumatoid', 0.1838),\n",
       "  ('life results', 0.1824),\n",
       "  ('diseases sensible', 0.1764),\n",
       "  ('critically important', 0.1717),\n",
       "  ('deadly cancers', 0.1625),\n",
       "  ('increased risk', 0.1604),\n",
       "  ('making', 0.1555),\n",
       "  ('liver', 0.1524),\n",
       "  ('infectious diseases', 0.1487),\n",
       "  ('causes', 0.147),\n",
       "  ('birthing multiple', 0.1447),\n",
       "  ('1000 iu', 0.1411),\n",
       "  ('flattened pelvis', 0.1409),\n",
       "  ('fracture essentially', 0.1385),\n",
       "  ('intestine increase', 0.1253),\n",
       "  ('maintenance', 0.1145),\n",
       "  ('known', 0.1091),\n",
       "  ('iu adults', 0.1011),\n",
       "  ('interacts', 0.1007),\n",
       "  ('disease dementia', 0.0843),\n",
       "  ('tissue cell', 0.0753),\n",
       "  ('type ii', 0.0658),\n",
       "  ('children', 0.0371),\n",
       "  ('small', 0.0112),\n",
       "  ('increase efficiency', 0.0003),\n",
       "  ('requiring cesarean', -0.0278)],\n",
       " 'MED-717': [('fructose intake', 0.7808),\n",
       "  ('50 fructose', 0.5016),\n",
       "  ('intake increased', 0.4795),\n",
       "  ('glucose mixtures', 0.4622),\n",
       "  ('commonly consumed', 0.403),\n",
       "  ('malabsorption 25', 0.392),\n",
       "  ('subjects consumed', 0.3701),\n",
       "  ('taken food', 0.3685),\n",
       "  ('fruits juices', 0.3411),\n",
       "  ('consumption high', 0.325),\n",
       "  ('people gastrointestinal', 0.3079),\n",
       "  ('abdominal pain', 0.2863),\n",
       "  ('consumed result', 0.2772),\n",
       "  ('absorption measured', 0.2699),\n",
       "  ('symptoms measured', 0.2359),\n",
       "  ('result increased', 0.2166),\n",
       "  ('syrup', 0.2161),\n",
       "  ('peaks occurred', 0.2072),\n",
       "  ('amounts commonly', 0.2064),\n",
       "  ('greater thirds', 0.194),\n",
       "  ('united states', 0.1916),\n",
       "  ('loose stools', 0.1901),\n",
       "  ('fast', 0.1794),\n",
       "  ('results half', 0.151),\n",
       "  ('measured hour', 0.1389),\n",
       "  ('mean breath', 0.1365),\n",
       "  ('corn', 0.1357),\n",
       "  ('crystalline', 0.1239),\n",
       "  ('setting study', 0.1217),\n",
       "  ('intervention subjects', 0.1177),\n",
       "  ('180 minute', 0.117),\n",
       "  ('water', 0.1113),\n",
       "  ('scores significantly', 0.1021),\n",
       "  ('living', 0.0973),\n",
       "  ('analyses differences', 0.0864),\n",
       "  ('hydrogen tests', 0.0778),\n",
       "  ('50 doses', 0.0686),\n",
       "  ('auc use', 0.0662),\n",
       "  ('normal free', 0.0547),\n",
       "  ('duration exam', 0.0506),\n",
       "  ('pain loose', 0.0487),\n",
       "  ('community performed', 0.0405),\n",
       "  ('considered shorten', 0.0341),\n",
       "  ('specialty clinic', 0.0326),\n",
       "  ('15 adults', 0.0318),\n",
       "  ('baseline dose', 0.0228),\n",
       "  ('114 minutes', 0.0183),\n",
       "  ('evaluate response', 0.0062),\n",
       "  ('using paired', -0.0071),\n",
       "  ('borborygmus', -0.0251)],\n",
       " 'MED-718': [('gas colon', 0.5057),\n",
       "  ('study gaseous', 0.4167),\n",
       "  ('bacteria symptoms', 0.3564),\n",
       "  ('symptoms week', 0.3467),\n",
       "  ('intervention participants', 0.3355),\n",
       "  ('feelings abdominal', 0.3307),\n",
       "  ('syndrome therapy', 0.3242),\n",
       "  ('crossover study', 0.32),\n",
       "  ('participants diets', 0.3104),\n",
       "  ('setting veterans', 0.3034),\n",
       "  ('employees intervention', 0.3019),\n",
       "  ('irritable bowel', 0.2996),\n",
       "  ('bloating participants', 0.2901),\n",
       "  ('design randomized', 0.2822),\n",
       "  ('preparations breath', 0.2754),\n",
       "  ('excretion results', 0.2735),\n",
       "  ('conclusions physician', 0.2701),\n",
       "  ('center participants', 0.267),\n",
       "  ('medical center', 0.2644),\n",
       "  ('increased rectal', 0.2594),\n",
       "  ('fermentable material', 0.2533),\n",
       "  ('25 healthy', 0.2458),\n",
       "  ('participants perceived', 0.2451),\n",
       "  ('period setting', 0.2274),\n",
       "  ('supplemented placebo', 0.2268),\n",
       "  ('excessive gas', 0.2126),\n",
       "  ('participants passed', 0.2119),\n",
       "  ('ingestion fibers', 0.2049),\n",
       "  ('10 lactulose', 0.204),\n",
       "  ('increase ingestion', 0.1948),\n",
       "  ('objective determine', 0.1908),\n",
       "  ('statistically significant', 0.1853),\n",
       "  ('05 increase', 0.1838),\n",
       "  ('reported', 0.1738),\n",
       "  ('production feelings', 0.1715),\n",
       "  ('distinguish excessive', 0.1546),\n",
       "  ('hydrogen production', 0.1392),\n",
       "  ('double blind', 0.1301),\n",
       "  ('healthy', 0.1281),\n",
       "  ('fiber measurements', 0.1274),\n",
       "  ('passages 19', 0.1262),\n",
       "  ('limiting supply', 0.1258),\n",
       "  ('nonabsorbable sugar', 0.1253),\n",
       "  ('consists', 0.106),\n",
       "  ('methylcellulose nonfermentable', 0.0687),\n",
       "  ('12 times', 0.0578),\n",
       "  ('day mean', 0.0491),\n",
       "  ('psyllium', 0.0332),\n",
       "  ('usually unrelated', 0.0225),\n",
       "  ('polled', 0.0059)],\n",
       " 'MED-719': [('intestinal gas', 0.5765),\n",
       "  ('flatulence linked', 0.5094),\n",
       "  ('effects legumes', 0.495),\n",
       "  ('unease flatulence', 0.4913),\n",
       "  ('excessive intestinal', 0.4693),\n",
       "  ('symptoms distressing', 0.4064),\n",
       "  ('origins intestinal', 0.3906),\n",
       "  ('variety symptoms', 0.3574),\n",
       "  ('gas particularly', 0.3354),\n",
       "  ('review describes', 0.3276),\n",
       "  ('causing embarrassment', 0.2905),\n",
       "  ('placed effects', 0.2811),\n",
       "  ('distressing review', 0.2763),\n",
       "  ('diet', 0.2622),\n",
       "  ('effects', 0.2523),\n",
       "  ('galactosidic groupings', 0.2447),\n",
       "  ('suggestions overcoming', 0.2403),\n",
       "  ('food processing', 0.2349),\n",
       "  ('oligosaccharides', 0.2333),\n",
       "  ('producing excessive', 0.2263),\n",
       "  ('unease', 0.2215),\n",
       "  ('compounds responsible', 0.1981),\n",
       "  ('presented including', 0.1955),\n",
       "  ('role raffinose', 0.1873),\n",
       "  ('composition methods', 0.182),\n",
       "  ('beans does', 0.1764),\n",
       "  ('polysaccharide derived', 0.1751),\n",
       "  ('addition causing', 0.173),\n",
       "  ('problem presented', 0.1606),\n",
       "  ('methods', 0.1513),\n",
       "  ('describes origins', 0.1472),\n",
       "  ('animals man', 0.1378),\n",
       "  ('remove problem', 0.1321),\n",
       "  ('oligomers formed', 0.1243),\n",
       "  ('developed analysis', 0.1218),\n",
       "  ('drug treatment', 0.12),\n",
       "  ('groupings', 0.1183),\n",
       "  ('plant', 0.1169),\n",
       "  ('particularly role', 0.1016),\n",
       "  ('variety', 0.0961),\n",
       "  ('containing alpha', 0.0739),\n",
       "  ('emphasised', 0.0711),\n",
       "  ('enzyme treatment', 0.0691),\n",
       "  ('responsible assumed', 0.0478),\n",
       "  ('breeding emphasised', 0.0443),\n",
       "  ('characterised', 0.0443),\n",
       "  ('man', 0.0439),\n",
       "  ('linked', 0.0424),\n",
       "  ('animals', 0.04),\n",
       "  ('does remove', -0.0319)],\n",
       " 'MED-720': [('functional disorders', 0.4518),\n",
       "  ('intestinal gas', 0.45),\n",
       "  ('related symptoms', 0.429),\n",
       "  ('abdominal pain', 0.4042),\n",
       "  ('symptoms challenge', 0.401),\n",
       "  ('flatulence reduction', 0.3953),\n",
       "  ('galactosidase reduced', 0.3646),\n",
       "  ('patients gas', 0.3482),\n",
       "  ('symptom score', 0.3412),\n",
       "  ('diarrhea measured', 0.3398),\n",
       "  ('alpha galactosidase', 0.3185),\n",
       "  ('pathophysiology', 0.3014),\n",
       "  ('galactosidase placebo', 0.2996),\n",
       "  ('galu induced', 0.2989),\n",
       "  ('reduced gas', 0.298),\n",
       "  ('pain discomfort', 0.2837),\n",
       "  ('treatment largely', 0.2833),\n",
       "  ('gas production', 0.2828),\n",
       "  ('excretion severity', 0.282),\n",
       "  ('distention', 0.276),\n",
       "  ('carbohydrates helpful', 0.2686),\n",
       "  ('frequent complaints', 0.2606),\n",
       "  ('hydrogen excretion', 0.2481),\n",
       "  ('following meal', 0.2403),\n",
       "  ('beans breath', 0.2087),\n",
       "  ('patients frequently', 0.2048),\n",
       "  ('rich fermentable', 0.1997),\n",
       "  ('administration randomized', 0.191),\n",
       "  ('aim', 0.1877),\n",
       "  ('effect alpha', 0.176),\n",
       "  ('occurrence bloating', 0.1667),\n",
       "  ('volunteers ingested', 0.1649),\n",
       "  ('1200 galu', 0.1641),\n",
       "  ('effective strategy', 0.1597),\n",
       "  ('largely unknown', 0.1568),\n",
       "  ('induced significant', 0.1426),\n",
       "  ('measured hr', 0.1177),\n",
       "  ('challenge test', 0.1091),\n",
       "  ('production represent', 0.1032),\n",
       "  ('apparent considered', 0.1011),\n",
       "  ('double blind', 0.0802),\n",
       "  ('excessive', 0.0736),\n",
       "  ('related', 0.0732),\n",
       "  ('breath', 0.0729),\n",
       "  ('controlled', 0.0415),\n",
       "  ('represent frequent', 0.0255),\n",
       "  ('volunteers healthy', 0.0239),\n",
       "  ('containing', -0.0126),\n",
       "  ('300 1200', -0.1113),\n",
       "  ('420', -0.14)],\n",
       " 'MED-721': [('bismuth therapy', 0.5496),\n",
       "  ('gastrointestinal disorders', 0.4253),\n",
       "  ('helicobacter pylori', 0.4186),\n",
       "  ('disease effective', 0.3514),\n",
       "  ('acts antimicrobial', 0.341),\n",
       "  ('amelioration symptoms', 0.3353),\n",
       "  ('modest efficacy', 0.334),\n",
       "  ('effective prophylactically', 0.3333),\n",
       "  ('diarrhea peptic', 0.3253),\n",
       "  ('ulcer', 0.3054),\n",
       "  ('conventional antibiotics', 0.2996),\n",
       "  ('treatment usually', 0.2917),\n",
       "  ('offers lower', 0.2637),\n",
       "  ('h2 receptor', 0.2539),\n",
       "  ('studies demonstrated', 0.2304),\n",
       "  ('subnitrate toxicity', 0.2201),\n",
       "  ('symptoms periods', 0.2099),\n",
       "  ('demonstrated intestinal', 0.2018),\n",
       "  ('antagonists costs', 0.2013),\n",
       "  ('prophylactically traveler', 0.1915),\n",
       "  ('histological improvement', 0.1817),\n",
       "  ('subsalicylate shown', 0.1743),\n",
       "  ('organism eliminating', 0.1719),\n",
       "  ('efficacy major', 0.1697),\n",
       "  ('recommendations', 0.1634),\n",
       "  ('subcitrate recent', 0.1463),\n",
       "  ('subgallate', 0.1301),\n",
       "  ('compounds used', 0.1293),\n",
       "  ('rate relapse', 0.129),\n",
       "  ('dosing week', 0.1267),\n",
       "  ('rare', 0.1241),\n",
       "  ('costs considerably', 0.0965),\n",
       "  ('sites occurring', 0.0944),\n",
       "  ('acute chronic', 0.0895),\n",
       "  ('agent', 0.0804),\n",
       "  ('intervals', 0.0678),\n",
       "  ('used', 0.0645),\n",
       "  ('colloidal', 0.062),\n",
       "  ('metal multiple', 0.0538),\n",
       "  ('considerably offers', 0.0496),\n",
       "  ('longer', 0.0451),\n",
       "  ('sequestration', 0.0416),\n",
       "  ('reported france', 0.0188),\n",
       "  ('inspired', 0.0017),\n",
       "  ('epidemic', -0.0033),\n",
       "  ('neurological', -0.0293),\n",
       "  ('free', -0.0435),\n",
       "  ('producing', -0.0601),\n",
       "  ('1970', -0.0683),\n",
       "  ('children', -0.1127)],\n",
       " 'MED-722': [('flatulence problems', 0.5132),\n",
       "  ('gas patients', 0.4667),\n",
       "  ('common flatulence', 0.4376),\n",
       "  ('complaints excessive', 0.4233),\n",
       "  ('pathophysiology management', 0.4182),\n",
       "  ('excessive gas', 0.4111),\n",
       "  ('excessive flatus', 0.395),\n",
       "  ('addresses pathophysiology', 0.39),\n",
       "  ('management complaints', 0.3891),\n",
       "  ('flatulence', 0.3812),\n",
       "  ('pathophysiology', 0.3732),\n",
       "  ('complaints', 0.3719),\n",
       "  ('noxious flatus', 0.369),\n",
       "  ('problems summarized', 0.3412),\n",
       "  ('flatus volume', 0.3273),\n",
       "  ('problems', 0.319),\n",
       "  ('complaints looking', 0.3058),\n",
       "  ('bloating distention', 0.3001),\n",
       "  ('physician document', 0.2862),\n",
       "  ('volume noxious', 0.286),\n",
       "  ('physician', 0.2816),\n",
       "  ('excessive eructation', 0.2806),\n",
       "  ('gas', 0.2768),\n",
       "  ('distention', 0.2721),\n",
       "  ('including excessive', 0.2691),\n",
       "  ('common difficult', 0.2573),\n",
       "  ('distention addition', 0.2411),\n",
       "  ('noxious', 0.2408),\n",
       "  ('review addresses', 0.2387),\n",
       "  ('elimination excessive', 0.2377),\n",
       "  ('impossible physician', 0.2285),\n",
       "  ('patients', 0.2161),\n",
       "  ('patients common', 0.2014),\n",
       "  ('summarized', 0.1996),\n",
       "  ('eructation bloating', 0.1942),\n",
       "  ('difficult', 0.188),\n",
       "  ('routes elimination', 0.1822),\n",
       "  ('looking sources', 0.1805),\n",
       "  ('sources', 0.1783),\n",
       "  ('management', 0.1698),\n",
       "  ('document review', 0.167),\n",
       "  ('eructation', 0.1573),\n",
       "  ('bloating', 0.1508),\n",
       "  ('sources routes', 0.1288),\n",
       "  ('volume', 0.1107),\n",
       "  ('difficult impossible', 0.0794),\n",
       "  ('looking', 0.0519),\n",
       "  ('addition common', 0.0333),\n",
       "  ('including', 0.0283),\n",
       "  ('addresses', 0.0112)],\n",
       " 'MED-723': [('rectal gas', 0.5219),\n",
       "  ('devices adsorb', 0.4864),\n",
       "  ('devices purported', 0.4863),\n",
       "  ('odor cushions', 0.4536),\n",
       "  ('adsorb odoriferous', 0.442),\n",
       "  ('anus methods', 0.4052),\n",
       "  ('gases instilled', 0.3874),\n",
       "  ('activated carbon', 0.3784),\n",
       "  ('charcoal containing', 0.3756),\n",
       "  ('gases conclusions', 0.3717),\n",
       "  ('removal product', 0.3601),\n",
       "  ('efficacy products', 0.3457),\n",
       "  ('device corrected', 0.3434),\n",
       "  ('adsorb malodorous', 0.3401),\n",
       "  ('pads worn', 0.3281),\n",
       "  ('methods tube', 0.3111),\n",
       "  ('ineffective adsorbing', 0.2919),\n",
       "  ('minimize problems', 0.2803),\n",
       "  ('products virtually', 0.2654),\n",
       "  ('malodorous sulfide', 0.263),\n",
       "  ('adsorbing 20', 0.2496),\n",
       "  ('briefs constructed', 0.2496),\n",
       "  ('nitrogen containing', 0.2421),\n",
       "  ('garments removed', 0.2398),\n",
       "  ('adsorbed virtually', 0.2374),\n",
       "  ('worn inside', 0.2261),\n",
       "  ('22 sulfide', 0.2112),\n",
       "  ('containing', 0.1937),\n",
       "  ('evidence supporting', 0.1914),\n",
       "  ('virtually anecdotal', 0.1858),\n",
       "  ('methylmercaptan instilled', 0.1832),\n",
       "  ('highly effective', 0.1802),\n",
       "  ('concentration ratio', 0.1788),\n",
       "  ('exposure', 0.177),\n",
       "  ('hydrogen', 0.1762),\n",
       "  ('results obtained', 0.1748),\n",
       "  ('objective variety', 0.1631),\n",
       "  ('constructed', 0.158),\n",
       "  ('space relative', 0.1359),\n",
       "  ('100', 0.1333),\n",
       "  ('pantaloon space', 0.1175),\n",
       "  ('showed subjects', 0.1175),\n",
       "  ('limited', 0.0957),\n",
       "  ('healthy volunteers', 0.0788),\n",
       "  ('fiber fabric', 0.0628),\n",
       "  ('40 ppm', 0.0565),\n",
       "  ('underwear', 0.0196),\n",
       "  ('impermeable', 0.015),\n",
       "  ('55 77', -0.0004),\n",
       "  ('mylar', -0.0218)],\n",
       " 'MED-724': [('intestinal gas', 0.5765),\n",
       "  ('flatulence linked', 0.5094),\n",
       "  ('effects legumes', 0.495),\n",
       "  ('unease flatulence', 0.4913),\n",
       "  ('excessive intestinal', 0.4693),\n",
       "  ('symptoms distressing', 0.4064),\n",
       "  ('origins intestinal', 0.3906),\n",
       "  ('variety symptoms', 0.3574),\n",
       "  ('gas particularly', 0.3354),\n",
       "  ('review describes', 0.3276),\n",
       "  ('causing embarrassment', 0.2905),\n",
       "  ('placed effects', 0.2811),\n",
       "  ('distressing review', 0.2763),\n",
       "  ('diet', 0.2622),\n",
       "  ('effects', 0.2523),\n",
       "  ('galactosidic groupings', 0.2447),\n",
       "  ('suggestions overcoming', 0.2403),\n",
       "  ('food processing', 0.2349),\n",
       "  ('oligosaccharides', 0.2333),\n",
       "  ('producing excessive', 0.2263),\n",
       "  ('unease', 0.2215),\n",
       "  ('compounds responsible', 0.1981),\n",
       "  ('presented including', 0.1955),\n",
       "  ('role raffinose', 0.1873),\n",
       "  ('composition methods', 0.182),\n",
       "  ('beans does', 0.1764),\n",
       "  ('polysaccharide derived', 0.1751),\n",
       "  ('addition causing', 0.173),\n",
       "  ('problem presented', 0.1606),\n",
       "  ('methods', 0.1513),\n",
       "  ('describes origins', 0.1472),\n",
       "  ('animals man', 0.1378),\n",
       "  ('remove problem', 0.1321),\n",
       "  ('oligomers formed', 0.1243),\n",
       "  ('developed analysis', 0.1218),\n",
       "  ('drug treatment', 0.12),\n",
       "  ('groupings', 0.1183),\n",
       "  ('plant', 0.1169),\n",
       "  ('particularly role', 0.1016),\n",
       "  ('variety', 0.0961),\n",
       "  ('containing alpha', 0.0739),\n",
       "  ('emphasised', 0.0711),\n",
       "  ('enzyme treatment', 0.0691),\n",
       "  ('responsible assumed', 0.0478),\n",
       "  ('breeding emphasised', 0.0443),\n",
       "  ('characterised', 0.0443),\n",
       "  ('man', 0.0439),\n",
       "  ('linked', 0.0424),\n",
       "  ('animals', 0.04),\n",
       "  ('does remove', -0.0319)],\n",
       " 'MED-726': [('alzheimer disease', 0.4563),\n",
       "  ('147 autopsies', 0.4259),\n",
       "  ('lipid profiles', 0.3928),\n",
       "  ('pathology population', 0.3634),\n",
       "  ('including apoe', 0.3202),\n",
       "  ('dyslipidemia increases', 0.3162),\n",
       "  ('neurofibrillary tangles', 0.3114),\n",
       "  ('examined analysis', 0.2789),\n",
       "  ('evidence ad', 0.261),\n",
       "  ('ldlc calculated', 0.2497),\n",
       "  ('factors subjects', 0.2342),\n",
       "  ('included brain', 0.2335),\n",
       "  ('searched evidence', 0.2315),\n",
       "  ('2003 residents', 0.2315),\n",
       "  ('compared subjects', 0.228),\n",
       "  ('metabolism methods', 0.2261),\n",
       "  ('plaque type', 0.223),\n",
       "  ('methods study', 0.2033),\n",
       "  ('hdlc non', 0.2018),\n",
       "  ('plaques nps', 0.1969),\n",
       "  ('using friedewald', 0.1783),\n",
       "  ('population level', 0.1763),\n",
       "  ('japan 76', 0.1648),\n",
       "  ('1998 2003', 0.1567),\n",
       "  ('71 women', 0.1559),\n",
       "  ('unclear', 0.1446),\n",
       "  ('examinations', 0.1442),\n",
       "  ('hisayama town', 0.1326),\n",
       "  ('specimens', 0.1304),\n",
       "  ('associations', 0.1171),\n",
       "  ('neuritic', 0.1111),\n",
       "  ('tangles', 0.1101),\n",
       "  ('models including', 0.1085),\n",
       "  ('low density', 0.1062),\n",
       "  ('disease guidelines', 0.1057),\n",
       "  ('results adjusted', 0.1023),\n",
       "  ('higher subjects', 0.0988),\n",
       "  ('higher risks', 0.0925),\n",
       "  ('nfts assessed', 0.0894),\n",
       "  ('high density', 0.0743),\n",
       "  ('stages cerad', 0.0661),\n",
       "  ('threshold effect', 0.0627),\n",
       "  ('establish registry', 0.0581),\n",
       "  ('measured 1988', 0.0427),\n",
       "  ('logistic', 0.0425),\n",
       "  ('subjects lower', 0.0388),\n",
       "  ('profiles significantly', 0.0212),\n",
       "  ('ε4 carrier', 0.0119),\n",
       "  ('respective quartiles', -0.017),\n",
       "  ('men', -0.0331)],\n",
       " 'MED-727': [('family physicians', 0.5693),\n",
       "  ('primary care', 0.4578),\n",
       "  ('physicians encompassed', 0.4484),\n",
       "  ('practice settings', 0.4304),\n",
       "  ('patient visits', 0.4172),\n",
       "  ('multimethod research', 0.4117),\n",
       "  ('health patients', 0.3822),\n",
       "  ('patients problems', 0.377),\n",
       "  ('patient questions', 0.321),\n",
       "  ('unseen policymakers', 0.3057),\n",
       "  ('observed outpatient', 0.3055),\n",
       "  ('using medical', 0.2935),\n",
       "  ('138 physicians', 0.2798),\n",
       "  ('variety patients', 0.2752),\n",
       "  ('12 care', 0.2711),\n",
       "  ('chronic illness', 0.2489),\n",
       "  ('study content', 0.2274),\n",
       "  ('research nurses', 0.2114),\n",
       "  ('describes community', 0.2068),\n",
       "  ('families time', 0.2024),\n",
       "  ('ethnographic fieldnotes', 0.2006),\n",
       "  ('structuring interaction', 0.1951),\n",
       "  ('policymakers understood', 0.1947),\n",
       "  ('ohio', 0.1939),\n",
       "  ('ways enhance', 0.1925),\n",
       "  ('background', 0.1868),\n",
       "  ('84 practices', 0.1819),\n",
       "  ('isolation article', 0.1615),\n",
       "  ('education feedback', 0.1593),\n",
       "  ('understood', 0.1513),\n",
       "  ('4454 patients', 0.1479),\n",
       "  ('illness 24', 0.1442),\n",
       "  ('record reviews', 0.1411),\n",
       "  ('planning treatment', 0.1396),\n",
       "  ('past year', 0.1382),\n",
       "  ('visits fully', 0.1381),\n",
       "  ('collected additional', 0.136),\n",
       "  ('demands opportunities', 0.1321),\n",
       "  ('range problems', 0.1307),\n",
       "  ('physical examination', 0.1279),\n",
       "  ('complexity average', 0.1145),\n",
       "  ('leaving aspects', 0.1059),\n",
       "  ('black box', 0.1038),\n",
       "  ('billing data', 0.1027),\n",
       "  ('common uses', 0.0938),\n",
       "  ('address wide', 0.0613),\n",
       "  ('northeast', 0.0578),\n",
       "  ('various stages', 0.0521),\n",
       "  ('uses time', 0.0447),\n",
       "  ('minutes percent', -0.0359)],\n",
       " 'MED-728': [('nutrition counseling', 0.5122),\n",
       "  ('physicians counseling', 0.4829),\n",
       "  ('dietitians healthcare', 0.4583),\n",
       "  ('practice behaviors', 0.4385),\n",
       "  ('healthcare', 0.4155),\n",
       "  ('kushner called', 0.4059),\n",
       "  ('change physicians', 0.4004),\n",
       "  ('multifaceted approach', 0.3915),\n",
       "  ('preventive services', 0.3849),\n",
       "  ('professionals barriers', 0.3508),\n",
       "  ('knowledge resources', 0.3233),\n",
       "  ('key components', 0.3143),\n",
       "  ('identify need', 0.3021),\n",
       "  ('visits included', 0.2975),\n",
       "  ('hypertension midcourse', 0.2884),\n",
       "  ('article recognized', 0.2728),\n",
       "  ('1995 pivotal', 0.2687),\n",
       "  ('described attitudes', 0.2575),\n",
       "  ('prevailing belief', 0.2457),\n",
       "  ('midcourse review', 0.2383),\n",
       "  ('changed healthy', 0.2364),\n",
       "  ('increase 75', 0.2356),\n",
       "  ('task force', 0.2261),\n",
       "  ('diagnosis cardiovascular', 0.2236),\n",
       "  ('proportion patients', 0.2185),\n",
       "  ('included ordering', 0.1951),\n",
       "  ('believe benefit', 0.1937),\n",
       "  ('disease diabetes', 0.1841),\n",
       "  ('surgeon general', 0.1775),\n",
       "  ('study', 0.1765),\n",
       "  ('objective increase', 0.1738),\n",
       "  ('receive primary', 0.1649),\n",
       "  ('let campaign', 0.1391),\n",
       "  ('continue believe', 0.1365),\n",
       "  ('proportion office', 0.115),\n",
       "  ('patients 2010', 0.0893),\n",
       "  ('fit nation', 0.0879),\n",
       "  ('physical', 0.0879),\n",
       "  ('adults', 0.0788),\n",
       "  ('years', 0.0697),\n",
       "  ('responsibility', 0.0478),\n",
       "  ('gap remains', 0.0469),\n",
       "  ('vision healthy', 0.0454),\n",
       "  ('today', 0.0431),\n",
       "  ('compensation lesser', 0.0278),\n",
       "  ('40 primary', 0.0232),\n",
       "  ('children', 0.0101),\n",
       "  ('lack time', -0.0166),\n",
       "  ('spotlight', -0.0724),\n",
       "  ('lady obama', -0.0941)],\n",
       " 'MED-729': [('carcasses split', 0.596),\n",
       "  ('carcass infected', 0.5735),\n",
       "  ('splitting saw', 0.4312),\n",
       "  ('measured saw', 0.4247),\n",
       "  ('tissue debris', 0.3947),\n",
       "  ('tissue recovered', 0.3796),\n",
       "  ('process cattle', 0.3754),\n",
       "  ('infected bovine', 0.362),\n",
       "  ('135 tissue', 0.3614),\n",
       "  ('total tissue', 0.3485),\n",
       "  ('slaughter line', 0.3418),\n",
       "  ('carcass 61', 0.3259),\n",
       "  ('accumulates splitting', 0.3231),\n",
       "  ('tissue controlled', 0.3155),\n",
       "  ('bovine spongiform', 0.3065),\n",
       "  ('resulting contamination', 0.3009),\n",
       "  ('processed', 0.2834),\n",
       "  ('101 tissue', 0.2817),\n",
       "  ('time pcr', 0.2798),\n",
       "  ('experimental abattoir', 0.2732),\n",
       "  ('cord material', 0.2688),\n",
       "  ('material using', 0.2493),\n",
       "  ('vertebral column', 0.2302),\n",
       "  ('experimental', 0.2289),\n",
       "  ('cross', 0.22),\n",
       "  ('work highlights', 0.2041),\n",
       "  ('swabbing', 0.2012),\n",
       "  ('assay measured', 0.1917),\n",
       "  ('cleaning indicates', 0.1911),\n",
       "  ('novel method', 0.1887),\n",
       "  ('procedure number', 0.1619),\n",
       "  ('abattoir 23', 0.1598),\n",
       "  ('15 originated', 0.1479),\n",
       "  ('half', 0.1476),\n",
       "  ('accumulated', 0.1404),\n",
       "  ('mg spinal', 0.1335),\n",
       "  ('modifications required', 0.1333),\n",
       "  ('mediated', 0.1266),\n",
       "  ('main risk', 0.123),\n",
       "  ('based real', 0.1201),\n",
       "  ('recovered 10', 0.1134),\n",
       "  ('line main', 0.1057),\n",
       "  ('indicates', 0.0844),\n",
       "  ('commercial plants', 0.0732),\n",
       "  ('encephalopathy enter', 0.0691),\n",
       "  ('importance effective', 0.0683),\n",
       "  ('united kingdom', 0.0641),\n",
       "  ('minimize', 0.0637),\n",
       "  ('depending particular', 0.0634),\n",
       "  ('face came', 0.0611)],\n",
       " 'MED-730': [('antimicrobial resistance', 0.4564),\n",
       "  ('coli 64', 0.451),\n",
       "  ('20 faecal', 0.383),\n",
       "  ('swiss pig', 0.3817),\n",
       "  ('pigs shortly', 0.3543),\n",
       "  ('campylobacter coli', 0.345),\n",
       "  ('organisms complicates', 0.338),\n",
       "  ('farms poor', 0.3317),\n",
       "  ('faecal samples', 0.3023),\n",
       "  ('herd increased', 0.2993),\n",
       "  ('finishing farms', 0.2968),\n",
       "  ('19 streptomycin', 0.2931),\n",
       "  ('strains', 0.2733),\n",
       "  ('infected humans', 0.2703),\n",
       "  ('lesions feed', 0.2121),\n",
       "  ('strict animal', 0.204),\n",
       "  ('ciprofloxacin 26', 0.1999),\n",
       "  ('tetracycline multiple', 0.1902),\n",
       "  ('complicates medical', 0.1867),\n",
       "  ('models prevalence', 0.182),\n",
       "  ('64', 0.1725),\n",
       "  ('pooled cultured', 0.1659),\n",
       "  ('management aspects', 0.1639),\n",
       "  ('animal flow', 0.1579),\n",
       "  ('performed resistance', 0.1461),\n",
       "  ('slaughter samples', 0.1401),\n",
       "  ('study showed', 0.1275),\n",
       "  ('analysed statistical', 0.1067),\n",
       "  ('floor pens', 0.0964),\n",
       "  ('world wide', 0.0897),\n",
       "  ('november', 0.0823),\n",
       "  ('increased odds', 0.073),\n",
       "  ('outcomes corrected', 0.0725),\n",
       "  ('ill thrift', 0.0662),\n",
       "  ('humans did', 0.0566),\n",
       "  ('presence lameness', 0.0552),\n",
       "  ('whey', 0.0515),\n",
       "  ('15', 0.0452),\n",
       "  ('micro', 0.043),\n",
       "  ('health status', 0.0402),\n",
       "  ('scratches shoulder', 0.0276),\n",
       "  ('dependency samples', 0.0259),\n",
       "  ('partially used', -0.0216),\n",
       "  ('holding', -0.022),\n",
       "  ('did risk', -0.024),\n",
       "  ('37 continuous', -0.0262),\n",
       "  ('additionally information', -0.0377),\n",
       "  ('non', -0.0529),\n",
       "  ('78', -0.0718),\n",
       "  ('shortened tails', -0.0729)],\n",
       " 'MED-731': [('anthrax rare', 0.6681),\n",
       "  ('anthrax meningitis', 0.6092),\n",
       "  ('anthracis humans', 0.5791),\n",
       "  ('bacillus anthracis', 0.571),\n",
       "  ('gastrointestinal anthrax', 0.5648),\n",
       "  ('anthrax acute', 0.5445),\n",
       "  ('cases anthrax', 0.5382),\n",
       "  ('anthrax cutaneous', 0.523),\n",
       "  ('meningitis rare', 0.4683),\n",
       "  ('acute bacterial', 0.4572),\n",
       "  ('anthrax differential', 0.434),\n",
       "  ('awareness anthrax', 0.4277),\n",
       "  ('caused bacillus', 0.4224),\n",
       "  ('bacterial infection', 0.4018),\n",
       "  ('infection caused', 0.3781),\n",
       "  ('meningitis arising', 0.3392),\n",
       "  ('oropharyngeal meningitis', 0.3329),\n",
       "  ('humans infected', 0.3128),\n",
       "  ('report rare', 0.306),\n",
       "  ('infected animals', 0.304),\n",
       "  ('acute', 0.2883),\n",
       "  ('contaminated animal', 0.2578),\n",
       "  ('infected natural', 0.2342),\n",
       "  ('95 human', 0.2305),\n",
       "  ('areas disease', 0.2278),\n",
       "  ('cutaneous respiratory', 0.2144),\n",
       "  ('contact infected', 0.2132),\n",
       "  ('animal products', 0.1973),\n",
       "  ('reported cases', 0.1904),\n",
       "  ('complication forms', 0.1903),\n",
       "  ('remains endemic', 0.1786),\n",
       "  ('gastrointestinal oropharyngeal', 0.1771),\n",
       "  ('differential diagnosis', 0.1507),\n",
       "  ('contaminated', 0.1443),\n",
       "  ('meat sick', 0.1198),\n",
       "  ('disease remains', 0.1055),\n",
       "  ('pictures ingestion', 0.0994),\n",
       "  ('sheep', 0.0921),\n",
       "  ('sick', 0.0913),\n",
       "  ('caused', 0.0898),\n",
       "  ('natural conditions', 0.0782),\n",
       "  ('different', 0.0559),\n",
       "  ('clinical', 0.0552),\n",
       "  ('need awareness', 0.047),\n",
       "  ('humans', 0.0323),\n",
       "  ('single family', 0.0313),\n",
       "  ('source patients', 0.0266),\n",
       "  ('half', -0.0164),\n",
       "  ('cooked', -0.0195),\n",
       "  ('forms', -0.0693)],\n",
       " 'MED-732': [('sponge samples', 0.5517),\n",
       "  ('detected sponge', 0.456),\n",
       "  ('samples examined', 0.4291),\n",
       "  ('products samples', 0.4199),\n",
       "  ('samples taken', 0.4024),\n",
       "  ('meat personnel', 0.3958),\n",
       "  ('abattoirs gfap', 0.3866),\n",
       "  ('retail meats', 0.3833),\n",
       "  ('carcases meat', 0.3697),\n",
       "  ('beef products', 0.3674),\n",
       "  ('indicators contamination', 0.3198),\n",
       "  ('tissue syntaxin', 0.319),\n",
       "  ('rooms abattoirs', 0.3126),\n",
       "  ('gfap detected', 0.3099),\n",
       "  ('tissue', 0.3089),\n",
       "  ('slaughter dressing', 0.2923),\n",
       "  ('contamination cns', 0.2878),\n",
       "  ('detected sample', 0.2809),\n",
       "  ('proteins', 0.2705),\n",
       "  ('sample', 0.2702),\n",
       "  ('cns specific', 0.2623),\n",
       "  ('examined', 0.2587),\n",
       "  ('taken slaughter', 0.2485),\n",
       "  ('contamination', 0.2483),\n",
       "  ('personnel surfaces', 0.2375),\n",
       "  ('surfaces involved', 0.2269),\n",
       "  ('specific', 0.2126),\n",
       "  ('retail', 0.2048),\n",
       "  ('taken carcases', 0.2005),\n",
       "  ('detected', 0.1912),\n",
       "  ('glial fibrillary', 0.1864),\n",
       "  ('dressing boning', 0.1809),\n",
       "  ('rooms', 0.1573),\n",
       "  ('chill rooms', 0.1319),\n",
       "  ('involved', 0.1286),\n",
       "  ('sample longissimus', 0.1081),\n",
       "  ('1b glial', 0.1037),\n",
       "  ('fibrillary acidic', 0.1036),\n",
       "  ('1b', 0.0982),\n",
       "  ('activities', 0.0978),\n",
       "  ('involved stunning', 0.0841),\n",
       "  ('striploin taken', 0.0767),\n",
       "  ('presence', 0.0672),\n",
       "  ('central', 0.0649),\n",
       "  ('nervous', 0.0315),\n",
       "  ('acidic', 0.0258),\n",
       "  ('muscle', 0.0229),\n",
       "  ('taken', 0.0076),\n",
       "  ('line', -0.0264),\n",
       "  ('hall', -0.0464)],\n",
       " 'MED-733': [('arthropathy chickens', 0.6377),\n",
       "  ('chickens covers', 0.5103),\n",
       "  ('pathogenesis amyloidosis', 0.5059),\n",
       "  ('amyloidogenicity various', 0.4976),\n",
       "  ('assess amyloidogenicity', 0.484),\n",
       "  ('amyloidosis general', 0.4508),\n",
       "  ('characterization chicken', 0.4471),\n",
       "  ('chicken joint', 0.4361),\n",
       "  ('model amyloid', 0.4213),\n",
       "  ('amyloidogenic faecalis', 0.4088),\n",
       "  ('birds field', 0.3908),\n",
       "  ('knowledge amyloid', 0.3908),\n",
       "  ('general birds', 0.3694),\n",
       "  ('covers pathogenesis', 0.3689),\n",
       "  ('amyloid saa', 0.3588),\n",
       "  ('animal model', 0.3429),\n",
       "  ('arthropathic', 0.3291),\n",
       "  ('arthropathy presented', 0.3239),\n",
       "  ('cases reported', 0.2933),\n",
       "  ('studies performed', 0.2905),\n",
       "  ('field cases', 0.2901),\n",
       "  ('various agents', 0.2779),\n",
       "  ('arthropathy biochemical', 0.2737),\n",
       "  ('review concludes', 0.231),\n",
       "  ('pathology', 0.2282),\n",
       "  ('presents overview', 0.2208),\n",
       "  ('infections', 0.2207),\n",
       "  ('knowledge', 0.1751),\n",
       "  ('protein', 0.1743),\n",
       "  ('reported', 0.1735),\n",
       "  ('gene involved', 0.1684),\n",
       "  ('covers', 0.1528),\n",
       "  ('involved', 0.133),\n",
       "  ('biochemical characterization', 0.131),\n",
       "  ('infections brown', 0.129),\n",
       "  ('faecalis infections', 0.125),\n",
       "  ('model', 0.1233),\n",
       "  ('compared enterococcus', 0.1209),\n",
       "  ('type', 0.1198),\n",
       "  ('present paper', 0.1166),\n",
       "  ('layers', 0.109),\n",
       "  ('aa', 0.1022),\n",
       "  ('performed assess', 0.1012),\n",
       "  ('compared', 0.0796),\n",
       "  ('current', 0.0577),\n",
       "  ('mrna expression', 0.054),\n",
       "  ('joint liver', 0.0453),\n",
       "  ('investigation serum', 0.0279),\n",
       "  ('local saa', -0.003),\n",
       "  ('expression joint', -0.0194)],\n",
       " 'MED-734': [('14 ducks', 0.6726),\n",
       "  ('seven ducks', 0.6701),\n",
       "  ('infected ducks', 0.6046),\n",
       "  ('ducks groups', 0.6029),\n",
       "  ('groups inoculated', 0.4352),\n",
       "  ('birds domestic', 0.4128),\n",
       "  ('dose oocysts', 0.404),\n",
       "  ('divided seven', 0.3374),\n",
       "  ('ducks remained', 0.3198),\n",
       "  ('total 28', 0.3053),\n",
       "  ('24 infected', 0.2972),\n",
       "  ('days 14', 0.2908),\n",
       "  ('inoculated os', 0.2399),\n",
       "  ('test day', 0.2322),\n",
       "  ('gallinaceous birds', 0.2302),\n",
       "  ('group used', 0.2253),\n",
       "  ('gondii infection', 0.2221),\n",
       "  ('days', 0.1962),\n",
       "  ('depending infectious', 0.187),\n",
       "  ('domestic', 0.171),\n",
       "  ('strain', 0.1698),\n",
       "  ('used control', 0.1465),\n",
       "  ('signs results', 0.1458),\n",
       "  ('100 47', 0.1454),\n",
       "  ('k21 strain', 0.1337),\n",
       "  ('os 10', 0.1334),\n",
       "  ('remaining group', 0.1282),\n",
       "  ('total', 0.1247),\n",
       "  ('22 liver', 0.1228),\n",
       "  ('bioassay mice', 0.1151),\n",
       "  ('strain avirulent', 0.1145),\n",
       "  ('titres decreased', 0.1134),\n",
       "  ('clinical', 0.0838),\n",
       "  ('range', 0.0781),\n",
       "  ('stomach 46', 0.0649),\n",
       "  ('divided', 0.0562),\n",
       "  ('54 13', 0.0456),\n",
       "  ('80 20', 0.0349),\n",
       "  ('compared', 0.031),\n",
       "  ('640 depending', 0.0291),\n",
       "  ('antibodies', 0.0255),\n",
       "  ('leg muscles', 0.0239),\n",
       "  ('increased', 0.0179),\n",
       "  ('relatively susceptible', 0.0162),\n",
       "  ('heart', 0.0094),\n",
       "  ('brain 91', 0.0016),\n",
       "  ('breast', -0.0143),\n",
       "  ('post', -0.0432),\n",
       "  ('indirect fluorescence', -0.0597),\n",
       "  ('remained', -0.1441)],\n",
       " 'MED-735': [('aspirin therapy', 0.6667),\n",
       "  ('aspirin 75', 0.5269),\n",
       "  ('risk factors', 0.4372),\n",
       "  ('gastroprotectants results', 0.4333),\n",
       "  ('ulcers quantitating', 0.4206),\n",
       "  ('information ulcer', 0.4148),\n",
       "  ('preventing vascular', 0.3653),\n",
       "  ('discussing risks', 0.3336),\n",
       "  ('inflammatory drugs', 0.2997),\n",
       "  ('dyspeptic', 0.2918),\n",
       "  ('different patients', 0.2885),\n",
       "  ('325 mg', 0.2553),\n",
       "  ('needs considering', 0.2542),\n",
       "  ('benefits patients', 0.2498),\n",
       "  ('benefit decisions', 0.2399),\n",
       "  ('patients followed', 0.2379),\n",
       "  ('duodenal ulcer', 0.2321),\n",
       "  ('events information', 0.2261),\n",
       "  ('included use', 0.2152),\n",
       "  ('symptoms significantly', 0.2113),\n",
       "  ('asymptomatic needs', 0.2059),\n",
       "  ('prevalence endoscopic', 0.2023),\n",
       "  ('mg daily', 0.2009),\n",
       "  ('incidence population', 0.1995),\n",
       "  ('drugs non', 0.1978),\n",
       "  ('187 patients', 0.197),\n",
       "  ('countries exclusions', 0.1931),\n",
       "  ('ci conclusions', 0.187),\n",
       "  ('decisions individual', 0.1865),\n",
       "  ('helicobacter', 0.1788),\n",
       "  ('include older', 0.1765),\n",
       "  ('113 patients', 0.1752),\n",
       "  ('population representative', 0.1558),\n",
       "  ('predictors methods', 0.1528),\n",
       "  ('taking low', 0.1508),\n",
       "  ('aim', 0.1457),\n",
       "  ('therapy', 0.1333),\n",
       "  ('months 95', 0.1214),\n",
       "  ('steroidal', 0.121),\n",
       "  ('daily recruited', 0.1207),\n",
       "  ('baseline', 0.0946),\n",
       "  ('infection increased', 0.0889),\n",
       "  ('later eligible', 0.0717),\n",
       "  ('149 did', 0.063),\n",
       "  ('anti', 0.0489),\n",
       "  ('15 20', 0.0245),\n",
       "  ('ratio 18', 0.0142),\n",
       "  ('10 patients', 0.0115),\n",
       "  ('age 70', 0.0041),\n",
       "  ('months later', -0.1095)],\n",
       " 'MED-736': [('diverticular disease', 0.7119),\n",
       "  ('diverticulitis cornerstone', 0.6611),\n",
       "  ('age diverticular', 0.6311),\n",
       "  ('uncomplicated diverticulitis', 0.5823),\n",
       "  ('disease strictures', 0.4419),\n",
       "  ('colon prevalent', 0.4097),\n",
       "  ('inflammatory bowel', 0.4023),\n",
       "  ('colitis associated', 0.401),\n",
       "  ('considered disease', 0.3293),\n",
       "  ('causes hospitalization', 0.3204),\n",
       "  ('elderly increasing', 0.3104),\n",
       "  ('peridiverticular abscess', 0.3001),\n",
       "  ('fistulisation', 0.2991),\n",
       "  ('maladies inflammatoires', 0.2921),\n",
       "  ('sténoses ou', 0.2826),\n",
       "  ('complications compris', 0.2794),\n",
       "  ('outpatient visits', 0.2782),\n",
       "  ('treatment aminosalicylates', 0.2763),\n",
       "  ('management antibiotic', 0.2594),\n",
       "  ('causes consultations', 0.2435),\n",
       "  ('western society', 0.2237),\n",
       "  ('younger 40', 0.2139),\n",
       "  ('uncomplicated', 0.2098),\n",
       "  ('prevalent conditions', 0.2027),\n",
       "  ('perforation', 0.1965),\n",
       "  ('intestinal la', 0.1945),\n",
       "  ('surgical', 0.1853),\n",
       "  ('colite segmentaire', 0.1801),\n",
       "  ('benefit treatment', 0.1567),\n",
       "  ('management required', 0.1516),\n",
       "  ('obstruction résumé', 0.1486),\n",
       "  ('primarily affecting', 0.1398),\n",
       "  ('incidence individuals', 0.1396),\n",
       "  ('cornerstone', 0.1292),\n",
       "  ('common histopathological', 0.1178),\n",
       "  ('society leading', 0.1132),\n",
       "  ('ambulatoires et', 0.0911),\n",
       "  ('se manifeste', 0.088),\n",
       "  ('repos', 0.0756),\n",
       "  ('récurrente ou', 0.0647),\n",
       "  ('société occidentale', 0.0505),\n",
       "  ('years', 0.0448),\n",
       "  ('partage des', 0.0368),\n",
       "  ('caractéristiques', 0.0368),\n",
       "  ('ans', 0.0257),\n",
       "  ('imposer', 0.0157),\n",
       "  ('elle touchait', 0.0),\n",
       "  ('profiter', -0.0184),\n",
       "  ('angulaire du', -0.0517),\n",
       "  ('presents', -0.0526)],\n",
       " 'MED-743': [('systematic reviews', 0.581),\n",
       "  ('search medline', 0.562),\n",
       "  ('search methods', 0.5588),\n",
       "  ('searched additional', 0.5281),\n",
       "  ('herbal medicines', 0.5239),\n",
       "  ('trials included', 0.4851),\n",
       "  ('register cochrane', 0.482),\n",
       "  ('studies investigated', 0.4661),\n",
       "  ('depression utilized', 0.435),\n",
       "  ('medicines st', 0.376),\n",
       "  ('bibliographies', 0.3748),\n",
       "  ('contents databases', 0.3668),\n",
       "  ('symptoms compared', 0.3617),\n",
       "  ('additional references', 0.348),\n",
       "  ('imipramine compared', 0.3357),\n",
       "  ('clinical endpoints', 0.3271),\n",
       "  ('efficacious fluoxetine', 0.306),\n",
       "  ('researchers contacted', 0.2934),\n",
       "  ('requirements studies', 0.2858),\n",
       "  ('cinahl amed', 0.2688),\n",
       "  ('efficacious compared', 0.2676),\n",
       "  ('investigated', 0.2575),\n",
       "  ('sources', 0.2407),\n",
       "  ('identified met', 0.2359),\n",
       "  ('st john', 0.227),\n",
       "  ('investigated saffron', 0.2215),\n",
       "  ('eligibility requirements', 0.2182),\n",
       "  ('papers previous', 0.1928),\n",
       "  ('wort treatment', 0.1862),\n",
       "  ('instruments assess', 0.1755),\n",
       "  ('watch psych', 0.1718),\n",
       "  ('meta', 0.17),\n",
       "  ('utilized validated', 0.1606),\n",
       "  ('treatment mild', 0.1599),\n",
       "  ('stigma investigated', 0.1528),\n",
       "  ('health', 0.1483),\n",
       "  ('methods computer', 0.1435),\n",
       "  ('combination', 0.1334),\n",
       "  ('info current', 0.1155),\n",
       "  ('significantly improve', 0.0942),\n",
       "  ('week week', 0.0904),\n",
       "  ('rhodiola located', 0.0875),\n",
       "  ('conclusion number', 0.0745),\n",
       "  ('placebo equally', 0.0572),\n",
       "  ('promise management', 0.0221),\n",
       "  ('decrease', -0.0028),\n",
       "  ('hand', -0.03),\n",
       "  ('petal significantly', -0.04),\n",
       "  ('individual', -0.0444),\n",
       "  ('combination lavender', -0.0457)],\n",
       " 'MED-744': [('saffron cultural', 0.4167),\n",
       "  ('aegean wall', 0.3731),\n",
       "  ('painting building', 0.3471),\n",
       "  ('xeste akrotiri', 0.3101),\n",
       "  ('used bronze', 0.3071),\n",
       "  ('building xeste', 0.2907),\n",
       "  ('presents new', 0.2867),\n",
       "  ('theran innovations', 0.2846),\n",
       "  ('representations complex', 0.2836),\n",
       "  ('innovations', 0.2778),\n",
       "  ('iconographic', 0.274),\n",
       "  ('frescoes appear', 0.2452),\n",
       "  ('image herbal', 0.2397),\n",
       "  ('millennium bce', 0.2357),\n",
       "  ('carturightianus', 0.2276),\n",
       "  ('illustration goddess', 0.225),\n",
       "  ('borrowed medicinal', 0.2224),\n",
       "  ('paper presents', 0.2163),\n",
       "  ('3000 1100', 0.2111),\n",
       "  ('meaning', 0.208),\n",
       "  ('active principle', 0.1977),\n",
       "  ('thematic exchange', 0.1787),\n",
       "  ('commercial interconnections', 0.174),\n",
       "  ('cultural', 0.1703),\n",
       "  ('including variety', 0.1694),\n",
       "  ('lines evidence', 0.1662),\n",
       "  ('associated phytotherapy', 0.1645),\n",
       "  ('methods display', 0.1639),\n",
       "  ('given crocus', 0.1545),\n",
       "  ('wall', 0.1508),\n",
       "  ('accurate image', 0.1304),\n",
       "  ('civilizations early', 0.1219),\n",
       "  ('earliest botanically', 0.1205),\n",
       "  ('bce indicate', 0.1194),\n",
       "  ('visual attention', 0.1138),\n",
       "  ('world', 0.1082),\n",
       "  ('age present', 0.0991),\n",
       "  ('monumental', 0.0857),\n",
       "  ('production', 0.0806),\n",
       "  ('primary subjects', 0.0755),\n",
       "  ('collection', 0.0672),\n",
       "  ('medicine', 0.0658),\n",
       "  ('2nd', 0.0574),\n",
       "  ('ninety', 0.0511),\n",
       "  ('blooms collection', 0.0508),\n",
       "  ('stigmas sheer', 0.0402),\n",
       "  ('divinity', 0.0287),\n",
       "  ('healing unusual', 0.0052),\n",
       "  ('concerns', -0.0181),\n",
       "  ('plucking', -0.1075)],\n",
       " 'MED-745': [('rct objective', 0.6201),\n",
       "  ('masked rct', 0.5838),\n",
       "  ('discrepancy rct', 0.5705),\n",
       "  ('bias validity', 0.542),\n",
       "  ('evidence difference', 0.4656),\n",
       "  ('normal rct', 0.4627),\n",
       "  ('scientific methodology', 0.456),\n",
       "  ('measure bias', 0.4488),\n",
       "  ('methodological stringency', 0.406),\n",
       "  ('rigorous evidence', 0.4044),\n",
       "  ('biases investigator', 0.3986),\n",
       "  ('untainted bias', 0.3753),\n",
       "  ('bias brief', 0.3553),\n",
       "  ('augment methodological', 0.3536),\n",
       "  ('experiments examined', 0.3292),\n",
       "  ('validity', 0.3126),\n",
       "  ('unbiased method', 0.3089),\n",
       "  ('accepted medicine', 0.3038),\n",
       "  ('realist sense', 0.2829),\n",
       "  ('methodology hypothetical', 0.2781),\n",
       "  ('argument presented', 0.2643),\n",
       "  ('experiment susceptible', 0.2595),\n",
       "  ('disciplinary sense', 0.2435),\n",
       "  ('knowledge untainted', 0.2405),\n",
       "  ('considered objective', 0.2359),\n",
       "  ('deviation truth', 0.2348),\n",
       "  ('standard concealment', 0.2305),\n",
       "  ('blind', 0.2126),\n",
       "  ('article examines', 0.2122),\n",
       "  ('placebo', 0.2041),\n",
       "  ('introduced masked', 0.2),\n",
       "  ('used judge', 0.185),\n",
       "  ('brief overview', 0.1823),\n",
       "  ('artifacts', 0.1745),\n",
       "  ('independent apparatus', 0.1676),\n",
       "  ('just theoretical', 0.163),\n",
       "  ('facts exist', 0.1613),\n",
       "  ('subversion', 0.1559),\n",
       "  ('consent briefly', 0.1486),\n",
       "  ('used', 0.1459),\n",
       "  ('examined augment', 0.118),\n",
       "  ('recent developments', 0.1167),\n",
       "  ('objective softer', 0.1092),\n",
       "  ('ideally performed', 0.1063),\n",
       "  ('indicate double', 0.1027),\n",
       "  ('self selection', 0.1004),\n",
       "  ('hypothetical platinum', 0.0764),\n",
       "  ('rests', 0.0398),\n",
       "  ('capable generating', -0.0088),\n",
       "  ('gold', -0.0474)],\n",
       " 'MED-746': [('erectile dysfunction', 0.4629),\n",
       "  ('200mg saffron', 0.4618),\n",
       "  ('saffron patients', 0.3881),\n",
       "  ('saffron studied', 0.3697),\n",
       "  ('dysfunction ed', 0.3597),\n",
       "  ('sativus saffron', 0.3525),\n",
       "  ('index erectile', 0.3488),\n",
       "  ('ed taking', 0.2889),\n",
       "  ('tablet containing', 0.2701),\n",
       "  ('ed male', 0.2549),\n",
       "  ('seen patients', 0.2468),\n",
       "  ('treatment 22', 0.2426),\n",
       "  ('start treatment', 0.2387),\n",
       "  ('penile', 0.2356),\n",
       "  ('male patients', 0.2238),\n",
       "  ('treatment end', 0.2085),\n",
       "  ('patients underwent', 0.1959),\n",
       "  ('20 90', 0.1919),\n",
       "  ('tumescence ilef', 0.1885),\n",
       "  ('questionnaire iief', 0.1831),\n",
       "  ('crocus sativus', 0.174),\n",
       "  ('higher patients', 0.1716),\n",
       "  ('function questionnaire', 0.1704),\n",
       "  ('end days', 0.1652),\n",
       "  ('function increased', 0.1624),\n",
       "  ('npt test', 0.1562),\n",
       "  ('studied male', 0.1554),\n",
       "  ('underwent nocturnal', 0.147),\n",
       "  ('study effect', 0.1458),\n",
       "  ('effect crocus', 0.1402),\n",
       "  ('scores significantly', 0.1265),\n",
       "  ('15 total', 0.1035),\n",
       "  ('morning took', 0.1026),\n",
       "  ('increased number', 0.0946),\n",
       "  ('duration', 0.0847),\n",
       "  ('improvement tip', 0.0738),\n",
       "  ('sexual', 0.0732),\n",
       "  ('events seen', 0.0685),\n",
       "  ('base rigidity', 0.0664),\n",
       "  ('001', 0.0571),\n",
       "  ('international index', 0.0537),\n",
       "  ('followed', 0.0514),\n",
       "  ('treatment 39', 0.0491),\n",
       "  ('showed positive', 0.0335),\n",
       "  ('total', 0.032),\n",
       "  ('statistically', 0.026),\n",
       "  ('90 001', 0.0089),\n",
       "  ('taking', -0.0134),\n",
       "  ('44', -0.0218),\n",
       "  ('containing', -0.0447)],\n",
       " 'MED-748': [('medical ethics', 0.5507),\n",
       "  ('ethical problem', 0.4909),\n",
       "  ('problem medical', 0.4717),\n",
       "  ('questions medical', 0.4434),\n",
       "  ('ethics treated', 0.4373),\n",
       "  ('approaches inseparability', 0.4204),\n",
       "  ('inseparability questions', 0.4096),\n",
       "  ('medical practices', 0.4062),\n",
       "  ('difficult cases', 0.3762),\n",
       "  ('physicians insufficiency', 0.3745),\n",
       "  ('moral theories', 0.3677),\n",
       "  ('questions social', 0.3667),\n",
       "  ('casuistical problems', 0.3641),\n",
       "  ('illustrative paradoxes', 0.3609),\n",
       "  ('question legitimacy', 0.3338),\n",
       "  ('problems', 0.333),\n",
       "  ('theories argue', 0.3073),\n",
       "  ('social theory', 0.307),\n",
       "  ('legitimacy social', 0.2871),\n",
       "  ('ideology critique', 0.2803),\n",
       "  ('assessment medical', 0.2756),\n",
       "  ('strategies ideology', 0.2526),\n",
       "  ('social history', 0.2444),\n",
       "  ('exercised physicians', 0.2343),\n",
       "  ('especially difficult', 0.2247),\n",
       "  ('global moral', 0.2171),\n",
       "  ('social authority', 0.2138),\n",
       "  ('critique seeing', 0.2102),\n",
       "  ('opposition', 0.2053),\n",
       "  ('cases', 0.2022),\n",
       "  ('consent approaches', 0.2019),\n",
       "  ('societies', 0.1835),\n",
       "  ('practice', 0.1831),\n",
       "  ('help reframe', 0.1824),\n",
       "  ('role based', 0.1726),\n",
       "  ('treated especially', 0.1349),\n",
       "  ('focus discussion', 0.1327),\n",
       "  ('attacks strategies', 0.127),\n",
       "  ('argued help', 0.1215),\n",
       "  ('liberal societies', 0.1183),\n",
       "  ('based argued', 0.1029),\n",
       "  ('institution', 0.0711),\n",
       "  ('history', 0.0674),\n",
       "  ('advantages global', 0.0643),\n",
       "  ('traditional', 0.0362),\n",
       "  ('illustrative', 0.0341),\n",
       "  ('voluntarist informed', 0.0297),\n",
       "  ('defences authority', 0.0107),\n",
       "  ('normative assessment', -0.006),\n",
       "  ('broadly adequately', -0.0092)],\n",
       " 'MED-749': [('medical school', 0.5044),\n",
       "  ('nutrition curricula', 0.4346),\n",
       "  ('training medical', 0.4316),\n",
       "  ('physicians perceived', 0.4304),\n",
       "  ('school inadequate', 0.4303),\n",
       "  ('curricula use', 0.389),\n",
       "  ('decrease medical', 0.3867),\n",
       "  ('number physicians', 0.3844),\n",
       "  ('schools worked', 0.3498),\n",
       "  ('1950s schools', 0.3144),\n",
       "  ('suggest medical', 0.3105),\n",
       "  ('nutrition decrease', 0.3058),\n",
       "  ('nutritional therapy', 0.2833),\n",
       "  ('program students', 0.277),\n",
       "  ('improve training', 0.2739),\n",
       "  ('inadequate literature', 0.2735),\n",
       "  ('school recent', 0.2489),\n",
       "  ('students perception', 0.2265),\n",
       "  ('quality nutrition', 0.2225),\n",
       "  ('inadequate', 0.2206),\n",
       "  ('program', 0.1881),\n",
       "  ('reduce morbidity', 0.1871),\n",
       "  ('certification program', 0.1828),\n",
       "  ('changed 1950s', 0.1797),\n",
       "  ('hours nutrition', 0.1766),\n",
       "  ('therapy', 0.1751),\n",
       "  ('importance clinical', 0.1699),\n",
       "  ('literature review', 0.1685),\n",
       "  ('appears declining', 0.1579),\n",
       "  ('perceived quality', 0.1453),\n",
       "  ('modeled cardiac', 0.1346),\n",
       "  ('fewer hours', 0.1316),\n",
       "  ('preceptors modeled', 0.1164),\n",
       "  ('data suggest', 0.1122),\n",
       "  ('problem implement', 0.1062),\n",
       "  ('historically', 0.105),\n",
       "  ('awareness problem', 0.0976),\n",
       "  ('life support', 0.0879),\n",
       "  ('support importance', 0.0769),\n",
       "  ('suggests perception', 0.0741),\n",
       "  ('recent', 0.0686),\n",
       "  ('heart association', 0.0648),\n",
       "  ('worked', 0.0635),\n",
       "  ('mortality number', 0.0563),\n",
       "  ('significantly changed', 0.048),\n",
       "  ('significantly', 0.0237),\n",
       "  ('targeted', 0.02),\n",
       "  ('american', 0.0128),\n",
       "  ('association', -0.0151),\n",
       "  ('appears', -0.0797)],\n",
       " 'MED-751': [('fats cholesterol', 0.6177),\n",
       "  ('cholesterol previously', 0.4738),\n",
       "  ('risk cardiovascular', 0.4405),\n",
       "  ('risk dietary', 0.4324),\n",
       "  ('body composition', 0.4175),\n",
       "  ('aims dietary', 0.413),\n",
       "  ('cholesterol eggs', 0.3993),\n",
       "  ('cvd years', 0.3784),\n",
       "  ('health aging', 0.3433),\n",
       "  ('older adults', 0.3205),\n",
       "  ('middle aged', 0.3141),\n",
       "  ('significant associations', 0.28),\n",
       "  ('coronary death', 0.2449),\n",
       "  ('item food', 0.2379),\n",
       "  ('risk community', 0.227),\n",
       "  ('consumption hr', 0.223),\n",
       "  ('type diabetes', 0.2222),\n",
       "  ('aged 70', 0.214),\n",
       "  ('79 health', 0.1962),\n",
       "  ('egg', 0.1878),\n",
       "  ('95 ci', 0.1877),\n",
       "  ('previously associated', 0.1805),\n",
       "  ('purpose study', 0.171),\n",
       "  ('hazards models', 0.1578),\n",
       "  ('subgroup analyses', 0.1554),\n",
       "  ('associated increased', 0.1544),\n",
       "  ('biological mechanism', 0.1506),\n",
       "  ('lower tertile', 0.1469),\n",
       "  ('ci 68', 0.1286),\n",
       "  ('assessed using', 0.1244),\n",
       "  ('15', 0.1232),\n",
       "  ('frequency questionnaire', 0.1194),\n",
       "  ('populations known', 0.1184),\n",
       "  ('disease', 0.106),\n",
       "  ('02 63', 0.1057),\n",
       "  ('week trend', 0.0962),\n",
       "  ('death stroke', 0.081),\n",
       "  ('dwelling', 0.0756),\n",
       "  ('203 incident', 0.0659),\n",
       "  ('events defined', 0.0621),\n",
       "  ('using cox', 0.0553),\n",
       "  ('32 upper', 0.0549),\n",
       "  ('51 week', 0.049),\n",
       "  ('proportional', 0.0294),\n",
       "  ('09 12', 0.016),\n",
       "  ('upper vs', 0.0131),\n",
       "  ('administered 108', 0.0038),\n",
       "  ('confirmed myocardial', 0.0012),\n",
       "  ('47 93', -0.0358),\n",
       "  ('29', -0.0512)],\n",
       " 'MED-752': [('phytoestrogens inhibit', 0.7571),\n",
       "  ('phytoestrogens expression', 0.6645),\n",
       "  ('reduce aromatase', 0.6514),\n",
       "  ('oestrogens kinetic', 0.6307),\n",
       "  ('48 aromatase', 0.5147),\n",
       "  ('steroidogenic enzymes', 0.4788),\n",
       "  ('converts androgens', 0.4779),\n",
       "  ('phytoestrogens singly', 0.4689),\n",
       "  ('estradiol', 0.4391),\n",
       "  ('genistein', 0.404),\n",
       "  ('kinetic studies', 0.3671),\n",
       "  ('compounds ineffective', 0.3317),\n",
       "  ('isoflavones induced', 0.3188),\n",
       "  ('enzyme paucity', 0.3137),\n",
       "  ('binding enzyme', 0.2952),\n",
       "  ('term effects', 0.2917),\n",
       "  ('investigated flavones', 0.2882),\n",
       "  ('studies showed', 0.2839),\n",
       "  ('testosterone', 0.2645),\n",
       "  ('paucity studies', 0.2559),\n",
       "  ('inhibition mrna', 0.2427),\n",
       "  ('preparations inhibit', 0.2423),\n",
       "  ('expression experiments', 0.2324),\n",
       "  ('dose dependently', 0.2287),\n",
       "  ('lower dose', 0.2177),\n",
       "  ('hypothesis', 0.2047),\n",
       "  ('converts', 0.1811),\n",
       "  ('mixtures compounds', 0.1811),\n",
       "  ('daidzein doses', 0.1754),\n",
       "  ('granulosa luteal', 0.1669),\n",
       "  ('investigating longer', 0.1503),\n",
       "  ('delayed time', 0.1487),\n",
       "  ('tissue accumulation', 0.1291),\n",
       "  ('compared controls', 0.1132),\n",
       "  ('05 higher', 0.1118),\n",
       "  ('cells exposed', 0.1083),\n",
       "  ('chronic dietary', 0.1061),\n",
       "  ('primary cultures', 0.1057),\n",
       "  ('quantitative real', 0.0982),\n",
       "  ('activity significantly', 0.0812),\n",
       "  ('4h period', 0.0777),\n",
       "  ('compare action', 0.0719),\n",
       "  ('measured ability', 0.0711),\n",
       "  ('nm combinations', 0.0683),\n",
       "  ('biochanin', 0.047),\n",
       "  ('free', 0.0211),\n",
       "  ('seen 10', 0.0117),\n",
       "  ('gl cells', 0.0094),\n",
       "  ('carried', -0.0007),\n",
       "  ('singly', -0.0588)],\n",
       " 'MED-753': [('estrogens naf', 0.5428),\n",
       "  ('effect soy', 0.5171),\n",
       "  ('lower estrogens', 0.4359),\n",
       "  ('foods breast', 0.3845),\n",
       "  ('randomized 96', 0.3657),\n",
       "  ('e1s assessed', 0.3302),\n",
       "  ('women produced', 0.286),\n",
       "  ('diet months', 0.2818),\n",
       "  ('estrone', 0.27),\n",
       "  ('isoflavones', 0.2682),\n",
       "  ('cancer risk', 0.2639),\n",
       "  ('effect examined', 0.2604),\n",
       "  ('001 conclusions', 0.2548),\n",
       "  ('86 e1s', 0.2508),\n",
       "  ('protective effect', 0.2206),\n",
       "  ('ng ml', 0.2009),\n",
       "  ('associated rs', 0.1954),\n",
       "  ('treatment serum', 0.1779),\n",
       "  ('56 individuals', 0.1736),\n",
       "  ('nuts', 0.161),\n",
       "  ('mean e2', 0.1546),\n",
       "  ('samples obtained', 0.1421),\n",
       "  ('limits applied', 0.1415),\n",
       "  ('background based', 0.1353),\n",
       "  ('97 correlated', 0.1287),\n",
       "  ('possible indicators', 0.1271),\n",
       "  ('lower high', 0.1262),\n",
       "  ('amounts consumed', 0.1253),\n",
       "  ('nipple aspirate', 0.1239),\n",
       "  ('repeated measures', 0.1172),\n",
       "  ('maintained', 0.1124),\n",
       "  ('interaction group', 0.1021),\n",
       "  ('using firstcyte', 0.1015),\n",
       "  ('vs 68', 0.0979),\n",
       "  ('113 vs', 0.097),\n",
       "  ('consumed asians', 0.096),\n",
       "  ('adverse effects', 0.0944),\n",
       "  ('using highly', 0.0912),\n",
       "  ('counters concerns', 0.0901),\n",
       "  ('48 001', 0.0859),\n",
       "  ('tofu', 0.0812),\n",
       "  ('methods cross', 0.0756),\n",
       "  ('did significantly', 0.0711),\n",
       "  ('radioimmunoassays mixed', 0.067),\n",
       "  ('rs 37', 0.0652),\n",
       "  ('servings', 0.0389),\n",
       "  ('10 μl', 0.0371),\n",
       "  ('07', 0.0222),\n",
       "  ('usual', 0.007),\n",
       "  ('sulfate', -0.0248)],\n",
       " 'MED-754': [('cholesterol lowering', 0.6445),\n",
       "  ('dietary adherence', 0.5919),\n",
       "  ('reductions dietary', 0.5894),\n",
       "  ('selected diets', 0.5486),\n",
       "  ('ldl dietary', 0.5127),\n",
       "  ('fat therapeutic', 0.5059),\n",
       "  ('metabolically controlled', 0.4549),\n",
       "  ('participants hyperlipidemia', 0.4537),\n",
       "  ('interventions percentage', 0.4031),\n",
       "  ('control diet', 0.3909),\n",
       "  ('combining foods', 0.3827),\n",
       "  ('portfolio compared', 0.3564),\n",
       "  ('administered levels', 0.3311),\n",
       "  ('reductions overall', 0.3262),\n",
       "  ('sterols soy', 0.2606),\n",
       "  ('2009 treatments', 0.2457),\n",
       "  ('frequencies emphasized', 0.2298),\n",
       "  ('participants randomized', 0.2268),\n",
       "  ('157', 0.2244),\n",
       "  ('compared low', 0.2086),\n",
       "  ('33 ldl', 0.2054),\n",
       "  ('nuts', 0.1967),\n",
       "  ('advice resulted', 0.1943),\n",
       "  ('06 mg', 0.1864),\n",
       "  ('design study', 0.183),\n",
       "  ('95 confidence', 0.1823),\n",
       "  ('context combining', 0.1823),\n",
       "  ('routine', 0.1735),\n",
       "  ('identifier nct00438425', 0.1662),\n",
       "  ('ci 13', 0.1583),\n",
       "  ('protein viscous', 0.155),\n",
       "  ('incorporation plant', 0.1456),\n",
       "  ('winnipeg vancouver', 0.1406),\n",
       "  ('168 174', 0.1394),\n",
       "  ('identifier', 0.1392),\n",
       "  ('treat', 0.1376),\n",
       "  ('proven highly', 0.1373),\n",
       "  ('26 control', 0.132),\n",
       "  ('2007 february', 0.1315),\n",
       "  ('10 001', 0.1241),\n",
       "  ('serum', 0.1182),\n",
       "  ('parallel design', 0.1127),\n",
       "  ('clinic visits', 0.0938),\n",
       "  ('lasting months', 0.0813),\n",
       "  ('fisher', 0.069),\n",
       "  ('differ significantly', 0.0647),\n",
       "  ('18 intensive', 0.0572),\n",
       "  ('attrition rate', 0.0467),\n",
       "  ('21 mg', -0.0135),\n",
       "  ('academic centers', -0.0318)],\n",
       " 'MED-756': [('telomere dysfunction', 0.5813),\n",
       "  ('lymphocytes 56', 0.3849),\n",
       "  ('tl highlighted', 0.375),\n",
       "  ('micronutrients mean', 0.3425),\n",
       "  ('damage genome', 0.3424),\n",
       "  ('low dietary', 0.3286),\n",
       "  ('information dietary', 0.3161),\n",
       "  ('shortening physiological', 0.3007),\n",
       "  ('length', 0.2961),\n",
       "  ('distribution trfs', 0.2705),\n",
       "  ('antioxidants observed', 0.2693),\n",
       "  ('lead chromosome', 0.2688),\n",
       "  ('study extensive', 0.2598),\n",
       "  ('ageing 008', 0.2492),\n",
       "  ('physiological relevance', 0.2477),\n",
       "  ('short trfs', 0.2355),\n",
       "  ('restriction fragment', 0.225),\n",
       "  ('cells exposed', 0.2207),\n",
       "  ('recent evidences', 0.2134),\n",
       "  ('healthy subjects', 0.2106),\n",
       "  ('blocked micronucleus', 0.2057),\n",
       "  ('peripheral blood', 0.1956),\n",
       "  ('vegetables related', 0.1834),\n",
       "  ('smoking status', 0.1809),\n",
       "  ('analysis association', 0.18),\n",
       "  ('consumption daily', 0.1781),\n",
       "  ('htert genotype', 0.175),\n",
       "  ('ionising radiation', 0.1743),\n",
       "  ('dysfunction visualised', 0.1658),\n",
       "  ('observed subjects', 0.1614),\n",
       "  ('factors influence', 0.1612),\n",
       "  ('assessed terminal', 0.1522),\n",
       "  ('care taken', 0.1518),\n",
       "  ('analysed slight', 0.1509),\n",
       "  ('beta carotene', 0.1485),\n",
       "  ('03 observed', 0.1474),\n",
       "  ('compared incidence', 0.1451),\n",
       "  ('nucleoplasmic', 0.1447),\n",
       "  ('radiation care', 0.1425),\n",
       "  ('maintenance', 0.1341),\n",
       "  ('capability detect', 0.1194),\n",
       "  ('erosion related', 0.116),\n",
       "  ('associated increased', 0.114),\n",
       "  ('did result', 0.0962),\n",
       "  ('bridges npbs', 0.0672),\n",
       "  ('cytokinesis blocked', 0.0617),\n",
       "  ('kb relative', 0.0531),\n",
       "  ('unrelated', 0.0389),\n",
       "  ('vitro', 0.0346),\n",
       "  ('explore', 0.0221)],\n",
       " 'MED-757': [('healthy lifestyles', 0.5992),\n",
       "  ('lifestyle adjustment', 0.5235),\n",
       "  ('exercise bmi', 0.4632),\n",
       "  ('lifestyle 05', 0.4253),\n",
       "  ('lifestyle middle', 0.4243),\n",
       "  ('habits visit', 0.3911),\n",
       "  ('cvd mortality', 0.3878),\n",
       "  ('current smoking', 0.377),\n",
       "  ('aged cohort', 0.3579),\n",
       "  ('fruits vegetables', 0.3488),\n",
       "  ('95 ci', 0.3378),\n",
       "  ('diabetes', 0.292),\n",
       "  ('64 atherosclerosis', 0.2806),\n",
       "  ('risk communities', 0.2776),\n",
       "  ('communities survey', 0.2731),\n",
       "  ('mortality strategies', 0.2675),\n",
       "  ('people hypertension', 0.2663),\n",
       "  ('fewer cardiovascular', 0.2539),\n",
       "  ('events 65', 0.2436),\n",
       "  ('socioeconomic status', 0.2417),\n",
       "  ('determine frequency', 0.2382),\n",
       "  ('kg m2', 0.2251),\n",
       "  ('encourage', 0.2104),\n",
       "  ('implemented especially', 0.2085),\n",
       "  ('disease events', 0.2063),\n",
       "  ('29 kg', 0.2011),\n",
       "  ('individuals did', 0.1987),\n",
       "  ('mortality 60', 0.1956),\n",
       "  ('did adopt', 0.1946),\n",
       "  ('subsequent rates', 0.1925),\n",
       "  ('african americans', 0.1923),\n",
       "  ('ci 39', 0.1817),\n",
       "  ('methods', 0.1815),\n",
       "  ('daily', 0.181),\n",
       "  ('15 708', 0.1771),\n",
       "  ('years conclusions', 0.1685),\n",
       "  ('age 45', 0.1662),\n",
       "  ('adopters lower', 0.1648),\n",
       "  ('compared individuals', 0.1388),\n",
       "  ('01 11', 0.1217),\n",
       "  ('people newly', 0.1158),\n",
       "  ('men', 0.1152),\n",
       "  ('92 years', 0.1112),\n",
       "  ('diverse', 0.0887),\n",
       "  ('18', 0.0813),\n",
       "  ('1344', 0.0634),\n",
       "  ('16 chi2p', 0.0544),\n",
       "  ('970 remainder', 0.0394),\n",
       "  ('m2 current', 0.0205),\n",
       "  ('non', 0.0132)],\n",
       " 'MED-758': [('mortality study', 0.4429),\n",
       "  ('conclusions low', 0.3922),\n",
       "  ('low risk', 0.3682),\n",
       "  ('lifestyle factors', 0.3567),\n",
       "  ('consumption mortality', 0.3483),\n",
       "  ('reduced cause', 0.3469),\n",
       "  ('participants low', 0.3324),\n",
       "  ('smoked healthy', 0.3096),\n",
       "  ('risk behaviors', 0.2801),\n",
       "  ('behaviors smoked', 0.2758),\n",
       "  ('relationship low', 0.2739),\n",
       "  ('moderate alcohol', 0.2574),\n",
       "  ('study', 0.2483),\n",
       "  ('study 1988', 0.2435),\n",
       "  ('states methods', 0.243),\n",
       "  ('national health', 0.2418),\n",
       "  ('examined relationship', 0.2239),\n",
       "  ('causes conclusions', 0.2072),\n",
       "  ('compared participants', 0.2057),\n",
       "  ('behaviors inversely', 0.2032),\n",
       "  ('95 ci', 0.2013),\n",
       "  ('data 16958', 0.1877),\n",
       "  ('17 years', 0.1815),\n",
       "  ('sample people', 0.1809),\n",
       "  ('results number', 0.1788),\n",
       "  ('diet', 0.1771),\n",
       "  ('objectives examined', 0.162),\n",
       "  ('14 years', 0.1522),\n",
       "  ('2006 results', 0.1518),\n",
       "  ('cardiovascular', 0.1383),\n",
       "  ('49 mortality', 0.1356),\n",
       "  ('43 95', 0.134),\n",
       "  ('survey iii', 0.1303),\n",
       "  ('neoplasms years', 0.1294),\n",
       "  ('ci 24', 0.1247),\n",
       "  ('periods representing', 0.1051),\n",
       "  ('37', 0.0917),\n",
       "  ('used', 0.0865),\n",
       "  ('adequate physical', 0.0818),\n",
       "  ('ratio ahr', 0.0789),\n",
       "  ('disease', 0.0737),\n",
       "  ('10 years', 0.0607),\n",
       "  ('confidence', 0.0593),\n",
       "  ('representing equivalent', 0.0432),\n",
       "  ('older', 0.0363),\n",
       "  ('56 major', 0.0362),\n",
       "  ('participants high', 0.0217),\n",
       "  ('powerful beneficial', 0.0152),\n",
       "  ('people united', 0.0007),\n",
       "  ('20', -0.0222)],\n",
       " 'MED-759': [('smoking low', 0.5136),\n",
       "  ('smoking diet', 0.48),\n",
       "  ('cervical cancer', 0.4326),\n",
       "  ('lower consumption', 0.4159),\n",
       "  ('fruits reduced', 0.4064),\n",
       "  ('effects tobacco', 0.4038),\n",
       "  ('intake negatively', 0.3851),\n",
       "  ('non smokers', 0.3844),\n",
       "  ('smokers known', 0.3792),\n",
       "  ('fruits vegetables', 0.3735),\n",
       "  ('effect cin3', 0.3231),\n",
       "  ('65 smokers', 0.3091),\n",
       "  ('carotenoids', 0.3081),\n",
       "  ('lesser effect', 0.296),\n",
       "  ('adjusting confounders', 0.2863),\n",
       "  ('worldwide lower', 0.2838),\n",
       "  ('tocopherol levels', 0.2752),\n",
       "  ('nutritional factors', 0.2553),\n",
       "  ('reduced serum', 0.2438),\n",
       "  ('common cancer', 0.2274),\n",
       "  ('consumption', 0.2147),\n",
       "  ('combined effects', 0.2024),\n",
       "  ('trend 001', 0.1918),\n",
       "  ('brazil 2003', 0.1918),\n",
       "  ('control study', 0.1844),\n",
       "  ('women worldwide', 0.1611),\n",
       "  ('validated ffq', 0.1548),\n",
       "  ('2005 sample', 0.1401),\n",
       "  ('findings suggest', 0.137),\n",
       "  ('neoplasia modified', 0.1312),\n",
       "  ('14 95', 0.109),\n",
       "  ('73 62', 0.1012),\n",
       "  ('são', 0.0963),\n",
       "  ('453', 0.0849),\n",
       "  ('status similar', 0.0807),\n",
       "  ('intraepithelial', 0.0806),\n",
       "  ('compared non', 0.077),\n",
       "  ('histologically confirmed', 0.076),\n",
       "  ('ci', 0.0709),\n",
       "  ('comprised 231', 0.0592),\n",
       "  ('risk', 0.056),\n",
       "  ('39 dark', 0.045),\n",
       "  ('second common', 0.0442),\n",
       "  ('observed total', 0.0143),\n",
       "  ('yellow', 0.0082),\n",
       "  ('green', 0.0007),\n",
       "  ('variables human', -0.002),\n",
       "  ('positively', -0.0258),\n",
       "  ('joint', -0.0393),\n",
       "  ('hospital based', -0.056)],\n",
       " 'MED-760': [('antioxidant spice', 0.6327),\n",
       "  ('dietary antioxidants', 0.5902),\n",
       "  ('plasma antioxidant', 0.5433),\n",
       "  ('antioxidants attenuate', 0.4986),\n",
       "  ('potential dietary', 0.4208),\n",
       "  ('incorporation spices', 0.4114),\n",
       "  ('spiced meal', 0.3856),\n",
       "  ('vivo oxidative', 0.3793),\n",
       "  ('reductions postprandial', 0.3427),\n",
       "  ('spices 02', 0.3417),\n",
       "  ('status metabolism', 0.2995),\n",
       "  ('culinary', 0.2922),\n",
       "  ('effects exists', 0.2872),\n",
       "  ('lipophilic', 0.2611),\n",
       "  ('total thiols', 0.2561),\n",
       "  ('men consumed', 0.2373),\n",
       "  ('plasma increased', 0.2221),\n",
       "  ('levels spiced', 0.2103),\n",
       "  ('objective study', 0.201),\n",
       "  ('tg enhance', 0.1956),\n",
       "  ('1200 kcal', 0.1801),\n",
       "  ('hydrophilic oxygen', 0.1725),\n",
       "  ('ferric reducing', 0.1717),\n",
       "  ('14 high', 0.1682),\n",
       "  ('meal 30', 0.1577),\n",
       "  ('stress little', 0.1537),\n",
       "  ('insulin', 0.1411),\n",
       "  ('consumed control', 0.1405),\n",
       "  ('significant', 0.1386),\n",
       "  ('little characterization', 0.138),\n",
       "  ('blend 5060', 0.1372),\n",
       "  ('differences', 0.132),\n",
       "  ('orac incorporation', 0.1247),\n",
       "  ('sessions blood', 0.1146),\n",
       "  ('min intervals', 0.1126),\n",
       "  ('potent vitro', 0.0993),\n",
       "  ('samples mixed', 0.0985),\n",
       "  ('help', 0.0963),\n",
       "  ('interaction 05', 0.0872),\n",
       "  ('defenses', 0.0827),\n",
       "  ('treatment time', 0.0799),\n",
       "  ('healthy', 0.0758),\n",
       "  ('crossover design', 0.0579),\n",
       "  ('sampled prior', 0.0517),\n",
       "  ('linear models', 0.0458),\n",
       "  ('absorbance', 0.0456),\n",
       "  ('radical', 0.0369),\n",
       "  ('009', 0.0292),\n",
       "  ('testing sessions', -0.0089),\n",
       "  ('corresponding 21', -0.0199)],\n",
       " 'MED-761': [('counseling internists', 0.6648),\n",
       "  ('counseling habits', 0.5746),\n",
       "  ('setting physicians', 0.534),\n",
       "  ('counsel patients', 0.5158),\n",
       "  ('counsel smokers', 0.514),\n",
       "  ('belts internists', 0.47),\n",
       "  ('health habits', 0.446),\n",
       "  ('nonsmoking internists', 0.4352),\n",
       "  ('medical schools', 0.4102),\n",
       "  ('suggests medical', 0.3557),\n",
       "  ('patients exercise', 0.3474),\n",
       "  ('programs', 0.3466),\n",
       "  ('practices substantially', 0.3348),\n",
       "  ('determine associations', 0.3142),\n",
       "  ('patients risk', 0.3092),\n",
       "  ('respondents', 0.3055),\n",
       "  ('indications used', 0.2939),\n",
       "  ('subgroups using', 0.2865),\n",
       "  ('interventions questionnaire', 0.2784),\n",
       "  ('generalists likely', 0.2626),\n",
       "  ('professional', 0.2614),\n",
       "  ('counseling ninety', 0.2603),\n",
       "  ('promotion activities', 0.2573),\n",
       "  ('objectives', 0.2555),\n",
       "  ('fellows american', 0.2335),\n",
       "  ('college', 0.2178),\n",
       "  ('21 regions', 0.212),\n",
       "  ('proportion women', 0.2117),\n",
       "  ('seat belts', 0.1854),\n",
       "  ('support', 0.1779),\n",
       "  ('housestaff training', 0.1773),\n",
       "  ('suggests emphasis', 0.1649),\n",
       "  ('regions selected', 0.1647),\n",
       "  ('used obtain', 0.1584),\n",
       "  ('11 drank', 0.1511),\n",
       "  ('analyses used', 0.137),\n",
       "  ('activities future', 0.1283),\n",
       "  ('activity data', 0.1278),\n",
       "  ('example nonsmoking', 0.1264),\n",
       "  ('64 discussed', 0.118),\n",
       "  ('thoroughness', 0.1149),\n",
       "  ('oversampled', 0.1056),\n",
       "  ('participants thousand', 0.1053),\n",
       "  ('states relatively', 0.1027),\n",
       "  ('use personal', 0.0888),\n",
       "  ('smoked cigarettes', 0.0798),\n",
       "  ('87 used', 0.074),\n",
       "  ('aggressiveness', 0.0629),\n",
       "  ('time men', 0.0614),\n",
       "  ('alcohol daily', 0.0391)],\n",
       " 'MED-762': [('program efeltp', 0.5548),\n",
       "  ('health ethiopian', 0.5281),\n",
       "  ('field epidemiology', 0.4795),\n",
       "  ('improve epidemiology', 0.4294),\n",
       "  ('building ethiopia', 0.4163),\n",
       "  ('health expertise', 0.3957),\n",
       "  ('training service', 0.3736),\n",
       "  ('laboratory training', 0.372),\n",
       "  ('program partnership', 0.36),\n",
       "  ('year competency', 0.3016),\n",
       "  ('established 2009', 0.2996),\n",
       "  ('outbreaks improving', 0.285),\n",
       "  ('comprehensive', 0.2561),\n",
       "  ('capacity building', 0.2479),\n",
       "  ('emergencies', 0.2441),\n",
       "  ('training 75', 0.2419),\n",
       "  ('prevention residents', 0.2348),\n",
       "  ('federal ministry', 0.2333),\n",
       "  ('opportunities improve', 0.2109),\n",
       "  ('working', 0.2064),\n",
       "  ('centers disease', 0.2007),\n",
       "  ('established moh', 0.1957),\n",
       "  ('ababa university', 0.1874),\n",
       "  ('didactic', 0.1869),\n",
       "  ('conducted 42', 0.1842),\n",
       "  ('make recommendations', 0.1729),\n",
       "  ('sustainable public', 0.1637),\n",
       "  ('institute addis', 0.1563),\n",
       "  ('bases established', 0.1559),\n",
       "  ('nutrition', 0.1478),\n",
       "  ('detect respond', 0.147),\n",
       "  ('11 surveillance', 0.1455),\n",
       "  ('10 scientific', 0.1444),\n",
       "  ('evaluations', 0.1253),\n",
       "  ('significant impacts', 0.1191),\n",
       "  ('setting', 0.1112),\n",
       "  ('provided valuable', 0.1013),\n",
       "  ('data make', 0.0867),\n",
       "  ('scientific conferences', 0.0766),\n",
       "  ('residents cohorts', 0.0704),\n",
       "  ('bureaus investigating', 0.0698),\n",
       "  ('school public', 0.0697),\n",
       "  ('27analyses surveillance', 0.0681),\n",
       "  ('manuscripts 2are', 0.0572),\n",
       "  ('young positive', 0.0423),\n",
       "  ('poster presentation', 0.0289),\n",
       "  ('regional', 0.0278),\n",
       "  ('systems had28oral', 0.0201),\n",
       "  ('country better', -0.009),\n",
       "  ('spend 25', -0.0643)],\n",
       " 'MED-816': [('pcos inconsistent', 0.6726),\n",
       "  ('women pcos', 0.6174),\n",
       "  ('management pcos', 0.5866),\n",
       "  ('pcos medline', 0.5645),\n",
       "  ('ovary syndrome', 0.5249),\n",
       "  ('obesity reviews', 0.519),\n",
       "  ('pcos 2012', 0.5),\n",
       "  ('obese women', 0.4608),\n",
       "  ('studies overweight', 0.4416),\n",
       "  ('women polycystic', 0.4402),\n",
       "  ('centrally obese', 0.4245),\n",
       "  ('searched studies', 0.4073),\n",
       "  ('metabolic reproductive', 0.3679),\n",
       "  ('weight outcomes', 0.3579),\n",
       "  ('cochrane central', 0.33),\n",
       "  ('inconsistent review', 0.3253),\n",
       "  ('controlled trials', 0.3241),\n",
       "  ('lipid profile', 0.3084),\n",
       "  ('cholesterol compared', 0.3023),\n",
       "  ('psychological features', 0.296),\n",
       "  ('categories body', 0.2938),\n",
       "  ('embase cinahl', 0.2838),\n",
       "  ('psycinfo', 0.2735),\n",
       "  ('association study', 0.271),\n",
       "  ('women central', 0.2399),\n",
       "  ('mass index', 0.2374),\n",
       "  ('syndrome', 0.2336),\n",
       "  ('decreased sex', 0.2179),\n",
       "  ('assessment insulin', 0.2137),\n",
       "  ('outcomes measured', 0.2026),\n",
       "  ('central register', 0.2021),\n",
       "  ('index hirsutism', 0.1669),\n",
       "  ('total testosterone', 0.1658),\n",
       "  ('normal weight', 0.1583),\n",
       "  ('higher fasting', 0.1574),\n",
       "  ('differences total', 0.146),\n",
       "  ('results suggest', 0.1428),\n",
       "  ('authors', 0.1313),\n",
       "  ('effect excess', 0.1211),\n",
       "  ('homeostatic model', 0.115),\n",
       "  ('30 eligible', 0.1128),\n",
       "  ('ratio 95', 0.0834),\n",
       "  ('suggest prevention', 0.0649),\n",
       "  ('resistance index', 0.0613),\n",
       "  ('low density', 0.0492),\n",
       "  ('international', 0.0424),\n",
       "  ('confidence', 0.0377),\n",
       "  ('worsened', 0.0183),\n",
       "  ('binding globulin', -0.0137),\n",
       "  ('shbg increased', -0.0493)],\n",
       " 'MED-818': [('maca plant', 0.4642),\n",
       "  ('lepidium meyenii', 0.4484),\n",
       "  ('andes hypocotyls', 0.4032),\n",
       "  ('central peruvian', 0.3685),\n",
       "  ('meyenii maca', 0.3469),\n",
       "  ('4000 meters', 0.3255),\n",
       "  ('plant', 0.3096),\n",
       "  ('lower health', 0.2934),\n",
       "  ('nutritional medicinal', 0.2832),\n",
       "  ('low chronic', 0.2595),\n",
       "  ('assess lower', 0.2508),\n",
       "  ('measure health', 0.2398),\n",
       "  ('life hrql', 0.2021),\n",
       "  ('level central', 0.1475),\n",
       "  ('chronic mountain', 0.1355),\n",
       "  ('questionnaire sf', 0.1233),\n",
       "  ('study designed', 0.1163),\n",
       "  ('sickness cms', 0.1104),\n",
       "  ('blood pressure', 0.0935),\n",
       "  ('levels interleukin', 0.0924),\n",
       "  ('summary measure', 0.0919),\n",
       "  ('grows', 0.0815),\n",
       "  ('survey used', 0.0743),\n",
       "  ('used obtain', 0.0683),\n",
       "  ('sf 20', 0.0662),\n",
       "  ('junin 4100', 0.0658),\n",
       "  ('conclusion consumption', 0.0512),\n",
       "  ('function hemoglobin', 0.0502),\n",
       "  ('significant association', 0.0482),\n",
       "  ('consumers compared', 0.0474),\n",
       "  ('better', 0.0446),\n",
       "  ('status scores', 0.0402),\n",
       "  ('properties', 0.0261),\n",
       "  ('andes', 0.0139),\n",
       "  ('meters sea', 0.0109),\n",
       "  ('hormone', 0.005),\n",
       "  ('score higher', 0.0044),\n",
       "  ('traditionally', -0.0085),\n",
       "  ('23 non', -0.0119),\n",
       "  ('extremity function', -0.0131),\n",
       "  ('subjects', -0.014),\n",
       "  ('successfully completed', -0.0154),\n",
       "  ('cross', -0.0284),\n",
       "  ('chair sit', -0.0748),\n",
       "  ('27', -0.0754),\n",
       "  ('sucsd test', -0.0836),\n",
       "  ('50 subjects', -0.085),\n",
       "  ('ratio 05', -0.1014),\n",
       "  ('01 showing', -0.1162),\n",
       "  ('sexual', -0.1723)],\n",
       " 'MED-819': [('subjects metformin', 0.6429),\n",
       "  ('metformin hypocaloric', 0.5284),\n",
       "  ('pcos women', 0.5034),\n",
       "  ('insulin resistance', 0.4729),\n",
       "  ('metformin 29', 0.4171),\n",
       "  ('obese overweight', 0.4056),\n",
       "  ('trial patients', 0.4005),\n",
       "  ('improving insulin', 0.3878),\n",
       "  ('27 pcos', 0.3871),\n",
       "  ('weight reduction', 0.3348),\n",
       "  ('methods women', 0.334),\n",
       "  ('patients diet', 0.3262),\n",
       "  ('gynaecology research', 0.3127),\n",
       "  ('compared hypocaloric', 0.308),\n",
       "  ('investigate efficacy', 0.2873),\n",
       "  ('polycystic ovary', 0.2857),\n",
       "  ('treatment period', 0.2763),\n",
       "  ('trial 17', 0.275),\n",
       "  ('fasting glucose', 0.2676),\n",
       "  ('mass index', 0.2646),\n",
       "  ('crp significantly', 0.2594),\n",
       "  ('waist circumference', 0.2329),\n",
       "  ('randomly allocated', 0.2183),\n",
       "  ('group 001', 0.211),\n",
       "  ('subjects completed', 0.2055),\n",
       "  ('level markers', 0.1991),\n",
       "  ('present study', 0.1725),\n",
       "  ('weeks high', 0.1709),\n",
       "  ('ir', 0.1686),\n",
       "  ('significant differences', 0.1658),\n",
       "  ('sensitivity check', 0.165),\n",
       "  ('homeostasis model', 0.1643),\n",
       "  ('serum concentration', 0.1361),\n",
       "  ('results total', 0.1355),\n",
       "  ('50 vs', 0.1287),\n",
       "  ('99 008', 0.1184),\n",
       "  ('society obstetrics', 0.1133),\n",
       "  ('08 14', 0.0987),\n",
       "  ('research 2012', 0.0865),\n",
       "  ('authors journal', 0.0863),\n",
       "  ('syndrome', 0.0841),\n",
       "  ('groups decrease', 0.0727),\n",
       "  ('13 subjects', 0.0709),\n",
       "  ('30', 0.0679),\n",
       "  ('index better', 0.0592),\n",
       "  ('60 004', 0.0541),\n",
       "  ('did', 0.0242),\n",
       "  ('vs 81', 0.0236),\n",
       "  ('total 10', -0.0586),\n",
       "  ('japan', -0.0745)],\n",
       " 'MED-820': [('marjoram tea', 0.5054),\n",
       "  ('marjoram herb', 0.5031),\n",
       "  ('regulate menstrual', 0.4827),\n",
       "  ('placebo tea', 0.3718),\n",
       "  ('traditional medicine', 0.3716),\n",
       "  ('ovary syndrome', 0.3656),\n",
       "  ('pcos randomised', 0.345),\n",
       "  ('intervention follicle', 0.3258),\n",
       "  ('herb origanum', 0.3179),\n",
       "  ('hormone progesterone', 0.314),\n",
       "  ('luteinising', 0.3049),\n",
       "  ('androgens research', 0.2954),\n",
       "  ('beneficial effects', 0.2864),\n",
       "  ('compared placebo', 0.2771),\n",
       "  ('herb', 0.2763),\n",
       "  ('women improve', 0.2579),\n",
       "  ('mechanisms contributing', 0.249),\n",
       "  ('trial methods', 0.2386),\n",
       "  ('metabolic parameters', 0.2332),\n",
       "  ('present study', 0.2257),\n",
       "  ('month intervention', 0.2231),\n",
       "  ('dehydroepiandrosterone', 0.2001),\n",
       "  ('investigate active', 0.1999),\n",
       "  ('women polycystic', 0.1964),\n",
       "  ('cycle pilot', 0.1959),\n",
       "  ('majorana locally', 0.1913),\n",
       "  ('homeostasis model', 0.1844),\n",
       "  ('locally reputed', 0.173),\n",
       "  ('improve insulin', 0.1718),\n",
       "  ('μu', 0.1555),\n",
       "  ('patients', 0.15),\n",
       "  ('confirm results', 0.1491),\n",
       "  ('dietetic association', 0.1442),\n",
       "  ('ability restore', 0.1436),\n",
       "  ('research needed', 0.1436),\n",
       "  ('dhea fasting', 0.1375),\n",
       "  ('measured baseline', 0.1152),\n",
       "  ('total', 0.1096),\n",
       "  ('change', 0.1079),\n",
       "  ('twice daily', 0.1052),\n",
       "  ('11 hormonal', 0.097),\n",
       "  ('controlled', 0.0818),\n",
       "  ('ir', 0.0776),\n",
       "  ('significantly reduced', 0.0748),\n",
       "  ('2015', 0.0726),\n",
       "  ('05 conclusions', 0.065),\n",
       "  ('blind', 0.0347),\n",
       "  ('08 homa', 0.027),\n",
       "  ('group 06', -0.0072),\n",
       "  ('sulphate', -0.017)],\n",
       " 'MED-821': [('women pcos', 0.6254),\n",
       "  ('pcos 18', 0.555),\n",
       "  ('intervention women', 0.5242),\n",
       "  ('kg women', 0.4564),\n",
       "  ('hypothesized weight', 0.3861),\n",
       "  ('randomized pilot', 0.3837),\n",
       "  ('overweight body', 0.3719),\n",
       "  ('study delivered', 0.3608),\n",
       "  ('fat intake', 0.3522),\n",
       "  ('participants', 0.3496),\n",
       "  ('diet effective', 0.3124),\n",
       "  ('18 age', 0.2859),\n",
       "  ('ovary', 0.2839),\n",
       "  ('assess feasibility', 0.2788),\n",
       "  ('polycystic', 0.2542),\n",
       "  ('comparing vegan', 0.2489),\n",
       "  ('infertility recruited', 0.2427),\n",
       "  ('kcal', 0.2408),\n",
       "  ('effective promoting', 0.2305),\n",
       "  ('confirm results', 0.2158),\n",
       "  ('67 analyses', 0.2148),\n",
       "  ('39 kg', 0.2139),\n",
       "  ('intention treat', 0.2026),\n",
       "  ('participants 112', 0.196),\n",
       "  ('groups significantly', 0.1758),\n",
       "  ('energy 02', 0.1728),\n",
       "  ('adoption', 0.1703),\n",
       "  ('001 months', 0.1523),\n",
       "  ('larger', 0.1492),\n",
       "  ('participate month', 0.1485),\n",
       "  ('participants lost', 0.1451),\n",
       "  ('suggest engagement', 0.1414),\n",
       "  ('2014', 0.1376),\n",
       "  ('syndrome', 0.1281),\n",
       "  ('rates needed', 0.1197),\n",
       "  ('energy 265', 0.1103),\n",
       "  ('promoting short', 0.1084),\n",
       "  ('low cal', 0.1004),\n",
       "  ('05', 0.0954),\n",
       "  ('age', 0.095),\n",
       "  ('black', 0.0844),\n",
       "  ('difference', 0.0747),\n",
       "  ('social media', 0.0557),\n",
       "  ('age 27', 0.0521),\n",
       "  ('attrition high', 0.0443),\n",
       "  ('interquartile range', 0.0439),\n",
       "  ('related percent', 0.0434),\n",
       "  ('rights', 0.0415),\n",
       "  ('elsevier rights', 0.014),\n",
       "  ('addresses', -0.0084)],\n",
       " 'MED-822': [('syndrome pcos', 0.6351),\n",
       "  ('ovary syndrome', 0.5071),\n",
       "  ('german pcos', 0.4967),\n",
       "  ('oligoanovulation hyperandrogenism', 0.4907),\n",
       "  ('metabolic syndrome', 0.4248),\n",
       "  ('polycystic', 0.351),\n",
       "  ('endocrine metabolic', 0.3455),\n",
       "  ('reproductive age', 0.3443),\n",
       "  ('52 dyslipidemia', 0.3265),\n",
       "  ('diabetes frequent', 0.3169),\n",
       "  ('resistance hyperinsulinemia', 0.3041),\n",
       "  ('followed obesity', 0.303),\n",
       "  ('cardiovascular risk', 0.3023),\n",
       "  ('westphalia germany', 0.2845),\n",
       "  ('higher bmi', 0.2753),\n",
       "  ('clinical characteristics', 0.2668),\n",
       "  ('syndrome', 0.2626),\n",
       "  ('mass androgen', 0.2341),\n",
       "  ('affects women', 0.2252),\n",
       "  ('patients insulin', 0.224),\n",
       "  ('patients patients', 0.2234),\n",
       "  ('pathogenesis present', 0.2151),\n",
       "  ('features family', 0.2095),\n",
       "  ('cohort heterogeneous', 0.2015),\n",
       "  ('parameters prospectively', 0.188),\n",
       "  ('glucose', 0.1852),\n",
       "  ('31 metabolic', 0.1727),\n",
       "  ('reactive protein', 0.1617),\n",
       "  ('metabolism positive', 0.1529),\n",
       "  ('populations', 0.1477),\n",
       "  ('data compared', 0.1346),\n",
       "  ('cell function', 0.1316),\n",
       "  ('elevated young', 0.1268),\n",
       "  ('combination', 0.1214),\n",
       "  ('46 incidence', 0.1051),\n",
       "  ('rhine', 0.1006),\n",
       "  ('caucasian populations', 0.0966),\n",
       "  ('body', 0.0941),\n",
       "  ('71 common', 0.0762),\n",
       "  ('matched control', 0.0718),\n",
       "  ('important role', 0.0654),\n",
       "  ('tolerance', 0.0599),\n",
       "  ('200 successive', 0.0513),\n",
       "  ('test patient', 0.0425),\n",
       "  ('levels impaired', 0.0381),\n",
       "  ('showed significantly', 0.0228),\n",
       "  ('oral', 0.0162),\n",
       "  ('98 age', 0.0135),\n",
       "  ('play', 0.0073),\n",
       "  ('history', -0.0029)],\n",
       " 'MED-823': [('pcos literature', 0.5578),\n",
       "  ('pcos reducing', 0.5313),\n",
       "  ('lifestyle management', 0.4524),\n",
       "  ('obesity medications', 0.4318),\n",
       "  ('different dietary', 0.4268),\n",
       "  ('treatment polycystic', 0.3945),\n",
       "  ('ovary syndrome', 0.3899),\n",
       "  ('studies weight', 0.387),\n",
       "  ('metabolic psychological', 0.3864),\n",
       "  ('intervention composition', 0.3802),\n",
       "  ('insulin resistance', 0.3597),\n",
       "  ('literature search', 0.3502),\n",
       "  ('anthropometric reproductive', 0.3441),\n",
       "  ('intake setting', 0.3379),\n",
       "  ('diet improved', 0.3111),\n",
       "  ('glycemic index', 0.3082),\n",
       "  ('selection criteria', 0.2968),\n",
       "  ('study compare', 0.2943),\n",
       "  ('index cinahl', 0.2797),\n",
       "  ('compositions studies', 0.2756),\n",
       "  ('menstrual regularity', 0.275),\n",
       "  ('ebm reviews', 0.2641),\n",
       "  ('cholesterol low', 0.2476),\n",
       "  ('overweight women', 0.2328),\n",
       "  ('psycinfo', 0.232),\n",
       "  ('medical index', 0.2284),\n",
       "  ('unclear aim', 0.2213),\n",
       "  ('monounsaturated fat', 0.2111),\n",
       "  ('majority studies', 0.197),\n",
       "  ('depression', 0.1952),\n",
       "  ('heterogeneity factors', 0.1944),\n",
       "  ('fibrinogen total', 0.1781),\n",
       "  ('conducted australasian', 0.1602),\n",
       "  ('quality life', 0.1558),\n",
       "  ('criteria 137', 0.1408),\n",
       "  ('published', 0.1345),\n",
       "  ('optimal', 0.1338),\n",
       "  ('2012 inclusion', 0.1326),\n",
       "  ('outcomes subtle', 0.1304),\n",
       "  ('total 154', 0.1246),\n",
       "  ('2013 academy', 0.1208),\n",
       "  ('greater reductions', 0.1174),\n",
       "  ('high protein', 0.0998),\n",
       "  ('choices irrespective', 0.0986),\n",
       "  ('bias total', 0.0861),\n",
       "  ('self', 0.074),\n",
       "  ('elsevier rights', 0.0417),\n",
       "  ('line', 0.0388),\n",
       "  ('taking anti', 0.0123),\n",
       "  ('january 19', 0.0088)],\n",
       " 'MED-824': [('patients pcos', 0.6403),\n",
       "  ('methods patients', 0.4762),\n",
       "  ('obese women', 0.4393),\n",
       "  ('treatments reproductive', 0.4115),\n",
       "  ('infertility groups', 0.4065),\n",
       "  ('including menstrual', 0.3666),\n",
       "  ('outcome obese', 0.3591),\n",
       "  ('hyperinsulinemia hyperandrogenemia', 0.3591),\n",
       "  ('hormone levels', 0.324),\n",
       "  ('metformin twice', 0.3114),\n",
       "  ('ovary', 0.3006),\n",
       "  ('outcome compared', 0.2975),\n",
       "  ('amelioration hyperinsulinemia', 0.2848),\n",
       "  ('differences groups', 0.2738),\n",
       "  ('intervention treatment', 0.2708),\n",
       "  ('luteinizing hormone', 0.2689),\n",
       "  ('women randomly', 0.2663),\n",
       "  ('studied prospectively', 0.2578),\n",
       "  ('biochemical data', 0.254),\n",
       "  ('pregnancy', 0.2456),\n",
       "  ('cycle pattern', 0.2325),\n",
       "  ('hospital irbid', 0.2324),\n",
       "  ('polycystic', 0.2321),\n",
       "  ('2005 women', 0.227),\n",
       "  ('objective', 0.2268),\n",
       "  ('significantly clinical', 0.2079),\n",
       "  ('mass index', 0.1959),\n",
       "  ('data treatments', 0.1913),\n",
       "  ('week group', 0.1807),\n",
       "  ('results significant', 0.1756),\n",
       "  ('day diet', 0.1657),\n",
       "  ('group 22', 0.1606),\n",
       "  ('31', 0.1521),\n",
       "  ('syndrome', 0.1504),\n",
       "  ('rates similar', 0.1367),\n",
       "  ('irbid jordan', 0.1359),\n",
       "  ('2003 april', 0.1319),\n",
       "  ('dehydroepiandrosterone sulfate', 0.1297),\n",
       "  ('50 carbohydrates', 0.1227),\n",
       "  ('prince rashed', 0.1214),\n",
       "  ('25 proteins', 0.1201),\n",
       "  ('body', 0.1148),\n",
       "  ('66 68', 0.1108),\n",
       "  ('1200 1400', 0.0881),\n",
       "  ('significant reduction', 0.0634),\n",
       "  ('terms age', 0.0618),\n",
       "  ('continued months', 0.0085),\n",
       "  ('18 significant', 0.0041),\n",
       "  ('assigned 850', -0.0066),\n",
       "  ('gm fiber', -0.0948)],\n",
       " 'MED-825': [('treatment pcos', 0.5311),\n",
       "  ('suggested diet', 0.4992),\n",
       "  ('diet higher', 0.4655),\n",
       "  ('diet hp', 0.4274),\n",
       "  ('caloric restriction', 0.4241),\n",
       "  ('carbohydrates', 0.4053),\n",
       "  ('high protein', 0.3832),\n",
       "  ('improves weight', 0.3794),\n",
       "  ('fat women', 0.3644),\n",
       "  ('metabolism effect', 0.3637),\n",
       "  ('fat sp', 0.362),\n",
       "  ('polycystic', 0.36),\n",
       "  ('blood lipids', 0.3092),\n",
       "  ('glucose did', 0.2683),\n",
       "  ('standard protein', 0.2628),\n",
       "  ('anthropometric measurements', 0.2559),\n",
       "  ('objective study', 0.2406),\n",
       "  ('higher ratio', 0.2403),\n",
       "  ('design controlled', 0.2238),\n",
       "  ('kg sp', 0.2153),\n",
       "  ('95 ci', 0.2101),\n",
       "  ('syndrome', 0.2071),\n",
       "  ('hormone', 0.1922),\n",
       "  ('background evidence', 0.1881),\n",
       "  ('persisted adjustment', 0.1812),\n",
       "  ('circumference reduced', 0.1762),\n",
       "  ('body', 0.171),\n",
       "  ('produced greater', 0.1698),\n",
       "  ('advantages treatment', 0.1671),\n",
       "  ('seven women', 0.1555),\n",
       "  ('conducted 57', 0.1367),\n",
       "  ('differences', 0.1337),\n",
       "  ('effect independent', 0.1285),\n",
       "  ('counseling baseline', 0.1271),\n",
       "  ('binding globulin', 0.1172),\n",
       "  ('pregnancy 23', 0.11),\n",
       "  ('15 energy', 0.1082),\n",
       "  ('performed blood', 0.108),\n",
       "  ('group', 0.1003),\n",
       "  ('collected results', 0.0983),\n",
       "  ('greater decreases', 0.095),\n",
       "  ('conclusion replacement', 0.0817),\n",
       "  ('rank minimization', 0.0738),\n",
       "  ('40 energy', 0.0728),\n",
       "  ('protein ad', 0.07),\n",
       "  ('mo waist', 0.0698),\n",
       "  ('dropped reasons', 0.0543),\n",
       "  ('30', 0.0306),\n",
       "  ('sex', 0.0226),\n",
       "  ('received monthly', -0.0279)],\n",
       " 'MED-826': [('pcos reflects', 0.6985),\n",
       "  ('ovarian disorder', 0.4789),\n",
       "  ('biomarkers ovarian', 0.4512),\n",
       "  ('society endocrinology', 0.4362),\n",
       "  ('evaluation androgens', 0.389),\n",
       "  ('endocrinologists great', 0.3858),\n",
       "  ('syndrome presence', 0.3644),\n",
       "  ('major criteria', 0.3613),\n",
       "  ('metabolic dysfunctions', 0.3456),\n",
       "  ('role obesity', 0.3316),\n",
       "  ('polycystic', 0.331),\n",
       "  ('emphasis hormonal', 0.3156),\n",
       "  ('phenotypic heterogeneity', 0.309),\n",
       "  ('different definitions', 0.3019),\n",
       "  ('disorder diagnostic', 0.2986),\n",
       "  ('potential biomarkers', 0.2848),\n",
       "  ('clinical research', 0.269),\n",
       "  ('aspects cardiovascular', 0.2686),\n",
       "  ('european society', 0.2253),\n",
       "  ('aetiological factors', 0.2168),\n",
       "  ('efforts decades', 0.1969),\n",
       "  ('laboratory evaluation', 0.1953),\n",
       "  ('supported notion', 0.1765),\n",
       "  ('tools', 0.1727),\n",
       "  ('neuropsychological aspects', 0.1659),\n",
       "  ('planning potential', 0.1624),\n",
       "  ('patient needs', 0.161),\n",
       "  ('involved development', 0.1558),\n",
       "  ('growing', 0.1516),\n",
       "  ('diabetes supported', 0.1487),\n",
       "  ('expected glucose', 0.1478),\n",
       "  ('offers critical', 0.1477),\n",
       "  ('dysfunctions paid', 0.1354),\n",
       "  ('women', 0.1335),\n",
       "  ('factors addition', 0.1327),\n",
       "  ('target treatment', 0.1286),\n",
       "  ('states including', 0.1213),\n",
       "  ('strategies affected', 0.1175),\n",
       "  ('choices based', 0.1135),\n",
       "  ('common', 0.1132),\n",
       "  ('perspective', 0.1106),\n",
       "  ('sleep', 0.1024),\n",
       "  ('attention role', 0.1015),\n",
       "  ('areas', 0.0957),\n",
       "  ('debate', 0.0803),\n",
       "  ('intolerance states', 0.078),\n",
       "  ('2014', 0.0415),\n",
       "  ('life events', 0.0348),\n",
       "  ('paper offers', 0.0258),\n",
       "  ('affected subject', -0.0366)],\n",
       " 'MED-827': [('adolescents pcos', 0.6478),\n",
       "  ('pcos recruited', 0.5595),\n",
       "  ('pcos ate', 0.5311),\n",
       "  ('pcos improve', 0.5189),\n",
       "  ('pcos 46', 0.4443),\n",
       "  ('ovarian syndrome', 0.4396),\n",
       "  ('eating habits', 0.439),\n",
       "  ('ingestion carbohydrates', 0.4356),\n",
       "  ('questionnaire eating', 0.4039),\n",
       "  ('phenotype polycystic', 0.3923),\n",
       "  ('metabolic concerns', 0.3883),\n",
       "  ('dietary diary', 0.3775),\n",
       "  ('adolescence girls', 0.371),\n",
       "  ('sedentary lifestyle', 0.3606),\n",
       "  ('unhealthy lifestyle', 0.3422),\n",
       "  ('worsen weight', 0.3388),\n",
       "  ('habits group', 0.3355),\n",
       "  ('intake calculated', 0.3154),\n",
       "  ('future metabolic', 0.31),\n",
       "  ('macronutrient intake', 0.2927),\n",
       "  ('negative calorie', 0.288),\n",
       "  ('ameliorating eating', 0.2797),\n",
       "  ('group adolescent', 0.2767),\n",
       "  ('weight', 0.2738),\n",
       "  ('likely cereals', 0.2485),\n",
       "  ('lifestyle purpose', 0.2366),\n",
       "  ('indexes girls', 0.2305),\n",
       "  ('syndrome', 0.2133),\n",
       "  ('related genetic', 0.211),\n",
       "  ('purpose study', 0.1711),\n",
       "  ('questionnaire', 0.1684),\n",
       "  ('thirty women', 0.163),\n",
       "  ('predisposition worsened', 0.1439),\n",
       "  ('compared group', 0.1313),\n",
       "  ('fibre controls', 0.1239),\n",
       "  ('meal 97', 0.1187),\n",
       "  ('recruited', 0.1138),\n",
       "  ('breakfast 20', 0.1125),\n",
       "  ('intake 72', 0.11),\n",
       "  ('controls despite', 0.0894),\n",
       "  ('comparable body', 0.0885),\n",
       "  ('daily', 0.0789),\n",
       "  ('versus 66', 0.0616),\n",
       "  ('results', 0.0482),\n",
       "  ('improve future', 0.0469),\n",
       "  ('ate', 0.0286),\n",
       "  ('gain increased', 0.0193),\n",
       "  ('evening', 0.0182),\n",
       "  ('047 ameliorating', 0.0032),\n",
       "  ('known', -0.0191)],\n",
       " 'MED-828': [('maca plant', 0.5302),\n",
       "  ('maca sexual', 0.4638),\n",
       "  ('effectiveness maca', 0.4434),\n",
       "  ('using cochrane', 0.3559),\n",
       "  ('assessed effects', 0.2737),\n",
       "  ('plant treatment', 0.2557),\n",
       "  ('menopausal women', 0.2525),\n",
       "  ('sexual dysfunction', 0.25),\n",
       "  ('searched 17', 0.2385),\n",
       "  ('studies limited', 0.2143),\n",
       "  ('aim review', 0.2141),\n",
       "  ('failed effects', 0.2111),\n",
       "  ('dysfunction methods', 0.2095),\n",
       "  ('rcts suggested', 0.2018),\n",
       "  ('lepidium meyenii', 0.1996),\n",
       "  ('root reported', 0.1871),\n",
       "  ('plant brassica', 0.1777),\n",
       "  ('assess clinical', 0.1548),\n",
       "  ('index erectile', 0.1388),\n",
       "  ('authors discrepancies', 0.1379),\n",
       "  ('andean', 0.1361),\n",
       "  ('suggested significant', 0.1335),\n",
       "  ('family preparations', 0.1307),\n",
       "  ('compared', 0.1238),\n",
       "  ('human patients', 0.1229),\n",
       "  ('positive effect', 0.1222),\n",
       "  ('statistical pooling', 0.12),\n",
       "  ('databases', 0.1194),\n",
       "  ('average methodological', 0.1164),\n",
       "  ('risk bias', 0.1155),\n",
       "  ('compared placebo', 0.1034),\n",
       "  ('provide limited', 0.1005),\n",
       "  ('extraction validations', 0.0948),\n",
       "  ('improve', 0.0914),\n",
       "  ('function total', 0.089),\n",
       "  ('mustard', 0.0829),\n",
       "  ('background', 0.0793),\n",
       "  ('inception april', 0.0688),\n",
       "  ('performed independently', 0.0565),\n",
       "  ('men respectively', 0.0559),\n",
       "  ('met inclusion', 0.0479),\n",
       "  ('resolved discussion', 0.0429),\n",
       "  ('quality primary', 0.0406),\n",
       "  ('cyclists', 0.0321),\n",
       "  ('sample size', 0.0244),\n",
       "  ('international index', 0.0086),\n",
       "  ('healthy adult', -0.007),\n",
       "  ('desire healthy', -0.022),\n",
       "  ('2010 included', -0.1067),\n",
       "  ('draw firm', -0.1192)],\n",
       " 'MED-829': [('pcos women', 0.6624),\n",
       "  ('fat women', 0.5483),\n",
       "  ('lower pcos', 0.4804),\n",
       "  ('ovary syndrome', 0.4649),\n",
       "  ('fat distribution', 0.4491),\n",
       "  ('bmi investigate', 0.4461),\n",
       "  ('insulin sensitivity', 0.4192),\n",
       "  ('androstenedione insulin', 0.3985),\n",
       "  ('women evaluated', 0.3576),\n",
       "  ('women 29', 0.3527),\n",
       "  ('resistance androgens', 0.3097),\n",
       "  ('methods thirty', 0.2995),\n",
       "  ('determination follicle', 0.2709),\n",
       "  ('luteinizing hormone', 0.2644),\n",
       "  ('waist hip', 0.2529),\n",
       "  ('matched age', 0.2448),\n",
       "  ('polycystic', 0.2405),\n",
       "  ('correlation analysis', 0.2347),\n",
       "  ('materials methods', 0.2264),\n",
       "  ('001 fasting', 0.2135),\n",
       "  ('estradiol 17', 0.2126),\n",
       "  ('sex', 0.2115),\n",
       "  ('higher patients', 0.2097),\n",
       "  ('parameters concerning', 0.2064),\n",
       "  ('compared control', 0.2048),\n",
       "  ('differences', 0.1947),\n",
       "  ('skinfold caliper', 0.1864),\n",
       "  ('present study', 0.1805),\n",
       "  ('samples obtained', 0.1783),\n",
       "  ('objectives aims', 0.1737),\n",
       "  ('controls 03', 0.1667),\n",
       "  ('dehydroepiandrosterone sulfate', 0.1609),\n",
       "  ('ratio free', 0.1573),\n",
       "  ('thickness determined', 0.1568),\n",
       "  ('triceps', 0.1494),\n",
       "  ('whitney test', 0.1447),\n",
       "  ('fai significantly', 0.1447),\n",
       "  ('significantly subcutaneous', 0.1419),\n",
       "  ('analyzed bioelectrical', 0.1356),\n",
       "  ('means analyzed', 0.1274),\n",
       "  ('performed body', 0.1253),\n",
       "  ('accumulation', 0.1231),\n",
       "  ('subjects 04', 0.1153),\n",
       "  ('region', 0.1101),\n",
       "  ('analyzed student', 0.0758),\n",
       "  ('calculated 100', 0.0665),\n",
       "  ('half', 0.0622),\n",
       "  ('binding globulin', 0.0549),\n",
       "  ('distribution materials', 0.0536),\n",
       "  ('basal', 0.0423)],\n",
       " 'MED-830': [('maca polysaccharides', 0.5755),\n",
       "  ('meyenii polysaccharides', 0.5282),\n",
       "  ('polysaccharides separated', 0.5177),\n",
       "  ('polysaccharides amylase', 0.5121),\n",
       "  ('starch maca', 0.5028),\n",
       "  ('polysaccharides lmps', 0.4704),\n",
       "  ('polysaccharides deproteinized', 0.47),\n",
       "  ('extract mae', 0.4652),\n",
       "  ('amylase glucoamylase', 0.4446),\n",
       "  ('soluble polysaccharides', 0.4141),\n",
       "  ('mae crude', 0.3906),\n",
       "  ('deproteinized sevag', 0.3485),\n",
       "  ('separated maca', 0.3481),\n",
       "  ('process polysaccharide', 0.3477),\n",
       "  ('starch', 0.34),\n",
       "  ('water soluble', 0.3006),\n",
       "  ('ml scavenging', 0.2982),\n",
       "  ('aqueous extract', 0.2906),\n",
       "  ('polysaccharides lepidium', 0.2657),\n",
       "  ('effectively removed', 0.2564),\n",
       "  ('lmps obtained', 0.2532),\n",
       "  ('galactose antioxidant', 0.2469),\n",
       "  ('rhamnose', 0.1986),\n",
       "  ('bioactive compounds', 0.1902),\n",
       "  ('0mg ml', 0.1838),\n",
       "  ('preparation process', 0.181),\n",
       "  ('separated', 0.1654),\n",
       "  ('tests revealed', 0.1648),\n",
       "  ('crude', 0.138),\n",
       "  ('high antioxidant', 0.1347),\n",
       "  ('arabinose glucose', 0.1191),\n",
       "  ('explored source', 0.1151),\n",
       "  ('hydroxyl free', 0.1112),\n",
       "  ('respectively results', 0.1053),\n",
       "  ('showed', 0.0979),\n",
       "  ('concentration ethanol', 0.0874),\n",
       "  ('copyright 2014', 0.0785),\n",
       "  ('activity', 0.078),\n",
       "  ('good capability', 0.0774),\n",
       "  ('85 respectively', 0.0768),\n",
       "  ('radical superoxide', 0.0566),\n",
       "  ('obtained changing', 0.0463),\n",
       "  ('radical', 0.0423),\n",
       "  ('precipitation', 0.0395),\n",
       "  ('compounds copyright', 0.0343),\n",
       "  ('elsevier', 0.0285),\n",
       "  ('changing concentration', 0.0003),\n",
       "  ('60 showed', -0.0157),\n",
       "  ('reserved', -0.0203),\n",
       "  ('rate 52', -0.066)],\n",
       " 'MED-831': [('hyperandrogenism apa', 0.6687),\n",
       "  ('pcos apa', 0.5761),\n",
       "  ('androgen apa', 0.5598),\n",
       "  ('role dheas', 0.553),\n",
       "  ('adrenal factors', 0.5457),\n",
       "  ('excess pcos', 0.5378),\n",
       "  ('androgen biosynthesis', 0.5353),\n",
       "  ('steroidogenesis response', 0.4544),\n",
       "  ('increased apa', 0.4361),\n",
       "  ('ovarian secretions', 0.4274),\n",
       "  ('30 pcos', 0.4257),\n",
       "  ('defects cortisol', 0.3809),\n",
       "  ('axis dysfunction', 0.3226),\n",
       "  ('apas particularly', 0.3059),\n",
       "  ('traits paradoxically', 0.293),\n",
       "  ('hyperplasia demonstrate', 0.287),\n",
       "  ('women suffering', 0.2839),\n",
       "  ('hydroxylase', 0.2573),\n",
       "  ('patients 21', 0.2572),\n",
       "  ('defects enzymes', 0.2569),\n",
       "  ('fraction women', 0.2489),\n",
       "  ('synthesis role', 0.2306),\n",
       "  ('generalized exaggeration', 0.2297),\n",
       "  ('overt hypothalamic', 0.2238),\n",
       "  ('factors including', 0.2203),\n",
       "  ('excess appear', 0.2195),\n",
       "  ('patients inherited', 0.2194),\n",
       "  ('approximately 20', 0.2157),\n",
       "  ('obesity insulin', 0.2136),\n",
       "  ('observations patients', 0.1979),\n",
       "  ('metabolism', 0.1973),\n",
       "  ('remains unclear', 0.1812),\n",
       "  ('production primarily', 0.169),\n",
       "  ('substantial heritabilities', 0.1608),\n",
       "  ('congenital', 0.1595),\n",
       "  ('role increased', 0.1577),\n",
       "  ('exact cause', 0.1335),\n",
       "  ('limited', 0.1258),\n",
       "  ('handful', 0.1258),\n",
       "  ('general population', 0.1172),\n",
       "  ('snps', 0.1118),\n",
       "  ('marker', 0.1113),\n",
       "  ('discovered', 0.1096),\n",
       "  ('cardiovascular', 0.1068),\n",
       "  ('non classic', 0.0982),\n",
       "  ('paradoxically men', 0.0839),\n",
       "  ('2014 elsevier', 0.0644),\n",
       "  ('play', 0.0129),\n",
       "  ('remains', -0.0359),\n",
       "  ('nature copyright', -0.0375)],\n",
       " 'MED-832': [('pcos aims', 0.5601),\n",
       "  ('lifestyle modifications', 0.5384),\n",
       "  ('hypothesize interventions', 0.4803),\n",
       "  ('treat obese', 0.4735),\n",
       "  ('exercise training', 0.4668),\n",
       "  ('set programme', 0.457),\n",
       "  ('hormonal metabolic', 0.3823),\n",
       "  ('improvement menstrual', 0.3819),\n",
       "  ('improvement insulin', 0.3608),\n",
       "  ('ovary syndrome', 0.3457),\n",
       "  ('women polycystic', 0.3441),\n",
       "  ('pilot study', 0.3436),\n",
       "  ('improve fertility', 0.337),\n",
       "  ('waist circumference', 0.296),\n",
       "  ('compare efficacy', 0.2912),\n",
       "  ('patients anovulatory', 0.2835),\n",
       "  ('follow ups', 0.2769),\n",
       "  ('women', 0.2623),\n",
       "  ('cycles', 0.2567),\n",
       "  ('mass index', 0.256),\n",
       "  ('aims current', 0.2537),\n",
       "  ('cumulative pregnancy', 0.2204),\n",
       "  ('groups differences', 0.2172),\n",
       "  ('serum levels', 0.2142),\n",
       "  ('patients ii', 0.2035),\n",
       "  ('training set', 0.2025),\n",
       "  ('data assessed', 0.2018),\n",
       "  ('significant body', 0.1923),\n",
       "  ('hyperproteic', 0.1922),\n",
       "  ('functions structured', 0.1882),\n",
       "  ('conclusions set', 0.1863),\n",
       "  ('resistance indexes', 0.183),\n",
       "  ('frequency menses', 0.1668),\n",
       "  ('dehydroepiandrosterone', 0.1665),\n",
       "  ('syndrome', 0.166),\n",
       "  ('group increased', 0.1654),\n",
       "  ('employed', 0.1568),\n",
       "  ('changed significantly', 0.1534),\n",
       "  ('similar demographic', 0.1319),\n",
       "  ('week', 0.1227),\n",
       "  ('ups primary', 0.1201),\n",
       "  ('successfully', 0.1166),\n",
       "  ('20 hypocaloric', 0.1145),\n",
       "  ('different 05', 0.1066),\n",
       "  ('24 week', 0.1042),\n",
       "  ('involved restoration', 0.0932),\n",
       "  ('pivotal factor', 0.0852),\n",
       "  ('baseline 12', 0.0809),\n",
       "  ('sulphate', 0.0313),\n",
       "  ('binding globulin', 0.0267)],\n",
       " 'MED-833': [('effects metformin', 0.5873),\n",
       "  ('metabolic disturbances', 0.4589),\n",
       "  ('women insulin', 0.442),\n",
       "  ('insulin resistance', 0.4377),\n",
       "  ('metformin placebo', 0.4308),\n",
       "  ('pcos prospective', 0.421),\n",
       "  ('menstrual patterns', 0.4103),\n",
       "  ('endocrine metabolic', 0.3815),\n",
       "  ('lifestyle changes', 0.3728),\n",
       "  ('effect diet', 0.3568),\n",
       "  ('progesterone glucose', 0.3437),\n",
       "  ('lipids measured', 0.3371),\n",
       "  ('parameters hyperandrogenism', 0.3344),\n",
       "  ('interventions resulted', 0.3202),\n",
       "  ('disturbances women', 0.3142),\n",
       "  ('aim study', 0.3139),\n",
       "  ('exercise improve', 0.3138),\n",
       "  ('gonadotropins', 0.3117),\n",
       "  ('cycle', 0.2974),\n",
       "  ('blind randomized', 0.2864),\n",
       "  ('months treatment', 0.2742),\n",
       "  ('mass index', 0.2713),\n",
       "  ('polycystic ovary', 0.2659),\n",
       "  ('1500 mg', 0.2648),\n",
       "  ('resistant women', 0.262),\n",
       "  ('thirty women', 0.257),\n",
       "  ('improve parameters', 0.2471),\n",
       "  ('evaluate effects', 0.245),\n",
       "  ('patterns evaluated', 0.2301),\n",
       "  ('fasting', 0.2204),\n",
       "  ('findings suggest', 0.2151),\n",
       "  ('serum concentrations', 0.1935),\n",
       "  ('treatment body', 0.1872),\n",
       "  ('decrease body', 0.1847),\n",
       "  ('similar weight', 0.1755),\n",
       "  ('waist hip', 0.1726),\n",
       "  ('blood pressure', 0.1697),\n",
       "  ('groups', 0.1664),\n",
       "  ('pbo control', 0.1643),\n",
       "  ('levels', 0.1554),\n",
       "  ('disturbances', 0.1358),\n",
       "  ('dehydroepiandrosterone', 0.1187),\n",
       "  ('significant reduction', 0.1143),\n",
       "  ('hirsutism', 0.1017),\n",
       "  ('double', 0.0992),\n",
       "  ('additive effect', 0.079),\n",
       "  ('mg', 0.0599),\n",
       "  ('trough', 0.0536),\n",
       "  ('resistance small', 0.0405),\n",
       "  ('homa', -0.0589)],\n",
       " 'MED-834': [('pcos affects', 0.5965),\n",
       "  ('interventions reproductive', 0.4588),\n",
       "  ('potential studies', 0.411),\n",
       "  ('controlled trials', 0.3861),\n",
       "  ('review meta', 0.3645),\n",
       "  ('conducted systematic', 0.3621),\n",
       "  ('polycystic', 0.3133),\n",
       "  ('searching pubmed', 0.3065),\n",
       "  ('cinahl', 0.3036),\n",
       "  ('endocrine profile', 0.2974),\n",
       "  ('22 women', 0.2931),\n",
       "  ('cochrane', 0.2876),\n",
       "  ('ovarian', 0.2634),\n",
       "  ('observed women', 0.2589),\n",
       "  ('fsh levels', 0.2538),\n",
       "  ('key concepts', 0.2361),\n",
       "  ('95 ci', 0.2331),\n",
       "  ('diet exercise', 0.2321),\n",
       "  ('androstenedione fai', 0.2277),\n",
       "  ('affects 18', 0.2176),\n",
       "  ('intervention vs', 0.2102),\n",
       "  ('syndrome', 0.1957),\n",
       "  ('total testosterone', 0.1665),\n",
       "  ('2013 systematically', 0.1552),\n",
       "  ('003 analyses', 0.155),\n",
       "  ('16 nmol', 0.1502),\n",
       "  ('levels mean', 0.1384),\n",
       "  ('age conducted', 0.1363),\n",
       "  ('0002', 0.124),\n",
       "  ('ci 88', 0.1189),\n",
       "  ('fg score', 0.1108),\n",
       "  ('registry 1966', 0.1008),\n",
       "  ('significant improvements', 0.0983),\n",
       "  ('sex', 0.0958),\n",
       "  ('nmol', 0.0947),\n",
       "  ('care', 0.072),\n",
       "  ('35 01', 0.068),\n",
       "  ('04 total', 0.0614),\n",
       "  ('using key', 0.0482),\n",
       "  ('april 30', 0.0465),\n",
       "  ('gallwey', 0.0456),\n",
       "  ('vs usual', 0.0349),\n",
       "  ('09 ng', 0.0298),\n",
       "  ('70', 0.0201),\n",
       "  ('42 iu', 0.0102),\n",
       "  ('47 0001', 0.0069),\n",
       "  ('binding globulin', 0.0009),\n",
       "  ('stimulating', -0.013),\n",
       "  ('free', -0.0284),\n",
       "  ('01 ferriman', -0.0768)],\n",
       " 'MED-835': [('phytoestrogens', 0.6261),\n",
       "  ('estradiol sex', 0.4892),\n",
       "  ('estradiol decreased', 0.462),\n",
       "  ('serum testosterone', 0.4425),\n",
       "  ('hyperandrogenic postmenopausal', 0.4362),\n",
       "  ('modify hormonal', 0.3918),\n",
       "  ('fat refined', 0.3799),\n",
       "  ('cholesterol', 0.3626),\n",
       "  ('diet designed', 0.35),\n",
       "  ('habits important', 0.3489),\n",
       "  ('intake decreases', 0.3347),\n",
       "  ('breast cancer', 0.3037),\n",
       "  ('serum levels', 0.3021),\n",
       "  ('insulin resistance', 0.2961),\n",
       "  ('oral glucose', 0.2711),\n",
       "  ('monounsaturated polyunsaturated', 0.2553),\n",
       "  ('carbohydrates rich', 0.2499),\n",
       "  ('tolerance test', 0.2424),\n",
       "  ('women additional', 0.2414),\n",
       "  ('ad libitum', 0.2411),\n",
       "  ('hip ratio', 0.2163),\n",
       "  ('bioavailability increased', 0.2157),\n",
       "  ('index foods', 0.2137),\n",
       "  ('group waist', 0.2135),\n",
       "  ('reduce risk', 0.2131),\n",
       "  ('meals twice', 0.2061),\n",
       "  ('western', 0.1963),\n",
       "  ('binding globulin', 0.1956),\n",
       "  ('effects', 0.182),\n",
       "  ('group 0038', 0.1818),\n",
       "  ('hypothesized ad', 0.1743),\n",
       "  ('intervention group', 0.1727),\n",
       "  ('ng ml', 0.1549),\n",
       "  ('rich', 0.1544),\n",
       "  ('levels randomized', 0.143),\n",
       "  ('resistance involving', 0.1313),\n",
       "  ('studies needed', 0.128),\n",
       "  ('06 kg', 0.1099),\n",
       "  ('25 versus', 0.1065),\n",
       "  ('low animal', 0.1053),\n",
       "  ('healthy volunteers', 0.0985),\n",
       "  ('compared control', 0.0953),\n",
       "  ('specially prepared', 0.0914),\n",
       "  ('selected 312', 0.0851),\n",
       "  ('33', 0.0735),\n",
       "  ('54 kg', 0.0692),\n",
       "  ('favorably', 0.0541),\n",
       "  ('36 45', 0.0396),\n",
       "  ('ml 20', 0.0329),\n",
       "  ('week months', 0.006)],\n",
       " 'MED-836': [('optimal diet', 0.5825),\n",
       "  ('dietary management', 0.5599),\n",
       "  ('diet women', 0.5167),\n",
       "  ('diet assist', 0.509),\n",
       "  ('weight management', 0.4863),\n",
       "  ('diet prevents', 0.4809),\n",
       "  ('nutrient deficiencies', 0.4628),\n",
       "  ('diet low', 0.4603),\n",
       "  ('promotes health', 0.4585),\n",
       "  ('sufficient nutrients', 0.4444),\n",
       "  ('energy restriction', 0.4135),\n",
       "  ('research dietary', 0.4037),\n",
       "  ('recommended pcos', 0.3935),\n",
       "  ('women polycystic', 0.393),\n",
       "  ('diet plays', 0.3881),\n",
       "  ('significant metabolic', 0.3712),\n",
       "  ('carbohydrate foods', 0.3712),\n",
       "  ('compensatory hyperinsulinaemia', 0.3451),\n",
       "  ('reducing insulin', 0.3426),\n",
       "  ('saturated fat', 0.3294),\n",
       "  ('glycaemic index', 0.291),\n",
       "  ('diabetes cvd', 0.2906),\n",
       "  ('chronic diseases', 0.2769),\n",
       "  ('balance evidence', 0.274),\n",
       "  ('management symptoms', 0.2496),\n",
       "  ('longevity reduces', 0.2457),\n",
       "  ('reproduction promotes', 0.2234),\n",
       "  ('regulation blood', 0.2224),\n",
       "  ('symptoms fertility', 0.2129),\n",
       "  ('reduces risk', 0.2092),\n",
       "  ('energy human', 0.2086),\n",
       "  ('lacking studies', 0.1901),\n",
       "  ('providing sufficient', 0.189),\n",
       "  ('certain cancers', 0.1835),\n",
       "  ('key factor', 0.1689),\n",
       "  ('studies focused', 0.1641),\n",
       "  ('ovary', 0.1634),\n",
       "  ('levels improving', 0.1608),\n",
       "  ('assist short', 0.1453),\n",
       "  ('role regulation', 0.1422),\n",
       "  ('growth', 0.1258),\n",
       "  ('composition se', 0.1156),\n",
       "  ('prevents', 0.1069),\n",
       "  ('predominantly low', 0.1019),\n",
       "  ('risks research', 0.0744),\n",
       "  ('target long', 0.0451),\n",
       "  ('fibre predominantly', 0.0411),\n",
       "  ('carries significant', 0.0334),\n",
       "  ('related', 0.0288),\n",
       "  ('plays', 0.0139)],\n",
       " 'MED-837': [('pcos intervention', 0.642),\n",
       "  ('obese women', 0.477),\n",
       "  ('pilot experiment', 0.4603),\n",
       "  ('participants randomized', 0.4225),\n",
       "  ('ovary syndrome', 0.4001),\n",
       "  ('intervention examined', 0.3823),\n",
       "  ('metabolism leptin', 0.3722),\n",
       "  ('performed study', 0.352),\n",
       "  ('metabolic reproductive', 0.3472),\n",
       "  ('patients', 0.3418),\n",
       "  ('fertility design', 0.3377),\n",
       "  ('bleeding trial', 0.3256),\n",
       "  ('lipoprotein markers', 0.3184),\n",
       "  ('test ogtt', 0.3101),\n",
       "  ('setting', 0.308),\n",
       "  ('weight secondary', 0.2957),\n",
       "  ('phenotype participants', 0.2941),\n",
       "  ('primary outcome', 0.2597),\n",
       "  ('auc insulins', 0.2571),\n",
       "  ('prevalence menstrual', 0.2549),\n",
       "  ('polycystic', 0.2545),\n",
       "  ('restricted diets', 0.2519),\n",
       "  ('fasting', 0.2226),\n",
       "  ('trial 14', 0.2211),\n",
       "  ('ideal composition', 0.2128),\n",
       "  ('groups differences', 0.2121),\n",
       "  ('hp 30', 0.2086),\n",
       "  ('change body', 0.1969),\n",
       "  ('term hypocaloric', 0.1954),\n",
       "  ('require multicenter', 0.194),\n",
       "  ('completed short', 0.1758),\n",
       "  ('circulating androgens', 0.1758),\n",
       "  ('26 patients', 0.1708),\n",
       "  ('seeking', 0.1609),\n",
       "  ('abnormalities increased', 0.1604),\n",
       "  ('increased benefit', 0.1507),\n",
       "  ('population likely', 0.1469),\n",
       "  ('55 carbohydrate', 0.1448),\n",
       "  ('15 protein', 0.1398),\n",
       "  ('protein 40', 0.1204),\n",
       "  ('academic medical', 0.1175),\n",
       "  ('levels 0001', 0.1168),\n",
       "  ('se improving', 0.1167),\n",
       "  ('03', 0.1163),\n",
       "  ('05 hour', 0.094),\n",
       "  ('loss groups', 0.093),\n",
       "  ('high protein', 0.0878),\n",
       "  ('variety measures', 0.0803),\n",
       "  ('term effects', 0.0597),\n",
       "  ('content held', -0.0144)],\n",
       " 'MED-838': [('acid dha', 0.6199),\n",
       "  ('docosahexaenoic', 0.5337),\n",
       "  ('22 6omega3', 0.4715),\n",
       "  ('fish oil', 0.4326),\n",
       "  ('22 carbons', 0.3983),\n",
       "  ('oil controls', 0.3569),\n",
       "  ('toxins fish', 0.3434),\n",
       "  ('hydrocarbon chain', 0.3219),\n",
       "  ('mm fatty', 0.2601),\n",
       "  ('safety issues', 0.2528),\n",
       "  ('6omega3 previous', 0.2358),\n",
       "  ('downregulation', 0.2266),\n",
       "  ('omega', 0.212),\n",
       "  ('alternative double', 0.2031),\n",
       "  ('development different', 0.1888),\n",
       "  ('did modulate', 0.1868),\n",
       "  ('acid results', 0.1796),\n",
       "  ('carbons alternative', 0.1565),\n",
       "  ('dose dependently', 0.1527),\n",
       "  ('studies', 0.151),\n",
       "  ('72 incubations', 0.1506),\n",
       "  ('dna', 0.1504),\n",
       "  ('microalga', 0.1434),\n",
       "  ('controlling cancer', 0.1427),\n",
       "  ('levels incubations', 0.1373),\n",
       "  ('controls growth', 0.1248),\n",
       "  ('expression proapoptotic', 0.1238),\n",
       "  ('apoptotic cells', 0.1235),\n",
       "  ('cytometry shows', 0.1113),\n",
       "  ('important step', 0.1089),\n",
       "  ('dependently 16', 0.0924),\n",
       "  ('bonds', 0.089),\n",
       "  ('bcl important', 0.0876),\n",
       "  ('repeatedly contamination', 0.0801),\n",
       "  ('breast', 0.0784),\n",
       "  ('386', 0.069),\n",
       "  ('longer', 0.0688),\n",
       "  ('crypthecodinium cohnii', 0.0681),\n",
       "  ('comprises', 0.0666),\n",
       "  ('mcf cells', 0.0663),\n",
       "  ('24', 0.0635),\n",
       "  ('anti', 0.056),\n",
       "  ('adha exhibited', 0.0515),\n",
       "  ('clean', 0.0397),\n",
       "  ('expression time', 0.0366),\n",
       "  ('induced sub', 0.0365),\n",
       "  ('western blot', 0.0019),\n",
       "  ('171', -0.0034),\n",
       "  ('59', -0.0362),\n",
       "  ('ratio 303', -0.0606)],\n",
       " 'MED-839': [('omega fatty', 0.5765),\n",
       "  ('medicine omega', 0.5686),\n",
       "  ('nutritionally therapeutically', 0.563),\n",
       "  ('omega 3s', 0.4946),\n",
       "  ('nutrition medicine', 0.4582),\n",
       "  ('supplementation flax', 0.4404),\n",
       "  ('health benefits', 0.4064),\n",
       "  ('ala supplementation', 0.4026),\n",
       "  ('natural medicine', 0.3988),\n",
       "  ('acids', 0.3749),\n",
       "  ('preventative therapeutic', 0.3469),\n",
       "  ('benefits natural', 0.3299),\n",
       "  ('oils recent', 0.3238),\n",
       "  ('protective mechanisms', 0.3116),\n",
       "  ('certain microalgae', 0.2976),\n",
       "  ('diseases believe', 0.2879),\n",
       "  ('triglycerides oxidative', 0.2866),\n",
       "  ('ecosystems', 0.2724),\n",
       "  ('oil safety', 0.2615),\n",
       "  ('cardiovascular', 0.2543),\n",
       "  ('therapeutically equivalent', 0.2339),\n",
       "  ('rich', 0.2299),\n",
       "  ('lowering plasma', 0.2269),\n",
       "  ('chain epa', 0.2251),\n",
       "  ('example pollutants', 0.2245),\n",
       "  ('diabetes', 0.216),\n",
       "  ('accumulated long', 0.2146),\n",
       "  ('efficacies', 0.2145),\n",
       "  ('therapeutic current', 0.2139),\n",
       "  ('believe plant', 0.208),\n",
       "  ('review discusses', 0.2031),\n",
       "  ('high levels', 0.1962),\n",
       "  ('organically', 0.1941),\n",
       "  ('value ala', 0.1897),\n",
       "  ('clinical trials', 0.1892),\n",
       "  ('healthy precursor', 0.1809),\n",
       "  ('disease atherosclerosis', 0.1789),\n",
       "  ('research suggests', 0.178),\n",
       "  ('dha predatory', 0.1765),\n",
       "  ('gene regulation', 0.1704),\n",
       "  ('bio conversion', 0.1596),\n",
       "  ('suggests increasing', 0.1523),\n",
       "  ('fish acquire', 0.1493),\n",
       "  ('species', 0.1068),\n",
       "  ('3s', 0.0942),\n",
       "  ('available', 0.0789),\n",
       "  ('cancer type', 0.0749),\n",
       "  ('origin', 0.0697),\n",
       "  ('nearly absent', 0.0118),\n",
       "  ('inefficient', -0.0006)],\n",
       " 'MED-840': [('focused sanitation', 0.512),\n",
       "  ('different cleaning', 0.45),\n",
       "  ('contamination fresh', 0.4382),\n",
       "  ('reducing bacterial', 0.4092),\n",
       "  ('surface contamination', 0.3757),\n",
       "  ('produce home', 0.3739),\n",
       "  ('fresh produce', 0.3661),\n",
       "  ('lettuce broccoli', 0.3466),\n",
       "  ('home setting', 0.3258),\n",
       "  ('wiping apples', 0.2943),\n",
       "  ('wipe', 0.2823),\n",
       "  ('lettuce soaking', 0.2743),\n",
       "  ('listeria innocua', 0.2714),\n",
       "  ('produce cold', 0.2464),\n",
       "  ('cfu', 0.2416),\n",
       "  ('tomatoes inoculated', 0.2353),\n",
       "  ('ii rinse', 0.2314),\n",
       "  ('water brush', 0.2277),\n",
       "  ('reductions innocua', 0.2081),\n",
       "  ('workers consider', 0.2044),\n",
       "  ('produce commercial', 0.2043),\n",
       "  ('instruct consumers', 0.1908),\n",
       "  ('surface soaking', 0.1905),\n",
       "  ('consumption', 0.1786),\n",
       "  ('dry paper', 0.1431),\n",
       "  ('solutions significantly', 0.1399),\n",
       "  ('brush running', 0.1172),\n",
       "  ('reduced', 0.1165),\n",
       "  ('towel presoaking', 0.1145),\n",
       "  ('soaking lemon', 0.1102),\n",
       "  ('determine efficacy', 0.0973),\n",
       "  ('solution vinegar', 0.0908),\n",
       "  ('methods', 0.0907),\n",
       "  ('section stem', 0.0822),\n",
       "  ('flower section', 0.08),\n",
       "  ('options available', 0.0786),\n",
       "  ('min tap', 0.0733),\n",
       "  ('effort focused', 0.0692),\n",
       "  ('water veggie', 0.0672),\n",
       "  ('procedures blossom', 0.0603),\n",
       "  ('significantly different', 0.0577),\n",
       "  ('89 log', 0.0485),\n",
       "  ('13', 0.0367),\n",
       "  ('similar results', 0.0152),\n",
       "  ('rub', 0.0095),\n",
       "  ('educators extension', -0.002),\n",
       "  ('05', -0.0027),\n",
       "  ('41 88', -0.0137),\n",
       "  ('showed', -0.0143),\n",
       "  ('ends', -0.0352)],\n",
       " 'MED-841': [('effects soy', 0.5737),\n",
       "  ('isoflavones study', 0.4512),\n",
       "  ('studies inconsistent', 0.3536),\n",
       "  ('korean women', 0.3487),\n",
       "  ('study 358', 0.3486),\n",
       "  ('menopausal status', 0.3452),\n",
       "  ('cancer effect', 0.3123),\n",
       "  ('association postmenopausal', 0.3072),\n",
       "  ('risk korean', 0.2846),\n",
       "  ('neoplasm dietary', 0.2769),\n",
       "  ('inverse association', 0.2464),\n",
       "  ('study population', 0.236),\n",
       "  ('lowest intake', 0.2359),\n",
       "  ('investigated effects', 0.2349),\n",
       "  ('women er', 0.2297),\n",
       "  ('receptor status', 0.2268),\n",
       "  ('intake breast', 0.2236),\n",
       "  ('asian populations', 0.2202),\n",
       "  ('intake quartile', 0.2156),\n",
       "  ('dose response', 0.2134),\n",
       "  ('findings suggest', 0.2129),\n",
       "  ('products examined', 0.2064),\n",
       "  ('logistic regression', 0.2),\n",
       "  ('findings epidemiological', 0.1856),\n",
       "  ('risk did', 0.1812),\n",
       "  ('objective investigated', 0.1783),\n",
       "  ('360 age', 0.1765),\n",
       "  ('related lower', 0.1529),\n",
       "  ('95 confidence', 0.1443),\n",
       "  ('quartile 36', 0.1401),\n",
       "  ('status estimated', 0.1291),\n",
       "  ('food', 0.1202),\n",
       "  ('protective effect', 0.1188),\n",
       "  ('questionnaire results', 0.1161),\n",
       "  ('15 mg', 0.1157),\n",
       "  ('vary depending', 0.1007),\n",
       "  ('populations', 0.0998),\n",
       "  ('background', 0.0981),\n",
       "  ('progesterone', 0.087),\n",
       "  ('matched controls', 0.0842),\n",
       "  ('stratified', 0.0807),\n",
       "  ('patients', 0.0781),\n",
       "  ('high consumption', 0.0659),\n",
       "  ('model significant', 0.0582),\n",
       "  ('22 association', 0.058),\n",
       "  ('08 03', 0.058),\n",
       "  ('20 64', 0.0341),\n",
       "  ('highest vs', 0.0337),\n",
       "  ('respectively using', 0.0056),\n",
       "  ('mg', -0.0264)],\n",
       " 'MED-842': [('tl brassicaceous', 0.5404),\n",
       "  ('tl spiked', 0.4662),\n",
       "  ('accumulation thallium', 0.4544),\n",
       "  ('grown tl', 0.4168),\n",
       "  ('accumulation leaves', 0.3934),\n",
       "  ('tl study', 0.3796),\n",
       "  ('crops', 0.3726),\n",
       "  ('tl leaves', 0.3426),\n",
       "  ('phytoremediation tl', 0.3407),\n",
       "  ('extents tl', 0.3318),\n",
       "  ('leaves revealed', 0.3313),\n",
       "  ('individual cultivars', 0.3296),\n",
       "  ('distribution tl', 0.2813),\n",
       "  ('cultivars green', 0.2774),\n",
       "  ('contaminated soils', 0.2581),\n",
       "  ('uptake extents', 0.2544),\n",
       "  ('pot culture', 0.2482),\n",
       "  ('elements ca', 0.2353),\n",
       "  ('accumulation', 0.2261),\n",
       "  ('mg specific', 0.2192),\n",
       "  ('cabbage distribution', 0.2121),\n",
       "  ('detoxify tl', 0.2043),\n",
       "  ('organelles help', 0.1941),\n",
       "  ('455', 0.1778),\n",
       "  ('stems significant', 0.1483),\n",
       "  ('specific subcellular', 0.1401),\n",
       "  ('major storage', 0.127),\n",
       "  ('tissues', 0.1238),\n",
       "  ('mainly concentrated', 0.1237),\n",
       "  ('trials studied', 0.1187),\n",
       "  ('widely', 0.1116),\n",
       "  ('results showed', 0.1086),\n",
       "  ('application potential', 0.1033),\n",
       "  ('vacuole cell', 0.0908),\n",
       "  ('differences', 0.0842),\n",
       "  ('fraction cytosol', 0.0835),\n",
       "  ('culture', 0.0735),\n",
       "  ('192 mg', 0.0674),\n",
       "  ('cell', 0.0567),\n",
       "  ('kg', 0.0565),\n",
       "  ('101', 0.0468),\n",
       "  ('known', 0.0436),\n",
       "  ('dw roots', 0.0423),\n",
       "  ('tolerate', 0.0378),\n",
       "  ('damage vital', 0.0338),\n",
       "  ('wall', 0.0298),\n",
       "  ('site', 0.0153),\n",
       "  ('avoid', -0.0041),\n",
       "  ('good', -0.0117),\n",
       "  ('majority 88', -0.0388)],\n",
       " 'MED-843': [('nystatin cure', 0.5723),\n",
       "  ('daily intravaginal', 0.3626),\n",
       "  ('cure rates', 0.3611),\n",
       "  ('treatment vulvovaginal', 0.3522),\n",
       "  ('volume cornstarch', 0.3385),\n",
       "  ('days treatment', 0.3298),\n",
       "  ('capsules', 0.3273),\n",
       "  ('fungistatic effectiveness', 0.3272),\n",
       "  ('intravaginal gelatin', 0.3246),\n",
       "  ('14 daily', 0.3142),\n",
       "  ('containing 100', 0.3115),\n",
       "  ('containing 600', 0.3042),\n",
       "  ('containing boric', 0.2723),\n",
       "  ('similar drugs', 0.255),\n",
       "  ('vagina half', 0.2479),\n",
       "  ('blind comparison', 0.2373),\n",
       "  ('effectiveness', 0.2357),\n",
       "  ('albicans', 0.2313),\n",
       "  ('92 10', 0.2274),\n",
       "  ('prescribed', 0.2225),\n",
       "  ('30 days', 0.1947),\n",
       "  ('acid powder', 0.1897),\n",
       "  ('treatment 72', 0.1893),\n",
       "  ('12 hours', 0.1829),\n",
       "  ('analyses indicated', 0.1701),\n",
       "  ('boron analyses', 0.1562),\n",
       "  ('creams self', 0.1417),\n",
       "  ('studies', 0.1358),\n",
       "  ('powder versus', 0.1326),\n",
       "  ('signs symptoms', 0.1239),\n",
       "  ('diluted volume', 0.1227),\n",
       "  ('effects cervical', 0.12),\n",
       "  ('cytologic features', 0.1109),\n",
       "  ('costly medication', 0.1097),\n",
       "  ('messy vaginal', 0.1083),\n",
       "  ('half life', 0.1069),\n",
       "  ('double', 0.1051),\n",
       "  ('patients better', 0.1013),\n",
       "  ('vitro', 0.0961),\n",
       "  ('use identical', 0.0887),\n",
       "  ('ph blood', 0.0753),\n",
       "  ('days 50', 0.0748),\n",
       "  ('cents', 0.0742),\n",
       "  ('speed alleviation', 0.0606),\n",
       "  ('compared costly', 0.0558),\n",
       "  ('unrelated ph', 0.0508),\n",
       "  ('versus use', 0.0489),\n",
       "  ('64', 0.0272),\n",
       "  ('indicated little', 0.0094),\n",
       "  ('untoward', -0.0583)],\n",
       " 'MED-844': [('mycotic vaginal', 0.6519),\n",
       "  ('mycotic vaginitis', 0.6093),\n",
       "  ('vaginal infections', 0.5677),\n",
       "  ('vaginitis observed', 0.5337),\n",
       "  ('examination vaginal', 0.4851),\n",
       "  ('mycotic infections', 0.466),\n",
       "  ('infection diagnostic', 0.4337),\n",
       "  ('used antifungal', 0.3929),\n",
       "  ('representing cytologic', 0.3842),\n",
       "  ('women chronic', 0.3787),\n",
       "  ('infections contrast', 0.3673),\n",
       "  ('subclinical mycotic', 0.3578),\n",
       "  ('infections followed', 0.3549),\n",
       "  ('chronic yeast', 0.3519),\n",
       "  ('98 patients', 0.3356),\n",
       "  ('acid microscopic', 0.3048),\n",
       "  ('followed microscopic', 0.2933),\n",
       "  ('examination', 0.2881),\n",
       "  ('prolonged therapy', 0.2834),\n",
       "  ('women', 0.2697),\n",
       "  ('symptomatic', 0.2524),\n",
       "  ('reaction mucous', 0.25),\n",
       "  ('effective curing', 0.2474),\n",
       "  ('unique chronic', 0.2366),\n",
       "  ('membrane chronic', 0.2357),\n",
       "  ('effective detecting', 0.2083),\n",
       "  ('ninety', 0.1999),\n",
       "  ('conventional', 0.193),\n",
       "  ('indicated treatment', 0.1918),\n",
       "  ('contrast', 0.1876),\n",
       "  ('commonly used', 0.1601),\n",
       "  ('residual subclinical', 0.1576),\n",
       "  ('observed representing', 0.1568),\n",
       "  ('choice prophylaxis', 0.1541),\n",
       "  ('agents clearly', 0.1497),\n",
       "  ('proved extremely', 0.1473),\n",
       "  ('tool', 0.1465),\n",
       "  ('agents boric', 0.1404),\n",
       "  ('highly predictive', 0.1289),\n",
       "  ('patients previously', 0.1284),\n",
       "  ('discharge', 0.1264),\n",
       "  ('measure probability', 0.125),\n",
       "  ('acid effective', 0.1099),\n",
       "  ('appeared', 0.089),\n",
       "  ('main reason', 0.0654),\n",
       "  ('ineffectiveness', 0.0639),\n",
       "  ('unique', 0.0487),\n",
       "  ('relapse', 0.0476),\n",
       "  ('provided highly', -0.0054),\n",
       "  ('respond', -0.0626)],\n",
       " 'MED-845': [('significant hdac', 0.6651),\n",
       "  ('histone deacetylases', 0.6582),\n",
       "  ('hdaci considered', 0.6269),\n",
       "  ('hdac control', 0.5745),\n",
       "  ('conformation hdac', 0.5598),\n",
       "  ('histone hyperacetylation', 0.5543),\n",
       "  ('inhibition histone', 0.5507),\n",
       "  ('drugs epigenetic', 0.5255),\n",
       "  ('epigenetic', 0.436),\n",
       "  ('embryos exposed', 0.3329),\n",
       "  ('trichostatin related', 0.3053),\n",
       "  ('specific tissues', 0.2993),\n",
       "  ('control gene', 0.2978),\n",
       "  ('related malformations', 0.2841),\n",
       "  ('changing histonic', 0.2623),\n",
       "  ('cancer recently', 0.2363),\n",
       "  ('modifies', 0.2315),\n",
       "  ('teratogenic dose', 0.2301),\n",
       "  ('immunostaining performed', 0.208),\n",
       "  ('level somites', 0.205),\n",
       "  ('nuclear extracts', 0.2018),\n",
       "  ('partial inhibition', 0.1981),\n",
       "  ('pregnant mice', 0.1895),\n",
       "  ('mouse', 0.1753),\n",
       "  ('protein conformation', 0.1735),\n",
       "  ('similar mechanisms', 0.1714),\n",
       "  ('enzyme assay', 0.1533),\n",
       "  ('alpha 51', 0.1465),\n",
       "  ('mg kg', 0.1399),\n",
       "  ('treated intraperitoneally', 0.1383),\n",
       "  ('1000 mg', 0.1266),\n",
       "  ('analyses', 0.114),\n",
       "  ('factor beta', 0.1139),\n",
       "  ('revealed h4', 0.1117),\n",
       "  ('considered promising', 0.1115),\n",
       "  ('affinity factor', 0.1098),\n",
       "  ('70 work', 0.1074),\n",
       "  ('performed anti', 0.1044),\n",
       "  ('axial skeleton', 0.0971),\n",
       "  ('explanted treatment', 0.0907),\n",
       "  ('valproic acid', 0.0883),\n",
       "  ('strict relationship', 0.0694),\n",
       "  ('aim', 0.0674),\n",
       "  ('western', 0.0573),\n",
       "  ('ba induces', 0.0486),\n",
       "  ('day', 0.0455),\n",
       "  ('velocity factor', 0.0405),\n",
       "  ('mixed type', 0.032),\n",
       "  ('non', -0.0323),\n",
       "  ('boric', -0.0782)],\n",
       " 'MED-846': [('antifungal mechanism', 0.516),\n",
       "  ('yeast vaginitis', 0.5146),\n",
       "  ('vaginal infection', 0.462),\n",
       "  ('infection methods', 0.4258),\n",
       "  ('methods yeast', 0.3907),\n",
       "  ('bacterial isolates', 0.3605),\n",
       "  ('fungicidal organic', 0.3414),\n",
       "  ('integrity boric', 0.3122),\n",
       "  ('intrinsic antimicrobial', 0.2984),\n",
       "  ('study use', 0.2782),\n",
       "  ('sodium borate', 0.2745),\n",
       "  ('efficacy vivo', 0.2741),\n",
       "  ('resistant strains', 0.273),\n",
       "  ('tested agar', 0.2727),\n",
       "  ('acid potential', 0.2649),\n",
       "  ('fluconazole resistant', 0.2422),\n",
       "  ('yielded lower', 0.2398),\n",
       "  ('development biofilm', 0.2343),\n",
       "  ('background', 0.2336),\n",
       "  ('contributes therapeutic', 0.2305),\n",
       "  ('metabolism appears', 0.2264),\n",
       "  ('inhibition oxidative', 0.2176),\n",
       "  ('intravaginally', 0.2084),\n",
       "  ('vitro', 0.1992),\n",
       "  ('concentrations attainable', 0.1979),\n",
       "  ('candida cdr1', 0.1868),\n",
       "  ('nitrogen broth', 0.1808),\n",
       "  ('cold anaerobic', 0.1794),\n",
       "  ('prolonged culture', 0.1784),\n",
       "  ('lacking objectives', 0.177),\n",
       "  ('treatment recurrent', 0.1757),\n",
       "  ('understand spectrum', 0.1731),\n",
       "  ('interfered development', 0.1711),\n",
       "  ('vital stain', 0.1648),\n",
       "  ('commonly cited', 0.1546),\n",
       "  ('physiology methods', 0.1544),\n",
       "  ('ergosterol', 0.1541),\n",
       "  ('transformation conclusions', 0.1497),\n",
       "  ('illuminated mechanism', 0.1257),\n",
       "  ('maintained integrity', 0.1237),\n",
       "  ('1563 6250', 0.119),\n",
       "  ('intrusion', 0.1182),\n",
       "  ('sub mic', 0.1171),\n",
       "  ('expression abrogated', 0.1041),\n",
       "  ('efflux pump', 0.0966),\n",
       "  ('degrees 24', 0.0824),\n",
       "  ('37 degrees', 0.0645),\n",
       "  ('propidium iodide', 0.0454),\n",
       "  ('did', 0.0371),\n",
       "  ('50 000', 0.0094)],\n",
       " 'MED-850': [('impaired folate', 0.5793),\n",
       "  ('association folate', 0.5662),\n",
       "  ('studies mthfr', 0.4888),\n",
       "  ('gastrointestinal cancers', 0.4653),\n",
       "  ('review meta', 0.4299),\n",
       "  ('intake risk', 0.4085),\n",
       "  ('methylenetetrahydrofolate reductase', 0.3807),\n",
       "  ('epidemiologic studies', 0.3746),\n",
       "  ('metabolism implicated', 0.3721),\n",
       "  ('role carcinogenesis', 0.3614),\n",
       "  ('inconsistent studies', 0.3524),\n",
       "  ('search performed', 0.332),\n",
       "  ('effects summary', 0.3247),\n",
       "  ('cancer methods', 0.2993),\n",
       "  ('a1298c', 0.2938),\n",
       "  ('background aims', 0.2669),\n",
       "  ('conducted systematic', 0.266),\n",
       "  ('versus lowest', 0.2654),\n",
       "  ('esophagus stomach', 0.2639),\n",
       "  ('reduced enzyme', 0.2623),\n",
       "  ('evaluating association', 0.2546),\n",
       "  ('mthfr 677tt', 0.2531),\n",
       "  ('odds ratios', 0.2428),\n",
       "  ('study specific', 0.233),\n",
       "  ('genetic', 0.2218),\n",
       "  ('polymorphism limited', 0.2216),\n",
       "  ('confidence interval', 0.2211),\n",
       "  ('subsites', 0.2135),\n",
       "  ('findings support', 0.208),\n",
       "  ('variant genotype', 0.1941),\n",
       "  ('suggests', 0.1881),\n",
       "  ('cancer 22', 0.1862),\n",
       "  ('65 esophageal', 0.1809),\n",
       "  ('polymorphisms 10', 0.1787),\n",
       "  ('13 estimates', 0.1692),\n",
       "  ('random effects', 0.1649),\n",
       "  ('ci 53', 0.1508),\n",
       "  ('cohort inconsistent', 0.1476),\n",
       "  ('weighted inverse', 0.1359),\n",
       "  ('squamous cell', 0.1359),\n",
       "  ('increasing evidence', 0.1343),\n",
       "  ('cardia', 0.1088),\n",
       "  ('published march', 0.1034),\n",
       "  ('ci 35', 0.0978),\n",
       "  ('noncardia', 0.0783),\n",
       "  ('2006', 0.0745),\n",
       "  ('pancreatic', 0.0679),\n",
       "  ('39', 0.0456),\n",
       "  ('play', 0.0331),\n",
       "  ('control 49', 0.0102)],\n",
       " 'MED-851': [('barrett oesophagus', 0.7015),\n",
       "  ('oesophagus metaplastic', 0.6707),\n",
       "  ('oesophageal adenocarcinoma', 0.6319),\n",
       "  ('chronic gastroesophageal', 0.5686),\n",
       "  ('risk oesophageal', 0.5664),\n",
       "  ('barrett 40', 0.5605),\n",
       "  ('oesophagus lack', 0.4931),\n",
       "  ('reflux', 0.4908),\n",
       "  ('metaplastic', 0.3794),\n",
       "  ('predisposes cancer', 0.3786),\n",
       "  ('squamous epithelium', 0.3439),\n",
       "  ('adenocarcinoma lack', 0.3332),\n",
       "  ('endoscopic', 0.3261),\n",
       "  ('inhibitors ppis', 0.3144),\n",
       "  ('gord', 0.2567),\n",
       "  ('main chemopreventative', 0.2549),\n",
       "  ('prevent progression', 0.2502),\n",
       "  ('40 fold', 0.2486),\n",
       "  ('affects distal', 0.2459),\n",
       "  ('replaces stratified', 0.2306),\n",
       "  ('proton pump', 0.2294),\n",
       "  ('aspirin', 0.2072),\n",
       "  ('diet suggested', 0.1843),\n",
       "  ('development develops', 0.1721),\n",
       "  ('columnar lined', 0.164),\n",
       "  ('surveillance strategies', 0.1624),\n",
       "  ('history cell', 0.1492),\n",
       "  ('pathogenesis', 0.1388),\n",
       "  ('berries', 0.1191),\n",
       "  ('green tea', 0.1117),\n",
       "  ('animal model', 0.0924),\n",
       "  ('hamper research', 0.0812),\n",
       "  ('research area', 0.0759),\n",
       "  ('suggested discuss', 0.0645),\n",
       "  ('unacceptable', 0.059),\n",
       "  ('evidence available', 0.0579),\n",
       "  ('understanding natural', 0.0554),\n",
       "  ('optimal treatment', 0.0478),\n",
       "  ('normally', 0.0448),\n",
       "  ('elsevier rights', 0.0432),\n",
       "  ('effects main', 0.0407),\n",
       "  ('copyright 2011', 0.0385),\n",
       "  ('fold', 0.0371),\n",
       "  ('agent', 0.0276),\n",
       "  ('increased', 0.0227),\n",
       "  ('testing new', 0.0211),\n",
       "  ('infrastructure facilitate', 0.008),\n",
       "  ('universally accepted', 0.0025),\n",
       "  ('origin does', -0.0026),\n",
       "  ('hope continued', -0.0052)],\n",
       " 'MED-852': [('oral cancer', 0.4236),\n",
       "  ('cancer 327', 0.4029),\n",
       "  ('327 pharyngeal', 0.3986),\n",
       "  ('italy cases', 0.3616),\n",
       "  ('cases 271', 0.3557),\n",
       "  ('cancer controls', 0.344),\n",
       "  ('esophageal cancer', 0.3382),\n",
       "  ('fiber 37', 0.3205),\n",
       "  ('diseases cases', 0.2831),\n",
       "  ('intake study', 0.2821),\n",
       "  ('1997', 0.2724),\n",
       "  ('hospital patients', 0.2417),\n",
       "  ('fiber intake', 0.2356),\n",
       "  ('patients incident', 0.2288),\n",
       "  ('study indicates', 0.2242),\n",
       "  ('incident histologically', 0.2118),\n",
       "  ('cellulose polysaccharide', 0.2117),\n",
       "  ('including alcohol', 0.2097),\n",
       "  ('types', 0.2076),\n",
       "  ('ors highest', 0.2028),\n",
       "  ('frequency questionnaire', 0.1952),\n",
       "  ('subjects', 0.1947),\n",
       "  ('33 total', 0.192),\n",
       "  ('950 subjects', 0.1892),\n",
       "  ('consumption energy', 0.1698),\n",
       "  ('tobacco consumption', 0.1696),\n",
       "  ('confounding factors', 0.1664),\n",
       "  ('investigated', 0.1638),\n",
       "  ('38 lignin', 0.1428),\n",
       "  ('data case', 0.1393),\n",
       "  ('conducted 1992', 0.1181),\n",
       "  ('protective role', 0.1157),\n",
       "  ('computed allowance', 0.1107),\n",
       "  ('using validated', 0.1094),\n",
       "  ('304 esophageal', 0.1045),\n",
       "  ('40 total', 0.0926),\n",
       "  ('acute nonneoplastic', 0.0785),\n",
       "  ('fiber 60', 0.0771),\n",
       "  ('admitted network', 0.0492),\n",
       "  ('similar vegetable', 0.0417),\n",
       "  ('age education', 0.04),\n",
       "  ('48 insoluble', 0.0353),\n",
       "  ('inverse relation', 0.0161),\n",
       "  ('stay', 0.0121),\n",
       "  ('sexes strata', 0.012),\n",
       "  ('51', 0.0036),\n",
       "  ('stronger', 0.0004),\n",
       "  ('englyst', -0.0129),\n",
       "  ('lowest quintile', -0.0264),\n",
       "  ('soluble', -0.0775)],\n",
       " 'MED-853': [('hydrogen peroxide', 0.4625),\n",
       "  ('poison control', 0.4169),\n",
       "  ('review exposures', 0.398),\n",
       "  ('gastrointestinal injury', 0.3908),\n",
       "  ('developed gastric', 0.3843),\n",
       "  ('ulcers', 0.378),\n",
       "  ('exposures oral', 0.366),\n",
       "  ('duodenal erosions', 0.3425),\n",
       "  ('outcomes toxicity', 0.3267),\n",
       "  ('persistent vomiting', 0.3201),\n",
       "  ('regional poison', 0.3071),\n",
       "  ('exposure resulted', 0.305),\n",
       "  ('ingestions children', 0.3023),\n",
       "  ('delineate epidemiology', 0.291),\n",
       "  ('consideration endoscopy', 0.2907),\n",
       "  ('agent symptoms', 0.2849),\n",
       "  ('oz conclusions', 0.24),\n",
       "  ('small ingestions', 0.2173),\n",
       "  ('retrospective chart', 0.2162),\n",
       "  ('injury occur', 0.2012),\n",
       "  ('670 exposures', 0.1996),\n",
       "  ('therapy medical', 0.1885),\n",
       "  ('developed multiple', 0.1853),\n",
       "  ('evaluation', 0.1805),\n",
       "  ('children patients', 0.1792),\n",
       "  ('conducted data', 0.1785),\n",
       "  ('managed', 0.1771),\n",
       "  ('1995 conducted', 0.1721),\n",
       "  ('17 years', 0.1665),\n",
       "  ('report persistent', 0.1663),\n",
       "  ('presented', 0.1616),\n",
       "  ('objective present', 0.1609),\n",
       "  ('present child', 0.1503),\n",
       "  ('months exposures', 0.1413),\n",
       "  ('patients report', 0.1374),\n",
       "  ('long island', 0.1345),\n",
       "  ('island regional', 0.1281),\n",
       "  ('extracted', 0.123),\n",
       "  ('bloody emesis', 0.115),\n",
       "  ('center methods', 0.1003),\n",
       "  ('asymptomatic 85', 0.0905),\n",
       "  ('years old', 0.0725),\n",
       "  ('benign outcome', 0.0667),\n",
       "  ('77 occurred', 0.0636),\n",
       "  ('january 1992', 0.061),\n",
       "  ('april', 0.0565),\n",
       "  ('route', 0.0319),\n",
       "  ('126 total', 0.013),\n",
       "  ('81', 0.0118),\n",
       "  ('reported 40', -0.0127)],\n",
       " 'MED-854': [('cage hydrogen', 0.5236),\n",
       "  ('cage hyperbaric', 0.5229),\n",
       "  ('embolism cage', 0.5054),\n",
       "  ('embolism hyperbaric', 0.4558),\n",
       "  ('cage report', 0.4399),\n",
       "  ('oxygen therapy', 0.4327),\n",
       "  ('hbot cases', 0.3874),\n",
       "  ('peroxide treated', 0.3693),\n",
       "  ('hematemesis left', 0.3333),\n",
       "  ('gas', 0.3103),\n",
       "  ('result cerebral', 0.2994),\n",
       "  ('reversing symptoms', 0.2911),\n",
       "  ('accidental ingestion', 0.2603),\n",
       "  ('impairment', 0.2472),\n",
       "  ('hemianopsia initial', 0.2245),\n",
       "  ('cause', 0.2095),\n",
       "  ('patient underwent', 0.2031),\n",
       "  ('sips 33', 0.198),\n",
       "  ('report case', 0.1955),\n",
       "  ('demonstrated resolution', 0.189),\n",
       "  ('confusion left', 0.1748),\n",
       "  ('did undergo', 0.1699),\n",
       "  ('introduction', 0.1649),\n",
       "  ('radiologic abnormalities', 0.1646),\n",
       "  ('concentrated', 0.1522),\n",
       "  ('small', 0.1483),\n",
       "  ('sided hemiplegia', 0.1471),\n",
       "  ('later developed', 0.144),\n",
       "  ('standard care', 0.1434),\n",
       "  ('consistent ischemia', 0.1413),\n",
       "  ('mri demonstrated', 0.1343),\n",
       "  ('laboratory studies', 0.1292),\n",
       "  ('studies chest', 0.1237),\n",
       "  ('discussion search', 0.1237),\n",
       "  ('homonymous', 0.114),\n",
       "  ('benefit', 0.1024),\n",
       "  ('eighteen hours', 0.092),\n",
       "  ('medline 1950', 0.0877),\n",
       "  ('report 48', 0.084),\n",
       "  ('60', 0.0804),\n",
       "  ('seven reported', 0.075),\n",
       "  ('left sided', 0.0584),\n",
       "  ('ray brain', 0.048),\n",
       "  ('minutes ata', 0.0434),\n",
       "  ('atmospheres absolute', 0.0375),\n",
       "  ('t2', 0.0364),\n",
       "  ('30 minutes', 0.0306),\n",
       "  ('old male', 0.0229),\n",
       "  ('vascular territories', 0.0128),\n",
       "  ('permanent', -0.0716)],\n",
       " 'MED-855': [('peroxide bleaching', 0.7295),\n",
       "  ('oxidising agent', 0.5043),\n",
       "  ('purpose disinfectants', 0.4728),\n",
       "  ('use hydrogen', 0.4179),\n",
       "  ('stain removers', 0.4112),\n",
       "  ('household products', 0.3544),\n",
       "  ('whitening products', 0.3461),\n",
       "  ('sterilisation ophthalmic', 0.3459),\n",
       "  ('foaming mouth', 0.3458),\n",
       "  ('significant oral', 0.3289),\n",
       "  ('oxygen stomach', 0.3279),\n",
       "  ('hair dyes', 0.3258),\n",
       "  ('caustic', 0.2972),\n",
       "  ('treated thermal', 0.2946),\n",
       "  ('oropharyngeal burns', 0.2744),\n",
       "  ('chlorine free', 0.272),\n",
       "  ('follow dermal', 0.2706),\n",
       "  ('reduce discomfort', 0.2696),\n",
       "  ('employed medicinally', 0.2597),\n",
       "  ('paper pulp', 0.2554),\n",
       "  ('principal use', 0.2465),\n",
       "  ('irrigated immediately', 0.2355),\n",
       "  ('formation lipid', 0.2296),\n",
       "  ('endoscopic instruments', 0.2251),\n",
       "  ('72 hours', 0.205),\n",
       "  ('water skin', 0.2033),\n",
       "  ('stridor sub', 0.2016),\n",
       "  ('gastritis reported', 0.1998),\n",
       "  ('inhalational exposures', 0.191),\n",
       "  ('gas embolisation', 0.1872),\n",
       "  ('solubility', 0.1842),\n",
       "  ('wounds closed', 0.181),\n",
       "  ('laryngospasm haemorrhagic', 0.1758),\n",
       "  ('bleaches', 0.1575),\n",
       "  ('including general', 0.1455),\n",
       "  ('stinging', 0.1299),\n",
       "  ('distension potential', 0.1294),\n",
       "  ('rarely tracheostomy', 0.1174),\n",
       "  ('lacrimation blurred', 0.1124),\n",
       "  ('solutions cause', 0.1114),\n",
       "  ('considered persistent', 0.0993),\n",
       "  ('venous arterial', 0.0976),\n",
       "  ('cytotoxic effect', 0.0926),\n",
       "  ('sinus tachycardia', 0.0904),\n",
       "  ('local', 0.0539),\n",
       "  ('brain infarction', 0.0216),\n",
       "  ('value unproven', 0.0156),\n",
       "  ('highly concentrated', 0.007),\n",
       "  ('15 minutes', -0.0052),\n",
       "  ('evolved exceeds', -0.006)],\n",
       " 'MED-857': [('meta analysis', 0.4936),\n",
       "  ('studies investigated', 0.458),\n",
       "  ('risk research', 0.4109),\n",
       "  ('inconsistent results', 0.3928),\n",
       "  ('prospective studies', 0.3716),\n",
       "  ('ala assessment', 0.3547),\n",
       "  ('cancer risk', 0.3429),\n",
       "  ('rrs weighted', 0.3391),\n",
       "  ('systematically searched', 0.3351),\n",
       "  ('explained differences', 0.294),\n",
       "  ('estimates categories', 0.2921),\n",
       "  ('inverse variances', 0.2916),\n",
       "  ('prostate cancer', 0.2746),\n",
       "  ('investigated relation', 0.2619),\n",
       "  ('linolenic acid', 0.2578),\n",
       "  ('limits dietary', 0.2526),\n",
       "  ('association heterogeneous', 0.2469),\n",
       "  ('using reported', 0.2312),\n",
       "  ('divergences results', 0.2295),\n",
       "  ('sizes adjustment', 0.2203),\n",
       "  ('sample sizes', 0.2104),\n",
       "  ('intake subjects', 0.2091),\n",
       "  ('research needed', 0.2058),\n",
       "  ('2008 log', 0.1969),\n",
       "  ('compared subjects', 0.1873),\n",
       "  ('decreased risk', 0.1781),\n",
       "  ('obtain pooled', 0.1744),\n",
       "  ('highest lowest', 0.1681),\n",
       "  ('log relative', 0.1649),\n",
       "  ('dietary alpha', 0.1534),\n",
       "  ('protective association', 0.1508),\n",
       "  ('published december', 0.142),\n",
       "  ('findings support', 0.1392),\n",
       "  ('results', 0.1352),\n",
       "  ('ci identified', 0.1322),\n",
       "  ('individual based', 0.1094),\n",
       "  ('support weak', 0.0992),\n",
       "  ('estimate 95', 0.0958),\n",
       "  ('interval', 0.0912),\n",
       "  ('conclude question', 0.0823),\n",
       "  ('partly', 0.077),\n",
       "  ('met inclusion', 0.0614),\n",
       "  ('86', 0.0499),\n",
       "  ('non cases', 0.0484),\n",
       "  ('99 divergences', 0.0409),\n",
       "  ('day significant', 0.0109),\n",
       "  ('confidence', 0.0008),\n",
       "  ('comparing highest', -0.001),\n",
       "  ('10 association', -0.031),\n",
       "  ('carried', -0.0424)],\n",
       " 'MED-859': [('phytonutrients vitamins', 0.5308),\n",
       "  ('fruits vegetables', 0.4577),\n",
       "  ('radiation fruits', 0.4418),\n",
       "  ('leaf spinach', 0.3865),\n",
       "  ('individual foods', 0.3852),\n",
       "  ('beta carotene', 0.3373),\n",
       "  ('shelf life', 0.3339),\n",
       "  ('assayed vitamin', 0.3336),\n",
       "  ('persists ionizing', 0.3141),\n",
       "  ('irradiation little', 0.31),\n",
       "  ('cultivars flat', 0.2994),\n",
       "  ('leaf tissues', 0.2819),\n",
       "  ('lesser doses', 0.2787),\n",
       "  ('depending cultivar', 0.2588),\n",
       "  ('trade prolonging', 0.247),\n",
       "  ('practices baby', 0.235),\n",
       "  ('form gamma', 0.2238),\n",
       "  ('overcoming quarantine', 0.2109),\n",
       "  ('free ascorbic', 0.1986),\n",
       "  ('industry practices', 0.1971),\n",
       "  ('acid levels', 0.1967),\n",
       "  ('oxidative', 0.1845),\n",
       "  ('consistent effect', 0.1838),\n",
       "  ('kgy depending', 0.1835),\n",
       "  ('indicator stress', 0.1728),\n",
       "  ('cesium 137', 0.1686),\n",
       "  ('lutein', 0.1601),\n",
       "  ('harvested surface', 0.1527),\n",
       "  ('increasing doses', 0.1475),\n",
       "  ('neoxanthin', 0.1358),\n",
       "  ('packaged air', 0.1287),\n",
       "  ('violaxanthin beta', 0.1187),\n",
       "  ('compound indicator', 0.116),\n",
       "  ('commercial', 0.1111),\n",
       "  ('concentrations atmospheres', 0.1078),\n",
       "  ('individual', 0.0883),\n",
       "  ('associated elevated', 0.0817),\n",
       "  ('barriers', 0.0815),\n",
       "  ('electron beams', 0.0779),\n",
       "  ('void', 0.0775),\n",
       "  ('versus', 0.0758),\n",
       "  ('little change', 0.0756),\n",
       "  ('tissues assayed', 0.0605),\n",
       "  ('information', 0.0598),\n",
       "  ('total', 0.0567),\n",
       "  ('change concentration', 0.0533),\n",
       "  ('lazio crinkled', 0.0468),\n",
       "  ('dihydroascorbic acid', 0.0365),\n",
       "  ('profiles', -0.003),\n",
       "  ('samish grown', -0.0242)],\n",
       " 'MED-860': [('microgreens contribute', 0.6166),\n",
       "  ('microgreens seedlings', 0.5993),\n",
       "  ('microgreen cotyledon', 0.5183),\n",
       "  ('vegetables herbs', 0.4729),\n",
       "  ('new culinary', 0.4185),\n",
       "  ('flavors', 0.416),\n",
       "  ('seedlings edible', 0.398),\n",
       "  ('densities phytonutrient', 0.3936),\n",
       "  ('edible garnish', 0.3779),\n",
       "  ('textures served', 0.3543),\n",
       "  ('varied μg', 0.3141),\n",
       "  ('leaves possessed', 0.3084),\n",
       "  ('zeaxanthin', 0.2889),\n",
       "  ('amaranth green', 0.2816),\n",
       "  ('colors crisp', 0.2585),\n",
       "  ('choices fresh', 0.2518),\n",
       "  ('ascorbic acids', 0.2473),\n",
       "  ('lutein', 0.2194),\n",
       "  ('contribute food', 0.2129),\n",
       "  ('consumers', 0.2118),\n",
       "  ('fw tocopherol', 0.2117),\n",
       "  ('concentrations mature', 0.2024),\n",
       "  ('usda national', 0.193),\n",
       "  ('25 commercially', 0.1912),\n",
       "  ('vivid', 0.1908),\n",
       "  ('currently available', 0.1889),\n",
       "  ('new salad', 0.1779),\n",
       "  ('phylloquinone', 0.1771),\n",
       "  ('gained popularity', 0.1736),\n",
       "  ('10 mg', 0.1698),\n",
       "  ('years small', 0.1661),\n",
       "  ('39 mg', 0.1608),\n",
       "  ('radish highest', 0.147),\n",
       "  ('mg', 0.1318),\n",
       "  ('147 mg', 0.116),\n",
       "  ('composition database', 0.1103),\n",
       "  ('100 fw', 0.095),\n",
       "  ('health', 0.0856),\n",
       "  ('ranged', 0.0654),\n",
       "  ('agencies recommendations', 0.0624),\n",
       "  ('scientific data', 0.0532),\n",
       "  ('cabbage cilantro', 0.0482),\n",
       "  ('respectively comparison', 0.0451),\n",
       "  ('possessed', 0.0443),\n",
       "  ('present study', 0.04),\n",
       "  ('daikon', 0.031),\n",
       "  ('20', 0.0271),\n",
       "  ('trend past', 0.0195),\n",
       "  ('12', 0.005),\n",
       "  ('assayed red', -0.018)],\n",
       " 'MED-861': [('intakes fats', 0.4687),\n",
       "  ('cancer associations', 0.4544),\n",
       "  ('cancer pca', 0.4003),\n",
       "  ('cancer tertile', 0.3676),\n",
       "  ('pca men', 0.3676),\n",
       "  ('confirmed prostate', 0.3652),\n",
       "  ('chromatography diet', 0.3418),\n",
       "  ('pca conclusions', 0.3394),\n",
       "  ('urology clinics', 0.3293),\n",
       "  ('assessed food', 0.3054),\n",
       "  ('investigate association', 0.2872),\n",
       "  ('209 men', 0.2727),\n",
       "  ('mufa reduced', 0.2486),\n",
       "  ('men 40', 0.2396),\n",
       "  ('acids reported', 0.237),\n",
       "  ('high linolenic', 0.2287),\n",
       "  ('12 70', 0.2278),\n",
       "  ('men high', 0.2208),\n",
       "  ('oleic', 0.2159),\n",
       "  ('frequency questionnaire', 0.2061),\n",
       "  ('control study', 0.2046),\n",
       "  ('37 ci', 0.1856),\n",
       "  ('cancer free', 0.1793),\n",
       "  ('principal source', 0.1717),\n",
       "  ('measured gas', 0.169),\n",
       "  ('high blood', 0.1678),\n",
       "  ('proportions increased', 0.1635),\n",
       "  ('free men', 0.1562),\n",
       "  ('newly diagnosed', 0.123),\n",
       "  ('results high', 0.1141),\n",
       "  ('objective', 0.111),\n",
       "  ('composition mol', 0.1096),\n",
       "  ('226', 0.1068),\n",
       "  ('80 years', 0.1039),\n",
       "  ('14', 0.0972),\n",
       "  ('risk', 0.0829),\n",
       "  ('histologically', 0.0817),\n",
       "  ('years', 0.079),\n",
       "  ('tertile 06', 0.0653),\n",
       "  ('design case', 0.0645),\n",
       "  ('mufa avocado', 0.0618),\n",
       "  ('myristic', 0.0568),\n",
       "  ('attending', 0.0557),\n",
       "  ('ci 16', 0.054),\n",
       "  ('53', 0.0347),\n",
       "  ('29 27', 0.0111),\n",
       "  ('98 moderate', -0.0006),\n",
       "  ('stearic', -0.0266),\n",
       "  ('old newly', -0.0348),\n",
       "  ('inversely related', -0.0504)],\n",
       " 'MED-862': [('vitamin exposure', 0.6074),\n",
       "  ('exposure uvb', 0.4625),\n",
       "  ('calcaemic functions', 0.3911),\n",
       "  ('traditional lifestyles', 0.3599),\n",
       "  ('related diseases', 0.3274),\n",
       "  ('cutaneous synthesis', 0.3202),\n",
       "  ('ca homeostasis', 0.3095),\n",
       "  ('clothing habits', 0.3019),\n",
       "  ('direct exposure', 0.2963),\n",
       "  ('habits reduced', 0.2867),\n",
       "  ('outdoors avoid', 0.2688),\n",
       "  ('day outdoors', 0.2665),\n",
       "  ('tropical sunlight', 0.2643),\n",
       "  ('risk insufficiency', 0.2636),\n",
       "  ('concentrations related', 0.2564),\n",
       "  ('having lifelong', 0.2555),\n",
       "  ('oh concentrations', 0.2418),\n",
       "  ('homeostasis changed', 0.2309),\n",
       "  ('important factors', 0.2229),\n",
       "  ('lifestyle uncertain', 0.2128),\n",
       "  ('years', 0.2097),\n",
       "  ('related age', 0.2076),\n",
       "  ('body current', 0.1869),\n",
       "  ('evolutionary perspective', 0.1808),\n",
       "  ('populations', 0.1752),\n",
       "  ('round exposure', 0.1741),\n",
       "  ('possible 25', 0.164),\n",
       "  ('concentration 115', 0.1619),\n",
       "  ('nmol concentration', 0.1567),\n",
       "  ('current western', 0.154),\n",
       "  ('bmi people', 0.1509),\n",
       "  ('10 years', 0.1507),\n",
       "  ('functions', 0.1424),\n",
       "  ('type vi', 0.1122),\n",
       "  ('years 43', 0.1102),\n",
       "  ('thirty pastoral', 0.0988),\n",
       "  ('spend', 0.0962),\n",
       "  ('cradle mankind', 0.092),\n",
       "  ('concentrations maasai', 0.091),\n",
       "  ('possible target', 0.0858),\n",
       "  ('perspective measured', 0.0804),\n",
       "  ('hadzabe 119', 0.0734),\n",
       "  ('agricultural revolution', 0.0673),\n",
       "  ('provide information', 0.0666),\n",
       "  ('tanzania skin', 0.0543),\n",
       "  ('sd', 0.0483),\n",
       "  ('measured liquid', 0.0227),\n",
       "  ('hunter gatherers', 0.0117),\n",
       "  ('range 58', -0.0141),\n",
       "  ('non', -0.0146)],\n",
       " 'MED-863': [('durian fruit', 0.5911),\n",
       "  ('durian inflict', 0.4885),\n",
       "  ('ripe durian', 0.4756),\n",
       "  ('fruit dropped', 0.4595),\n",
       "  ('durian', 0.4464),\n",
       "  ('devices durian', 0.4207),\n",
       "  ('dropped face', 0.3987),\n",
       "  ('face harvesting', 0.3623),\n",
       "  ('fruit harvesting', 0.3618),\n",
       "  ('drops tree', 0.3476),\n",
       "  ('fruit', 0.3103),\n",
       "  ('presented facial', 0.3053),\n",
       "  ('facial penetrating', 0.3036),\n",
       "  ('fruits tree', 0.3021),\n",
       "  ('eye injury', 0.2953),\n",
       "  ('harvesting fruits', 0.291),\n",
       "  ('importance facial', 0.2634),\n",
       "  ('facial eye', 0.2616),\n",
       "  ('face', 0.2577),\n",
       "  ('eye protective', 0.2482),\n",
       "  ('case report', 0.2451),\n",
       "  ('drops', 0.24),\n",
       "  ('injury drops', 0.238),\n",
       "  ('patient presented', 0.214),\n",
       "  ('dropped', 0.2059),\n",
       "  ('injury', 0.1974),\n",
       "  ('body injury', 0.1971),\n",
       "  ('penetrating eye', 0.1892),\n",
       "  ('tree authors', 0.1806),\n",
       "  ('tree', 0.1771),\n",
       "  ('harvesting season', 0.1732),\n",
       "  ('severe body', 0.1658),\n",
       "  ('tree case', 0.1533),\n",
       "  ('patient', 0.1437),\n",
       "  ('eye', 0.1377),\n",
       "  ('protective', 0.1306),\n",
       "  ('injury ripe', 0.1298),\n",
       "  ('inflict severe', 0.1291),\n",
       "  ('penetrating', 0.1285),\n",
       "  ('emphasized importance', 0.1115),\n",
       "  ('presented', 0.1085),\n",
       "  ('ripe', 0.1066),\n",
       "  ('authors emphasized', 0.103),\n",
       "  ('body', 0.099),\n",
       "  ('devices', 0.0927),\n",
       "  ('report describes', 0.0901),\n",
       "  ('case', 0.0769),\n",
       "  ('describes', 0.0513),\n",
       "  ('season', 0.04),\n",
       "  ('authors', 0.0138)],\n",
       " 'MED-864': [('lucidum lingzhi', 0.4493),\n",
       "  ('lingzhi toxic', 0.4373),\n",
       "  ('lingzhi mushroom', 0.4336),\n",
       "  ('ganoderma lucidum', 0.4314),\n",
       "  ('fulminant hepatitis', 0.4188),\n",
       "  ('boiled lingzhi', 0.4083),\n",
       "  ('lingzhi powder', 0.397),\n",
       "  ('taking lingzhi', 0.3927),\n",
       "  ('patient hong', 0.3604),\n",
       "  ('role lingzhi', 0.3505),\n",
       "  ('fatal fulminant', 0.3109),\n",
       "  ('hepatotoxic effect', 0.2996),\n",
       "  ('kong 2004', 0.2987),\n",
       "  ('related ganoderma', 0.2928),\n",
       "  ('patients toxic', 0.2822),\n",
       "  ('kong', 0.2729),\n",
       "  ('2004 2005', 0.2721),\n",
       "  ('hepatitis associated', 0.2521),\n",
       "  ('described patient', 0.2505),\n",
       "  ('2005 authors', 0.2462),\n",
       "  ('taken therapeutic', 0.2387),\n",
       "  ('lucidum', 0.2315),\n",
       "  ('drugs', 0.2221),\n",
       "  ('therapeutic agents', 0.1885),\n",
       "  ('mushroom powder', 0.1874),\n",
       "  ('occurred patients', 0.1777),\n",
       "  ('episode occurred', 0.1748),\n",
       "  ('months hepatotoxic', 0.1704),\n",
       "  ('patients taken', 0.1617),\n",
       "  ('case fatal', 0.1467),\n",
       "  ('traditionally boiled', 0.1225),\n",
       "  ('described', 0.1156),\n",
       "  ('preparation patients', 0.1151),\n",
       "  ('authors experienced', 0.0784),\n",
       "  ('effect related', 0.0726),\n",
       "  ('taken', 0.0617),\n",
       "  ('experienced case', 0.0508),\n",
       "  ('especially combination', 0.0494),\n",
       "  ('close monitoring', 0.045),\n",
       "  ('powder needs', 0.0379),\n",
       "  ('future', 0.0142),\n",
       "  ('agents traditionally', 0.0092),\n",
       "  ('close', 0.0049),\n",
       "  ('monitoring future', 0.0023),\n",
       "  ('switching taking', 0.0016),\n",
       "  ('especially', -0.0148),\n",
       "  ('needs', -0.0356),\n",
       "  ('form months', -0.0421),\n",
       "  ('form', -0.0442),\n",
       "  ('role', -0.0461)],\n",
       " 'MED-865': [('cancer prevention', 0.6079),\n",
       "  ('prostate cancer', 0.6071),\n",
       "  ('inhibits prostate', 0.5664),\n",
       "  ('treatments advanced', 0.3835),\n",
       "  ('prevent treat', 0.3527),\n",
       "  ('hormone refractory', 0.3426),\n",
       "  ('mouse prostate', 0.3414),\n",
       "  ('prevention necessary', 0.3404),\n",
       "  ('reduction pcna', 0.3339),\n",
       "  ('diet inhibits', 0.3332),\n",
       "  ('palliative care', 0.3201),\n",
       "  ('31 prostate', 0.2855),\n",
       "  ('pc3 lncap', 0.2853),\n",
       "  ('disease limited', 0.2798),\n",
       "  ('approaches control', 0.265),\n",
       "  ('health related', 0.2637),\n",
       "  ('transgenic adenocarcinoma', 0.246),\n",
       "  ('intraepithelial neoplasia', 0.2226),\n",
       "  ('earlier diagnosis', 0.1882),\n",
       "  ('poly adp', 0.1813),\n",
       "  ('cyclin d1', 0.1709),\n",
       "  ('assess efficacy', 0.169),\n",
       "  ('compound delayed', 0.1643),\n",
       "  ('leading cause', 0.1555),\n",
       "  ('cells treated', 0.155),\n",
       "  ('men earlier', 0.1518),\n",
       "  ('deaths american', 0.1478),\n",
       "  ('progression proliferation', 0.146),\n",
       "  ('rate patients', 0.1401),\n",
       "  ('study initially', 0.1291),\n",
       "  ('anti', 0.1275),\n",
       "  ('oral administration', 0.12),\n",
       "  ('suggest time', 0.1091),\n",
       "  ('centuries ayurveda', 0.1062),\n",
       "  ('51 reduction', 0.096),\n",
       "  ('fed mice', 0.0958),\n",
       "  ('issues', 0.0869),\n",
       "  ('risk centuries', 0.0865),\n",
       "  ('use bitter', 0.0779),\n",
       "  ('increases survival', 0.0753),\n",
       "  ('expression treatment', 0.0641),\n",
       "  ('remains second', 0.056),\n",
       "  ('new methods', 0.0517),\n",
       "  ('interfering cell', 0.048),\n",
       "  ('tramp transgenic', 0.0421),\n",
       "  ('functional food', 0.0398),\n",
       "  ('agent observed', 0.0341),\n",
       "  ('extract bme', 0.0092),\n",
       "  ('momordica charantia', -0.0716),\n",
       "  ('melon', -0.0769)],\n",
       " 'MED-866': [('melon hypoglycemic', 0.5301),\n",
       "  ('bitter melon', 0.5081),\n",
       "  ('melon extract', 0.4913),\n",
       "  ('recommended bitter', 0.4701),\n",
       "  ('lowering agents', 0.4281),\n",
       "  ('antineoplastic activities', 0.4263),\n",
       "  ('therapy bitter', 0.4226),\n",
       "  ('mellitus components', 0.422),\n",
       "  ('antiviral', 0.4217),\n",
       "  ('drug', 0.4001),\n",
       "  ('alternative therapy', 0.3871),\n",
       "  ('include hypoglycemic', 0.3566),\n",
       "  ('patients diabetes', 0.3313),\n",
       "  ('pharmacology clinical', 0.3176),\n",
       "  ('animal insulin', 0.2806),\n",
       "  ('safety efficacy', 0.2682),\n",
       "  ('recommend use', 0.2228),\n",
       "  ('effects data', 0.2211),\n",
       "  ('momordica charantia', 0.2076),\n",
       "  ('components', 0.2041),\n",
       "  ('reported adverse', 0.2039),\n",
       "  ('trials needed', 0.2008),\n",
       "  ('levels patients', 0.1992),\n",
       "  ('extract appear', 0.1879),\n",
       "  ('place therapy', 0.1717),\n",
       "  ('interactions place', 0.1556),\n",
       "  ('taken glucose', 0.1455),\n",
       "  ('reduced', 0.1444),\n",
       "  ('animals headaches', 0.1297),\n",
       "  ('structural similarities', 0.1283),\n",
       "  ('additive effects', 0.1259),\n",
       "  ('primarily used', 0.1257),\n",
       "  ('studies', 0.125),\n",
       "  ('controlled', 0.1218),\n",
       "  ('placebo controlled', 0.1191),\n",
       "  ('powder moderate', 0.1099),\n",
       "  ('favism', 0.108),\n",
       "  ('fruit dried', 0.0945),\n",
       "  ('use absence', 0.0893),\n",
       "  ('like', 0.0846),\n",
       "  ('supervision monitoring', 0.0717),\n",
       "  ('coma', 0.0694),\n",
       "  ('gamma glutamyltransferase', 0.0672),\n",
       "  ('double', 0.0665),\n",
       "  ('blood', 0.0618),\n",
       "  ('convulsions children', 0.0388),\n",
       "  ('fertility mice', 0.0258),\n",
       "  ('syndrome increases', 0.0228),\n",
       "  ('phosphatase levels', 0.001),\n",
       "  ('adequately powered', -0.0052)],\n",
       " 'MED-867': [('capsules charantia', 0.5089),\n",
       "  ('objectives momordica', 0.4195),\n",
       "  ('effectiveness charantia', 0.3636),\n",
       "  ('trial included', 0.3414),\n",
       "  ('ampalaya widely', 0.2865),\n",
       "  ('hypoglycemic effects', 0.2759),\n",
       "  ('cholesterol', 0.2499),\n",
       "  ('a1c hba1c', 0.2478),\n",
       "  ('secondary efficacy', 0.2439),\n",
       "  ('adverse events', 0.2214),\n",
       "  ('controlled type', 0.1886),\n",
       "  ('preparation main', 0.1861),\n",
       "  ('objective', 0.1782),\n",
       "  ('significant effect', 0.1765),\n",
       "  ('therapy patients', 0.1718),\n",
       "  ('a1c outset', 0.1717),\n",
       "  ('generally mild', 0.1712),\n",
       "  ('received placebo', 0.167),\n",
       "  ('serum creatinine', 0.1618),\n",
       "  ('mean fasting', 0.1586),\n",
       "  ('weight safety', 0.1569),\n",
       "  ('effects serum', 0.1551),\n",
       "  ('meals months', 0.1514),\n",
       "  ('results baseline', 0.1431),\n",
       "  ('alanine aminotransferase', 0.1415),\n",
       "  ('dose primary', 0.1287),\n",
       "  ('2004 outpatient', 0.121),\n",
       "  ('4825 significant', 0.1192),\n",
       "  ('groups similar', 0.1169),\n",
       "  ('included 40', 0.0963),\n",
       "  ('advertised', 0.092),\n",
       "  ('95', 0.0843),\n",
       "  ('bigger studies', 0.0763),\n",
       "  ('general hospital', 0.0757),\n",
       "  ('hepatic', 0.0707),\n",
       "  ('locally known', 0.0678),\n",
       "  ('achieved power', 0.0649),\n",
       "  ('potassium', 0.0557),\n",
       "  ('used estimate', 0.0531),\n",
       "  ('unable make', 0.0452),\n",
       "  ('april september', 0.0437),\n",
       "  ('times day', 0.0375),\n",
       "  ('88 observed', 0.0361),\n",
       "  ('blind', 0.029),\n",
       "  ('shed light', 0.0181),\n",
       "  ('11 reason', 0.0148),\n",
       "  ('18 years', 0.0034),\n",
       "  ('observed decline', -0.0027),\n",
       "  ('old newly', -0.0238),\n",
       "  ('philippine', -0.0652)],\n",
       " 'MED-868': [('adrenocortical carcinomas', 0.4739),\n",
       "  ('carcinomas rare', 0.4318),\n",
       "  ('melon extract', 0.3941),\n",
       "  ('reduce cancer', 0.3814),\n",
       "  ('bitter melon', 0.3769),\n",
       "  ('observe antiproliferative', 0.3361),\n",
       "  ('consumed vegetable', 0.2862),\n",
       "  ('traditional medicine', 0.2786),\n",
       "  ('progression reduce', 0.2394),\n",
       "  ('human mouse', 0.2373),\n",
       "  ('prevention diet', 0.2357),\n",
       "  ('prognosis approaches', 0.234),\n",
       "  ('diverse mechanisms', 0.2226),\n",
       "  ('poor prognosis', 0.2225),\n",
       "  ('model assess', 0.2194),\n",
       "  ('approaches control', 0.2159),\n",
       "  ('cellular tumor', 0.2125),\n",
       "  ('treatment decreased', 0.2029),\n",
       "  ('required steroidogenic', 0.1926),\n",
       "  ('bme extracts', 0.1681),\n",
       "  ('dose dependent', 0.1666),\n",
       "  ('levels inhibited', 0.1637),\n",
       "  ('cells treated', 0.1546),\n",
       "  ('suggesting additional', 0.1506),\n",
       "  ('widely consumed', 0.146),\n",
       "  ('cycle', 0.1387),\n",
       "  ('decreased key', 0.1244),\n",
       "  ('level insulin', 0.1193),\n",
       "  ('inhibitor 1a', 0.1181),\n",
       "  ('study used', 0.1161),\n",
       "  ('regulation cell', 0.1154),\n",
       "  ('acorn squash', 0.1135),\n",
       "  ('antigen p53', 0.1062),\n",
       "  ('second apoptosis', 0.0903),\n",
       "  ('cyclin d1', 0.0903),\n",
       "  ('zucchini', 0.0878),\n",
       "  ('factor receptor', 0.0867),\n",
       "  ('rare present', 0.0784),\n",
       "  ('blueberry', 0.0657),\n",
       "  ('proliferation did', 0.0562),\n",
       "  ('amp dependent', 0.0562),\n",
       "  ('countries', 0.0413),\n",
       "  ('treatment enhanced', 0.0305),\n",
       "  ('called janus', 0.0252),\n",
       "  ('used human', 0.0165),\n",
       "  ('threonine protein', 0.009),\n",
       "  ('downstream', -0.0364),\n",
       "  ('ribose polymerase', -0.0407),\n",
       "  ('like', -0.0479),\n",
       "  ('taken data', -0.0521)],\n",
       " 'MED-869': [('drink yerba', 0.5043),\n",
       "  ('tea consumption', 0.4789),\n",
       "  ('yerba mate', 0.4529),\n",
       "  ('mate tea', 0.4406),\n",
       "  ('tea bone', 0.4319),\n",
       "  ('mate consumption', 0.4205),\n",
       "  ('paraguariensis tea', 0.3795),\n",
       "  ('consumption bone', 0.3746),\n",
       "  ('drinkers higher', 0.3667),\n",
       "  ('drank', 0.2849),\n",
       "  ('program osteoporosis', 0.2805),\n",
       "  ('did drink', 0.2728),\n",
       "  ('postmenopausal women', 0.271),\n",
       "  ('higher argentina', 0.2428),\n",
       "  ('time menopause', 0.2313),\n",
       "  ('sinensis effects', 0.2027),\n",
       "  ('mate ilex', 0.1956),\n",
       "  ('coffee', 0.1805),\n",
       "  ('camellia', 0.1623),\n",
       "  ('higher femoral', 0.15),\n",
       "  ('multiple regression', 0.1416),\n",
       "  ('mineral', 0.1184),\n",
       "  ('bmd measured', 0.1151),\n",
       "  ('versus 858', 0.1136),\n",
       "  ('0028 results', 0.1046),\n",
       "  ('women did', 0.0963),\n",
       "  ('0001 higher', 0.0957),\n",
       "  ('dual energy', 0.0761),\n",
       "  ('effects', 0.0688),\n",
       "  ('chronic', 0.0645),\n",
       "  ('health', 0.0552),\n",
       "  ('suggest', 0.0416),\n",
       "  ('952 cm', 0.0395),\n",
       "  ('mass index', 0.0366),\n",
       "  ('explored program', 0.0301),\n",
       "  ('countries', 0.0209),\n",
       "  ('daily years', 0.0183),\n",
       "  ('2011', 0.0014),\n",
       "  ('south', -0.0014),\n",
       "  ('factor body', -0.0043),\n",
       "  ('previously', -0.0099),\n",
       "  ('cm versus', -0.0142),\n",
       "  ('146 identified', -0.0272),\n",
       "  ('showed positive', -0.0287),\n",
       "  ('neck', -0.0414),\n",
       "  ('776 cm', -0.0683),\n",
       "  ('equal number', -0.0728),\n",
       "  ('lumbar', -0.0772),\n",
       "  ('elsevier rights', -0.0842),\n",
       "  ('american', -0.1116)],\n",
       " 'MED-870': [('tea prepared', 0.6526),\n",
       "  ('brewed tea', 0.5601),\n",
       "  ('beverage social', 0.3965),\n",
       "  ('guarani', 0.3081),\n",
       "  ('paraguariensis dyslipoproteinemia', 0.3004),\n",
       "  ('coffee past', 0.2948),\n",
       "  ('leaves brewed', 0.2696),\n",
       "  ('ritualistic role', 0.2586),\n",
       "  ('societies used', 0.2414),\n",
       "  ('drunk', 0.2396),\n",
       "  ('metabolism ilex', 0.2161),\n",
       "  ('expression antioxidant', 0.2129),\n",
       "  ('america having', 0.2022),\n",
       "  ('herb', 0.1948),\n",
       "  ('antimutagenic effects', 0.1934),\n",
       "  ('minced', 0.1921),\n",
       "  ('drying process', 0.184),\n",
       "  ('alkylating', 0.1829),\n",
       "  ('glycation effects', 0.18),\n",
       "  ('generis', 0.1742),\n",
       "  ('prepared sui', 0.1712),\n",
       "  ('used source', 0.1617),\n",
       "  ('south', 0.1453),\n",
       "  ('chemical models', 0.145),\n",
       "  ('having evolved', 0.1274),\n",
       "  ('studies vaso', 0.1243),\n",
       "  ('ethnic', 0.1238),\n",
       "  ('heavy consumption', 0.1195),\n",
       "  ('green', 0.1183),\n",
       "  ('reduces ldl', 0.1177),\n",
       "  ('indicate contamination', 0.115),\n",
       "  ('mice', 0.107),\n",
       "  ('provide concise', 0.1014),\n",
       "  ('protecting cigarette', 0.0917),\n",
       "  ('novel interesting', 0.0743),\n",
       "  ('translational studies', 0.0671),\n",
       "  ('oropharyngeal cancer', 0.0664),\n",
       "  ('modern', 0.0638),\n",
       "  ('pancreatic lipase', 0.0608),\n",
       "  ('ampk uncoupling', 0.0603),\n",
       "  ('synergic statins', 0.0517),\n",
       "  ('macrophage migration', 0.0438),\n",
       "  ('health', 0.033),\n",
       "  ('lags impressive', 0.0318),\n",
       "  ('lieu', 0.0243),\n",
       "  ('induced lung', 0.0166),\n",
       "  ('15 years', 0.0158),\n",
       "  ('rights reserved', -0.0053),\n",
       "  ('copyright 2010', -0.027),\n",
       "  ('controversial', -0.0315)],\n",
       " 'MED-872': [('exposure amalgam', 0.5908),\n",
       "  ('increased hg', 0.5333),\n",
       "  ('metallic mercury', 0.5317),\n",
       "  ('hg vapour', 0.4654),\n",
       "  ('50 metallic', 0.4232),\n",
       "  ('μg day', 0.3533),\n",
       "  ('filled tooth', 0.345),\n",
       "  ('increase urinary', 0.3164),\n",
       "  ('environmental protection', 0.2793),\n",
       "  ('brain hg', 0.266),\n",
       "  ('agency exposure', 0.265),\n",
       "  ('majority restorations', 0.2613),\n",
       "  ('content increasing', 0.2564),\n",
       "  ('exceed dose', 0.2253),\n",
       "  ('various organs', 0.223),\n",
       "  ('vapour continuously', 0.2131),\n",
       "  ('grand total', 0.2126),\n",
       "  ('meconium', 0.1962),\n",
       "  ('teeth children', 0.1917),\n",
       "  ('67 million', 0.1825),\n",
       "  ('amniotic fluid', 0.167),\n",
       "  ('billion', 0.1631),\n",
       "  ('saliva', 0.1565),\n",
       "  ('pituitary gland', 0.1465),\n",
       "  ('evolves place', 0.1452),\n",
       "  ('age factors', 0.1394),\n",
       "  ('fillings determined', 0.1368),\n",
       "  ('load', 0.1325),\n",
       "  ('presented health', 0.1285),\n",
       "  ('exhaled breath', 0.119),\n",
       "  ('causing', 0.114),\n",
       "  ('body weight', 0.1112),\n",
       "  ('health canada', 0.1106),\n",
       "  ('surfaces', 0.0824),\n",
       "  ('colostrum', 0.0561),\n",
       "  ('groups', 0.0531),\n",
       "  ('elsevier rights', 0.0505),\n",
       "  ('46 billion', 0.0483),\n",
       "  ('based conservative', 0.0333),\n",
       "  ('scenarios considered', 0.0303),\n",
       "  ('181 million', 0.022),\n",
       "  ('statistics body', 0.019),\n",
       "  ('research incremental', 0.0115),\n",
       "  ('months', -0.0022),\n",
       "  ('2004 population', -0.0047),\n",
       "  ('americans carry', -0.0201),\n",
       "  ('rel 03', -0.0268),\n",
       "  ('established california', -0.0445),\n",
       "  ('122 million', -0.0475),\n",
       "  ('1995', -0.0781)],\n",
       " 'MED-876': [('mediterranean diet', 0.5605),\n",
       "  ('medd antioxidants', 0.4756),\n",
       "  ('antioxidant intake', 0.4382),\n",
       "  ('med diet', 0.4134),\n",
       "  ('medd lower', 0.3873),\n",
       "  ('intake compared', 0.3701),\n",
       "  ('vitamins intake', 0.3585),\n",
       "  ('cardiovascular disease', 0.3551),\n",
       "  ('lower adherence', 0.3517),\n",
       "  ('association medd', 0.3501),\n",
       "  ('calculated adherence', 0.3476),\n",
       "  ('diet lower', 0.3375),\n",
       "  ('intake arrhythmias', 0.3322),\n",
       "  ('antioxidants lower', 0.3253),\n",
       "  ('af nutritional', 0.2697),\n",
       "  ('or1 95', 0.2427),\n",
       "  ('lower incidence', 0.235),\n",
       "  ('patients af', 0.2325),\n",
       "  ('conclusions patients', 0.2168),\n",
       "  ('background aim', 0.2165),\n",
       "  ('administered days', 0.2082),\n",
       "  ('parameters assessed', 0.1968),\n",
       "  ('fibrillation copyright', 0.1932),\n",
       "  ('mmol 001', 0.1811),\n",
       "  ('median value', 0.1762),\n",
       "  ('study 400', 0.1705),\n",
       "  ('800 subjects', 0.1548),\n",
       "  ('long associated', 0.1507),\n",
       "  ('disease', 0.1479),\n",
       "  ('compared control', 0.1433),\n",
       "  ('frequency', 0.1398),\n",
       "  ('detected episode', 0.127),\n",
       "  ('18 mmol', 0.126),\n",
       "  ('13 vs', 0.124),\n",
       "  ('01 conclusions', 0.1125),\n",
       "  ('little information', 0.0901),\n",
       "  ('99', 0.0897),\n",
       "  ('q1 q3', 0.0808),\n",
       "  ('investigate relationship', 0.0785),\n",
       "  ('81', 0.0589),\n",
       "  ('56', 0.0499),\n",
       "  ('validated questionnaire', 0.0463),\n",
       "  ('included case', 0.0449),\n",
       "  ('group', 0.0317),\n",
       "  ('high levels', 0.0313),\n",
       "  ('spontaneous conversion', 0.0085),\n",
       "  ('elsevier rights', -0.0011),\n",
       "  ('30 patients', -0.0084),\n",
       "  ('self', -0.038),\n",
       "  ('score 22', -0.1042)],\n",
       " 'MED-877': [('energy drink', 0.5047),\n",
       "  ('drink platelet', 0.4915),\n",
       "  ('endothelial dysfunction', 0.4596),\n",
       "  ('consumption alters', 0.3706),\n",
       "  ('platelet function', 0.3489),\n",
       "  ('hypothesis energy', 0.3436),\n",
       "  ('myocardial infarction', 0.3407),\n",
       "  ('consumption 33', 0.3255),\n",
       "  ('reactive hyperemia', 0.3229),\n",
       "  ('decreases endothelial', 0.3084),\n",
       "  ('assessed adenosine', 0.302),\n",
       "  ('aggregation endothelial', 0.296),\n",
       "  ('anecdotally linked', 0.2713),\n",
       "  ('study', 0.2546),\n",
       "  ('34 male', 0.2436),\n",
       "  ('dysfunction tested', 0.2407),\n",
       "  ('heart rate', 0.2243),\n",
       "  ('tested hour', 0.1929),\n",
       "  ('induced micromol', 0.1808),\n",
       "  ('assessed changes', 0.1796),\n",
       "  ('pressure', 0.167),\n",
       "  ('diphosphate induced', 0.1655),\n",
       "  ('strongly associated', 0.1642),\n",
       "  ('ml', 0.1612),\n",
       "  ('05 heart', 0.1601),\n",
       "  ('optical aggregometry', 0.1528),\n",
       "  ('mean arterial', 0.1461),\n",
       "  ('consumption 250', 0.1454),\n",
       "  ('values significant', 0.1422),\n",
       "  ('young adults', 0.1386),\n",
       "  ('aggregation following', 0.1327),\n",
       "  ('significant increase', 0.1295),\n",
       "  ('compared control', 0.116),\n",
       "  ('years participated', 0.1156),\n",
       "  ('rhi results', 0.1152),\n",
       "  ('rich', 0.0986),\n",
       "  ('tonometry expressed', 0.0958),\n",
       "  ('changes peripheral', 0.0943),\n",
       "  ('death', 0.0916),\n",
       "  ('index', 0.0907),\n",
       "  ('healthy', 0.0613),\n",
       "  ('vs 07', 0.0591),\n",
       "  ('22 years', 0.0567),\n",
       "  ('copyright 2010', 0.0565),\n",
       "  ('respectively 01', 0.0488),\n",
       "  ('rate unaffected', 0.0216),\n",
       "  ('sugar free', 0.0069),\n",
       "  ('rights', -0.007),\n",
       "  ('13 vs', -0.031),\n",
       "  ('elsevier rights', -0.0361)],\n",
       " 'MED-878': [('effects coffee', 0.6807),\n",
       "  ('coffee endothelial', 0.5976),\n",
       "  ('caffeine antioxidants', 0.5641),\n",
       "  ('caffeinated cc', 0.428),\n",
       "  ('antioxidants influence', 0.364),\n",
       "  ('ingested cup', 0.3364),\n",
       "  ('endothelial function', 0.2879),\n",
       "  ('unfavorable cardiovascular', 0.268),\n",
       "  ('min 115', 0.2435),\n",
       "  ('mediated dilation', 0.2332),\n",
       "  ('beverage', 0.2206),\n",
       "  ('cc significantly', 0.2202),\n",
       "  ('unhealthy subjects', 0.2056),\n",
       "  ('background objectives', 0.1904),\n",
       "  ('fmd decreased', 0.1649),\n",
       "  ('future studies', 0.1618),\n",
       "  ('investigate acute', 0.1551),\n",
       "  ('influence', 0.1476),\n",
       "  ('crossover study', 0.1456),\n",
       "  ('decaffeinated dc', 0.1437),\n",
       "  ('function investigated', 0.1435),\n",
       "  ('diastolic blood', 0.1387),\n",
       "  ('min 18', 0.1209),\n",
       "  ('ingestion fmd', 0.1162),\n",
       "  ('flow', 0.1121),\n",
       "  ('subjects underwent', 0.1109),\n",
       "  ('increased systolic', 0.1108),\n",
       "  ('italian espresso', 0.1048),\n",
       "  ('fasting', 0.0983),\n",
       "  ('measured brachial', 0.0874),\n",
       "  ('did significantly', 0.0864),\n",
       "  ('30 min', 0.0839),\n",
       "  ('anova analysis', 0.0806),\n",
       "  ('world', 0.0754),\n",
       "  ('clinically', 0.0694),\n",
       "  ('05 did', 0.0658),\n",
       "  ('concentrations remained', 0.0629),\n",
       "  ('widely consumed', 0.0538),\n",
       "  ('methods total', 0.0512),\n",
       "  ('fully understood', 0.0392),\n",
       "  ('muu ml', 0.0211),\n",
       "  ('01', 0.0207),\n",
       "  ('total 20', 0.0203),\n",
       "  ('day intervals', 0.011),\n",
       "  ('09 60', 0.0041),\n",
       "  ('25', -0.0121),\n",
       "  ('blind', -0.0222),\n",
       "  ('underwent double', -0.0386),\n",
       "  ('females', -0.065),\n",
       "  ('10 males', -0.0805)],\n",
       " 'MED-880': [('effects caffeine', 0.6872),\n",
       "  ('plethysmograph caffeine', 0.4943),\n",
       "  ('coffee', 0.4386),\n",
       "  ('cocoa chocolate', 0.3936),\n",
       "  ('used pharmacologic', 0.3384),\n",
       "  ('remain controversial', 0.2903),\n",
       "  ('grocery items', 0.2803),\n",
       "  ('hypertension remain', 0.2788),\n",
       "  ('common nonessential', 0.2374),\n",
       "  ('drug study', 0.1934),\n",
       "  ('world common', 0.1932),\n",
       "  ('tea', 0.193),\n",
       "  ('oxide production', 0.1909),\n",
       "  ('nitroprusside', 0.1783),\n",
       "  ('little information', 0.172),\n",
       "  ('diseases including', 0.1683),\n",
       "  ('substance world', 0.1632),\n",
       "  ('monomethyl', 0.1456),\n",
       "  ('widely used', 0.1335),\n",
       "  ('300 mg', 0.1331),\n",
       "  ('mm hg', 0.1282),\n",
       "  ('vascular function', 0.1118),\n",
       "  ('mg', 0.1077),\n",
       "  ('diastolic blood', 0.101),\n",
       "  ('men oral', 0.0987),\n",
       "  ('augments', 0.088),\n",
       "  ('arginine', 0.0806),\n",
       "  ('purpose', 0.0799),\n",
       "  ('placebo group', 0.0663),\n",
       "  ('acetylcholine ach', 0.0645),\n",
       "  ('alter heart', 0.0625),\n",
       "  ('findings suggest', 0.0587),\n",
       "  ('administration', 0.0573),\n",
       "  ('humans study', 0.0558),\n",
       "  ('plethysmograph', 0.0511),\n",
       "  ('direct effect', 0.0489),\n",
       "  ('05 sodium', 0.0481),\n",
       "  ('ml tissue', 0.0432),\n",
       "  ('study forearm', 0.0398),\n",
       "  ('increased systolic', 0.0289),\n",
       "  ('inhibitor abolished', 0.0254),\n",
       "  ('baseline fbf', 0.0116),\n",
       "  ('intra', 0.0107),\n",
       "  ('similar', 0.0085),\n",
       "  ('26 ml', -0.0168),\n",
       "  ('using strain', -0.0214),\n",
       "  ('healthy young', -0.0241),\n",
       "  ('respectively did', -0.0338),\n",
       "  ('21', -0.0369),\n",
       "  ('min 100', -0.0374)],\n",
       " 'MED-884': [('analyzed oxalate', 0.6139),\n",
       "  ('oxalate cooking', 0.6035),\n",
       "  ('oxaluria individuals', 0.5735),\n",
       "  ('oxalate hyperoxaluria', 0.5616),\n",
       "  ('decreasing oxaluria', 0.5456),\n",
       "  ('oxalate losses', 0.5353),\n",
       "  ('recovery oxalate', 0.5159),\n",
       "  ('kidney stones', 0.5092),\n",
       "  ('potatoes oxalate', 0.4699),\n",
       "  ('75 kidney', 0.4154),\n",
       "  ('stones', 0.4),\n",
       "  ('primarily calcium', 0.3515),\n",
       "  ('vegetables boiling', 0.3494),\n",
       "  ('vegetables analyzed', 0.337),\n",
       "  ('water soluble', 0.3091),\n",
       "  ('74 soluble', 0.3083),\n",
       "  ('hyperoxaluria', 0.2994),\n",
       "  ('boiling markedly', 0.2942),\n",
       "  ('cooked', 0.2892),\n",
       "  ('cooking water', 0.2881),\n",
       "  ('development kidney', 0.2857),\n",
       "  ('absorbed insoluble', 0.2837),\n",
       "  ('enzymatic method', 0.2682),\n",
       "  ('cooking varied', 0.2601),\n",
       "  ('approximately 100', 0.2421),\n",
       "  ('reduced soluble', 0.2416),\n",
       "  ('53 baking', 0.2388),\n",
       "  ('soluble sources', 0.2087),\n",
       "  ('risk factor', 0.2025),\n",
       "  ('significantly reduce', 0.2004),\n",
       "  ('disorder types', 0.193),\n",
       "  ('analyzed', 0.1882),\n",
       "  ('varied greatly', 0.1453),\n",
       "  ('sources employing', 0.1431),\n",
       "  ('tested raw', 0.1367),\n",
       "  ('steaming revealed', 0.1327),\n",
       "  ('better absorbed', 0.1312),\n",
       "  ('composed primarily', 0.1268),\n",
       "  ('types', 0.1266),\n",
       "  ('proportion', 0.1183),\n",
       "  ('methods significantly', 0.1131),\n",
       "  ('losses losses', 0.1001),\n",
       "  ('87 effective', 0.0865),\n",
       "  ('high', 0.0826),\n",
       "  ('effective strategy', 0.0756),\n",
       "  ('development', 0.0686),\n",
       "  ('individuals predisposed', 0.0536),\n",
       "  ('content 30', 0.0302),\n",
       "  ('recovery', 0.0226),\n",
       "  ('ranging', -0.0288)],\n",
       " 'MED-885': [('volunteers oxalate', 0.5772),\n",
       "  ('diets oxalate', 0.5382),\n",
       "  ('spinach oxalate', 0.4409),\n",
       "  ('administered breakfast', 0.4302),\n",
       "  ('oxalate 182', 0.4286),\n",
       "  ('bioavailability sugar', 0.3797),\n",
       "  ('volunteers consumed', 0.3767),\n",
       "  ('solution diets', 0.3686),\n",
       "  ('diet test', 0.358),\n",
       "  ('control diets', 0.356),\n",
       "  ('tested women', 0.3312),\n",
       "  ('bioavailability', 0.3054),\n",
       "  ('120 mg', 0.2966),\n",
       "  ('triplicated latin', 0.2954),\n",
       "  ('women using', 0.2942),\n",
       "  ('study volunteers', 0.2769),\n",
       "  ('minerals calcium', 0.2724),\n",
       "  ('compared bioavailabilities', 0.2708),\n",
       "  ('test periods', 0.2705),\n",
       "  ('ingestion', 0.2596),\n",
       "  ('substances administered', 0.2522),\n",
       "  ('test substance', 0.2515),\n",
       "  ('ratio minerals', 0.2365),\n",
       "  ('excretion greater', 0.2132),\n",
       "  ('low bioavailability', 0.2123),\n",
       "  ('bioavailabilities spinach', 0.2025),\n",
       "  ('arrangement test', 0.187),\n",
       "  ('24 hr', 0.1809),\n",
       "  ('followed control', 0.1713),\n",
       "  ('25 solution', 0.1656),\n",
       "  ('beet fibre', 0.1648),\n",
       "  ('182 mg', 0.1628),\n",
       "  ('acid', 0.1617),\n",
       "  ('study', 0.1588),\n",
       "  ('40 spinach', 0.1561),\n",
       "  ('mg tested', 0.1539),\n",
       "  ('fibre compared', 0.1439),\n",
       "  ('sodium', 0.1434),\n",
       "  ('periods consisted', 0.1429),\n",
       "  ('square arrangement', 0.1332),\n",
       "  ('analysed daily', 0.1148),\n",
       "  ('respectively low', 0.1054),\n",
       "  ('greater 0001', 0.095),\n",
       "  ('days initial', 0.0773),\n",
       "  ('complex', 0.0738),\n",
       "  ('did differ', 0.0673),\n",
       "  ('attributable', 0.0453),\n",
       "  ('loss soluble', 0.0307),\n",
       "  ('significantly', 0.024),\n",
       "  ('processing', 0.0113)],\n",
       " 'MED-886': [('fatty acids', 0.6032),\n",
       "  ('flaxseed oil', 0.5752),\n",
       "  ('lipids differed', 0.5401),\n",
       "  ('fas linoleic', 0.5387),\n",
       "  ('alpha linolenic', 0.5177),\n",
       "  ('oil ho', 0.4483),\n",
       "  ('essential fa', 0.4154),\n",
       "  ('arachidonic acid', 0.4027),\n",
       "  ('lipoprotein lipids', 0.3743),\n",
       "  ('fa plant', 0.3607),\n",
       "  ('fa interfere', 0.3091),\n",
       "  ('cholesteryl', 0.2855),\n",
       "  ('metabolisms la', 0.2824),\n",
       "  ('interfere metabolism', 0.2814),\n",
       "  ('ratios excessive', 0.2653),\n",
       "  ('background hempseed', 0.2648),\n",
       "  ('esters ce', 0.2624),\n",
       "  ('intake essential', 0.2545),\n",
       "  ('fasting serum', 0.2086),\n",
       "  ('compared fo', 0.1897),\n",
       "  ('contain high', 0.1871),\n",
       "  ('acid', 0.1858),\n",
       "  ('total hdl', 0.1857),\n",
       "  ('origin effects', 0.1842),\n",
       "  ('2n alpha', 0.18),\n",
       "  ('insulin haemostatic', 0.1768),\n",
       "  ('18 2n', 0.171),\n",
       "  ('volunteers consumed', 0.1645),\n",
       "  ('effects serum', 0.1549),\n",
       "  ('minor effects', 0.1531),\n",
       "  ('periods separated', 0.153),\n",
       "  ('ala compete', 0.1422),\n",
       "  ('tg compared', 0.133),\n",
       "  ('significant changes', 0.1049),\n",
       "  ('known difference', 0.0985),\n",
       "  ('background', 0.0949),\n",
       "  ('crossover design', 0.0783),\n",
       "  ('weeks periods', 0.0714),\n",
       "  ('3n opposite', 0.0645),\n",
       "  ('enzymes known', 0.0613),\n",
       "  ('healthy humans', 0.0501),\n",
       "  ('humans methods', 0.0484),\n",
       "  ('001 proportion', 0.0354),\n",
       "  ('plant', 0.0331),\n",
       "  ('30 ml', 0.0261),\n",
       "  ('double blind', 0.0239),\n",
       "  ('washout period', 0.0101),\n",
       "  ('la gamma', -0.0046),\n",
       "  ('methods fourteen', -0.0304),\n",
       "  ('period 065', -0.0363)],\n",
       " 'MED-887': [('potatoes storage', 0.6647),\n",
       "  ('polyphenols stored', 0.5814),\n",
       "  ('fleshed potatoes', 0.5661),\n",
       "  ('total phenolics', 0.4271),\n",
       "  ('storage duration', 0.403),\n",
       "  ('foods critical', 0.3854),\n",
       "  ('antioxidant activity', 0.3829),\n",
       "  ('bioactive compounds', 0.3556),\n",
       "  ('months consumption', 0.3381),\n",
       "  ('properties plant', 0.2893),\n",
       "  ('monomeric anthocyanins', 0.2839),\n",
       "  ('differing flesh', 0.2717),\n",
       "  ('consumption study', 0.2283),\n",
       "  ('90 days', 0.2252),\n",
       "  ('pronounced fresh', 0.2068),\n",
       "  ('pro apoptotic', 0.1936),\n",
       "  ('extracts seven', 0.1855),\n",
       "  ('greater levels', 0.1787),\n",
       "  ('results suggest', 0.178),\n",
       "  ('duration strong', 0.1714),\n",
       "  ('uplc ms', 0.1603),\n",
       "  ('simulated commercial', 0.1546),\n",
       "  ('excellent source', 0.1541),\n",
       "  ('biological assays', 0.1506),\n",
       "  ('colon cancer', 0.1348),\n",
       "  ('techniques conjunction', 0.1341),\n",
       "  ('dpph abts', 0.1324),\n",
       "  ('viable', 0.1289),\n",
       "  ('colors', 0.1213),\n",
       "  ('compared solvent', 0.1135),\n",
       "  ('investigated', 0.1106),\n",
       "  ('control anticancer', 0.1079),\n",
       "  ('2p', 0.1037),\n",
       "  ('clones advanced', 0.1028),\n",
       "  ('operations health', 0.0997),\n",
       "  ('effects farm', 0.099),\n",
       "  ('ht 29', 0.0894),\n",
       "  ('purple fleshed', 0.0834),\n",
       "  ('white yellow', 0.0711),\n",
       "  ('fcr composition', 0.0709),\n",
       "  ('use', 0.0685),\n",
       "  ('μg ml', 0.0646),\n",
       "  ('cells compared', 0.0623),\n",
       "  ('activities suppressed', 0.0402),\n",
       "  ('selection co97227', 0.0297),\n",
       "  ('fork operations', 0.0241),\n",
       "  ('10', 0.0128),\n",
       "  ('hct 116', -0.0088),\n",
       "  ('majesty', -0.0246),\n",
       "  ('negative correlation', -0.0253)],\n",
       " 'MED-888': [('adipocytes treated', 0.5917),\n",
       "  ('adipocytes purpose', 0.532),\n",
       "  ('l1 adipocytes', 0.4887),\n",
       "  ('extract antilipogenic', 0.4154),\n",
       "  ('lipogenic inflammatory', 0.3693),\n",
       "  ('promoted lipolytic', 0.3677),\n",
       "  ('anti obesity', 0.3239),\n",
       "  ('expression lipogenic', 0.3211),\n",
       "  ('differentiated 3t3', 0.3202),\n",
       "  ('sweet potatoes', 0.3179),\n",
       "  ('obesity', 0.3127),\n",
       "  ('psps 3t3', 0.2955),\n",
       "  ('extract concentrations', 0.2836),\n",
       "  ('secretion leptin', 0.2769),\n",
       "  ('fat', 0.2707),\n",
       "  ('inflammatory effects', 0.2556),\n",
       "  ('3t3 l1', 0.244),\n",
       "  ('droplets suppressed', 0.1958),\n",
       "  ('using different', 0.1917),\n",
       "  ('different vitro', 0.1888),\n",
       "  ('factors promoted', 0.1818),\n",
       "  ('factors treatment', 0.1668),\n",
       "  ('purpose differentiated', 0.1625),\n",
       "  ('indicating growth', 0.1622),\n",
       "  ('activity psp', 0.1602),\n",
       "  ('antioxidative activity', 0.1576),\n",
       "  ('extract diminished', 0.1559),\n",
       "  ('effects', 0.1534),\n",
       "  ('diphenyl picrylhydrazyl', 0.1452),\n",
       "  ('current study', 0.1334),\n",
       "  ('expression mrnas', 0.1317),\n",
       "  ('sizes', 0.1205),\n",
       "  ('measured changes', 0.1147),\n",
       "  ('secretion indicating', 0.1131),\n",
       "  ('000 μg', 0.1018),\n",
       "  ('activity transition', 0.0992),\n",
       "  ('taken study', 0.0981),\n",
       "  ('sweet', 0.0863),\n",
       "  ('protein', 0.0845),\n",
       "  ('determine anti', 0.0804),\n",
       "  ('potential assay', 0.0759),\n",
       "  ('ions taken', 0.0702),\n",
       "  ('scavenging reducing', 0.0686),\n",
       "  ('determine', 0.0543),\n",
       "  ('ml', 0.0484),\n",
       "  ('purple', 0.0342),\n",
       "  ('chelating activity', 0.0331),\n",
       "  ('24 hours', 0.0152),\n",
       "  ('free', -0.0666),\n",
       "  ('ferric', -0.0742)],\n",
       " 'MED-890': [('aetiology colorectal', 0.4713),\n",
       "  ('diet aetiology', 0.4124),\n",
       "  ('colon cancer', 0.381),\n",
       "  ('cancer total', 0.3742),\n",
       "  ('hospital wards', 0.37),\n",
       "  ('harbin city', 0.3608),\n",
       "  ('study carried', 0.3177),\n",
       "  ('total 336', 0.296),\n",
       "  ('diseases interviewed', 0.2958),\n",
       "  ('neoplastic diseases', 0.2924),\n",
       "  ('case control', 0.2622),\n",
       "  ('intake important', 0.2593),\n",
       "  ('consumption consumed', 0.2466),\n",
       "  ('rectum alcohol', 0.2446),\n",
       "  ('history questionnaire', 0.2434),\n",
       "  ('number controls', 0.2428),\n",
       "  ('histologically confirmed', 0.2212),\n",
       "  ('important risk', 0.2135),\n",
       "  ('frequency consumption', 0.2047),\n",
       "  ('non neoplastic', 0.2032),\n",
       "  ('data concerning', 0.1996),\n",
       "  ('interviewed', 0.1911),\n",
       "  ('consumption meat', 0.1878),\n",
       "  ('multiple regression', 0.1654),\n",
       "  ('odds ratios', 0.1621),\n",
       "  ('computed multiple', 0.1516),\n",
       "  ('eggs bean', 0.1335),\n",
       "  ('city assess', 0.1236),\n",
       "  ('111', 0.1168),\n",
       "  ('confidence limits', 0.1168),\n",
       "  ('incident', 0.1116),\n",
       "  ('strong protective', 0.0962),\n",
       "  ('reduced', 0.0946),\n",
       "  ('celery strong', 0.0939),\n",
       "  ('assess role', 0.0908),\n",
       "  ('225', 0.0789),\n",
       "  ('equal number', 0.0725),\n",
       "  ('items obtained', 0.0718),\n",
       "  ('consumed single', 0.068),\n",
       "  ('concerning', 0.0673),\n",
       "  ('chives', 0.0634),\n",
       "  ('status used', 0.06),\n",
       "  ('used', 0.0493),\n",
       "  ('developing', 0.0461),\n",
       "  ('products grain', 0.0447),\n",
       "  ('carried', 0.0435),\n",
       "  ('associated increasing', 0.0353),\n",
       "  ('used vegetables', 0.0252),\n",
       "  ('particularly green', -0.0574),\n",
       "  ('male', -0.0606)],\n",
       " 'MED-891': [('bpa canned', 0.6457),\n",
       "  ('products bpa', 0.5955),\n",
       "  ('bpa food', 0.5922),\n",
       "  ('determination bisphenol', 0.544),\n",
       "  ('maximum bpa', 0.4957),\n",
       "  ('lower bpa', 0.4887),\n",
       "  ('78 canned', 0.4669),\n",
       "  ('soups bpa', 0.4343),\n",
       "  ('spectrometry analysis', 0.4016),\n",
       "  ('concentrations general', 0.3722),\n",
       "  ('analyze 78', 0.3713),\n",
       "  ('products method', 0.3592),\n",
       "  ('followed derivatization', 0.3534),\n",
       "  ('analysis validated', 0.338),\n",
       "  ('concentrations ng', 0.329),\n",
       "  ('products lower', 0.3041),\n",
       "  ('canned pure', 0.3),\n",
       "  ('phase extraction', 0.2595),\n",
       "  ('method based', 0.2588),\n",
       "  ('concentrations condensed', 0.2571),\n",
       "  ('concentrations did', 0.2506),\n",
       "  ('food types', 0.2445),\n",
       "  ('products differed', 0.2437),\n",
       "  ('60 products', 0.2161),\n",
       "  ('chromatography', 0.2081),\n",
       "  ('values 137', 0.197),\n",
       "  ('solid', 0.1855),\n",
       "  ('types specific', 0.1724),\n",
       "  ('paste products', 0.149),\n",
       "  ('products highest', 0.1287),\n",
       "  ('general mean', 0.1275),\n",
       "  ('european commission', 0.1206),\n",
       "  ('10 ng', 0.1188),\n",
       "  ('simulants', 0.1184),\n",
       "  ('189', 0.1114),\n",
       "  ('gas', 0.1114),\n",
       "  ('set', 0.1093),\n",
       "  ('migration limit', 0.1007),\n",
       "  ('23 ng', 0.0937),\n",
       "  ('105', 0.069),\n",
       "  ('respectively ready', 0.0619),\n",
       "  ('34 ng', 0.0554),\n",
       "  ('pure tomato', 0.0546),\n",
       "  ('differed considerably', 0.0516),\n",
       "  ('mg kg', 0.0483),\n",
       "  ('534', -0.0015),\n",
       "  ('serve soups', -0.0139),\n",
       "  ('15', -0.0186),\n",
       "  ('did', -0.0344),\n",
       "  ('tuna', -0.039)],\n",
       " 'MED-894': [('cassia cinnamomum', 0.5745),\n",
       "  ('cassia reduces', 0.5692),\n",
       "  ('intake cinnamomum', 0.4883),\n",
       "  ('lower coumarin', 0.4493),\n",
       "  ('reduces postprandial', 0.4372),\n",
       "  ('cassia subjects', 0.4361),\n",
       "  ('coumarin damage', 0.405),\n",
       "  ('cinnamomum zeylanicum', 0.3942),\n",
       "  ('replacement cassia', 0.3847),\n",
       "  ('gii ingestion', 0.2783),\n",
       "  ('placebo zeylanicum', 0.2413),\n",
       "  ('glycaemic', 0.2392),\n",
       "  ('capsules', 0.2379),\n",
       "  ('effect glucose', 0.226),\n",
       "  ('liver present', 0.2213),\n",
       "  ('affect postprandial', 0.2186),\n",
       "  ('shown intake', 0.2005),\n",
       "  ('crossover trial', 0.1768),\n",
       "  ('administered placebo', 0.1638),\n",
       "  ('lower', 0.1579),\n",
       "  ('previous studies', 0.1566),\n",
       "  ('tolerance igt', 0.1563),\n",
       "  ('aqueous extracts', 0.1282),\n",
       "  ('control lost', 0.1246),\n",
       "  ('healthy subjects', 0.1242),\n",
       "  ('does affect', 0.1207),\n",
       "  ('poor', 0.1192),\n",
       "  ('subjects impaired', 0.1129),\n",
       "  ('90 120', 0.1053),\n",
       "  ('concentrations plasma', 0.104),\n",
       "  ('venous blood', 0.0949),\n",
       "  ('75 oral', 0.0939),\n",
       "  ('capillary', 0.0803),\n",
       "  ('subjects shown', 0.0786),\n",
       "  ('positive effects', 0.0741),\n",
       "  ('60', 0.0656),\n",
       "  ('risk assessment', 0.0582),\n",
       "  ('start ogtt', 0.0544),\n",
       "  ('15', 0.0396),\n",
       "  ('present study', 0.0361),\n",
       "  ('finger prick', 0.0286),\n",
       "  ('federal institute', 0.0191),\n",
       "  ('europe suggested', 0.0095),\n",
       "  ('suggested replacement', 0.0084),\n",
       "  ('human', -0.0105),\n",
       "  ('min start', -0.0111),\n",
       "  ('use', -0.0207),\n",
       "  ('30', -0.0254),\n",
       "  ('response', -0.0639),\n",
       "  ('total', -0.0777)],\n",
       " 'MED-895': [('patients asthma', 0.4454),\n",
       "  ('asthma thirty', 0.4434),\n",
       "  ('asthma higher', 0.4281),\n",
       "  ('drinks fourteen', 0.4217),\n",
       "  ('exacerbations occurring', 0.4052),\n",
       "  ('drinks reacted', 0.401),\n",
       "  ('extrinsic asthma', 0.3816),\n",
       "  ('asthma benzoate', 0.3738),\n",
       "  ('tests drinking', 0.368),\n",
       "  ('acidic beverages', 0.3273),\n",
       "  ('solutions orange', 0.3073),\n",
       "  ('dioxide fall', 0.2864),\n",
       "  ('thirty 11', 0.2819),\n",
       "  ('fev1 sodium', 0.2785),\n",
       "  ('prior inhalation', 0.2781),\n",
       "  ('sulphur dioxide', 0.2766),\n",
       "  ('272 patients', 0.2696),\n",
       "  ('patients suffering', 0.2581),\n",
       "  ('ingestion solutions', 0.2569),\n",
       "  ('cryptogenic asthma', 0.2485),\n",
       "  ('patients inhibited', 0.2451),\n",
       "  ('substances', 0.2396),\n",
       "  ('sensitive patients', 0.2269),\n",
       "  ('11 gave', 0.2146),\n",
       "  ('drinking separate', 0.2119),\n",
       "  ('provocation', 0.1982),\n",
       "  ('suffering apparently', 0.1937),\n",
       "  ('tests', 0.183),\n",
       "  ('cromoglycate', 0.1685),\n",
       "  ('food allergy', 0.1676),\n",
       "  ('react agents', 0.1668),\n",
       "  ('separate occasions', 0.1594),\n",
       "  ('causal patients', 0.1584),\n",
       "  ('benzoate tartrazine', 0.1533),\n",
       "  ('wide range', 0.152),\n",
       "  ('proportion intrinsic', 0.1373),\n",
       "  ('higher', 0.1242),\n",
       "  ('reported cause', 0.1089),\n",
       "  ('solutions', 0.1078),\n",
       "  ('occurring', 0.0855),\n",
       "  ('used', 0.0763),\n",
       "  ('used preservative', 0.0627),\n",
       "  ('fall', 0.0613),\n",
       "  ('predominantly young', 0.0585),\n",
       "  ('gave', 0.0585),\n",
       "  ('did', 0.0533),\n",
       "  ('gave history', 0.0123),\n",
       "  ('apparently cryptogenic', 0.0091),\n",
       "  ('aged', -0.0332),\n",
       "  ('predominantly middle', -0.1113)],\n",
       " 'MED-897': [('beverages fe', 0.5834),\n",
       "  ('polyphenols compared', 0.4992),\n",
       "  ('cocoa beverages', 0.485),\n",
       "  ('fe absorption', 0.4444),\n",
       "  ('meal estimated', 0.3901),\n",
       "  ('coffee tea', 0.3833),\n",
       "  ('absorption bread', 0.3832),\n",
       "  ('rich phenolic', 0.3656),\n",
       "  ('monomeric flavonoids', 0.3404),\n",
       "  ('subjects erythrocyte', 0.3379),\n",
       "  ('mg total', 0.3336),\n",
       "  ('reduced fe', 0.3069),\n",
       "  ('piperita complex', 0.3031),\n",
       "  ('tea 79', 0.2539),\n",
       "  ('reduced absorption', 0.2492),\n",
       "  ('subjects', 0.2396),\n",
       "  ('acids chlorogenic', 0.237),\n",
       "  ('inhibitory cocoa', 0.2238),\n",
       "  ('products black', 0.1941),\n",
       "  ('demonstrate herb', 0.1859),\n",
       "  ('camomile matricaria', 0.1789),\n",
       "  ('polymerization products', 0.1742),\n",
       "  ('effects different', 0.1711),\n",
       "  ('verbena officinalis', 0.1658),\n",
       "  ('potent inhibitors', 0.1607),\n",
       "  ('incorporation', 0.135),\n",
       "  ('cordata pennyroyal', 0.1321),\n",
       "  ('absorption 60', 0.131),\n",
       "  ('structures rich', 0.1263),\n",
       "  ('serving', 0.1221),\n",
       "  ('84', 0.122),\n",
       "  ('peppermint mentha', 0.1212),\n",
       "  ('findings demonstrate', 0.118),\n",
       "  ('advice relation', 0.1178),\n",
       "  ('complex', 0.1168),\n",
       "  ('adult human', 0.1148),\n",
       "  ('flower 52', 0.1143),\n",
       "  ('identical concentration', 0.1112),\n",
       "  ('adding milk', 0.1009),\n",
       "  ('containing 100', 0.0946),\n",
       "  ('test', 0.0917),\n",
       "  ('water', 0.0813),\n",
       "  ('50 70', 0.0796),\n",
       "  ('vervain 59', 0.0549),\n",
       "  ('tilia', 0.0376),\n",
       "  ('radio', 0.035),\n",
       "  ('containing 20', 0.0349),\n",
       "  ('property considered', 0.0254),\n",
       "  ('pulegium', 0.0033),\n",
       "  ('fashion depending', -0.0142)],\n",
       " 'MED-898': [('tea iron', 0.4832),\n",
       "  ('intervention studies', 0.4605),\n",
       "  ('studies assessed', 0.4216),\n",
       "  ('iron studies', 0.421),\n",
       "  ('advice tea', 0.4067),\n",
       "  ('drinkers studies', 0.4037),\n",
       "  ('black tea', 0.3721),\n",
       "  ('35 references', 0.3543),\n",
       "  ('recent review', 0.3468),\n",
       "  ('correlations tea', 0.325),\n",
       "  ('drinking patterns', 0.3132),\n",
       "  ('literature likely', 0.3127),\n",
       "  ('references specific', 0.3103),\n",
       "  ('based advice', 0.2988),\n",
       "  ('evidence need', 0.2962),\n",
       "  ('background aims', 0.2935),\n",
       "  ('conclusions reported', 0.2742),\n",
       "  ('specific effects', 0.2718),\n",
       "  ('cases anemia', 0.2438),\n",
       "  ('terms methodogical', 0.24),\n",
       "  ('effects black', 0.2379),\n",
       "  ('deficiency groups', 0.2344),\n",
       "  ('formulate targeted', 0.2326),\n",
       "  ('assessed influence', 0.2141),\n",
       "  ('search', 0.1968),\n",
       "  ('status indices', 0.1934),\n",
       "  ('context', 0.1913),\n",
       "  ('nutrition different', 0.1898),\n",
       "  ('quality relevance', 0.1883),\n",
       "  ('limits absorption', 0.1784),\n",
       "  ('based', 0.1775),\n",
       "  ('blood indicators', 0.1741),\n",
       "  ('12 observational', 0.1579),\n",
       "  ('significant', 0.1555),\n",
       "  ('report additional', 0.1367),\n",
       "  ('uk population', 0.13),\n",
       "  ('observational', 0.1261),\n",
       "  ('countries', 0.1254),\n",
       "  ('compared', 0.118),\n",
       "  ('groups people', 0.1172),\n",
       "  ('cases', 0.1076),\n",
       "  ('people risk', 0.0977),\n",
       "  ('additional relationships', 0.0974),\n",
       "  ('population results', 0.095),\n",
       "  ('meals wait', 0.0862),\n",
       "  ('complexity influences', 0.0728),\n",
       "  ('negative correlations', 0.0697),\n",
       "  ('nondietary highlighting', 0.0683),\n",
       "  ('healthy people', 0.0667),\n",
       "  ('compared nontea', -0.0061)],\n",
       " 'MED-899': [('infants caused', 0.4572),\n",
       "  ('heiner syndrome', 0.3563),\n",
       "  ('anemia', 0.3406),\n",
       "  ('published misdiagnosis', 0.3217),\n",
       "  ('wheezing', 0.3045),\n",
       "  ('hs suspected', 0.2962),\n",
       "  ('birth chronic', 0.2928),\n",
       "  ('chronic pulmonary', 0.2924),\n",
       "  ('cm reports', 0.2914),\n",
       "  ('colic diarrhea', 0.2771),\n",
       "  ('patient milk', 0.271),\n",
       "  ('food hypersensitivity', 0.2651),\n",
       "  ('syndrome', 0.2546),\n",
       "  ('recurrent otitis', 0.2207),\n",
       "  ('age fed', 0.2137),\n",
       "  ('review', 0.2094),\n",
       "  ('cow', 0.2055),\n",
       "  ('series cases', 0.2033),\n",
       "  ('ilm bronchoalveolar', 0.1931),\n",
       "  ('affects primarily', 0.1861),\n",
       "  ('frequency eosinophilia', 0.182),\n",
       "  ('symptoms began', 0.1761),\n",
       "  ('suspected young', 0.1716),\n",
       "  ('vomiting', 0.1595),\n",
       "  ('disease obscure', 0.1533),\n",
       "  ('hemoptysis confirmed', 0.1532),\n",
       "  ('ph suspected', 0.1242),\n",
       "  ('29 months', 0.1185),\n",
       "  ('failure thrive', 0.1161),\n",
       "  ('open lung', 0.1156),\n",
       "  ('additional findings', 0.112),\n",
       "  ('bal gastric', 0.1038),\n",
       "  ('challenge tolerated', 0.0995),\n",
       "  ('specific', 0.0945),\n",
       "  ('months patient', 0.0928),\n",
       "  ('precipitins', 0.0883),\n",
       "  ('descending frequency', 0.0778),\n",
       "  ('weeks', 0.0748),\n",
       "  ('laden macrophages', 0.0685),\n",
       "  ('seven', 0.0515),\n",
       "  ('iron laden', 0.0473),\n",
       "  ('complicated', 0.0437),\n",
       "  ('parents consented', 0.0399),\n",
       "  ('biopsy', 0.0357),\n",
       "  ('total igm', 0.0343),\n",
       "  ('avoidance patient', 0.0271),\n",
       "  ('remarkable improvement', 0.0182),\n",
       "  ('media', 0.0117),\n",
       "  ('infiltrates', 0.0072),\n",
       "  ('ftt radiologic', -0.0321)],\n",
       " 'MED-900': [('allergy cma', 0.4909),\n",
       "  ('cow milk', 0.4867),\n",
       "  ('cma included', 0.4563),\n",
       "  ('milk allergy', 0.4512),\n",
       "  ('thai children', 0.3522),\n",
       "  ('children reviewed', 0.2979),\n",
       "  ('hospital past', 0.251),\n",
       "  ('otitis media', 0.2487),\n",
       "  ('department pediatrics', 0.2385),\n",
       "  ('clinical manifestations', 0.2372),\n",
       "  ('atopic diseases', 0.2214),\n",
       "  ('2007 criteria', 0.2163),\n",
       "  ('chulalongkom memorial', 0.2141),\n",
       "  ('past 10', 0.2125),\n",
       "  ('records patients', 0.2118),\n",
       "  ('patients mothers', 0.2114),\n",
       "  ('improvement symptoms', 0.205),\n",
       "  ('common problem', 0.2041),\n",
       "  ('included elimination', 0.2009),\n",
       "  ('13 patients', 0.1862),\n",
       "  ('diseases 64', 0.1672),\n",
       "  ('maternal restriction', 0.1656),\n",
       "  ('study demonstrates', 0.1364),\n",
       "  ('especially respiratory', 0.1318),\n",
       "  ('oral challenge', 0.1293),\n",
       "  ('anemia', 0.1256),\n",
       "  ('months days', 0.1213),\n",
       "  ('positive 61', 0.1156),\n",
       "  ('chronic serous', 0.1152),\n",
       "  ('usually overlooked', 0.101),\n",
       "  ('partial hydrolysate', 0.0965),\n",
       "  ('formula resulting', 0.0948),\n",
       "  ('girls 214', 0.0854),\n",
       "  ('feeding', 0.0778),\n",
       "  ('delayed speech', 0.0721),\n",
       "  ('products substitution', 0.0699),\n",
       "  ('continued breast', 0.0687),\n",
       "  ('family', 0.0644),\n",
       "  ('average duration', 0.0541),\n",
       "  ('failure thrive', 0.0519),\n",
       "  ('exclusively', 0.0392),\n",
       "  ('43 followed', 0.0254),\n",
       "  ('increased consumption', 0.0169),\n",
       "  ('soy formula', 0.0142),\n",
       "  ('gastrointestinal gi', 0.013),\n",
       "  ('prick', 0.0057),\n",
       "  ('phf 35', 0.0033),\n",
       "  ('168 girls', -0.0134),\n",
       "  ('20', -0.0259),\n",
       "  ('media', -0.0267)],\n",
       " 'MED-901': [('milk allergic', 0.5264),\n",
       "  ('allergy cma', 0.5079),\n",
       "  ('children cma', 0.4795),\n",
       "  ('ear infections', 0.3931),\n",
       "  ('56 milk', 0.388),\n",
       "  ('secretory otitis', 0.3832),\n",
       "  ('infancy associated', 0.36),\n",
       "  ('different atopic', 0.3466),\n",
       "  ('proportion children', 0.3383),\n",
       "  ('allergic rhinitis', 0.3169),\n",
       "  ('tympanostomy compared', 0.3168),\n",
       "  ('cow', 0.3152),\n",
       "  ('schoolchildren studied', 0.3021),\n",
       "  ('asthma', 0.3007),\n",
       "  ('dermatitis posed', 0.2873),\n",
       "  ('manifestations enhanced', 0.2798),\n",
       "  ('developed respiratory', 0.2735),\n",
       "  ('allergens tended', 0.2627),\n",
       "  ('infections conducted', 0.2625),\n",
       "  ('cohort study', 0.2343),\n",
       "  ('problems', 0.2273),\n",
       "  ('enrolling 56', 0.2093),\n",
       "  ('studied association', 0.1961),\n",
       "  ('compared controls', 0.1868),\n",
       "  ('associated recurrent', 0.1863),\n",
       "  ('studied', 0.1807),\n",
       "  ('chronic', 0.1679),\n",
       "  ('atopy', 0.1551),\n",
       "  ('prick tests', 0.1444),\n",
       "  ('risk secretory', 0.1432),\n",
       "  ('higher proportion', 0.1389),\n",
       "  ('204', 0.1375),\n",
       "  ('rom defined', 0.1351),\n",
       "  ('age 10', 0.1288),\n",
       "  ('posed significant', 0.1241),\n",
       "  ('positive skin', 0.1235),\n",
       "  ('15 acute', 0.1226),\n",
       "  ('developed', 0.1175),\n",
       "  ('years', 0.1008),\n",
       "  ('adenoidectomy', 0.0903),\n",
       "  ('food inhaled', 0.0854),\n",
       "  ('media episodes', 0.0805),\n",
       "  ('properly treated', 0.0685),\n",
       "  ('years 27', 0.0558),\n",
       "  ('vs', 0.0429),\n",
       "  ('control', 0.0423),\n",
       "  ('48 vs', -0.0011),\n",
       "  ('005 true', -0.006),\n",
       "  ('tended', -0.0206),\n",
       "  ('12 009', -0.0539)],\n",
       " 'MED-902': [('cytotoxicity extracts', 0.5307),\n",
       "  ('extract exposed', 0.4316),\n",
       "  ('leaf extract', 0.3988),\n",
       "  ('extracts widely', 0.3938),\n",
       "  ('levels ethanol', 0.3663),\n",
       "  ('cell viability', 0.3615),\n",
       "  ('extract decreased', 0.3522),\n",
       "  ('hepg2 cells', 0.3515),\n",
       "  ('exposed cells', 0.3491),\n",
       "  ('alter gsh', 0.3422),\n",
       "  ('atp levels', 0.3115),\n",
       "  ('toxic effects', 0.2989),\n",
       "  ('measuring intracellular', 0.2961),\n",
       "  ('solvents formed', 0.2653),\n",
       "  ('vivo vitro', 0.2424),\n",
       "  ('moringa stenopetala', 0.2405),\n",
       "  ('ldh investigation', 0.2363),\n",
       "  ('identify constituents', 0.2342),\n",
       "  ('seeds increased', 0.2297),\n",
       "  ('use vegetable', 0.2058),\n",
       "  ('investigation plant', 0.1938),\n",
       "  ('study illustrates', 0.1882),\n",
       "  ('leakage highly', 0.1805),\n",
       "  ('extracted individual', 0.1778),\n",
       "  ('affect cell', 0.1775),\n",
       "  ('widely used', 0.1691),\n",
       "  ('functional integrity', 0.1672),\n",
       "  ('wiley sons', 0.1653),\n",
       "  ('plant decreased', 0.1621),\n",
       "  ('significant depletion', 0.1559),\n",
       "  ('leaves did', 0.1538),\n",
       "  ('did increase', 0.1388),\n",
       "  ('culture screening', 0.1347),\n",
       "  ('ml water', 0.1339),\n",
       "  ('highest concentration', 0.1303),\n",
       "  ('dose time', 0.125),\n",
       "  ('incubating', 0.1235),\n",
       "  ('levels root', 0.1195),\n",
       "  ('500 microg', 0.1113),\n",
       "  ('use', 0.1057),\n",
       "  ('non toxic', 0.1013),\n",
       "  ('organic', 0.0835),\n",
       "  ('species', 0.0832),\n",
       "  ('assessed', 0.0815),\n",
       "  ('utility cell', 0.0704),\n",
       "  ('copyright 2005', 0.0627),\n",
       "  ('01 did', 0.0284),\n",
       "  ('microg', 0.0055),\n",
       "  ('manner', -0.0119),\n",
       "  ('copyright', -0.0147)],\n",
       " 'MED-903': [('anticancer agents', 0.5115),\n",
       "  ('determine antiproliferative', 0.4684),\n",
       "  ('antiproliferation potent', 0.4306),\n",
       "  ('leaf extracts', 0.4259),\n",
       "  ('extracts oleifera', 0.4184),\n",
       "  ('extracts potential', 0.4051),\n",
       "  ('therapeutic target', 0.3923),\n",
       "  ('quercetin kaempferol', 0.3666),\n",
       "  ('apoptosis key', 0.3496),\n",
       "  ('claimed therapeutic', 0.3455),\n",
       "  ('moringa oleifera', 0.3283),\n",
       "  ('medicinal', 0.3266),\n",
       "  ('drugs terms', 0.2988),\n",
       "  ('assay mle', 0.2743),\n",
       "  ('inhibition cell', 0.2702),\n",
       "  ('dose dependent', 0.2573),\n",
       "  ('human tumor', 0.2527),\n",
       "  ('kb cells', 0.2457),\n",
       "  ('chemoprevention claimed', 0.2447),\n",
       "  ('presence phenolics', 0.2414),\n",
       "  ('induce ros', 0.2389),\n",
       "  ('evaluated mtt', 0.2319),\n",
       "  ('cell proliferation', 0.2268),\n",
       "  ('suggesting modulation', 0.2172),\n",
       "  ('success plant', 0.2145),\n",
       "  ('fragmentation analyzed', 0.1893),\n",
       "  ('line model', 0.1773),\n",
       "  ('various concentrations', 0.1679),\n",
       "  ('concentrations 48', 0.1638),\n",
       "  ('action induction', 0.1566),\n",
       "  ('nuclei quantified', 0.1516),\n",
       "  ('morphological changes', 0.1342),\n",
       "  ('analysis indicated', 0.1339),\n",
       "  ('changes dna', 0.1337),\n",
       "  ('cancer copyright', 0.1326),\n",
       "  ('hptlc analysis', 0.1316),\n",
       "  ('using agarose', 0.1296),\n",
       "  ('terms variety', 0.123),\n",
       "  ('study designed', 0.1182),\n",
       "  ('redox sensitive', 0.1155),\n",
       "  ('propidium iodide', 0.1091),\n",
       "  ('gel electrophoresis', 0.0724),\n",
       "  ('agents present', 0.0667),\n",
       "  ('production suggesting', 0.0456),\n",
       "  ('events', 0.0422),\n",
       "  ('using human', 0.0351),\n",
       "  ('2011 elsevier', 0.0245),\n",
       "  ('provide inexhaustible', 0.021),\n",
       "  ('rights reserved', 0.0165),\n",
       "  ('addition', 0.0042)],\n",
       " 'MED-904': [('pasteurization milk', 0.7196),\n",
       "  ('benefits pasteurization', 0.5799),\n",
       "  ('pasteurization destroys', 0.5211),\n",
       "  ('milk advocate', 0.4425),\n",
       "  ('consumption prevent', 0.3373),\n",
       "  ('destroys important', 0.2776),\n",
       "  ('promote raw', 0.273),\n",
       "  ('bacteria public', 0.2676),\n",
       "  ('viable pathogenic', 0.2676),\n",
       "  ('ensures safety', 0.2632),\n",
       "  ('minimal vitamins', 0.2362),\n",
       "  ('reducing number', 0.2323),\n",
       "  ('studies lactose', 0.2175),\n",
       "  ('health', 0.2004),\n",
       "  ('food', 0.1971),\n",
       "  ('protective association', 0.1953),\n",
       "  ('significant effect', 0.1815),\n",
       "  ('farming', 0.1807),\n",
       "  ('treat', 0.1675),\n",
       "  ('levels qualitatively', 0.161),\n",
       "  ('b12 decreased', 0.1522),\n",
       "  ('statements', 0.1515),\n",
       "  ('standardized mean', 0.1503),\n",
       "  ('folate smd', 0.1452),\n",
       "  ('allergies cancer', 0.1431),\n",
       "  ('benefits', 0.1413),\n",
       "  ('organizations continue', 0.1214),\n",
       "  ('poor quality', 0.1045),\n",
       "  ('established pro', 0.093),\n",
       "  ('development studies', 0.0917),\n",
       "  ('40', 0.0887),\n",
       "  ('completed summarize', 0.0864),\n",
       "  ('advocacy groups', 0.0855),\n",
       "  ('74', 0.0752),\n",
       "  ('81 01', 0.0735),\n",
       "  ('heat', 0.072),\n",
       "  ('interpreted caution', 0.0694),\n",
       "  ('meta', 0.0689),\n",
       "  ('included studies', 0.0627),\n",
       "  ('nature perfect', 0.0596),\n",
       "  ('001 b2', 0.0423),\n",
       "  ('vitamin increased', 0.0402),\n",
       "  ('57 96', 0.0394),\n",
       "  ('smd 13', 0.0382),\n",
       "  ('confidence interval', 0.0247),\n",
       "  ('naturally relatively', 0.0181),\n",
       "  ('difference', 0.0166),\n",
       "  ('06', 0.0145),\n",
       "  ('intolerance systematic', 0.0119),\n",
       "  ('random effects', 0.0099)],\n",
       " 'MED-907': [('stroke risk', 0.649),\n",
       "  ('factors associated', 0.3811),\n",
       "  ('emerging risk', 0.3707),\n",
       "  ('worldwide unknown', 0.3201),\n",
       "  ('health research', 0.2628),\n",
       "  ('explore differences', 0.2583),\n",
       "  ('causes 38', 0.2373),\n",
       "  ('primary subtypes', 0.2267),\n",
       "  ('psychosocial stress', 0.223),\n",
       "  ('reduce burden', 0.2214),\n",
       "  ('apolipoproteins a1', 0.2038),\n",
       "  ('intracerebral', 0.2002),\n",
       "  ('background contribution', 0.1986),\n",
       "  ('current smoking', 0.1919),\n",
       "  ('history hypertension', 0.1752),\n",
       "  ('60 depression', 0.1581),\n",
       "  ('findings 3000', 0.1506),\n",
       "  ('undertook standardised', 0.1476),\n",
       "  ('current', 0.1471),\n",
       "  ('myocardial', 0.1446),\n",
       "  ('association known', 0.1411),\n",
       "  ('middle income', 0.141),\n",
       "  ('population', 0.1286),\n",
       "  ('23 waist', 0.1277),\n",
       "  ('patients acute', 0.1116),\n",
       "  ('72 hospital', 0.1055),\n",
       "  ('ors population', 0.1003),\n",
       "  ('worldwide march', 0.0912),\n",
       "  ('physical examination', 0.087),\n",
       "  ('institutes', 0.0826),\n",
       "  ('lowest tertile', 0.077),\n",
       "  ('particularly countries', 0.0704),\n",
       "  ('funding canadian', 0.0574),\n",
       "  ('48 diabetes', 0.0499),\n",
       "  ('control study', 0.0438),\n",
       "  ('pressure 160', 0.0391),\n",
       "  ('99 highest', 0.0369),\n",
       "  ('urine samples', 0.0345),\n",
       "  ('663', 0.0307),\n",
       "  ('rights reserved', 0.0272),\n",
       "  ('2010 elsevier', 0.0078),\n",
       "  ('network pfizer', 0.0035),\n",
       "  ('18 15', -0.0016),\n",
       "  ('binge drinking', -0.0052),\n",
       "  ('ci 82', -0.0062),\n",
       "  ('ingelheim copyright', -0.0075),\n",
       "  ('provided blood', -0.0081),\n",
       "  ('sex participants', -0.0191),\n",
       "  ('merck astrazeneca', -0.0207),\n",
       "  ('26 08', -0.0315)],\n",
       " 'MED-909': [('amla temperature', 0.558),\n",
       "  ('degradation amla', 0.548),\n",
       "  ('present amla', 0.4234),\n",
       "  ('studied ascorbic', 0.4185),\n",
       "  ('degradation kinetics', 0.3852),\n",
       "  ('activation energies', 0.3708),\n",
       "  ('amla phyllanthus', 0.352),\n",
       "  ('losses ascorbic', 0.3409),\n",
       "  ('acid solutions', 0.3324),\n",
       "  ('mole amla', 0.3208),\n",
       "  ('rate constant', 0.3024),\n",
       "  ('equation activation', 0.2773),\n",
       "  ('arrhenius equation', 0.2716),\n",
       "  ('process mathematical', 0.2632),\n",
       "  ('120 degrees', 0.2604),\n",
       "  ('state heating', 0.2535),\n",
       "  ('constant increased', 0.2513),\n",
       "  ('solution degradation', 0.245),\n",
       "  ('solutions initial', 0.241),\n",
       "  ('order magnitude', 0.2379),\n",
       "  ('pure vitamin', 0.2313),\n",
       "  ('50 120', 0.2296),\n",
       "  ('results obtained', 0.2007),\n",
       "  ('magnitude methods', 0.1998),\n",
       "  ('concentrations present', 0.1993),\n",
       "  ('emblica pure', 0.1865),\n",
       "  ('processing method', 0.1823),\n",
       "  ('steady state', 0.167),\n",
       "  ('followed order', 0.1622),\n",
       "  ('temperature data', 0.16),\n",
       "  ('adequately modeled', 0.1558),\n",
       "  ('kcal mole', 0.1376),\n",
       "  ('degrees', 0.1376),\n",
       "  ('phyllanthus emblica', 0.1292),\n",
       "  ('efficient', 0.1263),\n",
       "  ('normal open', 0.1231),\n",
       "  ('unsteady', 0.122),\n",
       "  ('time', 0.1126),\n",
       "  ('developed', 0.1075),\n",
       "  ('studied', 0.0848),\n",
       "  ('similar', 0.0804),\n",
       "  ('patented fuel', 0.0665),\n",
       "  ('present', 0.064),\n",
       "  ('cooking newly', 0.0626),\n",
       "  ('range', 0.0534),\n",
       "  ('predict losses', 0.0415),\n",
       "  ('efficient ecocooker', 0.0337),\n",
       "  ('49 kcal', 0.0154),\n",
       "  ('pan', -0.0076),\n",
       "  ('09', -0.0256)],\n",
       " 'MED-910': [('garlic preparations', 0.5655),\n",
       "  ('vitro antiaggregatory', 0.4215),\n",
       "  ('predictors antiplatelet', 0.4169),\n",
       "  ('antithrombotic effect', 0.4017),\n",
       "  ('uncrushed garlic', 0.3918),\n",
       "  ('platelets induced', 0.3571),\n",
       "  ('inhibit platelet', 0.3545),\n",
       "  ('induced extracts', 0.325),\n",
       "  ('cloves using', 0.3102),\n",
       "  ('crushed cooked', 0.296),\n",
       "  ('concentrations allicin', 0.288),\n",
       "  ('different cooking', 0.2851),\n",
       "  ('preparations', 0.2729),\n",
       "  ('microwaved samples', 0.2506),\n",
       "  ('significant', 0.2169),\n",
       "  ('samples reduced', 0.2145),\n",
       "  ('cardiovascular disease', 0.2124),\n",
       "  ('compared raw', 0.2001),\n",
       "  ('immersing boiling', 0.1914),\n",
       "  ('examined vitro', 0.1854),\n",
       "  ('restored complement', 0.1819),\n",
       "  ('aggregation compared', 0.1785),\n",
       "  ('using different', 0.1702),\n",
       "  ('previously crushed', 0.1689),\n",
       "  ('contribute prevention', 0.1652),\n",
       "  ('results suggest', 0.1628),\n",
       "  ('heating min', 0.1586),\n",
       "  ('ivaa microwaved', 0.1479),\n",
       "  ('prolonged incubation', 0.1476),\n",
       "  ('increasing consumed', 0.1469),\n",
       "  ('intensities concentrations', 0.1372),\n",
       "  ('monitored oven', 0.1324),\n",
       "  ('blood', 0.129),\n",
       "  ('versus uncrushed', 0.1265),\n",
       "  ('dose response', 0.1053),\n",
       "  ('widely recognized', 0.0981),\n",
       "  ('juice aggregation', 0.0946),\n",
       "  ('200 degrees', 0.0912),\n",
       "  ('affect ability', 0.0899),\n",
       "  ('disease examined', 0.083),\n",
       "  ('thiosulfinates responsible', 0.067),\n",
       "  ('temperatures completely', 0.045),\n",
       "  ('completely suppressed', 0.0446),\n",
       "  ('agents contribute', 0.0305),\n",
       "  ('previously', 0.0303),\n",
       "  ('moderate', 0.0278),\n",
       "  ('pyruvate levels', 0.0127),\n",
       "  ('strength monitored', 0.0077),\n",
       "  ('min did', -0.0161),\n",
       "  ('10', -0.0668)],\n",
       " 'MED-911': [('naegleria fowleri', 0.653),\n",
       "  ('amoebic meningoencephalitis', 0.5993),\n",
       "  ('fowleri free', 0.5582),\n",
       "  ('fowleri pam', 0.5237),\n",
       "  ('primary amoebic', 0.518),\n",
       "  ('amoeba commonly', 0.5179),\n",
       "  ('fowleri etiologic', 0.4925),\n",
       "  ('tourists fowleri', 0.4283),\n",
       "  ('meningoencephalitis', 0.3488),\n",
       "  ('naegleria', 0.3271),\n",
       "  ('warm freshwater', 0.2519),\n",
       "  ('free living', 0.2361),\n",
       "  ('lakes natural', 0.1847),\n",
       "  ('similar bacterial', 0.1671),\n",
       "  ('natural mineral', 0.1607),\n",
       "  ('water resort', 0.153),\n",
       "  ('disease similar', 0.1083),\n",
       "  ('travel medicine', 0.0925),\n",
       "  ('pam offers', 0.0921),\n",
       "  ('environments', 0.092),\n",
       "  ('acute fatal', 0.0901),\n",
       "  ('springs', 0.0758),\n",
       "  ('etiologic agent', 0.0729),\n",
       "  ('frequented tourists', 0.0719),\n",
       "  ('rare condition', 0.0687),\n",
       "  ('spas frequented', 0.0657),\n",
       "  ('meningitis key', 0.0634),\n",
       "  ('cases increasing', 0.0548),\n",
       "  ('presenting features', 0.0478),\n",
       "  ('agent primary', 0.0408),\n",
       "  ('nervous results', 0.037),\n",
       "  ('review focuses', 0.0351),\n",
       "  ('results', 0.0339),\n",
       "  ('days previously', 0.0323),\n",
       "  ('hot', 0.0297),\n",
       "  ('seven', 0.0109),\n",
       "  ('prevention treatment', 0.0044),\n",
       "  ('commonly', -0.0007),\n",
       "  ('disease copyright', -0.0059),\n",
       "  ('number reported', -0.023),\n",
       "  ('diagnose', -0.0345),\n",
       "  ('year', -0.0368),\n",
       "  ('rights reserved', -0.0428),\n",
       "  ('creating awareness', -0.0455),\n",
       "  ('offers insight', -0.0492),\n",
       "  ('2010 elsevier', -0.0549),\n",
       "  ('signs', -0.0852),\n",
       "  ('resort', -0.0894),\n",
       "  ('industry', -0.09),\n",
       "  ('difficult', -0.0968)],\n",
       " 'MED-912': [('prunes prunus', 0.4935),\n",
       "  ('prunes used', 0.4916),\n",
       "  ('prunes soaked', 0.4587),\n",
       "  ('prunus domestica', 0.4417),\n",
       "  ('prunes change', 0.4252),\n",
       "  ('hepatic disease', 0.4103),\n",
       "  ('beneficial hepatic', 0.3975),\n",
       "  ('prunes clinical', 0.3919),\n",
       "  ('including hepatitis', 0.3754),\n",
       "  ('remedy various', 0.3477),\n",
       "  ('prune juice', 0.3413),\n",
       "  ('dose prunes', 0.3321),\n",
       "  ('drink prune', 0.2873),\n",
       "  ('volunteers divided', 0.2522),\n",
       "  ('domestica', 0.2515),\n",
       "  ('diseases including', 0.2437),\n",
       "  ('166 healthy', 0.2346),\n",
       "  ('43g 23g', 0.2189),\n",
       "  ('designed effects', 0.2169),\n",
       "  ('used folks', 0.2144),\n",
       "  ('clinical trial', 0.2001),\n",
       "  ('group given', 0.1914),\n",
       "  ('reduction serum', 0.1691),\n",
       "  ('bilirubin', 0.1608),\n",
       "  ('test groups', 0.1365),\n",
       "  ('chemical', 0.1348),\n",
       "  ('week week', 0.1318),\n",
       "  ('randomly', 0.111),\n",
       "  ('appropriate cases', 0.1088),\n",
       "  ('function use', 0.1076),\n",
       "  ('early morning', 0.1059),\n",
       "  ('subject control', 0.1011),\n",
       "  ('samples taken', 0.0898),\n",
       "  ('glass water', 0.0861),\n",
       "  ('aspartate transaminase', 0.0815),\n",
       "  ('alteration', 0.0728),\n",
       "  ('significant', 0.0533),\n",
       "  ('eat', 0.0492),\n",
       "  ('alanine', 0.0414),\n",
       "  ('asked', 0.0411),\n",
       "  ('250ml', 0.0354),\n",
       "  ('healthy', 0.03),\n",
       "  ('approx', 0.0233),\n",
       "  ('drink blood', 0.0223),\n",
       "  ('fruit single', 0.0073),\n",
       "  ('phosphatase 017', -0.0038),\n",
       "  ('overnight subject', -0.0196),\n",
       "  ('prove', -0.02),\n",
       "  ('048', -0.0231),\n",
       "  ('double', -0.0514)],\n",
       " 'MED-913': [('gm foods', 0.5155),\n",
       "  ('animal toxicological', 0.3828),\n",
       "  ('safety genetically', 0.3539),\n",
       "  ('soybeans safe', 0.3344),\n",
       "  ('feeding studies', 0.3343),\n",
       "  ('risks studies', 0.3302),\n",
       "  ('assessment gm', 0.3213),\n",
       "  ('genetically modified', 0.3076),\n",
       "  ('consumers environmental', 0.2819),\n",
       "  ('research demands', 0.277),\n",
       "  ('governmental organizations', 0.2759),\n",
       "  ('raising concerns', 0.2748),\n",
       "  ('conducted biotechnology', 0.2612),\n",
       "  ('demands rigorous', 0.2543),\n",
       "  ('adverse effects', 0.2524),\n",
       "  ('plants subjected', 0.2519),\n",
       "  ('standards diverse', 0.2294),\n",
       "  ('critically reviewed', 0.2209),\n",
       "  ('area research', 0.2086),\n",
       "  ('main goal', 0.2069),\n",
       "  ('long term', 0.206),\n",
       "  ('corn', 0.2031),\n",
       "  ('references concerning', 0.1972),\n",
       "  ('international scientific', 0.19),\n",
       "  ('ngo suggested', 0.1872),\n",
       "  ('tomatoes available', 0.1841),\n",
       "  ('studies approval', 0.1829),\n",
       "  ('concerning human', 0.1728),\n",
       "  ('rice', 0.1709),\n",
       "  ('human animal', 0.1707),\n",
       "  ('non governmental', 0.1628),\n",
       "  ('diverse groups', 0.1626),\n",
       "  ('mainly maize', 0.1617),\n",
       "  ('respective conventional', 0.158),\n",
       "  ('important complex', 0.1484),\n",
       "  ('findings suggest', 0.1405),\n",
       "  ('lack studies', 0.1398),\n",
       "  ('number varieties', 0.1385),\n",
       "  ('health', 0.136),\n",
       "  ('consumption 2000', 0.128),\n",
       "  ('cucumber peas', 0.1024),\n",
       "  ('databases pubmed', 0.0979),\n",
       "  ('increased', 0.0689),\n",
       "  ('recent years', 0.0688),\n",
       "  ('modified', 0.0674),\n",
       "  ('information products', 0.0666),\n",
       "  ('review equilibrium', 0.0664),\n",
       "  ('elsevier rights', 0.0352),\n",
       "  ('increased 2006', -0.0254),\n",
       "  ('copyright 2011', -0.0341)],\n",
       " 'MED-918': [('dietary fructose', 0.7111),\n",
       "  ('fructose erythritol', 0.686),\n",
       "  ('erythritol beverage', 0.5495),\n",
       "  ('erythritol nonglycemic', 0.5037),\n",
       "  ('glucose enhances', 0.4963),\n",
       "  ('suggested erythritol', 0.489),\n",
       "  ('fructose 50', 0.4577),\n",
       "  ('fructose 33', 0.4214),\n",
       "  ('glucose beverage', 0.4139),\n",
       "  ('participants consumed', 0.3869),\n",
       "  ('carbohydrate malabsorption', 0.365),\n",
       "  ('fructose thirty', 0.3586),\n",
       "  ('dietary', 0.3143),\n",
       "  ('induces gastrointestinal', 0.3095),\n",
       "  ('postprandially breath', 0.3059),\n",
       "  ('sugar', 0.3025),\n",
       "  ('gastrointestinal tolerance', 0.2954),\n",
       "  ('alcohol suggested', 0.2881),\n",
       "  ('stools increased', 0.2728),\n",
       "  ('consumption large', 0.2404),\n",
       "  ('beverage 001', 0.2369),\n",
       "  ('intolerance', 0.2278),\n",
       "  ('nonglycemic', 0.2271),\n",
       "  ('bowel movements', 0.2207),\n",
       "  ('frequency watery', 0.1995),\n",
       "  ('coingestion equimolar', 0.1994),\n",
       "  ('increased 05', 0.1989),\n",
       "  ('enhance paracellular', 0.185),\n",
       "  ('pathways additional', 0.1814),\n",
       "  ('absorbed', 0.1755),\n",
       "  ('fast participants', 0.1668),\n",
       "  ('75', 0.1616),\n",
       "  ('worsened', 0.1335),\n",
       "  ('times auc', 0.1331),\n",
       "  ('adults participated', 0.1327),\n",
       "  ('frequency', 0.1267),\n",
       "  ('symptoms number', 0.1024),\n",
       "  ('known enhancer', 0.0872),\n",
       "  ('data suggest', 0.0854),\n",
       "  ('participated randomized', 0.0757),\n",
       "  ('respectively compared', 0.0484),\n",
       "  ('study overnight', 0.0417),\n",
       "  ('double masked', 0.0243),\n",
       "  ('hydrogen area', 0.014),\n",
       "  ('crossover', 0.0138),\n",
       "  ('24 hours', 0.0131),\n",
       "  ('elsevier rights', 0.0035),\n",
       "  ('rights', -0.0489),\n",
       "  ('seven', -0.0581),\n",
       "  ('copyright 2011', -0.0665)],\n",
       " 'MED-919': [('guidelines clinicians', 0.5478),\n",
       "  ('consensus guided', 0.4908),\n",
       "  ('task force', 0.4649),\n",
       "  ('care patients', 0.4159),\n",
       "  ('subcommittee clinical', 0.4096),\n",
       "  ('guided systematic', 0.3814),\n",
       "  ('vitamin deficiency', 0.3756),\n",
       "  ('supplementation suggested', 0.3659),\n",
       "  ('systematic reviews', 0.3588),\n",
       "  ('deficient patients', 0.3547),\n",
       "  ('member review', 0.3342),\n",
       "  ('emphasis care', 0.3203),\n",
       "  ('additional experts', 0.318),\n",
       "  ('needed changes', 0.3032),\n",
       "  ('recommend', 0.3024),\n",
       "  ('objective objective', 0.2888),\n",
       "  ('initial diagnostic', 0.2885),\n",
       "  ('draft prepared', 0.2862),\n",
       "  ('methodologist task', 0.2772),\n",
       "  ('test patients', 0.2667),\n",
       "  ('participants', 0.2592),\n",
       "  ('limit levels', 0.2535),\n",
       "  ('treatment', 0.2497),\n",
       "  ('screening individuals', 0.2426),\n",
       "  ('society', 0.2383),\n",
       "  ('written comments', 0.2292),\n",
       "  ('sufficient evidence', 0.2138),\n",
       "  ('web site', 0.2121),\n",
       "  ('funding remuneration', 0.2005),\n",
       "  ('composed chair', 0.183),\n",
       "  ('endocrine society', 0.1778),\n",
       "  ('conference calls', 0.1743),\n",
       "  ('suggested measurement', 0.1704),\n",
       "  ('benefit cardiovascular', 0.1677),\n",
       "  ('noncalcemic', 0.1573),\n",
       "  ('patients risk', 0.1497),\n",
       "  ('cosponsoring associations', 0.1425),\n",
       "  ('daily', 0.132),\n",
       "  ('stage', 0.115),\n",
       "  ('reliable assay', 0.1),\n",
       "  ('groups foods', 0.0947),\n",
       "  ('corporate', 0.0946),\n",
       "  ('serum', 0.0921),\n",
       "  ('present time', 0.0807),\n",
       "  ('affairs core', 0.0693),\n",
       "  ('25', 0.0665),\n",
       "  ('depending age', 0.0591),\n",
       "  ('calls mail', 0.0425),\n",
       "  ('common', 0.0346),\n",
       "  ('upper', 0.0303)],\n",
       " 'MED-920': [('vitamin tuberculosis', 0.5683),\n",
       "  ('tuberculosis treatment', 0.4993),\n",
       "  ('rekindled vitamin', 0.4866),\n",
       "  ('treat tuberculosis', 0.4525),\n",
       "  ('antituberculous therapy', 0.4396),\n",
       "  ('tuberculosis review', 0.428),\n",
       "  ('adjunct antituberculous', 0.4279),\n",
       "  ('insights immunomodulatory', 0.4209),\n",
       "  ('immunomodulatory', 0.4137),\n",
       "  ('use vitamin', 0.398),\n",
       "  ('tuberculosis pre', 0.3912),\n",
       "  ('mycobacterium tuberculosis', 0.3735),\n",
       "  ('antibiotic era', 0.3501),\n",
       "  ('vitamin adjunct', 0.3442),\n",
       "  ('dihydroxy vitamin', 0.338),\n",
       "  ('pulmonary tuberculosis', 0.3174),\n",
       "  ('antibiotic', 0.3154),\n",
       "  ('series vitamin', 0.3104),\n",
       "  ('pre antibiotic', 0.3017),\n",
       "  ('used treatment', 0.3015),\n",
       "  ('25 dihydroxy', 0.2864),\n",
       "  ('therapy historical', 0.2708),\n",
       "  ('infection mycobacterium', 0.2702),\n",
       "  ('therapy', 0.2637),\n",
       "  ('clinical trials', 0.2525),\n",
       "  ('discuss mechanisms', 0.2332),\n",
       "  ('new insights', 0.1886),\n",
       "  ('1alpha 25', 0.1786),\n",
       "  ('modulate host', 0.1717),\n",
       "  ('review', 0.1666),\n",
       "  ('infection', 0.1599),\n",
       "  ('mechanisms', 0.1533),\n",
       "  ('rekindled', 0.1527),\n",
       "  ('modulate', 0.1314),\n",
       "  ('treatment discuss', 0.1297),\n",
       "  ('pulmonary', 0.1258),\n",
       "  ('historical use', 0.1151),\n",
       "  ('host response', 0.1134),\n",
       "  ('1alpha', 0.0886),\n",
       "  ('clinical', 0.0848),\n",
       "  ('case series', 0.0765),\n",
       "  ('use', 0.0613),\n",
       "  ('adjunct', 0.0534),\n",
       "  ('era new', 0.0398),\n",
       "  ('series', 0.0074),\n",
       "  ('pre', 0.005),\n",
       "  ('properties', 0.0031),\n",
       "  ('response', 0.0013),\n",
       "  ('era', -0.0011),\n",
       "  ('case', -0.0547)],\n",
       " 'MED-921': [('tuberculosis infection', 0.5381),\n",
       "  ('tb major', 0.4459),\n",
       "  ('latent mycobacterium', 0.3949),\n",
       "  ('treat tb', 0.3906),\n",
       "  ('response mycobacteria', 0.387),\n",
       "  ('antimicrobial therapy', 0.3785),\n",
       "  ('drug resistant', 0.359),\n",
       "  ('estimated 32', 0.3274),\n",
       "  ('infection high', 0.3146),\n",
       "  ('disease emergence', 0.3126),\n",
       "  ('mortality responsible', 0.2864),\n",
       "  ('risk reactivation', 0.2485),\n",
       "  ('prevalence latent', 0.2466),\n",
       "  ('lifetime risk', 0.2342),\n",
       "  ('68 million', 0.2305),\n",
       "  ('tb vitamin', 0.2202),\n",
       "  ('global prevalence', 0.2058),\n",
       "  ('public health', 0.2023),\n",
       "  ('organisms necessitates', 0.1915),\n",
       "  ('20 lifetime', 0.1873),\n",
       "  ('necessitates development', 0.1865),\n",
       "  ('emergence drug', 0.1847),\n",
       "  ('disease randomised', 0.1831),\n",
       "  ('epidemiological evidence', 0.1687),\n",
       "  ('burden settings', 0.1565),\n",
       "  ('deficiency increased', 0.1555),\n",
       "  ('potentially huge', 0.1401),\n",
       "  ('studies conflicting', 0.1174),\n",
       "  ('prevalent people', 0.1121),\n",
       "  ('variation', 0.0973),\n",
       "  ('new agents', 0.096),\n",
       "  ('enhance immune', 0.0808),\n",
       "  ('long known', 0.0798),\n",
       "  ('research priority', 0.0701),\n",
       "  ('studies baseline', 0.05),\n",
       "  ('treatment results', 0.0462),\n",
       "  ('participants dosing', 0.0369),\n",
       "  ('2009 global', 0.0353),\n",
       "  ('metabolite', 0.029),\n",
       "  ('patients active', 0.0241),\n",
       "  ('measures', 0.0225),\n",
       "  ('era', 0.0134),\n",
       "  ('wealth', 0.0133),\n",
       "  ('vitro', 0.0055),\n",
       "  ('25 dihydoxyvitamin', -0.0067),\n",
       "  ('role adjunctive', -0.0082),\n",
       "  ('given safety', -0.0596),\n",
       "  ('low cost', -0.0715),\n",
       "  ('performed conduct', -0.0876),\n",
       "  ('carries', -0.1029)],\n",
       " 'MED-922': [('diets considered', 0.6431),\n",
       "  ('dietetyk2 folate', 0.5159),\n",
       "  ('nutrients aim', 0.5098),\n",
       "  ('vitamin deficiency', 0.4974),\n",
       "  ('low intake', 0.4944),\n",
       "  ('antioxidant status', 0.4575),\n",
       "  ('monitoring vegetarian', 0.4308),\n",
       "  ('animal foods', 0.4244),\n",
       "  ('health reduce', 0.4099),\n",
       "  ('vitamin 13', 0.3815),\n",
       "  ('ěmol vitamin', 0.3759),\n",
       "  ('vegetarian children', 0.3615),\n",
       "  ('vitamin 1245', 0.3566),\n",
       "  ('total homocysteine', 0.3394),\n",
       "  ('serum concentrations', 0.292),\n",
       "  ('comparison nonvegetarians', 0.2623),\n",
       "  ('ěg references', 0.26),\n",
       "  ('constituents analyzed', 0.2534),\n",
       "  ('folic', 0.2488),\n",
       "  ('methods study', 0.2474),\n",
       "  ('balance', 0.2422),\n",
       "  ('diseases known', 0.2304),\n",
       "  ('32 vegetarians', 0.2259),\n",
       "  ('restriction exclusion', 0.2256),\n",
       "  ('risk chronic', 0.2187),\n",
       "  ('essential', 0.2182),\n",
       "  ('iron range', 0.2081),\n",
       "  ('b12', 0.1892),\n",
       "  ('similar levels', 0.1876),\n",
       "  ('significantly lower', 0.181),\n",
       "  ('status insufficient', 0.1746),\n",
       "  ('548', 0.1633),\n",
       "  ('05 values', 0.1624),\n",
       "  ('15 ěmol', 0.159),\n",
       "  ('immunoenzymatic', 0.1505),\n",
       "  ('slightly affected', 0.1433),\n",
       "  ('vitamin 17', 0.1331),\n",
       "  ('mmol 0001', 0.1296),\n",
       "  ('tas', 0.1149),\n",
       "  ('reflected', 0.0893),\n",
       "  ('omnivores aged', 0.0861),\n",
       "  ('available kits', 0.0766),\n",
       "  ('polish', 0.059),\n",
       "  ('animal', 0.0382),\n",
       "  ('mother child', 0.0353),\n",
       "  ('50 children', 0.0242),\n",
       "  ('vs 45', 0.0235),\n",
       "  ('institute', 0.0233),\n",
       "  ('high pressure', -0.0312),\n",
       "  ('11 referred', -0.0376)],\n",
       " 'MED-923': [('chickens dexamethasone', 0.6209),\n",
       "  ('dexamethasone retards', 0.4999),\n",
       "  ('glucocorticoid receptor', 0.4845),\n",
       "  ('dexamethasone increased', 0.4845),\n",
       "  ('acres chickens', 0.4092),\n",
       "  ('metabolism broiler', 0.3948),\n",
       "  ('gr fatp1', 0.3804),\n",
       "  ('gallus gallus', 0.3007),\n",
       "  ('glycolytic pm', 0.2912),\n",
       "  ('35 days', 0.2889),\n",
       "  ('retards', 0.277),\n",
       "  ('density lipoprotein', 0.2642),\n",
       "  ('domesticus skeletal', 0.2624),\n",
       "  ('lipid uptake', 0.2425),\n",
       "  ('increased ampkα', 0.2242),\n",
       "  ('oxidative', 0.2236),\n",
       "  ('expression liver', 0.2221),\n",
       "  ('bf levels', 0.2185),\n",
       "  ('tissues fed', 0.2176),\n",
       "  ('conclusion fasting', 0.2169),\n",
       "  ('carnitine', 0.2168),\n",
       "  ('treatment days', 0.212),\n",
       "  ('promoted transcriptional', 0.2095),\n",
       "  ('growth facilitating', 0.2071),\n",
       "  ('genes related', 0.1936),\n",
       "  ('major pm', 0.1923),\n",
       "  ('pectoralis', 0.1898),\n",
       "  ('coa dehydrogenase', 0.1788),\n",
       "  ('gr lpl', 0.1758),\n",
       "  ('fabp', 0.1747),\n",
       "  ('activated protein', 0.165),\n",
       "  ('decreased biceps', 0.1643),\n",
       "  ('palmitoyltransferase', 0.1612),\n",
       "  ('adenosine monophosphate', 0.1496),\n",
       "  ('atgl protein', 0.1467),\n",
       "  ('femoris', 0.1451),\n",
       "  ('utilisation suggested', 0.1401),\n",
       "  ('muscle impaired', 0.1281),\n",
       "  ('mrna decreased', 0.1271),\n",
       "  ('body', 0.1127),\n",
       "  ('phosphorylation ctp1', 0.1044),\n",
       "  ('intramyocellular', 0.1031),\n",
       "  ('investigated male', 0.0954),\n",
       "  ('conclusion', 0.0796),\n",
       "  ('enhanced low', 0.0655),\n",
       "  ('thr172 phosphorylation', 0.0501),\n",
       "  ('long chain', 0.0416),\n",
       "  ('arbor acres', 0.0236),\n",
       "  ('unmatched', -0.0363),\n",
       "  ('old', -0.0419)],\n",
       " 'MED-927': [('blood lipids', 0.538),\n",
       "  ('oil significantly', 0.4675),\n",
       "  ('total cholesterol', 0.4584),\n",
       "  ('hyperlipidemia significantly', 0.4313),\n",
       "  ('density lipoprotein', 0.423),\n",
       "  ('randomized study', 0.3606),\n",
       "  ('120 mg', 0.3386),\n",
       "  ('parameters tested', 0.327),\n",
       "  ('assess effects', 0.3236),\n",
       "  ('mg dl', 0.3146),\n",
       "  ('diet', 0.2946),\n",
       "  ('received krill', 0.2925),\n",
       "  ('levels confidence', 0.2904),\n",
       "  ('objective', 0.2816),\n",
       "  ('conclusions results', 0.2753),\n",
       "  ('90 day', 0.2612),\n",
       "  ('increasing hdl', 0.2594),\n",
       "  ('patients treated', 0.2531),\n",
       "  ('measures primary', 0.2486),\n",
       "  ('effective reduction', 0.2456),\n",
       "  ('glucose results', 0.2427),\n",
       "  ('present study', 0.2378),\n",
       "  ('docosahexaenoic acid', 0.2363),\n",
       "  ('30 patients', 0.2219),\n",
       "  ('high levels', 0.2017),\n",
       "  ('prospective', 0.185),\n",
       "  ('epa', 0.1816),\n",
       "  ('tested baseline', 0.18),\n",
       "  ('compared fish', 0.1704),\n",
       "  ('mass index', 0.1692),\n",
       "  ('assigned groups', 0.1613),\n",
       "  ('study neptune', 0.1566),\n",
       "  ('multi center', 0.1536),\n",
       "  ('followed month', 0.1422),\n",
       "  ('quebec canada', 0.1403),\n",
       "  ('daily group', 0.1362),\n",
       "  ('cellulose', 0.135),\n",
       "  ('equal doses', 0.1313),\n",
       "  ('controlled follow', 0.1176),\n",
       "  ('technologies bioresources', 0.1152),\n",
       "  ('management', 0.1126),\n",
       "  ('visit total', 0.1089),\n",
       "  ('dependent effective', 0.0992),\n",
       "  ('healthy', 0.0891),\n",
       "  ('containing microcrystalline', 0.0869),\n",
       "  ('low density', 0.069),\n",
       "  ('194 348', 0.0679),\n",
       "  ('placebo containing', 0.0447),\n",
       "  ('gram', 0.0324),\n",
       "  ('laval', 0.0206)],\n",
       " 'MED-928': [('fa compositions', 0.5266),\n",
       "  ('fish oil', 0.5183),\n",
       "  ('dha formulations', 0.4581),\n",
       "  ('triacylglycerides', 0.3807),\n",
       "  ('superior bioavailability', 0.373),\n",
       "  ('derived fish', 0.3604),\n",
       "  ('supplements showed', 0.3495),\n",
       "  ('proxy bioavailability', 0.332),\n",
       "  ('oil rtag', 0.3295),\n",
       "  ('chemical forms', 0.3081),\n",
       "  ('doses different', 0.3058),\n",
       "  ('capsule ingestion', 0.3048),\n",
       "  ('differences epa', 0.2905),\n",
       "  ('trial compared', 0.2795),\n",
       "  ('omega', 0.2741),\n",
       "  ('suggested phospholipid', 0.2726),\n",
       "  ('free epa', 0.2502),\n",
       "  ('levels plasma', 0.2487),\n",
       "  ('pre dose', 0.2466),\n",
       "  ('conclusion studies', 0.2384),\n",
       "  ('compared uptake', 0.2343),\n",
       "  ('randomized 1680', 0.2251),\n",
       "  ('ethyl esters', 0.2103),\n",
       "  ('provoked krill', 0.2023),\n",
       "  ('taken consideration', 0.1936),\n",
       "  ('influence availability', 0.1911),\n",
       "  ('additionally proportion', 0.1886),\n",
       "  ('forms compared', 0.183),\n",
       "  ('blinded crossover', 0.1768),\n",
       "  ('36', 0.1596),\n",
       "  ('larger sample', 0.1582),\n",
       "  ('did contain', 0.1577),\n",
       "  ('analyzed pre', 0.1552),\n",
       "  ('auc0 72', 0.1484),\n",
       "  ('investigated depth', 0.1484),\n",
       "  ('31 randomized', 0.138),\n",
       "  ('dose 24', 0.1254),\n",
       "  ('longer', 0.118),\n",
       "  ('deviation values', 0.1059),\n",
       "  ('statistical pair', 0.1014),\n",
       "  ('75 ee', 0.1007),\n",
       "  ('high standard', 0.0992),\n",
       "  ('47 53', 0.0897),\n",
       "  ('mainly pl', 0.0779),\n",
       "  ('80 03', 0.052),\n",
       "  ('forms lc', 0.0374),\n",
       "  ('size carried', 0.0027),\n",
       "  ('22 total', 0.001),\n",
       "  ('young men', 0.0003),\n",
       "  ('identical', -0.0326)],\n",
       " 'MED-930': [('hchs seawater', 0.4485),\n",
       "  ('mean hexachlorobenzene', 0.4464),\n",
       "  ('concentrations measured', 0.4128),\n",
       "  ('fresh lindane', 0.3853),\n",
       "  ('volatilization', 0.3802),\n",
       "  ('levels compounds', 0.3754),\n",
       "  ('observed decrease', 0.3715),\n",
       "  ('decline levels', 0.3554),\n",
       "  ('bioconcentration', 0.3453),\n",
       "  ('decrease hcb', 0.345),\n",
       "  ('volatilization does', 0.3303),\n",
       "  ('measured seawater', 0.3285),\n",
       "  ('water low', 0.3206),\n",
       "  ('antarctic', 0.3171),\n",
       "  ('air samples', 0.3129),\n",
       "  ('ratios hcb', 0.3027),\n",
       "  ('low', 0.2635),\n",
       "  ('hcb surface', 0.2454),\n",
       "  ('low alpha', 0.2398),\n",
       "  ('deposition coastal', 0.2291),\n",
       "  ('sampling period', 0.2027),\n",
       "  ('suggest predominance', 0.1976),\n",
       "  ('gas', 0.1926),\n",
       "  ('air beginning', 0.1748),\n",
       "  ('seas', 0.1713),\n",
       "  ('air water', 0.1672),\n",
       "  ('hcb imply', 0.1618),\n",
       "  ('austral', 0.1482),\n",
       "  ('atmosphere', 0.1359),\n",
       "  ('current use', 0.1119),\n",
       "  ('probably', 0.1024),\n",
       "  ('probably current', 0.1007),\n",
       "  ('krill', 0.0994),\n",
       "  ('samples correlated', 0.0978),\n",
       "  ('predominance fresh', 0.0968),\n",
       "  ('period suggest', 0.0934),\n",
       "  ('gamma', 0.0897),\n",
       "  ('confirmed', 0.0602),\n",
       "  ('measured', 0.0567),\n",
       "  ('ratios demonstrate', 0.0539),\n",
       "  ('mean', 0.0355),\n",
       "  ('surface', 0.029),\n",
       "  ('use southern', 0.027),\n",
       "  ('account', 0.0263),\n",
       "  ('hemisphere', 0.0244),\n",
       "  ('demonstrate potential', 0.023),\n",
       "  ('fugacity ratios', 0.0098),\n",
       "  ('entering', 0.0037),\n",
       "  ('spring probably', -0.0205),\n",
       "  ('does', -0.0544)],\n",
       " 'MED-931': [('ecotoxicological', 0.515),\n",
       "  ('dde antarctic', 0.5096),\n",
       "  ('larval antarctic', 0.505),\n",
       "  ('variations larval', 0.4643),\n",
       "  ('uptake larval', 0.4545),\n",
       "  ('larval krill', 0.4229),\n",
       "  ('aquatic', 0.4152),\n",
       "  ('toxicological sensitivity', 0.4054),\n",
       "  ('dichloroethylene dde', 0.3928),\n",
       "  ('contaminant uptake', 0.3753),\n",
       "  ('aqueous uptake', 0.3686),\n",
       "  ('larvae comparable', 0.333),\n",
       "  ('water crustaceans', 0.3164),\n",
       "  ('body residue', 0.3107),\n",
       "  ('assessment polar', 0.2923),\n",
       "  ('ecosystems', 0.2823),\n",
       "  ('physiology appear', 0.2725),\n",
       "  ('approach environmental', 0.2716),\n",
       "  ('cold water', 0.2682),\n",
       "  ('narcosis immobility', 0.2654),\n",
       "  ('sensitivity non', 0.2588),\n",
       "  ('krill dde', 0.2584),\n",
       "  ('feeding', 0.2562),\n",
       "  ('sublethal', 0.2556),\n",
       "  ('clearance rate', 0.2502),\n",
       "  ('84 ml', 0.2422),\n",
       "  ('slower', 0.2337),\n",
       "  ('stages key', 0.2295),\n",
       "  ('findings small', 0.2225),\n",
       "  ('reported amphipod', 0.214),\n",
       "  ('euphausia superba', 0.2074),\n",
       "  ('behavioural', 0.1954),\n",
       "  ('risk', 0.1899),\n",
       "  ('mmol kg', 0.1798),\n",
       "  ('species finding', 0.1791),\n",
       "  ('preserved weight', 0.1763),\n",
       "  ('study evaluated', 0.1658),\n",
       "  ('findings adult', 0.1514),\n",
       "  ('variations', 0.1483),\n",
       "  ('testing', 0.1449),\n",
       "  ('tissue', 0.1389),\n",
       "  ('natural', 0.1092),\n",
       "  ('inhabiting', 0.1091),\n",
       "  ('importance time', 0.0976),\n",
       "  ('previous', 0.0803),\n",
       "  ('temperate species', 0.0733),\n",
       "  ('2011 elsevier', 0.0728),\n",
       "  ('copyright', 0.0502),\n",
       "  ('supports', 0.0211),\n",
       "  ('responses strongly', -0.002)],\n",
       " 'MED-933': [('cd arthritis', 0.593),\n",
       "  ('arthritis childhood', 0.5899),\n",
       "  ('occult cd', 0.5236),\n",
       "  ('monoarthritis boy', 0.5063),\n",
       "  ('axial arthritis', 0.5047),\n",
       "  ('recurrent monoarthritis', 0.459),\n",
       "  ('appearance arthritis', 0.4421),\n",
       "  ('coeliac', 0.4405),\n",
       "  ('arthritis treatment', 0.4206),\n",
       "  ('interval arthritis', 0.4091),\n",
       "  ('untreated cd', 0.3811),\n",
       "  ('cd child', 0.3791),\n",
       "  ('arthritis unclear', 0.36),\n",
       "  ('childhood', 0.3521),\n",
       "  ('disease', 0.3498),\n",
       "  ('cd years', 0.3471),\n",
       "  ('bowel disease', 0.3453),\n",
       "  ('11 years', 0.3021),\n",
       "  ('peripheral axial', 0.2754),\n",
       "  ('occult', 0.2619),\n",
       "  ('disease nutritional', 0.2489),\n",
       "  ('boy', 0.2247),\n",
       "  ('unique association', 0.2247),\n",
       "  ('presenting recurrent', 0.2032),\n",
       "  ('persistent remission', 0.2),\n",
       "  ('treatment', 0.1965),\n",
       "  ('case unique', 0.1746),\n",
       "  ('normal diagnosis', 0.1679),\n",
       "  ('introduction gluten', 0.1569),\n",
       "  ('untreated', 0.1539),\n",
       "  ('interval appearance', 0.153),\n",
       "  ('adult patients', 0.1527),\n",
       "  ('unclear origin', 0.1475),\n",
       "  ('years', 0.1451),\n",
       "  ('introduction', 0.1287),\n",
       "  ('persistent', 0.1277),\n",
       "  ('aga', 0.1218),\n",
       "  ('anti gliadin', 0.1192),\n",
       "  ('aged', 0.1028),\n",
       "  ('endomysium', 0.0995),\n",
       "  ('anti', 0.0973),\n",
       "  ('free diet', 0.0906),\n",
       "  ('antibody tests', 0.0862),\n",
       "  ('15 years', 0.0808),\n",
       "  ('resulted', 0.0796),\n",
       "  ('small bowel', 0.0546),\n",
       "  ('possibility', 0.0505),\n",
       "  ('physicians alert', 0.0432),\n",
       "  ('biopsy', 0.0332),\n",
       "  ('ema', 0.0087)],\n",
       " 'MED-934': [('stone disease', 0.4526),\n",
       "  ('diet low', 0.4232),\n",
       "  ('vegetarians uk', 0.4201),\n",
       "  ('vegetarians risk', 0.403),\n",
       "  ('hypothesis diet', 0.4012),\n",
       "  ('protein diet', 0.4003),\n",
       "  ('vegetarians findings', 0.3965),\n",
       "  ('survey vegetarians', 0.3644),\n",
       "  ('protein reduces', 0.3536),\n",
       "  ('prevalence urinary', 0.3464),\n",
       "  ('urinary stone', 0.3462),\n",
       "  ('diet taken', 0.3425),\n",
       "  ('animal protein', 0.3029),\n",
       "  ('class vegetarians', 0.3018),\n",
       "  ('taken vegetarians', 0.2951),\n",
       "  ('study carried', 0.2871),\n",
       "  ('40 60', 0.2846),\n",
       "  ('formation 40', 0.2685),\n",
       "  ('60 predicted', 0.2572),\n",
       "  ('effect low', 0.2363),\n",
       "  ('low animal', 0.235),\n",
       "  ('population matched', 0.2346),\n",
       "  ('showed prevalence', 0.2298),\n",
       "  ('reduces risk', 0.2292),\n",
       "  ('uk showed', 0.2232),\n",
       "  ('reduces', 0.2106),\n",
       "  ('general population', 0.2012),\n",
       "  ('protein', 0.1936),\n",
       "  ('social class', 0.1853),\n",
       "  ('predicted group', 0.1824),\n",
       "  ('determine effect', 0.1808),\n",
       "  ('risk', 0.1435),\n",
       "  ('disease nation', 0.1389),\n",
       "  ('population', 0.1361),\n",
       "  ('wide survey', 0.1331),\n",
       "  ('hypothesis', 0.1152),\n",
       "  ('formation', 0.1114),\n",
       "  ('social', 0.1073),\n",
       "  ('age sex', 0.1039),\n",
       "  ('general', 0.0995),\n",
       "  ('group individuals', 0.0958),\n",
       "  ('animal', 0.0861),\n",
       "  ('findings support', 0.0626),\n",
       "  ('nation wide', 0.0313),\n",
       "  ('class', 0.0287),\n",
       "  ('showed', 0.0257),\n",
       "  ('wide', -0.0014),\n",
       "  ('individuals taken', -0.0124),\n",
       "  ('carried', -0.0193),\n",
       "  ('support', -0.0205)],\n",
       " 'MED-936': [('ascorbate urinary', 0.5465),\n",
       "  ('calcium stone', 0.507),\n",
       "  ('oxalate controversial', 0.501),\n",
       "  ('urinary ph', 0.4636),\n",
       "  ('affected vitamin', 0.4106),\n",
       "  ('creatinine determination', 0.3766),\n",
       "  ('oxalate 28', 0.34),\n",
       "  ('citrate', 0.3386),\n",
       "  ('supplementation increase', 0.2903),\n",
       "  ('excretion risk', 0.2855),\n",
       "  ('difference urinary', 0.285),\n",
       "  ('edta difference', 0.278),\n",
       "  ('patients 43', 0.2702),\n",
       "  ('65 vitamin', 0.2515),\n",
       "  ('ph did', 0.2329),\n",
       "  ('patients received', 0.2326),\n",
       "  ('crystallization index', 0.2286),\n",
       "  ('24 hour', 0.2273),\n",
       "  ('subjects 25', 0.2153),\n",
       "  ('21 mg', 0.2098),\n",
       "  ('sodium', 0.2085),\n",
       "  ('vs 34', 0.2016),\n",
       "  ('controversial', 0.1949),\n",
       "  ('acid', 0.1852),\n",
       "  ('background contribution', 0.173),\n",
       "  ('ancillary analyses', 0.169),\n",
       "  ('change vs', 0.1689),\n",
       "  ('mg suggesting', 0.1633),\n",
       "  ('study aimed', 0.1572),\n",
       "  ('control subjects', 0.1535),\n",
       "  ('23 vs', 0.1497),\n",
       "  ('13 mg', 0.1457),\n",
       "  ('16 vs', 0.1145),\n",
       "  ('significant', 0.114),\n",
       "  ('methods seven', 0.1042),\n",
       "  ('spot fasting', 0.0928),\n",
       "  ('39', 0.0847),\n",
       "  ('15 control', 0.0795),\n",
       "  ('sample obtained', 0.07),\n",
       "  ('55 healthy', 0.0685),\n",
       "  ('20 healthy', 0.0584),\n",
       "  ('days', 0.0555),\n",
       "  ('70 vs', 0.0529),\n",
       "  ('vitro conversion', 0.0524),\n",
       "  ('91 46', 0.052),\n",
       "  ('mean tiselius', 0.0495),\n",
       "  ('05', 0.0435),\n",
       "  ('adult', -0.0033),\n",
       "  ('vessels', -0.035),\n",
       "  ('31 12', -0.0495)],\n",
       " 'MED-943': [('needles extract', 0.492),\n",
       "  ('methanol extract', 0.405),\n",
       "  ('extract determined', 0.3847),\n",
       "  ('butanol embryotoxic', 0.3826),\n",
       "  ('embryotoxic effects', 0.3808),\n",
       "  ('extract hour', 0.3714),\n",
       "  ('autoclaving needles', 0.3688),\n",
       "  ('toxin mouse', 0.3568),\n",
       "  ('pine soluble', 0.3485),\n",
       "  ('hexanes', 0.3341),\n",
       "  ('needles ponderosa', 0.3339),\n",
       "  ('toxin', 0.3331),\n",
       "  ('hexanes butanol', 0.3287),\n",
       "  ('stable toxin', 0.3248),\n",
       "  ('pregnant mice', 0.321),\n",
       "  ('mice autoclaving', 0.3204),\n",
       "  ('chloroform', 0.3156),\n",
       "  ('feeding toxin', 0.3087),\n",
       "  ('ponderosa pine', 0.2783),\n",
       "  ('resorption pregnant', 0.2679),\n",
       "  ('enhanced embryoresorptive', 0.2676),\n",
       "  ('measuring embryo', 0.2666),\n",
       "  ('embryo resorptive', 0.2549),\n",
       "  ('ethanol', 0.2533),\n",
       "  ('effects fresh', 0.244),\n",
       "  ('green pine', 0.2279),\n",
       "  ('effects', 0.2265),\n",
       "  ('gms autoclaved', 0.1964),\n",
       "  ('adult mice', 0.1948),\n",
       "  ('resorptive dose', 0.186),\n",
       "  ('dose', 0.1696),\n",
       "  ('soluble', 0.1689),\n",
       "  ('heat', 0.1556),\n",
       "  ('feeding enhanced', 0.1491),\n",
       "  ('resulted significant', 0.1376),\n",
       "  ('hour prior', 0.1239),\n",
       "  ('fresh green', 0.1119),\n",
       "  ('enhanced', 0.1079),\n",
       "  ('32 respectively', 0.1078),\n",
       "  ('significant weight', 0.1019),\n",
       "  ('effect 28', 0.0936),\n",
       "  ('study revealed', 0.086),\n",
       "  ('measuring', 0.0821),\n",
       "  ('95', 0.0693),\n",
       "  ('adult', 0.0546),\n",
       "  ('stable', 0.0214),\n",
       "  ('loss', 0.0038),\n",
       "  ('46 gms', -0.0105),\n",
       "  ('present', -0.0194),\n",
       "  ('erd50', -0.0385)],\n",
       " 'MED-944': [('nanotechnologies cosmetic', 0.6214),\n",
       "  ('nanomaterials consequently', 0.5932),\n",
       "  ('assistance nanotechnologies', 0.5443),\n",
       "  ('nps food', 0.5346),\n",
       "  ('containing nano', 0.5184),\n",
       "  ('nps usually', 0.4842),\n",
       "  ('cosmetic pharmaceuticals', 0.4834),\n",
       "  ('pharmaceuticals sunscreen', 0.402),\n",
       "  ('end products', 0.3974),\n",
       "  ('improve product', 0.3537),\n",
       "  ('sized particles', 0.351),\n",
       "  ('risks engineered', 0.3482),\n",
       "  ('care products', 0.317),\n",
       "  ('exposure levels', 0.3067),\n",
       "  ('important industrial', 0.2975),\n",
       "  ('powdered food', 0.2958),\n",
       "  ('consumer protection', 0.2833),\n",
       "  ('products pose', 0.2732),\n",
       "  ('application characterizing', 0.2673),\n",
       "  ('metal oxide', 0.2609),\n",
       "  ('produce standardized', 0.2518),\n",
       "  ('analytical instruments', 0.2431),\n",
       "  ('reports recent', 0.2392),\n",
       "  ('food matrices', 0.2387),\n",
       "  ('complementary', 0.2234),\n",
       "  ('number different', 0.1991),\n",
       "  ('know hazards', 0.1979),\n",
       "  ('generally added', 0.1971),\n",
       "  ('levels information', 0.1969),\n",
       "  ('metrics possible', 0.1962),\n",
       "  ('benefits vs', 0.1866),\n",
       "  ('different competences', 0.1812),\n",
       "  ('life assistance', 0.1768),\n",
       "  ('low concentration', 0.1723),\n",
       "  ('information different', 0.1607),\n",
       "  ('connected exposure', 0.1541),\n",
       "  ('examples end', 0.1404),\n",
       "  ('everyday life', 0.1363),\n",
       "  ('focused', 0.1334),\n",
       "  ('containing', 0.13),\n",
       "  ('evaluate correctly', 0.1241),\n",
       "  ('sectors need', 0.1173),\n",
       "  ('distributions quantitative', 0.1167),\n",
       "  ('significant challenges', 0.1107),\n",
       "  ('complexes incompatible', 0.0993),\n",
       "  ('matrices dispersed', 0.0891),\n",
       "  ('personal', 0.0891),\n",
       "  ('clearly emerges', 0.0627),\n",
       "  ('transversal studies', 0.0608),\n",
       "  ('legislate favor', 0.0555)],\n",
       " 'MED-945': [('health benefits', 0.4679),\n",
       "  ('tea isoflavone', 0.4122),\n",
       "  ('supplements optimised', 0.3952),\n",
       "  ('medicinal effects', 0.376),\n",
       "  ('supplements pfs', 0.3475),\n",
       "  ('metabolic syndrome', 0.3472),\n",
       "  ('rcts approaching', 0.3115),\n",
       "  ('commonly consumed', 0.3079),\n",
       "  ('conducting studies', 0.2945),\n",
       "  ('assess evidence', 0.2938),\n",
       "  ('measured bioavailability', 0.2899),\n",
       "  ('efficacy evaluation', 0.2872),\n",
       "  ('insufficient rcts', 0.2819),\n",
       "  ('consumed plant', 0.2794),\n",
       "  ('oral consumption', 0.2609),\n",
       "  ('published systematic', 0.2604),\n",
       "  ('green', 0.2417),\n",
       "  ('widely used', 0.2398),\n",
       "  ('estrogen related', 0.2319),\n",
       "  ('adopted approach', 0.2303),\n",
       "  ('digestive pathologies', 0.2222),\n",
       "  ('pfs europe', 0.2218),\n",
       "  ('food safety', 0.2201),\n",
       "  ('possible toxic', 0.2049),\n",
       "  ('topical applications', 0.1956),\n",
       "  ('conclusions drawn', 0.1939),\n",
       "  ('results', 0.1794),\n",
       "  ('based traditional', 0.1639),\n",
       "  ('populations using', 0.1595),\n",
       "  ('coadjuvant therapy', 0.1566),\n",
       "  ('lower doses', 0.1413),\n",
       "  ('larger', 0.1301),\n",
       "  ('caution', 0.1293),\n",
       "  ('obtained future', 0.1292),\n",
       "  ('2007 efficacy', 0.1291),\n",
       "  ('constitutes', 0.1258),\n",
       "  ('aloe vera', 0.1212),\n",
       "  ('general', 0.1191),\n",
       "  ('claims conclusive', 0.1099),\n",
       "  ('naturally occurring', 0.1015),\n",
       "  ('women undergoing', 0.0921),\n",
       "  ('applications presupposes', 0.0892),\n",
       "  ('bone resorption', 0.0875),\n",
       "  ('indicate affect', 0.061),\n",
       "  ('translated attenuation', 0.0604),\n",
       "  ('flashes', 0.0549),\n",
       "  ('remains', 0.0475),\n",
       "  ('scarce constitutes', 0.0445),\n",
       "  ('despite popularity', 0.0149),\n",
       "  ('highly variable', -0.0275)],\n",
       " 'MED-946': [('pharmacotherapy ibs', 0.7324),\n",
       "  ('chronic gastrointestinal', 0.4372),\n",
       "  ('symptom control', 0.4032),\n",
       "  ('evidence antispasmodics', 0.4025),\n",
       "  ('disorder role', 0.401),\n",
       "  ('treatment irritable', 0.3806),\n",
       "  ('pain studies', 0.3498),\n",
       "  ('studies excluded', 0.3463),\n",
       "  ('analyses ssris', 0.3442),\n",
       "  ('evaluate efficacy', 0.3343),\n",
       "  ('antidepressants placebo', 0.3013),\n",
       "  ('update review', 0.2885),\n",
       "  ('medline embase', 0.2724),\n",
       "  ('research use', 0.2702),\n",
       "  ('bowel', 0.2525),\n",
       "  ('32 symptom', 0.2423),\n",
       "  ('15 antidepressants', 0.2349),\n",
       "  ('agents spasmolytic', 0.2225),\n",
       "  ('improvement abdominal', 0.2076),\n",
       "  ('159 patients', 0.1992),\n",
       "  ('focused mainly', 0.1965),\n",
       "  ('releasing inhibitors', 0.1964),\n",
       "  ('bias unclear', 0.1953),\n",
       "  ('efficacy bulking', 0.1902),\n",
       "  ('studies 565', 0.1891),\n",
       "  ('randomization allocation', 0.1879),\n",
       "  ('basis language', 0.1872),\n",
       "  ('insoluble soluble', 0.1747),\n",
       "  ('independently extracted', 0.1708),\n",
       "  ('low items', 0.148),\n",
       "  ('serotonin releasing', 0.1409),\n",
       "  ('dicyclomine peppermint', 0.1406),\n",
       "  ('placebo 13', 0.1332),\n",
       "  ('10 studies', 0.1316),\n",
       "  ('individual patient', 0.1306),\n",
       "  ('sub group', 0.129),\n",
       "  ('ci 05', 0.1252),\n",
       "  ('cinahl psychinfo', 0.1151),\n",
       "  ('benefits cimteropium', 0.1096),\n",
       "  ('computer', 0.0986),\n",
       "  ('global', 0.0851),\n",
       "  ('34 40', 0.0769),\n",
       "  ('mean differences', 0.0704),\n",
       "  ('compared 22', 0.0398),\n",
       "  ('patients smd', 0.0388),\n",
       "  ('rr 49', 0.0155),\n",
       "  ('186', 0.0129),\n",
       "  ('2333 patients', 0.0074),\n",
       "  ('trimebutine', -0.0168),\n",
       "  ('pinaverium', -0.0191)],\n",
       " 'MED-947': [('burn wounds', 0.506),\n",
       "  ('wounds compare', 0.4889),\n",
       "  ('burns significantly', 0.4673),\n",
       "  ('degree burns', 0.4268),\n",
       "  ('treated topical', 0.3851),\n",
       "  ('vera cream', 0.3527),\n",
       "  ('treating', 0.3298),\n",
       "  ('sites treated', 0.3266),\n",
       "  ('healing partial', 0.3147),\n",
       "  ('aloe cream', 0.3014),\n",
       "  ('aloe vera', 0.3013),\n",
       "  ('evaluate efficacy', 0.2915),\n",
       "  ('ssd cream', 0.2821),\n",
       "  ('conducted clinical', 0.2754),\n",
       "  ('injury associated', 0.25),\n",
       "  ('sulfadiazine ssd', 0.2464),\n",
       "  ('cream randomly', 0.2417),\n",
       "  ('management remains', 0.2391),\n",
       "  ('patients similar', 0.2306),\n",
       "  ('included study', 0.2293),\n",
       "  ('methods', 0.2289),\n",
       "  ('healed 16', 0.2124),\n",
       "  ('rate epithelialization', 0.203),\n",
       "  ('compare results', 0.2024),\n",
       "  ('death disability', 0.2019),\n",
       "  ('thirty patients', 0.1868),\n",
       "  ('ssd conclusion', 0.1798),\n",
       "  ('types second', 0.1676),\n",
       "  ('high incidence', 0.1655),\n",
       "  ('65 days', 0.1616),\n",
       "  ('remains problematic', 0.1432),\n",
       "  ('results silver', 0.1343),\n",
       "  ('patient', 0.1274),\n",
       "  ('costly conducted', 0.1247),\n",
       "  ('sites different', 0.1217),\n",
       "  ('vs', 0.1098),\n",
       "  ('results clearly', 0.108),\n",
       "  ('different parts', 0.1071),\n",
       "  ('partial thickness', 0.106),\n",
       "  ('days respectively', 0.0999),\n",
       "  ('management', 0.0914),\n",
       "  ('15 vs', 0.0907),\n",
       "  ('degree', 0.0751),\n",
       "  ('body included', 0.0682),\n",
       "  ('randomly results', 0.0621),\n",
       "  ('completely', 0.0419),\n",
       "  ('demonstrated greater', 0.0308),\n",
       "  ('respectively 0001', 0.0233),\n",
       "  ('19 days', -0.0679),\n",
       "  ('18 73', -0.0882)],\n",
       " 'MED-948': [('vegetable seeds', 0.4949),\n",
       "  ('sprouts seeds', 0.4858),\n",
       "  ('seeds purchased', 0.4751),\n",
       "  ('sprouted vegetable', 0.469),\n",
       "  ('sakazakii seeds', 0.4634),\n",
       "  ('outbreaks salmonella', 0.4633),\n",
       "  ('quality sprouts', 0.3792),\n",
       "  ('shops seoul', 0.364),\n",
       "  ('sources outbreaks', 0.3637),\n",
       "  ('korea ninety', 0.3484),\n",
       "  ('samples contained', 0.3393),\n",
       "  ('radish', 0.3296),\n",
       "  ('used food', 0.3216),\n",
       "  ('implicated sources', 0.295),\n",
       "  ('stores analyzed', 0.2946),\n",
       "  ('infections profiled', 0.2911),\n",
       "  ('seeds 13', 0.2858),\n",
       "  ('cfu populations', 0.2856),\n",
       "  ('molds yeasts', 0.2714),\n",
       "  ('microbiological quality', 0.2671),\n",
       "  ('sakazakii significantly', 0.2434),\n",
       "  ('enterobacter', 0.2415),\n",
       "  ('96 samples', 0.2365),\n",
       "  ('turnip seeds', 0.1968),\n",
       "  ('supermarkets traditional', 0.1857),\n",
       "  ('korea', 0.1739),\n",
       "  ('purchased online', 0.1683),\n",
       "  ('markets', 0.1641),\n",
       "  ('cfu 36', 0.1508),\n",
       "  ('populations', 0.1423),\n",
       "  ('coli o157', 0.1335),\n",
       "  ('number total', 0.1313),\n",
       "  ('pathogenic', 0.1209),\n",
       "  ('significantly higher', 0.1066),\n",
       "  ('contained', 0.1063),\n",
       "  ('tested', 0.1061),\n",
       "  ('13 mixed', 0.1055),\n",
       "  ('bacteria tab', 0.1004),\n",
       "  ('69', 0.0815),\n",
       "  ('97 50', 0.0781),\n",
       "  ('tab molds', 0.0731),\n",
       "  ('h7 detected', 0.0698),\n",
       "  ('aerobic', 0.0449),\n",
       "  ('potentially', 0.0374),\n",
       "  ('significantly affected', 0.0368),\n",
       "  ('08', 0.0288),\n",
       "  ('tab 52', -0.0001),\n",
       "  ('department', -0.0023),\n",
       "  ('84', -0.0623),\n",
       "  ('alfalfa turnip', -0.1104)],\n",
       " 'MED-949': [('constipation study', 0.5416),\n",
       "  ('investigate efficacy', 0.4812),\n",
       "  ('herbal tea', 0.459),\n",
       "  ('effectiveness herbal', 0.453),\n",
       "  ('trial setting', 0.3768),\n",
       "  ('treatment chronic', 0.3616),\n",
       "  ('total medication', 0.356),\n",
       "  ('interventions participants', 0.3262),\n",
       "  ('intention treat', 0.3253),\n",
       "  ('study period', 0.3161),\n",
       "  ('bowel movements', 0.3017),\n",
       "  ('residents chronic', 0.2719),\n",
       "  ('day study', 0.2665),\n",
       "  ('doses dispensed', 0.2656),\n",
       "  ('standard treatment', 0.2557),\n",
       "  ('objective', 0.2477),\n",
       "  ('treat', 0.2466),\n",
       "  ('blind placebo', 0.2407),\n",
       "  ('setting 483', 0.2379),\n",
       "  ('regimen', 0.2371),\n",
       "  ('nursing', 0.2346),\n",
       "  ('home residents', 0.2323),\n",
       "  ('group clinical', 0.2296),\n",
       "  ('costs results', 0.2014),\n",
       "  ('design double', 0.1823),\n",
       "  ('included difference', 0.1749),\n",
       "  ('14 bowel', 0.1688),\n",
       "  ('county government', 0.1574),\n",
       "  ('analysis statistically', 0.1559),\n",
       "  ('period 28', 0.1467),\n",
       "  ('measurements primary', 0.1448),\n",
       "  ('assigned receive', 0.1241),\n",
       "  ('conclusion smooth', 0.1231),\n",
       "  ('home allentown', 0.1146),\n",
       "  ('operated', 0.1134),\n",
       "  ('period versus', 0.1054),\n",
       "  ('pennsylvania operated', 0.1023),\n",
       "  ('government participants', 0.1011),\n",
       "  ('increase number', 0.086),\n",
       "  ('itt', 0.0854),\n",
       "  ('movements secondary', 0.0821),\n",
       "  ('group 42', 0.0805),\n",
       "  ('lehigh', 0.0801),\n",
       "  ('pre', 0.0768),\n",
       "  ('parallel group', 0.0721),\n",
       "  ('86 randomly', 0.062),\n",
       "  ('44 experienced', 0.0305),\n",
       "  ('controlled armed', 0.0196),\n",
       "  ('experienced average', 0.0151),\n",
       "  ('period 017', -0.0236)],\n",
       " 'MED-950': [('studies multivitamin', 0.5979),\n",
       "  ('inconsistent epidemiologic', 0.484),\n",
       "  ('meta analysis', 0.4677),\n",
       "  ('epidemiologic studies', 0.439),\n",
       "  ('quality studies', 0.4049),\n",
       "  ('cohort studies', 0.3533),\n",
       "  ('cancer inconsistent', 0.3483),\n",
       "  ('literature systematically', 0.341),\n",
       "  ('risk breast', 0.3011),\n",
       "  ('studies indicated', 0.2934),\n",
       "  ('cochrane collaboration', 0.2811),\n",
       "  ('analyses duration', 0.2719),\n",
       "  ('studies randomized', 0.2581),\n",
       "  ('risk estimates', 0.2516),\n",
       "  ('model bias', 0.2503),\n",
       "  ('embase', 0.2275),\n",
       "  ('week analyses', 0.2272),\n",
       "  ('examine relationship', 0.2029),\n",
       "  ('overall multivariable', 0.1994),\n",
       "  ('association consumption', 0.1652),\n",
       "  ('odds ratio', 0.1614),\n",
       "  ('assessed revman', 0.1573),\n",
       "  ('trials ranged', 0.1525),\n",
       "  ('significantly associated', 0.1431),\n",
       "  ('decreased risk', 0.1419),\n",
       "  ('longer years', 0.1405),\n",
       "  ('significant conclusions', 0.1358),\n",
       "  ('27 studies', 0.1268),\n",
       "  ('studies case', 0.1254),\n",
       "  ('issue', 0.124),\n",
       "  ('background', 0.1178),\n",
       "  ('1950', 0.1073),\n",
       "  ('included 355', 0.1039),\n",
       "  ('2010 issue', 0.1038),\n",
       "  ('statistical software', 0.0985),\n",
       "  ('collaboration results', 0.096),\n",
       "  ('frequency current', 0.0804),\n",
       "  ('60 63', 0.0739),\n",
       "  ('080 subjects', 0.0726),\n",
       "  ('highlight need', 0.0671),\n",
       "  ('version', 0.0642),\n",
       "  ('00 95', 0.0624),\n",
       "  ('grade method', 0.0483),\n",
       "  ('library', 0.0423),\n",
       "  ('1980 july', 0.0374),\n",
       "  ('use significantly', 0.0326),\n",
       "  ('random', 0.0187),\n",
       "  ('swedish', 0.0077),\n",
       "  ('register controlled', 0.0001),\n",
       "  ('perform', -0.0804)],\n",
       " 'MED-951': [('vitamins prevention', 0.6213),\n",
       "  ('included review', 0.5577),\n",
       "  ('searched references', 0.4989),\n",
       "  ('studies combined', 0.4771),\n",
       "  ('cochrane', 0.4708),\n",
       "  ('supplementation affected', 0.4539),\n",
       "  ('conducted systematic', 0.4438),\n",
       "  ('results studies', 0.4425),\n",
       "  ('meta analysis', 0.4314),\n",
       "  ('studies showed', 0.3824),\n",
       "  ('evidence use', 0.3773),\n",
       "  ('assessed effect', 0.3572),\n",
       "  ('sensitivity analyses', 0.3533),\n",
       "  ('multivitamins', 0.3426),\n",
       "  ('cancer methods', 0.3355),\n",
       "  ('references', 0.3201),\n",
       "  ('use supplemental', 0.3103),\n",
       "  ('individually studies', 0.3039),\n",
       "  ('associations conclusions', 0.2951),\n",
       "  ('benefits use', 0.2894),\n",
       "  ('control studies', 0.2776),\n",
       "  ('use various', 0.2649),\n",
       "  ('trials', 0.2577),\n",
       "  ('pubmed embase', 0.2563),\n",
       "  ('database', 0.2387),\n",
       "  ('purposes mainly', 0.2354),\n",
       "  ('just rcts', 0.2345),\n",
       "  ('searched hand', 0.2316),\n",
       "  ('analyses running', 0.1976),\n",
       "  ('minerals incidence', 0.1947),\n",
       "  ('running meta', 0.1921),\n",
       "  ('subgroups benefit', 0.1627),\n",
       "  ('smokers use', 0.1535),\n",
       "  ('topic', 0.1504),\n",
       "  ('disease severity', 0.1429),\n",
       "  ('mainly alleged', 0.1375),\n",
       "  ('assessment individually', 0.1285),\n",
       "  ('benefit harmed', 0.1269),\n",
       "  ('cohort', 0.1256),\n",
       "  ('overall', 0.1249),\n",
       "  ('possible unidentified', 0.1246),\n",
       "  ('key', 0.1243),\n",
       "  ('higher quality', 0.1239),\n",
       "  ('showed relationship', 0.1165),\n",
       "  ('affects', 0.1122),\n",
       "  ('metastatic prostate', 0.1107),\n",
       "  ('results fourteen', 0.1075),\n",
       "  ('ingestion', 0.0913),\n",
       "  ('men', 0.0514),\n",
       "  ('high heterogeneity', 0.0147)],\n",
       " 'MED-953': [('consuming fvpd', 0.5541),\n",
       "  ('flavonoids carotenoids', 0.5125),\n",
       "  ('fvpd vasodilation', 0.5049),\n",
       "  ('dietary fibres', 0.4586),\n",
       "  ('vasodilation antioxidant', 0.4342),\n",
       "  ('vegetables protective', 0.4),\n",
       "  ('cvd puréed', 0.3985),\n",
       "  ('beneficial components', 0.3979),\n",
       "  ('diets rich', 0.3905),\n",
       "  ('vitamin 002', 0.3892),\n",
       "  ('rich fruits', 0.3724),\n",
       "  ('contribute cvd', 0.3574),\n",
       "  ('bioavailability', 0.3476),\n",
       "  ('physiological effects', 0.3339),\n",
       "  ('urinary phenolic', 0.33),\n",
       "  ('consumption significantly', 0.33),\n",
       "  ('based drink', 0.3255),\n",
       "  ('peaks ingestion', 0.3082),\n",
       "  ('status phytochemical', 0.2923),\n",
       "  ('metabolites 05', 0.2916),\n",
       "  ('iontophoresis fvpd', 0.2642),\n",
       "  ('flavoured', 0.2571),\n",
       "  ('diet blood', 0.2502),\n",
       "  ('risk factors', 0.2455),\n",
       "  ('061 overall', 0.2424),\n",
       "  ('products retain', 0.2312),\n",
       "  ('day vascular', 0.2192),\n",
       "  ('treatment effect', 0.2141),\n",
       "  ('019 003', 0.2119),\n",
       "  ('epidemiological studies', 0.2113),\n",
       "  ('vivo ldl', 0.21),\n",
       "  ('increasing micronutrient', 0.2033),\n",
       "  ('concentrations trend', 0.202),\n",
       "  ('sugar matched', 0.2006),\n",
       "  ('useful vehicles', 0.1812),\n",
       "  ('laser doppler', 0.1807),\n",
       "  ('study subjects', 0.1658),\n",
       "  ('oxidation', 0.1638),\n",
       "  ('90 min', 0.1513),\n",
       "  ('total nitrate', 0.1496),\n",
       "  ('70', 0.1079),\n",
       "  ('significantly lower', 0.1034),\n",
       "  ('aged 30', 0.1028),\n",
       "  ('400 ml', 0.0989),\n",
       "  ('years completed', 0.0965),\n",
       "  ('capacity', 0.0953),\n",
       "  ('reactivity assessed', 0.0577),\n",
       "  ('controlled crossover', 0.0576),\n",
       "  ('longer', 0.0549),\n",
       "  ('single blind', 0.0429)],\n",
       " 'MED-954': [('maternal phthalate', 0.6435),\n",
       "  ('hormones phthalate', 0.5426),\n",
       "  ('maternal urinary', 0.4746),\n",
       "  ('pregnant', 0.4745),\n",
       "  ('correlated maternal', 0.4455),\n",
       "  ('newborns general', 0.3829),\n",
       "  ('affect reproductive', 0.3516),\n",
       "  ('status fetal', 0.339),\n",
       "  ('exposure', 0.3243),\n",
       "  ('infant pair', 0.3135),\n",
       "  ('urinary levels', 0.3088),\n",
       "  ('metabolites female', 0.3056),\n",
       "  ('evaluate association', 0.2922),\n",
       "  ('steroid hormones', 0.2858),\n",
       "  ('investigation aim', 0.2729),\n",
       "  ('development human', 0.2655),\n",
       "  ('women', 0.2542),\n",
       "  ('pearson correlation', 0.2527),\n",
       "  ('mehp negatively', 0.2143),\n",
       "  ('pair recruited', 0.2066),\n",
       "  ('speculated', 0.2024),\n",
       "  ('analyzed levels', 0.1905),\n",
       "  ('serum suggest', 0.1898),\n",
       "  ('metabolites male', 0.1721),\n",
       "  ('marginally significantly', 0.1718),\n",
       "  ('recruited analyzed', 0.1704),\n",
       "  ('age adjusted', 0.1669),\n",
       "  ('level dehp', 0.1489),\n",
       "  ('levels mono', 0.1429),\n",
       "  ('mechanism awaits', 0.1415),\n",
       "  ('population total', 0.1261),\n",
       "  ('cord sex', 0.123),\n",
       "  ('total 155', 0.1212),\n",
       "  ('adjusting', 0.1209),\n",
       "  ('radioimmunoassay', 0.0972),\n",
       "  ('negatively correlated', 0.0963),\n",
       "  ('5oh', 0.0921),\n",
       "  ('ethyl', 0.0838),\n",
       "  ('significant', 0.0831),\n",
       "  ('stage', 0.079),\n",
       "  ('ranging 24', 0.0763),\n",
       "  ('chromatography electrospray', 0.0536),\n",
       "  ('mmp', 0.0377),\n",
       "  ('lc', 0.0329),\n",
       "  ('hydroxyhexyl', 0.0302),\n",
       "  ('2011 elsevier', 0.0151),\n",
       "  ('tandem', 0.0137),\n",
       "  ('29 05', -0.0123),\n",
       "  ('free', -0.0174),\n",
       "  ('rights reserved', -0.032)],\n",
       " 'MED-955': [('phthalate esters', 0.545),\n",
       "  ('contaminants indoor', 0.5),\n",
       "  ('phthalates general', 0.4656),\n",
       "  ('volatilization leaching', 0.4631),\n",
       "  ('indoor dust', 0.4361),\n",
       "  ('ubiquitous contaminants', 0.4276),\n",
       "  ('concentrations contributions', 0.4034),\n",
       "  ('hexyl phthalate', 0.3917),\n",
       "  ('esters varied', 0.391),\n",
       "  ('exposures varied', 0.3491),\n",
       "  ('exposure dehp', 0.3356),\n",
       "  ('dibp dust', 0.3314),\n",
       "  ('source exposure', 0.3101),\n",
       "  ('concentrations diethyl', 0.2648),\n",
       "  ('collected cities', 0.2612),\n",
       "  ('ethylhexyl', 0.2357),\n",
       "  ('cities china', 0.2322),\n",
       "  ('environment study', 0.2265),\n",
       "  ('profiles', 0.2205),\n",
       "  ('dicyclohexyl', 0.2163),\n",
       "  ('inhalation dermal', 0.2141),\n",
       "  ('daily intake', 0.2053),\n",
       "  ('china 75', 0.2012),\n",
       "  ('analyzed samples', 0.1981),\n",
       "  ('extrapolated urinary', 0.186),\n",
       "  ('metabolite', 0.1695),\n",
       "  ('source dep', 0.1684),\n",
       "  ('benzyl', 0.1516),\n",
       "  ('10 times', 0.1508),\n",
       "  ('elucidate sources', 0.1308),\n",
       "  ('ubiquitous', 0.129),\n",
       "  ('results indicated', 0.1152),\n",
       "  ('cities contrast', 0.0993),\n",
       "  ('di iso', 0.0942),\n",
       "  ('personal care', 0.0905),\n",
       "  ('33 results', 0.0674),\n",
       "  ('general population', 0.0598),\n",
       "  ('total dis', 0.054),\n",
       "  ('application consumer', 0.0365),\n",
       "  ('comparison analyzed', 0.0283),\n",
       "  ('times', 0.0255),\n",
       "  ('new', 0.0234),\n",
       "  ('higher', 0.0185),\n",
       "  ('significantly countries', 0.0136),\n",
       "  ('lower', 0.0115),\n",
       "  ('collected albany', 0.007),\n",
       "  ('depending type', -0.0018),\n",
       "  ('bis', -0.0085),\n",
       "  ('58 estimated', -0.0141),\n",
       "  ('usa respectively', -0.0282)],\n",
       " 'MED-956': [('emerging pollutants', 0.636),\n",
       "  ('compounds wastewater', 0.4743),\n",
       "  ('environmental protection', 0.423),\n",
       "  ('chemicals regulatory', 0.3959),\n",
       "  ('data phthalates', 0.3619),\n",
       "  ('defines emerging', 0.333),\n",
       "  ('performance sewage', 0.3314),\n",
       "  ('influent ranged', 0.3302),\n",
       "  ('epa united', 0.3274),\n",
       "  ('studied compounds', 0.3254),\n",
       "  ('wwtps determine', 0.3048),\n",
       "  ('20 years', 0.2755),\n",
       "  ('liter concentrations', 0.2752),\n",
       "  ('71 bisphenol', 0.27),\n",
       "  ('data emerging', 0.2699),\n",
       "  ('disinfectants', 0.2679),\n",
       "  ('poorly understood', 0.2531),\n",
       "  ('aquatic', 0.2504),\n",
       "  ('articles report', 0.244),\n",
       "  ('objective work', 0.2421),\n",
       "  ('impact', 0.2329),\n",
       "  ('pharmaceuticals including', 0.2272),\n",
       "  ('new', 0.2259),\n",
       "  ('environments', 0.1917),\n",
       "  ('varied 007', 0.1844),\n",
       "  ('agency defines', 0.1816),\n",
       "  ('ofloxacin', 0.1571),\n",
       "  ('inflammatories beta', 0.1453),\n",
       "  ('used quantified', 0.1433),\n",
       "  ('dehp widely', 0.1407),\n",
       "  ('deserve research', 0.1374),\n",
       "  ('human health', 0.1246),\n",
       "  ('40 removal', 0.1074),\n",
       "  ('highest molecules', 0.0917),\n",
       "  ('psychostimulant caffeine', 0.0906),\n",
       "  ('products deserve', 0.0904),\n",
       "  ('copyright 2011', 0.0862),\n",
       "  ('resistant treatment', 0.0853),\n",
       "  ('816 μg', 0.0822),\n",
       "  ('contrast media', 0.0751),\n",
       "  ('codeine', 0.0654),\n",
       "  ('elsevier gmbh', 0.0618),\n",
       "  ('plants', 0.0563),\n",
       "  ('63 μg', 0.0369),\n",
       "  ('did exceed', 0.0352),\n",
       "  ('anti', 0.0291),\n",
       "  ('90 studied', 0.019),\n",
       "  ('30', 0.0128),\n",
       "  ('rights reserved', 0.0048),\n",
       "  ('means 56', -0.1187)],\n",
       " 'MED-957': [('cosmetics ingredients', 0.6391),\n",
       "  ('phytocompounds capsicum', 0.5314),\n",
       "  ('conditioning agents', 0.4342),\n",
       "  ('fruit extract', 0.3511),\n",
       "  ('extract red', 0.339),\n",
       "  ('concentrations ranging', 0.3141),\n",
       "  ('promoters irritating', 0.302),\n",
       "  ('chloroform', 0.2781),\n",
       "  ('uv absorption', 0.2753),\n",
       "  ('allergic contact', 0.2568),\n",
       "  ('peppers', 0.2531),\n",
       "  ('aflatoxin content', 0.2481),\n",
       "  ('5y cells', 0.242),\n",
       "  ('used 19', 0.2394),\n",
       "  ('extract 60', 0.2294),\n",
       "  ('synoviocytes', 0.215),\n",
       "  ('pig skin', 0.2148),\n",
       "  ('prostaglandin biosynthesis', 0.2117),\n",
       "  ('solanacearum bacillus', 0.208),\n",
       "  ('pain sensation', 0.201),\n",
       "  ('protein', 0.1974),\n",
       "  ('studies suggested', 0.1938),\n",
       "  ('miscellaneous external', 0.1918),\n",
       "  ('administration use', 0.1846),\n",
       "  ('gave similar', 0.1833),\n",
       "  ('cord peripheral', 0.1801),\n",
       "  ('activator vanilloid', 0.1795),\n",
       "  ('fibers decrease', 0.1772),\n",
       "  ('counterirritant ingested', 0.1746),\n",
       "  ('fetuses', 0.166),\n",
       "  ('content significantly', 0.1645),\n",
       "  ('approximately 275', 0.1586),\n",
       "  ('oleoresin', 0.1571),\n",
       "  ('hepatocytes aggregation', 0.152),\n",
       "  ('cough sneezing', 0.15),\n",
       "  ('naproxen nonsteroidal', 0.1411),\n",
       "  ('seminal vesicles', 0.1335),\n",
       "  ('mutagenic salmonella', 0.1258),\n",
       "  ('rarely cyanosis', 0.1234),\n",
       "  ('methyl acetoxymethyl', 0.123),\n",
       "  ('potent tumor', 0.1222),\n",
       "  ('paprika generally', 0.1188),\n",
       "  ('groups fed', 0.1154),\n",
       "  ('103 subjects', 0.1126),\n",
       "  ('factory workers', 0.1008),\n",
       "  ('considered safe', 0.0981),\n",
       "  ('injections hindpaw', 0.0792),\n",
       "  ('month extension', 0.0634),\n",
       "  ('female', 0.0406),\n",
       "  ('mouse rabbit', -0.0002)],\n",
       " 'MED-958': [('breast cancer', 0.5935),\n",
       "  ('cancer women', 0.5491),\n",
       "  ('cancer including', 0.5197),\n",
       "  ('breast exams', 0.4772),\n",
       "  ('thermography introduced', 0.455),\n",
       "  ('mammograms ultrasound', 0.4422),\n",
       "  ('ultrasound thermography', 0.4132),\n",
       "  ('discusses screening', 0.3582),\n",
       "  ('cancer remains', 0.3495),\n",
       "  ('advances treatment', 0.3469),\n",
       "  ('frequently diagnosed', 0.3096),\n",
       "  ('thermography lag', 0.3068),\n",
       "  ('boost sensitivity', 0.2962),\n",
       "  ('diagnostic approach', 0.2938),\n",
       "  ('early detection', 0.2893),\n",
       "  ('women north', 0.2744),\n",
       "  ('tools medical', 0.2733),\n",
       "  ('treatment reduced', 0.2416),\n",
       "  ('lag screening', 0.2316),\n",
       "  ('sensitivity specificity', 0.2253),\n",
       "  ('invasive', 0.2251),\n",
       "  ('despite advances', 0.2096),\n",
       "  ('including clinical', 0.2077),\n",
       "  ('technology provide', 0.2047),\n",
       "  ('approach review', 0.1905),\n",
       "  ('leading cause', 0.1783),\n",
       "  ('lost diagnostic', 0.1719),\n",
       "  ('reduced mortality', 0.1681),\n",
       "  ('research required', 0.1643),\n",
       "  ('provide effective', 0.1619),\n",
       "  ('used screen', 0.1577),\n",
       "  ('1956 initially', 0.1538),\n",
       "  ('risk adjunctive', 0.1478),\n",
       "  ('1977 study', 0.1187),\n",
       "  ('light technological', 0.1153),\n",
       "  ('focus brought', 0.1141),\n",
       "  ('induced death', 0.0941),\n",
       "  ('confirm', 0.0889),\n",
       "  ('single tool', 0.0836),\n",
       "  ('industry additional', 0.0727),\n",
       "  ('combination', 0.0652),\n",
       "  ('effective non', 0.0608),\n",
       "  ('excellent predictability', 0.0339),\n",
       "  ('remains second', 0.0304),\n",
       "  ('advances maturation', 0.0297),\n",
       "  ('low', 0.0165),\n",
       "  ('incorporates', 0.0137),\n",
       "  ('initially accepted', 0.0019),\n",
       "  ('brought', -0.0092),\n",
       "  ('america', -0.0408)],\n",
       " 'MED-959': [('low cobalamin', 0.5971),\n",
       "  ('patients cobalamin', 0.5192),\n",
       "  ('patients low', 0.4202),\n",
       "  ('causes low', 0.3748),\n",
       "  ('364 patients', 0.3576),\n",
       "  ('hematologic abnormality', 0.3291),\n",
       "  ('hemoglobin values', 0.3248),\n",
       "  ('disturbances patients', 0.32),\n",
       "  ('analogue levels', 0.2973),\n",
       "  ('women 76', 0.2966),\n",
       "  ('levels assay', 0.2905),\n",
       "  ('binder 364', 0.2839),\n",
       "  ('yielded similar', 0.28),\n",
       "  ('abnormality compared', 0.2792),\n",
       "  ('differences patients', 0.2764),\n",
       "  ('marrow patients', 0.2603),\n",
       "  ('inverse relationship', 0.2525),\n",
       "  ('deficiency display', 0.2521),\n",
       "  ('radioassays', 0.2509),\n",
       "  ('anemia yielded', 0.2479),\n",
       "  ('serum', 0.2418),\n",
       "  ('estimated', 0.2286),\n",
       "  ('limited 47', 0.228),\n",
       "  ('assay binder', 0.2155),\n",
       "  ('failed register', 0.2099),\n",
       "  ('12 abnormalities', 0.2054),\n",
       "  ('discrepancy', 0.2042),\n",
       "  ('levels did', 0.2028),\n",
       "  ('correlated', 0.1998),\n",
       "  ('findings', 0.1998),\n",
       "  ('analysis limited', 0.1946),\n",
       "  ('binder failed', 0.1928),\n",
       "  ('suggest disproportionate', 0.1924),\n",
       "  ('neurologic disturbances', 0.1924),\n",
       "  ('values significantly', 0.1554),\n",
       "  ('level severity', 0.1382),\n",
       "  ('47 patients', 0.1367),\n",
       "  ('spinal cord', 0.1304),\n",
       "  ('megaloblastosis analysis', 0.1263),\n",
       "  ('changes bone', 0.1199),\n",
       "  ('pregnant', 0.1179),\n",
       "  ('patients pernicious', 0.1145),\n",
       "  ('combination symptoms', 0.113),\n",
       "  ('various causes', 0.1092),\n",
       "  ('pure intrinsic', 0.1024),\n",
       "  ('cerebral combination', 0.0894),\n",
       "  ('20 patients', 0.0843),\n",
       "  ('compared 19', 0.0595),\n",
       "  ('levels 33', 0.02),\n",
       "  ('10', 0.0189)],\n",
       " 'MED-960': [('cbl tests', 0.5952),\n",
       "  ('serum cbl', 0.5342),\n",
       "  ('cbl reference', 0.4812),\n",
       "  ('serum cobalamin', 0.4704),\n",
       "  ('studies included', 0.4618),\n",
       "  ('tests patient', 0.4562),\n",
       "  ('cbl supplementation', 0.4536),\n",
       "  ('assess evidence', 0.4197),\n",
       "  ('medical databases', 0.4168),\n",
       "  ('compared serum', 0.4129),\n",
       "  ('routinely ordered', 0.3942),\n",
       "  ('diagnosis conditions', 0.3927),\n",
       "  ('supplementation study', 0.3863),\n",
       "  ('employing clinical', 0.3601),\n",
       "  ('indication test', 0.3562),\n",
       "  ('quality assessed', 0.353),\n",
       "  ('seven medical', 0.3487),\n",
       "  ('estimates test', 0.3417),\n",
       "  ('aimed systematically', 0.3271),\n",
       "  ('subgroups methods', 0.3124),\n",
       "  ('conclusion review', 0.301),\n",
       "  ('searched 1990', 0.2855),\n",
       "  ('reference standard', 0.2652),\n",
       "  ('level considered', 0.257),\n",
       "  ('2878', 0.2561),\n",
       "  ('vitamin 12', 0.243),\n",
       "  ('criteria positive', 0.2425),\n",
       "  ('89 test', 0.2344),\n",
       "  ('nlr 72', 0.2316),\n",
       "  ('considered reliable', 0.1939),\n",
       "  ('bivariate model', 0.1612),\n",
       "  ('method age', 0.1595),\n",
       "  ('conditions amenable', 0.1543),\n",
       "  ('characteristic curves', 0.154),\n",
       "  ('employing methylmalonic', 0.1503),\n",
       "  ('34 13', 0.15),\n",
       "  ('hsroc', 0.1247),\n",
       "  ('acid referent', 0.1237),\n",
       "  ('54 included', 0.1226),\n",
       "  ('limited', 0.1195),\n",
       "  ('ci', 0.1074),\n",
       "  ('95', 0.1072),\n",
       "  ('performance did', 0.09),\n",
       "  ('employed', 0.0881),\n",
       "  ('2009', 0.0869),\n",
       "  ('vary', 0.0747),\n",
       "  ('gold', 0.0472),\n",
       "  ('summary receiver', 0.0397),\n",
       "  ('poorly quadas', 0.0157),\n",
       "  ('plr negative', -0.0612)],\n",
       " 'MED-962': [('treatment hypovitaminosis', 0.6654),\n",
       "  ('toddlers hypovitaminosis', 0.612),\n",
       "  ('hypovitaminosis 25', 0.5836),\n",
       "  ('vitamin d3', 0.5778),\n",
       "  ('hydroxyvitamin', 0.5249),\n",
       "  ('weekly vitamin', 0.4819),\n",
       "  ('pth suppression', 0.3806),\n",
       "  ('calcium raising', 0.3406),\n",
       "  ('difference pth', 0.3327),\n",
       "  ('children implications', 0.3121),\n",
       "  ('implications skeletal', 0.3058),\n",
       "  ('study interventions', 0.2941),\n",
       "  ('oh concentration', 0.2897),\n",
       "  ('overall health', 0.2817),\n",
       "  ('efficacy', 0.2791),\n",
       "  ('infants toddlers', 0.2768),\n",
       "  ('concentrations design', 0.2757),\n",
       "  ('serum measurements', 0.2727),\n",
       "  ('d2 vs', 0.2578),\n",
       "  ('common treatment', 0.2543),\n",
       "  ('wk randomized', 0.2453),\n",
       "  ('combined supplemental', 0.2437),\n",
       "  ('prescribed elemental', 0.241),\n",
       "  ('tripled 25', 0.2287),\n",
       "  ('pediatric clinic', 0.2271),\n",
       "  ('compare safety', 0.222),\n",
       "  ('daily', 0.211),\n",
       "  ('mg kg', 0.2107),\n",
       "  ('ensure compliance', 0.1815),\n",
       "  ('objective objective', 0.1811),\n",
       "  ('rise young', 0.1611),\n",
       "  ('regimens 000', 0.153),\n",
       "  ('nonsignificant daily', 0.153),\n",
       "  ('taken results', 0.1509),\n",
       "  ('subjects healthy', 0.1448),\n",
       "  ('iu oral', 0.1444),\n",
       "  ('short term', 0.1165),\n",
       "  ('suppression conclusions', 0.1095),\n",
       "  ('preplanned', 0.103),\n",
       "  ('66 daily', 0.0955),\n",
       "  ('groups', 0.0893),\n",
       "  ('providers individualize', 0.0862),\n",
       "  ('conducted urban', 0.073),\n",
       "  ('change', 0.0728),\n",
       "  ('50 000', 0.0227),\n",
       "  ('12', 0.0195),\n",
       "  ('20 ng', 0.0144),\n",
       "  ('clinic boston', 0.0098),\n",
       "  ('comparisons nonsignificant', -0.0019),\n",
       "  ('ml participated', -0.0203)],\n",
       " 'MED-963': [('quality eggs', 0.6329),\n",
       "  ('eggs caged', 0.6212),\n",
       "  ('range eggs', 0.5748),\n",
       "  ('eggs vs', 0.5595),\n",
       "  ('produced cages', 0.4813),\n",
       "  ('50 eggs', 0.478),\n",
       "  ('hens exposed', 0.4294),\n",
       "  ('egg cholesterol', 0.3925),\n",
       "  ('flock 500', 0.3848),\n",
       "  ('caged range', 0.3493),\n",
       "  ('produced shell', 0.3219),\n",
       "  ('range nutrient', 0.308),\n",
       "  ('acids higher', 0.2932),\n",
       "  ('laboratory production', 0.2917),\n",
       "  ('environment hen', 0.2898),\n",
       "  ('flock', 0.2853),\n",
       "  ('fat carotene', 0.2781),\n",
       "  ('feeding', 0.2544),\n",
       "  ('content samples', 0.2518),\n",
       "  ('produced free', 0.2425),\n",
       "  ('layers hatched', 0.2379),\n",
       "  ('study compared', 0.2235),\n",
       "  ('54 mg', 0.218),\n",
       "  ('brown layers', 0.2154),\n",
       "  ('significant effect', 0.2122),\n",
       "  ('production did', 0.2109),\n",
       "  ('vs 14', 0.2045),\n",
       "  ('levels affected', 0.181),\n",
       "  ('quality', 0.1789),\n",
       "  ('high 88', 0.1603),\n",
       "  ('05 monounsaturated', 0.1414),\n",
       "  ('hy line', 0.1339),\n",
       "  ('age age', 0.1312),\n",
       "  ('165 38', 0.1255),\n",
       "  ('varied 001', 0.1244),\n",
       "  ('62 wk', 0.1075),\n",
       "  ('care vaccination', 0.0977),\n",
       "  ('superior', 0.0935),\n",
       "  ('cholesterol 163', 0.0876),\n",
       "  ('affected husbandry', 0.0849),\n",
       "  ('divided', 0.0803),\n",
       "  ('did influence', 0.0785),\n",
       "  ('regimen difference', 0.0753),\n",
       "  ('76', 0.0735),\n",
       "  ('exposed lowest', 0.0652),\n",
       "  ('mg', 0.0496),\n",
       "  ('sent different', 0.0417),\n",
       "  ('17', 0.029),\n",
       "  ('public perceives', 0.0111),\n",
       "  ('access', -0.0017)],\n",
       " 'MED-965': [('nitric oxide', 0.6415),\n",
       "  ('endothelial dysfunction', 0.4924),\n",
       "  ('1980s nitric', 0.4544),\n",
       "  ('endothelium derived', 0.429),\n",
       "  ('precursor atherosclerosis', 0.3914),\n",
       "  ('vascular role', 0.3709),\n",
       "  ('cardiovascular signalling', 0.3671),\n",
       "  ('multifactorial oxidative', 0.3539),\n",
       "  ('elusive endothelium', 0.3323),\n",
       "  ('oxide fact', 0.3245),\n",
       "  ('inflammatory haemostatic', 0.2987),\n",
       "  ('mellitus elicit', 0.2878),\n",
       "  ('major cardiovascular', 0.2754),\n",
       "  ('bioavailability recognised', 0.2672),\n",
       "  ('factors diabetes', 0.2666),\n",
       "  ('changes bioavailability', 0.2559),\n",
       "  ('pathophysiological link', 0.2391),\n",
       "  ('signalling molecule', 0.2389),\n",
       "  ('ischaemic heart', 0.2363),\n",
       "  ('disease importance', 0.2363),\n",
       "  ('discovery 1980s', 0.2234),\n",
       "  ('circulating stimuli', 0.2198),\n",
       "  ('harmful circulating', 0.2001),\n",
       "  ('ed pathophysiological', 0.1994),\n",
       "  ('stress appears', 0.1951),\n",
       "  ('vaso active', 0.1926),\n",
       "  ('redox homeostasis', 0.1744),\n",
       "  ('loss vaso', 0.1667),\n",
       "  ('molecule changes', 0.1392),\n",
       "  ('underlying cellular', 0.1347),\n",
       "  ('relaxing', 0.1309),\n",
       "  ('risk', 0.1285),\n",
       "  ('crucial determining', 0.119),\n",
       "  ('early reversible', 0.1163),\n",
       "  ('fact elusive', 0.1152),\n",
       "  ('importance basic', 0.1127),\n",
       "  ('discovery', 0.1053),\n",
       "  ('changes associated', 0.0964),\n",
       "  ('activation', 0.0955),\n",
       "  ('responses', 0.0909),\n",
       "  ('derived', 0.0874),\n",
       "  ('scientists', 0.0866),\n",
       "  ('link', 0.0843),\n",
       "  ('characterised reduced', 0.0714),\n",
       "  ('clinicians alike', 0.0617),\n",
       "  ('high levels', 0.0594),\n",
       "  ('develop sustained', 0.0566),\n",
       "  ('appears common', 0.0383),\n",
       "  ('appear sequentially', -0.012),\n",
       "  ('body', -0.0511)],\n",
       " 'MED-966': [('improved endothelial', 0.5678),\n",
       "  ('exercise training', 0.5408),\n",
       "  ('results endothelial', 0.512),\n",
       "  ('training et', 0.4524),\n",
       "  ('aerobic et', 0.4407),\n",
       "  ('versus posttraining', 0.4317),\n",
       "  ('disease exercise', 0.416),\n",
       "  ('background coronary', 0.4052),\n",
       "  ('resistance training', 0.3831),\n",
       "  ('et patients', 0.3616),\n",
       "  ('et flow', 0.347),\n",
       "  ('dilation increased', 0.3235),\n",
       "  ('209 patients', 0.3114),\n",
       "  ('infarction et', 0.3105),\n",
       "  ('trained groups', 0.3081),\n",
       "  ('training 54', 0.2765),\n",
       "  ('et decreased', 0.2632),\n",
       "  ('types et', 0.2518),\n",
       "  ('myocardial', 0.2473),\n",
       "  ('levels 01', 0.2284),\n",
       "  ('improvement', 0.2203),\n",
       "  ('function evaluated', 0.2177),\n",
       "  ('conclusions patients', 0.2075),\n",
       "  ('detraining returned', 0.2075),\n",
       "  ('recent acute', 0.206),\n",
       "  ('patients randomized', 0.206),\n",
       "  ('measuring flow', 0.1976),\n",
       "  ('background', 0.1775),\n",
       "  ('artery', 0.1713),\n",
       "  ('ns et', 0.1678),\n",
       "  ('purpose study', 0.1621),\n",
       "  ('increased group', 0.1589),\n",
       "  ('et month', 0.1552),\n",
       "  ('relative effect', 0.1459),\n",
       "  ('prospectively', 0.1372),\n",
       "  ('methods results', 0.1352),\n",
       "  ('53', 0.1289),\n",
       "  ('factor level', 0.1218),\n",
       "  ('10', 0.1067),\n",
       "  ('remained unchanged', 0.1034),\n",
       "  ('weeks different', 0.1024),\n",
       "  ('function independently', 0.0893),\n",
       "  ('baseline', 0.0804),\n",
       "  ('willebrand factor', 0.0719),\n",
       "  ('16', 0.0532),\n",
       "  ('mediated', 0.0501),\n",
       "  ('effect disappeared', 0.0406),\n",
       "  ('von', 0.0326),\n",
       "  ('little known', 0.0306),\n",
       "  ('group lesser', -0.127)],\n",
       " 'MED-967': [('vegetable intervention', 0.4124),\n",
       "  ('reduced cardiovascular', 0.4014),\n",
       "  ('vasodilator conclusions', 0.3693),\n",
       "  ('week study', 0.361),\n",
       "  ('dietary biomarkers', 0.3607),\n",
       "  ('effects fruit', 0.3513),\n",
       "  ('intervention compliance', 0.3451),\n",
       "  ('study assessed', 0.3434),\n",
       "  ('improves vascular', 0.3215),\n",
       "  ('consumption improves', 0.3156),\n",
       "  ('cardiovascular morbidity', 0.3149),\n",
       "  ('evidence support', 0.2915),\n",
       "  ('intake limited', 0.2836),\n",
       "  ('arterial health', 0.2715),\n",
       "  ('hypertensive volunteers', 0.2679),\n",
       "  ('methods results', 0.2506),\n",
       "  ('association increased', 0.2503),\n",
       "  ('flow responses', 0.2352),\n",
       "  ('reported consuming', 0.2352),\n",
       "  ('run period', 0.2311),\n",
       "  ('function study', 0.2303),\n",
       "  ('dose dependent', 0.2276),\n",
       "  ('significant', 0.2022),\n",
       "  ('participants randomized', 0.2004),\n",
       "  ('12 week', 0.1944),\n",
       "  ('background observational', 0.1942),\n",
       "  ('portions daily', 0.1833),\n",
       "  ('increased groups', 0.1826),\n",
       "  ('improvements established', 0.1818),\n",
       "  ('weeks endothelium', 0.1814),\n",
       "  ('assessed venous', 0.1746),\n",
       "  ('responses sodium', 0.1712),\n",
       "  ('improvement forearm', 0.1628),\n",
       "  ('morbidity little', 0.1574),\n",
       "  ('03 association', 0.1558),\n",
       "  ('concentrations lutein', 0.1541),\n",
       "  ('sodium nitroprusside', 0.1404),\n",
       "  ('day participants', 0.14),\n",
       "  ('manner portion', 0.1382),\n",
       "  ('cryptoxanthin increased', 0.1172),\n",
       "  ('measuring concentrations', 0.0983),\n",
       "  ('concept', 0.0944),\n",
       "  ('plethysmography', 0.0903),\n",
       "  ('produces', 0.0796),\n",
       "  ('dependent independent', 0.0786),\n",
       "  ('acetylcholine', 0.0605),\n",
       "  ('occlusion', 0.0477),\n",
       "  ('total 117', 0.0382),\n",
       "  ('intra', 0.0377),\n",
       "  ('serial contemporaneous', 0.0292)],\n",
       " 'MED-969': [('endothelial biomedicine', 0.6486),\n",
       "  ('mechanisms endothelial', 0.6335),\n",
       "  ('endothelium highly', 0.6034),\n",
       "  ('endothelial cell', 0.5727),\n",
       "  ('definitions endothelial', 0.5725),\n",
       "  ('hemostasis endothelial', 0.5654),\n",
       "  ('understanding vascular', 0.5334),\n",
       "  ('time endothelial', 0.5002),\n",
       "  ('gap endothelial', 0.4746),\n",
       "  ('cell heterogeneity', 0.454),\n",
       "  ('vascular bed', 0.4283),\n",
       "  ('inflammation hemostasis', 0.4026),\n",
       "  ('specific hemostasis', 0.376),\n",
       "  ('heterogeneity important', 0.3681),\n",
       "  ('barrier function', 0.3665),\n",
       "  ('control vasomotor', 0.3297),\n",
       "  ('cell phenotypes', 0.3273),\n",
       "  ('leukocyte adhesion', 0.3239),\n",
       "  ('differentially regulated', 0.3215),\n",
       "  ('involved physiological', 0.2934),\n",
       "  ('phenotypes differentially', 0.2907),\n",
       "  ('important implications', 0.2694),\n",
       "  ('processes including', 0.2638),\n",
       "  ('cell activation', 0.2618),\n",
       "  ('metabolically active', 0.2607),\n",
       "  ('activation dysfunction', 0.2564),\n",
       "  ('inflammation', 0.2547),\n",
       "  ('consider mechanisms', 0.2471),\n",
       "  ('review', 0.214),\n",
       "  ('including control', 0.2007),\n",
       "  ('biomedicine iii', 0.1992),\n",
       "  ('developing strategies', 0.1725),\n",
       "  ('themes applied', 0.169),\n",
       "  ('function', 0.1665),\n",
       "  ('revisit definitions', 0.1661),\n",
       "  ('understanding', 0.1653),\n",
       "  ('organ', 0.1598),\n",
       "  ('space time', 0.1547),\n",
       "  ('basic research', 0.1511),\n",
       "  ('specific', 0.1499),\n",
       "  ('therapeutics', 0.1492),\n",
       "  ('trafficking', 0.1349),\n",
       "  ('goals diagnosis', 0.1227),\n",
       "  ('new goals', 0.1216),\n",
       "  ('highly', 0.1201),\n",
       "  ('tone', 0.0743),\n",
       "  ('discuss bench', 0.063),\n",
       "  ('dysfunction iv', 0.047),\n",
       "  ('ii discuss', 0.0162),\n",
       "  ('bed', -0.0004)],\n",
       " 'MED-970': [('dietary fibre', 0.4725),\n",
       "  ('vegetarians 31', 0.4497),\n",
       "  ('kingdom participants', 0.4486),\n",
       "  ('cohort study', 0.3831),\n",
       "  ('vegetarian diet', 0.3799),\n",
       "  ('england scotland', 0.3731),\n",
       "  ('scotland 15', 0.3336),\n",
       "  ('eaters compared', 0.3335),\n",
       "  ('high intake', 0.3202),\n",
       "  ('men women', 0.3159),\n",
       "  ('diet main', 0.3142),\n",
       "  ('design prospective', 0.3041),\n",
       "  ('epic oxford', 0.2959),\n",
       "  ('diverticular disease', 0.2904),\n",
       "  ('participants recruited', 0.2904),\n",
       "  ('mainly health', 0.2812),\n",
       "  ('ages 50', 0.2656),\n",
       "  ('47 033', 0.2536),\n",
       "  ('fifths intake', 0.2523),\n",
       "  ('frequency questionnaire', 0.2489),\n",
       "  ('validated food', 0.2308),\n",
       "  ('examine associations', 0.2284),\n",
       "  ('33 reported', 0.2277),\n",
       "  ('conclusions consuming', 0.2225),\n",
       "  ('disease design', 0.2041),\n",
       "  ('033 men', 0.1963),\n",
       "  ('baseline intake', 0.1892),\n",
       "  ('459', 0.1891),\n",
       "  ('meat', 0.1682),\n",
       "  ('main outcome', 0.1515),\n",
       "  ('001 trend', 0.14),\n",
       "  ('risk 59', 0.1285),\n",
       "  ('11 years', 0.1197),\n",
       "  ('years', 0.1116),\n",
       "  ('14 day', 0.1076),\n",
       "  ('25 day', 0.1031),\n",
       "  ('multivariate cox', 0.094),\n",
       "  ('living', 0.0819),\n",
       "  ('higher', 0.0802),\n",
       "  ('united', 0.0801),\n",
       "  ('hospital death', 0.0747),\n",
       "  ('day men', 0.0743),\n",
       "  ('mutual adjustment', 0.0684),\n",
       "  ('models results', 0.0616),\n",
       "  ('41 lower', 0.0579),\n",
       "  ('46 78', 0.049),\n",
       "  ('95 confidence', 0.0421),\n",
       "  ('130', 0.0403),\n",
       "  ('806 admissions', 0.0161),\n",
       "  ('certificates hazard', 0.0067)],\n",
       " 'MED-972': [('dietary fibre', 0.5155),\n",
       "  ('fibre vegetarians', 0.5069),\n",
       "  ('vegetarians non', 0.4847),\n",
       "  ('consumption dietary', 0.4651),\n",
       "  ('non vegetarian', 0.4584),\n",
       "  ('vegetarian groups', 0.4545),\n",
       "  ('disease vegetarian', 0.4497),\n",
       "  ('vegetarians significantly', 0.4403),\n",
       "  ('vegetarians vegetarians', 0.4378),\n",
       "  ('vegetarians 21', 0.4357),\n",
       "  ('diverticular disease', 0.4313),\n",
       "  ('vegetarian', 0.393),\n",
       "  ('vegetarians 33', 0.3824),\n",
       "  ('subjects diverticular', 0.3667),\n",
       "  ('cereal fibre', 0.3563),\n",
       "  ('disease colon', 0.3509),\n",
       "  ('colon related', 0.3498),\n",
       "  ('symptomless diverticular', 0.3406),\n",
       "  ('intake cereal', 0.3326),\n",
       "  ('low intake', 0.3295),\n",
       "  ('vegetarians 12', 0.2954),\n",
       "  ('intake', 0.2899),\n",
       "  ('related consumption', 0.2853),\n",
       "  ('prevalence symptomless', 0.265),\n",
       "  ('mean fibre', 0.2558),\n",
       "  ('commoner non', 0.2543),\n",
       "  ('prevalence', 0.2423),\n",
       "  ('disease commoner', 0.2416),\n",
       "  ('41 day', 0.2347),\n",
       "  ('day non', 0.1955),\n",
       "  ('non', 0.1878),\n",
       "  ('disease', 0.1643),\n",
       "  ('21 day', 0.1555),\n",
       "  ('significantly higher', 0.1248),\n",
       "  ('comparison subjects', 0.1187),\n",
       "  ('study', 0.1148),\n",
       "  ('subjects', 0.1111),\n",
       "  ('evidence low', 0.1055),\n",
       "  ('33', 0.081),\n",
       "  ('comparison', 0.0801),\n",
       "  ('groups provided', 0.0735),\n",
       "  ('provided evidence', 0.0577),\n",
       "  ('low', 0.0325),\n",
       "  ('presence', 0.0245),\n",
       "  ('mean', 0.0212),\n",
       "  ('related', 0.0193),\n",
       "  ('day', 0.0187),\n",
       "  ('12 comparison', 0.0185),\n",
       "  ('significantly', 0.0127),\n",
       "  ('provided', 0.01)],\n",
       " 'MED-973': [('dietary fiber', 0.6755),\n",
       "  ('types foods', 0.524),\n",
       "  ('recommendations dietary', 0.5121),\n",
       "  ('countries cereals', 0.458),\n",
       "  ('unrefined foods', 0.433),\n",
       "  ('intake range', 0.4281),\n",
       "  ('vegetarian diet', 0.4193),\n",
       "  ('guidelines fat', 0.4096),\n",
       "  ('vegetables highest', 0.4076),\n",
       "  ('nutritionally adequate', 0.3973),\n",
       "  ('highest fiber', 0.3782),\n",
       "  ('people consuming', 0.3776),\n",
       "  ('ugandan diet', 0.3611),\n",
       "  ('diet bulky', 0.356),\n",
       "  ('butter beans', 0.3227),\n",
       "  ('fat 1800', 0.317),\n",
       "  ('fiber different', 0.3163),\n",
       "  ('intake rural', 0.3007),\n",
       "  ('amounts peanut', 0.2979),\n",
       "  ('kcal omnivorous', 0.2556),\n",
       "  ('intake 35', 0.2491),\n",
       "  ('wholemeal bread', 0.2485),\n",
       "  ('internationally vary', 0.2464),\n",
       "  ('2400 kcal', 0.2383),\n",
       "  ('grains selected', 0.2329),\n",
       "  ('leafy', 0.2203),\n",
       "  ('meats', 0.2187),\n",
       "  ('recommendations inconsistent', 0.2169),\n",
       "  ('low fiber', 0.2149),\n",
       "  ('fiber 1000', 0.2105),\n",
       "  ('50 fiber', 0.2047),\n",
       "  ('fruit results', 0.1989),\n",
       "  ('80 day', 0.1826),\n",
       "  ('widely 20', 0.1688),\n",
       "  ('containing large', 0.1623),\n",
       "  ('definition constitutes', 0.1231),\n",
       "  ('energy', 0.1203),\n",
       "  ('desirable promote', 0.1045),\n",
       "  ('day types', 0.0972),\n",
       "  ('modest amounts', 0.0943),\n",
       "  ('inconsistent high', 0.0923),\n",
       "  ('populations', 0.0831),\n",
       "  ('minimum 15', 0.083),\n",
       "  ('goes', 0.0403),\n",
       "  ('burkitt trowell', 0.0359),\n",
       "  ('contribute 90', 0.0349),\n",
       "  ('consumed simian', 0.009),\n",
       "  ('using human', -0.001),\n",
       "  ('hypothesis developed', -0.0236),\n",
       "  ('apes similar', -0.0605)],\n",
       " 'MED-974': [('diverticulitis cd', 0.5451),\n",
       "  ('diverticulitis reduce', 0.5313),\n",
       "  ('mortality cd', 0.4774),\n",
       "  ('understanding morbidity', 0.3988),\n",
       "  ('comorbidities perforation', 0.379),\n",
       "  ('cd methods', 0.3539),\n",
       "  ('resection episodes', 0.3248),\n",
       "  ('current practice', 0.322),\n",
       "  ('treatment complicated', 0.3113),\n",
       "  ('perforation reduced', 0.3099),\n",
       "  ('disease', 0.3),\n",
       "  ('rates 10', 0.285),\n",
       "  ('002 comorbidities', 0.2723),\n",
       "  ('patients hospitalized', 0.2644),\n",
       "  ('needed redefine', 0.2549),\n",
       "  ('reporting mortality', 0.251),\n",
       "  ('outcomes determined', 0.2381),\n",
       "  ('managed nonoperatively', 0.2262),\n",
       "  ('retrospectively', 0.2083),\n",
       "  ('diabetes collagen', 0.2065),\n",
       "  ('elective', 0.1974),\n",
       "  ('outdated literature', 0.1858),\n",
       "  ('conclusion today', 0.1852),\n",
       "  ('introduction knowledge', 0.1809),\n",
       "  ('analyzed characteristics', 0.1678),\n",
       "  ('seven patients', 0.1644),\n",
       "  ('aim study', 0.1619),\n",
       "  ('data coupled', 0.139),\n",
       "  ('episode calls', 0.1381),\n",
       "  ('use significantly', 0.1337),\n",
       "  ('compared past', 0.1167),\n",
       "  ('immunocompromised patients', 0.1134),\n",
       "  ('leak patient', 0.107),\n",
       "  ('vascular', 0.0912),\n",
       "  ('using chi', 0.0778),\n",
       "  ('methods thirty', 0.0718),\n",
       "  ('excluding', 0.0633),\n",
       "  ('mean age', 0.0557),\n",
       "  ('new prospective', 0.0503),\n",
       "  ('compromise highly', 0.0403),\n",
       "  ('seventy percent', 0.0321),\n",
       "  ('total 89', 0.0302),\n",
       "  ('stratagem', 0.0263),\n",
       "  ('target groups', 0.0176),\n",
       "  ('total 46', 0.0131),\n",
       "  ('fisher', 0.0104),\n",
       "  ('53 presented', 0.0059),\n",
       "  ('gender steroids', -0.0052),\n",
       "  ('squared', -0.0075),\n",
       "  ('41', -0.0123)],\n",
       " 'MED-975': [('diverticular disease', 0.6512),\n",
       "  ('symptomatic diverticular', 0.6133),\n",
       "  ('disease colon', 0.6082),\n",
       "  ('diverticular', 0.5874),\n",
       "  ('disease involves', 0.4608),\n",
       "  ('colon', 0.4427),\n",
       "  ('pathogenesis disease', 0.4016),\n",
       "  ('disease appeared', 0.3957),\n",
       "  ('commonest disease', 0.3912),\n",
       "  ('disease clinical', 0.3812),\n",
       "  ('colon western', 0.3476),\n",
       "  ('new disease', 0.3368),\n",
       "  ('colon new', 0.3359),\n",
       "  ('disease high', 0.332),\n",
       "  ('appearance disease', 0.294),\n",
       "  ('age pathogenesis', 0.234),\n",
       "  ('aetiology', 0.2186),\n",
       "  ('clinical scene', 0.2167),\n",
       "  ('excessive segmentation', 0.208),\n",
       "  ('patients symptomatic', 0.2001),\n",
       "  ('diet results', 0.1986),\n",
       "  ('segmentation does', 0.1921),\n",
       "  ('beginning century', 0.1828),\n",
       "  ('segmentation', 0.1811),\n",
       "  ('appeared beginning', 0.1762),\n",
       "  ('century commonest', 0.162),\n",
       "  ('historical appearance', 0.1514),\n",
       "  ('60', 0.1396),\n",
       "  ('western world', 0.1327),\n",
       "  ('involves excessive', 0.1175),\n",
       "  ('carbohydrates author', 0.117),\n",
       "  ('years', 0.1139),\n",
       "  ('suggest removal', 0.1024),\n",
       "  ('scene geographical', 0.1023),\n",
       "  ('treated 70', 0.1011),\n",
       "  ('world people', 0.097),\n",
       "  ('patients', 0.0854),\n",
       "  ('treated', 0.0841),\n",
       "  ('author treated', 0.0804),\n",
       "  ('commonest', 0.0767),\n",
       "  ('results effects', 0.0763),\n",
       "  ('fibre diet', 0.0762),\n",
       "  ('bran discussed', 0.0517),\n",
       "  ('involves', 0.0495),\n",
       "  ('discussed', 0.0361),\n",
       "  ('people', 0.0331),\n",
       "  ('explain', 0.0262),\n",
       "  ('distribution', -0.0084),\n",
       "  ('fibre', -0.011),\n",
       "  ('does', -0.0607)],\n",
       " 'MED-976': [('predisposing conditions', 0.3832),\n",
       "  ('diverticular disease', 0.3311),\n",
       "  ('especially diverticular', 0.3279),\n",
       "  ('causes deficient', 0.3233),\n",
       "  ('phleboliths', 0.3231),\n",
       "  ('hernia rarer', 0.3187),\n",
       "  ('genetic causes', 0.3164),\n",
       "  ('conditions common', 0.3151),\n",
       "  ('deficient intake', 0.3088),\n",
       "  ('phleboliths especially', 0.3056),\n",
       "  ('communities conditions', 0.2803),\n",
       "  ('factor predisposing', 0.279),\n",
       "  ('causes', 0.2586),\n",
       "  ('rarer developing', 0.2516),\n",
       "  ('developing countries', 0.2507),\n",
       "  ('hiatus hernia', 0.2431),\n",
       "  ('dietary fibre', 0.2418),\n",
       "  ('environmental genetic', 0.2396),\n",
       "  ('hernia', 0.2395),\n",
       "  ('intake dietary', 0.2309),\n",
       "  ('common factor', 0.2282),\n",
       "  ('developed communities', 0.2125),\n",
       "  ('disease hiatus', 0.2103),\n",
       "  ('disease', 0.2068),\n",
       "  ('communities', 0.2053),\n",
       "  ('genetic', 0.1956),\n",
       "  ('deficient', 0.1787),\n",
       "  ('rarer', 0.1756),\n",
       "  ('countries', 0.1681),\n",
       "  ('environmental', 0.1641),\n",
       "  ('intake', 0.1519),\n",
       "  ('common', 0.1277),\n",
       "  ('hiatus', 0.1247),\n",
       "  ('common black', 0.1237),\n",
       "  ('conditions', 0.1196),\n",
       "  ('finding suggests', 0.1183),\n",
       "  ('fibre common', 0.1051),\n",
       "  ('factor', 0.0804),\n",
       "  ('developing', 0.0776),\n",
       "  ('americans', 0.0734),\n",
       "  ('americans finding', 0.0708),\n",
       "  ('white americans', 0.0325),\n",
       "  ('suggests', 0.0301),\n",
       "  ('developed', 0.0202),\n",
       "  ('finding', 0.0132),\n",
       "  ('economically developed', 0.0033),\n",
       "  ('especially', -0.0006),\n",
       "  ('black', -0.0034),\n",
       "  ('black white', -0.0279),\n",
       "  ('economically', -0.0669)],\n",
       " 'MED-977': [('study constipation', 0.6543),\n",
       "  ('constipation secondary', 0.6357),\n",
       "  ('constipation low', 0.6013),\n",
       "  ('diverticulosis 1569', 0.5251),\n",
       "  ('asymptomatic diverticulosis', 0.5065),\n",
       "  ('odds diverticulosis', 0.4866),\n",
       "  ('stools reduced', 0.4324),\n",
       "  ('low dietary', 0.4029),\n",
       "  ('frequent bowel', 0.3872),\n",
       "  ('knowledge diverticular', 0.3796),\n",
       "  ('hard stools', 0.3635),\n",
       "  ('sectional colonoscopy', 0.3434),\n",
       "  ('1569 controls', 0.3244),\n",
       "  ('habits analysis', 0.2767),\n",
       "  ('aims asymptomatic', 0.2751),\n",
       "  ('reduced odds', 0.2681),\n",
       "  ('mechanism limited', 0.2679),\n",
       "  ('association dietary', 0.2619),\n",
       "  ('disease', 0.2476),\n",
       "  ('controls participants', 0.2111),\n",
       "  ('examined associations', 0.2037),\n",
       "  ('evidence mechanism', 0.2003),\n",
       "  ('mean intake', 0.1865),\n",
       "  ('background aims', 0.1815),\n",
       "  ('based study', 0.1693),\n",
       "  ('compared regular', 0.1666),\n",
       "  ('reporting hard', 0.1607),\n",
       "  ('conclusions cross', 0.1481),\n",
       "  ('lowest mean', 0.1458),\n",
       "  ('interval ci', 0.1436),\n",
       "  ('22 incomplete', 0.1314),\n",
       "  ('physical activity', 0.1263),\n",
       "  ('biased responses', 0.1203),\n",
       "  ('ratio 56', 0.1195),\n",
       "  ('539 individuals', 0.1165),\n",
       "  ('secondary', 0.1135),\n",
       "  ('straining', 0.1118),\n",
       "  ('fiber', 0.1111),\n",
       "  ('intake 25', 0.0795),\n",
       "  ('55 02', 0.0701),\n",
       "  ('wk', 0.0587),\n",
       "  ('individuals', 0.0577),\n",
       "  ('commonly attributed', 0.0569),\n",
       "  ('versus day', 0.0361),\n",
       "  ('20 association', 0.0306),\n",
       "  ('increased risk', 0.0228),\n",
       "  ('quartile', 0.0048),\n",
       "  ('40 80', -0.0141),\n",
       "  ('71 30', -0.0376),\n",
       "  ('85', -0.0838)],\n",
       " 'MED-978': [('colocutaneous fistula', 0.6791),\n",
       "  ('diverticulitis colocutaneous', 0.6508),\n",
       "  ('fistula diverticulitis', 0.6486),\n",
       "  ('diverticulitis relatively', 0.6068),\n",
       "  ('fistula uncommon', 0.5947),\n",
       "  ('sigmoidocutaneous fistula', 0.5751),\n",
       "  ('colon diverticulum', 0.5219),\n",
       "  ('reported fistulas', 0.4952),\n",
       "  ('caused diverticular', 0.4914),\n",
       "  ('fistula abdominal', 0.4899),\n",
       "  ('closure fistula', 0.4626),\n",
       "  ('fistulectomy performed', 0.4404),\n",
       "  ('cases colocutaneous', 0.4368),\n",
       "  ('recrudescent sigmoidocutaneous', 0.3661),\n",
       "  ('gastrografin enema', 0.3313),\n",
       "  ('colon', 0.3055),\n",
       "  ('drainage operation', 0.2976),\n",
       "  ('uneventful patient', 0.297),\n",
       "  ('postoperative course', 0.2923),\n",
       "  ('conservative therapy', 0.2747),\n",
       "  ('possibility recurrence', 0.2651),\n",
       "  ('relatively rare', 0.2596),\n",
       "  ('perforation', 0.2532),\n",
       "  ('japanese 56', 0.2412),\n",
       "  ('discharged reported', 0.2282),\n",
       "  ('radical surgery', 0.2199),\n",
       "  ('enema managed', 0.2106),\n",
       "  ('diagnosed recrudescent', 0.2086),\n",
       "  ('delayed', 0.1814),\n",
       "  ('disease', 0.1805),\n",
       "  ('therapy possible', 0.1556),\n",
       "  ('complete closure', 0.1526),\n",
       "  ('managed patient', 0.1521),\n",
       "  ('abdominal computed', 0.1455),\n",
       "  ('possible case', 0.1329),\n",
       "  ('formation did', 0.1162),\n",
       "  ('nutrition antibiotics', 0.1143),\n",
       "  ('considered necessary', 0.113),\n",
       "  ('sigmoid', 0.1112),\n",
       "  ('old male', 0.1015),\n",
       "  ('years treatment', 0.0932),\n",
       "  ('skin caused', 0.0659),\n",
       "  ('pain diagnosed', 0.0501),\n",
       "  ('hospital', 0.0446),\n",
       "  ('year', 0.0426),\n",
       "  ('did improve', 0.0195),\n",
       "  ('effective cases', 0.0041),\n",
       "  ('performed', -0.0067),\n",
       "  ('anterior', -0.0093),\n",
       "  ('improve low', -0.015)],\n",
       " 'MED-979': [('jejunal diverticula', 0.6358),\n",
       "  ('diverticulosis rare', 0.632),\n",
       "  ('diverticulitis appear', 0.6052),\n",
       "  ('diverticula uncommon', 0.605),\n",
       "  ('appendicitis cholecystitis', 0.5632),\n",
       "  ('ileal diverticulosis', 0.5583),\n",
       "  ('perforation jejunal', 0.5404),\n",
       "  ('cholecystitis colonic', 0.5118),\n",
       "  ('like gastrointestinal', 0.5075),\n",
       "  ('similar appendicitis', 0.5053),\n",
       "  ('ileal perforation', 0.5019),\n",
       "  ('gastrointestinal hemorrhage', 0.4423),\n",
       "  ('acute abdomen', 0.4369),\n",
       "  ('peritonitis', 0.4021),\n",
       "  ('rare condition', 0.3858),\n",
       "  ('nausea malnutrition', 0.3836),\n",
       "  ('nonspecific symptoms', 0.3802),\n",
       "  ('complications seen', 0.3765),\n",
       "  ('disease usually', 0.3642),\n",
       "  ('symptoms like', 0.35),\n",
       "  ('non obstructive', 0.3307),\n",
       "  ('acquired disease', 0.3218),\n",
       "  ('abdomen similar', 0.3122),\n",
       "  ('challenges diagnosis', 0.2789),\n",
       "  ('perforation', 0.2708),\n",
       "  ('laparotomy incidentally', 0.2543),\n",
       "  ('symptomatic present', 0.25),\n",
       "  ('present chronic', 0.224),\n",
       "  ('asymptomatic', 0.219),\n",
       "  ('obstruction majority', 0.214),\n",
       "  ('obstructive follow', 0.2128),\n",
       "  ('appear atypical', 0.2108),\n",
       "  ('formidable challenges', 0.2065),\n",
       "  ('treatment', 0.1738),\n",
       "  ('present formidable', 0.1674),\n",
       "  ('like pain', 0.156),\n",
       "  ('multiple non', 0.1545),\n",
       "  ('reported emergency', 0.1489),\n",
       "  ('condition continues', 0.1065),\n",
       "  ('presentation like', 0.0997),\n",
       "  ('silent', 0.0874),\n",
       "  ('presenting 63', 0.0795),\n",
       "  ('similar', 0.0501),\n",
       "  ('incidentally giant', 0.0454),\n",
       "  ('year old', 0.035),\n",
       "  ('acquired', 0.0124),\n",
       "  ('16 months', -0.0023),\n",
       "  ('months', -0.0172),\n",
       "  ('male reported', -0.0394),\n",
       "  ('patient doing', -0.0403)],\n",
       " 'MED-980': [('decline homocysteine', 0.6753),\n",
       "  ('brain atrophy', 0.5121),\n",
       "  ('impairment dementia', 0.4422),\n",
       "  ('homocysteine 13', 0.4073),\n",
       "  ('atrophy subjects', 0.3932),\n",
       "  ('lowered dietary', 0.349),\n",
       "  ('brain assessed', 0.3236),\n",
       "  ('supplementation vitamins', 0.3102),\n",
       "  ('delay development', 0.2955),\n",
       "  ('elderly mild', 0.2616),\n",
       "  ('cognitive', 0.2459),\n",
       "  ('slowed treatment', 0.2425),\n",
       "  ('lower active', 0.2347),\n",
       "  ('treated folic', 0.2005),\n",
       "  ('mri scans', 0.1892),\n",
       "  ('related baseline', 0.1798),\n",
       "  ('168 participants', 0.1758),\n",
       "  ('risk factor', 0.1609),\n",
       "  ('95 ci', 0.1489),\n",
       "  ('70 old', 0.1418),\n",
       "  ('particular suffer', 0.1339),\n",
       "  ('b12', 0.1194),\n",
       "  ('active treatment', 0.1124),\n",
       "  ('participants 85', 0.1108),\n",
       "  ('difference adverse', 0.1093),\n",
       "  ('background increased', 0.1063),\n",
       "  ('half develop', 0.1054),\n",
       "  ('group 001', 0.102),\n",
       "  ('test scores', 0.1006),\n",
       "  ('63', 0.0981),\n",
       "  ('trials needed', 0.0895),\n",
       "  ('category conclusions', 0.089),\n",
       "  ('24 months', 0.079),\n",
       "  ('blind', 0.0771),\n",
       "  ('trial vitacog', 0.0663),\n",
       "  ('22 placebo', 0.0614),\n",
       "  ('objective determine', 0.0587),\n",
       "  ('acid mg', 0.0546),\n",
       "  ('plasma', 0.0522),\n",
       "  ('volunteered cranial', 0.0397),\n",
       "  ('convert', 0.035),\n",
       "  ('08 94', 0.0309),\n",
       "  ('20', 0.0285),\n",
       "  ('serial volumetric', 0.0213),\n",
       "  ('sixteen percent', 0.0016),\n",
       "  ('year 76', -0.0019),\n",
       "  ('administration', -0.004),\n",
       "  ('271 individuals', -0.0055),\n",
       "  ('single center', -0.03),\n",
       "  ('com isrctn94410159', -0.0542)],\n",
       " 'MED-981': [('homocysteine vegetarians', 0.641),\n",
       "  ('homocysteine vitamin', 0.6378),\n",
       "  ('elevate homocysteine', 0.5223),\n",
       "  ('conditions cvd', 0.4621),\n",
       "  ('thcy levels', 0.4053),\n",
       "  ('deficiency vitamin', 0.3783),\n",
       "  ('dietary source', 0.3652),\n",
       "  ('systematic review', 0.3406),\n",
       "  ('used fortification', 0.3366),\n",
       "  ('nutritional scientific', 0.3174),\n",
       "  ('contributor chronic', 0.2927),\n",
       "  ('biomarker contributor', 0.2871),\n",
       "  ('indicating elevated', 0.2838),\n",
       "  ('available supplement', 0.2728),\n",
       "  ('strong evidence', 0.2654),\n",
       "  ('vegans identified', 0.2613),\n",
       "  ('compared concentrations', 0.2544),\n",
       "  ('plasma total', 0.2375),\n",
       "  ('screening using', 0.2241),\n",
       "  ('exclusion criteria', 0.2016),\n",
       "  ('studies 1999', 0.1991),\n",
       "  ('unreliable cyanocobalamin', 0.1943),\n",
       "  ('gaps present', 0.1913),\n",
       "  ('ovovegetarians', 0.1841),\n",
       "  ('food unreliable', 0.1803),\n",
       "  ('potentially greater', 0.1797),\n",
       "  ('study confirmed', 0.1763),\n",
       "  ('levels major', 0.1734),\n",
       "  ('participants', 0.1581),\n",
       "  ('meta', 0.1571),\n",
       "  ('risk', 0.1501),\n",
       "  ('seventeen studies', 0.1431),\n",
       "  ('lactovegetarians lacto', 0.1389),\n",
       "  ('population potentially', 0.1385),\n",
       "  ('using set', 0.1333),\n",
       "  ('2010 revealed', 0.1225),\n",
       "  ('restrict products', 0.1225),\n",
       "  ('omnivores present', 0.1098),\n",
       "  ('appraise range', 0.0994),\n",
       "  ('cross sectional', 0.0861),\n",
       "  ('case studies', 0.0836),\n",
       "  ('investigate', 0.0797),\n",
       "  ('usually used', 0.0649),\n",
       "  ('concluded usual', 0.0514),\n",
       "  ('3230', 0.0507),\n",
       "  ('relationship exists', 0.0473),\n",
       "  ('animal products', 0.0314),\n",
       "  ('did differ', 0.0253),\n",
       "  ('443 entries', 0.0146),\n",
       "  ('employed', -0.0098)],\n",
       " 'MED-982': [('homocysteine hcy', 0.5923),\n",
       "  ('suggest homocysteine', 0.57),\n",
       "  ('mechanisms hcy', 0.5492),\n",
       "  ('hyperhomocysteinemia risk', 0.5353),\n",
       "  ('hcy neurotoxicity', 0.5341),\n",
       "  ('moderate hyperhomocysteinemia', 0.5299),\n",
       "  ('damage hcy', 0.4956),\n",
       "  ('damage cognitive', 0.4826),\n",
       "  ('brain damage', 0.4369),\n",
       "  ('disturbed methylation', 0.4087),\n",
       "  ('neurodegenerative diseases', 0.4031),\n",
       "  ('memory decline', 0.395),\n",
       "  ('hcy folate', 0.3948),\n",
       "  ('neurotoxicity pharmacological', 0.3933),\n",
       "  ('cognitive memory', 0.3518),\n",
       "  ('numerous neurotoxic', 0.3495),\n",
       "  ('methylation redox', 0.3406),\n",
       "  ('tau protein', 0.3222),\n",
       "  ('diseases human', 0.3058),\n",
       "  ('reverse hcy', 0.2995),\n",
       "  ('various antioxidants', 0.2941),\n",
       "  ('studies suggest', 0.29),\n",
       "  ('important mechanisms', 0.277),\n",
       "  ('risk factor', 0.2515),\n",
       "  ('deficiency cause', 0.2436),\n",
       "  ('review describes', 0.2428),\n",
       "  ('activating methyl', 0.2297),\n",
       "  ('cause disturbed', 0.2197),\n",
       "  ('investigated role', 0.2138),\n",
       "  ('blocked folate', 0.21),\n",
       "  ('methyl aspartate', 0.2069),\n",
       "  ('b12 deficiency', 0.2049),\n",
       "  ('neuronal', 0.2014),\n",
       "  ('years investigated', 0.1965),\n",
       "  ('pharmacological agents', 0.1816),\n",
       "  ('accumulation apoptosis', 0.1686),\n",
       "  ('decline numerous', 0.1614),\n",
       "  ('effect mediated', 0.1522),\n",
       "  ('glutamate', 0.1418),\n",
       "  ('vitamin', 0.1375),\n",
       "  ('subtype numerous', 0.1164),\n",
       "  ('mild', 0.102),\n",
       "  ('protein', 0.0957),\n",
       "  ('influx amyloid', 0.0699),\n",
       "  ('suggest', 0.0461),\n",
       "  ('potentials promoting', 0.0423),\n",
       "  ('promoting calcium', 0.031),\n",
       "  ('agents', 0.026),\n",
       "  ('known', -0.0656),\n",
       "  ('plays', -0.1677)],\n",
       " 'MED-983': [('alzheimer disease', 0.5625),\n",
       "  ('disease estimate', 0.4867),\n",
       "  ('disease 2050', 0.4634),\n",
       "  ('forecast global', 0.4262),\n",
       "  ('forecasts data', 0.4073),\n",
       "  ('disease world', 0.3933),\n",
       "  ('model used', 0.3707),\n",
       "  ('progression methods', 0.3393),\n",
       "  ('disease onset', 0.3204),\n",
       "  ('data epidemiological', 0.3181),\n",
       "  ('stochastic multistate', 0.3061),\n",
       "  ('epidemic', 0.3053),\n",
       "  ('delay disease', 0.2959),\n",
       "  ('methods stochastic', 0.28),\n",
       "  ('preventive strategies', 0.2772),\n",
       "  ('2050 nearly', 0.2695),\n",
       "  ('results 2006', 0.2639),\n",
       "  ('background goal', 0.2531),\n",
       "  ('reduce global', 0.2514),\n",
       "  ('worldwide prevalence', 0.2358),\n",
       "  ('impact interventions', 0.23),\n",
       "  ('studies risks', 0.225),\n",
       "  ('entire decline', 0.2113),\n",
       "  ('population ages', 0.2106),\n",
       "  ('evaluate potential', 0.2037),\n",
       "  ('advances therapeutic', 0.1789),\n",
       "  ('burden', 0.175),\n",
       "  ('delays', 0.1489),\n",
       "  ('results', 0.1475),\n",
       "  ('prevalent cases', 0.137),\n",
       "  ('cases need', 0.1325),\n",
       "  ('nearly million', 0.106),\n",
       "  ('modest year', 0.1015),\n",
       "  ('level care', 0.0983),\n",
       "  ('26 million', 0.098),\n",
       "  ('united nations', 0.0935),\n",
       "  ('million fewer', 0.0728),\n",
       "  ('needing high', 0.0713),\n",
       "  ('85 persons', 0.0661),\n",
       "  ('decreases persons', 0.0578),\n",
       "  ('lead', 0.0552),\n",
       "  ('care equivalent', 0.0515),\n",
       "  ('used conjunction', 0.0178),\n",
       "  ('prevalence quadruple', 0.0156),\n",
       "  ('nursing home', 0.0055),\n",
       "  ('43 prevalent', -0.0051),\n",
       "  ('significantly', -0.0268),\n",
       "  ('face', -0.043),\n",
       "  ('persons', -0.0457),\n",
       "  ('looming', -0.1163)],\n",
       " 'MED-984': [('12 homocysteine', 0.6212),\n",
       "  ('fasting homocysteine', 0.62),\n",
       "  ('meals cysteine', 0.5057),\n",
       "  ('13 subjects', 0.4922),\n",
       "  ('cysteinylglycine concentrations', 0.4539),\n",
       "  ('analyses breakfast', 0.4458),\n",
       "  ('plasma methionine', 0.4445),\n",
       "  ('thiols dietary', 0.4441),\n",
       "  ('homocysteine small', 0.4427),\n",
       "  ('protein subjects', 0.4036),\n",
       "  ('dinner 1500', 0.3997),\n",
       "  ('meals', 0.3952),\n",
       "  ('protein dinner', 0.3826),\n",
       "  ('fasting', 0.3782),\n",
       "  ('dietary changes', 0.365),\n",
       "  ('mild hyperhomocysteinemia', 0.361),\n",
       "  ('homocysteine 33', 0.3542),\n",
       "  ('free protein', 0.3406),\n",
       "  ('19 dinner', 0.2926),\n",
       "  ('subjects normal', 0.2802),\n",
       "  ('evaluation vitamin', 0.2573),\n",
       "  ('changes plasma', 0.25),\n",
       "  ('aminothiol compounds', 0.2191),\n",
       "  ('investigated total', 0.2171),\n",
       "  ('bound ratios', 0.2099),\n",
       "  ('0900 containing', 0.201),\n",
       "  ('deficiency states', 0.186),\n",
       "  ('cardiovascular disease', 0.1799),\n",
       "  ('protein bound', 0.1655),\n",
       "  ('mean sd', 0.1503),\n",
       "  ('24 29', 0.1336),\n",
       "  ('approximately 50', 0.1311),\n",
       "  ('concentrations 22', 0.1255),\n",
       "  ('15 18', 0.125),\n",
       "  ('followed significant', 0.1121),\n",
       "  ('16 mumol', 0.1026),\n",
       "  ('increase free', 0.0975),\n",
       "  ('containing approximately', 0.0857),\n",
       "  ('indicate biological', 0.0813),\n",
       "  ('87', 0.0748),\n",
       "  ('patients', 0.0742),\n",
       "  ('nonsignificant increase', 0.0698),\n",
       "  ('significant decline', 0.0597),\n",
       "  ('20 brief', 0.0526),\n",
       "  ('states associated', 0.027),\n",
       "  ('synchronous fluctuations', 0.018),\n",
       "  ('separate effects', 0.0124),\n",
       "  ('associated moderate', -0.0126),\n",
       "  ('aged', -0.0186),\n",
       "  ('difficult', -0.0576)],\n",
       " 'MED-985': [('alzheimer disease', 0.6381),\n",
       "  ('disease ad', 0.5668),\n",
       "  ('ad sporadic', 0.4776),\n",
       "  ('form neurodegenerative', 0.4699),\n",
       "  ('ad onset', 0.4687),\n",
       "  ('ad epidemiological', 0.4271),\n",
       "  ('called hyperhomocysteinemia', 0.4255),\n",
       "  ('ad higher', 0.4234),\n",
       "  ('hypothesis homocysteine', 0.4007),\n",
       "  ('influence ad', 0.3502),\n",
       "  ('genetic factors', 0.3304),\n",
       "  ('confirmed ad', 0.3213),\n",
       "  ('disease vast', 0.3057),\n",
       "  ('risk factor', 0.2755),\n",
       "  ('ad common', 0.2738),\n",
       "  ('hcy', 0.272),\n",
       "  ('implicated hypothesis', 0.2531),\n",
       "  ('epidemiological investigations', 0.2406),\n",
       "  ('potential mechanisms', 0.2338),\n",
       "  ('cause combination', 0.2068),\n",
       "  ('evidence accumulated', 0.2026),\n",
       "  ('accumulated', 0.1635),\n",
       "  ('studies potential', 0.1437),\n",
       "  ('higher plasma', 0.1378),\n",
       "  ('reasons existing', 0.1319),\n",
       "  ('sporadic', 0.1275),\n",
       "  ('prompted observation', 0.1263),\n",
       "  ('age matched', 0.1234),\n",
       "  ('hhcy ad', 0.1173),\n",
       "  ('exist review', 0.0859),\n",
       "  ('existing conflicting', 0.0813),\n",
       "  ('studies randomized', 0.0774),\n",
       "  ('including observational', 0.0772),\n",
       "  ('plasma levels', 0.0744),\n",
       "  ('environmental', 0.0676),\n",
       "  ('results exist', 0.0607),\n",
       "  ('initially', 0.049),\n",
       "  ('cases', 0.0458),\n",
       "  ('patients histologically', 0.0431),\n",
       "  ('examine recent', 0.042),\n",
       "  ('summarize reports', 0.0366),\n",
       "  ('suggestions future', 0.031),\n",
       "  ('development finally', 0.0256),\n",
       "  ('controls', 0.0187),\n",
       "  ('vitro', 0.0134),\n",
       "  ('far implicates', 0.0109),\n",
       "  ('exist', -0.02),\n",
       "  ('vast majority', -0.0444),\n",
       "  ('relationship', -0.0703),\n",
       "  ('clear', -0.125)],\n",
       " 'MED-986': [('homocysteine lowering', 0.6805),\n",
       "  ('homocysteine linked', 0.615),\n",
       "  ('trials homocysteine', 0.6119),\n",
       "  ('vitamins reduce', 0.45),\n",
       "  ('folate status', 0.3904),\n",
       "  ('study duration', 0.3214),\n",
       "  ('lowered daily', 0.3168),\n",
       "  ('risk dementia', 0.313),\n",
       "  ('supplementation individuals', 0.3071),\n",
       "  ('19 english', 0.3029),\n",
       "  ('reduce risk', 0.2909),\n",
       "  ('comparison studies', 0.2849),\n",
       "  ('review', 0.2757),\n",
       "  ('95 ci', 0.2656),\n",
       "  ('randomized trials', 0.2534),\n",
       "  ('later life', 0.2407),\n",
       "  ('studies enable', 0.2341),\n",
       "  ('meta', 0.2249),\n",
       "  ('prolonged treatment', 0.1934),\n",
       "  ('impairment remains', 0.1914),\n",
       "  ('folic', 0.1907),\n",
       "  ('countries low', 0.1856),\n",
       "  ('performed systematic', 0.1752),\n",
       "  ('origin vitamin', 0.175),\n",
       "  ('b12 b6', 0.1661),\n",
       "  ('ci 09', 0.1595),\n",
       "  ('individuals cognitive', 0.1568),\n",
       "  ('stratified analyses', 0.1556),\n",
       "  ('life reliably', 0.1517),\n",
       "  ('10 20', 0.1499),\n",
       "  ('23 04', 0.1316),\n",
       "  ('05 participants', 0.1315),\n",
       "  ('12 40', 0.1171),\n",
       "  ('elevated total', 0.0961),\n",
       "  ('placebo', 0.0848),\n",
       "  ('entry standardized', 0.0729),\n",
       "  ('language', 0.0674),\n",
       "  ('acid performed', 0.0637),\n",
       "  ('existing', 0.0613),\n",
       "  ('linked', 0.0578),\n",
       "  ('04 significant', 0.0461),\n",
       "  ('scores', 0.045),\n",
       "  ('combination does', 0.0407),\n",
       "  ('controlled', 0.0385),\n",
       "  ('appear improve', 0.0301),\n",
       "  ('plasma', 0.0226),\n",
       "  ('size', -0.0085),\n",
       "  ('smd 14', -0.0088),\n",
       "  ('participants came', -0.0364),\n",
       "  ('08 28', -0.0529)],\n",
       " 'MED-987': [('factors homocysteine', 0.6492),\n",
       "  ('dementia studies', 0.5688),\n",
       "  ('dementia 667', 0.4003),\n",
       "  ('poor cognition', 0.3866),\n",
       "  ('studies elevated', 0.3481),\n",
       "  ('risk alzheimer', 0.3392),\n",
       "  ('folate vitamins', 0.3005),\n",
       "  ('vascular risk', 0.2922),\n",
       "  ('framingham study', 0.2667),\n",
       "  ('related nutritional', 0.2556),\n",
       "  ('deficiencies methods', 0.2482),\n",
       "  ('associated poor', 0.2448),\n",
       "  ('studies newly', 0.2088),\n",
       "  ('sectional studies', 0.2009),\n",
       "  ('liter risk', 0.1957),\n",
       "  ('levels precede', 0.19),\n",
       "  ('cognition', 0.1851),\n",
       "  ('background', 0.1825),\n",
       "  ('667 women', 0.1772),\n",
       "  ('plasma levels', 0.1694),\n",
       "  ('examined relation', 0.1692),\n",
       "  ('subjects', 0.1681),\n",
       "  ('disease nearly', 0.1662),\n",
       "  ('sample examined', 0.1615),\n",
       "  ('including 83', 0.1585),\n",
       "  ('adjust age', 0.1572),\n",
       "  ('median follow', 0.1543),\n",
       "  ('total 1092', 0.1506),\n",
       "  ('425', 0.1506),\n",
       "  ('76 years', 0.1506),\n",
       "  ('95 percent', 0.1467),\n",
       "  ('sex apolipoprotein', 0.1463),\n",
       "  ('methods total', 0.1393),\n",
       "  ('period years', 0.1277),\n",
       "  ('newly diagnosed', 0.1184),\n",
       "  ('proportional hazards', 0.1157),\n",
       "  ('14 micromol', 0.0852),\n",
       "  ('earlier relative', 0.0766),\n",
       "  ('cross', 0.0709),\n",
       "  ('interval increase', 0.0666),\n",
       "  ('required', 0.0653),\n",
       "  ('line measured', 0.0644),\n",
       "  ('sd base', 0.0569),\n",
       "  ('used multivariable', 0.052),\n",
       "  ('genotype', 0.0454),\n",
       "  ('men mean', 0.0442),\n",
       "  ('doubled conclusions', 0.0442),\n",
       "  ('b12 b6', 0.0398),\n",
       "  ('developed 111', 0.0395),\n",
       "  ('log transformed', -0.008)],\n",
       " 'MED-988': [('disease homocysteine', 0.6975),\n",
       "  ('homocysteine promotes', 0.6714),\n",
       "  ('cofactors homocysteine', 0.6656),\n",
       "  ('hyperhomocysteinemia folate', 0.609),\n",
       "  ('links hyperhomocysteinemia', 0.5669),\n",
       "  ('reduction homocysteine', 0.5244),\n",
       "  ('atherothrombotic disorders', 0.4915),\n",
       "  ('risk atherosclerosis', 0.4543),\n",
       "  ('folate status', 0.4255),\n",
       "  ('supplementation cardiovascular', 0.3858),\n",
       "  ('increased risk', 0.3828),\n",
       "  ('cardiovascular events', 0.3752),\n",
       "  ('pathologies', 0.3578),\n",
       "  ('require vitamins', 0.3433),\n",
       "  ('oxidant mechanisms', 0.3214),\n",
       "  ('systemic endothelial', 0.3183),\n",
       "  ('cofactors', 0.3081),\n",
       "  ('elevated plasma', 0.3054),\n",
       "  ('metabolism', 0.2827),\n",
       "  ('enzymes require', 0.2712),\n",
       "  ('mediator disorders', 0.2634),\n",
       "  ('thrombosis variety', 0.2592),\n",
       "  ('mechanisms marker', 0.2497),\n",
       "  ('levels particularly', 0.2392),\n",
       "  ('alzheimer disease', 0.2347),\n",
       "  ('lowering plasma', 0.2285),\n",
       "  ('birth defects', 0.2075),\n",
       "  ('diabetes renal', 0.2075),\n",
       "  ('osteoporosis', 0.1771),\n",
       "  ('review data', 0.1736),\n",
       "  ('cellular protein', 0.1551),\n",
       "  ('stress article', 0.1517),\n",
       "  ('status predictive', 0.1315),\n",
       "  ('orders raised', 0.1191),\n",
       "  ('large body', 0.1166),\n",
       "  ('data links', 0.1115),\n",
       "  ('population marker', 0.1112),\n",
       "  ('hypothesis reduction', 0.1086),\n",
       "  ('primary cause', 0.1038),\n",
       "  ('catalyzed number', 0.084),\n",
       "  ('trials failed', 0.0768),\n",
       "  ('require', 0.0711),\n",
       "  ('published elsevier', 0.0626),\n",
       "  ('general population', 0.0624),\n",
       "  ('promotes', 0.0496),\n",
       "  ('power plasma', 0.0469),\n",
       "  ('common', -0.048),\n",
       "  ('raised appealing', -0.0564),\n",
       "  ('events spite', -0.0801),\n",
       "  ('actually plays', -0.0923)],\n",
       " 'MED-990': [('association homocysteine', 0.6043),\n",
       "  ('cognitive impairment', 0.3958),\n",
       "  ('elderly persons', 0.3592),\n",
       "  ('reduced cerebral', 0.3214),\n",
       "  ('markers cardiovascular', 0.3133),\n",
       "  ('hyperintensities occur', 0.2938),\n",
       "  ('folate levels', 0.2798),\n",
       "  ('non demented', 0.2636),\n",
       "  ('interrelationships non', 0.2605),\n",
       "  ('neurological diseases', 0.2578),\n",
       "  ('community dwelling', 0.2546),\n",
       "  ('imaging brain', 0.2442),\n",
       "  ('hypertension excluded', 0.2344),\n",
       "  ('lipid profile', 0.232),\n",
       "  ('objectives elevated', 0.2312),\n",
       "  ('relatively healthy', 0.2178),\n",
       "  ('emerged risk', 0.2137),\n",
       "  ('global cerebral', 0.1952),\n",
       "  ('correlated effects', 0.1945),\n",
       "  ('effects dissociated', 0.1871),\n",
       "  ('psychiatry published', 0.1851),\n",
       "  ('hippocampal', 0.1841),\n",
       "  ('medical conditions', 0.1818),\n",
       "  ('population methods', 0.1799),\n",
       "  ('asian population', 0.176),\n",
       "  ('controlling age', 0.1691),\n",
       "  ('studied report', 0.14),\n",
       "  ('participants underwent', 0.1262),\n",
       "  ('matter volume', 0.1258),\n",
       "  ('magnetic resonance', 0.1161),\n",
       "  ('ventricles', 0.1159),\n",
       "  ('12 markers', 0.1158),\n",
       "  ('evaluated persons', 0.1109),\n",
       "  ('mass index', 0.1101),\n",
       "  ('mellitus', 0.1018),\n",
       "  ('plasma', 0.1008),\n",
       "  ('related white', 0.0981),\n",
       "  ('55 years', 0.0976),\n",
       "  ('223 004', 0.0937),\n",
       "  ('level copyright', 0.0846),\n",
       "  ('scores reduced', 0.0843),\n",
       "  ('domains', 0.0624),\n",
       "  ('education', 0.0583),\n",
       "  ('elsevier rights', 0.0514),\n",
       "  ('fasting', 0.0474),\n",
       "  ('single', 0.0094),\n",
       "  ('volume 20', 0.0075),\n",
       "  ('38 df', -0.0078),\n",
       "  ('speed processing', -0.0184),\n",
       "  ('american association', -0.0292)],\n",
       " 'MED-991': [('impairment dementia', 0.6161),\n",
       "  ('cognitive mortality', 0.5629),\n",
       "  ('impairment participants', 0.4305),\n",
       "  ('impairment medical', 0.4245),\n",
       "  ('longitudinal cognitive', 0.3763),\n",
       "  ('older cognitive', 0.3692),\n",
       "  ('risk disability', 0.355),\n",
       "  ('care costs', 0.3476),\n",
       "  ('including neuropsychological', 0.3356),\n",
       "  ('disability increased', 0.3284),\n",
       "  ('cerebrovascular disease', 0.3272),\n",
       "  ('annual death', 0.2921),\n",
       "  ('study 1770', 0.2795),\n",
       "  ('normal cognition', 0.265),\n",
       "  ('prevalence estimates', 0.258),\n",
       "  ('costs progression', 0.2538),\n",
       "  ('neurologic examination', 0.2448),\n",
       "  ('assessment population', 0.2391),\n",
       "  ('health retirement', 0.2359),\n",
       "  ('conditions limitations', 0.2259),\n",
       "  ('demographics memory', 0.2219),\n",
       "  ('included prodromal', 0.2208),\n",
       "  ('march 2005', 0.2187),\n",
       "  ('stroke progressed', 0.206),\n",
       "  ('15 cognitive', 0.193),\n",
       "  ('disease participants', 0.193),\n",
       "  ('nonresponse attrition', 0.1851),\n",
       "  ('assign diagnosis', 0.1847),\n",
       "  ('11 cognitive', 0.1684),\n",
       "  ('increased risk', 0.1598),\n",
       "  ('objective', 0.1506),\n",
       "  ('july 2001', 0.1424),\n",
       "  ('attrition conclusion', 0.1341),\n",
       "  ('states determine', 0.1204),\n",
       "  ('subtypes vary', 0.1184),\n",
       "  ('241 selected', 0.1135),\n",
       "  ('weights derived', 0.0989),\n",
       "  ('history used', 0.0978),\n",
       "  ('56 nondeceased', 0.0885),\n",
       "  ('results 2002', 0.0728),\n",
       "  ('national', 0.0654),\n",
       "  ('million people', 0.0625),\n",
       "  ('adams aging', 0.0508),\n",
       "  ('prevalent united', 0.0171),\n",
       "  ('856 completed', 0.0146),\n",
       "  ('completed initial', 0.0135),\n",
       "  ('setting home', 0.0108),\n",
       "  ('20 annual', -0.0099),\n",
       "  ('individuals 180', -0.0303),\n",
       "  ('month follow', -0.0595)],\n",
       " 'MED-992': [('homocysteine levels', 0.6466),\n",
       "  ('lifestyle interventions', 0.5088),\n",
       "  ('40 self', 0.3321),\n",
       "  ('stress management', 0.3193),\n",
       "  ('disease risk', 0.2884),\n",
       "  ('diet interact', 0.282),\n",
       "  ('lifestyle', 0.271),\n",
       "  ('results subjects', 0.249),\n",
       "  ('interventions favorably', 0.2459),\n",
       "  ('associated cardiac', 0.2414),\n",
       "  ('current research', 0.2413),\n",
       "  ('vitamin intake', 0.2328),\n",
       "  ('enhancement sessions', 0.2327),\n",
       "  ('approaches', 0.2192),\n",
       "  ('categories conclusions', 0.2049),\n",
       "  ('plant based', 0.2035),\n",
       "  ('program subject', 0.2014),\n",
       "  ('12 micromol', 0.197),\n",
       "  ('concerns comprehensive', 0.1964),\n",
       "  ('enrollment week', 0.1874),\n",
       "  ('levels directly', 0.1795),\n",
       "  ('results suggest', 0.1785),\n",
       "  ('caffeine', 0.1741),\n",
       "  ('spirituality enhancement', 0.1656),\n",
       "  ('known modulators', 0.1636),\n",
       "  ('levels fell', 0.1614),\n",
       "  ('background plasma', 0.1612),\n",
       "  ('self selected', 0.1518),\n",
       "  ('methods report', 0.1498),\n",
       "  ('participated vegan', 0.1494),\n",
       "  ('reduce blood', 0.1417),\n",
       "  ('subgroup analysis', 0.1416),\n",
       "  ('exclusion tobacco', 0.1361),\n",
       "  ('factors addition', 0.1348),\n",
       "  ('broad based', 0.133),\n",
       "  ('group support', 0.1254),\n",
       "  ('fasting plasma', 0.115),\n",
       "  ('attended residential', 0.113),\n",
       "  ('66 micromol', 0.1056),\n",
       "  ('53 micromol', 0.1023),\n",
       "  ('observed', 0.0925),\n",
       "  ('raises', 0.0914),\n",
       "  ('micromol sd', 0.0888),\n",
       "  ('oklahoma', 0.0878),\n",
       "  ('fell 13', 0.0824),\n",
       "  ('center america', 0.0794),\n",
       "  ('america sulphur', 0.0702),\n",
       "  ('0001 subgroup', 0.0525),\n",
       "  ('moderate physical', 0.0269),\n",
       "  ('range demographic', 0.0083)],\n",
       " 'MED-993': [('folate status', 0.6145),\n",
       "  ('collected dietary', 0.4307),\n",
       "  ('dietary fiber', 0.4163),\n",
       "  ('intakes predicted', 0.3748),\n",
       "  ('frequency questionnaires', 0.3732),\n",
       "  ('prevalence biochemical', 0.3531),\n",
       "  ('concentrations subjects', 0.3217),\n",
       "  ('recruited fasting', 0.3145),\n",
       "  ('food frequency', 0.3041),\n",
       "  ('deficiency subjects', 0.2996),\n",
       "  ('low dietary', 0.2972),\n",
       "  ('nutriture humans', 0.2938),\n",
       "  ('homocysteine concentrations', 0.2909),\n",
       "  ('canadian', 0.2857),\n",
       "  ('participants classified', 0.2853),\n",
       "  ('adolescents aged', 0.278),\n",
       "  ('results suggest', 0.2729),\n",
       "  ('questionnaires fourteen', 0.2565),\n",
       "  ('224 recruited', 0.2548),\n",
       "  ('suggest consumption', 0.2507),\n",
       "  ('objective study', 0.2471),\n",
       "  ('blood samples', 0.2362),\n",
       "  ('requirements 23', 0.2229),\n",
       "  ('assess association', 0.2168),\n",
       "  ('requirements', 0.2049),\n",
       "  ('significantly associated', 0.1913),\n",
       "  ('fiber', 0.1903),\n",
       "  ('patterns assessed', 0.1799),\n",
       "  ('functional consequences', 0.177),\n",
       "  ('recruited', 0.1761),\n",
       "  ('female', 0.1695),\n",
       "  ('14 19', 0.1501),\n",
       "  ('lactoovovegetarians', 0.149),\n",
       "  ('increase serum', 0.1449),\n",
       "  ('biosynthesis', 0.1147),\n",
       "  ('depletion produced', 0.1103),\n",
       "  ('suggesting degree', 0.1087),\n",
       "  ('expected summary', 0.1049),\n",
       "  ('providing complementary', 0.0872),\n",
       "  ('strategy', 0.0759),\n",
       "  ('promote intestinal', 0.0684),\n",
       "  ('main', 0.055),\n",
       "  ('record recorded', 0.0523),\n",
       "  ('001', 0.0386),\n",
       "  ('polysaccharide significantly', 0.0385),\n",
       "  ('omnivores basis', 0.0324),\n",
       "  ('percent 17', 0.0143),\n",
       "  ('despite', -0.0106),\n",
       "  ('increase nonstarch', -0.0178),\n",
       "  ('26', -0.0341)],\n",
       " 'MED-994': [('dementia risk', 0.567),\n",
       "  ('lower homocysteine', 0.4808),\n",
       "  ('decline alzheimer', 0.4575),\n",
       "  ('cerebral atrophy', 0.3751),\n",
       "  ('mild cognitive', 0.3732),\n",
       "  ('modify nongenetic', 0.3708),\n",
       "  ('prevent atrophy', 0.3613),\n",
       "  ('lowering elevated', 0.3562),\n",
       "  ('related cognitive', 0.3551),\n",
       "  ('using vitamins', 0.3289),\n",
       "  ('risk factors', 0.3255),\n",
       "  ('decrease gm', 0.3197),\n",
       "  ('focusing elderly', 0.3195),\n",
       "  ('supplementation slow', 0.3083),\n",
       "  ('treatment reduces', 0.2997),\n",
       "  ('high homocysteine', 0.2928),\n",
       "  ('shrinkage brain', 0.2864),\n",
       "  ('approach modify', 0.2795),\n",
       "  ('specifically vulnerable', 0.2605),\n",
       "  ('decline results', 0.2517),\n",
       "  ('largely prevented', 0.2513),\n",
       "  ('impairment according', 0.2513),\n",
       "  ('component ad', 0.2451),\n",
       "  ('baseline associated', 0.2392),\n",
       "  ('warranted progression', 0.2386),\n",
       "  ('gm regions', 0.2276),\n",
       "  ('key brain', 0.221),\n",
       "  ('disease', 0.2114),\n",
       "  ('mg slowed', 0.1956),\n",
       "  ('bayesian network', 0.1905),\n",
       "  ('confined participants', 0.1894),\n",
       "  ('temporal lobe', 0.1853),\n",
       "  ('trials focusing', 0.181),\n",
       "  ('b12 mg', 0.1768),\n",
       "  ('according 2004', 0.1666),\n",
       "  ('beneficial effect', 0.1388),\n",
       "  ('petersen criteria', 0.1319),\n",
       "  ('participants causal', 0.1212),\n",
       "  ('20 mg', 0.119),\n",
       "  ('folic', 0.1128),\n",
       "  ('placebo group', 0.1075),\n",
       "  ('analysis indicates', 0.1072),\n",
       "  ('fold cerebral', 0.0961),\n",
       "  ('subjects increased', 0.0882),\n",
       "  ('including medial', 0.0842),\n",
       "  ('plasma', 0.054),\n",
       "  ('volume demonstrating', 0.028),\n",
       "  ('median', 0.0198),\n",
       "  ('subjets', -0.017),\n",
       "  ('median 11', -0.1113)],\n",
       " 'MED-995': [('exposure pbdes', 0.503),\n",
       "  ('concentrations breast', 0.4403),\n",
       "  ('mothers', 0.4249),\n",
       "  ('exposure collected', 0.4081),\n",
       "  ('breast milk', 0.4045),\n",
       "  ('birth sampled', 0.3954),\n",
       "  ('dust samples', 0.3695),\n",
       "  ('milk house', 0.33),\n",
       "  ('routes exposure', 0.3295),\n",
       "  ('polybrominated diphenyl', 0.2617),\n",
       "  ('homes subset', 0.25),\n",
       "  ('samples 46', 0.2293),\n",
       "  ('samples analyzed', 0.2057),\n",
       "  ('indoor environment', 0.1997),\n",
       "  ('boston massachusetts', 0.1958),\n",
       "  ('study', 0.1939),\n",
       "  ('weeks', 0.1873),\n",
       "  ('concentrations log', 0.1864),\n",
       "  ('association bde', 0.1727),\n",
       "  ('used areas', 0.172),\n",
       "  ('body burden', 0.1694),\n",
       "  ('associations', 0.1694),\n",
       "  ('consumption dairy', 0.1685),\n",
       "  ('ethers', 0.1594),\n",
       "  ('diet play', 0.1545),\n",
       "  ('41', 0.1532),\n",
       "  ('results support', 0.1473),\n",
       "  ('01 low', 0.144),\n",
       "  ('electrical devices', 0.1303),\n",
       "  ('habits particularly', 0.1274),\n",
       "  ('using questionnaire', 0.1235),\n",
       "  ('designed', 0.1053),\n",
       "  ('draw conclusions', 0.1041),\n",
       "  ('gathered', 0.1034),\n",
       "  ('mass spectrometry', 0.1028),\n",
       "  ('normally distributed', 0.098),\n",
       "  ('data personal', 0.0942),\n",
       "  ('prominent roles', 0.0902),\n",
       "  ('209 reported', 0.0897),\n",
       "  ('detection rates', 0.0871),\n",
       "  ('participants vacuuming', 0.0783),\n",
       "  ('005 meat', 0.0683),\n",
       "  ('003 including', 0.0543),\n",
       "  ('positive', 0.0538),\n",
       "  ('76 003', 0.0413),\n",
       "  ('explore', 0.0362),\n",
       "  ('using gas', 0.0204),\n",
       "  ('key', 0.0163),\n",
       "  ('adult human', 0.0067),\n",
       "  ('furniture', -0.0099)],\n",
       " 'MED-996': [('investigated pbdes', 0.612),\n",
       "  ('pbdes gestational', 0.6081),\n",
       "  ('pbdes persistent', 0.6079),\n",
       "  ('polybrominated', 0.5502),\n",
       "  ('ethers pbdes', 0.5485),\n",
       "  ('bde concentrations', 0.4561),\n",
       "  ('exposure pathways', 0.4052),\n",
       "  ('specific brominated', 0.3765),\n",
       "  ('impacts perinatal', 0.369),\n",
       "  ('chemicals used', 0.3438),\n",
       "  ('diphenyl ethers', 0.3368),\n",
       "  ('investigations fetal', 0.3209),\n",
       "  ('gestational compartment', 0.2943),\n",
       "  ('textiles plastics', 0.2864),\n",
       "  ('median concentrations', 0.2775),\n",
       "  ('1970s', 0.2647),\n",
       "  ('retardants', 0.2228),\n",
       "  ('bde 99', 0.2003),\n",
       "  ('dominant congeners', 0.1914),\n",
       "  ('accumulation humans', 0.1808),\n",
       "  ('persistent', 0.1794),\n",
       "  ('used flame', 0.1724),\n",
       "  ('amniotic fluid', 0.1723),\n",
       "  ('study reports', 0.146),\n",
       "  ('need investigations', 0.1424),\n",
       "  ('total detected', 0.1362),\n",
       "  ('21842', 0.1334),\n",
       "  ('second trimester', 0.1306),\n",
       "  ('identified levels', 0.1277),\n",
       "  ('203 206', 0.1262),\n",
       "  ('women southeast', 0.1226),\n",
       "  ('samples collected', 0.1213),\n",
       "  ('measured gc', 0.1203),\n",
       "  ('16', 0.1046),\n",
       "  ('3795 pg', 0.1031),\n",
       "  ('organic', 0.0862),\n",
       "  ('consumer products', 0.0823),\n",
       "  ('2009 women', 0.0819),\n",
       "  ('fluid range', 0.0719),\n",
       "  ('humans noted', 0.0676),\n",
       "  ('10 respectively', 0.0661),\n",
       "  ('12', 0.0643),\n",
       "  ('pg ml', 0.0481),\n",
       "  ('health', 0.0475),\n",
       "  ('47', 0.031),\n",
       "  ('nci average', 0.0077),\n",
       "  ('usa', -0.0067),\n",
       "  ('date', -0.0219),\n",
       "  ('southeast michigan', -0.0585),\n",
       "  ('representing 23', -0.0769)],\n",
       " 'MED-998': [('pbdes children', 0.6062),\n",
       "  ('neuropsychological development', 0.4742),\n",
       "  ('polybrominated diphenyl', 0.41),\n",
       "  ('potential effects', 0.3923),\n",
       "  ('infant development', 0.3841),\n",
       "  ('hydroxylated pbdes', 0.3828),\n",
       "  ('pops bde', 0.3775),\n",
       "  ('tested children', 0.3717),\n",
       "  ('unmeasured bde', 0.3525),\n",
       "  ('increasing pbde', 0.3399),\n",
       "  ('development small', 0.3348),\n",
       "  ('development 12', 0.3309),\n",
       "  ('organic pollutants', 0.3251),\n",
       "  ('colostrum infant', 0.2773),\n",
       "  ('studies evaluated', 0.277),\n",
       "  ('birth cohort', 0.263),\n",
       "  ('σ7pbdes', 0.2422),\n",
       "  ('worse infant', 0.2401),\n",
       "  ('conclusions findings', 0.2173),\n",
       "  ('pops association', 0.217),\n",
       "  ('209 metabolites', 0.2107),\n",
       "  ('background', 0.1749),\n",
       "  ('congener separately', 0.165),\n",
       "  ('ethers', 0.1615),\n",
       "  ('toxic stable', 0.1535),\n",
       "  ('assess', 0.1442),\n",
       "  ('slightly weaker', 0.1432),\n",
       "  ('showed association', 0.1398),\n",
       "  ('age analyzed', 0.1323),\n",
       "  ('bayley scales', 0.1283),\n",
       "  ('placenta easily', 0.1258),\n",
       "  ('01', 0.1256),\n",
       "  ('persistent', 0.1237),\n",
       "  ('153 154', 0.1234),\n",
       "  ('lipid 25', 0.1175),\n",
       "  ('mental', 0.1167),\n",
       "  ('10 95', 0.1143),\n",
       "  ('highest concentrations', 0.1131),\n",
       "  ('samples 290', 0.0849),\n",
       "  ('reach brain', 0.0825),\n",
       "  ('increasing potential', 0.0746),\n",
       "  ('objectives goal', 0.0737),\n",
       "  ('18 months', 0.0708),\n",
       "  ('40', 0.0549),\n",
       "  ('47', 0.0411),\n",
       "  ('ci 66', 0.0394),\n",
       "  ('women', 0.0297),\n",
       "  ('recruited spanish', 0.012),\n",
       "  ('log ng', -0.0087),\n",
       "  ('cross', -0.0457)],\n",
       " 'MED-999': [('levels pbdes', 0.6873),\n",
       "  ('ethers pbdes', 0.6236),\n",
       "  ('pollutants body', 0.5473),\n",
       "  ('polybrominated diphenyl', 0.5431),\n",
       "  ('brominated flame', 0.4911),\n",
       "  ('widespread environmental', 0.447),\n",
       "  ('fires reducing', 0.3948),\n",
       "  ('human exposure', 0.3713),\n",
       "  ('people fires', 0.3362),\n",
       "  ('bdes', 0.3315),\n",
       "  ('risks derived', 0.3311),\n",
       "  ('combustible materials', 0.3151),\n",
       "  ('retardants', 0.3143),\n",
       "  ('bfrs used', 0.3009),\n",
       "  ('ethers', 0.297),\n",
       "  ('reducing flammability', 0.2838),\n",
       "  ('body burden', 0.2748),\n",
       "  ('congeners', 0.2365),\n",
       "  ('protect people', 0.2073),\n",
       "  ('burden general', 0.2048),\n",
       "  ('european countries', 0.1964),\n",
       "  ('concerning levels', 0.1762),\n",
       "  ('persistent organic', 0.1732),\n",
       "  ('products probably', 0.1488),\n",
       "  ('main routes', 0.1478),\n",
       "  ('differences studies', 0.1283),\n",
       "  ('daily intake', 0.1167),\n",
       "  ('209 comparatively', 0.112),\n",
       "  ('results notable', 0.111),\n",
       "  ('years', 0.1039),\n",
       "  ('various issues', 0.086),\n",
       "  ('health', 0.0619),\n",
       "  ('used', 0.0552),\n",
       "  ('fish seafood', 0.0458),\n",
       "  ('countries usa', 0.04),\n",
       "  ('recent scientific', 0.0373),\n",
       "  ('sum total', 0.0363),\n",
       "  ('coincidences important', 0.0353),\n",
       "  ('directly related', 0.0312),\n",
       "  ('class', 0.0015),\n",
       "  ('population increasing', -0.0033),\n",
       "  ('47 49', -0.0041),\n",
       "  ('elsevier rights', -0.0101),\n",
       "  ('limited number', -0.0225),\n",
       "  ('dairy', -0.0226),\n",
       "  ('spite', -0.0529),\n",
       "  ('copyright 2011', -0.0811),\n",
       "  ('china japan', -0.0849),\n",
       "  ('information human', -0.0877),\n",
       "  ('investigation copyright', -0.0884)],\n",
       " 'MED-1000': [('effects rodents', 0.5881),\n",
       "  ('demonstrated neurotoxic', 0.5424),\n",
       "  ('brominated flame', 0.4421),\n",
       "  ('investigating neurobehavioral', 0.4328),\n",
       "  ('group chemicals', 0.3612),\n",
       "  ('029 effects', 0.354),\n",
       "  ('retardants humans', 0.3531),\n",
       "  ('methods biomonitoring', 0.3455),\n",
       "  ('compared concentrations', 0.3152),\n",
       "  ('pbde exposure', 0.3137),\n",
       "  ('confounders used', 0.3077),\n",
       "  ('studies demonstrated', 0.2981),\n",
       "  ('detrimental', 0.2748),\n",
       "  ('congeners', 0.2665),\n",
       "  ('program environmental', 0.2537),\n",
       "  ('prevent reports', 0.238),\n",
       "  ('animal vitro', 0.2308),\n",
       "  ('studies far', 0.2278),\n",
       "  ('biomarkers internal', 0.2216),\n",
       "  ('background animal', 0.2172),\n",
       "  ('domains', 0.2169),\n",
       "  ('levels 10', 0.2046),\n",
       "  ('153 209', 0.1979),\n",
       "  ('tbbpa cognitive', 0.1861),\n",
       "  ('appeared years', 0.1816),\n",
       "  ('diphenyl ether', 0.1711),\n",
       "  ('multiple regression', 0.1681),\n",
       "  ('data sparse', 0.167),\n",
       "  ('95 ci', 0.1637),\n",
       "  ('average decrease', 0.1616),\n",
       "  ('nes collected', 0.1455),\n",
       "  ('motor function', 0.1451),\n",
       "  ('20 033', 0.1361),\n",
       "  ('34', 0.1248),\n",
       "  ('health surveillance', 0.1203),\n",
       "  ('15', 0.1015),\n",
       "  ('flanders', 0.0905),\n",
       "  ('ci 56', 0.0793),\n",
       "  ('hexabromocyclododecane', 0.0783),\n",
       "  ('fold increase', 0.0706),\n",
       "  ('17 years', 0.0683),\n",
       "  ('used household', 0.0652),\n",
       "  ('belgium assessed', 0.064),\n",
       "  ('ft4 tsh', 0.0443),\n",
       "  ('finger', 0.0213),\n",
       "  ('level 18', 0.0152),\n",
       "  ('did', 0.0043),\n",
       "  ('taps preferred', -0.0198),\n",
       "  ('blood', -0.0445),\n",
       "  ('515 adolescents', -0.1155)],\n",
       " 'MED-1002': [('pbdes thyroid', 0.6532),\n",
       "  ('brominated pbdes', 0.6051),\n",
       "  ('pbdes disrupt', 0.5997),\n",
       "  ('polybrominated diphenyl', 0.5182),\n",
       "  ('concentrations bde', 0.4991),\n",
       "  ('disrupt thyroid', 0.4776),\n",
       "  ('pbde4 observed', 0.4427),\n",
       "  ('hydroxylated pbde', 0.4341),\n",
       "  ('prenatal exposure', 0.4322),\n",
       "  ('σpbde5 σoh', 0.4091),\n",
       "  ('higher brominated', 0.4034),\n",
       "  ('adverse neurodevelopmental', 0.4),\n",
       "  ('concentrations lower', 0.3732),\n",
       "  ('transthyretin', 0.3584),\n",
       "  ('bde 207', 0.3099),\n",
       "  ('exposures elevated', 0.2996),\n",
       "  ('pilot study', 0.2831),\n",
       "  ('associations tsh', 0.2818),\n",
       "  ('characterize risks', 0.2792),\n",
       "  ('chemicals', 0.2775),\n",
       "  ('bde 85', 0.2443),\n",
       "  ('ethers', 0.2421),\n",
       "  ('bde49 inverse', 0.232),\n",
       "  ('disrupt', 0.2304),\n",
       "  ('209 hydroxylated', 0.2294),\n",
       "  ('inverse association', 0.2227),\n",
       "  ('pregnant women', 0.2202),\n",
       "  ('measured serum', 0.2161),\n",
       "  ('σttr binders', 0.1927),\n",
       "  ('second trimester', 0.182),\n",
       "  ('stimulating hormone', 0.1669),\n",
       "  ('084', 0.1668),\n",
       "  ('function contribute', 0.1567),\n",
       "  ('levels positive', 0.153),\n",
       "  ('explore', 0.1514),\n",
       "  ('investigation warranted', 0.1488),\n",
       "  ('known bind', 0.1411),\n",
       "  ('17 154', 0.1339),\n",
       "  ('t4 weak', 0.129),\n",
       "  ('ng lipid', 0.114),\n",
       "  ('outcomes conducted', 0.0926),\n",
       "  ('women median', 0.0728),\n",
       "  ('183', 0.0727),\n",
       "  ('2008 2009', 0.0717),\n",
       "  ('date', 0.0686),\n",
       "  ('inconsistent results', 0.0646),\n",
       "  ('25 second', 0.0435),\n",
       "  ('relationships free', 0.0307),\n",
       "  ('ml sum', -0.0405),\n",
       "  ('california suggest', -0.0849)],\n",
       " 'MED-1003': [('children exposures', 0.5817),\n",
       "  ('exposures polybrominated', 0.5509),\n",
       "  ('pbdes adverse', 0.5432),\n",
       "  ('child pbde', 0.5029),\n",
       "  ('endocrine disruptors', 0.4764),\n",
       "  ('pbdes highest', 0.4664),\n",
       "  ('neurobehavioral development', 0.4483),\n",
       "  ('concentrations associated', 0.3993),\n",
       "  ('neurotoxicants animals', 0.3786),\n",
       "  ('conclusions prenatal', 0.31),\n",
       "  ('background california', 0.2967),\n",
       "  ('flame retardants', 0.2943),\n",
       "  ('adverse impacts', 0.2935),\n",
       "  ('development participants', 0.2698),\n",
       "  ('cohort methods', 0.2517),\n",
       "  ('birth weight', 0.2334),\n",
       "  ('chamacos center', 0.219),\n",
       "  ('levels conclusions', 0.191),\n",
       "  ('coordination cognition', 0.1883),\n",
       "  ('associated concurrent', 0.1871),\n",
       "  ('diphenyl', 0.1599),\n",
       "  ('particularly nondominant', 0.1583),\n",
       "  ('associations altered', 0.1576),\n",
       "  ('age significantly', 0.1532),\n",
       "  ('school age', 0.1495),\n",
       "  ('task years', 0.1447),\n",
       "  ('iq associations', 0.1441),\n",
       "  ('utero', 0.1228),\n",
       "  ('310 years', 0.109),\n",
       "  ('measured continuous', 0.1047),\n",
       "  ('study largest', 0.0917),\n",
       "  ('ether', 0.0914),\n",
       "  ('maternal thyroid', 0.0913),\n",
       "  ('concurrent teacher', 0.0911),\n",
       "  ('animals objective', 0.0899),\n",
       "  ('health assessment', 0.0843),\n",
       "  ('samples examined', 0.0831),\n",
       "  ('investigate relation', 0.0735),\n",
       "  ('associated poorer', 0.0724),\n",
       "  ('processing speed', 0.0594),\n",
       "  ('date contributes', 0.0587),\n",
       "  ('contributes growing', 0.0516),\n",
       "  ('motor', 0.0464),\n",
       "  ('decrements', 0.0451),\n",
       "  ('worldwide', 0.0442),\n",
       "  ('323 results', 0.0247),\n",
       "  ('attention fine', 0.0001),\n",
       "  ('salinas', -0.0565),\n",
       "  ('verbal scale', -0.0571),\n",
       "  ('significantly marginally', -0.0853)],\n",
       " 'MED-1004': [('concentrations pbdes', 0.6255),\n",
       "  ('pbde diet', 0.537),\n",
       "  ('dust diet', 0.5171),\n",
       "  ('background exposure', 0.4685),\n",
       "  ('polybrominated diphenyl', 0.4167),\n",
       "  ('intake contaminated', 0.4075),\n",
       "  ('body burdens', 0.3899),\n",
       "  ('route exposure', 0.3829),\n",
       "  ('significant bde', 0.3553),\n",
       "  ('diet variables', 0.3185),\n",
       "  ('contaminated poultry', 0.2692),\n",
       "  ('thought exposure', 0.2442),\n",
       "  ('intake methods', 0.2434),\n",
       "  ('concentrations 40', 0.2298),\n",
       "  ('associated consumption', 0.2287),\n",
       "  ('congeners associated', 0.2248),\n",
       "  ('objectives primary', 0.2171),\n",
       "  ('background', 0.2098),\n",
       "  ('work empirically', 0.1998),\n",
       "  ('lipid respectively', 0.1924),\n",
       "  ('serum levels', 0.1755),\n",
       "  ('questionnaire ffq', 0.1733),\n",
       "  ('diet little', 0.1725),\n",
       "  ('ethers', 0.1478),\n",
       "  ('health', 0.1466),\n",
       "  ('little work', 0.1461),\n",
       "  ('mass index', 0.1442),\n",
       "  ('united states', 0.1421),\n",
       "  ('153 association', 0.1261),\n",
       "  ('examination survey', 0.1214),\n",
       "  ('009 lower', 0.1044),\n",
       "  ('geometric mean', 0.1042),\n",
       "  ('27 009', 0.0785),\n",
       "  ('2004 national', 0.0763),\n",
       "  ('dairy fish', 0.0739),\n",
       "  ('contributes significantly', 0.073),\n",
       "  ('survey regressed', 0.0729),\n",
       "  ('similar trends', 0.0707),\n",
       "  ('vegetarians 23', 0.0594),\n",
       "  ('age sex', 0.059),\n",
       "  ('adjusting', 0.0533),\n",
       "  ('99 100', 0.0458),\n",
       "  ('41 48', 0.0397),\n",
       "  ('meat contributes', 0.0349),\n",
       "  ('medium high', 0.0099),\n",
       "  ('0005 observed', 0.0078),\n",
       "  ('instruments robust', 0.0047),\n",
       "  ('ethnicity income', -0.0234),\n",
       "  ('red', -0.0477),\n",
       "  ('omnivores', -0.0546)],\n",
       " 'MED-1005': [('systematic review', 0.5605),\n",
       "  ('cochrane controlled', 0.5233),\n",
       "  ('fibre antispasmodics', 0.489),\n",
       "  ('efficacy trials', 0.4387),\n",
       "  ('studies compared', 0.4317),\n",
       "  ('compared fibre', 0.3816),\n",
       "  ('irritable bowel', 0.3382),\n",
       "  ('compared placebo', 0.3062),\n",
       "  ('sources medline', 0.292),\n",
       "  ('therapy compared', 0.2903),\n",
       "  ('peppermint oil', 0.2838),\n",
       "  ('oil treatment', 0.2818),\n",
       "  ('96 trials', 0.2697),\n",
       "  ('placebo 1778', 0.2677),\n",
       "  ('treatment random', 0.2628),\n",
       "  ('duration therapy', 0.2605),\n",
       "  ('embase', 0.2252),\n",
       "  ('effect limited', 0.2234),\n",
       "  ('data symptoms', 0.2111),\n",
       "  ('studied otilonium', 0.2087),\n",
       "  ('relative risk', 0.2038),\n",
       "  ('syndrome eligible', 0.2032),\n",
       "  ('pain treatment', 0.1984),\n",
       "  ('inclusion minimum', 0.1965),\n",
       "  ('objective determine', 0.1958),\n",
       "  ('2008', 0.1827),\n",
       "  ('32', 0.1799),\n",
       "  ('improvement abdominal', 0.1765),\n",
       "  ('various', 0.1746),\n",
       "  ('meta', 0.1696),\n",
       "  ('considered week', 0.1651),\n",
       "  ('symptoms 55', 0.1597),\n",
       "  ('register april', 0.1521),\n",
       "  ('confidence interval', 0.1516),\n",
       "  ('symptoms 87', 0.1389),\n",
       "  ('results 12', 0.1348),\n",
       "  ('assessment cure', 0.1323),\n",
       "  ('global', 0.1115),\n",
       "  ('model used', 0.1071),\n",
       "  ('63', 0.1011),\n",
       "  ('591 patients', 0.0936),\n",
       "  ('patients relative', 0.0851),\n",
       "  ('78 showed', 0.0834),\n",
       "  ('used pool', 0.0365),\n",
       "  ('426 patients', 0.0357),\n",
       "  ('persisting results', 0.0206),\n",
       "  ('392', 0.012),\n",
       "  ('435', -0.0204),\n",
       "  ('adults', -0.0342),\n",
       "  ('hyoscine', -0.0627)],\n",
       " 'MED-1006': [('pain ibs', 0.6192),\n",
       "  ('physicians gastroenterologists', 0.4339),\n",
       "  ('treatment abdominal', 0.422),\n",
       "  ('pain improve', 0.4213),\n",
       "  ('cognitive interventions', 0.4114),\n",
       "  ('nervous gastrointestinal', 0.4089),\n",
       "  ('bowel syndrome', 0.3928),\n",
       "  ('pharmacological treatment', 0.3766),\n",
       "  ('therapies diarrhea', 0.3532),\n",
       "  ('context irritable', 0.3302),\n",
       "  ('hypnotherapy demonstrated', 0.3223),\n",
       "  ('resistant constipation', 0.3005),\n",
       "  ('non pharmacological', 0.2851),\n",
       "  ('specialists review', 0.2695),\n",
       "  ('studies antispasmodics', 0.2674),\n",
       "  ('ischemic colitis', 0.2504),\n",
       "  ('probiotics difficult', 0.241),\n",
       "  ('primary care', 0.2397),\n",
       "  ('drugs lubiprostone', 0.2324),\n",
       "  ('patients refractory', 0.2316),\n",
       "  ('targeting central', 0.2171),\n",
       "  ('evidence current', 0.1973),\n",
       "  ('patients reduce', 0.196),\n",
       "  ('absorbable antibiotic', 0.1947),\n",
       "  ('challenging problem', 0.17),\n",
       "  ('fermentable carbohydrates', 0.1686),\n",
       "  ('functional', 0.1639),\n",
       "  ('interpret strains', 0.1492),\n",
       "  ('used studies', 0.1391),\n",
       "  ('serotonin reuptake', 0.1388),\n",
       "  ('effective subgroups', 0.1352),\n",
       "  ('rifaximin', 0.1326),\n",
       "  ('use daily', 0.1318),\n",
       "  ('diet low', 0.1286),\n",
       "  ('including peppermint', 0.1277),\n",
       "  ('tcas shown', 0.1225),\n",
       "  ('fodmap', 0.1206),\n",
       "  ('intensive nature', 0.1183),\n",
       "  ('antagonists', 0.1084),\n",
       "  ('use restricted', 0.1041),\n",
       "  ('bloating', 0.0911),\n",
       "  ('alosetron ramosetron', 0.0785),\n",
       "  ('limited isphagula', 0.0744),\n",
       "  ('future non', 0.0734),\n",
       "  ('cyclase agonist', 0.0685),\n",
       "  ('different quantities', 0.0605),\n",
       "  ('polyols', 0.0487),\n",
       "  ('excellent results', 0.0456),\n",
       "  ('availability labor', 0.0309),\n",
       "  ('second line', 0.0264)],\n",
       " 'MED-1007': [('irritable bowel', 0.5284),\n",
       "  ('gastrointestinal disorders', 0.5109),\n",
       "  ('prevalence irritable', 0.5066),\n",
       "  ('disorder underestimated', 0.4323),\n",
       "  ('disorder', 0.378),\n",
       "  ('syndrome sufferers', 0.3683),\n",
       "  ('determine prevalence', 0.3669),\n",
       "  ('symptoms general', 0.3553),\n",
       "  ('survey used', 0.3456),\n",
       "  ('motility disorder', 0.3244),\n",
       "  ('alternating constipation', 0.3155),\n",
       "  ('screening interview', 0.3085),\n",
       "  ('minority sufferers', 0.3054),\n",
       "  ('poorly quantified', 0.2901),\n",
       "  ('medically diagnosed', 0.272),\n",
       "  ('fulfilling irritable', 0.2699),\n",
       "  ('sufferers undiagnosed', 0.2692),\n",
       "  ('rome ii', 0.2581),\n",
       "  ('undiagnosed meeting', 0.2452),\n",
       "  ('patterns impact', 0.2351),\n",
       "  ('background impact', 0.2332),\n",
       "  ('information irritable', 0.2277),\n",
       "  ('random digit', 0.2276),\n",
       "  ('pain discomfort', 0.2258),\n",
       "  ('aim determine', 0.2237),\n",
       "  ('methods phase', 0.2201),\n",
       "  ('ii information', 0.2181),\n",
       "  ('health considerable', 0.2132),\n",
       "  ('14 medically', 0.1851),\n",
       "  ('quantified clinicians', 0.1848),\n",
       "  ('diarrhoea previously', 0.1801),\n",
       "  ('results total', 0.1674),\n",
       "  ('community', 0.1622),\n",
       "  ('extent non', 0.1536),\n",
       "  ('prompting consultation', 0.1517),\n",
       "  ('socioeconomic', 0.1256),\n",
       "  ('quota', 0.1204),\n",
       "  ('reported alternating', 0.1188),\n",
       "  ('using depth', 0.1164),\n",
       "  ('syndrome 5009', 0.0989),\n",
       "  ('lives collected', 0.0949),\n",
       "  ('telephone dialing', 0.0931),\n",
       "  ('bed reduced', 0.0834),\n",
       "  ('vs days', 0.0778),\n",
       "  ('healthy controls', 0.0727),\n",
       "  ('conclusions 76', 0.0666),\n",
       "  ('10 abdominal', 0.0573),\n",
       "  ('diagnosed 63', 0.054),\n",
       "  ('work vs', 0.0177),\n",
       "  ('manning', -0.0153)],\n",
       " 'MED-1008': [('peppermint oil', 0.6092),\n",
       "  ('patients peppermint', 0.4767),\n",
       "  ('bowel syndrome', 0.457),\n",
       "  ('oil enteric', 0.4423),\n",
       "  ('oil patients', 0.3611),\n",
       "  ('treating irritable', 0.3545),\n",
       "  ('effectiveness enteric', 0.332),\n",
       "  ('small intestinal', 0.3149),\n",
       "  ('study symptoms', 0.2865),\n",
       "  ('syndrome aim', 0.27),\n",
       "  ('defecation symptom', 0.2636),\n",
       "  ('intolerance celiac', 0.2465),\n",
       "  ('diarrhoea', 0.2444),\n",
       "  ('coated capsules', 0.2421),\n",
       "  ('patients affected', 0.2293),\n",
       "  ('bacterial overgrowth', 0.205),\n",
       "  ('symptoms similar', 0.2021),\n",
       "  ('evaluated abdominal', 0.2012),\n",
       "  ('mucus', 0.1908),\n",
       "  ('frequency scores', 0.1788),\n",
       "  ('placebo weeks', 0.1721),\n",
       "  ('incomplete', 0.1673),\n",
       "  ('evacuation pain', 0.1671),\n",
       "  ('methods', 0.1597),\n",
       "  ('test effectiveness', 0.1584),\n",
       "  ('studied variable', 0.1522),\n",
       "  ('gas', 0.1439),\n",
       "  ('introduction use', 0.1415),\n",
       "  ('rome ii', 0.1347),\n",
       "  ('disease excluded', 0.1343),\n",
       "  ('assessed therapy', 0.1286),\n",
       "  ('breath tests', 0.1256),\n",
       "  ('urgency', 0.117),\n",
       "  ('lactose lactulose', 0.1153),\n",
       "  ('compared mean', 0.1128),\n",
       "  ('significant reduction', 0.0882),\n",
       "  ('01 compared', 0.0876),\n",
       "  ('change', 0.0744),\n",
       "  ('group 009', 0.0706),\n",
       "  ('negative antibody', 0.0695),\n",
       "  ('19 13', 0.066),\n",
       "  ('results 75', 0.0588),\n",
       "  ('compared 38', 0.0558),\n",
       "  ('improves', 0.046),\n",
       "  ('probably presence', 0.0404),\n",
       "  ('10 60', 0.0303),\n",
       "  ('twice', 0.025),\n",
       "  ('seven patients', 0.0043),\n",
       "  ('bloating', 0.0021),\n",
       "  ('basal total', -0.0105)],\n",
       " 'MED-1009': [('outpatients ibs', 0.5316),\n",
       "  ('release peppermint', 0.4974),\n",
       "  ('week colpermin', 0.4805),\n",
       "  ('peppermint oil', 0.4665),\n",
       "  ('bowel syndrome', 0.4087),\n",
       "  ('colpermin placebo', 0.399),\n",
       "  ('enteric coated', 0.3774),\n",
       "  ('herbal', 0.3345),\n",
       "  ('controlling symptoms', 0.3046),\n",
       "  ('took capsule', 0.289),\n",
       "  ('study 90', 0.2871),\n",
       "  ('remedies particularly', 0.2793),\n",
       "  ('outpatients', 0.2773),\n",
       "  ('evaluated symptoms', 0.277),\n",
       "  ('free abdominal', 0.259),\n",
       "  ('placebo controlled', 0.2509),\n",
       "  ('conducted randomized', 0.2463),\n",
       "  ('suffering abdominal', 0.2352),\n",
       "  ('daily weeks', 0.2122),\n",
       "  ('pain reduced', 0.2113),\n",
       "  ('safe therapeutic', 0.2011),\n",
       "  ('week 14', 0.1783),\n",
       "  ('subjects took', 0.1715),\n",
       "  ('therapeutic agent', 0.1619),\n",
       "  ('controls 001', 0.1559),\n",
       "  ('syndrome', 0.1559),\n",
       "  ('reported helpful', 0.1437),\n",
       "  ('001 severity', 0.1425),\n",
       "  ('delayed release', 0.1339),\n",
       "  ('subjects free', 0.1339),\n",
       "  ('number subjects', 0.1222),\n",
       "  ('patients fourth', 0.119),\n",
       "  ('agent patients', 0.1067),\n",
       "  ('eighth', 0.1058),\n",
       "  ('effective', 0.1044),\n",
       "  ('study', 0.0955),\n",
       "  ('discomfort changed', 0.0882),\n",
       "  ('oil', 0.0784),\n",
       "  ('irritable', 0.0766),\n",
       "  ('group', 0.0614),\n",
       "  ('significantly', 0.0587),\n",
       "  ('changed week', 0.0551),\n",
       "  ('compared', 0.0297),\n",
       "  ('times', 0.0196),\n",
       "  ('quality', 0.0177),\n",
       "  ('double', 0.0149),\n",
       "  ('visited', 0.0034),\n",
       "  ('reaction', -0.009),\n",
       "  ('life number', -0.0232),\n",
       "  ('blind', -0.0388)],\n",
       " 'MED-1010': [('studies sexual', 0.5106),\n",
       "  ('caused antidepressants', 0.4792),\n",
       "  ('impact sertraline', 0.4504),\n",
       "  ('studies differences', 0.4259),\n",
       "  ('quantify sd', 0.406),\n",
       "  ('prescribed drug', 0.3485),\n",
       "  ('meta analysis', 0.3421),\n",
       "  ('questionnaires methods', 0.3346),\n",
       "  ('using medline', 0.3281),\n",
       "  ('escitalopram', 0.3143),\n",
       "  ('investigated direct', 0.3019),\n",
       "  ('drugs decreasing', 0.2972),\n",
       "  ('cochrane collaboration', 0.2912),\n",
       "  ('duloxetine', 0.2884),\n",
       "  ('fluoxetine imipramine', 0.2841),\n",
       "  ('used assess', 0.2691),\n",
       "  ('underestimated adverse', 0.2669),\n",
       "  ('dysfunction results', 0.2547),\n",
       "  ('scarcely report', 0.2405),\n",
       "  ('considered clinical', 0.2394),\n",
       "  ('significance findings', 0.236),\n",
       "  ('basis studies', 0.23),\n",
       "  ('reduce significance', 0.2212),\n",
       "  ('variation compounds', 0.2204),\n",
       "  ('nefazodone discussion', 0.22),\n",
       "  ('citalopram', 0.2081),\n",
       "  ('secondary outcome', 0.1988),\n",
       "  ('assumptions inclusion', 0.1954),\n",
       "  ('measures rates', 0.19),\n",
       "  ('directly questioned', 0.1849),\n",
       "  ('references', 0.1802),\n",
       "  ('discussion treatment', 0.1758),\n",
       "  ('revman version', 0.1679),\n",
       "  ('report aim', 0.167),\n",
       "  ('isi', 0.1427),\n",
       "  ('order impact', 0.1192),\n",
       "  ('emergent desire', 0.1173),\n",
       "  ('bupropion', 0.1125),\n",
       "  ('arousal', 0.1107),\n",
       "  ('used', 0.1035),\n",
       "  ('web knowledge', 0.1027),\n",
       "  ('compared placebo', 0.0909),\n",
       "  ('patients previous', 0.0892),\n",
       "  ('total specific', 0.0833),\n",
       "  ('ranging 25', 0.0812),\n",
       "  ('phenelzine', 0.0709),\n",
       "  ('agomelatine', 0.0647),\n",
       "  ('80 patients', 0.0005),\n",
       "  ('open label', -0.0358),\n",
       "  ('significantly higher', -0.0629)],\n",
       " 'MED-1011': [('using placebos', 0.6318),\n",
       "  ('ibs quality', 0.4139),\n",
       "  ('treatment control', 0.3998),\n",
       "  ('randomized open', 0.3786),\n",
       "  ('treatment irritable', 0.3753),\n",
       "  ('clinical studies', 0.3577),\n",
       "  ('non concealed', 0.3569),\n",
       "  ('reduced symptom', 0.3372),\n",
       "  ('consent trial', 0.3247),\n",
       "  ('concealment deception', 0.3139),\n",
       "  ('influence subjective', 0.2909),\n",
       "  ('methods', 0.29),\n",
       "  ('trial august', 0.2651),\n",
       "  ('treatment significantly', 0.2627),\n",
       "  ('severity scale', 0.2584),\n",
       "  ('bowel', 0.2481),\n",
       "  ('controlled week', 0.2459),\n",
       "  ('primary outcome', 0.2237),\n",
       "  ('non', 0.2163),\n",
       "  ('healing processes', 0.213),\n",
       "  ('pills inert', 0.2053),\n",
       "  ('elucidate physicians', 0.2025),\n",
       "  ('research warranted', 0.1849),\n",
       "  ('controls quality', 0.1838),\n",
       "  ('findings open', 0.1798),\n",
       "  ('rome', 0.175),\n",
       "  ('diagnosed', 0.1743),\n",
       "  ('sss 008', 0.1552),\n",
       "  ('mind body', 0.1552),\n",
       "  ('widely believed', 0.1369),\n",
       "  ('substance like', 0.1315),\n",
       "  ('nct01010191', 0.131),\n",
       "  ('interaction providers', 0.1303),\n",
       "  ('administration superior', 0.1175),\n",
       "  ('april 2010', 0.1124),\n",
       "  ('sugar pills', 0.1078),\n",
       "  ('midpoint vs', 0.1005),\n",
       "  ('matched patient', 0.0994),\n",
       "  ('sd global', 0.0729),\n",
       "  ('gis secondary', 0.0701),\n",
       "  ('gov', 0.0664),\n",
       "  ('02 03', 0.0567),\n",
       "  ('group', 0.0445),\n",
       "  ('qol 21', 0.0297),\n",
       "  ('score 150', 0.0136),\n",
       "  ('47 18', 0.0127),\n",
       "  ('70 patients', -0.0089),\n",
       "  ('trend favoring', -0.0099),\n",
       "  ('academic center', -0.0126),\n",
       "  ('primarily female', -0.0745)],\n",
       " 'MED-1012': [('ibs treatments', 0.6163),\n",
       "  ('symptoms studies', 0.4679),\n",
       "  ('interventions limited', 0.4605),\n",
       "  ('irritable bowel', 0.4289),\n",
       "  ('assess efficacy', 0.422),\n",
       "  ('randomized controlled', 0.407),\n",
       "  ('symptom control', 0.3971),\n",
       "  ('compared placebo', 0.378),\n",
       "  ('pain studies', 0.3574),\n",
       "  ('capsules', 0.3124),\n",
       "  ('antispasmodic', 0.3084),\n",
       "  ('safety enteric', 0.3023),\n",
       "  ('common disorder', 0.3008),\n",
       "  ('focus symptom', 0.2787),\n",
       "  ('adverse events', 0.2773),\n",
       "  ('study quality', 0.2741),\n",
       "  ('cochrane', 0.2693),\n",
       "  ('interventions', 0.2692),\n",
       "  ('peppermint oil', 0.2651),\n",
       "  ('literature search', 0.259),\n",
       "  ('future studies', 0.2569),\n",
       "  ('term treatment', 0.2444),\n",
       "  ('practice medical', 0.2434),\n",
       "  ('including antidepressants', 0.2265),\n",
       "  ('considered inclusion', 0.2166),\n",
       "  ('improvement abdominal', 0.2084),\n",
       "  ('short term', 0.2059),\n",
       "  ('goals aim', 0.1985),\n",
       "  ('oil patients', 0.1885),\n",
       "  ('minimum', 0.1746),\n",
       "  ('weeks considered', 0.1695),\n",
       "  ('patients relative', 0.1668),\n",
       "  ('risk bias', 0.1623),\n",
       "  ('studies 357', 0.1602),\n",
       "  ('background', 0.1578),\n",
       "  ('risk 14', 0.1236),\n",
       "  ('using intention', 0.1201),\n",
       "  ('95 confidence', 0.1154),\n",
       "  ('analyzed using', 0.0881),\n",
       "  ('global', 0.0775),\n",
       "  ('event heartburn', 0.0762),\n",
       "  ('february 2013', 0.0273),\n",
       "  ('64 79', 0.0256),\n",
       "  ('interval 78', 0.0206),\n",
       "  ('392 patients', 0.0174),\n",
       "  ('evaluated 726', -0.0142),\n",
       "  ('long', -0.0148),\n",
       "  ('nature commonly', -0.035),\n",
       "  ('significantly superior', -0.0404),\n",
       "  ('data cross', -0.0524)],\n",
       " 'MED-1013': [('ibs worse', 0.7198),\n",
       "  ('individuals ibs', 0.6385),\n",
       "  ('ibs affected', 0.627),\n",
       "  ('worse health', 0.5216),\n",
       "  ('diminished qol', 0.5171),\n",
       "  ('impact hrqol', 0.4506),\n",
       "  ('generally poorer', 0.4407),\n",
       "  ('poorer general', 0.4349),\n",
       "  ('irritable bowel', 0.4022),\n",
       "  ('health related', 0.3903),\n",
       "  ('patients worse', 0.38),\n",
       "  ('severity bowel', 0.3654),\n",
       "  ('hrqol patients', 0.359),\n",
       "  ('changes qol', 0.3431),\n",
       "  ('qol general', 0.3363),\n",
       "  ('gastroesophageal reflux', 0.3142),\n",
       "  ('underestimation impact', 0.3073),\n",
       "  ('symptoms greater', 0.281),\n",
       "  ('constipation dominant', 0.2766),\n",
       "  ('irritable', 0.2625),\n",
       "  ('general population', 0.2354),\n",
       "  ('various disease', 0.2239),\n",
       "  ('individual functioning', 0.2161),\n",
       "  ('syndrome', 0.2051),\n",
       "  ('diarrhea', 0.186),\n",
       "  ('patients milder', 0.1821),\n",
       "  ('young elderly', 0.1647),\n",
       "  ('population', 0.1633),\n",
       "  ('psychological conditions', 0.1546),\n",
       "  ('renal disease', 0.1278),\n",
       "  ('compared patients', 0.1194),\n",
       "  ('affected', 0.1148),\n",
       "  ('functioning quality', 0.1144),\n",
       "  ('major differences', 0.1038),\n",
       "  ('individualize therapeutic', 0.0879),\n",
       "  ('specific instruments', 0.0805),\n",
       "  ('sex psychological', 0.0721),\n",
       "  ('used clinical', 0.0616),\n",
       "  ('life', 0.0609),\n",
       "  ('dominant severity', 0.0579),\n",
       "  ('long term', 0.046),\n",
       "  ('intervention data', 0.0415),\n",
       "  ('diabetes end', 0.0346),\n",
       "  ('related', 0.0276),\n",
       "  ('strategy optimize', 0.0198),\n",
       "  ('stage', 0.0101),\n",
       "  ('evidence indicates', 0.003),\n",
       "  ('consideration factors', 0.0013),\n",
       "  ('presently', -0.0367),\n",
       "  ('available widely', -0.0833)],\n",
       " 'MED-1014': [('ibs medications', 0.7463),\n",
       "  ('management ibs', 0.6892),\n",
       "  ('improvements ibs', 0.6838),\n",
       "  ('ibs complex', 0.6034),\n",
       "  ('new ibs', 0.572),\n",
       "  ('medications investigated', 0.4743),\n",
       "  ('symptoms discuss', 0.4456),\n",
       "  ('supporting medication', 0.4243),\n",
       "  ('pharmacologic approaches', 0.4232),\n",
       "  ('irritable bowel', 0.4169),\n",
       "  ('treatments specific', 0.4041),\n",
       "  ('new medications', 0.3898),\n",
       "  ('efficacy various', 0.333),\n",
       "  ('evidence based', 0.3289),\n",
       "  ('syndrome difficult', 0.3042),\n",
       "  ('regimens adverse', 0.2968),\n",
       "  ('review progress', 0.2904),\n",
       "  ('expand therapeutic', 0.2727),\n",
       "  ('fluoxetine', 0.2565),\n",
       "  ('pregabalin', 0.2515),\n",
       "  ('symptoms rifaximin', 0.2438),\n",
       "  ('studies currently', 0.2348),\n",
       "  ('dual opioid', 0.211),\n",
       "  ('based management', 0.2001),\n",
       "  ('initiation efficacy', 0.1897),\n",
       "  ('fiber supplementation', 0.1889),\n",
       "  ('demonstrated improvements', 0.1807),\n",
       "  ('citalopram', 0.1756),\n",
       "  ('dicyclomine', 0.1705),\n",
       "  ('gabapentin octreotide', 0.1659),\n",
       "  ('background', 0.1528),\n",
       "  ('treatment loperamide', 0.1392),\n",
       "  ('currently available', 0.1356),\n",
       "  ('predefined periods', 0.1126),\n",
       "  ('ketotifen', 0.1093),\n",
       "  ('amitriptyline trimipramine', 0.1051),\n",
       "  ('antagonist jnj', 0.0967),\n",
       "  ('2014 karger', 0.096),\n",
       "  ('assessed prospectively', 0.0815),\n",
       "  ('key message', 0.0753),\n",
       "  ('psyllium bran', 0.0738),\n",
       "  ('peppermint', 0.0732),\n",
       "  ('lubiprostone', 0.0722),\n",
       "  ('days', 0.0699),\n",
       "  ('variety novel', 0.0364),\n",
       "  ('better', 0.0363),\n",
       "  ('ag basel', -0.0039),\n",
       "  ('define place', -0.0172),\n",
       "  ('27018966 2014', -0.0258),\n",
       "  ('oil', -0.0587)],\n",
       " 'MED-1015': [('acupuncture ibs', 0.6252),\n",
       "  ('relief ibs', 0.5601),\n",
       "  ('ibs methods', 0.5296),\n",
       "  ('ar ibs', 0.4681),\n",
       "  ('sham acupuncture', 0.4586),\n",
       "  ('adult ibs', 0.4471),\n",
       "  ('life ibs', 0.4307),\n",
       "  ('83 ibs', 0.3991),\n",
       "  ('18 ibs', 0.3941),\n",
       "  ('treatments', 0.3865),\n",
       "  ('greater acupuncture', 0.378),\n",
       "  ('symptom severity', 0.2979),\n",
       "  ('adequate relief', 0.2903),\n",
       "  ('run sham', 0.2641),\n",
       "  ('improvement scale', 0.2522),\n",
       "  ('methods total', 0.2353),\n",
       "  ('quality life', 0.2277),\n",
       "  ('results effects', 0.2082),\n",
       "  ('secondary outcomes', 0.2028),\n",
       "  ('arm study', 0.1957),\n",
       "  ('responders run', 0.1803),\n",
       "  ('patients 75', 0.1776),\n",
       "  ('limited patient', 0.1771),\n",
       "  ('groups improved', 0.1698),\n",
       "  ('gis range', 0.1591),\n",
       "  ('eliminating responders', 0.145),\n",
       "  ('evidence support', 0.1364),\n",
       "  ('objective compare', 0.1352),\n",
       "  ('generally mild', 0.1335),\n",
       "  ('sss', 0.1328),\n",
       "  ('practitioner interaction', 0.1302),\n",
       "  ('vs 32', 0.1287),\n",
       "  ('weeks', 0.1268),\n",
       "  ('total 230', 0.1194),\n",
       "  ('study did', 0.1194),\n",
       "  ('control group', 0.1145),\n",
       "  ('differences statistically', 0.1071),\n",
       "  ('yrs randomly', 0.0937),\n",
       "  ('global', 0.0824),\n",
       "  ('included waitlist', 0.0751),\n",
       "  ('group 37', 0.0416),\n",
       "  ('25 groups', 0.0401),\n",
       "  ('13 56', 0.0393),\n",
       "  ('vs 001', 0.0322),\n",
       "  ('superiority', 0.0298),\n",
       "  ('true', 0.0235),\n",
       "  ('females average', 0.0199),\n",
       "  ('adult', 0.0128),\n",
       "  ('substantively change', 0.0018),\n",
       "  ('21 18', -0.0125)],\n",
       " 'MED-1016': [('linaclotide linzess', 0.6836),\n",
       "  ('linaclotide', 0.6829),\n",
       "  ('syndrome constipation', 0.5644),\n",
       "  ('constipation chronic', 0.5426),\n",
       "  ('constipation', 0.5343),\n",
       "  ('irritable bowel', 0.5192),\n",
       "  ('bowel syndrome', 0.5014),\n",
       "  ('idiopathic constipation', 0.4677),\n",
       "  ('linzess irritable', 0.4381),\n",
       "  ('linzess', 0.3859),\n",
       "  ('bowel', 0.3717),\n",
       "  ('chronic', 0.3166),\n",
       "  ('chronic idiopathic', 0.3048),\n",
       "  ('syndrome', 0.2789),\n",
       "  ('irritable', 0.2528),\n",
       "  ('idiopathic', 0.1553)],\n",
       " 'MED-1017': [('ibs mainly', 0.7249),\n",
       "  ('gastrointestinal disorder', 0.6141),\n",
       "  ('life ibs', 0.5858),\n",
       "  ('bowel syndrome', 0.5405),\n",
       "  ('common gastrointestinal', 0.4975),\n",
       "  ('reducing symptom', 0.4469),\n",
       "  ('diverse symptoms', 0.4323),\n",
       "  ('disorder', 0.3924),\n",
       "  ('exclusion intestinal', 0.3905),\n",
       "  ('symptoms sufficiently', 0.3838),\n",
       "  ('current pharmacological', 0.3541),\n",
       "  ('alternative medicines', 0.3191),\n",
       "  ('severity limiting', 0.3128),\n",
       "  ('inflammatory markers', 0.3122),\n",
       "  ('need pharmacotherapy', 0.3104),\n",
       "  ('absence inflammatory', 0.3042),\n",
       "  ('based exclusion', 0.2922),\n",
       "  ('iberogast hypnotherapy', 0.2905),\n",
       "  ('specific herbal', 0.2821),\n",
       "  ('important clinical', 0.2775),\n",
       "  ('irritable', 0.2527),\n",
       "  ('therapies patients', 0.2129),\n",
       "  ('conditions absence', 0.2114),\n",
       "  ('propose integrative', 0.1844),\n",
       "  ('does alleviate', 0.1799),\n",
       "  ('general population', 0.1759),\n",
       "  ('behavior therapy', 0.1695),\n",
       "  ('recommending cam', 0.1621),\n",
       "  ('diagnosis', 0.1607),\n",
       "  ('mainly based', 0.1515),\n",
       "  ('seek relief', 0.1452),\n",
       "  ('gap', 0.123),\n",
       "  ('yoga', 0.1218),\n",
       "  ('best treatment', 0.1169),\n",
       "  ('antigens current', 0.1137),\n",
       "  ('limiting quality', 0.1021),\n",
       "  ('trials shown', 0.098),\n",
       "  ('cognitive behavior', 0.0931),\n",
       "  ('achievable initial', 0.0888),\n",
       "  ('acupuncture', 0.0865),\n",
       "  ('steps direction', 0.0775),\n",
       "  ('effects led', 0.073),\n",
       "  ('management', 0.0725),\n",
       "  ('benefits need', 0.0721),\n",
       "  ('peppermint oil', 0.0707),\n",
       "  ('number practitioners', 0.0561),\n",
       "  ('life significant', 0.0482),\n",
       "  ('complementary', 0.0314),\n",
       "  ('past decade', 0.0063),\n",
       "  ('considered increasing', -0.0113)],\n",
       " 'MED-1018': [('study retinopathy', 0.5288),\n",
       "  ('complications trial', 0.5203),\n",
       "  ('trial years', 0.4218),\n",
       "  ('control complications', 0.4211),\n",
       "  ('duration diabetes', 0.4042),\n",
       "  ('glycemia close', 0.3691),\n",
       "  ('1983 1989', 0.3504),\n",
       "  ('design randomized', 0.3499),\n",
       "  ('completed interventions', 0.3166),\n",
       "  ('measures change', 0.2988),\n",
       "  ('follow design', 0.2879),\n",
       "  ('insulin injections', 0.2857),\n",
       "  ('objective', 0.2784),\n",
       "  ('treatment consisted', 0.2743),\n",
       "  ('setting patients', 0.2741),\n",
       "  ('1441 patients', 0.2714),\n",
       "  ('29 centers', 0.2694),\n",
       "  ('baseline follow', 0.269),\n",
       "  ('primary prevention', 0.265),\n",
       "  ('13 39', 0.2616),\n",
       "  ('clinical', 0.2594),\n",
       "  ('risk progression', 0.2569),\n",
       "  ('magnitude decrease', 0.2539),\n",
       "  ('recovery times', 0.2529),\n",
       "  ('12 month', 0.2527),\n",
       "  ('followed beneficial', 0.2398),\n",
       "  ('monitoring', 0.2388),\n",
       "  ('doses adjusted', 0.2351),\n",
       "  ('lower intensive', 0.2223),\n",
       "  ('centers enrolled', 0.2177),\n",
       "  ('worsening followed', 0.2159),\n",
       "  ('results cumulative', 0.2131),\n",
       "  ('color fundus', 0.1974),\n",
       "  ('secondary', 0.1968),\n",
       "  ('subgroups conclusions', 0.1954),\n",
       "  ('aiming levels', 0.1899),\n",
       "  ('examinations completed', 0.1822),\n",
       "  ('consisted daily', 0.1504),\n",
       "  ('visits small', 0.1432),\n",
       "  ('moderate nonproliferative', 0.1393),\n",
       "  ('safely possible', 0.131),\n",
       "  ('54 conventional', 0.1241),\n",
       "  ('cohort 49', 0.1107),\n",
       "  ('15', 0.1),\n",
       "  ('ninety percent', 0.0898),\n",
       "  ('stereoscopic', 0.076),\n",
       "  ('11 intensive', 0.0665),\n",
       "  ('based self', 0.0454),\n",
       "  ('strongly support', 0.0345),\n",
       "  ('injection pump', 0.0198)],\n",
       " 'MED-1019': [('diabetic retinopathy', 0.7028),\n",
       "  ('complication diabetes', 0.6328),\n",
       "  ('people diabetes', 0.5852),\n",
       "  ('diabetes remains', 0.4644),\n",
       "  ('blood pressure', 0.4047),\n",
       "  ('complications including', 0.3938),\n",
       "  ('specific microvascular', 0.3632),\n",
       "  ('blood lipids', 0.348),\n",
       "  ('destructive retina', 0.325),\n",
       "  ('blindness working', 0.3212),\n",
       "  ('poor vitrectomy', 0.3176),\n",
       "  ('macular oedema', 0.3162),\n",
       "  ('heart failure', 0.3017),\n",
       "  ('therapies intraocular', 0.2806),\n",
       "  ('including stroke', 0.2682),\n",
       "  ('control blood', 0.2538),\n",
       "  ('reduction risk', 0.246),\n",
       "  ('disease', 0.242),\n",
       "  ('glucose', 0.2393),\n",
       "  ('optimum control', 0.2126),\n",
       "  ('leading cause', 0.2022),\n",
       "  ('progression timely', 0.196),\n",
       "  ('threatening systemic', 0.1917),\n",
       "  ('aged people', 0.1796),\n",
       "  ('coronary', 0.1725),\n",
       "  ('inhibition angiogenic', 0.1666),\n",
       "  ('timely laser', 0.1496),\n",
       "  ('conventional therapy', 0.1437),\n",
       "  ('antivascular endothelial', 0.136),\n",
       "  ('useful patients', 0.1215),\n",
       "  ('factors regenerative', 0.1206),\n",
       "  ('surgery', 0.1199),\n",
       "  ('associated increased', 0.1162),\n",
       "  ('ability reverse', 0.1158),\n",
       "  ('factor agents', 0.1144),\n",
       "  ('effective preservation', 0.1078),\n",
       "  ('needed advanced', 0.0961),\n",
       "  ('elsevier rights', 0.0586),\n",
       "  ('outlook future', 0.0542),\n",
       "  ('sight', 0.0481),\n",
       "  ('people identified', 0.0403),\n",
       "  ('steroids antivascular', 0.0299),\n",
       "  ('common', 0.0067),\n",
       "  ('respond poorly', 0.006),\n",
       "  ('occasionally needed', -0.0002),\n",
       "  ('promising copyright', -0.0152),\n",
       "  ('injection', -0.0207),\n",
       "  ('2010', -0.0213),\n",
       "  ('remains', -0.0243),\n",
       "  ('new', -0.0257)],\n",
       " 'MED-1020': [('diabetic retinopathy', 0.5772),\n",
       "  ('retinopathy past', 0.5285),\n",
       "  ('photocoagulation prp', 0.5126),\n",
       "  ('vision loss', 0.4744),\n",
       "  ('retinal lesions', 0.4632),\n",
       "  ('laser prp', 0.4538),\n",
       "  ('review diabetic', 0.4431),\n",
       "  ('effects prp', 0.4016),\n",
       "  ('recurrence neovascularization', 0.3651),\n",
       "  ('arrays retinal', 0.3296),\n",
       "  ('treatment decrease', 0.32),\n",
       "  ('laser summary', 0.3104),\n",
       "  ('pan retinal', 0.3046),\n",
       "  ('recent findings', 0.297),\n",
       "  ('purpose review', 0.2893),\n",
       "  ('cause visual', 0.2865),\n",
       "  ('prp clinics', 0.2562),\n",
       "  ('findings pascal', 0.2458),\n",
       "  ('lesions shorter', 0.2447),\n",
       "  ('minimize effects', 0.2415),\n",
       "  ('treatment patients', 0.2345),\n",
       "  ('impairment working', 0.2317),\n",
       "  ('ophthalmologists mind', 0.204),\n",
       "  ('pattern scan', 0.1898),\n",
       "  ('eliminate recurrence', 0.1876),\n",
       "  ('regression', 0.1842),\n",
       "  ('provided effective', 0.1824),\n",
       "  ('past decades', 0.1795),\n",
       "  ('burns', 0.168),\n",
       "  ('proliferative', 0.1673),\n",
       "  ('developed', 0.165),\n",
       "  ('substituted conventional', 0.1487),\n",
       "  ('loss patients', 0.1425),\n",
       "  ('including duration', 0.1417),\n",
       "  ('discuss differences', 0.1407),\n",
       "  ('safety', 0.1278),\n",
       "  ('leading cause', 0.1255),\n",
       "  ('traditional argon', 0.1156),\n",
       "  ('parameters optimal', 0.1133),\n",
       "  ('traditional', 0.1127),\n",
       "  ('settings including', 0.1099),\n",
       "  ('achieve comparable', 0.1017),\n",
       "  ('risk severe', 0.0914),\n",
       "  ('studies needed', 0.077),\n",
       "  ('adults worldwide', 0.0654),\n",
       "  ('profile compared', 0.0646),\n",
       "  ('age', 0.0613),\n",
       "  ('delivery', 0.0604),\n",
       "  ('creates', -0.0045),\n",
       "  ('amore comfortable', -0.0049)],\n",
       " 'MED-1021': [('diabetic retinopathy', 0.5791),\n",
       "  ('synthesis studies', 0.382),\n",
       "  ('research vision', 0.3662),\n",
       "  ('cochrane collaboration', 0.3609),\n",
       "  ('primary prevention', 0.3513),\n",
       "  ('blindness working', 0.3505),\n",
       "  ('review english', 0.3491),\n",
       "  ('insufficient evidence', 0.3421),\n",
       "  ('ophthalmology database', 0.3378),\n",
       "  ('dr macular', 0.3378),\n",
       "  ('new interventions', 0.3349),\n",
       "  ('vitrectomy', 0.3293),\n",
       "  ('best evidence', 0.3186),\n",
       "  ('randomized controlled', 0.3068),\n",
       "  ('intravitreal injections', 0.3052),\n",
       "  ('management dr', 0.3035),\n",
       "  ('uncertain objective', 0.2725),\n",
       "  ('improves visual', 0.2634),\n",
       "  ('search medline', 0.2563),\n",
       "  ('edema evidence', 0.2424),\n",
       "  ('conventional treatment', 0.2338),\n",
       "  ('association research', 0.2107),\n",
       "  ('lowering therapy', 0.2062),\n",
       "  ('analyses included', 0.2025),\n",
       "  ('working aged', 0.1965),\n",
       "  ('photocoagulation reduces', 0.1898),\n",
       "  ('context', 0.1837),\n",
       "  ('incidence progression', 0.1792),\n",
       "  ('recommend routine', 0.1789),\n",
       "  ('treatment failed', 0.1781),\n",
       "  ('follow meta', 0.1652),\n",
       "  ('used identify', 0.163),\n",
       "  ('support use', 0.1517),\n",
       "  ('eyes persistent', 0.1504),\n",
       "  ('steroids considered', 0.1497),\n",
       "  ('focal laser', 0.1416),\n",
       "  ('risk moderate', 0.1339),\n",
       "  ('pan retinal', 0.1321),\n",
       "  ('antivascular endothelial', 0.1283),\n",
       "  ('safety lipid', 0.1208),\n",
       "  ('patients', 0.1082),\n",
       "  ('months follow', 0.1076),\n",
       "  ('control remains', 0.1069),\n",
       "  ('institutes health', 0.0933),\n",
       "  ('included delphi', 0.0915),\n",
       "  ('united states', 0.0899),\n",
       "  ('1966 2007', 0.0672),\n",
       "  ('tight', 0.0513),\n",
       "  ('nonproliferative proliferative', 0.0432),\n",
       "  ('50 patients', -0.0318)],\n",
       " 'MED-1023': [('cmv retinitis', 0.6153),\n",
       "  ('aids cmv', 0.5193),\n",
       "  ('retinitis afflicted', 0.496),\n",
       "  ('cytomegalovirus', 0.4788),\n",
       "  ('aids epidemic', 0.4369),\n",
       "  ('vision loss', 0.4249),\n",
       "  ('hiv medications', 0.4067),\n",
       "  ('control retinitis', 0.3979),\n",
       "  ('immunodeficiency syndrome', 0.3691),\n",
       "  ('afflicted 25', 0.3631),\n",
       "  ('cidofovir administered', 0.359),\n",
       "  ('ganciclovir reservoir', 0.3149),\n",
       "  ('medications intravitreal', 0.2895),\n",
       "  ('post haart', 0.2775),\n",
       "  ('retinitis long', 0.2731),\n",
       "  ('recovery uveitis', 0.2706),\n",
       "  ('epidemic treatment', 0.2617),\n",
       "  ('macula', 0.2227),\n",
       "  ('afflicted', 0.2099),\n",
       "  ('classification retinal', 0.1915),\n",
       "  ('25 42', 0.1831),\n",
       "  ('era vision', 0.181),\n",
       "  ('injections cost', 0.1619),\n",
       "  ('incidence severity', 0.1574),\n",
       "  ('years', 0.128),\n",
       "  ('important causes', 0.1183),\n",
       "  ('immune status', 0.1088),\n",
       "  ('health care', 0.1069),\n",
       "  ('strategy treat', 0.1036),\n",
       "  ('detachments important', 0.0915),\n",
       "  ('moderate severe', 0.0751),\n",
       "  ('countries face', 0.0691),\n",
       "  ('inadequate supplies', 0.068),\n",
       "  ('decreases incidence', 0.0644),\n",
       "  ('term preservation', 0.0583),\n",
       "  ('loss patients', 0.0577),\n",
       "  ('surgical implantation', 0.0574),\n",
       "  ('lesions', 0.0554),\n",
       "  ('requires thorough', 0.0524),\n",
       "  ('cost effective', 0.0406),\n",
       "  ('patient survival', 0.0179),\n",
       "  ('patients pre', 0.0146),\n",
       "  ('changed', 0.0057),\n",
       "  ('oral', 0.0034),\n",
       "  ('especially zone', 0.0025),\n",
       "  ('started improved', 0.0021),\n",
       "  ('common', -0.0106),\n",
       "  ('sustained release', -0.0141),\n",
       "  ('anti', -0.0178),\n",
       "  ('foscarnet', -0.0733)],\n",
       " 'MED-1025': [('evaluation defecography', 0.6839),\n",
       "  ('defecography evaluates', 0.6569),\n",
       "  ('sensation defecation', 0.5938),\n",
       "  ('defecation suspected', 0.5917),\n",
       "  ('defecography primarily', 0.5531),\n",
       "  ('rectum anal', 0.5446),\n",
       "  ('defecation', 0.5428),\n",
       "  ('morphology rectum', 0.5186),\n",
       "  ('rectum subsequent', 0.5144),\n",
       "  ('constipation', 0.4939),\n",
       "  ('paste rectum', 0.4921),\n",
       "  ('anal canal', 0.4909),\n",
       "  ('suspected prolapse', 0.4728),\n",
       "  ('longstanding constipation', 0.456),\n",
       "  ('rectal pain', 0.4423),\n",
       "  ('rectal', 0.4309),\n",
       "  ('constipation unexplained', 0.4243),\n",
       "  ('injection barium', 0.3869),\n",
       "  ('functional evaluation', 0.3847),\n",
       "  ('unexplained anal', 0.3564),\n",
       "  ('examination', 0.3533),\n",
       "  ('interpretation examination', 0.342),\n",
       "  ('anal', 0.3407),\n",
       "  ('evacuation ability', 0.2968),\n",
       "  ('physiologic setting', 0.2682),\n",
       "  ('technique interpretation', 0.2385),\n",
       "  ('primarily performed', 0.2109),\n",
       "  ('canal', 0.194),\n",
       "  ('evaluates', 0.1882),\n",
       "  ('outlined review', 0.1826),\n",
       "  ('residual', 0.1732),\n",
       "  ('pain residual', 0.1702),\n",
       "  ('patients', 0.1644),\n",
       "  ('morphology', 0.1554),\n",
       "  ('suspected', 0.1515),\n",
       "  ('sensation', 0.1514),\n",
       "  ('setting', 0.1423),\n",
       "  ('patients longstanding', 0.1367),\n",
       "  ('setting injection', 0.1353),\n",
       "  ('ability structural', 0.1319),\n",
       "  ('evaluates real', 0.1316),\n",
       "  ('real time', 0.106),\n",
       "  ('work', 0.0989),\n",
       "  ('work patients', 0.0948),\n",
       "  ('paste', 0.0885),\n",
       "  ('longstanding', 0.0853),\n",
       "  ('subsequent', 0.078),\n",
       "  ('unexplained', 0.074),\n",
       "  ('primarily', 0.0665),\n",
       "  ('time', 0.0588)],\n",
       " 'MED-1026': [('pressure veins', 0.5379),\n",
       "  ('veins pressure', 0.5162),\n",
       "  ('leg veins', 0.4765),\n",
       "  ('patients varicose', 0.444),\n",
       "  ('varicose veins', 0.443),\n",
       "  ('pressure patients', 0.4178),\n",
       "  ('pressures superficial', 0.3881),\n",
       "  ('abdominal pressure', 0.3852),\n",
       "  ('veins 24', 0.3735),\n",
       "  ('pressure leg', 0.3725),\n",
       "  ('veins normal', 0.3664),\n",
       "  ('varicose', 0.3426),\n",
       "  ('veins increasing', 0.3286),\n",
       "  ('veins', 0.3266),\n",
       "  ('superficial leg', 0.2974),\n",
       "  ('veins concluded', 0.2946),\n",
       "  ('24 patients', 0.2903),\n",
       "  ('distribution varicose', 0.252),\n",
       "  ('pressures', 0.2427),\n",
       "  ('intra abdominal', 0.2154),\n",
       "  ('studied controls', 0.2111),\n",
       "  ('pressure rose', 0.2099),\n",
       "  ('normal controls', 0.1999),\n",
       "  ('superficial', 0.1942),\n",
       "  ('significantly squatting', 0.1767),\n",
       "  ('sitting preventing', 0.1725),\n",
       "  ('controls rise', 0.1622),\n",
       "  ('patients', 0.1197),\n",
       "  ('defaecation cause', 0.1168),\n",
       "  ('preventing transmission', 0.1127),\n",
       "  ('wide variation', 0.109),\n",
       "  ('preventing', 0.1061),\n",
       "  ('difference positions', 0.0946),\n",
       "  ('positions', 0.0867),\n",
       "  ('normal', 0.0855),\n",
       "  ('variation geographical', 0.0629),\n",
       "  ('better sitting', 0.0616),\n",
       "  ('concluded difference', 0.0614),\n",
       "  ('wide', 0.0468),\n",
       "  ('cause wide', 0.0269),\n",
       "  ('significantly', 0.0217),\n",
       "  ('increasing intra', 0.0202),\n",
       "  ('transmission intra', 0.0101),\n",
       "  ('studied', -0.0009),\n",
       "  ('rise', -0.0086),\n",
       "  ('distribution', -0.0176),\n",
       "  ('concluded', -0.0317),\n",
       "  ('rose', -0.0472),\n",
       "  ('cause', -0.0557),\n",
       "  ('adopted', -0.1326)],\n",
       " 'MED-1027': [('disorders faecal', 0.5221),\n",
       "  ('aetiology varicose', 0.4555),\n",
       "  ('faecal arrest', 0.4127),\n",
       "  ('thrombosis haemorrhoids', 0.4089),\n",
       "  ('haemorrhoids', 0.4044),\n",
       "  ('disorders', 0.4027),\n",
       "  ('cause disorders', 0.3776),\n",
       "  ('concepts aetiology', 0.3776),\n",
       "  ('haemorrhoids examined', 0.374),\n",
       "  ('varicose', 0.363),\n",
       "  ('varicose veins', 0.3525),\n",
       "  ('faecal', 0.3494),\n",
       "  ('suggested fundamental', 0.3394),\n",
       "  ('light epidemiological', 0.3189),\n",
       "  ('epidemiological evidence', 0.3101),\n",
       "  ('aetiology', 0.3025),\n",
       "  ('diet', 0.3002),\n",
       "  ('current concepts', 0.2918),\n",
       "  ('low residue', 0.2917),\n",
       "  ('residue diet', 0.2861),\n",
       "  ('deep vein', 0.2845),\n",
       "  ('vein thrombosis', 0.2779),\n",
       "  ('epidemiological', 0.2764),\n",
       "  ('veins deep', 0.2711),\n",
       "  ('veins', 0.2603),\n",
       "  ('concepts', 0.2379),\n",
       "  ('suggested', 0.2357),\n",
       "  ('evidence wanting', 0.23),\n",
       "  ('low', 0.2044),\n",
       "  ('thrombosis', 0.2028),\n",
       "  ('wanting suggested', 0.201),\n",
       "  ('result low', 0.1888),\n",
       "  ('evidence', 0.1847),\n",
       "  ('fundamental', 0.1783),\n",
       "  ('vein', 0.1738),\n",
       "  ('fundamental cause', 0.1693),\n",
       "  ('wanting', 0.153),\n",
       "  ('deep', 0.1438),\n",
       "  ('examined light', 0.1364),\n",
       "  ('residue', 0.1333),\n",
       "  ('examined', 0.1202),\n",
       "  ('current', 0.1028),\n",
       "  ('light', 0.1001),\n",
       "  ('cause', 0.091),\n",
       "  ('arrest result', 0.0696),\n",
       "  ('arrest', 0.0683),\n",
       "  ('result', 0.0358)],\n",
       " 'MED-1028': [('faecal retention', 0.5704),\n",
       "  ('colon length', 0.4968),\n",
       "  ('hidden constipation', 0.3396),\n",
       "  ('abdominal pain', 0.3308),\n",
       "  ('intra peritoneal', 0.3307),\n",
       "  ('polyps malignancies', 0.3205),\n",
       "  ('patients prolapsed', 0.3189),\n",
       "  ('reservoirs clinical', 0.3095),\n",
       "  ('radiographs 48', 0.3066),\n",
       "  ('severity haemorrhoidal', 0.3029),\n",
       "  ('functional disease', 0.297),\n",
       "  ('tested patients', 0.2952),\n",
       "  ('underwent hemicolectomy', 0.285),\n",
       "  ('specific hypotheses', 0.2778),\n",
       "  ('ingestion estimation', 0.2732),\n",
       "  ('compared controls', 0.2718),\n",
       "  ('56 patients', 0.2693),\n",
       "  ('epidemiological evidence', 0.2662),\n",
       "  ('bacterial counts', 0.2614),\n",
       "  ('ctt increased', 0.2584),\n",
       "  ('results constipated', 0.253),\n",
       "  ('diverticulosis', 0.2489),\n",
       "  ('significantly prolonged', 0.2395),\n",
       "  ('251', 0.2301),\n",
       "  ('persisting symptoms', 0.2247),\n",
       "  ('exempt appendicitis', 0.2209),\n",
       "  ('operation time', 0.2114),\n",
       "  ('halitosis patients', 0.2111),\n",
       "  ('questionnaire completed', 0.2048),\n",
       "  ('rest', 0.2037),\n",
       "  ('patients 90', 0.2024),\n",
       "  ('significant correlation', 0.1988),\n",
       "  ('repetitiveness incompleteness', 0.1982),\n",
       "  ('prokinetic drug', 0.1964),\n",
       "  ('40 258', 0.1909),\n",
       "  ('iliac fossa', 0.1887),\n",
       "  ('loading bloating', 0.173),\n",
       "  ('intervention did', 0.1541),\n",
       "  ('observed patient', 0.1533),\n",
       "  ('frequent post', 0.15),\n",
       "  ('radio opaque', 0.1405),\n",
       "  ('meteorism cluster', 0.1365),\n",
       "  ('women significantly', 0.1355),\n",
       "  ('significant reductions', 0.1332),\n",
       "  ('factors seldom', 0.1263),\n",
       "  ('perforated', 0.1245),\n",
       "  ('281 healthy', 0.1245),\n",
       "  ('mediastinal gas', 0.0884),\n",
       "  ('fibre rich', 0.0841),\n",
       "  ('years meaning', 0.0652)],\n",
       " 'MED-1029': [('bowel movements', 0.5134),\n",
       "  ('bowel emptying', 0.5132),\n",
       "  ('normal bowel', 0.4567),\n",
       "  ('intensity defecation', 0.4409),\n",
       "  ('volunteers compared', 0.4398),\n",
       "  ('sitting defecation', 0.4202),\n",
       "  ('healthy volunteers', 0.4106),\n",
       "  ('assessed straining', 0.4037),\n",
       "  ('emptying defecating', 0.3972),\n",
       "  ('volunteers ages', 0.3706),\n",
       "  ('subjective impression', 0.3117),\n",
       "  ('emptying degree', 0.3043),\n",
       "  ('needed sensation', 0.2672),\n",
       "  ('squatting position', 0.263),\n",
       "  ('recorded position', 0.2592),\n",
       "  ('defecating alternative', 0.2532),\n",
       "  ('compared sitting', 0.2512),\n",
       "  ('time needed', 0.2474),\n",
       "  ('effort consecutive', 0.2396),\n",
       "  ('posture necessitates', 0.2379),\n",
       "  ('digital timer', 0.2346),\n",
       "  ('standard sized', 0.232),\n",
       "  ('movements', 0.2278),\n",
       "  ('apparently healthy', 0.2251),\n",
       "  ('alternative positions', 0.2239),\n",
       "  ('sitting standard', 0.2161),\n",
       "  ('assessed', 0.205),\n",
       "  ('years normal', 0.1993),\n",
       "  ('forces', 0.1967),\n",
       "  ('excessive expulsive', 0.1875),\n",
       "  ('lower', 0.1721),\n",
       "  ('present study', 0.1663),\n",
       "  ('function asked', 0.1644),\n",
       "  ('66 years', 0.1622),\n",
       "  ('ages', 0.1594),\n",
       "  ('32', 0.1592),\n",
       "  ('degree', 0.1509),\n",
       "  ('sized', 0.1496),\n",
       "  ('positions 0001', 0.1491),\n",
       "  ('compare', 0.1395),\n",
       "  ('aim', 0.1365),\n",
       "  ('conclusion', 0.1171),\n",
       "  ('confirmed', 0.1085),\n",
       "  ('ages 17', 0.0988),\n",
       "  ('cm', 0.0804),\n",
       "  ('use', 0.0803),\n",
       "  ('41', 0.0626),\n",
       "  ('toilet', 0.0323),\n",
       "  ('net', 0.0292),\n",
       "  ('high sitting', 0.0251)],\n",
       " 'MED-1030': [('valsalva maneuver', 0.467),\n",
       "  ('21 decrease', 0.4573),\n",
       "  ('11 reduction', 0.4561),\n",
       "  ('arterial pressure', 0.4064),\n",
       "  ('reduction mean', 0.3585),\n",
       "  ('changes vascular', 0.3535),\n",
       "  ('significant decrease', 0.3407),\n",
       "  ('associated 21', 0.339),\n",
       "  ('pressure minus', 0.3327),\n",
       "  ('straining phase', 0.3288),\n",
       "  ('decrease vascular', 0.3287),\n",
       "  ('spinal fluid', 0.3215),\n",
       "  ('iv changes', 0.3036),\n",
       "  ('series patients', 0.2993),\n",
       "  ('fluid pressure', 0.2982),\n",
       "  ('perfusion pressure', 0.2923),\n",
       "  ('ii 11', 0.2901),\n",
       "  ('pressure produced', 0.2868),\n",
       "  ('decrease internal', 0.2857),\n",
       "  ('levels phase', 0.2619),\n",
       "  ('control levels', 0.2607),\n",
       "  ('values following', 0.2579),\n",
       "  ('measurements cerebral', 0.2498),\n",
       "  ('cerebral spinal', 0.2473),\n",
       "  ('cerebral perfusion', 0.2448),\n",
       "  ('measurements', 0.2318),\n",
       "  ('19', 0.2314),\n",
       "  ('phases ii', 0.2111),\n",
       "  ('produced 22', 0.2089),\n",
       "  ('maneuver', 0.2035),\n",
       "  ('data indicate', 0.1969),\n",
       "  ('resistance occurred', 0.1949),\n",
       "  ('calculate index', 0.1949),\n",
       "  ('occurred phases', 0.1915),\n",
       "  ('flow obtained', 0.1896),\n",
       "  ('significant', 0.189),\n",
       "  ('magnitude maintain', 0.1779),\n",
       "  ('carotid', 0.1762),\n",
       "  ('patients', 0.1762),\n",
       "  ('increase internal', 0.1706),\n",
       "  ('computed mean', 0.1696),\n",
       "  ('return control', 0.1659),\n",
       "  ('modest significant', 0.1657),\n",
       "  ('iii followed', 0.1649),\n",
       "  ('following release', 0.1421),\n",
       "  ('minus cerebral', 0.1199),\n",
       "  ('rapid', 0.1188),\n",
       "  ('blood', 0.1149),\n",
       "  ('indicate', 0.1086),\n",
       "  ('used', 0.0908)],\n",
       " 'MED-1031': [('constipation', 0.6633),\n",
       "  ('simple constipation', 0.6599),\n",
       "  ('habitual bowel', 0.6332),\n",
       "  ('bowel elimination', 0.6217),\n",
       "  ('alleviates bowel', 0.5872),\n",
       "  ('emptying bowels', 0.5602),\n",
       "  ('bowels principal', 0.5562),\n",
       "  ('defecation posture', 0.5233),\n",
       "  ('normal bowel', 0.441),\n",
       "  ('colon organs', 0.4375),\n",
       "  ('used defecation', 0.4241),\n",
       "  ('recto anal', 0.4192),\n",
       "  ('difficulty emptying', 0.41),\n",
       "  ('cause obstructive', 0.3731),\n",
       "  ('elimination prevents', 0.3665),\n",
       "  ('act rectal', 0.3517),\n",
       "  ('habitual', 0.3385),\n",
       "  ('anal region', 0.3326),\n",
       "  ('reflex alleviates', 0.2856),\n",
       "  ('posture normally', 0.2796),\n",
       "  ('sitting posture', 0.2714),\n",
       "  ('toilet seats', 0.2681),\n",
       "  ('inhibitory', 0.2665),\n",
       "  ('movement frequency', 0.2603),\n",
       "  ('emptying natural', 0.2601),\n",
       "  ('alignment recto', 0.2585),\n",
       "  ('frequency difficulty', 0.2562),\n",
       "  ('final act', 0.1756),\n",
       "  ('consequence', 0.1708),\n",
       "  ('primary', 0.1597),\n",
       "  ('straining potential', 0.1591),\n",
       "  ('population normal', 0.1469),\n",
       "  ('angle', 0.1463),\n",
       "  ('permits smooth', 0.146),\n",
       "  ('excessive', 0.1392),\n",
       "  ('seats considerable', 0.1253),\n",
       "  ('proportion population', 0.1204),\n",
       "  ('simple', 0.1169),\n",
       "  ('resultant damage', 0.1053),\n",
       "  ('common', 0.1024),\n",
       "  ('normally used', 0.098),\n",
       "  ('squatting permits', 0.0977),\n",
       "  ('nature', 0.0934),\n",
       "  ('time day', 0.0916),\n",
       "  ('evidence', 0.085),\n",
       "  ('association sitting', 0.0827),\n",
       "  ('human', 0.0446),\n",
       "  ('region possibly', 0.0097),\n",
       "  ('response strong', -0.007),\n",
       "  ('contributes considerably', -0.0564)],\n",
       " 'MED-1032': [('study syncope', 0.5053),\n",
       "  ('syncope 13', 0.4849),\n",
       "  ('defecation syncope', 0.4577),\n",
       "  ('20 patients', 0.4509),\n",
       "  ('syncope 11', 0.3819),\n",
       "  ('episodes fourteen', 0.3617),\n",
       "  ('patients defecation', 0.3382),\n",
       "  ('recurred patients', 0.337),\n",
       "  ('disorder subgroup', 0.303),\n",
       "  ('13 women', 0.3018),\n",
       "  ('literature patients', 0.2926),\n",
       "  ('problems cardiac', 0.2802),\n",
       "  ('recurrences unassociated', 0.2794),\n",
       "  ('11 patients', 0.2719),\n",
       "  ('multiple episodes', 0.2718),\n",
       "  ('illness causing', 0.2662),\n",
       "  ('years patients', 0.2603),\n",
       "  ('additional patients', 0.2518),\n",
       "  ('patients died', 0.2489),\n",
       "  ('diseases transient', 0.2358),\n",
       "  ('majority recurrences', 0.2287),\n",
       "  ('distinct clinical', 0.223),\n",
       "  ('seven patients', 0.2062),\n",
       "  ('patients majority', 0.2023),\n",
       "  ('ischemic attacks', 0.1845),\n",
       "  ('chronic', 0.1827),\n",
       "  ('prospective study', 0.1807),\n",
       "  ('patients marked', 0.1803),\n",
       "  ('59 years', 0.1757),\n",
       "  ('new medical', 0.1671),\n",
       "  ('attacks additional', 0.1657),\n",
       "  ('gastrointestinal', 0.1654),\n",
       "  ('defecate asleep', 0.1631),\n",
       "  ('hypotension identifiable', 0.1626),\n",
       "  ('pathologic abnormalities', 0.1558),\n",
       "  ('subgroup larger', 0.1482),\n",
       "  ('follow period', 0.1348),\n",
       "  ('changes sleep', 0.1296),\n",
       "  ('unassociated', 0.1219),\n",
       "  ('cause', 0.1063),\n",
       "  ('recumbent', 0.1058),\n",
       "  ('association physiologic', 0.1054),\n",
       "  ('knowledge previous', 0.0821),\n",
       "  ('evaluated', 0.0812),\n",
       "  ('entity multiple', 0.0607),\n",
       "  ('urge', 0.0474),\n",
       "  ('tract', 0.0365),\n",
       "  ('single', 0.0362),\n",
       "  ('men mean', 0.0212),\n",
       "  ('mean age', -0.0046)],\n",
       " 'MED-1033': [('bos psychosomatic', 0.5683),\n",
       "  ('psychosomatic disorder', 0.508),\n",
       "  ('constipation presented', 0.4856),\n",
       "  ('bowel obsession', 0.4505),\n",
       "  ('diagnosis bos', 0.4394),\n",
       "  ('disorder remains', 0.3876),\n",
       "  ('symptoms results', 0.3652),\n",
       "  ('disorder', 0.3634),\n",
       "  ('man chronic', 0.3624),\n",
       "  ('objective bowel', 0.3186),\n",
       "  ('somatic psychological', 0.3149),\n",
       "  ('obsession syndrome', 0.3123),\n",
       "  ('bos frequently', 0.2817),\n",
       "  ('compulsions evacuation', 0.2764),\n",
       "  ('diet compulsions', 0.2662),\n",
       "  ('behavioral therapy', 0.2437),\n",
       "  ('evacuation social', 0.2386),\n",
       "  ('isolation depressed', 0.2256),\n",
       "  ('psychological domains', 0.215),\n",
       "  ('prevalent thought', 0.1951),\n",
       "  ('remission', 0.1848),\n",
       "  ('depressed mood', 0.1703),\n",
       "  ('thought clinicians', 0.1561),\n",
       "  ('therapy led', 0.1448),\n",
       "  ('case report', 0.1446),\n",
       "  ('frequently diagnosed', 0.1386),\n",
       "  ('man', 0.1253),\n",
       "  ('report 32', 0.1218),\n",
       "  ('presented restricted', 0.1218),\n",
       "  ('social', 0.1212),\n",
       "  ('properly treat', 0.1086),\n",
       "  ('thought', 0.0969),\n",
       "  ('old man', 0.0855),\n",
       "  ('assess diagnose', 0.0725),\n",
       "  ('cognitive', 0.0647),\n",
       "  ('intersection somatic', 0.0627),\n",
       "  ('probably prevalent', 0.0595),\n",
       "  ('domains adequately', 0.0578),\n",
       "  ('mood satisfying', 0.0547),\n",
       "  ('results maintained', 0.044),\n",
       "  ('objective', 0.04),\n",
       "  ('conclusion', -0.03),\n",
       "  ('remains intersection', -0.0337),\n",
       "  ('aware', -0.0363),\n",
       "  ('treat copyright', -0.0367),\n",
       "  ('existence order', -0.0439),\n",
       "  ('year follow', -0.0496),\n",
       "  ('led complete', -0.0518),\n",
       "  ('rights reserved', -0.0766),\n",
       "  ('2013 elsevier', -0.1049)],\n",
       " 'MED-1034': [('symptom questionnaires', 0.5464),\n",
       "  ('bowel diaries', 0.5367),\n",
       "  ('interviewed gastroenterologist', 0.4153),\n",
       "  ('diaries women', 0.398),\n",
       "  ('survey olmsted', 0.3898),\n",
       "  ('subjects diarrhea', 0.3872),\n",
       "  ('disorders method', 0.3505),\n",
       "  ('variations stool', 0.343),\n",
       "  ('habits reflect', 0.3349),\n",
       "  ('urgency infrequently', 0.2968),\n",
       "  ('subjects interviewed', 0.2941),\n",
       "  ('background symptom', 0.2837),\n",
       "  ('26 constipation', 0.2636),\n",
       "  ('disease conclusions', 0.257),\n",
       "  ('health disease', 0.2533),\n",
       "  ('mn women', 0.2527),\n",
       "  ('04 rectal', 0.2435),\n",
       "  ('diarrhea 31', 0.2391),\n",
       "  ('15 defecation', 0.216),\n",
       "  ('aim assess', 0.2064),\n",
       "  ('incomplete evacuation', 0.2055),\n",
       "  ('provide snapshot', 0.2028),\n",
       "  ('subjects maintained', 0.1845),\n",
       "  ('wk results', 0.1808),\n",
       "  ('observations support', 0.1761),\n",
       "  ('frequency form', 0.1712),\n",
       "  ('community based', 0.1575),\n",
       "  ('reported', 0.1568),\n",
       "  ('53 asymptomatic', 0.1537),\n",
       "  ('16', 0.1397),\n",
       "  ('infrequently 25', 0.1387),\n",
       "  ('27 normals', 0.13),\n",
       "  ('odds ratio', 0.1283),\n",
       "  ('useful discriminating', 0.1214),\n",
       "  ('randomly selected', 0.1106),\n",
       "  ('olmsted county', 0.1084),\n",
       "  ('278', 0.0869),\n",
       "  ('association partly', 0.0845),\n",
       "  ('day day', 0.075),\n",
       "  ('time generally', 0.0672),\n",
       "  ('loose', 0.0587),\n",
       "  ('21', 0.0525),\n",
       "  ('02', 0.0501),\n",
       "  ('10', 0.0464),\n",
       "  ('end 95', 0.0344),\n",
       "  ('generally hard', 0.0137),\n",
       "  ('bristol', 0.0072),\n",
       "  ('soft formed', -0.0072),\n",
       "  ('12 increased', -0.0282),\n",
       "  ('ci increased', -0.0529)],\n",
       " 'MED-1035': [('bowel frequency', 0.5159),\n",
       "  ('record bowel', 0.4906),\n",
       "  ('surveys bowel', 0.4875),\n",
       "  ('frequency defecation', 0.4846),\n",
       "  ('discrepancy bowel', 0.4742),\n",
       "  ('changed bowel', 0.45),\n",
       "  ('questioned bowel', 0.4491),\n",
       "  ('irritable bowel', 0.4203),\n",
       "  ('hospital outpatients', 0.4011),\n",
       "  ('episodes changed', 0.3872),\n",
       "  ('outpatients', 0.3816),\n",
       "  ('outpatients questioned', 0.3775),\n",
       "  ('defecation agreed', 0.3623),\n",
       "  ('patients discrepancy', 0.3552),\n",
       "  ('habits asked', 0.3349),\n",
       "  ('frequency findings', 0.3236),\n",
       "  ('actions week', 0.3056),\n",
       "  ('discrepancy', 0.3008),\n",
       "  ('diary', 0.2931),\n",
       "  ('weeks', 0.2906),\n",
       "  ('diary booklets', 0.2824),\n",
       "  ('suggest irritable', 0.2671),\n",
       "  ('findings', 0.2618),\n",
       "  ('predicting episodes', 0.2598),\n",
       "  ('patients routinely', 0.2505),\n",
       "  ('booklets weeks', 0.2382),\n",
       "  ('day patients', 0.237),\n",
       "  ('16', 0.2344),\n",
       "  ('recorded', 0.2333),\n",
       "  ('asked record', 0.2328),\n",
       "  ('habit based', 0.2249),\n",
       "  ('figures frequency', 0.2245),\n",
       "  ('overall recalled', 0.2219),\n",
       "  ('questionnaires suggest', 0.2207),\n",
       "  ('patients bad', 0.2033),\n",
       "  ('routinely', 0.1996),\n",
       "  ('agreed fairly', 0.1873),\n",
       "  ('diagnosed', 0.1803),\n",
       "  ('population surveys', 0.1641),\n",
       "  ('difference norm', 0.1623),\n",
       "  ('exaggeration difference', 0.1524),\n",
       "  ('syndrome correctly', 0.1478),\n",
       "  ('fairly closely', 0.147),\n",
       "  ('questioned', 0.1232),\n",
       "  ('findings cast', 0.1225),\n",
       "  ('suggest', 0.1217),\n",
       "  ('doubt value', 0.0789),\n",
       "  ('bad predicting', 0.0442),\n",
       "  ('based solely', -0.0039),\n",
       "  ('value population', -0.0869)],\n",
       " 'MED-1036': [('intestine chemoreceptor', 0.5806),\n",
       "  ('colonic contractions', 0.5482),\n",
       "  ('changes colonic', 0.5281),\n",
       "  ('colonic musculature', 0.518),\n",
       "  ('excitability colonic', 0.5026),\n",
       "  ('intestine', 0.4898),\n",
       "  ('proximal gut', 0.4843),\n",
       "  ('burst colon', 0.4793),\n",
       "  ('colon eating', 0.4555),\n",
       "  ('chemoreceptor stimulation', 0.4526),\n",
       "  ('increased motor', 0.4102),\n",
       "  ('food stomach', 0.3751),\n",
       "  ('indicates increased', 0.3579),\n",
       "  ('important mechanoreceptor', 0.3292),\n",
       "  ('effect cephalic', 0.3258),\n",
       "  ('motility produced', 0.3234),\n",
       "  ('mucosal', 0.3124),\n",
       "  ('stimulation appears', 0.3044),\n",
       "  ('musculature changes', 0.3),\n",
       "  ('changes excitability', 0.2834),\n",
       "  ('eating species', 0.2778),\n",
       "  ('hormonal neural', 0.2754),\n",
       "  ('contractions electrical', 0.2691),\n",
       "  ('eating candidates', 0.2418),\n",
       "  ('greater', 0.2286),\n",
       "  ('evidence indicates', 0.2269),\n",
       "  ('means effect', 0.2237),\n",
       "  ('sympathetic systems', 0.215),\n",
       "  ('appears', 0.2124),\n",
       "  ('released proximal', 0.2097),\n",
       "  ('appears important', 0.2092),\n",
       "  ('species', 0.2089),\n",
       "  ('parasympathetic', 0.1899),\n",
       "  ('bringing effect', 0.1893),\n",
       "  ('polypeptide', 0.1885),\n",
       "  ('origin greater', 0.181),\n",
       "  ('nature change', 0.1751),\n",
       "  ('response results', 0.171),\n",
       "  ('involve changes', 0.1625),\n",
       "  ('animals', 0.1558),\n",
       "  ('burst', 0.1319),\n",
       "  ('pathways', 0.1312),\n",
       "  ('migrating', 0.1276),\n",
       "  ('waves', 0.0852),\n",
       "  ('systems responsible', 0.0769),\n",
       "  ('function', 0.0645),\n",
       "  ('pacemakers', 0.0538),\n",
       "  ('unknown involve', 0.0316),\n",
       "  ('electrical slow', 0.0201),\n",
       "  ('exact', 0.0016)],\n",
       " 'MED-1037': [('medicine vastly', 0.4821),\n",
       "  ('medicine born', 0.4465),\n",
       "  ('knowledge medicine', 0.4447),\n",
       "  ('humanities medicine', 0.4353),\n",
       "  ('egypt', 0.3637),\n",
       "  ('medicine', 0.3437),\n",
       "  ('afflicting ancient', 0.2896),\n",
       "  ('historians antiquity', 0.2873),\n",
       "  ('scientific enquiry', 0.2733),\n",
       "  ('extent diseases', 0.2675),\n",
       "  ('diseases afflicting', 0.2644),\n",
       "  ('sciences humanities', 0.2618),\n",
       "  ('civilizations arisen', 0.2585),\n",
       "  ('medical organization', 0.2561),\n",
       "  ('educated society', 0.2388),\n",
       "  ('intense sciences', 0.2332),\n",
       "  ('enquiry social', 0.2169),\n",
       "  ('knowledge', 0.2163),\n",
       "  ('humanities', 0.2126),\n",
       "  ('writings historians', 0.205),\n",
       "  ('populus', 0.1828),\n",
       "  ('vastly underestimated', 0.1763),\n",
       "  ('development millennia', 0.1728),\n",
       "  ('born educated', 0.1714),\n",
       "  ('ancient', 0.171),\n",
       "  ('survive medical', 0.1685),\n",
       "  ('overcome superstitions', 0.157),\n",
       "  ('society overcome', 0.1481),\n",
       "  ('artefacts survive', 0.135),\n",
       "  ('underestimated artefacts', 0.1313),\n",
       "  ('vastly', 0.1286),\n",
       "  ('society', 0.1278),\n",
       "  ('cradle scientific', 0.1276),\n",
       "  ('social development', 0.1174),\n",
       "  ('artefacts', 0.088),\n",
       "  ('papyri', 0.045),\n",
       "  ('study evidence', 0.0297),\n",
       "  ('reliefs writings', 0.0233),\n",
       "  ('arisen', 0.0209),\n",
       "  ('born', 0.0199),\n",
       "  ('development', 0.0126),\n",
       "  ('superstitions nomadic', -0.0057),\n",
       "  ('extent', -0.0164),\n",
       "  ('organization', -0.0263),\n",
       "  ('nomadic ancestors', -0.0604),\n",
       "  ('tomb', -0.0713),\n",
       "  ('cradle', -0.0929),\n",
       "  ('tell intense', -0.1396),\n",
       "  ('undoubtedly', -0.1484),\n",
       "  ('bas', -0.1658)],\n",
       " 'MED-1038': [('fiber stool', 0.578),\n",
       "  ('dietary fiber', 0.5303),\n",
       "  ('stool output', 0.5091),\n",
       "  ('dietary factors', 0.4824),\n",
       "  ('fiber disease', 0.446),\n",
       "  ('detergent fiber', 0.4214),\n",
       "  ('diet accounted', 0.4194),\n",
       "  ('remained dietary', 0.3803),\n",
       "  ('predictive stool', 0.379),\n",
       "  ('differences stool', 0.3708),\n",
       "  ('low stool', 0.3664),\n",
       "  ('did dietary', 0.3543),\n",
       "  ('fiber results', 0.3428),\n",
       "  ('independently diet', 0.333),\n",
       "  ('variance stool', 0.3156),\n",
       "  ('examined effects', 0.3121),\n",
       "  ('relationship fiber', 0.3045),\n",
       "  ('factors controlled', 0.2904),\n",
       "  ('accounted variance', 0.2717),\n",
       "  ('neutral detergent', 0.2626),\n",
       "  ('results suggest', 0.2576),\n",
       "  ('mediating variables', 0.2567),\n",
       "  ('fiber source', 0.2431),\n",
       "  ('output remained', 0.2393),\n",
       "  ('disease', 0.2291),\n",
       "  ('personality measures', 0.2287),\n",
       "  ('frequency independently', 0.217),\n",
       "  ('controlled personality', 0.2159),\n",
       "  ('measures used', 0.2109),\n",
       "  ('hypothesized relationship', 0.2067),\n",
       "  ('weight', 0.1973),\n",
       "  ('output primary', 0.1971),\n",
       "  ('output did', 0.189),\n",
       "  ('variables', 0.1778),\n",
       "  ('results', 0.1742),\n",
       "  ('factors predispose', 0.1426),\n",
       "  ('examined', 0.1291),\n",
       "  ('frequency substantial', 0.1239),\n",
       "  ('primary', 0.1201),\n",
       "  ('individual differences', 0.1148),\n",
       "  ('source predictive', 0.1135),\n",
       "  ('output individuals', 0.1023),\n",
       "  ('used', 0.0776),\n",
       "  ('particularly', 0.0536),\n",
       "  ('persons low', 0.0479),\n",
       "  ('individual', 0.0479),\n",
       "  ('total', 0.0439),\n",
       "  ('persons', -0.0095),\n",
       "  ('individuals benefit', -0.0516),\n",
       "  ('neutral', -0.0666)],\n",
       " 'MED-1039': [('disorders bowel', 0.561),\n",
       "  ('ulcerative colitis', 0.5273),\n",
       "  ('bos ocd', 0.4861),\n",
       "  ('bowel obsession', 0.4656),\n",
       "  ('intestinal disorders', 0.4597),\n",
       "  ('gastroenterologists', 0.4562),\n",
       "  ('colitis functional', 0.4521),\n",
       "  ('gastroenterologists faced', 0.4488),\n",
       "  ('ocd like', 0.4425),\n",
       "  ('colitis overlapping', 0.418),\n",
       "  ('symptoms bos', 0.4119),\n",
       "  ('bos antidepressants', 0.4066),\n",
       "  ('fecal incontinence', 0.4065),\n",
       "  ('disorders', 0.4022),\n",
       "  ('incontinence compulsive', 0.3757),\n",
       "  ('patient ulcerative', 0.372),\n",
       "  ('studies treatment', 0.3474),\n",
       "  ('symptoms marked', 0.3452),\n",
       "  ('obsession syndrome', 0.3428),\n",
       "  ('acute symptoms', 0.3272),\n",
       "  ('fear fecal', 0.3038),\n",
       "  ('functional syndrome', 0.2864),\n",
       "  ('compulsive behaviors', 0.2823),\n",
       "  ('antidepressants published', 0.2815),\n",
       "  ('functional intestinal', 0.2802),\n",
       "  ('syndrome characterized', 0.2769),\n",
       "  ('fecal', 0.2434),\n",
       "  ('clinical', 0.2343),\n",
       "  ('diagnosis prevent', 0.2178),\n",
       "  ('bos help', 0.2116),\n",
       "  ('help clinicians', 0.2033),\n",
       "  ('faced diagnostic', 0.1873),\n",
       "  ('overlapping functional', 0.1857),\n",
       "  ('case studies', 0.1783),\n",
       "  ('appropriate treatment', 0.1702),\n",
       "  ('characterized fear', 0.134),\n",
       "  ('behaviors', 0.123),\n",
       "  ('evacuation checking', 0.119),\n",
       "  ('patients', 0.1173),\n",
       "  ('problem', 0.1099),\n",
       "  ('psychotherapy male', 0.1095),\n",
       "  ('unnecessary investigations', 0.1068),\n",
       "  ('sparse case', 0.1043),\n",
       "  ('investigations', 0.0945),\n",
       "  ('prevent unnecessary', 0.0556),\n",
       "  ('published', 0.0495),\n",
       "  ('differential', 0.0138),\n",
       "  ('recognition', -0.0018),\n",
       "  ('successful', -0.0196),\n",
       "  ('like', -0.0236)],\n",
       " 'MED-1040': [('bowel habits', 0.522),\n",
       "  ('constipation common', 0.4699),\n",
       "  ('subjects ibs', 0.4673),\n",
       "  ('gastrointestinal abnormality', 0.4574),\n",
       "  ('medications gastrointestinal', 0.4533),\n",
       "  ('evaluating diarrhoea', 0.4516),\n",
       "  ('normal stool', 0.4314),\n",
       "  ('confounders help', 0.3683),\n",
       "  ('relevant medication', 0.3265),\n",
       "  ('colonoscopy laboratory', 0.315),\n",
       "  ('symptom diaries', 0.3097),\n",
       "  ('loose consistency', 0.3079),\n",
       "  ('organic disease', 0.3071),\n",
       "  ('differences disappeared', 0.2991),\n",
       "  ('hypothesized exclusion', 0.2981),\n",
       "  ('investigations exclude', 0.2926),\n",
       "  ('based studies', 0.2826),\n",
       "  ('intake', 0.2714),\n",
       "  ('excluding subjects', 0.267),\n",
       "  ('habit important', 0.2619),\n",
       "  ('effects considered', 0.2619),\n",
       "  ('objective defining', 0.2554),\n",
       "  ('terms abdominal', 0.2519),\n",
       "  ('general population', 0.251),\n",
       "  ('incomplete evacuation', 0.2265),\n",
       "  ('differences terms', 0.2209),\n",
       "  ('urgency straining', 0.2022),\n",
       "  ('normal hypothesized', 0.2),\n",
       "  ('studied random', 0.1896),\n",
       "  ('carefully studied', 0.1854),\n",
       "  ('abnormalities women', 0.1843),\n",
       "  ('clinically', 0.1843),\n",
       "  ('week day', 0.1814),\n",
       "  ('47 incomplete', 0.1555),\n",
       "  ('earlier population', 0.1413),\n",
       "  ('defecatory', 0.1413),\n",
       "  ('irritable', 0.1345),\n",
       "  ('men terms', 0.1339),\n",
       "  ('10 loose', 0.1295),\n",
       "  ('age differences', 0.1284),\n",
       "  ('common', 0.1222),\n",
       "  ('reported 36', 0.1161),\n",
       "  ('evacuation gender', 0.116),\n",
       "  ('70 years', 0.0972),\n",
       "  ('12 hard', 0.0798),\n",
       "  ('bloating degree', 0.0786),\n",
       "  ('better', 0.069),\n",
       "  ('98', 0.0686),\n",
       "  ('pain', 0.0622),\n",
       "  ('subjects 18', 0.0454)],\n",
       " 'MED-1041': [('specialties gastroenterology', 0.5669),\n",
       "  ('gastroenterological symptoms', 0.5307),\n",
       "  ('medical symptoms', 0.5063),\n",
       "  ('physicians described', 0.4999),\n",
       "  ('gastroenterology subject', 0.4898),\n",
       "  ('pharaonic physicians', 0.4836),\n",
       "  ('physicians ancient', 0.4537),\n",
       "  ('disorders served', 0.4469),\n",
       "  ('diseases', 0.4441),\n",
       "  ('medical papyri', 0.4351),\n",
       "  ('host gastroenterological', 0.4185),\n",
       "  ('did diseases', 0.4181),\n",
       "  ('medical', 0.405),\n",
       "  ('care disorders', 0.3715),\n",
       "  ('diseases know', 0.3691),\n",
       "  ('therapeutics prescribed', 0.3089),\n",
       "  ('anorectal conditions', 0.2923),\n",
       "  ('symptoms extensive', 0.2899),\n",
       "  ('surviving medical', 0.2868),\n",
       "  ('feces represented', 0.2758),\n",
       "  ('prescribed clinical', 0.264),\n",
       "  ('disease mechanism', 0.2552),\n",
       "  ('devoted care', 0.2502),\n",
       "  ('organs notable', 0.2452),\n",
       "  ('ancient egypt', 0.2285),\n",
       "  ('notable specialties', 0.2206),\n",
       "  ('papyri did', 0.2157),\n",
       "  ('gastric', 0.202),\n",
       "  ('array therapeutics', 0.1892),\n",
       "  ('popular practice', 0.1848),\n",
       "  ('enemas', 0.1475),\n",
       "  ('conditions thinking', 0.1211),\n",
       "  ('subject matter', 0.1189),\n",
       "  ('peccans absorbed', 0.1171),\n",
       "  ('purgation', 0.1076),\n",
       "  ('knowledge', 0.1061),\n",
       "  ('described host', 0.079),\n",
       "  ('accounts', 0.0494),\n",
       "  ('extensive', 0.0484),\n",
       "  ('served', 0.0453),\n",
       "  ('major cause', 0.0421),\n",
       "  ('circulating materia', 0.0401),\n",
       "  ('matter occupied', 0.03),\n",
       "  ('did', 0.0218),\n",
       "  ('rationale', 0.0204),\n",
       "  ('portion', -0.0069),\n",
       "  ('self', -0.0091),\n",
       "  ('individual', -0.0255),\n",
       "  ('mechanism circulating', -0.0351),\n",
       "  ('popular', -0.0626)],\n",
       " 'MED-1042': [('colonic motility', 0.6372),\n",
       "  ('understanding colonic', 0.6114),\n",
       "  ('colonic', 0.5224),\n",
       "  ('colon relatively', 0.4957),\n",
       "  ('human colon', 0.4865),\n",
       "  ('constipation reviewed', 0.4738),\n",
       "  ('motility especially', 0.4251),\n",
       "  ('demonstrated viscus', 0.3908),\n",
       "  ('propulsive contractions', 0.3861),\n",
       "  ('contractions complex', 0.3828),\n",
       "  ('circadian trend', 0.3683),\n",
       "  ('idiopathic constipation', 0.3417),\n",
       "  ('viscus especially', 0.3399),\n",
       "  ('unknown viscus', 0.318),\n",
       "  ('prolonged recording', 0.2944),\n",
       "  ('sleep features', 0.2588),\n",
       "  ('recording', 0.2563),\n",
       "  ('physiological stimuli', 0.2505),\n",
       "  ('years techniques', 0.2432),\n",
       "  ('activity recent', 0.2403),\n",
       "  ('propulsive', 0.2352),\n",
       "  ('reviewed article', 0.2316),\n",
       "  ('recent years', 0.2184),\n",
       "  ('alterations patients', 0.2131),\n",
       "  ('periods', 0.2112),\n",
       "  ('patients chronic', 0.2043),\n",
       "  ('understanding', 0.2042),\n",
       "  ('concerning motor', 0.198),\n",
       "  ('meals sleep', 0.1924),\n",
       "  ('dynamic', 0.1857),\n",
       "  ('trend responsive', 0.1764),\n",
       "  ('relatively unknown', 0.172),\n",
       "  ('especially prolonged', 0.1678),\n",
       "  ('process', 0.1578),\n",
       "  ('defecatory process', 0.1535),\n",
       "  ('amplitude', 0.1468),\n",
       "  ('complex', 0.1424),\n",
       "  ('relatively', 0.1319),\n",
       "  ('meals', 0.1273),\n",
       "  ('human', 0.118),\n",
       "  ('allow better', 0.1084),\n",
       "  ('especially concerning', 0.0988),\n",
       "  ('properties', 0.0868),\n",
       "  ('way demonstrated', 0.0787),\n",
       "  ('idiopathic', 0.0641),\n",
       "  ('patients', 0.0625),\n",
       "  ('contracts according', 0.0284),\n",
       "  ('features high', 0.0276),\n",
       "  ('perfected', 0.0099),\n",
       "  ('perfected allow', -0.0087)],\n",
       " 'MED-1045': [('colon cancer', 0.603),\n",
       "  ('potentially carcinogenic', 0.4996),\n",
       "  ('cancer rare', 0.4846),\n",
       "  ('cancer recommendations', 0.4642),\n",
       "  ('prophylaxis colon', 0.4421),\n",
       "  ('affect bowel', 0.4309),\n",
       "  ('changes diet', 0.3954),\n",
       "  ('fecal bile', 0.3626),\n",
       "  ('foods effects', 0.3477),\n",
       "  ('deaths western', 0.3319),\n",
       "  ('cause changes', 0.2913),\n",
       "  ('ingestion bran', 0.2672),\n",
       "  ('sterols noxious', 0.2643),\n",
       "  ('sterols longer', 0.2628),\n",
       "  ('increased fat', 0.2566),\n",
       "  ('fall intake', 0.2407),\n",
       "  ('physiology decreased', 0.2347),\n",
       "  ('secular changes', 0.2311),\n",
       "  ('acids', 0.2278),\n",
       "  ('evidence suggests', 0.2246),\n",
       "  ('intake higher', 0.2224),\n",
       "  ('unlikely adopted', 0.2129),\n",
       "  ('developing populations', 0.21),\n",
       "  ('possible prophylaxis', 0.2067),\n",
       "  ('lower fat', 0.1967),\n",
       "  ('constitution concentrations', 0.1881),\n",
       "  ('time prone', 0.1732),\n",
       "  ('genetic', 0.1625),\n",
       "  ('suggests following', 0.1609),\n",
       "  ('longer transit', 0.1588),\n",
       "  ('nonprone populations', 0.1572),\n",
       "  ('primary cause', 0.1476),\n",
       "  ('past developing', 0.1447),\n",
       "  ('day adventists', 0.1343),\n",
       "  ('populations higher', 0.131),\n",
       "  ('intensive study', 0.1257),\n",
       "  ('average mortality', 0.0953),\n",
       "  ('future', 0.0876),\n",
       "  ('finnish', 0.0814),\n",
       "  ('milieu intérieur', 0.0569),\n",
       "  ('mormons rural', 0.0486),\n",
       "  ('importance', 0.0316),\n",
       "  ('rates seventh', 0.03),\n",
       "  ('fiber containing', 0.0299),\n",
       "  ('demand', 0.0222),\n",
       "  ('currently accounts', 0.0161),\n",
       "  ('raise', -0.0059),\n",
       "  ('respective roles', -0.0067),\n",
       "  ('favor production', -0.0214),\n",
       "  ('apart', -0.0391)],\n",
       " 'MED-1046': [('colonic pressure', 0.5554),\n",
       "  ('stimulated gastric', 0.486),\n",
       "  ('analysis gastric', 0.4638),\n",
       "  ('aspiration nasogastric', 0.4632),\n",
       "  ('secretion measured', 0.4268),\n",
       "  ('feeding control', 0.3859),\n",
       "  ('tested food', 0.3436),\n",
       "  ('minutes cephalic', 0.3301),\n",
       "  ('unprepared sigmoid', 0.3301),\n",
       "  ('normal subjects', 0.3205),\n",
       "  ('increased acid', 0.3205),\n",
       "  ('pressures unprepared', 0.3),\n",
       "  ('recording intraluminal', 0.2924),\n",
       "  ('tube', 0.2836),\n",
       "  ('continuous aspiration', 0.2594),\n",
       "  ('output basal', 0.2486),\n",
       "  ('mm hg', 0.2282),\n",
       "  ('stimuli control', 0.2269),\n",
       "  ('24 studied', 0.2222),\n",
       "  ('pressures compared', 0.2205),\n",
       "  ('120', 0.2157),\n",
       "  ('60 minute', 0.2113),\n",
       "  ('06', 0.2069),\n",
       "  ('taste modified', 0.2039),\n",
       "  ('compared control', 0.2012),\n",
       "  ('measured simultaneously', 0.1976),\n",
       "  ('sum test', 0.19),\n",
       "  ('mmol 30', 0.1813),\n",
       "  ('values', 0.1784),\n",
       "  ('expressed mmol', 0.1702),\n",
       "  ('mean age', 0.1585),\n",
       "  ('segment activity', 0.1561),\n",
       "  ('study data', 0.1528),\n",
       "  ('random order', 0.1482),\n",
       "  ('22 years', 0.1479),\n",
       "  ('records continued', 0.1459),\n",
       "  ('contrast effect', 0.1377),\n",
       "  ('sight smell', 0.1317),\n",
       "  ('discussion sham', 0.1236),\n",
       "  ('test increased', 0.1124),\n",
       "  ('correlated significantly', 0.1049),\n",
       "  ('34 increase', 0.1007),\n",
       "  ('45 02', 0.1007),\n",
       "  ('topics', 0.0874),\n",
       "  ('best stimulus', 0.0835),\n",
       "  ('computer', 0.0697),\n",
       "  ('significantly different', 0.0542),\n",
       "  ('derived fully', 0.0477),\n",
       "  ('did', 0.0364),\n",
       "  ('03 increased', -0.0185)],\n",
       " 'MED-1047': [('studies laxative', 0.4284),\n",
       "  ('foods resisted', 0.3685),\n",
       "  ('wheat bran', 0.3638),\n",
       "  ('dietary fiber', 0.3632),\n",
       "  ('suggested cereal', 0.3596),\n",
       "  ('africa extended', 0.3467),\n",
       "  ('colonic disorders', 0.3403),\n",
       "  ('trowell uganda', 0.3314),\n",
       "  ('extended studies', 0.3314),\n",
       "  ('metabolic diseases', 0.3183),\n",
       "  ('studies african', 0.3172),\n",
       "  ('colon stream', 0.2878),\n",
       "  ('disorders trowell', 0.2773),\n",
       "  ('noninfective diseases', 0.2772),\n",
       "  ('alimentary', 0.2768),\n",
       "  ('fundamental studies', 0.2595),\n",
       "  ('century walker', 0.2398),\n",
       "  ('plant foods', 0.2293),\n",
       "  ('blacks later', 0.2219),\n",
       "  ('resisted', 0.218),\n",
       "  ('fiber protected', 0.2161),\n",
       "  ('refined', 0.2153),\n",
       "  ('early decades', 0.1995),\n",
       "  ('flour caused', 0.1988),\n",
       "  ('new physiological', 0.1906),\n",
       "  ('digestion', 0.1881),\n",
       "  ('rarity appendicitis', 0.1858),\n",
       "  ('decades 20th', 0.177),\n",
       "  ('united states', 0.176),\n",
       "  ('hemicellulose', 0.1636),\n",
       "  ('concept regard', 0.1601),\n",
       "  ('southgate proposed', 0.1591),\n",
       "  ('diseases loss', 0.1573),\n",
       "  ('disorders rural', 0.156),\n",
       "  ('enzymes man', 0.152),\n",
       "  ('evidence rarity', 0.1319),\n",
       "  ('lignin', 0.1309),\n",
       "  ('terms residue', 0.1275),\n",
       "  ('sugar lesser', 0.1203),\n",
       "  ('cleave postulated', 0.1081),\n",
       "  ('extent white', 0.1044),\n",
       "  ('hypothesis', 0.0861),\n",
       "  ('burkitt collected', 0.0754),\n",
       "  ('caused certain', 0.0746),\n",
       "  ('chemical methods', 0.0633),\n",
       "  ('inquiry stemmed', 0.0532),\n",
       "  ('asia 1972', 0.0243),\n",
       "  ('collected massive', 0.0081),\n",
       "  ('venous', -0.0114),\n",
       "  ('stemmed', -0.0464)],\n",
       " 'MED-1048': [('stool types', 0.5009),\n",
       "  ('bowels women', 0.388),\n",
       "  ('838 men', 0.3536),\n",
       "  ('bristol population', 0.3212),\n",
       "  ('questioned 838', 0.3046),\n",
       "  ('shifted constipation', 0.2731),\n",
       "  ('mushy questionnaire', 0.2575),\n",
       "  ('habit people', 0.2524),\n",
       "  ('community unknown', 0.2469),\n",
       "  ('men women', 0.2443),\n",
       "  ('minority practice', 0.2395),\n",
       "  ('types community', 0.2325),\n",
       "  ('33 women', 0.2314),\n",
       "  ('comprising 72', 0.2247),\n",
       "  ('1059 women', 0.22),\n",
       "  ('61 men', 0.2174),\n",
       "  ('irregularity compared', 0.2046),\n",
       "  ('symptoms accounted', 0.2014),\n",
       "  ('population aspect', 0.1747),\n",
       "  ('random stratified', 0.168),\n",
       "  ('human physiology', 0.1643),\n",
       "  ('sample east', 0.1631),\n",
       "  ('half population', 0.1572),\n",
       "  ('agreed moderately', 0.1505),\n",
       "  ('cases', 0.1456),\n",
       "  ('types shifted', 0.1455),\n",
       "  ('scale passed', 0.1392),\n",
       "  ('kept records', 0.137),\n",
       "  ('slow transit', 0.1281),\n",
       "  ('ranging hard', 0.1256),\n",
       "  ('compared older', 0.1193),\n",
       "  ('form validated', 0.1168),\n",
       "  ('constipated', 0.1149),\n",
       "  ('lumps', 0.1138),\n",
       "  ('little effect', 0.1039),\n",
       "  ('accounted 56', 0.1018),\n",
       "  ('defecated', 0.1003),\n",
       "  ('daily week', 0.0759),\n",
       "  ('regular 24', 0.0578),\n",
       "  ('enjoyed', 0.0535),\n",
       "  ('conventionally normal', 0.0501),\n",
       "  ('earlier', 0.0495),\n",
       "  ('hour cycle', 0.0453),\n",
       "  ('common', 0.0365),\n",
       "  ('sexes regular', 0.0336),\n",
       "  ('discovered young', 0.0226),\n",
       "  ('especially disadvantaged', 0.0094),\n",
       "  ('bearing', -0.0193),\n",
       "  ('twice', -0.0404),\n",
       "  ('40', -0.0449)],\n",
       " 'MED-1049': [('functioning constipation', 0.5853),\n",
       "  ('constipation older', 0.5685),\n",
       "  ('constipation', 0.5465),\n",
       "  ('bowel movements', 0.5332),\n",
       "  ('bowel movement', 0.5179),\n",
       "  ('details bowel', 0.4606),\n",
       "  ('bowel', 0.4307),\n",
       "  ('caring patients', 0.3598),\n",
       "  ('patients pain', 0.3597),\n",
       "  ('nurses need', 0.358),\n",
       "  ('nurses', 0.3109),\n",
       "  ('function nurses', 0.3019),\n",
       "  ('body functioning', 0.2794),\n",
       "  ('attitude caring', 0.2699),\n",
       "  ('problematic like', 0.2694),\n",
       "  ('caring', 0.2616),\n",
       "  ('pain', 0.253),\n",
       "  ('adults especially', 0.2399),\n",
       "  ('older adults', 0.2374),\n",
       "  ('movement function', 0.2292),\n",
       "  ('patients', 0.2241),\n",
       "  ('vital information', 0.2203),\n",
       "  ('need assess', 0.2145),\n",
       "  ('problematic', 0.2141),\n",
       "  ('support treat', 0.2118),\n",
       "  ('movements provide', 0.2004),\n",
       "  ('vital', 0.2004),\n",
       "  ('treat attitude', 0.1975),\n",
       "  ('provide vital', 0.1974),\n",
       "  ('adults', 0.1925),\n",
       "  ('especially problematic', 0.1844),\n",
       "  ('attitude', 0.1759),\n",
       "  ('treat', 0.1752),\n",
       "  ('older', 0.1748),\n",
       "  ('need', 0.1641),\n",
       "  ('assess support', 0.1537),\n",
       "  ('functioning', 0.1448),\n",
       "  ('information body', 0.1332),\n",
       "  ('function', 0.1195),\n",
       "  ('body', 0.1166),\n",
       "  ('support', 0.1085),\n",
       "  ('movement', 0.1076),\n",
       "  ('provide', 0.1017),\n",
       "  ('assess', 0.0947),\n",
       "  ('especially', 0.0666),\n",
       "  ('details', 0.0508),\n",
       "  ('like hearing', 0.0495),\n",
       "  ('information', 0.0476),\n",
       "  ('hearing details', 0.0474),\n",
       "  ('like', 0.0262)],\n",
       " 'MED-1050': [('hcps intervention', 0.6264),\n",
       "  ('health care', 0.4948),\n",
       "  ('clinics methods', 0.4726),\n",
       "  ('interventions promote', 0.461),\n",
       "  ('clinics 05', 0.4046),\n",
       "  ('program followed', 0.4021),\n",
       "  ('randomized 15', 0.3885),\n",
       "  ('lower hcps', 0.3775),\n",
       "  ('providers', 0.3701),\n",
       "  ('group patients', 0.3323),\n",
       "  ('control hmo', 0.3218),\n",
       "  ('experience multidisciplinary', 0.3134),\n",
       "  ('increased referral', 0.2916),\n",
       "  ('pattern improvement', 0.291),\n",
       "  ('evaluated clinical', 0.2812),\n",
       "  ('496 patients', 0.2484),\n",
       "  ('strategy primary', 0.2447),\n",
       "  ('methods randomized', 0.2329),\n",
       "  ('members matched', 0.2207),\n",
       "  ('015', 0.216),\n",
       "  ('control intake', 0.2041),\n",
       "  ('lifestyles', 0.1987),\n",
       "  ('initiative attitudes', 0.1977),\n",
       "  ('effect self', 0.1893),\n",
       "  ('cmr increased', 0.1717),\n",
       "  ('93 821', 0.1666),\n",
       "  ('hba1', 0.1615),\n",
       "  ('personally 77', 0.1441),\n",
       "  ('conclusions', 0.1352),\n",
       "  ('profile provide', 0.1342),\n",
       "  ('vs baseline', 0.1209),\n",
       "  ('69', 0.1206),\n",
       "  ('performance', 0.1064),\n",
       "  ('directly correlated', 0.0973),\n",
       "  ('prevention copyright', 0.0922),\n",
       "  ('israel results', 0.0793),\n",
       "  ('angiography tests', 0.0619),\n",
       "  ('rights reserved', 0.0532),\n",
       "  ('body weight', 0.0407),\n",
       "  ('71 048', 0.033),\n",
       "  ('specifically salt', 0.0278),\n",
       "  ('048 lower', 0.0157),\n",
       "  ('increased blood', -0.0016),\n",
       "  ('january', -0.0158),\n",
       "  ('meat', -0.0241),\n",
       "  ('2010', -0.0269),\n",
       "  ('somewhat haloed', -0.0297),\n",
       "  ('valuable somewhat', -0.0369),\n",
       "  ('red', -0.0426),\n",
       "  ('fruit vegetable', -0.072)],\n",
       " 'MED-1051': [('physician advice', 0.5267),\n",
       "  ('medicine clinics', 0.5237),\n",
       "  ('encourage patients', 0.4766),\n",
       "  ('change interventions', 0.4729),\n",
       "  ('family medicine', 0.4415),\n",
       "  ('intervention materials', 0.4334),\n",
       "  ('patient responses', 0.4149),\n",
       "  ('changes smoking', 0.386),\n",
       "  ('missouri participants', 0.3851),\n",
       "  ('clinics southeastern', 0.376),\n",
       "  ('advice quit', 0.3633),\n",
       "  ('915 interventions', 0.3599),\n",
       "  ('results patients', 0.3534),\n",
       "  ('patients quit', 0.3335),\n",
       "  ('designed encourage', 0.3263),\n",
       "  ('support integrated', 0.3135),\n",
       "  ('participants adult', 0.3104),\n",
       "  ('findings support', 0.2863),\n",
       "  ('community based', 0.2847),\n",
       "  ('outcome measures', 0.2753),\n",
       "  ('individualization', 0.2751),\n",
       "  ('priming effect', 0.2734),\n",
       "  ('month follow', 0.2588),\n",
       "  ('responses behavioral', 0.2558),\n",
       "  ('prevention', 0.235),\n",
       "  ('information activities', 0.2213),\n",
       "  ('follow setting', 0.218),\n",
       "  ('measures recall', 0.2145),\n",
       "  ('model disease', 0.2092),\n",
       "  ('prior receiving', 0.2043),\n",
       "  ('controlled trial', 0.1985),\n",
       "  ('objective explore', 0.1887),\n",
       "  ('printed educational', 0.1877),\n",
       "  ('physical activity', 0.1657),\n",
       "  ('materials applying', 0.158),\n",
       "  ('conclusions', 0.1551),\n",
       "  ('95 ci', 0.1376),\n",
       "  ('rating use', 0.1349),\n",
       "  ('84', 0.134),\n",
       "  ('35', 0.1334),\n",
       "  ('group family', 0.1315),\n",
       "  ('catalyst', 0.1276),\n",
       "  ('confidence', 0.1162),\n",
       "  ('02', 0.115),\n",
       "  ('main', 0.1097),\n",
       "  ('topic likely', 0.1089),\n",
       "  ('provide depth', 0.0769),\n",
       "  ('51', 0.0587),\n",
       "  ('eat', -0.0126),\n",
       "  ('24 hours', -0.0233)],\n",
       " 'MED-1053': [('conclusion physicians', 0.5328),\n",
       "  ('health education', 0.5139),\n",
       "  ('physicians healthy', 0.5003),\n",
       "  ('healthier habits', 0.4885),\n",
       "  ('physician disclosure', 0.4835),\n",
       "  ('enhanced physician', 0.4766),\n",
       "  ('prevention patients', 0.4533),\n",
       "  ('habits educational', 0.4193),\n",
       "  ('patients knowledge', 0.3966),\n",
       "  ('patient motivation', 0.3504),\n",
       "  ('discuss prevention', 0.3449),\n",
       "  ('video physician', 0.3393),\n",
       "  ('personal practices', 0.3263),\n",
       "  ('adopt healthy', 0.3068),\n",
       "  ('professionals', 0.3058),\n",
       "  ('patients adopt', 0.3031),\n",
       "  ('general medical', 0.2999),\n",
       "  ('testing physician', 0.296),\n",
       "  ('practice demonstrate', 0.2891),\n",
       "  ('behaviors design', 0.2762),\n",
       "  ('consider encouraging', 0.2653),\n",
       "  ('studies shown', 0.2641),\n",
       "  ('videos improving', 0.2477),\n",
       "  ('regarding exercise', 0.2307),\n",
       "  ('context studies', 0.2153),\n",
       "  ('disclosures healthy', 0.2129),\n",
       "  ('clinic', 0.2003),\n",
       "  ('believable motivating', 0.1995),\n",
       "  ('disclosure video', 0.1953),\n",
       "  ('discussion personal', 0.1931),\n",
       "  ('institutions consider', 0.1718),\n",
       "  ('included control', 0.1505),\n",
       "  ('shown subjects', 0.1501),\n",
       "  ('knowledge published', 0.1499),\n",
       "  ('information', 0.1484),\n",
       "  ('credibility', 0.141),\n",
       "  ('enhanced conveying', 0.1359),\n",
       "  ('diet', 0.1338),\n",
       "  ('bike helmet', 0.1239),\n",
       "  ('did viewers', 0.1225),\n",
       "  ('001 conclusion', 0.1208),\n",
       "  ('n2 65', 0.0843),\n",
       "  ('practices apple', 0.0598),\n",
       "  ('revealed additional', 0.0496),\n",
       "  ('brief', 0.0428),\n",
       "  ('university general', 0.0301),\n",
       "  ('visible desk', 0.0279),\n",
       "  ('waiting room', -0.0131),\n",
       "  ('atlanta ga', -0.0368),\n",
       "  ('half minute', -0.0616)],\n",
       " 'MED-1054': [('diseases ncds', 0.6749),\n",
       "  ('ncds developing', 0.6248),\n",
       "  ('communicable diseases', 0.5865),\n",
       "  ('ncds discussed', 0.5255),\n",
       "  ('increase ncds', 0.4862),\n",
       "  ('burden developed', 0.396),\n",
       "  ('triggering diseases', 0.3952),\n",
       "  ('ncds similar', 0.3804),\n",
       "  ('main trends', 0.3639),\n",
       "  ('cvd', 0.3385),\n",
       "  ('based deaths', 0.3107),\n",
       "  ('main mortality', 0.3026),\n",
       "  ('transition countries', 0.2973),\n",
       "  ('developed world', 0.296),\n",
       "  ('high cholesterol', 0.2773),\n",
       "  ('urbanization', 0.2717),\n",
       "  ('diabetes', 0.263),\n",
       "  ('non communicable', 0.2552),\n",
       "  ('cancer', 0.2455),\n",
       "  ('alarming data', 0.2359),\n",
       "  ('obesity promotes', 0.2325),\n",
       "  ('development multi', 0.2228),\n",
       "  ('sedentary lifestyles', 0.2087),\n",
       "  ('dramatic increase', 0.2017),\n",
       "  ('secondary prevention', 0.1959),\n",
       "  ('growth', 0.1755),\n",
       "  ('blood pressure', 0.1688),\n",
       "  ('countries true', 0.1606),\n",
       "  ('factors primary', 0.1528),\n",
       "  ('factorial based', 0.1346),\n",
       "  ('policy promising', 0.1303),\n",
       "  ('long time', 0.1231),\n",
       "  ('time non', 0.1173),\n",
       "  ('copyright 2011', 0.108),\n",
       "  ('communicable', 0.1074),\n",
       "  ('smoking', 0.0885),\n",
       "  ('discussed', 0.0835),\n",
       "  ('data', 0.0785),\n",
       "  ('world particular', 0.0744),\n",
       "  ('reverse', 0.074),\n",
       "  ('populated', 0.074),\n",
       "  ('functional food', 0.0554),\n",
       "  ('accompanied physical', 0.0485),\n",
       "  ('globalization supermarket', 0.0236),\n",
       "  ('leads', 0.0208),\n",
       "  ('copyright', 0.0196),\n",
       "  ('middle income', -0.0026),\n",
       "  ('elsevier rights', -0.0082),\n",
       "  ('high quality', -0.0085),\n",
       "  ('happen low', -0.0373)],\n",
       " 'MED-1055': [('strategy diet', 0.4657),\n",
       "  ('world health', 0.4593),\n",
       "  ('health disassociate', 0.4478),\n",
       "  ('demolish 2004', 0.3653),\n",
       "  ('diseases obesity', 0.3577),\n",
       "  ('nutrient poor', 0.3549),\n",
       "  ('2003 fao', 0.3472),\n",
       "  ('nation policy', 0.3465),\n",
       "  ('reasons global', 0.3298),\n",
       "  ('world sugar', 0.2952),\n",
       "  ('prevent control', 0.2866),\n",
       "  ('impediment trade', 0.2857),\n",
       "  ('policy makers', 0.2837),\n",
       "  ('activity health', 0.2696),\n",
       "  ('government hostility', 0.2612),\n",
       "  ('strategy report', 0.2588),\n",
       "  ('salty foods', 0.2576),\n",
       "  ('dominant nation', 0.2547),\n",
       "  ('agriculture organization', 0.2371),\n",
       "  ('organization expert', 0.2313),\n",
       "  ('physical inactivity', 0.231),\n",
       "  ('2004 world', 0.2266),\n",
       "  ('chief causes', 0.2231),\n",
       "  ('nations brake', 0.2206),\n",
       "  ('current government', 0.2175),\n",
       "  ('states sectors', 0.2156),\n",
       "  ('world powerful', 0.215),\n",
       "  ('drink production', 0.206),\n",
       "  ('dense fatty', 0.2056),\n",
       "  ('ideologies', 0.2033),\n",
       "  ('weaknesses strengths', 0.2001),\n",
       "  ('current pressures', 0.195),\n",
       "  ('prevention chronic', 0.1942),\n",
       "  ('challenged international', 0.1916),\n",
       "  ('morbidity mortality', 0.1859),\n",
       "  ('improve public', 0.171),\n",
       "  ('initiatives designed', 0.157),\n",
       "  ('interests challenged', 0.1509),\n",
       "  ('prevalence increased', 0.139),\n",
       "  ('need expressed', 0.1345),\n",
       "  ('draft', 0.1208),\n",
       "  ('manufacturing industry', 0.1173),\n",
       "  ('vegetables', 0.1095),\n",
       "  ('2002', 0.0857),\n",
       "  ('half century', 0.0811),\n",
       "  ('better legacy', 0.0702),\n",
       "  ('cancers sites', 0.0691),\n",
       "  ('future generations', 0.0666),\n",
       "  ('report opposed', 0.0554),\n",
       "  ('scientific knowledge', 0.0317)],\n",
       " 'MED-1056': [('shifts diet', 0.5348),\n",
       "  ('heresy diets', 0.4884),\n",
       "  ('dietary challenges', 0.4617),\n",
       "  ('obesity thought', 0.4361),\n",
       "  ('foods increased', 0.4349),\n",
       "  ('processed foods', 0.389),\n",
       "  ('policy shifts', 0.3553),\n",
       "  ('beverages reduced', 0.3252),\n",
       "  ('sedentary time', 0.3137),\n",
       "  ('increases overweight', 0.3124),\n",
       "  ('sweetened', 0.3064),\n",
       "  ('1970 began', 0.3043),\n",
       "  ('home intake', 0.2861),\n",
       "  ('seen changes', 0.2805),\n",
       "  ('oils sugar', 0.2562),\n",
       "  ('reduced physical', 0.2386),\n",
       "  ('decades', 0.2293),\n",
       "  ('recognized diabetes', 0.1997),\n",
       "  ('thought heresy', 0.197),\n",
       "  ('1990', 0.1961),\n",
       "  ('reliance processed', 0.1942),\n",
       "  ('addressing prevention', 0.1927),\n",
       "  ('hypertension', 0.186),\n",
       "  ('ago discussion', 0.1792),\n",
       "  ('challenges faced', 0.1601),\n",
       "  ('major health', 0.1552),\n",
       "  ('greater use', 0.1489),\n",
       "  ('use edible', 0.1436),\n",
       "  ('activity increased', 0.1415),\n",
       "  ('countries higher', 0.141),\n",
       "  ('pandemic', 0.1355),\n",
       "  ('began dominate', 0.1329),\n",
       "  ('globe urban', 0.1277),\n",
       "  ('countries despite', 0.1253),\n",
       "  ('impending global', 0.125),\n",
       "  ('saharan', 0.1008),\n",
       "  ('explored', 0.0927),\n",
       "  ('middle income', 0.0885),\n",
       "  ('scale programmatic', 0.0813),\n",
       "  ('asia', 0.0787),\n",
       "  ('away', 0.0776),\n",
       "  ('despite major', 0.072),\n",
       "  ('poorest countries', 0.0661),\n",
       "  ('world did', 0.0647),\n",
       "  ('urban rural', 0.0591),\n",
       "  ('south', 0.0244),\n",
       "  ('did clearly', -0.0355),\n",
       "  ('ones', -0.0388),\n",
       "  ('documented array', -0.0601),\n",
       "  ('status concurrent', -0.0619)],\n",
       " 'MED-1058': [('sugar association', 0.6246),\n",
       "  ('sugar lobby', 0.5419),\n",
       "  ('rejects sugar', 0.5193),\n",
       "  ('sugar industry', 0.5123),\n",
       "  ('sugar account', 0.4987),\n",
       "  ('suggests sugar', 0.4976),\n",
       "  ('diet association', 0.449),\n",
       "  ('guidelines association', 0.4278),\n",
       "  ('guidelines healthy', 0.3856),\n",
       "  ('demanded congress', 0.3797),\n",
       "  ('healthy diet', 0.3784),\n",
       "  ('congress', 0.374),\n",
       "  ('report guidelines', 0.3608),\n",
       "  ('congress end', 0.3535),\n",
       "  ('association demanded', 0.3405),\n",
       "  ('withdraws guidelines', 0.3283),\n",
       "  ('world health', 0.3209),\n",
       "  ('health organization', 0.2929),\n",
       "  ('secretary health', 0.2653),\n",
       "  ('food industry', 0.2457),\n",
       "  ('eating', 0.2291),\n",
       "  ('association representing', 0.22),\n",
       "  ('health human', 0.1929),\n",
       "  ('association big', 0.181),\n",
       "  ('critical report', 0.1589),\n",
       "  ('organization unless', 0.1564),\n",
       "  ('strongly rejects', 0.1431),\n",
       "  ('lobby criticisms', 0.1388),\n",
       "  ('influence report', 0.1316),\n",
       "  ('unless withdraws', 0.1292),\n",
       "  ('groups', 0.1274),\n",
       "  ('account 10', 0.1198),\n",
       "  ('highly critical', 0.1086),\n",
       "  ('groups asked', 0.1083),\n",
       "  ('report withdrawn', 0.1055),\n",
       "  ('percent healthy', 0.1054),\n",
       "  ('end funding', 0.0948),\n",
       "  ('asked secretary', 0.0791),\n",
       "  ('demanded', 0.0728),\n",
       "  ('withdrawn strongly', 0.0649),\n",
       "  ('services use', 0.0444),\n",
       "  ('unless', 0.0421),\n",
       "  ('percent', 0.0316),\n",
       "  ('account', 0.0233),\n",
       "  ('strongly', 0.0227),\n",
       "  ('criticisms', 0.0207),\n",
       "  ('industry highly', 0.0071),\n",
       "  ('use', -0.0244),\n",
       "  ('funding', -0.0258),\n",
       "  ('human', -0.0695)],\n",
       " 'MED-1060': [('palmitate induced', 0.5459),\n",
       "  ('er stress', 0.532),\n",
       "  ('lipotoxic er', 0.5306),\n",
       "  ('stress mitochondrial', 0.5053),\n",
       "  ('diabetes endoplasmic', 0.4873),\n",
       "  ('crosstalk lipotoxic', 0.4564),\n",
       "  ('apoptosis causes', 0.4017),\n",
       "  ('saturated fatty', 0.3996),\n",
       "  ('diet induced', 0.397),\n",
       "  ('cells diabetes', 0.39),\n",
       "  ('proteins death', 0.3714),\n",
       "  ('ire1 dependent', 0.3614),\n",
       "  ('fat', 0.3591),\n",
       "  ('intrinsic mitochondrial', 0.3575),\n",
       "  ('stress elicited', 0.3208),\n",
       "  ('causes cell', 0.2989),\n",
       "  ('greater pancreatic', 0.2897),\n",
       "  ('p53 upregulated', 0.2865),\n",
       "  ('contribute dysfunction', 0.2836),\n",
       "  ('loss glucose', 0.2773),\n",
       "  ('diets rich', 0.2502),\n",
       "  ('foxo3a activation', 0.2453),\n",
       "  ('induced loss', 0.234),\n",
       "  ('environmental', 0.2288),\n",
       "  ('perk induced', 0.2242),\n",
       "  ('cells saturated', 0.2222),\n",
       "  ('kinase pkr', 0.2092),\n",
       "  ('elucidates crosstalk', 0.2023),\n",
       "  ('akt inhibition', 0.1949),\n",
       "  ('depends inositol', 0.1874),\n",
       "  ('analysis identified', 0.1607),\n",
       "  ('upregulated modulator', 0.1552),\n",
       "  ('cytochrome release', 0.154),\n",
       "  ('pathway', 0.1536),\n",
       "  ('mass study', 0.1477),\n",
       "  ('protein reduced', 0.1466),\n",
       "  ('microarray analysis', 0.1405),\n",
       "  ('elicited cells', 0.1376),\n",
       "  ('induction depends', 0.1347),\n",
       "  ('dp5 p53', 0.0986),\n",
       "  ('bh3 proteins', 0.0981),\n",
       "  ('tolerance twofold', 0.078),\n",
       "  ('nh2 terminal', 0.0671),\n",
       "  ('signature', 0.0615),\n",
       "  ('mice protected', 0.0364),\n",
       "  ('rat human', 0.0285),\n",
       "  ('promoter puma', 0.0194),\n",
       "  ('protected high', 0.0158),\n",
       "  ('dependent jun', 0.0047),\n",
       "  ('tribbles trb3', -0.0508)],\n",
       " 'MED-1061': [('obesity studied', 0.5654),\n",
       "  ('insulin concentrations', 0.534),\n",
       "  ('intake obesity', 0.5149),\n",
       "  ('independent obesity', 0.4734),\n",
       "  ('nondiabetic men', 0.4618),\n",
       "  ('215 nondiabetic', 0.4539),\n",
       "  ('association diet', 0.4435),\n",
       "  ('elevated fasting', 0.4237),\n",
       "  ('diet plasma', 0.4051),\n",
       "  ('carbohydrate intake', 0.3944),\n",
       "  ('monounsaturated fatty', 0.3798),\n",
       "  ('fatty', 0.3742),\n",
       "  ('men coronary', 0.3733),\n",
       "  ('consumption saturated', 0.3603),\n",
       "  ('adjusting age', 0.3274),\n",
       "  ('analysis intake', 0.3143),\n",
       "  ('coronary artery', 0.3031),\n",
       "  ('21 fasting', 0.2952),\n",
       "  ('determine association', 0.2894),\n",
       "  ('men aged', 0.2768),\n",
       "  ('16 intake', 0.2746),\n",
       "  ('waist', 0.2746),\n",
       "  ('cholesterol positively', 0.2572),\n",
       "  ('concentrations 215', 0.2544),\n",
       "  ('index 15', 0.2364),\n",
       "  ('calories negatively', 0.213),\n",
       "  ('disease methods', 0.2056),\n",
       "  ('05 body', 0.2052),\n",
       "  ('24 intake', 0.202),\n",
       "  ('circumference ratio', 0.1971),\n",
       "  ('related elevated', 0.1963),\n",
       "  ('sectional findings', 0.1945),\n",
       "  ('hip ratio', 0.1744),\n",
       "  ('years angiographically', 0.1729),\n",
       "  ('background', 0.1564),\n",
       "  ('independently body', 0.1547),\n",
       "  ('methods results', 0.1476),\n",
       "  ('mass', 0.1456),\n",
       "  ('acids did', 0.1426),\n",
       "  ('composition', 0.1284),\n",
       "  ('studied', 0.1274),\n",
       "  ('multivariate analysis', 0.1132),\n",
       "  ('concentration independent', 0.1117),\n",
       "  ('cross', 0.1035),\n",
       "  ('ratio did', 0.0972),\n",
       "  ('index 18', 0.0718),\n",
       "  ('aged 32', 0.0693),\n",
       "  ('74 years', 0.0561),\n",
       "  ('proven', 0.0105),\n",
       "  ('26 23', -0.0047)],\n",
       " 'MED-1062': [('diabetes develops', 0.6992),\n",
       "  ('insulin resistance', 0.6897),\n",
       "  ('diabetes increasing', 0.6881),\n",
       "  ('obesity epidemic', 0.6306),\n",
       "  ('obesity insulin', 0.6299),\n",
       "  ('cause obesity', 0.586),\n",
       "  ('fats cause', 0.5256),\n",
       "  ('diabetes molecular', 0.5117),\n",
       "  ('high fat', 0.504),\n",
       "  ('pancreatic insulin', 0.4864),\n",
       "  ('diet induced', 0.4093),\n",
       "  ('increasing pancreatic', 0.4014),\n",
       "  ('beta cell', 0.3764),\n",
       "  ('economic burden', 0.3416),\n",
       "  ('resistance beta', 0.338),\n",
       "  ('induced beta', 0.3189),\n",
       "  ('western diets', 0.3168),\n",
       "  ('cell dysfunction', 0.3024),\n",
       "  ('epidemic poses', 0.2934),\n",
       "  ('diets rich', 0.2912),\n",
       "  ('deficiency results', 0.2616),\n",
       "  ('reticulum stress', 0.2513),\n",
       "  ('prevalence type', 0.228),\n",
       "  ('stress proposed', 0.2013),\n",
       "  ('main causes', 0.2),\n",
       "  ('resistance increase', 0.1786),\n",
       "  ('apoptosis contribute', 0.1781),\n",
       "  ('death western', 0.1634),\n",
       "  ('nefas cause', 0.1623),\n",
       "  ('health socio', 0.1554),\n",
       "  ('saturated', 0.1551),\n",
       "  ('genetically predisposed', 0.1364),\n",
       "  ('increasing dramatically', 0.1351),\n",
       "  ('prevent type', 0.1341),\n",
       "  ('novel targeted', 0.1188),\n",
       "  ('pathway main', 0.1172),\n",
       "  ('individuals fail', 0.1147),\n",
       "  ('acids', 0.1072),\n",
       "  ('linking high', 0.0874),\n",
       "  ('proposed mechanism', 0.0778),\n",
       "  ('way development', 0.0728),\n",
       "  ('non esterified', 0.0625),\n",
       "  ('regulators involved', 0.0545),\n",
       "  ('progressive', 0.0451),\n",
       "  ('loss better', 0.0299),\n",
       "  ('dramatically result', 0.0263),\n",
       "  ('circulating', 0.0052),\n",
       "  ('understood identified', 0.0004),\n",
       "  ('er', -0.0016),\n",
       "  ('poses', -0.0722)],\n",
       " 'MED-1063': [('diabetes findings', 0.5991),\n",
       "  ('fat composition', 0.5173),\n",
       "  ('plasma cholesterol', 0.4603),\n",
       "  ('epidemiologic studies', 0.4592),\n",
       "  ('suggest dietary', 0.3995),\n",
       "  ('questionnaires suggest', 0.3586),\n",
       "  ('prospectively investigated', 0.3227),\n",
       "  ('contribute etiology', 0.3144),\n",
       "  ('mass index', 0.3118),\n",
       "  ('use biomarker', 0.3103),\n",
       "  ('stearic acid', 0.2928),\n",
       "  ('mellitus design', 0.2895),\n",
       "  ('risk confirmation', 0.2573),\n",
       "  ('education parental', 0.2452),\n",
       "  ('findings use', 0.2405),\n",
       "  ('ester', 0.2347),\n",
       "  ('waist hip', 0.2344),\n",
       "  ('phospholipid pl', 0.2326),\n",
       "  ('background', 0.2298),\n",
       "  ('warranted objective', 0.2296),\n",
       "  ('alcohol intake', 0.2221),\n",
       "  ('results adjustment', 0.212),\n",
       "  ('ce incidence', 0.2096),\n",
       "  ('identified follow', 0.2051),\n",
       "  ('particularly saturated', 0.205),\n",
       "  ('expressed percentage', 0.2019),\n",
       "  ('age', 0.1791),\n",
       "  ('quintiles', 0.1717),\n",
       "  ('profile particularly', 0.1698),\n",
       "  ('acids incident', 0.1666),\n",
       "  ('proportions 16', 0.1606),\n",
       "  ('08 0013', 0.1558),\n",
       "  ('influences', 0.1539),\n",
       "  ('18 conclusions', 0.15),\n",
       "  ('physical activity', 0.1493),\n",
       "  ('60', 0.1474),\n",
       "  ('liquid chromatography', 0.1453),\n",
       "  ('inversely associated', 0.1428),\n",
       "  ('sex baseline', 0.1404),\n",
       "  ('2909 adults', 0.1347),\n",
       "  ('plasma positively', 0.1301),\n",
       "  ('aged 45', 0.1243),\n",
       "  ('0001', 0.1171),\n",
       "  ('cigarette', 0.1131),\n",
       "  ('252 identified', 0.0918),\n",
       "  ('gamma', 0.091),\n",
       "  ('dihomo', 0.0487),\n",
       "  ('20 3n', 0.0456),\n",
       "  ('37 0001', 0.0426),\n",
       "  ('00 75', 0.0395)],\n",
       " 'MED-1066': [('glucose tolerance', 0.6055),\n",
       "  ('lipoproteins triglyceride', 0.495),\n",
       "  ('metabolic syndrome', 0.4758),\n",
       "  ('nonalcoholic steatohepatitis', 0.4485),\n",
       "  ('calculated ogtt', 0.4478),\n",
       "  ('syndrome postprandial', 0.4424),\n",
       "  ('relations dietary', 0.4418),\n",
       "  ('nash patients', 0.4407),\n",
       "  ('oral fat', 0.4265),\n",
       "  ('metabolism evaluated', 0.3953),\n",
       "  ('25 patients', 0.3919),\n",
       "  ('alimentary record', 0.3704),\n",
       "  ('fat 13', 0.3691),\n",
       "  ('affecting insulin', 0.3478),\n",
       "  ('modulating hepatic', 0.3323),\n",
       "  ('mass index', 0.3296),\n",
       "  ('polyunsaturated', 0.3221),\n",
       "  ('nonobese', 0.3183),\n",
       "  ('standard oral', 0.2968),\n",
       "  ('total kcal', 0.2965),\n",
       "  ('normolipidemic', 0.2917),\n",
       "  ('habits promote', 0.2851),\n",
       "  ('0001 cholesterol', 0.2737),\n",
       "  ('compared controls', 0.2353),\n",
       "  ('load test', 0.2308),\n",
       "  ('defect apob', 0.2186),\n",
       "  ('controls saturated', 0.2095),\n",
       "  ('sensitivity index', 0.1932),\n",
       "  ('63 mg', 0.1831),\n",
       "  ('findings provide', 0.1761),\n",
       "  ('patients richer', 0.1745),\n",
       "  ('antioxidant activity', 0.1493),\n",
       "  ('healthy', 0.1415),\n",
       "  ('vs 23', 0.139),\n",
       "  ('gender matched', 0.1382),\n",
       "  ('14 total', 0.134),\n",
       "  ('respectively 002', 0.1244),\n",
       "  ('correlated', 0.1101),\n",
       "  ('age', 0.1047),\n",
       "  ('hours hours', 0.1042),\n",
       "  ('secretion conclusion', 0.0859),\n",
       "  ('flat strikingly', 0.0606),\n",
       "  ('12 vs', 0.0602),\n",
       "  ('fiber', 0.0481),\n",
       "  ('isi different', 0.036),\n",
       "  ('506 108', 0.0264),\n",
       "  ('405', 0.026),\n",
       "  ('84 43', 0.0134),\n",
       "  ('poorer', -0.0136),\n",
       "  ('10 total', -0.0491)],\n",
       " 'MED-1067': [('mediated steatosis', 0.6615),\n",
       "  ('effect oleic', 0.5685),\n",
       "  ('attenuate palmitic', 0.5385),\n",
       "  ('monounsaturated oleic', 0.5345),\n",
       "  ('steatogenic apoptotic', 0.4926),\n",
       "  ('hepatocytes apoptosis', 0.4807),\n",
       "  ('hepatocites toxicity', 0.4701),\n",
       "  ('acid hepatocityc', 0.4144),\n",
       "  ('24 oleic', 0.4048),\n",
       "  ('incubation fatty', 0.3733),\n",
       "  ('models nonalcoholic', 0.3706),\n",
       "  ('diets triglyceride', 0.3683),\n",
       "  ('srebp', 0.3182),\n",
       "  ('liver', 0.3141),\n",
       "  ('fat', 0.2845),\n",
       "  ('lower cells', 0.2774),\n",
       "  ('studies shown', 0.2674),\n",
       "  ('combined apoptosis', 0.2659),\n",
       "  ('effects mediated', 0.2497),\n",
       "  ('attenuate', 0.2292),\n",
       "  ('unknown methods', 0.2243),\n",
       "  ('impact incubation', 0.2241),\n",
       "  ('pparalpha expression', 0.2084),\n",
       "  ('protective effect', 0.1928),\n",
       "  ('background aim', 0.1887),\n",
       "  ('vitro model', 0.1818),\n",
       "  ('acid prevent', 0.1785),\n",
       "  ('western diets', 0.1774),\n",
       "  ('toxic', 0.1747),\n",
       "  ('models', 0.1714),\n",
       "  ('degree effects', 0.1699),\n",
       "  ('se associated', 0.1675),\n",
       "  ('hepg2 huh7', 0.1627),\n",
       "  ('cells treated', 0.1525),\n",
       "  ('impaired', 0.1507),\n",
       "  ('insulin signalling', 0.1476),\n",
       "  ('pathogenetic', 0.1433),\n",
       "  ('inversely proportional', 0.1401),\n",
       "  ('wrl68 impact', 0.1298),\n",
       "  ('acid 33', 0.1186),\n",
       "  ('provide biological', 0.1042),\n",
       "  ('evaluated', 0.1009),\n",
       "  ('signalling despite', 0.0858),\n",
       "  ('32 mm', 0.0822),\n",
       "  ('66', 0.0799),\n",
       "  ('lines', 0.0547),\n",
       "  ('larger cells', 0.053),\n",
       "  ('gene activation', 0.0488),\n",
       "  ('despite higher', 0.0472),\n",
       "  ('combined molar', -0.005)],\n",
       " 'MED-1068': [('underlying nafld', 0.6898),\n",
       "  ('obesity rates', 0.6128),\n",
       "  ('fatty liver', 0.5697),\n",
       "  ('hepatic lipotoxicity', 0.5548),\n",
       "  ('steatohepatitis molecular', 0.5123),\n",
       "  ('intrahepatic lipid', 0.5078),\n",
       "  ('increased triglyceride', 0.4995),\n",
       "  ('acute steatohepatitis', 0.496),\n",
       "  ('liver disease', 0.4814),\n",
       "  ('acids ffas', 0.4666),\n",
       "  ('simple steatosis', 0.4506),\n",
       "  ('lipoapoptosis include', 0.4401),\n",
       "  ('lipotoxicity despite', 0.4152),\n",
       "  ('linked lipid', 0.3985),\n",
       "  ('health problems', 0.3557),\n",
       "  ('degree intrahepatic', 0.3512),\n",
       "  ('mitochondrial dysfunction', 0.2952),\n",
       "  ('pathways involved', 0.2536),\n",
       "  ('oxidative', 0.2445),\n",
       "  ('er stress', 0.2273),\n",
       "  ('poorly understood', 0.212),\n",
       "  ('especially saturated', 0.1999),\n",
       "  ('rise western', 0.1923),\n",
       "  ('increases multitude', 0.1909),\n",
       "  ('important cellular', 0.1854),\n",
       "  ('developing nuanced', 0.184),\n",
       "  ('effective therapeutics', 0.1831),\n",
       "  ('prevalent', 0.1685),\n",
       "  ('recent literature', 0.1649),\n",
       "  ('experimental models', 0.1568),\n",
       "  ('severity ranges', 0.1545),\n",
       "  ('understanding molecular', 0.15),\n",
       "  ('disease date', 0.1185),\n",
       "  ('apoptosis known', 0.1155),\n",
       "  ('saturation controls', 0.1141),\n",
       "  ('load relevant', 0.1139),\n",
       "  ('acute', 0.108),\n",
       "  ('hallmark traits', 0.1062),\n",
       "  ('suggests', 0.0984),\n",
       "  ('patients review', 0.0867),\n",
       "  ('prevent reverse', 0.0754),\n",
       "  ('kinase jnk', 0.0706),\n",
       "  ('contrast increased', 0.0663),\n",
       "  ('alcoholic', 0.0582),\n",
       "  ('ranges simple', 0.0545),\n",
       "  ('elevated free', 0.0528),\n",
       "  ('including non', 0.0502),\n",
       "  ('rates closely', 0.0364),\n",
       "  ('play important', 0.0363),\n",
       "  ('lead targeted', 0.0187)],\n",
       " 'MED-1069': [('fat emulsions', 0.5822),\n",
       "  ('pufa ingestion', 0.5789),\n",
       "  ('specific fatty', 0.5598),\n",
       "  ('fats differing', 0.5144),\n",
       "  ('effects glucose', 0.4905),\n",
       "  ('polyunsaturated pufa', 0.4628),\n",
       "  ('sensitivity pufa', 0.4552),\n",
       "  ('sfa fat', 0.4339),\n",
       "  ('monounsaturated mufa', 0.4196),\n",
       "  ('subjects ingested', 0.4027),\n",
       "  ('stimulated insulin', 0.4013),\n",
       "  ('overweight obese', 0.372),\n",
       "  ('level ingestion', 0.3686),\n",
       "  ('acids exert', 0.346),\n",
       "  ('reduction insulin', 0.3383),\n",
       "  ('elevation plasma', 0.3249),\n",
       "  ('nefas elevated', 0.3131),\n",
       "  ('ingestion reduced', 0.3116),\n",
       "  ('diabetic humans', 0.308),\n",
       "  ('fat water', 0.2802),\n",
       "  ('plasma specific', 0.2646),\n",
       "  ('24 plasma', 0.2633),\n",
       "  ('regular intervals', 0.2484),\n",
       "  ('hypothesis prolonged', 0.2396),\n",
       "  ('secretion sfa', 0.2395),\n",
       "  ('methods examined', 0.2142),\n",
       "  ('following oral', 0.2018),\n",
       "  ('hours initiation', 0.192),\n",
       "  ('approximately fold', 0.1892),\n",
       "  ('conclusions interpretation', 0.189),\n",
       "  ('different', 0.1789),\n",
       "  ('non diabetic', 0.177),\n",
       "  ('associated absolute', 0.1732),\n",
       "  ('aims', 0.164),\n",
       "  ('cell function', 0.1394),\n",
       "  ('mmol', 0.1382),\n",
       "  ('containing predominantly', 0.1349),\n",
       "  ('assess gsis', 0.1224),\n",
       "  ('20 mmol', 0.1171),\n",
       "  ('weeks apart', 0.1061),\n",
       "  ('implies impaired', 0.1012),\n",
       "  ('resistance subjects', 0.0943),\n",
       "  ('beta', 0.0926),\n",
       "  ('saturation resulted', 0.0917),\n",
       "  ('clamp', 0.0767),\n",
       "  ('water control', 0.0708),\n",
       "  ('individual', 0.046),\n",
       "  ('random order', 0.0404),\n",
       "  ('secretion failed', 0.023),\n",
       "  ('seven', -0.0286)],\n",
       " 'MED-1070': [('pancreatic beta', 0.4573),\n",
       "  ('diabetes longevity', 0.4342),\n",
       "  ('decreased beta', 0.4338),\n",
       "  ('diabetes genetic', 0.4088),\n",
       "  ('intracellular lipofuscin', 0.4012),\n",
       "  ('obesity suggest', 0.3835),\n",
       "  ('mouse beta', 0.3515),\n",
       "  ('hypothesis defects', 0.3426),\n",
       "  ('insulinomas', 0.3418),\n",
       "  ('mice aged', 0.3379),\n",
       "  ('aged cells', 0.3212),\n",
       "  ('diabetic 45', 0.3186),\n",
       "  ('unknown rodents', 0.306),\n",
       "  ('pathogenesis type', 0.2814),\n",
       "  ('turnover implicated', 0.2604),\n",
       "  ('30 years', 0.2455),\n",
       "  ('estimate lifespan', 0.2331),\n",
       "  ('methods lb', 0.2287),\n",
       "  ('cells unknown', 0.2254),\n",
       "  ('rodents long', 0.2251),\n",
       "  ('genetic markers', 0.2234),\n",
       "  ('years methods', 0.219),\n",
       "  ('primates proportion', 0.2135),\n",
       "  ('cell neogenesis', 0.2063),\n",
       "  ('little adaptive', 0.1996),\n",
       "  ('old half', 0.1852),\n",
       "  ('non diabetic', 0.1843),\n",
       "  ('20 years', 0.1823),\n",
       "  ('estimated dimensional', 0.1811),\n",
       "  ('differences', 0.1719),\n",
       "  ('body', 0.164),\n",
       "  ('correlated age', 0.1631),\n",
       "  ('years remained', 0.159),\n",
       "  ('mouse 10', 0.1589),\n",
       "  ('intracellular', 0.1589),\n",
       "  ('aims', 0.148),\n",
       "  ('alpha cells', 0.1429),\n",
       "  ('accumulation', 0.1414),\n",
       "  ('3d mathematical', 0.128),\n",
       "  ('neurons estimate', 0.1268),\n",
       "  ('years 15', 0.1218),\n",
       "  ('years 97', 0.1092),\n",
       "  ('weeks', 0.1052),\n",
       "  ('morphometry sections', 0.101),\n",
       "  ('unlike young', 0.0939),\n",
       "  ('electron microscopical', 0.0776),\n",
       "  ('long', 0.0725),\n",
       "  ('population', 0.0719),\n",
       "  ('increased 90', 0.0048),\n",
       "  ('human using', -0.0482)],\n",
       " 'MED-1071': [('disease nafld', 0.6817),\n",
       "  ('fatty liver', 0.6601),\n",
       "  ('hepatocyte lipoapoptosis', 0.604),\n",
       "  ('palmitate induced', 0.5878),\n",
       "  ('induction lipoapoptosis', 0.5429),\n",
       "  ('saturated fatty', 0.5255),\n",
       "  ('lipoapoptosis l02', 0.5209),\n",
       "  ('human liver', 0.4968),\n",
       "  ('levels hepatocyte', 0.4315),\n",
       "  ('nonalcoholic fatty', 0.4138),\n",
       "  ('hepg2 cells', 0.4017),\n",
       "  ('investigate saturated', 0.301),\n",
       "  ('bax upregulation', 0.2907),\n",
       "  ('l02', 0.2862),\n",
       "  ('underlying mechanisms', 0.231),\n",
       "  ('background elevated', 0.2237),\n",
       "  ('synthase kinase', 0.2063),\n",
       "  ('aim purpose', 0.2033),\n",
       "  ('acid levels', 0.202),\n",
       "  ('reticulum stress', 0.1939),\n",
       "  ('therapeutic target', 0.1856),\n",
       "  ('glycogen', 0.1821),\n",
       "  ('able induce', 0.1662),\n",
       "  ('cells treated', 0.1516),\n",
       "  ('activation unfolded', 0.1481),\n",
       "  ('disease', 0.1465),\n",
       "  ('protein response', 0.1434),\n",
       "  ('activity lithium', 0.1292),\n",
       "  ('morphological changes', 0.1176),\n",
       "  ('suppressed', 0.1153),\n",
       "  ('indicated dephosphorylation', 0.1136),\n",
       "  ('methods human', 0.1112),\n",
       "  ('results data', 0.102),\n",
       "  ('did affect', 0.0977),\n",
       "  ('treated sodium', 0.0962),\n",
       "  ('flow cytometry', 0.0926),\n",
       "  ('showed', 0.0914),\n",
       "  ('induced jun', 0.091),\n",
       "  ('potential', 0.0889),\n",
       "  ('knockdown gsk', 0.087),\n",
       "  ('serum', 0.0852),\n",
       "  ('microscopy used', 0.0749),\n",
       "  ('blot analysis', 0.0668),\n",
       "  ('transfection transmission', 0.0665),\n",
       "  ('detect caspase', 0.0641),\n",
       "  ('3β expression', 0.0618),\n",
       "  ('shrna', -0.0182),\n",
       "  ('48', -0.0381),\n",
       "  ('electron', -0.0469),\n",
       "  ('activity western', -0.0759)],\n",
       " 'MED-1072': [('insulin concentrations', 0.5986),\n",
       "  ('mass index', 0.4831),\n",
       "  ('intake fasting', 0.4808),\n",
       "  ('overall adiposity', 0.4745),\n",
       "  ('predictors fasting', 0.4745),\n",
       "  ('transformed fasting', 0.474),\n",
       "  ('fat 45', 0.4682),\n",
       "  ('obesity diet', 0.4664),\n",
       "  ('fat energy', 0.4426),\n",
       "  ('abdominal obesity', 0.441),\n",
       "  ('insulin 25', 0.4123),\n",
       "  ('652 men', 0.3575),\n",
       "  ('aging study', 0.3553),\n",
       "  ('saturated fatty', 0.3476),\n",
       "  ('intake statistically', 0.3357),\n",
       "  ('men aged', 0.3274),\n",
       "  ('ratio dietary', 0.3127),\n",
       "  ('postprandial', 0.305),\n",
       "  ('diet high', 0.2816),\n",
       "  ('85 followed', 0.2778),\n",
       "  ('normative aging', 0.2741),\n",
       "  ('abdomen hip', 0.2668),\n",
       "  ('decrease postprandial', 0.2666),\n",
       "  ('physical activity', 0.257),\n",
       "  ('aged 43', 0.2545),\n",
       "  ('study log', 0.2374),\n",
       "  ('energy correlation', 0.2255),\n",
       "  ('used body', 0.2163),\n",
       "  ('energy saturated', 0.2076),\n",
       "  ('relationship body', 0.1914),\n",
       "  ('log transformed', 0.1894),\n",
       "  ('concentrations age', 0.1702),\n",
       "  ('examine relationship', 0.1698),\n",
       "  ('acid energy', 0.1616),\n",
       "  ('data suggest', 0.1596),\n",
       "  ('followed normative', 0.1572),\n",
       "  ('significant independent', 0.1525),\n",
       "  ('coefficients ranging', 0.1512),\n",
       "  ('cigarette smoking', 0.1433),\n",
       "  ('transformed', 0.143),\n",
       "  ('models used', 0.1377),\n",
       "  ('index multivariate', 0.1335),\n",
       "  ('adjusted', 0.1252),\n",
       "  ('14 total', 0.1251),\n",
       "  ('14 18', 0.1074),\n",
       "  ('percentage total', 0.0939),\n",
       "  ('25', 0.0851),\n",
       "  ('purpose', 0.0755),\n",
       "  ('ranging', 0.0559),\n",
       "  ('high', 0.0255)],\n",
       " 'MED-1097': [('moses maimonides', 0.5342),\n",
       "  ('maimonides overcame', 0.4732),\n",
       "  ('moses', 0.4502),\n",
       "  ('tragedy maimonides', 0.4149),\n",
       "  ('maimonides 1135', 0.3913),\n",
       "  ('maimonides codified', 0.3807),\n",
       "  ('physician era', 0.3721),\n",
       "  ('extensively medicine', 0.3691),\n",
       "  ('lessons physicians', 0.3416),\n",
       "  ('revolutionized jewish', 0.3323),\n",
       "  ('physician philosopher', 0.3235),\n",
       "  ('jewish thinker', 0.3154),\n",
       "  ('philosophy medical', 0.3113),\n",
       "  ('medical works', 0.2822),\n",
       "  ('jewish law', 0.2545),\n",
       "  ('1204 physician', 0.2451),\n",
       "  ('philosopher greatest', 0.2325),\n",
       "  ('middle ages', 0.2062),\n",
       "  ('despite long', 0.1996),\n",
       "  ('continents despite', 0.1883),\n",
       "  ('philosophical writings', 0.1763),\n",
       "  ('works span', 0.1544),\n",
       "  ('thinker middle', 0.1496),\n",
       "  ('overcame obstacles', 0.1336),\n",
       "  ('persecution exile', 0.133),\n",
       "  ('faced life', 0.1273),\n",
       "  ('century', 0.1172),\n",
       "  ('wrote extensively', 0.1098),\n",
       "  ('law revolutionized', 0.1081),\n",
       "  ('skills sought', 0.1029),\n",
       "  ('sought continents', 0.097),\n",
       "  ('caring patients', 0.0757),\n",
       "  ('achievements provides', 0.0723),\n",
       "  ('provides insight', 0.0653),\n",
       "  ('12th century', 0.0618),\n",
       "  ('mind body', 0.0538),\n",
       "  ('remarkable', 0.0462),\n",
       "  ('1135', 0.0457),\n",
       "  ('clinical', 0.0339),\n",
       "  ('guide perplexed', 0.0337),\n",
       "  ('tragedy', 0.001),\n",
       "  ('provides', -0.0005),\n",
       "  ('rational', -0.0029),\n",
       "  ('1204', -0.0196),\n",
       "  ('world', -0.0274),\n",
       "  ('topics', -0.0489),\n",
       "  ('known', -0.0994),\n",
       "  ('leading', -0.1203),\n",
       "  ('days', -0.1292),\n",
       "  ('relationship', -0.1484)],\n",
       " 'MED-1098': [('110 food', 0.5224),\n",
       "  ('dibenzofurans pcbs', 0.4789),\n",
       "  ('dde analyzed', 0.3718),\n",
       "  ('beef', 0.3617),\n",
       "  ('teq intakes', 0.3465),\n",
       "  ('samples purchased', 0.3465),\n",
       "  ('adults dioxins', 0.3333),\n",
       "  ('pooled food', 0.3217),\n",
       "  ('purchased 1995', 0.3207),\n",
       "  ('sampling measurement', 0.317),\n",
       "  ('chicken pork', 0.2926),\n",
       "  ('weight dairy', 0.2871),\n",
       "  ('lots category', 0.2837),\n",
       "  ('analyzed pooled', 0.2302),\n",
       "  ('concentrations ocean', 0.2195),\n",
       "  ('aged 12', 0.213),\n",
       "  ('concentration farm', 0.2011),\n",
       "  ('cheese', 0.1989),\n",
       "  ('freshwater fish', 0.1986),\n",
       "  ('weight children', 0.1848),\n",
       "  ('mean daily', 0.1795),\n",
       "  ('butter ppt', 0.1718),\n",
       "  ('toxic', 0.1545),\n",
       "  ('estimates higher', 0.1407),\n",
       "  ('parts trillion', 0.1303),\n",
       "  ('wet weight', 0.1296),\n",
       "  ('category lowest', 0.1262),\n",
       "  ('san diego', 0.1225),\n",
       "  ('pg parts', 0.1131),\n",
       "  ('supermarkets', 0.1059),\n",
       "  ('fillet', 0.1044),\n",
       "  ('chicago il', 0.1011),\n",
       "  ('ga binghamton', 0.089),\n",
       "  ('mono ortho', 0.0848),\n",
       "  ('year', 0.0802),\n",
       "  ('body', 0.075),\n",
       "  ('42 30', 0.068),\n",
       "  ('world health', 0.0666),\n",
       "  ('study separate', 0.0622),\n",
       "  ('coplanar', 0.0547),\n",
       "  ('80 yr', 0.0531),\n",
       "  ('51', 0.0528),\n",
       "  ('09 ppt', 0.0446),\n",
       "  ('equivalent', 0.0391),\n",
       "  ('grown', 0.0386),\n",
       "  ('16 ppt', 0.0302),\n",
       "  ('vegandiet', 0.0276),\n",
       "  ('men women', 0.0102),\n",
       "  ('ca human', -0.0029),\n",
       "  ('nursing', -0.0151)],\n",
       " 'MED-1099': [('chemicals exposures', 0.6473),\n",
       "  ('exposure chemical', 0.5672),\n",
       "  ('pollutant chemicals', 0.5601),\n",
       "  ('endocrine disruption', 0.5572),\n",
       "  ('exposures generally', 0.5154),\n",
       "  ('potential effects', 0.4982),\n",
       "  ('chemicals widespread', 0.498),\n",
       "  ('humans exposure', 0.496),\n",
       "  ('endocrine function', 0.4591),\n",
       "  ('discussed endocrine', 0.432),\n",
       "  ('exposures difficult', 0.4306),\n",
       "  ('commonly exposed', 0.4225),\n",
       "  ('chemicals remains', 0.3987),\n",
       "  ('pollutant', 0.3882),\n",
       "  ('high exposures', 0.374),\n",
       "  ('disruption humans', 0.3636),\n",
       "  ('function exposures', 0.3562),\n",
       "  ('experiments wildlife', 0.3551),\n",
       "  ('environment affect', 0.3336),\n",
       "  ('chemical agent', 0.3299),\n",
       "  ('laboratory experiments', 0.3252),\n",
       "  ('clear effects', 0.3212),\n",
       "  ('evidence discussed', 0.3104),\n",
       "  ('exposed', 0.2978),\n",
       "  ('generally low', 0.2664),\n",
       "  ('wildlife relatively', 0.2344),\n",
       "  ('signaling', 0.2281),\n",
       "  ('humans commonly', 0.2278),\n",
       "  ('difficult demonstrate', 0.213),\n",
       "  ('sound potential', 0.2121),\n",
       "  ('science sound', 0.1978),\n",
       "  ('data humans', 0.19),\n",
       "  ('discussed', 0.1842),\n",
       "  ('instances data', 0.1614),\n",
       "  ('largely undemonstrated', 0.1584),\n",
       "  ('demonstrate instances', 0.1548),\n",
       "  ('largely', 0.1527),\n",
       "  ('widespread', 0.1415),\n",
       "  ('affect', 0.1348),\n",
       "  ('remains', 0.1177),\n",
       "  ('generally', 0.1151),\n",
       "  ('underlying', 0.1106),\n",
       "  ('ratio birth', 0.0926),\n",
       "  ('including age', 0.0824),\n",
       "  ('sex', 0.0781),\n",
       "  ('puberty', 0.0711),\n",
       "  ('weaning', 0.0637),\n",
       "  ('outcome', 0.0573),\n",
       "  ('high', 0.0394),\n",
       "  ('real', -0.0331)],\n",
       " 'MED-1100': [('endocrine disruptors', 0.6296),\n",
       "  ('associations testosterone', 0.5759),\n",
       "  ('organochlorine levels', 0.5266),\n",
       "  ('androgenic systems', 0.5218),\n",
       "  ('serum pcbs', 0.4969),\n",
       "  ('altering thyroid', 0.4937),\n",
       "  ('biphenyls', 0.4333),\n",
       "  ('testosterone native', 0.3696),\n",
       "  ('pesticides adult', 0.3586),\n",
       "  ('chlorinated', 0.3563),\n",
       "  ('estrogen', 0.3518),\n",
       "  ('hexachlorobenzene hcb', 0.3273),\n",
       "  ('concentrations males', 0.3117),\n",
       "  ('cholesterol triglycerides', 0.285),\n",
       "  ('associations', 0.283),\n",
       "  ('bmi analytes', 0.2571),\n",
       "  ('dichlorodiphenyldichloroethylene', 0.257),\n",
       "  ('pcbs 52', 0.2535),\n",
       "  ('concentrations females', 0.2509),\n",
       "  ('adjusted total', 0.25),\n",
       "  ('congeners', 0.2335),\n",
       "  ('analytes lowest', 0.2303),\n",
       "  ('inversely correlated', 0.2096),\n",
       "  ('men women', 0.2066),\n",
       "  ('05', 0.1981),\n",
       "  ('analyzed samples', 0.1967),\n",
       "  ('concentration 23', 0.1897),\n",
       "  ('703 adult', 0.1895),\n",
       "  ('206 pcbs', 0.1872),\n",
       "  ('men 436', 0.1806),\n",
       "  ('age body', 0.1673),\n",
       "  ('objective studied', 0.1635),\n",
       "  ('systems', 0.152),\n",
       "  ('median 17', 0.15),\n",
       "  ('118 138', 0.1427),\n",
       "  ('170', 0.1426),\n",
       "  ('values odds', 0.1416),\n",
       "  ('considered separately', 0.1364),\n",
       "  ('74', 0.1324),\n",
       "  ('referent', 0.1254),\n",
       "  ('population methods', 0.1203),\n",
       "  ('interval ci', 0.1117),\n",
       "  ('conclusions elevation', 0.1036),\n",
       "  ('known action', 0.0919),\n",
       "  ('mohawk population', 0.0886),\n",
       "  ('collected fasting', 0.0882),\n",
       "  ('using wet', 0.0811),\n",
       "  ('mirex associated', 0.0808),\n",
       "  ('using logistic', 0.0617),\n",
       "  ('257 men', 0.047)],\n",
       " 'MED-1101': [('biphenyls pcbs', 0.6256),\n",
       "  ('mixtures polychlorinated', 0.614),\n",
       "  ('congeners concentrations', 0.5177),\n",
       "  ('development mixtures', 0.4791),\n",
       "  ('relevant pcb', 0.4749),\n",
       "  ('revealed mixtures', 0.4012),\n",
       "  ('concentrations used', 0.3894),\n",
       "  ('inducers', 0.3639),\n",
       "  ('toxicogenomic analysis', 0.363),\n",
       "  ('genes mix3', 0.3472),\n",
       "  ('exposure data', 0.3434),\n",
       "  ('steroid lipid', 0.3375),\n",
       "  ('human fetal', 0.3142),\n",
       "  ('effects exerted', 0.2962),\n",
       "  ('environmentally relevant', 0.2935),\n",
       "  ('ndl congener', 0.2896),\n",
       "  ('genitalia development', 0.2893),\n",
       "  ('feature congeners', 0.2869),\n",
       "  ('displaying different', 0.2841),\n",
       "  ('defined estrogenic', 0.2818),\n",
       "  ('non dioxin', 0.2789),\n",
       "  ('internal exposure', 0.2713),\n",
       "  ('function genes', 0.2656),\n",
       "  ('expression profiles', 0.2644),\n",
       "  ('metabolism', 0.2537),\n",
       "  ('cells model', 0.2472),\n",
       "  ('profiles dl', 0.2441),\n",
       "  ('cytochrome 450', 0.2432),\n",
       "  ('programming', 0.2257),\n",
       "  ('cavernosa cells', 0.2247),\n",
       "  ('levels modulates', 0.221),\n",
       "  ('defined', 0.2173),\n",
       "  ('involved genitourinary', 0.215),\n",
       "  ('communication morphogenetic', 0.1954),\n",
       "  ('grouped', 0.176),\n",
       "  ('derived human', 0.1607),\n",
       "  ('analysis revealed', 0.1592),\n",
       "  ('model male', 0.1553),\n",
       "  ('epithelial mesenchymal', 0.1493),\n",
       "  ('shared modes', 0.1492),\n",
       "  ('corpora', 0.145),\n",
       "  ('highly persistent', 0.1373),\n",
       "  ('mainly', 0.121),\n",
       "  ('actin related', 0.1103),\n",
       "  ('growth data', 0.1013),\n",
       "  ('evaluated human', 0.091),\n",
       "  ('2011 elsevier', 0.0778),\n",
       "  ('like', 0.071),\n",
       "  ('modulated smooth', 0.0661),\n",
       "  ('rights reserved', -0.0064)],\n",
       " 'MED-1103': [('acrylamide exposure', 0.6814),\n",
       "  ('intake risk', 0.5053),\n",
       "  ('association dietary', 0.4572),\n",
       "  ('human carcinogen', 0.4278),\n",
       "  ('foods hazard', 0.3956),\n",
       "  ('associations observed', 0.3952),\n",
       "  ('diet cancer', 0.3813),\n",
       "  ('studies suggestive', 0.3385),\n",
       "  ('increase risk', 0.3358),\n",
       "  ('adjusted analysis', 0.3204),\n",
       "  ('everyday foods', 0.2961),\n",
       "  ('cohort study', 0.2886),\n",
       "  ('risk histological', 0.2809),\n",
       "  ('various cancers', 0.2796),\n",
       "  ('2002 epidemiological', 0.2657),\n",
       "  ('day increment', 0.2544),\n",
       "  ('95 ci', 0.2334),\n",
       "  ('120 852', 0.2229),\n",
       "  ('hazards models', 0.2155),\n",
       "  ('hr multiple', 0.2146),\n",
       "  ('background', 0.19),\n",
       "  ('available multivariable', 0.1865),\n",
       "  ('aim prospective', 0.1856),\n",
       "  ('categories quintiles', 0.1792),\n",
       "  ('61', 0.1741),\n",
       "  ('smokers using', 0.1735),\n",
       "  ('frequency questionnaire', 0.1618),\n",
       "  ('probable human', 0.1543),\n",
       "  ('person years', 0.1422),\n",
       "  ('participants total', 0.1392),\n",
       "  ('combined', 0.1358),\n",
       "  ('confirmed cases', 0.1248),\n",
       "  ('baseline 000', 0.1222),\n",
       "  ('continuous variable', 0.1142),\n",
       "  ('presence', 0.11),\n",
       "  ('myeloma 98', 0.0953),\n",
       "  ('14', 0.0926),\n",
       "  ('investigate time', 0.088),\n",
       "  ('16 years', 0.0854),\n",
       "  ('hrs men', 0.0822),\n",
       "  ('follicular lymphoma', 0.0568),\n",
       "  ('using random', 0.0392),\n",
       "  ('10 µg', 0.0382),\n",
       "  ('lymphatic', 0.0251),\n",
       "  ('233 microscopically', 0.0177),\n",
       "  ('27 28', 0.0137),\n",
       "  ('03', 0.0074),\n",
       "  ('netherlands', -0.0016),\n",
       "  ('women separately', -0.0072),\n",
       "  ('september 1986', -0.0431)],\n",
       " 'MED-1104': [('multiple myeloma', 0.5918),\n",
       "  ('myeloma mm', 0.5248),\n",
       "  ('dose melphalan', 0.4632),\n",
       "  ('multimodality therapeutic', 0.398),\n",
       "  ('molecular targeted', 0.3943),\n",
       "  ('melphalan autologous', 0.3669),\n",
       "  ('changed treatment', 0.3227),\n",
       "  ('novel agents', 0.315),\n",
       "  ('immunomodulatory drugs', 0.312),\n",
       "  ('strategies mm', 0.2899),\n",
       "  ('intractable hematological', 0.2751),\n",
       "  ('research advanced', 0.2682),\n",
       "  ('mm achievement', 0.2621),\n",
       "  ('new therapeutic', 0.2573),\n",
       "  ('treatment strategies', 0.2452),\n",
       "  ('inhibitors dramatically', 0.2355),\n",
       "  ('disease years', 0.2297),\n",
       "  ('mm intractable', 0.2232),\n",
       "  ('clinical research', 0.21),\n",
       "  ('approaches warranted', 0.209),\n",
       "  ('proteasome inhibitors', 0.207),\n",
       "  ('dramatically changed', 0.2026),\n",
       "  ('multimodality', 0.1898),\n",
       "  ('availability molecular', 0.1677),\n",
       "  ('hematological', 0.1592),\n",
       "  ('high dose', 0.1558),\n",
       "  ('overall survival', 0.1521),\n",
       "  ('drugs', 0.1454),\n",
       "  ('survival research', 0.1389),\n",
       "  ('dramatically', 0.1371),\n",
       "  ('cure disease', 0.1249),\n",
       "  ('advanced remarkably', 0.1245),\n",
       "  ('remarkably new', 0.1225),\n",
       "  ('multiple', 0.1221),\n",
       "  ('basic clinical', 0.0906),\n",
       "  ('dose', 0.0749),\n",
       "  ('introduction high', 0.0681),\n",
       "  ('recently basic', 0.063),\n",
       "  ('recently', 0.0596),\n",
       "  ('autologous stem', 0.0527),\n",
       "  ('extension', 0.0268),\n",
       "  ('transplantation availability', 0.0231),\n",
       "  ('achievement', 0.0182),\n",
       "  ('response rate', 0.0173),\n",
       "  ('resulted', 0.0005),\n",
       "  ('overall', -0.0039),\n",
       "  ('cell', -0.0066),\n",
       "  ('development', -0.0272),\n",
       "  ('agents', -0.0342),\n",
       "  ('warranted', -0.0494)],\n",
       " 'MED-1105': [('multiple myeloma', 0.5742),\n",
       "  ('myeloma chemotherapy', 0.4373),\n",
       "  ('bullous eruption', 0.4224),\n",
       "  ('tense bullous', 0.329),\n",
       "  ('produces monoclonal', 0.3269),\n",
       "  ('bullae immunoflourescence', 0.2993),\n",
       "  ('proliferative disorder', 0.2983),\n",
       "  ('immunoglobulin protein', 0.2954),\n",
       "  ('disease rarely', 0.2719),\n",
       "  ('plasma cell', 0.2449),\n",
       "  ('man longstanding', 0.2436),\n",
       "  ('55 year', 0.2414),\n",
       "  ('previous treatments', 0.2301),\n",
       "  ('malignant', 0.2201),\n",
       "  ('disorder produces', 0.2156),\n",
       "  ('longstanding recurrent', 0.2017),\n",
       "  ('weight loss', 0.1951),\n",
       "  ('disease', 0.1843),\n",
       "  ('eruption hypertrophic', 0.1835),\n",
       "  ('lesions', 0.1701),\n",
       "  ('immunoflourescence', 0.1691),\n",
       "  ('protein skin', 0.1644),\n",
       "  ('revealed subepidermal', 0.164),\n",
       "  ('patients longstanding', 0.1607),\n",
       "  ('treatment multiple', 0.1604),\n",
       "  ('unusual', 0.1551),\n",
       "  ('lesions regressed', 0.1494),\n",
       "  ('chemotherapy lesions', 0.1426),\n",
       "  ('body accompanied', 0.136),\n",
       "  ('hypertrophic scars', 0.1328),\n",
       "  ('eruption investigated', 0.118),\n",
       "  ('man', 0.1161),\n",
       "  ('large tense', 0.1105),\n",
       "  ('features multiple', 0.1071),\n",
       "  ('glucocorticoids', 0.1053),\n",
       "  ('staining observed', 0.0795),\n",
       "  ('loss', 0.0775),\n",
       "  ('examination multiple', 0.0745),\n",
       "  ('old', 0.0453),\n",
       "  ('fatique', 0.0403),\n",
       "  ('investigated development', 0.0347),\n",
       "  ('response previous', 0.0173),\n",
       "  ('produces', 0.015),\n",
       "  ('involvement', 0.0101),\n",
       "  ('patients', 0.0022),\n",
       "  ('detailed labarotory', -0.0007),\n",
       "  ('year', -0.0198),\n",
       "  ('revealed', -0.023),\n",
       "  ('included oral', -0.0395),\n",
       "  ('dapsone', -0.0821)],\n",
       " 'MED-1106': [('incidence vegetarians', 0.4908),\n",
       "  ('diets affect', 0.4544),\n",
       "  ('risk cancers', 0.4432),\n",
       "  ('objective cancer', 0.3992),\n",
       "  ('033 cancers', 0.3606),\n",
       "  ('studies including', 0.3585),\n",
       "  ('vegans cancer', 0.3525),\n",
       "  ('544 vegetarians', 0.3444),\n",
       "  ('eaters 64', 0.3216),\n",
       "  ('meat eaters', 0.3086),\n",
       "  ('006 colorectal', 0.301),\n",
       "  ('united kingdom', 0.2888),\n",
       "  ('design pooled', 0.2821),\n",
       "  ('647 british', 0.2711),\n",
       "  ('heterogeneity 010', 0.2637),\n",
       "  ('population risk', 0.2602),\n",
       "  ('stomach', 0.2466),\n",
       "  ('62', 0.2381),\n",
       "  ('analysis prospective', 0.2359),\n",
       "  ('cox proportional', 0.2358),\n",
       "  ('men women', 0.2275),\n",
       "  ('hazards models', 0.2236),\n",
       "  ('sites combined', 0.2154),\n",
       "  ('3275 meat', 0.2141),\n",
       "  ('26 vegetarians', 0.21),\n",
       "  ('nonvegetarians', 0.2085),\n",
       "  ('registries', 0.2071),\n",
       "  ('8612 fish', 0.1995),\n",
       "  ('rrs 95', 0.1862),\n",
       "  ('eaters 23', 0.1738),\n",
       "  ('status estimated', 0.1732),\n",
       "  ('background', 0.1726),\n",
       "  ('large', 0.1661),\n",
       "  ('tissue rrs', 0.1628),\n",
       "  ('comprising 32', 0.1619),\n",
       "  ('0007 conclusion', 0.1582),\n",
       "  ('groups', 0.1574),\n",
       "  ('2246 vegans', 0.1532),\n",
       "  ('myeloma rrs', 0.1497),\n",
       "  ('cis 66', 0.1459),\n",
       "  ('using multivariate', 0.1449),\n",
       "  ('34', 0.1364),\n",
       "  ('followed nationwide', 0.1287),\n",
       "  ('20 544', 0.1016),\n",
       "  ('hematopoietic tissue', 0.0983),\n",
       "  ('4998 incident', 0.082),\n",
       "  ('1203', 0.0785),\n",
       "  ('affect', 0.076),\n",
       "  ('10 520', 0.0755),\n",
       "  ('03 84', 0.0723)],\n",
       " 'MED-1107': [('mgus subtypes', 0.6335),\n",
       "  ('clinical mgus', 0.5795),\n",
       "  ('mgus igm', 0.5046),\n",
       "  ('mgus smoldering', 0.4612),\n",
       "  ('iga mgus', 0.4194),\n",
       "  ('gammopathy', 0.3628),\n",
       "  ('mgus light', 0.3505),\n",
       "  ('subtypes defined', 0.3449),\n",
       "  ('smoldering myeloma', 0.3359),\n",
       "  ('distinct clinical', 0.3206),\n",
       "  ('chain mgus', 0.3116),\n",
       "  ('igm igg', 0.2833),\n",
       "  ('non immunoglobulin', 0.2493),\n",
       "  ('monoclonal', 0.2471),\n",
       "  ('30 years', 0.204),\n",
       "  ('mechanisms regulate', 0.203),\n",
       "  ('smoldering', 0.1904),\n",
       "  ('defined non', 0.1855),\n",
       "  ('undetermined significance', 0.1809),\n",
       "  ('diagnosed', 0.1733),\n",
       "  ('entity evolved', 0.1613),\n",
       "  ('management provide', 0.153),\n",
       "  ('patient disease', 0.1517),\n",
       "  ('better understand', 0.1479),\n",
       "  ('unique', 0.1467),\n",
       "  ('definition', 0.1455),\n",
       "  ('state molecular', 0.1409),\n",
       "  ('biology', 0.1398),\n",
       "  ('years ago', 0.1329),\n",
       "  ('discuss novel', 0.1321),\n",
       "  ('regulate transformation', 0.1314),\n",
       "  ('evidence multiple', 0.1244),\n",
       "  ('used targeted', 0.124),\n",
       "  ('strategies basis', 0.1209),\n",
       "  ('patients tailored', 0.1167),\n",
       "  ('intermediate stages', 0.0946),\n",
       "  ('risk', 0.0918),\n",
       "  ('research studies', 0.082),\n",
       "  ('future directions', 0.0635),\n",
       "  ('reasonable', 0.0573),\n",
       "  ('blown multiple', 0.0435),\n",
       "  ('current', 0.0306),\n",
       "  ('candidates', 0.0196),\n",
       "  ('define high', 0.0167),\n",
       "  ('treated outside', 0.0136),\n",
       "  ('2011 aacr', -0.0206),\n",
       "  ('light chain', -0.0267),\n",
       "  ('individual', -0.0379),\n",
       "  ('consistently preceded', -0.0596),\n",
       "  ('available allow', -0.0689)],\n",
       " 'MED-1108': [('aspartame health', 0.5701),\n",
       "  ('intake risks', 0.4207),\n",
       "  ('soda cohorts', 0.4154),\n",
       "  ('assessed diet', 0.4114),\n",
       "  ('concerns remain', 0.3347),\n",
       "  ('diet nurses', 0.3202),\n",
       "  ('safety reports', 0.3151),\n",
       "  ('health related', 0.2933),\n",
       "  ('cancers inconsistent', 0.288),\n",
       "  ('consume regular', 0.2782),\n",
       "  ('study hpfs', 0.2686),\n",
       "  ('sugar sweetened', 0.2619),\n",
       "  ('rrs 95', 0.2329),\n",
       "  ('findings preserve', 0.2293),\n",
       "  ('did consume', 0.2243),\n",
       "  ('prospectively evaluated', 0.1922),\n",
       "  ('study nhs', 0.1864),\n",
       "  ('hematopoetic', 0.1824),\n",
       "  ('leukemias calculated', 0.1814),\n",
       "  ('results cohorts', 0.178),\n",
       "  ('background', 0.1691),\n",
       "  ('reports artificial', 0.165),\n",
       "  ('remain objective', 0.1638),\n",
       "  ('detrimental effect', 0.1622),\n",
       "  ('proportional hazards', 0.1557),\n",
       "  ('despite', 0.1527),\n",
       "  ('hodgkin', 0.1491),\n",
       "  ('combined significant', 0.1353),\n",
       "  ('men daily', 0.1289),\n",
       "  ('cis using', 0.1249),\n",
       "  ('rr 66', 0.1189),\n",
       "  ('higher consumption', 0.1107),\n",
       "  ('analyzed separately', 0.1038),\n",
       "  ('limited', 0.1018),\n",
       "  ('285 multiple', 0.1002),\n",
       "  ('02 conclusion', 0.0964),\n",
       "  ('unexpected elevated', 0.0945),\n",
       "  ('sex effects', 0.0829),\n",
       "  ('using cox', 0.076),\n",
       "  ('pooled 42', 0.07),\n",
       "  ('women contrast', 0.062),\n",
       "  ('design repeatedly', 0.0494),\n",
       "  ('myeloma rr', 0.0456),\n",
       "  ('1324 non', 0.0445),\n",
       "  ('20 40', -0.0035),\n",
       "  ('ruling chance', -0.0039),\n",
       "  ('339', -0.0053),\n",
       "  ('power regular', -0.0062),\n",
       "  ('51', -0.0389),\n",
       "  ('serving', -0.0719)],\n",
       " 'MED-1109': [('multiple myeloma', 0.4855),\n",
       "  ('mm cases', 0.4315),\n",
       "  ('mm family', 0.3794),\n",
       "  ('cancers degree', 0.3215),\n",
       "  ('major hospitals', 0.3104),\n",
       "  ('multivariate analysis', 0.2941),\n",
       "  ('china questionnaire', 0.2795),\n",
       "  ('matched patient', 0.2661),\n",
       "  ('study consisting', 0.2426),\n",
       "  ('case control', 0.2326),\n",
       "  ('china increased', 0.2189),\n",
       "  ('relatives observed', 0.1869),\n",
       "  ('association risk', 0.1758),\n",
       "  ('environmental factors', 0.1603),\n",
       "  ('ethnic geographic', 0.1595),\n",
       "  ('distribution multiple', 0.1556),\n",
       "  ('information demographics', 0.1529),\n",
       "  ('mm interesting', 0.1445),\n",
       "  ('new finding', 0.1251),\n",
       "  ('history frequency', 0.1206),\n",
       "  ('associated increased', 0.1163),\n",
       "  ('controls sex', 0.1153),\n",
       "  ('mm shallot', 0.1109),\n",
       "  ('used obtain', 0.1007),\n",
       "  ('220 confirmed', 0.0985),\n",
       "  ('41 93', 0.0939),\n",
       "  ('contribute development', 0.0865),\n",
       "  ('background distinctive', 0.0864),\n",
       "  ('ci 50', 0.0667),\n",
       "  ('conclusion', 0.0635),\n",
       "  ('85 soy', 0.0576),\n",
       "  ('observed 03', 0.0526),\n",
       "  ('53 significantly', 0.0432),\n",
       "  ('carried major', 0.0369),\n",
       "  ('individually', 0.0172),\n",
       "  ('fish significantly', 0.0152),\n",
       "  ('smoked', 0.0127),\n",
       "  ('elsevier', 0.0046),\n",
       "  ('consumption pickled', 0.0002),\n",
       "  ('black tea', -0.0056),\n",
       "  ('confirmed copyright', -0.0076),\n",
       "  ('decreased risk', -0.0077),\n",
       "  ('27', -0.0165),\n",
       "  ('ci 36', -0.0196),\n",
       "  ('diet', -0.0293),\n",
       "  ('contrast', -0.0376),\n",
       "  ('75 green', -0.0417),\n",
       "  ('52 fried', -0.073),\n",
       "  ('garlic 60', -0.091),\n",
       "  ('northwest', -0.0955)],\n",
       " 'MED-1110': [('mgus patients', 0.473),\n",
       "  ('patients curcumin', 0.4622),\n",
       "  ('effect curcumin', 0.44),\n",
       "  ('determined patients', 0.3587),\n",
       "  ('initiating therapy', 0.3328),\n",
       "  ('20 patients', 0.3227),\n",
       "  ('urine samples', 0.3149),\n",
       "  ('administered grams', 0.2971),\n",
       "  ('samples collected', 0.2947),\n",
       "  ('cells osteoclasts', 0.2918),\n",
       "  ('study administered', 0.2868),\n",
       "  ('patients visit', 0.2854),\n",
       "  ('results oral', 0.2831),\n",
       "  ('curcumin blood', 0.2609),\n",
       "  ('determine effect', 0.2504),\n",
       "  ('calcium', 0.2481),\n",
       "  ('therapeutic', 0.2422),\n",
       "  ('b2 microglobulin', 0.2355),\n",
       "  ('recruited', 0.2294),\n",
       "  ('hydroxyvitamin d3', 0.2218),\n",
       "  ('myeloma potential', 0.2069),\n",
       "  ('visit serum', 0.2024),\n",
       "  ('plasma cells', 0.1952),\n",
       "  ('epg', 0.1841),\n",
       "  ('blood count', 0.1828),\n",
       "  ('cells', 0.1791),\n",
       "  ('levels', 0.1699),\n",
       "  ('group having', 0.156),\n",
       "  ('decrease paraprotein', 0.151),\n",
       "  ('collagen results', 0.1477),\n",
       "  ('collected visit', 0.144),\n",
       "  ('bone specific', 0.1427),\n",
       "  ('count', 0.1404),\n",
       "  ('multiple', 0.1342),\n",
       "  ('role', 0.1331),\n",
       "  ('second void', 0.1268),\n",
       "  ('27 patients', 0.1253),\n",
       "  ('conclusion possible', 0.1216),\n",
       "  ('25', 0.1182),\n",
       "  ('load select', 0.1154),\n",
       "  ('immunoglobulin electrophoresis', 0.1102),\n",
       "  ('phosphatase determined', 0.1031),\n",
       "  ('warrants', 0.0988),\n",
       "  ('30 reduction', 0.0802),\n",
       "  ('day', 0.0795),\n",
       "  ('baseline', 0.0784),\n",
       "  ('able decrease', 0.0749),\n",
       "  ('12', 0.0412),\n",
       "  ('percent 10', -0.0444),\n",
       "  ('telopeptide', -0.0892)],\n",
       " 'MED-1111': [('prevalence mgus', 0.5941),\n",
       "  ('mgus premalignant', 0.5896),\n",
       "  ('monoclonal gammopathy', 0.5559),\n",
       "  ('gammopathy undetermined', 0.4927),\n",
       "  ('mm patients', 0.4882),\n",
       "  ('myeloma', 0.4695),\n",
       "  ('patterns monoclonal', 0.4001),\n",
       "  ('proliferative disorder', 0.382),\n",
       "  ('preceded mm', 0.3487),\n",
       "  ('immunoglobulin abnormalities', 0.287),\n",
       "  ('premalignant', 0.2791),\n",
       "  ('undetermined significance', 0.2448),\n",
       "  ('cancer screening', 0.2271),\n",
       "  ('progression multiple', 0.2153),\n",
       "  ('markers needed', 0.1993),\n",
       "  ('abnormalities prior', 0.1982),\n",
       "  ('adults enrolled', 0.1946),\n",
       "  ('diagnosis present', 0.1802),\n",
       "  ('plasma cell', 0.1671),\n",
       "  ('years prior', 0.1571),\n",
       "  ('novel molecular', 0.1553),\n",
       "  ('prediagnostic serum', 0.1522),\n",
       "  ('prostate lung', 0.1505),\n",
       "  ('risk', 0.1401),\n",
       "  ('longitudinally prevalence', 0.1332),\n",
       "  ('concentration involved', 0.1318),\n",
       "  ('population based', 0.127),\n",
       "  ('subjects developed', 0.1234),\n",
       "  ('study asymptomatic', 0.0941),\n",
       "  ('increase prior', 0.0911),\n",
       "  ('life long', 0.0868),\n",
       "  ('stage consistently', 0.086),\n",
       "  ('course study', 0.0858),\n",
       "  ('71 subjects', 0.0841),\n",
       "  ('proteins electrophoresis', 0.084),\n",
       "  ('involved flc', 0.0836),\n",
       "  ('kappa', 0.0808),\n",
       "  ('ovarian plco', 0.0779),\n",
       "  ('showed yearly', 0.0696),\n",
       "  ('light chains', 0.0682),\n",
       "  ('known', 0.0633),\n",
       "  ('stage 77', 0.0623),\n",
       "  ('ratio levels', 0.0486),\n",
       "  ('82', 0.041),\n",
       "  ('469', 0.0273),\n",
       "  ('lambda free', 0.0178),\n",
       "  ('96 years', 0.0136),\n",
       "  ('approximately half', 0.0061),\n",
       "  ('better', 0.0004),\n",
       "  ('100', -0.0217)],\n",
       " 'MED-1112': [('curcumin regulates', 0.4692),\n",
       "  ('multiple myeloma', 0.3948),\n",
       "  ('chemopreventive agent', 0.3279),\n",
       "  ('factor kappab', 0.3242),\n",
       "  ('suppression proliferation', 0.3225),\n",
       "  ('diferuloylmethane agent', 0.2943),\n",
       "  ('inhibition ikk', 0.2883),\n",
       "  ('mm patients', 0.2881),\n",
       "  ('proliferation mm', 0.2852),\n",
       "  ('little toxicity', 0.2772),\n",
       "  ('modulator binding', 0.2565),\n",
       "  ('melphalan overall', 0.2517),\n",
       "  ('p65', 0.2427),\n",
       "  ('chemoresistance induced', 0.2354),\n",
       "  ('molecular basis', 0.229),\n",
       "  ('prevented nuclear', 0.2277),\n",
       "  ('safe agent', 0.2245),\n",
       "  ('pharmacologically', 0.2171),\n",
       "  ('regulated gene', 0.2098),\n",
       "  ('cyclin d1', 0.2071),\n",
       "  ('toxicity humans', 0.1966),\n",
       "  ('treatment using', 0.1906),\n",
       "  ('nuclear retention', 0.1882),\n",
       "  ('interleukin led', 0.1693),\n",
       "  ('cell cycle', 0.1659),\n",
       "  ('activated caspase', 0.1612),\n",
       "  ('ikkgamma', 0.161),\n",
       "  ('central role', 0.1493),\n",
       "  ('survival', 0.1366),\n",
       "  ('induced polyadenosine', 0.1285),\n",
       "  ('induction', 0.1203),\n",
       "  ('assay prevented', 0.1202),\n",
       "  ('polymerase', 0.1192),\n",
       "  ('results indicate', 0.119),\n",
       "  ('constitutively active', 0.119),\n",
       "  ('humans nf', 0.1106),\n",
       "  ('cell lines', 0.108),\n",
       "  ('using target', 0.101),\n",
       "  ('multiple', 0.0919),\n",
       "  ('agent known', 0.0891),\n",
       "  ('mobility gel', 0.082),\n",
       "  ('bcl bcl', 0.0787),\n",
       "  ('vincristine', 0.0667),\n",
       "  ('explored', 0.0568),\n",
       "  ('immunocytochemistry', 0.0461),\n",
       "  ('domain peptide', 0.0457),\n",
       "  ('products including', 0.0297),\n",
       "  ('shift', 0.0016),\n",
       "  ('showed consitutively', -0.0208),\n",
       "  ('ribose', -0.0535)],\n",
       " 'MED-1113': [('monoclonal gammopathy', 0.4798),\n",
       "  ('study curcumin', 0.4341),\n",
       "  ('significance mgus', 0.4279),\n",
       "  ('multiple myeloma', 0.4121),\n",
       "  ('4g dose', 0.3539),\n",
       "  ('assess effect', 0.3061),\n",
       "  ('randomised groups', 0.3024),\n",
       "  ('study followed', 0.2531),\n",
       "  ('studying multiple', 0.2515),\n",
       "  ('smoldering', 0.2229),\n",
       "  ('increased placebo', 0.217),\n",
       "  ('smm represent', 0.2158),\n",
       "  ('useful models', 0.2025),\n",
       "  ('therapy findings', 0.1997),\n",
       "  ('marker analyses', 0.1971),\n",
       "  ('slow disease', 0.1924),\n",
       "  ('double blind', 0.1849),\n",
       "  ('rflc reduced', 0.1576),\n",
       "  ('difference clonal', 0.1575),\n",
       "  ('arm patients', 0.155),\n",
       "  ('smm 36', 0.1519),\n",
       "  ('undetermined', 0.1508),\n",
       "  ('label extension', 0.1399),\n",
       "  ('controlled', 0.1382),\n",
       "  ('dflc involved', 0.1341),\n",
       "  ('months completion', 0.132),\n",
       "  ('tended', 0.1268),\n",
       "  ('bone turnover', 0.1262),\n",
       "  ('levels tended', 0.1241),\n",
       "  ('expressed mean', 0.1154),\n",
       "  ('flc response', 0.1071),\n",
       "  ('developing early', 0.1),\n",
       "  ('time intervals', 0.0977),\n",
       "  ('urine samples', 0.0962),\n",
       "  ('18 8g', 0.0879),\n",
       "  ('open', 0.0846),\n",
       "  ('chain ratio', 0.0845),\n",
       "  ('nonclonal light', 0.0817),\n",
       "  ('25 patients', 0.0702),\n",
       "  ('involved free', 0.0617),\n",
       "  ('udpyd marker', 0.0394),\n",
       "  ('administering', 0.0393),\n",
       "  ('copyright 2012', 0.0251),\n",
       "  ('copyright', 0.0218),\n",
       "  ('paired test', 0.0147),\n",
       "  ('wiley periodicals', 0.0056),\n",
       "  ('patients 19', 0.0007),\n",
       "  ('student', -0.0107),\n",
       "  ('17', -0.0167),\n",
       "  ('crossing', -0.0334)],\n",
       " 'MED-1114': [('exposed meat', 0.4465),\n",
       "  ('lymphoma workers', 0.3949),\n",
       "  ('conducted multicenter', 0.3287),\n",
       "  ('lymphoma 49', 0.3065),\n",
       "  ('lymphoma excluded', 0.2986),\n",
       "  ('cases hodgkin', 0.2926),\n",
       "  ('studies', 0.2895),\n",
       "  ('meat 19', 0.2756),\n",
       "  ('study 1998', 0.2701),\n",
       "  ('assessed exposure', 0.2635),\n",
       "  ('follicular lymphoma', 0.2457),\n",
       "  ('007 cases', 0.2398),\n",
       "  ('lymphocytic', 0.2397),\n",
       "  ('controls collected', 0.2284),\n",
       "  ('2004 czech', 0.221),\n",
       "  ('myeloma 40', 0.2126),\n",
       "  ('non hodgkin', 0.2016),\n",
       "  ('workers longer', 0.1983),\n",
       "  ('italy spain', 0.1983),\n",
       "  ('67 exposure', 0.1972),\n",
       "  ('information occupational', 0.1909),\n",
       "  ('leukemia 35', 0.1893),\n",
       "  ('chicken', 0.1694),\n",
       "  ('339 cases', 0.167),\n",
       "  ('cases non', 0.1591),\n",
       "  ('germany ireland', 0.1549),\n",
       "  ('questionnaires', 0.1433),\n",
       "  ('14 69', 0.1133),\n",
       "  ('chronic', 0.1078),\n",
       "  ('large cell', 0.0975),\n",
       "  ('55 95', 0.0926),\n",
       "  ('general types', 0.0919),\n",
       "  ('increase risk', 0.089),\n",
       "  ('46 exposure', 0.0841),\n",
       "  ('37', 0.0832),\n",
       "  ('wiley liss', 0.076),\n",
       "  ('excluded 2007', 0.0665),\n",
       "  ('mainly', 0.0652),\n",
       "  ('france', 0.0651),\n",
       "  ('interval ci', 0.063),\n",
       "  ('multiple', 0.042),\n",
       "  ('did', 0.0345),\n",
       "  ('conclusive evidence', 0.0272),\n",
       "  ('history assessed', 0.0263),\n",
       "  ('apparent diffuse', 0.013),\n",
       "  ('01', 0.0081),\n",
       "  ('90', -0.006),\n",
       "  ('ors', -0.0142),\n",
       "  ('appear represent', -0.0348),\n",
       "  ('22', -0.1031)],\n",
       " 'MED-1115': [('gammopathies blacks', 0.6134),\n",
       "  ('monoclonal gammopathy', 0.5419),\n",
       "  ('myeloma blacks', 0.5131),\n",
       "  ('mgus myeloma', 0.5043),\n",
       "  ('racial disparity', 0.4765),\n",
       "  ('multiple myeloma', 0.454),\n",
       "  ('premalignant mgus', 0.4106),\n",
       "  ('risk blacks', 0.4101),\n",
       "  ('blacks higher', 0.4012),\n",
       "  ('risk monoclonal', 0.3965),\n",
       "  ('gammopathy undetermined', 0.3754),\n",
       "  ('significance mgus', 0.3678),\n",
       "  ('blacks compared', 0.365),\n",
       "  ('higher risk', 0.3239),\n",
       "  ('disparity prevalence', 0.2988),\n",
       "  ('higher prevalence', 0.2959),\n",
       "  ('ethnic groups', 0.2761),\n",
       "  ('seen africans', 0.2758),\n",
       "  ('literature racial', 0.2651),\n",
       "  ('race contrast', 0.2445),\n",
       "  ('pathogenesis', 0.2413),\n",
       "  ('adjusting socioeconomic', 0.2395),\n",
       "  ('predisposition higher', 0.2258),\n",
       "  ('progression differ', 0.2207),\n",
       "  ('cytogenetic characteristics', 0.2186),\n",
       "  ('whites increased', 0.1838),\n",
       "  ('prevalence premalignant', 0.1742),\n",
       "  ('increased', 0.1722),\n",
       "  ('suggesting genetic', 0.1704),\n",
       "  ('multiple', 0.1646),\n",
       "  ('threefold', 0.1609),\n",
       "  ('mexico review', 0.1522),\n",
       "  ('inform management', 0.139),\n",
       "  ('studies emerging', 0.1309),\n",
       "  ('compared', 0.1251),\n",
       "  ('notably persons', 0.1236),\n",
       "  ('undetermined', 0.1219),\n",
       "  ('contrast increased', 0.1169),\n",
       "  ('emerging', 0.1144),\n",
       "  ('data suggest', 0.0836),\n",
       "  ('influence', 0.0821),\n",
       "  ('americans similarly', 0.079),\n",
       "  ('noted adjusting', 0.068),\n",
       "  ('stage data', 0.0218),\n",
       "  ('patient', -0.0052),\n",
       "  ('lower certain', -0.0117),\n",
       "  ('discuss future', -0.0149),\n",
       "  ('japan', -0.0485),\n",
       "  ('conditions positively', -0.0785),\n",
       "  ('baseline', -0.1366)],\n",
       " 'MED-1116': [('bacteria rheumatic', 0.5895),\n",
       "  ('infection proteus', 0.5074),\n",
       "  ('microorganisms autoimmune', 0.4842),\n",
       "  ('rheumatic diseases', 0.4691),\n",
       "  ('proteus mirabilis', 0.4675),\n",
       "  ('proteus therapy', 0.4669),\n",
       "  ('molecular mimicry', 0.4292),\n",
       "  ('mimicry pathological', 0.4189),\n",
       "  ('pathological mechanisms', 0.416),\n",
       "  ('rheumatoid arthritis', 0.4138),\n",
       "  ('mirabilis possible', 0.4125),\n",
       "  ('autoimmune diseases', 0.3965),\n",
       "  ('diseases review', 0.3942),\n",
       "  ('diseases', 0.3801),\n",
       "  ('association bacteria', 0.3773),\n",
       "  ('association microorganisms', 0.3687),\n",
       "  ('mechanisms proposed', 0.3671),\n",
       "  ('infection', 0.3466),\n",
       "  ('arthritic condition', 0.3441),\n",
       "  ('arthritis', 0.3365),\n",
       "  ('bacteria', 0.3348),\n",
       "  ('arthritis upper', 0.3163),\n",
       "  ('diseases special', 0.3074),\n",
       "  ('tract infection', 0.3059),\n",
       "  ('anti proteus', 0.3014),\n",
       "  ('molecular', 0.3003),\n",
       "  ('mimicry', 0.2901),\n",
       "  ('emphasis rheumatoid', 0.2859),\n",
       "  ('severe arthritic', 0.2843),\n",
       "  ('rheumatoid', 0.2832),\n",
       "  ('possible cause', 0.2508),\n",
       "  ('review deals', 0.2414),\n",
       "  ('prospective trials', 0.2384),\n",
       "  ('upper urinary', 0.2255),\n",
       "  ('trials involving', 0.219),\n",
       "  ('explain association', 0.211),\n",
       "  ('proposed', 0.1821),\n",
       "  ('proposed explain', 0.1811),\n",
       "  ('cause severe', 0.1625),\n",
       "  ('therapy carried', 0.162),\n",
       "  ('possible', 0.1401),\n",
       "  ('association', 0.1325),\n",
       "  ('special emphasis', 0.1288),\n",
       "  ('involving anti', 0.1126),\n",
       "  ('involving', 0.1076),\n",
       "  ('condition', 0.0452),\n",
       "  ('special', 0.028),\n",
       "  ('tract', 0.0224),\n",
       "  ('deals', 0.0039),\n",
       "  ('carried', -0.0583)],\n",
       " 'MED-1118': [('proteus titres', 0.4581),\n",
       "  ('mirabilis antibody', 0.4492),\n",
       "  ('mirabilis ra', 0.4073),\n",
       "  ('sera collected', 0.4049),\n",
       "  ('53 ra', 0.3957),\n",
       "  ('antibody levels', 0.385),\n",
       "  ('diet mirabilis', 0.3675),\n",
       "  ('patients rheumatoid', 0.3657),\n",
       "  ('mirabilis escherichia', 0.3655),\n",
       "  ('ra treatment', 0.357),\n",
       "  ('patients vegetarian', 0.3325),\n",
       "  ('diet responders', 0.3302),\n",
       "  ('results patients', 0.3097),\n",
       "  ('disease activity', 0.2891),\n",
       "  ('clinical trial', 0.2821),\n",
       "  ('igg concentration', 0.2796),\n",
       "  ('fasting year', 0.2738),\n",
       "  ('antibody coli', 0.2399),\n",
       "  ('indirect immunofluorescence', 0.219),\n",
       "  ('study compared', 0.2066),\n",
       "  ('immunoassay respectively', 0.2051),\n",
       "  ('patients took', 0.204),\n",
       "  ('diet non', 0.2012),\n",
       "  ('levels correlated', 0.1999),\n",
       "  ('significantly 001', 0.196),\n",
       "  ('greater patients', 0.196),\n",
       "  ('methods', 0.1913),\n",
       "  ('responders correlation', 0.1882),\n",
       "  ('decrease disease', 0.1829),\n",
       "  ('change titre', 0.1616),\n",
       "  ('objective measure', 0.1562),\n",
       "  ('aetiopathogenetic role', 0.1542),\n",
       "  ('mean anti', 0.1522),\n",
       "  ('significant change', 0.1441),\n",
       "  ('total', 0.1432),\n",
       "  ('responded', 0.1386),\n",
       "  ('role', 0.1287),\n",
       "  ('activity index', 0.1174),\n",
       "  ('values 05', 0.112),\n",
       "  ('unchanged patient', 0.1098),\n",
       "  ('coli unchanged', 0.1074),\n",
       "  ('responders omnivores', 0.1056),\n",
       "  ('technique enzyme', 0.1041),\n",
       "  ('groups', 0.1029),\n",
       "  ('correlation decrease', 0.0997),\n",
       "  ('time points', 0.0966),\n",
       "  ('took controlled', 0.0884),\n",
       "  ('supports', 0.0866),\n",
       "  ('compared baseline', 0.0759),\n",
       "  ('modified stoke', -0.0033)],\n",
       " 'MED-1120': [('molecular mimicry', 0.5527),\n",
       "  ('mimicry epitope', 0.5135),\n",
       "  ('mimic cardiac', 0.4845),\n",
       "  ('mimicry hallmark', 0.4792),\n",
       "  ('cardiac myosin', 0.453),\n",
       "  ('mimic', 0.4131),\n",
       "  ('hallmark pathogenesis', 0.4105),\n",
       "  ('myosin recent', 0.3884),\n",
       "  ('pathogenesis rheumatic', 0.3875),\n",
       "  ('structurally mimic', 0.3874),\n",
       "  ('streptococcal protein', 0.3712),\n",
       "  ('fever streptococcal', 0.3593),\n",
       "  ('rheumatic carditis', 0.3485),\n",
       "  ('protein cardiac', 0.3444),\n",
       "  ('human disease', 0.3377),\n",
       "  ('rheumatic heart', 0.3145),\n",
       "  ('models immunized', 0.3112),\n",
       "  ('molecular', 0.3107),\n",
       "  ('animal models', 0.3017),\n",
       "  ('coil streptococcal', 0.2959),\n",
       "  ('glucosamine helical', 0.2957),\n",
       "  ('carbohydrate epitope', 0.2925),\n",
       "  ('models', 0.2803),\n",
       "  ('pathogenic', 0.2763),\n",
       "  ('carditis animal', 0.2731),\n",
       "  ('epitope spreading', 0.255),\n",
       "  ('heart disease', 0.25),\n",
       "  ('mechanisms', 0.2375),\n",
       "  ('immune response', 0.2309),\n",
       "  ('hallmark', 0.2098),\n",
       "  ('fever', 0.2091),\n",
       "  ('group carbohydrate', 0.2054),\n",
       "  ('protein structurally', 0.2051),\n",
       "  ('streptococcus attacks', 0.2025),\n",
       "  ('helical', 0.1983),\n",
       "  ('recent studies', 0.1734),\n",
       "  ('attacks', 0.153),\n",
       "  ('epitope acetyl', 0.1381),\n",
       "  ('involved', 0.1334),\n",
       "  ('spreading', 0.127),\n",
       "  ('chronic', 0.1102),\n",
       "  ('process evidence', 0.1059),\n",
       "  ('coiled coil', 0.1056),\n",
       "  ('potential', 0.0892),\n",
       "  ('response group', 0.0869),\n",
       "  ('reviewed', 0.0834),\n",
       "  ('valve', 0.0809),\n",
       "  ('unraveled', 0.0787),\n",
       "  ('human', 0.0631),\n",
       "  ('cell', 0.0031)],\n",
       " 'MED-1121': [('rheumatoid arthritis', 0.5876),\n",
       "  ('ra especially', 0.53),\n",
       "  ('ra chronic', 0.5261),\n",
       "  ('patients ra', 0.4661),\n",
       "  ('microbes ra', 0.4232),\n",
       "  ('proteus urinary', 0.4106),\n",
       "  ('disabling polyarthritic', 0.3826),\n",
       "  ('disease process', 0.3822),\n",
       "  ('ra propose', 0.3322),\n",
       "  ('mirabilis', 0.3238),\n",
       "  ('infections main', 0.3218),\n",
       "  ('urinary tract', 0.3091),\n",
       "  ('tract infections', 0.3045),\n",
       "  ('chronic', 0.2887),\n",
       "  ('affects mainly', 0.2765),\n",
       "  ('antibodies patients', 0.2553),\n",
       "  ('use antibiotics', 0.2403),\n",
       "  ('mainly women', 0.2275),\n",
       "  ('cytopathic auto', 0.2216),\n",
       "  ('bacterial measures', 0.2166),\n",
       "  ('studies different', 0.2097),\n",
       "  ('microbial immunological', 0.1947),\n",
       "  ('molecular studies', 0.1828),\n",
       "  ('cross reactivity', 0.1728),\n",
       "  ('factors presence', 0.169),\n",
       "  ('evidence based', 0.1679),\n",
       "  ('parts world', 0.1628),\n",
       "  ('different parts', 0.1552),\n",
       "  ('results various', 0.1541),\n",
       "  ('main triggering', 0.1437),\n",
       "  ('assists perpetuation', 0.1366),\n",
       "  ('treatments', 0.1346),\n",
       "  ('anti', 0.1248),\n",
       "  ('strong link', 0.1186),\n",
       "  ('middle old', 0.1185),\n",
       "  ('antigens assists', 0.1181),\n",
       "  ('measures involving', 0.1135),\n",
       "  ('process production', 0.1036),\n",
       "  ('diets high', 0.0957),\n",
       "  ('water', 0.0663),\n",
       "  ('propose sub', 0.0632),\n",
       "  ('early stages', 0.0556),\n",
       "  ('use', 0.048),\n",
       "  ('cranberry', 0.0464),\n",
       "  ('targeted tissue', 0.0458),\n",
       "  ('mimicry', 0.0447),\n",
       "  ('currently', 0.0441),\n",
       "  ('employed', 0.04),\n",
       "  ('vegetarian', -0.0081),\n",
       "  ('fruit juices', -0.0817)],\n",
       " 'MED-1122': [('mirabilis urinary', 0.5767),\n",
       "  ('urines ra', 0.551),\n",
       "  ('ra reported', 0.4968),\n",
       "  ('mirabilis elisa', 0.4925),\n",
       "  ('patients rheumatoid', 0.4131),\n",
       "  ('sera raised', 0.4076),\n",
       "  ('patients urine', 0.3999),\n",
       "  ('arthritis', 0.3893),\n",
       "  ('patients raised', 0.3647),\n",
       "  ('bacteriuria frequently', 0.3454),\n",
       "  ('specific proteus', 0.296),\n",
       "  ('patients infected', 0.2946),\n",
       "  ('aim study', 0.2511),\n",
       "  ('raised levels', 0.244),\n",
       "  ('bacteria levels', 0.2353),\n",
       "  ('immunoblotting results', 0.2203),\n",
       "  ('patients detected', 0.2176),\n",
       "  ('commonest infecting', 0.2019),\n",
       "  ('results analysis', 0.2006),\n",
       "  ('matched controls', 0.2003),\n",
       "  ('determine explanation', 0.1887),\n",
       "  ('freshly voided', 0.1802),\n",
       "  ('0063 levels', 0.1741),\n",
       "  ('0001 0001', 0.168),\n",
       "  ('comparison antibody', 0.156),\n",
       "  ('52 infected', 0.1537),\n",
       "  ('linked immunosorbent', 0.1519),\n",
       "  ('investigating frequency', 0.1502),\n",
       "  ('igm', 0.1483),\n",
       "  ('ra 48', 0.1456),\n",
       "  ('33', 0.1408),\n",
       "  ('reacted', 0.1289),\n",
       "  ('25', 0.118),\n",
       "  ('ml numbers', 0.1106),\n",
       "  ('76 patients', 0.0948),\n",
       "  ('ability medication', 0.0892),\n",
       "  ('presence', 0.0796),\n",
       "  ('determined enzyme', 0.0792),\n",
       "  ('asymptomatic', 0.0703),\n",
       "  ('prolonged control', 0.0642),\n",
       "  ('age physical', 0.0631),\n",
       "  ('group possible', 0.0576),\n",
       "  ('number identity', 0.0544),\n",
       "  ('highly improbable', 0.0423),\n",
       "  ('blood', 0.0355),\n",
       "  ('differences', 0.0329),\n",
       "  ('twice', 0.008),\n",
       "  ('tract', -0.0071),\n",
       "  ('10 ml', -0.0072),\n",
       "  ('pure growth', -0.0232)],\n",
       " 'MED-1123': [('review economic', 0.4712),\n",
       "  ('systematic literature', 0.418),\n",
       "  ('clinical economic', 0.4147),\n",
       "  ('127 valid', 0.3538),\n",
       "  ('pharmacoeconomic', 0.3535),\n",
       "  ('arthritis ra', 0.352),\n",
       "  ('costs extensively', 0.3516),\n",
       "  ('extensively evaluated', 0.3476),\n",
       "  ('analyses applied', 0.3367),\n",
       "  ('issues ra', 0.3361),\n",
       "  ('financial impact', 0.3205),\n",
       "  ('recent publications', 0.3184),\n",
       "  ('burden healthcare', 0.3182),\n",
       "  ('publications health', 0.3004),\n",
       "  ('valid articles', 0.2847),\n",
       "  ('diseases associated', 0.2831),\n",
       "  ('medical costs', 0.2827),\n",
       "  ('impact aspects', 0.2809),\n",
       "  ('objectives provide', 0.256),\n",
       "  ('productivity costs', 0.2547),\n",
       "  ('relevant predictors', 0.2484),\n",
       "  ('different therapeutic', 0.2168),\n",
       "  ('quality life', 0.2097),\n",
       "  ('utility scores', 0.2049),\n",
       "  ('reducing disease', 0.2028),\n",
       "  ('scores showed', 0.1879),\n",
       "  ('worldwide differences', 0.1813),\n",
       "  ('future research', 0.172),\n",
       "  ('practice settings', 0.1564),\n",
       "  ('evidence usual', 0.1489),\n",
       "  ('account estimating', 0.1474),\n",
       "  ('decades', 0.1424),\n",
       "  ('concerning use', 0.1401),\n",
       "  ('systems society', 0.1262),\n",
       "  ('addressed frequently', 0.1237),\n",
       "  ('severity', 0.1231),\n",
       "  ('introduction biological', 0.1209),\n",
       "  ('activity age', 0.1179),\n",
       "  ('significantly raised', 0.102),\n",
       "  ('national economies', 0.0927),\n",
       "  ('marked improvements', 0.0871),\n",
       "  ('loss patients', 0.0747),\n",
       "  ('art', 0.0745),\n",
       "  ('agents significantly', 0.0549),\n",
       "  ('direct indirect', 0.0428),\n",
       "  ('socioeconomic status', 0.0424),\n",
       "  ('poorest quality', 0.0281),\n",
       "  ('targets individual', -0.0316),\n",
       "  ('patients led', -0.0563),\n",
       "  ('anti', -0.0979)],\n",
       " 'MED-1124': [('fecal microflora', 0.5845),\n",
       "  ('vegan diet', 0.4945),\n",
       "  ('diet fecal', 0.479),\n",
       "  ('diet study', 0.4643),\n",
       "  ('uncooked vegan', 0.4179),\n",
       "  ('microbiological techniques', 0.39),\n",
       "  ('quantitative bacterial', 0.3893),\n",
       "  ('glc bacterial', 0.3874),\n",
       "  ('flora individual', 0.3807),\n",
       "  ('cellular fatty', 0.3653),\n",
       "  ('direct stool', 0.352),\n",
       "  ('acid profiles', 0.3475),\n",
       "  ('conventional diet', 0.3453),\n",
       "  ('group consumed', 0.3293),\n",
       "  ('eighteen volunteers', 0.3194),\n",
       "  ('discontinuation vegan', 0.3109),\n",
       "  ('control group', 0.3016),\n",
       "  ('bacteriology groups', 0.2966),\n",
       "  ('chromatography glc', 0.2611),\n",
       "  ('significantly test', 0.2491),\n",
       "  ('techniques isolation', 0.2369),\n",
       "  ('sample gas', 0.2259),\n",
       "  ('month study', 0.2214),\n",
       "  ('groups results', 0.2126),\n",
       "  ('studied', 0.1987),\n",
       "  ('suggest uncooked', 0.1954),\n",
       "  ('enumeration different', 0.1952),\n",
       "  ('sample reflects', 0.1933),\n",
       "  ('identification enumeration', 0.1782),\n",
       "  ('month conventional', 0.1753),\n",
       "  ('alters', 0.164),\n",
       "  ('significant change', 0.1485),\n",
       "  ('species', 0.1403),\n",
       "  ('type', 0.1403),\n",
       "  ('extracted directly', 0.1366),\n",
       "  ('culture did', 0.1338),\n",
       "  ('randomly', 0.1292),\n",
       "  ('used detect', 0.1285),\n",
       "  ('differences similarities', 0.1186),\n",
       "  ('mixed', 0.1156),\n",
       "  ('computerized analysis', 0.111),\n",
       "  ('extreme', 0.1073),\n",
       "  ('liquid', 0.1041),\n",
       "  ('divided', 0.0988),\n",
       "  ('performed profile', 0.0973),\n",
       "  ('using classical', 0.0697),\n",
       "  ('induction discontinuation', 0.0649),\n",
       "  ('western type', 0.0573),\n",
       "  ('represents', 0.0291),\n",
       "  ('did', -0.0092)],\n",
       " 'MED-1125': [('rheumatoid arthritis', 0.5387),\n",
       "  ('ra patients', 0.4855),\n",
       "  ('severe arthritic', 0.4576),\n",
       "  ('arthritic disorder', 0.4397),\n",
       "  ('mirabilis elevated', 0.3975),\n",
       "  ('infection causative', 0.3425),\n",
       "  ('consequently ra', 0.3386),\n",
       "  ('proteus esrral', 0.3336),\n",
       "  ('upper urinary', 0.3186),\n",
       "  ('bacteria reported', 0.3167),\n",
       "  ('proteus bacteria', 0.304),\n",
       "  ('joint damages', 0.2911),\n",
       "  ('antibodies patients', 0.2807),\n",
       "  ('antibiotics biological', 0.2744),\n",
       "  ('16 different', 0.2542),\n",
       "  ('autoantibodies evoked', 0.2478),\n",
       "  ('cross reactive', 0.2211),\n",
       "  ('causative amino', 0.2145),\n",
       "  ('countries caused', 0.2129),\n",
       "  ('arginine doublets', 0.2089),\n",
       "  ('elevated levels', 0.206),\n",
       "  ('mechanism involves', 0.1982),\n",
       "  ('esrral irret', 0.1845),\n",
       "  ('apmis published', 0.1843),\n",
       "  ('affecting approximately', 0.1756),\n",
       "  ('studies indicate', 0.1723),\n",
       "  ('acid sequences', 0.1661),\n",
       "  ('stages triggered', 0.1606),\n",
       "  ('patients treated', 0.1552),\n",
       "  ('published', 0.1447),\n",
       "  ('genetic molecular', 0.1424),\n",
       "  ('citrullinated protein', 0.1323),\n",
       "  ('levels specific', 0.1293),\n",
       "  ('disorder', 0.1265),\n",
       "  ('biological studies', 0.1242),\n",
       "  ('early anti', 0.1111),\n",
       "  ('acid', 0.1106),\n",
       "  ('peptidyl', 0.1104),\n",
       "  ('different', 0.109),\n",
       "  ('population', 0.0965),\n",
       "  ('explaining early', 0.0889),\n",
       "  ('deiminase explaining', 0.078),\n",
       "  ('protein', 0.0718),\n",
       "  ('published john', 0.068),\n",
       "  ('agents', 0.068),\n",
       "  ('microbe', 0.0544),\n",
       "  ('damages 2013', 0.0357),\n",
       "  ('agents avoid', 0.0037),\n",
       "  ('tract', -0.0026),\n",
       "  ('acted', -0.0051)],\n",
       " 'MED-1126': [('bioactive lignans', 0.7204),\n",
       "  ('lignans possessing', 0.7132),\n",
       "  ('lignans enormous', 0.7085),\n",
       "  ('lignans synthetic', 0.6882),\n",
       "  ('lignans', 0.6791),\n",
       "  ('lignans class', 0.6733),\n",
       "  ('units lignans', 0.6425),\n",
       "  ('growing lignans', 0.6245),\n",
       "  ('deals lignans', 0.605),\n",
       "  ('phenylpropanoid units', 0.5067),\n",
       "  ('plant metabolites', 0.4988),\n",
       "  ('synthetic derivatives', 0.4618),\n",
       "  ('various pharmacological', 0.4175),\n",
       "  ('reported bioactive', 0.3713),\n",
       "  ('therapeutic agents', 0.3357),\n",
       "  ('new therapeutic', 0.3122),\n",
       "  ('derivatives applications', 0.3002),\n",
       "  ('metabolites', 0.2975),\n",
       "  ('consists phenylpropane', 0.2939),\n",
       "  ('anticancer antioxidant', 0.259),\n",
       "  ('diversity growing', 0.2426),\n",
       "  ('enormous structural', 0.2383),\n",
       "  ('molecular backbone', 0.2333),\n",
       "  ('plant', 0.2203),\n",
       "  ('dimerization', 0.2094),\n",
       "  ('produced oxidative', 0.2062),\n",
       "  ('activities comprises', 0.1991),\n",
       "  ('inflammatory immunosuppressive', 0.1909),\n",
       "  ('applications cancer', 0.1864),\n",
       "  ('synthetic', 0.1718),\n",
       "  ('cancer chemotherapy', 0.1591),\n",
       "  ('applications', 0.1534),\n",
       "  ('anti inflammatory', 0.1526),\n",
       "  ('units', 0.1202),\n",
       "  ('antimicrobial', 0.0986),\n",
       "  ('development potential', 0.0969),\n",
       "  ('class secondary', 0.0825),\n",
       "  ('c6 c3', 0.0796),\n",
       "  ('comprises data', 0.0655),\n",
       "  ('highlight recently', 0.0595),\n",
       "  ('consists', 0.0367),\n",
       "  ('agents', 0.0346),\n",
       "  ('produced', -0.0013),\n",
       "  ('reviewed articles', -0.0132),\n",
       "  ('possessing', -0.0161),\n",
       "  ('anti', -0.0537),\n",
       "  ('step', -0.0603),\n",
       "  ('reported 100', -0.061),\n",
       "  ('deals', -0.0725),\n",
       "  ('peer', -0.1143)],\n",
       " 'MED-1127': [('rheumatoid arthritis', 0.5913),\n",
       "  ('arthritis caused', 0.5425),\n",
       "  ('arthritis crippling', 0.4875),\n",
       "  ('cause disease', 0.3515),\n",
       "  ('disabling joint', 0.3382),\n",
       "  ('eqrraa cause', 0.3189),\n",
       "  ('affects', 0.3021),\n",
       "  ('20 million', 0.2888),\n",
       "  ('scientific research', 0.2832),\n",
       "  ('popper suggested', 0.2637),\n",
       "  ('management disease', 0.2475),\n",
       "  ('original problem', 0.2473),\n",
       "  ('affects hla', 0.2449),\n",
       "  ('philosopher science', 0.2171),\n",
       "  ('antibodies proteus', 0.2145),\n",
       "  ('crippling', 0.2063),\n",
       "  ('refutations', 0.201),\n",
       "  ('women smokers', 0.1803),\n",
       "  ('esrral haemolysin', 0.1601),\n",
       "  ('caused upper', 0.1591),\n",
       "  ('dr1 individuals', 0.1549),\n",
       "  ('facts change', 0.1409),\n",
       "  ('infection', 0.1389),\n",
       "  ('shared epitope', 0.1357),\n",
       "  ('alter', 0.1351),\n",
       "  ('xi collagen', 0.1334),\n",
       "  ('urinary tract', 0.1326),\n",
       "  ('14', 0.1257),\n",
       "  ('different', 0.1236),\n",
       "  ('anti', 0.1078),\n",
       "  ('investigated methods', 0.1),\n",
       "  ('therapy assessed', 0.0923),\n",
       "  ('theory using', 0.0885),\n",
       "  ('people occurs', 0.0859),\n",
       "  ('amino acids', 0.0777),\n",
       "  ('generate new', 0.0734),\n",
       "  ('different countries', 0.0729),\n",
       "  ('karl', 0.0672),\n",
       "  ('suggested', 0.0669),\n",
       "  ('molecular mimicry', 0.0599),\n",
       "  ('bacteria', 0.0514),\n",
       "  ('bold conjectures', 0.0359),\n",
       "  ('urease resembles', 0.0288),\n",
       "  ('existing', 0.0135),\n",
       "  ('million', 0.013),\n",
       "  ('separately conjunction', 0.0081),\n",
       "  ('sequences generate', 0.0062),\n",
       "  ('occurs predominantly', -0.0182),\n",
       "  ('carry shared', -0.0341),\n",
       "  ('resembles type', -0.0477)],\n",
       " 'MED-1128': [('etiopathogenesis ra', 0.6085),\n",
       "  ('rheumatoid arthritis', 0.5765),\n",
       "  ('ra chronic', 0.4988),\n",
       "  ('patients ra', 0.4938),\n",
       "  ('ra required', 0.4596),\n",
       "  ('chronic inflammatory', 0.4394),\n",
       "  ('management ra', 0.4354),\n",
       "  ('ra extensive', 0.4285),\n",
       "  ('arthritic potentially', 0.4266),\n",
       "  ('bacteria etiopathogenesis', 0.4163),\n",
       "  ('mirabilis bacteria', 0.407),\n",
       "  ('various microbial', 0.3616),\n",
       "  ('disease association', 0.3574),\n",
       "  ('ra prospective', 0.353),\n",
       "  ('research groups', 0.3308),\n",
       "  ('affecting women', 0.33),\n",
       "  ('agents implicated', 0.3194),\n",
       "  ('role proteus', 0.3003),\n",
       "  ('microbiological molecular', 0.2833),\n",
       "  ('microbe disease', 0.2684),\n",
       "  ('independent research', 0.2659),\n",
       "  ('studies carried', 0.2551),\n",
       "  ('supports role', 0.2405),\n",
       "  ('current treatments', 0.238),\n",
       "  ('use antimicrobial', 0.2369),\n",
       "  ('extensive literature', 0.2338),\n",
       "  ('various genetic', 0.216),\n",
       "  ('women middle', 0.2138),\n",
       "  ('markers criteria', 0.2129),\n",
       "  ('novel therapeutic', 0.2114),\n",
       "  ('mainly affecting', 0.198),\n",
       "  ('suggested used', 0.1869),\n",
       "  ('causation', 0.184),\n",
       "  ('potentially disabling', 0.168),\n",
       "  ('characteristic clinical', 0.1668),\n",
       "  ('based results', 0.1657),\n",
       "  ('measures patients', 0.1624),\n",
       "  ('establish therapeutic', 0.1507),\n",
       "  ('ra new', 0.1501),\n",
       "  ('management', 0.1202),\n",
       "  ('middle age', 0.1078),\n",
       "  ('required', 0.1057),\n",
       "  ('immunological', 0.1016),\n",
       "  ('used current', 0.0948),\n",
       "  ('prospective longitudinal', 0.0905),\n",
       "  ('groups', 0.09),\n",
       "  ('dietary', 0.0861),\n",
       "  ('features various', 0.0818),\n",
       "  ('carried independent', 0.0588),\n",
       "  ('benefit', -0.0295)],\n",
       " 'MED-1129': [('autoimmune responses', 0.5219),\n",
       "  ('streptococcal peptides', 0.4998),\n",
       "  ('streptococci heart', 0.4918),\n",
       "  ('hla class', 0.3902),\n",
       "  ('rheumatic heart', 0.383),\n",
       "  ('recognition immunodominant', 0.3703),\n",
       "  ('complex mechanisms', 0.3253),\n",
       "  ('dr7dr53 molecules', 0.3111),\n",
       "  ('type cytokines', 0.2839),\n",
       "  ('peptide patients', 0.2788),\n",
       "  ('mimicry', 0.2659),\n",
       "  ('proposed triggering', 0.2612),\n",
       "  ('severe rhd', 0.2608),\n",
       "  ('molecular', 0.2539),\n",
       "  ('valvular lesions', 0.2368),\n",
       "  ('cells infiltrating', 0.2345),\n",
       "  ('review present', 0.2334),\n",
       "  ('ii molecules', 0.2307),\n",
       "  ('involved recognition', 0.227),\n",
       "  ('cell receptor', 0.2219),\n",
       "  ('hearts displayed', 0.2159),\n",
       "  ('related development', 0.2132),\n",
       "  ('disease', 0.2055),\n",
       "  ('illustrate complex', 0.1987),\n",
       "  ('cdr3 sequences', 0.1866),\n",
       "  ('displayed oligoclonal', 0.1861),\n",
       "  ('associated dq', 0.1732),\n",
       "  ('m5 peptide', 0.1654),\n",
       "  ('tcr bvbj', 0.1638),\n",
       "  ('sequences able', 0.1602),\n",
       "  ('antigens little', 0.1541),\n",
       "  ('responses', 0.1488),\n",
       "  ('clones', 0.1458),\n",
       "  ('focusing interactions', 0.144),\n",
       "  ('tissue damage', 0.1428),\n",
       "  ('th1', 0.1414),\n",
       "  ('patients produced', 0.1398),\n",
       "  ('results illustrate', 0.1365),\n",
       "  ('fever rf', 0.1274),\n",
       "  ('ag basel', 0.1231),\n",
       "  ('expansions intralesional', 0.1169),\n",
       "  ('class', 0.1146),\n",
       "  ('data cellular', 0.0906),\n",
       "  ('low homology', 0.0841),\n",
       "  ('ag', 0.0813),\n",
       "  ('usage', 0.0723),\n",
       "  ('2004 karger', 0.07),\n",
       "  ('peripheral blood', 0.0283),\n",
       "  ('copyright', 0.0273),\n",
       "  ('identical', 0.0265)],\n",
       " 'MED-1130': [('diet ra', 0.4938),\n",
       "  ('ra patients', 0.4311),\n",
       "  ('disease improvement', 0.4302),\n",
       "  ('patients diet', 0.414),\n",
       "  ('stool samples', 0.4062),\n",
       "  ('understanding diet', 0.4048),\n",
       "  ('samples 53', 0.3902),\n",
       "  ('flora patients', 0.3868),\n",
       "  ('ra recently', 0.3572),\n",
       "  ('months diet', 0.3493),\n",
       "  ('improvement indices', 0.3338),\n",
       "  ('trial analysed', 0.3308),\n",
       "  ('faecal flora', 0.3214),\n",
       "  ('clinical assessments', 0.3156),\n",
       "  ('intervention period', 0.3055),\n",
       "  ('observed patients', 0.2913),\n",
       "  ('acids based', 0.2653),\n",
       "  ('association intestinal', 0.2603),\n",
       "  ('vegan diet', 0.2593),\n",
       "  ('yr vegetarian', 0.254),\n",
       "  ('effect yr', 0.2538),\n",
       "  ('recently demonstrated', 0.249),\n",
       "  ('period patients', 0.2487),\n",
       "  ('based repeated', 0.2477),\n",
       "  ('patients changed', 0.247),\n",
       "  ('finding association', 0.2265),\n",
       "  ('significantly 13', 0.2104),\n",
       "  ('lactovegetarian', 0.2072),\n",
       "  ('indices constructed', 0.2068),\n",
       "  ('implications understanding', 0.2039),\n",
       "  ('cellular fatty', 0.1905),\n",
       "  ('constructed patients', 0.1901),\n",
       "  ('significant alteration', 0.173),\n",
       "  ('chromatography bacterial', 0.1542),\n",
       "  ('beneficial', 0.1529),\n",
       "  ('assigned group', 0.1516),\n",
       "  ('point intervention', 0.1471),\n",
       "  ('sample', 0.1215),\n",
       "  ('months', 0.1162),\n",
       "  ('difference periods', 0.0921),\n",
       "  ('high', 0.0551),\n",
       "  ('using direct', 0.0528),\n",
       "  ('affect', 0.0474),\n",
       "  ('group low', 0.0456),\n",
       "  ('time', 0.0438),\n",
       "  ('sample gas', 0.0326),\n",
       "  ('omnivorous vegan', 0.0306),\n",
       "  ('hi group', 0.0254),\n",
       "  ('liquid', -0.01),\n",
       "  ('li differed', -0.0268)],\n",
       " 'MED-1131': [('flora diet', 0.5082),\n",
       "  ('diet changes', 0.4772),\n",
       "  ('faecal flora', 0.4652),\n",
       "  ('lactobacilli control', 0.4389),\n",
       "  ('flora ra', 0.4219),\n",
       "  ('flora 001', 0.3936),\n",
       "  ('decrease rheumatoid', 0.3657),\n",
       "  ('disease improvement', 0.3607),\n",
       "  ('ra patients', 0.3506),\n",
       "  ('living food', 0.3303),\n",
       "  ('direct stool', 0.3188),\n",
       "  ('differences faecal', 0.3176),\n",
       "  ('induced decrease', 0.3038),\n",
       "  ('control group', 0.3014),\n",
       "  ('clinical assessments', 0.2998),\n",
       "  ('microbial', 0.2952),\n",
       "  ('intervention month', 0.2795),\n",
       "  ('patients randomized', 0.2614),\n",
       "  ('patients changes', 0.261),\n",
       "  ('acids method', 0.2589),\n",
       "  ('lo categories', 0.2502),\n",
       "  ('disease', 0.236),\n",
       "  ('group low', 0.233),\n",
       "  ('low improvement', 0.2305),\n",
       "  ('groups test', 0.2217),\n",
       "  ('fatty', 0.2062),\n",
       "  ('001 difference', 0.206),\n",
       "  ('receive living', 0.1906),\n",
       "  ('samples collected', 0.1878),\n",
       "  ('43', 0.1742),\n",
       "  ('liquid chromatography', 0.1724),\n",
       "  ('continue ordinary', 0.1679),\n",
       "  ('ordinary omnivorous', 0.1434),\n",
       "  ('conclude vegan', 0.1391),\n",
       "  ('uncooked', 0.1346),\n",
       "  ('method', 0.1339),\n",
       "  ('induced change', 0.1274),\n",
       "  ('proved simple', 0.1137),\n",
       "  ('pre', 0.107),\n",
       "  ('analysed direct', 0.1057),\n",
       "  ('clarify role', 0.1014),\n",
       "  ('high improvement', 0.0891),\n",
       "  ('constructed', 0.0737),\n",
       "  ('rich', 0.0541),\n",
       "  ('hi group', 0.0507),\n",
       "  ('index constructed', 0.0457),\n",
       "  ('way detect', 0.0263),\n",
       "  ('cellular', 0.0244),\n",
       "  ('gas', -0.0269),\n",
       "  ('individual', -0.0404)],\n",
       " 'MED-1133': [('kidney stone', 0.6214),\n",
       "  ('1994 13', 0.4642),\n",
       "  ('history stone', 0.4179),\n",
       "  ('women kidney', 0.4056),\n",
       "  ('reinitiated data', 0.3321),\n",
       "  ('survey nhanes', 0.3307),\n",
       "  ('history objective', 0.3189),\n",
       "  ('prevalence calculated', 0.2849),\n",
       "  ('yr hiatus', 0.2836),\n",
       "  ('multivariable models', 0.2695),\n",
       "  ('changing epidemiology', 0.255),\n",
       "  ('examination survey', 0.2534),\n",
       "  ('sectional analysis', 0.2497),\n",
       "  ('outcome measurements', 0.2472),\n",
       "  ('stones 95', 0.2423),\n",
       "  ('risk factors', 0.2378),\n",
       "  ('results limitations', 0.2343),\n",
       "  ('states identify', 0.2261),\n",
       "  ('objective current', 0.2108),\n",
       "  ('health', 0.2055),\n",
       "  ('cohort particularly', 0.2048),\n",
       "  ('nationally representative', 0.1919),\n",
       "  ('used identify', 0.1879),\n",
       "  ('73 001', 0.1878),\n",
       "  ('men prevalence', 0.1716),\n",
       "  ('self reported', 0.1566),\n",
       "  ('collection', 0.154),\n",
       "  ('data represent', 0.1528),\n",
       "  ('individuals diet', 0.1495),\n",
       "  ('inference regarding', 0.146),\n",
       "  ('49 001', 0.1208),\n",
       "  ('iii', 0.12),\n",
       "  ('limits', 0.1163),\n",
       "  ('diabetes strongly', 0.1152),\n",
       "  ('disease white', 0.1137),\n",
       "  ('12 compared', 0.1132),\n",
       "  ('design setting', 0.1032),\n",
       "  ('interval ci', 0.1013),\n",
       "  ('common', 0.1001),\n",
       "  ('participants cross', 0.0915),\n",
       "  ('ratio 37', 0.0844),\n",
       "  ('individuals 11', 0.0736),\n",
       "  ('hispanic 60', 0.0705),\n",
       "  ('marked increase', 0.0531),\n",
       "  ('001 black', 0.0187),\n",
       "  ('2007 2010', 0.0179),\n",
       "  ('normal weight', -0.0029),\n",
       "  ('non', -0.0588),\n",
       "  ('affect approximately', -0.0674),\n",
       "  ('play important', -0.0766)],\n",
       " 'MED-1134': [('protein intake', 0.5068),\n",
       "  ('fiber intakes', 0.4587),\n",
       "  ('results icsfs', 0.4198),\n",
       "  ('intakes risk', 0.4035),\n",
       "  ('diet control', 0.387),\n",
       "  ('diets differed', 0.3365),\n",
       "  ('research dietitian', 0.3105),\n",
       "  ('potential confounders', 0.2997),\n",
       "  ('decrease urinary', 0.2964),\n",
       "  ('validated food', 0.287),\n",
       "  ('ninety icsfs', 0.2832),\n",
       "  ('idiopathic calcium', 0.268),\n",
       "  ('achieved reduction', 0.2638),\n",
       "  ('95 ci', 0.2371),\n",
       "  ('compositions analyzed', 0.232),\n",
       "  ('diet 25', 0.225),\n",
       "  ('frequency questionnaires', 0.213),\n",
       "  ('sulfate outputs', 0.2123),\n",
       "  ('conclusions results', 0.1996),\n",
       "  ('oxalate', 0.1977),\n",
       "  ('recommendations checked', 0.1967),\n",
       "  ('assigned low', 0.196),\n",
       "  ('hour urea', 0.1845),\n",
       "  ('compliance total', 0.1838),\n",
       "  ('31 icsfs', 0.1661),\n",
       "  ('intervention oral', 0.1636),\n",
       "  ('group patients', 0.1602),\n",
       "  ('evaluate impact', 0.156),\n",
       "  ('stone formers', 0.1498),\n",
       "  ('control group', 0.147),\n",
       "  ('purpose article', 0.1377),\n",
       "  ('phoning food', 0.1302),\n",
       "  ('mmol day', 0.1288),\n",
       "  ('family history', 0.1226),\n",
       "  ('significantly 24', 0.111),\n",
       "  ('ci 22', 0.1078),\n",
       "  ('recurrence', 0.1074),\n",
       "  ('fiber', 0.1065),\n",
       "  ('12', 0.1041),\n",
       "  ('randomly', 0.0806),\n",
       "  ('fluid', 0.0756),\n",
       "  ('10 total', 0.074),\n",
       "  ('written leaflet', 0.0632),\n",
       "  ('carried research', 0.0622),\n",
       "  ('baseline months', 0.0471),\n",
       "  ('differed significantly', 0.0372),\n",
       "  ('energy high', 0.014),\n",
       "  ('58', -0.0045),\n",
       "  ('animal', -0.0078),\n",
       "  ('sex personal', -0.0832)],\n",
       " 'MED-1135': [('protein intake', 0.4908),\n",
       "  ('excretion calcium', 0.4446),\n",
       "  ('intake caused', 0.4371),\n",
       "  ('incidence calcium', 0.4338),\n",
       "  ('calcium stone', 0.3741),\n",
       "  ('idiopathic stone', 0.369),\n",
       "  ('animal protein', 0.3689),\n",
       "  ('men recurrent', 0.3373),\n",
       "  ('recurrent idiopathic', 0.3338),\n",
       "  ('formers consumed', 0.3282),\n",
       "  ('intakes intermediate', 0.3211),\n",
       "  ('urinary risk', 0.3185),\n",
       "  ('increase urinary', 0.3103),\n",
       "  ('excretion', 0.3086),\n",
       "  ('stone formation', 0.2984),\n",
       "  ('oxalate', 0.2949),\n",
       "  ('male population', 0.2772),\n",
       "  ('markedly increased', 0.2712),\n",
       "  ('uric acid', 0.2676),\n",
       "  ('main urinary', 0.2654),\n",
       "  ('protein did', 0.2587),\n",
       "  ('diet conversely', 0.2533),\n",
       "  ('formers high', 0.2502),\n",
       "  ('consumption animal', 0.2495),\n",
       "  ('disease related', 0.2469),\n",
       "  ('protein examined', 0.2409),\n",
       "  ('risk factors', 0.2403),\n",
       "  ('high animal', 0.2376),\n",
       "  ('vegetarians associated', 0.2153),\n",
       "  ('caused significant', 0.2143),\n",
       "  ('formers animal', 0.2141),\n",
       "  ('related consumption', 0.2123),\n",
       "  ('low excretion', 0.2098),\n",
       "  ('examined male', 0.2094),\n",
       "  ('incidence', 0.1998),\n",
       "  ('factors markedly', 0.1974),\n",
       "  ('population recurrent', 0.1845),\n",
       "  ('normal men', 0.1585),\n",
       "  ('subjects', 0.1244),\n",
       "  ('probability forming', 0.1119),\n",
       "  ('acid', 0.1047),\n",
       "  ('related', 0.092),\n",
       "  ('combination main', 0.0733),\n",
       "  ('hypothesis', 0.0555),\n",
       "  ('did normal', 0.0392),\n",
       "  ('overall', 0.0231),\n",
       "  ('single', 0.0013),\n",
       "  ('did', -0.0352),\n",
       "  ('low relative', -0.042),\n",
       "  ('taken', -0.0756)],\n",
       " 'MED-1136': [('protein urinary', 0.4979),\n",
       "  ('protein diet', 0.4662),\n",
       "  ('urinary nitrogen', 0.4636),\n",
       "  ('urinary calcium', 0.4584),\n",
       "  ('increase excretion', 0.4177),\n",
       "  ('male subjects', 0.3943),\n",
       "  ('dietary purine', 0.3931),\n",
       "  ('increase dietary', 0.3885),\n",
       "  ('urinary risk', 0.386),\n",
       "  ('dietary consumption', 0.3716),\n",
       "  ('diet significantly', 0.3559),\n",
       "  ('uric acid', 0.341),\n",
       "  ('glycosaminoglycans increase', 0.3305),\n",
       "  ('total urinary', 0.3185),\n",
       "  ('factors stone', 0.3126),\n",
       "  ('nitrogen day', 0.3056),\n",
       "  ('animal protein', 0.3055),\n",
       "  ('increase 34', 0.3011),\n",
       "  ('risk factors', 0.288),\n",
       "  ('ingestion', 0.2544),\n",
       "  ('oxalate 24', 0.2485),\n",
       "  ('forming stones', 0.2478),\n",
       "  ('studies carried', 0.2438),\n",
       "  ('factors markedly', 0.2346),\n",
       "  ('acid overall', 0.2341),\n",
       "  ('normal male', 0.2138),\n",
       "  ('increased average', 0.1756),\n",
       "  ('consumption animal', 0.1737),\n",
       "  ('mmol day', 0.1727),\n",
       "  ('volume', 0.164),\n",
       "  ('high animal', 0.157),\n",
       "  ('calcium 23', 0.1562),\n",
       "  ('probability forming', 0.1489),\n",
       "  ('subjects determine', 0.1349),\n",
       "  ('11 mmol', 0.1347),\n",
       "  ('ph', 0.1301),\n",
       "  ('term effect', 0.1266),\n",
       "  ('caused', 0.1231),\n",
       "  ('day animal', 0.1222),\n",
       "  ('calculated combination', 0.1218),\n",
       "  ('average 368', 0.12),\n",
       "  ('250 period', 0.106),\n",
       "  ('significantly', 0.1034),\n",
       "  ('period high', 0.0902),\n",
       "  ('short term', 0.0815),\n",
       "  ('caused 48', 0.068),\n",
       "  ('day accompanying', 0.053),\n",
       "  ('relative', 0.0498),\n",
       "  ('determine', 0.0134),\n",
       "  ('carried normal', -0.0026)],\n",
       " 'MED-1137': [('diet kidney', 0.5735),\n",
       "  ('kidney stones', 0.5643),\n",
       "  ('risk kidney', 0.5122),\n",
       "  ('cancer nutrition', 0.3815),\n",
       "  ('high intakes', 0.3713),\n",
       "  ('diets association', 0.3704),\n",
       "  ('stone formation', 0.3426),\n",
       "  ('new kidney', 0.3418),\n",
       "  ('association examined', 0.3327),\n",
       "  ('stones 10', 0.3167),\n",
       "  ('higher risk', 0.3088),\n",
       "  ('lifetime prevalence', 0.2619),\n",
       "  ('investigation cancer', 0.2523),\n",
       "  ('morbidity records', 0.2452),\n",
       "  ('examined 51', 0.239),\n",
       "  ('11', 0.2375),\n",
       "  ('100 day', 0.2253),\n",
       "  ('cohort', 0.224),\n",
       "  ('population wide', 0.2153),\n",
       "  ('european prospective', 0.2083),\n",
       "  ('objective investigate', 0.2049),\n",
       "  ('compared eat', 0.1998),\n",
       "  ('day hr', 0.1884),\n",
       "  ('formation high', 0.1882),\n",
       "  ('public prevention', 0.1861),\n",
       "  ('development objective', 0.1782),\n",
       "  ('increasing', 0.1633),\n",
       "  ('cohort 303', 0.1622),\n",
       "  ('cox proportional', 0.1586),\n",
       "  ('participants oxford', 0.1564),\n",
       "  ('intake zinc', 0.1553),\n",
       "  ('confidence intervals', 0.1416),\n",
       "  ('fruit fibre', 0.1176),\n",
       "  ('vegetarians 80', 0.1149),\n",
       "  ('important', 0.1149),\n",
       "  ('wholegrain', 0.1135),\n",
       "  ('statistics england', 0.09),\n",
       "  ('regression', 0.0845),\n",
       "  ('fish', 0.0827),\n",
       "  ('episode', 0.0757),\n",
       "  ('336 participants', 0.074),\n",
       "  ('participants attended', 0.0687),\n",
       "  ('performed calculate', 0.0662),\n",
       "  ('35 73', 0.0651),\n",
       "  ('cereals magnesium', 0.061),\n",
       "  ('ci 57', 0.0584),\n",
       "  ('hospital new', 0.0359),\n",
       "  ('low meat', 0.0179),\n",
       "  ('arm', -0.0182),\n",
       "  ('scottish', -0.0304)],\n",
       " 'MED-1138': [('metabolic study', 0.4651),\n",
       "  ('protein sources', 0.3939),\n",
       "  ('subjects consumed', 0.3896),\n",
       "  ('diet containing', 0.3821),\n",
       "  ('animal proteins', 0.362),\n",
       "  ('intake animal', 0.3422),\n",
       "  ('phase subjects', 0.3315),\n",
       "  ('results', 0.3248),\n",
       "  ('total 15', 0.321),\n",
       "  ('randomized crossover', 0.3089),\n",
       "  ('consumed standard', 0.3014),\n",
       "  ('limit intake', 0.2889),\n",
       "  ('sources urinary', 0.2812),\n",
       "  ('conclusions consuming', 0.28),\n",
       "  ('repeated measures', 0.2685),\n",
       "  ('methods total', 0.2673),\n",
       "  ('serum uric', 0.2444),\n",
       "  ('samples collected', 0.2354),\n",
       "  ('fish serum', 0.2267),\n",
       "  ('sodium mean', 0.2264),\n",
       "  ('purpose compared', 0.2256),\n",
       "  ('healthy subjects', 0.213),\n",
       "  ('week phase', 0.2069),\n",
       "  ('638 641', 0.2022),\n",
       "  ('oxalate highest', 0.1972),\n",
       "  ('calcium citrate', 0.1934),\n",
       "  ('index stone', 0.1904),\n",
       "  ('day 003', 0.1901),\n",
       "  ('chemistry', 0.1884),\n",
       "  ('copyright 2014', 0.1809),\n",
       "  ('risk materials', 0.1675),\n",
       "  ('beef chicken', 0.1659),\n",
       "  ('associated increased', 0.1646),\n",
       "  ('education research', 0.1605),\n",
       "  ('vs mg', 0.1545),\n",
       "  ('difference phases', 0.1429),\n",
       "  ('acid reflected', 0.1389),\n",
       "  ('associated lower', 0.1333),\n",
       "  ('using mixed', 0.1183),\n",
       "  ('forming propensity', 0.106),\n",
       "  ('ph sulfate', 0.0951),\n",
       "  ('rights', 0.0893),\n",
       "  ('respectively 05', 0.0776),\n",
       "  ('reflected saturation', 0.0699),\n",
       "  ('formers advised', 0.039),\n",
       "  ('79 08', 0.0333),\n",
       "  ('american', 0.0223),\n",
       "  ('published elsevier', 0.0208),\n",
       "  ('67', 0.0081),\n",
       "  ('48', -0.0116)],\n",
       " 'MED-1139': [('pesticides occupational', 0.6592),\n",
       "  ('carcinogenic mechanisms', 0.4884),\n",
       "  ('occupational studies', 0.4649),\n",
       "  ('term exposure', 0.4428),\n",
       "  ('exposures general', 0.4094),\n",
       "  ('putative associations', 0.362),\n",
       "  ('increased risk', 0.3423),\n",
       "  ('chronic diseases', 0.3351),\n",
       "  ('cancer different', 0.3234),\n",
       "  ('indicating environmental', 0.2783),\n",
       "  ('non occupational', 0.2622),\n",
       "  ('discuss potential', 0.2591),\n",
       "  ('lymphoma results', 0.2537),\n",
       "  ('growing evidence', 0.2475),\n",
       "  ('sites studied', 0.2209),\n",
       "  ('settings elevated', 0.2178),\n",
       "  ('hodgkin disease', 0.2055),\n",
       "  ('studied odds', 0.2017),\n",
       "  ('prevalence', 0.1991),\n",
       "  ('205 cancer', 0.1987),\n",
       "  ('use increased', 0.1928),\n",
       "  ('regression analyses', 0.1825),\n",
       "  ('general population', 0.1583),\n",
       "  ('factor different', 0.1578),\n",
       "  ('people residing', 0.1569),\n",
       "  ('agriculture', 0.1563),\n",
       "  ('related lower', 0.1441),\n",
       "  ('logistic', 0.1365),\n",
       "  ('health districts', 0.1248),\n",
       "  ('scarce', 0.1173),\n",
       "  ('organ', 0.1116),\n",
       "  ('support extend', 0.1102),\n",
       "  ('long', 0.0935),\n",
       "  ('matched controls', 0.0913),\n",
       "  ('capita study', 0.0898),\n",
       "  ('age', 0.0872),\n",
       "  ('collected computerized', 0.0782),\n",
       "  ('objective', 0.0697),\n",
       "  ('15 45', 0.0621),\n",
       "  ('hectares devoted', 0.0597),\n",
       "  ('832 969', 0.0467),\n",
       "  ('use conditional', 0.0401),\n",
       "  ('based case', 0.0349),\n",
       "  ('andalusia south', 0.0222),\n",
       "  ('1998 2005', 0.0216),\n",
       "  ('2013 elsevier', 0.0155),\n",
       "  ('consisted 34', 0.0055),\n",
       "  ('copyright', 0.002),\n",
       "  ('ireland', -0.0289),\n",
       "  ('10', -0.0639)],\n",
       " 'MED-1140': [('food hazards', 0.5676),\n",
       "  ('conventional food', 0.5016),\n",
       "  ('grown food', 0.4172),\n",
       "  ('consumer concern', 0.4151),\n",
       "  ('food intensified', 0.3626),\n",
       "  ('respect food', 0.3329),\n",
       "  ('healthier safer', 0.3243),\n",
       "  ('organically grown', 0.3221),\n",
       "  ('health matter', 0.3063),\n",
       "  ('compared conventional', 0.2925),\n",
       "  ('environmental contaminants', 0.2874),\n",
       "  ('safety aspects', 0.276),\n",
       "  ('evidence scarce', 0.2684),\n",
       "  ('concern quality', 0.2667),\n",
       "  ('alternatives significance', 0.2662),\n",
       "  ('ones dietary', 0.2488),\n",
       "  ('mycotoxin', 0.2485),\n",
       "  ('fewer agrochemical', 0.2432),\n",
       "  ('vegetables expected', 0.235),\n",
       "  ('increasing demand', 0.2314),\n",
       "  ('cereal crops', 0.2205),\n",
       "  ('dietary nitrate', 0.2101),\n",
       "  ('microorganisms available', 0.2022),\n",
       "  ('generalized conclusions', 0.2009),\n",
       "  ('evidence extremely', 0.1989),\n",
       "  ('residues conventionally', 0.1964),\n",
       "  ('urgent', 0.195),\n",
       "  ('anecdotal', 0.1946),\n",
       "  ('reports abound', 0.1833),\n",
       "  ('products', 0.1826),\n",
       "  ('remain tentative', 0.1796),\n",
       "  ('leafy', 0.1691),\n",
       "  ('pathogenic', 0.151),\n",
       "  ('preventing generalized', 0.1445),\n",
       "  ('biological', 0.1389),\n",
       "  ('emerges difficult', 0.1315),\n",
       "  ('debate hand', 0.1294),\n",
       "  ('absence adequate', 0.1269),\n",
       "  ('state knowledge', 0.1196),\n",
       "  ('recent', 0.1139),\n",
       "  ('studies area', 0.107),\n",
       "  ('endogenous', 0.0899),\n",
       "  ('threat human', 0.0844),\n",
       "  ('root tuber', 0.071),\n",
       "  ('clear picture', 0.0399),\n",
       "  ('does', 0.0342),\n",
       "  ('years primarily', 0.0263),\n",
       "  ('origins respect', 0.0227),\n",
       "  ('weigh', -0.0024),\n",
       "  ('primarily drives', -0.0691)],\n",
       " 'MED-1142': [('chlorinated pesticides', 0.6686),\n",
       "  ('pesticide sources', 0.636),\n",
       "  ('dibenzofurans', 0.5701),\n",
       "  ('pesticides changes', 0.5542),\n",
       "  ('ratio pcdds', 0.4786),\n",
       "  ('dichlorophenoxyacetic acid', 0.4713),\n",
       "  ('congeners monitored', 0.4383),\n",
       "  ('exposure', 0.3909),\n",
       "  ('ocdd formation', 0.372),\n",
       "  ('impurities changes', 0.3578),\n",
       "  ('precursors involved', 0.3496),\n",
       "  ('pentachloronitrobenzene', 0.3453),\n",
       "  ('sunlight formulations', 0.3376),\n",
       "  ('mediated ultraviolet', 0.2869),\n",
       "  ('maximum concentration', 0.258),\n",
       "  ('source fingerprints', 0.2522),\n",
       "  ('environment use', 0.2431),\n",
       "  ('pcnb formulations', 0.2412),\n",
       "  ('quartz', 0.2112),\n",
       "  ('df ratio', 0.1979),\n",
       "  ('concentration 93', 0.1977),\n",
       "  ('result formation', 0.1973),\n",
       "  ('various', 0.1916),\n",
       "  ('formulations 5600', 0.1911),\n",
       "  ('routes types', 0.189),\n",
       "  ('established manufacturing', 0.1774),\n",
       "  ('formation 155', 0.17),\n",
       "  ('provide preliminary', 0.1658),\n",
       "  ('kg formulation', 0.1643),\n",
       "  ('insights possible', 0.1619),\n",
       "  ('fs formed', 0.1607),\n",
       "  ('acid', 0.1501),\n",
       "  ('140', 0.1487),\n",
       "  ('similar yields', 0.1474),\n",
       "  ('currently used', 0.1467),\n",
       "  ('change formulation', 0.1391),\n",
       "  ('detailed evaluations', 0.1319),\n",
       "  ('28 μg', 0.1206),\n",
       "  ('tubes', 0.1147),\n",
       "  ('teq', 0.101),\n",
       "  ('natural', 0.0869),\n",
       "  ('increased 980', 0.0811),\n",
       "  ('present study', 0.0675),\n",
       "  ('did', 0.056),\n",
       "  ('involved copyright', 0.0395),\n",
       "  ('study worst', 0.0379),\n",
       "  ('pcnb australia', -0.001),\n",
       "  ('annum contributed', -0.0021),\n",
       "  ('3000', -0.0189),\n",
       "  ('2012 elsevier', -0.0466)],\n",
       " 'MED-1143': [('purchase organically', 0.6051),\n",
       "  ('organic produce', 0.5995),\n",
       "  ('organically grown', 0.549),\n",
       "  ('produce consumers', 0.5222),\n",
       "  ('organically pesticides', 0.4671),\n",
       "  ('choice organically', 0.4654),\n",
       "  ('conventional produce', 0.4508),\n",
       "  ('produce value', 0.4014),\n",
       "  ('consumers mitigate', 0.3695),\n",
       "  ('produce believe', 0.36),\n",
       "  ('conventionally grown', 0.3478),\n",
       "  ('individuals purchase', 0.3477),\n",
       "  ('pesticides conventionally', 0.339),\n",
       "  ('consumer choice', 0.3345),\n",
       "  ('produce examined', 0.3336),\n",
       "  ('cost conventional', 0.3103),\n",
       "  ('hazardous conventional', 0.2939),\n",
       "  ('median 50', 0.2773),\n",
       "  ('43 suggest', 0.2732),\n",
       "  ('significant premiums', 0.2633),\n",
       "  ('likely use', 0.2526),\n",
       "  ('grown', 0.2428),\n",
       "  ('reduction relatively', 0.2302),\n",
       "  ('cost', 0.226),\n",
       "  ('ingestion related', 0.2251),\n",
       "  ('risk reduction', 0.2144),\n",
       "  ('conventionally', 0.2091),\n",
       "  ('value risk', 0.1949),\n",
       "  ('alternative willing', 0.1937),\n",
       "  ('obtain median', 0.1925),\n",
       "  ('suggest individuals', 0.1831),\n",
       "  ('perceived', 0.1819),\n",
       "  ('discussions questionnaires', 0.167),\n",
       "  ('appear likely', 0.1534),\n",
       "  ('significant', 0.1477),\n",
       "  ('obtain', 0.1457),\n",
       "  ('substantially hazardous', 0.1426),\n",
       "  ('exploratory', 0.1425),\n",
       "  ('implied incremental', 0.1298),\n",
       "  ('relative estimates', 0.1288),\n",
       "  ('group', 0.1156),\n",
       "  ('believe substantially', 0.1152),\n",
       "  ('contaminated drinking', 0.1144),\n",
       "  ('mitigate', 0.1065),\n",
       "  ('related', 0.0673),\n",
       "  ('automobile', 0.0615),\n",
       "  ('relatively large', 0.0559),\n",
       "  ('focus', 0.0437),\n",
       "  ('water', -0.0025),\n",
       "  ('seatbelts', -0.0327)],\n",
       " 'MED-1144': [('food hazards', 0.5762),\n",
       "  ('safer food', 0.4821),\n",
       "  ('food buyers', 0.4292),\n",
       "  ('grown food', 0.38),\n",
       "  ('production practices', 0.3406),\n",
       "  ('shaping agricultural', 0.3395),\n",
       "  ('public risk', 0.3354),\n",
       "  ('safety concerns', 0.3295),\n",
       "  ('buyers estimated', 0.3255),\n",
       "  ('perceptions including', 0.3241),\n",
       "  ('public health', 0.3056),\n",
       "  ('range food', 0.2988),\n",
       "  ('elicit consumers', 0.2861),\n",
       "  ('organic fresh', 0.2754),\n",
       "  ('hazards identify', 0.2705),\n",
       "  ('produce compared', 0.2672),\n",
       "  ('compared public', 0.2599),\n",
       "  ('consumption production', 0.2556),\n",
       "  ('demand safer', 0.2383),\n",
       "  ('conventionally grown', 0.2297),\n",
       "  ('microbial pathogens', 0.219),\n",
       "  ('pesticide residue', 0.2093),\n",
       "  ('boston area', 0.2037),\n",
       "  ('concerns little', 0.1976),\n",
       "  ('90 survey', 0.1913),\n",
       "  ('area surveyed', 0.1889),\n",
       "  ('regulatory agencies', 0.1816),\n",
       "  ('natural toxins', 0.1793),\n",
       "  ('based study', 0.1701),\n",
       "  ('variety factors', 0.17),\n",
       "  ('factors consistently', 0.1602),\n",
       "  ('analyses indicate', 0.1501),\n",
       "  ('study 700', 0.1477),\n",
       "  ('specific categories', 0.1466),\n",
       "  ('states despite', 0.1332),\n",
       "  ('approach targets', 0.1278),\n",
       "  ('perceived reduction', 0.1128),\n",
       "  ('despite documented', 0.1122),\n",
       "  ('vehicle accidents', 0.1076),\n",
       "  ('recommended future', 0.1029),\n",
       "  ('magnitude', 0.0979),\n",
       "  ('distrust', 0.0834),\n",
       "  ('predictive higher', 0.071),\n",
       "  ('communication efforts', 0.0635),\n",
       "  ('united', 0.0256),\n",
       "  ('200 million', 0.0216),\n",
       "  ('dissimilar based', 0.0204),\n",
       "  ('nearly 50', -0.0019),\n",
       "  ('median annual', -0.0022),\n",
       "  ('mortality', -0.0191)],\n",
       " 'MED-1146': [('cancer risks', 0.5418),\n",
       "  ('added pesticide', 0.4518),\n",
       "  ('prevention estimates', 0.4163),\n",
       "  ('risk estimates', 0.3975),\n",
       "  ('increased fruit', 0.3943),\n",
       "  ('attributed intake', 0.3818),\n",
       "  ('uncertainties potential', 0.3235),\n",
       "  ('residue sampling', 0.321),\n",
       "  ('analysis potential', 0.2865),\n",
       "  ('consumption', 0.2847),\n",
       "  ('prevented increasing', 0.2824),\n",
       "  ('nutritional epidemiology', 0.2742),\n",
       "  ('epa methods', 0.2606),\n",
       "  ('environmental protection', 0.2507),\n",
       "  ('arising additional', 0.2507),\n",
       "  ('vegetables copyright', 0.2503),\n",
       "  ('cases theoretically', 0.2498),\n",
       "  ('estimated using', 0.2477),\n",
       "  ('residual confounding', 0.2394),\n",
       "  ('cases prevented', 0.2391),\n",
       "  ('risk overwhelming', 0.2307),\n",
       "  ('using published', 0.2272),\n",
       "  ('day number', 0.2217),\n",
       "  ('usda resulting', 0.2196),\n",
       "  ('bioassays', 0.2115),\n",
       "  ('caused added', 0.2088),\n",
       "  ('studies reliance', 0.2025),\n",
       "  ('population increased', 0.1919),\n",
       "  ('year caused', 0.1791),\n",
       "  ('half', 0.1579),\n",
       "  ('current paper', 0.1534),\n",
       "  ('upper', 0.1462),\n",
       "  ('grown', 0.1425),\n",
       "  ('000', 0.1395),\n",
       "  ('potency', 0.1371),\n",
       "  ('reliance rodent', 0.1245),\n",
       "  ('population', 0.1179),\n",
       "  ('agency', 0.1152),\n",
       "  ('number contrasted', 0.1034),\n",
       "  ('provides', 0.1),\n",
       "  ('conventionally', 0.0905),\n",
       "  ('data department', 0.0883),\n",
       "  ('20 000', 0.0825),\n",
       "  ('concerned', 0.081),\n",
       "  ('provides confidence', 0.0653),\n",
       "  ('meta', 0.0499),\n",
       "  ('rights reserved', 0.0413),\n",
       "  ('overwhelming difference', 0.0332),\n",
       "  ('2012 elsevier', 0.0262),\n",
       "  ('10', 0.0262)],\n",
       " 'MED-1147': [('phosphate fertilizers', 0.5768),\n",
       "  ('levels manure', 0.5258),\n",
       "  ('bioavailability cd', 0.4611),\n",
       "  ('sources cadmium', 0.46),\n",
       "  ('organic pigs', 0.4349),\n",
       "  ('ingestion soil', 0.3566),\n",
       "  ('conventional pigs', 0.3555),\n",
       "  ('deposition', 0.3546),\n",
       "  ('farm', 0.3397),\n",
       "  ('liver manure', 0.3222),\n",
       "  ('soil differences', 0.3172),\n",
       "  ('pigs 40', 0.2974),\n",
       "  ('included organic', 0.2899),\n",
       "  ('outdoors fed', 0.2632),\n",
       "  ('analyzed cd', 0.254),\n",
       "  ('feed 39', 0.25),\n",
       "  ('levels kidneys', 0.2476),\n",
       "  ('digested', 0.2467),\n",
       "  ('differences feed', 0.2432),\n",
       "  ('exposure environment', 0.2197),\n",
       "  ('cd 991', 0.2181),\n",
       "  ('compositions bioavailability', 0.1731),\n",
       "  ('protein contributed', 0.1652),\n",
       "  ('control program', 0.1594),\n",
       "  ('water quality', 0.1546),\n",
       "  ('result lower', 0.1537),\n",
       "  ('sd 15', 0.1382),\n",
       "  ('potato', 0.1338),\n",
       "  ('long term', 0.1266),\n",
       "  ('higher levels', 0.1099),\n",
       "  ('main sources', 0.1046),\n",
       "  ('37 84', 0.0978),\n",
       "  ('raised outdoors', 0.0909),\n",
       "  ('absorption spectrometry', 0.0906),\n",
       "  ('significantly', 0.0756),\n",
       "  ('linear relationship', 0.0722),\n",
       "  ('present study', 0.0608),\n",
       "  ('weight mean', 0.0575),\n",
       "  ('51 microg', 0.057),\n",
       "  ('different', 0.0528),\n",
       "  ('growing finishing', 0.0442),\n",
       "  ('contained', 0.0412),\n",
       "  ('96', 0.0291),\n",
       "  ('fiber', 0.0192),\n",
       "  ('microwave', 0.0176),\n",
       "  ('indoors', 0.0099),\n",
       "  ('graphite furnace', 0.0021),\n",
       "  ('17 microg', -0.0282),\n",
       "  ('contained beet', -0.0416),\n",
       "  ('spite', -0.0586)],\n",
       " 'MED-1148': [('exposure pesticides', 0.6226),\n",
       "  ('hypospadias suggests', 0.4786),\n",
       "  ('intake nonorganic', 0.3438),\n",
       "  ('contamination', 0.3252),\n",
       "  ('examined association', 0.3181),\n",
       "  ('pregnancy associated', 0.3159),\n",
       "  ('understood exposure', 0.3015),\n",
       "  ('purpose etiology', 0.3003),\n",
       "  ('offspring materials', 0.2857),\n",
       "  ('findings inconsistent', 0.2856),\n",
       "  ('considered risk', 0.2781),\n",
       "  ('conventional organic', 0.2625),\n",
       "  ('alternative products', 0.2548),\n",
       "  ('odds ratios', 0.2514),\n",
       "  ('poorly understood', 0.2501),\n",
       "  ('finding chemical', 0.2357),\n",
       "  ('lifestyle factors', 0.2257),\n",
       "  ('dietary choice', 0.2099),\n",
       "  ('birth year', 0.2009),\n",
       "  ('research published', 0.1995),\n",
       "  ('factor findings', 0.1927),\n",
       "  ('residues frequently', 0.1901),\n",
       "  ('36 conclusions', 0.167),\n",
       "  ('alcohol consumption', 0.1653),\n",
       "  ('materials methods', 0.1626),\n",
       "  ('education research', 0.1548),\n",
       "  ('geography child', 0.1513),\n",
       "  ('butter rarely', 0.1488),\n",
       "  ('related', 0.1385),\n",
       "  ('egg fruit', 0.1355),\n",
       "  ('study boys', 0.1338),\n",
       "  ('urological', 0.1218),\n",
       "  ('age body', 0.1214),\n",
       "  ('vegetables meat', 0.1178),\n",
       "  ('models constructed', 0.1167),\n",
       "  ('health', 0.1019),\n",
       "  ('regarding demographic', 0.0941),\n",
       "  ('conclusions large', 0.0899),\n",
       "  ('306 mothers', 0.0824),\n",
       "  ('2013', 0.0731),\n",
       "  ('mass index', 0.0648),\n",
       "  ('interviews conducted', 0.0623),\n",
       "  ('control', 0.0596),\n",
       "  ('american', 0.0514),\n",
       "  ('published elsevier', 0.0386),\n",
       "  ('milk dairy', 0.037),\n",
       "  ('finding copyright', 0.0367),\n",
       "  ('18 95', 0.0227),\n",
       "  ('high current', -0.0088),\n",
       "  ('ci 09', -0.029)],\n",
       " 'MED-1149': [('organic food', 0.5544),\n",
       "  ('food consumers', 0.4189),\n",
       "  ('consumers rarely', 0.3977),\n",
       "  ('consumer attitude', 0.3699),\n",
       "  ('intake clusters', 0.3484),\n",
       "  ('background lifestyle', 0.339),\n",
       "  ('participants nutrinet', 0.336),\n",
       "  ('14 organic', 0.3331),\n",
       "  ('fatty acids', 0.3203),\n",
       "  ('studies analyzing', 0.2893),\n",
       "  ('association overweight', 0.2827),\n",
       "  ('demographic characteristics', 0.2695),\n",
       "  ('health markers', 0.2578),\n",
       "  ('specific socio', 0.2504),\n",
       "  ('participants', 0.2452),\n",
       "  ('alcoholic', 0.2187),\n",
       "  ('cohort cluster', 0.2168),\n",
       "  ('guidelines compared', 0.2166),\n",
       "  ('adherence nutritional', 0.2135),\n",
       "  ('rarely described', 0.209),\n",
       "  ('healthier', 0.2015),\n",
       "  ('use 18', 0.1972),\n",
       "  ('included plant', 0.1865),\n",
       "  ('santé cohort', 0.1859),\n",
       "  ('acids minerals', 0.1844),\n",
       "  ('compared interested', 0.184),\n",
       "  ('311 adult', 0.1825),\n",
       "  ('confounders including', 0.1776),\n",
       "  ('reasons differed', 0.1752),\n",
       "  ('identify behaviors', 0.1692),\n",
       "  ('occasional ocop', 0.1666),\n",
       "  ('frequency use', 0.1647),\n",
       "  ('30 obesity', 0.1533),\n",
       "  ('products sizeable', 0.1462),\n",
       "  ('assessed 54', 0.1226),\n",
       "  ('fibers', 0.11),\n",
       "  ('increasing methods', 0.1077),\n",
       "  ('accounting', 0.1073),\n",
       "  ('respectively 0001', 0.099),\n",
       "  ('showed intermediate', 0.0913),\n",
       "  ('highly educated', 0.0903),\n",
       "  ('figures conclusions', 0.0894),\n",
       "  ('using polytomous', 0.0757),\n",
       "  ('36', 0.064),\n",
       "  ('meat milk', 0.0505),\n",
       "  ('42 48', 0.0486),\n",
       "  ('logistic', 0.0399),\n",
       "  ('62 men', 0.0361),\n",
       "  ('rcop highly', 0.0187),\n",
       "  ('markedly lower', -0.0624)],\n",
       " 'MED-1150': [('organic food', 0.6026),\n",
       "  ('diets organically', 0.554),\n",
       "  ('organically grown', 0.5341),\n",
       "  ('benefits organic', 0.477),\n",
       "  ('organically raised', 0.464),\n",
       "  ('fruit flies', 0.4579),\n",
       "  ('grown food', 0.3903),\n",
       "  ('flies raised', 0.3749),\n",
       "  ('raised diets', 0.3718),\n",
       "  ('raised produce', 0.361),\n",
       "  ('model fruit', 0.3505),\n",
       "  ('effects dietary', 0.3465),\n",
       "  ('food nutritionally', 0.344),\n",
       "  ('food bestows', 0.3439),\n",
       "  ('unclear organically', 0.3373),\n",
       "  ('fly drosophila', 0.3343),\n",
       "  ('evidence organically', 0.3332),\n",
       "  ('food market', 0.3286),\n",
       "  ('health flies', 0.3079),\n",
       "  ('nutritionally superior', 0.2844),\n",
       "  ('health effects', 0.2698),\n",
       "  ('effects fly', 0.2663),\n",
       "  ('raisins soy', 0.2195),\n",
       "  ('bestows health', 0.2022),\n",
       "  ('beans flies', 0.196),\n",
       "  ('consuming', 0.1905),\n",
       "  ('provide animals', 0.1793),\n",
       "  ('conventionally grown', 0.1719),\n",
       "  ('fertility longevity', 0.1691),\n",
       "  ('evaluate potential', 0.1667),\n",
       "  ('health data', 0.1645),\n",
       "  ('sources greater', 0.156),\n",
       "  ('fastest growing', 0.1515),\n",
       "  ('model experimentally', 0.1356),\n",
       "  ('variety tests', 0.1329),\n",
       "  ('extracts conventionally', 0.1233),\n",
       "  ('sector unclear', 0.1121),\n",
       "  ('greater stress', 0.1028),\n",
       "  ('using provide', 0.0888),\n",
       "  ('tangible benefits', 0.0821),\n",
       "  ('bananas potatoes', 0.0693),\n",
       "  ('greater activity', 0.0683),\n",
       "  ('superior conventionally', 0.0674),\n",
       "  ('components using', 0.0635),\n",
       "  ('used characterized', 0.0616),\n",
       "  ('designed assess', 0.0496),\n",
       "  ('additionally observed', 0.011),\n",
       "  ('overall', -0.0041),\n",
       "  ('convenient', -0.0617),\n",
       "  ('resistance', -0.0657)],\n",
       " 'MED-1151': [('organic foods', 0.5104),\n",
       "  ('background organically', 0.4468),\n",
       "  ('food reduce', 0.3993),\n",
       "  ('pesticide residues', 0.3644),\n",
       "  ('risks cancer', 0.3545),\n",
       "  ('hypothesis eating', 0.3187),\n",
       "  ('foods results', 0.3157),\n",
       "  ('reported consumption', 0.3108),\n",
       "  ('women reported', 0.3066),\n",
       "  ('63 women', 0.2996),\n",
       "  ('associated reduction', 0.275),\n",
       "  ('cancer 53', 0.2238),\n",
       "  ('study 623', 0.2188),\n",
       "  ('non hodgkin', 0.2065),\n",
       "  ('residues methods', 0.1909),\n",
       "  ('96 conclusions', 0.1726),\n",
       "  ('frequency consumption', 0.1714),\n",
       "  ('conventionally produced', 0.1703),\n",
       "  ('lymphoma rr', 0.1679),\n",
       "  ('relative risks', 0.1658),\n",
       "  ('ci 65', 0.1643),\n",
       "  ('study little', 0.1593),\n",
       "  ('sarcoma breast', 0.1541),\n",
       "  ('little decrease', 0.1373),\n",
       "  ('possibly non', 0.1318),\n",
       "  ('hypothesis', 0.1312),\n",
       "  ('examined', 0.1292),\n",
       "  ('07 soft', 0.1193),\n",
       "  ('background', 0.1147),\n",
       "  ('incidence reported', 0.1107),\n",
       "  ('aged uk', 0.1075),\n",
       "  ('common', 0.1016),\n",
       "  ('03 95', 0.0981),\n",
       "  ('confidence interval', 0.0965),\n",
       "  ('rr 37', 0.0826),\n",
       "  ('769 cases', 0.0825),\n",
       "  ('15 associated', 0.0808),\n",
       "  ('cases', 0.077),\n",
       "  ('82 27', 0.07),\n",
       "  ('models used', 0.0664),\n",
       "  ('total', 0.0613),\n",
       "  ('baseline 30', 0.0575),\n",
       "  ('contain', 0.057),\n",
       "  ('years cox', 0.0523),\n",
       "  ('tissue', 0.0523),\n",
       "  ('080', 0.0232),\n",
       "  ('middle', -0.0028),\n",
       "  ('large prospective', -0.005),\n",
       "  ('99', -0.0061),\n",
       "  ('usually vs', -0.0507)],\n",
       " 'MED-1152': [('testicular cancer', 0.4752),\n",
       "  ('suggest organochlorine', 0.4382),\n",
       "  ('tc increasing', 0.4235),\n",
       "  ('cancer tc', 0.4067),\n",
       "  ('risk tc', 0.3747),\n",
       "  ('exposures ops', 0.3595),\n",
       "  ('development tc', 0.3355),\n",
       "  ('ors tc', 0.3095),\n",
       "  ('hexachlorobenzene hcb', 0.3018),\n",
       "  ('50 cases', 0.3008),\n",
       "  ('17 cases', 0.2902),\n",
       "  ('concentrations total', 0.2776),\n",
       "  ('exposure', 0.2726),\n",
       "  ('tc household', 0.2678),\n",
       "  ('incidence', 0.2503),\n",
       "  ('associated risk', 0.2476),\n",
       "  ('dde', 0.2135),\n",
       "  ('determine environmental', 0.2121),\n",
       "  ('previous research', 0.2026),\n",
       "  ('compared controls', 0.1959),\n",
       "  ('implicated pathogenesis', 0.1954),\n",
       "  ('association observed', 0.1945),\n",
       "  ('influence development', 0.1908),\n",
       "  ('increasing worldwide', 0.1894),\n",
       "  ('recent findings', 0.1887),\n",
       "  ('reasons increase', 0.1878),\n",
       "  ('decades', 0.1687),\n",
       "  ('including dichlorodiphenyldichloroethylene', 0.1564),\n",
       "  ('study', 0.1483),\n",
       "  ('adjusted ors', 0.1309),\n",
       "  ('remains unknown', 0.1305),\n",
       "  ('ci 00', 0.1242),\n",
       "  ('household insecticide', 0.1229),\n",
       "  ('higher serum', 0.121),\n",
       "  ('hospital based', 0.1032),\n",
       "  ('increase remains', 0.0963),\n",
       "  ('01', 0.084),\n",
       "  ('control', 0.0825),\n",
       "  ('use', 0.0562),\n",
       "  ('11 14', 0.0496),\n",
       "  ('adjusted 34', 0.0476),\n",
       "  ('crude', 0.0436),\n",
       "  ('isomer', 0.0402),\n",
       "  ('15 95', 0.0329),\n",
       "  ('91 adjusted', 0.0249),\n",
       "  ('based case', 0.0015),\n",
       "  ('participants', -0.0033),\n",
       "  ('adjusted 23', -0.0134),\n",
       "  ('additional support', -0.0428),\n",
       "  ('09', -0.1198)],\n",
       " 'MED-1153': [('op pesticides', 0.5728),\n",
       "  ('exposure organophosphate', 0.5698),\n",
       "  ('risks children', 0.5098),\n",
       "  ('dimethylthiophosphate children', 0.4975),\n",
       "  ('adhd children', 0.4907),\n",
       "  ('known neurotoxic', 0.4409),\n",
       "  ('disorders', 0.3691),\n",
       "  ('common children', 0.3501),\n",
       "  ('examined risks', 0.3421),\n",
       "  ('exposure', 0.3409),\n",
       "  ('hyperactivity', 0.3341),\n",
       "  ('dmap metabolite', 0.3321),\n",
       "  ('common compounds', 0.3106),\n",
       "  ('alkylphosphates', 0.3089),\n",
       "  ('higher concentrations', 0.3051),\n",
       "  ('daps especially', 0.2797),\n",
       "  ('139 children', 0.2649),\n",
       "  ('properties studies', 0.2365),\n",
       "  ('dialkyl phosphate', 0.2257),\n",
       "  ('examine association', 0.2219),\n",
       "  ('attention deficit', 0.2211),\n",
       "  ('age 15', 0.2036),\n",
       "  ('prevalence prospective', 0.1885),\n",
       "  ('duration urinary', 0.1857),\n",
       "  ('age', 0.1773),\n",
       "  ('studies needed', 0.1767),\n",
       "  ('hypothesis op', 0.1715),\n",
       "  ('interview parent', 0.1371),\n",
       "  ('years participants', 0.1244),\n",
       "  ('findings support', 0.1213),\n",
       "  ('based slightly', 0.1143),\n",
       "  ('examination survey', 0.112),\n",
       "  ('95 confidence', 0.1015),\n",
       "  ('general population', 0.0992),\n",
       "  ('iv results', 0.0989),\n",
       "  ('nutrition', 0.0973),\n",
       "  ('data national', 0.0888),\n",
       "  ('14 10', 0.087),\n",
       "  ('non detectable', 0.0833),\n",
       "  ('double odds', 0.0694),\n",
       "  ('median', 0.0608),\n",
       "  ('ethnicity poverty', 0.0571),\n",
       "  ('results nineteen', 0.0562),\n",
       "  ('met diagnostic', 0.0325),\n",
       "  ('statistical manual', 0.0293),\n",
       "  ('sex', 0.0241),\n",
       "  ('methods cross', -0.0116),\n",
       "  ('income', -0.02),\n",
       "  ('23 02', -0.0431),\n",
       "  ('fold', -0.0513)],\n",
       " 'MED-1156': [('organochlorines nhl', 0.6949),\n",
       "  ('nhl inconsistent', 0.492),\n",
       "  ('imprecise exposure', 0.4354),\n",
       "  ('pcbs study', 0.3888),\n",
       "  ('examine associations', 0.3863),\n",
       "  ('exposure assessment', 0.3701),\n",
       "  ('inconsistent results', 0.3636),\n",
       "  ('lymphoma', 0.3458),\n",
       "  ('limited statistical', 0.3335),\n",
       "  ('measured concentrations', 0.319),\n",
       "  ('cohort study', 0.3128),\n",
       "  ('subcohort persons', 0.2945),\n",
       "  ('tissue levels', 0.2883),\n",
       "  ('samples risk', 0.2697),\n",
       "  ('trends ddt', 0.2685),\n",
       "  ('health evidence', 0.2588),\n",
       "  ('results incidence', 0.2573),\n",
       "  ('nonachlor based', 0.2546),\n",
       "  ('non hodgkin', 0.2542),\n",
       "  ('256 subcohort', 0.2537),\n",
       "  ('concentrations dichlorodiphenyltrichlorethane', 0.2422),\n",
       "  ('intervals cis', 0.2406),\n",
       "  ('higher risk', 0.2201),\n",
       "  ('estimates higher', 0.211),\n",
       "  ('adipose tissue', 0.2088),\n",
       "  ('mass index', 0.2045),\n",
       "  ('interquartile range', 0.1973),\n",
       "  ('persons diagnosed', 0.1935),\n",
       "  ('methods conducted', 0.1854),\n",
       "  ('10 polychlorinated', 0.1783),\n",
       "  ('objective purpose', 0.1782),\n",
       "  ('factor non', 0.1759),\n",
       "  ('oxychlordane 35', 0.1748),\n",
       "  ('monotonic dose', 0.1733),\n",
       "  ('analyzed cox', 0.1631),\n",
       "  ('categorical models', 0.1619),\n",
       "  ('13 95', 0.1562),\n",
       "  ('053 persons', 0.1547),\n",
       "  ('new environmental', 0.1402),\n",
       "  ('adjusting body', 0.1401),\n",
       "  ('congeners', 0.1378),\n",
       "  ('response trends', 0.1324),\n",
       "  ('men women', 0.1176),\n",
       "  ('statistical power', 0.1161),\n",
       "  ('38 respectively', 0.1063),\n",
       "  ('danish cancer', 0.0884),\n",
       "  ('range increases', 0.0824),\n",
       "  ('18', 0.0709),\n",
       "  ('contrast', 0.0523),\n",
       "  ('11', 0.0454)],\n",
       " 'MED-1157': [('pesticides included', 0.5228),\n",
       "  ('rinsability pesticide', 0.4955),\n",
       "  ('samples crops', 0.4467),\n",
       "  ('experimental farm', 0.4388),\n",
       "  ('treating produce', 0.3941),\n",
       "  ('resulting samples', 0.3629),\n",
       "  ('produce tap', 0.3593),\n",
       "  ('laboratory', 0.3554),\n",
       "  ('treated harvested', 0.3505),\n",
       "  ('water extraction', 0.331),\n",
       "  ('initiated research', 0.3173),\n",
       "  ('fortified residues', 0.3158),\n",
       "  ('soil metabolite', 0.3003),\n",
       "  ('reduced rinsability', 0.2976),\n",
       "  ('study fungicides', 0.2923),\n",
       "  ('field fortified', 0.2582),\n",
       "  ('chlorpyrifos reduced', 0.2485),\n",
       "  ('grown', 0.2475),\n",
       "  ('removed residues', 0.2412),\n",
       "  ('approximately 35', 0.2382),\n",
       "  ('1997', 0.2317),\n",
       "  ('examining effect', 0.2303),\n",
       "  ('solubility', 0.2155),\n",
       "  ('weathering prior', 0.211),\n",
       "  ('markets grown', 0.2037),\n",
       "  ('ddt statistical', 0.1899),\n",
       "  ('program objective', 0.1793),\n",
       "  ('test showed', 0.1714),\n",
       "  ('conditions variety', 0.1675),\n",
       "  ('sources contains', 0.163),\n",
       "  ('growing treating', 0.1591),\n",
       "  ('food', 0.1558),\n",
       "  ('used', 0.1537),\n",
       "  ('local', 0.1486),\n",
       "  ('iprodione', 0.147),\n",
       "  ('methoxychlor', 0.1465),\n",
       "  ('permethrin', 0.1427),\n",
       "  ('retail', 0.1251),\n",
       "  ('endosulfan', 0.1223),\n",
       "  ('unwashed', 0.0991),\n",
       "  ('divided', 0.0971),\n",
       "  ('multi residue', 0.0949),\n",
       "  ('malathion diazinon', 0.0918),\n",
       "  ('normal', 0.0826),\n",
       "  ('bifenthrin', 0.0821),\n",
       "  ('using wilcoxon', 0.0818),\n",
       "  ('mimic closely', 0.0352),\n",
       "  ('world', 0.0331),\n",
       "  ('residues vinclozolin', -0.0247),\n",
       "  ('captan', -0.0297)],\n",
       " 'MED-1158': [('alkaline solutions', 0.5953),\n",
       "  ('acidic solutions', 0.5749),\n",
       "  ('acid solutions', 0.5712),\n",
       "  ('solutions organochlorines', 0.4735),\n",
       "  ('efficiencies acidic', 0.4412),\n",
       "  ('contaminated potatoes', 0.4341),\n",
       "  ('eliminated acidic', 0.4194),\n",
       "  ('solutions sodium', 0.4055),\n",
       "  ('pesticides', 0.401),\n",
       "  ('solutions effective', 0.401),\n",
       "  ('chloride alkaline', 0.3556),\n",
       "  ('solutions radish', 0.343),\n",
       "  ('pesticides completely', 0.3239),\n",
       "  ('citric ascorbic', 0.3236),\n",
       "  ('peroxide neutral', 0.321),\n",
       "  ('tap water', 0.3197),\n",
       "  ('solutions elimination', 0.3182),\n",
       "  ('eliminated pesticides', 0.3175),\n",
       "  ('water elimination', 0.3147),\n",
       "  ('organophosphorus', 0.3064),\n",
       "  ('efficiencies', 0.2833),\n",
       "  ('sodium chloride', 0.2649),\n",
       "  ('acid hydrogen', 0.2618),\n",
       "  ('followed citric', 0.2571),\n",
       "  ('neutral solutions', 0.2442),\n",
       "  ('hydrogen peroxide', 0.2362),\n",
       "  ('results indicated', 0.2362),\n",
       "  ('naturally contaminated', 0.2246),\n",
       "  ('compounds', 0.2177),\n",
       "  ('acetic', 0.2076),\n",
       "  ('removal ranged', 0.2061),\n",
       "  ('examined results', 0.2006),\n",
       "  ('100 pirimphos', 0.1982),\n",
       "  ('pirimphos methyl', 0.1657),\n",
       "  ('percentage', 0.1582),\n",
       "  ('investigation radish', 0.1536),\n",
       "  ('87 100', 0.1457),\n",
       "  ('profenofos', 0.1318),\n",
       "  ('methyl 87', 0.117),\n",
       "  ('ranged 98', 0.1091),\n",
       "  ('methyl malathion', 0.1029),\n",
       "  ('73', 0.1011),\n",
       "  ('malathion 100', 0.099),\n",
       "  ('dde', 0.0922),\n",
       "  ('carbonate', 0.0808),\n",
       "  ('effective neutral', 0.0688),\n",
       "  ('completely', 0.0545),\n",
       "  ('indicated', 0.016),\n",
       "  ('hand', -0.0298),\n",
       "  ('loss followed', -0.0449)],\n",
       " 'MED-1160': [('pesticides washing', 0.6893),\n",
       "  ('tomatoes detergent', 0.6366),\n",
       "  ('remove pesticide', 0.522),\n",
       "  ('dishwashing liquids', 0.5075),\n",
       "  ('detergents chinese', 0.5029),\n",
       "  ('washing practical', 0.4954),\n",
       "  ('removal chlorpyrifos', 0.4745),\n",
       "  ('washing increased', 0.4615),\n",
       "  ('water detergent', 0.4615),\n",
       "  ('detergent pesticide', 0.4477),\n",
       "  ('chp chlorothalonil', 0.4381),\n",
       "  ('cherry tomatoes', 0.414),\n",
       "  ('pesticides increased', 0.4122),\n",
       "  ('higher solubilizing', 0.3638),\n",
       "  ('used kitchen', 0.3574),\n",
       "  ('detergents compared', 0.3312),\n",
       "  ('favored pesticide', 0.3203),\n",
       "  ('residues fruits', 0.3146),\n",
       "  ('washed cherry', 0.3143),\n",
       "  ('enhanced removal', 0.3087),\n",
       "  ('vegetables commonly', 0.3044),\n",
       "  ('distilled', 0.2784),\n",
       "  ('80 cht', 0.2627),\n",
       "  ('acid lower', 0.2624),\n",
       "  ('solubility chp', 0.2602),\n",
       "  ('concentrations', 0.2527),\n",
       "  ('detergent 250', 0.2526),\n",
       "  ('42 chp', 0.233),\n",
       "  ('10 nacl', 0.227),\n",
       "  ('cht readily', 0.2149),\n",
       "  ('practical', 0.1934),\n",
       "  ('soaking', 0.1837),\n",
       "  ('higher solutions', 0.1805),\n",
       "  ('micelle concentrations', 0.1781),\n",
       "  ('logkow value', 0.1637),\n",
       "  ('effect substantially', 0.1381),\n",
       "  ('20 min', 0.138),\n",
       "  ('chinese', 0.127),\n",
       "  ('removal copyright', 0.1132),\n",
       "  ('produced shielding', 0.1022),\n",
       "  ('reduced effectiveness', 0.0901),\n",
       "  ('ph', 0.0849),\n",
       "  ('market tested', 0.0492),\n",
       "  ('444 mg', 0.0441),\n",
       "  ('50 mg', 0.037),\n",
       "  ('rights reserved', 0.0289),\n",
       "  ('2013 elsevier', 0.0244),\n",
       "  ('remained', 0.0172),\n",
       "  ('min sufficient', 0.0131),\n",
       "  ('invariant independent', -0.0588)],\n",
       " 'MED-1161': [('pesticide residues', 0.7095),\n",
       "  ('pesticides foods', 0.7022),\n",
       "  ('pesticide diversified', 0.6305),\n",
       "  ('increase pesticide', 0.5818),\n",
       "  ('lowering pesticide', 0.4957),\n",
       "  ('unpredictable chemicals', 0.4563),\n",
       "  ('chemicals imperative', 0.3781),\n",
       "  ('increasing agricultural', 0.3272),\n",
       "  ('degradation various', 0.325),\n",
       "  ('environmental factors', 0.2859),\n",
       "  ('foods varied', 0.2817),\n",
       "  ('pasteurization blanching', 0.2803),\n",
       "  ('consumer deleterious', 0.2729),\n",
       "  ('inputs used', 0.2706),\n",
       "  ('residues major', 0.2646),\n",
       "  ('remove residues', 0.2559),\n",
       "  ('detergents reported', 0.2556),\n",
       "  ('peracetic acid', 0.241),\n",
       "  ('harvest treatments', 0.2361),\n",
       "  ('human health', 0.2181),\n",
       "  ('foods washing', 0.2118),\n",
       "  ('concentration increase', 0.2051),\n",
       "  ('end products', 0.2022),\n",
       "  ('international trade', 0.2001),\n",
       "  ('chlorine chlorine', 0.1948),\n",
       "  ('iprodione', 0.1947),\n",
       "  ('brewing resulted', 0.1855),\n",
       "  ('alternatives decontamination', 0.1781),\n",
       "  ('peroxide', 0.174),\n",
       "  ('soaking solutions', 0.1654),\n",
       "  ('reducing level', 0.1649),\n",
       "  ('preparation processing', 0.156),\n",
       "  ('effect depends', 0.1542),\n",
       "  ('handling storage', 0.1536),\n",
       "  ('diversified information', 0.1489),\n",
       "  ('peeling trimming', 0.1481),\n",
       "  ('major bottleneck', 0.1444),\n",
       "  ('folds concentration', 0.1321),\n",
       "  ('milling baking', 0.1167),\n",
       "  ('treatments like', 0.0961),\n",
       "  ('substrate', 0.0587),\n",
       "  ('canning scrambling', 0.0573),\n",
       "  ('cold', 0.0466),\n",
       "  ('literature', 0.0435),\n",
       "  ('post', 0.0429),\n",
       "  ('making malting', 0.0418),\n",
       "  ('reported affect', 0.0323),\n",
       "  ('invariably contain', 0.0177),\n",
       "  ('nature', -0.0071),\n",
       "  ('left', -0.0128)],\n",
       " 'MED-1162': [('vegetables pesticide', 0.5166),\n",
       "  ('pesticides', 0.4954),\n",
       "  ('pesticides avoided', 0.494),\n",
       "  ('vegetables lower', 0.4552),\n",
       "  ('concerns pesticide', 0.4524),\n",
       "  ('fruits vegetables', 0.4156),\n",
       "  ('organic fruits', 0.4145),\n",
       "  ('vegetables conventional', 0.4004),\n",
       "  ('avoid imported', 0.3918),\n",
       "  ('foods specific', 0.3825),\n",
       "  ('vegetables specific', 0.3711),\n",
       "  ('detected organic', 0.3674),\n",
       "  ('typical dietary', 0.3253),\n",
       "  ('avoided conventional', 0.3248),\n",
       "  ('vegetables pose', 0.3178),\n",
       "  ('residues conventional', 0.3171),\n",
       "  ('specific fruits', 0.3154),\n",
       "  ('imported foods', 0.3125),\n",
       "  ('urged avoid', 0.3124),\n",
       "  ('residues encouraged', 0.2993),\n",
       "  ('imported fruits', 0.2942),\n",
       "  ('consumer exposure', 0.2843),\n",
       "  ('choose organic', 0.2749),\n",
       "  ('lower levels', 0.2619),\n",
       "  ('consumers frequently', 0.2509),\n",
       "  ('health concerns', 0.2473),\n",
       "  ('residues frequently', 0.2305),\n",
       "  ('conventional forms', 0.2276),\n",
       "  ('dietary consumer', 0.2235),\n",
       "  ('risks', 0.2132),\n",
       "  ('studies demonstrated', 0.1561),\n",
       "  ('exposure', 0.1412),\n",
       "  ('levels', 0.1281),\n",
       "  ('frequently detected', 0.1249),\n",
       "  ('concerns', 0.122),\n",
       "  ('highly contaminated', 0.11),\n",
       "  ('encouraged choose', 0.1078),\n",
       "  ('forms studies', 0.0762),\n",
       "  ('frequently urged', 0.0704),\n",
       "  ('significance similarly', 0.0689),\n",
       "  ('typical', 0.058),\n",
       "  ('demonstrate imported', 0.0571),\n",
       "  ('appear', 0.0267),\n",
       "  ('domestic', 0.0192),\n",
       "  ('pose greater', 0.0032),\n",
       "  ('does appear', -0.0036),\n",
       "  ('specific', -0.0085),\n",
       "  ('research does', -0.0562),\n",
       "  ('singled', -0.0837),\n",
       "  ('highly', -0.088)],\n",
       " 'MED-1164': [('pesticide use', 0.5318),\n",
       "  ('assessed organophosphorus', 0.4925),\n",
       "  ('organic diets', 0.4693),\n",
       "  ('diets children', 0.4347),\n",
       "  ('exposure diet', 0.4033),\n",
       "  ('children classified', 0.3706),\n",
       "  ('washington preschool', 0.3434),\n",
       "  ('conventional foods', 0.3169),\n",
       "  ('estimates urinary', 0.3083),\n",
       "  ('dose estimates', 0.3017),\n",
       "  ('metabolites agricultural', 0.2982),\n",
       "  ('mean concentrations', 0.2944),\n",
       "  ('parents reduce', 0.2931),\n",
       "  ('use data', 0.2788),\n",
       "  ('home collected', 0.2648),\n",
       "  ('levels environmental', 0.2613),\n",
       "  ('diets 21', 0.26),\n",
       "  ('parents kept', 0.2597),\n",
       "  ('current guidelines', 0.2519),\n",
       "  ('diaries days', 0.2509),\n",
       "  ('shifting exposures', 0.247),\n",
       "  ('metabolites significantly', 0.2454),\n",
       "  ('analyzed op', 0.2393),\n",
       "  ('urinary dimethyl', 0.2301),\n",
       "  ('monitoring seattle', 0.2283),\n",
       "  ('label information', 0.2269),\n",
       "  ('risk consumption', 0.2265),\n",
       "  ('alkylphosphate', 0.2183),\n",
       "  ('collection distinguished', 0.213),\n",
       "  ('fruits vegetables', 0.2075),\n",
       "  ('biological', 0.1806),\n",
       "  ('protection', 0.1681),\n",
       "  ('factor 34', 0.1563),\n",
       "  ('agency', 0.1546),\n",
       "  ('17 03', 0.1528),\n",
       "  ('juice reduce', 0.1455),\n",
       "  ('assessed', 0.1423),\n",
       "  ('micro', 0.1347),\n",
       "  ('produce', 0.1345),\n",
       "  ('24 hr', 0.1295),\n",
       "  ('respectively 0001', 0.0867),\n",
       "  ('differed factor', 0.0758),\n",
       "  ('samples 18', 0.0729),\n",
       "  ('median total', 0.0692),\n",
       "  ('range uncertain', 0.0603),\n",
       "  ('provide relatively', 0.0593),\n",
       "  ('times higher', 0.0348),\n",
       "  ('negligible risk', 0.0287),\n",
       "  ('06 02', -0.0158),\n",
       "  ('came', -0.0557)],\n",
       " 'MED-1165': [('pbdes cooking', 0.6127),\n",
       "  ('foodstuffs investigated', 0.4997),\n",
       "  ('oil food', 0.4546),\n",
       "  ('concentrations food', 0.4489),\n",
       "  ('ethers pbdes', 0.4396),\n",
       "  ('cooking depended', 0.4332),\n",
       "  ('polybrominated', 0.4296),\n",
       "  ('meat', 0.4284),\n",
       "  ('included fish', 0.4173),\n",
       "  ('samples cooking', 0.4154),\n",
       "  ('cooked fried', 0.4075),\n",
       "  ('pah levels', 0.3495),\n",
       "  ('hydrocarbons', 0.3444),\n",
       "  ('diphenyl ethers', 0.3158),\n",
       "  ('concentrations frying', 0.2955),\n",
       "  ('cooked general', 0.2898),\n",
       "  ('changes levels', 0.2878),\n",
       "  ('bean potato', 0.2722),\n",
       "  ('16 polycyclic', 0.263),\n",
       "  ('boiled samples', 0.2546),\n",
       "  ('olive oil', 0.2508),\n",
       "  ('analyzed variations', 0.2479),\n",
       "  ('loin pork', 0.235),\n",
       "  ('hexachlorobenzene', 0.2335),\n",
       "  ('fish excepting', 0.2291),\n",
       "  ('enhanced hcb', 0.2257),\n",
       "  ('veal steak', 0.2109),\n",
       "  ('noted tuna', 0.2042),\n",
       "  ('thigh chicken', 0.2005),\n",
       "  ('various', 0.2004),\n",
       "  ('concentrations sardine', 0.1987),\n",
       "  ('aromatic', 0.1971),\n",
       "  ('processes enhanced', 0.1935),\n",
       "  ('values especially', 0.1548),\n",
       "  ('results study', 0.1452),\n",
       "  ('mainly specific', 0.1439),\n",
       "  ('rib lamb', 0.1328),\n",
       "  ('especially notable', 0.1311),\n",
       "  ('rice', 0.1173),\n",
       "  ('item raw', 0.1163),\n",
       "  ('roasted', 0.1095),\n",
       "  ('general terms', 0.1002),\n",
       "  ('means reducing', 0.0858),\n",
       "  ('corresponded', 0.0646),\n",
       "  ('breast', 0.0636),\n",
       "  ('string', 0.0562),\n",
       "  ('induced', 0.0552),\n",
       "  ('scarce differences', 0.0505),\n",
       "  ('processes limited', 0.0358),\n",
       "  ('excepting hake', 0.0249)],\n",
       " 'MED-1166': [('pesticides neurotoxic', 0.5522),\n",
       "  ('op pesticides', 0.5163),\n",
       "  ('postnatal exposure', 0.4993),\n",
       "  ('context organophosphate', 0.4634),\n",
       "  ('children cognitive', 0.4482),\n",
       "  ('exposure op', 0.4365),\n",
       "  ('conclusions prenatal', 0.3587),\n",
       "  ('birth cohort', 0.324),\n",
       "  ('studies examined', 0.3182),\n",
       "  ('age analyses', 0.2867),\n",
       "  ('poorer intellectual', 0.2844),\n",
       "  ('assessment mothers', 0.2661),\n",
       "  ('lower levels', 0.2334),\n",
       "  ('chronic', 0.2293),\n",
       "  ('school age', 0.2236),\n",
       "  ('quintile children', 0.211),\n",
       "  ('health assessment', 0.2058),\n",
       "  ('development objective', 0.2024),\n",
       "  ('farmworker families', 0.2011),\n",
       "  ('adversely affect', 0.2001),\n",
       "  ('high doses', 0.1944),\n",
       "  ('average concentrations', 0.1829),\n",
       "  ('4th', 0.1821),\n",
       "  ('relations cognitive', 0.1788),\n",
       "  ('children salinas', 0.1731),\n",
       "  ('study higher', 0.1728),\n",
       "  ('dap metabolites', 0.172),\n",
       "  ('analyses adjusted', 0.1696),\n",
       "  ('quotient iq', 0.1647),\n",
       "  ('abilities', 0.1613),\n",
       "  ('phosphate', 0.1538),\n",
       "  ('scores working', 0.1523),\n",
       "  ('results', 0.1434),\n",
       "  ('working memory', 0.125),\n",
       "  ('months years', 0.121),\n",
       "  ('329 children', 0.1131),\n",
       "  ('processing speed', 0.1036),\n",
       "  ('wechsler', 0.0897),\n",
       "  ('measurement environment', 0.0834),\n",
       "  ('half', 0.075),\n",
       "  ('intelligence home', 0.0688),\n",
       "  ('california assessed', 0.0663),\n",
       "  ('urine collected', 0.0595),\n",
       "  ('general population', 0.0549),\n",
       "  ('old', 0.0375),\n",
       "  ('nonetheless range', 0.0365),\n",
       "  ('predominantly latino', 0.0021),\n",
       "  ('verbal', -0.0058),\n",
       "  ('dialkyl', -0.0115),\n",
       "  ('measured second', -0.019)],\n",
       " 'MED-1167': [('pesticides elevated', 0.7123),\n",
       "  ('pesticides chronic', 0.6428),\n",
       "  ('pesticides world', 0.6239),\n",
       "  ('association pesticide', 0.5026),\n",
       "  ('health impacts', 0.4219),\n",
       "  ('diseases like', 0.3643),\n",
       "  ('oxidative stress', 0.3202),\n",
       "  ('damages epigenetic', 0.3147),\n",
       "  ('association exposure', 0.3129),\n",
       "  ('problems particularly', 0.3061),\n",
       "  ('impacts rapidly', 0.2944),\n",
       "  ('reproductive disorders', 0.2895),\n",
       "  ('world concerns', 0.2857),\n",
       "  ('neurodegenerative', 0.2286),\n",
       "  ('birth defects', 0.2263),\n",
       "  ('particularly asthma', 0.2251),\n",
       "  ('pathways main', 0.2223),\n",
       "  ('nephropathies', 0.2222),\n",
       "  ('wide use', 0.2194),\n",
       "  ('types cancers', 0.2145),\n",
       "  ('upr impairment', 0.2081),\n",
       "  ('parkinson', 0.1992),\n",
       "  ('systemic lupus', 0.1904),\n",
       "  ('enzymes receptors', 0.1903),\n",
       "  ('endocrine', 0.1857),\n",
       "  ('review present', 0.1836),\n",
       "  ('growing huge', 0.1718),\n",
       "  ('stress endoplasmic', 0.1675),\n",
       "  ('amyotrophic lateral', 0.1603),\n",
       "  ('incidence', 0.16),\n",
       "  ('chronic fatigue', 0.1557),\n",
       "  ('diabetes', 0.153),\n",
       "  ('aging', 0.1487),\n",
       "  ('evidence relation', 0.1402),\n",
       "  ('effective mechanisms', 0.129),\n",
       "  ('introduce genetic', 0.1242),\n",
       "  ('different', 0.1152),\n",
       "  ('ion channels', 0.1106),\n",
       "  ('sclerosis', 0.1069),\n",
       "  ('like perturbation', 0.0978),\n",
       "  ('ubiquitin proteasome', 0.0876),\n",
       "  ('copd cardiovascular', 0.086),\n",
       "  ('coronary artery', 0.0766),\n",
       "  ('erythematous', 0.0659),\n",
       "  ('homeostasis induced', 0.0554),\n",
       "  ('rheumatoid', 0.0461),\n",
       "  ('als birth', 0.0367),\n",
       "  ('action copyright', 0.0334),\n",
       "  ('defective autophagy', 0.0333),\n",
       "  ('2013 elsevier', 0.0199)],\n",
       " 'MED-1169': [('op pesticides', 0.5715),\n",
       "  ('reduces organophosphate', 0.5666),\n",
       "  ('pesticides negative', 0.4999),\n",
       "  ('organophosphate exposure', 0.4851),\n",
       "  ('diet reduces', 0.4278),\n",
       "  ('higher pesticide', 0.42),\n",
       "  ('reduced op', 0.3836),\n",
       "  ('suggest organic', 0.3682),\n",
       "  ('conventional food', 0.3404),\n",
       "  ('lower conventional', 0.3235),\n",
       "  ('negative health', 0.2895),\n",
       "  ('food consumption', 0.2797),\n",
       "  ('children relatively', 0.2797),\n",
       "  ('metabolism objectives', 0.2437),\n",
       "  ('production commonly', 0.2403),\n",
       "  ('limits', 0.2281),\n",
       "  ('exposure', 0.2276),\n",
       "  ('commonly uses', 0.2233),\n",
       "  ('daps 96', 0.2057),\n",
       "  ('using gc', 0.1914),\n",
       "  ('deemed healthier', 0.1777),\n",
       "  ('body', 0.173),\n",
       "  ('studies different', 0.1718),\n",
       "  ('significant conclusions', 0.1678),\n",
       "  ('diethyl', 0.1499),\n",
       "  ('morning voids', 0.1334),\n",
       "  ('methods thirteen', 0.1315),\n",
       "  ('adults methods', 0.1252),\n",
       "  ('403 respectively', 0.0956),\n",
       "  ('phase half', 0.094),\n",
       "  ('levels dialkylphosphate', 0.0913),\n",
       "  ('2014 elsevier', 0.0873),\n",
       "  ('80', 0.0852),\n",
       "  ('crossover', 0.0712),\n",
       "  ('small sample', 0.0691),\n",
       "  ('ms detection', 0.0662),\n",
       "  ('populations required', 0.0642),\n",
       "  ('week significantly', 0.0503),\n",
       "  ('investigate clinical', 0.0361),\n",
       "  ('mean total', 0.036),\n",
       "  ('meant difference', 0.027),\n",
       "  ('days crossed', 0.0236),\n",
       "  ('011', 0.0217),\n",
       "  ('023 252', -0.0194),\n",
       "  ('294', -0.0247),\n",
       "  ('participants randomly', -0.0289),\n",
       "  ('sd 435', -0.029),\n",
       "  ('relevance copyright', -0.0309),\n",
       "  ('51 μg', -0.0339),\n",
       "  ('larger scale', -0.0351)],\n",
       " 'MED-1170': [('20 studies', 0.5533),\n",
       "  ('pesticides occupational', 0.4768),\n",
       "  ('studies involved', 0.4053),\n",
       "  ('systematic review', 0.3934),\n",
       "  ('risk estimates', 0.3789),\n",
       "  ('parent exposure', 0.3729),\n",
       "  ('identified medline', 0.3518),\n",
       "  ('exposure defined', 0.3347),\n",
       "  ('examine potential', 0.3208),\n",
       "  ('results interpreted', 0.2922),\n",
       "  ('significant associations', 0.2915),\n",
       "  ('impact work', 0.2702),\n",
       "  ('search 15', 0.2652),\n",
       "  ('cohort studies', 0.2494),\n",
       "  ('publications submitted', 0.247),\n",
       "  ('minimizing parental', 0.2252),\n",
       "  ('analysis relative', 0.218),\n",
       "  ('evidence leading', 0.2174),\n",
       "  ('odds ratio', 0.2134),\n",
       "  ('children young', 0.2109),\n",
       "  ('2010 retrieved', 0.2085),\n",
       "  ('diagnosis results', 0.1995),\n",
       "  ('studies north', 0.1908),\n",
       "  ('control studies', 0.1905),\n",
       "  ('europe conclusions', 0.186),\n",
       "  ('1974', 0.1849),\n",
       "  ('meta', 0.1757),\n",
       "  ('windows', 0.1734),\n",
       "  ('settings occurrence', 0.1586),\n",
       "  ('tumors combining', 0.1488),\n",
       "  ('adults methods', 0.1476),\n",
       "  ('extracted', 0.1472),\n",
       "  ('occurrence brain', 0.1397),\n",
       "  ('lists', 0.129),\n",
       "  ('geographic location', 0.1268),\n",
       "  ('industry title', 0.1232),\n",
       "  ('models separate', 0.1139),\n",
       "  ('interpreted caution', 0.0798),\n",
       "  ('known copyright', 0.0713),\n",
       "  ('stratification', 0.0638),\n",
       "  ('involved farm', 0.0619),\n",
       "  ('30 95', 0.0515),\n",
       "  ('combining case', 0.0403),\n",
       "  ('supports', 0.0392),\n",
       "  ('2013 elsevier', 0.0311),\n",
       "  ('significantly increased', 0.0201),\n",
       "  ('astroglial brain', 0.0176),\n",
       "  ('america', 0.0161),\n",
       "  ('random', -0.0032),\n",
       "  ('11', -0.0519)],\n",
       " 'MED-1171': [('development neurotoxicants', 0.6825),\n",
       "  ('pesticides children', 0.5805),\n",
       "  ('chemicals impair', 0.566),\n",
       "  ('exposure organochlorine', 0.5535),\n",
       "  ('including organophosphate', 0.5397),\n",
       "  ('polychlorinated biphenyls', 0.5158),\n",
       "  ('neurotoxicants cross', 0.5018),\n",
       "  ('exposure assessment', 0.4638),\n",
       "  ('mentioned chemicals', 0.4619),\n",
       "  ('problems exposure', 0.4369),\n",
       "  ('neonates exposed', 0.4358),\n",
       "  ('evaluating impact', 0.4142),\n",
       "  ('biomarker exposure', 0.414),\n",
       "  ('induced exposure', 0.406),\n",
       "  ('brain exposure', 0.3925),\n",
       "  ('mercury effect', 0.3873),\n",
       "  ('children reviewing', 0.3789),\n",
       "  ('pcbs', 0.371),\n",
       "  ('effects human', 0.3642),\n",
       "  ('neurodevelopment inconsistent', 0.3493),\n",
       "  ('children induced', 0.3454),\n",
       "  ('measure child', 0.3096),\n",
       "  ('reviewing recent', 0.304),\n",
       "  ('studies indicate', 0.3006),\n",
       "  ('affecting endpoints', 0.2929),\n",
       "  ('progress epidemiology', 0.2576),\n",
       "  ('concentration', 0.2549),\n",
       "  ('suggest prenatal', 0.2535),\n",
       "  ('assessment based', 0.2457),\n",
       "  ('regarding reduction', 0.2343),\n",
       "  ('proportion abnormal', 0.2217),\n",
       "  ('lead', 0.2216),\n",
       "  ('cognitive motor', 0.2171),\n",
       "  ('performance impairments', 0.2054),\n",
       "  ('tools used', 0.2041),\n",
       "  ('literature answer', 0.1948),\n",
       "  ('indicate negative', 0.1935),\n",
       "  ('fairly comprehensive', 0.1927),\n",
       "  ('reflexes', 0.1745),\n",
       "  ('attention potential', 0.1745),\n",
       "  ('language outcomes', 0.1743),\n",
       "  ('prospective cohorts', 0.1674),\n",
       "  ('designed using', 0.1633),\n",
       "  ('article aims', 0.1552),\n",
       "  ('placenta', 0.1204),\n",
       "  ('significant association', 0.1173),\n",
       "  ('level 10', 0.1094),\n",
       "  ('laboratory animal', 0.1006),\n",
       "  ('measures majority', 0.0679),\n",
       "  ('higher', 0.0543)],\n",
       " 'MED-1172': [('pesticides children', 0.6427),\n",
       "  ('pesticide exposure', 0.607),\n",
       "  ('children exposure', 0.5905),\n",
       "  ('op pesticides', 0.5843),\n",
       "  ('exposure study', 0.4672),\n",
       "  ('frequent exposure', 0.4543),\n",
       "  ('particularly children', 0.4524),\n",
       "  ('organophosphorus', 0.4444),\n",
       "  ('chlorpyrifos op', 0.4149),\n",
       "  ('adults children', 0.3842),\n",
       "  ('health effects', 0.3568),\n",
       "  ('exposure adults', 0.3312),\n",
       "  ('longitudinal exposure', 0.3212),\n",
       "  ('malathion chlorpyrifos', 0.3136),\n",
       "  ('detected levels', 0.2692),\n",
       "  ('cpes conducted', 0.2573),\n",
       "  ('adverse', 0.2529),\n",
       "  ('assessed young', 0.2441),\n",
       "  ('effect op', 0.2369),\n",
       "  ('children switched', 0.2269),\n",
       "  ('metabolites', 0.2105),\n",
       "  ('sources patterns', 0.2045),\n",
       "  ('objectives assessed', 0.1871),\n",
       "  ('concentrations reduced', 0.1743),\n",
       "  ('years', 0.1707),\n",
       "  ('background widespread', 0.1681),\n",
       "  ('studied', 0.1649),\n",
       "  ('age consumed', 0.1523),\n",
       "  ('organic diets', 0.1509),\n",
       "  ('intervention period', 0.1395),\n",
       "  ('daily period', 0.1366),\n",
       "  ('urban suburban', 0.1249),\n",
       "  ('urine samples', 0.1215),\n",
       "  ('11 years', 0.1167),\n",
       "  ('days summer', 0.115),\n",
       "  ('seasonal effect', 0.1057),\n",
       "  ('conducted greater', 0.1034),\n",
       "  ('2003 2004', 0.0903),\n",
       "  ('washington area', 0.0773),\n",
       "  ('fruits vegetables', 0.0766),\n",
       "  ('conventional', 0.0655),\n",
       "  ('15 consecutive', 0.0569),\n",
       "  ('used novel', 0.0416),\n",
       "  ('fall sampling', 0.0402),\n",
       "  ('need', 0.0389),\n",
       "  ('collected twice', 0.0354),\n",
       "  ('items median', 0.0175),\n",
       "  ('design allowed', 0.0113),\n",
       "  ('fresh', -0.0062),\n",
       "  ('nondetected', -0.0244)],\n",
       " 'MED-1173': [('designed questionnaire', 0.5033),\n",
       "  ('organic foods', 0.3933),\n",
       "  ('mailed 1998', 0.348),\n",
       "  ('58 responded', 0.345),\n",
       "  ('2000 swedish', 0.3055),\n",
       "  ('welfare mailed', 0.2986),\n",
       "  ('swedish citizens', 0.298),\n",
       "  ('18 65', 0.2939),\n",
       "  ('efb perceived', 0.2882),\n",
       "  ('mailed', 0.2808),\n",
       "  ('self reported', 0.2653),\n",
       "  ('sample 2000', 0.2641),\n",
       "  ('1154 58', 0.2613),\n",
       "  ('behaviour organic', 0.2456),\n",
       "  ('attitudes behaviour', 0.2447),\n",
       "  ('sample', 0.2443),\n",
       "  ('related perceived', 0.2428),\n",
       "  ('food choice', 0.2407),\n",
       "  ('foods strongly', 0.2326),\n",
       "  ('human health', 0.2318),\n",
       "  ('65 years', 0.2283),\n",
       "  ('wide sample', 0.2173),\n",
       "  ('responded self', 0.2164),\n",
       "  ('results indicate', 0.1982),\n",
       "  ('ages 18', 0.1962),\n",
       "  ('frequency results', 0.195),\n",
       "  ('1998 random', 0.1641),\n",
       "  ('years 1154', 0.1566),\n",
       "  ('environment animal', 0.153),\n",
       "  ('choice terms', 0.1365),\n",
       "  ('environmentally', 0.1296),\n",
       "  ('citizens ages', 0.1222),\n",
       "  ('efbs refraining', 0.1203),\n",
       "  ('designed', 0.1121),\n",
       "  ('friendly', 0.1079),\n",
       "  ('purchase frequency', 0.0958),\n",
       "  ('nation', 0.0927),\n",
       "  ('concerned', 0.0906),\n",
       "  ('better predictors', 0.0865),\n",
       "  ('perceived benefit', 0.0847),\n",
       "  ('motives better', 0.065),\n",
       "  ('terms human', 0.0644),\n",
       "  ('consequences', 0.0593),\n",
       "  ('years', 0.0475),\n",
       "  ('indicate', 0.0164),\n",
       "  ('random', 0.0123),\n",
       "  ('egoistic motives', 0.0074),\n",
       "  ('better', -0.0052),\n",
       "  ('performance', -0.054),\n",
       "  ('car driving', -0.0862)],\n",
       " 'MED-1174': [('urinary biomonitoring', 0.4994),\n",
       "  ('dietary organophosphorus', 0.4815),\n",
       "  ('children urinary', 0.4593),\n",
       "  ('pesticides provides', 0.4031),\n",
       "  ('children exposure', 0.3896),\n",
       "  ('15 day', 0.3812),\n",
       "  ('daily urine', 0.3738),\n",
       "  ('effect exposures', 0.373),\n",
       "  ('measure dietary', 0.3679),\n",
       "  ('biomonitoring substituted', 0.3441),\n",
       "  ('concentrations specific', 0.2977),\n",
       "  ('substituted children', 0.2809),\n",
       "  ('school age', 0.2772),\n",
       "  ('metabolites frequent', 0.2679),\n",
       "  ('malathion chlorpyrifos', 0.2678),\n",
       "  ('introduction organic', 0.2678),\n",
       "  ('23 elementary', 0.2544),\n",
       "  ('chlorpyrifos decreased', 0.2494),\n",
       "  ('consumption days', 0.2466),\n",
       "  ('diets reintroduced', 0.2458),\n",
       "  ('day study', 0.2448),\n",
       "  ('exclusively diet', 0.2256),\n",
       "  ('concluded children', 0.2223),\n",
       "  ('design measure', 0.2094),\n",
       "  ('metabolites lower', 0.1909),\n",
       "  ('nondetect levels', 0.1894),\n",
       "  ('bedtime voids', 0.1825),\n",
       "  ('effectiveness intervention', 0.1824),\n",
       "  ('samples morning', 0.1791),\n",
       "  ('knowledge study', 0.1767),\n",
       "  ('children conventional', 0.1734),\n",
       "  ('collected', 0.1545),\n",
       "  ('levels immediately', 0.1432),\n",
       "  ('elementary', 0.1265),\n",
       "  ('frequent statistical', 0.1233),\n",
       "  ('significance conclusion', 0.1196),\n",
       "  ('used agricultural', 0.116),\n",
       "  ('detection', 0.1109),\n",
       "  ('protective', 0.1108),\n",
       "  ('spot daily', 0.1094),\n",
       "  ('group', 0.0949),\n",
       "  ('production concluded', 0.0949),\n",
       "  ('used novel', 0.0907),\n",
       "  ('used', 0.0899),\n",
       "  ('assess', 0.0877),\n",
       "  ('longitudinal design', 0.0845),\n",
       "  ('reintroduced median', 0.0726),\n",
       "  ('provides', 0.0428),\n",
       "  ('items consecutive', 0.0088),\n",
       "  ('remained', -0.0217)],\n",
       " 'MED-1175': [('included studies', 0.542),\n",
       "  ('exposure analyses', 0.4514),\n",
       "  ('sources searches', 0.4277),\n",
       "  ('data extraction', 0.4115),\n",
       "  ('conducted systematic', 0.3876),\n",
       "  ('independently abstracted', 0.3441),\n",
       "  ('medline 1950', 0.3225),\n",
       "  ('odds ratios', 0.3187),\n",
       "  ('confidence intervals', 0.2951),\n",
       "  ('models used', 0.2867),\n",
       "  ('random effects', 0.2846),\n",
       "  ('research childhood', 0.2798),\n",
       "  ('yielded 31', 0.2787),\n",
       "  ('susceptibility assessment', 0.2726),\n",
       "  ('stronger studies', 0.2539),\n",
       "  ('objectives conducted', 0.2508),\n",
       "  ('obtain summary', 0.2436),\n",
       "  ('authors independently', 0.2414),\n",
       "  ('elevated risks', 0.2394),\n",
       "  ('ors 95', 0.2327),\n",
       "  ('improved pesticide', 0.2283),\n",
       "  ('collected offspring', 0.217),\n",
       "  ('04 herbicides', 0.1946),\n",
       "  ('89 childhood', 0.1917),\n",
       "  ('maternal occupational', 0.1861),\n",
       "  ('leukemia paternal', 0.1774),\n",
       "  ('meta', 0.1667),\n",
       "  ('overall association', 0.1659),\n",
       "  ('85 exposure', 0.1635),\n",
       "  ('time windows', 0.1613),\n",
       "  ('88 34', 0.1612),\n",
       "  ('assessment basic', 0.1506),\n",
       "  ('confounder', 0.1424),\n",
       "  ('genetic', 0.1411),\n",
       "  ('windows 36', 0.1391),\n",
       "  ('low total', 0.1373),\n",
       "  ('total quality', 0.1314),\n",
       "  ('ci 53', 0.1234),\n",
       "  ('subgroups', 0.1196),\n",
       "  ('indices continued', 0.1165),\n",
       "  ('follow existing', 0.1131),\n",
       "  ('scores 39', 0.1076),\n",
       "  ('ill defined', 0.1055),\n",
       "  ('62 farm', 0.0966),\n",
       "  ('yielded', 0.0673),\n",
       "  ('electronic', 0.0652),\n",
       "  ('control scores', 0.0439),\n",
       "  ('10 conclusions', 0.0165),\n",
       "  ('slightly stronger', -0.0023),\n",
       "  ('70', -0.0218)],\n",
       " 'MED-1176': [('pesticides neurodevelopmental', 0.5985),\n",
       "  ('investigated neurodevelopmental', 0.5409),\n",
       "  ('organophosphate op', 0.4592),\n",
       "  ('studies investigated', 0.4394),\n",
       "  ('childhood exposures', 0.4166),\n",
       "  ('understand effects', 0.3618),\n",
       "  ('neonates meta', 0.3486),\n",
       "  ('mainly toddlers', 0.3459),\n",
       "  ('decade op', 0.3446),\n",
       "  ('assessed prenatal', 0.3281),\n",
       "  ('meta analysis', 0.3266),\n",
       "  ('induces neurotoxic', 0.3006),\n",
       "  ('deficits associated', 0.2959),\n",
       "  ('ops cognitive', 0.292),\n",
       "  ('sources pubmed', 0.2826),\n",
       "  ('research needed', 0.2666),\n",
       "  ('children growing', 0.2461),\n",
       "  ('age published', 0.2367),\n",
       "  ('measurements exposure', 0.2354),\n",
       "  ('reviewed collectively', 0.235),\n",
       "  ('development', 0.2288),\n",
       "  ('14 studies', 0.2239),\n",
       "  ('data sources', 0.2211),\n",
       "  ('seven articles', 0.2168),\n",
       "  ('present article', 0.1959),\n",
       "  ('related working', 0.1877),\n",
       "  ('dose response', 0.1874),\n",
       "  ('years behavioral', 0.1792),\n",
       "  ('negative effects', 0.1775),\n",
       "  ('science ebsco', 0.1731),\n",
       "  ('windows development', 0.1682),\n",
       "  ('evidence neurological', 0.1671),\n",
       "  ('evaluated aim', 0.154),\n",
       "  ('abnormal reflexes', 0.1492),\n",
       "  ('measures 27', 0.1293),\n",
       "  ('different', 0.1255),\n",
       "  ('longitudinal rated', 0.1238),\n",
       "  ('scielo', 0.111),\n",
       "  ('working memory', 0.1072),\n",
       "  ('web', 0.0982),\n",
       "  ('rated low', 0.0917),\n",
       "  ('springerlink', 0.0539),\n",
       "  ('induces', 0.0276),\n",
       "  ('number participants', 0.024),\n",
       "  ('support hypothesis', 0.0222),\n",
       "  ('18 years', 0.0214),\n",
       "  ('2012 english', 0.0188),\n",
       "  ('attention seen', 0.0116),\n",
       "  ('doaj eligibility', 0.0058),\n",
       "  ('spanish', -0.0769)],\n",
       " 'MED-1177': [('systematic review', 0.5649),\n",
       "  ('risk estimates', 0.4828),\n",
       "  ('publications english', 0.4525),\n",
       "  ('exposure pesticides', 0.4388),\n",
       "  ('searched medline', 0.4313),\n",
       "  ('studies association', 0.4148),\n",
       "  ('publications extraction', 0.3931),\n",
       "  ('effect models', 0.3775),\n",
       "  ('exposure mrr', 0.3646),\n",
       "  ('list identified', 0.3165),\n",
       "  ('results rr', 0.3089),\n",
       "  ('leukaemia strongest', 0.29),\n",
       "  ('authors using', 0.2655),\n",
       "  ('published', 0.2608),\n",
       "  ('ci 92', 0.2545),\n",
       "  ('separate analyses', 0.2487),\n",
       "  ('extraction relative', 0.2475),\n",
       "  ('indoor exposure', 0.2435),\n",
       "  ('21 exposure', 0.2343),\n",
       "  ('control studies', 0.234),\n",
       "  ('provide quantitative', 0.2304),\n",
       "  ('random effect', 0.2206),\n",
       "  ('respectively conclusions', 0.2098),\n",
       "  ('significantly associated', 0.1962),\n",
       "  ('decrease use', 0.194),\n",
       "  ('preventive actions', 0.18),\n",
       "  ('19 95', 0.1751),\n",
       "  ('meta', 0.1583),\n",
       "  ('data scarce', 0.158),\n",
       "  ('findings support', 0.1576),\n",
       "  ('1966', 0.1561),\n",
       "  ('mrr 16', 0.1522),\n",
       "  ('ascertainment opportune', 0.1498),\n",
       "  ('location biocide', 0.1218),\n",
       "  ('non lymphocytic', 0.1119),\n",
       "  ('mrr 74', 0.1014),\n",
       "  ('1987 2009', 0.0996),\n",
       "  ('including educational', 0.0943),\n",
       "  ('conducted stratification', 0.0918),\n",
       "  ('2010 elsevier', 0.085),\n",
       "  ('children', 0.0767),\n",
       "  ('windows', 0.0744),\n",
       "  ('45 outdoor', 0.0655),\n",
       "  ('ci 37', 0.0654),\n",
       "  ('mrr 30', 0.0614),\n",
       "  ('residential purposes', 0.06),\n",
       "  ('pregnancy copyright', 0.0512),\n",
       "  ('december', 0.0507),\n",
       "  ('anll', 0.0417),\n",
       "  ('53', 0.0301)],\n",
       " 'MED-1178': [('review evidence', 0.5074),\n",
       "  ('organic foods', 0.5025),\n",
       "  ('published literature', 0.4242),\n",
       "  ('diets studies', 0.4145),\n",
       "  ('foods unclear', 0.4131),\n",
       "  ('literature lacks', 0.3897),\n",
       "  ('cochrane library', 0.3665),\n",
       "  ('limitation studies', 0.3113),\n",
       "  ('foods reduce', 0.2981),\n",
       "  ('english language', 0.2945),\n",
       "  ('infection studies', 0.283),\n",
       "  ('reports comparisons', 0.2788),\n",
       "  ('extracted data', 0.2622),\n",
       "  ('medline january', 0.2543),\n",
       "  ('studies humans', 0.2449),\n",
       "  ('nutrient contaminant', 0.2413),\n",
       "  ('health benefits', 0.234),\n",
       "  ('2009 bibliographies', 0.2106),\n",
       "  ('did differ', 0.2005),\n",
       "  ('effects', 0.1992),\n",
       "  ('farming method', 0.1871),\n",
       "  ('synthesis', 0.1684),\n",
       "  ('embase cab', 0.1679),\n",
       "  ('lower urinary', 0.1591),\n",
       "  ('higher conventional', 0.1558),\n",
       "  ('pork risk', 0.1551),\n",
       "  ('small escherichia', 0.1505),\n",
       "  ('retail chicken', 0.1441),\n",
       "  ('campylobacter infection', 0.1439),\n",
       "  ('differences populations', 0.1343),\n",
       "  ('met inclusion', 0.132),\n",
       "  ('17 studies', 0.1293),\n",
       "  ('agricola toxnet', 0.1284),\n",
       "  ('did identify', 0.1271),\n",
       "  ('unrelated', 0.121),\n",
       "  ('eczema wheeze', 0.1152),\n",
       "  ('january 1966', 0.1081),\n",
       "  ('primary funding', 0.1028),\n",
       "  ('resistant antibiotics', 0.0936),\n",
       "  ('adults did', 0.0914),\n",
       "  ('33 ci', 0.0908),\n",
       "  ('children', 0.0829),\n",
       "  ('allowed limits', 0.0773),\n",
       "  ('humans 223', 0.0752),\n",
       "  ('common', 0.064),\n",
       "  ('library', 0.0613),\n",
       "  ('breast', 0.0208),\n",
       "  ('21 45', 0.0053),\n",
       "  ('reported significantly', 0.0016),\n",
       "  ('milk semen', -0.021)],\n",
       " 'MED-1179': [('organic foods', 0.6334),\n",
       "  ('supermarkets organic', 0.555),\n",
       "  ('organic reviews', 0.505),\n",
       "  ('products contain', 0.4498),\n",
       "  ('dietary variety', 0.3812),\n",
       "  ('diets convincingly', 0.3793),\n",
       "  ('disease organic', 0.3598),\n",
       "  ('food production', 0.3544),\n",
       "  ('promoting effects', 0.309),\n",
       "  ('specialty stores', 0.3085),\n",
       "  ('labeling standards', 0.2984),\n",
       "  ('conventional supermarkets', 0.2941),\n",
       "  ('regulated terms', 0.2931),\n",
       "  ('expose consumers', 0.279),\n",
       "  ('production contaminants', 0.2789),\n",
       "  ('deficits eating', 0.2657),\n",
       "  ('farming studies', 0.2576),\n",
       "  ('trade association', 0.2529),\n",
       "  ('consumption defines', 0.2525),\n",
       "  ('variety consistent', 0.2343),\n",
       "  ('reviews health', 0.234),\n",
       "  ('benefits deficits', 0.2279),\n",
       "  ('market', 0.226),\n",
       "  ('pediatricians incorporate', 0.2234),\n",
       "  ('grown billion', 0.2128),\n",
       "  ('consumers fewer', 0.1977),\n",
       "  ('quality', 0.1967),\n",
       "  ('premium designed', 0.1943),\n",
       "  ('agriculture myplate', 0.1924),\n",
       "  ('advantages', 0.1909),\n",
       "  ('conventionally produced', 0.1765),\n",
       "  ('practices', 0.1703),\n",
       "  ('disease promoting', 0.164),\n",
       "  ('1996', 0.1581),\n",
       "  ('environmental impact', 0.1555),\n",
       "  ('report provides', 0.1551),\n",
       "  ('fewer pesticides', 0.1541),\n",
       "  ('costs competitive', 0.1421),\n",
       "  ('conventional approaches', 0.1327),\n",
       "  ('evidence available', 0.1276),\n",
       "  ('yields comparable', 0.1257),\n",
       "  ('2010 according', 0.1203),\n",
       "  ('human studies', 0.08),\n",
       "  ('patients families', 0.0754),\n",
       "  ('convincingly demonstrated', 0.062),\n",
       "  ('28', 0.0437),\n",
       "  ('protection result', 0.0304),\n",
       "  ('does support', 0.0198),\n",
       "  ('discussing', 0.0086),\n",
       "  ('powered human', -0.032)],\n",
       " 'MED-1180': [('antioxidants strawberries', 0.5233),\n",
       "  ('strawberry extracts', 0.511),\n",
       "  ('antioxidants analyzed', 0.4989),\n",
       "  ('effects extracts', 0.4406),\n",
       "  ('strawberries ht29', 0.4111),\n",
       "  ('extracts cancer', 0.3702),\n",
       "  ('cells extracts', 0.3529),\n",
       "  ('extracts range', 0.3495),\n",
       "  ('extracts decreased', 0.3234),\n",
       "  ('extracts organically', 0.3163),\n",
       "  ('ascorbate cancer', 0.3134),\n",
       "  ('secondary metabolites', 0.3114),\n",
       "  ('organic cultivation', 0.3108),\n",
       "  ('higher antiproliferative', 0.2924),\n",
       "  ('cultivation compared', 0.2825),\n",
       "  ('metabolites anticarcinogenic', 0.277),\n",
       "  ('higher organically', 0.2766),\n",
       "  ('correlations levels', 0.2757),\n",
       "  ('mcf investigated', 0.2432),\n",
       "  ('action compounds', 0.2198),\n",
       "  ('ht29 cells', 0.2064),\n",
       "  ('cells dose', 0.2021),\n",
       "  ('synergistic action', 0.2017),\n",
       "  ('cultivars', 0.1996),\n",
       "  ('addition effects', 0.198),\n",
       "  ('investigated possible', 0.1868),\n",
       "  ('compared controls', 0.1814),\n",
       "  ('proliferation investigated', 0.1682),\n",
       "  ('compared conventional', 0.1491),\n",
       "  ('colon', 0.1408),\n",
       "  ('significance effect', 0.1352),\n",
       "  ('conventionally grown', 0.1332),\n",
       "  ('decreased proliferation', 0.1267),\n",
       "  ('dehydroascorbate significantly', 0.1248),\n",
       "  ('inhibition compared', 0.1224),\n",
       "  ('levels', 0.1188),\n",
       "  ('cells negative', 0.1107),\n",
       "  ('vitamin', 0.1088),\n",
       "  ('negative correlation', 0.1029),\n",
       "  ('types highest', 0.0779),\n",
       "  ('concentration conventionally', 0.0703),\n",
       "  ('average 53', 0.0673),\n",
       "  ('properties', 0.0563),\n",
       "  ('breast cancer', 0.0545),\n",
       "  ('activity cell', 0.0384),\n",
       "  ('26 56', 0.0002),\n",
       "  ('dependent way', -0.0087),\n",
       "  ('range 41', -0.0254),\n",
       "  ('lie', -0.1001),\n",
       "  ('second highest', -0.128)],\n",
       " 'MED-1181': [('organic foods', 0.5325),\n",
       "  ('nutritional differences', 0.5083),\n",
       "  ('perceptions nutritious', 0.486),\n",
       "  ('meta analyses', 0.4181),\n",
       "  ('nutritious scientific', 0.4162),\n",
       "  ('reviews concluded', 0.3772),\n",
       "  ('foods recent', 0.3554),\n",
       "  ('studies additionally', 0.332),\n",
       "  ('scientific opinion', 0.3318),\n",
       "  ('non organic', 0.3106),\n",
       "  ('consumers perceptions', 0.3041),\n",
       "  ('significant differences', 0.2703),\n",
       "  ('acids', 0.2698),\n",
       "  ('343 peer', 0.2605),\n",
       "  ('minerals vitamins', 0.26),\n",
       "  ('conventional crops', 0.2298),\n",
       "  ('peer reviewed', 0.2279),\n",
       "  ('evidence higher', 0.2272),\n",
       "  ('range antioxidants', 0.2251),\n",
       "  ('mineral fertilisers', 0.2189),\n",
       "  ('comparators', 0.1974),\n",
       "  ('regions production', 0.1923),\n",
       "  ('phenolic', 0.1846),\n",
       "  ('flavones flavonols', 0.1816),\n",
       "  ('intervention epidemiological', 0.1805),\n",
       "  ('present study', 0.1799),\n",
       "  ('linked reduced', 0.164),\n",
       "  ('compounds previously', 0.1517),\n",
       "  ('publications indicate', 0.1433),\n",
       "  ('certain cancers', 0.1326),\n",
       "  ('systems', 0.1237),\n",
       "  ('residues times', 0.119),\n",
       "  ('non use', 0.1162),\n",
       "  ('contained significantly', 0.113),\n",
       "  ('seasons', 0.1054),\n",
       "  ('including cvd', 0.0986),\n",
       "  ('neurodegenerative diseases', 0.0915),\n",
       "  ('stilbenes', 0.0906),\n",
       "  ('meaningful', 0.0849),\n",
       "  ('69', 0.0743),\n",
       "  ('44', 0.0687),\n",
       "  ('additionally frequency', 0.065),\n",
       "  ('chronic', 0.0606),\n",
       "  ('toxic metal', 0.0597),\n",
       "  ('partially', 0.0364),\n",
       "  ('51 95', 0.0243),\n",
       "  ('17', 0.0183),\n",
       "  ('26', -0.0065),\n",
       "  ('86 higher', -0.0163),\n",
       "  ('ci 12', -0.0199)],\n",
       " 'MED-1182': [('organic farms', 0.6534),\n",
       "  ('farms produce', 0.5673),\n",
       "  ('fruit soil', 0.5221),\n",
       "  ('farmed soils', 0.4749),\n",
       "  ('agroecosystems', 0.4614),\n",
       "  ('foods fastest', 0.4412),\n",
       "  ('counterparts organically', 0.4137),\n",
       "  ('produce nutritious', 0.4088),\n",
       "  ('varieties strawberries', 0.398),\n",
       "  ('global food', 0.347),\n",
       "  ('healthier soils', 0.3441),\n",
       "  ('evaluated varieties', 0.3372),\n",
       "  ('california', 0.2952),\n",
       "  ('people buy', 0.2898),\n",
       "  ('phenolic compounds', 0.2816),\n",
       "  ('fastest growing', 0.2662),\n",
       "  ('diversity biogeochemical', 0.2622),\n",
       "  ('sensory panels', 0.2565),\n",
       "  ('better tasting', 0.2451),\n",
       "  ('higher quality', 0.2316),\n",
       "  ('total carbon', 0.2191),\n",
       "  ('flavor overall', 0.2184),\n",
       "  ('nitrogen greater', 0.2118),\n",
       "  ('microbial', 0.2112),\n",
       "  ('findings justify', 0.2054),\n",
       "  ('conventional counterparts', 0.1981),\n",
       "  ('industry people', 0.175),\n",
       "  ('longer shelf', 0.1703),\n",
       "  ('produced', 0.1696),\n",
       "  ('analyzed traditional', 0.1665),\n",
       "  ('life phytochemical', 0.1614),\n",
       "  ('pesticide degradation', 0.1597),\n",
       "  ('potassium variety', 0.1569),\n",
       "  ('concentrations micronutrients', 0.145),\n",
       "  ('ascorbic acid', 0.1448),\n",
       "  ('significant differences', 0.1447),\n",
       "  ('overall acceptance', 0.1429),\n",
       "  ('endemic genes', 0.1357),\n",
       "  ('13 pairs', 0.1326),\n",
       "  ('dry matter', 0.0969),\n",
       "  ('organoleptic properties', 0.0861),\n",
       "  ('resilience stress', 0.084),\n",
       "  ('functional capability', 0.0827),\n",
       "  ('quantifying effects', 0.079),\n",
       "  ('methodology principal', 0.0788),\n",
       "  ('dna using', 0.0718),\n",
       "  ('times years', 0.0577),\n",
       "  ('microarray technology', 0.0408),\n",
       "  ('additional investigations', 0.0267),\n",
       "  ('interactions', -0.0099)],\n",
       " 'MED-1184': [('bacteria sulfide', 0.566),\n",
       "  ('feces patients', 0.5617),\n",
       "  ('colitis uniformly', 0.4902),\n",
       "  ('ulcerative colitis', 0.4861),\n",
       "  ('cultured colonocytes', 0.4808),\n",
       "  ('nacl sulfide', 0.448),\n",
       "  ('reducing bacteria', 0.4426),\n",
       "  ('bacteria interferes', 0.416),\n",
       "  ('produced bacteria', 0.4012),\n",
       "  ('butyrate mucosal', 0.3988),\n",
       "  ('polyps', 0.3789),\n",
       "  ('contain sulfate', 0.3694),\n",
       "  ('regulation colonic', 0.3616),\n",
       "  ('bowel', 0.3549),\n",
       "  ('rectum', 0.3286),\n",
       "  ('pathogenesis uc', 0.3176),\n",
       "  ('mucosal', 0.3046),\n",
       "  ('10 patients', 0.288),\n",
       "  ('mucosal hyperproliferation', 0.2865),\n",
       "  ('compared nacl', 0.2779),\n",
       "  ('metabolism cultured', 0.2479),\n",
       "  ('biopsies', 0.2232),\n",
       "  ('sigmoid', 0.213),\n",
       "  ('disease incubated', 0.1898),\n",
       "  ('reversed samples', 0.1821),\n",
       "  ('hyperproliferation reversed', 0.1796),\n",
       "  ('05 effect', 0.1564),\n",
       "  ('sodium hydrogen', 0.1453),\n",
       "  ('inflammatory', 0.1425),\n",
       "  ('crypt significantly', 0.1348),\n",
       "  ('study shows', 0.1272),\n",
       "  ('assessed bromodeoxyuridine', 0.1251),\n",
       "  ('uc confirm', 0.1248),\n",
       "  ('patients caner', 0.1177),\n",
       "  ('support possible', 0.1142),\n",
       "  ('cells', 0.1119),\n",
       "  ('mmol combination', 0.1011),\n",
       "  ('treatment', 0.0856),\n",
       "  ('samples coincubated', 0.0816),\n",
       "  ('19 05', 0.0813),\n",
       "  ('uniformly contain', 0.0701),\n",
       "  ('interferes', 0.0536),\n",
       "  ('significantly', 0.0516),\n",
       "  ('proliferation 54', 0.0476),\n",
       "  ('dependent energy', 0.036),\n",
       "  ('shows', 0.0341),\n",
       "  ('labeling entire', 0.0135),\n",
       "  ('phase compared', -0.0197),\n",
       "  ('compartments increase', -0.0394),\n",
       "  ('zone upper', -0.0805)],\n",
       " 'MED-1185': [('acids sulfites', 0.6474),\n",
       "  ('endogenous sulfite', 0.5889),\n",
       "  ('sulfur containing', 0.5425),\n",
       "  ('sulfiting', 0.5214),\n",
       "  ('so2 generated', 0.3547),\n",
       "  ('additives', 0.3504),\n",
       "  ('containing foods', 0.319),\n",
       "  ('amino', 0.3154),\n",
       "  ('beverages deficiency', 0.3137),\n",
       "  ('spoilage bleaching', 0.3007),\n",
       "  ('gastrointestinal signs', 0.2968),\n",
       "  ('agents used', 0.2934),\n",
       "  ('1664 approved', 0.2894),\n",
       "  ('understand substances', 0.2874),\n",
       "  ('controlling microbial', 0.2737),\n",
       "  ('consequence fermentation', 0.251),\n",
       "  ('generated stomach', 0.2407),\n",
       "  ('symptoms occur', 0.2364),\n",
       "  ('united states', 0.2169),\n",
       "  ('states long', 0.1994),\n",
       "  ('1800s', 0.1975),\n",
       "  ('endogenous', 0.1668),\n",
       "  ('adults predominantly', 0.1658),\n",
       "  ('regarded safe', 0.1566),\n",
       "  ('preventing browning', 0.1518),\n",
       "  ('normal processing', 0.142),\n",
       "  ('reactions mild', 0.1364),\n",
       "  ('use easy', 0.1275),\n",
       "  ('ago', 0.0969),\n",
       "  ('05 population', 0.0919),\n",
       "  ('immune response', 0.0866),\n",
       "  ('common sensitivity', 0.0837),\n",
       "  ('deficiency mitochondrial', 0.083),\n",
       "  ('widely ranging', 0.082),\n",
       "  ('severe majority', 0.0809),\n",
       "  ('greater risk', 0.0767),\n",
       "  ('words', 0.0752),\n",
       "  ('uncommonly reported', 0.0744),\n",
       "  ('occurs asthmatic', 0.0703),\n",
       "  ('nonasthmatics', 0.0674),\n",
       "  ('reported preschool', 0.0666),\n",
       "  ('enzyme ige', 0.065),\n",
       "  ('steroid dependent', 0.0528),\n",
       "  ('abstract truncated', 0.0413),\n",
       "  ('include dermatologic', 0.0392),\n",
       "  ('500 000', 0.037),\n",
       "  ('experiencing', 0.0252),\n",
       "  ('individuals live', 0.0211),\n",
       "  ('responses completely', 0.0095),\n",
       "  ('women', -0.0418)],\n",
       " 'MED-1186': [('rs diets', 0.6464),\n",
       "  ('diets wk', 0.5313),\n",
       "  ('metabolism subjects', 0.4181),\n",
       "  ('protein metabolism', 0.387),\n",
       "  ('starch', 0.379),\n",
       "  ('study consumed', 0.3613),\n",
       "  ('high rs', 0.3224),\n",
       "  ('rs markers', 0.3196),\n",
       "  ('macronutrients', 0.2941),\n",
       "  ('protein fermentation', 0.2928),\n",
       "  ('participated randomized', 0.2928),\n",
       "  ('consumed high', 0.2867),\n",
       "  ('suggest rs', 0.2821),\n",
       "  ('subjects', 0.2794),\n",
       "  ('crossover study', 0.2605),\n",
       "  ('markers colonic', 0.2586),\n",
       "  ('total nitrogen', 0.2546),\n",
       "  ('consumed', 0.246),\n",
       "  ('01 fecal', 0.2247),\n",
       "  ('results suggest', 0.2121),\n",
       "  ('wk', 0.2057),\n",
       "  ('daily excretion', 0.2003),\n",
       "  ('low rs', 0.1853),\n",
       "  ('39 chi', 0.1809),\n",
       "  ('investigated', 0.168),\n",
       "  ('69', 0.1589),\n",
       "  ('ammonia', 0.1565),\n",
       "  ('effect resistant', 0.153),\n",
       "  ('increased 84', 0.152),\n",
       "  ('period', 0.1386),\n",
       "  ('33', 0.1343),\n",
       "  ('001 daily', 0.1333),\n",
       "  ('attenuates accumulation', 0.1237),\n",
       "  ('concentrations', 0.1234),\n",
       "  ('fell mg', 0.1221),\n",
       "  ('49 microgram', 0.1042),\n",
       "  ('86 42', 0.0973),\n",
       "  ('15', 0.0863),\n",
       "  ('significantly ph', 0.0829),\n",
       "  ('chi sem', 0.0813),\n",
       "  ('harmful byproducts', 0.0809),\n",
       "  ('did change', 0.0712),\n",
       "  ('microgram', 0.0582),\n",
       "  ('phenols decreased', 0.0578),\n",
       "  ('10 microgram', 0.0517),\n",
       "  ('decreased 397', 0.0449),\n",
       "  ('05 high', 0.044),\n",
       "  ('kept', 0.0078),\n",
       "  ('human', -0.0138),\n",
       "  ('278', -0.0579)],\n",
       " 'MED-1187': [('uc patients', 0.5827),\n",
       "  ('pathogenesis uc', 0.5788),\n",
       "  ('relapse uc', 0.5044),\n",
       "  ('relapses ulcerative', 0.4866),\n",
       "  ('remission recruited', 0.4154),\n",
       "  ('colitis', 0.3846),\n",
       "  ('causes relapses', 0.382),\n",
       "  ('diet relapse', 0.3764),\n",
       "  ('uc methods', 0.3557),\n",
       "  ('modifiable dietary', 0.3219),\n",
       "  ('disease activity', 0.3219),\n",
       "  ('uc aim', 0.3191),\n",
       "  ('studies needed', 0.3061),\n",
       "  ('cohort study', 0.2815),\n",
       "  ('background aims', 0.2751),\n",
       "  ('implicated pathogenesis', 0.2589),\n",
       "  ('patients recruited', 0.2392),\n",
       "  ('factors associated', 0.2374),\n",
       "  ('methods prospective', 0.2314),\n",
       "  ('determine effect', 0.2298),\n",
       "  ('hospitals followed', 0.2014),\n",
       "  ('regression controlling', 0.167),\n",
       "  ('non dietary', 0.1626),\n",
       "  ('confidence intervals', 0.1551),\n",
       "  ('intake high', 0.1524),\n",
       "  ('categorised tertiles', 0.1424),\n",
       "  ('odds ratio', 0.1399),\n",
       "  ('cent patients', 0.1322),\n",
       "  ('determine sulphur', 0.1284),\n",
       "  ('habitual', 0.1177),\n",
       "  ('unknown', 0.117),\n",
       "  ('recruited 96', 0.1153),\n",
       "  ('questionnaire categorised', 0.0992),\n",
       "  ('compounds', 0.0921),\n",
       "  ('12 protein', 0.0859),\n",
       "  ('results total', 0.0828),\n",
       "  ('using validated', 0.0767),\n",
       "  ('reducing', 0.0749),\n",
       "  ('08', 0.069),\n",
       "  ('district general', 0.0648),\n",
       "  ('followed year', 0.059),\n",
       "  ('compared', 0.058),\n",
       "  ('alcoholic', 0.0565),\n",
       "  ('particularly red', 0.0509),\n",
       "  ('191', 0.0444),\n",
       "  ('observed increased', 0.019),\n",
       "  ('25 19', -0.0055),\n",
       "  ('processed meat', -0.0101),\n",
       "  ('controlling non', -0.0527),\n",
       "  ('ci 67', -0.0718)],\n",
       " 'MED-1188': [('000 inpatients', 0.4262),\n",
       "  ('hospitals access', 0.3853),\n",
       "  ('medical practice', 0.3626),\n",
       "  ('missionaries working', 0.3396),\n",
       "  ('number patients', 0.3392),\n",
       "  ('diagnostic facilities', 0.3337),\n",
       "  ('estimates incidence', 0.3246),\n",
       "  ('information medical', 0.3218),\n",
       "  ('75 mission', 0.3207),\n",
       "  ('25 hospitals', 0.3168),\n",
       "  ('1981 details', 0.3109),\n",
       "  ('patients seen', 0.3092),\n",
       "  ('eighteen missionaries', 0.2949),\n",
       "  ('diarrhoea 914', 0.2744),\n",
       "  ('914 typhoid', 0.263),\n",
       "  ('admitted year', 0.2621),\n",
       "  ('outpatients', 0.2575),\n",
       "  ('cases inflammatory', 0.2525),\n",
       "  ('diarrhoea typhoid', 0.2412),\n",
       "  ('treated included', 0.2395),\n",
       "  ('disease million', 0.2388),\n",
       "  ('859 cases', 0.2316),\n",
       "  ('collected total', 0.2264),\n",
       "  ('saharan african', 0.2039),\n",
       "  ('countries provided', 0.1927),\n",
       "  ('working', 0.1896),\n",
       "  ('seen admitted', 0.184),\n",
       "  ('provided information', 0.1813),\n",
       "  ('access facility', 0.1742),\n",
       "  ('stations', 0.1702),\n",
       "  ('facility frequency', 0.1629),\n",
       "  ('population', 0.1493),\n",
       "  ('disease ulcerative', 0.1423),\n",
       "  ('reliable estimates', 0.1255),\n",
       "  ('prevalence crohn', 0.1172),\n",
       "  ('000', 0.1149),\n",
       "  ('cases bloody', 0.1144),\n",
       "  ('24 sub', 0.1133),\n",
       "  ('support', 0.1071),\n",
       "  ('histological support', 0.0895),\n",
       "  ('914', 0.088),\n",
       "  ('limited access', 0.0651),\n",
       "  ('190 000', 0.033),\n",
       "  ('preceding year', 0.0312),\n",
       "  ('bowel', 0.0207),\n",
       "  ('included 12', 0.0138),\n",
       "  ('sub', -0.0284),\n",
       "  ('difficult', -0.0436),\n",
       "  ('west', -0.0553),\n",
       "  ('likely time', -0.0657)],\n",
       " 'MED-1190': [('cholesterol values', 0.4793),\n",
       "  ('free chd', 0.4555),\n",
       "  ('chd studies', 0.4525),\n",
       "  ('children low', 0.4271),\n",
       "  ('fat children', 0.3979),\n",
       "  ('hdl representative', 0.3445),\n",
       "  ('high children', 0.3412),\n",
       "  ('black africans', 0.3063),\n",
       "  ('heart disease', 0.2807),\n",
       "  ('measured birth', 0.2683),\n",
       "  ('low sufferers', 0.2668),\n",
       "  ('sufferers coronary', 0.2665),\n",
       "  ('94 mmol', 0.2558),\n",
       "  ('olds 60', 0.2527),\n",
       "  ('youth age', 0.2488),\n",
       "  ('children active', 0.2445),\n",
       "  ('olds 16', 0.2388),\n",
       "  ('values 96', 0.215),\n",
       "  ('representative population', 0.2115),\n",
       "  ('diet free', 0.2061),\n",
       "  ('56 54', 0.2012),\n",
       "  ('concentrations constitued', 0.1938),\n",
       "  ('traditional diet', 0.1912),\n",
       "  ('total serum', 0.1738),\n",
       "  ('studies', 0.1584),\n",
       "  ('mean values', 0.1524),\n",
       "  ('adults remain', 0.1474),\n",
       "  ('groups', 0.1364),\n",
       "  ('proportion constitutes', 0.1344),\n",
       "  ('old high', 0.1279),\n",
       "  ('10 12', 0.1182),\n",
       "  ('100 ml', 0.1043),\n",
       "  ('transvaal showed', 0.1041),\n",
       "  ('mmol 36', 0.103),\n",
       "  ('61', 0.0992),\n",
       "  ('47 total', 0.0843),\n",
       "  ('69 year', 0.0819),\n",
       "  ('rural south', 0.0697),\n",
       "  ('density', 0.0677),\n",
       "  ('did whites', 0.0446),\n",
       "  ('ml respectively', 0.0438),\n",
       "  ('live', 0.0398),\n",
       "  ('65 mg', 0.0373),\n",
       "  ('frugal traditional', 0.0343),\n",
       "  ('did fall', 0.0278),\n",
       "  ('western', 0.0274),\n",
       "  ('18', 0.0228),\n",
       "  ('high fibre', 0.0204),\n",
       "  ('45', -0.0152),\n",
       "  ('animal protein', -0.0794)],\n",
       " 'MED-1192': [('trials drugs', 0.5218),\n",
       "  ('reducing chd', 0.476),\n",
       "  ('lowering drugs', 0.4518),\n",
       "  ('cardiovascular disease', 0.4346),\n",
       "  ('quantitative efficacy', 0.4165),\n",
       "  ('cardioselective blockers', 0.4114),\n",
       "  ('meta analyses', 0.3858),\n",
       "  ('diastolic blood', 0.3834),\n",
       "  ('infarction risk', 0.3435),\n",
       "  ('pressure study', 0.3254),\n",
       "  ('disease guidelines', 0.321),\n",
       "  ('stroke 62', 0.3185),\n",
       "  ('efficacy different', 0.3183),\n",
       "  ('stroke blood', 0.3136),\n",
       "  ('strokes 108', 0.3043),\n",
       "  ('48 reduction', 0.3007),\n",
       "  ('selection randomised', 0.2953),\n",
       "  ('19 trials', 0.2926),\n",
       "  ('source medline', 0.287),\n",
       "  ('studied differences', 0.2834),\n",
       "  ('inhibitors angiotensin', 0.2712),\n",
       "  ('thiazides', 0.2703),\n",
       "  ('treatment 90', 0.2663),\n",
       "  ('cohort studies', 0.2644),\n",
       "  ('25 chd', 0.2581),\n",
       "  ('effective percentage', 0.2509),\n",
       "  ('confidence interval', 0.2347),\n",
       "  ('reduction 29', 0.2306),\n",
       "  ('main classes', 0.2258),\n",
       "  ('fell categories', 0.218),\n",
       "  ('control group', 0.2084),\n",
       "  ('46 stroke', 0.2063),\n",
       "  ('points preventing', 0.2054),\n",
       "  ('non cardioselective', 0.2001),\n",
       "  ('measuring treating', 0.1924),\n",
       "  ('data source', 0.1896),\n",
       "  ('28 calcium', 0.1832),\n",
       "  ('pleiotropic effects', 0.1792),\n",
       "  ('effect limited', 0.1777),\n",
       "  ('totalling 958', 0.1695),\n",
       "  ('interpreted context', 0.1614),\n",
       "  ('standard dose', 0.1608),\n",
       "  ('2007 study', 0.1512),\n",
       "  ('infarct 04', 0.1347),\n",
       "  ('34 compared', 0.1288),\n",
       "  ('recent', 0.1072),\n",
       "  ('events people', 0.1053),\n",
       "  ('aged 60', 0.1005),\n",
       "  ('compared 15', 0.0893),\n",
       "  ('10 mm', 0.034)],\n",
       " 'MED-1193': [('trials statin', 0.6252),\n",
       "  ('statins reduced', 0.5934),\n",
       "  ('reduce ldl', 0.4619),\n",
       "  ('cholesterol difference', 0.3768),\n",
       "  ('meta analysis', 0.373),\n",
       "  ('stroke reduction', 0.3641),\n",
       "  ('mortality rr', 0.3361),\n",
       "  ('vascular mortality', 0.3182),\n",
       "  ('reductions lowest', 0.3152),\n",
       "  ('revascularisations participants', 0.3027),\n",
       "  ('low risk', 0.2965),\n",
       "  ('22 trials', 0.2825),\n",
       "  ('trials versus', 0.2487),\n",
       "  ('0001 coronary', 0.2418),\n",
       "  ('event risk', 0.2157),\n",
       "  ('medical research', 0.2147),\n",
       "  ('remain uncertain', 0.2046),\n",
       "  ('guidelines need', 0.2018),\n",
       "  ('research council', 0.1886),\n",
       "  ('control 134', 0.1868),\n",
       "  ('effects people', 0.1814),\n",
       "  ('mmol median', 0.1807),\n",
       "  ('cancer incidence', 0.1683),\n",
       "  ('summary background', 0.1629),\n",
       "  ('follow years', 0.1431),\n",
       "  ('known hazards', 0.1203),\n",
       "  ('european community', 0.1125),\n",
       "  ('612 difference', 0.1088),\n",
       "  ('trend participants', 0.1012),\n",
       "  ('537 mean', 0.1001),\n",
       "  ('reconsidered funding', 0.0988),\n",
       "  ('therapy present', 0.0963),\n",
       "  ('85 95', 0.0959),\n",
       "  ('04 reflected', 0.0901),\n",
       "  ('individual participant', 0.0878),\n",
       "  ('participants separated', 0.0857),\n",
       "  ('foundation australia', 0.0676),\n",
       "  ('20 20', 0.0639),\n",
       "  ('reflected significant', 0.0629),\n",
       "  ('0012 similar', 0.0629),\n",
       "  ('british heart', 0.0612),\n",
       "  ('10 rr', 0.0593),\n",
       "  ('fatal myocardial', 0.0537),\n",
       "  ('sex baseline', 0.0428),\n",
       "  ('1000 years', 0.0381),\n",
       "  ('national health', 0.0244),\n",
       "  ('ci 36', 0.0198),\n",
       "  ('categories higher', 0.0185),\n",
       "  ('06 non', 0.0073),\n",
       "  ('69 99', -0.0204)],\n",
       " 'MED-1194': [('ncds mainly', 0.649),\n",
       "  ('prevent ncds', 0.6367),\n",
       "  ('diseases ncds', 0.6353),\n",
       "  ('ncds reducing', 0.633),\n",
       "  ('noncommunicable diseases', 0.5408),\n",
       "  ('precursors ncds', 0.5236),\n",
       "  ('cancers cardiovascular', 0.4985),\n",
       "  ('strategies prevent', 0.427),\n",
       "  ('cardiometabolic risk', 0.3994),\n",
       "  ('scale ncd', 0.3793),\n",
       "  ('diseases responsible', 0.3663),\n",
       "  ('deaths worldwide', 0.3582),\n",
       "  ('reducing dietary', 0.3479),\n",
       "  ('cancers', 0.3444),\n",
       "  ('respiratory diseases', 0.3378),\n",
       "  ('effective approaches', 0.3217),\n",
       "  ('need policies', 0.3075),\n",
       "  ('care reduces', 0.3053),\n",
       "  ('diseases diabetes', 0.3028),\n",
       "  ('thirds deaths', 0.2938),\n",
       "  ('countries urgent', 0.2865),\n",
       "  ('reducing major', 0.2608),\n",
       "  ('factors infections', 0.2541),\n",
       "  ('chronic', 0.2374),\n",
       "  ('primary care', 0.2273),\n",
       "  ('regulation designed', 0.2138),\n",
       "  ('comprehensive', 0.2031),\n",
       "  ('worldwide low', 0.2013),\n",
       "  ('major risk', 0.1931),\n",
       "  ('lowering prices', 0.1841),\n",
       "  ('alcohol control', 0.1831),\n",
       "  ('factors including', 0.1749),\n",
       "  ('sugars regulation', 0.1696),\n",
       "  ('control taxes', 0.1525),\n",
       "  ('tobacco', 0.136),\n",
       "  ('precursors', 0.1251),\n",
       "  ('approaches large', 0.1213),\n",
       "  ('dietary salt', 0.118),\n",
       "  ('unhealthy', 0.1152),\n",
       "  ('fats', 0.1085),\n",
       "  ('implementing universal', 0.1048),\n",
       "  ('fruits vegetables', 0.0927),\n",
       "  ('income countries', 0.0699),\n",
       "  ('scale', 0.0516),\n",
       "  ('improving availability', 0.04),\n",
       "  ('education increasing', 0.0109),\n",
       "  ('consumption fresh', -0.0021),\n",
       "  ('mainly', -0.0156),\n",
       "  ('public', -0.0722),\n",
       "  ('sales advertising', -0.1283)],\n",
       " 'MED-1195': [('symptoms antioxidant', 0.5132),\n",
       "  ('analyzed depressive', 0.4268),\n",
       "  ('symptoms measured', 0.424),\n",
       "  ('health questionnaire', 0.3477),\n",
       "  ('significant associations', 0.3124),\n",
       "  ('measured serum', 0.3119),\n",
       "  ('supplement use', 0.3023),\n",
       "  ('cutpoint 10', 0.3003),\n",
       "  ('carotenoids mainly', 0.2869),\n",
       "  ('covariates conclusion', 0.2497),\n",
       "  ('95 ci', 0.2092),\n",
       "  ('main analyses', 0.2014),\n",
       "  ('sectional data', 0.1968),\n",
       "  ('years analyzed', 0.1905),\n",
       "  ('associated reduced', 0.1816),\n",
       "  ('examination surveys', 0.1783),\n",
       "  ('score cutpoint', 0.177),\n",
       "  ('dose response', 0.1669),\n",
       "  ('85 years', 0.1641),\n",
       "  ('trend 035', 0.1611),\n",
       "  ('adults aged', 0.1605),\n",
       "  ('control dietary', 0.1603),\n",
       "  ('levels', 0.1524),\n",
       "  ('increase exposure', 0.1459),\n",
       "  ('quartiles q4', 0.1328),\n",
       "  ('using patient', 0.132),\n",
       "  ('design complexity', 0.1311),\n",
       "  ('data higher', 0.1309),\n",
       "  ('2005 06', 0.1274),\n",
       "  ('community dwelling', 0.1258),\n",
       "  ('aged 20', 0.1219),\n",
       "  ('μmol vs', 0.1215),\n",
       "  ('zeaxanthin intake', 0.1065),\n",
       "  ('overall sd', 0.1054),\n",
       "  ('men women', 0.0919),\n",
       "  ('zero inflated', 0.0722),\n",
       "  ('status cross', 0.0716),\n",
       "  ('retinol free', 0.0643),\n",
       "  ('final sample', 0.064),\n",
       "  ('models taking', 0.0634),\n",
       "  ('poisson regression', 0.047),\n",
       "  ('consisted multiple', 0.0422),\n",
       "  ('23', 0.0362),\n",
       "  ('q1', 0.0254),\n",
       "  ('62', 0.0007),\n",
       "  ('76', -0.0185),\n",
       "  ('37 overall', -0.0203),\n",
       "  ('esters', -0.0208),\n",
       "  ('consisted 798', -0.0356),\n",
       "  ('use independent', -0.0489)],\n",
       " 'MED-1196': [('diet depression', 0.6403),\n",
       "  ('studies diet', 0.5894),\n",
       "  ('overall diet', 0.5231),\n",
       "  ('studies depression', 0.5209),\n",
       "  ('nutrients aims', 0.4969),\n",
       "  ('cohort dietary', 0.4669),\n",
       "  ('depression 58', 0.4601),\n",
       "  ('association dietary', 0.4523),\n",
       "  ('background studies', 0.3461),\n",
       "  ('later food', 0.3202),\n",
       "  ('confounders participants', 0.3158),\n",
       "  ('high fat', 0.3013),\n",
       "  ('analyses carried', 0.2966),\n",
       "  ('3486 participants', 0.2817),\n",
       "  ('years whitehall', 0.2545),\n",
       "  ('sweetened desserts', 0.2543),\n",
       "  ('fried', 0.2515),\n",
       "  ('risk factor', 0.2411),\n",
       "  ('participants 26', 0.2407),\n",
       "  ('using overall', 0.2203),\n",
       "  ('ci 56', 0.2188),\n",
       "  ('loaded vegetables', 0.213),\n",
       "  ('58 95', 0.2103),\n",
       "  ('examine association', 0.2048),\n",
       "  ('95 ci', 0.2001),\n",
       "  ('dairy products', 0.1872),\n",
       "  ('refined grains', 0.1848),\n",
       "  ('assessed years', 0.1833),\n",
       "  ('pattern protective', 0.182),\n",
       "  ('center epidemiologic', 0.1783),\n",
       "  ('ces scale', 0.1661),\n",
       "  ('scale results', 0.1648),\n",
       "  ('identified', 0.1625),\n",
       "  ('women mean', 0.1604),\n",
       "  ('approach method', 0.1539),\n",
       "  ('focused primarily', 0.1436),\n",
       "  ('heavily loaded', 0.1403),\n",
       "  ('primarily individual', 0.132),\n",
       "  ('74', 0.1308),\n",
       "  ('self reported', 0.1287),\n",
       "  ('lowest tertile', 0.1235),\n",
       "  ('processed meat', 0.1188),\n",
       "  ('23 conclusions', 0.1179),\n",
       "  ('middle aged', 0.1),\n",
       "  ('ii', 0.0935),\n",
       "  ('highest tertile', 0.0827),\n",
       "  ('products self', 0.0805),\n",
       "  ('fish', 0.0503),\n",
       "  ('contrast high', 0.0371),\n",
       "  ('carried', -0.0033)],\n",
       " 'MED-1198': [('ascorbic acid', 0.5311),\n",
       "  ('aa modulates', 0.4857),\n",
       "  ('modulates catecholaminergic', 0.4093),\n",
       "  ('conclusions aa', 0.3943),\n",
       "  ('aa placebo', 0.3696),\n",
       "  ('women aa', 0.3437),\n",
       "  ('decreases stress', 0.3028),\n",
       "  ('mood methods', 0.2999),\n",
       "  ('young adults', 0.2941),\n",
       "  ('oxytocin', 0.2552),\n",
       "  ('vascular function', 0.2516),\n",
       "  ('acid', 0.2458),\n",
       "  ('trial results', 0.2457),\n",
       "  ('prolactin release', 0.2285),\n",
       "  ('vaginal', 0.2262),\n",
       "  ('cohabiting sexual', 0.2214),\n",
       "  ('placebo 39', 0.215),\n",
       "  ('benefit noncohabitants', 0.2138),\n",
       "  ('mg day', 0.1945),\n",
       "  ('stress reactivity', 0.1886),\n",
       "  ('activation disinhibition', 0.1877),\n",
       "  ('daily diaries', 0.1739),\n",
       "  ('42', 0.1724),\n",
       "  ('release processes', 0.1692),\n",
       "  ('masturbation daily', 0.1661),\n",
       "  ('controlled', 0.1649),\n",
       "  ('day cetebe', 0.1647),\n",
       "  ('suggests central', 0.1629),\n",
       "  ('processes relevant', 0.1596),\n",
       "  ('frequency effect', 0.1567),\n",
       "  ('mechanism responsible', 0.1507),\n",
       "  ('14 day', 0.1498),\n",
       "  ('improves', 0.1479),\n",
       "  ('approach anxiety', 0.1453),\n",
       "  ('background', 0.1429),\n",
       "  ('differential benefit', 0.14),\n",
       "  ('double', 0.1355),\n",
       "  ('young', 0.1276),\n",
       "  ('completed beck', 0.126),\n",
       "  ('3000', 0.1235),\n",
       "  ('partners recorded', 0.1143),\n",
       "  ('scores', 0.1093),\n",
       "  ('healthy', 0.1084),\n",
       "  ('depression inventory', 0.104),\n",
       "  ('group reported', 0.1038),\n",
       "  ('increase fsi', 0.0887),\n",
       "  ('prominent subjects', 0.084),\n",
       "  ('penile', 0.0512),\n",
       "  ('reported greater', 0.0449),\n",
       "  ('blind', 0.0264)],\n",
       " 'MED-1199': [('lycopene depressive', 0.564),\n",
       "  ('vegetables depressive', 0.5267),\n",
       "  ('carotenoids aim', 0.4729),\n",
       "  ('tomatoes tomato', 0.4701),\n",
       "  ('oxidative stress', 0.4283),\n",
       "  ('different vegetables', 0.4139),\n",
       "  ('powerful antioxidant', 0.3819),\n",
       "  ('depression scale', 0.3702),\n",
       "  ('prevention depressive', 0.3491),\n",
       "  ('symptoms limitations', 0.3225),\n",
       "  ('item geriatric', 0.2848),\n",
       "  ('older dietary', 0.2697),\n",
       "  ('stress defective', 0.2543),\n",
       "  ('symptoms increasing', 0.2489),\n",
       "  ('community dwelling', 0.2389),\n",
       "  ('using 30', 0.2365),\n",
       "  ('related pathogenesis', 0.2359),\n",
       "  ('intake assessed', 0.187),\n",
       "  ('symptoms 34', 0.1796),\n",
       "  ('potentially confounding', 0.1756),\n",
       "  ('aim study', 0.1674),\n",
       "  ('lower prevalence', 0.157),\n",
       "  ('history questionnaire', 0.1514),\n",
       "  ('similar relationships', 0.1497),\n",
       "  ('years', 0.12),\n",
       "  ('results suggest', 0.1192),\n",
       "  ('evaluated using', 0.1131),\n",
       "  ('valid self', 0.1078),\n",
       "  ('population', 0.1041),\n",
       "  ('background enhanced', 0.1031),\n",
       "  ('use', 0.0824),\n",
       "  ('defenses related', 0.0816),\n",
       "  ('products 00', 0.0799),\n",
       "  ('episodes conclusions', 0.0783),\n",
       "  ('20 respectively', 0.076),\n",
       "  ('anti', 0.07),\n",
       "  ('odds ratios', 0.0647),\n",
       "  ('scale cut', 0.0629),\n",
       "  ('respectively adjustments', 0.0628),\n",
       "  ('including 986', 0.0515),\n",
       "  ('major source', 0.0462),\n",
       "  ('elsevier rights', 0.0425),\n",
       "  ('analyzed cross', 0.0297),\n",
       "  ('japanese individuals', 0.0106),\n",
       "  ('kinds', 0.0069),\n",
       "  ('rich', 0.0004),\n",
       "  ('14 severe', -0.0034),\n",
       "  ('2012', -0.0154),\n",
       "  ('findings copyright', -0.0154),\n",
       "  ('aged 70', -0.0458)],\n",
       " 'MED-1200': [('oxidative stress', 0.6671),\n",
       "  ('trigger oxidative', 0.5664),\n",
       "  ('disorders factors', 0.5147),\n",
       "  ('implicated pathophysiology', 0.4726),\n",
       "  ('neuropsychiatric disorders', 0.4657),\n",
       "  ('depression genetic', 0.4657),\n",
       "  ('stress implicated', 0.4574),\n",
       "  ('cellular damage', 0.4539),\n",
       "  ('damage lipids', 0.4515),\n",
       "  ('using antioxidants', 0.3672),\n",
       "  ('schizophrenia', 0.3618),\n",
       "  ('abnormal neural', 0.349),\n",
       "  ('cellular levels', 0.3403),\n",
       "  ('patients psychiatric', 0.3328),\n",
       "  ('nongenetic factors', 0.3141),\n",
       "  ('therapeutics psychiatric', 0.3123),\n",
       "  ('factors trigger', 0.3111),\n",
       "  ('major depression', 0.31),\n",
       "  ('antioxidants pufas', 0.3014),\n",
       "  ('genetic', 0.2825),\n",
       "  ('leading abnormal', 0.2741),\n",
       "  ('increased cellular', 0.2677),\n",
       "  ('novel therapeutic', 0.2613),\n",
       "  ('proteins dna', 0.2483),\n",
       "  ('lipids', 0.2313),\n",
       "  ('cause increased', 0.2252),\n",
       "  ('mechanism patients', 0.2244),\n",
       "  ('functions reactive', 0.2225),\n",
       "  ('oxygen', 0.2169),\n",
       "  ('supplements treatment', 0.2121),\n",
       "  ('bipolar', 0.209),\n",
       "  ('dangerously interfere', 0.2037),\n",
       "  ('defense mechanism', 0.1935),\n",
       "  ('potential strategies', 0.1925),\n",
       "  ('excessive', 0.1911),\n",
       "  ('implicated', 0.164),\n",
       "  ('proteins', 0.1604),\n",
       "  ('outcomes using', 0.1545),\n",
       "  ('cautious use', 0.1491),\n",
       "  ('growth differentiation', 0.1451),\n",
       "  ('levels', 0.1443),\n",
       "  ('functions', 0.141),\n",
       "  ('treatment management', 0.14),\n",
       "  ('article overview', 0.1082),\n",
       "  ('long term', 0.105),\n",
       "  ('results time', 0.0784),\n",
       "  ('term', 0.0577),\n",
       "  ('species capacity', 0.0535),\n",
       "  ('provided promising', 0.0105),\n",
       "  ('present', 0.0061)],\n",
       " 'MED-1201': [('folate depression', 0.6604),\n",
       "  ('folate cohort', 0.5602),\n",
       "  ('depressive patients', 0.4739),\n",
       "  ('low dietary', 0.419),\n",
       "  ('prevention depression', 0.4156),\n",
       "  ('conclusions low', 0.4005),\n",
       "  ('studies focused', 0.3876),\n",
       "  ('hpl depression', 0.347),\n",
       "  ('sectional studies', 0.2797),\n",
       "  ('setting cohort', 0.277),\n",
       "  ('socioeconomic status', 0.2664),\n",
       "  ('follow period', 0.2614),\n",
       "  ('intake conclusions', 0.2517),\n",
       "  ('cobalamin receiving', 0.2472),\n",
       "  ('remained significant', 0.2363),\n",
       "  ('cohort 256', 0.2358),\n",
       "  ('methods studied', 0.2283),\n",
       "  ('vitamin total', 0.2268),\n",
       "  ('95 ci', 0.2169),\n",
       "  ('association dietary', 0.2019),\n",
       "  ('rr 04', 0.1981),\n",
       "  ('patients', 0.1926),\n",
       "  ('1989', 0.1857),\n",
       "  ('baseline hpl', 0.1813),\n",
       "  ('levels', 0.1777),\n",
       "  ('significant adjustment', 0.1653),\n",
       "  ('diagnosis', 0.1463),\n",
       "  ('getting discharge', 0.1314),\n",
       "  ('recruited 1984', 0.1291),\n",
       "  ('focused', 0.1279),\n",
       "  ('background cross', 0.1268),\n",
       "  ('60 years', 0.1202),\n",
       "  ('median energy', 0.1128),\n",
       "  ('results mean', 0.1117),\n",
       "  ('role prevention', 0.1104),\n",
       "  ('58 86', 0.1042),\n",
       "  ('published', 0.1005),\n",
       "  ('years', 0.0882),\n",
       "  ('blood', 0.079),\n",
       "  ('76 median', 0.0645),\n",
       "  ('2000 consisted', 0.0608),\n",
       "  ('313', 0.0596),\n",
       "  ('current', 0.0569),\n",
       "  ('microg day', 0.0303),\n",
       "  ('fibre', 0.0182),\n",
       "  ('factor severe', -0.0),\n",
       "  ('finland results', -0.0127),\n",
       "  ('men aged', -0.0155),\n",
       "  ('aged 42', -0.0773),\n",
       "  ('eastern', -0.1219)],\n",
       " 'MED-1202': [('depression folate', 0.571),\n",
       "  ('studies examined', 0.5496),\n",
       "  ('systematic review', 0.5077),\n",
       "  ('research contradictory', 0.4942),\n",
       "  ('depression research', 0.4883),\n",
       "  ('observational studies', 0.4822),\n",
       "  ('evidence low', 0.4547),\n",
       "  ('studies 15', 0.4522),\n",
       "  ('examined association', 0.444),\n",
       "  ('contradictory association', 0.4182),\n",
       "  ('confounding pooled', 0.3594),\n",
       "  ('research', 0.3404),\n",
       "  ('cohort study', 0.3288),\n",
       "  ('95 ci', 0.3248),\n",
       "  ('sectional studies', 0.32),\n",
       "  ('folate pooling', 0.3197),\n",
       "  ('controlled trials', 0.3192),\n",
       "  ('lower depression', 0.3154),\n",
       "  ('accumulating evidence', 0.3072),\n",
       "  ('reverse causality', 0.287),\n",
       "  ('examining risk', 0.2802),\n",
       "  ('odds ratio', 0.2489),\n",
       "  ('causal', 0.2389),\n",
       "  ('pooled adjusted', 0.2365),\n",
       "  ('confirm refute', 0.2288),\n",
       "  ('surveys', 0.2186),\n",
       "  ('chance bias', 0.214),\n",
       "  ('unadjusted 55', 0.2063),\n",
       "  ('examined', 0.1836),\n",
       "  ('relevant', 0.1817),\n",
       "  ('adjustment potential', 0.1759),\n",
       "  ('levels', 0.1675),\n",
       "  ('15 315', 0.1635),\n",
       "  ('11 relevant', 0.1539),\n",
       "  ('definitive randomised', 0.152),\n",
       "  ('remained', 0.1435),\n",
       "  ('studies seven', 0.1416),\n",
       "  ('test therapeutic', 0.1301),\n",
       "  ('participants', 0.1238),\n",
       "  ('showed significant', 0.1218),\n",
       "  ('42 95', 0.0792),\n",
       "  ('91 relationship', 0.0771),\n",
       "  ('control cross', 0.0719),\n",
       "  ('participants case', 0.0646),\n",
       "  ('population', 0.0511),\n",
       "  ('benefit', 0.0319),\n",
       "  ('presence', 0.023),\n",
       "  ('83', 0.019),\n",
       "  ('26', 0.0103),\n",
       "  ('ci 10', -0.0243)],\n",
       " 'MED-1203': [('mood disorders', 0.6189),\n",
       "  ('prevention disorders', 0.5604),\n",
       "  ('depressive symptomatology', 0.5581),\n",
       "  ('disorders lower', 0.5236),\n",
       "  ('disorders great', 0.3995),\n",
       "  ('epidemiological studies', 0.3945),\n",
       "  ('symptomatology general', 0.3505),\n",
       "  ('studies indicated', 0.3358),\n",
       "  ('low folate', 0.326),\n",
       "  ('disorder collected', 0.3226),\n",
       "  ('supplements feasible', 0.3106),\n",
       "  ('associated poor', 0.2918),\n",
       "  ('risk mood', 0.2798),\n",
       "  ('familial risk', 0.274),\n",
       "  ('later teenage', 0.2716),\n",
       "  ('levels adherence', 0.2512),\n",
       "  ('public health', 0.246),\n",
       "  ('dsm iv', 0.2423),\n",
       "  ('24 years', 0.2331),\n",
       "  ('early twenties', 0.2325),\n",
       "  ('mg daily', 0.226),\n",
       "  ('randomised folic', 0.2259),\n",
       "  ('evidence reduced', 0.222),\n",
       "  ('long term', 0.2052),\n",
       "  ('unwell limitations', 0.1947),\n",
       "  ('expected conclusions', 0.1875),\n",
       "  ('manifest later', 0.1798),\n",
       "  ('36 months', 0.1775),\n",
       "  ('participants aged', 0.1743),\n",
       "  ('acid delayed', 0.1711),\n",
       "  ('background', 0.1545),\n",
       "  ('aged 14', 0.1535),\n",
       "  ('months', 0.1469),\n",
       "  ('results incidence', 0.1253),\n",
       "  ('population method', 0.1216),\n",
       "  ('prognosis primary', 0.1144),\n",
       "  ('trial participants', 0.1133),\n",
       "  ('indicated links', 0.0848),\n",
       "  ('56', 0.0807),\n",
       "  ('tolerated', 0.0747),\n",
       "  ('years increased', 0.0706),\n",
       "  ('taking', 0.07),\n",
       "  ('placebo liquid', 0.0579),\n",
       "  ('double blind', 0.0564),\n",
       "  ('significant difference', 0.0378),\n",
       "  ('parallel group', 0.0368),\n",
       "  ('daily identical', 0.0354),\n",
       "  ('collected 112', -0.0022),\n",
       "  ('elsevier rights', -0.063),\n",
       "  ('17 respectively', -0.0647)],\n",
       " 'MED-1204': [('ruptured plaques', 0.5851),\n",
       "  ('atherosclerotic', 0.5609),\n",
       "  ('plaques observations', 0.483),\n",
       "  ('injuring plaque', 0.421),\n",
       "  ('dynamics plaque', 0.3995),\n",
       "  ('cardiovascular events', 0.3902),\n",
       "  ('morphologic characteristics', 0.3779),\n",
       "  ('alter cholesterol', 0.351),\n",
       "  ('rupture elucidate', 0.3485),\n",
       "  ('investigated transformation', 0.2706),\n",
       "  ('static histological', 0.2692),\n",
       "  ('images dynamics', 0.2666),\n",
       "  ('biological membranes', 0.2474),\n",
       "  ('erosion leading', 0.2444),\n",
       "  ('crystals damage', 0.2395),\n",
       "  ('acute cardiovascular', 0.2333),\n",
       "  ('events process', 0.2156),\n",
       "  ('observations suggest', 0.2077),\n",
       "  ('methods experiments', 0.2),\n",
       "  ('cut tore', 0.1985),\n",
       "  ('sharp edged', 0.19),\n",
       "  ('leading cause', 0.1862),\n",
       "  ('capable injuring', 0.184),\n",
       "  ('erosion novel', 0.1822),\n",
       "  ('background', 0.1713),\n",
       "  ('results', 0.1656),\n",
       "  ('determine growing', 0.1586),\n",
       "  ('strategies alter', 0.1561),\n",
       "  ('prevent', 0.1512),\n",
       "  ('volume changes', 0.1397),\n",
       "  ('01 did', 0.139),\n",
       "  ('20 40', 0.1366),\n",
       "  ('spatial', 0.132),\n",
       "  ('crystallization supersaturated', 0.1161),\n",
       "  ('microm path', 0.1132),\n",
       "  ('state measured', 0.1116),\n",
       "  ('development therapeutic', 0.1057),\n",
       "  ('vitro', 0.1016),\n",
       "  ('hypothesis hypothesized', 0.0992),\n",
       "  ('solid state', 0.0897),\n",
       "  ('growth 99', 0.0752),\n",
       "  ('cap hypothesis', 0.0715),\n",
       "  ('configuration rapidly', 0.0545),\n",
       "  ('correlated directly', 0.0456),\n",
       "  ('cylinders', 0.0443),\n",
       "  ('temperature', 0.044),\n",
       "  ('room', 0.0052),\n",
       "  ('timed second', -0.0003),\n",
       "  ('45 min', -0.0276),\n",
       "  ('graduated', -0.0781)],\n",
       " 'MED-1205': [('cholesterol crystals', 0.526),\n",
       "  ('carotid plaques', 0.5232),\n",
       "  ('plaque disruption', 0.504),\n",
       "  ('cholesterol expands', 0.4734),\n",
       "  ('cc perforations', 0.4635),\n",
       "  ('ccs damage', 0.4563),\n",
       "  ('plaques role', 0.4377),\n",
       "  ('unknown cholesterol', 0.43),\n",
       "  ('pd thrombus', 0.4178),\n",
       "  ('cardiovascular events', 0.4026),\n",
       "  ('ccs coronary', 0.3916),\n",
       "  ('0001 plaques', 0.3509),\n",
       "  ('crystallization tearing', 0.3337),\n",
       "  ('intima triggering', 0.3225),\n",
       "  ('fibrous tissues', 0.2977),\n",
       "  ('disruption pd', 0.278),\n",
       "  ('causes', 0.2705),\n",
       "  ('unfixed carotid', 0.2436),\n",
       "  ('syndrome perforating', 0.2339),\n",
       "  ('associated clinical', 0.2304),\n",
       "  ('avoiding ethanol', 0.1904),\n",
       "  ('dissolve', 0.1897),\n",
       "  ('solvents', 0.1854),\n",
       "  ('symptoms 0001', 0.1817),\n",
       "  ('confocal microscopy', 0.1786),\n",
       "  ('using vacuum', 0.1534),\n",
       "  ('enhanced detection', 0.1531),\n",
       "  ('strong associations', 0.1517),\n",
       "  ('dehydration significantly', 0.1463),\n",
       "  ('significantly higher', 0.1268),\n",
       "  ('patients died', 0.1206),\n",
       "  ('study tested', 0.1189),\n",
       "  ('degrees patients', 0.118),\n",
       "  ('size 02', 0.0807),\n",
       "  ('occur vivo', 0.0762),\n",
       "  ('examined 37', 0.0748),\n",
       "  ('tissues prepared', 0.0719),\n",
       "  ('unknown', 0.0681),\n",
       "  ('compared sem', 0.0672),\n",
       "  ('causes 12', 0.0623),\n",
       "  ('expands', 0.0598),\n",
       "  ('content using', 0.0558),\n",
       "  ('25', 0.053),\n",
       "  ('independent predictor', 0.045),\n",
       "  ('using light', 0.0254),\n",
       "  ('19 neurologic', 0.0111),\n",
       "  ('electron', -0.0053),\n",
       "  ('non acute', -0.0118),\n",
       "  ('53 vs', -0.0635),\n",
       "  ('46 0003', -0.1071)],\n",
       " 'MED-1207': [('inflammatory process', 0.6154),\n",
       "  ('plaque instability', 0.5486),\n",
       "  ('atherosclerosis copyright', 0.5464),\n",
       "  ('intimal injury', 0.5236),\n",
       "  ('underlying injurious', 0.4968),\n",
       "  ('rupture hypothesized', 0.4563),\n",
       "  ('acute coronary', 0.4127),\n",
       "  ('trigger causes', 0.3593),\n",
       "  ('injury saturated', 0.3559),\n",
       "  ('reactive protein', 0.3531),\n",
       "  ('response arterial', 0.3466),\n",
       "  ('induced cell', 0.3338),\n",
       "  ('lipid association', 0.3316),\n",
       "  ('statin therapy', 0.3218),\n",
       "  ('resulting accumulation', 0.3042),\n",
       "  ('signaling macrophages', 0.2857),\n",
       "  ('induce foam', 0.272),\n",
       "  ('apoptosis intracellular', 0.2679),\n",
       "  ('critical process', 0.264),\n",
       "  ('cholesterol crystallizes', 0.2538),\n",
       "  ('core vulnerable', 0.252),\n",
       "  ('leads formation', 0.2472),\n",
       "  ('model', 0.2461),\n",
       "  ('expansion tear', 0.2344),\n",
       "  ('rich necrotic', 0.2324),\n",
       "  ('time integral', 0.2307),\n",
       "  ('wall', 0.2305),\n",
       "  ('clinical syndrome', 0.225),\n",
       "  ('association published', 0.2219),\n",
       "  ('aspirin', 0.2196),\n",
       "  ('direct mechanism', 0.2131),\n",
       "  ('rabbit model', 0.1957),\n",
       "  ('cycle signaling', 0.194),\n",
       "  ('primed', 0.1939),\n",
       "  ('recent studies', 0.1839),\n",
       "  ('received attention', 0.1812),\n",
       "  ('extra cellular', 0.1728),\n",
       "  ('crystals perforating', 0.1466),\n",
       "  ('stage ii', 0.1426),\n",
       "  ('marker selecting', 0.1298),\n",
       "  ('patients died', 0.1187),\n",
       "  ('agents', 0.1176),\n",
       "  ('explain local', 0.1089),\n",
       "  ('protein reliable', 0.1011),\n",
       "  ('demonstrated high', 0.0944),\n",
       "  ('semi liquid', 0.0795),\n",
       "  ('cap observation', 0.0577),\n",
       "  ('ethanol dissolve', 0.0463),\n",
       "  ('published elsevier', 0.0381),\n",
       "  ('rights', -0.0166)],\n",
       " 'MED-1208': [('meals final', 0.397),\n",
       "  ('average meal', 0.3838),\n",
       "  ('studies food', 0.3692),\n",
       "  ('fascination meals', 0.3568),\n",
       "  ('macabre fascination', 0.3487),\n",
       "  ('true consumption', 0.3112),\n",
       "  ('67 desserts', 0.3062),\n",
       "  ('popular anecdotes', 0.2812),\n",
       "  ('2756 calories', 0.2654),\n",
       "  ('overconsumption findings', 0.2509),\n",
       "  ('analyses reveal', 0.2501),\n",
       "  ('servings', 0.2467),\n",
       "  ('fried', 0.2412),\n",
       "  ('temporal discounting', 0.2346),\n",
       "  ('catalog actual', 0.2249),\n",
       "  ('requests calorie', 0.2159),\n",
       "  ('beverages findings', 0.2027),\n",
       "  ('close zero', 0.1932),\n",
       "  ('247', 0.187),\n",
       "  ('contrast popular', 0.1848),\n",
       "  ('desires value', 0.1832),\n",
       "  ('rich', 0.1798),\n",
       "  ('obesity copyright', 0.1792),\n",
       "  ('studies created', 0.1607),\n",
       "  ('findings average', 0.154),\n",
       "  ('empirical', 0.1332),\n",
       "  ('states recent', 0.1213),\n",
       "  ('ill effects', 0.1212),\n",
       "  ('offers window', 0.1192),\n",
       "  ('period content', 0.119),\n",
       "  ('2012 elsevier', 0.1118),\n",
       "  ('daily recommended', 0.0998),\n",
       "  ('campaigns', 0.0991),\n",
       "  ('future', 0.0854),\n",
       "  ('case', 0.0816),\n",
       "  ('mediate feelings', 0.0724),\n",
       "  ('frequent requests', 0.0691),\n",
       "  ('branded', 0.0622),\n",
       "  ('60 39', 0.0591),\n",
       "  ('counterintuitively engage', 0.0475),\n",
       "  ('meat 83', 0.0314),\n",
       "  ('relating artificial', 0.0263),\n",
       "  ('rights reserved', 0.0237),\n",
       "  ('mortality salience', 0.0176),\n",
       "  ('individuals executed', 0.0051),\n",
       "  ('soft', 0.0036),\n",
       "  ('united', -0.0119),\n",
       "  ('model environmentally', -0.0207),\n",
       "  ('individual', -0.0291),\n",
       "  ('people warned', -0.1299)],\n",
       " 'MED-1209': [('habits adults', 0.5463),\n",
       "  ('lifestyle choices', 0.5133),\n",
       "  ('adherence healthy', 0.4801),\n",
       "  ('habits findings', 0.4748),\n",
       "  ('compare adherence', 0.4503),\n",
       "  ('regular exercise', 0.4432),\n",
       "  ('adherence decreased', 0.3526),\n",
       "  ('lifestyle lower', 0.3517),\n",
       "  ('healthy weight', 0.3417),\n",
       "  ('health', 0.3308),\n",
       "  ('associated cardiovascular', 0.3293),\n",
       "  ('nutrition examination', 0.2971),\n",
       "  ('diabetes', 0.2716),\n",
       "  ('trends', 0.2632),\n",
       "  ('12 times', 0.263),\n",
       "  ('individuals history', 0.2501),\n",
       "  ('mass index', 0.2446),\n",
       "  ('2001 2006', 0.2279),\n",
       "  ('history hypertension', 0.2277),\n",
       "  ('survey 1988', 0.2243),\n",
       "  ('maintaining', 0.2166),\n",
       "  ('smoking national', 0.2164),\n",
       "  ('years body', 0.2161),\n",
       "  ('alcohol consumption', 0.2142),\n",
       "  ('fruits vegetables', 0.2044),\n",
       "  ('disease mortality', 0.2039),\n",
       "  ('people conditions', 0.2025),\n",
       "  ('18 years', 0.1984),\n",
       "  ('decreases documented', 0.1979),\n",
       "  ('eating', 0.1851),\n",
       "  ('whites period', 0.1676),\n",
       "  ('gone 15', 0.1634),\n",
       "  ('minorities', 0.1594),\n",
       "  ('methods', 0.1524),\n",
       "  ('implications future', 0.1444),\n",
       "  ('men', 0.1404),\n",
       "  ('findings broad', 0.1399),\n",
       "  ('rates changed', 0.1328),\n",
       "  ('43 05', 0.1294),\n",
       "  ('women day', 0.125),\n",
       "  ('36', 0.12),\n",
       "  ('results national', 0.1172),\n",
       "  ('use increased', 0.1139),\n",
       "  ('index 30', 0.0937),\n",
       "  ('aged 40', 0.08),\n",
       "  ('risk', 0.0694),\n",
       "  ('51', 0.0656),\n",
       "  ('non hispanic', 0.0462),\n",
       "  ('1994 compared', 0.0357),\n",
       "  ('moderate', 0.0209)],\n",
       " 'MED-1210': [('diet quality', 0.5645),\n",
       "  ('poor diet', 0.5285),\n",
       "  ('health 2014', 0.451),\n",
       "  ('quality index', 0.3675),\n",
       "  ('index 2010', 0.3141),\n",
       "  ('ahei scores', 0.3047),\n",
       "  ('chronic disease', 0.3014),\n",
       "  ('years life', 0.2819),\n",
       "  ('poor', 0.267),\n",
       "  ('indices healthy', 0.2626),\n",
       "  ('indices lower', 0.2579),\n",
       "  ('risk factor', 0.2509),\n",
       "  ('assessed hei', 0.2412),\n",
       "  ('life lost', 0.2362),\n",
       "  ('mediterranean', 0.2244),\n",
       "  ('cvd 384', 0.2207),\n",
       "  ('12 years', 0.2057),\n",
       "  ('examined scores', 0.2008),\n",
       "  ('bloomberg school', 0.1885),\n",
       "  ('adjustment multiple', 0.187),\n",
       "  ('frequency questionnaire', 0.1868),\n",
       "  ('hazards models', 0.1845),\n",
       "  ('cancer indices', 0.1822),\n",
       "  ('stop hypertension', 0.173),\n",
       "  ('increasing quintiles', 0.1727),\n",
       "  ('26 lower', 0.17),\n",
       "  ('amed dash', 0.1623),\n",
       "  ('covariates having', 0.1595),\n",
       "  ('estimated multivariate', 0.1489),\n",
       "  ('observational study', 0.1483),\n",
       "  ('deaths occurred', 0.1473),\n",
       "  ('fit', 0.1472),\n",
       "  ('results suggest', 0.1272),\n",
       "  ('time metric', 0.1073),\n",
       "  ('commonly used', 0.102),\n",
       "  ('805 participants', 0.0907),\n",
       "  ('95 confidence', 0.0787),\n",
       "  ('including 483', 0.0785),\n",
       "  ('thought leading', 0.0727),\n",
       "  ('enrollment cox', 0.066),\n",
       "  ('postmenopausal women', 0.0513),\n",
       "  ('63', 0.041),\n",
       "  ('government', 0.0406),\n",
       "  ('20 23', 0.0278),\n",
       "  ('better', 0.0176),\n",
       "  ('public domain', 0.0032),\n",
       "  ('oxford university', -0.0022),\n",
       "  ('johns', -0.0024),\n",
       "  ('692', -0.0102),\n",
       "  ('significant 18', -0.0113)],\n",
       " 'MED-1211': [('health lifestyles', 0.6139),\n",
       "  ('healthy lifestyle', 0.5503),\n",
       "  ('prevalence health', 0.4817),\n",
       "  ('lifestyle characteristics', 0.4724),\n",
       "  ('prevalence healthy', 0.4303),\n",
       "  ('healthy weight', 0.4034),\n",
       "  ('lifestyles united', 0.3998),\n",
       "  ('trends prevalence', 0.3964),\n",
       "  ('trends results', 0.3941),\n",
       "  ('increase healthy', 0.3908),\n",
       "  ('used 1994', 0.3654),\n",
       "  ('1994 2007', 0.3465),\n",
       "  ('behavioral risk', 0.34),\n",
       "  ('lifestyles despite', 0.3322),\n",
       "  ('lifestyles increased', 0.3148),\n",
       "  ('activity prevalence', 0.3035),\n",
       "  ('factor surveillance', 0.3016),\n",
       "  ('states methods', 0.288),\n",
       "  ('consumption physical', 0.2691),\n",
       "  ('data behavioral', 0.2579),\n",
       "  ('characteristics having', 0.2569),\n",
       "  ('regions', 0.2407),\n",
       "  ('declines smoking', 0.2252),\n",
       "  ('overall', 0.2201),\n",
       "  ('results percentages', 0.2185),\n",
       "  ('vegetable consumption', 0.2073),\n",
       "  ('activity concurrent', 0.2002),\n",
       "  ('regression assess', 0.1954),\n",
       "  ('regions 2007', 0.1815),\n",
       "  ('consuming fruits', 0.165),\n",
       "  ('remains', 0.1649),\n",
       "  ('objectives examined', 0.1608),\n",
       "  ('increases overweight', 0.1593),\n",
       "  ('examined temporal', 0.1513),\n",
       "  ('changes', 0.1395),\n",
       "  ('decrease showed', 0.1374),\n",
       "  ('conclusions large', 0.1231),\n",
       "  ('despite regional', 0.1214),\n",
       "  ('weight 10', 0.1207),\n",
       "  ('south midwest', 0.1192),\n",
       "  ('smoke increase', 0.1176),\n",
       "  ('used', 0.1075),\n",
       "  ('minimally time', 0.0977),\n",
       "  ('individuals did', 0.0975),\n",
       "  ('united', 0.0706),\n",
       "  ('northeast west', 0.0691),\n",
       "  ('used logistic', 0.0598),\n",
       "  ('varied modestly', 0.033),\n",
       "  ('presence', 0.0109),\n",
       "  ('showed strongest', -0.0457)],\n",
       " 'MED-1212': [('health recommendations', 0.5817),\n",
       "  ('healthy lifestyles', 0.5435),\n",
       "  ('lifestyle indicator', 0.487),\n",
       "  ('guidelines emphasize', 0.4842),\n",
       "  ('substantial health', 0.4679),\n",
       "  ('create healthy', 0.4498),\n",
       "  ('characteristics hlcs', 0.4343),\n",
       "  ('prevalence healthy', 0.4032),\n",
       "  ('studies demonstrate', 0.3936),\n",
       "  ('report prevalences', 0.3914),\n",
       "  ('lifestyles recent', 0.3631),\n",
       "  ('consistent clinical', 0.323),\n",
       "  ('methods national', 0.3227),\n",
       "  ('2000 obtained', 0.3054),\n",
       "  ('objectives study', 0.2966),\n",
       "  ('single healthy', 0.2898),\n",
       "  ('background public', 0.2553),\n",
       "  ('surveillance consists', 0.2465),\n",
       "  ('epidemiologic', 0.2446),\n",
       "  ('benefits objectives', 0.2323),\n",
       "  ('emphasize importance', 0.2234),\n",
       "  ('indicator major', 0.2231),\n",
       "  ('using data', 0.2184),\n",
       "  ('mass index', 0.2037),\n",
       "  ('height meters', 0.2009),\n",
       "  ('physical activity', 0.1985),\n",
       "  ('behavioral risk', 0.198),\n",
       "  ('annual statewide', 0.1913),\n",
       "  ('subgroups results', 0.1841),\n",
       "  ('95 confidence', 0.1828),\n",
       "  ('major demographic', 0.1588),\n",
       "  ('000 adults', 0.1421),\n",
       "  ('times week', 0.1344),\n",
       "  ('40 39', 0.1333),\n",
       "  ('combination level', 0.1304),\n",
       "  ('telephone surveys', 0.1199),\n",
       "  ('kilograms', 0.1182),\n",
       "  ('followed', 0.1062),\n",
       "  ('little variation', 0.0956),\n",
       "  ('30 minutes', 0.0929),\n",
       "  ('153 000', 0.0837),\n",
       "  ('nonsmoking 76', 0.0816),\n",
       "  ('consists', 0.08),\n",
       "  ('range pattern', 0.0723),\n",
       "  ('household', 0.0693),\n",
       "  ('level remotely', 0.0526),\n",
       "  ('22 overall', 0.0366),\n",
       "  ('consuming fruits', 0.0281),\n",
       "  ('18', 0.0071),\n",
       "  ('divided square', 0.001)],\n",
       " 'MED-1213': [('health 20', 0.6009),\n",
       "  ('improving cardiovascular', 0.5687),\n",
       "  ('20 improvement', 0.5507),\n",
       "  ('2020 cardiovascular', 0.5352),\n",
       "  ('health behaviors', 0.5024),\n",
       "  ('target improving', 0.4265),\n",
       "  ('impact goals', 0.3825),\n",
       "  ('association 2020', 0.376),\n",
       "  ('heart association', 0.3662),\n",
       "  ('national health', 0.3408),\n",
       "  ('hypercholesterolemia hypertension', 0.3153),\n",
       "  ('current trends', 0.3064),\n",
       "  ('2020 men', 0.2762),\n",
       "  ('suggest obesity', 0.2762),\n",
       "  ('forward projections', 0.2667),\n",
       "  ('behavior smoking', 0.2314),\n",
       "  ('range 14', 0.228),\n",
       "  ('points prevalence', 0.226),\n",
       "  ('methods results', 0.2254),\n",
       "  ('body mass', 0.2095),\n",
       "  ('activity levels', 0.205),\n",
       "  ('pressure', 0.2027),\n",
       "  ('metrics sought', 0.199),\n",
       "  ('diet quality', 0.1988),\n",
       "  ('continue', 0.1812),\n",
       "  ('cycles 1999', 0.1803),\n",
       "  ('increase affect', 0.18),\n",
       "  ('define', 0.175),\n",
       "  ('conclusions american', 0.1674),\n",
       "  ('confidence interval', 0.1414),\n",
       "  ('10', 0.1389),\n",
       "  ('years', 0.1356),\n",
       "  ('42', 0.1342),\n",
       "  ('individual level', 0.1298),\n",
       "  ('adults aged', 0.1168),\n",
       "  ('mellitus', 0.1096),\n",
       "  ('declined prevalence', 0.1089),\n",
       "  ('fasting glucose', 0.0942),\n",
       "  ('changed', 0.0867),\n",
       "  ('intermediate ideal', 0.081),\n",
       "  ('disease free', 0.0783),\n",
       "  ('included 35', 0.06),\n",
       "  ('women respectively', 0.057),\n",
       "  ('poor points', 0.0531),\n",
       "  ('composite', 0.0464),\n",
       "  ('blood', 0.0462),\n",
       "  ('increased 2008', 0.0113),\n",
       "  ('examination survey', 0.0032),\n",
       "  ('53', -0.0064),\n",
       "  ('77 men', -0.0495)],\n",
       " 'MED-1215': [('colectomies mortality', 0.5842),\n",
       "  ('colitis increasing', 0.5498),\n",
       "  ('cdc trends', 0.4774),\n",
       "  ('background clostridium', 0.4625),\n",
       "  ('incidence studies', 0.3691),\n",
       "  ('large hospitals', 0.267),\n",
       "  ('identified decade', 0.267),\n",
       "  ('sepsis 40', 0.2475),\n",
       "  ('health concern', 0.24),\n",
       "  ('admission associated', 0.2384),\n",
       "  ('2006 2010', 0.219),\n",
       "  ('study design', 0.2144),\n",
       "  ('electrolyte disorders', 0.2105),\n",
       "  ('sample nis', 0.2102),\n",
       "  ('coagulopathy odds', 0.2019),\n",
       "  ('increasing associated', 0.2013),\n",
       "  ('renal failure', 0.2005),\n",
       "  ('congestive heart', 0.1977),\n",
       "  ('ci', 0.1977),\n",
       "  ('day mortality', 0.1886),\n",
       "  ('compared 2001', 0.1712),\n",
       "  ('nationwide', 0.1648),\n",
       "  ('surgeons published', 0.1579),\n",
       "  ('97 acute', 0.1543),\n",
       "  ('algorithm identified', 0.1374),\n",
       "  ('conclusions', 0.1361),\n",
       "  ('examined multivariable', 0.1345),\n",
       "  ('american college', 0.1328),\n",
       "  ('25 surgery', 0.1328),\n",
       "  ('37 fluid', 0.1315),\n",
       "  ('states earlier', 0.1264),\n",
       "  ('fold cross', 0.126),\n",
       "  ('predictors total', 0.1258),\n",
       "  ('age greater', 0.1235),\n",
       "  ('stratification counseling', 0.1164),\n",
       "  ('2005 period', 0.1152),\n",
       "  ('05 14', 0.115),\n",
       "  ('united states', 0.1147),\n",
       "  ('copyright 2013', 0.1114),\n",
       "  ('build', 0.1104),\n",
       "  ('weight loss', 0.0887),\n",
       "  ('30 compared', 0.0791),\n",
       "  ('limited', 0.0743),\n",
       "  ('rates 09', 0.0729),\n",
       "  ('peripheral vascular', 0.0715),\n",
       "  ('521 discharges', 0.0589),\n",
       "  ('respiratory', 0.0563),\n",
       "  ('witnessed', 0.0438),\n",
       "  ('remain', -0.0194),\n",
       "  ('used lasso', -0.03)],\n",
       " 'MED-1216': [('difficile infections', 0.7209),\n",
       "  ('infections cdis', 0.6196),\n",
       "  ('commensal pathogen', 0.5172),\n",
       "  ('water difficile', 0.4594),\n",
       "  ('clostridium', 0.4534),\n",
       "  ('community cdis', 0.4374),\n",
       "  ('intestinal tracts', 0.407),\n",
       "  ('microbiology infectious', 0.387),\n",
       "  ('used antibiotic', 0.3745),\n",
       "  ('diseases', 0.3619),\n",
       "  ('general practitioner', 0.342),\n",
       "  ('elderly hospitalized', 0.312),\n",
       "  ('counts toxigenic', 0.301),\n",
       "  ('clinical', 0.2599),\n",
       "  ('host factors', 0.2537),\n",
       "  ('birds reptiles', 0.2147),\n",
       "  ('infection 2012', 0.2089),\n",
       "  ('zoonotic potential', 0.202),\n",
       "  ('food environment', 0.197),\n",
       "  ('calves immediate', 0.1963),\n",
       "  ('traditionally seen', 0.1944),\n",
       "  ('requiring visit', 0.1758),\n",
       "  ('predisposing factors', 0.1746),\n",
       "  ('ubiquitous based', 0.1525),\n",
       "  ('environment direct', 0.1504),\n",
       "  ('animals', 0.146),\n",
       "  ('patients used', 0.1456),\n",
       "  ('absolute counts', 0.141),\n",
       "  ('fish', 0.1402),\n",
       "  ('european society', 0.1175),\n",
       "  ('relatively healthy', 0.1144),\n",
       "  ('lower prevalence', 0.1136),\n",
       "  ('america', 0.1087),\n",
       "  ('pcr ribotypes', 0.1063),\n",
       "  ('ribotype 078', 0.1029),\n",
       "  ('studies conducted', 0.0972),\n",
       "  ('sources outbreaks', 0.0957),\n",
       "  ('needs considered', 0.0926),\n",
       "  ('rates north', 0.0813),\n",
       "  ('importance increased', 0.0757),\n",
       "  ('type', 0.0664),\n",
       "  ('products processed', 0.062),\n",
       "  ('believe overall', 0.0591),\n",
       "  ('transmission humans', 0.0426),\n",
       "  ('numbers piglets', 0.036),\n",
       "  ('soil water', 0.0319),\n",
       "  ('circumstantial evidence', 0.028),\n",
       "  ('humans proven', 0.0098),\n",
       "  ('dose unknown', -0.0259),\n",
       "  ('future emerging', -0.0384)],\n",
       " 'MED-1217': [('clostridium difficile', 0.6577),\n",
       "  ('difficile different', 0.6308),\n",
       "  ('difficile recognized', 0.6242),\n",
       "  ('difficile food', 0.6116),\n",
       "  ('difficile', 0.6055),\n",
       "  ('difficile positive', 0.6024),\n",
       "  ('potential difficile', 0.5929),\n",
       "  ('association difficile', 0.5669),\n",
       "  ('percentage difficile', 0.5607),\n",
       "  ('reports difficile', 0.5351),\n",
       "  ('clostridium', 0.5262),\n",
       "  ('prevalence contamination', 0.3895),\n",
       "  ('pathogen decades', 0.3448),\n",
       "  ('meat products', 0.3348),\n",
       "  ('contamination retail', 0.3236),\n",
       "  ('animal disease', 0.3235),\n",
       "  ('pathogen', 0.2983),\n",
       "  ('disease established', 0.2638),\n",
       "  ('foods difficulties', 0.2592),\n",
       "  ('food transmitted', 0.2451),\n",
       "  ('50 european', 0.219),\n",
       "  ('america prevalence', 0.186),\n",
       "  ('food rising', 0.1846),\n",
       "  ('countries', 0.1814),\n",
       "  ('products ranges', 0.1774),\n",
       "  ('studies', 0.1715),\n",
       "  ('north america', 0.1554),\n",
       "  ('rising findings', 0.1492),\n",
       "  ('recognized important', 0.1472),\n",
       "  ('data association', 0.1467),\n",
       "  ('different', 0.14),\n",
       "  ('findings vary', 0.1366),\n",
       "  ('retail', 0.1299),\n",
       "  ('number reports', 0.1239),\n",
       "  ('difficulties associated', 0.1208),\n",
       "  ('summarizes current', 0.1131),\n",
       "  ('2010 elsevier', 0.1096),\n",
       "  ('established recently', 0.1041),\n",
       "  ('organism discusses', 0.0858),\n",
       "  ('associated', 0.0821),\n",
       "  ('associated isolation', 0.0731),\n",
       "  ('samples', 0.0683),\n",
       "  ('positive', 0.0676),\n",
       "  ('percentage', 0.0633),\n",
       "  ('important human', 0.0467),\n",
       "  ('discusses potential', 0.0393),\n",
       "  ('chapter', 0.0278),\n",
       "  ('lower', 0.0239),\n",
       "  ('agent', 0.0165),\n",
       "  ('copyright', 0.0139)],\n",
       " 'MED-1218': [('contamination acquired', 0.5428),\n",
       "  ('mrsa difficile', 0.5192),\n",
       "  ('established pathogens', 0.5182),\n",
       "  ('pigs difficile', 0.4662),\n",
       "  ('contamination carcasses', 0.45),\n",
       "  ('preevisceration mrsa', 0.4284),\n",
       "  ('isolates recovered', 0.423),\n",
       "  ('retail pork', 0.4052),\n",
       "  ('resistant staphylococcus', 0.4037),\n",
       "  ('infections linked', 0.4006),\n",
       "  ('clostridium', 0.3594),\n",
       "  ('farm comparison', 0.3165),\n",
       "  ('slaughterhouse environment', 0.3151),\n",
       "  ('recovered pigs', 0.3051),\n",
       "  ('swabs', 0.2825),\n",
       "  ('reports carriage', 0.2728),\n",
       "  ('environmental samples', 0.2669),\n",
       "  ('identified ribotype', 0.2637),\n",
       "  ('study demonstrated', 0.2402),\n",
       "  ('recent increase', 0.2397),\n",
       "  ('significant cross', 0.2275),\n",
       "  ('prevalence peaked', 0.2226),\n",
       "  ('processing facility', 0.2213),\n",
       "  ('address gap', 0.1954),\n",
       "  ('postscald tanks', 0.1909),\n",
       "  ('68 isolates', 0.1893),\n",
       "  ('environment evident', 0.1811),\n",
       "  ('community', 0.1754),\n",
       "  ('increased 14', 0.1625),\n",
       "  ('31 carcasses', 0.1607),\n",
       "  ('sampled postbleed', 0.1435),\n",
       "  ('28 pigs', 0.1344),\n",
       "  ('prevalence declined', 0.1332),\n",
       "  ('type', 0.1311),\n",
       "  ('54', 0.1265),\n",
       "  ('150 days', 0.1246),\n",
       "  ('predominated', 0.1221),\n",
       "  ('tested positive', 0.1145),\n",
       "  ('spa type', 0.1021),\n",
       "  ('isolated nasal', 0.0984),\n",
       "  ('recovered', 0.0943),\n",
       "  ('unclear', 0.0849),\n",
       "  ('age prevalence', 0.0813),\n",
       "  ('processing evidence', 0.068),\n",
       "  ('holding', 0.0433),\n",
       "  ('age 19', 0.0336),\n",
       "  ('birth', 0.0303),\n",
       "  ('80', 0.0166),\n",
       "  ('t034 predominated', -0.0042),\n",
       "  ('26 market', -0.0052)],\n",
       " 'MED-1219': [('difficile transmission', 0.6676),\n",
       "  ('thought clostridium', 0.4489),\n",
       "  ('infection transmitted', 0.4366),\n",
       "  ('infection research', 0.4356),\n",
       "  ('isolates obtained', 0.3646),\n",
       "  ('infection continued', 0.3269),\n",
       "  ('subtypes infection', 0.3219),\n",
       "  ('data hospital', 0.302),\n",
       "  ('2007 onward', 0.2786),\n",
       "  ('health care', 0.2647),\n",
       "  ('endemic', 0.2494),\n",
       "  ('incidence time', 0.2482),\n",
       "  ('performed genome', 0.2463),\n",
       "  ('funded clinical', 0.2373),\n",
       "  ('interventions targeting', 0.2281),\n",
       "  ('disease 333', 0.2114),\n",
       "  ('settings community', 0.202),\n",
       "  ('consistent transmission', 0.1917),\n",
       "  ('diverse sources', 0.1874),\n",
       "  ('conclusions year', 0.1814),\n",
       "  ('epidemiologic links', 0.1779),\n",
       "  ('translational', 0.1753),\n",
       "  ('identified study', 0.1671),\n",
       "  ('march 2011', 0.1597),\n",
       "  ('united kingdom', 0.1459),\n",
       "  ('methods september', 0.1416),\n",
       "  ('126 patients', 0.1407),\n",
       "  ('genetically distinct', 0.1345),\n",
       "  ('evolution rates', 0.1126),\n",
       "  ('hampered identification', 0.1087),\n",
       "  ('cases reductions', 0.1057),\n",
       "  ('background thought', 0.1024),\n",
       "  ('spread', 0.1),\n",
       "  ('april 2008', 0.0952),\n",
       "  ('10 snvs', 0.091),\n",
       "  ('location results', 0.0866),\n",
       "  ('major', 0.082),\n",
       "  ('obtained symptomatic', 0.0732),\n",
       "  ('single nucleotide', 0.0722),\n",
       "  ('precise', 0.0717),\n",
       "  ('patients snvs', 0.0704),\n",
       "  ('cases oxfordshire', 0.0679),\n",
       "  ('957', 0.0581),\n",
       "  ('groups finding', 0.0493),\n",
       "  ('patients 38', 0.0462),\n",
       "  ('reservoir', 0.0256),\n",
       "  ('patients play', 0.0231),\n",
       "  ('days apart', 0.0101),\n",
       "  ('period 45', 0.0047),\n",
       "  ('evaluated 1223', -0.0049)],\n",
       " 'MED-1220': [('difficile infection', 0.6438),\n",
       "  ('infectious diarrhoea', 0.5642),\n",
       "  ('difficile pigs', 0.529),\n",
       "  ('clostridium', 0.4886),\n",
       "  ('animals diarrhoeal', 0.4441),\n",
       "  ('infection cdi', 0.4163),\n",
       "  ('causes infectious', 0.3693),\n",
       "  ('zoonosis exists', 0.3624),\n",
       "  ('flora animal', 0.3518),\n",
       "  ('environmental contamination', 0.3025),\n",
       "  ('food borne', 0.2957),\n",
       "  ('gastrointestinal tract', 0.292),\n",
       "  ('borne transmission', 0.2766),\n",
       "  ('non diarrhoeal', 0.2731),\n",
       "  ('cdi increasing', 0.2681),\n",
       "  ('meat products', 0.2599),\n",
       "  ('usa cattle', 0.2591),\n",
       "  ('humans animals', 0.238),\n",
       "  ('antimicrobial', 0.2184),\n",
       "  ('common problems', 0.2074),\n",
       "  ('strains', 0.1922),\n",
       "  ('pigs horses', 0.1822),\n",
       "  ('issue animal', 0.1731),\n",
       "  ('health issue', 0.164),\n",
       "  ('human insection', 0.1511),\n",
       "  ('ribotype common', 0.1445),\n",
       "  ('canada', 0.1435),\n",
       "  ('100 ribotype', 0.1327),\n",
       "  ('community acquired', 0.1302),\n",
       "  ('078 common', 0.127),\n",
       "  ('epidemiology', 0.1234),\n",
       "  ('europe human', 0.1196),\n",
       "  ('physicians veterinarians', 0.1147),\n",
       "  ('albeit proven', 0.1101),\n",
       "  ('tract pcr', 0.1073),\n",
       "  ('recent changes', 0.1031),\n",
       "  ('likely excessive', 0.0915),\n",
       "  ('20 40', 0.0755),\n",
       "  ('driving', 0.0725),\n",
       "  ('manner', 0.0615),\n",
       "  ('organism just', 0.0492),\n",
       "  ('83 study', 0.0466),\n",
       "  ('potential reservoir', 0.0391),\n",
       "  ('sits', 0.0301),\n",
       "  ('scientists', 0.0242),\n",
       "  ('increasing world', 0.015),\n",
       "  ('genetically identical', 0.0029),\n",
       "  ('successfully deal', -0.0045),\n",
       "  ('resolution human', -0.0383),\n",
       "  ('completely clear', -0.0747)],\n",
       " 'MED-1221': [('difficile infections', 0.6821),\n",
       "  ('infections cdi', 0.6138),\n",
       "  ('epidemiology clostridium', 0.5793),\n",
       "  ('understand difficile', 0.575),\n",
       "  ('understanding cdis', 0.5538),\n",
       "  ('infections', 0.4272),\n",
       "  ('pathogen infrequently', 0.3487),\n",
       "  ('foodborne transmission', 0.3465),\n",
       "  ('changing epidemiology', 0.3281),\n",
       "  ('zoonotic', 0.3187),\n",
       "  ('important pathogen', 0.3154),\n",
       "  ('contextualizes current', 0.2622),\n",
       "  ('studies indicate', 0.2599),\n",
       "  ('targeting medical', 0.2286),\n",
       "  ('recent molecular', 0.2276),\n",
       "  ('based prevention', 0.2271),\n",
       "  ('restricted health', 0.226),\n",
       "  ('environment strains', 0.2167),\n",
       "  ('critical', 0.2123),\n",
       "  ('infrequently addressed', 0.196),\n",
       "  ('care', 0.1932),\n",
       "  ('poultry', 0.1907),\n",
       "  ('behavior change', 0.1888),\n",
       "  ('exposure important', 0.1858),\n",
       "  ('genome sequencing', 0.1856),\n",
       "  ('articles', 0.1766),\n",
       "  ('settings', 0.1639),\n",
       "  ('develop science', 0.1606),\n",
       "  ('transmission hospitals', 0.1593),\n",
       "  ('epidemic clones', 0.1572),\n",
       "  ('foods humans', 0.1358),\n",
       "  ('traditionally assumed', 0.1326),\n",
       "  ('common', 0.1267),\n",
       "  ('reduce human', 0.1111),\n",
       "  ('possible measures', 0.1016),\n",
       "  ('personnel needed', 0.0982),\n",
       "  ('case', 0.0973),\n",
       "  ('emerging presence', 0.0768),\n",
       "  ('animals possible', 0.0763),\n",
       "  ('enhanced educational', 0.0763),\n",
       "  ('inadvertently', 0.0611),\n",
       "  ('indicate', 0.0607),\n",
       "  ('longer', 0.0554),\n",
       "  ('non', 0.0487),\n",
       "  ('transmission confirmed', 0.019),\n",
       "  ('raw', 0.0129),\n",
       "  ('present humans', 0.0106),\n",
       "  ('companion', -0.003),\n",
       "  ('susceptible people', -0.0031),\n",
       "  ('salads order', -0.0635)],\n",
       " 'MED-1223': [('milk growth', 0.5843),\n",
       "  ('cow milk', 0.5399),\n",
       "  ('cow', 0.3673),\n",
       "  ('biological outcomes', 0.3537),\n",
       "  ('dietary behavior', 0.3516),\n",
       "  ('early childhood', 0.3494),\n",
       "  ('development mechanism', 0.3213),\n",
       "  ('growth igf', 0.3103),\n",
       "  ('age menarche', 0.302),\n",
       "  ('outcomes methods', 0.27),\n",
       "  ('history consequences', 0.2591),\n",
       "  ('growth turn', 0.2502),\n",
       "  ('assess life', 0.2479),\n",
       "  ('behavior potential', 0.2303),\n",
       "  ('different stages', 0.2262),\n",
       "  ('consumption different', 0.2249),\n",
       "  ('role insulin', 0.2199),\n",
       "  ('long term', 0.2199),\n",
       "  ('age', 0.2102),\n",
       "  ('mediating relationship', 0.1934),\n",
       "  ('effects unknown', 0.1855),\n",
       "  ('conclusions', 0.1831),\n",
       "  ('slow growth', 0.1824),\n",
       "  ('national health', 0.1762),\n",
       "  ('parameters especially', 0.1753),\n",
       "  ('regard linear', 0.1672),\n",
       "  ('adolescence nhanes', 0.1648),\n",
       "  ('united states', 0.1633),\n",
       "  ('bioactive molecule', 0.1625),\n",
       "  ('copyright 2011', 0.1573),\n",
       "  ('2004', 0.1501),\n",
       "  ('examination', 0.1453),\n",
       "  ('evolutionarily', 0.1447),\n",
       "  ('consumption rapid', 0.1267),\n",
       "  ('middle', 0.1165),\n",
       "  ('tends', 0.0993),\n",
       "  ('years support', 0.0984),\n",
       "  ('exert effects', 0.0953),\n",
       "  ('data positive', 0.0702),\n",
       "  ('prior', 0.0609),\n",
       "  ('alter human', 0.0597),\n",
       "  ('role enhancing', 0.0445),\n",
       "  ('existing literature', 0.044),\n",
       "  ('like', 0.0121),\n",
       "  ('candidate', 0.0103),\n",
       "  ('negative', 0.0019),\n",
       "  ('especially vis', -0.0085),\n",
       "  ('wiley periodicals', -0.0167),\n",
       "  ('evolutionarily novel', -0.0259),\n",
       "  ('1999', -0.0412)],\n",
       " 'MED-1224': [('proteins adolescents', 0.5742),\n",
       "  ('adolescents overweight', 0.5041),\n",
       "  ('dietary protein', 0.4762),\n",
       "  ('weight loss', 0.4728),\n",
       "  ('insulinotropic effect', 0.4683),\n",
       "  ('adults dietary', 0.4609),\n",
       "  ('effects milk', 0.4554),\n",
       "  ('dairy proteins', 0.4551),\n",
       "  ('group diet', 0.4232),\n",
       "  ('adolescents unclear', 0.418),\n",
       "  ('proteins reduce', 0.4151),\n",
       "  ('outcomes bmi', 0.4112),\n",
       "  ('casein groups', 0.3864),\n",
       "  ('induce weight', 0.3604),\n",
       "  ('reduce body', 0.3587),\n",
       "  ('concentration overweight', 0.3516),\n",
       "  ('loss dairy', 0.3038),\n",
       "  ('kg mean', 0.2985),\n",
       "  ('physical activity', 0.2953),\n",
       "  ('secretion estimated', 0.272),\n",
       "  ('circumference plasma', 0.2669),\n",
       "  ('changes plasma', 0.2583),\n",
       "  ('waist circumference', 0.2512),\n",
       "  ('homeostatic model', 0.2344),\n",
       "  ('protein randomization', 0.2335),\n",
       "  ('age scores', 0.2321),\n",
       "  ('35 protein', 0.2023),\n",
       "  ('bmi 25', 0.2021),\n",
       "  ('peptide concentration', 0.2005),\n",
       "  ('wk skim', 0.1925),\n",
       "  ('15', 0.191),\n",
       "  ('whey', 0.1878),\n",
       "  ('remains elucidated', 0.1821),\n",
       "  ('data suggest', 0.1749),\n",
       "  ('intervention began', 0.1636),\n",
       "  ('significant changes', 0.1454),\n",
       "  ('studied 12', 0.1431),\n",
       "  ('groups compared', 0.1243),\n",
       "  ('203 aged', 0.1092),\n",
       "  ('test drinks', 0.1065),\n",
       "  ('contained', 0.0889),\n",
       "  ('02 significant', 0.0865),\n",
       "  ('greater pretest', 0.0734),\n",
       "  ('objective', 0.0655),\n",
       "  ('secondary increased', 0.0648),\n",
       "  ('model assessment', 0.0632),\n",
       "  ('32 studied', 0.0543),\n",
       "  ('control', 0.0454),\n",
       "  ('baseline water', 0.0425),\n",
       "  ('increase bazs', 0.0369)],\n",
       " 'MED-1226': [('early menarche', 0.5296),\n",
       "  ('milk consumption', 0.485),\n",
       "  ('dairy fat', 0.4246),\n",
       "  ('intake past', 0.3663),\n",
       "  ('consumption age', 0.3115),\n",
       "  ('overweight conclusions', 0.3078),\n",
       "  ('positive associations', 0.3019),\n",
       "  ('nutrition examination', 0.3001),\n",
       "  ('nhanes', 0.259),\n",
       "  ('intake marginally', 0.2391),\n",
       "  ('study assessed', 0.2314),\n",
       "  ('2004 samples', 0.2218),\n",
       "  ('childhood', 0.2177),\n",
       "  ('12 yrs', 0.2076),\n",
       "  ('health', 0.1991),\n",
       "  ('yrs regression', 0.1841),\n",
       "  ('calcium protein', 0.1826),\n",
       "  ('05 highest', 0.1799),\n",
       "  ('contributed early', 0.1782),\n",
       "  ('data derive', 0.1776),\n",
       "  ('cox regression', 0.1677),\n",
       "  ('products linked', 0.1657),\n",
       "  ('2657 women', 0.1512),\n",
       "  ('middle', 0.1313),\n",
       "  ('background components', 0.1298),\n",
       "  ('girls age', 0.1276),\n",
       "  ('hr 03', 0.126),\n",
       "  ('drank', 0.1242),\n",
       "  ('intake 38', 0.1041),\n",
       "  ('42', 0.0976),\n",
       "  ('age 20', 0.0926),\n",
       "  ('indicated total', 0.0857),\n",
       "  ('olds', 0.0824),\n",
       "  ('25 23', 0.0818),\n",
       "  ('greater risk', 0.0814),\n",
       "  ('percentile increased', 0.0791),\n",
       "  ('remained', 0.0734),\n",
       "  ('lowest tertiles', 0.0726),\n",
       "  ('reach', 0.0606),\n",
       "  ('rarely hr', 0.049),\n",
       "  ('varied daily', 0.0381),\n",
       "  ('negative relationship', 0.0355),\n",
       "  ('blacks', 0.0228),\n",
       "  ('49', 0.0138),\n",
       "  ('analysis weak', 0.0127),\n",
       "  ('vs', 0.0072),\n",
       "  ('06 compared', -0.0001),\n",
       "  ('32 10', -0.0022),\n",
       "  ('controlling', -0.0065),\n",
       "  ('likely whites', -0.0351)],\n",
       " 'MED-1227': [('studies 639', 0.4541),\n",
       "  ('methodologic flaws', 0.4412),\n",
       "  ('obesity conducted', 0.3944),\n",
       "  ('infant feeding', 0.3757),\n",
       "  ('control studies', 0.3515),\n",
       "  ('controlling confounders', 0.3419),\n",
       "  ('clinic 533', 0.3183),\n",
       "  ('error confounding', 0.3178),\n",
       "  ('clinical variables', 0.3097),\n",
       "  ('previous studies', 0.302),\n",
       "  ('studies insufficient', 0.2883),\n",
       "  ('flaws type', 0.281),\n",
       "  ('weight', 0.2808),\n",
       "  ('healthy children', 0.271),\n",
       "  ('adolescent clinic', 0.2693),\n",
       "  ('patients 12', 0.2673),\n",
       "  ('nonblinding', 0.2668),\n",
       "  ('methodologic standards', 0.2574),\n",
       "  ('nonobese based', 0.2535),\n",
       "  ('feeding does', 0.2416),\n",
       "  ('conflicting results', 0.2261),\n",
       "  ('results', 0.2104),\n",
       "  ('subject classified', 0.1805),\n",
       "  ('18 years', 0.1713),\n",
       "  ('conducted case', 0.1634),\n",
       "  ('type ii', 0.1568),\n",
       "  ('trend rates', 0.1554),\n",
       "  ('analysis raw', 0.1529),\n",
       "  ('insufficient attention', 0.1425),\n",
       "  ('family history', 0.1395),\n",
       "  ('data later', 0.138),\n",
       "  ('attending montreal', 0.136),\n",
       "  ('high school', 0.1338),\n",
       "  ('rates breast', 0.1268),\n",
       "  ('relative risk', 0.1181),\n",
       "  ('delayed introduction', 0.1112),\n",
       "  ('groups magnitude', 0.1104),\n",
       "  ('solid foods', 0.099),\n",
       "  ('similarly aged', 0.0934),\n",
       "  ('skinfolds', 0.0933),\n",
       "  ('revealed significantly', 0.0923),\n",
       "  ('attending', 0.0776),\n",
       "  ('slightly increased', 0.0645),\n",
       "  ('provided little', 0.0603),\n",
       "  ('telephone interview', 0.0387),\n",
       "  ('benefit demographic', 0.0383),\n",
       "  ('triceps subscapular', 0.0377),\n",
       "  ('persisted', 0.0265),\n",
       "  ('does', 0.0105),\n",
       "  ('protect', 0.0071)],\n",
       " 'MED-1229': [('mechanisms mtorc1', 0.5122),\n",
       "  ('regulation milk', 0.5056),\n",
       "  ('milk materno', 0.4576),\n",
       "  ('food infants', 0.4117),\n",
       "  ('milk exosomes', 0.4107),\n",
       "  ('nutrient promoting', 0.3799),\n",
       "  ('metabolic processes', 0.3741),\n",
       "  ('growth regulated', 0.3676),\n",
       "  ('microrna 21', 0.3013),\n",
       "  ('rapamycin', 0.2931),\n",
       "  ('review presents', 0.2834),\n",
       "  ('acids increase', 0.2813),\n",
       "  ('postnatal growth', 0.2783),\n",
       "  ('neonatal relay', 0.2778),\n",
       "  ('mammals cell', 0.2489),\n",
       "  ('human breast', 0.2459),\n",
       "  ('contain microrna', 0.2425),\n",
       "  ('cell growth', 0.2307),\n",
       "  ('regulation', 0.2256),\n",
       "  ('mechanistic target', 0.2221),\n",
       "  ('glucose', 0.2208),\n",
       "  ('preferential amino', 0.2158),\n",
       "  ('plasma levels', 0.2119),\n",
       "  ('mammals', 0.2058),\n",
       "  ('information mechanisms', 0.1989),\n",
       "  ('continued cow', 0.1853),\n",
       "  ('consumption', 0.1768),\n",
       "  ('glp insulin', 0.1727),\n",
       "  ('peptide', 0.1605),\n",
       "  ('polypeptide gip', 0.1552),\n",
       "  ('hormone gh', 0.1524),\n",
       "  ('processes human', 0.1463),\n",
       "  ('lack information', 0.1386),\n",
       "  ('genetic transfection', 0.1327),\n",
       "  ('sensitive kinase', 0.132),\n",
       "  ('complex', 0.1289),\n",
       "  ('increase', 0.1274),\n",
       "  ('signaling adolescence', 0.1236),\n",
       "  ('species specific', 0.121),\n",
       "  ('functionally active', 0.1066),\n",
       "  ('dependent', 0.096),\n",
       "  ('contain', 0.0925),\n",
       "  ('persistent high', 0.0808),\n",
       "  ('exosomes regularly', 0.0714),\n",
       "  ('diseases civilization', 0.0656),\n",
       "  ('adulthood continued', 0.0605),\n",
       "  ('presents', 0.0586),\n",
       "  ('transfer preferential', 0.0513),\n",
       "  ('ideal', 0.0357),\n",
       "  ('programming persistent', 0.0343)],\n",
       " 'MED-1230': [('published obesity', 0.5502),\n",
       "  ('funded projects', 0.4883),\n",
       "  ('funding sources', 0.4858),\n",
       "  ('nutrition research', 0.4698),\n",
       "  ('research linking', 0.4536),\n",
       "  ('support obesity', 0.4482),\n",
       "  ('outcomes published', 0.4116),\n",
       "  ('articles included', 0.3645),\n",
       "  ('list funded', 0.3595),\n",
       "  ('research methodology', 0.3553),\n",
       "  ('new research', 0.345),\n",
       "  ('study examined', 0.3281),\n",
       "  ('project determined', 0.3188),\n",
       "  ('nih study', 0.3117),\n",
       "  ('linking food', 0.306),\n",
       "  ('included financial', 0.2955),\n",
       "  ('programs 17', 0.2885),\n",
       "  ('food intake', 0.2823),\n",
       "  ('sources', 0.2774),\n",
       "  ('dairy consumption', 0.2654),\n",
       "  ('sponsored', 0.2565),\n",
       "  ('national institutes', 0.2543),\n",
       "  ('consistent evidence', 0.2508),\n",
       "  ('programs fluid', 0.2287),\n",
       "  ('2005', 0.2259),\n",
       "  ('consumption study', 0.2239),\n",
       "  ('prevention benefit', 0.2221),\n",
       "  ('article conclusions', 0.2133),\n",
       "  ('2001', 0.2125),\n",
       "  ('62 sponsored', 0.2119),\n",
       "  ('commodity promotion', 0.2078),\n",
       "  ('federal government', 0.1972),\n",
       "  ('2012', 0.1885),\n",
       "  ('fluid milk', 0.1859),\n",
       "  ('health', 0.1797),\n",
       "  ('pubmed', 0.172),\n",
       "  ('bias source', 0.1715),\n",
       "  ('groups investigators', 0.1703),\n",
       "  ('checkoff funded', 0.1536),\n",
       "  ('did identify', 0.1335),\n",
       "  ('using ovid', 0.1157),\n",
       "  ('using', 0.0891),\n",
       "  ('sponsorship copyright', 0.0831),\n",
       "  ('public generic', 0.0808),\n",
       "  ('principal investigator', 0.0584),\n",
       "  ('seventy', 0.0309),\n",
       "  ('elsevier rights', 0.022),\n",
       "  ('individual located', -0.0258),\n",
       "  ('semi', -0.0352),\n",
       "  ('drawn distinct', -0.0604)],\n",
       " 'MED-1231': [('fiber intake', 0.5495),\n",
       "  ('lower intake', 0.5021),\n",
       "  ('lower cardiovascular', 0.4736),\n",
       "  ('explain cardioprotective', 0.4348),\n",
       "  ('low fiber', 0.4339),\n",
       "  ('lifestyle variables', 0.4107),\n",
       "  ('investigate lower', 0.3846),\n",
       "  ('participants dietary', 0.3735),\n",
       "  ('lower lifetime', 0.3527),\n",
       "  ('lifetime intake', 0.3404),\n",
       "  ('intake objective', 0.3288),\n",
       "  ('deleterious associations', 0.3193),\n",
       "  ('lifetime fiber', 0.3152),\n",
       "  ('associations explained', 0.3023),\n",
       "  ('cardiovascular sequelae', 0.2991),\n",
       "  ('promoting consumption', 0.2941),\n",
       "  ('stiffening adulthood', 0.2858),\n",
       "  ('disease risk', 0.2604),\n",
       "  ('artery stiffness', 0.2388),\n",
       "  ('intake conclusions', 0.2384),\n",
       "  ('cohort study', 0.2337),\n",
       "  ('fiber 24', 0.2333),\n",
       "  ('tertiles distensibility', 0.2054),\n",
       "  ('did stiff', 0.2048),\n",
       "  ('study did', 0.2048),\n",
       "  ('95 ci', 0.2022),\n",
       "  ('ages 13', 0.196),\n",
       "  ('means prevent', 0.19),\n",
       "  ('young elastic', 0.1862),\n",
       "  ('fruit vegetables', 0.1838),\n",
       "  ('background', 0.1717),\n",
       "  ('objective investigate', 0.169),\n",
       "  ('results adjustment', 0.1657),\n",
       "  ('influenced lifetime', 0.1558),\n",
       "  ('young life', 0.1474),\n",
       "  ('compliance', 0.1455),\n",
       "  ('repeated measures', 0.1288),\n",
       "  ('grains deleterious', 0.1093),\n",
       "  ('ultrasonography ascertained', 0.1045),\n",
       "  ('measures median', 0.098),\n",
       "  ('assessed ages', 0.0977),\n",
       "  ('energy', 0.0877),\n",
       "  ('36 repeated', 0.0802),\n",
       "  ('influenced', 0.0761),\n",
       "  ('reversed', 0.0747),\n",
       "  ('subjects', 0.0675),\n",
       "  ('compared', 0.0608),\n",
       "  ('sex specific', 0.0375),\n",
       "  ('known', 0.0127),\n",
       "  ('offer means', -0.0327)],\n",
       " 'MED-1232': [('dietary fiber', 0.4752),\n",
       "  ('dietary variables', 0.45),\n",
       "  ('fiber incidence', 0.3769),\n",
       "  ('intake dfi', 0.3508),\n",
       "  ('intake impact', 0.35),\n",
       "  ('63 fiber', 0.3323),\n",
       "  ('research aimed', 0.3248),\n",
       "  ('background aims', 0.3089),\n",
       "  ('detected 12', 0.2934),\n",
       "  ('confounders', 0.2858),\n",
       "  ('high dfi', 0.2835),\n",
       "  ('blood pressure', 0.275),\n",
       "  ('analyses using', 0.2725),\n",
       "  ('population level', 0.263),\n",
       "  ('1647 unselected', 0.2623),\n",
       "  ('high dietary', 0.2623),\n",
       "  ('rate diabetes', 0.2606),\n",
       "  ('incidence stroke', 0.2584),\n",
       "  ('fibrinogenaemia erytrosedimentation', 0.2573),\n",
       "  ('clinical nutrition', 0.2395),\n",
       "  ('clarifying high', 0.2189),\n",
       "  ('european society', 0.2),\n",
       "  ('based quintiles', 0.1815),\n",
       "  ('insulin uricaemia', 0.1787),\n",
       "  ('subjects', 0.1785),\n",
       "  ('detected', 0.1656),\n",
       "  ('lipids', 0.1641),\n",
       "  ('hypertrophy covariables', 0.1471),\n",
       "  ('reduced risk', 0.1403),\n",
       "  ('cox models', 0.1287),\n",
       "  ('daily', 0.1191),\n",
       "  ('biometrics', 0.1131),\n",
       "  ('metabolism rights', 0.1128),\n",
       "  ('general', 0.1054),\n",
       "  ('intaking cut', 0.0938),\n",
       "  ('year', 0.0803),\n",
       "  ('disease left', 0.0704),\n",
       "  ('003', 0.0695),\n",
       "  ('smoking pulmonary', 0.0681),\n",
       "  ('resistance', 0.0513),\n",
       "  ('50 003', 0.0405),\n",
       "  ('17', 0.0354),\n",
       "  ('31', 0.0298),\n",
       "  ('soluble hr', 0.0243),\n",
       "  ('elsevier', 0.017),\n",
       "  ('ventricular', 0.0154),\n",
       "  ('hr 35', -0.0049),\n",
       "  ('25 insoluble', -0.0109),\n",
       "  ('copyright', -0.0162),\n",
       "  ('46', -0.0178)],\n",
       " 'MED-1233': [('studies reporting', 0.4646),\n",
       "  ('dietary fiber', 0.4162),\n",
       "  ('reduction evidence', 0.3892),\n",
       "  ('cohort studies', 0.3806),\n",
       "  ('databases searched', 0.3656),\n",
       "  ('stroke evidence', 0.3651),\n",
       "  ('evidence low', 0.3298),\n",
       "  ('intake total', 0.3186),\n",
       "  ('paucity data', 0.3033),\n",
       "  ('reduced stroke', 0.295),\n",
       "  ('support dietary', 0.2852),\n",
       "  ('future studies', 0.282),\n",
       "  ('fiber paucity', 0.2762),\n",
       "  ('findings support', 0.246),\n",
       "  ('risk prospective', 0.2339),\n",
       "  ('1990 2012', 0.2201),\n",
       "  ('intake inversely', 0.2145),\n",
       "  ('methods multiple', 0.2141),\n",
       "  ('vegetables conclusions', 0.2033),\n",
       "  ('searched healthy', 0.1908),\n",
       "  ('background purpose', 0.1902),\n",
       "  ('regarding association', 0.1841),\n",
       "  ('low heterogeneity', 0.1836),\n",
       "  ('recommendations increase', 0.1775),\n",
       "  ('met inclusion', 0.1748),\n",
       "  ('published january', 0.1738),\n",
       "  ('95 confidence', 0.165),\n",
       "  ('focus', 0.1576),\n",
       "  ('conclusions regarding', 0.1537),\n",
       "  ('88 01', 0.1471),\n",
       "  ('incidence hemorrhagic', 0.1416),\n",
       "  ('foods precludes', 0.1388),\n",
       "  ('day 93', 0.1385),\n",
       "  ('21 studies', 0.1297),\n",
       "  ('cereals', 0.1204),\n",
       "  ('analysis', 0.1098),\n",
       "  ('data fiber', 0.1085),\n",
       "  ('northern europe', 0.1074),\n",
       "  ('participant', 0.1064),\n",
       "  ('precludes conclusions', 0.0853),\n",
       "  ('type examine', 0.0833),\n",
       "  ('59 soluble', 0.0778),\n",
       "  ('multiple electronic', 0.073),\n",
       "  ('united states', 0.0621),\n",
       "  ('need future', 0.0595),\n",
       "  ('relation insoluble', 0.0551),\n",
       "  ('day associated', 0.0533),\n",
       "  ('japan met', 0.0395),\n",
       "  ('different', -0.0085),\n",
       "  ('australia', -0.03)],\n",
       " 'MED-1234': [('dietary fiber', 0.5922),\n",
       "  ('fiber risk', 0.4687),\n",
       "  ('intake cvd', 0.4499),\n",
       "  ('association dietary', 0.4399),\n",
       "  ('recent dietary', 0.4267),\n",
       "  ('underlying cardioprotective', 0.4247),\n",
       "  ('lipid reduction', 0.4241),\n",
       "  ('inverse association', 0.4225),\n",
       "  ('weight regulation', 0.3759),\n",
       "  ('grain consumption', 0.3727),\n",
       "  ('improve cvd', 0.3665),\n",
       "  ('diets study', 0.3544),\n",
       "  ('reduction chronic', 0.3416),\n",
       "  ('cvd extensively', 0.3351),\n",
       "  ('starch relation', 0.3082),\n",
       "  ('association stronger', 0.3064),\n",
       "  ('risk weight', 0.3062),\n",
       "  ('glucose metabolism', 0.2888),\n",
       "  ('regular consumption', 0.2816),\n",
       "  ('cardiovascular', 0.2589),\n",
       "  ('increased consumption', 0.2581),\n",
       "  ('various food', 0.2568),\n",
       "  ('chronic inflammation', 0.2485),\n",
       "  ('multiple mechanisms', 0.2453),\n",
       "  ('stronger cereal', 0.2416),\n",
       "  ('nuts resistant', 0.229),\n",
       "  ('guidelines endorsed', 0.222),\n",
       "  ('health multiple', 0.211),\n",
       "  ('fruits vegetables', 0.2054),\n",
       "  ('explore biological', 0.1926),\n",
       "  ('control explore', 0.1895),\n",
       "  ('effect', 0.1853),\n",
       "  ('types grains', 0.1848),\n",
       "  ('blood pressure', 0.1835),\n",
       "  ('epidemiological', 0.1822),\n",
       "  ('regulation improved', 0.1755),\n",
       "  ('light evidence', 0.1734),\n",
       "  ('future research', 0.1728),\n",
       "  ('focus various', 0.1673),\n",
       "  ('study different', 0.1442),\n",
       "  ('extensively studied', 0.142),\n",
       "  ('sources improve', 0.1407),\n",
       "  ('recent', 0.134),\n",
       "  ('body', 0.1293),\n",
       "  ('legumes', 0.1283),\n",
       "  ('studies increased', 0.1236),\n",
       "  ('different ethnic', 0.1223),\n",
       "  ('relationship', 0.0575),\n",
       "  ('rich', 0.0543),\n",
       "  ('groups', 0.0008)],\n",
       " 'MED-1236': [('diabetes reversed', 0.6436),\n",
       "  ('insulin suppression', 0.6005),\n",
       "  ('reproducibly bariatric', 0.5258),\n",
       "  ('metabolic abnormalities', 0.469),\n",
       "  ('hypoenergetic feeding', 0.461),\n",
       "  ('diabetes worthwhile', 0.4466),\n",
       "  ('insulin secretion', 0.4391),\n",
       "  ('suppression hepatic', 0.4251),\n",
       "  ('normal metabolism', 0.4185),\n",
       "  ('surgery effect', 0.3893),\n",
       "  ('hepatic glucose', 0.3803),\n",
       "  ('dramatic reversal', 0.3679),\n",
       "  ('suppresses glucose', 0.3455),\n",
       "  ('rate fatty', 0.3309),\n",
       "  ('balance established', 0.3235),\n",
       "  ('secretion reversible', 0.2962),\n",
       "  ('return normal', 0.282),\n",
       "  ('dynamic defects', 0.2791),\n",
       "  ('resistance beta', 0.2767),\n",
       "  ('sensitivity restored', 0.273),\n",
       "  ('changes immediately', 0.2687),\n",
       "  ('liver causes', 0.2575),\n",
       "  ('levels fall', 0.2549),\n",
       "  ('triacylglycerol', 0.2527),\n",
       "  ('restriction', 0.2388),\n",
       "  ('established disease', 0.2228),\n",
       "  ('acids derived', 0.212),\n",
       "  ('dysfunction', 0.2096),\n",
       "  ('restoration', 0.208),\n",
       "  ('sequence pathogenesis', 0.1881),\n",
       "  ('progresses ectopic', 0.1687),\n",
       "  ('maintain plasma', 0.1502),\n",
       "  ('clear picture', 0.1375),\n",
       "  ('facilitates development', 0.1349),\n",
       "  ('mediated', 0.1207),\n",
       "  ('combining information', 0.1113),\n",
       "  ('days', 0.11),\n",
       "  ('essential time', 0.1035),\n",
       "  ('quantifying major', 0.0897),\n",
       "  ('muscle remains', 0.0877),\n",
       "  ('prospective observation', 0.0863),\n",
       "  ('events', 0.0863),\n",
       "  ('explicable', 0.0768),\n",
       "  ('positive energy', 0.0739),\n",
       "  ('environmental factors', 0.0718),\n",
       "  ('weeks months', 0.0524),\n",
       "  ('caused inherited', 0.0148),\n",
       "  ('solely terms', 0.0035),\n",
       "  ('circulating locally', -0.0085),\n",
       "  ('cells increased', -0.0106)],\n",
       " 'MED-1237': [('diabetes reverse', 0.6619),\n",
       "  ('diabetes disproves', 0.6049),\n",
       "  ('diabetes depends', 0.6047),\n",
       "  ('days bariatric', 0.46),\n",
       "  ('chronic calorie', 0.454),\n",
       "  ('insulin sensitivity', 0.4291),\n",
       "  ('metabolic inhibition', 0.4274),\n",
       "  ('decrease food', 0.4269),\n",
       "  ('fat normalisation', 0.4005),\n",
       "  ('beta cell', 0.3883),\n",
       "  ('metabolism days', 0.3843),\n",
       "  ('fasting glucose', 0.3762),\n",
       "  ('profound decrease', 0.3606),\n",
       "  ('hyperglycaemia clear', 0.3032),\n",
       "  ('irreversible', 0.2937),\n",
       "  ('low calorie', 0.2885),\n",
       "  ('diet novel', 0.2858),\n",
       "  ('events reversal', 0.2746),\n",
       "  ('meals onset', 0.2617),\n",
       "  ('cell damage', 0.2511),\n",
       "  ('depends sudden', 0.2462),\n",
       "  ('disproves', 0.2408),\n",
       "  ('resolution hepatic', 0.2291),\n",
       "  ('spill pancreas', 0.2274),\n",
       "  ('observe pathophysiological', 0.2255),\n",
       "  ('fall liver', 0.2228),\n",
       "  ('cycle hypothesis', 0.2083),\n",
       "  ('effect counterpoint', 0.2013),\n",
       "  ('step fall', 0.1921),\n",
       "  ('progressive', 0.1696),\n",
       "  ('function restored', 0.1605),\n",
       "  ('life long', 0.1492),\n",
       "  ('concept doubt', 0.1428),\n",
       "  ('direct surgical', 0.1283),\n",
       "  ('intake does', 0.1235),\n",
       "  ('results showed', 0.1193),\n",
       "  ('measure intra', 0.1181),\n",
       "  ('postulates', 0.1022),\n",
       "  ('showed different', 0.097),\n",
       "  ('magnetic resonance', 0.0955),\n",
       "  ('demonstrated normal', 0.0887),\n",
       "  ('organ', 0.078),\n",
       "  ('secretion weeks', 0.0548),\n",
       "  ('courses resolution', 0.0501),\n",
       "  ('accepted type', 0.0396),\n",
       "  ('majority people', -0.0072),\n",
       "  ('identified twin', -0.0173),\n",
       "  ('excess leads', -0.0219),\n",
       "  ('self', -0.0251),\n",
       "  ('people susceptible', -0.0662)],\n",
       " 'MED-1238': [('impaired glucose', 0.5947),\n",
       "  ('fat glucose', 0.5804),\n",
       "  ('changes fatty', 0.5768),\n",
       "  ('metabolism impaired', 0.5643),\n",
       "  ('fat induced', 0.5641),\n",
       "  ('fat inconsistencies', 0.5423),\n",
       "  ('glucose tolerance', 0.536),\n",
       "  ('decreased insulin', 0.5022),\n",
       "  ('inactivity metabolic', 0.4992),\n",
       "  ('metabolic studies', 0.4934),\n",
       "  ('animal fat', 0.4851),\n",
       "  ('insulin insensitivity', 0.4829),\n",
       "  ('obesity', 0.4526),\n",
       "  ('diabetes', 0.4335),\n",
       "  ('induced dietary', 0.4333),\n",
       "  ('relationship dietary', 0.4279),\n",
       "  ('insulin binding', 0.3889),\n",
       "  ('feeding ameliorated', 0.3583),\n",
       "  ('lower intakes', 0.3509),\n",
       "  ('diets independent', 0.3359),\n",
       "  ('60 years', 0.3023),\n",
       "  ('high carbohydrate', 0.2747),\n",
       "  ('impairment associated', 0.2724),\n",
       "  ('monounsaturated polyunsaturated', 0.2621),\n",
       "  ('develop disturbances', 0.26),\n",
       "  ('metabolism fully', 0.2544),\n",
       "  ('transporters related', 0.2509),\n",
       "  ('respect fat', 0.2508),\n",
       "  ('related changes', 0.25),\n",
       "  ('studies suggest', 0.2497),\n",
       "  ('composition membrane', 0.2424),\n",
       "  ('unsaturated', 0.2373),\n",
       "  ('appears deleterious', 0.2068),\n",
       "  ('acid epidemiological', 0.2),\n",
       "  ('experimental animals', 0.1876),\n",
       "  ('inconsistencies data', 0.1805),\n",
       "  ('subjects lower', 0.1803),\n",
       "  ('omega', 0.1469),\n",
       "  ('tolerance', 0.1434),\n",
       "  ('epidemiological data', 0.1366),\n",
       "  ('proportion', 0.1307),\n",
       "  ('basal', 0.1202),\n",
       "  ('prone develop', 0.0965),\n",
       "  ('fully elucidated', 0.0821),\n",
       "  ('humans suggest', 0.0623),\n",
       "  ('years', 0.0593),\n",
       "  ('better measures', 0.0455),\n",
       "  ('sensitivity saturated', 0.0437),\n",
       "  ('clustering high', 0.0416),\n",
       "  ('result better', -0.0104)],\n",
       " 'MED-1240': [('new antiemetic', 0.6036),\n",
       "  ('antiemetics impact', 0.5969),\n",
       "  ('postoperative nausea', 0.5127),\n",
       "  ('drug developments', 0.5108),\n",
       "  ('ward antiemetic', 0.5073),\n",
       "  ('postanesthesia care', 0.4329),\n",
       "  ('vomiting research', 0.4121),\n",
       "  ('antagonist aprepitant', 0.3929),\n",
       "  ('ponv studies', 0.3771),\n",
       "  ('dosing safety', 0.377),\n",
       "  ('understanding prevention', 0.3525),\n",
       "  ('ease dosing', 0.3492),\n",
       "  ('developments helped', 0.3328),\n",
       "  ('impact pharmocogenetics', 0.312),\n",
       "  ('care unit', 0.3022),\n",
       "  ('area postoperative', 0.2866),\n",
       "  ('formulations guidelines', 0.2849),\n",
       "  ('therapy area', 0.2714),\n",
       "  ('postdischarge', 0.2594),\n",
       "  ('guidelines risk', 0.2535),\n",
       "  ('antagonist palonosetron', 0.2522),\n",
       "  ('research initiated', 0.2487),\n",
       "  ('clinical practitioners', 0.2409),\n",
       "  ('efficacy correlated', 0.2347),\n",
       "  ('regarding effects', 0.2344),\n",
       "  ('discharge', 0.2277),\n",
       "  ('meta analysis', 0.2115),\n",
       "  ('introduced updated', 0.2035),\n",
       "  ('help guide', 0.2007),\n",
       "  ('effect ecg', 0.1819),\n",
       "  ('evaluation controversies', 0.1682),\n",
       "  ('phase', 0.1659),\n",
       "  ('stepdown unit', 0.1629),\n",
       "  ('anesthesia samba', 0.1568),\n",
       "  ('patient', 0.1555),\n",
       "  ('introduction', 0.1442),\n",
       "  ('interval butyrophenones', 0.1435),\n",
       "  ('cost safety', 0.1425),\n",
       "  ('concerns arisen', 0.1379),\n",
       "  ('ethics', 0.1293),\n",
       "  ('nk receptor', 0.1164),\n",
       "  ('hydroxytryptamine ht3', 0.1133),\n",
       "  ('prolongation qtc', 0.1097),\n",
       "  ('data existing', 0.0957),\n",
       "  ('genetic makeup', 0.0917),\n",
       "  ('metabolism resulting', 0.0887),\n",
       "  ('depends', 0.05),\n",
       "  ('frontier need', 0.0135),\n",
       "  ('society', -0.0149),\n",
       "  ('second generation', -0.0723)],\n",
       " 'MED-1241': [('aromatherapy postoperative', 0.5267),\n",
       "  ('controlled breathing', 0.4557),\n",
       "  ('ponv relief', 0.3759),\n",
       "  ('nausea vomiting', 0.3492),\n",
       "  ('antiemetics data', 0.3463),\n",
       "  ('rescue medication', 0.3408),\n",
       "  ('blind randomized', 0.3293),\n",
       "  ('symptoms study', 0.3255),\n",
       "  ('postoperative', 0.3225),\n",
       "  ('peppermint ar', 0.3029),\n",
       "  ('intervention based', 0.3014),\n",
       "  ('symptoms 0024', 0.2951),\n",
       "  ('initial treatment', 0.295),\n",
       "  ('subjects ponv', 0.2949),\n",
       "  ('alternative prescribed', 0.2942),\n",
       "  ('evaluated controlled', 0.2587),\n",
       "  ('efficacious ar', 0.2533),\n",
       "  ('risk factor', 0.2447),\n",
       "  ('relief design', 0.2435),\n",
       "  ('26 intervention', 0.2339),\n",
       "  ('support use', 0.2307),\n",
       "  ('society perianesthesia', 0.2266),\n",
       "  ('purpose', 0.2164),\n",
       "  ('16 ar', 0.2087),\n",
       "  ('nurses published', 0.201),\n",
       "  ('little scientific', 0.1945),\n",
       "  ('ar 62', 0.1904),\n",
       "  ('statistically significant', 0.1784),\n",
       "  ('assessment occurred', 0.1782),\n",
       "  ('symptomatic subjects', 0.1754),\n",
       "  ('used methods', 0.1709),\n",
       "  ('design single', 0.1657),\n",
       "  ('versus', 0.1444),\n",
       "  ('196 gender', 0.1351),\n",
       "  ('cb initiated', 0.132),\n",
       "  ('offered persistent', 0.1125),\n",
       "  ('minutes post', 0.107),\n",
       "  ('versus 57', 0.0996),\n",
       "  ('initiated delay', 0.0963),\n",
       "  ('repeated', 0.0943),\n",
       "  ('complaint', 0.0939),\n",
       "  ('scientific evidence', 0.0932),\n",
       "  ('conjunction', 0.0919),\n",
       "  ('enrollment second', 0.0795),\n",
       "  ('received', 0.0743),\n",
       "  ('2014 american', 0.0474),\n",
       "  ('rights', 0.0381),\n",
       "  ('21', 0.008),\n",
       "  ('elsevier', -0.002),\n",
       "  ('occurred 10', -0.0515)],\n",
       " 'MED-1242': [('risk scores', 0.5665),\n",
       "  ('simplified scores', 0.3927),\n",
       "  ('predicting postoperative', 0.3856),\n",
       "  ('postoperative nausea', 0.3795),\n",
       "  ('regression analyses', 0.368),\n",
       "  ('patients identified', 0.3574),\n",
       "  ('recently centers', 0.3348),\n",
       "  ('present incidences', 0.3059),\n",
       "  ('centers oulu', 0.2953),\n",
       "  ('prophylaxis various', 0.2865),\n",
       "  ('odds ratio', 0.2801),\n",
       "  ('opioids risk', 0.2746),\n",
       "  ('types surgery', 0.2703),\n",
       "  ('ponv study', 0.2545),\n",
       "  ('validated combined', 0.2534),\n",
       "  ('analyses original', 0.2462),\n",
       "  ('methods', 0.2386),\n",
       "  ('operating characteristic', 0.2372),\n",
       "  ('power methods', 0.2287),\n",
       "  ('anesthesia', 0.219),\n",
       "  ('estimate potential', 0.2151),\n",
       "  ('study investigated', 0.2091),\n",
       "  ('independently developed', 0.2061),\n",
       "  ('curves results', 0.2059),\n",
       "  ('significant', 0.2037),\n",
       "  ('adult patients', 0.2002),\n",
       "  ('95 confidence', 0.1858),\n",
       "  ('background recently', 0.1856),\n",
       "  ('based logistic', 0.182),\n",
       "  ('final score', 0.1775),\n",
       "  ('24 surgery', 0.1718),\n",
       "  ('scores cross', 0.1604),\n",
       "  ('simplification did', 0.16),\n",
       "  ('finland 520', 0.1504),\n",
       "  ('interval 71', 0.1491),\n",
       "  ('weaken discriminating', 0.131),\n",
       "  ('79 conclusions', 0.1291),\n",
       "  ('predictors female', 0.1215),\n",
       "  ('motion sickness', 0.1063),\n",
       "  ('received inhalational', 0.0966),\n",
       "  ('using area', 0.093),\n",
       "  ('ratio 06', 0.0891),\n",
       "  ('broad applicability', 0.0791),\n",
       "  ('63', 0.0694),\n",
       "  ('nonsmoking', 0.0645),\n",
       "  ('wuerzburg germany', 0.04),\n",
       "  ('2202 received', 0.0357),\n",
       "  ('significant loss', 0.0309),\n",
       "  ('10', -0.0064),\n",
       "  ('receiver', -0.0284)],\n",
       " 'MED-1243': [('prophylactic ondansetron', 0.5608),\n",
       "  ('prophylactic antiemetic', 0.5032),\n",
       "  ('anesthesia prophylactic', 0.4784),\n",
       "  ('antiemetic incidence', 0.4721),\n",
       "  ('treatment ponv', 0.4421),\n",
       "  ('treated prophylactically', 0.4206),\n",
       "  ('scores nausea', 0.4184),\n",
       "  ('promethazine purpose', 0.4142),\n",
       "  ('postoperatively iv', 0.4108),\n",
       "  ('antiemetic mg', 0.3922),\n",
       "  ('vomiting ponv', 0.3866),\n",
       "  ('risk postoperative', 0.3842),\n",
       "  ('frequently patients', 0.3354),\n",
       "  ('vomiting', 0.3298),\n",
       "  ('intravenous', 0.3237),\n",
       "  ('patients administered', 0.3188),\n",
       "  ('using aromatic', 0.3126),\n",
       "  ('isopropyl alcohol', 0.31),\n",
       "  ('breakthrough ponv', 0.3037),\n",
       "  ('recommend inhalation', 0.2958),\n",
       "  ('option treatment', 0.2954),\n",
       "  ('therapy 70', 0.2942),\n",
       "  ('mg iv', 0.2915),\n",
       "  ('reduction vnrs', 0.2911),\n",
       "  ('symptoms groups', 0.2787),\n",
       "  ('ipa group', 0.2613),\n",
       "  ('incidence', 0.229),\n",
       "  ('study determine', 0.1904),\n",
       "  ('included analysis', 0.187),\n",
       "  ('requirements similar', 0.1861),\n",
       "  ('findings recommend', 0.1813),\n",
       "  ('administered general', 0.1808),\n",
       "  ('alcohol', 0.16),\n",
       "  ('faster time', 0.1584),\n",
       "  ('resolution breakthrough', 0.1578),\n",
       "  ('randomized', 0.1577),\n",
       "  ('effective', 0.1417),\n",
       "  ('frequently', 0.1261),\n",
       "  ('measurements noted', 0.1199),\n",
       "  ('differences', 0.1119),\n",
       "  ('group', 0.0852),\n",
       "  ('identified high', 0.085),\n",
       "  ('demographics verbal', 0.0827),\n",
       "  ('data 85', 0.0772),\n",
       "  ('subjects enrolled', 0.0749),\n",
       "  ('scores decreased', 0.0653),\n",
       "  ('received', 0.0632),\n",
       "  ('numeric rating', 0.0609),\n",
       "  ('baseline', 0.0244),\n",
       "  ('time 50', -0.0035)],\n",
       " 'MED-1244': [('inhaled peppermint', 0.5076),\n",
       "  ('nausea study', 0.478),\n",
       "  ('nauseated post', 0.4308),\n",
       "  ('intervention groups', 0.4005),\n",
       "  ('spirits placebo', 0.3778),\n",
       "  ('operatively participants', 0.354),\n",
       "  ('standard antiemetics', 0.3428),\n",
       "  ('posttest research', 0.3427),\n",
       "  ('spirits group', 0.3055),\n",
       "  ('design pretest', 0.303),\n",
       "  ('administered', 0.2956),\n",
       "  ('methods women', 0.2925),\n",
       "  ('research design', 0.2762),\n",
       "  ('examined effect', 0.2756),\n",
       "  ('nurses', 0.2694),\n",
       "  ('post operatively', 0.2604),\n",
       "  ('reassessed participants', 0.255),\n",
       "  ('participants using', 0.2507),\n",
       "  ('promethazine', 0.2475),\n",
       "  ('group significantly', 0.246),\n",
       "  ('preoperative diagnoses', 0.2442),\n",
       "  ('suppositories methods', 0.2441),\n",
       "  ('aromatherapy control', 0.2399),\n",
       "  ('control group', 0.2348),\n",
       "  ('mother baby', 0.2273),\n",
       "  ('section design', 0.2264),\n",
       "  ('usually intravenous', 0.2248),\n",
       "  ('levels', 0.2194),\n",
       "  ('group inhaled', 0.2181),\n",
       "  ('received standard', 0.2176),\n",
       "  ('purpose', 0.2113),\n",
       "  ('participants rated', 0.2095),\n",
       "  ('findings', 0.2068),\n",
       "  ('water', 0.1989),\n",
       "  ('thirty', 0.1914),\n",
       "  ('baseline administered', 0.1896),\n",
       "  ('study replicated', 0.1891),\n",
       "  ('adjunct treatment', 0.1872),\n",
       "  ('inert placebo', 0.1839),\n",
       "  ('groups minutes', 0.1752),\n",
       "  ('initial', 0.1585),\n",
       "  ('unit assessed', 0.1385),\n",
       "  ('randomly assigned', 0.1384),\n",
       "  ('similar', 0.1123),\n",
       "  ('different', 0.1089),\n",
       "  ('admission hospital', 0.106),\n",
       "  ('significantly lower', 0.0999),\n",
       "  ('ondansetron', 0.0963),\n",
       "  ('green colored', 0.0572),\n",
       "  ('using point', 0.0041)],\n",
       " 'MED-1245': [('postoperative nausea', 0.5722),\n",
       "  ('postdischarge nausea', 0.5128),\n",
       "  ('vomiting ponv', 0.4627),\n",
       "  ('vomiting pdnv', 0.4433),\n",
       "  ('mainstay antiemetic', 0.3844),\n",
       "  ('surgeries comprise', 0.3483),\n",
       "  ('30 surgeries', 0.3339),\n",
       "  ('ponv continues', 0.2806),\n",
       "  ('risk patients', 0.275),\n",
       "  ('pdnv especially', 0.2634),\n",
       "  ('prevent treat', 0.2594),\n",
       "  ('care facilities', 0.254),\n",
       "  ('multimodal management', 0.2526),\n",
       "  ('populations prophylaxis', 0.2485),\n",
       "  ('postdischarge', 0.2476),\n",
       "  ('hydroxytryptamine type', 0.2382),\n",
       "  ('patients spend', 0.2369),\n",
       "  ('inpatient', 0.2332),\n",
       "  ('antagonists longer', 0.2312),\n",
       "  ('common complaints', 0.2195),\n",
       "  ('continue mainstay', 0.2155),\n",
       "  ('high risk', 0.1929),\n",
       "  ('acting serotonin', 0.1764),\n",
       "  ('antagonist multimodal', 0.1617),\n",
       "  ('providers issues', 0.1492),\n",
       "  ('approaches neurokinin', 0.1461),\n",
       "  ('million ambulatory', 0.1314),\n",
       "  ('facilities particularly', 0.1211),\n",
       "  ('published elsevier', 0.0952),\n",
       "  ('related problem', 0.0941),\n",
       "  ('management novel', 0.0932),\n",
       "  ('especially significant', 0.0863),\n",
       "  ('increasing attention', 0.0825),\n",
       "  ('health', 0.0795),\n",
       "  ('swiftly effectively', 0.0652),\n",
       "  ('techniques', 0.0641),\n",
       "  ('60 combined', 0.0597),\n",
       "  ('continues common', 0.0468),\n",
       "  ('visits united', 0.0383),\n",
       "  ('receptor', 0.0215),\n",
       "  ('ht', 0.0148),\n",
       "  ('newer', 0.0073),\n",
       "  ('56 million', 0.0072),\n",
       "  ('states relatively', -0.0068),\n",
       "  ('gaining', -0.0086),\n",
       "  ('brief', -0.0226),\n",
       "  ('70 80', -0.0232),\n",
       "  ('prominence related', -0.0299),\n",
       "  ('significant context', -0.0664),\n",
       "  ('effectively copyright', -0.0823)],\n",
       " 'MED-1246': [('nausea investigators', 0.6075),\n",
       "  ('nausea pacu', 0.5069),\n",
       "  ('randomized aromatherapy', 0.4926),\n",
       "  ('nausea 100', 0.4865),\n",
       "  ('aromatherapy isopropyl', 0.4391),\n",
       "  ('antiemetic therapy', 0.3917),\n",
       "  ('33 ambulatory', 0.3611),\n",
       "  ('reduce postoperative', 0.3596),\n",
       "  ('se aromatherapy', 0.3515),\n",
       "  ('subjects rated', 0.3325),\n",
       "  ('surgery patients', 0.3242),\n",
       "  ('placebo vapors', 0.3187),\n",
       "  ('controlled breathing', 0.3179),\n",
       "  ('differ treatments', 0.3098),\n",
       "  ('severity postoperative', 0.3039),\n",
       "  ('therapy pacu', 0.3036),\n",
       "  ('independent treatment', 0.2644),\n",
       "  ('scale vas', 0.2603),\n",
       "  ('actual aroma', 0.2539),\n",
       "  ('effective alcohol', 0.2523),\n",
       "  ('mouth minutes', 0.2383),\n",
       "  ('received randomized', 0.2012),\n",
       "  ('overall satisfaction', 0.1942),\n",
       "  ('pacu stay', 0.1885),\n",
       "  ('investigators', 0.182),\n",
       "  ('complained', 0.177),\n",
       "  ('suggests beneficial', 0.1638),\n",
       "  ('fact saline', 0.1637),\n",
       "  ('scores decreased', 0.1587),\n",
       "  ('conventional intravenous', 0.1568),\n",
       "  ('scented gauze', 0.1557),\n",
       "  ('exhaled', 0.1542),\n",
       "  ('mean se', 0.1486),\n",
       "  ('100 mm', 0.1451),\n",
       "  ('studied', 0.1412),\n",
       "  ('nostrils', 0.1399),\n",
       "  ('group', 0.1355),\n",
       "  ('visual', 0.1316),\n",
       "  ('oil', 0.1282),\n",
       "  ('005', 0.1206),\n",
       "  ('management 86', 0.1101),\n",
       "  ('deeply nose', 0.1084),\n",
       "  ('52 patients', 0.0933),\n",
       "  ('28 mm', 0.0907),\n",
       "  ('pads held', 0.0894),\n",
       "  ('peppermint', 0.077),\n",
       "  ('43 mm', 0.045),\n",
       "  ('directly beneath', 0.0298),\n",
       "  ('later', -0.0045),\n",
       "  ('60', -0.0178)],\n",
       " 'MED-1247': [('chemotherapy induced', 0.4645),\n",
       "  ('determining efficacy', 0.4562),\n",
       "  ('trial study', 0.4423),\n",
       "  ('treatment groups', 0.4371),\n",
       "  ('spicata mentha', 0.4213),\n",
       "  ('regimen patients', 0.4174),\n",
       "  ('mentha piperita', 0.3971),\n",
       "  ('methods randomised', 0.3871),\n",
       "  ('vomiting cinv', 0.3654),\n",
       "  ('treatment reduced', 0.359),\n",
       "  ('study patients', 0.3568),\n",
       "  ('study aimed', 0.3555),\n",
       "  ('cinv methods', 0.3447),\n",
       "  ('previous antiemetic', 0.3131),\n",
       "  ('induced nausea', 0.3111),\n",
       "  ('piperita placebo', 0.2837),\n",
       "  ('treatment placebo', 0.2829),\n",
       "  ('mentha', 0.2676),\n",
       "  ('spicata spicata', 0.2662),\n",
       "  ('effects reported', 0.2651),\n",
       "  ('eligibility criteria', 0.2616),\n",
       "  ('patients randomly', 0.2409),\n",
       "  ('compared control', 0.21),\n",
       "  ('statistical', 0.1904),\n",
       "  ('clinical', 0.1823),\n",
       "  ('analysed group', 0.1769),\n",
       "  ('relative risk', 0.1767),\n",
       "  ('05 compared', 0.1608),\n",
       "  ('cost effective', 0.1585),\n",
       "  ('results significant', 0.1531),\n",
       "  ('patients cost', 0.151),\n",
       "  ('intensity number', 0.147),\n",
       "  ('essential', 0.1297),\n",
       "  ('included χ2', 0.1293),\n",
       "  ('possible', 0.1257),\n",
       "  ('test courses', 0.1244),\n",
       "  ('blind', 0.1204),\n",
       "  ('control', 0.1112),\n",
       "  ('events 24', 0.095),\n",
       "  ('double', 0.0895),\n",
       "  ('occurred time', 0.0854),\n",
       "  ('used conclusion', 0.0804),\n",
       "  ('emetic events', 0.0787),\n",
       "  ('group continued', 0.0705),\n",
       "  ('met', 0.0451),\n",
       "  ('safe effective', 0.0352),\n",
       "  ('oils used', 0.0322),\n",
       "  ('patients guardians', 0.0246),\n",
       "  ('prior', 0.0074),\n",
       "  ('20', 0.0034)],\n",
       " 'MED-1248': [('anaesthesia preferring', 0.4873),\n",
       "  ('patients thought', 0.4806),\n",
       "  ('prescribers rectal', 0.4769),\n",
       "  ('prefer medication', 0.4599),\n",
       "  ('want analgesic', 0.45),\n",
       "  ('rectal drug', 0.4407),\n",
       "  ('whilst anaesthesia', 0.4275),\n",
       "  ('analgesic drug', 0.4245),\n",
       "  ('medication mouth', 0.4199),\n",
       "  ('drugs administered', 0.4151),\n",
       "  ('rectal diclofenac', 0.4113),\n",
       "  ('thought drugs', 0.4102),\n",
       "  ('attitudes rectal', 0.4079),\n",
       "  ('discuss patients', 0.3877),\n",
       "  ('administration patients', 0.3836),\n",
       "  ('patients pre', 0.381),\n",
       "  ('adult patients', 0.3807),\n",
       "  ('suggest prescribers', 0.377),\n",
       "  ('medication', 0.3767),\n",
       "  ('preferring orally', 0.3604),\n",
       "  ('patients attending', 0.3524),\n",
       "  ('surgery surveyed', 0.3468),\n",
       "  ('patients sensitive', 0.3449),\n",
       "  ('pre operatively', 0.3365),\n",
       "  ('rectum', 0.3198),\n",
       "  ('diclofenac discuss', 0.313),\n",
       "  ('young patients', 0.3016),\n",
       "  ('patients did', 0.2979),\n",
       "  ('ninety patients', 0.2824),\n",
       "  ('determine attitudes', 0.2304),\n",
       "  ('orally available', 0.2286),\n",
       "  ('mouth', 0.2283),\n",
       "  ('route administration', 0.2051),\n",
       "  ('anonymous questionnaire', 0.1808),\n",
       "  ('sodium administered', 0.1738),\n",
       "  ('sensitive prefer', 0.1564),\n",
       "  ('suppositories', 0.1525),\n",
       "  ('surveyed', 0.1492),\n",
       "  ('strong feelings', 0.1415),\n",
       "  ('administered', 0.1259),\n",
       "  ('feelings route', 0.1219),\n",
       "  ('attending', 0.1061),\n",
       "  ('did want', 0.0981),\n",
       "  ('thought', 0.0948),\n",
       "  ('order', 0.0816),\n",
       "  ('day case', 0.0798),\n",
       "  ('discussed strong', 0.0628),\n",
       "  ('happy', -0.0101),\n",
       "  ('did', -0.0306),\n",
       "  ('whilst', -0.0393)],\n",
       " 'MED-1249': [('protein diet', 0.6431),\n",
       "  ('diets similar', 0.5844),\n",
       "  ('conventional diet', 0.5537),\n",
       "  ('diet containing', 0.5343),\n",
       "  ('effect dietary', 0.5172),\n",
       "  ('diet replaced', 0.4761),\n",
       "  ('cholesterol levels', 0.4708),\n",
       "  ('feeding conventional', 0.4376),\n",
       "  ('diet animal', 0.4354),\n",
       "  ('studies feeding', 0.4272),\n",
       "  ('fat', 0.4239),\n",
       "  ('protein level', 0.4169),\n",
       "  ('healthy normolipidemic', 0.4159),\n",
       "  ('diet second', 0.4133),\n",
       "  ('mixed protein', 0.3646),\n",
       "  ('carbohydrate', 0.3605),\n",
       "  ('composition study', 0.3432),\n",
       "  ('animal protein', 0.3371),\n",
       "  ('sterol composition', 0.3127),\n",
       "  ('replaced soy', 0.2859),\n",
       "  ('respect carbohydrate', 0.2554),\n",
       "  ('study incorporated', 0.25),\n",
       "  ('women investigated', 0.2432),\n",
       "  ('meat', 0.2382),\n",
       "  ('mean plasma', 0.2171),\n",
       "  ('milk', 0.185),\n",
       "  ('subjects study', 0.1826),\n",
       "  ('level significantly', 0.1622),\n",
       "  ('subjects gave', 0.1513),\n",
       "  ('healthy', 0.1455),\n",
       "  ('73', 0.1437),\n",
       "  ('investigated separate', 0.1166),\n",
       "  ('analogues', 0.1162),\n",
       "  ('containing mixed', 0.1066),\n",
       "  ('plant', 0.1044),\n",
       "  ('significantly lower', 0.1032),\n",
       "  ('number improvements', 0.1027),\n",
       "  ('design involving', 0.0855),\n",
       "  ('young', 0.0853),\n",
       "  ('used cross', 0.0807),\n",
       "  ('second', 0.0674),\n",
       "  ('similar', 0.0605),\n",
       "  ('used', 0.0557),\n",
       "  ('gave indication', 0.0486),\n",
       "  ('days used', 0.0475),\n",
       "  ('involving groups', 0.0474),\n",
       "  ('based experience', 0.0183),\n",
       "  ('lasted 78', -0.01),\n",
       "  ('lasted', -0.0111),\n",
       "  ('animal', -0.0168)],\n",
       " 'MED-1250': [('protein diets', 0.5841),\n",
       "  ('subjects fed', 0.526),\n",
       "  ('diets mean', 0.5149),\n",
       "  ('lipid levels', 0.4525),\n",
       "  ('normolipidemic men', 0.4513),\n",
       "  ('diets cross', 0.445),\n",
       "  ('design diet', 0.4341),\n",
       "  ('subjects consumed', 0.4235),\n",
       "  ('plant proteins', 0.4017),\n",
       "  ('fed plant', 0.3927),\n",
       "  ('animal protein', 0.3701),\n",
       "  ('cholesterol subjects', 0.3547),\n",
       "  ('indicated ingestion', 0.3512),\n",
       "  ('protein blood', 0.3344),\n",
       "  ('protein substituted', 0.3242),\n",
       "  ('supplied beef', 0.3052),\n",
       "  ('fasting', 0.2981),\n",
       "  ('men aged', 0.2842),\n",
       "  ('55 plant', 0.2825),\n",
       "  ('hypercholesterolemic effect', 0.2779),\n",
       "  ('fed 42', 0.2664),\n",
       "  ('yr subjects', 0.2541),\n",
       "  ('investigated healthy', 0.2472),\n",
       "  ('period proteins', 0.2365),\n",
       "  ('study serum', 0.2311),\n",
       "  ('mean plasma', 0.2287),\n",
       "  ('beginning study', 0.1616),\n",
       "  ('samples collected', 0.1599),\n",
       "  ('levels significantly', 0.1571),\n",
       "  ('analyzed total', 0.1537),\n",
       "  ('84 12', 0.1244),\n",
       "  ('compared period', 0.1228),\n",
       "  ('day intervals', 0.1127),\n",
       "  ('commonly used', 0.1125),\n",
       "  ('sources', 0.1032),\n",
       "  ('significant differences', 0.1011),\n",
       "  ('consumed 48', 0.0985),\n",
       "  ('significantly 05', 0.093),\n",
       "  ('21', 0.0911),\n",
       "  ('increased', 0.0849),\n",
       "  ('aged 18', 0.0813),\n",
       "  ('effect', 0.08),\n",
       "  ('dl compared', 0.0769),\n",
       "  ('136', 0.0732),\n",
       "  ('19 mg', 0.064),\n",
       "  ('young', 0.0601),\n",
       "  ('27 yr', 0.0289),\n",
       "  ('venous blood', -0.0107),\n",
       "  ('low density', -0.0154),\n",
       "  ('animal', -0.0187)],\n",
       " 'MED-1252': [('diets proteins', 0.5694),\n",
       "  ('diets low', 0.5346),\n",
       "  ('dietary cholesterol', 0.483),\n",
       "  ('diet groups', 0.462),\n",
       "  ('mixed diets', 0.4484),\n",
       "  ('low cholesterol', 0.441),\n",
       "  ('polyunsaturated saturated', 0.4295),\n",
       "  ('fat 05', 0.4252),\n",
       "  ('decreased dietary', 0.4197),\n",
       "  ('lipoprotein', 0.4139),\n",
       "  ('animal fats', 0.386),\n",
       "  ('dl diets', 0.3852),\n",
       "  ('protein mixed', 0.3847),\n",
       "  ('individuals hypocholesterolemic', 0.3806),\n",
       "  ('35 dietary', 0.3719),\n",
       "  ('cholesterol remained', 0.3573),\n",
       "  ('menus contributed', 0.3564),\n",
       "  ('soy animal', 0.3426),\n",
       "  ('young men', 0.335),\n",
       "  ('energy protein', 0.3156),\n",
       "  ('proteins isolated', 0.2836),\n",
       "  ('animal proteins', 0.2815),\n",
       "  ('65 mixed', 0.2773),\n",
       "  ('cholesterol 16', 0.2493),\n",
       "  ('mg dl', 0.1963),\n",
       "  ('identical menus', 0.1929),\n",
       "  ('saturated', 0.1753),\n",
       "  ('added balance', 0.1734),\n",
       "  ('protein 30', 0.1707),\n",
       "  ('egg yolk', 0.1631),\n",
       "  ('vegetables', 0.1572),\n",
       "  ('slightly high', 0.152),\n",
       "  ('200 mg', 0.1516),\n",
       "  ('mean reduction', 0.1481),\n",
       "  ('16 13', 0.141),\n",
       "  ('elevated plasma', 0.1393),\n",
       "  ('remained constant', 0.0928),\n",
       "  ('classified', 0.0838),\n",
       "  ('nonresponders', 0.0777),\n",
       "  ('subjects', 0.0773),\n",
       "  ('307 mg', 0.0757),\n",
       "  ('grains', 0.0728),\n",
       "  ('effects similar', 0.0676),\n",
       "  ('24 subjects', 0.0634),\n",
       "  ('groups significantly', 0.0461),\n",
       "  ('001', 0.0408),\n",
       "  ('substituting', 0.0262),\n",
       "  ('218', 0.0009),\n",
       "  ('end protocol', -0.0196),\n",
       "  ('extracted animal', -0.0295)],\n",
       " 'MED-1253': [('dietary intervention', 0.5367),\n",
       "  ('studies fat', 0.4773),\n",
       "  ('intervention study', 0.4393),\n",
       "  ('compared soy', 0.4153),\n",
       "  ('replacement meat', 0.3856),\n",
       "  ('meat tofu', 0.3824),\n",
       "  ('ldl reduction', 0.3699),\n",
       "  ('additional subjects', 0.3368),\n",
       "  ('macronutrients fibre', 0.3321),\n",
       "  ('triglycerides mean', 0.3175),\n",
       "  ('meat 150', 0.3092),\n",
       "  ('polyunsaturated', 0.2939),\n",
       "  ('hdl small', 0.2777),\n",
       "  ('design randomized', 0.2766),\n",
       "  ('replacing lean', 0.2603),\n",
       "  ('healthy males', 0.2583),\n",
       "  ('35', 0.2492),\n",
       "  ('textured protein', 0.2121),\n",
       "  ('isoprotein substitution', 0.2111),\n",
       "  ('serum', 0.1953),\n",
       "  ('differ studies', 0.1935),\n",
       "  ('enhance small', 0.1832),\n",
       "  ('95 ci', 0.1815),\n",
       "  ('results seven', 0.1778),\n",
       "  ('isocaloric', 0.1766),\n",
       "  ('62 completed', 0.176),\n",
       "  ('objectives', 0.1734),\n",
       "  ('15 mmol', 0.1708),\n",
       "  ('prior analysis', 0.1707),\n",
       "  ('saturated', 0.1686),\n",
       "  ('concentrations study', 0.1566),\n",
       "  ('carefully controlled', 0.1397),\n",
       "  ('2000 54', 0.1384),\n",
       "  ('associated decrease', 0.136),\n",
       "  ('compliant excluded', 0.1345),\n",
       "  ('31 017', 0.1343),\n",
       "  ('european journal', 0.128),\n",
       "  ('43 03', 0.123),\n",
       "  ('mmol', 0.1201),\n",
       "  ('compared 290', 0.1025),\n",
       "  ('02 14', 0.0956),\n",
       "  ('influence', 0.0889),\n",
       "  ('aged', 0.0806),\n",
       "  ('free living', 0.0779),\n",
       "  ('university contribution', 0.0772),\n",
       "  ('19', 0.0354),\n",
       "  ('periods month', 0.0299),\n",
       "  ('difference 08', 0.0284),\n",
       "  ('contribution commonwealth', 0.0078),\n",
       "  ('veterans affairs', -0.0248)],\n",
       " 'MED-1254': [('meat soy', 0.4726),\n",
       "  ('ldl oxidation', 0.4526),\n",
       "  ('diet compared', 0.4356),\n",
       "  ('compared meat', 0.4253),\n",
       "  ('saturated fat', 0.4083),\n",
       "  ('vitro ldl', 0.4035),\n",
       "  ('lipoproteins', 0.3408),\n",
       "  ('intervention subjects', 0.3313),\n",
       "  ('oxidation design', 0.3077),\n",
       "  ('triglycerides significantly', 0.2988),\n",
       "  ('affected tofu', 0.2607),\n",
       "  ('design randomized', 0.2569),\n",
       "  ('decrease coronary', 0.2553),\n",
       "  ('risk factors', 0.2547),\n",
       "  ('studied deakin', 0.2519),\n",
       "  ('isoprotein substitution', 0.2348),\n",
       "  ('individuals studied', 0.2335),\n",
       "  ('total cholesterol', 0.2275),\n",
       "  ('replacing lean', 0.2132),\n",
       "  ('results analysis', 0.2085),\n",
       "  ('including serum', 0.2023),\n",
       "  ('objective investigate', 0.193),\n",
       "  ('heart disease', 0.19),\n",
       "  ('vii fibrinogen', 0.1834),\n",
       "  ('lower vitro', 0.1811),\n",
       "  ('compared', 0.1762),\n",
       "  ('35', 0.1704),\n",
       "  ('protein', 0.1548),\n",
       "  ('significantly affected', 0.1431),\n",
       "  ('living healthy', 0.1416),\n",
       "  ('ratio alcohol', 0.1391),\n",
       "  ('university subjects', 0.134),\n",
       "  ('conclusions increase', 0.1321),\n",
       "  ('day isocaloric', 0.1219),\n",
       "  ('fiber', 0.1021),\n",
       "  ('significantly longer', 0.094),\n",
       "  ('males aged', 0.0887),\n",
       "  ('lag phase', 0.0816),\n",
       "  ('expected associated', 0.0805),\n",
       "  ('cross', 0.0718),\n",
       "  ('62', 0.0678),\n",
       "  ('years completed', 0.0628),\n",
       "  ('containing 150', 0.0623),\n",
       "  ('290', 0.052),\n",
       "  ('setting free', 0.0458),\n",
       "  ('similar energy', 0.0292),\n",
       "  ('seven day', 0.017),\n",
       "  ('grams', 0.0072),\n",
       "  ('month duration', -0.0186),\n",
       "  ('compliant excluded', -0.0213)],\n",
       " 'MED-1256': [('effects beef', 0.567),\n",
       "  ('processed meats', 0.3976),\n",
       "  ('rcts identified', 0.3951),\n",
       "  ('consumption red', 0.3198),\n",
       "  ('limited consumption', 0.3073),\n",
       "  ('strategies reduce', 0.3053),\n",
       "  ('included analysis', 0.292),\n",
       "  ('cardiovascular risk', 0.2744),\n",
       "  ('chd role', 0.2727),\n",
       "  ('changes fasting', 0.2646),\n",
       "  ('evaluate effects', 0.2563),\n",
       "  ('12 mg', 0.2283),\n",
       "  ('total cholesterol', 0.226),\n",
       "  ('conclusion changes', 0.2161),\n",
       "  ('versus poultry', 0.2043),\n",
       "  ('relative baseline', 0.2041),\n",
       "  ('available food', 0.2031),\n",
       "  ('905', 0.1887),\n",
       "  ('adherence dietary', 0.1845),\n",
       "  ('adverse', 0.1773),\n",
       "  ('inclusion lean', 0.172),\n",
       "  ('meta', 0.1666),\n",
       "  ('unclear objective', 0.162),\n",
       "  ('vs low', 0.1573),\n",
       "  ('plays', 0.1563),\n",
       "  ('background', 0.1435),\n",
       "  ('association published', 0.1397),\n",
       "  ('2012 national', 0.1294),\n",
       "  ('choices', 0.1246),\n",
       "  ('triacylglycerols 367', 0.1207),\n",
       "  ('published 1950', 0.1161),\n",
       "  ('promoting', 0.1142),\n",
       "  ('lipids methods', 0.0876),\n",
       "  ('variety available', 0.0818),\n",
       "  ('met prespecified', 0.0794),\n",
       "  ('disease total', 0.0787),\n",
       "  ('762 vs', 0.074),\n",
       "  ('respectively vs', 0.0714),\n",
       "  ('fish', 0.0694),\n",
       "  ('standard error', 0.0642),\n",
       "  ('long', 0.0579),\n",
       "  ('total 124', 0.0461),\n",
       "  ('2010 considered', 0.0381),\n",
       "  ('national', 0.0237),\n",
       "  ('free chronic', 0.0204),\n",
       "  ('rights reserved', -0.0069),\n",
       "  ('published elsevier', -0.009),\n",
       "  ('630', -0.0097),\n",
       "  ('406 subjects', -0.0137),\n",
       "  ('profile significantly', -0.0823)],\n",
       " 'MED-1257': [('meat protein', 0.6343),\n",
       "  ('red meat', 0.4992),\n",
       "  ('diets high', 0.4586),\n",
       "  ('weight gain', 0.4463),\n",
       "  ('compared diets', 0.4412),\n",
       "  ('meat low', 0.4271),\n",
       "  ('insulin resistance', 0.4257),\n",
       "  ('fat', 0.4123),\n",
       "  ('intake associated', 0.3645),\n",
       "  ('diets low', 0.3533),\n",
       "  ('vegetable protein', 0.3303),\n",
       "  ('protein appeared', 0.3179),\n",
       "  ('associated 13', 0.302),\n",
       "  ('reductions ldl', 0.2991),\n",
       "  ('chd compared', 0.2883),\n",
       "  ('metabolic', 0.2821),\n",
       "  ('carbohydrate', 0.2791),\n",
       "  ('weight lower', 0.2745),\n",
       "  ('poultry', 0.2704),\n",
       "  ('heart association', 0.2605),\n",
       "  ('low red', 0.2576),\n",
       "  ('soy interventions', 0.2534),\n",
       "  ('increase risk', 0.2433),\n",
       "  ('interventions assessed', 0.2383),\n",
       "  ('years kg', 0.2315),\n",
       "  ('association associated', 0.2314),\n",
       "  ('nuts low', 0.219),\n",
       "  ('day nurses', 0.2124),\n",
       "  ('higher total', 0.2019),\n",
       "  ('syndrome long', 0.2011),\n",
       "  ('fish associated', 0.1964),\n",
       "  ('mortality rate', 0.1941),\n",
       "  ('125', 0.194),\n",
       "  ('health', 0.1889),\n",
       "  ('recent data', 0.1758),\n",
       "  ('shown effects', 0.1478),\n",
       "  ('resistance', 0.1474),\n",
       "  ('rate', 0.1235),\n",
       "  ('dairy', 0.1196),\n",
       "  ('months', 0.1168),\n",
       "  ('study', 0.1163),\n",
       "  ('disease', 0.1127),\n",
       "  ('containing', 0.1018),\n",
       "  ('associated small', 0.0787),\n",
       "  ('30 lower', 0.0749),\n",
       "  ('performed far', 0.0574),\n",
       "  ('20', 0.0171),\n",
       "  ('american', 0.0085),\n",
       "  ('animal', -0.0148),\n",
       "  ('23', -0.0471)],\n",
       " 'MED-1258': [('cholesterol reductions', 0.6662),\n",
       "  ('diets low', 0.568),\n",
       "  ('lower ldl', 0.5376),\n",
       "  ('diets combining', 0.5228),\n",
       "  ('effectiveness dietary', 0.5151),\n",
       "  ('ldl similarly', 0.4826),\n",
       "  ('portfolio diet', 0.474),\n",
       "  ('sterols combined', 0.4472),\n",
       "  ('reductions low', 0.4408),\n",
       "  ('combined interventions', 0.4286),\n",
       "  ('001 reductions', 0.4269),\n",
       "  ('reduced cardiovascular', 0.4232),\n",
       "  ('weight loss', 0.4212),\n",
       "  ('diet 001', 0.418),\n",
       "  ('control diets', 0.3926),\n",
       "  ('containing almonds', 0.3924),\n",
       "  ('serum triglycerides', 0.3854),\n",
       "  ('lipoprotein lp', 0.3804),\n",
       "  ('trials reduced', 0.3558),\n",
       "  ('hdl significantly', 0.3534),\n",
       "  ('portfolio lower', 0.3469),\n",
       "  ('saturated fat', 0.3439),\n",
       "  ('low saturated', 0.3373),\n",
       "  ('interventions single', 0.3354),\n",
       "  ('hyperlipidemic subjects', 0.3342),\n",
       "  ('statins increase', 0.3239),\n",
       "  ('subjects consumed', 0.3205),\n",
       "  ('diet 35', 0.2734),\n",
       "  ('13 low', 0.2703),\n",
       "  ('dairy foods', 0.2665),\n",
       "  ('soy proteins', 0.2311),\n",
       "  ('homocysteine', 0.2298),\n",
       "  ('concentrations', 0.2271),\n",
       "  ('cardiovascular events', 0.2021),\n",
       "  ('achieved similar', 0.2004),\n",
       "  ('kg respectively', 0.1967),\n",
       "  ('fasting', 0.1901),\n",
       "  ('combining number', 0.1596),\n",
       "  ('ratio significantly', 0.1535),\n",
       "  ('12 001', 0.148),\n",
       "  ('reported recent', 0.1475),\n",
       "  ('wheat cereals', 0.1432),\n",
       "  ('test control', 0.1125),\n",
       "  ('fibers 000', 0.109),\n",
       "  ('weeks phase', 0.0824),\n",
       "  ('viscous', 0.0658),\n",
       "  ('16 000', 0.0546),\n",
       "  ('blood blood', 0.0448),\n",
       "  ('increase potential', 0.0104),\n",
       "  ('difference seen', 0.0073)],\n",
       " 'MED-1259': [('blueberries 75', 0.4641),\n",
       "  ('reduce postprandial', 0.4059),\n",
       "  ('fat breakfast', 0.389),\n",
       "  ('carbohydrate low', 0.3831),\n",
       "  ('group postprandially', 0.3723),\n",
       "  ('participants 14', 0.3329),\n",
       "  ('design treatments', 0.3212),\n",
       "  ('received treatments', 0.3195),\n",
       "  ('treatments weeks', 0.316),\n",
       "  ('high carbohydrate', 0.3105),\n",
       "  ('phenolic compounds', 0.3033),\n",
       "  ('measured fasting', 0.3016),\n",
       "  ('consumption mean', 0.2938),\n",
       "  ('low blueberry', 0.2604),\n",
       "  ('participants', 0.2576),\n",
       "  ('doses changes', 0.2501),\n",
       "  ('oxidation consumed', 0.2448),\n",
       "  ('likely effects', 0.2432),\n",
       "  ('lipoprotein oxidation', 0.2293),\n",
       "  ('sugar content', 0.2099),\n",
       "  ('oxidative protection', 0.2025),\n",
       "  ('different groups', 0.194),\n",
       "  ('higher 75', 0.1936),\n",
       "  ('dose 35', 0.1857),\n",
       "  ('weeks cross', 0.1792),\n",
       "  ('bioactive', 0.1747),\n",
       "  ('family compounds', 0.1743),\n",
       "  ('content matching', 0.1657),\n",
       "  ('control group', 0.1576),\n",
       "  ('orac significantly', 0.1484),\n",
       "  ('changes serum', 0.1438),\n",
       "  ('fructose ascorbate', 0.1359),\n",
       "  ('groups knowledge', 0.1295),\n",
       "  ('significant trend', 0.1294),\n",
       "  ('radical', 0.1254),\n",
       "  ('serum oxygen', 0.1147),\n",
       "  ('practically consumable', 0.109),\n",
       "  ('showed', 0.1075),\n",
       "  ('lag time', 0.0995),\n",
       "  ('different', 0.0964),\n",
       "  ('acid', 0.09),\n",
       "  ('urate', 0.0874),\n",
       "  ('provide statistically', 0.0861),\n",
       "  ('quantity', 0.0814),\n",
       "  ('typical high', 0.0793),\n",
       "  ('sought', 0.0653),\n",
       "  ('vivo', 0.0631),\n",
       "  ('absorbance capacity', 0.0571),\n",
       "  ('major', 0.0454),\n",
       "  ('directly indirectly', -0.0045)],\n",
       " 'MED-1261': [('fructose decrease', 0.6652),\n",
       "  ('concerns fructose', 0.5749),\n",
       "  ('fructose undertook', 0.535),\n",
       "  ('metabolic effects', 0.4736),\n",
       "  ('reduced hba1c', 0.4486),\n",
       "  ('fructose confirm', 0.4268),\n",
       "  ('carbohydrates data', 0.3972),\n",
       "  ('fasting insulin', 0.3825),\n",
       "  ('glucose md', 0.3563),\n",
       "  ('catalytic doses', 0.316),\n",
       "  ('feeding trials', 0.3125),\n",
       "  ('effects models', 0.2791),\n",
       "  ('95 ci', 0.2747),\n",
       "  ('adverse effects', 0.2742),\n",
       "  ('tag uric', 0.2712),\n",
       "  ('high glycaemic', 0.2583),\n",
       "  ('10 meal', 0.2549),\n",
       "  ('index meals', 0.2464),\n",
       "  ('limit strength', 0.2373),\n",
       "  ('cinahl cochrane', 0.2353),\n",
       "  ('isoenergetic', 0.2212),\n",
       "  ('acid subgroup', 0.2002),\n",
       "  ('conditions small', 0.1994),\n",
       "  ('differences', 0.1932),\n",
       "  ('seen absence', 0.1903),\n",
       "  ('contrary concerns', 0.1786),\n",
       "  ('ci 72', 0.178),\n",
       "  ('quantified i2', 0.1638),\n",
       "  ('heterogeneity assessed', 0.1623),\n",
       "  ('pooled generic', 0.1547),\n",
       "  ('undertook meta', 0.1534),\n",
       "  ('months trials', 0.1524),\n",
       "  ('control adverse', 0.1511),\n",
       "  ('analysis controlled', 0.1354),\n",
       "  ('118 met', 0.1201),\n",
       "  ('inverse variance', 0.1183),\n",
       "  ('subgroup sensitivity', 0.1159),\n",
       "  ('doses 36', 0.1091),\n",
       "  ('25', 0.1074),\n",
       "  ('body', 0.0979),\n",
       "  ('quality total', 0.0796),\n",
       "  ('44 07', 0.0792),\n",
       "  ('i2 heyland', 0.0761),\n",
       "  ('using random', 0.0759),\n",
       "  ('benefit seen', 0.0728),\n",
       "  ('longer term', 0.0519),\n",
       "  ('subjects assess', 0.0445),\n",
       "  ('library', 0.0217),\n",
       "  ('embase', 0.0162),\n",
       "  ('md 40', 0.0028)],\n",
       " 'MED-1262': [('fruit intake', 0.564),\n",
       "  ('nutrition therapy', 0.5455),\n",
       "  ('diabetes guidelines', 0.5278),\n",
       "  ('recommend intake', 0.5208),\n",
       "  ('fruit medical', 0.4924),\n",
       "  ('reduce fruit', 0.4579),\n",
       "  ('impact glycemic', 0.4215),\n",
       "  ('high intake', 0.4081),\n",
       "  ('intake negative', 0.3845),\n",
       "  ('resulted eating', 0.3725),\n",
       "  ('therapy advice', 0.3723),\n",
       "  ('dietary recalls', 0.3631),\n",
       "  ('weight loss', 0.3588),\n",
       "  ('registered dietitian', 0.3372),\n",
       "  ('interventions medical', 0.3301),\n",
       "  ('overweight patients', 0.2822),\n",
       "  ('intervention participants', 0.273),\n",
       "  ('recommend restricting', 0.2479),\n",
       "  ('human health', 0.2444),\n",
       "  ('hba1c decreased', 0.2399),\n",
       "  ('important clinical', 0.2355),\n",
       "  ('consume pieces', 0.2298),\n",
       "  ('positive effects', 0.2243),\n",
       "  ('intention treat', 0.2143),\n",
       "  ('affects', 0.2065),\n",
       "  ('using day', 0.194),\n",
       "  ('fiber', 0.174),\n",
       "  ('12 weeks', 0.1648),\n",
       "  ('ci 95', 0.1469),\n",
       "  ('body', 0.1449),\n",
       "  ('control', 0.1441),\n",
       "  ('125 grams', 0.1423),\n",
       "  ('background', 0.1396),\n",
       "  ('groups conclusions', 0.1297),\n",
       "  ('professionals concerns', 0.1139),\n",
       "  ('men women', 0.1019),\n",
       "  ('option type', 0.1002),\n",
       "  ('studies addressing', 0.0996),\n",
       "  ('trial high', 0.0981),\n",
       "  ('http www', 0.0908),\n",
       "  ('gov identifier', 0.0889),\n",
       "  ('62 groups', 0.0727),\n",
       "  ('nct01010594', 0.065),\n",
       "  ('newly diagnosed', 0.0515),\n",
       "  ('circumference difference', 0.0339),\n",
       "  ('172', 0.0172),\n",
       "  ('self reported', -0.0074),\n",
       "  ('18 83', -0.0226),\n",
       "  ('population consisted', -0.0324),\n",
       "  ('51', -0.0665)],\n",
       " 'MED-1265': [('methylmercury bmaa', 0.5824),\n",
       "  ('neurotoxins bmaa', 0.5742),\n",
       "  ('toxicity methylmercury', 0.5645),\n",
       "  ('elusive methylmercury', 0.5148),\n",
       "  ('methylmercury interaction', 0.5054),\n",
       "  ('dependent neurotoxicity', 0.4769),\n",
       "  ('μm toxicity', 0.4653),\n",
       "  ('potentiated methylmercury', 0.4624),\n",
       "  ('environmental neurotoxins', 0.4613),\n",
       "  ('neurotoxicity importantly', 0.4588),\n",
       "  ('concentrations bmaa', 0.4441),\n",
       "  ('bmaa attenuated', 0.3897),\n",
       "  ('toxic', 0.3781),\n",
       "  ('neurodegenerative diseases', 0.3574),\n",
       "  ('toxicity potentiated', 0.3539),\n",
       "  ('combined toxicity', 0.3461),\n",
       "  ('toxicity addition', 0.3347),\n",
       "  ('methylamino', 0.3093),\n",
       "  ('μm caused', 0.2995),\n",
       "  ('exposure', 0.2828),\n",
       "  ('cortical cultures', 0.2793),\n",
       "  ('monoethyl', 0.2753),\n",
       "  ('environmental factors', 0.2702),\n",
       "  ('diseases elusive', 0.2597),\n",
       "  ('importantly concentrations', 0.2529),\n",
       "  ('cultures compounds', 0.2517),\n",
       "  ('factors involved', 0.2419),\n",
       "  ('attenuated', 0.2189),\n",
       "  ('compounds independently', 0.2109),\n",
       "  ('glutathione monoethyl', 0.2106),\n",
       "  ('role exposure', 0.1773),\n",
       "  ('depletion', 0.1618),\n",
       "  ('levels furthermore', 0.15),\n",
       "  ('induced', 0.1492),\n",
       "  ('bmaa 10', 0.1474),\n",
       "  ('effect main', 0.1305),\n",
       "  ('antioxidant', 0.1232),\n",
       "  ('alanine', 0.1181),\n",
       "  ('100 μm', 0.1175),\n",
       "  ('glutathione decreased', 0.1145),\n",
       "  ('results indicate', 0.114),\n",
       "  ('indicate synergistic', 0.1089),\n",
       "  ('elusive', 0.1068),\n",
       "  ('ester results', 0.1053),\n",
       "  ('main cellular', 0.0825),\n",
       "  ('interaction level', 0.0817),\n",
       "  ('dependent', 0.0769),\n",
       "  ('determination', 0.0712),\n",
       "  ('cell permeant', 0.066),\n",
       "  ('primary', 0.0632)],\n",
       " 'MED-1266': [('als amyotrophic', 0.5216),\n",
       "  ('als ramifications', 0.511),\n",
       "  ('diseases bmaa', 0.5086),\n",
       "  ('trigger als', 0.4417),\n",
       "  ('bmaa induced', 0.4403),\n",
       "  ('complex als', 0.4311),\n",
       "  ('development neurodegenerative', 0.4115),\n",
       "  ('potential environmental', 0.3358),\n",
       "  ('parkinsonism dementia', 0.3351),\n",
       "  ('alanine', 0.3338),\n",
       "  ('diseases like', 0.3237),\n",
       "  ('alzheimer', 0.3133),\n",
       "  ('cause intraneuronal', 0.3037),\n",
       "  ('number toxic', 0.297),\n",
       "  ('methylamino', 0.2941),\n",
       "  ('protein amino', 0.2924),\n",
       "  ('als lacking', 0.2709),\n",
       "  ('protein misfolding', 0.2636),\n",
       "  ('oxidative stress', 0.2505),\n",
       "  ('acid strong', 0.2426),\n",
       "  ('ampa receptors', 0.2362),\n",
       "  ('action nmda', 0.2325),\n",
       "  ('sclerosis non', 0.2189),\n",
       "  ('lateral', 0.208),\n",
       "  ('neurons including', 0.2028),\n",
       "  ('acid beta', 0.1965),\n",
       "  ('evidence support', 0.1943),\n",
       "  ('agonist action', 0.1743),\n",
       "  ('motor', 0.1699),\n",
       "  ('link toxin', 0.1676),\n",
       "  ('non protein', 0.1624),\n",
       "  ('action', 0.1578),\n",
       "  ('ecology pharmacology', 0.1533),\n",
       "  ('associated high', 0.1468),\n",
       "  ('implicated', 0.1412),\n",
       "  ('ramifications ubiquitous', 0.1272),\n",
       "  ('including direct', 0.1224),\n",
       "  ('induction', 0.1192),\n",
       "  ('role development', 0.1142),\n",
       "  ('article discuss', 0.0939),\n",
       "  ('hallmark', 0.0846),\n",
       "  ('strong possibility', 0.0755),\n",
       "  ('depletion glutathione', 0.0621),\n",
       "  ('enormous', 0.0501),\n",
       "  ('lacking substantial', 0.0483),\n",
       "  ('ubiquitous cyanobacteria', 0.0479),\n",
       "  ('play major', 0.0322),\n",
       "  ('animal', 0.0216),\n",
       "  ('history', -0.0055),\n",
       "  ('pdc guam', -0.0696)],\n",
       " 'MED-1267': [('bmaa cyanobacterial', 0.559),\n",
       "  ('bmaa neurotoxic', 0.5241),\n",
       "  ('bioaccumulate ecosystems', 0.4172),\n",
       "  ('alanine bmaa', 0.387),\n",
       "  ('bmaa biosynthesized', 0.3847),\n",
       "  ('biosynthesis neurotoxin', 0.3228),\n",
       "  ('devastating neurodegenerative', 0.3209),\n",
       "  ('zooplankton various', 0.2969),\n",
       "  ('nonprotein amino', 0.2934),\n",
       "  ('guam pacific', 0.2933),\n",
       "  ('ecosystem combined', 0.2801),\n",
       "  ('concentrations organisms', 0.2772),\n",
       "  ('methylamino', 0.2578),\n",
       "  ('monitoring bmaa', 0.2489),\n",
       "  ('surface blooms', 0.2399),\n",
       "  ('higher trophic', 0.2318),\n",
       "  ('acid produced', 0.2164),\n",
       "  ('higher concentrations', 0.2053),\n",
       "  ('ecosystem baltic', 0.2041),\n",
       "  ('diseases island', 0.2029),\n",
       "  ('biosynthesis', 0.2022),\n",
       "  ('globally hypothesized', 0.2003),\n",
       "  ('widespread globally', 0.1993),\n",
       "  ('benthic', 0.1873),\n",
       "  ('food webs', 0.187),\n",
       "  ('various vertebrates', 0.1804),\n",
       "  ('mussels', 0.1679),\n",
       "  ('consumption included', 0.1459),\n",
       "  ('species used', 0.1396),\n",
       "  ('alarming requires', 0.1378),\n",
       "  ('genera dominating', 0.1296),\n",
       "  ('indirectly feed', 0.1236),\n",
       "  ('water', 0.1227),\n",
       "  ('body', 0.1093),\n",
       "  ('long term', 0.1057),\n",
       "  ('based recently', 0.1008),\n",
       "  ('causative', 0.0916),\n",
       "  ('demonstrate based', 0.082),\n",
       "  ('2007 2008', 0.0812),\n",
       "  ('used human', 0.0696),\n",
       "  ('brain dwelling', 0.0629),\n",
       "  ('requires', 0.0627),\n",
       "  ('webs ending', 0.0504),\n",
       "  ('populations', 0.038),\n",
       "  ('detected muscle', 0.0361),\n",
       "  ('oysters', 0.0313),\n",
       "  ('levels directly', 0.0251),\n",
       "  ('hplc ms', 0.0178),\n",
       "  ('temperate', 0.0022),\n",
       "  ('possible transfer', -0.0041)],\n",
       " 'MED-1268': [('sporadic als', 0.5565),\n",
       "  ('factors als', 0.5494),\n",
       "  ('sclerosis als', 0.51),\n",
       "  ('als cohort', 0.5018),\n",
       "  ('amyotrophic', 0.4124),\n",
       "  ('sporadically environmental', 0.4075),\n",
       "  ('lateral sclerosis', 0.4014),\n",
       "  ('triggers implicated', 0.3708),\n",
       "  ('environmental triggers', 0.3571),\n",
       "  ('sclerosis', 0.3176),\n",
       "  ('occur sporadically', 0.3076),\n",
       "  ('produced neurotoxin', 0.2807),\n",
       "  ('lc ms', 0.2594),\n",
       "  ('common risk', 0.2407),\n",
       "  ('disease relatively', 0.2321),\n",
       "  ('implicated including', 0.2226),\n",
       "  ('cases occur', 0.2222),\n",
       "  ('lateral', 0.2212),\n",
       "  ('contaminated bmaa', 0.2113),\n",
       "  ('2013 elsevier', 0.1913),\n",
       "  ('factors', 0.1853),\n",
       "  ('lived annapolis', 0.1693),\n",
       "  ('identify potential', 0.1656),\n",
       "  ('contaminated', 0.1599),\n",
       "  ('ms', 0.1579),\n",
       "  ('cyanobacteria produced', 0.1508),\n",
       "  ('patients local', 0.1412),\n",
       "  ('bmaa common', 0.1406),\n",
       "  ('methylamino alanine', 0.1357),\n",
       "  ('usa developed', 0.133),\n",
       "  ('developed', 0.1289),\n",
       "  ('cohort patients', 0.1277),\n",
       "  ('short time', 0.1219),\n",
       "  ('patients frequent', 0.1135),\n",
       "  ('study aimed', 0.1076),\n",
       "  ('maryland', 0.0899),\n",
       "  ('lived', 0.0704),\n",
       "  ('rights reserved', 0.0666),\n",
       "  ('including beta', 0.055),\n",
       "  ('consumption', -0.0009),\n",
       "  ('web lifetime', -0.0017),\n",
       "  ('proximity questionnaire', -0.0106),\n",
       "  ('patients copyright', -0.0128),\n",
       "  ('conclude presence', -0.0253),\n",
       "  ('market tested', -0.0274),\n",
       "  ('samples blue', -0.0301),\n",
       "  ('crab contaminated', -0.0304),\n",
       "  ('bay', -0.032),\n",
       "  ('fish', -0.051),\n",
       "  ('chesapeake bay', -0.0533)],\n",
       " 'MED-1271': [('cyanotoxin bmaa', 0.5565),\n",
       "  ('environment amyotrophic', 0.4561),\n",
       "  ('toxin identified', 0.3708),\n",
       "  ('dietary exposures', 0.369),\n",
       "  ('bmaa concentrations', 0.3234),\n",
       "  ('mussels subsequently', 0.2976),\n",
       "  ('exposure', 0.2872),\n",
       "  ('sclerosis clusters', 0.2848),\n",
       "  ('coast bmaa', 0.2848),\n",
       "  ('america toxin', 0.2836),\n",
       "  ('identified marine', 0.2815),\n",
       "  ('shellfish consumption', 0.2717),\n",
       "  ('als cluster', 0.2646),\n",
       "  ('severe neurodegenerative', 0.2498),\n",
       "  ('sclerosis western', 0.2455),\n",
       "  ('concentrations results', 0.2399),\n",
       "  ('highest picocyanobacteria', 0.2202),\n",
       "  ('suspected cause', 0.2187),\n",
       "  ('western pacific', 0.2046),\n",
       "  ('temporal cluster', 0.2045),\n",
       "  ('coastal district', 0.2026),\n",
       "  ('abundances recorded', 0.1762),\n",
       "  ('islands', 0.1595),\n",
       "  ('search identified', 0.1556),\n",
       "  ('oysters', 0.1461),\n",
       "  ('cases identified', 0.1414),\n",
       "  ('background', 0.141),\n",
       "  ('disorder', 0.1398),\n",
       "  ('important area', 0.1382),\n",
       "  ('objectives aimed', 0.131),\n",
       "  ('expert center', 0.1087),\n",
       "  ('production consumption', 0.1082),\n",
       "  ('mediterranean', 0.0969),\n",
       "  ('lateral', 0.0952),\n",
       "  ('1994 2009', 0.0874),\n",
       "  ('europe north', 0.0791),\n",
       "  ('cluster 0024', 0.0774),\n",
       "  ('collections', 0.0706),\n",
       "  ('performed', 0.0674),\n",
       "  ('hérault district', 0.0653),\n",
       "  ('sporadic', 0.0642),\n",
       "  ('thau lagoon', 0.0572),\n",
       "  ('serial', 0.0491),\n",
       "  ('southern france', 0.0362),\n",
       "  ('data potential', 0.0275),\n",
       "  ('direct link', 0.0224),\n",
       "  ('summer highest', 0.0112),\n",
       "  ('blind', 0.0108),\n",
       "  ('existence', 0.0079),\n",
       "  ('add new', -0.0281)],\n",
       " 'MED-1272': [('cyanobacterial neurotoxins', 0.7123),\n",
       "  ('exposure cyanobacterial', 0.6241),\n",
       "  ('cyanobacteria produce', 0.5781),\n",
       "  ('amyotrophic', 0.4304),\n",
       "  ('neurotoxins bmaa', 0.4252),\n",
       "  ('aerosolized toxins', 0.4249),\n",
       "  ('algal blooms', 0.4248),\n",
       "  ('association toxic', 0.3646),\n",
       "  ('neurodegenerative', 0.3645),\n",
       "  ('toxins helpful', 0.3553),\n",
       "  ('incidence als', 0.3411),\n",
       "  ('bmaa als', 0.3307),\n",
       "  ('blooms new', 0.2695),\n",
       "  ('lake history', 0.2444),\n",
       "  ('residents enfield', 0.2279),\n",
       "  ('sclerosis', 0.2091),\n",
       "  ('consuming fish', 0.195),\n",
       "  ('cases diagnosed', 0.1844),\n",
       "  ('disease number', 0.1784),\n",
       "  ('als 10', 0.1762),\n",
       "  ('alanine', 0.1733),\n",
       "  ('nh incidence', 0.1666),\n",
       "  ('bmaa liked', 0.1559),\n",
       "  ('exposure include', 0.1557),\n",
       "  ('lateral', 0.146),\n",
       "  ('chronic', 0.1339),\n",
       "  ('patients lived', 0.1336),\n",
       "  ('beta methylamino', 0.1331),\n",
       "  ('lived near', 0.1302),\n",
       "  ('expected', 0.1006),\n",
       "  ('ingestion', 0.0941),\n",
       "  ('community databases', 0.0904),\n",
       "  ('brain', 0.0876),\n",
       "  ('institution', 0.0652),\n",
       "  ('including analysis', 0.0627),\n",
       "  ('sporadic', 0.0615),\n",
       "  ('near', 0.0564),\n",
       "  ('water', 0.0526),\n",
       "  ('produce', 0.0494),\n",
       "  ('cluster directly', 0.0467),\n",
       "  ('town encompassing', 0.0399),\n",
       "  ('information patients', 0.0388),\n",
       "  ('demographic', 0.0354),\n",
       "  ('hampshire development', 0.0166),\n",
       "  ('helpful test', 0.0147),\n",
       "  ('new england', 0.013),\n",
       "  ('mascoma', 0.0121),\n",
       "  ('high', 0.0073),\n",
       "  ('100 000', -0.0059),\n",
       "  ('25 times', -0.1281)],\n",
       " 'MED-1273': [('als pathogenesis', 0.5123),\n",
       "  ('sclerosis als', 0.4999),\n",
       "  ('als conducted', 0.4634),\n",
       "  ('trauma als', 0.4159),\n",
       "  ('cases amyotrophic', 0.3907),\n",
       "  ('lateral sclerosis', 0.3711),\n",
       "  ('1983 cases', 0.3134),\n",
       "  ('sclerosis', 0.3011),\n",
       "  ('rivers wis', 0.2747),\n",
       "  ('wis probability', 0.2483),\n",
       "  ('cases', 0.2445),\n",
       "  ('previous studies', 0.2398),\n",
       "  ('pathogenesis suggest', 0.2359),\n",
       "  ('diagnosed long', 0.2319),\n",
       "  ('retrospective analysis', 0.2291),\n",
       "  ('control study', 0.2286),\n",
       "  ('risk factors', 0.2243),\n",
       "  ('residents rivers', 0.2043),\n",
       "  ('causative role', 0.202),\n",
       "  ('family history', 0.1911),\n",
       "  ('lateral', 0.1866),\n",
       "  ('cancer reported', 0.1814),\n",
       "  ('study using', 0.1771),\n",
       "  ('case patient', 0.1756),\n",
       "  ('concerning cause', 0.1601),\n",
       "  ('term residents', 0.1571),\n",
       "  ('1975', 0.1457),\n",
       "  ('probability occurred', 0.1338),\n",
       "  ('subjects matched', 0.1282),\n",
       "  ('explored continued', 0.1158),\n",
       "  ('clusters subsequent', 0.1109),\n",
       "  ('surveillance epidemiologic', 0.1099),\n",
       "  ('findings support', 0.1073),\n",
       "  ('history', 0.0956),\n",
       "  ('lake michigan', 0.0916),\n",
       "  ('patient age', 0.088),\n",
       "  ('residence', 0.0704),\n",
       "  ('support', 0.0701),\n",
       "  ('conducted', 0.0633),\n",
       "  ('trauma frequent', 0.0591),\n",
       "  ('analysis provide', 0.0546),\n",
       "  ('freshly caught', 0.049),\n",
       "  ('chance 05', 0.046),\n",
       "  ('proposing role', -0.0056),\n",
       "  ('potential', -0.0162),\n",
       "  ('fish', -0.0259),\n",
       "  ('role diet', -0.0362),\n",
       "  ('physical', -0.0443),\n",
       "  ('age gender', -0.0541),\n",
       "  ('frequent consumption', -0.1244)],\n",
       " 'MED-1274': [('shark fins', 0.6019),\n",
       "  ('sharks varied', 0.5852),\n",
       "  ('sharks threatened', 0.581),\n",
       "  ('habits sharks', 0.5702),\n",
       "  ('soup sharks', 0.5467),\n",
       "  ('fish mammals', 0.5366),\n",
       "  ('sharks south', 0.5138),\n",
       "  ('shark products', 0.5072),\n",
       "  ('sharks known', 0.4935),\n",
       "  ('bioaccumulate marine', 0.4268),\n",
       "  ('cyanobacteria bioaccumulate', 0.3856),\n",
       "  ('mammals crustaceans', 0.3812),\n",
       "  ('bioaccumulate toxins', 0.3642),\n",
       "  ('living marine', 0.3421),\n",
       "  ('populations declining', 0.2717),\n",
       "  ('plankton', 0.2685),\n",
       "  ('threatened groups', 0.261),\n",
       "  ('risks consumers', 0.2547),\n",
       "  ('different species', 0.2448),\n",
       "  ('mammals', 0.2415),\n",
       "  ('feeding habits', 0.2408),\n",
       "  ('toxins pose', 0.2193),\n",
       "  ('detected species', 0.1756),\n",
       "  ('examined concentrations', 0.1362),\n",
       "  ('neurotoxin methylamino', 0.1315),\n",
       "  ('suggest consumption', 0.1264),\n",
       "  ('globally', 0.1197),\n",
       "  ('human exposure', 0.0856),\n",
       "  ('soup', 0.0783),\n",
       "  ('pose health', 0.0665),\n",
       "  ('quadrupole lc', 0.0643),\n",
       "  ('neurodegenerative diseases', 0.0588),\n",
       "  ('growing demand', 0.0558),\n",
       "  ('groups', 0.0548),\n",
       "  ('seven', 0.0535),\n",
       "  ('varied including', 0.0484),\n",
       "  ('species free', 0.0367),\n",
       "  ('south florida', 0.0175),\n",
       "  ('web study', 0.0064),\n",
       "  ('fd triple', 0.0),\n",
       "  ('clips', -0.0017),\n",
       "  ('support growing', -0.0134),\n",
       "  ('144 1836', -0.0182),\n",
       "  ('results important', -0.0319),\n",
       "  ('mg wet', -0.0361),\n",
       "  ('methods bmaa', -0.0372),\n",
       "  ('using hplc', -0.0409),\n",
       "  ('alanine', -0.0416),\n",
       "  ('ng', -0.0477),\n",
       "  ('known', -0.115)],\n",
       " 'MED-1276': [('clusters disease', 0.4422),\n",
       "  ('sclerosis inconclusive', 0.4243),\n",
       "  ('studies used', 0.4203),\n",
       "  ('spatial clustering', 0.4162),\n",
       "  ('inconclusive studies', 0.4061),\n",
       "  ('apparent clusters', 0.4047),\n",
       "  ('amyotrophic lateral', 0.3551),\n",
       "  ('sclerosis', 0.3081),\n",
       "  ('clustering condition', 0.2794),\n",
       "  ('used geographic', 0.2611),\n",
       "  ('processes studies', 0.2502),\n",
       "  ('small number', 0.2485),\n",
       "  ('sample cases', 0.2399),\n",
       "  ('previous evidence', 0.2348),\n",
       "  ('scan statistic', 0.2316),\n",
       "  ('different conclusions', 0.2203),\n",
       "  ('analysis conducted', 0.2184),\n",
       "  ('conducted different', 0.2109),\n",
       "  ('study', 0.2085),\n",
       "  ('basis cluster', 0.2),\n",
       "  ('factors exist', 0.191),\n",
       "  ('single significant', 0.1749),\n",
       "  ('identified southeast', 0.1731),\n",
       "  ('time death', 0.1724),\n",
       "  ('detection exploring', 0.1688),\n",
       "  ('death single', 0.1682),\n",
       "  ('statistic authors', 0.1674),\n",
       "  ('000 cases', 0.1642),\n",
       "  ('lateral', 0.1566),\n",
       "  ('location', 0.1498),\n",
       "  ('stages', 0.1359),\n",
       "  ('cycle different', 0.1267),\n",
       "  ('central finland', 0.1244),\n",
       "  ('south central', 0.1236),\n",
       "  ('identified apparent', 0.1112),\n",
       "  ('potential risk', 0.1065),\n",
       "  ('results demonstrate', 0.0987),\n",
       "  ('1995', 0.0902),\n",
       "  ('exist result', 0.0802),\n",
       "  ('based large', 0.0742),\n",
       "  ('points life', 0.0588),\n",
       "  ('neighboring', 0.055),\n",
       "  ('examine 000', 0.0474),\n",
       "  ('occurred chance', 0.0451),\n",
       "  ('central', 0.0442),\n",
       "  ('1985 december', 0.0289),\n",
       "  ('closely matching', 0.0082),\n",
       "  ('birth time', 0.0073),\n",
       "  ('died june', -0.0547),\n",
       "  ('provide convincing', -0.0645)],\n",
       " 'MED-1277': [('als caused', 0.5902),\n",
       "  ('familial als', 0.5761),\n",
       "  ('als methods', 0.4835),\n",
       "  ('als need', 0.4353),\n",
       "  ('mutations genes', 0.3397),\n",
       "  ('leading syndrome', 0.2916),\n",
       "  ('consensus amyotrophic', 0.2874),\n",
       "  ('caused gene', 0.2421),\n",
       "  ('sclerosis', 0.2158),\n",
       "  ('fals', 0.2153),\n",
       "  ('relatively little', 0.1923),\n",
       "  ('factors trigger', 0.1889),\n",
       "  ('lifestyle factors', 0.1887),\n",
       "  ('familial', 0.1832),\n",
       "  ('environments smoking', 0.1828),\n",
       "  ('lateral', 0.1745),\n",
       "  ('etiologically important', 0.1745),\n",
       "  ('load ecosystems', 0.1682),\n",
       "  ('environment interactions', 0.1557),\n",
       "  ('exposure neurotoxic', 0.1552),\n",
       "  ('epidemiologic studies', 0.1513),\n",
       "  ('increased risk', 0.1321),\n",
       "  ('death', 0.1117),\n",
       "  ('patients relatively', 0.1062),\n",
       "  ('need research', 0.1037),\n",
       "  ('neuron', 0.1012),\n",
       "  ('recent evidence', 0.0976),\n",
       "  ('strengthened theory', 0.0884),\n",
       "  ('10 total', 0.0868),\n",
       "  ('estimating cyanobacterial', 0.0836),\n",
       "  ('motor', 0.0794),\n",
       "  ('methylamino alanine', 0.0759),\n",
       "  ('agricultural environments', 0.074),\n",
       "  ('sports trauma', 0.0739),\n",
       "  ('used assess', 0.064),\n",
       "  ('chronic', 0.0591),\n",
       "  ('acid', 0.0552),\n",
       "  ('broad scientific', 0.0364),\n",
       "  ('cases controls', 0.0301),\n",
       "  ('bmaa produced', 0.022),\n",
       "  ('direct indirect', 0.0179),\n",
       "  ('vulnerable individuals', 0.0158),\n",
       "  ('including lead', 0.0121),\n",
       "  ('pesticides', 0.0104),\n",
       "  ('relative roles', 0.0033),\n",
       "  ('rigorous', -0.0159),\n",
       "  ('combined', -0.0257),\n",
       "  ('total population', -0.0454),\n",
       "  ('paid', -0.086),\n",
       "  ('reveal', -0.1024)],\n",
       " 'MED-1278': [('bmaa elevated', 0.4856),\n",
       "  ('acid bmaa', 0.4758),\n",
       "  ('guam bmaa', 0.4567),\n",
       "  ('island guam', 0.4157),\n",
       "  ('amino methylaminopropionic', 0.4133),\n",
       "  ('toxicity bmaa', 0.3816),\n",
       "  ('produced cyanobacterial', 0.3721),\n",
       "  ('development bmaa', 0.3622),\n",
       "  ('variety aquatic', 0.3047),\n",
       "  ('amyotrophic lateral', 0.2828),\n",
       "  ('elevated incidence', 0.2341),\n",
       "  ('species', 0.2264),\n",
       "  ('acid', 0.2149),\n",
       "  ('activity excitotoxic', 0.2094),\n",
       "  ('ataxia convulsions', 0.207),\n",
       "  ('influx coupled', 0.1824),\n",
       "  ('affect neural', 0.1765),\n",
       "  ('increases generation', 0.1748),\n",
       "  ('acts predominantly', 0.1732),\n",
       "  ('chicks monkeys', 0.1719),\n",
       "  ('worldwide suggesting', 0.1716),\n",
       "  ('adversely affect', 0.1698),\n",
       "  ('identified island', 0.1661),\n",
       "  ('zebrafish research', 0.1583),\n",
       "  ('research shown', 0.1551),\n",
       "  ('neurodegenerative disease', 0.1533),\n",
       "  ('shown produced', 0.1501),\n",
       "  ('demonstrates ability', 0.1497),\n",
       "  ('significant compound', 0.1461),\n",
       "  ('tissues implicates', 0.1394),\n",
       "  ('pdc identified', 0.1342),\n",
       "  ('oxygen species', 0.1312),\n",
       "  ('activity general', 0.128),\n",
       "  ('neurons observed', 0.126),\n",
       "  ('ubiquitous', 0.1255),\n",
       "  ('understand modes', 0.1175),\n",
       "  ('aetiology', 0.1158),\n",
       "  ('exposure limits', 0.1091),\n",
       "  ('mitochondrial', 0.1075),\n",
       "  ('symptoms', 0.0992),\n",
       "  ('sclerosis', 0.0968),\n",
       "  ('generation reactive', 0.0961),\n",
       "  ('studies mice', 0.0932),\n",
       "  ('association', 0.0831),\n",
       "  ('ros ca2', 0.0783),\n",
       "  ('current', 0.0473),\n",
       "  ('environments', 0.044),\n",
       "  ('rats leeches', 0.0424),\n",
       "  ('vitro', 0.0302),\n",
       "  ('health', 0.0103)],\n",
       " 'MED-1279': [('implicated als', 0.6544),\n",
       "  ('als fatal', 0.6032),\n",
       "  ('als cases', 0.596),\n",
       "  ('studies als', 0.5888),\n",
       "  ('sclerosis als', 0.5607),\n",
       "  ('clusters als', 0.5364),\n",
       "  ('development als', 0.5331),\n",
       "  ('fatal neurodegenerative', 0.4868),\n",
       "  ('neurodegenerative syndrome', 0.4775),\n",
       "  ('als explore', 0.4216),\n",
       "  ('amyotrophic', 0.4202),\n",
       "  ('als help', 0.4182),\n",
       "  ('lateral sclerosis', 0.4011),\n",
       "  ('bmaa als', 0.3432),\n",
       "  ('genetic environmental', 0.3352),\n",
       "  ('link neurotoxin', 0.3271),\n",
       "  ('trauma pesticides', 0.2952),\n",
       "  ('environmental risks', 0.2945),\n",
       "  ('sclerosis', 0.2855),\n",
       "  ('fatal', 0.28),\n",
       "  ('factors implicated', 0.2529),\n",
       "  ('syndrome known', 0.2391),\n",
       "  ('inherited', 0.2221),\n",
       "  ('neurotoxin bmaa', 0.2216),\n",
       "  ('risks number', 0.2213),\n",
       "  ('electrical injuries', 0.1997),\n",
       "  ('lateral', 0.1997),\n",
       "  ('cyanobacterial derived', 0.1742),\n",
       "  ('hypothesized link', 0.1692),\n",
       "  ('trauma', 0.1679),\n",
       "  ('metals', 0.1662),\n",
       "  ('known cause', 0.1598),\n",
       "  ('included heavy', 0.1558),\n",
       "  ('radiation', 0.1377),\n",
       "  ('spatial clustering', 0.1341),\n",
       "  ('number epidemiological', 0.13),\n",
       "  ('studies employ', 0.1294),\n",
       "  ('development', 0.1204),\n",
       "  ('cases', 0.1109),\n",
       "  ('methylamino alanine', 0.0828),\n",
       "  ('investigate possible', 0.0795),\n",
       "  ('employ', 0.0757),\n",
       "  ('despite', 0.0744),\n",
       "  ('clear associations', 0.0743),\n",
       "  ('small proportion', 0.0734),\n",
       "  ('literature important', 0.0683),\n",
       "  ('electromagnetic', 0.0568),\n",
       "  ('help guide', 0.0315),\n",
       "  ('disparities distribution', 0.01),\n",
       "  ('beta', -0.009)],\n",
       " 'MED-1280': [('cyanotoxins taxonomically', 0.6051),\n",
       "  ('known cyanotoxins', 0.5975),\n",
       "  ('groups cyanobacteria', 0.5927),\n",
       "  ('cyanobacteria generate', 0.5843),\n",
       "  ('including cyanobacterial', 0.5487),\n",
       "  ('ubiquity cyanobacteria', 0.5405),\n",
       "  ('cyanobacteria terrestrial', 0.5209),\n",
       "  ('cyanobacterial symbionts', 0.4898),\n",
       "  ('hepatotoxic microcystins', 0.4582),\n",
       "  ('production hepatotoxic', 0.4432),\n",
       "  ('taxonomically sporadic', 0.4099),\n",
       "  ('microcystins production', 0.4062),\n",
       "  ('molecules hazardous', 0.3804),\n",
       "  ('neurotoxins considered', 0.3696),\n",
       "  ('phylogenetically unpredictable', 0.3363),\n",
       "  ('single neurotoxin', 0.3303),\n",
       "  ('genus production', 0.33),\n",
       "  ('single genus', 0.3219),\n",
       "  ('members genera', 0.3203),\n",
       "  ('unpredictable', 0.2971),\n",
       "  ('limited single', 0.2889),\n",
       "  ('unpredictable report', 0.2875),\n",
       "  ('hazardous human', 0.2858),\n",
       "  ('sporadic example', 0.2411),\n",
       "  ('appears limited', 0.2139),\n",
       "  ('example members', 0.2006),\n",
       "  ('taxonomically', 0.194),\n",
       "  ('exposure', 0.1805),\n",
       "  ('freshwater', 0.1744),\n",
       "  ('generate molecules', 0.1711),\n",
       "  ('brackish', 0.1624),\n",
       "  ('groups', 0.1607),\n",
       "  ('symbionts free', 0.1543),\n",
       "  ('alanine produced', 0.146),\n",
       "  ('methylamino', 0.1405),\n",
       "  ('report single', 0.1338),\n",
       "  ('nodularins appears', 0.1329),\n",
       "  ('terrestrial', 0.1259),\n",
       "  ('produce', 0.1258),\n",
       "  ('environments suggests', 0.1207),\n",
       "  ('ubiquity', 0.1181),\n",
       "  ('human health', 0.1174),\n",
       "  ('marine environments', 0.0961),\n",
       "  ('spread human', 0.0813),\n",
       "  ('produced known', 0.0802),\n",
       "  ('potential wide', 0.0494),\n",
       "  ('human', 0.0482),\n",
       "  ('suggests', 0.0468),\n",
       "  ('living', 0.0128),\n",
       "  ('free', -0.0719)],\n",
       " 'MED-1281': [('ca2 sensing', 0.7022),\n",
       "  ('proteins ca2', 0.6851),\n",
       "  ('calcium sensors', 0.6072),\n",
       "  ('ca2 cam', 0.5782),\n",
       "  ('calcium ion', 0.539),\n",
       "  ('transduced ca2', 0.5074),\n",
       "  ('calmodulin', 0.4385),\n",
       "  ('cellular processes', 0.3971),\n",
       "  ('mediated intracellular', 0.3833),\n",
       "  ('proteins difficulty', 0.3554),\n",
       "  ('proteins known', 0.3496),\n",
       "  ('different signaling', 0.3335),\n",
       "  ('variety cellular', 0.311),\n",
       "  ('transient signals', 0.2984),\n",
       "  ('ubiquitous second', 0.2976),\n",
       "  ('crucial regulation', 0.2872),\n",
       "  ('messenger crucial', 0.2815),\n",
       "  ('cam widespread', 0.2779),\n",
       "  ('sensors proteome', 0.2742),\n",
       "  ('processes diverse', 0.271),\n",
       "  ('eukaryotic cell', 0.2288),\n",
       "  ('binding proteins', 0.2281),\n",
       "  ('box proteins', 0.2189),\n",
       "  ('coimmunoprecipitation', 0.2054),\n",
       "  ('interactions identified', 0.205),\n",
       "  ('difficulty identifying', 0.2018),\n",
       "  ('proteins ribosomal', 0.1889),\n",
       "  ('key obstacle', 0.1776),\n",
       "  ('used identify', 0.1628),\n",
       "  ('large', 0.1492),\n",
       "  ('uncharacterized proteins', 0.1417),\n",
       "  ('changes number', 0.1384),\n",
       "  ('assays', 0.1355),\n",
       "  ('pathways selection', 0.1353),\n",
       "  ('26s subunits', 0.1336),\n",
       "  ('dependent', 0.1268),\n",
       "  ('display technique', 0.1254),\n",
       "  ('scale', 0.1238),\n",
       "  ('mrna display', 0.1235),\n",
       "  ('induced conformational', 0.1048),\n",
       "  ('proteasome', 0.0994),\n",
       "  ('scanned human', 0.0808),\n",
       "  ('best studied', 0.0763),\n",
       "  ('downstream target', 0.0614),\n",
       "  ('partners', 0.0582),\n",
       "  ('using pull', 0.0365),\n",
       "  ('previously', 0.0294),\n",
       "  ('deubiquitinating', 0.0112),\n",
       "  ('belong', 0.0007),\n",
       "  ('families dead', -0.0808)],\n",
       " 'MED-1282': [('endemic als', 0.5045),\n",
       "  ('excitement neurogenetics', 0.3868),\n",
       "  ('develop neurodegenerations', 0.3408),\n",
       "  ('diseases including', 0.2861),\n",
       "  ('parkinson disease', 0.2685),\n",
       "  ('environmental causes', 0.2526),\n",
       "  ('genetic susceptibility', 0.2327),\n",
       "  ('brains rekindled', 0.2207),\n",
       "  ('foci', 0.2007),\n",
       "  ('biomagnification', 0.1895),\n",
       "  ('sporadic', 0.189),\n",
       "  ('died alzheimer', 0.1873),\n",
       "  ('years ago', 0.1852),\n",
       "  ('specialized roots', 0.1508),\n",
       "  ('diverted attention', 0.1494),\n",
       "  ('neurotoxicity cyanobacterial', 0.1443),\n",
       "  ('non neurological', 0.1432),\n",
       "  ('627 microg', 0.1415),\n",
       "  ('seeds flying', 0.1387),\n",
       "  ('intriguing finding', 0.126),\n",
       "  ('95 microg', 0.1155),\n",
       "  ('brains guamanians', 0.1103),\n",
       "  ('al recently', 0.1088),\n",
       "  ('8mm suggests', 0.1066),\n",
       "  ('brains reservoir', 0.1032),\n",
       "  ('using original', 0.1008),\n",
       "  ('control brains', 0.1002),\n",
       "  ('fold greater', 0.0936),\n",
       "  ('huntington', 0.0863),\n",
       "  ('animals forage', 0.0828),\n",
       "  ('produced symbiotic', 0.0794),\n",
       "  ('alanine', 0.0731),\n",
       "  ('beta methylamino', 0.0699),\n",
       "  ('average concentration', 0.0693),\n",
       "  ('world possible', 0.0681),\n",
       "  ('north', 0.0653),\n",
       "  ('flour various', 0.0589),\n",
       "  ('findings murch', 0.0495),\n",
       "  ('american patients', 0.0453),\n",
       "  ('patients died', 0.0451),\n",
       "  ('prevent', 0.0431),\n",
       "  ('rekindled bmaa', 0.0324),\n",
       "  ('different hplc', 0.026),\n",
       "  ('protein bound', 0.0204),\n",
       "  ('worldwide montine', 0.0121),\n",
       "  ('mash colleagues', 0.0111),\n",
       "  ('cycas micronesica', 0.0096),\n",
       "  ('unable reproduce', 0.0052),\n",
       "  ('foxes pigs', -0.0048),\n",
       "  ('used cox', -0.1191)],\n",
       " 'MED-1283': [('als epidemiology', 0.6877),\n",
       "  ('epidemiology challenges', 0.4481),\n",
       "  ('progressive neurodegenerative', 0.4232),\n",
       "  ('syndromic aspects', 0.4053),\n",
       "  ('amyotrophic', 0.3542),\n",
       "  ('studies building', 0.3443),\n",
       "  ('working multidisciplinary', 0.331),\n",
       "  ('disease current', 0.3207),\n",
       "  ('neuropathologic findings', 0.3044),\n",
       "  ('future studies', 0.2952),\n",
       "  ('sclerosis', 0.2819),\n",
       "  ('study design', 0.2757),\n",
       "  ('traumatic encephalomyelopathy', 0.2537),\n",
       "  ('novel study', 0.2508),\n",
       "  ('focus recent', 0.2495),\n",
       "  ('findings chronic', 0.2401),\n",
       "  ('trends incidence', 0.2333),\n",
       "  ('life etiology', 0.2263),\n",
       "  ('lateral', 0.2212),\n",
       "  ('studies case', 0.2167),\n",
       "  ('consortia addressing', 0.1926),\n",
       "  ('identify areas', 0.1926),\n",
       "  ('characterized cohorts', 0.1883),\n",
       "  ('large scale', 0.177),\n",
       "  ('prognostic factors', 0.1563),\n",
       "  ('registry resource', 0.1538),\n",
       "  ('population based', 0.1521),\n",
       "  ('control studies', 0.1404),\n",
       "  ('environment interactions', 0.1278),\n",
       "  ('style factors', 0.1232),\n",
       "  ('newly diagnosed', 0.1231),\n",
       "  ('factors smoking', 0.116),\n",
       "  ('building national', 0.1159),\n",
       "  ('early life', 0.1142),\n",
       "  ('definition familial', 0.1014),\n",
       "  ('bmaa excitotoxic', 0.09),\n",
       "  ('storing biological', 0.0869),\n",
       "  ('meaning lifetime', 0.0849),\n",
       "  ('resource future', 0.0688),\n",
       "  ('versus sporadic', 0.0683),\n",
       "  ('options discussed', 0.0648),\n",
       "  ('patients', 0.0616),\n",
       "  ('use statins', 0.0481),\n",
       "  ('methylamino', 0.0107),\n",
       "  ('cyanobacteria terrestrial', -0.0258),\n",
       "  ('produced', -0.0429),\n",
       "  ('aquatic habitat', -0.0489),\n",
       "  ('military service', -0.0619),\n",
       "  ('disappearance endemic', -0.0648),\n",
       "  ('pacific', -0.0904)],\n",
       " 'MED-1284': [('total bmaa', 0.4162),\n",
       "  ('bmaa cycad', 0.3978),\n",
       "  ('analysis 30', 0.368),\n",
       "  ('bmaa removed', 0.3511),\n",
       "  ('neurotoxin', 0.2987),\n",
       "  ('cycad seeds', 0.2945),\n",
       "  ('differences bmaa', 0.2924),\n",
       "  ('processed endosperm', 0.2818),\n",
       "  ('removed 90', 0.2756),\n",
       "  ('flour analysis', 0.268),\n",
       "  ('efficient removing', 0.244),\n",
       "  ('acid', 0.2193),\n",
       "  ('staple eaten', 0.2127),\n",
       "  ('processing furthermore', 0.2043),\n",
       "  ('methylamino', 0.2037),\n",
       "  ('propanoic acid', 0.1926),\n",
       "  ('complex', 0.1914),\n",
       "  ('mean values', 0.1867),\n",
       "  ('different samples', 0.1845),\n",
       "  ('widespread neurofibrillary', 0.1715),\n",
       "  ('contains extremely', 0.1656),\n",
       "  ('low levels', 0.1576),\n",
       "  ('85 total', 0.1571),\n",
       "  ('widespread', 0.1475),\n",
       "  ('circinalis', 0.145),\n",
       "  ('005 weight', 0.144),\n",
       "  ('guam testing', 0.1264),\n",
       "  ('undergone', 0.1233),\n",
       "  ('content', 0.1233),\n",
       "  ('soaking indicated', 0.119),\n",
       "  ('investigation levels', 0.1111),\n",
       "  ('cause', 0.1068),\n",
       "  ('greater', 0.1002),\n",
       "  ('rota contains', 0.0996),\n",
       "  ('nerve cells', 0.0986),\n",
       "  ('prepared chamorro', 0.0905),\n",
       "  ('hours', 0.0838),\n",
       "  ('observed amyotrophic', 0.0811),\n",
       "  ('single', 0.0782),\n",
       "  ('99 total', 0.0731),\n",
       "  ('regional differences', 0.0659),\n",
       "  ('thoroughness', 0.0529),\n",
       "  ('washing procedure', 0.0488),\n",
       "  ('sclerosis', 0.0295),\n",
       "  ('collected villages', 0.0292),\n",
       "  ('delayed', 0.0237),\n",
       "  ('cells observed', 0.0058),\n",
       "  ('dementia', -0.0046),\n",
       "  ('undergone 24', -0.0158),\n",
       "  ('woman years', -0.0398)],\n",
       " 'MED-1285': [('guam afflicted', 0.4143),\n",
       "  ('foxes generated', 0.4055),\n",
       "  ('chamorro people', 0.3934),\n",
       "  ('flying foxes', 0.3891),\n",
       "  ('chamorro consumption', 0.388),\n",
       "  ('neuropathologies flying', 0.3774),\n",
       "  ('complex neurodegenerative', 0.3665),\n",
       "  ('world chamorro', 0.3662),\n",
       "  ('foxes forage', 0.3557),\n",
       "  ('neurodegenerative diseases', 0.3074),\n",
       "  ('people guam', 0.2988),\n",
       "  ('pdc neuropathologies', 0.255),\n",
       "  ('neuropathologies', 0.2499),\n",
       "  ('consumption flying', 0.2491),\n",
       "  ('neurotoxins result', 0.2424),\n",
       "  ('plant neurotoxins', 0.2346),\n",
       "  ('neurotoxic cycad', 0.2287),\n",
       "  ('diseases known', 0.2266),\n",
       "  ('afflicted complex', 0.2252),\n",
       "  ('forage neurotoxic', 0.2163),\n",
       "  ('afflicted', 0.1922),\n",
       "  ('similarities als', 0.1887),\n",
       "  ('als pdc', 0.1816),\n",
       "  ('doses plant', 0.1789),\n",
       "  ('cumulative doses', 0.1734),\n",
       "  ('flying', 0.1599),\n",
       "  ('known als', 0.1596),\n",
       "  ('far higher', 0.1438),\n",
       "  ('cycad seeds', 0.1391),\n",
       "  ('populations', 0.1365),\n",
       "  ('populations world', 0.1267),\n",
       "  ('high cumulative', 0.1252),\n",
       "  ('forage', 0.1088),\n",
       "  ('complex', 0.0998),\n",
       "  ('plant', 0.0953),\n",
       "  ('rate populations', 0.0872),\n",
       "  ('result als', 0.0838),\n",
       "  ('higher rate', 0.0826),\n",
       "  ('pdc similarities', 0.079),\n",
       "  ('generated', 0.0718),\n",
       "  ('seeds', 0.0567),\n",
       "  ('people', 0.0371),\n",
       "  ('similarities', 0.0359),\n",
       "  ('consumption', 0.0261),\n",
       "  ('pd far', -0.0075),\n",
       "  ('ad', -0.0224),\n",
       "  ('result', -0.0371),\n",
       "  ('pdc', -0.0478),\n",
       "  ('known', -0.1181),\n",
       "  ('sufficiently', -0.149)],\n",
       " 'MED-1287': [('blooms cyanobacteria', 0.5277),\n",
       "  ('bmaa biomagnify', 0.5016),\n",
       "  ('demonstrate cyanobacteria', 0.4775),\n",
       "  ('neurotoxin', 0.4551),\n",
       "  ('bmaa concentrations', 0.4253),\n",
       "  ('neurotoxin beta', 0.3968),\n",
       "  ('bmaa implicated', 0.3946),\n",
       "  ('cyanobacteria south', 0.3903),\n",
       "  ('biomagnify terrestrial', 0.3702),\n",
       "  ('development neurodegenerative', 0.3701),\n",
       "  ('alanine bmaa', 0.3699),\n",
       "  ('significant environmental', 0.3453),\n",
       "  ('disease amyotrophic', 0.3421),\n",
       "  ('chain bmaa', 0.3311),\n",
       "  ('concentrations ranging', 0.3199),\n",
       "  ('range bmaa', 0.3151),\n",
       "  ('examined blooms', 0.2903),\n",
       "  ('beta methylamino', 0.2719),\n",
       "  ('methylamino alanine', 0.2691),\n",
       "  ('food chain', 0.2133),\n",
       "  ('risk development', 0.1934),\n",
       "  ('florida bmaa', 0.1933),\n",
       "  ('including species', 0.1911),\n",
       "  ('diseases', 0.1858),\n",
       "  ('associated potential', 0.1791),\n",
       "  ('alzheimer', 0.1779),\n",
       "  ('wide range', 0.1718),\n",
       "  ('μg concentration', 0.1709),\n",
       "  ('terrestrial', 0.1605),\n",
       "  ('approximately 7000', 0.1547),\n",
       "  ('beta', 0.1445),\n",
       "  ('parkinson', 0.1337),\n",
       "  ('limits approximately', 0.1201),\n",
       "  ('potential long', 0.1124),\n",
       "  ('recent studies', 0.1102),\n",
       "  ('implicated', 0.103),\n",
       "  ('sclerosis', 0.1),\n",
       "  ('including', 0.0957),\n",
       "  ('detection', 0.0904),\n",
       "  ('used human', 0.0817),\n",
       "  ('human health', 0.0806),\n",
       "  ('produce', 0.0783),\n",
       "  ('lateral', 0.0768),\n",
       "  ('term', 0.0694),\n",
       "  ('demonstrate', 0.0676),\n",
       "  ('ranging assay', 0.0641),\n",
       "  ('animals including', 0.0565),\n",
       "  ('als examined', 0.0372),\n",
       "  ('south florida', 0.0017),\n",
       "  ('content resident', -0.009)],\n",
       " 'MED-1288': [('fox cycad', 0.4379),\n",
       "  ('foxes feed', 0.4272),\n",
       "  ('flying fox', 0.4099),\n",
       "  ('cycad neurotoxins', 0.4076),\n",
       "  ('biomagnified guam', 0.3915),\n",
       "  ('bmaa dose', 0.3881),\n",
       "  ('foxes related', 0.3731),\n",
       "  ('alanine bmaa', 0.3658),\n",
       "  ('methylamino alanine', 0.3653),\n",
       "  ('fox resulted', 0.3649),\n",
       "  ('guamanian flying', 0.3561),\n",
       "  ('neurotoxins biomagnified', 0.3358),\n",
       "  ('specimens guamanian', 0.3251),\n",
       "  ('guam ecosystem', 0.3232),\n",
       "  ('beta methylamino', 0.2777),\n",
       "  ('biomagnified', 0.2517),\n",
       "  ('equivalent bmaa', 0.2444),\n",
       "  ('levels museum', 0.2243),\n",
       "  ('hypothesis cycad', 0.2242),\n",
       "  ('museum specimens', 0.2199),\n",
       "  ('single flying', 0.2161),\n",
       "  ('cycad flour', 0.216),\n",
       "  ('flying', 0.1946),\n",
       "  ('seeds flying', 0.1836),\n",
       "  ('ecosystem consumption', 0.1821),\n",
       "  ('dose obtained', 0.1792),\n",
       "  ('feasting flying', 0.1682),\n",
       "  ('feed confirming', 0.1345),\n",
       "  ('consumption', 0.1305),\n",
       "  ('kg', 0.1273),\n",
       "  ('014 kg', 0.1251),\n",
       "  ('obtained eating', 0.1248),\n",
       "  ('specimens', 0.1214),\n",
       "  ('occurs higher', 0.1177),\n",
       "  ('levels', 0.1103),\n",
       "  ('consumption single', 0.1076),\n",
       "  ('eating 174', 0.1012),\n",
       "  ('174 014', 0.0955),\n",
       "  ('neuropathologic', 0.0938),\n",
       "  ('beta', 0.0709),\n",
       "  ('traditional', 0.0708),\n",
       "  ('resulted', 0.0653),\n",
       "  ('traditional feasting', 0.0571),\n",
       "  ('resulted equivalent', 0.0526),\n",
       "  ('related prevalence', 0.0366),\n",
       "  ('disease', 0.0364),\n",
       "  ('confirming hypothesis', 0.0242),\n",
       "  ('related', 0.0236),\n",
       "  ('flour', 0.0145),\n",
       "  ('processed', -0.033)],\n",
       " 'MED-1289': [('bmaa neurotoxic', 0.5559),\n",
       "  ('toxic compounds', 0.4436),\n",
       "  ('alanine bmaa', 0.4394),\n",
       "  ('cyanobacteria genus', 0.4375),\n",
       "  ('neurotoxic nonprotein', 0.4211),\n",
       "  ('guam ecosystem', 0.3787),\n",
       "  ('metabolism', 0.3756),\n",
       "  ('trophic levels', 0.3526),\n",
       "  ('biomagnification', 0.3383),\n",
       "  ('symbionts', 0.3325),\n",
       "  ('free amino', 0.3225),\n",
       "  ('bmaa polar', 0.3116),\n",
       "  ('produce methylamino', 0.3075),\n",
       "  ('concentrations increased', 0.3037),\n",
       "  ('nostoc produce', 0.2925),\n",
       "  ('genus', 0.2733),\n",
       "  ('polar nonlipophilic', 0.2686),\n",
       "  ('ecosystem released', 0.2522),\n",
       "  ('form acid', 0.2294),\n",
       "  ('compounds food', 0.226),\n",
       "  ('died amyotrophic', 0.2167),\n",
       "  ('tissues endogenous', 0.1969),\n",
       "  ('disease suggests', 0.1831),\n",
       "  ('causing incipient', 0.1763),\n",
       "  ('seeds cycad', 0.1734),\n",
       "  ('eaten chamorro', 0.154),\n",
       "  ('canadian patients', 0.1511),\n",
       "  ('recurrent neurological', 0.1474),\n",
       "  ('dementia complex', 0.1402),\n",
       "  ('trees', 0.1248),\n",
       "  ('occurs outside', 0.1193),\n",
       "  ('triangle', 0.1129),\n",
       "  ('latency period', 0.1102),\n",
       "  ('people brain', 0.1059),\n",
       "  ('fold bound', 0.0935),\n",
       "  ('various', 0.0935),\n",
       "  ('sclerosis parkinsonism', 0.0931),\n",
       "  ('complex hydrolyzed', 0.0922),\n",
       "  ('patients died', 0.0816),\n",
       "  ('fits classic', 0.0719),\n",
       "  ('10', 0.0711),\n",
       "  ('lateral', 0.0666),\n",
       "  ('years decades', 0.0487),\n",
       "  ('removing', 0.0409),\n",
       "  ('flour flying', 0.0292),\n",
       "  ('people presence', 0.0215),\n",
       "  ('accumulating transported', 0.0169),\n",
       "  ('foxes', 0.0069),\n",
       "  ('240 fold', -0.024),\n",
       "  ('unclear', -0.0296)],\n",
       " 'MED-1290': [('bmaa neurotoxicity', 0.4922),\n",
       "  ('related neurodegenerative', 0.4903),\n",
       "  ('neurotoxicity', 0.4608),\n",
       "  ('neurodegenerative', 0.4372),\n",
       "  ('bmaa hypothesis', 0.4326),\n",
       "  ('neurodegenerative diseases', 0.432),\n",
       "  ('possible hypothesis', 0.3997),\n",
       "  ('cyanobacteria bmaa', 0.3944),\n",
       "  ('chronic bmaa', 0.3801),\n",
       "  ('hypothesis cause', 0.3534),\n",
       "  ('cause als', 0.3445),\n",
       "  ('diseases remains', 0.3411),\n",
       "  ('ways chronic', 0.3334),\n",
       "  ('neurotoxicity prevented', 0.3163),\n",
       "  ('cyanobacteria', 0.2867),\n",
       "  ('treatment possible', 0.2802),\n",
       "  ('possible ways', 0.2747),\n",
       "  ('chronic', 0.274),\n",
       "  ('hypothesis', 0.2736),\n",
       "  ('remains proven', 0.2704),\n",
       "  ('als age', 0.2687),\n",
       "  ('bmaa', 0.2654),\n",
       "  ('diseases', 0.2636),\n",
       "  ('reviews possible', 0.2494),\n",
       "  ('als', 0.2451),\n",
       "  ('cause', 0.2351),\n",
       "  ('treatment', 0.218),\n",
       "  ('possible', 0.2109),\n",
       "  ('paper reviews', 0.2009),\n",
       "  ('hypothesis correct', 0.1966),\n",
       "  ('prevented', 0.1956),\n",
       "  ('related', 0.191),\n",
       "  ('ask treatment', 0.1852),\n",
       "  ('prevented treated', 0.1762),\n",
       "  ('age related', 0.1718),\n",
       "  ('reviews', 0.1679),\n",
       "  ('remains', 0.1625),\n",
       "  ('proven early', 0.1402),\n",
       "  ('paper', 0.1268),\n",
       "  ('proven', 0.1202),\n",
       "  ('treated', 0.1143),\n",
       "  ('ways', 0.1047),\n",
       "  ('early', 0.0965),\n",
       "  ('correct paper', 0.0911),\n",
       "  ('age', 0.0795),\n",
       "  ('early ask', 0.0594),\n",
       "  ('ask', 0.0214),\n",
       "  ('correct', 0.0045)],\n",
       " 'MED-1291': [('mushrooms studies', 0.5916),\n",
       "  ('mushrooms modulate', 0.5804),\n",
       "  ('mushroom extracts', 0.5121),\n",
       "  ('mushrooms oral', 0.4785),\n",
       "  ('biologic activities', 0.4252),\n",
       "  ('supplements based', 0.4019),\n",
       "  ('extracts dietary', 0.3868),\n",
       "  ('enhance immune', 0.3751),\n",
       "  ('potential health', 0.343),\n",
       "  ('determine antitumor', 0.2483),\n",
       "  ('theories enhance', 0.2438),\n",
       "  ('cytokines cognate', 0.241),\n",
       "  ('extracts highlight', 0.2391),\n",
       "  ('potentially significant', 0.2375),\n",
       "  ('shown stimulatory', 0.2355),\n",
       "  ('important components', 0.2324),\n",
       "  ('studies addressed', 0.2251),\n",
       "  ('surprising paucity', 0.2096),\n",
       "  ('benefits surprising', 0.2094),\n",
       "  ('widespread use', 0.2008),\n",
       "  ('epidemiologic experimental', 0.1907),\n",
       "  ('administration animals', 0.1748),\n",
       "  ('vitro despite', 0.1693),\n",
       "  ('despite widespread', 0.1644),\n",
       "  ('metals including', 0.1578),\n",
       "  ('function promote', 0.1525),\n",
       "  ('need evidence', 0.1489),\n",
       "  ('review present', 0.1452),\n",
       "  ('animals humans', 0.141),\n",
       "  ('cell activation', 0.1241),\n",
       "  ('mononuclear cell', 0.1179),\n",
       "  ('contamination 137cs', 0.1116),\n",
       "  ('biology respect', 0.1035),\n",
       "  ('oral', 0.0954),\n",
       "  ('extent select', 0.095),\n",
       "  ('modulate', 0.0932),\n",
       "  ('toxic', 0.0909),\n",
       "  ('based', 0.0863),\n",
       "  ('arsenic', 0.0828),\n",
       "  ('receptors', 0.0793),\n",
       "  ('activity data', 0.0749),\n",
       "  ('attempts', 0.0735),\n",
       "  ('presence radioactive', 0.0692),\n",
       "  ('phenotypic expression', 0.0686),\n",
       "  ('addressed', 0.0658),\n",
       "  ('comparative', 0.0501),\n",
       "  ('responsiveness particularly', 0.0371),\n",
       "  ('lead cadmium', 0.0247),\n",
       "  ('humans number', 0.0211),\n",
       "  ('data tempered', -0.0163)],\n",
       " 'MED-1292': [('claims mushrooms', 0.6524),\n",
       "  ('mushrooms beneficial', 0.6133),\n",
       "  ('mushrooms innumerable', 0.5331),\n",
       "  ('enormous biologic', 0.4742),\n",
       "  ('biologic activity', 0.4356),\n",
       "  ('observations anecdotal', 0.3324),\n",
       "  ('extracts modulate', 0.3245),\n",
       "  ('speculation substance', 0.3161),\n",
       "  ('tumor biology', 0.3057),\n",
       "  ('innumerable claims', 0.302),\n",
       "  ('considerable data', 0.2707),\n",
       "  ('scientific', 0.2684),\n",
       "  ('vivo effects', 0.2675),\n",
       "  ('modulate immunity', 0.2656),\n",
       "  ('biology', 0.2638),\n",
       "  ('anecdotal lack', 0.2502),\n",
       "  ('significant potential', 0.2473),\n",
       "  ('remains considerable', 0.2301),\n",
       "  ('characterized based', 0.2272),\n",
       "  ('potential toxicity', 0.2269),\n",
       "  ('effects reflect', 0.225),\n",
       "  ('clinical trials', 0.2243),\n",
       "  ('implications inhibition', 0.2103),\n",
       "  ('suppressed', 0.1922),\n",
       "  ('based phenomenology', 0.1921),\n",
       "  ('cytopathic', 0.1903),\n",
       "  ('antigens frequently', 0.1878),\n",
       "  ('lesions', 0.1744),\n",
       "  ('human disease', 0.1433),\n",
       "  ('vitro', 0.1396),\n",
       "  ('growth majority', 0.1314),\n",
       "  ('responses including', 0.1251),\n",
       "  ('review attempt', 0.1188),\n",
       "  ('beneficial unfortunately', 0.114),\n",
       "  ('number effects', 0.1111),\n",
       "  ('lack standardization', 0.1106),\n",
       "  ('including defective', 0.1087),\n",
       "  ('focus dendritic', 0.1085),\n",
       "  ('induce tolerance', 0.1054),\n",
       "  ('patients significant', 0.1042),\n",
       "  ('use', 0.0665),\n",
       "  ('populations ability', 0.059),\n",
       "  ('result improved', 0.0425),\n",
       "  ('treatment human', 0.0317),\n",
       "  ('influence human', 0.0277),\n",
       "  ('frequently self', 0.0254),\n",
       "  ('exhibit', 0.0138),\n",
       "  ('perspective particular', 0.0055),\n",
       "  ('substance respect', -0.0105),\n",
       "  ('cells direct', -0.0242)],\n",
       " 'MED-1293': [('augmenting immunity', 0.5817),\n",
       "  ('immunity diseases', 0.5565),\n",
       "  ('immune incredible', 0.4761),\n",
       "  ('domain nutrition', 0.4745),\n",
       "  ('foods augmenting', 0.473),\n",
       "  ('functional nutraceutical', 0.4544),\n",
       "  ('exploring diet', 0.4533),\n",
       "  ('immunomodulating properties', 0.4225),\n",
       "  ('responses defense', 0.4015),\n",
       "  ('health linkages', 0.3483),\n",
       "  ('interventions led', 0.3455),\n",
       "  ('homeostasis array', 0.33),\n",
       "  ('diseases review', 0.3109),\n",
       "  ('regimens', 0.2829),\n",
       "  ('anti inflammatory', 0.2817),\n",
       "  ('inflammatory', 0.2751),\n",
       "  ('new therapeutic', 0.2699),\n",
       "  ('organs cells', 0.2483),\n",
       "  ('area research', 0.2399),\n",
       "  ('helpful cancer', 0.2392),\n",
       "  ('investigated recommended', 0.2379),\n",
       "  ('undesired responses', 0.2125),\n",
       "  ('ginger', 0.2082),\n",
       "  ('botanicals investigated', 0.1903),\n",
       "  ('body', 0.1818),\n",
       "  ('interfering pathways', 0.1733),\n",
       "  ('free radical', 0.1666),\n",
       "  ('enabled humans', 0.1621),\n",
       "  ('bestowed functional', 0.1537),\n",
       "  ('information disseminated', 0.1516),\n",
       "  ('insurgence interaction', 0.1443),\n",
       "  ('importance', 0.1369),\n",
       "  ('incredible arrangement', 0.1281),\n",
       "  ('widespread acceptance', 0.1217),\n",
       "  ('garlic allium', 0.1158),\n",
       "  ('sativa licorice', 0.1155),\n",
       "  ('plants carry', 0.1083),\n",
       "  ('natural', 0.1018),\n",
       "  ('hypericum perforatum', 0.096),\n",
       "  ('echinacea black', 0.0748),\n",
       "  ('nigella', 0.0744),\n",
       "  ('camellia sinensis', 0.0701),\n",
       "  ('avenues', 0.0668),\n",
       "  ('various menaces', 0.0337),\n",
       "  ('zingiber', 0.0181),\n",
       "  ('officinale', -0.0015),\n",
       "  ('astragalus', -0.0057),\n",
       "  ('coneflower', -0.009),\n",
       "  ('tea', -0.0293),\n",
       "  ('st john', -0.0871)],\n",
       " 'MED-1294': [('beta glucans', 0.5524),\n",
       "  ('glucans modulate', 0.5518),\n",
       "  ('polysaccharides investigated', 0.4793),\n",
       "  ('natural polysaccharides', 0.4624),\n",
       "  ('oral preparations', 0.4376),\n",
       "  ('modulate immune', 0.4271),\n",
       "  ('immunological effects', 0.4259),\n",
       "  ('glucans safe', 0.4253),\n",
       "  ('parenterally applied', 0.331),\n",
       "  ('investigated immunological', 0.3258),\n",
       "  ('low systemic', 0.3193),\n",
       "  ('orally applied', 0.3178),\n",
       "  ('preparations thought', 0.3124),\n",
       "  ('effects mainly', 0.2908),\n",
       "  ('dietary insoluble', 0.2753),\n",
       "  ('clinical trials', 0.271),\n",
       "  ('immune vivo', 0.2671),\n",
       "  ('trials dietary', 0.2648),\n",
       "  ('immune strengthening', 0.2468),\n",
       "  ('effects low', 0.2431),\n",
       "  ('receptor interactions', 0.2316),\n",
       "  ('safe immune', 0.2199),\n",
       "  ('investigations revealed', 0.2178),\n",
       "  ('detected effects', 0.2163),\n",
       "  ('revealed orally', 0.2122),\n",
       "  ('applied beta', 0.2105),\n",
       "  ('systemic availability', 0.2042),\n",
       "  ('vitro investigations', 0.2036),\n",
       "  ('exert effects', 0.1952),\n",
       "  ('studies taken', 0.1931),\n",
       "  ('previous findings', 0.185),\n",
       "  ('explaining possible', 0.1833),\n",
       "  ('various', 0.1799),\n",
       "  ('interactions', 0.1642),\n",
       "  ('vivo', 0.1543),\n",
       "  ('intake', 0.152),\n",
       "  ('heterogeneous group', 0.1505),\n",
       "  ('modulate', 0.1018),\n",
       "  ('yeast', 0.092),\n",
       "  ('mainly depend', 0.0854),\n",
       "  ('group natural', 0.0705),\n",
       "  ('performed results', 0.0455),\n",
       "  ('source structure', 0.0338),\n",
       "  ('mode actions', 0.0295),\n",
       "  ('applied', 0.028),\n",
       "  ('clearly indicate', 0.0223),\n",
       "  ('meantime', -0.0076),\n",
       "  ('strengthening', -0.0131),\n",
       "  ('human', -0.0326),\n",
       "  ('taken', -0.0403)],\n",
       " 'MED-1295': [('polysaccharides', 0.6156),\n",
       "  ('number polysaccharides', 0.5984),\n",
       "  ('beta glucans', 0.5203),\n",
       "  ('glucan sources', 0.5085),\n",
       "  ('polysaccharides beta', 0.4997),\n",
       "  ('glycosidic linkage', 0.4897),\n",
       "  ('glucan backbone', 0.4735),\n",
       "  ('glucans suitable', 0.4683),\n",
       "  ('bioactive properties', 0.4615),\n",
       "  ('glucan solubilization', 0.4027),\n",
       "  ('years bioactive', 0.3739),\n",
       "  ('medicinal properties', 0.3374),\n",
       "  ('common structure', 0.3164),\n",
       "  ('chemical nature', 0.3067),\n",
       "  ('variety sources', 0.2837),\n",
       "  ('sources common', 0.2768),\n",
       "  ('applications various', 0.2768),\n",
       "  ('backbone essential', 0.2236),\n",
       "  ('functional role', 0.2228),\n",
       "  ('insoluble chemical', 0.2135),\n",
       "  ('relationships presents', 0.2053),\n",
       "  ('medical applications', 0.1982),\n",
       "  ('activity relationships', 0.1951),\n",
       "  ('health effects', 0.1949),\n",
       "  ('structure transforming', 0.1894),\n",
       "  ('solubilization methods', 0.1682),\n",
       "  ('mystery established', 0.1679),\n",
       "  ('nature health', 0.1594),\n",
       "  ('essential', 0.1556),\n",
       "  ('linkage widespread', 0.1448),\n",
       "  ('established insoluble', 0.1428),\n",
       "  ('properties affected', 0.1428),\n",
       "  ('modifications review', 0.1421),\n",
       "  ('role mystery', 0.1298),\n",
       "  ('widespread', 0.1276),\n",
       "  ('transforming soluble', 0.1253),\n",
       "  ('methods changing', 0.1216),\n",
       "  ('cases functional', 0.119),\n",
       "  ('published', 0.0894),\n",
       "  ('attracted attention', 0.0877),\n",
       "  ('methods', 0.0836),\n",
       "  ('examines beta', 0.0785),\n",
       "  ('particulate', 0.0644),\n",
       "  ('discusses', 0.0431),\n",
       "  ('possibilities future', 0.038),\n",
       "  ('presents current', 0.0235),\n",
       "  ('affected positively', -0.0174),\n",
       "  ('discusses effectiveness', -0.0187),\n",
       "  ('state', -0.0484),\n",
       "  ('negatively', -0.067)],\n",
       " 'MED-1296': [('used immunomodulators', 0.6558),\n",
       "  ('immunomodulators tested', 0.6498),\n",
       "  ('reactions immunomodulators', 0.611),\n",
       "  ('immunomodulators', 0.5987),\n",
       "  ('natural immunomodulators', 0.5921),\n",
       "  ('immunomodulators testing', 0.5526),\n",
       "  ('immunomodulators getting', 0.5219),\n",
       "  ('limited effects', 0.4043),\n",
       "  ('mediocre effects', 0.3345),\n",
       "  ('effects purpose', 0.2773),\n",
       "  ('claims mediocre', 0.2467),\n",
       "  ('active molecule', 0.2282),\n",
       "  ('tested limited', 0.2239),\n",
       "  ('effects', 0.2092),\n",
       "  ('humoral branches', 0.1985),\n",
       "  ('immune', 0.1761),\n",
       "  ('optimistic claims', 0.154),\n",
       "  ('branches immune', 0.1477),\n",
       "  ('commonly used', 0.1405),\n",
       "  ('cellular humoral', 0.1247),\n",
       "  ('molecule', 0.104),\n",
       "  ('evaluated data', 0.0925),\n",
       "  ('purpose present', 0.0894),\n",
       "  ('testing cellular', 0.0874),\n",
       "  ('number metastases', 0.0797),\n",
       "  ('tested', 0.0771),\n",
       "  ('claims', 0.0745),\n",
       "  ('directly compare', 0.0742),\n",
       "  ('molecule strongly', 0.0732),\n",
       "  ('popular popularity', 0.0727),\n",
       "  ('reactions', 0.0718),\n",
       "  ('natural', 0.0629),\n",
       "  ('strongly stimulating', 0.0605),\n",
       "  ('present study', 0.0574),\n",
       "  ('branches', 0.0544),\n",
       "  ('number', 0.0375),\n",
       "  ('resveratrol lowered', 0.0362),\n",
       "  ('using', 0.0335),\n",
       "  ('model', 0.0295),\n",
       "  ('cancer model', 0.0277),\n",
       "  ('model glucan', 0.0245),\n",
       "  ('glucan resveratrol', 0.0109),\n",
       "  ('study directly', 0.0096),\n",
       "  ('using lewis', -0.0084),\n",
       "  ('lung', -0.0086),\n",
       "  ('lowered', -0.009),\n",
       "  ('consistently active', -0.0233),\n",
       "  ('confirmed', -0.0269),\n",
       "  ('brings', -0.0302),\n",
       "  ('strongly', -0.0356)],\n",
       " 'MED-1298': [('obesity induced', 0.5492),\n",
       "  ('insulin resistance', 0.5474),\n",
       "  ('dietary fibers', 0.5227),\n",
       "  ('effects dietary', 0.467),\n",
       "  ('improves inflammatory', 0.4373),\n",
       "  ('bdg induced', 0.4151),\n",
       "  ('humans insulin', 0.3987),\n",
       "  ('beta glycans', 0.3945),\n",
       "  ('proinflammatory cytokines', 0.3635),\n",
       "  ('fibers beta', 0.3569),\n",
       "  ('increased circulating', 0.3374),\n",
       "  ('adipose', 0.3176),\n",
       "  ('expression antiinflammatory', 0.2923),\n",
       "  ('suggested systemic', 0.2877),\n",
       "  ('circulating levels', 0.2795),\n",
       "  ('interleukin', 0.2674),\n",
       "  ('normal diet', 0.2643),\n",
       "  ('starch daily', 0.2598),\n",
       "  ('subjects ingested', 0.254),\n",
       "  ('il 10', 0.249),\n",
       "  ('potent effects', 0.2469),\n",
       "  ('reactive protein', 0.2347),\n",
       "  ('consumption improves', 0.2205),\n",
       "  ('innate', 0.207),\n",
       "  ('subclinical inflammation', 0.2011),\n",
       "  ('infection subjects', 0.1816),\n",
       "  ('studies indicate', 0.181),\n",
       "  ('waxy maize', 0.1788),\n",
       "  ('immune animal', 0.1745),\n",
       "  ('treatment increased', 0.1727),\n",
       "  ('resistance suggested', 0.1715),\n",
       "  ('investigated randomized', 0.1637),\n",
       "  ('weeks significantly', 0.1634),\n",
       "  ('tissue peripheral', 0.1621),\n",
       "  ('contributing factor', 0.1486),\n",
       "  ('condition activation', 0.1478),\n",
       "  ('capsules predefined', 0.1461),\n",
       "  ('food recording', 0.1435),\n",
       "  ('rna mrna', 0.1352),\n",
       "  ('unaffected bdg', 0.132),\n",
       "  ('blood gene', 0.1279),\n",
       "  ('reducing secretion', 0.1032),\n",
       "  ('daily maintenance', 0.101),\n",
       "  ('changes pro', 0.0851),\n",
       "  ('crossover design', 0.0814),\n",
       "  ('double blind', 0.0657),\n",
       "  ('highly purified', 0.0414),\n",
       "  ('screened 180', 0.0305),\n",
       "  ('counting provided', 0.0085),\n",
       "  ('absence signs', -0.0188)],\n",
       " 'MED-1299': [('glucan supplement', 0.4153),\n",
       "  ('baker yeast', 0.3292),\n",
       "  ('effective reducing', 0.3288),\n",
       "  ('symptoms psychological', 0.31),\n",
       "  ('psychological women', 0.2947),\n",
       "  ('improves mood', 0.2887),\n",
       "  ('health perception', 0.2871),\n",
       "  ('symptoms compared', 0.285),\n",
       "  ('stress self', 0.2786),\n",
       "  ('supplementation wellmune', 0.2546),\n",
       "  ('respiratory symptoms', 0.245),\n",
       "  ('energy levels', 0.2339),\n",
       "  ('effect specific', 0.2261),\n",
       "  ('reported fewer', 0.2217),\n",
       "  ('group reported', 0.2189),\n",
       "  ('cold flu', 0.217),\n",
       "  ('wellmune reduces', 0.2166),\n",
       "  ('specific beta', 0.2165),\n",
       "  ('study evaluated', 0.2142),\n",
       "  ('subjects useful', 0.1892),\n",
       "  ('maintaining immune', 0.1884),\n",
       "  ('useful approach', 0.1846),\n",
       "  ('psychological survey', 0.1805),\n",
       "  ('daily dietary', 0.1734),\n",
       "  ('05 conclusions', 0.1663),\n",
       "  ('administered', 0.1608),\n",
       "  ('healthy women', 0.1494),\n",
       "  ('poms psychological', 0.1319),\n",
       "  ('vigor 19', 0.1287),\n",
       "  ('overall global', 0.127),\n",
       "  ('moderate levels', 0.1252),\n",
       "  ('extracted', 0.1207),\n",
       "  ('108 23', 0.1138),\n",
       "  ('placebo 38', 0.1126),\n",
       "  ('protection', 0.0936),\n",
       "  ('weeks used', 0.0935),\n",
       "  ('log used', 0.0927),\n",
       "  ('state quantitative', 0.0923),\n",
       "  ('changes', 0.0866),\n",
       "  ('15', 0.0833),\n",
       "  ('wellmune 39', 0.083),\n",
       "  ('tract', 0.0675),\n",
       "  ('superior mental', 0.0443),\n",
       "  ('12 weeks', 0.0435),\n",
       "  ('29 better', 0.0318),\n",
       "  ('old prescreened', 0.0226),\n",
       "  ('vs', 0.0086),\n",
       "  ('250 mg', -0.0054),\n",
       "  ('data daily', -0.0154),\n",
       "  ('10', -0.034)],\n",
       " 'MED-1300': [('brewers yeast', 0.4753),\n",
       "  ('900 mg', 0.3841),\n",
       "  ('infections received', 0.3213),\n",
       "  ('effect brewers', 0.3142),\n",
       "  ('randomized multicentric', 0.3138),\n",
       "  ('glucan significantly', 0.3097),\n",
       "  ('insoluble yeast', 0.2912),\n",
       "  ('episodes healthy', 0.2812),\n",
       "  ('symptom score', 0.2797),\n",
       "  ('consumption number', 0.2644),\n",
       "  ('028 efficacy', 0.2473),\n",
       "  ('sleep difficulties', 0.2472),\n",
       "  ('caused cold', 0.2435),\n",
       "  ('participants recurring', 0.237),\n",
       "  ('162 healthy', 0.2328),\n",
       "  ('clinical', 0.212),\n",
       "  ('study demonstrated', 0.2038),\n",
       "  ('weeks subjects', 0.2006),\n",
       "  ('investigated methods', 0.1924),\n",
       "  ('placebo 041', 0.1919),\n",
       "  ('population supplementation', 0.1814),\n",
       "  ('day course', 0.174),\n",
       "  ('subjects instructed', 0.1719),\n",
       "  ('supplementation insoluble', 0.1684),\n",
       "  ('16 weeks', 0.1684),\n",
       "  ('common', 0.1681),\n",
       "  ('125 beta', 0.1678),\n",
       "  ('15 lower', 0.1655),\n",
       "  ('protocol population', 0.1604),\n",
       "  ('difficulties caused', 0.16),\n",
       "  ('healthy subject', 0.1543),\n",
       "  ('significantly reduced', 0.1435),\n",
       "  ('rate predefined', 0.1411),\n",
       "  ('beta', 0.1326),\n",
       "  ('participants 012', 0.1163),\n",
       "  ('subject investigated', 0.1147),\n",
       "  ('investigator episode', 0.1119),\n",
       "  ('double blind', 0.1072),\n",
       "  ('physicians 004', 0.1063),\n",
       "  ('compared', 0.0997),\n",
       "  ('body potential', 0.0936),\n",
       "  ('mean', 0.0921),\n",
       "  ('diary rate', 0.0782),\n",
       "  ('defend invading', 0.0732),\n",
       "  ('caused', 0.0723),\n",
       "  ('better', 0.0332),\n",
       "  ('increased', 0.0229),\n",
       "  ('5th day', -0.0044),\n",
       "  ('preparation 81', -0.0082),\n",
       "  ('opposed', -0.016)],\n",
       " 'MED-1301': [('nafld patients', 0.6216),\n",
       "  ('nafld grain', 0.5895),\n",
       "  ('liver disease', 0.4655),\n",
       "  ('evidence dietary', 0.4542),\n",
       "  ('steatohepatitis 97', 0.4136),\n",
       "  ('consumption grains', 0.4068),\n",
       "  ('fatty', 0.3687),\n",
       "  ('insulin resistance', 0.3631),\n",
       "  ('anthropometric indices', 0.3581),\n",
       "  ('habits contribute', 0.3305),\n",
       "  ('explore associations', 0.3146),\n",
       "  ('composition analysis', 0.2947),\n",
       "  ('biochemical inflammatory', 0.2926),\n",
       "  ('ldl', 0.2895),\n",
       "  ('controls matched', 0.2806),\n",
       "  ('methods seventy', 0.2517),\n",
       "  ('performed 58', 0.2508),\n",
       "  ('consumption increased', 0.2407),\n",
       "  ('characteristics patients', 0.2294),\n",
       "  ('having histological', 0.2208),\n",
       "  ('adjusting abdominal', 0.2187),\n",
       "  ('associated higher', 0.2109),\n",
       "  ('severe disease', 0.1871),\n",
       "  ('available participants', 0.1852),\n",
       "  ('markers available', 0.1807),\n",
       "  ('present study', 0.1796),\n",
       "  ('medical history', 0.1646),\n",
       "  ('elastography performed', 0.1563),\n",
       "  ('ci 001', 0.1538),\n",
       "  ('levels case', 0.1414),\n",
       "  ('frequency questionnaire', 0.1413),\n",
       "  ('interleukin levels', 0.141),\n",
       "  ('physical activity', 0.1393),\n",
       "  ('refined', 0.133),\n",
       "  ('odds', 0.1264),\n",
       "  ('associated lower', 0.1207),\n",
       "  ('alcoholic', 0.1184),\n",
       "  ('05 consumption', 0.1156),\n",
       "  ('tended', 0.1118),\n",
       "  ('34 patients', 0.1109),\n",
       "  ('favorably affected', 0.0942),\n",
       "  ('tnf conclusions', 0.0911),\n",
       "  ('semi quantitative', 0.0906),\n",
       "  ('non', 0.0865),\n",
       "  ('adiponectin', 0.0636),\n",
       "  ('sex body', 0.0584),\n",
       "  ('levels 23', 0.0435),\n",
       "  ('28 009', 0.038),\n",
       "  ('94 000', -0.0214),\n",
       "  ('homa', -0.036)],\n",
       " 'MED-1302': [('disease nafld', 0.7075),\n",
       "  ('nafld nutrient', 0.6776),\n",
       "  ('nafld eating', 0.6763),\n",
       "  ('nafld partially', 0.6702),\n",
       "  ('impact nafld', 0.6696),\n",
       "  ('risk nafld', 0.655),\n",
       "  ('fatty liver', 0.5928),\n",
       "  ('liver diseases', 0.5389),\n",
       "  ('treatment fatty', 0.5284),\n",
       "  ('rates obesity', 0.4967),\n",
       "  ('nutritional recommendations', 0.4878),\n",
       "  ('risk fatty', 0.4782),\n",
       "  ('poor diet', 0.4662),\n",
       "  ('weight loss', 0.4413),\n",
       "  ('lack nutritional', 0.4384),\n",
       "  ('diet increasing', 0.4377),\n",
       "  ('emphasising weight', 0.4106),\n",
       "  ('healthy diet', 0.3762),\n",
       "  ('eating', 0.3212),\n",
       "  ('related diseases', 0.3029),\n",
       "  ('intake reduced', 0.2981),\n",
       "  ('guidelines patients', 0.2824),\n",
       "  ('nonalcoholic', 0.2748),\n",
       "  ('physical activity', 0.2527),\n",
       "  ('current evidence', 0.2335),\n",
       "  ('prevent treatment', 0.2043),\n",
       "  ('activity emphasising', 0.1896),\n",
       "  ('consuming mainly', 0.1644),\n",
       "  ('composition switching', 0.156),\n",
       "  ('literature suggests', 0.1516),\n",
       "  ('diagnosis', 0.1351),\n",
       "  ('associations', 0.1299),\n",
       "  ('provide tailored', 0.1264),\n",
       "  ('phytochemical', 0.1234),\n",
       "  ('originates poor', 0.1234),\n",
       "  ('having impact', 0.1213),\n",
       "  ('suggests opportunities', 0.1186),\n",
       "  ('review examine', 0.1077),\n",
       "  ('epidemiological', 0.1044),\n",
       "  ('suggests', 0.0911),\n",
       "  ('loss limited', 0.0627),\n",
       "  ('mainly refined', 0.0579),\n",
       "  ('healthy', 0.055),\n",
       "  ('studies consistently', 0.0304),\n",
       "  ('current', 0.029),\n",
       "  ('conjunction rise', 0.0079),\n",
       "  ('partially originates', 0.0013),\n",
       "  ('reduced risk', -0.0011),\n",
       "  ('rate', -0.0172),\n",
       "  ('grains having', -0.0372)],\n",
       " 'MED-1303': [('varieties oats', 0.6166),\n",
       "  ('avena sativa', 0.5396),\n",
       "  ('oat dietary', 0.5363),\n",
       "  ('uses avena', 0.4996),\n",
       "  ('oat potential', 0.4774),\n",
       "  ('various phytoconstituents', 0.4593),\n",
       "  ('health oats', 0.4166),\n",
       "  ('sativa highlight', 0.3682),\n",
       "  ('important dietary', 0.3592),\n",
       "  ('cultivated worldwide', 0.3537),\n",
       "  ('like avenanthramides', 0.3324),\n",
       "  ('potential therapeutic', 0.3251),\n",
       "  ('antidiabetic', 0.3055),\n",
       "  ('wide spectrum', 0.2998),\n",
       "  ('varieties', 0.2994),\n",
       "  ('triterpenoid', 0.2866),\n",
       "  ('traditional uses', 0.2862),\n",
       "  ('number countries', 0.2709),\n",
       "  ('tocols', 0.265),\n",
       "  ('flavonoids', 0.2617),\n",
       "  ('like antioxidant', 0.2455),\n",
       "  ('anticholesterolaemic wide', 0.2401),\n",
       "  ('saponins sterols', 0.2387),\n",
       "  ('related availability', 0.2281),\n",
       "  ('available rich', 0.2264),\n",
       "  ('chemical composition', 0.2181),\n",
       "  ('polysaccharide forms', 0.1913),\n",
       "  ('lipids', 0.1891),\n",
       "  ('antispasmodic antitumor', 0.1878),\n",
       "  ('important minerals', 0.1857),\n",
       "  ('article summarize', 0.1834),\n",
       "  ('activities indicates', 0.1832),\n",
       "  ('number important', 0.1787),\n",
       "  ('human health', 0.1593),\n",
       "  ('use', 0.1565),\n",
       "  ('possesses different', 0.147),\n",
       "  ('staple people', 0.1435),\n",
       "  ('alkaloid gramine', 0.1392),\n",
       "  ('fiber contains', 0.0803),\n",
       "  ('considered stimulant', 0.074),\n",
       "  ('healing', 0.0706),\n",
       "  ('people', 0.0663),\n",
       "  ('biological', 0.0662),\n",
       "  ('production', 0.0622),\n",
       "  ('contribute human', 0.0564),\n",
       "  ('indole', 0.0456),\n",
       "  ('long considered', 0.0381),\n",
       "  ('agent', 0.0107),\n",
       "  ('mixed linkage', -0.0087),\n",
       "  ('neurotonic', -0.0887)],\n",
       " 'MED-1304': [('disease nafld', 0.7481),\n",
       "  ('nafld common', 0.7205),\n",
       "  ('nafld significantly', 0.6972),\n",
       "  ('hepatic steatosis', 0.6555),\n",
       "  ('nafld heavy', 0.637),\n",
       "  ('rapidly nafld', 0.635),\n",
       "  ('steatohepatitis nash', 0.6166),\n",
       "  ('fatty liver', 0.6128),\n",
       "  ('liver disease', 0.6103),\n",
       "  ('nonalcoholic steatohepatitis', 0.5938),\n",
       "  ('simple steatosis', 0.5848),\n",
       "  ('improve steatosis', 0.5768),\n",
       "  ('hepatically nonalcoholic', 0.5426),\n",
       "  ('cirrhosis obesity', 0.4876),\n",
       "  ('liver biopsy', 0.4744),\n",
       "  ('mellitus dyslipidemia', 0.4631),\n",
       "  ('steatosis absence', 0.4558),\n",
       "  ('improve steatohepatitis', 0.4465),\n",
       "  ('common liver', 0.3908),\n",
       "  ('progress cirrhosis', 0.3866),\n",
       "  ('evidence hepatic', 0.3817),\n",
       "  ('fatty', 0.3618),\n",
       "  ('obesity insulin', 0.327),\n",
       "  ('nash progress', 0.2903),\n",
       "  ('weight loss', 0.2869),\n",
       "  ('disease individuals', 0.2466),\n",
       "  ('risk cardiovascular', 0.213),\n",
       "  ('incidence increasing', 0.1586),\n",
       "  ('etiologies including', 0.1561),\n",
       "  ('western world', 0.1557),\n",
       "  ('cornerstone treatment', 0.1519),\n",
       "  ('relatively benign', 0.1421),\n",
       "  ('number pharmacologic', 0.1407),\n",
       "  ('significant alcohol', 0.128),\n",
       "  ('biopsy remains', 0.1087),\n",
       "  ('requires imaging', 0.1042),\n",
       "  ('spectrum ranging', 0.1025),\n",
       "  ('thiazolidinediones', 0.0828),\n",
       "  ('gold standard', 0.0713),\n",
       "  ('patient subgroups', 0.0589),\n",
       "  ('prognosis', 0.0582),\n",
       "  ('including significant', 0.0476),\n",
       "  ('vitamin', 0.0473),\n",
       "  ('10 weight', 0.0429),\n",
       "  ('heavy enrichment', 0.0244),\n",
       "  ('resistance', 0.0203),\n",
       "  ('absence competing', 0.0202),\n",
       "  ('believed', 0.0144),\n",
       "  ('agents', 0.0058),\n",
       "  ('select', -0.0234)],\n",
       " 'MED-1305': [('intake grains', 0.5121),\n",
       "  ('diet results', 0.5003),\n",
       "  ('weight regulation', 0.4778),\n",
       "  ('intervention studies', 0.4124),\n",
       "  ('mechanisms grain', 0.4013),\n",
       "  ('carbohydrates satiety', 0.3914),\n",
       "  ('glycemic index', 0.3907),\n",
       "  ('refined cereal', 0.3825),\n",
       "  ('understand epidemiological', 0.3731),\n",
       "  ('higher intake', 0.3597),\n",
       "  ('review available', 0.3332),\n",
       "  ('modulating intestinal', 0.3178),\n",
       "  ('healthier lifestyle', 0.3162),\n",
       "  ('potential mechanisms', 0.3129),\n",
       "  ('overweight try', 0.307),\n",
       "  ('trials provide', 0.2995),\n",
       "  ('results clarify', 0.2871),\n",
       "  ('scientific literature', 0.2843),\n",
       "  ('intake help', 0.2827),\n",
       "  ('cardiovascular diseases', 0.2701),\n",
       "  ('consumption cause', 0.2567),\n",
       "  ('duration intervention', 0.2504),\n",
       "  ('type diabetes', 0.2476),\n",
       "  ('refined', 0.242),\n",
       "  ('diverging results', 0.2327),\n",
       "  ('regulation evaluate', 0.2318),\n",
       "  ('effective reducing', 0.203),\n",
       "  ('body', 0.1948),\n",
       "  ('topic', 0.1904),\n",
       "  ('based products', 0.1844),\n",
       "  ('viewpoint aims', 0.1835),\n",
       "  ('index fermentation', 0.1528),\n",
       "  ('size', 0.151),\n",
       "  ('microflora', 0.1505),\n",
       "  ('cancer', 0.1487),\n",
       "  ('lower energy', 0.1344),\n",
       "  ('methodology needed', 0.132),\n",
       "  ('habitual', 0.1313),\n",
       "  ('non digestible', 0.1287),\n",
       "  ('adequate', 0.1161),\n",
       "  ('clarify question', 0.1108),\n",
       "  ('favoring se', 0.1076),\n",
       "  ('demonstrate higher', 0.1041),\n",
       "  ('rights reserved', 0.098),\n",
       "  ('small sample', 0.0946),\n",
       "  ('contrast', 0.0833),\n",
       "  ('affected', 0.0413),\n",
       "  ('relationship', -0.0035),\n",
       "  ('copyright 2011', -0.0182),\n",
       "  ('simply marker', -0.04)],\n",
       " 'MED-1307': [('nafld sonographic', 0.6996),\n",
       "  ('liver ultrasound', 0.6251),\n",
       "  ('nafld common', 0.5889),\n",
       "  ('nafld despite', 0.5574),\n",
       "  ('liver biopsy', 0.5287),\n",
       "  ('bedside ultrasound', 0.467),\n",
       "  ('limitations ultrasound', 0.4644),\n",
       "  ('steatosis replace', 0.4391),\n",
       "  ('moderate hepatic', 0.4257),\n",
       "  ('hepatic echoes', 0.3907),\n",
       "  ('heterogeneous liver', 0.3707),\n",
       "  ('fibrosis purpose', 0.3593),\n",
       "  ('common liver', 0.3446),\n",
       "  ('hepatorenal', 0.3075),\n",
       "  ('characteristic sonographic', 0.298),\n",
       "  ('diagnostic accuracy', 0.2886),\n",
       "  ('screening', 0.2779),\n",
       "  ('fatty', 0.2727),\n",
       "  ('diseases guidelines', 0.2692),\n",
       "  ('histology imaging', 0.2548),\n",
       "  ('imaging secondary', 0.2504),\n",
       "  ('non alcoholic', 0.2419),\n",
       "  ('prior studies', 0.2306),\n",
       "  ('association study', 0.2067),\n",
       "  ('blurring portal', 0.2018),\n",
       "  ('low effect', 0.1992),\n",
       "  ('utility limitations', 0.1879),\n",
       "  ('purpose review', 0.1868),\n",
       "  ('attenuation image', 0.183),\n",
       "  ('recommended standard', 0.1733),\n",
       "  ('invasive method', 0.1702),\n",
       "  ('33', 0.1471),\n",
       "  ('detecting moderate', 0.1466),\n",
       "  ('tissue thickness', 0.1387),\n",
       "  ('identify potential', 0.1304),\n",
       "  ('cause abnormal', 0.127),\n",
       "  ('uniform heterogeneous', 0.1169),\n",
       "  ('care', 0.1075),\n",
       "  ('american association', 0.0993),\n",
       "  ('united states', 0.0821),\n",
       "  ('despite ability', 0.0731),\n",
       "  ('ease use', 0.0726),\n",
       "  ('diffuse', 0.0722),\n",
       "  ('cases', 0.0562),\n",
       "  ('echoes increased', 0.0548),\n",
       "  ('involves greater', 0.0469),\n",
       "  ('vein subcutaneous', 0.0357),\n",
       "  ('presence', 0.0013),\n",
       "  ('filling', 0.001),\n",
       "  ('entire field', -0.0125)],\n",
       " 'MED-1308': [('intakes wg', 0.6538),\n",
       "  ('wg refined', 0.5041),\n",
       "  ('diets purported', 0.4924),\n",
       "  ('substituting wg', 0.4879),\n",
       "  ('wg rich', 0.4759),\n",
       "  ('wg benefit', 0.4752),\n",
       "  ('grain wg', 0.4507),\n",
       "  ('current dietary', 0.4316),\n",
       "  ('weight regulation', 0.4309),\n",
       "  ('rich diets', 0.4234),\n",
       "  ('grain consumed', 0.4062),\n",
       "  ('refined grains', 0.3864),\n",
       "  ('wg lost', 0.3848),\n",
       "  ('intrinsic wg', 0.376),\n",
       "  ('obesity recent', 0.3316),\n",
       "  ('nutrient', 0.3291),\n",
       "  ('bmi reduced', 0.317),\n",
       "  ('beneficial bioactive', 0.3112),\n",
       "  ('ingredients', 0.3056),\n",
       "  ('modulate appetite', 0.2934),\n",
       "  ('foods differentially', 0.2929),\n",
       "  ('recommendations', 0.2895),\n",
       "  ('benefit body', 0.2834),\n",
       "  ('weight', 0.2718),\n",
       "  ('reduced risk', 0.2648),\n",
       "  ('consumption', 0.2581),\n",
       "  ('rg', 0.2397),\n",
       "  ('consumed nature', 0.2255),\n",
       "  ('physiologic factors', 0.2222),\n",
       "  ('likely mitigating', 0.215),\n",
       "  ('energy utilization', 0.1999),\n",
       "  ('lost refining', 0.191),\n",
       "  ('health', 0.1729),\n",
       "  ('epidemiological studies', 0.1601),\n",
       "  ('recent clinical', 0.1555),\n",
       "  ('common', 0.1534),\n",
       "  ('components intrinsic', 0.148),\n",
       "  ('lower', 0.1456),\n",
       "  ('biochemical structural', 0.1388),\n",
       "  ('reconstituting', 0.1225),\n",
       "  ('role body', 0.119),\n",
       "  ('elicit effects', 0.1109),\n",
       "  ('purported', 0.0687),\n",
       "  ('trials failed', 0.0633),\n",
       "  ('advocate substituting', 0.0522),\n",
       "  ('maintenance', 0.0483),\n",
       "  ('varies type', 0.0416),\n",
       "  ('processing', 0.0407),\n",
       "  ('failed support', 0.0241),\n",
       "  ('higher', 0.0191)],\n",
       " 'MED-1309': [('oat consumption', 0.5676),\n",
       "  ('obesity associated', 0.5647),\n",
       "  ('reduced obesity', 0.4394),\n",
       "  ('fatty liver', 0.4301),\n",
       "  ('oat reduced', 0.4168),\n",
       "  ('subjects bmi', 0.4145),\n",
       "  ('therapy metabolic', 0.4107),\n",
       "  ('improved lipid', 0.3895),\n",
       "  ('clinical trial', 0.3794),\n",
       "  ('beta glucan', 0.3544),\n",
       "  ('diseases including', 0.3368),\n",
       "  ('animal model', 0.2677),\n",
       "  ('profiles hepatic', 0.2583),\n",
       "  ('18 65', 0.2535),\n",
       "  ('liver protecting', 0.2492),\n",
       "  ('including ast', 0.2353),\n",
       "  ('ingestion', 0.2309),\n",
       "  ('act adjuvant', 0.2219),\n",
       "  ('anatomic changes', 0.2098),\n",
       "  ('function including', 0.2021),\n",
       "  ('waist', 0.1997),\n",
       "  ('16 group', 0.1959),\n",
       "  ('patients', 0.1906),\n",
       "  ('great diversity', 0.1893),\n",
       "  ('data showed', 0.1884),\n",
       "  ('resources help', 0.1798),\n",
       "  ('conclusion consumption', 0.1767),\n",
       "  ('body', 0.1767),\n",
       "  ('confirm effect', 0.1724),\n",
       "  ('alcoholic', 0.1675),\n",
       "  ('27 aged', 0.1635),\n",
       "  ('tolerated adverse', 0.1567),\n",
       "  ('weeks data', 0.1553),\n",
       "  ('rich beta', 0.1438),\n",
       "  ('daily supplement', 0.1436),\n",
       "  ('image analysis', 0.1387),\n",
       "  ('aged', 0.1213),\n",
       "  ('12 weeks', 0.1039),\n",
       "  ('including non', 0.1011),\n",
       "  ('divided control', 0.098),\n",
       "  ('taking placebo', 0.0963),\n",
       "  ('hip', 0.0932),\n",
       "  ('recent', 0.0862),\n",
       "  ('containing', 0.0769),\n",
       "  ('cereal respectively', 0.0767),\n",
       "  ('ratio profiles', 0.0701),\n",
       "  ('ultrasonic image', 0.0596),\n",
       "  ('taking', 0.0422),\n",
       "  ('decrements', 0.0383),\n",
       "  ('randomly', -0.0041)],\n",
       " 'MED-1311': [('erbitux cetuximab', 0.7116),\n",
       "  ('models cetuximab', 0.6886),\n",
       "  ('monotherapies cetuximab', 0.6055),\n",
       "  ('tumor responsiveness', 0.5202),\n",
       "  ('cetuximab failed', 0.5179),\n",
       "  ('egfr levels', 0.5151),\n",
       "  ('studied tumors', 0.4333),\n",
       "  ('combination regimens', 0.402),\n",
       "  ('antitumor activities', 0.3677),\n",
       "  ('observed cisplatin', 0.3556),\n",
       "  ('therapeutic enhancement', 0.3455),\n",
       "  ('factor receptor', 0.3176),\n",
       "  ('responsive a549', 0.3063),\n",
       "  ('human xenograft', 0.2983),\n",
       "  ('assessed relationship', 0.2705),\n",
       "  ('responsive ht29', 0.2635),\n",
       "  ('preclinical activity', 0.2477),\n",
       "  ('growth factor', 0.2345),\n",
       "  ('clinical setting', 0.2306),\n",
       "  ('responsiveness agent', 0.2151),\n",
       "  ('molecular determinants', 0.2068),\n",
       "  ('variable levels', 0.2031),\n",
       "  ('monotherapy does', 0.1926),\n",
       "  ('does correlate', 0.1892),\n",
       "  ('cpt', 0.183),\n",
       "  ('cell kill', 0.1801),\n",
       "  ('understood assessed', 0.174),\n",
       "  ('proved significantly', 0.1725),\n",
       "  ('best predictor', 0.1717),\n",
       "  ('hct116', 0.1665),\n",
       "  ('basal total', 0.16),\n",
       "  ('resistant weakly', 0.1451),\n",
       "  ('models studied', 0.1421),\n",
       "  ('corresponding log', 0.1333),\n",
       "  ('model 001', 0.1326),\n",
       "  ('py1068 epidermal', 0.1316),\n",
       "  ('geo', 0.1227),\n",
       "  ('n87 models', 0.1205),\n",
       "  ('lx hcc70', 0.1121),\n",
       "  ('treatment 25', 0.1115),\n",
       "  ('a549 widr', 0.1034),\n",
       "  ('q3dx5 failed', 0.0711),\n",
       "  ('mg mouse', 0.0637),\n",
       "  ('using human', 0.0609),\n",
       "  ('10 days', 0.0511),\n",
       "  ('48 mg', 0.0506),\n",
       "  ('lovo', 0.0417),\n",
       "  ('effectively delayed', 0.011),\n",
       "  ('single agent', 0.006),\n",
       "  ('injection q3d', -0.0444)],\n",
       " 'MED-1312': [('vip treated', 0.6042),\n",
       "  ('vip skin', 0.5805),\n",
       "  ('inflammation vip', 0.5629),\n",
       "  ('oligomer skin', 0.4229),\n",
       "  ('skin treatment', 0.4129),\n",
       "  ('application vip', 0.4023),\n",
       "  ('skin fragments', 0.3992),\n",
       "  ('dermis culture', 0.3786),\n",
       "  ('analysis tnf', 0.3265),\n",
       "  ('fragments stimulated', 0.321),\n",
       "  ('histological analysis', 0.3209),\n",
       "  ('treatment extract', 0.3132),\n",
       "  ('plastic surgery', 0.3037),\n",
       "  ('vasoactive', 0.3031),\n",
       "  ('induce inflammation', 0.3029),\n",
       "  ('antiinflammatory', 0.302),\n",
       "  ('intestinal peptide', 0.2886),\n",
       "  ('decreased tnf', 0.2877),\n",
       "  ('oligomer mean', 0.2847),\n",
       "  ('treated', 0.282),\n",
       "  ('peptide', 0.2808),\n",
       "  ('supernatants vasodilation', 0.2784),\n",
       "  ('vasodilation studied', 0.2476),\n",
       "  ('surgery maintained', 0.2403),\n",
       "  ('fragments plastic', 0.2394),\n",
       "  ('neuromediator', 0.2272),\n",
       "  ('culture supernatants', 0.2214),\n",
       "  ('effect', 0.1953),\n",
       "  ('extract decreased', 0.18),\n",
       "  ('oatmeal extract', 0.1696),\n",
       "  ('alpha dosage', 0.1646),\n",
       "  ('slides edema', 0.1608),\n",
       "  ('analysis performed', 0.1588),\n",
       "  ('semiquantitative scores', 0.1449),\n",
       "  ('evaluated', 0.1409),\n",
       "  ('aim study', 0.1402),\n",
       "  ('placed contact', 0.1349),\n",
       "  ('surface dilated', 0.1348),\n",
       "  ('conditions', 0.1331),\n",
       "  ('image', 0.1256),\n",
       "  ('culture', 0.1225),\n",
       "  ('vessels', 0.1152),\n",
       "  ('eosin stained', 0.102),\n",
       "  ('survival', 0.0992),\n",
       "  ('increased application', 0.0953),\n",
       "  ('significantly', 0.0934),\n",
       "  ('mean surface', 0.0881),\n",
       "  ('studied quantifying', 0.0864),\n",
       "  ('medium', 0.0616),\n",
       "  ('dosage culture', 0.0559)],\n",
       " 'MED-1313': [('toxicities treatment', 0.6265),\n",
       "  ('agents dermatological', 0.547),\n",
       "  ('dermatological toxicity', 0.5333),\n",
       "  ('antineoplastic', 0.4676),\n",
       "  ('kinase inhibitors', 0.4429),\n",
       "  ('current treatment', 0.427),\n",
       "  ('toxicity largely', 0.3961),\n",
       "  ('patients rash', 0.3638),\n",
       "  ('cancers recently', 0.3577),\n",
       "  ('controlling rash', 0.3439),\n",
       "  ('cetuximab erlotinib', 0.3375),\n",
       "  ('multiple tki', 0.3273),\n",
       "  ('egfr positive', 0.3087),\n",
       "  ('use agents', 0.3021),\n",
       "  ('multiple anti', 0.2699),\n",
       "  ('effect profile', 0.2643),\n",
       "  ('epidermal growth', 0.2591),\n",
       "  ('tumour necrosis', 0.2542),\n",
       "  ('significant limiting', 0.2416),\n",
       "  ('largely ineffective', 0.2283),\n",
       "  ('a2 tumour', 0.2281),\n",
       "  ('inflammatory properties', 0.2),\n",
       "  ('present management', 0.1913),\n",
       "  ('panitumumab sorafenib', 0.1904),\n",
       "  ('antibodies small', 0.1852),\n",
       "  ('necrosis factor', 0.185),\n",
       "  ('modalities', 0.1623),\n",
       "  ('molecule tyrosine', 0.1536),\n",
       "  ('oatmeal lotion', 0.1407),\n",
       "  ('eruption', 0.1403),\n",
       "  ('response partial', 0.1361),\n",
       "  ('assessable patients', 0.135),\n",
       "  ('effects arachidonic', 0.1332),\n",
       "  ('small molecule', 0.1283),\n",
       "  ('factor alpha', 0.1249),\n",
       "  ('pathways excellent', 0.1156),\n",
       "  ('current', 0.1112),\n",
       "  ('form acneiform', 0.1017),\n",
       "  ('complete response', 0.0961),\n",
       "  ('step', 0.0828),\n",
       "  ('phospholipase a2', 0.0741),\n",
       "  ('efficient controlling', 0.0678),\n",
       "  ('induced', 0.0669),\n",
       "  ('recently', 0.0644),\n",
       "  ('11 patients', 0.0539),\n",
       "  ('acid cytosolic', 0.0451),\n",
       "  ('frequently form', 0.0311),\n",
       "  ('100 associated', 0.0179),\n",
       "  ('known', -0.0197),\n",
       "  ('colloidal', -0.0236)],\n",
       " 'MED-1314': [('egfr inhibitors', 0.6971),\n",
       "  ('erlotinib characterised', 0.5855),\n",
       "  ('profile egfr', 0.5152),\n",
       "  ('antibody cetuximab', 0.4692),\n",
       "  ('therapies eruption', 0.4561),\n",
       "  ('targeted therapies', 0.4465),\n",
       "  ('tumours increasing', 0.4281),\n",
       "  ('eruption xerosis', 0.4098),\n",
       "  ('anti tumour', 0.3933),\n",
       "  ('skin toxicity', 0.3902),\n",
       "  ('eczema changes', 0.367),\n",
       "  ('increasing tolerability', 0.3651),\n",
       "  ('solid tumours', 0.3344),\n",
       "  ('use epidermal', 0.3207),\n",
       "  ('xerosis controlled', 0.3125),\n",
       "  ('reactions dominated', 0.305),\n",
       "  ('reactions available', 0.3037),\n",
       "  ('reactions improved', 0.3024),\n",
       "  ('acneiform eruption', 0.2848),\n",
       "  ('recommended dosages', 0.2753),\n",
       "  ('overview treatment', 0.2644),\n",
       "  ('growth factor', 0.2602),\n",
       "  ('treatment compliance', 0.2577),\n",
       "  ('effects constitute', 0.244),\n",
       "  ('inhibitor related', 0.2377),\n",
       "  ('toxicity correlates', 0.2375),\n",
       "  ('titrate dosing', 0.2365),\n",
       "  ('group skin', 0.2338),\n",
       "  ('emollients present', 0.2114),\n",
       "  ('tyrosine', 0.179),\n",
       "  ('changes', 0.1585),\n",
       "  ('receptor', 0.1481),\n",
       "  ('allow patients', 0.1456),\n",
       "  ('changes hair', 0.142),\n",
       "  ('treatment solid', 0.1395),\n",
       "  ('monoclonal', 0.1157),\n",
       "  ('characterised unique', 0.1053),\n",
       "  ('activity offers', 0.1038),\n",
       "  ('controlled standard', 0.0968),\n",
       "  ('significant obstacle', 0.0961),\n",
       "  ('today evaluate', 0.081),\n",
       "  ('case basis', 0.0766),\n",
       "  ('nails possibility', 0.0722),\n",
       "  ('significant', 0.0688),\n",
       "  ('studies needed', 0.0685),\n",
       "  ('improved future', 0.0641),\n",
       "  ('multi', 0.0285),\n",
       "  ('disciplinary management', 0.0282),\n",
       "  ('use', -0.0049),\n",
       "  ('best', -0.0124)],\n",
       " 'MED-1315': [('mechanisms cetuximab', 0.6646),\n",
       "  ('egfr resistance', 0.6489),\n",
       "  ('inhibition cancer', 0.4573),\n",
       "  ('resistant antiproliferative', 0.4329),\n",
       "  ('cancer research', 0.4219),\n",
       "  ('egfr independent', 0.4091),\n",
       "  ('resistance mechanisms', 0.3852),\n",
       "  ('results colorectal', 0.3726),\n",
       "  ('lines kras', 0.3651),\n",
       "  ('selective mek1', 0.3645),\n",
       "  ('tumor growth', 0.3596),\n",
       "  ('inhibitor panel', 0.3198),\n",
       "  ('dose dependent', 0.306),\n",
       "  ('activation ras', 0.2833),\n",
       "  ('sw480 braf', 0.2798),\n",
       "  ('xenografts combined', 0.262),\n",
       "  ('akt pathway', 0.257),\n",
       "  ('inhibition increased', 0.2283),\n",
       "  ('hct116 sw48', 0.2168),\n",
       "  ('design evaluated', 0.2029),\n",
       "  ('human hct15', 0.1927),\n",
       "  ('cr exception', 0.1904),\n",
       "  ('effects confirmed', 0.1833),\n",
       "  ('apoptotic effects', 0.1792),\n",
       "  ('sensitive treatment', 0.1787),\n",
       "  ('pathway cells', 0.1783),\n",
       "  ('patients', 0.1734),\n",
       "  ('vitro vivo', 0.1515),\n",
       "  ('effects blockade', 0.1513),\n",
       "  ('selumetinib pimasertib', 0.1483),\n",
       "  ('mutation', 0.1461),\n",
       "  ('mutation ht29', 0.1415),\n",
       "  ('cells acquired', 0.1395),\n",
       "  ('primary acquired', 0.1284),\n",
       "  ('induced synergistic', 0.1243),\n",
       "  ('dependent', 0.1169),\n",
       "  ('effects bay', 0.1124),\n",
       "  ('mice survival', 0.1105),\n",
       "  ('survival conclusion', 0.1047),\n",
       "  ('expression sirna', 0.1024),\n",
       "  ('9766 induced', 0.0831),\n",
       "  ('2014', 0.0685),\n",
       "  ('86', 0.0648),\n",
       "  ('geo', 0.0614),\n",
       "  ('anti', 0.046),\n",
       "  ('highly', 0.0415),\n",
       "  ('nude', 0.0183),\n",
       "  ('bearing', 0.0014),\n",
       "  ('panel human', -0.0021),\n",
       "  ('lovo', -0.0575)],\n",
       " 'MED-1316': [('colloidal oatmeal', 0.7044),\n",
       "  ('oatmeal produced', 0.6762),\n",
       "  ('oatmeal cleanser', 0.5416),\n",
       "  ('oat boiling', 0.5364),\n",
       "  ('oatmeal skin', 0.496),\n",
       "  ('oatmeal derive', 0.4802),\n",
       "  ('oat saponins', 0.4585),\n",
       "  ('functions oat', 0.4209),\n",
       "  ('extract colloidal', 0.3792),\n",
       "  ('moisturizer', 0.3528),\n",
       "  ('relieve itch', 0.3502),\n",
       "  ('soothing agent', 0.3333),\n",
       "  ('antioxidant anti', 0.3292),\n",
       "  ('dermatoses 1945', 0.3127),\n",
       "  ('forms powders', 0.2863),\n",
       "  ('centuries soothing', 0.2722),\n",
       "  ('protectant drug', 0.2668),\n",
       "  ('dosage', 0.2645),\n",
       "  ('buffer soothing', 0.2517),\n",
       "  ('starches', 0.2428),\n",
       "  ('phenols confers', 0.2351),\n",
       "  ('inflammatory agent', 0.2342),\n",
       "  ('various xerotic', 0.2302),\n",
       "  ('ready use', 0.2209),\n",
       "  ('ultraviolet absorbers', 0.2205),\n",
       "  ('available various', 0.2096),\n",
       "  ('boiling', 0.2056),\n",
       "  ('shaving gels', 0.1678),\n",
       "  ('water', 0.1602),\n",
       "  ('chemical', 0.156),\n",
       "  ('produced', 0.1533),\n",
       "  ('administration fda', 0.149),\n",
       "  ('clinical properties', 0.1475),\n",
       "  ('functional properties', 0.1447),\n",
       "  ('bath shampoos', 0.1438),\n",
       "  ('grinding', 0.1416),\n",
       "  ('standardized united', 0.1393),\n",
       "  ('creams currently', 0.1279),\n",
       "  ('pharmacopeia', 0.1263),\n",
       "  ('regulated food', 0.1248),\n",
       "  ('beta glucan', 0.0944),\n",
       "  ('finely', 0.0889),\n",
       "  ('final monograph', 0.0841),\n",
       "  ('agent', 0.0811),\n",
       "  ('polymorphism high', 0.0732),\n",
       "  ('today', 0.0653),\n",
       "  ('holding', 0.0652),\n",
       "  ('states', 0.0183),\n",
       "  ('june 2003', -0.0193),\n",
       "  ('presence different', -0.0309)],\n",
       " 'MED-1317': [('effects colon', 0.5528),\n",
       "  ('associated cyclooxygenase', 0.4853),\n",
       "  ('inhibit cox', 0.4363),\n",
       "  ('related antiproliferative', 0.4111),\n",
       "  ('chronic inflammation', 0.3981),\n",
       "  ('proliferation cox', 0.394),\n",
       "  ('effect avenanthramides', 0.3728),\n",
       "  ('bran reduce', 0.357),\n",
       "  ('carcinogenesis proliferation', 0.3402),\n",
       "  ('ls174t cox', 0.3342),\n",
       "  ('elucidated chronic', 0.3201),\n",
       "  ('cox negative', 0.3068),\n",
       "  ('attenuate proliferation', 0.3051),\n",
       "  ('polyphenols oats', 0.2914),\n",
       "  ('cancer high', 0.2914),\n",
       "  ('pge production', 0.2879),\n",
       "  ('avns attenuate', 0.2836),\n",
       "  ('reduce risk', 0.2821),\n",
       "  ('caco cells', 0.2731),\n",
       "  ('causally related', 0.273),\n",
       "  ('epithelium causally', 0.2715),\n",
       "  ('suggest consumption', 0.2511),\n",
       "  ('examined effect', 0.2381),\n",
       "  ('underlying protection', 0.2345),\n",
       "  ('mechanism underlying', 0.226),\n",
       "  ('growth examined', 0.2199),\n",
       "  ('significantly inhibited', 0.2105),\n",
       "  ('high intake', 0.2024),\n",
       "  ('grain foods', 0.2016),\n",
       "  ('lipopolysaccharide', 0.1772),\n",
       "  ('anti', 0.1606),\n",
       "  ('results suggest', 0.1543),\n",
       "  ('enriched extract', 0.1476),\n",
       "  ('macrophages avns', 0.1386),\n",
       "  ('hct116 human', 0.1355),\n",
       "  ('potent', 0.1223),\n",
       "  ('enzyme activity', 0.1209),\n",
       "  ('avns avexo', 0.112),\n",
       "  ('methylated form', 0.1089),\n",
       "  ('cell viability', 0.1042),\n",
       "  ('ch3', 0.0927),\n",
       "  ('ht29', 0.0765),\n",
       "  ('characteristics normal', 0.067),\n",
       "  ('lines', 0.0659),\n",
       "  ('display', 0.0605),\n",
       "  ('fiber', 0.0443),\n",
       "  ('induced differentiated', 0.0317),\n",
       "  ('mouse', 0.0306),\n",
       "  ('production non', 0.0214),\n",
       "  ('did', 0.015)],\n",
       " 'MED-1318': [('rice consumption', 0.5614),\n",
       "  ('cvd rice', 0.4975),\n",
       "  ('japanese population', 0.4026),\n",
       "  ('examined association', 0.3543),\n",
       "  ('consumption risk', 0.3154),\n",
       "  ('type diabetes', 0.3089),\n",
       "  ('food frequency', 0.2796),\n",
       "  ('disease cvd', 0.2791),\n",
       "  ('society nutrition', 0.2678),\n",
       "  ('prospective study', 0.2602),\n",
       "  ('lowest rice', 0.2398),\n",
       "  ('69 rice', 0.2384),\n",
       "  ('objective examined', 0.2052),\n",
       "  ('morbidity', 0.1901),\n",
       "  ('ihd multivariable', 0.1826),\n",
       "  ('men women', 0.1794),\n",
       "  ('population design', 0.1734),\n",
       "  ('4395 incident', 0.1689),\n",
       "  ('38 ihd', 0.1598),\n",
       "  ('cohort 1993', 0.1545),\n",
       "  ('background', 0.1469),\n",
       "  ('95 ci', 0.1442),\n",
       "  ('aged 40', 0.1317),\n",
       "  ('limited', 0.1283),\n",
       "  ('american society', 0.1251),\n",
       "  ('according quintiles', 0.1249),\n",
       "  ('mortality 2014', 0.1248),\n",
       "  ('13', 0.1211),\n",
       "  ('index endpoint', 0.1181),\n",
       "  ('effect modifications', 0.118),\n",
       "  ('cases ischemic', 0.1156),\n",
       "  ('91 223', 0.0988),\n",
       "  ('hr', 0.0779),\n",
       "  ('ii hrs', 0.0759),\n",
       "  ('08 84', 0.0705),\n",
       "  ('body mass', 0.0672),\n",
       "  ('aged', 0.0603),\n",
       "  ('sex effect', 0.0562),\n",
       "  ('incidence 1990', 0.0516),\n",
       "  ('frequency questionnaires', 0.0384),\n",
       "  ('01', 0.0358),\n",
       "  ('total', 0.0356),\n",
       "  ('2705', 0.0308),\n",
       "  ('interactions', 0.0249),\n",
       "  ('highest compared', -0.006),\n",
       "  ('updated self', -0.0111),\n",
       "  ('2007', -0.0119),\n",
       "  ('2009 cohort', -0.0234),\n",
       "  ('18 follow', -0.044),\n",
       "  ('apart', -0.0542)],\n",
       " 'MED-1319': [('diets consumed', 0.5148),\n",
       "  ('foods plant', 0.4471),\n",
       "  ('richer foods', 0.4309),\n",
       "  ('survey dietary', 0.4298),\n",
       "  ('dietary fiber', 0.3706),\n",
       "  ('animal protein', 0.3542),\n",
       "  ('preference foods', 0.3517),\n",
       "  ('mean intakes', 0.3417),\n",
       "  ('china showed', 0.3342),\n",
       "  ('ecologic survey', 0.3148),\n",
       "  ('plant origin', 0.3061),\n",
       "  ('consumed industrialized', 0.3047),\n",
       "  ('effect nutrients', 0.2943),\n",
       "  ('multiple intake', 0.263),\n",
       "  ('14 energy', 0.2585),\n",
       "  ('characteristics 65', 0.2485),\n",
       "  ('intake biomarker', 0.2431),\n",
       "  ('substantially richer', 0.2243),\n",
       "  ('counties rural', 0.2151),\n",
       "  ('protein tenth', 0.213),\n",
       "  ('minimization fat', 0.2004),\n",
       "  ('societies mean', 0.1995),\n",
       "  ('cholesterol concentration', 0.1986),\n",
       "  ('intake disease', 0.1961),\n",
       "  ('origin breadth', 0.1899),\n",
       "  ('industrialized western', 0.1892),\n",
       "  ('amounts commonly', 0.1587),\n",
       "  ('aggregate effect', 0.1579),\n",
       "  ('increases chronic', 0.1572),\n",
       "  ('reflected substantial', 0.1533),\n",
       "  ('diseases prevented', 0.1379),\n",
       "  ('findings suggest', 0.1365),\n",
       "  ('life style', 0.1359),\n",
       "  ('enrichment', 0.1347),\n",
       "  ('mortality rates', 0.1305),\n",
       "  ('united states', 0.1134),\n",
       "  ('mean plasma', 0.1101),\n",
       "  ('investigated multiple', 0.1082),\n",
       "  ('degenerative diseases', 0.0943),\n",
       "  ('33 reflected', 0.0854),\n",
       "  ('fiber', 0.0745),\n",
       "  ('breadth consistency', 0.0724),\n",
       "  ('substantial preference', 0.0686),\n",
       "  ('principal hypothesis', 0.0562),\n",
       "  ('compared', 0.0414),\n",
       "  ('associations appropriately', 0.0326),\n",
       "  ('49 mmol', 0.0214),\n",
       "  ('adjusted appears', -0.0067),\n",
       "  ('does', -0.0634),\n",
       "  ('suggest small', -0.0714)],\n",
       " 'MED-1320': [('rice consumptions', 0.5709),\n",
       "  ('dietary risk', 0.5199),\n",
       "  ('carbohydrate intake', 0.4634),\n",
       "  ('foods', 0.4415),\n",
       "  ('processing nutrient', 0.4094),\n",
       "  ('ascertained diet', 0.3869),\n",
       "  ('health study', 0.3843),\n",
       "  ('diabetes comparing', 0.3822),\n",
       "  ('consumptions relation', 0.3738),\n",
       "  ('higher intake', 0.3669),\n",
       "  ('rice 17', 0.353),\n",
       "  ('intake white', 0.3401),\n",
       "  ('compared serving', 0.3116),\n",
       "  ('cooked equivalent', 0.2891),\n",
       "  ('effects risk', 0.2733),\n",
       "  ('week serving', 0.2711),\n",
       "  ('cohorts participants', 0.27),\n",
       "  ('cardiovascular disease', 0.2697),\n",
       "  ('professionals', 0.2509),\n",
       "  ('refined grains', 0.2441),\n",
       "  ('lifestyle practices', 0.234),\n",
       "  ('factors higher', 0.2327),\n",
       "  ('men women', 0.2271),\n",
       "  ('study 1986', 0.2248),\n",
       "  ('associated 36', 0.2189),\n",
       "  ('context different', 0.217),\n",
       "  ('2006 nurses', 0.208),\n",
       "  ('men 157', 0.1928),\n",
       "  ('disease cancer', 0.1861),\n",
       "  ('week brown', 0.1841),\n",
       "  ('97 servings', 0.1795),\n",
       "  ('cases type', 0.1667),\n",
       "  ('person years', 0.1518),\n",
       "  ('yr design', 0.1482),\n",
       "  ('support recommendation', 0.14),\n",
       "  ('relation type', 0.14),\n",
       "  ('30 42', 0.1336),\n",
       "  ('examine', 0.1261),\n",
       "  ('contents', 0.1161),\n",
       "  ('pooled multivariate', 0.1146),\n",
       "  ('participants free', 0.1069),\n",
       "  ('grams day', 0.1065),\n",
       "  ('16', 0.1022),\n",
       "  ('confidence interval', 0.0947),\n",
       "  ('2005', 0.0942),\n",
       "  ('estimated replacing', 0.087),\n",
       "  ('associated lower', 0.0721),\n",
       "  ('507 incident', 0.0672),\n",
       "  ('results 318', 0.0461),\n",
       "  ('interval 21', -0.02)],\n",
       " 'MED-1321': [('rice lipids', 0.6507),\n",
       "  ('dietary pls', 0.6122),\n",
       "  ('phospholipids pls', 0.5984),\n",
       "  ('pls rice', 0.5836),\n",
       "  ('importance pls', 0.4607),\n",
       "  ('variation pls', 0.4439),\n",
       "  ('class lipid', 0.4415),\n",
       "  ('pls improve', 0.3934),\n",
       "  ('major starch', 0.3881),\n",
       "  ('pl composition', 0.3808),\n",
       "  ('profiling phosphatidylcholine', 0.3663),\n",
       "  ('nutrient compared', 0.3451),\n",
       "  ('systemically reviewed', 0.3097),\n",
       "  ('functional significance', 0.2786),\n",
       "  ('lyso forms', 0.2756),\n",
       "  ('endosperm represent', 0.2631),\n",
       "  ('analysis discussed', 0.2589),\n",
       "  ('cereals copyright', 0.246),\n",
       "  ('bran storage', 0.2321),\n",
       "  ('cooking eating', 0.2303),\n",
       "  ('protein', 0.2287),\n",
       "  ('significant health', 0.2204),\n",
       "  ('physicochemical properties', 0.2178),\n",
       "  ('outlines', 0.2058),\n",
       "  ('different methods', 0.1994),\n",
       "  ('amylose affecting', 0.1937),\n",
       "  ('consumers identified', 0.187),\n",
       "  ('flavour paddy', 0.1855),\n",
       "  ('major class', 0.1698),\n",
       "  ('long consumed', 0.1667),\n",
       "  ('countries', 0.1567),\n",
       "  ('minor', 0.1552),\n",
       "  ('genetic', 0.1515),\n",
       "  ('use quality', 0.1513),\n",
       "  ('enhances understanding', 0.1457),\n",
       "  ('literature class', 0.1429),\n",
       "  ('consequences variation', 0.1382),\n",
       "  ('storage considered', 0.1259),\n",
       "  ('diseases reduce', 0.125),\n",
       "  ('copyright 2013', 0.117),\n",
       "  ('inclusion complexes', 0.1148),\n",
       "  ('future exploitation', 0.1148),\n",
       "  ('deterioration pc', 0.1143),\n",
       "  ('staple', 0.1073),\n",
       "  ('drugs', 0.0624),\n",
       "  ('asian', 0.0539),\n",
       "  ('considered trigger', 0.0503),\n",
       "  ('rights reserved', 0.0428),\n",
       "  ('associated rancid', 0.0329),\n",
       "  ('content boosting', 0.0193)],\n",
       " 'MED-1322': [('grain intake', 0.5455),\n",
       "  ('intake risk', 0.4583),\n",
       "  ('intake refined', 0.4581),\n",
       "  ('diabetes risk', 0.4517),\n",
       "  ('grains suggest', 0.4047),\n",
       "  ('refined grains', 0.383),\n",
       "  ('associations observed', 0.3555),\n",
       "  ('studies suggested', 0.3456),\n",
       "  ('association intake', 0.329),\n",
       "  ('health recommendations', 0.3274),\n",
       "  ('meta analysis', 0.3243),\n",
       "  ('inverse associations', 0.2933),\n",
       "  ('cohort studies', 0.2904),\n",
       "  ('cereals wheat', 0.2852),\n",
       "  ('dose response', 0.2695),\n",
       "  ('conducted systematic', 0.2608),\n",
       "  ('grains nonlinear', 0.2573),\n",
       "  ('associated reduced', 0.2393),\n",
       "  ('effects model', 0.2332),\n",
       "  ('suggested protective', 0.2192),\n",
       "  ('consumed', 0.2171),\n",
       "  ('searched pubmed', 0.2165),\n",
       "  ('risk servings', 0.2164),\n",
       "  ('servings day', 0.2158),\n",
       "  ('increased risk', 0.2097),\n",
       "  ('95', 0.2084),\n",
       "  ('included', 0.191),\n",
       "  ('studies white', 0.1851),\n",
       "  ('warrant investigations', 0.174),\n",
       "  ('random effects', 0.1688),\n",
       "  ('analysis prospective', 0.1676),\n",
       "  ('bran brown', 0.162),\n",
       "  ('summary relative', 0.1569),\n",
       "  ('rice inverse', 0.1506),\n",
       "  ('database', 0.15),\n",
       "  ('04 53', 0.1493),\n",
       "  ('0001 refined', 0.1461),\n",
       "  ('10 grains', 0.1412),\n",
       "  ('observed subtypes', 0.1393),\n",
       "  ('replace refined', 0.1378),\n",
       "  ('bread', 0.123),\n",
       "  ('different', 0.1055),\n",
       "  ('ci 58', 0.0927),\n",
       "  ('5th 2013', 0.074),\n",
       "  ('2013', 0.0434),\n",
       "  ('sixteen', 0.0424),\n",
       "  ('high', 0.0349),\n",
       "  ('81 82', 0.0044),\n",
       "  ('june', -0.0151),\n",
       "  ('support public', -0.037)],\n",
       " 'MED-1323': [('diet scores', 0.5711),\n",
       "  ('carbohydrate diet', 0.5342),\n",
       "  ('background fat', 0.529),\n",
       "  ('diabetes', 0.4849),\n",
       "  ('low carbohydrate', 0.4756),\n",
       "  ('free t2d', 0.4123),\n",
       "  ('t2d cardiovascular', 0.4086),\n",
       "  ('cohort study', 0.3834),\n",
       "  ('study conducted', 0.2747),\n",
       "  ('compare associations', 0.2603),\n",
       "  ('physical activity', 0.2565),\n",
       "  ('health professionals', 0.2455),\n",
       "  ('alcohol intake', 0.229),\n",
       "  ('mass index', 0.2272),\n",
       "  ('significantly associated', 0.2267),\n",
       "  ('study free', 0.2253),\n",
       "  ('attenuated association', 0.2229),\n",
       "  ('conducted participants', 0.2206),\n",
       "  ('total energy', 0.2197),\n",
       "  ('processed meat', 0.2134),\n",
       "  ('foods red', 0.2076),\n",
       "  ('95 ci', 0.2072),\n",
       "  ('design prospective', 0.2066),\n",
       "  ('models results', 0.2037),\n",
       "  ('cancer', 0.1992),\n",
       "  ('sources influence', 0.1868),\n",
       "  ('men low', 0.1823),\n",
       "  ('01 conclusions', 0.181),\n",
       "  ('compared quintile', 0.1768),\n",
       "  ('family history', 0.1746),\n",
       "  ('baseline', 0.1708),\n",
       "  ('objective objective', 0.1669),\n",
       "  ('obtain protein', 0.1655),\n",
       "  ('scores incident', 0.1647),\n",
       "  ('type', 0.1611),\n",
       "  ('frequency questionnaires', 0.1594),\n",
       "  ('follow adjustments', 0.1537),\n",
       "  ('coffee intake', 0.1487),\n",
       "  ('age smoking', 0.1428),\n",
       "  ('58 trend', 0.1422),\n",
       "  ('using cox', 0.1378),\n",
       "  ('inversely', 0.1146),\n",
       "  ('ratio hr', 0.1123),\n",
       "  ('vegetable', 0.0958),\n",
       "  ('66 92', 0.0911),\n",
       "  ('trend 20', 0.0668),\n",
       "  ('2689', 0.0352),\n",
       "  ('30', 0.0001),\n",
       "  ('40 475', -0.0287),\n",
       "  ('animal', -0.044)],\n",
       " 'MED-1324': [('meal carbohydrate', 0.6341),\n",
       "  ('meals repeated', 0.5886),\n",
       "  ('25 carbohydrate', 0.5854),\n",
       "  ('received meals', 0.5852),\n",
       "  ('insulin responses', 0.5704),\n",
       "  ('responses carbohydrates', 0.558),\n",
       "  ('glucose insulin', 0.5529),\n",
       "  ('glycemic responses', 0.5522),\n",
       "  ('glucose response', 0.5464),\n",
       "  ('glucose serum', 0.5428),\n",
       "  ('test meal', 0.5352),\n",
       "  ('meal addition', 0.5272),\n",
       "  ('blood glucose', 0.5057),\n",
       "  ('diabetic subjects', 0.494),\n",
       "  ('carbohydrates slightly', 0.4903),\n",
       "  ('carbohydrate potato', 0.4833),\n",
       "  ('addition fat', 0.483),\n",
       "  ('increased insulin', 0.461),\n",
       "  ('protein fat', 0.4445),\n",
       "  ('difference glycemic', 0.4395),\n",
       "  ('reduced glycemic', 0.4168),\n",
       "  ('potato 04', 0.3967),\n",
       "  ('noninsulin dependent', 0.3916),\n",
       "  ('fat reduced', 0.3895),\n",
       "  ('spaghetti meals', 0.3755),\n",
       "  ('containing 25', 0.354),\n",
       "  ('fat blood', 0.3492),\n",
       "  ('mashed potato', 0.3095),\n",
       "  ('subjects received', 0.2874),\n",
       "  ('protein increased', 0.2395),\n",
       "  ('repeated addition', 0.215),\n",
       "  ('responses measured', 0.1697),\n",
       "  ('given blood', 0.1645),\n",
       "  ('14', 0.1638),\n",
       "  ('05 addition', 0.125),\n",
       "  ('serum', 0.1237),\n",
       "  ('protein', 0.1171),\n",
       "  ('test', 0.1134),\n",
       "  ('containing', 0.1),\n",
       "  ('63 001', 0.0932),\n",
       "  ('ns different', 0.0925),\n",
       "  ('mashed', 0.0917),\n",
       "  ('spaghetti 94', 0.0751),\n",
       "  ('94 ns', 0.0732),\n",
       "  ('slightly reduced', 0.069),\n",
       "  ('higher', 0.0646),\n",
       "  ('001 change', 0.0503),\n",
       "  ('received', 0.0241),\n",
       "  ('coingestion', 0.0208),\n",
       "  ('dependent', 0.0009)],\n",
       " 'MED-1326': [('diabetes chinese', 0.615),\n",
       "  ('diabetes epidemic', 0.5799),\n",
       "  ('adults diabetes', 0.5192),\n",
       "  ('diabetes 50', 0.4319),\n",
       "  ('prediabetes 76', 0.3666),\n",
       "  ('glucose tolerance', 0.3366),\n",
       "  ('china strategies', 0.2784),\n",
       "  ('impaired fasting', 0.2576),\n",
       "  ('results age', 0.2462),\n",
       "  ('million adults', 0.2458),\n",
       "  ('participated study', 0.2422),\n",
       "  ('health', 0.2417),\n",
       "  ('conducted national', 0.2186),\n",
       "  ('epidemic conducted', 0.217),\n",
       "  ('glucose 11', 0.2037),\n",
       "  ('14 provinces', 0.2014),\n",
       "  ('strategies aimed', 0.1943),\n",
       "  ('lifestyle', 0.1851),\n",
       "  ('society', 0.1802),\n",
       "  ('mass index', 0.1771),\n",
       "  ('estimate prevalence', 0.1762),\n",
       "  ('rapid change', 0.1745),\n",
       "  ('fast participants', 0.1689),\n",
       "  ('background', 0.1574),\n",
       "  ('urban residents', 0.1506),\n",
       "  ('women conclusions', 0.14),\n",
       "  ('16 men', 0.1393),\n",
       "  ('148 million', 0.1288),\n",
       "  ('kilograms divided', 0.121),\n",
       "  ('representative sample', 0.1209),\n",
       "  ('municipalities participated', 0.1202),\n",
       "  ('42 million', 0.1202),\n",
       "  ('40', 0.1128),\n",
       "  ('60 years', 0.1118),\n",
       "  ('identify undiagnosed', 0.0981),\n",
       "  ('10 men', 0.0959),\n",
       "  ('june 2007', 0.0901),\n",
       "  ('study overnight', 0.0891),\n",
       "  ('20 years', 0.084),\n",
       "  ('tolerance higher', 0.0835),\n",
       "  ('massachusetts medical', 0.0821),\n",
       "  ('needed 2010', 0.0816),\n",
       "  ('46 239', 0.0787),\n",
       "  ('concern', 0.0743),\n",
       "  ('underwent oral', 0.0451),\n",
       "  ('12 18', 0.0304),\n",
       "  ('isolated impaired', 0.0223),\n",
       "  ('accounting 92', -0.0135),\n",
       "  ('24 25', -0.0223),\n",
       "  ('vs men', -0.072)],\n",
       " 'MED-1327': [('fiber intakes', 0.5448),\n",
       "  ('intakes risk', 0.4719),\n",
       "  ('diabetes', 0.3948),\n",
       "  ('t2d cardiovascular', 0.393),\n",
       "  ('cvd weight', 0.3839),\n",
       "  ('grain interventions', 0.3753),\n",
       "  ('effects metabolic', 0.357),\n",
       "  ('studies investigating', 0.3486),\n",
       "  ('intake vascular', 0.3414),\n",
       "  ('disease prevention', 0.3328),\n",
       "  ('weight gain', 0.3295),\n",
       "  ('health literature', 0.3293),\n",
       "  ('cohort studies', 0.3252),\n",
       "  ('ldl cholesterol', 0.2951),\n",
       "  ('differences fasting', 0.2604),\n",
       "  ('glucose total', 0.26),\n",
       "  ('grain high', 0.2468),\n",
       "  ('large intervention', 0.243),\n",
       "  ('factors identified', 0.2343),\n",
       "  ('interventions differences', 0.2222),\n",
       "  ('comprehensive quantitative', 0.2151),\n",
       "  ('001 rct', 0.1943),\n",
       "  ('evidence support', 0.192),\n",
       "  ('pubmed study', 0.1881),\n",
       "  ('cumulative index', 0.1612),\n",
       "  ('allied health', 0.1603),\n",
       "  ('2012 searching', 0.1511),\n",
       "  ('medical database', 0.149),\n",
       "  ('cochrane', 0.1484),\n",
       "  ('13', 0.1387),\n",
       "  ('meta', 0.1239),\n",
       "  ('groups controls', 0.1195),\n",
       "  ('random effects', 0.1192),\n",
       "  ('intermediates require', 0.1089),\n",
       "  ('standardized protocol', 0.0977),\n",
       "  ('mmol 95', 0.0949),\n",
       "  ('1966 february', 0.0933),\n",
       "  ('64 kg', 0.0916),\n",
       "  ('humans aim', 0.0899),\n",
       "  ('consuming 48', 0.0879),\n",
       "  ('corrected findings', 0.0755),\n",
       "  ('models compared', 0.0629),\n",
       "  ('82 mmol', 0.0609),\n",
       "  ('index nursing', 0.0588),\n",
       "  ('45 prospective', 0.0518),\n",
       "  ('rare consumers', 0.0339),\n",
       "  ('26 lower', 0.028),\n",
       "  ('circulating', 0.0013),\n",
       "  ('ci 69', -0.0058),\n",
       "  ('21 total', -0.0285)],\n",
       " 'MED-1328': [('obesity major', 0.5383),\n",
       "  ('changes overweight', 0.4684),\n",
       "  ('dalys worldwide', 0.4485),\n",
       "  ('increases prevalence', 0.3859),\n",
       "  ('girls overweight', 0.3502),\n",
       "  ('population health', 0.3295),\n",
       "  ('trends essential', 0.3169),\n",
       "  ('findings worldwide', 0.3002),\n",
       "  ('increased children', 0.2538),\n",
       "  ('1980 2013', 0.2406),\n",
       "  ('deaths', 0.2401),\n",
       "  ('monitoring changes', 0.2188),\n",
       "  ('risks substantial', 0.2171),\n",
       "  ('developing countries', 0.2109),\n",
       "  ('million', 0.2009),\n",
       "  ('federated states', 0.1959),\n",
       "  ('disability adjusted', 0.1945),\n",
       "  ('global action', 0.179),\n",
       "  ('years urgent', 0.172),\n",
       "  ('national success', 0.1671),\n",
       "  ('widespread calls', 0.1609),\n",
       "  ('life years', 0.1577),\n",
       "  ('effects linear', 0.1347),\n",
       "  ('data height', 0.1105),\n",
       "  ('bmi 25', 0.1089),\n",
       "  ('decision makers', 0.0971),\n",
       "  ('23 girls', 0.0969),\n",
       "  ('33 years', 0.0947),\n",
       "  ('prevalence 95', 0.0901),\n",
       "  ('funding melinda', 0.0873),\n",
       "  ('kiribati federated', 0.081),\n",
       "  ('countries 12', 0.0809),\n",
       "  ('elsevier rights', 0.077),\n",
       "  ('year 19', 0.0769),\n",
       "  ('foundation copyright', 0.0596),\n",
       "  ('gates foundation', 0.0595),\n",
       "  ('leadership needed', 0.0542),\n",
       "  ('adults estimated', 0.048),\n",
       "  ('1769 included', 0.0403),\n",
       "  ('21', 0.0323),\n",
       "  ('38 37', 0.0244),\n",
       "  ('intervene funding', 0.0181),\n",
       "  ('micronesia libya', 0.0177),\n",
       "  ('intervals uis', -0.0092),\n",
       "  ('bias self', -0.0131),\n",
       "  ('50 men', -0.0132),\n",
       "  ('kuwait', -0.0133),\n",
       "  ('244 spatiotemporal', -0.0148),\n",
       "  ('used mixed', -0.0499),\n",
       "  ('tonga samoa', -0.0752)],\n",
       " 'MED-1329': [('rice foods', 0.4715),\n",
       "  ('foods stroke', 0.4392),\n",
       "  ('consumed china', 0.4355),\n",
       "  ('stroke chinese', 0.41),\n",
       "  ('refined carbohydrates', 0.3901),\n",
       "  ('consumptions cooked', 0.3739),\n",
       "  ('southern chinese', 0.34),\n",
       "  ('consumption risk', 0.3394),\n",
       "  ('foods high', 0.3246),\n",
       "  ('widely consumed', 0.3092),\n",
       "  ('stroke risk', 0.3049),\n",
       "  ('obtained 374', 0.2928),\n",
       "  ('information diet', 0.2702),\n",
       "  ('stroke southern', 0.2388),\n",
       "  ('white', 0.2287),\n",
       "  ('factors corresponding', 0.2207),\n",
       "  ('controlling confounding', 0.2153),\n",
       "  ('control study', 0.2127),\n",
       "  ('consumed', 0.2064),\n",
       "  ('analyses performed', 0.2013),\n",
       "  ('controls increased', 0.1933),\n",
       "  ('study conducted', 0.1908),\n",
       "  ('associated higher', 0.1633),\n",
       "  ('significant dose', 0.1587),\n",
       "  ('odds ratios', 0.1387),\n",
       "  ('lowest intake', 0.1315),\n",
       "  ('population information', 0.1243),\n",
       "  ('refined', 0.122),\n",
       "  ('ischemic', 0.1218),\n",
       "  ('cases', 0.1174),\n",
       "  ('mean weekly', 0.1121),\n",
       "  ('lifestyle obtained', 0.1103),\n",
       "  ('68 13', 0.1038),\n",
       "  ('logistic', 0.1001),\n",
       "  ('national', 0.0986),\n",
       "  ('464 hospital', 0.0975),\n",
       "  ('appeared significantly', 0.0942),\n",
       "  ('relationships observed', 0.0895),\n",
       "  ('03 40', 0.0821),\n",
       "  ('association published', 0.0736),\n",
       "  ('2010 national', 0.0655),\n",
       "  ('rights reserved', 0.0641),\n",
       "  ('patients', 0.0591),\n",
       "  ('95 confidence', 0.0375),\n",
       "  ('31', 0.0292),\n",
       "  ('published elsevier', 0.0253),\n",
       "  ('congee', 0.0146),\n",
       "  ('response', -0.0173),\n",
       "  ('noodle associated', -0.0314),\n",
       "  ('adults', -0.0875)],\n",
       " 'MED-1330': [('dm prevalence', 0.5235),\n",
       "  ('studies diabetes', 0.4724),\n",
       "  ('trends methods', 0.4528),\n",
       "  ('studies selected', 0.448),\n",
       "  ('2010 studies', 0.4225),\n",
       "  ('review trends', 0.4083),\n",
       "  ('search conducted', 0.3795),\n",
       "  ('identify determinants', 0.376),\n",
       "  ('studies difference', 0.3481),\n",
       "  ('criteria prevalence', 0.3455),\n",
       "  ('reported associations', 0.3141),\n",
       "  ('populations studies', 0.3139),\n",
       "  ('regions china', 0.3082),\n",
       "  ('rising diabetes', 0.3034),\n",
       "  ('10 years', 0.2897),\n",
       "  ('aims systematically', 0.28),\n",
       "  ('estimates reported', 0.2796),\n",
       "  ('effective strategies', 0.2766),\n",
       "  ('diabetes western', 0.2642),\n",
       "  ('years identify', 0.263),\n",
       "  ('included met', 0.2553),\n",
       "  ('published 2000', 0.2493),\n",
       "  ('methods', 0.2325),\n",
       "  ('history obesity', 0.2224),\n",
       "  ('epidemic important', 0.2179),\n",
       "  ('prevalence adults', 0.2096),\n",
       "  ('adults china', 0.1966),\n",
       "  ('hypertension conclusion', 0.1883),\n",
       "  ('residents compared', 0.1714),\n",
       "  ('scale studies', 0.1667),\n",
       "  ('regions', 0.1606),\n",
       "  ('consistent commonly', 0.1557),\n",
       "  ('review increase', 0.1543),\n",
       "  ('elsevier ireland', 0.1424),\n",
       "  ('important levels', 0.1392),\n",
       "  ('pre determined', 0.1363),\n",
       "  ('copyright 2012', 0.13),\n",
       "  ('national level', 0.1252),\n",
       "  ('22 studies', 0.1238),\n",
       "  ('rural populations', 0.0989),\n",
       "  ('government develop', 0.0912),\n",
       "  ('prevent manage', 0.0888),\n",
       "  ('past', 0.0846),\n",
       "  ('manuscripts', 0.0576),\n",
       "  ('need large', 0.0539),\n",
       "  ('included family', 0.051),\n",
       "  ('higher urban', 0.0393),\n",
       "  ('females finding', -0.0027),\n",
       "  ('rights', -0.0211),\n",
       "  ('males', -0.0352)],\n",
       " 'MED-1331': [('diet shifts', 0.6501),\n",
       "  ('world diet', 0.4553),\n",
       "  ('fat energy', 0.4537),\n",
       "  ('large shifts', 0.4536),\n",
       "  ('composition diets', 0.4484),\n",
       "  ('obesity developing', 0.4377),\n",
       "  ('diet physical', 0.4343),\n",
       "  ('foods asf', 0.4154),\n",
       "  ('shifts composition', 0.3955),\n",
       "  ('energy imbalance', 0.3835),\n",
       "  ('saturated fat', 0.3776),\n",
       "  ('changes accelerating', 0.372),\n",
       "  ('undernutrition concerns', 0.3342),\n",
       "  ('related intake', 0.3174),\n",
       "  ('developing world', 0.3125),\n",
       "  ('increases energy', 0.298),\n",
       "  ('consuming high', 0.2962),\n",
       "  ('health effects', 0.289),\n",
       "  ('notes changes', 0.2695),\n",
       "  ('current agriculture', 0.2572),\n",
       "  ('physical activity', 0.2336),\n",
       "  ('high asf', 0.2265),\n",
       "  ('focuses livestock', 0.2165),\n",
       "  ('intakes heart', 0.2139),\n",
       "  ('rigorous dynamic', 0.2068),\n",
       "  ('linked increased', 0.205),\n",
       "  ('intake animal', 0.1982),\n",
       "  ('countries point', 0.1918),\n",
       "  ('cardiovascular disease', 0.1657),\n",
       "  ('patterns', 0.1621),\n",
       "  ('policy', 0.1581),\n",
       "  ('strategy linkages', 0.1577),\n",
       "  ('speeding process', 0.1439),\n",
       "  ('analysis implications', 0.1422),\n",
       "  ('point prevalence', 0.138),\n",
       "  ('major role', 0.1351),\n",
       "  ('proportion population', 0.1286),\n",
       "  ('sector', 0.096),\n",
       "  ('focuses', 0.0858),\n",
       "  ('disease great', 0.0853),\n",
       "  ('documents large', 0.0637),\n",
       "  ('longitudinal analysis', 0.0362),\n",
       "  ('adverse', 0.0187),\n",
       "  ('using china', -0.0013),\n",
       "  ('does consider', -0.0198),\n",
       "  ('cancer', -0.0205),\n",
       "  ('promotion does', -0.0273),\n",
       "  ('longer', -0.029),\n",
       "  ('play', -0.061),\n",
       "  ('ignored', -0.0986)],\n",
       " 'MED-1332': [('diabetes japan', 0.6175),\n",
       "  ('diabetes varies', 0.5198),\n",
       "  ('japan unclear', 0.4423),\n",
       "  ('varies studies', 0.3579),\n",
       "  ('ichushi databases', 0.3501),\n",
       "  ('definitions incident', 0.3491),\n",
       "  ('diabetes 95', 0.3283),\n",
       "  ('articles included', 0.3088),\n",
       "  ('medline embase', 0.3003),\n",
       "  ('various definitions', 0.2965),\n",
       "  ('uncertainty regarding', 0.2897),\n",
       "  ('explain heterogeneity', 0.2823),\n",
       "  ('pooled incidence', 0.2784),\n",
       "  ('previous epidemiologic', 0.2635),\n",
       "  ('results i2', 0.2609),\n",
       "  ('data important', 0.2522),\n",
       "  ('studies initiated', 0.2486),\n",
       "  ('unclear reviewed', 0.248),\n",
       "  ('11 studies', 0.2277),\n",
       "  ('reports tended', 0.2256),\n",
       "  ('conclusions systematic', 0.2246),\n",
       "  ('confidence interval', 0.2097),\n",
       "  ('background', 0.1958),\n",
       "  ('random effects', 0.1568),\n",
       "  ('laboratory data', 0.148),\n",
       "  ('accurate estimation', 0.1471),\n",
       "  ('meta', 0.1429),\n",
       "  ('evaluated', 0.1411),\n",
       "  ('2012 reviewers', 0.1292),\n",
       "  ('databases september', 0.1275),\n",
       "  ('population results', 0.1198),\n",
       "  ('initiated 1980', 0.1159),\n",
       "  ('2003', 0.1129),\n",
       "  ('interval 10', 0.0958),\n",
       "  ('person years', 0.0956),\n",
       "  ('001 stratified', 0.0956),\n",
       "  ('14 years', 0.0892),\n",
       "  ('ranged', 0.0751),\n",
       "  ('52 1000', 0.0737),\n",
       "  ('follow period', 0.0626),\n",
       "  ('20', 0.0584),\n",
       "  ('1824', 0.0551),\n",
       "  ('high degree', 0.054),\n",
       "  ('1000', 0.0262),\n",
       "  ('included 33', 0.0226),\n",
       "  ('analyses entirely', 0.0019),\n",
       "  ('803 participants', -0.0156),\n",
       "  ('tended lower', -0.0641),\n",
       "  ('386', -0.0895),\n",
       "  ('based self', -0.0964)],\n",
       " 'MED-1333': [('pancreatic carcinogenesis', 0.6199),\n",
       "  ('diabetes inhibits', 0.4607),\n",
       "  ('diabetics streptozotocin', 0.3798),\n",
       "  ('carcinogen mediated', 0.3759),\n",
       "  ('glycemic index', 0.3459),\n",
       "  ('adenocarcinomas express', 0.3449),\n",
       "  ('cancer association', 0.3277),\n",
       "  ('high insulin', 0.3201),\n",
       "  ('beta cell', 0.3106),\n",
       "  ('intolerance risk', 0.2687),\n",
       "  ('tightly dietary', 0.2647),\n",
       "  ('age adjusted', 0.2366),\n",
       "  ('association accounted', 0.2143),\n",
       "  ('activity hepatic', 0.2132),\n",
       "  ('decreased postprandial', 0.2116),\n",
       "  ('hamsters reasonable', 0.2032),\n",
       "  ('mortality japan', 0.2023),\n",
       "  ('reports indicate', 0.183),\n",
       "  ('epidemiology confirms', 0.1813),\n",
       "  ('evidence macrobiotic', 0.1705),\n",
       "  ('diets mediterranean', 0.1623),\n",
       "  ('control smoking', 0.1581),\n",
       "  ('substantially preventable', 0.1563),\n",
       "  ('increased adult', 0.1463),\n",
       "  ('impact early', 0.1415),\n",
       "  ('secretion suggestive', 0.1412),\n",
       "  ('stimulate mitosis', 0.135),\n",
       "  ('animal products', 0.1336),\n",
       "  ('mortality dramatically', 0.1207),\n",
       "  ('actions international', 0.1181),\n",
       "  ('coupled exercise', 0.1139),\n",
       "  ('acts promoter', 0.1095),\n",
       "  ('acid potential', 0.1002),\n",
       "  ('weight', 0.0962),\n",
       "  ('survival time', 0.0918),\n",
       "  ('diurnal', 0.0831),\n",
       "  ('harcourt', 0.0794),\n",
       "  ('training', 0.0601),\n",
       "  ('oleic acid', 0.0537),\n",
       "  ('function previous', 0.05),\n",
       "  ('view consistent', 0.0449),\n",
       "  ('copyright 2001', 0.0351),\n",
       "  ('receptors stimulate', 0.0348),\n",
       "  ('century imply', 0.023),\n",
       "  ('levels indirectly', -0.0056),\n",
       "  ('new', -0.0077),\n",
       "  ('dramatically copyright', -0.0085),\n",
       "  ('vegan', -0.0103),\n",
       "  ('african americans', -0.0115),\n",
       "  ('reasons slash', -0.0378)],\n",
       " 'MED-1334': [('rates obesity', 0.5502),\n",
       "  ('obesity adults', 0.5494),\n",
       "  ('obesity chinese', 0.518),\n",
       "  ('obesity entire', 0.4434),\n",
       "  ('trend overweight', 0.3893),\n",
       "  ('diets increasing', 0.3794),\n",
       "  ('child obesity', 0.3713),\n",
       "  ('costs nutrition', 0.3636),\n",
       "  ('diet replaced', 0.3376),\n",
       "  ('china prevalence', 0.3366),\n",
       "  ('major declines', 0.3178),\n",
       "  ('diet major', 0.3174),\n",
       "  ('18 percent', 0.3048),\n",
       "  ('promoting healthier', 0.3002),\n",
       "  ('control overweight', 0.2959),\n",
       "  ('2002 china', 0.2923),\n",
       "  ('chinese adults', 0.275),\n",
       "  ('economic health', 0.2601),\n",
       "  ('sedentary activity', 0.2422),\n",
       "  ('trend', 0.2353),\n",
       "  ('prevalence', 0.2233),\n",
       "  ('western', 0.2109),\n",
       "  ('major economic', 0.1969),\n",
       "  ('policies added', 0.1891),\n",
       "  ('increasing physical', 0.1723),\n",
       "  ('guidelines prevention', 0.1473),\n",
       "  ('population government', 0.1412),\n",
       "  ('changes family', 0.1333),\n",
       "  ('entire population', 0.1312),\n",
       "  ('reducing child', 0.1307),\n",
       "  ('added national', 0.1169),\n",
       "  ('traditional', 0.1163),\n",
       "  ('children teenagers', 0.1009),\n",
       "  ('implemented selected', 0.095),\n",
       "  ('main reasons', 0.0879),\n",
       "  ('social cultural', 0.083),\n",
       "  ('2003 2007', 0.0801),\n",
       "  ('keys curb', 0.0721),\n",
       "  ('environments', 0.0709),\n",
       "  ('planning disease', 0.0628),\n",
       "  ('respectively education', 0.0541),\n",
       "  ('released 2010', 0.0456),\n",
       "  ('work management', 0.0297),\n",
       "  ('dominate focus', -0.0001),\n",
       "  ('promulgated', -0.0008),\n",
       "  ('multisectoral cooperation', -0.0057),\n",
       "  ('research projects', -0.0082),\n",
       "  ('increasing corporate', -0.0164),\n",
       "  ('time facilitating', -0.0622),\n",
       "  ('samples small', -0.0814)],\n",
       " 'MED-1335': [('postprandial glycaemia', 0.5342),\n",
       "  ('food chinese', 0.4709),\n",
       "  ('glucose rice', 0.4521),\n",
       "  ('chinese ethnicity', 0.4442),\n",
       "  ('rice varieties', 0.4218),\n",
       "  ('diabetes increases', 0.4202),\n",
       "  ('ethnic differences', 0.418),\n",
       "  ('european chinese', 0.4044),\n",
       "  ('high intakes', 0.3956),\n",
       "  ('responses glucose', 0.3526),\n",
       "  ('chewing rice', 0.3524),\n",
       "  ('carbohydrate', 0.3483),\n",
       "  ('high china', 0.3451),\n",
       "  ('eating', 0.2847),\n",
       "  ('compared europeans', 0.2685),\n",
       "  ('intakes white', 0.2379),\n",
       "  ('chinese 32', 0.2352),\n",
       "  ('explained differences', 0.2337),\n",
       "  ('populations high', 0.2126),\n",
       "  ('extent chewing', 0.2084),\n",
       "  ('levels extent', 0.1872),\n",
       "  ('variety important', 0.1835),\n",
       "  ('important determinants', 0.1515),\n",
       "  ('varieties 001', 0.1346),\n",
       "  ('glucose jasmine', 0.1265),\n",
       "  ('studies following', 0.1168),\n",
       "  ('aims', 0.1157),\n",
       "  ('responses following', 0.1135),\n",
       "  ('01 05', 0.0999),\n",
       "  ('risk ratio', 0.0954),\n",
       "  ('suggesting need', 0.0953),\n",
       "  ('rates especially', 0.0915),\n",
       "  ('amylase activity', 0.0674),\n",
       "  ('curve conclusions', 0.0634),\n",
       "  ('measured incremental', 0.0606),\n",
       "  ('investigated physical', 0.0598),\n",
       "  ('examined possible', 0.0582),\n",
       "  ('type', 0.0548),\n",
       "  ('staple', 0.0492),\n",
       "  ('001 39', 0.0461),\n",
       "  ('60 greater', 0.0437),\n",
       "  ('medicine 2012', 0.0299),\n",
       "  ('volunteers', 0.0296),\n",
       "  ('attended', 0.0153),\n",
       "  ('uk', 0.0089),\n",
       "  ('self identified', 0.0087),\n",
       "  ('31 healthy', -0.0026),\n",
       "  ('doongara parboiled', -0.0121),\n",
       "  ('approximately 20', -0.028),\n",
       "  ('basmati brown', -0.0993)],\n",
       " 'MED-1337': [('milk intake', 0.58),\n",
       "  ('intake risk', 0.4342),\n",
       "  ('contains calcium', 0.3808),\n",
       "  ('health potential', 0.3508),\n",
       "  ('fracture prevention', 0.3393),\n",
       "  ('mineral research', 0.3334),\n",
       "  ('vitamin', 0.329),\n",
       "  ('phosphorus protein', 0.2987),\n",
       "  ('ingredients improve', 0.278),\n",
       "  ('assess association', 0.2763),\n",
       "  ('risk women', 0.2725),\n",
       "  ('pooled rr', 0.2684),\n",
       "  ('analyses based', 0.2481),\n",
       "  ('hip', 0.2453),\n",
       "  ('society bone', 0.2446),\n",
       "  ('objective study', 0.2294),\n",
       "  ('studies 195', 0.2253),\n",
       "  ('confidence interval', 0.2147),\n",
       "  ('women 3574', 0.2117),\n",
       "  ('effects', 0.2111),\n",
       "  ('studies scale', 0.209),\n",
       "  ('men women', 0.1957),\n",
       "  ('middle aged', 0.193),\n",
       "  ('91 95', 0.1903),\n",
       "  ('01 conclusion', 0.1834),\n",
       "  ('reference lists', 0.1791),\n",
       "  ('total', 0.174),\n",
       "  ('data extracted', 0.1707),\n",
       "  ('prospective cohort', 0.1697),\n",
       "  ('contains', 0.1648),\n",
       "  ('daily approximately', 0.1634),\n",
       "  ('needed', 0.1563),\n",
       "  ('models data', 0.1425),\n",
       "  ('test 37', 0.1412),\n",
       "  ('meta', 0.136),\n",
       "  ('idea compare', 0.1319),\n",
       "  ('mg', 0.1203),\n",
       "  ('embase search', 0.1127),\n",
       "  ('united states', 0.1108),\n",
       "  ('75', 0.1105),\n",
       "  ('2011 american', 0.0778),\n",
       "  ('approximately 300', 0.0448),\n",
       "  ('149 men', 0.0163),\n",
       "  ('ovid', 0.0133),\n",
       "  ('glass', -0.0035),\n",
       "  ('independent observers', -0.0091),\n",
       "  ('2010 experts', -0.016),\n",
       "  ('field', -0.0267),\n",
       "  ('search june', -0.0292),\n",
       "  ('non english', -0.0521)],\n",
       " 'MED-1338': [('swedish cohorts', 0.4852),\n",
       "  ('cohort studies', 0.452),\n",
       "  ('higher milk', 0.4094),\n",
       "  ('women men', 0.3839),\n",
       "  ('survival models', 0.3352),\n",
       "  ('cohorts 61', 0.3305),\n",
       "  ('consumption fracture', 0.3191),\n",
       "  ('adjusted mortality', 0.3113),\n",
       "  ('women died', 0.3032),\n",
       "  ('541 women', 0.3002),\n",
       "  ('subsamples additional', 0.29),\n",
       "  ('17 women', 0.2817),\n",
       "  ('women responded', 0.2746),\n",
       "  ('questionnaires', 0.2683),\n",
       "  ('studies setting', 0.2559),\n",
       "  ('biomarker conclusions', 0.2553),\n",
       "  ('women 39', 0.2514),\n",
       "  ('61 433', 0.2447),\n",
       "  ('participants large', 0.2289),\n",
       "  ('main outcome', 0.2075),\n",
       "  ('main inflammatory', 0.202),\n",
       "  ('serum interleukin', 0.1956),\n",
       "  ('13 corresponding', 0.1929),\n",
       "  ('339 men', 0.1876),\n",
       "  ('examine high', 0.1871),\n",
       "  ('1997 administered', 0.1866),\n",
       "  ('counties central', 0.1797),\n",
       "  ('mean follow', 0.1629),\n",
       "  ('positive association', 0.1613),\n",
       "  ('oxidative stress', 0.1579),\n",
       "  ('years baseline', 0.1497),\n",
       "  ('cause', 0.1446),\n",
       "  ('years 15', 0.1424),\n",
       "  ('112 men', 0.1361),\n",
       "  ('45 79', 0.1356),\n",
       "  ('compared', 0.1344),\n",
       "  ('residual confounding', 0.1282),\n",
       "  ('day 93', 0.1164),\n",
       "  ('confidence interval', 0.108),\n",
       "  ('interval 80', 0.1047),\n",
       "  ('intake urine', 0.0974),\n",
       "  ('1166 hip', 0.0938),\n",
       "  ('second food', 0.0914),\n",
       "  ('04 men', 0.0761),\n",
       "  ('cautious', 0.0428),\n",
       "  ('died 5066', 0.0244),\n",
       "  ('iso', 0.0154),\n",
       "  ('20 years', 0.0008),\n",
       "  ('ratio glasses', -0.0206),\n",
       "  ('pgf2α', -0.0226)],\n",
       " 'MED-1339': [('calcium supplementation', 0.6459),\n",
       "  ('supplementation influences', 0.4714),\n",
       "  ('prevention osteoporosis', 0.4526),\n",
       "  ('bmd longitudinal', 0.4291),\n",
       "  ('bone accretion', 0.4246),\n",
       "  ('females childhood', 0.3619),\n",
       "  ('pubertal growth', 0.3537),\n",
       "  ('studies', 0.3422),\n",
       "  ('growth long', 0.3269),\n",
       "  ('young adulthood', 0.3177),\n",
       "  ('fragility fractures', 0.3095),\n",
       "  ('participants approximately', 0.3014),\n",
       "  ('accretion females', 0.3009),\n",
       "  ('skeletal size', 0.2904),\n",
       "  ('trial recruited', 0.2866),\n",
       "  ('longitudinal models', 0.2812),\n",
       "  ('radius bmd', 0.2769),\n",
       "  ('effects remained', 0.2754),\n",
       "  ('intake final', 0.2662),\n",
       "  ('remained metacarpals', 0.2448),\n",
       "  ('size results', 0.2432),\n",
       "  ('total body', 0.2423),\n",
       "  ('recruited 354', 0.2324),\n",
       "  ('outcomes significantly', 0.2299),\n",
       "  ('final stature', 0.2175),\n",
       "  ('mineral', 0.216),\n",
       "  ('bmd tbbmd', 0.2054),\n",
       "  ('year endpoint', 0.203),\n",
       "  ('frame conclusions', 0.1903),\n",
       "  ('menarche showed', 0.1884),\n",
       "  ('received additional', 0.1818),\n",
       "  ('effect post', 0.1737),\n",
       "  ('short term', 0.1557),\n",
       "  ('stratifications compliance', 0.154),\n",
       "  ('mg primary', 0.146),\n",
       "  ('tall persons', 0.1356),\n",
       "  ('vary time', 0.1295),\n",
       "  ('distal proximal', 0.1056),\n",
       "  ('sectional area', 0.0997),\n",
       "  ('influenced', 0.0929),\n",
       "  ('cross', 0.091),\n",
       "  ('cortical indexes', 0.0888),\n",
       "  ('placebo group', 0.087),\n",
       "  ('stage optionally', 0.0853),\n",
       "  ('known', 0.0701),\n",
       "  ('spurt diminishing', 0.0689),\n",
       "  ('univariate analyses', 0.0449),\n",
       "  ('approximately 830', 0.0417),\n",
       "  ('670', 0.0194),\n",
       "  ('vanished', -0.0476)],\n",
       " 'MED-1340': [('teenage milk', 0.5723),\n",
       "  ('consumption teenage', 0.4292),\n",
       "  ('foods ages', 0.3365),\n",
       "  ('fracture risk', 0.3245),\n",
       "  ('consumption adversely', 0.3158),\n",
       "  ('height association', 0.31),\n",
       "  ('current diet', 0.3084),\n",
       "  ('high consumption', 0.2997),\n",
       "  ('health study', 0.2827),\n",
       "  ('adolescence recommended', 0.282),\n",
       "  ('association attenuated', 0.2641),\n",
       "  ('older health', 0.256),\n",
       "  ('weight smoking', 0.2471),\n",
       "  ('positive association', 0.2415),\n",
       "  ('significant higher', 0.2382),\n",
       "  ('risk increasing', 0.2359),\n",
       "  ('later life', 0.2299),\n",
       "  ('partially mediated', 0.2273),\n",
       "  ('medication use', 0.2221),\n",
       "  ('ages 13', 0.2212),\n",
       "  ('recommended promote', 0.2207),\n",
       "  ('postmenopausal women', 0.2029),\n",
       "  ('1226 hip', 0.1967),\n",
       "  ('17 association', 0.1897),\n",
       "  ('frequency consumption', 0.1887),\n",
       "  ('physical activity', 0.1866),\n",
       "  ('ml', 0.1745),\n",
       "  ('exposures', 0.1595),\n",
       "  ('design prospective', 0.158),\n",
       "  ('investigate role', 0.1562),\n",
       "  ('lower risk', 0.1559),\n",
       "  ('cohort', 0.1555),\n",
       "  ('years influences', 0.1512),\n",
       "  ('adults investigate', 0.1136),\n",
       "  ('conclusion relevance', 0.1085),\n",
       "  ('baseline current', 0.1047),\n",
       "  ('main outcome', 0.1025),\n",
       "  ('proportional hazards', 0.0997),\n",
       "  ('oz 240', 0.099),\n",
       "  ('models used', 0.095),\n",
       "  ('00 95', 0.0766),\n",
       "  ('measures cox', 0.0647),\n",
       "  ('nurses', 0.0472),\n",
       "  ('study 22', 0.0421),\n",
       "  ('united states', 0.0297),\n",
       "  ('glass fl', 0.0278),\n",
       "  ('biennial questionnaires', 0.0014),\n",
       "  ('490 men', -0.0106),\n",
       "  ('rr 06', -0.0366),\n",
       "  ('000 caucasian', -0.0754)],\n",
       " 'MED-1341': [('galactosemia associations', 0.5681),\n",
       "  ('bmd patients', 0.4666),\n",
       "  ('evaluated bone', 0.4334),\n",
       "  ('calcium level', 0.4325),\n",
       "  ('nutritional factors', 0.427),\n",
       "  ('absorptiometry correlated', 0.419),\n",
       "  ('05 osteocalcin', 0.4161),\n",
       "  ('health adults', 0.4056),\n",
       "  ('metabolism contribute', 0.3902),\n",
       "  ('mineral density', 0.3816),\n",
       "  ('hormonal status', 0.3673),\n",
       "  ('biomarkers results', 0.3374),\n",
       "  ('correlations bmi', 0.3286),\n",
       "  ('women weight', 0.3202),\n",
       "  ('inversely associated', 0.3153),\n",
       "  ('related alterations', 0.3109),\n",
       "  ('women disease', 0.2909),\n",
       "  ('clinical factors', 0.2765),\n",
       "  ('variables explored', 0.268),\n",
       "  ('patients introduction', 0.2627),\n",
       "  ('management strategies', 0.2588),\n",
       "  ('increased fracture', 0.2454),\n",
       "  ('lower spinal', 0.2436),\n",
       "  ('summary study', 0.2426),\n",
       "  ('spine 63', 0.2416),\n",
       "  ('correlated age', 0.2356),\n",
       "  ('level predicted', 0.2236),\n",
       "  ('05 women', 0.2187),\n",
       "  ('higher gonadotropin', 0.1977),\n",
       "  ('percentage subjects', 0.1894),\n",
       "  ('appears multifactorial', 0.1777),\n",
       "  ('hip 014', 0.175),\n",
       "  ('sexes conclusions', 0.1655),\n",
       "  ('dual energy', 0.1509),\n",
       "  ('insufficiency', 0.1415),\n",
       "  ('relationships', 0.1394),\n",
       "  ('afford insights', 0.1364),\n",
       "  ('significant difference', 0.136),\n",
       "  ('models higher', 0.1157),\n",
       "  ('58', 0.1139),\n",
       "  ('telopeptides', 0.1104),\n",
       "  ('years', 0.1061),\n",
       "  ('ray', 0.0671),\n",
       "  ('32', 0.0645),\n",
       "  ('896 cm', 0.0603),\n",
       "  ('vs 18', 0.0592),\n",
       "  ('reported sustaining', 0.0591),\n",
       "  ('27 vs', 0.0307),\n",
       "  ('cross', 0.019),\n",
       "  ('men 799', 0.0024)],\n",
       " 'MED-1342': [('depression trials', 0.6236),\n",
       "  ('indicate antidepressants', 0.5417),\n",
       "  ('medication limited', 0.5257),\n",
       "  ('published trials', 0.5203),\n",
       "  ('meta analyses', 0.4296),\n",
       "  ('placebo differences', 0.415),\n",
       "  ('ssri', 0.3561),\n",
       "  ('approval medication', 0.3218),\n",
       "  ('limited aimed', 0.315),\n",
       "  ('treatment implications', 0.3071),\n",
       "  ('efficacy selective', 0.2846),\n",
       "  ('findings glaxosmithkline', 0.2839),\n",
       "  ('benefits compared', 0.2792),\n",
       "  ('paroxetine provides', 0.2695),\n",
       "  ('sponsored clinical', 0.2686),\n",
       "  ('published unpublished', 0.2661),\n",
       "  ('initial fda', 0.263),\n",
       "  ('selective serotonin', 0.2492),\n",
       "  ('reuptake', 0.2469),\n",
       "  ('larger drug', 0.2342),\n",
       "  ('conclusions available', 0.2262),\n",
       "  ('baseline severity', 0.2191),\n",
       "  ('evidence indicates', 0.2105),\n",
       "  ('provides modest', 0.2063),\n",
       "  ('results', 0.1882),\n",
       "  ('differences', 0.1868),\n",
       "  ('hrsd', 0.176),\n",
       "  ('set published', 0.1652),\n",
       "  ('included change', 0.1646),\n",
       "  ('background previous', 0.1623),\n",
       "  ('superior treatment', 0.1611),\n",
       "  ('discussed', 0.1514),\n",
       "  ('hamilton rating', 0.1421),\n",
       "  ('opportunity assess', 0.1074),\n",
       "  ('manufacturer methods', 0.1066),\n",
       "  ('inhibitor', 0.1065),\n",
       "  ('36 generalized', 0.0998),\n",
       "  ('individuals replicated', 0.097),\n",
       "  ('required post', 0.0793),\n",
       "  ('32', 0.0706),\n",
       "  ('disorder 20', 0.0688),\n",
       "  ('79 magnitude', 0.054),\n",
       "  ('scale', 0.0522),\n",
       "  ('double', 0.039),\n",
       "  ('generalized anxiety', 0.0389),\n",
       "  ('blind', 0.0366),\n",
       "  ('17 respectively', 0.0337),\n",
       "  ('27 independent', 0.0335),\n",
       "  ('online providing', 0.0304),\n",
       "  ('12', 0.0168)],\n",
       " 'MED-1343': [('drug effectiveness', 0.5939),\n",
       "  ('trials reported', 0.5514),\n",
       "  ('antidepressant agents', 0.5497),\n",
       "  ('evidence base', 0.498),\n",
       "  ('meta analyses', 0.4686),\n",
       "  ('12 antidepressant', 0.3994),\n",
       "  ('obtained reviews', 0.39),\n",
       "  ('medicine valuable', 0.3803),\n",
       "  ('analyses fda', 0.3519),\n",
       "  ('reporting clinical', 0.3501),\n",
       "  ('conducted systematic', 0.3275),\n",
       "  ('studies viewed', 0.3246),\n",
       "  ('94 trials', 0.3218),\n",
       "  ('drugs 32', 0.3092),\n",
       "  ('methods obtained', 0.294),\n",
       "  ('literature appeared', 0.2938),\n",
       "  ('published outcomes', 0.2865),\n",
       "  ('decisions journal', 0.2849),\n",
       "  ('consequences researchers', 0.2709),\n",
       "  ('risk benefit', 0.2621),\n",
       "  ('reports effect', 0.2568),\n",
       "  ('effect size', 0.2549),\n",
       "  ('massachusetts medical', 0.2518),\n",
       "  ('separate meta', 0.2394),\n",
       "  ('22 studies', 0.2375),\n",
       "  ('sponsors decisions', 0.2314),\n",
       "  ('unrealistic estimates', 0.2312),\n",
       "  ('determine bias', 0.2282),\n",
       "  ('11 studies', 0.2045),\n",
       "  ('ratio methods', 0.1893),\n",
       "  ('reviewers publish', 0.1849),\n",
       "  ('analysis showed', 0.1794),\n",
       "  ('overall conclusions', 0.1761),\n",
       "  ('sets showed', 0.1486),\n",
       "  ('agents involving', 0.1384),\n",
       "  ('data set', 0.1273),\n",
       "  ('unbiased', 0.1258),\n",
       "  ('valuable extent', 0.1172),\n",
       "  ('resulted failure', 0.1082),\n",
       "  ('professionals patients', 0.1052),\n",
       "  ('exceptions', 0.1045),\n",
       "  ('negative questionable', 0.0958),\n",
       "  ('derived entire', 0.0882),\n",
       "  ('conveyed positive', 0.0289),\n",
       "  ('identify matching', 0.0289),\n",
       "  ('increase', -0.0011),\n",
       "  ('copyright 2008', -0.0129),\n",
       "  ('3449', -0.0525),\n",
       "  ('food', -0.0615),\n",
       "  ('total 37', -0.0777)],\n",
       " 'MED-1344': [('asserts placebos', 0.5592),\n",
       "  ('medical ethical', 0.3976),\n",
       "  ('notion medical', 0.3799),\n",
       "  ('physician requirement', 0.3515),\n",
       "  ('medical council', 0.347),\n",
       "  ('implications patients', 0.3278),\n",
       "  ('administered patient', 0.3136),\n",
       "  ('right prescribe', 0.312),\n",
       "  ('involve deception', 0.3051),\n",
       "  ('patient autonomy', 0.299),\n",
       "  ('informed', 0.297),\n",
       "  ('practical implications', 0.2845),\n",
       "  ('effective clinical', 0.2802),\n",
       "  ('complexities prescription', 0.2752),\n",
       "  ('adverse effects', 0.2703),\n",
       "  ('ethical tension', 0.2669),\n",
       "  ('practice general', 0.2515),\n",
       "  ('potential problem', 0.2282),\n",
       "  ('treatments', 0.2166),\n",
       "  ('pessimistic', 0.2096),\n",
       "  ('limited', 0.1997),\n",
       "  ('psychological health', 0.1974),\n",
       "  ('positive illusions', 0.197),\n",
       "  ('council ambivalent', 0.1942),\n",
       "  ('hitherto', 0.174),\n",
       "  ('association asserts', 0.1632),\n",
       "  ('individuals unduly', 0.1583),\n",
       "  ('antidepressants numerous', 0.1546),\n",
       "  ('setting', 0.1472),\n",
       "  ('ambivalent', 0.1472),\n",
       "  ('providers', 0.1326),\n",
       "  ('depressed', 0.1297),\n",
       "  ('claim significantly', 0.1282),\n",
       "  ('world treatment', 0.1268),\n",
       "  ('unavoidable role', 0.1237),\n",
       "  ('honest notion', 0.1214),\n",
       "  ('important meta', 0.1168),\n",
       "  ('requirement open', 0.1163),\n",
       "  ('individuals deemed', 0.1149),\n",
       "  ('codes hitherto', 0.1138),\n",
       "  ('achieve', 0.106),\n",
       "  ('health exactly', 0.105),\n",
       "  ('research potential', 0.0993),\n",
       "  ('overlooked synonymous', 0.0821),\n",
       "  ('american', 0.0762),\n",
       "  ('realistic oneself', 0.0616),\n",
       "  ('examines case', 0.0603),\n",
       "  ('primary', 0.0561),\n",
       "  ('expensive provocative', 0.0258),\n",
       "  ('future', 0.0062)],\n",
       " 'MED-1345': [('effects antidepressants', 0.5289),\n",
       "  ('analysis antidepressant', 0.5221),\n",
       "  ('antidepressants small', 0.5189),\n",
       "  ('criticisms clinical', 0.5015),\n",
       "  ('antidepressant clinical', 0.4763),\n",
       "  ('small criticisms', 0.4432),\n",
       "  ('meta analysis', 0.4388),\n",
       "  ('trials analyzed', 0.4328),\n",
       "  ('difference drug', 0.4258),\n",
       "  ('reaction article', 0.4211),\n",
       "  ('criticisms', 0.4183),\n",
       "  ('article', 0.4091),\n",
       "  ('article challenging', 0.3841),\n",
       "  ('drug', 0.3691),\n",
       "  ('media article', 0.368),\n",
       "  ('clinical trials', 0.3654),\n",
       "  ('article question', 0.3439),\n",
       "  ('article explores', 0.3405),\n",
       "  ('published', 0.3188),\n",
       "  ('published covered', 0.3041),\n",
       "  ('denial effects', 0.2984),\n",
       "  ('significant reactions', 0.2965),\n",
       "  ('effects', 0.2929),\n",
       "  ('trials indicating', 0.2897),\n",
       "  ('meta', 0.2718),\n",
       "  ('wisdom published', 0.2664),\n",
       "  ('analyzed reactions', 0.2649),\n",
       "  ('reactions ranged', 0.2635),\n",
       "  ('challenging received', 0.2626),\n",
       "  ('explores reaction', 0.2593),\n",
       "  ('ranged denial', 0.2584),\n",
       "  ('clinically significant', 0.2573),\n",
       "  ('question meta', 0.25),\n",
       "  ('difference', 0.2443),\n",
       "  ('clinically', 0.2361),\n",
       "  ('patients difference', 0.2313),\n",
       "  ('drug placebo', 0.2095),\n",
       "  ('countered', 0.2044),\n",
       "  ('explored countered', 0.1962),\n",
       "  ('extensively media', 0.1727),\n",
       "  ('explored', 0.1475),\n",
       "  ('analyzed', 0.1396),\n",
       "  ('significant', 0.1355),\n",
       "  ('small', 0.1267),\n",
       "  ('received', 0.1095),\n",
       "  ('patients', 0.1022),\n",
       "  ('covered', 0.0956),\n",
       "  ('extensively', 0.084),\n",
       "  ('ranged', 0.0763),\n",
       "  ('indicating', 0.0157)],\n",
       " 'MED-1347': [('published trials', 0.5528),\n",
       "  ('antidepressants relation', 0.5313),\n",
       "  ('meta analyses', 0.5136),\n",
       "  ('trials failed', 0.495),\n",
       "  ('antidepressant medication', 0.4889),\n",
       "  ('antidepressants better', 0.4866),\n",
       "  ('methods review', 0.4779),\n",
       "  ('generation antidepressants', 0.4738),\n",
       "  ('placebo differences', 0.4623),\n",
       "  ('differences drug', 0.4433),\n",
       "  ('ssris inert', 0.4419),\n",
       "  ('drug risks', 0.4261),\n",
       "  ('advantage ssris', 0.4248),\n",
       "  ('response antidepressant', 0.4057),\n",
       "  ('equal antidepressants', 0.3986),\n",
       "  ('included unpublished', 0.3973),\n",
       "  ('failed significant', 0.3536),\n",
       "  ('analyses included', 0.3429),\n",
       "  ('medication response', 0.3413),\n",
       "  ('drug placebo', 0.3206),\n",
       "  ('significant depressed', 0.2972),\n",
       "  ('meta', 0.2566),\n",
       "  ('response methods', 0.2291),\n",
       "  ('aims evaluate', 0.2223),\n",
       "  ('clinically significant', 0.2147),\n",
       "  ('differences', 0.1961),\n",
       "  ('choice depressed', 0.1911),\n",
       "  ('published', 0.1871),\n",
       "  ('evaluate new', 0.186),\n",
       "  ('inert', 0.1788),\n",
       "  ('public prescribing', 0.1784),\n",
       "  ('fda revealed', 0.1582),\n",
       "  ('physicians conclusions', 0.155),\n",
       "  ('treatment choice', 0.1543),\n",
       "  ('documents obtained', 0.1479),\n",
       "  ('included', 0.1378),\n",
       "  ('patients', 0.1237),\n",
       "  ('risks exercise', 0.1235),\n",
       "  ('psychotherapy benefits', 0.1226),\n",
       "  ('conclusions incur', 0.108),\n",
       "  ('calculated', 0.1009),\n",
       "  ('decision information', 0.0819),\n",
       "  ('administration', 0.046),\n",
       "  ('better', 0.0361),\n",
       "  ('benefits', 0.0127),\n",
       "  ('information public', -0.0096),\n",
       "  ('new generation', -0.0207),\n",
       "  ('equal', -0.0492),\n",
       "  ('revealed explicit', -0.0594),\n",
       "  ('obtained food', -0.0614)],\n",
       " 'MED-1348': [('antidepressants findings', 0.6522),\n",
       "  ('depression small', 0.551),\n",
       "  ('depression medical', 0.4928),\n",
       "  ('treatments ineffective', 0.4626),\n",
       "  ('meta analysis', 0.4584),\n",
       "  ('drugs marginal', 0.4269),\n",
       "  ('paroxetine study', 0.419),\n",
       "  ('efficacy attributable', 0.4146),\n",
       "  ('clinically insignificant', 0.3817),\n",
       "  ('alternative treatments', 0.3705),\n",
       "  ('medications severely', 0.3691),\n",
       "  ('baseline severity', 0.365),\n",
       "  ('placebo difference', 0.3421),\n",
       "  ('studies previously', 0.3264),\n",
       "  ('ssris newest', 0.3115),\n",
       "  ('groups trials', 0.304),\n",
       "  ('remain clinical', 0.2994),\n",
       "  ('significance patients', 0.2955),\n",
       "  ('benefit falls', 0.2928),\n",
       "  ('findings suggest', 0.2922),\n",
       "  ('nefazodone', 0.2764),\n",
       "  ('effects different', 0.2757),\n",
       "  ('doctors measure', 0.2682),\n",
       "  ('dummy tablet', 0.2602),\n",
       "  ('initial hrsd', 0.2547),\n",
       "  ('monoamine', 0.2475),\n",
       "  ('scores obscure', 0.2358),\n",
       "  ('moderate severe', 0.2272),\n",
       "  ('did researchers', 0.213),\n",
       "  ('datasets available', 0.2009),\n",
       "  ('journal pmed', 0.1884),\n",
       "  ('important insight', 0.1713),\n",
       "  ('institute health', 0.1581),\n",
       "  ('doubts', 0.15),\n",
       "  ('psychotherapy talk', 0.1492),\n",
       "  ('reaching conventional', 0.1377),\n",
       "  ('differences increased', 0.1352),\n",
       "  ('chemicals regulate', 0.1248),\n",
       "  ('unmotivated suicidal', 0.1241),\n",
       "  ('fda uk', 0.1152),\n",
       "  ('current', 0.1121),\n",
       "  ('oxidases', 0.1117),\n",
       "  ('using hamilton', 0.0935),\n",
       "  ('background feels', 0.0876),\n",
       "  ('months years', 0.0707),\n",
       "  ('questionnaire 18', 0.0604),\n",
       "  ('web sites', 0.0452),\n",
       "  ('0050045', 0.0359),\n",
       "  ('normalize brain', 0.0191),\n",
       "  ('21 item', 0.0058)],\n",
       " 'MED-1349': [('antidepressants supposed', 0.7385),\n",
       "  ('effect antidepressants', 0.704),\n",
       "  ('antidepressants induce', 0.7039),\n",
       "  ('difference antidepressants', 0.6852),\n",
       "  ('popular antidepressants', 0.6737),\n",
       "  ('antidepressants placebos', 0.5879),\n",
       "  ('serotonin theory', 0.4685),\n",
       "  ('lack serotonin', 0.4577),\n",
       "  ('drug companies', 0.4274),\n",
       "  ('depression popular', 0.4079),\n",
       "  ('likely depressed', 0.3844),\n",
       "  ('hidden drug', 0.3823),\n",
       "  ('benefits placebo', 0.3697),\n",
       "  ('imbalance theory', 0.3695),\n",
       "  ('curing depression', 0.3677),\n",
       "  ('blind serotonin', 0.3643),\n",
       "  ('supposed effectiveness', 0.355),\n",
       "  ('decrease effect', 0.3308),\n",
       "  ('chemical imbalance', 0.3276),\n",
       "  ('published data', 0.2729),\n",
       "  ('clinical trials', 0.2703),\n",
       "  ('theory analyses', 0.2562),\n",
       "  ('evidence chemical', 0.2469),\n",
       "  ('benefit small', 0.2421),\n",
       "  ('reveals benefits', 0.2323),\n",
       "  ('biological vulnerability', 0.2173),\n",
       "  ('therapeutic', 0.2156),\n",
       "  ('induce biological', 0.2093),\n",
       "  ('statistical difference', 0.2043),\n",
       "  ('analyses', 0.2001),\n",
       "  ('theory close', 0.196),\n",
       "  ('specifically lack', 0.1863),\n",
       "  ('depressed future', 0.1861),\n",
       "  ('companies reveals', 0.1831),\n",
       "  ('effect', 0.1817),\n",
       "  ('brain supposed', 0.1644),\n",
       "  ('levels', 0.1625),\n",
       "  ('science', 0.1394),\n",
       "  ('unpublished', 0.1312),\n",
       "  ('work fixing', 0.1048),\n",
       "  ('patients doctors', 0.0947),\n",
       "  ('making people', 0.0848),\n",
       "  ('history science', 0.0832),\n",
       "  ('successfully break', 0.0748),\n",
       "  ('fact', 0.0609),\n",
       "  ('wrong instead', 0.0588),\n",
       "  ('popular', 0.0105),\n",
       "  ('primary', -0.0002),\n",
       "  ('increase', -0.0099),\n",
       "  ('instead curing', -0.0553)],\n",
       " 'MED-1350': [('doctors paternalism', 0.5622),\n",
       "  ('biomedical approach', 0.4056),\n",
       "  ('patients rights', 0.3975),\n",
       "  ('patients different', 0.391),\n",
       "  ('question doctors', 0.3766),\n",
       "  ('medicalization pharmaceuticalization', 0.3758),\n",
       "  ('questionable medicalization', 0.3754),\n",
       "  ('rights movement', 0.3508),\n",
       "  ('patients felt', 0.3498),\n",
       "  ('1960s broad', 0.3469),\n",
       "  ('medical dominance', 0.3278),\n",
       "  ('disclosure medical', 0.309),\n",
       "  ('changes contributed', 0.3084),\n",
       "  ('care sector', 0.2976),\n",
       "  ('scholars changes', 0.2921),\n",
       "  ('instead patient', 0.2878),\n",
       "  ('explore patients', 0.2789),\n",
       "  ('doctor tried', 0.2629),\n",
       "  ('medicines health', 0.2521),\n",
       "  ('informed consent', 0.2463),\n",
       "  ('pharmaceuticalization depression', 0.2454),\n",
       "  ('ill health', 0.2403),\n",
       "  ('help problems', 0.219),\n",
       "  ('contributed downplay', 0.2173),\n",
       "  ('oriented perspective', 0.1962),\n",
       "  ('broad based', 0.1894),\n",
       "  ('different accounts', 0.1759),\n",
       "  ('negative experiences', 0.1737),\n",
       "  ('sick listing', 0.1616),\n",
       "  ('report perceptions', 0.1607),\n",
       "  ('nature problems', 0.1413),\n",
       "  ('active participation', 0.1355),\n",
       "  ('sector methodology', 0.1253),\n",
       "  ('order strengthen', 0.1232),\n",
       "  ('individual personal', 0.1189),\n",
       "  ('swedish non', 0.1131),\n",
       "  ('sleeplessness personal', 0.1113),\n",
       "  ('overall study', 0.107),\n",
       "  ('non profit', 0.1067),\n",
       "  ('withdraw', 0.1062),\n",
       "  ('strong feelings', 0.1037),\n",
       "  ('background starting', 0.0763),\n",
       "  ('suggests dynamics', 0.0537),\n",
       "  ('listened', 0.0519),\n",
       "  ('profit organization', 0.0437),\n",
       "  ('encounters', 0.0321),\n",
       "  ('cases exceptionally', 0.0016),\n",
       "  ('used', -0.0117),\n",
       "  ('exceptionally quick', -0.0566),\n",
       "  ('181 kilen', -0.0846)],\n",
       " 'MED-1351': [('burdens psychiatrists', 0.5042),\n",
       "  ('ties psychiatrists', 0.4853),\n",
       "  ('psychiatry pharmaceutical', 0.4577),\n",
       "  ('relationship psychiatry', 0.4556),\n",
       "  ('pharmaceutical industry', 0.4229),\n",
       "  ('patients conflicts', 0.418),\n",
       "  ('psychiatrists researchers', 0.4171),\n",
       "  ('financial relationships', 0.4012),\n",
       "  ('research conflicts', 0.3749),\n",
       "  ('trust psychiatrists', 0.3209),\n",
       "  ('conflicts threaten', 0.3162),\n",
       "  ('medical profession', 0.3002),\n",
       "  ('interests patients', 0.3001),\n",
       "  ('professional judgments', 0.2908),\n",
       "  ('loss trust', 0.2661),\n",
       "  ('regulatory burdens', 0.2603),\n",
       "  ('public concerns', 0.2384),\n",
       "  ('risks bias', 0.2338),\n",
       "  ('treatment seeking', 0.2216),\n",
       "  ('goal conflict', 0.2177),\n",
       "  ('associations developing', 0.2058),\n",
       "  ('industry unduly', 0.2041),\n",
       "  ('integrity professional', 0.1984),\n",
       "  ('disclosure individual', 0.1396),\n",
       "  ('guideline development', 0.1299),\n",
       "  ('individual institutional', 0.1296),\n",
       "  ('illness', 0.1241),\n",
       "  ('policies protect', 0.1167),\n",
       "  ('past decade', 0.1052),\n",
       "  ('companies come', 0.0985),\n",
       "  ('role designing', 0.0984),\n",
       "  ('advocacy', 0.0961),\n",
       "  ('neurology', 0.094),\n",
       "  ('authors', 0.0857),\n",
       "  ('reasonable conflict', 0.0732),\n",
       "  ('neurosciences 2014', 0.0698),\n",
       "  ('involving primary', 0.0476),\n",
       "  ('research education', 0.0417),\n",
       "  ('cultural change', 0.0411),\n",
       "  ('avoid undue', 0.0355),\n",
       "  ('institutions carry', 0.0305),\n",
       "  ('considerable autonomy', 0.02),\n",
       "  ('measures', 0.0199),\n",
       "  ('strengthened engaged', 0.0167),\n",
       "  ('stronger evidence', 0.0101),\n",
       "  ('play vital', 0.0066),\n",
       "  ('traditionally granted', -0.008),\n",
       "  ('japanese society', -0.0198),\n",
       "  ('continue', -0.0335),\n",
       "  ('limited', -0.0675)],\n",
       " 'MED-1352': [('antidepressants designed', 0.74),\n",
       "  ('serotonin regulates', 0.6043),\n",
       "  ('death antidepressants', 0.5829),\n",
       "  ('regulate neurotransmitter', 0.5025),\n",
       "  ('evolutionary medicine', 0.3697),\n",
       "  ('major depressive', 0.3689),\n",
       "  ('medications line', 0.3546),\n",
       "  ('biological functioning', 0.3358),\n",
       "  ('evolved regulated', 0.3161),\n",
       "  ('belief psychiatry', 0.3043),\n",
       "  ('fungi adaptive', 0.297),\n",
       "  ('perturb mechanisms', 0.2806),\n",
       "  ('medicine disruption', 0.2684),\n",
       "  ('review supports', 0.252),\n",
       "  ('treatment people', 0.2386),\n",
       "  ('development neuronal', 0.2361),\n",
       "  ('neurogenesis flawed', 0.2318),\n",
       "  ('symptoms', 0.2233),\n",
       "  ('plants animals', 0.2196),\n",
       "  ('ancient biochemical', 0.2183),\n",
       "  ('caution prescription', 0.2142),\n",
       "  ('including emotion', 0.2102),\n",
       "  ('brain susceptibility', 0.2073),\n",
       "  ('current diagnostic', 0.2015),\n",
       "  ('flawed use', 0.1856),\n",
       "  ('specific conditions', 0.1855),\n",
       "  ('reproduction principle', 0.178),\n",
       "  ('apoptosis programmed', 0.1691),\n",
       "  ('effective reducing', 0.1676),\n",
       "  ('clotting process', 0.1638),\n",
       "  ('practices greater', 0.1612),\n",
       "  ('future episodes', 0.1603),\n",
       "  ('supports', 0.1554),\n",
       "  ('hyponatremia low', 0.1513),\n",
       "  ('elderly review', 0.1432),\n",
       "  ('number adaptive', 0.1397),\n",
       "  ('method distinguish', 0.1387),\n",
       "  ('neurons revert', 0.1363),\n",
       "  ('developmental problems', 0.1361),\n",
       "  ('electrolyte balance', 0.1091),\n",
       "  ('studies purport', 0.1048),\n",
       "  ('cancer recovery', 0.0974),\n",
       "  ('altered informed', 0.0804),\n",
       "  ('stroke death', 0.0802),\n",
       "  ('modestly effective', 0.0799),\n",
       "  ('health', 0.0749),\n",
       "  ('widely held', 0.0684),\n",
       "  ('sexual romantic', 0.0581),\n",
       "  ('life increase', 0.0453),\n",
       "  ('discontinued contrary', -0.0008)],\n",
       " 'MED-1353': [('depression potentially', 0.5002),\n",
       "  ('management depression', 0.4716),\n",
       "  ('global disability', 0.4423),\n",
       "  ('depression long', 0.4093),\n",
       "  ('disorder affecting', 0.3722),\n",
       "  ('huge burden', 0.3506),\n",
       "  ('resistant depression', 0.3292),\n",
       "  ('disability 2004', 0.3007),\n",
       "  ('costing billion', 0.2924),\n",
       "  ('life threatening', 0.2759),\n",
       "  ('society costing', 0.271),\n",
       "  ('world health', 0.2623),\n",
       "  ('burden individual', 0.2584),\n",
       "  ('cause global', 0.2446),\n",
       "  ('millions people', 0.2336),\n",
       "  ('health organisation', 0.2242),\n",
       "  ('milder depression', 0.211),\n",
       "  ('2000 world', 0.2078),\n",
       "  ('important problems', 0.1967),\n",
       "  ('developed world', 0.1925),\n",
       "  ('huge', 0.1806),\n",
       "  ('leading cause', 0.1656),\n",
       "  ('discovery antidepressants', 0.1595),\n",
       "  ('2004 developed', 0.158),\n",
       "  ('long term', 0.1497),\n",
       "  ('costing', 0.145),\n",
       "  ('persist intolerability', 0.124),\n",
       "  ('2030', 0.1163),\n",
       "  ('resistant', 0.0873),\n",
       "  ('potentially life', 0.0793),\n",
       "  ('term important', 0.0772),\n",
       "  ('trials highlighted', 0.0692),\n",
       "  ('individual society', 0.0537),\n",
       "  ('people globe', 0.0416),\n",
       "  ('limited efficacy', 0.04),\n",
       "  ('limelight controversial', 0.0152),\n",
       "  ('revolutionized understanding', 0.0147),\n",
       "  ('understanding management', 0.0125),\n",
       "  ('publication kirsch', -0.0104),\n",
       "  ('long debated', -0.0171),\n",
       "  ('serendipitous', -0.0259),\n",
       "  ('recently', -0.0263),\n",
       "  ('project', -0.0325),\n",
       "  ('existence treatment', -0.0338),\n",
       "  ('whilst', -0.0388),\n",
       "  ('benefits short', -0.0395),\n",
       "  ('onset', -0.0449),\n",
       "  ('brought public', -0.051),\n",
       "  ('role placebo', -0.0619),\n",
       "  ('milder', -0.1276)],\n",
       " 'MED-1354': [('antidepressant medications', 0.6958),\n",
       "  ('medication compared', 0.6157),\n",
       "  ('disorder mdd', 0.5546),\n",
       "  ('depression benefit', 0.5382),\n",
       "  ('severity depression', 0.5301),\n",
       "  ('depression objective', 0.5125),\n",
       "  ('benefit medications', 0.4854),\n",
       "  ('mdd little', 0.4606),\n",
       "  ('pharmacological effect', 0.3891),\n",
       "  ('relative pill', 0.3842),\n",
       "  ('meta analyses', 0.3601),\n",
       "  ('medication placebo', 0.3507),\n",
       "  ('disorder selected', 0.3505),\n",
       "  ('effect sizes', 0.3308),\n",
       "  ('moderate symptoms', 0.3264),\n",
       "  ('psycinfo cochrane', 0.3248),\n",
       "  ('little evidence', 0.3054),\n",
       "  ('outpatients included', 0.3049),\n",
       "  ('trials fda', 0.2856),\n",
       "  ('evidence specific', 0.2856),\n",
       "  ('treatment major', 0.2622),\n",
       "  ('severity patients', 0.2392),\n",
       "  ('threshold clinically', 0.2353),\n",
       "  ('magnitude benefit', 0.2284),\n",
       "  ('databases', 0.2103),\n",
       "  ('study selection', 0.2066),\n",
       "  ('standard definition', 0.1678),\n",
       "  ('differences varied', 0.1662),\n",
       "  ('searched january', 0.164),\n",
       "  ('25', 0.1499),\n",
       "  ('minimal nonexistent', 0.1393),\n",
       "  ('comparison weeks', 0.1373),\n",
       "  ('individual patient', 0.1347),\n",
       "  ('did exclude', 0.1333),\n",
       "  ('utilized hamilton', 0.1332),\n",
       "  ('period utilized', 0.1326),\n",
       "  ('level data', 0.1263),\n",
       "  ('march 2009', 0.1192),\n",
       "  ('authors provided', 0.1116),\n",
       "  ('washout period', 0.0957),\n",
       "  ('type effect', 0.094),\n",
       "  ('represent best', 0.0737),\n",
       "  ('comprised adult', 0.0638),\n",
       "  ('original data', 0.055),\n",
       "  ('increases baseline', 0.0542),\n",
       "  ('extraction individual', 0.0249),\n",
       "  ('718 patients', 0.0039),\n",
       "  ('cohen', -0.0059),\n",
       "  ('estimated 20', -0.0416),\n",
       "  ('january 1980', -0.0439)],\n",
       " 'MED-1355': [('treatments depression', 0.6693),\n",
       "  ('disorders effective', 0.5698),\n",
       "  ('improve depressive', 0.5674),\n",
       "  ('depression exercise', 0.5439),\n",
       "  ('antidepressant medications', 0.5257),\n",
       "  ('depressive symptoms', 0.4959),\n",
       "  ('depression shown', 0.4943),\n",
       "  ('depression anxiety', 0.4684),\n",
       "  ('achieved psychopharmaceuticals', 0.4535),\n",
       "  ('psychological disorders', 0.4488),\n",
       "  ('moderate depression', 0.4382),\n",
       "  ('states treatments', 0.431),\n",
       "  ('decreased symptoms', 0.4261),\n",
       "  ('adjunct medications', 0.414),\n",
       "  ('medications extensively', 0.4105),\n",
       "  ('favorably antidepressant', 0.4022),\n",
       "  ('common psychiatric', 0.3935),\n",
       "  ('reduce anxiety', 0.3918),\n",
       "  ('symptoms used', 0.3776),\n",
       "  ('efficient treatment', 0.3773),\n",
       "  ('exercise treatment', 0.3642),\n",
       "  ('treatment alternative', 0.3612),\n",
       "  ('improved physical', 0.3582),\n",
       "  ('associated improved', 0.3041),\n",
       "  ('functioning psychological', 0.2861),\n",
       "  ('general medical', 0.2813),\n",
       "  ('studies support', 0.2709),\n",
       "  ('support use', 0.2635),\n",
       "  ('anxiety common', 0.2366),\n",
       "  ('line treatment', 0.2361),\n",
       "  ('health life', 0.2206),\n",
       "  ('treatment mild', 0.213),\n",
       "  ('inactivity appears', 0.2011),\n",
       "  ('degrees effectiveness', 0.1961),\n",
       "  ('shown reduce', 0.1833),\n",
       "  ('effective cost', 0.1818),\n",
       "  ('improve', 0.1672),\n",
       "  ('level achieved', 0.1533),\n",
       "  ('shown effective', 0.1523),\n",
       "  ('varying degrees', 0.1462),\n",
       "  ('satisfaction', 0.1411),\n",
       "  ('extensively studied', 0.0949),\n",
       "  ('millions individuals', 0.0947),\n",
       "  ('alternative variety', 0.0901),\n",
       "  ('activity', 0.0833),\n",
       "  ('conditions seen', 0.0715),\n",
       "  ('appears associated', 0.0495),\n",
       "  ('setting', 0.0363),\n",
       "  ('individuals united', -0.002),\n",
       "  ('consistently', -0.0071)],\n",
       " 'MED-1356': [('disorders adults', 0.5229),\n",
       "  ('physical disorders', 0.4954),\n",
       "  ('prevalence mental', 0.4532),\n",
       "  ('disorders association', 0.4487),\n",
       "  ('substance use', 0.4221),\n",
       "  ('disorders did', 0.407),\n",
       "  ('disorders lifespan', 0.3709),\n",
       "  ('physical activity', 0.3613),\n",
       "  ('major depression', 0.3527),\n",
       "  ('compare prevalence', 0.3208),\n",
       "  ('states methods', 0.3137),\n",
       "  ('psychotic disorders', 0.3083),\n",
       "  ('national comorbidity', 0.2931),\n",
       "  ('regression analyses', 0.2856),\n",
       "  ('survey 8098', 0.2629),\n",
       "  ('comorbid', 0.2549),\n",
       "  ('negative association', 0.2492),\n",
       "  ('differences sociodemographic', 0.2381),\n",
       "  ('lower prevalence', 0.2359),\n",
       "  ('reported frequency', 0.2326),\n",
       "  ('background objective', 0.2152),\n",
       "  ('phobia 78', 0.213),\n",
       "  ('self reported', 0.2057),\n",
       "  ('significantly associated', 0.2052),\n",
       "  ('mechanism association', 0.2009),\n",
       "  ('adjusting differences', 0.1973),\n",
       "  ('60 regular', 0.1758),\n",
       "  ('97 agoraphobia', 0.1686),\n",
       "  ('adults united', 0.1667),\n",
       "  ('56 96', 0.1428),\n",
       "  ('incident recurrent', 0.1369),\n",
       "  ('lifespan needed', 0.1313),\n",
       "  ('ages 15', 0.1268),\n",
       "  ('future research', 0.125),\n",
       "  ('associated affective', 0.121),\n",
       "  ('attacks', 0.1158),\n",
       "  ('used compare', 0.1054),\n",
       "  ('longitudinal data', 0.0961),\n",
       "  ('conclusions slightly', 0.0959),\n",
       "  ('current', 0.0942),\n",
       "  ('75', 0.0879),\n",
       "  ('half', 0.0619),\n",
       "  ('did did', 0.0617),\n",
       "  ('63', 0.0554),\n",
       "  ('representative sample', 0.0427),\n",
       "  ('persisted', 0.0346),\n",
       "  ('multiple logistic', 0.0248),\n",
       "  ('significantly', 0.0172),\n",
       "  ('social', -0.0051),\n",
       "  ('43 94', -0.0251)],\n",
       " 'MED-1357': [('exercise antidepressants', 0.6194),\n",
       "  ('reducing depression', 0.517),\n",
       "  ('conclusions exercise', 0.4816),\n",
       "  ('interventional studies', 0.4224),\n",
       "  ('weeks treatment', 0.3752),\n",
       "  ('studies suggested', 0.3725),\n",
       "  ('training reduce', 0.3445),\n",
       "  ('mental disorders', 0.315),\n",
       "  ('assess effectiveness', 0.3147),\n",
       "  ('program compared', 0.2965),\n",
       "  ('measures included', 0.291),\n",
       "  ('treatment secondary', 0.2842),\n",
       "  ('standard medication', 0.2829),\n",
       "  ('severity mdd', 0.2775),\n",
       "  ('combination therapy', 0.2765),\n",
       "  ('suggested regular', 0.2744),\n",
       "  ('response patients', 0.2469),\n",
       "  ('previous observational', 0.2375),\n",
       "  ('older persons', 0.2189),\n",
       "  ('did differ', 0.217),\n",
       "  ('considered alternative', 0.188),\n",
       "  ('equally effective', 0.1839),\n",
       "  ('symptoms initially', 0.1759),\n",
       "  ('conducted 16', 0.1758),\n",
       "  ('underwent comprehensive', 0.1658),\n",
       "  ('facilitate', 0.1628),\n",
       "  ('objective', 0.1622),\n",
       "  ('manual mental', 0.1547),\n",
       "  ('sertraline hydrochloride', 0.1533),\n",
       "  ('using diagnostic', 0.1459),\n",
       "  ('bdi', 0.1373),\n",
       "  ('baseline levels', 0.1255),\n",
       "  ('methods men', 0.1218),\n",
       "  ('life satisfaction', 0.1126),\n",
       "  ('67 adjustment', 0.1087),\n",
       "  ('dysfunctional', 0.0992),\n",
       "  ('cognitions', 0.097),\n",
       "  ('including presence', 0.081),\n",
       "  ('capacity life', 0.0773),\n",
       "  ('groups exhibited', 0.0621),\n",
       "  ('curve models', 0.0607),\n",
       "  ('50 years', 0.0578),\n",
       "  ('women', 0.0517),\n",
       "  ('assigned randomly', 0.0516),\n",
       "  ('years assigned', 0.0374),\n",
       "  ('exhibited fastest', 0.0358),\n",
       "  ('scale', 0.0247),\n",
       "  ('fourth edition', 0.0003),\n",
       "  ('esteem anxiety', -0.0139),\n",
       "  ('hamilton', -0.0263)],\n",
       " 'MED-1358': [('mood effects', 0.5167),\n",
       "  ('sessions exercise', 0.4531),\n",
       "  ('acute mood', 0.4478),\n",
       "  ('exercise issues', 0.4315),\n",
       "  ('studies suggest', 0.4156),\n",
       "  ('results studies', 0.3919),\n",
       "  ('mood addressed', 0.3903),\n",
       "  ('literature acute', 0.3858),\n",
       "  ('definition mood', 0.3808),\n",
       "  ('effects associated', 0.3794),\n",
       "  ('single sessions', 0.3589),\n",
       "  ('possible mechanisms', 0.3549),\n",
       "  ('research discussed', 0.3231),\n",
       "  ('recommendations', 0.3081),\n",
       "  ('suggest clinical', 0.3075),\n",
       "  ('experimental design', 0.2963),\n",
       "  ('exercise finally', 0.2962),\n",
       "  ('mechanisms recommendations', 0.2956),\n",
       "  ('addressed results', 0.2908),\n",
       "  ('literature', 0.2907),\n",
       "  ('regarding experimental', 0.2867),\n",
       "  ('benefit acutely', 0.2853),\n",
       "  ('subjects benefit', 0.2838),\n",
       "  ('sessions', 0.2793),\n",
       "  ('single bout', 0.2766),\n",
       "  ('recent 1976', 0.2688),\n",
       "  ('future research', 0.2563),\n",
       "  ('associated participation', 0.2536),\n",
       "  ('1995 literature', 0.2523),\n",
       "  ('recommendations future', 0.2388),\n",
       "  ('recent', 0.2358),\n",
       "  ('ecological validity', 0.2282),\n",
       "  ('documents recent', 0.2208),\n",
       "  ('participation single', 0.2174),\n",
       "  ('1976 1995', 0.215),\n",
       "  ('acutely single', 0.2083),\n",
       "  ('subjects', 0.2066),\n",
       "  ('issues regarding', 0.2023),\n",
       "  ('nonclinical subjects', 0.1949),\n",
       "  ('discussed', 0.1939),\n",
       "  ('acutely', 0.1885),\n",
       "  ('design ecological', 0.1791),\n",
       "  ('suggest', 0.1785),\n",
       "  ('validity operational', 0.1681),\n",
       "  ('bout', 0.1645),\n",
       "  ('design', 0.1618),\n",
       "  ('operational definition', 0.148),\n",
       "  ('associated', 0.1459),\n",
       "  ('finally possible', 0.1108),\n",
       "  ('paper documents', 0.1004)],\n",
       " 'MED-1359': [('exercise depression', 0.5202),\n",
       "  ('exercise meditation', 0.5011),\n",
       "  ('included trials', 0.4882),\n",
       "  ('depression reduction', 0.4805),\n",
       "  ('antidepressant effect', 0.4546),\n",
       "  ('depression compared', 0.4451),\n",
       "  ('moderate depression', 0.4293),\n",
       "  ('compared treatment', 0.4233),\n",
       "  ('meditation mindfulness', 0.398),\n",
       "  ('placebo despite', 0.3857),\n",
       "  ('placebo intervention', 0.3817),\n",
       "  ('based interventions', 0.3663),\n",
       "  ('reducing symptoms', 0.3247),\n",
       "  ('overall effect', 0.3218),\n",
       "  ('used treatment', 0.2815),\n",
       "  ('usual care', 0.2729),\n",
       "  ('determined efficacy', 0.2644),\n",
       "  ('depressed adults', 0.2614),\n",
       "  ('larger trials', 0.2599),\n",
       "  ('retrieved studies', 0.2445),\n",
       "  ('level studies', 0.2383),\n",
       "  ('effect physical', 0.2373),\n",
       "  ('engage program', 0.2196),\n",
       "  ('relaxation recognized', 0.1873),\n",
       "  ('moderate level', 0.1812),\n",
       "  ('physically healthy', 0.1762),\n",
       "  ('analysis exercise', 0.1701),\n",
       "  ('related parts', 0.1692),\n",
       "  ('13 studies', 0.1681),\n",
       "  ('recommended people', 0.167),\n",
       "  ('compared', 0.1663),\n",
       "  ('despite fact', 0.1643),\n",
       "  ('meta', 0.1606),\n",
       "  ('condition categorized', 0.1595),\n",
       "  ('high methodological', 0.1462),\n",
       "  ('present study', 0.1448),\n",
       "  ('15 passed', 0.1319),\n",
       "  ('control', 0.1255),\n",
       "  ('showed significant', 0.1189),\n",
       "  ('size reduced', 0.1186),\n",
       "  ('previous', 0.1158),\n",
       "  ('clinically', 0.1114),\n",
       "  ('reduction impossible', 0.1103),\n",
       "  ('adults 89', 0.107),\n",
       "  ('passed inclusion', 0.0788),\n",
       "  ('wiley sons', 0.0661),\n",
       "  ('sufficient information', 0.0387),\n",
       "  ('sizes main', 0.0139),\n",
       "  ('favoring', 0.0098),\n",
       "  ('2013', -0.0368)],\n",
       " 'MED-1360': [('exercise patients', 0.5481),\n",
       "  ('reductions depression', 0.4674),\n",
       "  ('receiving aerobic', 0.4534),\n",
       "  ('active treatment', 0.4395),\n",
       "  ('treatment scores', 0.4388),\n",
       "  ('conclusions efficacy', 0.3995),\n",
       "  ('weeks patients', 0.3872),\n",
       "  ('treatments tended', 0.3855),\n",
       "  ('patients underwent', 0.362),\n",
       "  ('standard antidepressant', 0.36),\n",
       "  ('prospective randomized', 0.3456),\n",
       "  ('smile study', 0.3234),\n",
       "  ('conditions supervised', 0.3225),\n",
       "  ('comparable patients', 0.2919),\n",
       "  ('sertraline 50', 0.279),\n",
       "  ('underwent structured', 0.2747),\n",
       "  ('concealment blinded', 0.2636),\n",
       "  ('exercise 40', 0.2624),\n",
       "  ('057 treatment', 0.2603),\n",
       "  ('symptom monitoring', 0.2596),\n",
       "  ('patients mdd', 0.2548),\n",
       "  ('16 weeks', 0.2487),\n",
       "  ('groups significantly', 0.2449),\n",
       "  ('mg daily', 0.224),\n",
       "  ('home supervised', 0.2218),\n",
       "  ('achieved remission', 0.2169),\n",
       "  ('controls methods', 0.2152),\n",
       "  ('response rates', 0.2006),\n",
       "  ('objective assess', 0.1885),\n",
       "  ('2005 performed', 0.1881),\n",
       "  ('expectations ongoing', 0.188),\n",
       "  ('medication 47', 0.1792),\n",
       "  ('better placebo', 0.1781),\n",
       "  ('results months', 0.1741),\n",
       "  ('hospital total', 0.1626),\n",
       "  ('setting', 0.1585),\n",
       "  ('31 057', 0.1287),\n",
       "  ('october 2000', 0.1267),\n",
       "  ('202 adults', 0.1165),\n",
       "  ('49 men', 0.1154),\n",
       "  ('tended higher', 0.1136),\n",
       "  ('45', 0.112),\n",
       "  ('suggesting considerable', 0.1043),\n",
       "  ('men diagnosed', 0.1042),\n",
       "  ('ham scores', 0.0904),\n",
       "  ('completed hamilton', 0.0882),\n",
       "  ('longer meeting', 0.0677),\n",
       "  ('153 women', 0.0427),\n",
       "  ('nonspecific factors', 0.0291),\n",
       "  ('different', -0.0467)],\n",
       " 'MED-1362': [('meta analyses', 0.5562),\n",
       "  ('search performed', 0.4481),\n",
       "  ('studies study', 0.3927),\n",
       "  ('cohort studies', 0.3904),\n",
       "  ('adherence mediterranean', 0.3726),\n",
       "  ('aim research', 0.3666),\n",
       "  ('model cochrane', 0.3658),\n",
       "  ('cancer mortality', 0.3524),\n",
       "  ('95 ci', 0.3515),\n",
       "  ('publication bias', 0.3389),\n",
       "  ('effect model', 0.3352),\n",
       "  ('risk reduction', 0.3322),\n",
       "  ('inclusion criteria', 0.3315),\n",
       "  ('ratios rrs', 0.3269),\n",
       "  ('mortality incidence', 0.3106),\n",
       "  ('effects adherence', 0.3089),\n",
       "  ('scopus embase', 0.3087),\n",
       "  ('md overall', 0.2992),\n",
       "  ('2014 inclusion', 0.2942),\n",
       "  ('55 colorectal', 0.2761),\n",
       "  ('package review', 0.2728),\n",
       "  ('databases', 0.2647),\n",
       "  ('evidence substantial', 0.2515),\n",
       "  ('control studies', 0.2506),\n",
       "  ('met objectives', 0.2453),\n",
       "  ('regression tests', 0.241),\n",
       "  ('egger regression', 0.2396),\n",
       "  ('changes observed', 0.2374),\n",
       "  ('associated significant', 0.2277),\n",
       "  ('rr 96', 0.2185),\n",
       "  ('limited evidence', 0.2183),\n",
       "  ('manager cohort', 0.2181),\n",
       "  ('analyses highest', 0.2166),\n",
       "  ('diet', 0.1952),\n",
       "  ('observed breast', 0.1888),\n",
       "  ('ci 80', 0.1832),\n",
       "  ('substantial publication', 0.1674),\n",
       "  ('software package', 0.1539),\n",
       "  ('99 03', 0.1235),\n",
       "  ('january 10', 0.1112),\n",
       "  ('bias high', 0.108),\n",
       "  ('including 368', 0.1073),\n",
       "  ('tests provided', 0.0862),\n",
       "  ('subjects 12', 0.0835),\n",
       "  ('pancreatic', 0.081),\n",
       "  ('using random', 0.0751),\n",
       "  ('enclosed', 0.0719),\n",
       "  ('aerodigestive', 0.0642),\n",
       "  ('83 nonsignificant', 0.0628),\n",
       "  ('0001 62', 0.0312)],\n",
       " 'MED-1363': [('dietary guidelines', 0.6132),\n",
       "  ('recommendations cardiovascular', 0.5752),\n",
       "  ('mediterranean diet', 0.5127),\n",
       "  ('guidelines promote', 0.48),\n",
       "  ('diet predimed', 0.4656),\n",
       "  ('health effects', 0.4534),\n",
       "  ('sound nutritional', 0.4274),\n",
       "  ('clinical trials', 0.3938),\n",
       "  ('prevention based', 0.3909),\n",
       "  ('epidemiologic studies', 0.3701),\n",
       "  ('dieta mediterránea', 0.3526),\n",
       "  ('disease risk', 0.3438),\n",
       "  ('heart study', 0.3323),\n",
       "  ('predictive chronic', 0.3251),\n",
       "  ('upgrade health', 0.3096),\n",
       "  ('high fat', 0.306),\n",
       "  ('protective effects', 0.2867),\n",
       "  ('usually based', 0.2723),\n",
       "  ('predimed prevención', 0.2698),\n",
       "  ('meals 2013', 0.2682),\n",
       "  ('points main', 0.2606),\n",
       "  ('cereals reducing', 0.2309),\n",
       "  ('obtained mediterranean', 0.2158),\n",
       "  ('evidence obtained', 0.2035),\n",
       "  ('results large', 0.1843),\n",
       "  ('reducing sodium', 0.1824),\n",
       "  ('maintaining moderate', 0.1718),\n",
       "  ('red meats', 0.1526),\n",
       "  ('trial lyon', 0.1499),\n",
       "  ('poultry dairy', 0.1484),\n",
       "  ('hard end', 0.1414),\n",
       "  ('late 1950s', 0.1372),\n",
       "  ('study traditional', 0.1362),\n",
       "  ('legumes nuts', 0.1298),\n",
       "  ('characteristics include', 0.1289),\n",
       "  ('consumed', 0.1221),\n",
       "  ('alcohol intake', 0.1219),\n",
       "  ('pattern changing', 0.1204),\n",
       "  ('fruits relatively', 0.0864),\n",
       "  ('crete greece', 0.0822),\n",
       "  ('greater', 0.0783),\n",
       "  ('growing areas', 0.0759),\n",
       "  ('rights', 0.0412),\n",
       "  ('consumption wine', 0.032),\n",
       "  ('fish', 0.0299),\n",
       "  ('used extra', 0.0275),\n",
       "  ('sound', 0.0211),\n",
       "  ('2013 elsevier', 0.0088),\n",
       "  ('southern italy', 0.0065),\n",
       "  ('olive oil', -0.0144)],\n",
       " 'MED-1365': [('bread intake', 0.6145),\n",
       "  ('anthropometric measures', 0.406),\n",
       "  ('habits assessed', 0.3837),\n",
       "  ('prevención dieta', 0.3756),\n",
       "  ('time dietary', 0.3698),\n",
       "  ('style food', 0.3349),\n",
       "  ('consumption change', 0.3331),\n",
       "  ('consumption mediterranean', 0.3265),\n",
       "  ('fat', 0.3052),\n",
       "  ('intake gained', 0.2948),\n",
       "  ('intake reduction', 0.2939),\n",
       "  ('ffq baseline', 0.2932),\n",
       "  ('association changes', 0.2634),\n",
       "  ('quartiles change', 0.2581),\n",
       "  ('cvd prevención', 0.2489),\n",
       "  ('losing waist', 0.235),\n",
       "  ('assess association', 0.2161),\n",
       "  ('circumference gain', 0.2108),\n",
       "  ('weight kg', 0.2101),\n",
       "  ('2213 participants', 0.209),\n",
       "  ('mediterránea predimed', 0.2017),\n",
       "  ('studied analysed', 0.1998),\n",
       "  ('adjust covariates', 0.1944),\n",
       "  ('trial assess', 0.1885),\n",
       "  ('abdominal', 0.1826),\n",
       "  ('results suggest', 0.1795),\n",
       "  ('years participants', 0.1688),\n",
       "  ('energy adjusted', 0.1685),\n",
       "  ('scarcely studied', 0.1636),\n",
       "  ('trend 001', 0.1529),\n",
       "  ('predimed trial', 0.1518),\n",
       "  ('assessed validated', 0.1473),\n",
       "  ('long term', 0.1454),\n",
       "  ('measures gaining', 0.1405),\n",
       "  ('003 28', 0.1328),\n",
       "  ('participants highest', 0.1254),\n",
       "  ('associated increase', 0.1168),\n",
       "  ('associated lower', 0.1121),\n",
       "  ('76 kg', 0.1121),\n",
       "  ('measures scarcely', 0.1081),\n",
       "  ('multivariate models', 0.0936),\n",
       "  ('response relationships', 0.0858),\n",
       "  ('white grain', 0.0815),\n",
       "  ('reduction 36', 0.0783),\n",
       "  ('cm follow', 0.0654),\n",
       "  ('repeatedly', 0.0534),\n",
       "  ('significant dose', 0.0511),\n",
       "  ('33 odds', 0.0489),\n",
       "  ('setting associated', 0.0405),\n",
       "  ('style', -0.014)],\n",
       " 'MED-1366': [('mediterranean diet', 0.552),\n",
       "  ('diets lower', 0.5414),\n",
       "  ('diet mainly', 0.5107),\n",
       "  ('1950s naples', 0.4616),\n",
       "  ('diet public', 0.4321),\n",
       "  ('concern diet', 0.4269),\n",
       "  ('diet changing', 0.4202),\n",
       "  ('european diets', 0.3921),\n",
       "  ('heart diet', 0.3883),\n",
       "  ('lower meat', 0.3514),\n",
       "  ('early 1950s', 0.3232),\n",
       "  ('naples observed', 0.3038),\n",
       "  ('fat major', 0.2928),\n",
       "  ('eat', 0.2914),\n",
       "  ('saturated fat', 0.2831),\n",
       "  ('vegetarian differs', 0.2716),\n",
       "  ('parents eat', 0.2622),\n",
       "  ('health problem', 0.257),\n",
       "  ('medical textbooks', 0.1974),\n",
       "  ('low incidences', 0.1949),\n",
       "  ('low', 0.183),\n",
       "  ('dietary villain', 0.1701),\n",
       "  ('meat', 0.1667),\n",
       "  ('coronary', 0.1384),\n",
       "  ('confined medical', 0.1301),\n",
       "  ('dairy products', 0.1297),\n",
       "  ('dessert', 0.0883),\n",
       "  ('disease longer', 0.0875),\n",
       "  ('countries study', 0.0856),\n",
       "  ('study demonstrated', 0.0717),\n",
       "  ('uses fruit', 0.0714),\n",
       "  ('mainly', 0.0701),\n",
       "  ('problem began', 0.0675),\n",
       "  ('associated later', 0.0606),\n",
       "  ('longer confined', 0.0598),\n",
       "  ('northern european', 0.0564),\n",
       "  ('healthy', 0.0493),\n",
       "  ('began early', 0.044),\n",
       "  ('led', 0.0341),\n",
       "  ('observations led', 0.0323),\n",
       "  ('came good', -0.0012),\n",
       "  ('changing', -0.0204),\n",
       "  ('major', -0.0227),\n",
       "  ('public', -0.0287),\n",
       "  ('uses', -0.0327),\n",
       "  ('persuade children', -0.0355),\n",
       "  ('american', -0.0457),\n",
       "  ('research seven', -0.0471),\n",
       "  ('today', -0.0561),\n",
       "  ('tell', -0.1679)],\n",
       " 'MED-1371': [('mediterranean diet', 0.4671),\n",
       "  ('adherence md', 0.4544),\n",
       "  ('diet md', 0.4162),\n",
       "  ('prevention dietary', 0.333),\n",
       "  ('md risk', 0.3255),\n",
       "  ('epidemiological evidence', 0.3116),\n",
       "  ('investigated association', 0.3062),\n",
       "  ('bc identified', 0.2888),\n",
       "  ('risk breast', 0.2797),\n",
       "  ('reduce risk', 0.2728),\n",
       "  ('md excluding', 0.2564),\n",
       "  ('premenopausal women', 0.2164),\n",
       "  ('results support', 0.2138),\n",
       "  ('regression models', 0.213),\n",
       "  ('cancer', 0.2102),\n",
       "  ('confidence interval', 0.2007),\n",
       "  ('018 estrogen', 0.1958),\n",
       "  ('studies remains', 0.1921),\n",
       "  ('ptrend 037', 0.1903),\n",
       "  ('11 years', 0.1809),\n",
       "  ('inversely associated', 0.1712),\n",
       "  ('048 hr', 0.169),\n",
       "  ('80 95', 0.164),\n",
       "  ('women association', 0.1638),\n",
       "  ('estimated adapted', 0.1631),\n",
       "  ('2012 uicc', 0.1627),\n",
       "  ('062 women', 0.1555),\n",
       "  ('modest reduced', 0.1534),\n",
       "  ('hr 93', 0.1474),\n",
       "  ('335 062', 0.1425),\n",
       "  ('european', 0.1328),\n",
       "  ('2000', 0.1191),\n",
       "  ('potential scope', 0.1138),\n",
       "  ('scarce conflicting', 0.1125),\n",
       "  ('overall', 0.1038),\n",
       "  ('countries', 0.1027),\n",
       "  ('identified 862', 0.0887),\n",
       "  ('cox proportional', 0.0881),\n",
       "  ('alcohol related', 0.0804),\n",
       "  ('invasive', 0.0766),\n",
       "  ('negative er', 0.0762),\n",
       "  ('total 009', 0.0658),\n",
       "  ('recruited 1992', 0.0645),\n",
       "  ('years average', 0.0466),\n",
       "  ('ci 65', 0.0408),\n",
       "  ('incident', 0.0297),\n",
       "  ('216', 0.0221),\n",
       "  ('high vs', -0.0253),\n",
       "  ('modification copyright', -0.0337),\n",
       "  ('armed score', -0.0622)],\n",
       " 'MED-1373': [('factors atherosclerosis', 0.6145),\n",
       "  ('oils atherosclerosis', 0.5649),\n",
       "  ('modulate endothelial', 0.4881),\n",
       "  ('inflammatory hypolipidemic', 0.4695),\n",
       "  ('endothelium involved', 0.4673),\n",
       "  ('vascular dysfunction', 0.4319),\n",
       "  ('inflammatory disease', 0.3956),\n",
       "  ('effects cardiovascular', 0.3923),\n",
       "  ('eicosanoids prostaglandins', 0.364),\n",
       "  ('olive oil', 0.3573),\n",
       "  ('dietary oils', 0.3567),\n",
       "  ('demonstrated antioxidant', 0.3211),\n",
       "  ('leukotrienes adhesion', 0.3181),\n",
       "  ('disease compounds', 0.3105),\n",
       "  ('mediterranean diet', 0.3067),\n",
       "  ('mechanisms involve', 0.2957),\n",
       "  ('tocopherols sterols', 0.2581),\n",
       "  ('anti inflammatory', 0.2559),\n",
       "  ('lipids known', 0.25),\n",
       "  ('traditional risk', 0.2345),\n",
       "  ('comparing monounsaturated', 0.2195),\n",
       "  ('specific cytokines', 0.2187),\n",
       "  ('predispose', 0.2048),\n",
       "  ('polyphenols', 0.1987),\n",
       "  ('increase expression', 0.174),\n",
       "  ('factor kappab', 0.1736),\n",
       "  ('beneficial effects', 0.1727),\n",
       "  ('triterpenoids', 0.1662),\n",
       "  ('dysfunction manifested', 0.1574),\n",
       "  ('oxygen species', 0.1553),\n",
       "  ('evidence supporting', 0.1549),\n",
       "  ('knowledge effects', 0.1505),\n",
       "  ('importance', 0.132),\n",
       "  ('activation nuclear', 0.13),\n",
       "  ('molecules firm', 0.1272),\n",
       "  ('acid rich', 0.1199),\n",
       "  ('known roles', 0.1178),\n",
       "  ('composed hydrocarbons', 0.1143),\n",
       "  ('release nitric', 0.0998),\n",
       "  ('investigated', 0.0996),\n",
       "  ('studies comparing', 0.0826),\n",
       "  ('molecules cases', 0.0816),\n",
       "  ('contained voo', 0.0774),\n",
       "  ('plasma', 0.0729),\n",
       "  ('constitute', 0.0665),\n",
       "  ('different', 0.059),\n",
       "  ('traces despite', 0.0271),\n",
       "  ('concentration non', 0.0022),\n",
       "  ('summarize current', -0.0263),\n",
       "  ('virgin', -0.0282)],\n",
       " 'MED-1374': [('mediterranean diet', 0.7),\n",
       "  ('components mediterranean', 0.5913),\n",
       "  ('definitions mediterranean', 0.5875),\n",
       "  ('unique mediterranean', 0.5364),\n",
       "  ('diet adherence', 0.5159),\n",
       "  ('dietary patterns', 0.4971),\n",
       "  ('diet linked', 0.4748),\n",
       "  ('diet health', 0.4672),\n",
       "  ('benefits dietary', 0.4398),\n",
       "  ('diet different', 0.3997),\n",
       "  ('effect diet', 0.3994),\n",
       "  ('healthy dietary', 0.3855),\n",
       "  ('reduced mortality', 0.3597),\n",
       "  ('diet overlap', 0.3585),\n",
       "  ('diet forum', 0.3478),\n",
       "  ('including reduced', 0.3212),\n",
       "  ('disease definitions', 0.3054),\n",
       "  ('patterns aspects', 0.2837),\n",
       "  ('health benefits', 0.2807),\n",
       "  ('studies components', 0.2789),\n",
       "  ('adherence', 0.2619),\n",
       "  ('mortality risk', 0.2502),\n",
       "  ('cardiovascular', 0.2242),\n",
       "  ('settings scores', 0.2225),\n",
       "  ('study health', 0.2193),\n",
       "  ('aspects unique', 0.212),\n",
       "  ('definitions', 0.1999),\n",
       "  ('number health', 0.1967),\n",
       "  ('settings study', 0.1794),\n",
       "  ('employed define', 0.1766),\n",
       "  ('components', 0.1721),\n",
       "  ('epidemiological', 0.1595),\n",
       "  ('lower incidence', 0.1532),\n",
       "  ('including', 0.1475),\n",
       "  ('scores increasingly', 0.1339),\n",
       "  ('overlap healthy', 0.1195),\n",
       "  ('constitutes', 0.1172),\n",
       "  ('lower', 0.1094),\n",
       "  ('vary', 0.0951),\n",
       "  ('geographical', 0.0948),\n",
       "  ('effect', 0.082),\n",
       "  ('risk', 0.0644),\n",
       "  ('forum article', 0.0633),\n",
       "  ('asked clinicians', 0.0582),\n",
       "  ('increasingly', 0.0548),\n",
       "  ('incidence', 0.0485),\n",
       "  ('linked number', 0.0405),\n",
       "  ('increasingly employed', 0.0132),\n",
       "  ('researchers', -0.02),\n",
       "  ('article asked', -0.0233)],\n",
       " 'MED-1375': [('vegetarian diets', 0.6227),\n",
       "  ('foods reduce', 0.5606),\n",
       "  ('reduced mortality', 0.4276),\n",
       "  ('information diet', 0.358),\n",
       "  ('consuming preferentially', 0.3559),\n",
       "  ('fats', 0.3443),\n",
       "  ('semiquantitative food', 0.342),\n",
       "  ('fp emphasized', 0.3202),\n",
       "  ('nuts cereals', 0.3003),\n",
       "  ('preference plant', 0.2761),\n",
       "  ('fruit vegetables', 0.2729),\n",
       "  ('energy adjusted', 0.2679),\n",
       "  ('better conformity', 0.264),\n",
       "  ('risk better', 0.2551),\n",
       "  ('meats meat', 0.2501),\n",
       "  ('priori defined', 0.2402),\n",
       "  ('message provegetarian', 0.2297),\n",
       "  ('mortality design', 0.2276),\n",
       "  ('potatoes positively', 0.2244),\n",
       "  ('95 ci', 0.2225),\n",
       "  ('quintiles used', 0.2201),\n",
       "  ('causes 130', 0.1991),\n",
       "  ('legumes', 0.1979),\n",
       "  ('easily understood', 0.1934),\n",
       "  ('76 cardiovascular', 0.1879),\n",
       "  ('2014', 0.1827),\n",
       "  ('frequency questionnaire', 0.1732),\n",
       "  ('conclusions omnivorous', 0.1608),\n",
       "  ('points', 0.1549),\n",
       "  ('89 conclusions', 0.1484),\n",
       "  ('negatively weighted', 0.1404),\n",
       "  ('national death', 0.1383),\n",
       "  ('range 12', 0.1344),\n",
       "  ('7216 participants', 0.1237),\n",
       "  ('society', 0.1076),\n",
       "  ('controlled trials', 0.1074),\n",
       "  ('follow period', 0.1052),\n",
       "  ('eggs fish', 0.1046),\n",
       "  ('noncancer', 0.0975),\n",
       "  ('review medical', 0.096),\n",
       "  ('com isrctn35739639', 0.0949),\n",
       "  ('products', 0.0898),\n",
       "  ('baseline yearly', 0.074),\n",
       "  ('www controlled', 0.0664),\n",
       "  ('57 women', 0.0568),\n",
       "  ('40 compared', 0.0543),\n",
       "  ('american', 0.0276),\n",
       "  ('323 deaths', 0.0271),\n",
       "  ('olive oil', 0.0152),\n",
       "  ('animal', -0.0014)],\n",
       " 'MED-1376': [('blue zones', 0.4855),\n",
       "  ('100 years', 0.3537),\n",
       "  ('people live', 0.3427),\n",
       "  ('places world', 0.3032),\n",
       "  ('activities healthy', 0.2926),\n",
       "  ('zones recently', 0.2799),\n",
       "  ('lifestyle characteristics', 0.2738),\n",
       "  ('1420 people', 0.2623),\n",
       "  ('sharing common', 0.2532),\n",
       "  ('places sardinia', 0.2488),\n",
       "  ('background places', 0.2439),\n",
       "  ('percent people', 0.2342),\n",
       "  ('people aged', 0.2225),\n",
       "  ('active past', 0.2188),\n",
       "  ('80 percent', 0.2023),\n",
       "  ('males 98', 0.1889),\n",
       "  ('day naps', 0.1852),\n",
       "  ('psychological characteristics', 0.1755),\n",
       "  ('prolonged life', 0.1695),\n",
       "  ('reported daily', 0.1688),\n",
       "  ('frequent socializing', 0.1575),\n",
       "  ('italy okinawa', 0.1476),\n",
       "  ('various', 0.1337),\n",
       "  ('greece', 0.133),\n",
       "  ('90 higher', 0.1322),\n",
       "  ('men women', 0.1269),\n",
       "  ('people ikaria', 0.1252),\n",
       "  ('costa', 0.1215),\n",
       "  ('using standard', 0.1181),\n",
       "  ('peninsula', 0.1095),\n",
       "  ('island', 0.1011),\n",
       "  ('procedures results', 0.0987),\n",
       "  ('interaction environmental', 0.0965),\n",
       "  ('higher european', 0.0949),\n",
       "  ('yrs studied', 0.0847),\n",
       "  ('linda california', 0.0795),\n",
       "  ('nicoya', 0.0736),\n",
       "  ('study methods', 0.0632),\n",
       "  ('avoidance smoking', 0.0524),\n",
       "  ('order understand', 0.0405),\n",
       "  ('voluntarily enrolled', 0.0278),\n",
       "  ('30 men', 0.0224),\n",
       "  ('rica named', 0.0181),\n",
       "  ('depression conclusion', 0.014),\n",
       "  ('livers', 0.012),\n",
       "  ('13 sample', 0.0052),\n",
       "  ('eating', 0.0036),\n",
       "  ('low rates', -0.0127),\n",
       "  ('extremely', -0.0229),\n",
       "  ('depict secrets', -0.0256)],\n",
       " 'MED-1377': [('dietary research', 0.618),\n",
       "  ('eating index', 0.4446),\n",
       "  ('lack consistency', 0.3584),\n",
       "  ('diet lower', 0.2997),\n",
       "  ('findings indicate', 0.2948),\n",
       "  ('adherence index', 0.2865),\n",
       "  ('methods used', 0.2768),\n",
       "  ('examined relationships', 0.2759),\n",
       "  ('consumed combination', 0.2691),\n",
       "  ('single nutrients', 0.264),\n",
       "  ('index 2010', 0.2606),\n",
       "  ('health study', 0.2585),\n",
       "  ('research topic', 0.2363),\n",
       "  ('indices healthy', 0.2349),\n",
       "  ('cis estimated', 0.2253),\n",
       "  ('core tenets', 0.2113),\n",
       "  ('cardiovascular disease', 0.2103),\n",
       "  ('eating plate', 0.2045),\n",
       "  ('adjusted hrs', 0.1987),\n",
       "  ('guidance focused', 0.1949),\n",
       "  ('hypertension dash', 0.1809),\n",
       "  ('124 item', 0.1807),\n",
       "  ('frequency questionnaire', 0.1758),\n",
       "  ('multiple scores', 0.1741),\n",
       "  ('76 80', 0.1619),\n",
       "  ('examined separately', 0.1414),\n",
       "  ('mediterranean', 0.1413),\n",
       "  ('823 data', 0.1312),\n",
       "  ('collective body', 0.1247),\n",
       "  ('mortality nih', 0.123),\n",
       "  ('increased attention', 0.1114),\n",
       "  ('associated 12', 0.0965),\n",
       "  ('specific deaths', 0.096),\n",
       "  ('cancer', 0.0876),\n",
       "  ('ci 73', 0.0729),\n",
       "  ('85 women', 0.067),\n",
       "  ('419 deaths', 0.0644),\n",
       "  ('28 decreased', 0.0576),\n",
       "  ('captured ahei', 0.0433),\n",
       "  ('comparing highest', 0.0418),\n",
       "  ('including federal', 0.0412),\n",
       "  ('15 follow', 0.04),\n",
       "  ('women hei', 0.0343),\n",
       "  ('23 502', 0.0193),\n",
       "  ('hampered', 0.0161),\n",
       "  ('lowest quintile', 0.0088),\n",
       "  ('harvard', -0.0066),\n",
       "  ('alternative', -0.0092),\n",
       "  ('americanized amed', -0.0423),\n",
       "  ('men', -0.0522)],\n",
       " 'MED-1378': [('longevity complex', 0.5737),\n",
       "  ('diet longevity', 0.5393),\n",
       "  ('aging foods', 0.5002),\n",
       "  ('expectancy nutrition', 0.4555),\n",
       "  ('link aging', 0.4434),\n",
       "  ('dietary factors', 0.4363),\n",
       "  ('reviews pathophysiological', 0.3964),\n",
       "  ('human health', 0.3951),\n",
       "  ('extending life', 0.3773),\n",
       "  ('life expectancy', 0.3714),\n",
       "  ('complex phenomenon', 0.3615),\n",
       "  ('epigenetic effects', 0.3426),\n",
       "  ('influence physiological', 0.3424),\n",
       "  ('overall mortality', 0.3139),\n",
       "  ('calorie restriction', 0.3113),\n",
       "  ('effects morbidities', 0.2974),\n",
       "  ('socio economic', 0.2862),\n",
       "  ('phenomenon environmental', 0.2745),\n",
       "  ('factors influence', 0.2664),\n",
       "  ('impact overall', 0.2606),\n",
       "  ('pathways', 0.2583),\n",
       "  ('oxidative', 0.2389),\n",
       "  ('important moderator', 0.2267),\n",
       "  ('scientific research', 0.2216),\n",
       "  ('mediterranean', 0.2195),\n",
       "  ('extensive', 0.2085),\n",
       "  ('chocolate', 0.1843),\n",
       "  ('inflammatory properties', 0.1783),\n",
       "  ('probiotics', 0.167),\n",
       "  ('populations furthermore', 0.1565),\n",
       "  ('components additionally', 0.1456),\n",
       "  ('recognized important', 0.1301),\n",
       "  ('remains', 0.1197),\n",
       "  ('nuts', 0.1167),\n",
       "  ('prebiotics attracted', 0.1158),\n",
       "  ('supporting anti', 0.089),\n",
       "  ('higher financial', 0.0879),\n",
       "  ('behavioral', 0.0762),\n",
       "  ('2013 elsevier', 0.0756),\n",
       "  ('closely related', 0.0746),\n",
       "  ('traditional', 0.0745),\n",
       "  ('beans avocados', 0.0735),\n",
       "  ('cost closely', 0.0464),\n",
       "  ('educational', 0.0186),\n",
       "  ('individual', 0.0183),\n",
       "  ('orange juice', -0.0052),\n",
       "  ('dark', -0.0232),\n",
       "  ('copyright', -0.0419),\n",
       "  ('red', -0.0719),\n",
       "  ('ireland', -0.0936)],\n",
       " 'MED-1380': [('mediterranean diet', 0.5296),\n",
       "  ('cancer nutrition', 0.4109),\n",
       "  ('epic participants', 0.3561),\n",
       "  ('health effects', 0.3511),\n",
       "  ('adjusted mortality', 0.3214),\n",
       "  ('increased adherence', 0.3038),\n",
       "  ('inverse association', 0.2929),\n",
       "  ('segment european', 0.2621),\n",
       "  ('men women', 0.2555),\n",
       "  ('objective investigate', 0.255),\n",
       "  ('prospective cohort', 0.2528),\n",
       "  ('enrolment main', 0.2444),\n",
       "  ('increase mortality', 0.2439),\n",
       "  ('important covariates', 0.2435),\n",
       "  ('study setting', 0.2431),\n",
       "  ('diet generating', 0.2425),\n",
       "  ('setting greek', 0.2362),\n",
       "  ('disease diabetes', 0.2313),\n",
       "  ('seafood intake', 0.2277),\n",
       "  ('lower mortality', 0.2179),\n",
       "  ('consumption 23', 0.2169),\n",
       "  ('coronary heart', 0.2086),\n",
       "  ('contributions cereals', 0.2047),\n",
       "  ('nuts olive', 0.1821),\n",
       "  ('652 deaths', 0.1797),\n",
       "  ('saturated lipid', 0.1755),\n",
       "  ('dairy consumption', 0.1709),\n",
       "  ('802 932', 0.1653),\n",
       "  ('consumption meat', 0.165),\n",
       "  ('ethanol consumption', 0.1629),\n",
       "  ('349 men', 0.1602),\n",
       "  ('moderate consumption', 0.1579),\n",
       "  ('cause occurred', 0.1552),\n",
       "  ('consumption 16', 0.1517),\n",
       "  ('confidence interval', 0.1491),\n",
       "  ('results mean', 0.1405),\n",
       "  ('survival status', 0.1372),\n",
       "  ('consumption vegetables', 0.1354),\n",
       "  ('possibly heterogeneous', 0.1148),\n",
       "  ('423', 0.1121),\n",
       "  ('previously diagnosed', 0.0835),\n",
       "  ('minimal contributions', 0.0722),\n",
       "  ('occurred 12', 0.0522),\n",
       "  ('high fish', 0.0366),\n",
       "  ('score 864', 0.0244),\n",
       "  ('individual', 0.0209),\n",
       "  ('years', 0.0203),\n",
       "  ('legumes', 0.0187),\n",
       "  ('ratio 10', -0.0311),\n",
       "  ('june 2008', -0.0515)],\n",
       " 'MED-1381': [('effect nuts', 0.64),\n",
       "  ('nut consumption', 0.6261),\n",
       "  ('populations nuts', 0.5525),\n",
       "  ('nuts similar', 0.4996),\n",
       "  ('nuts ihd', 0.4967),\n",
       "  ('past nut', 0.4877),\n",
       "  ('elderly nut', 0.4474),\n",
       "  ('frequency nut', 0.4349),\n",
       "  ('findings nutritional', 0.3865),\n",
       "  ('based diets', 0.3815),\n",
       "  ('higher vegetarian', 0.3292),\n",
       "  ('consumption protect', 0.3166),\n",
       "  ('associations vegetarians', 0.3056),\n",
       "  ('consumption inversely', 0.2818),\n",
       "  ('novel findings', 0.2685),\n",
       "  ('diets mediterranean', 0.2647),\n",
       "  ('important plant', 0.2592),\n",
       "  ('consumption substantial', 0.2561),\n",
       "  ('decreased risk', 0.23),\n",
       "  ('similar associations', 0.2299),\n",
       "  ('protective effect', 0.2156),\n",
       "  ('epidemiology past', 0.2087),\n",
       "  ('nonvegetarian populations', 0.2075),\n",
       "  ('women health', 0.1897),\n",
       "  ('constitute important', 0.1767),\n",
       "  ('documented higher', 0.1502),\n",
       "  ('ihd increase', 0.1472),\n",
       "  ('related cause', 0.1443),\n",
       "  ('frequency quantity', 0.1298),\n",
       "  ('increase longevity', 0.1254),\n",
       "  ('based', 0.1247),\n",
       "  ('study', 0.1097),\n",
       "  ('mortality causes', 0.1069),\n",
       "  ('day adventists', 0.0966),\n",
       "  ('heart', 0.0897),\n",
       "  ('elderly importantly', 0.0883),\n",
       "  ('seventh day', 0.0862),\n",
       "  ('protect ischemic', 0.0837),\n",
       "  ('iowa', 0.0796),\n",
       "  ('asian', 0.0705),\n",
       "  ('myocardial infarction', 0.0678),\n",
       "  ('offset increased', 0.0559),\n",
       "  ('populations', 0.0527),\n",
       "  ('groups whites', 0.0271),\n",
       "  ('large prospective', 0.0084),\n",
       "  ('inverse', 0.002),\n",
       "  ('men', -0.0034),\n",
       "  ('offer', -0.0495),\n",
       "  ('california', -0.0578),\n",
       "  ('blacks', -0.0908)],\n",
       " 'MED-1383': [('intake antioxidant', 0.5916),\n",
       "  ('dietary intervention', 0.4787),\n",
       "  ('neac analyzed', 0.443),\n",
       "  ('baseline neac', 0.4299),\n",
       "  ('cardiovascular risk', 0.3682),\n",
       "  ('frap levels', 0.3344),\n",
       "  ('rich foods', 0.33),\n",
       "  ('aims intake', 0.3174),\n",
       "  ('increase blood', 0.3123),\n",
       "  ('mediterranean', 0.2946),\n",
       "  ('levels intervention', 0.2922),\n",
       "  ('effects examined', 0.2691),\n",
       "  ('baseline significantly', 0.2686),\n",
       "  ('supplemented', 0.2598),\n",
       "  ('low fat', 0.2437),\n",
       "  ('significantly increased', 0.226),\n",
       "  ('diet 13', 0.2258),\n",
       "  ('μmol 95', 0.2243),\n",
       "  ('med nuts', 0.218),\n",
       "  ('synergistic effects', 0.2155),\n",
       "  ('background aims', 0.2061),\n",
       "  ('predimed prevención', 0.2029),\n",
       "  ('assays plasma', 0.1973),\n",
       "  ('participants high', 0.1841),\n",
       "  ('μmol 11', 0.18),\n",
       "  ('disease effectiveness', 0.1606),\n",
       "  ('study large', 0.1601),\n",
       "  ('mediterránea study', 0.1577),\n",
       "  ('randomized clinical', 0.1516),\n",
       "  ('ferric reducing', 0.1513),\n",
       "  ('oil', 0.1488),\n",
       "  ('non enzymatic', 0.1359),\n",
       "  ('total radical', 0.1316),\n",
       "  ('39 participants', 0.1238),\n",
       "  ('takes account', 0.1196),\n",
       "  ('tac level', 0.115),\n",
       "  ('reducing', 0.0818),\n",
       "  ('virgin olive', 0.0675),\n",
       "  ('48 μmol', 0.0647),\n",
       "  ('109', 0.0615),\n",
       "  ('similar results', 0.0566),\n",
       "  ('potential trap', 0.0536),\n",
       "  ('voo 72', 0.0499),\n",
       "  ('elsevier rights', 0.0484),\n",
       "  ('quartile', 0.0466),\n",
       "  ('ci 34', 0.0455),\n",
       "  ('shows year', 0.0293),\n",
       "  ('rights', -0.0055),\n",
       "  ('arm', -0.0105),\n",
       "  ('randomly', -0.052)],\n",
       " 'MED-1386': [('walnuts impact', 0.5964),\n",
       "  ('reduce cancer', 0.5094),\n",
       "  ('affect cancer', 0.5041),\n",
       "  ('inflammation development', 0.4488),\n",
       "  ('risk cancer', 0.4427),\n",
       "  ('chronic diseases', 0.4368),\n",
       "  ('cancer initiated', 0.4359),\n",
       "  ('cancer diabetes', 0.3882),\n",
       "  ('obesity emerging', 0.3827),\n",
       "  ('implicated etiology', 0.3234),\n",
       "  ('epidemiological suggests', 0.2955),\n",
       "  ('biomarkers', 0.2939),\n",
       "  ('disease particularly', 0.287),\n",
       "  ('nutrition research', 0.2848),\n",
       "  ('facilitating healthful', 0.2694),\n",
       "  ('progresses implicated', 0.2346),\n",
       "  ('consumption reduced', 0.2266),\n",
       "  ('prevention effect', 0.2262),\n",
       "  ('evidence primarily', 0.2231),\n",
       "  ('cardiovascular', 0.21),\n",
       "  ('risk explored', 0.2068),\n",
       "  ('diet encouraging', 0.2043),\n",
       "  ('published literature', 0.2),\n",
       "  ('visceral', 0.1925),\n",
       "  ('conditions affect', 0.1869),\n",
       "  ('advice strategies', 0.1844),\n",
       "  ('consumption', 0.1765),\n",
       "  ('critical message', 0.1711),\n",
       "  ('mortality', 0.1646),\n",
       "  ('trials needed', 0.1569),\n",
       "  ('affect', 0.1445),\n",
       "  ('patterns reduce', 0.1435),\n",
       "  ('prognosis type', 0.1178),\n",
       "  ('particularly context', 0.1175),\n",
       "  ('plant based', 0.1145),\n",
       "  ('potential', 0.1134),\n",
       "  ('based', 0.111),\n",
       "  ('mediterranean diet', 0.1087),\n",
       "  ('positive effects', 0.1039),\n",
       "  ('documents associations', 0.0975),\n",
       "  ('behavior paper', 0.0923),\n",
       "  ('explore', 0.0877),\n",
       "  ('needed better', 0.0692),\n",
       "  ('connections', 0.0434),\n",
       "  ('follow human', 0.0323),\n",
       "  ('emerging human', 0.0315),\n",
       "  ('translation application', -0.0122),\n",
       "  ('public individualized', -0.0144),\n",
       "  ('se humans', -0.0565),\n",
       "  ('humans far', -0.0847)],\n",
       " 'MED-1387': [('nuts diabetes', 0.5424),\n",
       "  ('inverse association', 0.4906),\n",
       "  ('relation nut', 0.4197),\n",
       "  ('intake inversely', 0.4091),\n",
       "  ('studies published', 0.3647),\n",
       "  ('diabetes attenuated', 0.3567),\n",
       "  ('8862 cvd', 0.3566),\n",
       "  ('cardiovascular disease', 0.3442),\n",
       "  ('dietary pattern', 0.3373),\n",
       "  ('chronic diseases', 0.3219),\n",
       "  ('background epidemiologic', 0.3214),\n",
       "  ('pooled rrs', 0.3131),\n",
       "  ('assessed relation', 0.3109),\n",
       "  ('rrs 95', 0.3018),\n",
       "  ('mortality design', 0.2699),\n",
       "  ('association consumption', 0.2697),\n",
       "  ('searched', 0.2639),\n",
       "  ('attenuated rr', 0.2575),\n",
       "  ('effects model', 0.2527),\n",
       "  ('multivariable adjusted', 0.2422),\n",
       "  ('random effects', 0.2388),\n",
       "  ('mass index', 0.2119),\n",
       "  ('diabetes 66', 0.1935),\n",
       "  ('cohort', 0.1803),\n",
       "  ('02 ns', 0.1738),\n",
       "  ('objective', 0.1674),\n",
       "  ('embase', 0.1614),\n",
       "  ('published march', 0.1418),\n",
       "  ('pattern prevention', 0.1417),\n",
       "  ('adjustment body', 0.137),\n",
       "  ('risk', 0.1362),\n",
       "  ('conclusions', 0.1194),\n",
       "  ('meta', 0.1181),\n",
       "  ('655 type', 0.1133),\n",
       "  ('16 ns', 0.1071),\n",
       "  ('stroke 85', 0.1054),\n",
       "  ('ihd overall', 0.0976),\n",
       "  ('incremental serving', 0.0962),\n",
       "  ('818 mortality', 0.0924),\n",
       "  ('cis serving', 0.0921),\n",
       "  ('reports 18', 0.0858),\n",
       "  ('ischemic heart', 0.0853),\n",
       "  ('60', 0.0809),\n",
       "  ('84 19', 0.0723),\n",
       "  ('12', 0.0707),\n",
       "  ('6623 ischemic', 0.013),\n",
       "  ('used pool', 0.0125),\n",
       "  ('2014 american', 0.009),\n",
       "  ('31 reports', 0.007),\n",
       "  ('extreme quantiles', -0.0294)],\n",
       " 'MED-1388': [('nut consumption', 0.4265),\n",
       "  ('spanish cohort', 0.4203),\n",
       "  ('cohort study', 0.3736),\n",
       "  ('mortality assessed', 0.2924),\n",
       "  ('consumption cause', 0.277),\n",
       "  ('sun seguimiento', 0.2757),\n",
       "  ('aim study', 0.2452),\n",
       "  ('analyses adjusted', 0.2441),\n",
       "  ('assess association', 0.2428),\n",
       "  ('university navarra', 0.2205),\n",
       "  ('participants followed', 0.2191),\n",
       "  ('participants consumed', 0.2191),\n",
       "  ('significantly associated', 0.2097),\n",
       "  ('universidad', 0.1985),\n",
       "  ('quantitative food', 0.1972),\n",
       "  ('wk analyses', 0.194),\n",
       "  ('index association', 0.1897),\n",
       "  ('energy adjusted', 0.1849),\n",
       "  ('analysis participants', 0.1825),\n",
       "  ('method used', 0.1704),\n",
       "  ('hazards models', 0.1634),\n",
       "  ('95 confidence', 0.1577),\n",
       "  ('residuals method', 0.1478),\n",
       "  ('associated reduced', 0.1465),\n",
       "  ('follow project', 0.1463),\n",
       "  ('used second', 0.1443),\n",
       "  ('86 conclusion', 0.1428),\n",
       "  ('using validated', 0.1416),\n",
       "  ('servings servings', 0.1338),\n",
       "  ('confounding factors', 0.131),\n",
       "  ('total', 0.1284),\n",
       "  ('using cox', 0.1227),\n",
       "  ('quintiles', 0.1093),\n",
       "  ('graduates', 0.0971),\n",
       "  ('elsevier rights', 0.0963),\n",
       "  ('baseline', 0.0947),\n",
       "  ('authorities national', 0.0942),\n",
       "  ('mailed questionnaires', 0.0906),\n",
       "  ('formed', 0.089),\n",
       "  ('families', 0.0873),\n",
       "  ('information', 0.0873),\n",
       "  ('intervals', 0.084),\n",
       "  ('self', 0.0727),\n",
       "  ('postal', 0.0692),\n",
       "  ('17 184', 0.0478),\n",
       "  ('collected biennially', 0.0455),\n",
       "  ('rights', 0.0168),\n",
       "  ('copyright 2014', 0.0155),\n",
       "  ('collected permanent', -0.0182),\n",
       "  ('23', -0.0222)],\n",
       " 'MED-1389': [('metabolic syndrome', 0.6239),\n",
       "  ('mets management', 0.5118),\n",
       "  ('adherence mediterranean', 0.4279),\n",
       "  ('mets aged', 0.4202),\n",
       "  ('risk diabetes', 0.4133),\n",
       "  ('systemic oxidative', 0.409),\n",
       "  ('meddiet groups', 0.3653),\n",
       "  ('dna mets', 0.3531),\n",
       "  ('reduces oxidative', 0.3514),\n",
       "  ('prevention cvd', 0.3484),\n",
       "  ('damage lipids', 0.3257),\n",
       "  ('mets non', 0.3241),\n",
       "  ('low fat', 0.3064),\n",
       "  ('biomarkers presents', 0.2943),\n",
       "  ('diets ad', 0.2439),\n",
       "  ('disease', 0.2249),\n",
       "  ('background aims', 0.2178),\n",
       "  ('f2 isoprostane', 0.2167),\n",
       "  ('evidence recommend', 0.2083),\n",
       "  ('predimed study', 0.2021),\n",
       "  ('001 conclusions', 0.1713),\n",
       "  ('increase systemic', 0.158),\n",
       "  ('changes', 0.1571),\n",
       "  ('borderline significance', 0.1525),\n",
       "  ('high risk', 0.1503),\n",
       "  ('deoxyguanosine', 0.1496),\n",
       "  ('european', 0.1496),\n",
       "  ('identifier nct00123456', 0.1435),\n",
       "  ('recommend traditional', 0.1247),\n",
       "  ('nuts', 0.1221),\n",
       "  ('aged 55', 0.1194),\n",
       "  ('society', 0.1106),\n",
       "  ('individuals investigated', 0.1059),\n",
       "  ('groups versus', 0.1047),\n",
       "  ('higher decrease', 0.1021),\n",
       "  ('management registered', 0.1016),\n",
       "  ('damage base', 0.0914),\n",
       "  ('week', 0.0875),\n",
       "  ('oxo dihydro', 0.0635),\n",
       "  ('classic feature', 0.0624),\n",
       "  ('olive oil', 0.0542),\n",
       "  ('urine levels', 0.0522),\n",
       "  ('rights reserved', 0.0424),\n",
       "  ('participants received', 0.0317),\n",
       "  ('30 day', 0.0169),\n",
       "  ('2012 elsevier', -0.0031),\n",
       "  ('controlled parallel', -0.0066),\n",
       "  ('education free', -0.0175),\n",
       "  ('110 female', -0.0194),\n",
       "  ('extra virgin', -0.1073)],\n",
       " 'MED-1390': [('olive oil', 0.5143),\n",
       "  ('mediterranean population', 0.4376),\n",
       "  ('oil risk', 0.34),\n",
       "  ('cardiovascular mortality', 0.3069),\n",
       "  ('consumption associated', 0.2439),\n",
       "  ('significant associations', 0.243),\n",
       "  ('323 deaths', 0.2218),\n",
       "  ('men women', 0.2113),\n",
       "  ('aim assess', 0.2078),\n",
       "  ('cohort study', 0.2048),\n",
       "  ('low fat', 0.1834),\n",
       "  ('80 years', 0.1802),\n",
       "  ('adjusted tertile', 0.1757),\n",
       "  ('energy adjusted', 0.1693),\n",
       "  ('population high', 0.1674),\n",
       "  ('death index', 0.1565),\n",
       "  ('background unknown', 0.1541),\n",
       "  ('intervention groups', 0.152),\n",
       "  ('aged', 0.1319),\n",
       "  ('multivariate cox', 0.128),\n",
       "  ('questionnaires multivariate', 0.126),\n",
       "  ('disease increased', 0.1238),\n",
       "  ('virgin common', 0.1182),\n",
       "  ('included 216', 0.1075),\n",
       "  ('conducted observational', 0.1067),\n",
       "  ('reduced risk', 0.1011),\n",
       "  ('present analysis', 0.0967),\n",
       "  ('specifically extra', 0.0963),\n",
       "  ('trials com', 0.0915),\n",
       "  ('reference higher', 0.0905),\n",
       "  ('cancer', 0.0858),\n",
       "  ('prevención', 0.0836),\n",
       "  ('35 hr', 0.0827),\n",
       "  ('predimed study', 0.0774),\n",
       "  ('mediterránea predimed', 0.0755),\n",
       "  ('61 95', 0.0751),\n",
       "  ('variety', 0.0743),\n",
       "  ('48 hr', 0.0702),\n",
       "  ('nuts', 0.0623),\n",
       "  ('medical records', 0.0542),\n",
       "  ('hazards generalized', 0.0523),\n",
       "  ('international standard', 0.0506),\n",
       "  ('infarction', 0.0493),\n",
       "  ('isrctn35739639', 0.0274),\n",
       "  ('median', 0.0198),\n",
       "  ('sustain benefit', 0.0169),\n",
       "  ('http www', 0.0056),\n",
       "  ('yearly repeated', -0.0149),\n",
       "  ('october 2005', -0.0673),\n",
       "  ('ci 29', -0.1097)],\n",
       " 'MED-1393': [('mediterranean diet', 0.5721),\n",
       "  ('meddiet nuts', 0.4829),\n",
       "  ('diet mechanisms', 0.4424),\n",
       "  ('reduction cardiovascular', 0.4371),\n",
       "  ('mediterránea predimed', 0.3942),\n",
       "  ('afforded meddiets', 0.3915),\n",
       "  ('plaque meddiet', 0.3879),\n",
       "  ('meddiets remain', 0.3724),\n",
       "  ('low fat', 0.3591),\n",
       "  ('intervention mean', 0.2966),\n",
       "  ('predimed trial', 0.2918),\n",
       "  ('control diet', 0.2913),\n",
       "  ('trials com', 0.2445),\n",
       "  ('conclusions compared', 0.2368),\n",
       "  ('mixed nuts', 0.2127),\n",
       "  ('158', 0.1958),\n",
       "  ('prevención', 0.194),\n",
       "  ('intima media', 0.1822),\n",
       "  ('contribute mechanistic', 0.1785),\n",
       "  ('mm regressed', 0.1693),\n",
       "  ('imt control', 0.1646),\n",
       "  ('confidence interval', 0.1643),\n",
       "  ('034 maximum', 0.157),\n",
       "  ('multivariate model', 0.1476),\n",
       "  ('175 plaque', 0.1458),\n",
       "  ('052 mm', 0.1448),\n",
       "  ('bifurcation common', 0.1404),\n",
       "  ('associated delayed', 0.1361),\n",
       "  ('virgin olive', 0.1279),\n",
       "  ('group 084', 0.1254),\n",
       "  ('protection afforded', 0.1245),\n",
       "  ('assessed baseline', 0.124),\n",
       "  ('high cardiovascular', 0.1202),\n",
       "  ('remain uncovered', 0.1192),\n",
       "  ('com unique', 0.1171),\n",
       "  ('010', 0.113),\n",
       "  ('supplemented extra', 0.1058),\n",
       "  ('153 093', 0.0958),\n",
       "  ('identifier isrctn35739639', 0.0918),\n",
       "  ('30', 0.0874),\n",
       "  ('events observed', 0.0756),\n",
       "  ('changes ica', 0.0748),\n",
       "  ('164 subjects', 0.0634),\n",
       "  ('mean years', 0.0453),\n",
       "  ('ultrasound features', 0.0403),\n",
       "  ('features best', 0.0266),\n",
       "  ('subcohort', 0.0204),\n",
       "  ('206', 0.0082),\n",
       "  ('complete data', 0.0018),\n",
       "  ('url', -0.0202)],\n",
       " 'MED-1394': [('mediterranean diet', 0.546),\n",
       "  ('randomized trial', 0.4072),\n",
       "  ('inverse association', 0.3722),\n",
       "  ('events diet', 0.3305),\n",
       "  ('prevention cardiovascular', 0.3193),\n",
       "  ('control diet', 0.3106),\n",
       "  ('cohort studies', 0.3024),\n",
       "  ('spain randomly', 0.2951),\n",
       "  ('reduce dietary', 0.295),\n",
       "  ('fat participants', 0.2921),\n",
       "  ('association adherence', 0.2796),\n",
       "  ('secondary prevention', 0.2672),\n",
       "  ('methods multicenter', 0.2585),\n",
       "  ('multivariable adjusted', 0.2543),\n",
       "  ('95 ci', 0.2401),\n",
       "  ('background observational', 0.2318),\n",
       "  ('reduced incidence', 0.2108),\n",
       "  ('myocardial infarction', 0.2077),\n",
       "  ('analyses primary', 0.1973),\n",
       "  ('salud carlos', 0.1964),\n",
       "  ('median follow', 0.1962),\n",
       "  ('288 participants', 0.1863),\n",
       "  ('intake biomarker', 0.1825),\n",
       "  ('effects reported', 0.1743),\n",
       "  ('persons enrolled', 0.1666),\n",
       "  ('events methods', 0.1629),\n",
       "  ('disease', 0.1522),\n",
       "  ('isrctn35739639', 0.1305),\n",
       "  ('ci 54', 0.1269),\n",
       "  ('80 years', 0.1052),\n",
       "  ('iii controlled', 0.105),\n",
       "  ('mixed nuts', 0.1042),\n",
       "  ('57 women', 0.0943),\n",
       "  ('depending group', 0.0914),\n",
       "  ('virgin olive', 0.0856),\n",
       "  ('109 events', 0.0741),\n",
       "  ('oil 96', 0.0555),\n",
       "  ('received quarterly', 0.0554),\n",
       "  ('respectively versus', 0.0539),\n",
       "  ('educational sessions', 0.0517),\n",
       "  ('point event', 0.0494),\n",
       "  ('assignment free', 0.0305),\n",
       "  ('supplemented extra', 0.0286),\n",
       "  ('persons high', 0.0233),\n",
       "  ('government', 0.0117),\n",
       "  ('com number', 0.0106),\n",
       "  ('self', 0.001),\n",
       "  ('nonfood gifts', -0.0062),\n",
       "  ('ratios 70', -0.0602),\n",
       "  ('good', -0.0675)],\n",
       " 'MED-1395': [('trial compared', 0.4797),\n",
       "  ('prospective randomised', 0.446),\n",
       "  ('diet myocardial', 0.4241),\n",
       "  ('main endpoints', 0.4065),\n",
       "  ('experimental group', 0.4051),\n",
       "  ('experimental 302', 0.3806),\n",
       "  ('patients randomly', 0.3741),\n",
       "  ('prevention coronary', 0.3685),\n",
       "  ('myocardial infarction', 0.3666),\n",
       "  ('mediterranean diet', 0.3659),\n",
       "  ('303 patients', 0.3335),\n",
       "  ('diet usual', 0.294),\n",
       "  ('randomisation year', 0.2926),\n",
       "  ('cardiac deaths', 0.2893),\n",
       "  ('infarct prudent', 0.2696),\n",
       "  ('overall mortality', 0.2687),\n",
       "  ('serum lipids', 0.2523),\n",
       "  ('alpha linolenic', 0.2486),\n",
       "  ('weeks', 0.2305),\n",
       "  ('increased granulocyte', 0.2255),\n",
       "  ('main', 0.2225),\n",
       "  ('diets secondary', 0.2215),\n",
       "  ('patients seen', 0.218),\n",
       "  ('acids confirmed', 0.2083),\n",
       "  ('prognostic variables', 0.2034),\n",
       "  ('control group', 0.2012),\n",
       "  ('mean follow', 0.2003),\n",
       "  ('deaths control', 0.1943),\n",
       "  ('vitamin increased', 0.1865),\n",
       "  ('16 cardiac', 0.1825),\n",
       "  ('mortality 20', 0.1781),\n",
       "  ('body mass', 0.1631),\n",
       "  ('single blinded', 0.146),\n",
       "  ('non fatal', 0.1397),\n",
       "  ('ci 12', 0.137),\n",
       "  ('001', 0.1358),\n",
       "  ('consumed significantly', 0.1309),\n",
       "  ('adjusted', 0.1287),\n",
       "  ('blood pressure', 0.1254),\n",
       "  ('95 ci', 0.1206),\n",
       "  ('rich', 0.1197),\n",
       "  ('groups risk', 0.119),\n",
       "  ('measurements plasma', 0.1123),\n",
       "  ('index remained', 0.1053),\n",
       "  ('efficient presently', 0.1023),\n",
       "  ('82', 0.095),\n",
       "  ('events', 0.074),\n",
       "  ('59 001', 0.0537),\n",
       "  ('count decreased', -0.0027),\n",
       "  ('combined 27', -0.0074)],\n",
       " 'MED-1397': [('omega pufas', 0.57),\n",
       "  ('plants rich', 0.55),\n",
       "  ('high antioxidants', 0.5491),\n",
       "  ('vitamins edible', 0.5447),\n",
       "  ('antioxidants edible', 0.5432),\n",
       "  ('pufa high', 0.4907),\n",
       "  ('evolved diet', 0.4499),\n",
       "  ('fat vegans', 0.4425),\n",
       "  ('human nutrition', 0.4399),\n",
       "  ('vitamin cultivated', 0.3831),\n",
       "  ('ala plant', 0.3735),\n",
       "  ('linoleic', 0.3689),\n",
       "  ('wild plants', 0.3665),\n",
       "  ('diet omnivores', 0.3579),\n",
       "  ('high intake', 0.3578),\n",
       "  ('beings evolved', 0.3192),\n",
       "  ('acids', 0.3175),\n",
       "  ('important metabolism', 0.2836),\n",
       "  ('compounds increase', 0.2594),\n",
       "  ('body fat', 0.2574),\n",
       "  ('vegans', 0.2346),\n",
       "  ('cholesterol increases', 0.1978),\n",
       "  ('regulation arachidonic', 0.1774),\n",
       "  ('advantage consumption', 0.169),\n",
       "  ('phenols', 0.1677),\n",
       "  ('oxidative modification', 0.1525),\n",
       "  ('contained increasingly', 0.1498),\n",
       "  ('provide alpha', 0.1438),\n",
       "  ('intake does', 0.1334),\n",
       "  ('countries contained', 0.1273),\n",
       "  ('balanced', 0.1117),\n",
       "  ('important terms', 0.106),\n",
       "  ('fish', 0.0936),\n",
       "  ('reserves', 0.0913),\n",
       "  ('wild', 0.0838),\n",
       "  ('long term', 0.0783),\n",
       "  ('prospective epidemiological', 0.0657),\n",
       "  ('contributed', 0.0635),\n",
       "  ('ala inversely', 0.0537),\n",
       "  ('la favors', 0.0496),\n",
       "  ('western societies', 0.0479),\n",
       "  ('aggregation contrast', 0.0467),\n",
       "  ('exist', 0.0435),\n",
       "  ('heart disease', 0.0433),\n",
       "  ('effect recognized', 0.0393),\n",
       "  ('response thrombin', 0.0046),\n",
       "  ('lowering blood', -0.0061),\n",
       "  ('systematically analyze', -0.0212),\n",
       "  ('men', -0.0262),\n",
       "  ('problem insufficient', -0.0677)],\n",
       " 'MED-1398': [('lower cvd', 0.5469),\n",
       "  ('mediterranean diet', 0.5323),\n",
       "  ('mediterranean populations', 0.4074),\n",
       "  ('epidemiological studies', 0.3855),\n",
       "  ('cvd proposed', 0.3778),\n",
       "  ('studies reported', 0.3579),\n",
       "  ('associations lower', 0.3463),\n",
       "  ('significant reduction', 0.344),\n",
       "  ('proposed 1950s', 0.3336),\n",
       "  ('cardiovascular complications', 0.3304),\n",
       "  ('diet heart', 0.3186),\n",
       "  ('diet 2013', 0.2894),\n",
       "  ('heart study', 0.2851),\n",
       "  ('reported associations', 0.2737),\n",
       "  ('pharmacological approach', 0.252),\n",
       "  ('1999 reports', 0.2516),\n",
       "  ('low risk', 0.2479),\n",
       "  ('modern version', 0.2313),\n",
       "  ('1994', 0.2153),\n",
       "  ('final analyses', 0.214),\n",
       "  ('nonfatal', 0.2138),\n",
       "  ('overall mortality', 0.2103),\n",
       "  ('non mediterranean', 0.2015),\n",
       "  ('inverse association', 0.2011),\n",
       "  ('study 2003', 0.1992),\n",
       "  ('prevention fatal', 0.1792),\n",
       "  ('evidence based', 0.1739),\n",
       "  ('large epidemiological', 0.1666),\n",
       "  ('approaches', 0.1604),\n",
       "  ('associated significant', 0.1528),\n",
       "  ('medicine', 0.1404),\n",
       "  ('trial', 0.1389),\n",
       "  ('prevention adoption', 0.135),\n",
       "  ('score risk', 0.1175),\n",
       "  ('considered effective', 0.1172),\n",
       "  ('disease', 0.1154),\n",
       "  ('controlled', 0.1123),\n",
       "  ('study greece', 0.1071),\n",
       "  ('2012 reports', 0.0997),\n",
       "  ('concept', 0.0908),\n",
       "  ('lyon', 0.0895),\n",
       "  ('pattern considered', 0.0883),\n",
       "  ('benefits long', 0.0748),\n",
       "  ('predimed', 0.0639),\n",
       "  ('new cancers', 0.057),\n",
       "  ('complications 2011', 0.0488),\n",
       "  ('population contrary', 0.037),\n",
       "  ('intermediate', 0.0237),\n",
       "  ('term adhesion', -0.0027),\n",
       "  ('populations gain', -0.0607)],\n",
       " 'MED-1399': [('cardioprotective diet', 0.4434),\n",
       "  ('prevention trial', 0.411),\n",
       "  ('heart study', 0.37),\n",
       "  ('study randomized', 0.3669),\n",
       "  ('myocardial infarction', 0.329),\n",
       "  ('46 months', 0.3265),\n",
       "  ('modifiable risk', 0.3225),\n",
       "  ('mortality include', 0.3197),\n",
       "  ('factors recurrence', 0.2774),\n",
       "  ('decrease cardiovascular', 0.277),\n",
       "  ('months patient', 0.2692),\n",
       "  ('27 months', 0.2546),\n",
       "  ('background lyon', 0.2414),\n",
       "  ('studied mediterranean', 0.237),\n",
       "  ('nonfatal', 0.2295),\n",
       "  ('maintained years', 0.2277),\n",
       "  ('presents results', 0.2212),\n",
       "  ('striking protective', 0.2204),\n",
       "  ('associated pharmacological', 0.2171),\n",
       "  ('cholesterol mmol', 0.2107),\n",
       "  ('reduced 14', 0.2073),\n",
       "  ('major secondary', 0.2071),\n",
       "  ('mm hg', 0.2023),\n",
       "  ('follow mean', 0.1932),\n",
       "  ('minor events', 0.1887),\n",
       "  ('44 prudent', 0.1884),\n",
       "  ('composite outcomes', 0.185),\n",
       "  ('comprehensive strategy', 0.1818),\n",
       "  ('hospital', 0.1662),\n",
       "  ('combining cardiac', 0.1661),\n",
       "  ('risk 18', 0.1658),\n",
       "  ('previous intermediate', 0.1551),\n",
       "  ('aimed testing', 0.155),\n",
       "  ('studied', 0.1447),\n",
       "  ('include primarily', 0.1391),\n",
       "  ('did alter', 0.1121),\n",
       "  ('associated increased', 0.1058),\n",
       "  ('95 events', 0.1048),\n",
       "  ('significantly independently', 0.101),\n",
       "  ('group 0001', 0.0934),\n",
       "  ('59 82', 0.09),\n",
       "  ('leukocyte count', 0.0893),\n",
       "  ('sex adjusted', 0.0889),\n",
       "  ('peripheral embolism', 0.0558),\n",
       "  ('versus 180', 0.0494),\n",
       "  ('ranging 64', 0.0462),\n",
       "  ('53 traditional', 0.024),\n",
       "  ('deals relationships', -0.0003),\n",
       "  ('western type', -0.0209),\n",
       "  ('9x10 female', -0.0352)],\n",
       " 'MED-1400': [('mediterranean diet', 0.5633),\n",
       "  ('diet health', 0.4242),\n",
       "  ('studies included', 0.4195),\n",
       "  ('meta analysis', 0.4158),\n",
       "  ('updated meta', 0.3822),\n",
       "  ('aimed update', 0.3715),\n",
       "  ('health outcomes', 0.3561),\n",
       "  ('studies showed', 0.3352),\n",
       "  ('mortality studies', 0.3279),\n",
       "  ('investigated effects', 0.3222),\n",
       "  ('literature search', 0.3205),\n",
       "  ('review process', 0.3144),\n",
       "  ('included previous', 0.3097),\n",
       "  ('conducted inclusion', 0.2926),\n",
       "  ('diseases recent', 0.2893),\n",
       "  ('provided adherence', 0.2537),\n",
       "  ('study overall', 0.2519),\n",
       "  ('objective aimed', 0.2428),\n",
       "  ('95 ci', 0.2395),\n",
       "  ('stroke meta', 0.2321),\n",
       "  ('model significantly', 0.2252),\n",
       "  ('databases', 0.212),\n",
       "  ('study cancer', 0.2083),\n",
       "  ('association overall', 0.2017),\n",
       "  ('reported protective', 0.1955),\n",
       "  ('2010 results', 0.1937),\n",
       "  ('chronic degenerative', 0.1932),\n",
       "  ('significant reduction', 0.1868),\n",
       "  ('94 cardiovascular', 0.1647),\n",
       "  ('comprehensive', 0.1606),\n",
       "  ('analysis confirms', 0.1595),\n",
       "  ('96 neurodegenerative', 0.1539),\n",
       "  ('cohort prospective', 0.1501),\n",
       "  ('investigated mild', 0.1474),\n",
       "  ('process showed', 0.1421),\n",
       "  ('background', 0.138),\n",
       "  ('confirms larger', 0.1293),\n",
       "  ('rr 92', 0.1027),\n",
       "  ('cognitive', 0.0912),\n",
       "  ('status design', 0.0851),\n",
       "  ('major', 0.0826),\n",
       "  ('significantly influenced', 0.0746),\n",
       "  ('contributor model', 0.0734),\n",
       "  ('random effects', 0.0574),\n",
       "  ('long', 0.0408),\n",
       "  ('subjects', 0.0379),\n",
       "  ('electronic', 0.0314),\n",
       "  ('different', 0.0153),\n",
       "  ('june', -0.0295),\n",
       "  ('87', -0.0454)],\n",
       " 'MED-1401': [('debated epidemiologic', 0.4813),\n",
       "  ('iron intake', 0.4773),\n",
       "  ('evidence inconsistent', 0.4381),\n",
       "  ('chd mortality', 0.4363),\n",
       "  ('epidemiologic evidence', 0.427),\n",
       "  ('summarize literature', 0.3405),\n",
       "  ('cohort studies', 0.3326),\n",
       "  ('pubmed used', 0.3086),\n",
       "  ('eligible studies', 0.3015),\n",
       "  ('additional articles', 0.2891),\n",
       "  ('potential mechanisms', 0.2484),\n",
       "  ('association dietary', 0.2392),\n",
       "  ('incidence heme', 0.237),\n",
       "  ('associated rr', 0.2245),\n",
       "  ('coronary', 0.2062),\n",
       "  ('inconsistent aimed', 0.2042),\n",
       "  ('establish causal', 0.2027),\n",
       "  ('future research', 0.1981),\n",
       "  ('aimed quantitatively', 0.1919),\n",
       "  ('embase', 0.1724),\n",
       "  ('95 cis', 0.1686),\n",
       "  ('mortality future', 0.167),\n",
       "  ('mortality transferrin', 0.166),\n",
       "  ('concentration inversely', 0.1627),\n",
       "  ('meta', 0.1607),\n",
       "  ('needed', 0.1481),\n",
       "  ('disease', 0.1388),\n",
       "  ('published june', 0.1363),\n",
       "  ('ci 28', 0.1277),\n",
       "  ('fixed effects', 0.1205),\n",
       "  ('32 cohorts', 0.1187),\n",
       "  ('including 292', 0.1033),\n",
       "  ('participants', 0.097),\n",
       "  ('stores', 0.0922),\n",
       "  ('hand search', 0.092),\n",
       "  ('57', 0.0908),\n",
       "  ('follow included', 0.0835),\n",
       "  ('using random', 0.0709),\n",
       "  ('elevated', 0.0575),\n",
       "  ('contentiously', 0.0457),\n",
       "  ('ci 76', 0.038),\n",
       "  ('2013 peer', 0.027),\n",
       "  ('999', 0.0202),\n",
       "  ('68', 0.0168),\n",
       "  ('conducting', 0.014),\n",
       "  ('body', 0.0129),\n",
       "  ('454 participants', 0.0015),\n",
       "  ('saturation serum', -0.0034),\n",
       "  ('82 respectively', -0.0094),\n",
       "  ('average 10', -0.0913)],\n",
       " 'MED-1402': [('mediterranean diet', 0.4771),\n",
       "  ('meta analyses', 0.4604),\n",
       "  ('cohort studies', 0.455),\n",
       "  ('studies proposed', 0.4191),\n",
       "  ('objective update', 0.4029),\n",
       "  ('updated search', 0.4017),\n",
       "  ('electronic databases', 0.3769),\n",
       "  ('health outcomes', 0.3462),\n",
       "  ('conducted comprehensive', 0.3416),\n",
       "  ('investigated association', 0.334),\n",
       "  ('adherence points', 0.3301),\n",
       "  ('diet reported', 0.3293),\n",
       "  ('subjects updated', 0.3166),\n",
       "  ('design conducted', 0.243),\n",
       "  ('proposing literature', 0.2397),\n",
       "  ('95 ci', 0.234),\n",
       "  ('present previous', 0.2299),\n",
       "  ('risk cvd', 0.228),\n",
       "  ('june 2013', 0.2111),\n",
       "  ('recent', 0.1932),\n",
       "  ('objective', 0.1922),\n",
       "  ('overall mortality', 0.1882),\n",
       "  ('categories consumption', 0.179),\n",
       "  ('includes different', 0.1691),\n",
       "  ('terms morbidity', 0.1554),\n",
       "  ('results point', 0.1552),\n",
       "  ('pattern terms', 0.1437),\n",
       "  ('data coming', 0.1337),\n",
       "  ('score ranges', 0.1317),\n",
       "  ('neoplastic disease', 0.1206),\n",
       "  ('ranges minimal', 0.1175),\n",
       "  ('group composing', 0.1029),\n",
       "  ('disease relative', 0.0997),\n",
       "  ('cut values', 0.0971),\n",
       "  ('electronic', 0.0943),\n",
       "  ('status utilize', 0.0903),\n",
       "  ('prospective', 0.0897),\n",
       "  ('individual level', 0.0665),\n",
       "  ('96', 0.0663),\n",
       "  ('increase', 0.0618),\n",
       "  ('population', 0.0593),\n",
       "  ('412 subjects', 0.0588),\n",
       "  ('tool estimation', 0.0527),\n",
       "  ('used compute', 0.0458),\n",
       "  ('10 reduced', 0.0414),\n",
       "  ('ci 87', 0.0281),\n",
       "  ('18 maximal', 0.0244),\n",
       "  ('healthy', 0.0225),\n",
       "  ('population 172', -0.0363),\n",
       "  ('easy tool', -0.0551)],\n",
       " 'MED-1403': [('t2dm heme', 0.5887),\n",
       "  ('risk t2dm', 0.5122),\n",
       "  ('meat heme', 0.473),\n",
       "  ('t2dm mediterranean', 0.4449),\n",
       "  ('diabetes mellitus', 0.4043),\n",
       "  ('iron intake', 0.4026),\n",
       "  ('high dietary', 0.3863),\n",
       "  ('cardiovascular risk', 0.3502),\n",
       "  ('observed increased', 0.3162),\n",
       "  ('intake incidence', 0.2928),\n",
       "  ('processed meat', 0.2837),\n",
       "  ('background epidemiological', 0.2691),\n",
       "  ('consumption red', 0.2649),\n",
       "  ('lifestyle variables', 0.2583),\n",
       "  ('quantitative food', 0.2554),\n",
       "  ('risk trial', 0.2399),\n",
       "  ('subjects higher', 0.2354),\n",
       "  ('131 diabetics', 0.2149),\n",
       "  ('study evaluate', 0.2056),\n",
       "  ('hazard models', 0.1965),\n",
       "  ('mediterranean population', 0.1944),\n",
       "  ('direct associations', 0.1809),\n",
       "  ('ratio hr', 0.1626),\n",
       "  ('predimed trial', 0.1463),\n",
       "  ('beverages hr', 0.1454),\n",
       "  ('hr 02', 0.139),\n",
       "  ('57', 0.1293),\n",
       "  ('98 alcoholic', 0.1284),\n",
       "  ('identifier isrctn35739639', 0.1102),\n",
       "  ('chinese populations', 0.1045),\n",
       "  ('frequency questionnaire', 0.1021),\n",
       "  ('unadjusted adjusted', 0.0926),\n",
       "  ('registration identifier', 0.0753),\n",
       "  ('reduce increase', 0.0732),\n",
       "  ('newly diagnosed', 0.0694),\n",
       "  ('ci 01', 0.0642),\n",
       "  ('women aged', 0.0616),\n",
       "  ('maximum years', 0.0609),\n",
       "  ('subset participants', 0.043),\n",
       "  ('66 secondarily', 0.0385),\n",
       "  ('energy', 0.034),\n",
       "  ('observed coffee', 0.0275),\n",
       "  ('hr 30', 0.0273),\n",
       "  ('adult', 0.0242),\n",
       "  ('validated semi', 0.0208),\n",
       "  ('healthy', 0.0189),\n",
       "  ('socio', 0.0026),\n",
       "  ('93', -0.0258),\n",
       "  ('04', -0.0623),\n",
       "  ('1073 non', -0.0907)],\n",
       " 'MED-1404': [('studies evaluated', 0.5368),\n",
       "  ('trials databases', 0.4516),\n",
       "  ('effects meta', 0.4168),\n",
       "  ('methods pubmed', 0.397),\n",
       "  ('diet mediterranean', 0.3369),\n",
       "  ('publications allocated', 0.3284),\n",
       "  ('primary analyses', 0.3225),\n",
       "  ('prospective studies', 0.3135),\n",
       "  ('embase', 0.2965),\n",
       "  ('diabetes copyright', 0.2922),\n",
       "  ('allocated 17', 0.2742),\n",
       "  ('subgroup analyses', 0.2623),\n",
       "  ('original research', 0.255),\n",
       "  ('work meta', 0.247),\n",
       "  ('language publications', 0.2184),\n",
       "  ('20 november', 0.218),\n",
       "  ('results major', 0.2154),\n",
       "  ('cochrane', 0.2146),\n",
       "  ('objective purpose', 0.1911),\n",
       "  ('primary prevention', 0.1899),\n",
       "  ('95 ci', 0.1865),\n",
       "  ('materials', 0.1822),\n",
       "  ('central register', 0.1743),\n",
       "  ('results limitations', 0.1706),\n",
       "  ('sectional identified', 0.162),\n",
       "  ('development type', 0.161),\n",
       "  ('clinical', 0.157),\n",
       "  ('2013', 0.1518),\n",
       "  ('trials yielding', 0.147),\n",
       "  ('limited prospective', 0.1435),\n",
       "  ('beneficial nutritional', 0.1348),\n",
       "  ('random effects', 0.1279),\n",
       "  ('participants systematic', 0.1256),\n",
       "  ('health status', 0.1219),\n",
       "  ('conclusions presented', 0.1218),\n",
       "  ('23 reduced', 0.1141),\n",
       "  ('major public', 0.0991),\n",
       "  ('tools confounders', 0.0956),\n",
       "  ('adjusted', 0.0897),\n",
       "  ('concerning best', 0.0707),\n",
       "  ('136 846', 0.0579),\n",
       "  ('needs constitute', 0.0579),\n",
       "  ('cross', 0.0549),\n",
       "  ('based region', 0.0489),\n",
       "  ('higher adherence', 0.0442),\n",
       "  ('elsevier rights', 0.044),\n",
       "  ('reflect local', 0.0126),\n",
       "  ('89 subgroup', 0.0031),\n",
       "  ('upper versus', -0.0324),\n",
       "  ('ci 66', -0.051)],\n",
       " 'MED-1405': [('polyphenols reduce', 0.637),\n",
       "  ('background polyphenols', 0.586),\n",
       "  ('total polyphenols', 0.4922),\n",
       "  ('diseases antioxidant', 0.4547),\n",
       "  ('12 polyphenol', 0.4161),\n",
       "  ('cardiovascular risk', 0.3906),\n",
       "  ('lower intakes', 0.3808),\n",
       "  ('ci polyphenol', 0.3589),\n",
       "  ('high polyphenol', 0.3351),\n",
       "  ('reduced risk', 0.3051),\n",
       "  ('cvd chronic', 0.3034),\n",
       "  ('anti inflammatory', 0.2865),\n",
       "  ('rest flavonoids', 0.2722),\n",
       "  ('blood pressure', 0.2717),\n",
       "  ('mortality aim', 0.2611),\n",
       "  ('insulin resistance', 0.2468),\n",
       "  ('assessing effects', 0.2467),\n",
       "  ('lipids', 0.2414),\n",
       "  ('ffq phenol', 0.2411),\n",
       "  ('epidemiological studies', 0.2368),\n",
       "  ('primary prevention', 0.2335),\n",
       "  ('mediterranean diet', 0.2222),\n",
       "  ('quintiles total', 0.2067),\n",
       "  ('especially stilbenes', 0.2023),\n",
       "  ('associations apparent', 0.198),\n",
       "  ('beneficial effects', 0.1962),\n",
       "  ('lignans significantly', 0.1947),\n",
       "  ('versus lowest', 0.1864),\n",
       "  ('risk subjects', 0.1826),\n",
       "  ('study 447', 0.164),\n",
       "  ('proportional hazard', 0.1541),\n",
       "  ('consumption data', 0.146),\n",
       "  ('questionnaires ffq', 0.1258),\n",
       "  ('subclasses', 0.1128),\n",
       "  ('resistance previous', 0.0958),\n",
       "  ('using time', 0.0867),\n",
       "  ('95 confidence', 0.0859),\n",
       "  ('hr 48', 0.0755),\n",
       "  ('327 deaths', 0.0711),\n",
       "  ('isrctn35739639', 0.0708),\n",
       "  ('trend 03', 0.0648),\n",
       "  ('clinical trial', 0.0628),\n",
       "  ('models results', 0.0617),\n",
       "  ('parallel group', 0.0524),\n",
       "  ('determine optimal', 0.0499),\n",
       "  ('matching food', 0.0485),\n",
       "  ('multivariate', 0.0414),\n",
       "  ('content reported', 0.0256),\n",
       "  ('25', 0.0153),\n",
       "  ('explorer', -0.0086)],\n",
       " 'MED-1406': [('magnesium intake', 0.5182),\n",
       "  ('risk mediterranean', 0.4141),\n",
       "  ('intake mortality', 0.3436),\n",
       "  ('assess associations', 0.3239),\n",
       "  ('mediterránea study', 0.3109),\n",
       "  ('mortality compared', 0.3019),\n",
       "  ('cardiovascular deaths', 0.2968),\n",
       "  ('study included', 0.2703),\n",
       "  ('adjusted tertiles', 0.2602),\n",
       "  ('cvd trial', 0.2512),\n",
       "  ('reduction mortality', 0.2473),\n",
       "  ('inversely associated', 0.204),\n",
       "  ('adults high', 0.1815),\n",
       "  ('95 ci', 0.1759),\n",
       "  ('men women', 0.1746),\n",
       "  ('index medical', 0.1669),\n",
       "  ('aim', 0.1668),\n",
       "  ('high risk', 0.163),\n",
       "  ('cox regressions', 0.1624),\n",
       "  ('median follow', 0.1588),\n",
       "  ('isrctn35739639', 0.1575),\n",
       "  ('fitted multivariable', 0.1552),\n",
       "  ('analyses generalized', 0.1401),\n",
       "  ('models used', 0.1339),\n",
       "  ('prevención dieta', 0.1262),\n",
       "  ('supplemented nuts', 0.1193),\n",
       "  ('repeated measurements', 0.119),\n",
       "  ('323 total', 0.1142),\n",
       "  ('nuts olive', 0.1113),\n",
       "  ('7216 men', 0.1046),\n",
       "  ('aged', 0.1046),\n",
       "  ('aged 55', 0.0951),\n",
       "  ('estimating equation', 0.0925),\n",
       "  ('cancer', 0.0892),\n",
       "  ('disease', 0.0773),\n",
       "  ('45', 0.0742),\n",
       "  ('compared', 0.0642),\n",
       "  ('population', 0.052),\n",
       "  ('baseline energy', 0.0516),\n",
       "  ('80 predimed', 0.0474),\n",
       "  ('events', 0.0285),\n",
       "  ('advice', 0.0111),\n",
       "  ('participants assigned', 0.0105),\n",
       "  ('com', 0.0073),\n",
       "  ('lower consumers', -0.0089),\n",
       "  ('34', -0.0104),\n",
       "  ('deaths 277', -0.0255),\n",
       "  ('linkage national', -0.0297),\n",
       "  ('control', -0.0337),\n",
       "  ('hr 66', -0.0435)],\n",
       " 'MED-1407': [('mediterranean tradition', 0.5045),\n",
       "  ('mediterranean cuisine', 0.4928),\n",
       "  ('cousine rich', 0.3361),\n",
       "  ('cuisine used', 0.3263),\n",
       "  ('sound traditions', 0.3173),\n",
       "  ('colors aromas', 0.2963),\n",
       "  ('harmony', 0.2888),\n",
       "  ('pizza identified', 0.2787),\n",
       "  ('variety tasty', 0.276),\n",
       "  ('diet combine', 0.273),\n",
       "  ('support taste', 0.2658),\n",
       "  ('caloric intake', 0.2604),\n",
       "  ('folklore', 0.2147),\n",
       "  ('preserves health', 0.2108),\n",
       "  ('sense preserves', 0.2006),\n",
       "  ('wide variety', 0.1923),\n",
       "  ('gastronomic', 0.1896),\n",
       "  ('tradition offers', 0.1873),\n",
       "  ('individual sense', 0.1814),\n",
       "  ('meat sauce', 0.166),\n",
       "  ('confusion', 0.1457),\n",
       "  ('everybody despite', 0.1408),\n",
       "  ('nature talking', 0.1302),\n",
       "  ('satisfaction consumers', 0.128),\n",
       "  ('memories', 0.1271),\n",
       "  ('spirit', 0.1201),\n",
       "  ('mixture pseudo', 0.1162),\n",
       "  ('dish', 0.1144),\n",
       "  ('novelty sound', 0.1022),\n",
       "  ('vital functions', 0.0993),\n",
       "  ('live', 0.0957),\n",
       "  ('despite believe', 0.0873),\n",
       "  ('choices', 0.0825),\n",
       "  ('goodness', 0.0719),\n",
       "  ('help solve', 0.0664),\n",
       "  ('reader coincides', 0.0594),\n",
       "  ('body perform', 0.0545),\n",
       "  ('scents absolutely', 0.0525),\n",
       "  ('use substances', 0.0486),\n",
       "  ('identified noodles', 0.0381),\n",
       "  ('used time', 0.0362),\n",
       "  ('needs individual', 0.0231),\n",
       "  ('qualitative quantitative', 0.0159),\n",
       "  ('carried everybody', 0.0004),\n",
       "  ('identified', -0.0013),\n",
       "  ('line health', -0.0015),\n",
       "  ('absolute', -0.013),\n",
       "  ('properly generating', -0.0449),\n",
       "  ('normal', -0.0614),\n",
       "  ('inviting', -0.0748)],\n",
       " 'MED-1408': [('studies included', 0.637),\n",
       "  ('meta analysis', 0.5553),\n",
       "  ('mediterranean diet', 0.4495),\n",
       "  ('disease meta', 0.4267),\n",
       "  ('subgroup analyses', 0.3809),\n",
       "  ('sought pubmed', 0.3802),\n",
       "  ('estimates extracted', 0.352),\n",
       "  ('rr association', 0.3321),\n",
       "  ('diet risk', 0.3254),\n",
       "  ('analyses highlighted', 0.3086),\n",
       "  ('aims quantitatively', 0.2835),\n",
       "  ('examine association', 0.2635),\n",
       "  ('publications providing', 0.2532),\n",
       "  ('adjusted effect', 0.2491),\n",
       "  ('pubmed october', 0.2482),\n",
       "  ('89 depression', 0.2456),\n",
       "  ('stroke rr', 0.2454),\n",
       "  ('regression analysis', 0.2312),\n",
       "  ('methods potentially', 0.2293),\n",
       "  ('confidence interval', 0.2263),\n",
       "  ('aforementioned outcomes', 0.2103),\n",
       "  ('quantitatively synthesize', 0.2046),\n",
       "  ('terms reduced', 0.1976),\n",
       "  ('societies 2013', 0.1957),\n",
       "  ('potentially eligible', 0.194),\n",
       "  ('rr 60', 0.1936),\n",
       "  ('adherence independent', 0.189),\n",
       "  ('2012 maximally', 0.167),\n",
       "  ('cognitive impairment', 0.1623),\n",
       "  ('prevention sizeable', 0.1586),\n",
       "  ('pertained parkinson', 0.1542),\n",
       "  ('extracted separate', 0.1524),\n",
       "  ('rr 68', 0.1452),\n",
       "  ('95', 0.1421),\n",
       "  ('diseases special', 0.1313),\n",
       "  ('highlighted protective', 0.1262),\n",
       "  ('actions moderate', 0.1231),\n",
       "  ('54', 0.1156),\n",
       "  ('given aging', 0.1018),\n",
       "  ('consistently', 0.091),\n",
       "  ('western societies', 0.0849),\n",
       "  ('43 83', 0.0512),\n",
       "  ('performed high', 0.0492),\n",
       "  ('october 31', 0.048),\n",
       "  ('relative', 0.0395),\n",
       "  ('series brain', 0.0359),\n",
       "  ('american neurological', -0.0187),\n",
       "  ('special value', -0.0397),\n",
       "  ('fade away', -0.0449),\n",
       "  ('males concerning', -0.1161)],\n",
       " 'MED-1409': [('men 1960', 0.4178),\n",
       "  ('148 men', 0.4164),\n",
       "  ('prevalence coronary', 0.3961),\n",
       "  ('cardiovascular diseases', 0.3891),\n",
       "  ('area men', 0.3452),\n",
       "  ('compares prevalence', 0.3317),\n",
       "  ('study population', 0.3074),\n",
       "  ('men complete', 0.2828),\n",
       "  ('chd rf', 0.2757),\n",
       "  ('001 hypertensive', 0.2499),\n",
       "  ('cretan', 0.2443),\n",
       "  ('45 1991', 0.2411),\n",
       "  ('42 subjects', 0.2206),\n",
       "  ('smokers', 0.2137),\n",
       "  ('group years', 0.211),\n",
       "  ('compared 14', 0.2077),\n",
       "  ('pa compared', 0.2056),\n",
       "  ('rural area', 0.1987),\n",
       "  ('area examined', 0.1933),\n",
       "  ('physical activity', 0.1854),\n",
       "  ('140 mmhg', 0.1797),\n",
       "  ('compared 43', 0.1784),\n",
       "  ('heart', 0.1715),\n",
       "  ('group higher', 0.1691),\n",
       "  ('subjects farmers', 0.168),\n",
       "  ('74 subjects', 0.1598),\n",
       "  ('disease subjects', 0.1571),\n",
       "  ('resting electrocardiogram', 0.1562),\n",
       "  ('compared 35', 0.1559),\n",
       "  ('related dietary', 0.1498),\n",
       "  ('complete examination', 0.1264),\n",
       "  ('cholesterol tsch', 0.1259),\n",
       "  ('compares', 0.1078),\n",
       "  ('19 compared', 0.1071),\n",
       "  ('thirty years', 0.1043),\n",
       "  ('factors', 0.102),\n",
       "  ('taken place', 0.0849),\n",
       "  ('style changes', 0.0581),\n",
       "  ('260 mg', 0.058),\n",
       "  ('95 mmhg', 0.0482),\n",
       "  ('ns diastolic', 0.0467),\n",
       "  ('old', 0.0464),\n",
       "  ('heavy', 0.041),\n",
       "  ('20', 0.0403),\n",
       "  ('serum', 0.0349),\n",
       "  ('daily', 0.0102),\n",
       "  ('01', -0.0078),\n",
       "  ('mmol 12', -0.0496),\n",
       "  ('opposed 33', -0.0628),\n",
       "  ('light', -0.066)],\n",
       " 'MED-1410': [('15 cohorts', 0.5453),\n",
       "  ('died 15', 0.4884),\n",
       "  ('deaths causes', 0.4671),\n",
       "  ('cohorts differed', 0.3865),\n",
       "  ('579 men', 0.3472),\n",
       "  ('45 stroke', 0.3401),\n",
       "  ('accounted 85', 0.3295),\n",
       "  ('men aged', 0.3137),\n",
       "  ('cohorts seven', 0.3031),\n",
       "  ('accounted differences', 0.3003),\n",
       "  ('disease 55', 0.274),\n",
       "  ('causes 96', 0.2409),\n",
       "  ('smoking habits', 0.2366),\n",
       "  ('countries study', 0.2333),\n",
       "  ('activity cohorts', 0.2326),\n",
       "  ('serum cholesterol', 0.2275),\n",
       "  ('mean age', 0.2223),\n",
       "  ('characteristics populations', 0.2217),\n",
       "  ('variance rates', 0.2161),\n",
       "  ('habits explained', 0.2095),\n",
       "  ('cause coronary', 0.207),\n",
       "  ('weight fatness', 0.1955),\n",
       "  ('rates related', 0.1935),\n",
       "  ('comprising 11', 0.1781),\n",
       "  ('59 years', 0.1681),\n",
       "  ('causal relationships', 0.1681),\n",
       "  ('causes 80', 0.1652),\n",
       "  ('stroke oleic', 0.1621),\n",
       "  ('inclusion ratio', 0.1558),\n",
       "  ('alcohol death', 0.1524),\n",
       "  ('explained 46', 0.149),\n",
       "  ('monounsaturates', 0.1419),\n",
       "  ('entry 288', 0.1261),\n",
       "  ('average diets', 0.1149),\n",
       "  ('evaluating risks', 0.1137),\n",
       "  ('cancer', 0.1134),\n",
       "  ('aged 40', 0.1106),\n",
       "  ('cohorts olive', 0.1092),\n",
       "  ('rates low', 0.1074),\n",
       "  ('physical activity', 0.0998),\n",
       "  ('main', 0.0977),\n",
       "  ('blood pressure', 0.0837),\n",
       "  ('populations urged', 0.0707),\n",
       "  ('years', 0.0688),\n",
       "  ('differences unrelated', 0.0536),\n",
       "  ('serum', 0.0275),\n",
       "  ('healthy', 0.0073),\n",
       "  ('proteins carbohydrates', 0.0071),\n",
       "  ('negatively', -0.0074),\n",
       "  ('related positively', -0.0226)],\n",
       " 'MED-1411': [('mediterranean diet', 0.531),\n",
       "  ('study meta', 0.5277),\n",
       "  ('metabolic syndrome', 0.4991),\n",
       "  ('ms components', 0.432),\n",
       "  ('assessed effect', 0.3857),\n",
       "  ('diet components', 0.3546),\n",
       "  ('clinical studies', 0.3456),\n",
       "  ('analyze epidemiological', 0.3423),\n",
       "  ('science cochrane', 0.2943),\n",
       "  ('pubmed embase', 0.2885),\n",
       "  ('low cardiovascular', 0.2774),\n",
       "  ('ms like', 0.2629),\n",
       "  ('secondary prevention', 0.2386),\n",
       "  ('studies 35', 0.2295),\n",
       "  ('objectives aim', 0.2221),\n",
       "  ('population methods', 0.2197),\n",
       "  ('96 triglycerides', 0.2161),\n",
       "  ('cholesterol', 0.2055),\n",
       "  ('trials showed', 0.1943),\n",
       "  ('individual components', 0.1923),\n",
       "  ('health importance', 0.1828),\n",
       "  ('random effects', 0.1803),\n",
       "  ('disease', 0.1776),\n",
       "  ('mg dl', 0.1775),\n",
       "  ('difference 95', 0.158),\n",
       "  ('hazard ratio', 0.1552),\n",
       "  ('college cardiology', 0.1472),\n",
       "  ('adherence', 0.1457),\n",
       "  ('mean', 0.1431),\n",
       "  ('adult population', 0.1427),\n",
       "  ('central register', 0.1415),\n",
       "  ('like waist', 0.1387),\n",
       "  ('web science', 0.1327),\n",
       "  ('long associated', 0.1235),\n",
       "  ('english language', 0.0976),\n",
       "  ('906 participants', 0.0962),\n",
       "  ('elsevier rights', 0.0948),\n",
       "  ('pattern easily', 0.089),\n",
       "  ('18 diastolic', 0.0867),\n",
       "  ('58 mm', 0.0853),\n",
       "  ('foundation published', 0.0788),\n",
       "  ('ci 24', 0.0766),\n",
       "  ('16 additionally', 0.0752),\n",
       "  ('534', 0.0699),\n",
       "  ('02 high', 0.0431),\n",
       "  ('13 cross', 0.0405),\n",
       "  ('ratio 69', 0.0271),\n",
       "  ('2010 50', 0.0199),\n",
       "  ('cultures cost', 0.0064),\n",
       "  ('considerable public', -0.0017)],\n",
       " 'MED-1412': [('schoolchildren feeding', 0.4795),\n",
       "  ('faecal ph', 0.4666),\n",
       "  ('mean ph', 0.3511),\n",
       "  ('lower groups', 0.3384),\n",
       "  ('low fat', 0.3268),\n",
       "  ('feeding studies', 0.3079),\n",
       "  ('westernized diet', 0.3065),\n",
       "  ('schoolchildren', 0.295),\n",
       "  ('diet', 0.278),\n",
       "  ('dwellers consumed', 0.2624),\n",
       "  ('faeces significantly', 0.2501),\n",
       "  ('meal significantly', 0.2218),\n",
       "  ('ate traditional', 0.2196),\n",
       "  ('groups rural', 0.2183),\n",
       "  ('significantly lower', 0.2139),\n",
       "  ('diet urban', 0.2067),\n",
       "  ('children significantly', 0.204),\n",
       "  ('significantly groups', 0.202),\n",
       "  ('black children', 0.1967),\n",
       "  ('consumed partially', 0.194),\n",
       "  ('12 years', 0.1893),\n",
       "  ('bread replaced', 0.166),\n",
       "  ('did differ', 0.1642),\n",
       "  ('significantly acid', 0.1617),\n",
       "  ('children institution', 0.1473),\n",
       "  ('acid white', 0.1391),\n",
       "  ('butter sugar', 0.1323),\n",
       "  ('supplement', 0.1259),\n",
       "  ('bran crunchies', 0.1208),\n",
       "  ('groups white', 0.1157),\n",
       "  ('years ate', 0.1111),\n",
       "  ('studies', 0.107),\n",
       "  ('consumed daily', 0.1055),\n",
       "  ('urban dwellers', 0.1037),\n",
       "  ('milk', 0.0944),\n",
       "  ('institution mean', 0.0914),\n",
       "  ('south african', 0.0898),\n",
       "  ('means significantly', 0.0888),\n",
       "  ('skim', 0.0755),\n",
       "  ('ate', 0.0751),\n",
       "  ('days duration', 0.0724),\n",
       "  ('effect mean', 0.0704),\n",
       "  ('maize', 0.0643),\n",
       "  ('consisted', 0.0407),\n",
       "  ('traditional high', 0.0317),\n",
       "  ('10', 0.0309),\n",
       "  ('values', 0.0289),\n",
       "  ('replaced', 0.012),\n",
       "  ('oranges consumed', -0.0003),\n",
       "  ('high fibre', -0.019)],\n",
       " 'MED-1413': [('digestive organs', 0.7091),\n",
       "  ('gastrointestinal gi', 0.6488),\n",
       "  ('oro gastrointestinal', 0.5772),\n",
       "  ('gut microbiota', 0.514),\n",
       "  ('oesophagus', 0.4645),\n",
       "  ('organs constitute', 0.4472),\n",
       "  ('digestion', 0.4379),\n",
       "  ('cavity pharynx', 0.4195),\n",
       "  ('dietary interventions', 0.4088),\n",
       "  ('stomach small', 0.4031),\n",
       "  ('faeces interactions', 0.3854),\n",
       "  ('intestine large', 0.3846),\n",
       "  ('prebiotics', 0.3714),\n",
       "  ('physiological functions', 0.3545),\n",
       "  ('rectum anus', 0.3525),\n",
       "  ('consisting oral', 0.3507),\n",
       "  ('metabolic products', 0.3199),\n",
       "  ('carbohydrates human', 0.3123),\n",
       "  ('homeostasis health', 0.3107),\n",
       "  ('tract complex', 0.3017),\n",
       "  ('small molecules', 0.2833),\n",
       "  ('probiotics polyphenols', 0.2771),\n",
       "  ('regions gi', 0.2687),\n",
       "  ('non digestible', 0.2625),\n",
       "  ('affect composition', 0.2563),\n",
       "  ('processes commensal', 0.2468),\n",
       "  ('functions main', 0.2456),\n",
       "  ('host genes', 0.2248),\n",
       "  ('regulate diverse', 0.2241),\n",
       "  ('review summarise', 0.2214),\n",
       "  ('immunological processes', 0.2148),\n",
       "  ('body', 0.2147),\n",
       "  ('therapy', 0.2005),\n",
       "  ('human oro', 0.1935),\n",
       "  ('bacteria able', 0.1907),\n",
       "  ('changes antibiotic', 0.1738),\n",
       "  ('absorb subsequent', 0.1644),\n",
       "  ('analyses elucidated', 0.1488),\n",
       "  ('furthermore important', 0.1459),\n",
       "  ('products', 0.1453),\n",
       "  ('interactions', 0.1444),\n",
       "  ('changes normal', 0.1375),\n",
       "  ('formed lower', 0.1291),\n",
       "  ('confounding factors', 0.1219),\n",
       "  ('adults include', 0.1165),\n",
       "  ('increasingly', 0.089),\n",
       "  ('community generally', 0.0881),\n",
       "  ('groups observed', 0.0832),\n",
       "  ('indigenous', 0.0673),\n",
       "  ('intrinsic human', 0.0313)],\n",
       " 'MED-1414': [('acidification colon', 0.5927),\n",
       "  ('colonic ph', 0.5474),\n",
       "  ('bile acids', 0.5251),\n",
       "  ('carcinogens carcinogens', 0.5234),\n",
       "  ('suggests carcinogens', 0.5202),\n",
       "  ('carcinogens responsible', 0.5079),\n",
       "  ('promotes carcinogen', 0.4998),\n",
       "  ('colon dietary', 0.4942),\n",
       "  ('degraded bile', 0.4904),\n",
       "  ('carcinogen formation', 0.4819),\n",
       "  ('development colorectal', 0.4769),\n",
       "  ('colonic', 0.4718),\n",
       "  ('acids cholesterol', 0.4675),\n",
       "  ('colon', 0.4663),\n",
       "  ('colorectal cancer', 0.4581),\n",
       "  ('cancer bacterially', 0.4507),\n",
       "  ('high colonic', 0.4454),\n",
       "  ('bile', 0.442),\n",
       "  ('cholesterol proposed', 0.4403),\n",
       "  ('substances acidification', 0.4289),\n",
       "  ('bacterial digestion', 0.4063),\n",
       "  ('bacterially degraded', 0.4062),\n",
       "  ('bacterially', 0.331),\n",
       "  ('fatty acids', 0.3239),\n",
       "  ('acids', 0.3223),\n",
       "  ('ph promotes', 0.315),\n",
       "  ('following bacterial', 0.3099),\n",
       "  ('dietary fibre', 0.2954),\n",
       "  ('acids milk', 0.2859),\n",
       "  ('cancer', 0.2747),\n",
       "  ('dietary', 0.2711),\n",
       "  ('digestion', 0.2551),\n",
       "  ('formation substances', 0.2548),\n",
       "  ('milk lactose', 0.2194),\n",
       "  ('short chain', 0.2156),\n",
       "  ('substances', 0.2065),\n",
       "  ('evidence', 0.1949),\n",
       "  ('individuals prevent', 0.1884),\n",
       "  ('prevent process', 0.1859),\n",
       "  ('chain', 0.1784),\n",
       "  ('lactose intolerant', 0.1718),\n",
       "  ('promotes', 0.1711),\n",
       "  ('degraded', 0.151),\n",
       "  ('proposed high', 0.1279),\n",
       "  ('proposed', 0.1073),\n",
       "  ('fibre following', 0.1021),\n",
       "  ('responsible development', 0.1008),\n",
       "  ('considerable', 0.0783),\n",
       "  ('individuals', 0.075),\n",
       "  ('following', 0.0694)],\n",
       " 'MED-1415': [('intestinal microbiota', 0.6575),\n",
       "  ('diets microbiota', 0.6276),\n",
       "  ('microbiota total', 0.5651),\n",
       "  ('14 microbial', 0.4649),\n",
       "  ('complex microbial', 0.4361),\n",
       "  ('samples vegetarians', 0.4269),\n",
       "  ('examined faecal', 0.4204),\n",
       "  ('bacterial genera', 0.4115),\n",
       "  ('enterococcus spp', 0.3942),\n",
       "  ('regular diets', 0.3916),\n",
       "  ('144 vegans', 0.3904),\n",
       "  ('stool ph', 0.3627),\n",
       "  ('vegan samples', 0.3346),\n",
       "  ('counts bacteroides', 0.3328),\n",
       "  ('community inhabiting', 0.3256),\n",
       "  ('controls coli', 0.2838),\n",
       "  ('bacteriological', 0.2811),\n",
       "  ('citrobacter spp', 0.2197),\n",
       "  ('spp subjects', 0.2086),\n",
       "  ('ph counts', 0.2032),\n",
       "  ('genera computed', 0.1894),\n",
       "  ('biovars klebsiella', 0.1809),\n",
       "  ('consuming', 0.1758),\n",
       "  ('enumeration main', 0.1747),\n",
       "  ('strict vegan', 0.1669),\n",
       "  ('consisting 10', 0.1654),\n",
       "  ('remain unaltered', 0.1623),\n",
       "  ('105 equal', 0.1614),\n",
       "  ('conclusions maintaining', 0.16),\n",
       "  ('ordinary omnivorous', 0.1576),\n",
       "  ('differ groups', 0.1509),\n",
       "  ('results', 0.1446),\n",
       "  ('aerobic', 0.1416),\n",
       "  ('relative numbers', 0.13),\n",
       "  ('background objectives', 0.1218),\n",
       "  ('human body', 0.1102),\n",
       "  ('isolation', 0.1086),\n",
       "  ('lower 001', 0.097),\n",
       "  ('total cell', 0.0953),\n",
       "  ('influence regular', 0.0893),\n",
       "  ('control subjects', 0.0801),\n",
       "  ('widely unknown', 0.0742),\n",
       "  ('significant shift', 0.0591),\n",
       "  ('used classical', 0.0511),\n",
       "  ('significantly correlated', 0.0511),\n",
       "  ('matched age', 0.0469),\n",
       "  ('widely', 0.0401),\n",
       "  ('represents largest', 0.0156),\n",
       "  ('gender used', -0.0128),\n",
       "  ('did', -0.0214)],\n",
       " 'MED-1416': [('colon subjects', 0.5753),\n",
       "  ('colon contents', 0.5575),\n",
       "  ('faecal urobilinogen', 0.5456),\n",
       "  ('urobilinogen levels', 0.5449),\n",
       "  ('reaction colon', 0.5264),\n",
       "  ('cancer colon', 0.513),\n",
       "  ('ph stools', 0.5111),\n",
       "  ('stools higher', 0.5108),\n",
       "  ('developing cancer', 0.3349),\n",
       "  ('levels ph', 0.3322),\n",
       "  ('mucous cells', 0.3284),\n",
       "  ('mean faecal', 0.3185),\n",
       "  ('alkaline reaction', 0.3158),\n",
       "  ('cells acidic', 0.3074),\n",
       "  ('high risk', 0.2959),\n",
       "  ('higher subjects', 0.2899),\n",
       "  ('tumorigenic effect', 0.276),\n",
       "  ('action mucus', 0.2489),\n",
       "  ('fermented', 0.2481),\n",
       "  ('group high', 0.2325),\n",
       "  ('population group', 0.2319),\n",
       "  ('protective differences', 0.2119),\n",
       "  ('food roughage', 0.2055),\n",
       "  ('subjects', 0.2012),\n",
       "  ('cells', 0.1896),\n",
       "  ('socioeconomic status', 0.1698),\n",
       "  ('levels', 0.169),\n",
       "  ('diet manner', 0.1304),\n",
       "  ('patterns', 0.1271),\n",
       "  ('reaction', 0.1254),\n",
       "  ('differences dependent', 0.1238),\n",
       "  ('age sex', 0.1197),\n",
       "  ('fermented milk', 0.1157),\n",
       "  ('effect direct', 0.1097),\n",
       "  ('status', 0.0951),\n",
       "  ('low risk', 0.09),\n",
       "  ('developing', 0.0874),\n",
       "  ('food', 0.0787),\n",
       "  ('contents', 0.0745),\n",
       "  ('matched', 0.0652),\n",
       "  ('fatty acids', 0.0652),\n",
       "  ('appears', 0.0469),\n",
       "  ('proper mastication', 0.0439),\n",
       "  ('chain', 0.038),\n",
       "  ('mean', 0.0361),\n",
       "  ('products', 0.0262),\n",
       "  ('proper', 0.0087),\n",
       "  ('cellulose vegetable', -0.0279),\n",
       "  ('hand appears', -0.0527),\n",
       "  ('fibre short', -0.079)],\n",
       " 'MED-1417': [('colonic microbiota', 0.6416),\n",
       "  ('microbiomes analyzed', 0.5557),\n",
       "  ('mediated microbiota', 0.5486),\n",
       "  ('carcinogenic metabolites', 0.5236),\n",
       "  ('sporadic colon', 0.516),\n",
       "  ('hypothesis colon', 0.5094),\n",
       "  ('influence diet', 0.4457),\n",
       "  ('carcinogenesis objective', 0.4198),\n",
       "  ('metabolites measured', 0.4135),\n",
       "  ('cancer risk', 0.3849),\n",
       "  ('balance microbial', 0.381),\n",
       "  ('bacteria major', 0.3625),\n",
       "  ('studies suggested', 0.355),\n",
       "  ('abundant fecal', 0.3523),\n",
       "  ('major fermentative', 0.3409),\n",
       "  ('encoding methanogenesis', 0.3206),\n",
       "  ('secondary bile', 0.3127),\n",
       "  ('enterotype total', 0.3036),\n",
       "  ('background epidemiologic', 0.3032),\n",
       "  ('acid concentrations', 0.2966),\n",
       "  ('fecal short', 0.2924),\n",
       "  ('influenced balance', 0.2487),\n",
       "  ('production health', 0.2201),\n",
       "  ('prevotella', 0.2189),\n",
       "  ('fermentative butyrate', 0.2162),\n",
       "  ('composition fundamentally', 0.212),\n",
       "  ('sporadic', 0.208),\n",
       "  ('gene pyrosequencing', 0.2),\n",
       "  ('risk rural', 0.1942),\n",
       "  ('chain reaction', 0.185),\n",
       "  ('examine hypothesis', 0.1724),\n",
       "  ('ribosomal rna', 0.1692),\n",
       "  ('results support', 0.1685),\n",
       "  ('deconjugating', 0.1646),\n",
       "  ('promoting', 0.1492),\n",
       "  ('16s', 0.1443),\n",
       "  ('major influence', 0.1416),\n",
       "  ('hydrogen sulfide', 0.1336),\n",
       "  ('africans low', 0.131),\n",
       "  ('mass', 0.102),\n",
       "  ('chromatography', 0.0988),\n",
       "  ('groups', 0.0969),\n",
       "  ('higher native', 0.0772),\n",
       "  ('65', 0.0737),\n",
       "  ('fundamentally different', 0.0686),\n",
       "  ('sex matched', 0.0671),\n",
       "  ('americans encoding', 0.0639),\n",
       "  ('12 healthy', 0.037),\n",
       "  ('significantly abundant', 0.0167),\n",
       "  ('aged 50', 0.0133)],\n",
       " 'MED-1418': [('insult colonic', 0.5262),\n",
       "  ('genotoxicity sulfide', 0.5113),\n",
       "  ('colon chronic', 0.5022),\n",
       "  ('sulfate reducing', 0.4138),\n",
       "  ('bacteria large', 0.3902),\n",
       "  ('colorectal cancer', 0.382),\n",
       "  ('previously sulfide', 0.3725),\n",
       "  ('disorders ulcerative', 0.352),\n",
       "  ('intestine represents', 0.3488),\n",
       "  ('reducing bacteria', 0.343),\n",
       "  ('genomic instability', 0.3139),\n",
       "  ('base oxidation', 0.309),\n",
       "  ('cellular metabolism', 0.2965),\n",
       "  ('chronic disorders', 0.2964),\n",
       "  ('represents environmental', 0.2861),\n",
       "  ('epithelium', 0.2833),\n",
       "  ('oxidized', 0.2789),\n",
       "  ('hydrogen', 0.2767),\n",
       "  ('glycosylase', 0.2573),\n",
       "  ('free radicals', 0.2473),\n",
       "  ('micromol damage', 0.2429),\n",
       "  ('predisposing genetic', 0.2214),\n",
       "  ('cotreatment butylhydroxyanisole', 0.202),\n",
       "  ('underlying mechanisms', 0.1919),\n",
       "  ('cumulative mutations', 0.1914),\n",
       "  ('implicate', 0.1872),\n",
       "  ('clinical', 0.187),\n",
       "  ('nature dna', 0.18),\n",
       "  ('evidence circumstantial', 0.1795),\n",
       "  ('induced concentrations', 0.1795),\n",
       "  ('studies linked', 0.1778),\n",
       "  ('cancer point', 0.1662),\n",
       "  ('mammalian cells', 0.1623),\n",
       "  ('background', 0.1546),\n",
       "  ('damage effectively', 0.1452),\n",
       "  ('present study', 0.1312),\n",
       "  ('concentrations low', 0.1197),\n",
       "  ('strongly', 0.0966),\n",
       "  ('cells treated', 0.0965),\n",
       "  ('results confirm', 0.0745),\n",
       "  ('remain undefined', 0.0739),\n",
       "  ('formamidopyrimidine fapy', 0.0609),\n",
       "  ('untreated', 0.0542),\n",
       "  ('showed previously', 0.0536),\n",
       "  ('nuclei', 0.0442),\n",
       "  ('chinese hamster', 0.0424),\n",
       "  ('produced indigenous', 0.0342),\n",
       "  ('treatment increased', 0.0191),\n",
       "  ('ovary cells', 0.0118),\n",
       "  ('similar human', 0.0037)],\n",
       " 'MED-1419': [('diets genotoxicity', 0.4859),\n",
       "  ('water diet', 0.4309),\n",
       "  ('volunteers consuming', 0.4304),\n",
       "  ('low dietary', 0.3955),\n",
       "  ('12 days', 0.3927),\n",
       "  ('diet rich', 0.3921),\n",
       "  ('poor vegetables', 0.3723),\n",
       "  ('differences diets', 0.365),\n",
       "  ('water volunteers', 0.3635),\n",
       "  ('meat sugar', 0.3398),\n",
       "  ('consumed seven', 0.3339),\n",
       "  ('wholemeal products', 0.3203),\n",
       "  ('started consume', 0.3118),\n",
       "  ('vegetables free', 0.3067),\n",
       "  ('human faecal', 0.2972),\n",
       "  ('mean dna', 0.272),\n",
       "  ('diet twice', 0.2668),\n",
       "  ('healthy', 0.2614),\n",
       "  ('meat low', 0.235),\n",
       "  ('sugar poor', 0.2348),\n",
       "  ('enriched', 0.2219),\n",
       "  ('days week', 0.2127),\n",
       "  ('fibre increase', 0.2035),\n",
       "  ('peroxide treatment', 0.198),\n",
       "  ('determine effects', 0.1861),\n",
       "  ('significant differences', 0.1637),\n",
       "  ('susceptibility cells', 0.1331),\n",
       "  ('colon adenocarcinoma', 0.1323),\n",
       "  ('length', 0.1144),\n",
       "  ('incubation', 0.1133),\n",
       "  ('pretreatment types', 0.1125),\n",
       "  ('assessed single', 0.1013),\n",
       "  ('contribute', 0.1002),\n",
       "  ('enhanced risk', 0.087),\n",
       "  ('total intensity', 0.0856),\n",
       "  ('treatment', 0.0836),\n",
       "  ('different', 0.0779),\n",
       "  ('purine bases', 0.0715),\n",
       "  ('gel', 0.0683),\n",
       "  ('caused', 0.0597),\n",
       "  ('generation', 0.0565),\n",
       "  ('tails', 0.0513),\n",
       "  ('comet assay', 0.0437),\n",
       "  ('additional hydrogen', 0.0272),\n",
       "  ('cell line', 0.0119),\n",
       "  ('second period', 0.0057),\n",
       "  ('ht29', 0.0046),\n",
       "  ('target', -0.023),\n",
       "  ('images reflects', -0.0272),\n",
       "  ('19a', -0.0595)],\n",
       " 'MED-1420': [('diet colonic', 0.6358),\n",
       "  ('topical nutrients', 0.5501),\n",
       "  ('reducing colon', 0.5273),\n",
       "  ('cancer microbiota', 0.4852),\n",
       "  ('mucosa maintain', 0.4795),\n",
       "  ('microbiota synthesizes', 0.4551),\n",
       "  ('colons harbor', 0.4297),\n",
       "  ('acids control', 0.4264),\n",
       "  ('small intestine', 0.4191),\n",
       "  ('link diet', 0.4117),\n",
       "  ('metabolism', 0.3985),\n",
       "  ('used gut', 0.3963),\n",
       "  ('reducing bacteria', 0.3816),\n",
       "  ('obesity summary', 0.3578),\n",
       "  ('fatty acids', 0.3575),\n",
       "  ('highlight mechanisms', 0.3511),\n",
       "  ('bacteria response', 0.3364),\n",
       "  ('utilizable folate', 0.3208),\n",
       "  ('health', 0.3088),\n",
       "  ('products food', 0.303),\n",
       "  ('function disease', 0.2842),\n",
       "  ('purpose review', 0.2753),\n",
       "  ('residues genotoxic', 0.265),\n",
       "  ('control proliferation', 0.2494),\n",
       "  ('patterns recent', 0.2363),\n",
       "  ('influences diversity', 0.2322),\n",
       "  ('species characterization', 0.23),\n",
       "  ('differentiation reducing', 0.2296),\n",
       "  ('short chain', 0.2234),\n",
       "  ('sulfur', 0.2207),\n",
       "  ('based 16s', 0.2085),\n",
       "  ('strains evidence', 0.2078),\n",
       "  ('risk patients', 0.2026),\n",
       "  ('focused', 0.1934),\n",
       "  ('human studies', 0.187),\n",
       "  ('supports survival', 0.1751),\n",
       "  ('dna revealed', 0.1513),\n",
       "  ('production supports', 0.1449),\n",
       "  ('preferentially used', 0.1303),\n",
       "  ('1000 kcal', 0.1277),\n",
       "  ('day human', 0.1202),\n",
       "  ('culture free', 0.0805),\n",
       "  ('populations unfortunately', 0.073),\n",
       "  ('7000 different', 0.0659),\n",
       "  ('synthesizes large', 0.0642),\n",
       "  ('directly influences', 0.058),\n",
       "  ('determine efficiency', 0.0526),\n",
       "  ('high meat', 0.0162),\n",
       "  ('releasing', -0.0015),\n",
       "  ('large pool', -0.0875)],\n",
       " 'MED-1421': [('colitis sulfide', 0.6448),\n",
       "  ('sulfide luminally', 0.6219),\n",
       "  ('fecal sulfide', 0.6097),\n",
       "  ('meat sulfide', 0.5679),\n",
       "  ('sulfide generation', 0.5574),\n",
       "  ('inorganic sulfur', 0.459),\n",
       "  ('sulfite objective', 0.4503),\n",
       "  ('production intestinal', 0.3624),\n",
       "  ('bacterially derived', 0.3581),\n",
       "  ('luminally acting', 0.3337),\n",
       "  ('background hydrogen', 0.3284),\n",
       "  ('diet fecal', 0.3119),\n",
       "  ('saas meat', 0.3058),\n",
       "  ('acids saas', 0.3043),\n",
       "  ('reactive substances', 0.303),\n",
       "  ('generation colon', 0.2939),\n",
       "  ('metabolic suite', 0.2771),\n",
       "  ('amino acids', 0.2612),\n",
       "  ('implicated ulcerative', 0.2603),\n",
       "  ('ammonia lowry', 0.2579),\n",
       "  ('cell poison', 0.2352),\n",
       "  ('protein digestion', 0.2341),\n",
       "  ('intake ranged', 0.2264),\n",
       "  ('urinary', 0.2134),\n",
       "  ('important substrate', 0.208),\n",
       "  ('casein correlated', 0.1836),\n",
       "  ('cultures supplemented', 0.1788),\n",
       "  ('serum albumin', 0.1673),\n",
       "  ('vegetarian', 0.1468),\n",
       "  ('men housed', 0.1431),\n",
       "  ('sem', 0.1355),\n",
       "  ('study design', 0.1141),\n",
       "  ('vivo human', 0.1124),\n",
       "  ('healthy', 0.1079),\n",
       "  ('bovine serum', 0.1023),\n",
       "  ('001', 0.1008),\n",
       "  ('probably driven', 0.0926),\n",
       "  ('samples collected', 0.0913),\n",
       "  ('human large', 0.0871),\n",
       "  ('mmol kg', 0.0871),\n",
       "  ('model culture', 0.0692),\n",
       "  ('derived cell', 0.066),\n",
       "  ('use', 0.0563),\n",
       "  ('additionally 10', 0.0344),\n",
       "  ('48 results', 0.0316),\n",
       "  ('objective assessed', 0.0278),\n",
       "  ('38 31', 0.007),\n",
       "  ('measured disappearance', 0.005),\n",
       "  ('600 high', 0.0041),\n",
       "  ('22 02', -0.0092)],\n",
       " 'MED-1425': [('incidence crohn', 0.5583),\n",
       "  ('disease dietary', 0.469),\n",
       "  ('dietary change', 0.4192),\n",
       "  ('disease strongly', 0.3763),\n",
       "  ('correlated intake', 0.3466),\n",
       "  ('increased intake', 0.3445),\n",
       "  ('correlated increased', 0.329),\n",
       "  ('japanese population', 0.2858),\n",
       "  ('increased incidence', 0.2831),\n",
       "  ('1966 1985', 0.2829),\n",
       "  ('association reported', 0.2732),\n",
       "  ('1985 univariate', 0.2712),\n",
       "  ('total fat', 0.2704),\n",
       "  ('fat 919', 0.2455),\n",
       "  ('polyunsaturated fatty', 0.2415),\n",
       "  ('acid intake', 0.2315),\n",
       "  ('examined correlation', 0.2284),\n",
       "  ('animal fat', 0.211),\n",
       "  ('total protein', 0.1987),\n",
       "  ('daily', 0.196),\n",
       "  ('study association', 0.1899),\n",
       "  ('milk protein', 0.1894),\n",
       "  ('strongly 001', 0.1767),\n",
       "  ('analysis showed', 0.1762),\n",
       "  ('compared annually', 0.1691),\n",
       "  ('clinical studies', 0.1673),\n",
       "  ('intake animal', 0.1562),\n",
       "  ('protein 055', 0.155),\n",
       "  ('studies suggests', 0.1531),\n",
       "  ('component compared', 0.1362),\n",
       "  ('919 animal', 0.1195),\n",
       "  ('001 multivariate', 0.1191),\n",
       "  ('contribute development', 0.1179),\n",
       "  ('change', 0.108),\n",
       "  ('acids 883', 0.0988),\n",
       "  ('protein 924', 0.0866),\n",
       "  ('second factor', 0.0824),\n",
       "  ('examined', 0.0819),\n",
       "  ('941 001', 0.0766),\n",
       "  ('present study', 0.073),\n",
       "  ('univariate', 0.0614),\n",
       "  ('strongest independent', 0.058),\n",
       "  ('vegetable', 0.0198),\n",
       "  ('suggests', 0.0186),\n",
       "  ('fish', 0.0025),\n",
       "  ('792', -0.0103),\n",
       "  ('population', -0.0164),\n",
       "  ('482', -0.0209),\n",
       "  ('homogeneous', -0.0405),\n",
       "  ('weaker', -0.1219)],\n",
       " 'MED-1426': [('colonic metabolism', 0.5413),\n",
       "  ('protein supplementation', 0.5),\n",
       "  ('intake bacterial', 0.4997),\n",
       "  ('faecal ammonia', 0.4985),\n",
       "  ('fatty acids', 0.4172),\n",
       "  ('increased dietary', 0.412),\n",
       "  ('basal nutrient', 0.3961),\n",
       "  ('isolated faecal', 0.3932),\n",
       "  ('carbohydrate intake', 0.3925),\n",
       "  ('nutricia', 0.3793),\n",
       "  ('intake total', 0.3484),\n",
       "  ('volunteers measured', 0.2924),\n",
       "  ('samples phenols', 0.288),\n",
       "  ('ammonia 002', 0.2879),\n",
       "  ('acid', 0.2812),\n",
       "  ('substances urinary', 0.2799),\n",
       "  ('fortimel', 0.267),\n",
       "  ('metabolites clearly', 0.2656),\n",
       "  ('week basal', 0.2617),\n",
       "  ('valeric acid', 0.2514),\n",
       "  ('organic', 0.2441),\n",
       "  ('regimens', 0.2382),\n",
       "  ('noted supplementary', 0.2259),\n",
       "  ('intake remained', 0.2246),\n",
       "  ('period percentage', 0.2201),\n",
       "  ('protein leads', 0.2198),\n",
       "  ('unchanged study', 0.2127),\n",
       "  ('reflected increase', 0.2103),\n",
       "  ('healthy', 0.2089),\n",
       "  ('rich', 0.1914),\n",
       "  ('factor analysis', 0.1883),\n",
       "  ('background evaluate', 0.1852),\n",
       "  ('significantly 15', 0.1697),\n",
       "  ('compounds isolated', 0.1647),\n",
       "  ('samples 10', 0.159),\n",
       "  ('007', 0.1513),\n",
       "  ('short', 0.1456),\n",
       "  ('leads altered', 0.1397),\n",
       "  ('formation', 0.1275),\n",
       "  ('chain', 0.1263),\n",
       "  ('paired tests', 0.126),\n",
       "  ('different', 0.1144),\n",
       "  ('energy resistant', 0.1098),\n",
       "  ('used', 0.1086),\n",
       "  ('pattern especially', 0.1048),\n",
       "  ('120 different', 0.0992),\n",
       "  ('04 noted', 0.063),\n",
       "  ('23 007', 0.0475),\n",
       "  ('zoetermeer', 0.0298),\n",
       "  ('netherlands', 0.0234)],\n",
       " 'MED-1428': [('lowered ldl', 0.5344),\n",
       "  ('minimized ldl', 0.4901),\n",
       "  ('lowered 70', 0.4646),\n",
       "  ('cholesterol range', 0.464),\n",
       "  ('ldl range', 0.4475),\n",
       "  ('target ldl', 0.3981),\n",
       "  ('normal low', 0.3811),\n",
       "  ('lipoprotein', 0.3531),\n",
       "  ('low density', 0.3486),\n",
       "  ('ldl 100', 0.3395),\n",
       "  ('studies lowered', 0.331),\n",
       "  ('70 mg', 0.3138),\n",
       "  ('atherosclerosis randomized', 0.2984),\n",
       "  ('gatherers healthy', 0.2888),\n",
       "  ('living primates', 0.2827),\n",
       "  ('healthy human', 0.2617),\n",
       "  ('events minimized', 0.2503),\n",
       "  ('lowered', 0.2468),\n",
       "  ('free living', 0.2182),\n",
       "  ('develop atherosclerosis', 0.208),\n",
       "  ('hunter gatherers', 0.2038),\n",
       "  ('neonates free', 0.2011),\n",
       "  ('current guidelines', 0.1983),\n",
       "  ('risk individuals', 0.1943),\n",
       "  ('coronary', 0.1852),\n",
       "  ('randomized trial', 0.1747),\n",
       "  ('native', 0.1584),\n",
       "  ('range 50', 0.1494),\n",
       "  ('wild mammals', 0.1369),\n",
       "  ('lead substantial', 0.1314),\n",
       "  ('mammals develop', 0.1188),\n",
       "  ('surfaced studies', 0.1154),\n",
       "  ('mg dl', 0.111),\n",
       "  ('100', 0.1025),\n",
       "  ('data suggest', 0.1),\n",
       "  ('range', 0.0982),\n",
       "  ('heart', 0.0849),\n",
       "  ('living', 0.0842),\n",
       "  ('dl major', 0.0837),\n",
       "  ('current', 0.0726),\n",
       "  ('major safety', 0.0684),\n",
       "  ('setting target', 0.0652),\n",
       "  ('115 mg', 0.0626),\n",
       "  ('disease', 0.0592),\n",
       "  ('concerns surfaced', 0.0241),\n",
       "  ('undertreatment high', 0.0064),\n",
       "  ('develop', -0.0024),\n",
       "  ('substantial', -0.0159),\n",
       "  ('human', -0.0373),\n",
       "  ('events', -0.0381)],\n",
       " 'MED-1429': [('steinberg 2004', 0.646),\n",
       "  ('2004 lipid', 0.5135),\n",
       "  ('190 steinberg', 0.476),\n",
       "  ('briefly reviews', 0.3898),\n",
       "  ('lipid res', 0.3894),\n",
       "  ('2006 lipid', 0.3296),\n",
       "  ('studies led', 0.3192),\n",
       "  ('14 traced', 0.3041),\n",
       "  ('discovery statins', 0.3005),\n",
       "  ('45 1583', 0.2958),\n",
       "  ('2005', 0.2928),\n",
       "  ('1984 coronary', 0.2861),\n",
       "  ('cholesterol levels', 0.2762),\n",
       "  ('lowering treatment', 0.2756),\n",
       "  ('morbidity mortality', 0.2168),\n",
       "  ('primary intervention', 0.2153),\n",
       "  ('series traces', 0.2124),\n",
       "  ('evidence evidence', 0.2015),\n",
       "  ('fed rabbit', 0.2006),\n",
       "  ('levels official', 0.1924),\n",
       "  ('classic work', 0.1745),\n",
       "  ('45', 0.1734),\n",
       "  ('disease events', 0.1729),\n",
       "  ('179 190', 0.1597),\n",
       "  ('fed', 0.1575),\n",
       "  ('fraction patients', 0.157),\n",
       "  ('cholestyramine significantly', 0.1549),\n",
       "  ('showing decreasing', 0.1522),\n",
       "  ('number important', 0.1516),\n",
       "  ('scale clinical', 0.148),\n",
       "  ('2037 2051', 0.1459),\n",
       "  ('final', 0.1458),\n",
       "  ('goal small', 0.1435),\n",
       "  ('large randomized', 0.1331),\n",
       "  ('hypothesis', 0.1307),\n",
       "  ('risk', 0.129),\n",
       "  ('safety remarkable', 0.1249),\n",
       "  ('health', 0.1188),\n",
       "  ('model breakthrough', 0.1174),\n",
       "  ('accumulation', 0.1016),\n",
       "  ('kinds supporting', 0.093),\n",
       "  ('questions remained', 0.0877),\n",
       "  ('double blind', 0.0857),\n",
       "  ('res 47', 0.0788),\n",
       "  ('national public', 0.0781),\n",
       "  ('point time', 0.0746),\n",
       "  ('different', 0.0742),\n",
       "  ('1913', 0.0537),\n",
       "  ('anitschkow', 0.0342),\n",
       "  ('led', 0.0186)],\n",
       " 'MED-1430': [('diet groups', 0.5208),\n",
       "  ('tg values', 0.4526),\n",
       "  ('hdl vegetarians', 0.4463),\n",
       "  ('total cholesterol', 0.4329),\n",
       "  ('restricted vegetarians', 0.413),\n",
       "  ('triglyceride', 0.3869),\n",
       "  ('density lipoprotein', 0.3564),\n",
       "  ('ldl compared', 0.3556),\n",
       "  ('collected 76', 0.3467),\n",
       "  ('conclusion vegetarian', 0.3409),\n",
       "  ('values omnivores', 0.3221),\n",
       "  ('methods blood', 0.3001),\n",
       "  ('01 hdl', 0.28),\n",
       "  ('values 155', 0.2754),\n",
       "  ('groups', 0.2704),\n",
       "  ('reported vegans', 0.2645),\n",
       "  ('001 tg', 0.2552),\n",
       "  ('separated different', 0.2521),\n",
       "  ('omnivores decreased', 0.2499),\n",
       "  ('reported samples', 0.2275),\n",
       "  ('samples higher', 0.217),\n",
       "  ('males females', 0.2143),\n",
       "  ('dl group', 0.2008),\n",
       "  ('compare levels', 0.1841),\n",
       "  ('lacto', 0.1761),\n",
       "  ('dl 69', 0.1712),\n",
       "  ('56', 0.1587),\n",
       "  ('67 mg', 0.1546),\n",
       "  ('products restricted', 0.1531),\n",
       "  ('84 mg', 0.1454),\n",
       "  ('results significant', 0.142),\n",
       "  ('difference reported', 0.1344),\n",
       "  ('standard deviation', 0.134),\n",
       "  ('total', 0.1271),\n",
       "  ('respectively 123', 0.1218),\n",
       "  ('ratio significantly', 0.1036),\n",
       "  ('tc 208', 0.1033),\n",
       "  ('141 06', 0.0998),\n",
       "  ('deviation tc', 0.0988),\n",
       "  ('dl 81', 0.0851),\n",
       "  ('dosing', 0.0822),\n",
       "  ('high density', 0.066),\n",
       "  ('53 mg', 0.0623),\n",
       "  ('ovo', 0.0616),\n",
       "  ('objective', 0.0515),\n",
       "  ('90 mg', 0.0476),\n",
       "  ('30', 0.034),\n",
       "  ('lowest', 0.0001),\n",
       "  ('43 42', -0.0178),\n",
       "  ('animal', -0.1039)],\n",
       " 'MED-1431': [('advanced glycation', 0.6076),\n",
       "  ('elders dementia', 0.5314),\n",
       "  ('cognitive aging', 0.5238),\n",
       "  ('adults diabetes', 0.5114),\n",
       "  ('rate diabetes', 0.4798),\n",
       "  ('diabetes diminished', 0.4197),\n",
       "  ('results older', 0.3987),\n",
       "  ('dementia 495', 0.3552),\n",
       "  ('cardiovascular disease', 0.3456),\n",
       "  ('products ages', 0.342),\n",
       "  ('ages cross', 0.3356),\n",
       "  ('glucose mean', 0.3277),\n",
       "  ('estimated glomerular', 0.2959),\n",
       "  ('disease estimated', 0.2602),\n",
       "  ('risk cognitive', 0.2502),\n",
       "  ('920 elders', 0.2413),\n",
       "  ('05 different', 0.2383),\n",
       "  ('education hypertension', 0.2272),\n",
       "  ('mental state', 0.2092),\n",
       "  ('impairment higher', 0.2022),\n",
       "  ('baseline age', 0.1934),\n",
       "  ('digit symbol', 0.187),\n",
       "  ('age 74', 0.1825),\n",
       "  ('proteins', 0.1775),\n",
       "  ('confidence interval', 0.1768),\n",
       "  ('year decline', 0.1731),\n",
       "  ('ratio 55', 0.1701),\n",
       "  ('objective studies', 0.1565),\n",
       "  ('62 95', 0.1494),\n",
       "  ('425 normal', 0.1449),\n",
       "  ('association peripheral', 0.1397),\n",
       "  ('sd test', 0.1385),\n",
       "  ('regression results', 0.1322),\n",
       "  ('repeatedly years', 0.1252),\n",
       "  ('overall 001', 0.1212),\n",
       "  ('03 incident', 0.1182),\n",
       "  ('worse baseline', 0.1096),\n",
       "  ('level compared', 0.1053),\n",
       "  ('analyzed tertile', 0.0987),\n",
       "  ('remained similar', 0.0946),\n",
       "  ('urine pentosidine', 0.0848),\n",
       "  ('little known', 0.0835),\n",
       "  ('sex race', 0.079),\n",
       "  ('mixed', 0.0678),\n",
       "  ('substitution test', 0.0232),\n",
       "  ('22 odds', 0.0116),\n",
       "  ('modified mini', 0.0082),\n",
       "  ('07 26', -0.0048),\n",
       "  ('32 tests', -0.006),\n",
       "  ('17', -0.0115)],\n",
       " 'MED-1432': [('sirtuins sirts', 0.7402),\n",
       "  ('sirts family', 0.719),\n",
       "  ('mammalian sirts', 0.6818),\n",
       "  ('mammals sirt1', 0.6595),\n",
       "  ('sirt roles', 0.6323),\n",
       "  ('sirt1 identified', 0.5849),\n",
       "  ('sirts discusses', 0.5817),\n",
       "  ('isoforms sirt', 0.553),\n",
       "  ('deacetylases emerging', 0.5496),\n",
       "  ('sirt life', 0.5213),\n",
       "  ('sirt3 mitochondria', 0.4544),\n",
       "  ('repair sirt3', 0.4291),\n",
       "  ('connection sirt', 0.4168),\n",
       "  ('nad dependent', 0.3857),\n",
       "  ('diseases seven', 0.3507),\n",
       "  ('family nicotinamide', 0.3486),\n",
       "  ('molecules regulate', 0.3173),\n",
       "  ('mitochondrial bioenergetics', 0.2914),\n",
       "  ('roles mammalian', 0.2624),\n",
       "  ('neurodegenerative diseases', 0.257),\n",
       "  ('nucleus regulate', 0.254),\n",
       "  ('including cancers', 0.2514),\n",
       "  ('nematodes', 0.2116),\n",
       "  ('aging age', 0.2077),\n",
       "  ('metabolic disorders', 0.207),\n",
       "  ('adenine dinucleotide', 0.2054),\n",
       "  ('range organisms', 0.2044),\n",
       "  ('review describes', 0.2007),\n",
       "  ('transcription genes', 0.1962),\n",
       "  ('mechanisms underlying', 0.1951),\n",
       "  ('roles effect', 0.1889),\n",
       "  ('yeasts', 0.183),\n",
       "  ('regulates', 0.172),\n",
       "  ('identified mammals', 0.1716),\n",
       "  ('dna repair', 0.1541),\n",
       "  ('isoforms', 0.1166),\n",
       "  ('flies', 0.113),\n",
       "  ('calorie restriction', 0.1102),\n",
       "  ('emerging key', 0.1072),\n",
       "  ('reported controversial', 0.076),\n",
       "  ('prolonging effects', 0.0756),\n",
       "  ('describes functional', 0.0723),\n",
       "  ('mainly localized', 0.0494),\n",
       "  ('initial studies', 0.039),\n",
       "  ('intervention longevity', 0.0235),\n",
       "  ('relevance', 0.0196),\n",
       "  ('family', 0.0169),\n",
       "  ('dependent', -0.0071),\n",
       "  ('robust experimental', -0.011),\n",
       "  ('strong connection', -0.0386)],\n",
       " 'MED-1433': [('advanced glycation', 0.7352),\n",
       "  ('dietary ages', 0.6023),\n",
       "  ('quantify ages', 0.4453),\n",
       "  ('products ages', 0.4432),\n",
       "  ('aging provide', 0.4377),\n",
       "  ('diseases aging', 0.4354),\n",
       "  ('ages vivo', 0.4331),\n",
       "  ('aging cardiovascular', 0.4264),\n",
       "  ('concentrations older', 0.4172),\n",
       "  ('reducing sugar', 0.4),\n",
       "  ('higher ages', 0.3894),\n",
       "  ('proteins macromolecules', 0.3735),\n",
       "  ('restriction ages', 0.3628),\n",
       "  ('adults higher', 0.3435),\n",
       "  ('mellitus results', 0.3366),\n",
       "  ('insulin resistance', 0.3327),\n",
       "  ('adults chronic', 0.3235),\n",
       "  ('food people', 0.2961),\n",
       "  ('tissues damaged', 0.287),\n",
       "  ('cardiovascular diseases', 0.2834),\n",
       "  ('amino', 0.2815),\n",
       "  ('group compounds', 0.2407),\n",
       "  ('endogenously humans', 0.2307),\n",
       "  ('intake reported', 0.23),\n",
       "  ('complications', 0.2278),\n",
       "  ('healing insulin', 0.2269),\n",
       "  ('enzymatic way', 0.2252),\n",
       "  ('end products', 0.2237),\n",
       "  ('complex group', 0.2211),\n",
       "  ('degenerative', 0.2177),\n",
       "  ('years increased', 0.2039),\n",
       "  ('lifespan animal', 0.2032),\n",
       "  ('alzheimer', 0.1992),\n",
       "  ('damaged years', 0.1843),\n",
       "  ('implicated development', 0.1767),\n",
       "  ('humans greater', 0.1689),\n",
       "  ('non enzymatic', 0.1574),\n",
       "  ('models humans', 0.1536),\n",
       "  ('people identify', 0.129),\n",
       "  ('identify mechanisms', 0.1273),\n",
       "  ('explain human', 0.1176),\n",
       "  ('progressing', 0.1151),\n",
       "  ('increased evidence', 0.1146),\n",
       "  ('reacts', 0.1035),\n",
       "  ('results studies', 0.1028),\n",
       "  ('paper summarize', 0.1009),\n",
       "  ('heterogeneous', 0.099),\n",
       "  ('suggestions future', 0.059),\n",
       "  ('healthy', 0.0368),\n",
       "  ('vivo', 0.012)],\n",
       " 'MED-1434': [('proteins sirtuins', 0.7325),\n",
       "  ('histone deacetylases', 0.5874),\n",
       "  ('focus sirt1', 0.4707),\n",
       "  ('histone substrates', 0.4693),\n",
       "  ('nad suppress', 0.4452),\n",
       "  ('suppress genome', 0.4235),\n",
       "  ('expand sirtuins', 0.408),\n",
       "  ('non histone', 0.4035),\n",
       "  ('regulated nicotinamide', 0.3803),\n",
       "  ('proteins related', 0.3638),\n",
       "  ('repair enzymes', 0.3449),\n",
       "  ('focus review', 0.3232),\n",
       "  ('coactivators', 0.323),\n",
       "  ('therapeutic targets', 0.3207),\n",
       "  ('energy metabolism', 0.2948),\n",
       "  ('diseases focus', 0.2922),\n",
       "  ('genome wide', 0.2795),\n",
       "  ('transcription upregulate', 0.2691),\n",
       "  ('recently neuroprotective', 0.2675),\n",
       "  ('kinases transcription', 0.2638),\n",
       "  ('mechanisms play', 0.2464),\n",
       "  ('restriction recently', 0.2335),\n",
       "  ('regarding protective', 0.2261),\n",
       "  ('regulator', 0.2253),\n",
       "  ('key role', 0.2133),\n",
       "  ('substrates', 0.1975),\n",
       "  ('compiled serve', 0.1836),\n",
       "  ('disorders cerebral', 0.1825),\n",
       "  ('effects elicited', 0.1805),\n",
       "  ('role longevity', 0.1682),\n",
       "  ('silent information', 0.1534),\n",
       "  ('dna', 0.1473),\n",
       "  ('dependent', 0.1362),\n",
       "  ('hopefully help', 0.1357),\n",
       "  ('acute chronic', 0.1203),\n",
       "  ('alzheimer disease', 0.1174),\n",
       "  ('comprehensive reference', 0.1171),\n",
       "  ('summarize latest', 0.1148),\n",
       "  ('adenine', 0.1108),\n",
       "  ('select set', 0.1034),\n",
       "  ('sclerosis multiple', 0.1007),\n",
       "  ('parkinson', 0.089),\n",
       "  ('centering non', 0.0707),\n",
       "  ('amyotrophic lateral', 0.0655),\n",
       "  ('brain expression', 0.0564),\n",
       "  ('group', 0.0486),\n",
       "  ('targets future', 0.0478),\n",
       "  ('introduce distribution', 0.0341),\n",
       "  ('nervous date', 0.0322),\n",
       "  ('ischemia axonal', -0.0029)],\n",
       " 'MED-1435': [('neuroimaging studies', 0.4884),\n",
       "  ('study aging', 0.4327),\n",
       "  ('scans 92', 0.3913),\n",
       "  ('studies lacking', 0.388),\n",
       "  ('brain atrophy', 0.3706),\n",
       "  ('scans', 0.3197),\n",
       "  ('significant longitudinal', 0.3149),\n",
       "  ('greater decline', 0.3033),\n",
       "  ('lacking quantified', 0.2872),\n",
       "  ('slower rates', 0.277),\n",
       "  ('magnetic resonance', 0.2749),\n",
       "  ('years baseline', 0.2617),\n",
       "  ('changes pathology', 0.2615),\n",
       "  ('tissue loss', 0.2594),\n",
       "  ('images baseline', 0.2432),\n",
       "  ('baseline baltimore', 0.2305),\n",
       "  ('loss older', 0.2258),\n",
       "  ('compared temporal', 0.2243),\n",
       "  ('tissue inferred', 0.2184),\n",
       "  ('regions white', 0.2156),\n",
       "  ('92 nondemented', 0.2132),\n",
       "  ('total brain', 0.2116),\n",
       "  ('study', 0.209),\n",
       "  ('matter volume', 0.2052),\n",
       "  ('volumes subgroup', 0.2017),\n",
       "  ('adults data', 0.1836),\n",
       "  ('lobar regions', 0.1775),\n",
       "  ('85 years', 0.1772),\n",
       "  ('annual rates', 0.1615),\n",
       "  ('cognitively healthy', 0.1591),\n",
       "  ('individuals remain', 0.1587),\n",
       "  ('regional pattern', 0.1534),\n",
       "  ('quantified', 0.1381),\n",
       "  ('years', 0.1345),\n",
       "  ('medically cognitively', 0.1314),\n",
       "  ('gray 001', 0.1301),\n",
       "  ('changes widespread', 0.1292),\n",
       "  ('direct measurements', 0.1107),\n",
       "  ('demonstrate significant', 0.1035),\n",
       "  ('cross', 0.0964),\n",
       "  ('subgroup 24', 0.0787),\n",
       "  ('frontal parietal', 0.0772),\n",
       "  ('age 59', 0.0762),\n",
       "  ('essential information', 0.0705),\n",
       "  ('extent mesial', 0.0609),\n",
       "  ('cm3 respectively', 0.0505),\n",
       "  ('ventricles increased', 0.0009),\n",
       "  ('insular', -0.0053),\n",
       "  ('orbital inferior', -0.0056),\n",
       "  ('cingulate', -0.0061)],\n",
       " 'MED-1436': [('review sirtuins', 0.7631),\n",
       "  ('sirtuins family', 0.6621),\n",
       "  ('mammalian sirt1', 0.593),\n",
       "  ('oxygen sirt1', 0.5516),\n",
       "  ('sirt1 overexpression', 0.4923),\n",
       "  ('promoting longevity', 0.4131),\n",
       "  ('decrease sirt1', 0.4101),\n",
       "  ('recent advances', 0.394),\n",
       "  ('ageing shown', 0.3581),\n",
       "  ('neuroprotection cognitive', 0.3358),\n",
       "  ('recent studies', 0.3318),\n",
       "  ('stress regulation', 0.3018),\n",
       "  ('oxidative stress', 0.2971),\n",
       "  ('deacetylase activity', 0.2932),\n",
       "  ('prevents oxidative', 0.293),\n",
       "  ('conserved evolution', 0.2807),\n",
       "  ('nad recently', 0.2793),\n",
       "  ('regulation foxo', 0.2732),\n",
       "  ('enzymes highly', 0.2594),\n",
       "  ('revealed mechanisms', 0.2479),\n",
       "  ('resveratrol strongly', 0.2391),\n",
       "  ('review', 0.2108),\n",
       "  ('catabolic tissue', 0.1985),\n",
       "  ('alzheimer disease', 0.1983),\n",
       "  ('understanding role', 0.1871),\n",
       "  ('acetylated', 0.1558),\n",
       "  ('known promote', 0.1536),\n",
       "  ('disease pathology', 0.1466),\n",
       "  ('inhibit mtor', 0.1363),\n",
       "  ('transcription factors', 0.1299),\n",
       "  ('recently', 0.129),\n",
       "  ('findings accumulative', 0.1109),\n",
       "  ('apoptosis increases', 0.1107),\n",
       "  ('factors addition', 0.1105),\n",
       "  ('mammalian', 0.1104),\n",
       "  ('aims discuss', 0.1104),\n",
       "  ('activity dose', 0.0955),\n",
       "  ('reactive', 0.0954),\n",
       "  ('signalling summary', 0.0764),\n",
       "  ('overexpression prevents', 0.0672),\n",
       "  ('notch pathway', 0.0521),\n",
       "  ('gene', 0.0466),\n",
       "  ('substrate', 0.0444),\n",
       "  ('healthy', 0.0436),\n",
       "  ('increasing binding', 0.0393),\n",
       "  ('family', 0.0299),\n",
       "  ('production influence', 0.0062),\n",
       "  ('influence adam10', 0.0055),\n",
       "  ('direct inactivation', -0.0343),\n",
       "  ('shown affect', -0.0538)],\n",
       " 'MED-1437': [('sirtuins barcelona', 0.6177),\n",
       "  ('establishes sirtuins', 0.4999),\n",
       "  ('sirtuins major', 0.468),\n",
       "  ('barcelona hosted', 0.4185),\n",
       "  ('protein deacetylases', 0.4149),\n",
       "  ('biomedical research', 0.4053),\n",
       "  ('emerging findings', 0.3601),\n",
       "  ('targeting pathophysiology', 0.3402),\n",
       "  ('understanding functions', 0.3374),\n",
       "  ('biology', 0.3221),\n",
       "  ('hot topics', 0.2794),\n",
       "  ('focused evolutionary', 0.2791),\n",
       "  ('work summarized', 0.2614),\n",
       "  ('cellular homeostasis', 0.252),\n",
       "  ('experts biochemistry', 0.226),\n",
       "  ('physiological processes', 0.2241),\n",
       "  ('hosted scientific', 0.2179),\n",
       "  ('scientific meeting', 0.217),\n",
       "  ('drug targeting', 0.178),\n",
       "  ('lifespan cancer', 0.175),\n",
       "  ('family proteins', 0.1748),\n",
       "  ('bringing experts', 0.1663),\n",
       "  ('summarized establishes', 0.1662),\n",
       "  ('completely focused', 0.1636),\n",
       "  ('lies understanding', 0.1592),\n",
       "  ('recently', 0.1579),\n",
       "  ('substrates', 0.1546),\n",
       "  ('mice models', 0.152),\n",
       "  ('expanding field', 0.1502),\n",
       "  ('molecules work', 0.1405),\n",
       "  ('models', 0.1385),\n",
       "  ('diseases act', 0.1341),\n",
       "  ('restriction diabetes', 0.1253),\n",
       "  ('cellular transformation', 0.1212),\n",
       "  ('energy calorie', 0.1211),\n",
       "  ('transformation energy', 0.1148),\n",
       "  ('longevity', 0.1007),\n",
       "  ('protein', 0.0956),\n",
       "  ('conserved', 0.0806),\n",
       "  ('processes undoubtedly', 0.0761),\n",
       "  ('work', 0.0643),\n",
       "  ('answer lies', 0.0351),\n",
       "  ('growth', 0.0319),\n",
       "  ('tie diversity', 0.0127),\n",
       "  ('range', 0.007),\n",
       "  ('act', 0.0003),\n",
       "  ('bringing', -0.0021),\n",
       "  ('meeting completely', -0.0057),\n",
       "  ('major players', -0.0256),\n",
       "  ('field stay', -0.0473)],\n",
       " 'MED-1438': [('serum methylglyoxal', 0.568),\n",
       "  ('smg diabetes', 0.4894),\n",
       "  ('increased diabetes', 0.4318),\n",
       "  ('aging examined', 0.4262),\n",
       "  ('glycations end', 0.4208),\n",
       "  ('cognitive decline', 0.4149),\n",
       "  ('oxidant stress', 0.3744),\n",
       "  ('cardiovascular risk', 0.3326),\n",
       "  ('smg cognitive', 0.3137),\n",
       "  ('demented', 0.2996),\n",
       "  ('mental state', 0.2881),\n",
       "  ('mmse points', 0.2761),\n",
       "  ('neurotoxicity serum', 0.2693),\n",
       "  ('models assessed', 0.2664),\n",
       "  ('serum levels', 0.2573),\n",
       "  ('adjusted model', 0.2458),\n",
       "  ('decline mini', 0.2435),\n",
       "  ('study elevated', 0.2232),\n",
       "  ('kidney function', 0.2133),\n",
       "  ('assessed association', 0.2123),\n",
       "  ('stress', 0.1964),\n",
       "  ('assessed elisa', 0.1894),\n",
       "  ('factors added', 0.1885),\n",
       "  ('26 mmse', 0.1866),\n",
       "  ('background', 0.1681),\n",
       "  ('genotype significant', 0.1621),\n",
       "  ('cognitively normal', 0.1605),\n",
       "  ('controlling sociodemographic', 0.1534),\n",
       "  ('conclusions higher', 0.1429),\n",
       "  ('products increase', 0.1424),\n",
       "  ('derivatives', 0.14),\n",
       "  ('years education', 0.1342),\n",
       "  ('cell injury', 0.1314),\n",
       "  ('function apoe4', 0.1305),\n",
       "  ('significance unchanged', 0.1215),\n",
       "  ('tobit mixed', 0.1158),\n",
       "  ('clinically evident', 0.1121),\n",
       "  ('subjects', 0.1066),\n",
       "  ('267 non', 0.1055),\n",
       "  ('annual', 0.0823),\n",
       "  ('increase baseline', 0.074),\n",
       "  ('regression', 0.0694),\n",
       "  ('03', 0.0479),\n",
       "  ('suggesting generality', 0.0461),\n",
       "  ('differ sex', 0.0371),\n",
       "  ('points unit', 0.0286),\n",
       "  ('exam', 0.0188),\n",
       "  ('relationship did', 0.0057),\n",
       "  ('associated faster', -0.0259),\n",
       "  ('compromise', -0.0313)],\n",
       " 'MED-1439': [('stereological methods', 0.4481),\n",
       "  ('older participants', 0.4144),\n",
       "  ('age mean', 0.4084),\n",
       "  ('women age', 0.3224),\n",
       "  ('underwent mris', 0.3206),\n",
       "  ('participants', 0.3134),\n",
       "  ('brain volume', 0.3117),\n",
       "  ('32 women', 0.301),\n",
       "  ('methods methods', 0.2922),\n",
       "  ('brains initial', 0.2824),\n",
       "  ('sd 78', 0.2796),\n",
       "  ('results annual', 0.2769),\n",
       "  ('purpose study', 0.2661),\n",
       "  ('average volume', 0.2583),\n",
       "  ('ventricles normal', 0.2581),\n",
       "  ('34 men', 0.2527),\n",
       "  ('baseline', 0.2505),\n",
       "  ('conclusions findings', 0.2454),\n",
       "  ('female brains', 0.2194),\n",
       "  ('related disproportional', 0.2173),\n",
       "  ('related cerebral', 0.2135),\n",
       "  ('investigate longitudinal', 0.2075),\n",
       "  ('sd cerebral', 0.2066),\n",
       "  ('cerebellum age', 0.2045),\n",
       "  ('range 74', 0.1981),\n",
       "  ('men women', 0.1959),\n",
       "  ('enlargement lateral', 0.1943),\n",
       "  ('years range', 0.1938),\n",
       "  ('examinations', 0.1852),\n",
       "  ('defined cortex', 0.1817),\n",
       "  ('atrophy cerebrum', 0.1733),\n",
       "  ('percentage change', 0.1605),\n",
       "  ('using unbiased', 0.1598),\n",
       "  ('87 years', 0.1567),\n",
       "  ('mri decreased', 0.1556),\n",
       "  ('underwent', 0.133),\n",
       "  ('identical conclusions', 0.1192),\n",
       "  ('related', 0.1029),\n",
       "  ('year 001', 0.0903),\n",
       "  ('different men', 0.0863),\n",
       "  ('annual decrease', 0.0781),\n",
       "  ('method cavalieri', 0.0774),\n",
       "  ('white matter', 0.0729),\n",
       "  ('basal ganglia', 0.0507),\n",
       "  ('changes human', 0.0452),\n",
       "  ('significantly different', 0.0294),\n",
       "  ('principle', 0.0192),\n",
       "  ('magnetic', -0.0021),\n",
       "  ('male female', -0.0375),\n",
       "  ('apart', -0.1255)],\n",
       " 'MED-1440': [('ad sirtuins', 0.5958),\n",
       "  ('sirt1 levels', 0.5705),\n",
       "  ('sirtuins increase', 0.5165),\n",
       "  ('factors alzheimer', 0.3991),\n",
       "  ('sirt1 decreased', 0.3886),\n",
       "  ('metabolism compared', 0.3543),\n",
       "  ('amyloid aβ42', 0.337),\n",
       "  ('aging', 0.3281),\n",
       "  ('tau mrna', 0.2803),\n",
       "  ('western immunoblots', 0.2705),\n",
       "  ('cerebellum analyses', 0.256),\n",
       "  ('model ad', 0.2512),\n",
       "  ('related disorders', 0.2363),\n",
       "  ('associated accumulation', 0.233),\n",
       "  ('cognitive impairment', 0.2086),\n",
       "  ('patients 19', 0.2075),\n",
       "  ('protein correlated', 0.2034),\n",
       "  ('increase lifespan', 0.1983),\n",
       "  ('regulation cellular', 0.1896),\n",
       "  ('risk factors', 0.1578),\n",
       "  ('29 protein', 0.1548),\n",
       "  ('analyses', 0.1293),\n",
       "  ('brains', 0.123),\n",
       "  ('45 parietal', 0.1188),\n",
       "  ('22 using', 0.1174),\n",
       "  ('compared concentration', 0.1171),\n",
       "  ('cohort', 0.1144),\n",
       "  ('patients individuals', 0.0992),\n",
       "  ('translated', 0.083),\n",
       "  ('230 protein', 0.0747),\n",
       "  ('scores proximate', 0.0746),\n",
       "  ('367 protein', 0.0674),\n",
       "  ('36 subjects', 0.0645),\n",
       "  ('subjects confirmed', 0.0604),\n",
       "  ('levels remained', 0.0585),\n",
       "  ('119 weakly', 0.0535),\n",
       "  ('triple transgenic', 0.0519),\n",
       "  ('global', 0.0498),\n",
       "  ('049 contrast', 0.045),\n",
       "  ('death r2', 0.0434),\n",
       "  ('072 significant', 0.0403),\n",
       "  ('negatively duration', 0.0383),\n",
       "  ('significant reduction', 0.0215),\n",
       "  ('individuals mild', 0.0173),\n",
       "  ('weakly insoluble', 0.0145),\n",
       "  ('r2 326', 0.0129),\n",
       "  ('animal', 0.0086),\n",
       "  ('filament', 0.0002),\n",
       "  ('situ', -0.0375),\n",
       "  ('paired helical', -0.0422)],\n",
       " 'MED-1441': [('common spices', 0.5381),\n",
       "  ('salsa components', 0.515),\n",
       "  ('cooking practices', 0.4485),\n",
       "  ('food additives', 0.4254),\n",
       "  ('antimicrobial properties', 0.4049),\n",
       "  ('food spoilage', 0.3784),\n",
       "  ('demonstrated ingredients', 0.3715),\n",
       "  ('common food', 0.3513),\n",
       "  ('cuisines recent', 0.3307),\n",
       "  ('microorganisms developed', 0.3031),\n",
       "  ('aureus evidenced', 0.285),\n",
       "  ('practices incorporated', 0.2684),\n",
       "  ('developed laboratory', 0.2615),\n",
       "  ('recent studies', 0.2519),\n",
       "  ('effects organisms', 0.2232),\n",
       "  ('ethnic', 0.2104),\n",
       "  ('interdisciplinarity inherent', 0.2075),\n",
       "  ('promotes use', 0.1958),\n",
       "  ('process science', 0.1885),\n",
       "  ('employed garlic', 0.1732),\n",
       "  ('students enjoyed', 0.1724),\n",
       "  ('ethanol extracted', 0.1522),\n",
       "  ('science students', 0.1482),\n",
       "  ('focusing definitions', 0.1473),\n",
       "  ('fungus saccharomyces', 0.1438),\n",
       "  ('methodology evaluate', 0.1426),\n",
       "  ('multiple', 0.1375),\n",
       "  ('extracted modification', 0.1351),\n",
       "  ('exercise promotes', 0.1301),\n",
       "  ('bacillus', 0.1275),\n",
       "  ('jalapeño tested', 0.1244),\n",
       "  ('responses secondary', 0.1077),\n",
       "  ('cilantro', 0.1031),\n",
       "  ('statistically significant', 0.1011),\n",
       "  ('crossed cultural', 0.0973),\n",
       "  ('tomato onion', 0.0963),\n",
       "  ('coli component', 0.0961),\n",
       "  ('cereus', 0.0949),\n",
       "  ('sensitivity employed', 0.0906),\n",
       "  ('employed', 0.0816),\n",
       "  ('boundaries appear', 0.0807),\n",
       "  ('modification kirby', 0.0717),\n",
       "  ('consistently', 0.0708),\n",
       "  ('compared control', 0.0697),\n",
       "  ('learning', 0.0622),\n",
       "  ('increase number', 0.0494),\n",
       "  ('comparison preliminary', 0.0468),\n",
       "  ('nutmeg', 0.037),\n",
       "  ('cinnamon clove', 0.0335),\n",
       "  ('slightly inhibited', 0.0187)],\n",
       " 'MED-1442': [('twins rated', 0.5604),\n",
       "  ('smell stimuli', 0.5046),\n",
       "  ('adult twins', 0.5027),\n",
       "  ('differences taste', 0.4989),\n",
       "  ('taste receptor', 0.462),\n",
       "  ('variation olfactory', 0.4124),\n",
       "  ('chemosensory aspects', 0.3986),\n",
       "  ('genetic variation', 0.3362),\n",
       "  ('flavor ethanol', 0.3175),\n",
       "  ('gene tas2r60', 0.305),\n",
       "  ('tas2r50 flavor', 0.3049),\n",
       "  ('sucrose sodium', 0.3038),\n",
       "  ('traits individual', 0.2854),\n",
       "  ('stimuli', 0.2802),\n",
       "  ('phenotype results', 0.2767),\n",
       "  ('simple foods', 0.2738),\n",
       "  ('detected ratings', 0.2696),\n",
       "  ('associations detected', 0.2682),\n",
       "  ('basil traits', 0.2452),\n",
       "  ('time traits', 0.2442),\n",
       "  ('bitter', 0.2437),\n",
       "  ('variants', 0.2431),\n",
       "  ('influences perception', 0.2419),\n",
       "  ('citric acid', 0.2412),\n",
       "  ('potassium chloride', 0.2128),\n",
       "  ('scnn1d study', 0.2081),\n",
       "  ('drinks partially', 0.2009),\n",
       "  ('aspects water', 0.1933),\n",
       "  ('quinine androstenone', 0.1862),\n",
       "  ('differences stable', 0.1812),\n",
       "  ('hydrochloride', 0.1729),\n",
       "  ('receptor gene', 0.1681),\n",
       "  ('subunit epithelial', 0.1556),\n",
       "  ('phenylthiocarbamide ptc', 0.155),\n",
       "  ('cilantro variants', 0.1534),\n",
       "  ('encoding', 0.1502),\n",
       "  ('new associations', 0.1432),\n",
       "  ('cinnamon', 0.1397),\n",
       "  ('galaxolide', 0.1388),\n",
       "  ('single nucleotide', 0.1361),\n",
       "  ('subjects', 0.1345),\n",
       "  ('adult', 0.1314),\n",
       "  ('explored', 0.1311),\n",
       "  ('trpa1 gnat3', 0.1253),\n",
       "  ('analyses confirmed', 0.1174),\n",
       "  ('partially accounted', 0.1161),\n",
       "  ('genotyped 44', 0.0602),\n",
       "  ('previous', 0.0407),\n",
       "  ('h2', 0.018),\n",
       "  ('71', -0.0107)],\n",
       " 'MED-1443': [('coriander oil', 0.5264),\n",
       "  ('oil ultraviolet', 0.3862),\n",
       "  ('tolerance coriander', 0.3853),\n",
       "  ('lipolotion coriander', 0.3781),\n",
       "  ('used antimicrobial', 0.3478),\n",
       "  ('effect test', 0.346),\n",
       "  ('compared placebo', 0.3364),\n",
       "  ('blind study', 0.3348),\n",
       "  ('mild antiinflammatory', 0.3333),\n",
       "  ('fragrance present', 0.3303),\n",
       "  ('test vivo', 0.325),\n",
       "  ('40 volunteers', 0.3172),\n",
       "  ('preparations assessed', 0.3058),\n",
       "  ('inflammatory', 0.2972),\n",
       "  ('test substances', 0.2942),\n",
       "  ('potency', 0.2912),\n",
       "  ('reduced uv', 0.2872),\n",
       "  ('investigated', 0.2799),\n",
       "  ('methods', 0.2769),\n",
       "  ('erythema effective', 0.2588),\n",
       "  ('positive controls', 0.2585),\n",
       "  ('investigated anti', 0.2564),\n",
       "  ('present study', 0.2257),\n",
       "  ('irradiated', 0.2249),\n",
       "  ('areas treated', 0.2238),\n",
       "  ('results compared', 0.2223),\n",
       "  ('tolerance test', 0.2141),\n",
       "  ('volunteers', 0.213),\n",
       "  ('treated occlusion', 0.2108),\n",
       "  ('hydrocortisone skin', 0.209),\n",
       "  ('controlled double', 0.209),\n",
       "  ('enrolled monocentric', 0.2071),\n",
       "  ('bo effect', 0.1868),\n",
       "  ('irradiated fold', 0.1865),\n",
       "  ('concomitant treatment', 0.1749),\n",
       "  ('non irradiated', 0.1543),\n",
       "  ('enrolled', 0.1499),\n",
       "  ('used place', 0.1463),\n",
       "  ('containing essential', 0.1403),\n",
       "  ('useful', 0.14),\n",
       "  ('skin diseases', 0.1385),\n",
       "  ('concentrations excellent', 0.1376),\n",
       "  ('valerate', 0.1357),\n",
       "  ('agent natural', 0.1228),\n",
       "  ('summary background', 0.0951),\n",
       "  ('vehicle served', 0.0912),\n",
       "  ('measured photometrically', 0.0849),\n",
       "  ('hours lipolotion', 0.0807),\n",
       "  ('48', 0.0786),\n",
       "  ('betamethasone valerate', -0.004)],\n",
       " 'MED-1444': [('coriander coriandrum', 0.6323),\n",
       "  ('sativum herbal', 0.5922),\n",
       "  ('medicinal uses', 0.5394),\n",
       "  ('valuable herb', 0.4812),\n",
       "  ('herbal', 0.4616),\n",
       "  ('family apiceae', 0.4467),\n",
       "  ('traditional remedies', 0.4388),\n",
       "  ('civilizations plant', 0.4289),\n",
       "  ('culinary', 0.3987),\n",
       "  ('bioactives wide', 0.3733),\n",
       "  ('plant', 0.3275),\n",
       "  ('phytochemistry biological', 0.3063),\n",
       "  ('different civilizations', 0.2955),\n",
       "  ('flavoring', 0.2813),\n",
       "  ('essential oil', 0.262),\n",
       "  ('potential uses', 0.2431),\n",
       "  ('isolated seeds', 0.241),\n",
       "  ('array pharmacological', 0.2389),\n",
       "  ('disorders folk', 0.2139),\n",
       "  ('different parts', 0.2134),\n",
       "  ('treatment different', 0.1996),\n",
       "  ('medicine systems', 0.1905),\n",
       "  ('functional food', 0.1816),\n",
       "  ('uses functional', 0.1766),\n",
       "  ('activities ascribed', 0.1683),\n",
       "  ('linalool isolated', 0.1647),\n",
       "  ('nutraceutical industry', 0.1589),\n",
       "  ('anti dyslipidemic', 0.1588),\n",
       "  ('anxiolytic', 0.1418),\n",
       "  ('petroselinic', 0.1368),\n",
       "  ('neuro protective', 0.1264),\n",
       "  ('review focuses', 0.1254),\n",
       "  ('belonging family', 0.1229),\n",
       "  ('lead detoxifying', 0.1189),\n",
       "  ('depressant', 0.1145),\n",
       "  ('wiley sons', 0.1107),\n",
       "  ('source lipids', 0.1044),\n",
       "  ('aerial', 0.1013),\n",
       "  ('presence multitude', 0.0922),\n",
       "  ('industry copyright', 0.0857),\n",
       "  ('inflammatory', 0.0824),\n",
       "  ('agent traditional', 0.0809),\n",
       "  ('acid', 0.0656),\n",
       "  ('epileptic', 0.0606),\n",
       "  ('explore', 0.06),\n",
       "  ('diabetic', 0.0263),\n",
       "  ('mutagenic', 0.0151),\n",
       "  ('high', -0.0105),\n",
       "  ('anti', -0.0306),\n",
       "  ('2012', -0.0349)],\n",
       " 'MED-1445': [('low fat', 0.5088),\n",
       "  ('dietary intake', 0.4477),\n",
       "  ('postmenopausal women', 0.4179),\n",
       "  ('intervention group', 0.4151),\n",
       "  ('weight change', 0.4087),\n",
       "  ('insulin sensitivity', 0.4008),\n",
       "  ('control diet', 0.3978),\n",
       "  ('maintain exercise', 0.3868),\n",
       "  ('fat plant', 0.3589),\n",
       "  ('national cholesterol', 0.3517),\n",
       "  ('weight decreased', 0.3377),\n",
       "  ('setting 64', 0.3329),\n",
       "  ('exercise free', 0.3239),\n",
       "  ('vegan diet', 0.3176),\n",
       "  ('subjects methods', 0.3136),\n",
       "  ('metabolism', 0.3129),\n",
       "  ('overweight', 0.2915),\n",
       "  ('012 regression', 0.2872),\n",
       "  ('effect low', 0.2772),\n",
       "  ('outpatient setting', 0.2583),\n",
       "  ('compared kg', 0.2504),\n",
       "  ('investigated effect', 0.2469),\n",
       "  ('difference groups', 0.2356),\n",
       "  ('baseline 14', 0.2264),\n",
       "  ('group body', 0.2212),\n",
       "  ('001 index', 0.2157),\n",
       "  ('living individuals', 0.2128),\n",
       "  ('guidelines', 0.2052),\n",
       "  ('resting', 0.187),\n",
       "  ('setting', 0.1862),\n",
       "  ('plant based', 0.179),\n",
       "  ('control', 0.1773),\n",
       "  ('weeks', 0.1702),\n",
       "  ('size energy', 0.17),\n",
       "  ('results mean', 0.1695),\n",
       "  ('asked maintain', 0.1629),\n",
       "  ('free living', 0.1584),\n",
       "  ('based national', 0.1549),\n",
       "  ('absence prescribed', 0.1521),\n",
       "  ('limits asked', 0.1436),\n",
       "  ('increased 017', 0.1324),\n",
       "  ('randomly', 0.1306),\n",
       "  ('standard deviation', 0.1214),\n",
       "  ('education', 0.0941),\n",
       "  ('rate reported', 0.0763),\n",
       "  ('despite', 0.0743),\n",
       "  ('significant 17', 0.0735),\n",
       "  ('05 thermic', 0.0506),\n",
       "  ('conclusion adoption', 0.0461),\n",
       "  ('sensitivity increased', 0.0047)],\n",
       " 'MED-1446': [('protein intake', 0.5532),\n",
       "  ('obesity 62', 0.4571),\n",
       "  ('weight inconsistent', 0.4382),\n",
       "  ('obesity cohort', 0.4239),\n",
       "  ('related overweight', 0.4215),\n",
       "  ('obesity long', 0.4025),\n",
       "  ('fat', 0.3531),\n",
       "  ('examinations dietary', 0.3206),\n",
       "  ('white men', 0.3109),\n",
       "  ('association protein', 0.2971),\n",
       "  ('men ages', 0.2824),\n",
       "  ('diabetes chronic', 0.2784),\n",
       "  ('chicago western', 0.2634),\n",
       "  ('potential confounders', 0.262),\n",
       "  ('height weight', 0.2364),\n",
       "  ('cohort 730', 0.2165),\n",
       "  ('literature association', 0.197),\n",
       "  ('40 55', 0.1869),\n",
       "  ('study aimed', 0.1788),\n",
       "  ('long term', 0.1736),\n",
       "  ('1966', 0.1701),\n",
       "  ('little known', 0.1694),\n",
       "  ('run', 0.1542),\n",
       "  ('followed 1958', 0.1537),\n",
       "  ('age education', 0.1445),\n",
       "  ('follow adjustment', 0.1435),\n",
       "  ('electric study', 0.143),\n",
       "  ('employed', 0.1408),\n",
       "  ('trend 053', 0.1407),\n",
       "  ('results indicate', 0.1332),\n",
       "  ('62 68', 0.1287),\n",
       "  ('disease odds', 0.1284),\n",
       "  ('higher quartiles', 0.123),\n",
       "  ('saturated', 0.1193),\n",
       "  ('01 participants', 0.117),\n",
       "  ('trained', 0.1158),\n",
       "  ('baseline examinations', 0.1104),\n",
       "  ('compared', 0.107),\n",
       "  ('animal vegetable', 0.1068),\n",
       "  ('sequential', 0.106),\n",
       "  ('history method', 0.1022),\n",
       "  ('measured annually', 0.0927),\n",
       "  ('twice', 0.0758),\n",
       "  ('smoking alcohol', 0.0734),\n",
       "  ('gee used', 0.0623),\n",
       "  ('interviewers generalized', 0.0609),\n",
       "  ('lowest quartile', 0.058),\n",
       "  ('total animal', 0.035),\n",
       "  ('burke comprehensive', 0.0306),\n",
       "  ('seven', -0.029)],\n",
       " 'MED-1447': [('diabetes recruited', 0.471),\n",
       "  ('dietary recalls', 0.4349),\n",
       "  ('intervention program', 0.3842),\n",
       "  ('sites participants', 0.3636),\n",
       "  ('micronutrient intake', 0.3599),\n",
       "  ('diet attend', 0.3593),\n",
       "  ('calcium intake', 0.3542),\n",
       "  ('changes nutrient', 0.3458),\n",
       "  ('increases intake', 0.3346),\n",
       "  ('protective nutrients', 0.332),\n",
       "  ('individuals overweight', 0.33),\n",
       "  ('total fat', 0.3289),\n",
       "  ('10 sites', 0.3093),\n",
       "  ('sites insurance', 0.3),\n",
       "  ('weeks participants', 0.2995),\n",
       "  ('assess effects', 0.2972),\n",
       "  ('background objectives', 0.2947),\n",
       "  ('participants significantly', 0.285),\n",
       "  ('effects macro', 0.2797),\n",
       "  ('ninety individuals', 0.2785),\n",
       "  ('completed baseline', 0.2769),\n",
       "  ('usual diets', 0.276),\n",
       "  ('methods', 0.2719),\n",
       "  ('01 cholesterol', 0.2484),\n",
       "  ('control sites', 0.246),\n",
       "  ('006 monounsaturated', 0.2382),\n",
       "  ('states subjects', 0.2329),\n",
       "  ('settings united', 0.2238),\n",
       "  ('002 conclusions', 0.2103),\n",
       "  ('saturated 006', 0.1977),\n",
       "  ('reduces intake', 0.1969),\n",
       "  ('fiber 002', 0.193),\n",
       "  ('differences changes', 0.1856),\n",
       "  ('02 increased', 0.1778),\n",
       "  ('results compared', 0.1766),\n",
       "  ('corporate setting', 0.1764),\n",
       "  ('fiber carotene', 0.1699),\n",
       "  ('company seventy', 0.1677),\n",
       "  ('conclusions 18', 0.166),\n",
       "  ('recalls group', 0.1613),\n",
       "  ('indicates need', 0.1431),\n",
       "  ('individuals', 0.1407),\n",
       "  ('009 protein', 0.1285),\n",
       "  ('day', 0.1075),\n",
       "  ('04 potassium', 0.0674),\n",
       "  ('continued', 0.0671),\n",
       "  ('randomly', 0.047),\n",
       "  ('183', 0.0037),\n",
       "  ('asked', -0.0191),\n",
       "  ('vegan', -0.0282)],\n",
       " 'MED-1448': [('medical expenditures', 0.5868),\n",
       "  ('aggregate medical', 0.5075),\n",
       "  ('including absenteeism', 0.4551),\n",
       "  ('lost productivity', 0.3945),\n",
       "  ('productivity including', 0.3778),\n",
       "  ('obesity employees', 0.3708),\n",
       "  ('2006 medical', 0.369),\n",
       "  ('excess costs', 0.3218),\n",
       "  ('expenditure panel', 0.3136),\n",
       "  ('employees methods', 0.2947),\n",
       "  ('expenditures value', 0.2925),\n",
       "  ('obese men', 0.2886),\n",
       "  ('aggregate annual', 0.283),\n",
       "  ('savings employers', 0.2702),\n",
       "  ('results men', 0.2698),\n",
       "  ('analysis 2006', 0.2675),\n",
       "  ('presenteeism overweight', 0.2642),\n",
       "  ('costs conclusions', 0.2577),\n",
       "  ('attributable obesity', 0.2569),\n",
       "  ('reduce prevalence', 0.2543),\n",
       "  ('objective quantify', 0.25),\n",
       "  ('mass index', 0.2338),\n",
       "  ('sectional analysis', 0.224),\n",
       "  ('prevalence', 0.2072),\n",
       "  ('survey results', 0.1976),\n",
       "  ('quantify capita', 0.1883),\n",
       "  ('index', 0.1856),\n",
       "  ('estimates range', 0.1788),\n",
       "  ('health wellness', 0.1787),\n",
       "  ('overweight 6087', 0.1726),\n",
       "  ('billion individuals', 0.1659),\n",
       "  ('employees 73', 0.1655),\n",
       "  ('index 35', 0.1619),\n",
       "  ('efforts', 0.1372),\n",
       "  ('methods', 0.1237),\n",
       "  ('37 obese', 0.1193),\n",
       "  ('population', 0.0969),\n",
       "  ('result significant', 0.0965),\n",
       "  ('methods cross', 0.0947),\n",
       "  ('survey 2008', 0.0924),\n",
       "  ('women estimates', 0.0822),\n",
       "  ('responsible 61', 0.072),\n",
       "  ('grade iii', 0.0632),\n",
       "  ('range 797', 0.0424),\n",
       "  ('represent', 0.0371),\n",
       "  ('6694 grade', 0.0328),\n",
       "  ('individuals body', 0.0167),\n",
       "  ('national', -0.0065),\n",
       "  ('ii', -0.0278),\n",
       "  ('range 322', -0.0847)],\n",
       " 'MED-1449': [('improve health', 0.4937),\n",
       "  ('medical costs', 0.4597),\n",
       "  ('health outcomes', 0.4488),\n",
       "  ('programs improve', 0.4371),\n",
       "  ('health spending', 0.4358),\n",
       "  ('disease prevention', 0.4236),\n",
       "  ('programs absenteeism', 0.4215),\n",
       "  ('costs fall', 0.4196),\n",
       "  ('prevention wellness', 0.3955),\n",
       "  ('soaring health', 0.3953),\n",
       "  ('health lower', 0.3939),\n",
       "  ('productivity health', 0.3763),\n",
       "  ('wellness programs', 0.3723),\n",
       "  ('programs medical', 0.3679),\n",
       "  ('beneficial budgets', 0.3316),\n",
       "  ('savings associated', 0.3298),\n",
       "  ('lower costs', 0.311),\n",
       "  ('prevention', 0.277),\n",
       "  ('budgets productivity', 0.2716),\n",
       "  ('workplace disease', 0.2714),\n",
       "  ('improve', 0.2648),\n",
       "  ('programs prove', 0.2557),\n",
       "  ('mechanisms work', 0.2432),\n",
       "  ('outcomes', 0.2291),\n",
       "  ('findings needed', 0.2113),\n",
       "  ('fall 73', 0.207),\n",
       "  ('work broader', 0.2068),\n",
       "  ('prove beneficial', 0.2049),\n",
       "  ('spent wellness', 0.2038),\n",
       "  ('27 dollar', 0.2015),\n",
       "  ('meta analysis', 0.1985),\n",
       "  ('costs critical', 0.1969),\n",
       "  ('growing workplace', 0.1847),\n",
       "  ('disease', 0.1586),\n",
       "  ('literature costs', 0.1509),\n",
       "  ('productivity', 0.1507),\n",
       "  ('work', 0.136),\n",
       "  ('investment suggests', 0.1311),\n",
       "  ('spending growing', 0.1293),\n",
       "  ('adoption programs', 0.1205),\n",
       "  ('applicability findings', 0.1163),\n",
       "  ('fall', 0.1002),\n",
       "  ('suggests wider', 0.0702),\n",
       "  ('return', 0.0663),\n",
       "  ('amid soaring', 0.0537),\n",
       "  ('spent exploration', 0.0384),\n",
       "  ('spent', 0.0268),\n",
       "  ('suggests', 0.013),\n",
       "  ('amid', -0.0062),\n",
       "  ('dollar', -0.0236)],\n",
       " 'MED-1450': [('diet corporate', 0.4998),\n",
       "  ('dietary intervention', 0.4753),\n",
       "  ('low fat', 0.4102),\n",
       "  ('diabetes randomized', 0.4076),\n",
       "  ('methods employees', 0.4033),\n",
       "  ('intervention group', 0.4029),\n",
       "  ('program anthropometric', 0.372),\n",
       "  ('glycemic control', 0.3696),\n",
       "  ('corporate setting', 0.3466),\n",
       "  ('biochemical measures', 0.328),\n",
       "  ('study', 0.3112),\n",
       "  ('background objectives', 0.3033),\n",
       "  ('lipids individuals', 0.2968),\n",
       "  ('lipoprotein ldl', 0.2939),\n",
       "  ('major company', 0.2822),\n",
       "  ('hemoglobin hba1c', 0.2689),\n",
       "  ('setting subjects', 0.2574),\n",
       "  ('determine effects', 0.25),\n",
       "  ('respectively 001', 0.2489),\n",
       "  ('levels', 0.2404),\n",
       "  ('study completers', 0.2393),\n",
       "  ('10 sites', 0.2347),\n",
       "  ('mass index', 0.2318),\n",
       "  ('plant based', 0.2221),\n",
       "  ('vegan', 0.2211),\n",
       "  ('levels decreased', 0.2175),\n",
       "  ('control groups', 0.2174),\n",
       "  ('baseline', 0.2167),\n",
       "  ('effects low', 0.2141),\n",
       "  ('sites major', 0.2061),\n",
       "  ('mean changes', 0.2015),\n",
       "  ('improves body', 0.2014),\n",
       "  ('kg m2', 0.2002),\n",
       "  ('dl control', 0.199),\n",
       "  ('08 kg', 0.1961),\n",
       "  ('cafeteria options', 0.1852),\n",
       "  ('weight plasma', 0.185),\n",
       "  ('support work', 0.177),\n",
       "  ('measures multicenter', 0.1732),\n",
       "  ('changes 18', 0.1722),\n",
       "  ('weight fell', 0.169),\n",
       "  ('individuals', 0.1644),\n",
       "  ('13', 0.1544),\n",
       "  ('m2 previous', 0.1186),\n",
       "  ('previous diagnosis', 0.1166),\n",
       "  ('06', 0.109),\n",
       "  ('weekly', 0.0987),\n",
       "  ('available make', 0.0522),\n",
       "  ('group mg', 0.037),\n",
       "  ('25 kg', -0.0011)],\n",
       " 'MED-1451': [('corporate health', 0.534),\n",
       "  ('workforce health', 0.5274),\n",
       "  ('health safety', 0.4758),\n",
       "  ('safety companies', 0.4524),\n",
       "  ('safety workforce', 0.4438),\n",
       "  ('conclusions companies', 0.4329),\n",
       "  ('health achievement', 0.4268),\n",
       "  ('efforts reduce', 0.4158),\n",
       "  ('results portfolio', 0.4084),\n",
       "  ('focus health', 0.4008),\n",
       "  ('reduce workforce', 0.3957),\n",
       "  ('performance corporate', 0.3907),\n",
       "  ('performance methods', 0.386),\n",
       "  ('companies focus', 0.3727),\n",
       "  ('methods stock', 0.3466),\n",
       "  ('stock market', 0.3452),\n",
       "  ('comprehensive efforts', 0.3418),\n",
       "  ('risks', 0.3283),\n",
       "  ('hypothesis comprehensive', 0.3214),\n",
       "  ('cultures health', 0.3113),\n",
       "  ('workforce yield', 0.3051),\n",
       "  ('using simulation', 0.2912),\n",
       "  ('market performance', 0.2857),\n",
       "  ('associated company', 0.2719),\n",
       "  ('research identified', 0.2625),\n",
       "  ('workforce outperformed', 0.2606),\n",
       "  ('manage', 0.2486),\n",
       "  ('value investors', 0.2451),\n",
       "  ('support building', 0.2244),\n",
       "  ('winning approach', 0.2059),\n",
       "  ('methods', 0.2047),\n",
       "  ('evidence support', 0.2028),\n",
       "  ('tracked different', 0.2018),\n",
       "  ('winners tracked', 0.198),\n",
       "  ('identified association', 0.19),\n",
       "  ('different scenarios', 0.1883),\n",
       "  ('aspects', 0.1647),\n",
       "  ('focusing', 0.1586),\n",
       "  ('objective', 0.1473),\n",
       "  ('achievement', 0.1473),\n",
       "  ('test', 0.1357),\n",
       "  ('competitive advantage', 0.1278),\n",
       "  ('business equally', 0.1237),\n",
       "  ('recognized', 0.0918),\n",
       "  ('equally conclusions', 0.0882),\n",
       "  ('yield', 0.073),\n",
       "  ('greater value', 0.0662),\n",
       "  ('past', 0.058),\n",
       "  ('provides', 0.0417),\n",
       "  ('culture', 0.0414)],\n",
       " 'MED-1454': [('dietary fat', 0.6547),\n",
       "  ('diet importance', 0.5326),\n",
       "  ('insulin resistance', 0.5082),\n",
       "  ('change dietary', 0.491),\n",
       "  ('related metabolic', 0.4894),\n",
       "  ('diet mufa', 0.4268),\n",
       "  ('alter insulin', 0.4155),\n",
       "  ('diet ns', 0.4095),\n",
       "  ('diet 01', 0.3732),\n",
       "  ('controlled isoenergetic', 0.3699),\n",
       "  ('kanwu study', 0.3636),\n",
       "  ('lipoprotein', 0.3347),\n",
       "  ('decreased monounsaturated', 0.3192),\n",
       "  ('study included', 0.2756),\n",
       "  ('acids influenced', 0.2739),\n",
       "  ('included 162', 0.2676),\n",
       "  ('proportion saturated', 0.267),\n",
       "  ('random supplements', 0.2657),\n",
       "  ('disorders aim', 0.2545),\n",
       "  ('mufa 001', 0.239),\n",
       "  ('aims hypothesis', 0.2325),\n",
       "  ('03 did', 0.2219),\n",
       "  ('quality alter', 0.2172),\n",
       "  ('healthy subjects', 0.2145),\n",
       "  ('lp increased', 0.2092),\n",
       "  ('interpretation change', 0.2006),\n",
       "  ('oil', 0.1945),\n",
       "  ('effects', 0.1864),\n",
       "  ('importance', 0.1811),\n",
       "  ('01 decreased', 0.1807),\n",
       "  ('12 lower', 0.1799),\n",
       "  ('humans methods', 0.1779),\n",
       "  ('diet 10', 0.1655),\n",
       "  ('group second', 0.1631),\n",
       "  ('saturated safa', 0.1482),\n",
       "  ('placebo results', 0.1419),\n",
       "  ('resistance related', 0.1318),\n",
       "  ('05 difference', 0.1176),\n",
       "  ('containing high', 0.1152),\n",
       "  ('intake 37e', 0.0979),\n",
       "  ('fish', 0.0974),\n",
       "  ('chosen', 0.0947),\n",
       "  ('months', 0.0916),\n",
       "  ('improves', 0.0879),\n",
       "  ('significantly impaired', 0.0851),\n",
       "  ('secretion beneficial', 0.0782),\n",
       "  ('seen individuals', 0.0685),\n",
       "  ('sensitivity significantly', 0.0523),\n",
       "  ('median', 0.038),\n",
       "  ('low density', 0.0199)],\n",
       " 'MED-1455': [('lipotoxicity occur', 0.6145),\n",
       "  ('fatty acids', 0.5563),\n",
       "  ('dietary sfa', 0.5305),\n",
       "  ('dyslipidemia', 0.5266),\n",
       "  ('tfa intake', 0.5223),\n",
       "  ('acids tfas', 0.426),\n",
       "  ('insulin resistance', 0.4248),\n",
       "  ('influence dietary', 0.4213),\n",
       "  ('obesity focus', 0.3621),\n",
       "  ('liver cardiovascular', 0.3557),\n",
       "  ('lifestyle modification', 0.3542),\n",
       "  ('sfas', 0.349),\n",
       "  ('cardiovascular diseases', 0.3479),\n",
       "  ('metabolic', 0.3335),\n",
       "  ('chronic inflammation', 0.3302),\n",
       "  ('intake promotion', 0.3185),\n",
       "  ('tfas considered', 0.3077),\n",
       "  ('acids involved', 0.3075),\n",
       "  ('atherosclerosis hypertension', 0.2877),\n",
       "  ('cancer atherosclerosis', 0.2752),\n",
       "  ('ingestion', 0.273),\n",
       "  ('reticulum stress', 0.2692),\n",
       "  ('endotoxemia interactions', 0.2665),\n",
       "  ('excessive amounts', 0.2641),\n",
       "  ('contributing disease', 0.2457),\n",
       "  ('effects represented', 0.2378),\n",
       "  ('stress', 0.2333),\n",
       "  ('cardiovascular endothelial', 0.23),\n",
       "  ('degenerative diseases', 0.2253),\n",
       "  ('stress saturated', 0.2181),\n",
       "  ('alteration gut', 0.2153),\n",
       "  ('considered risk', 0.2121),\n",
       "  ('indirect effects', 0.2059),\n",
       "  ('process exacerbates', 0.2058),\n",
       "  ('systems insulin', 0.2026),\n",
       "  ('transfatty', 0.1935),\n",
       "  ('pathways perpetuate', 0.1731),\n",
       "  ('including important', 0.1721),\n",
       "  ('elucidate influence', 0.1701),\n",
       "  ('microbiota systems', 0.162),\n",
       "  ('favor proinflammatory', 0.1609),\n",
       "  ('heart hypertrophy', 0.1471),\n",
       "  ('factor', 0.1465),\n",
       "  ('autoimmunity allergy', 0.1407),\n",
       "  ('target organs', 0.1373),\n",
       "  ('systems', 0.1022),\n",
       "  ('focus paper', 0.0964),\n",
       "  ('strategy treatment', 0.0818),\n",
       "  ('interactions', 0.0571),\n",
       "  ('state', 0.0372)],\n",
       " 'MED-1456': [('vegan diet', 0.5747),\n",
       "  ('vegans 25', 0.4921),\n",
       "  ('hypothesis dietary', 0.4586),\n",
       "  ('01 vegans', 0.4307),\n",
       "  ('21 vegans', 0.3438),\n",
       "  ('total 24', 0.2962),\n",
       "  ('001 polyunsaturated', 0.294),\n",
       "  ('improved insulin', 0.2862),\n",
       "  ('participated study', 0.2837),\n",
       "  ('cardioprotective lower', 0.2753),\n",
       "  ('london uk', 0.2695),\n",
       "  ('glucose mmol', 0.2563),\n",
       "  ('test hypothesis', 0.2545),\n",
       "  ('14 001', 0.2484),\n",
       "  ('interventions', 0.2435),\n",
       "  ('01 conclusion', 0.2286),\n",
       "  ('05 concentrations', 0.227),\n",
       "  ('levels energy', 0.221),\n",
       "  ('content assessed', 0.2122),\n",
       "  ('biochemical profile', 0.2111),\n",
       "  ('plasma triacylglycerol', 0.2052),\n",
       "  ('mass index', 0.2038),\n",
       "  ('intramyocellular', 0.1925),\n",
       "  ('ci 16', 0.1922),\n",
       "  ('results difference', 0.1902),\n",
       "  ('omnivores subjects', 0.1901),\n",
       "  ('design case', 0.1878),\n",
       "  ('soleus', 0.179),\n",
       "  ('imcl levels', 0.1769),\n",
       "  ('impedance results', 0.1666),\n",
       "  ('hospital', 0.1661),\n",
       "  ('setting imperial', 0.1582),\n",
       "  ('storage design', 0.1498),\n",
       "  ('matched matched', 0.146),\n",
       "  ('concentrations significant', 0.1426),\n",
       "  ('vivo proton', 0.132),\n",
       "  ('53 005', 0.1298),\n",
       "  ('medicine hammersmith', 0.1286),\n",
       "  ('difference homa', 0.1278),\n",
       "  ('sensitivity beta', 0.1152),\n",
       "  ('09', 0.1142),\n",
       "  ('polysaccharides 20', 0.1121),\n",
       "  ('027 higher', 0.0754),\n",
       "  ('school medicine', 0.0608),\n",
       "  ('001 nonstarch', 0.0604),\n",
       "  ('32', 0.0432),\n",
       "  ('systolic blood', 0.0258),\n",
       "  ('waist', 0.0166),\n",
       "  ('gender', 0.0064),\n",
       "  ('magnetic', -0.0413)],\n",
       " 'MED-1457': [('fat diet', 0.5337),\n",
       "  ('obesity type', 0.4877),\n",
       "  ('mice hfd', 0.4587),\n",
       "  ('hfd downregulates', 0.4267),\n",
       "  ('mechanism hfd', 0.4174),\n",
       "  ('mitochondrial biogenesis', 0.4167),\n",
       "  ('observed diabetes', 0.4163),\n",
       "  ('muscle biopsies', 0.4105),\n",
       "  ('insulin resistant', 0.4066),\n",
       "  ('dysfunction prediabetic', 0.3689),\n",
       "  ('peroxisome', 0.3476),\n",
       "  ('experiment fed', 0.3235),\n",
       "  ('slc25a12 peroxisome', 0.3061),\n",
       "  ('days muscle', 0.2946),\n",
       "  ('genes differentially', 0.2896),\n",
       "  ('involved oxidative', 0.2867),\n",
       "  ('pgc1beta mrna', 0.2781),\n",
       "  ('mass function', 0.2657),\n",
       "  ('hypothesis fed', 0.2444),\n",
       "  ('fed c57bl', 0.2383),\n",
       "  ('ndufv1 sdhb', 0.2092),\n",
       "  ('proliferator activated', 0.2033),\n",
       "  ('decreased members', 0.2008),\n",
       "  ('isoenergetic', 0.1834),\n",
       "  ('changes mimic', 0.1809),\n",
       "  ('males', 0.1805),\n",
       "  ('01 25', 0.1796),\n",
       "  ('intervention oligonucleotide', 0.1782),\n",
       "  ('bonferonni adjusted', 0.1624),\n",
       "  ('analysis revealed', 0.1619),\n",
       "  ('separate experiment', 0.1553),\n",
       "  ('10', 0.1441),\n",
       "  ('phosphorylation', 0.1384),\n",
       "  ('microarray', 0.1381),\n",
       "  ('mrnas', 0.1349),\n",
       "  ('resistance sustained', 0.1331),\n",
       "  ('associated high', 0.1267),\n",
       "  ('oxphos decreased', 0.1265),\n",
       "  ('protein approximately', 0.1253),\n",
       "  ('adjusted 001', 0.1172),\n",
       "  ('6j mice', 0.11),\n",
       "  ('weeks', 0.1048),\n",
       "  ('90 cytochrome', 0.0986),\n",
       "  ('complex ii', 0.0826),\n",
       "  ('gamma', 0.0683),\n",
       "  ('20 01', 0.0577),\n",
       "  ('necessary', 0.033),\n",
       "  ('40 combined', 0.0134),\n",
       "  ('affect expression', 0.0124),\n",
       "  ('revealed 297', -0.0183)],\n",
       " 'MED-1458': [('intake vegans', 0.5373),\n",
       "  ('vegans 11', 0.523),\n",
       "  ('objectives vegans', 0.4827),\n",
       "  ('vegans lower', 0.4727),\n",
       "  ('vegans 36', 0.4308),\n",
       "  ('mtdna vegans', 0.414),\n",
       "  ('vegans 18', 0.3851),\n",
       "  ('insulin resistance', 0.3835),\n",
       "  ('intramyocellular lipid', 0.3259),\n",
       "  ('measurement visceral', 0.3005),\n",
       "  ('euglycemic', 0.2995),\n",
       "  ('compared omnivores', 0.29),\n",
       "  ('higher glucose', 0.2614),\n",
       "  ('135 significant', 0.2457),\n",
       "  ('ir development', 0.2324),\n",
       "  ('51 vs', 0.223),\n",
       "  ('significant differences', 0.2186),\n",
       "  ('lower imcl', 0.2161),\n",
       "  ('mass index', 0.2047),\n",
       "  ('05 vs', 0.2044),\n",
       "  ('comparable mitochondrial', 0.2035),\n",
       "  ('activity energy', 0.201),\n",
       "  ('layer parameters', 0.1992),\n",
       "  ('bioimpedance bia', 0.1944),\n",
       "  ('aim study', 0.1914),\n",
       "  ('vs controls', 0.1891),\n",
       "  ('race age', 0.1781),\n",
       "  ('controls 13', 0.1732),\n",
       "  ('clamp muscle', 0.1599),\n",
       "  ('diseases higher', 0.1536),\n",
       "  ('sensitivity compared', 0.151),\n",
       "  ('078 537', 0.148),\n",
       "  ('014', 0.1464),\n",
       "  ('36 12', 0.1459),\n",
       "  ('content subjects', 0.142),\n",
       "  ('relates markers', 0.1413),\n",
       "  ('biopsies performed', 0.1324),\n",
       "  ('10', 0.1295),\n",
       "  ('906 conclusions', 0.1277),\n",
       "  ('slightly higher', 0.1096),\n",
       "  ('anthropometry', 0.0982),\n",
       "  ('95 confidence', 0.0966),\n",
       "  ('μmol min', 0.08),\n",
       "  ('ultrasound', 0.079),\n",
       "  ('18 16', 0.0758),\n",
       "  ('402 212', 0.0517),\n",
       "  ('performed citrate', 0.0486),\n",
       "  ('24 550', 0.0434),\n",
       "  ('disposal value', 0.0267),\n",
       "  ('sex body', -0.0194)],\n",
       " 'MED-1459': [('insulin resistance', 0.7059),\n",
       "  ('metabolic disorder', 0.6666),\n",
       "  ('complex metabolic', 0.6299),\n",
       "  ('pathogenesis insulin', 0.5912),\n",
       "  ('impaired insulin', 0.5824),\n",
       "  ('ectopic lipid', 0.4871),\n",
       "  ('pathways implicated', 0.4812),\n",
       "  ('changes fatty', 0.4788),\n",
       "  ('metabolic', 0.4745),\n",
       "  ('lipid deposition', 0.4481),\n",
       "  ('lipid metabolites', 0.4467),\n",
       "  ('signaling insulin', 0.4403),\n",
       "  ('metabolites diacylglycerols', 0.4296),\n",
       "  ('pathway accumulation', 0.4212),\n",
       "  ('upr pathway', 0.3924),\n",
       "  ('energy expenditure', 0.3919),\n",
       "  ('resistance pathways', 0.3837),\n",
       "  ('disorder defies', 0.3812),\n",
       "  ('unfolded protein', 0.3531),\n",
       "  ('metabolites activation', 0.3513),\n",
       "  ('immune pathways', 0.3512),\n",
       "  ('etiological pathway', 0.3497),\n",
       "  ('implicated pathogenesis', 0.3413),\n",
       "  ('uptake lipogenesis', 0.332),\n",
       "  ('resistance complex', 0.3214),\n",
       "  ('pathways closely', 0.3197),\n",
       "  ('ceramides liver', 0.3169),\n",
       "  ('disorder', 0.2798),\n",
       "  ('skeletal muscle', 0.2738),\n",
       "  ('expenditure impact', 0.2729),\n",
       "  ('liver skeletal', 0.2728),\n",
       "  ('protein response', 0.2595),\n",
       "  ('leading impaired', 0.2437),\n",
       "  ('linked changes', 0.2385),\n",
       "  ('ceramides', 0.2218),\n",
       "  ('ultimately accumulation', 0.2097),\n",
       "  ('defies single', 0.1947),\n",
       "  ('ectopic', 0.1871),\n",
       "  ('activation unfolded', 0.187),\n",
       "  ('acid uptake', 0.1862),\n",
       "  ('implicated', 0.1806),\n",
       "  ('impact', 0.1719),\n",
       "  ('complex', 0.1572),\n",
       "  ('signaling', 0.1295),\n",
       "  ('muscle common', 0.1292),\n",
       "  ('closely linked', 0.1027),\n",
       "  ('innate', 0.0911),\n",
       "  ('single etiological', 0.0855),\n",
       "  ('deposition', 0.0569),\n",
       "  ('specific', 0.0245)],\n",
       " 'MED-1460': [('insulin resistance', 0.7634),\n",
       "  ('metabolic syndrome', 0.6655),\n",
       "  ('syndromes obesity', 0.6068),\n",
       "  ('mellitus metabolic', 0.5867),\n",
       "  ('obesity type', 0.5737),\n",
       "  ('muscle insulin', 0.563),\n",
       "  ('linking insulin', 0.5353),\n",
       "  ('ffa level', 0.4861),\n",
       "  ('fatty acids', 0.4588),\n",
       "  ('metabolic', 0.4574),\n",
       "  ('type diabetes', 0.4486),\n",
       "  ('mellitus', 0.4463),\n",
       "  ('skeletal muscle', 0.4429),\n",
       "  ('resistance syndromes', 0.4322),\n",
       "  ('inflammation mitochondrial', 0.4196),\n",
       "  ('mechanisms postulated', 0.3945),\n",
       "  ('oxidative stress', 0.3692),\n",
       "  ('induced muscle', 0.3611),\n",
       "  ('muscle myocytes', 0.3492),\n",
       "  ('elevated plasma', 0.3428),\n",
       "  ('condition associated', 0.3074),\n",
       "  ('resistance accordantly', 0.291),\n",
       "  ('exposure skeletal', 0.2875),\n",
       "  ('acids induced', 0.2646),\n",
       "  ('stress', 0.2606),\n",
       "  ('syndromes precisely', 0.2406),\n",
       "  ('physiological', 0.2399),\n",
       "  ('dysfunction important', 0.2285),\n",
       "  ('inflammation', 0.2218),\n",
       "  ('factors', 0.2204),\n",
       "  ('evidence supporting', 0.2131),\n",
       "  ('placing mitochondrial', 0.2063),\n",
       "  ('linking', 0.1793),\n",
       "  ('associated development', 0.1793),\n",
       "  ('involvement propositions', 0.1781),\n",
       "  ('reviewed experimental', 0.1773),\n",
       "  ('integrative', 0.1749),\n",
       "  ('common factor', 0.1732),\n",
       "  ('saturated', 0.1505),\n",
       "  ('important', 0.1257),\n",
       "  ('model placing', 0.1253),\n",
       "  ('concentrations', 0.1226),\n",
       "  ('type', 0.1161),\n",
       "  ('including randle', 0.1145),\n",
       "  ('level', 0.1054),\n",
       "  ('cycle', 0.0928),\n",
       "  ('propose', 0.0903),\n",
       "  ('vivo vitro', 0.054),\n",
       "  ('free', 0.016),\n",
       "  ('plays', 0.0039)],\n",
       " 'MED-1461': [('insulin resistance', 0.6434),\n",
       "  ('alterations diabetes', 0.5397),\n",
       "  ('offspring diabetic', 0.5251),\n",
       "  ('diabetes 14', 0.5144),\n",
       "  ('abnormalities lipid', 0.4809),\n",
       "  ('diabetes useful', 0.4186),\n",
       "  ('prediabetic states', 0.3888),\n",
       "  ('normal fat', 0.3786),\n",
       "  ('studied euglycemic', 0.3762),\n",
       "  ('triglyceride store', 0.3725),\n",
       "  ('subcutaneous adipocytes', 0.3707),\n",
       "  ('parents model', 0.3244),\n",
       "  ('selected intramyocellular', 0.3168),\n",
       "  ('lean offspring', 0.3012),\n",
       "  ('metabolism', 0.2754),\n",
       "  ('suggested intramuscular', 0.2655),\n",
       "  ('14 young', 0.256),\n",
       "  ('main predictors', 0.2532),\n",
       "  ('habits studied', 0.2404),\n",
       "  ('stepwise regression', 0.23),\n",
       "  ('risk developing', 0.222),\n",
       "  ('associated body', 0.2165),\n",
       "  ('test hypothesis', 0.2133),\n",
       "  ('subjects matched', 0.209),\n",
       "  ('resistance best', 0.2083),\n",
       "  ('13c nmr', 0.1885),\n",
       "  ('anthropomorphic parameters', 0.1851),\n",
       "  ('sensitivity conclusion', 0.1791),\n",
       "  ('saturated unsaturated', 0.1662),\n",
       "  ('soleus 01', 0.165),\n",
       "  ('type iib', 0.1644),\n",
       "  ('clamp assess', 0.1644),\n",
       "  ('muscles assess', 0.1562),\n",
       "  ('chains dual', 0.1527),\n",
       "  ('fiber type', 0.1476),\n",
       "  ('ray energy', 0.1474),\n",
       "  ('localized', 0.1451),\n",
       "  ('model vivo', 0.1434),\n",
       "  ('parameters life', 0.1422),\n",
       "  ('spectroscopy revealed', 0.1235),\n",
       "  ('tools noninvasively', 0.123),\n",
       "  ('magnetic resonance', 0.1224),\n",
       "  ('distribution characterized', 0.1198),\n",
       "  ('acid levels', 0.1143),\n",
       "  ('tibialis anterior', 0.1052),\n",
       "  ('19 showed', 0.0979),\n",
       "  ('higher content', 0.0909),\n",
       "  ('plasma free', 0.0611),\n",
       "  ('store primary', 0.0578),\n",
       "  ('1h nuclear', 0.0535)],\n",
       " 'MED-1463': [('mechanisms lipotoxicity', 0.7164),\n",
       "  ('diabetes lipotoxicity', 0.713),\n",
       "  ('insulin resistance', 0.7048),\n",
       "  ('metabolic syndrome', 0.5862),\n",
       "  ('obesity type', 0.5845),\n",
       "  ('link obesity', 0.5795),\n",
       "  ('diabetes initial', 0.5044),\n",
       "  ('ffa induced', 0.4995),\n",
       "  ('intervention metabolic', 0.4994),\n",
       "  ('hyperinsulinemia er', 0.4935),\n",
       "  ('inflammation oxidative', 0.4721),\n",
       "  ('cause insulin', 0.443),\n",
       "  ('prevailing hypotheses', 0.3841),\n",
       "  ('fatty acids', 0.3828),\n",
       "  ('pathophysiological link', 0.38),\n",
       "  ('molecular mechanism', 0.3317),\n",
       "  ('evidence ffa', 0.3303),\n",
       "  ('hypothesis prevention', 0.3273),\n",
       "  ('initial cause', 0.3171),\n",
       "  ('glucose potential', 0.3051),\n",
       "  ('concept explanation', 0.2909),\n",
       "  ('resistance prevailing', 0.2764),\n",
       "  ('stress relative', 0.262),\n",
       "  ('focus irs', 0.2535),\n",
       "  ('beta cells', 0.2347),\n",
       "  ('irs serine', 0.2343),\n",
       "  ('syndrome', 0.231),\n",
       "  ('potential approach', 0.2209),\n",
       "  ('importance hypothesized', 0.2136),\n",
       "  ('induced', 0.2119),\n",
       "  ('kinases article', 0.1845),\n",
       "  ('receptor signal', 0.1827),\n",
       "  ('article provides', 0.1739),\n",
       "  ('advances molecular', 0.171),\n",
       "  ('discussed focus', 0.168),\n",
       "  ('feedback loop', 0.1606),\n",
       "  ('remains determined', 0.1468),\n",
       "  ('prevention increased', 0.1398),\n",
       "  ('documented literature', 0.1393),\n",
       "  ('cellular', 0.1333),\n",
       "  ('acid', 0.1211),\n",
       "  ('cells synergy', 0.1139),\n",
       "  ('type', 0.1058),\n",
       "  ('role gpr40', 0.0932),\n",
       "  ('vivo recent', 0.0879),\n",
       "  ('negative', 0.0749),\n",
       "  ('stages', 0.0714),\n",
       "  ('secretion vitro', 0.0704),\n",
       "  ('substantial support', 0.0305),\n",
       "  ('free', -0.0022)],\n",
       " 'MED-1464': [('diabetes cohort', 0.6456),\n",
       "  ('ffas increased', 0.4607),\n",
       "  ('free fatty', 0.452),\n",
       "  ('atherosclerosis risk', 0.4515),\n",
       "  ('fasting glucose', 0.4098),\n",
       "  ('ffas independently', 0.3965),\n",
       "  ('circumference triglycerides', 0.376),\n",
       "  ('study aged', 0.3404),\n",
       "  ('obese', 0.3109),\n",
       "  ('communities study', 0.2906),\n",
       "  ('580 incident', 0.2826),\n",
       "  ('inflammation markers', 0.2815),\n",
       "  ('research design', 0.267),\n",
       "  ('bmi waist', 0.2655),\n",
       "  ('566', 0.2607),\n",
       "  ('plasma samples', 0.2555),\n",
       "  ('cohort middle', 0.249),\n",
       "  ('heart rate', 0.2367),\n",
       "  ('04 57', 0.2243),\n",
       "  ('independently associated', 0.2213),\n",
       "  ('methods case', 0.2176),\n",
       "  ('significant conclusions', 0.2069),\n",
       "  ('race', 0.2011),\n",
       "  ('african american', 0.1875),\n",
       "  ('acids', 0.1871),\n",
       "  ('model adjusted', 0.1847),\n",
       "  ('used randomly', 0.167),\n",
       "  ('64 years', 0.1652),\n",
       "  ('american white', 0.1616),\n",
       "  ('years prevalent', 0.158),\n",
       "  ('type', 0.1567),\n",
       "  ('normal weight', 0.1559),\n",
       "  ('men women', 0.1517),\n",
       "  ('relative risks', 0.1292),\n",
       "  ('95', 0.1274),\n",
       "  ('weight highest', 0.1273),\n",
       "  ('aged 45', 0.126),\n",
       "  ('sex', 0.1202),\n",
       "  ('results baseline', 0.1171),\n",
       "  ('levels systemic', 0.1134),\n",
       "  ('formal', 0.0952),\n",
       "  ('hip ratio', 0.0887),\n",
       "  ('noncases 10', 0.087),\n",
       "  ('score 63', 0.0829),\n",
       "  ('associated female', 0.078),\n",
       "  ('vs quartile', 0.0774),\n",
       "  ('ascertained exams', 0.067),\n",
       "  ('ci 20', 0.0216),\n",
       "  ('center hazard', -0.0059),\n",
       "  ('level lowest', -0.0223)],\n",
       " 'MED-1465': [('intramyocellular lipid', 0.5968),\n",
       "  ('lipid imcl', 0.5821),\n",
       "  ('imcl accumulation', 0.5433),\n",
       "  ('hyperinsulinemia elevated', 0.4953),\n",
       "  ('insulin sensitivity', 0.4659),\n",
       "  ('correlated imcl', 0.4363),\n",
       "  ('diet imcl', 0.436),\n",
       "  ('reduced insulin', 0.3761),\n",
       "  ('fat', 0.3715),\n",
       "  ('data lipid', 0.3668),\n",
       "  ('infusion intralipid', 0.3544),\n",
       "  ('hour imcl', 0.3453),\n",
       "  ('interindividual variation', 0.3332),\n",
       "  ('induced studied', 0.3286),\n",
       "  ('spectroscopy mrs', 0.328),\n",
       "  ('accumulation induced', 0.3217),\n",
       "  ('nonesterified fatty', 0.2907),\n",
       "  ('unclear factors', 0.2585),\n",
       "  ('glucose clamp', 0.2547),\n",
       "  ('heparin imcl', 0.1786),\n",
       "  ('resonance', 0.1764),\n",
       "  ('significant changes', 0.1596),\n",
       "  ('quantified magnetic', 0.1521),\n",
       "  ('physiological relevance', 0.1424),\n",
       "  ('circulating', 0.14),\n",
       "  ('infusion protocol', 0.1361),\n",
       "  ('148', 0.1352),\n",
       "  ('effects high', 0.1279),\n",
       "  ('sensitivity present', 0.123),\n",
       "  ('nonesterified', 0.1094),\n",
       "  ('maximum 120', 0.1088),\n",
       "  ('levels started', 0.1047),\n",
       "  ('nefa levels', 0.102),\n",
       "  ('164', 0.0957),\n",
       "  ('acid', 0.0928),\n",
       "  ('reaching minimum', 0.0877),\n",
       "  ('showed greater', 0.0688),\n",
       "  ('003 sol', 0.0664),\n",
       "  ('soleus', 0.0631),\n",
       "  ('gir strongly', 0.0573),\n",
       "  ('83 baseline', 0.0524),\n",
       "  ('12', 0.0519),\n",
       "  ('16', 0.0477),\n",
       "  ('subjects underwent', 0.0462),\n",
       "  ('storage', 0.0445),\n",
       "  ('60', 0.0329),\n",
       "  ('ta muscle', 0.03),\n",
       "  ('healthy male', -0.0083),\n",
       "  ('relationship', -0.0407),\n",
       "  ('05', -0.0491)],\n",
       " 'MED-1466': [('glucose muscle', 0.623),\n",
       "  ('insulin resistance', 0.5734),\n",
       "  ('ffa decrease', 0.5718),\n",
       "  ('ffa glucose', 0.5554),\n",
       "  ('inhibition glucose', 0.5507),\n",
       "  ('free fatty', 0.5256),\n",
       "  ('fasting explain', 0.5214),\n",
       "  ('glucose oxidation', 0.5182),\n",
       "  ('accumulation ffa', 0.5044),\n",
       "  ('acids ffa', 0.5014),\n",
       "  ('fatty acids', 0.5001),\n",
       "  ('diets obesity', 0.4725),\n",
       "  ('decrease glucose', 0.469),\n",
       "  ('resulting glucose', 0.4393),\n",
       "  ('brain fasting', 0.435),\n",
       "  ('obesity', 0.4305),\n",
       "  ('muscle studies', 0.4245),\n",
       "  ('glucose transport', 0.4212),\n",
       "  ('skeletal muscle', 0.4159),\n",
       "  ('fasting', 0.4156),\n",
       "  ('lipid diets', 0.4056),\n",
       "  ('phosphorylation mechanism', 0.3885),\n",
       "  ('redirect glucose', 0.388),\n",
       "  ('glucose phosphate', 0.388),\n",
       "  ('explain insulin', 0.379),\n",
       "  ('rat muscle', 0.3657),\n",
       "  ('lipid', 0.3582),\n",
       "  ('high lipid', 0.3381),\n",
       "  ('muscle brain', 0.338),\n",
       "  ('phosphate accumulation', 0.3069),\n",
       "  ('muscle indicating', 0.2932),\n",
       "  ('transport phosphorylation', 0.2872),\n",
       "  ('direct inhibition', 0.2507),\n",
       "  ('acids', 0.2406),\n",
       "  ('studies suggest', 0.2244),\n",
       "  ('resistance associated', 0.2159),\n",
       "  ('oxidation resulting', 0.2112),\n",
       "  ('suggest competition', 0.2099),\n",
       "  ('decrease', 0.2062),\n",
       "  ('mechanism', 0.1862),\n",
       "  ('human skeletal', 0.1669),\n",
       "  ('accumulation', 0.1439),\n",
       "  ('competition free', 0.1334),\n",
       "  ('explain', 0.1067),\n",
       "  ('rat', 0.0882),\n",
       "  ('redirect', 0.063),\n",
       "  ('associated high', 0.0518),\n",
       "  ('resulting', 0.0507),\n",
       "  ('indicating', 0.0432),\n",
       "  ('human', -0.0255)],\n",
       " 'MED-1467': [('fat adverse', 0.6705),\n",
       "  ('obesity metabolic', 0.6605),\n",
       "  ('abdominal adiposity', 0.6433),\n",
       "  ('insulin resistance', 0.6303),\n",
       "  ('different lipid', 0.5104),\n",
       "  ('metabolic sequelae', 0.491),\n",
       "  ('hyperinsulinemia', 0.4838),\n",
       "  ('lipodystrophy studies', 0.4805),\n",
       "  ('dyslipidemia patients', 0.4583),\n",
       "  ('control obesity', 0.4453),\n",
       "  ('increased cardiovascular', 0.4365),\n",
       "  ('relate atheromatous', 0.42),\n",
       "  ('triglyceride subcutaneous', 0.4171),\n",
       "  ('leptin increased', 0.4148),\n",
       "  ('pathway insulin', 0.409),\n",
       "  ('greater lipolytic', 0.4045),\n",
       "  ('metabolically protective', 0.4037),\n",
       "  ('adiponectin levels', 0.386),\n",
       "  ('perivascular fat', 0.3792),\n",
       "  ('tissue metabolically', 0.3754),\n",
       "  ('intra abdominal', 0.3356),\n",
       "  ('inflammatory cytokines', 0.3303),\n",
       "  ('metabolism partitioning', 0.3155),\n",
       "  ('especially gluteofemoral', 0.3075),\n",
       "  ('liver', 0.2871),\n",
       "  ('diacylglycerol ceramide', 0.2782),\n",
       "  ('hyperinsulinemia unimpaired', 0.2541),\n",
       "  ('intramyocellular', 0.2182),\n",
       "  ('hormone irisin', 0.2173),\n",
       "  ('studies suggest', 0.2121),\n",
       "  ('acids generates', 0.1974),\n",
       "  ('resistance anomalies', 0.1916),\n",
       "  ('long associated', 0.1866),\n",
       "  ('possible augmentation', 0.185),\n",
       "  ('conditions unclear', 0.1497),\n",
       "  ('exercising', 0.1424),\n",
       "  ('tissue adult', 0.1116),\n",
       "  ('oxidizes', 0.0987),\n",
       "  ('properties pericardial', 0.0897),\n",
       "  ('importance humans', 0.0848),\n",
       "  ('mediated greater', 0.084),\n",
       "  ('roles different', 0.0838),\n",
       "  ('men issues', 0.0672),\n",
       "  ('usual living', 0.0605),\n",
       "  ('suggest deep', 0.0511),\n",
       "  ('recognizable brown', 0.0503),\n",
       "  ('small variable', 0.0146),\n",
       "  ('disease clearly', 0.0063),\n",
       "  ('women vs', 0.0034),\n",
       "  ('depots help', -0.0864)],\n",
       " 'MED-1468': [('obesity increasing', 0.652),\n",
       "  ('obesity suggesting', 0.6439),\n",
       "  ('obesity life', 0.5851),\n",
       "  ('obese individuals', 0.547),\n",
       "  ('metabolic disorders', 0.5337),\n",
       "  ('developed fat', 0.4944),\n",
       "  ('increased lipid', 0.4926),\n",
       "  ('intervention obesity', 0.4664),\n",
       "  ('fat cell', 0.4599),\n",
       "  ('adipocytes adults', 0.4403),\n",
       "  ('adipocyte death', 0.4195),\n",
       "  ('health problem', 0.3759),\n",
       "  ('body mass', 0.3721),\n",
       "  ('lipid storage', 0.3623),\n",
       "  ('weight loss', 0.3559),\n",
       "  ('risk cardiovascular', 0.3411),\n",
       "  ('type diabetes', 0.3369),\n",
       "  ('10 fat', 0.3171),\n",
       "  ('adult ages', 0.2661),\n",
       "  ('life expectancy', 0.2552),\n",
       "  ('developed countries', 0.2288),\n",
       "  ('childhood adolescence', 0.1912),\n",
       "  ('generation rate', 0.1713),\n",
       "  ('epidemic manner', 0.1655),\n",
       "  ('high turnover', 0.1352),\n",
       "  ('lean', 0.1109),\n",
       "  ('problem enhancing', 0.1078),\n",
       "  ('major determinant', 0.0987),\n",
       "  ('history factors', 0.0939),\n",
       "  ('new therapeutic', 0.0905),\n",
       "  ('start decrease', 0.0872),\n",
       "  ('cells stays', 0.0749),\n",
       "  ('14c', 0.0738),\n",
       "  ('altered', 0.0735),\n",
       "  ('understood increased', 0.0728),\n",
       "  ('dna approximately', 0.0604),\n",
       "  ('time recent', 0.0589),\n",
       "  ('cells', 0.0585),\n",
       "  ('analysing integration', 0.0531),\n",
       "  ('constitutes public', 0.0515),\n",
       "  ('number condition', 0.0504),\n",
       "  ('tight regulation', 0.0424),\n",
       "  ('storage developed', 0.0394),\n",
       "  ('levels', 0.037),\n",
       "  ('dynamics stable', 0.0336),\n",
       "  ('onset', 0.0086),\n",
       "  ('individuals marked', 0.0012),\n",
       "  ('humans fully', -0.0217),\n",
       "  ('derived nuclear', -0.0353),\n",
       "  ('bomb tests', -0.0832)],\n",
       " 'MED-1470': [('intramuscular lipid', 0.59),\n",
       "  ('insulin resistance', 0.5675),\n",
       "  ('assessed hyperinsulinaemic', 0.474),\n",
       "  ('related bmi', 0.4468),\n",
       "  ('muscle biopsy', 0.4303),\n",
       "  ('relation intramuscular', 0.4087),\n",
       "  ('fatty', 0.3892),\n",
       "  ('triglycerides non', 0.3767),\n",
       "  ('recent muscle', 0.3758),\n",
       "  ('fasting plasma', 0.3736),\n",
       "  ('diabetic', 0.3677),\n",
       "  ('aim study', 0.3478),\n",
       "  ('test intramyocellular', 0.3301),\n",
       "  ('obese humans', 0.326),\n",
       "  ('1h nmr', 0.3254),\n",
       "  ('spectroscopy good', 0.2967),\n",
       "  ('esterified', 0.2879),\n",
       "  ('min determination', 0.285),\n",
       "  ('normal weight', 0.2773),\n",
       "  ('approximately 45', 0.2749),\n",
       "  ('resistance aim', 0.2748),\n",
       "  ('spectroscopy soleus', 0.2605),\n",
       "  ('imcl', 0.235),\n",
       "  ('studied using', 0.2325),\n",
       "  ('analysis showed', 0.2295),\n",
       "  ('proton nuclear', 0.2257),\n",
       "  ('linear regression', 0.2226),\n",
       "  ('invasively localized', 0.2166),\n",
       "  ('kg', 0.2108),\n",
       "  ('mmol clamp', 0.205),\n",
       "  ('resonance', 0.1864),\n",
       "  ('sectional', 0.1831),\n",
       "  ('acids', 0.1735),\n",
       "  ('showed inverse', 0.1681),\n",
       "  ('using novel', 0.1669),\n",
       "  ('concentrations determined', 0.1654),\n",
       "  ('enables', 0.152),\n",
       "  ('correlation 579', 0.1477),\n",
       "  ('sensitivity non', 0.1454),\n",
       "  ('adults 23', 0.1308),\n",
       "  ('m2', 0.1186),\n",
       "  ('24 kg', 0.1087),\n",
       "  ('120', 0.1084),\n",
       "  ('content value', 0.1016),\n",
       "  ('good indicator', 0.0997),\n",
       "  ('magnetic', 0.0661),\n",
       "  ('0267', 0.0632),\n",
       "  ('29 years', 0.0275),\n",
       "  ('years', 0.0272),\n",
       "  ('value 100', -0.0003)],\n",
       " 'MED-1471': [('plasma ffas', 0.6523),\n",
       "  ('obesity commonly', 0.65),\n",
       "  ('insulin resistance', 0.636),\n",
       "  ('link obesity', 0.6245),\n",
       "  ('hyperinsulinemia obesity', 0.6083),\n",
       "  ('obesity remains', 0.5514),\n",
       "  ('hyperinsulinemia lowering', 0.5351),\n",
       "  ('ffas link', 0.5214),\n",
       "  ('subjects obese', 0.5079),\n",
       "  ('treatment obese', 0.494),\n",
       "  ('fatty acid', 0.492),\n",
       "  ('antilipolytic', 0.4725),\n",
       "  ('lowered fasting', 0.4496),\n",
       "  ('improve insulin', 0.3841),\n",
       "  ('fasting', 0.3765),\n",
       "  ('euglycemic', 0.3646),\n",
       "  ('13 obese', 0.3501),\n",
       "  ('diabetic subjects', 0.3353),\n",
       "  ('glucose uptake', 0.3217),\n",
       "  ('important cardiovascular', 0.2948),\n",
       "  ('risk factors', 0.2655),\n",
       "  ('10 obese', 0.2392),\n",
       "  ('tolerance tests', 0.2354),\n",
       "  ('conclude lowering', 0.2287),\n",
       "  ('chronically elevated', 0.2263),\n",
       "  ('tested hypothesis', 0.2013),\n",
       "  ('nondiabetic', 0.1621),\n",
       "  ('clamps', 0.1494),\n",
       "  ('resistance', 0.1488),\n",
       "  ('00 lean', 0.145),\n",
       "  ('study groups', 0.1255),\n",
       "  ('twofold higher', 0.1124),\n",
       "  ('uncertain', 0.1066),\n",
       "  ('patients type', 0.1062),\n",
       "  ('subjects impaired', 0.0984),\n",
       "  ('levels improve', 0.0875),\n",
       "  ('long acting', 0.0837),\n",
       "  ('improve oral', 0.0733),\n",
       "  ('plasma', 0.0724),\n",
       "  ('control', 0.0595),\n",
       "  ('areas', 0.0577),\n",
       "  ('drug', 0.0532),\n",
       "  ('acipimox placebo', 0.0436),\n",
       "  ('11 patients', 0.0299),\n",
       "  ('60', 0.0283),\n",
       "  ('approximately 50', 0.0271),\n",
       "  ('approximately 30', 0.0128),\n",
       "  ('75 performed', 0.0092),\n",
       "  ('free', 0.0004),\n",
       "  ('separate mornings', -0.0231)],\n",
       " 'MED-1472': [('concentrations ffas', 0.5995),\n",
       "  ('glucose uptake', 0.4939),\n",
       "  ('ffas 197', 0.4934),\n",
       "  ('fatty', 0.4539),\n",
       "  ('hyperinsulinemic clamps', 0.4029),\n",
       "  ('mmol basal', 0.3928),\n",
       "  ('inhibit glucose', 0.383),\n",
       "  ('physiological concentrations', 0.3398),\n",
       "  ('suggest physiological', 0.3373),\n",
       "  ('muscle concentrations', 0.3273),\n",
       "  ('studied seven', 0.3181),\n",
       "  ('acids', 0.3073),\n",
       "  ('70 min', 0.2905),\n",
       "  ('transport phosphorylation', 0.2857),\n",
       "  ('concentrations blunted', 0.2843),\n",
       "  ('healthy men', 0.2774),\n",
       "  ('phosphate pi', 0.2713),\n",
       "  ('uptake increased', 0.2412),\n",
       "  ('intramuscular ph', 0.2344),\n",
       "  ('peak early', 0.2281),\n",
       "  ('groups', 0.2188),\n",
       "  ('16 mmol', 0.2124),\n",
       "  ('basal 35', 0.2118),\n",
       "  ('lack initial', 0.1981),\n",
       "  ('using 31p', 0.1965),\n",
       "  ('05 high', 0.19),\n",
       "  ('studies conclusion', 0.185),\n",
       "  ('spectroscopy rates', 0.1836),\n",
       "  ('41 vs', 0.1829),\n",
       "  ('min humans', 0.1811),\n",
       "  ('effects free', 0.1727),\n",
       "  ('140 min', 0.1701),\n",
       "  ('45 min', 0.1683),\n",
       "  ('184 17', 0.1683),\n",
       "  ('013 001', 0.1674),\n",
       "  ('preceding reduction', 0.1368),\n",
       "  ('pi rose', 0.1336),\n",
       "  ('ph decreased', 0.1323),\n",
       "  ('52 micromol', 0.1214),\n",
       "  ('vs control', 0.1171),\n",
       "  ('21 213', 0.1122),\n",
       "  ('body', 0.1014),\n",
       "  ('measured', 0.0874),\n",
       "  ('nuclear magnetic', 0.0675),\n",
       "  ('06', 0.0659),\n",
       "  ('presence', 0.0632),\n",
       "  ('exposure 184', 0.0631),\n",
       "  ('calf muscle', 0.0498),\n",
       "  ('18', 0.0422),\n",
       "  ('disposal', 0.0304)],\n",
       " 'MED-1473': [('muscle glucose', 0.5205),\n",
       "  ('insulin resistance', 0.5168),\n",
       "  ('free fatty', 0.4829),\n",
       "  ('lipids cause', 0.4257),\n",
       "  ('levels euglycemic', 0.3381),\n",
       "  ('metabolism', 0.335),\n",
       "  ('measured 15', 0.2994),\n",
       "  ('reduction muscle', 0.2886),\n",
       "  ('phosphate concentrations', 0.2781),\n",
       "  ('resonance spectroscopy', 0.2723),\n",
       "  ('13c 31p', 0.2712),\n",
       "  ('healthy subjects', 0.2337),\n",
       "  ('humans skeletal', 0.2264),\n",
       "  ('concentrations measured', 0.2263),\n",
       "  ('resistance humans', 0.2199),\n",
       "  ('low 18', 0.2191),\n",
       "  ('synthesis elevated', 0.2138),\n",
       "  ('rate body', 0.2052),\n",
       "  ('acids thought', 0.1893),\n",
       "  ('phosphorylation followed', 0.1833),\n",
       "  ('decreased continuously', 0.1754),\n",
       "  ('pyruvate dehydrogenase', 0.1673),\n",
       "  ('subjects presence', 0.1641),\n",
       "  ('values vs', 0.1625),\n",
       "  ('kg', 0.1608),\n",
       "  ('min simultaneous', 0.1545),\n",
       "  ('control infusion', 0.1477),\n",
       "  ('reduction oxidative', 0.1456),\n",
       "  ('high 93', 0.1432),\n",
       "  ('results demonstrate', 0.1352),\n",
       "  ('01 contrast', 0.1317),\n",
       "  ('conditions', 0.1307),\n",
       "  ('plasma free', 0.1292),\n",
       "  ('uptake affected', 0.1061),\n",
       "  ('preceded fall', 0.1011),\n",
       "  ('50 reduction', 0.1005),\n",
       "  ('examine mechanism', 0.1001),\n",
       "  ('pm clamp', 0.0972),\n",
       "  ('approximately 195', 0.0932),\n",
       "  ('sem control', 0.089),\n",
       "  ('05 rates', 0.0881),\n",
       "  ('nuclear', 0.0843),\n",
       "  ('02 mm', 0.0814),\n",
       "  ('control 237', 0.0803),\n",
       "  ('originally postulated', 0.0763),\n",
       "  ('vs mumol', 0.0696),\n",
       "  ('26 mm', 0.0459),\n",
       "  ('magnetic', -0.0042),\n",
       "  ('transport', -0.0249),\n",
       "  ('400 pm', -0.0696)],\n",
       " 'MED-1474': [('muscle lipid', 0.6659),\n",
       "  ('insulin resistance', 0.6216),\n",
       "  ('mechanisms lipid', 0.5811),\n",
       "  ('increased metabolic', 0.5612),\n",
       "  ('accumulation obesity', 0.5468),\n",
       "  ('lipids accumulate', 0.5439),\n",
       "  ('exposure fatty', 0.5186),\n",
       "  ('muscle mechanisms', 0.4934),\n",
       "  ('adipose tissue', 0.4791),\n",
       "  ('oxidative stress', 0.4236),\n",
       "  ('diabetes suggest', 0.4185),\n",
       "  ('mechanisms effects', 0.4124),\n",
       "  ('acids causes', 0.3901),\n",
       "  ('metabolites long', 0.3874),\n",
       "  ('excess dietary', 0.3858),\n",
       "  ('ceramides impair', 0.3774),\n",
       "  ('pathways mitochondrial', 0.3732),\n",
       "  ('recent findings', 0.3574),\n",
       "  ('inflammatory signalling', 0.3519),\n",
       "  ('genetic dietary', 0.3138),\n",
       "  ('diacylglycerol', 0.2815),\n",
       "  ('reduced intramuscular', 0.2678),\n",
       "  ('review acute', 0.2536),\n",
       "  ('stress forward', 0.2466),\n",
       "  ('resistance recent', 0.2404),\n",
       "  ('tissue liver', 0.2396),\n",
       "  ('summary studies', 0.2315),\n",
       "  ('action challenged', 0.2174),\n",
       "  ('major contributors', 0.2137),\n",
       "  ('coenzyme', 0.2081),\n",
       "  ('exists initial', 0.181),\n",
       "  ('remains clarified', 0.1798),\n",
       "  ('accumulate', 0.1709),\n",
       "  ('genetically modified', 0.1672),\n",
       "  ('suggest plausible', 0.1623),\n",
       "  ('events leading', 0.1617),\n",
       "  ('strongly associated', 0.1479),\n",
       "  ('chain', 0.1431),\n",
       "  ('exposure', 0.1359),\n",
       "  ('load', 0.1302),\n",
       "  ('gene deletions', 0.1237),\n",
       "  ('examine latest', 0.1195),\n",
       "  ('fully elucidated', 0.1165),\n",
       "  ('demonstrated situations', 0.115),\n",
       "  ('synthesis', 0.1038),\n",
       "  ('storage increased', 0.0869),\n",
       "  ('secondary', 0.0762),\n",
       "  ('development maintenance', 0.0611),\n",
       "  ('directly crosstalk', 0.0536),\n",
       "  ('animals humans', -0.0608)],\n",
       " 'MED-1475': [('adolescents bmi', 0.497),\n",
       "  ('insulin resistance', 0.4844),\n",
       "  ('adolescents study', 0.4628),\n",
       "  ('fat oxidation', 0.4443),\n",
       "  ('intralipid il', 0.3904),\n",
       "  ('underwent hyperinsulinemic', 0.3805),\n",
       "  ('changes intramyocellular', 0.3553),\n",
       "  ('plasma tg', 0.3367),\n",
       "  ('results il', 0.3096),\n",
       "  ('ffa', 0.3036),\n",
       "  ('study aimed', 0.2949),\n",
       "  ('increases imcl', 0.2946),\n",
       "  ('significantly race', 0.2841),\n",
       "  ('methods thirteen', 0.276),\n",
       "  ('examine changes', 0.2585),\n",
       "  ('15 caucasian', 0.2561),\n",
       "  ('resistance african', 0.2496),\n",
       "  ('explain predisposition', 0.2441),\n",
       "  ('imcl reductions', 0.2428),\n",
       "  ('associated significant', 0.2259),\n",
       "  ('euglycemic', 0.2224),\n",
       "  ('american', 0.2147),\n",
       "  ('decreased il', 0.2078),\n",
       "  ('difference groups', 0.1868),\n",
       "  ('01', 0.1838),\n",
       "  ('comparable aa', 0.1792),\n",
       "  ('materials methods', 0.1757),\n",
       "  ('anterior muscle', 0.1709),\n",
       "  ('accumulation', 0.1667),\n",
       "  ('ml caucasian', 0.1616),\n",
       "  ('resonance spectroscopy', 0.1563),\n",
       "  ('infusion plasma', 0.1508),\n",
       "  ('hepatic', 0.1358),\n",
       "  ('acute', 0.1342),\n",
       "  ('spectroscopy tibialis', 0.1296),\n",
       "  ('oxidation', 0.1265),\n",
       "  ('clamp', 0.1258),\n",
       "  ('wet weight', 0.1182),\n",
       "  ('85th', 0.1102),\n",
       "  ('underwent', 0.11),\n",
       "  ('increased significantly', 0.1046),\n",
       "  ('occasions random', 0.1032),\n",
       "  ('mg kg', 0.0965),\n",
       "  ('20', 0.0842),\n",
       "  ('conclusions healthy', 0.0748),\n",
       "  ('normal saline', 0.0713),\n",
       "  ('overnight 12', 0.0701),\n",
       "  ('1h magnetic', 0.0516),\n",
       "  ('44 ns', 0.0277),\n",
       "  ('sensitivity decreased', 0.0059)],\n",
       " 'MED-1476': [('occupied neanderthals', 0.5411),\n",
       "  ('neanderthals contemporary', 0.5147),\n",
       "  ('cave site', 0.4856),\n",
       "  ('neanderthals neanderthals', 0.4834),\n",
       "  ('excavations 1991', 0.4365),\n",
       "  ('neanderthal cannibalism', 0.3614),\n",
       "  ('rhone river', 0.3588),\n",
       "  ('000 years', 0.3525),\n",
       "  ('modern rhone', 0.346),\n",
       "  ('inference neanderthal', 0.3427),\n",
       "  ('excavations', 0.33),\n",
       "  ('ago excavations', 0.3185),\n",
       "  ('rich paleontological', 0.2991),\n",
       "  ('site moula', 0.2874),\n",
       "  ('approximately 100', 0.2836),\n",
       "  ('moula guercy', 0.2645),\n",
       "  ('meters modern', 0.2434),\n",
       "  ('contemporary stone', 0.2392),\n",
       "  ('tools faunal', 0.2253),\n",
       "  ('guercy 80', 0.2171),\n",
       "  ('paleobotanical', 0.2104),\n",
       "  ('000', 0.2086),\n",
       "  ('stone tools', 0.1959),\n",
       "  ('controlled stratigraphic', 0.1948),\n",
       "  ('river', 0.1873),\n",
       "  ('faunal remains', 0.1795),\n",
       "  ('assemblages including', 0.1709),\n",
       "  ('80 meters', 0.1568),\n",
       "  ('bone spatial', 0.1334),\n",
       "  ('archaeological', 0.13),\n",
       "  ('rich', 0.1199),\n",
       "  ('comparative analysis', 0.1161),\n",
       "  ('contemporary', 0.1079),\n",
       "  ('ungulate bone', 0.082),\n",
       "  ('analysis hominid', 0.079),\n",
       "  ('skeletal', 0.0668),\n",
       "  ('distributions modifications', 0.0639),\n",
       "  ('spatial contexts', 0.0541),\n",
       "  ('including parts', 0.0521),\n",
       "  ('years', 0.0503),\n",
       "  ('site', 0.05),\n",
       "  ('ago', 0.0464),\n",
       "  ('occupied', 0.0334),\n",
       "  ('representations', 0.0281),\n",
       "  ('cannibalism', 0.0275),\n",
       "  ('yielded', 0.0141),\n",
       "  ('controlled', -0.0258),\n",
       "  ('remains tightly', -0.0495),\n",
       "  ('inference', -0.0912),\n",
       "  ('approximately', -0.0966)],\n",
       " 'MED-1478': [('prevalent evolution', 0.4751),\n",
       "  ('diseases modern', 0.4173),\n",
       "  ('civilization refinements', 0.3796),\n",
       "  ('model changed', 0.3745),\n",
       "  ('quarter century', 0.3261),\n",
       "  ('diets prevalent', 0.3219),\n",
       "  ('ancestors contributed', 0.3163),\n",
       "  ('recommendations impressively', 0.2857),\n",
       "  ('century passed', 0.2857),\n",
       "  ('epidemiological', 0.2746),\n",
       "  ('changed respects', 0.26),\n",
       "  ('departures nutrition', 0.2523),\n",
       "  ('levels refined', 0.2473),\n",
       "  ('testable hypotheses', 0.2449),\n",
       "  ('studies multiplied', 0.222),\n",
       "  ('aspects model', 0.2173),\n",
       "  ('evidence continues', 0.214),\n",
       "  ('ways endemic', 0.2113),\n",
       "  ('discordance', 0.2085),\n",
       "  ('needs past', 0.1756),\n",
       "  ('heuristic value', 0.1561),\n",
       "  ('chronic', 0.1534),\n",
       "  ('ago furthermore', 0.1509),\n",
       "  ('definable ways', 0.1376),\n",
       "  ('years', 0.1363),\n",
       "  ('cholesterol intake', 0.1237),\n",
       "  ('research needs', 0.1216),\n",
       "  ('contributed greatly', 0.1215),\n",
       "  ('risk groups', 0.1136),\n",
       "  ('rest conventional', 0.1104),\n",
       "  ('levels protein', 0.1091),\n",
       "  ('said outset', 0.1022),\n",
       "  ('hunter gatherer', 0.0929),\n",
       "  ('respects anthropological', 0.0923),\n",
       "  ('physical activity', 0.0822),\n",
       "  ('raised necessity', 0.0799),\n",
       "  ('groups compared', 0.0747),\n",
       "  ('controlled trials', 0.0721),\n",
       "  ('resulting', 0.0679),\n",
       "  ('25 years', 0.063),\n",
       "  ('energy throughput', 0.0596),\n",
       "  ('clinical laboratory', 0.0573),\n",
       "  ('lower', 0.0459),\n",
       "  ('targets closer', 0.0136),\n",
       "  ('primarily unsaturated', 0.0088),\n",
       "  ('higher current', 0.0042),\n",
       "  ('common official', -0.0058),\n",
       "  ('fiber', -0.0119),\n",
       "  ('sodium', -0.0155),\n",
       "  ('did', -0.0265)],\n",
       " 'MED-1479': [('diets mismatched', 0.6074),\n",
       "  ('metabolic disease', 0.5087),\n",
       "  ('mismatched evolved', 0.4877),\n",
       "  ('evolutionary discordance', 0.4748),\n",
       "  ('mismatch model', 0.4551),\n",
       "  ('human dietary', 0.3823),\n",
       "  ('evolutionary paradigms', 0.3702),\n",
       "  ('adaptations appear', 0.3666),\n",
       "  ('effects habits', 0.3538),\n",
       "  ('disease model', 0.3482),\n",
       "  ('industrialized diets', 0.332),\n",
       "  ('understanding evolved', 0.3098),\n",
       "  ('human health', 0.304),\n",
       "  ('mechanisms humans', 0.2781),\n",
       "  ('physiology', 0.2765),\n",
       "  ('ill suited', 0.2646),\n",
       "  ('neolithic', 0.2478),\n",
       "  ('rates chronic', 0.2417),\n",
       "  ('era ill', 0.2285),\n",
       "  ('current research', 0.22),\n",
       "  ('life course', 0.2155),\n",
       "  ('biology implies', 0.2121),\n",
       "  ('paleolithic review', 0.2106),\n",
       "  ('center evolutionary', 0.2076),\n",
       "  ('imprint eating', 0.2024),\n",
       "  ('model human', 0.2012),\n",
       "  ('interventions', 0.2006),\n",
       "  ('human bodies', 0.1995),\n",
       "  ('nutrition center', 0.1973),\n",
       "  ('paradigms human', 0.1885),\n",
       "  ('implies instinctual', 0.1859),\n",
       "  ('model remains', 0.1793),\n",
       "  ('strongly genetic', 0.1749),\n",
       "  ('social physiological', 0.1713),\n",
       "  ('reciprocal effects', 0.1663),\n",
       "  ('review', 0.1636),\n",
       "  ('limited assumption', 0.1615),\n",
       "  ('behavioral', 0.1434),\n",
       "  ('modern industrialized', 0.1427),\n",
       "  ('likely reflect', 0.1388),\n",
       "  ('increasing rates', 0.1157),\n",
       "  ('humans learn', 0.0981),\n",
       "  ('niche constructing', 0.0923),\n",
       "  ('broader', 0.0694),\n",
       "  ('influenced human', 0.0588),\n",
       "  ('argue utility', 0.0518),\n",
       "  ('utero', 0.0079),\n",
       "  ('useful tools', -0.0089),\n",
       "  ('appear strongly', -0.0132),\n",
       "  ('determined rooted', -0.0151)],\n",
       " 'MED-1482': [('hygiene hcws', 0.6993),\n",
       "  ('hand hygiene', 0.6267),\n",
       "  ('hcws hand', 0.6212),\n",
       "  ('hygiene compliance', 0.5953),\n",
       "  ('hcws did', 0.5739),\n",
       "  ('hcw patients', 0.5567),\n",
       "  ('care workers', 0.5125),\n",
       "  ('contact precaution', 0.5116),\n",
       "  ('hcw rarely', 0.5038),\n",
       "  ('hcw nurse', 0.4977),\n",
       "  ('increase hcws', 0.4864),\n",
       "  ('hcw similar', 0.4712),\n",
       "  ('precautions thought', 0.4315),\n",
       "  ('51 compliance', 0.4198),\n",
       "  ('similar compliance', 0.4004),\n",
       "  ('methods hospital', 0.4),\n",
       "  ('nurses higher', 0.3915),\n",
       "  ('patients contact', 0.3761),\n",
       "  ('intensive care', 0.3658),\n",
       "  ('health care', 0.3568),\n",
       "  ('compliance noncontact', 0.3446),\n",
       "  ('exception nurses', 0.3445),\n",
       "  ('workers', 0.3368),\n",
       "  ('room contact', 0.2988),\n",
       "  ('differences hand', 0.2882),\n",
       "  ('isolation methods', 0.2819),\n",
       "  ('rooms noncontact', 0.2589),\n",
       "  ('units trained', 0.2484),\n",
       "  ('rooms micu', 0.2413),\n",
       "  ('nurse doctor', 0.2385),\n",
       "  ('sicu intensive', 0.2197),\n",
       "  ('50 contact', 0.2162),\n",
       "  ('awareness sought', 0.2069),\n",
       "  ('surgical', 0.1917),\n",
       "  ('rates 67', 0.186),\n",
       "  ('rarely', 0.147),\n",
       "  ('431 51', 0.1374),\n",
       "  ('trained observer', 0.1326),\n",
       "  ('higher rate', 0.1218),\n",
       "  ('stratified', 0.1202),\n",
       "  ('rates 36', 0.1193),\n",
       "  ('75', 0.0889),\n",
       "  ('96 213', 0.0874),\n",
       "  ('background', 0.0844),\n",
       "  ('did differ', 0.0838),\n",
       "  ('sought determine', 0.0646),\n",
       "  ('directly', 0.0376),\n",
       "  ('132', 0.0277),\n",
       "  ('rooms 10', 0.023),\n",
       "  ('published mosby', -0.0812)],\n",
       " 'MED-1483': [('trials included', 0.5997),\n",
       "  ('effects medicine', 0.5537),\n",
       "  ('compared effects', 0.5402),\n",
       "  ('treatment effects', 0.4822),\n",
       "  ('small studies', 0.4571),\n",
       "  ('context medical', 0.4437),\n",
       "  ('reviews cdsr', 0.4341),\n",
       "  ('interventions according', 0.4285),\n",
       "  ('studies additional', 0.4107),\n",
       "  ('defined efficacy', 0.4057),\n",
       "  ('benefits harms', 0.4001),\n",
       "  ('cochrane', 0.3654),\n",
       "  ('study selection', 0.3638),\n",
       "  ('occasionally clinical', 0.3303),\n",
       "  ('evaluation data', 0.3066),\n",
       "  ('data extraction', 0.3062),\n",
       "  ('large beneficial', 0.2937),\n",
       "  ('nonfatal outcomes', 0.2914),\n",
       "  ('assessed types', 0.2718),\n",
       "  ('effects uncommon', 0.2704),\n",
       "  ('pertained mortality', 0.2475),\n",
       "  ('plots comparisons', 0.2474),\n",
       "  ('topics large', 0.2377),\n",
       "  ('sizes typically', 0.2338),\n",
       "  ('meta', 0.2294),\n",
       "  ('analysis maintained', 0.2202),\n",
       "  ('selection separated', 0.219),\n",
       "  ('cdsr forest', 0.212),\n",
       "  ('frequency features', 0.2038),\n",
       "  ('11 trials', 0.2014),\n",
       "  ('issue study', 0.2001),\n",
       "  ('odds ratio', 0.197),\n",
       "  ('binary outcome', 0.1917),\n",
       "  ('subsequently published', 0.1609),\n",
       "  ('significant 05', 0.1525),\n",
       "  ('20 trials', 0.152),\n",
       "  ('concerns quality', 0.1503),\n",
       "  ('median', 0.1494),\n",
       "  ('severe respiratory', 0.1487),\n",
       "  ('appeared small', 0.1452),\n",
       "  ('02 60', 0.1367),\n",
       "  ('98 large', 0.1309),\n",
       "  ('newborns conclusions', 0.1261),\n",
       "  ('3082', 0.1082),\n",
       "  ('500 selected', 0.0964),\n",
       "  ('85 002', 0.0901),\n",
       "  ('extracorporeal oxygenation', 0.0896),\n",
       "  ('ratio decreased', 0.0843),\n",
       "  ('2010 issue', 0.0702),\n",
       "  ('group depth', 0.057)],\n",
       " 'MED-1484': [('nosocomial infections', 0.5175),\n",
       "  ('infections hai', 0.4848),\n",
       "  ('infections surveillance', 0.4406),\n",
       "  ('data hais', 0.4337),\n",
       "  ('hospitals adjusted', 0.3946),\n",
       "  ('cause morbidity', 0.3912),\n",
       "  ('number healthcare', 0.3857),\n",
       "  ('967 pneumonia', 0.3242),\n",
       "  ('prevention data', 0.3068),\n",
       "  ('study provide', 0.302),\n",
       "  ('existing data', 0.2953),\n",
       "  ('discharge survey', 0.2946),\n",
       "  ('synopsis objective', 0.2939),\n",
       "  ('percentage patients', 0.2938),\n",
       "  ('centers disease', 0.2862),\n",
       "  ('estimated deaths', 0.285),\n",
       "  ('pneumonia 30', 0.2811),\n",
       "  ('sources main', 0.2792),\n",
       "  ('hais newborns', 0.258),\n",
       "  ('risk nurseries', 0.2548),\n",
       "  ('infections 11', 0.2493),\n",
       "  ('nnis data', 0.2474),\n",
       "  ('authors used', 0.2461),\n",
       "  ('states method', 0.2031),\n",
       "  ('national level', 0.1898),\n",
       "  ('step approach', 0.1854),\n",
       "  ('outside icus', 0.1632),\n",
       "  ('surgical site', 0.1622),\n",
       "  ('high', 0.1611),\n",
       "  ('facilities approximately', 0.1592),\n",
       "  ('used multi', 0.1566),\n",
       "  ('association survey', 0.147),\n",
       "  ('million 33', 0.1438),\n",
       "  ('205 surgical', 0.1247),\n",
       "  ('single source', 0.1165),\n",
       "  ('059 newborns', 0.1158),\n",
       "  ('urinary', 0.1041),\n",
       "  ('35 967', 0.0955),\n",
       "  ('19', 0.0899),\n",
       "  ('used supplement', 0.0863),\n",
       "  ('include federal', 0.0799),\n",
       "  ('bloodstream', 0.0788),\n",
       "  ('data 1990', 0.0656),\n",
       "  ('417', 0.062),\n",
       "  ('2002 conducted', 0.0413),\n",
       "  ('makes best', 0.039),\n",
       "  ('13 088', 0.0352),\n",
       "  ('946 adults', 0.0335),\n",
       "  ('665', 0.009),\n",
       "  ('children outside', -0.001)],\n",
       " 'MED-1486': [('statins treatment', 0.6347),\n",
       "  ('treatment expectations', 0.4623),\n",
       "  ('expectations factors', 0.3938),\n",
       "  ('swedish patients', 0.3814),\n",
       "  ('questionnaires health', 0.3749),\n",
       "  ('patient belief', 0.3665),\n",
       "  ('treatment effect', 0.347),\n",
       "  ('identify patients', 0.3372),\n",
       "  ('results medical', 0.3357),\n",
       "  ('risk factors', 0.3296),\n",
       "  ('used outcome', 0.326),\n",
       "  ('patients poor', 0.3257),\n",
       "  ('objective study', 0.3113),\n",
       "  ('cardiovascular disease', 0.3009),\n",
       "  ('prescribing', 0.2916),\n",
       "  ('examine factors', 0.2887),\n",
       "  ('poor belief', 0.2864),\n",
       "  ('belief methods', 0.2836),\n",
       "  ('patients using', 0.2738),\n",
       "  ('postal questionnaires', 0.272),\n",
       "  ('methods', 0.2703),\n",
       "  ('rationale applied', 0.2507),\n",
       "  ('methods 829', 0.2499),\n",
       "  ('lower treatment', 0.2459),\n",
       "  ('practice implications', 0.2459),\n",
       "  ('history coronary', 0.2401),\n",
       "  ('applied physicians', 0.2378),\n",
       "  ('associated negative', 0.2255),\n",
       "  ('829 swedish', 0.2135),\n",
       "  ('perceived', 0.2121),\n",
       "  ('control health', 0.1815),\n",
       "  ('education group', 0.167),\n",
       "  ('social situation', 0.1529),\n",
       "  ('implications association', 0.1529),\n",
       "  ('group reduce', 0.1425),\n",
       "  ('measurement results', 0.1397),\n",
       "  ('associated higher', 0.1388),\n",
       "  ('satisfaction', 0.1374),\n",
       "  ('communication suggested', 0.1319),\n",
       "  ('01 shorter', 0.1305),\n",
       "  ('disease reported', 0.1185),\n",
       "  ('did affect', 0.106),\n",
       "  ('benefits emphasizes', 0.0853),\n",
       "  ('time perspectives', 0.0769),\n",
       "  ('risk non', 0.075),\n",
       "  ('population', 0.0642),\n",
       "  ('10 year', 0.0624),\n",
       "  ('slightly', 0.0307),\n",
       "  ('life', 0.0286),\n",
       "  ('tools', 0.0182)],\n",
       " 'MED-1487': [('benefit screening', 0.5863),\n",
       "  ('accept health', 0.5288),\n",
       "  ('interventions patients', 0.5247),\n",
       "  ('benefit study', 0.5036),\n",
       "  ('health care', 0.4955),\n",
       "  ('patients agreeing', 0.4494),\n",
       "  ('purpose informed', 0.4372),\n",
       "  ('results participation', 0.4329),\n",
       "  ('respondents indicated', 0.4313),\n",
       "  ('interventions practitioners', 0.4187),\n",
       "  ('patients decisions', 0.4139),\n",
       "  ('study assessed', 0.3945),\n",
       "  ('benefits affect', 0.3901),\n",
       "  ('sent questionnaires', 0.3798),\n",
       "  ('prevention respondents', 0.3719),\n",
       "  ('intervention requires', 0.3633),\n",
       "  ('cancer medication', 0.3565),\n",
       "  ('decision accept', 0.3547),\n",
       "  ('participants estimates', 0.3513),\n",
       "  ('risk reduction', 0.3371),\n",
       "  ('understanding likely', 0.3339),\n",
       "  ('conferred interventions', 0.3156),\n",
       "  ('methods general', 0.2948),\n",
       "  ('considered justified', 0.2918),\n",
       "  ('disease estimates', 0.2894),\n",
       "  ('years patients', 0.2887),\n",
       "  ('overestimated intervention', 0.2865),\n",
       "  ('hip fracture', 0.2529),\n",
       "  ('cardiovascular disease', 0.2478),\n",
       "  ('higher estimates', 0.2423),\n",
       "  ('predictors', 0.2355),\n",
       "  ('90 participants', 0.2291),\n",
       "  ('bowel cancer', 0.2278),\n",
       "  ('medication 69', 0.2271),\n",
       "  ('achieved examples', 0.2162),\n",
       "  ('screening 94', 0.2141),\n",
       "  ('discussing', 0.2102),\n",
       "  ('level education', 0.2069),\n",
       "  ('registered', 0.1987),\n",
       "  ('70 years', 0.1982),\n",
       "  ('breast', 0.1925),\n",
       "  ('deaths prevented', 0.1692),\n",
       "  ('indicate minimum', 0.1386),\n",
       "  ('354', 0.1199),\n",
       "  ('aged 50', 0.0999),\n",
       "  ('group 000', 0.0954),\n",
       "  ('977', 0.0946),\n",
       "  ('undergoing', 0.0822),\n",
       "  ('10 years', 0.0347),\n",
       "  ('82', 0.031)],\n",
       " 'MED-1488': [('patients expectations', 0.5629),\n",
       "  ('primary care', 0.5137),\n",
       "  ('sample patients', 0.4965),\n",
       "  ('hypertension asked', 0.474),\n",
       "  ('benefit antihypertensive', 0.4161),\n",
       "  ('deciding receive', 0.4138),\n",
       "  ('care group', 0.407),\n",
       "  ('treatment demographic', 0.4024),\n",
       "  ('investigate patient', 0.3898),\n",
       "  ('higher benefit', 0.3401),\n",
       "  ('surveyed', 0.3315),\n",
       "  ('results participants', 0.3174),\n",
       "  ('anonymous questionnaire', 0.3155),\n",
       "  ('influencing willingness', 0.3052),\n",
       "  ('practice list', 0.3037),\n",
       "  ('aims discover', 0.2988),\n",
       "  ('additional drugs', 0.2965),\n",
       "  ('treatments great', 0.2908),\n",
       "  ('information explain', 0.2869),\n",
       "  ('research methods', 0.2808),\n",
       "  ('stratified', 0.2379),\n",
       "  ('women', 0.2351),\n",
       "  ('people greater', 0.2241),\n",
       "  ('education slope', 0.2218),\n",
       "  ('explain variability', 0.2171),\n",
       "  ('expected mean', 0.2002),\n",
       "  ('understanding risks', 0.1855),\n",
       "  ('difference nnt5', 0.1847),\n",
       "  ('importance', 0.1712),\n",
       "  ('starting terms', 0.1628),\n",
       "  ('largest number', 0.1471),\n",
       "  ('smallest benefit', 0.1408),\n",
       "  ('available demands', 0.1395),\n",
       "  ('gender years', 0.1291),\n",
       "  ('taking', 0.1258),\n",
       "  ('decision easy', 0.111),\n",
       "  ('certainly view', 0.1028),\n",
       "  ('12', 0.0965),\n",
       "  ('individual', 0.0936),\n",
       "  ('prevent myocardial', 0.09),\n",
       "  ('23 years', 0.0822),\n",
       "  ('addition second', 0.0762),\n",
       "  ('longer time', 0.0677),\n",
       "  ('15 95', 0.0566),\n",
       "  ('difficulty reaching', 0.0536),\n",
       "  ('tablets disappeared', 0.0508),\n",
       "  ('17', 0.0308),\n",
       "  ('men', 0.0177),\n",
       "  ('carried single', -0.005),\n",
       "  ('ci 10', -0.007)],\n",
       " 'MED-1489': [('nutrition patients', 0.5004),\n",
       "  ('adherence sustained', 0.4749),\n",
       "  ('cvd responded', 0.47),\n",
       "  ('achieved coronary', 0.4254),\n",
       "  ('patients established', 0.4072),\n",
       "  ('cardiovascular participants', 0.3851),\n",
       "  ('received counseling', 0.3467),\n",
       "  ('stroke adherent', 0.3459),\n",
       "  ('therapy', 0.3424),\n",
       "  ('events dietary', 0.3402),\n",
       "  ('62 nonadherent', 0.3292),\n",
       "  ('methods followed', 0.3282),\n",
       "  ('participants adherent', 0.3156),\n",
       "  ('test adherence', 0.315),\n",
       "  ('small study', 0.3137),\n",
       "  ('198 patients', 0.3044),\n",
       "  ('study skepticism', 0.2965),\n",
       "  ('considered participants', 0.2928),\n",
       "  ('purpose follow', 0.2809),\n",
       "  ('volunteers received', 0.2792),\n",
       "  ('consecutive patient', 0.2658),\n",
       "  ('plant based', 0.2648),\n",
       "  ('reported studies', 0.258),\n",
       "  ('cad arrest', 0.2453),\n",
       "  ('outcomes', 0.2401),\n",
       "  ('events conclusion', 0.2392),\n",
       "  ('experienced low', 0.2369),\n",
       "  ('artery disease', 0.2286),\n",
       "  ('treatment deserves', 0.2265),\n",
       "  ('adherent eliminated', 0.2114),\n",
       "  ('interested transitioning', 0.2082),\n",
       "  ('responded intensive', 0.2053),\n",
       "  ('adjunct', 0.1915),\n",
       "  ('therapy thirteen', 0.1757),\n",
       "  ('experienced adverse', 0.1712),\n",
       "  ('broader populations', 0.1711),\n",
       "  ('reversal small', 0.1701),\n",
       "  ('judged recurrent', 0.1669),\n",
       "  ('disease totaled', 0.146),\n",
       "  ('89', 0.1404),\n",
       "  ('succeed larger', 0.1372),\n",
       "  ('rate significantly', 0.131),\n",
       "  ('usual', 0.1293),\n",
       "  ('177', 0.1194),\n",
       "  ('meat added', 0.1016),\n",
       "  ('convert', 0.0949),\n",
       "  ('dairy fish', 0.0638),\n",
       "  ('years experienced', 0.0572),\n",
       "  ('epidemic', 0.0571),\n",
       "  ('oil results', 0.0091)],\n",
       " 'MED-1490': [('study aimed', 0.4666),\n",
       "  ('threshold design', 0.4493),\n",
       "  ('subjects drug', 0.4246),\n",
       "  ('307 subjects', 0.4094),\n",
       "  ('subjects wished', 0.406),\n",
       "  ('lowering drug', 0.4031),\n",
       "  ('hypothetical cholesterol', 0.3812),\n",
       "  ('myocardial infarction', 0.3486),\n",
       "  ('subjects history', 0.3436),\n",
       "  ('drug strategies', 0.3365),\n",
       "  ('benefit hypothetical', 0.3195),\n",
       "  ('wished told', 0.3174),\n",
       "  ('subject preventive', 0.3015),\n",
       "  ('interview group', 0.3011),\n",
       "  ('design studied', 0.2955),\n",
       "  ('event predictors', 0.2819),\n",
       "  ('uptake informed', 0.2777),\n",
       "  ('objectives', 0.2775),\n",
       "  ('coronary care', 0.2695),\n",
       "  ('subjects just', 0.2596),\n",
       "  ('values expectation', 0.2521),\n",
       "  ('absolute risk', 0.2306),\n",
       "  ('results', 0.2277),\n",
       "  ('views medicinal', 0.2234),\n",
       "  ('reduction groups', 0.223),\n",
       "  ('subjects views', 0.2174),\n",
       "  ('affected', 0.201),\n",
       "  ('strategies tension', 0.1943),\n",
       "  ('know chance', 0.1869),\n",
       "  ('patient', 0.1806),\n",
       "  ('using written', 0.1805),\n",
       "  ('care unit', 0.161),\n",
       "  ('average prolongation', 0.1589),\n",
       "  ('looked proximity', 0.1564),\n",
       "  ('told numerical', 0.1503),\n",
       "  ('median values', 0.1482),\n",
       "  ('starting', 0.1482),\n",
       "  ('taking cardio', 0.1378),\n",
       "  ('drugs eighty', 0.1372),\n",
       "  ('current', 0.1305),\n",
       "  ('conclusion majority', 0.1157),\n",
       "  ('just discharged', 0.1104),\n",
       "  ('20 30', 0.1038),\n",
       "  ('27', 0.0898),\n",
       "  ('higher actual', 0.0874),\n",
       "  ('taking general', 0.0803),\n",
       "  ('group 100', 0.0659),\n",
       "  ('12 12', 0.0263),\n",
       "  ('life', 0.0213),\n",
       "  ('18 months', -0.0448)],\n",
       " 'MED-1491': [('dietary flaxseed', 0.5734),\n",
       "  ('fatty acid', 0.5371),\n",
       "  ('fat ls', 0.5265),\n",
       "  ('fed pork', 0.4962),\n",
       "  ('pigs fed', 0.4902),\n",
       "  ('flaxseed 11', 0.4868),\n",
       "  ('longissimus muscle', 0.4267),\n",
       "  ('pork underestimated', 0.3992),\n",
       "  ('fed fa', 0.384),\n",
       "  ('loin picnic', 0.3666),\n",
       "  ('backfat lss', 0.3559),\n",
       "  ('adipose', 0.3483),\n",
       "  ('measured loin', 0.3247),\n",
       "  ('intakes', 0.312),\n",
       "  ('10 dietary', 0.2867),\n",
       "  ('primals lean', 0.265),\n",
       "  ('chain fa', 0.2643),\n",
       "  ('11 weeks', 0.2628),\n",
       "  ('ls plus', 0.2601),\n",
       "  ('feeding', 0.2511),\n",
       "  ('enrichment inclusion', 0.2422),\n",
       "  ('exceeded primals', 0.2301),\n",
       "  ('combination muscle', 0.2108),\n",
       "  ('underestimated restricted', 0.208),\n",
       "  ('seafood', 0.2073),\n",
       "  ('serving exceeded', 0.201),\n",
       "  ('fold', 0.1794),\n",
       "  ('levels combination', 0.1771),\n",
       "  ('2013', 0.1616),\n",
       "  ('restricted pure', 0.1614),\n",
       "  ('consumed presently', 0.1538),\n",
       "  ('potential increase', 0.1234),\n",
       "  ('daily long', 0.1199),\n",
       "  ('typically low', 0.1169),\n",
       "  ('weeks measured', 0.115),\n",
       "  ('22 5n', 0.1114),\n",
       "  ('epimysium', 0.1077),\n",
       "  ('acid', 0.1019),\n",
       "  ('05 particularly', 0.0965),\n",
       "  ('content necessary', 0.0732),\n",
       "  ('tissues', 0.0727),\n",
       "  ('plus mm', 0.0635),\n",
       "  ('controls 001', 0.0579),\n",
       "  ('particularly 20', 0.05),\n",
       "  ('mg 100', 0.0412),\n",
       "  ('claim canada', 0.0375),\n",
       "  ('amplified total', 0.0348),\n",
       "  ('300 mg', 0.0242),\n",
       "  ('butt', 0.0203),\n",
       "  ('societies typically', 0.001)],\n",
       " 'MED-1492': [('reduction hypertensive', 0.5742),\n",
       "  ('risk reductions', 0.523),\n",
       "  ('blood pressures', 0.522),\n",
       "  ('lowering treatments', 0.4789),\n",
       "  ('reducing blood', 0.407),\n",
       "  ('trials included', 0.4005),\n",
       "  ('compare risk', 0.3757),\n",
       "  ('pressures methods', 0.371),\n",
       "  ('cardiovascular events', 0.3696),\n",
       "  ('types treatments', 0.3437),\n",
       "  ('different regimens', 0.3317),\n",
       "  ('prespecified analysis', 0.3233),\n",
       "  ('effect varies', 0.3113),\n",
       "  ('baseline sbp', 0.3098),\n",
       "  ('evidence differences', 0.2971),\n",
       "  ('background benefits', 0.2881),\n",
       "  ('seven comparisons', 0.2847),\n",
       "  ('different blood', 0.283),\n",
       "  ('different baseline', 0.283),\n",
       "  ('comparison primary', 0.2793),\n",
       "  ('unlikely effectiveness', 0.2792),\n",
       "  ('differences proportionate', 0.2709),\n",
       "  ('pressure cut', 0.2693),\n",
       "  ('lower levels', 0.2634),\n",
       "  ('therapy findings', 0.2614),\n",
       "  ('summary estimates', 0.2587),\n",
       "  ('magnitude effect', 0.2524),\n",
       "  ('methods thirty', 0.2431),\n",
       "  ('effectiveness', 0.2423),\n",
       "  ('dbp categories', 0.2304),\n",
       "  ('data supportive', 0.2268),\n",
       "  ('180 mmhg', 0.2219),\n",
       "  ('groups defined', 0.2204),\n",
       "  ('random effects', 0.2073),\n",
       "  ('remains uncertainty', 0.194),\n",
       "  ('conclusion appears', 0.188),\n",
       "  ('140 140', 0.1699),\n",
       "  ('commonly used', 0.1609),\n",
       "  ('suggest additional', 0.1437),\n",
       "  ('controlled', 0.1427),\n",
       "  ('159 160', 0.1411),\n",
       "  ('meta', 0.1233),\n",
       "  ('targets', 0.1228),\n",
       "  ('objective', 0.1218),\n",
       "  ('majority patients', 0.1198),\n",
       "  ('history', 0.1154),\n",
       "  ('according higher', 0.0948),\n",
       "  ('20 079', 0.0884),\n",
       "  ('meeting', 0.0468),\n",
       "  ('201 566', 0.0293)],\n",
       " 'MED-1493': [('benefits flaxseed', 0.7347),\n",
       "  ('flaxseed various', 0.686),\n",
       "  ('dietary fibers', 0.5393),\n",
       "  ('nutritional importance', 0.4747),\n",
       "  ('alpha linoleic', 0.4486),\n",
       "  ('rich oil', 0.4392),\n",
       "  ('alternative dietary', 0.4381),\n",
       "  ('meet dietary', 0.3883),\n",
       "  ('presence omega', 0.3824),\n",
       "  ('processed foods', 0.339),\n",
       "  ('antioxidant agent', 0.3259),\n",
       "  ('functional components', 0.2967),\n",
       "  ('rich', 0.2947),\n",
       "  ('fibers', 0.2758),\n",
       "  ('therapeutic value', 0.2479),\n",
       "  ('preparations curative', 0.2421),\n",
       "  ('strong basis', 0.2273),\n",
       "  ('diabetes enhancement', 0.224),\n",
       "  ('secoisolariciresinol diglucoside', 0.2153),\n",
       "  ('pivotal role', 0.202),\n",
       "  ('enhancement spatial', 0.1965),\n",
       "  ('numerous health', 0.1906),\n",
       "  ('resources meet', 0.1796),\n",
       "  ('minerals', 0.1766),\n",
       "  ('body literature', 0.1679),\n",
       "  ('acid', 0.1642),\n",
       "  ('products availability', 0.1599),\n",
       "  ('protein', 0.157),\n",
       "  ('constitute', 0.1538),\n",
       "  ('respect remarkable', 0.1463),\n",
       "  ('enables', 0.1451),\n",
       "  ('developing countries', 0.1429),\n",
       "  ('application various', 0.1366),\n",
       "  ('forthcoming generations', 0.1316),\n",
       "  ('typically focusing', 0.1305),\n",
       "  ('massive increase', 0.125),\n",
       "  ('agent extensive', 0.1227),\n",
       "  ('alpha', 0.1173),\n",
       "  ('cardiovascular diseases', 0.113),\n",
       "  ('preventive role', 0.111),\n",
       "  ('discusses length', 0.1028),\n",
       "  ('sciences', 0.0763),\n",
       "  ('researchers engaged', 0.0631),\n",
       "  ('cell line', 0.056),\n",
       "  ('review question', 0.0466),\n",
       "  ('spatial memory', 0.0355),\n",
       "  ('size population', 0.032),\n",
       "  ('diseases cancer', 0.0262),\n",
       "  ('urge exploration', 0.0257),\n",
       "  ('position domain', 0.0012)],\n",
       " 'MED-1494': [('supplementation flaxseed', 0.648),\n",
       "  ('flaxseed hypertension', 0.6409),\n",
       "  ('levels fatty', 0.429),\n",
       "  ('lower flaxseed', 0.4194),\n",
       "  ('benefit dietary', 0.419),\n",
       "  ('ingestion antihypertensive', 0.3659),\n",
       "  ('linolenic acid', 0.3655),\n",
       "  ('hypertension commonly', 0.3515),\n",
       "  ('plasma levels', 0.3198),\n",
       "  ('variety foods', 0.311),\n",
       "  ('patients cardiovascular', 0.3077),\n",
       "  ('enterolignans increased', 0.2904),\n",
       "  ('fed group', 0.2904),\n",
       "  ('trial sbp', 0.2564),\n",
       "  ('fiber provide', 0.2501),\n",
       "  ('daily ingestion', 0.2497),\n",
       "  ('benefits patients', 0.2378),\n",
       "  ('lignans', 0.2342),\n",
       "  ('levels correlated', 0.2307),\n",
       "  ('disease purpose', 0.2159),\n",
       "  ('examine effects', 0.2151),\n",
       "  ('weights significantly', 0.2078),\n",
       "  ('acid levels', 0.1866),\n",
       "  ('associated peripheral', 0.1812),\n",
       "  ('artery', 0.1672),\n",
       "  ('commonly associated', 0.1664),\n",
       "  ('entered trial', 0.1639),\n",
       "  ('did increase', 0.1539),\n",
       "  ('systolic', 0.1429),\n",
       "  ('15 mm', 0.1407),\n",
       "  ('50 fold', 0.1249),\n",
       "  ('compared placebo', 0.1106),\n",
       "  ('patients prospective', 0.11),\n",
       "  ('fold', 0.1076),\n",
       "  ('potent', 0.1066),\n",
       "  ('lower dbp', 0.1032),\n",
       "  ('different groups', 0.1002),\n",
       "  ('significantly different', 0.0934),\n",
       "  ('baseline obtained', 0.0929),\n",
       "  ('body', 0.0835),\n",
       "  ('achieved selectively', 0.0739),\n",
       "  ('months plasma', 0.0706),\n",
       "  ('30', 0.0705),\n",
       "  ('total', 0.0624),\n",
       "  ('work identified', 0.0542),\n",
       "  ('circulating', 0.0502),\n",
       "  ('animal', 0.0322),\n",
       "  ('110 total', 0.0172),\n",
       "  ('double', -0.0143),\n",
       "  ('milled', -0.0505)],\n",
       " 'MED-1495': [('formulation beef', 0.5241),\n",
       "  ('beef patties', 0.4795),\n",
       "  ('sensory analysis', 0.4345),\n",
       "  ('color ph', 0.406),\n",
       "  ('tp ingredients', 0.404),\n",
       "  ('effect flaxseed', 0.4011),\n",
       "  ('fs tp', 0.4002),\n",
       "  ('quality characteristics', 0.3759),\n",
       "  ('characteristics cooked', 0.375),\n",
       "  ('fs tomato', 0.3575),\n",
       "  ('addition 10', 0.3457),\n",
       "  ('ingredients used', 0.3355),\n",
       "  ('response surface', 0.3341),\n",
       "  ('percentages fs', 0.3256),\n",
       "  ('20 respectively', 0.3188),\n",
       "  ('flour', 0.3078),\n",
       "  ('fs addition', 0.3056),\n",
       "  ('analysis performed', 0.2819),\n",
       "  ('product', 0.2716),\n",
       "  ('assessment color', 0.2702),\n",
       "  ('acceptance fs', 0.27),\n",
       "  ('products 05', 0.2626),\n",
       "  ('loss cooked', 0.2563),\n",
       "  ('increased formulation', 0.25),\n",
       "  ('values', 0.2498),\n",
       "  ('methodology', 0.2451),\n",
       "  ('tp increased', 0.2416),\n",
       "  ('parameters decreased', 0.2407),\n",
       "  ('study effect', 0.2339),\n",
       "  ('formulation', 0.2317),\n",
       "  ('acceptable score', 0.2269),\n",
       "  ('affected sensory', 0.2254),\n",
       "  ('effect observed', 0.2243),\n",
       "  ('assessed', 0.2148),\n",
       "  ('texture profile', 0.1998),\n",
       "  ('weight', 0.1917),\n",
       "  ('paste tp', 0.1881),\n",
       "  ('tpa parameters', 0.1777),\n",
       "  ('copyright 2014', 0.1699),\n",
       "  ('patties furthermore', 0.1614),\n",
       "  ('furthermore', 0.1559),\n",
       "  ('decreased weight', 0.1535),\n",
       "  ('addition adversely', 0.1531),\n",
       "  ('used', 0.1511),\n",
       "  ('juiciness firmness', 0.1481),\n",
       "  ('general', 0.1405),\n",
       "  ('preparation', 0.128),\n",
       "  ('rights', 0.039),\n",
       "  ('elsevier rights', -0.0064),\n",
       "  ('opposite', -0.0092)],\n",
       " 'MED-1496': [('oxidative stress', 0.5789),\n",
       "  ('stress neurodegenerative', 0.5535),\n",
       "  ('prevalence neurodegenerative', 0.4597),\n",
       "  ('stress os', 0.4524),\n",
       "  ('diseases nd', 0.4245),\n",
       "  ('aging research', 0.3931),\n",
       "  ('ros protect', 0.3882),\n",
       "  ('nd reviews', 0.3786),\n",
       "  ('different scientific', 0.3352),\n",
       "  ('emerged works', 0.3201),\n",
       "  ('nd increases', 0.3168),\n",
       "  ('os received', 0.3042),\n",
       "  ('research involving', 0.3033),\n",
       "  ('changes mitochondria', 0.2932),\n",
       "  ('damages excessive', 0.27),\n",
       "  ('common causes', 0.2344),\n",
       "  ('glucocorticoids inflammation', 0.2309),\n",
       "  ('published recently', 0.2214),\n",
       "  ('thousands genes', 0.2194),\n",
       "  ('cells organisms', 0.2174),\n",
       "  ('received attention', 0.2084),\n",
       "  ('diagnosis tracking', 0.2026),\n",
       "  ('protein aggregation', 0.2007),\n",
       "  ('oxygen', 0.187),\n",
       "  ('better understanding', 0.1774),\n",
       "  ('directory supported', 0.1438),\n",
       "  ('looked terms', 0.1334),\n",
       "  ('personnel improvement', 0.1288),\n",
       "  ('biochemical markers', 0.1228),\n",
       "  ('environment explain', 0.1034),\n",
       "  ('vitro vivo', 0.0979),\n",
       "  ('cycle protein', 0.0918),\n",
       "  ('protect brain', 0.0895),\n",
       "  ('reactive', 0.086),\n",
       "  ('supported brazilian', 0.0838),\n",
       "  ('years', 0.0769),\n",
       "  ('role', 0.0762),\n",
       "  ('search download', 0.0754),\n",
       "  ('field focus', 0.0649),\n",
       "  ('lack sensitivity', 0.052),\n",
       "  ('interventions knows', 0.0485),\n",
       "  ('10 different', 0.0474),\n",
       "  ('continue contribute', 0.0462),\n",
       "  ('metals insulin', 0.0388),\n",
       "  ('engine looked', 0.0275),\n",
       "  ('nutrition', 0.0213),\n",
       "  ('coordination higher', 0.0106),\n",
       "  ('capes used', -0.0255),\n",
       "  ('ministry education', -0.0328),\n",
       "  ('intimate', -0.138)],\n",
       " 'MED-1497': [('tbi constitutes', 0.6582),\n",
       "  ('traumatic brain', 0.5664),\n",
       "  ('tbi aβ', 0.5439),\n",
       "  ('tbi patients', 0.5377),\n",
       "  ('tbi relevance', 0.5067),\n",
       "  ('stress neurodegeneration', 0.4612),\n",
       "  ('neurodegeneration leads', 0.448),\n",
       "  ('brain swelling', 0.4351),\n",
       "  ('impairment epidemiological', 0.4294),\n",
       "  ('causes brain', 0.4094),\n",
       "  ('cognitive impairment', 0.4073),\n",
       "  ('problem neurobehavioral', 0.3807),\n",
       "  ('hypoxia disrupts', 0.3465),\n",
       "  ('disability causes', 0.3375),\n",
       "  ('sequelae contributing', 0.3311),\n",
       "  ('injury', 0.3241),\n",
       "  ('patients die', 0.3098),\n",
       "  ('stress', 0.2878),\n",
       "  ('oxidative', 0.2783),\n",
       "  ('30 patients', 0.2766),\n",
       "  ('inflammatory responses', 0.2573),\n",
       "  ('disrupts blood', 0.2505),\n",
       "  ('pathological', 0.2407),\n",
       "  ('blood brain', 0.2028),\n",
       "  ('economic problem', 0.1996),\n",
       "  ('global health', 0.1995),\n",
       "  ('aβ plaques', 0.1744),\n",
       "  ('constitutes major', 0.1735),\n",
       "  ('therapeutic interventions', 0.1731),\n",
       "  ('progression disease', 0.1633),\n",
       "  ('barrier function', 0.1532),\n",
       "  ('diagnose risk', 0.1458),\n",
       "  ('epidemiological studies', 0.1409),\n",
       "  ('function increases', 0.1295),\n",
       "  ('axonal', 0.1239),\n",
       "  ('interventions copyright', 0.1096),\n",
       "  ('leads cognitive', 0.1065),\n",
       "  ('long term', 0.0975),\n",
       "  ('understanding help', 0.0885),\n",
       "  ('genes', 0.0874),\n",
       "  ('important epigenetic', 0.0846),\n",
       "  ('acts important', 0.0752),\n",
       "  ('focuses', 0.0721),\n",
       "  ('socio', 0.0643),\n",
       "  ('term', 0.0578),\n",
       "  ('copyright 2012', 0.0461),\n",
       "  ('patients', 0.0429),\n",
       "  ('relevance', 0.041),\n",
       "  ('elsevier rights', 0.037),\n",
       "  ('ad design', -0.0093)],\n",
       " 'MED-1498': [('evidence low', 0.59),\n",
       "  ('systematic review', 0.5122),\n",
       "  ('low recommendations', 0.4211),\n",
       "  ('based evidence', 0.3713),\n",
       "  ('healthcare research', 0.3514),\n",
       "  ('disease systematic', 0.3505),\n",
       "  ('evidence restrict', 0.3397),\n",
       "  ('research quality', 0.3394),\n",
       "  ('studies documented', 0.3387),\n",
       "  ('alzheimer disease', 0.3249),\n",
       "  ('absence definitive', 0.318),\n",
       "  ('dementing illnesses', 0.311),\n",
       "  ('proposed study', 0.3086),\n",
       "  ('aging concluded', 0.306),\n",
       "  ('public health', 0.2865),\n",
       "  ('research', 0.2639),\n",
       "  ('interventions propose', 0.2425),\n",
       "  ('role risk', 0.2412),\n",
       "  ('protective factors', 0.2395),\n",
       "  ('late life', 0.2385),\n",
       "  ('institute aging', 0.2364),\n",
       "  ('health order', 0.2363),\n",
       "  ('lifestyle interventions', 0.2345),\n",
       "  ('high low', 0.2085),\n",
       "  ('disease', 0.2083),\n",
       "  ('reasonable recommendations', 0.2065),\n",
       "  ('efficacy', 0.1999),\n",
       "  ('levels mental', 0.1803),\n",
       "  ('inactivity smoking', 0.1794),\n",
       "  ('propose modest', 0.1487),\n",
       "  ('head injury', 0.1193),\n",
       "  ('concluded overall', 0.1169),\n",
       "  ('national institute', 0.1135),\n",
       "  ('agency', 0.1059),\n",
       "  ('years', 0.1034),\n",
       "  ('restrict physicians', 0.1018),\n",
       "  ('life', 0.0825),\n",
       "  ('40 years', 0.0795),\n",
       "  ('study 10', 0.073),\n",
       "  ('quality national', 0.0717),\n",
       "  ('fat diet', 0.06),\n",
       "  ('groups', 0.0535),\n",
       "  ('order gain', 0.0396),\n",
       "  ('non', 0.0057),\n",
       "  ('000 subjects', -0.0015),\n",
       "  ('physical', -0.0188),\n",
       "  ('available', -0.0326),\n",
       "  ('saturated', -0.0509),\n",
       "  ('making', -0.0591),\n",
       "  ('randomly', -0.0606)],\n",
       " 'MED-1499': [('bioactive nutrients', 0.564),\n",
       "  ('natural products', 0.5501),\n",
       "  ('phytonutrients distinct', 0.4978),\n",
       "  ('nature gifted', 0.4481),\n",
       "  ('plethora flora', 0.4297),\n",
       "  ('occurring phyto', 0.4247),\n",
       "  ('nuts diverse', 0.4234),\n",
       "  ('neurodegeneration improve', 0.3913),\n",
       "  ('mankind plethora', 0.389),\n",
       "  ('polyphenolic antioxidants', 0.38),\n",
       "  ('vegetables herbs', 0.3622),\n",
       "  ('gifted mankind', 0.3466),\n",
       "  ('neuroinflammation neuroprotective', 0.3434),\n",
       "  ('array bioactive', 0.3231),\n",
       "  ('neuroprotective effects', 0.3186),\n",
       "  ('neurodegenerative diseases', 0.3117),\n",
       "  ('plethora', 0.3068),\n",
       "  ('present natural', 0.3046),\n",
       "  ('naturally occurring', 0.3024),\n",
       "  ('occurring compounds', 0.2751),\n",
       "  ('curative effects', 0.2451),\n",
       "  ('prevention cure', 0.2406),\n",
       "  ('bearing fruits', 0.2374),\n",
       "  ('effects various', 0.2293),\n",
       "  ('pathways associated', 0.2282),\n",
       "  ('dysfunctions accumulated', 0.2236),\n",
       "  ('nuts walnut', 0.2008),\n",
       "  ('suggests naturally', 0.1947),\n",
       "  ('compounds ad', 0.1914),\n",
       "  ('neuronal', 0.1566),\n",
       "  ('potentially', 0.1455),\n",
       "  ('protein folding', 0.1436),\n",
       "  ('accumulated', 0.1324),\n",
       "  ('disease', 0.1316),\n",
       "  ('evidence suggests', 0.1299),\n",
       "  ('associated protein', 0.1247),\n",
       "  ('products', 0.1141),\n",
       "  ('pivotal role', 0.1129),\n",
       "  ('improve memory', 0.108),\n",
       "  ('cognitive function', 0.0991),\n",
       "  ('parkinson', 0.0916),\n",
       "  ('rely mainly', 0.0859),\n",
       "  ('alzheimer', 0.0761),\n",
       "  ('molecular', 0.0613),\n",
       "  ('evaluating review', 0.0486),\n",
       "  ('plays', 0.0449),\n",
       "  ('distinct', 0.0219),\n",
       "  ('hinder', 0.0108),\n",
       "  ('bearing', 0.0028),\n",
       "  ('mainly action', 0.0027)],\n",
       " 'MED-1500': [('intake vegetables', 0.4653),\n",
       "  ('systematic review', 0.4644),\n",
       "  ('bibliographies retrieved', 0.4538),\n",
       "  ('methods searched', 0.4401),\n",
       "  ('literature', 0.3919),\n",
       "  ('searched medline', 0.3835),\n",
       "  ('fruit vegetable', 0.3661),\n",
       "  ('associated reduced', 0.3531),\n",
       "  ('cochrane', 0.3429),\n",
       "  ('studies fruit', 0.3363),\n",
       "  ('association studies', 0.3346),\n",
       "  ('studies total', 0.3233),\n",
       "  ('evidence association', 0.3218),\n",
       "  ('included reported', 0.2927),\n",
       "  ('regular consumption', 0.2891),\n",
       "  ('intake', 0.2749),\n",
       "  ('consumption lacking', 0.2674),\n",
       "  ('dementia slower', 0.2659),\n",
       "  ('publisher databases', 0.2642),\n",
       "  ('cohort studies', 0.235),\n",
       "  ('disease cognitive', 0.2265),\n",
       "  ('articles cohort', 0.2254),\n",
       "  ('currently unsupported', 0.2229),\n",
       "  ('decline older', 0.2168),\n",
       "  ('alzheimer disease', 0.1918),\n",
       "  ('embase', 0.1833),\n",
       "  ('longer included', 0.1766),\n",
       "  ('combined conclusion', 0.1498),\n",
       "  ('lacking', 0.1346),\n",
       "  ('age associated', 0.1322),\n",
       "  ('rates cognitive', 0.1314),\n",
       "  ('analytically combined', 0.1301),\n",
       "  ('background', 0.1294),\n",
       "  ('met inclusion', 0.1258),\n",
       "  ('004 participants', 0.1245),\n",
       "  ('slower rates', 0.1231),\n",
       "  ('consumption analytically', 0.1228),\n",
       "  ('library different', 0.1185),\n",
       "  ('regard frequency', 0.1001),\n",
       "  ('disease', 0.0962),\n",
       "  ('analyzed', 0.0772),\n",
       "  ('follow', 0.0599),\n",
       "  ('risk', 0.0522),\n",
       "  ('currently', 0.0351),\n",
       "  ('biosis alois', 0.0334),\n",
       "  ('different', 0.0186),\n",
       "  ('months longer', 0.0127),\n",
       "  ('total 44', -0.039),\n",
       "  ('separately', -0.0616),\n",
       "  ('increased', -0.0911)],\n",
       " 'MED-1501': [('cognitive decline', 0.5514),\n",
       "  ('prevention cognitive', 0.481),\n",
       "  ('assess associations', 0.4035),\n",
       "  ('reviewed areas', 0.3842),\n",
       "  ('exposures genetics', 0.3799),\n",
       "  ('institute aging', 0.3776),\n",
       "  ('cognition data', 0.3672),\n",
       "  ('data synthesis', 0.3566),\n",
       "  ('function limitations', 0.3508),\n",
       "  ('background biological', 0.3335),\n",
       "  ('evidence risk', 0.3246),\n",
       "  ('definition exposures', 0.3155),\n",
       "  ('alzgene cochrane', 0.3039),\n",
       "  ('nutritional factors', 0.2906),\n",
       "  ('database systematic', 0.2874),\n",
       "  ('contribute delay', 0.2706),\n",
       "  ('applications research', 0.2606),\n",
       "  ('medical factors', 0.2566),\n",
       "  ('medline hugepedia', 0.253),\n",
       "  ('heterogeneous studies', 0.2486),\n",
       "  ('beneficial factors', 0.2463),\n",
       "  ('health', 0.2346),\n",
       "  ('development evaluation', 0.2219),\n",
       "  ('extraction information', 0.2101),\n",
       "  ('studies 300', 0.1996),\n",
       "  ('reviews 1984', 0.1869),\n",
       "  ('limited current', 0.1854),\n",
       "  ('english language', 0.1844),\n",
       "  ('toxic environmental', 0.1817),\n",
       "  ('maintain', 0.1799),\n",
       "  ('apolipoprotein epsilon4', 0.1718),\n",
       "  ('general populations', 0.1706),\n",
       "  ('adult participants', 0.1642),\n",
       "  ('reported physical', 0.1616),\n",
       "  ('16 systematic', 0.1589),\n",
       "  ('controlled trials', 0.1545),\n",
       "  ('populations followed', 0.1487),\n",
       "  ('tobacco use', 0.1301),\n",
       "  ('social economic', 0.122),\n",
       "  ('using grade', 0.1138),\n",
       "  ('2009 study', 0.1107),\n",
       "  ('associated increased', 0.1099),\n",
       "  ('127', 0.0925),\n",
       "  ('behavioral social', 0.0892),\n",
       "  ('leisure activities', 0.0826),\n",
       "  ('50 years', 0.0769),\n",
       "  ('excluded small', 0.0665),\n",
       "  ('researcher verified', 0.0285),\n",
       "  ('22', 0.0222),\n",
       "  ('october', -0.0599)],\n",
       " 'MED-1502': [('animal research', 0.4822),\n",
       "  ('diet damage', 0.4226),\n",
       "  ('evidence dietary', 0.4017),\n",
       "  ('evidence western', 0.3991),\n",
       "  ('western diet', 0.3916),\n",
       "  ('body evidence', 0.387),\n",
       "  ('hfs diets', 0.3808),\n",
       "  ('human research', 0.3677),\n",
       "  ('based animal', 0.3467),\n",
       "  ('neurodegenerative conditions', 0.3371),\n",
       "  ('understanding hfs', 0.3319),\n",
       "  ('neuroimaging', 0.3185),\n",
       "  ('evidence neuropsychological', 0.3113),\n",
       "  ('systems review', 0.3092),\n",
       "  ('induced impairments', 0.2848),\n",
       "  ('growing understanding', 0.2699),\n",
       "  ('research data', 0.2699),\n",
       "  ('refined carbohydrates', 0.2672),\n",
       "  ('damage various', 0.2572),\n",
       "  ('diet high', 0.2483),\n",
       "  ('epidemiological', 0.2478),\n",
       "  ('fat', 0.2478),\n",
       "  ('brain function', 0.2382),\n",
       "  ('running hfs', 0.2337),\n",
       "  ('published', 0.2274),\n",
       "  ('2013 published', 0.2207),\n",
       "  ('refined', 0.22),\n",
       "  ('hippocampal systems', 0.1927),\n",
       "  ('memory cognition', 0.1868),\n",
       "  ('cognition hedonics', 0.1731),\n",
       "  ('decades generated', 0.169),\n",
       "  ('various', 0.1546),\n",
       "  ('causal link', 0.1546),\n",
       "  ('conditions examined', 0.1531),\n",
       "  ('attention deficit', 0.1524),\n",
       "  ('based', 0.1459),\n",
       "  ('contribute development', 0.1417),\n",
       "  ('frontal limbic', 0.1408),\n",
       "  ('disrupt', 0.1355),\n",
       "  ('examined human', 0.1206),\n",
       "  ('functions learning', 0.1193),\n",
       "  ('high saturated', 0.113),\n",
       "  ('rights reserved', 0.1108),\n",
       "  ('elsevier', 0.0945),\n",
       "  ('humans using', 0.0908),\n",
       "  ('converging lines', 0.0813),\n",
       "  ('generated convincing', 0.0526),\n",
       "  ('early stage', 0.0275),\n",
       "  ('conditions crown', -0.0207),\n",
       "  ('organizing principal', -0.0733)],\n",
       " 'MED-1503': [('lutein zeaxanthin', 0.6835),\n",
       "  ('carotenoids lutein', 0.6692),\n",
       "  ('zeaxanthin macula', 0.5771),\n",
       "  ('health carotenoids', 0.5713),\n",
       "  ('macular pigment', 0.4183),\n",
       "  ('retina barrier', 0.2901),\n",
       "  ('concentrations brain', 0.2791),\n",
       "  ('macula', 0.2686),\n",
       "  ('suggest dietary', 0.2497),\n",
       "  ('preferentially accumulate', 0.2277),\n",
       "  ('eye preferentially', 0.2127),\n",
       "  ('epidemiologic studies', 0.2071),\n",
       "  ('significantly dha', 0.1947),\n",
       "  ('concentrations matched', 0.1911),\n",
       "  ('centenarians', 0.1895),\n",
       "  ('influence cognitive', 0.1834),\n",
       "  ('benefit maintaining', 0.1662),\n",
       "  ('mp used', 0.161),\n",
       "  ('lower individuals', 0.156),\n",
       "  ('population based', 0.1488),\n",
       "  ('education hypertension', 0.1388),\n",
       "  ('primates significantly', 0.1373),\n",
       "  ('adjustment covariates', 0.1282),\n",
       "  ('significantly related', 0.1257),\n",
       "  ('placebo controlled', 0.122),\n",
       "  ('normal cognitive', 0.1217),\n",
       "  ('combined treatment', 0.1187),\n",
       "  ('learning improved', 0.1161),\n",
       "  ('tissue significantly', 0.1104),\n",
       "  ('associations attenuated', 0.1012),\n",
       "  ('idea', 0.0972),\n",
       "  ('memory scores', 0.0943),\n",
       "  ('used biomarker', 0.0926),\n",
       "  ('12', 0.0826),\n",
       "  ('women', 0.0809),\n",
       "  ('trend efficient', 0.0732),\n",
       "  ('antemortem measures', 0.0703),\n",
       "  ('healthy', 0.0695),\n",
       "  ('fluency strength', 0.059),\n",
       "  ('measures global', 0.0555),\n",
       "  ('older adults', 0.0461),\n",
       "  ('examination', 0.0448),\n",
       "  ('800', 0.0349),\n",
       "  ('nonhuman', 0.0245),\n",
       "  ('human', 0.0171),\n",
       "  ('cross blood', 0.0157),\n",
       "  ('mo double', 0.0024),\n",
       "  ('mg verbal', -0.017),\n",
       "  ('univariate analyses', -0.0283),\n",
       "  ('sex', -0.1038)],\n",
       " 'MED-1504': [('factors alzheimer', 0.4963),\n",
       "  ('insufficient evidence', 0.4444),\n",
       "  ('evidence factor', 0.4159),\n",
       "  ('modifiable factors', 0.404),\n",
       "  ('low associations', 0.3842),\n",
       "  ('investigated risk', 0.3803),\n",
       "  ('included studies', 0.3747),\n",
       "  ('conclusions association', 0.367),\n",
       "  ('independent panel', 0.3626),\n",
       "  ('panel insufficient', 0.3471),\n",
       "  ('cohort studies', 0.3409),\n",
       "  ('expert presentations', 0.3218),\n",
       "  ('ad objective', 0.3207),\n",
       "  ('assessment use', 0.3129),\n",
       "  ('data abstracted', 0.3055),\n",
       "  ('synthesis diabetes', 0.2951),\n",
       "  ('hyperlipidemia midlife', 0.2704),\n",
       "  ('healthcare research', 0.2325),\n",
       "  ('report commissioned', 0.2254),\n",
       "  ('cognitive activities', 0.225),\n",
       "  ('national institutes', 0.2197),\n",
       "  ('participants aged', 0.2137),\n",
       "  ('state science', 0.2112),\n",
       "  ('trials years', 0.2111),\n",
       "  ('background numerous', 0.1985),\n",
       "  ('2009 expert', 0.1945),\n",
       "  ('cochrane', 0.1943),\n",
       "  ('acid intake', 0.1841),\n",
       "  ('discussions considered', 0.1794),\n",
       "  ('developed countries', 0.1782),\n",
       "  ('decline', 0.1724),\n",
       "  ('current tobacco', 0.1715),\n",
       "  ('health state', 0.1654),\n",
       "  ('present key', 0.1589),\n",
       "  ('publications medline', 0.1547),\n",
       "  ('eligibility data', 0.148),\n",
       "  ('years exposure', 0.1382),\n",
       "  ('moderate high', 0.1308),\n",
       "  ('ad mediterranean', 0.1264),\n",
       "  ('led', 0.1184),\n",
       "  ('minimum sample', 0.0795),\n",
       "  ('physical activity', 0.0737),\n",
       "  ('currently', 0.0554),\n",
       "  ('general populations', 0.0547),\n",
       "  ('firm', 0.0241),\n",
       "  ('folic', 0.0224),\n",
       "  ('sizes 300', 0.0167),\n",
       "  ('english language', 0.0147),\n",
       "  ('1984 october', -0.0058),\n",
       "  ('50 randomized', -0.0203)],\n",
       " 'MED-1505': [('mental cardiometabolic', 0.6354),\n",
       "  ('diet cardiometabolic', 0.6144),\n",
       "  ('cardiometabolic health', 0.604),\n",
       "  ('diets mental', 0.5817),\n",
       "  ('poor diet', 0.5144),\n",
       "  ('mental health', 0.4875),\n",
       "  ('health risk', 0.4434),\n",
       "  ('lifestyle risk', 0.4135),\n",
       "  ('chronic disease', 0.3999),\n",
       "  ('illness mediterranean', 0.3865),\n",
       "  ('style diet', 0.3858),\n",
       "  ('illness including', 0.3806),\n",
       "  ('health understood', 0.3785),\n",
       "  ('poor physical', 0.3612),\n",
       "  ('pathways nutrients', 0.3427),\n",
       "  ('risk factors', 0.3142),\n",
       "  ('including poor', 0.3013),\n",
       "  ('vitamins brain', 0.2902),\n",
       "  ('investigated mental', 0.2858),\n",
       "  ('fatty acids', 0.2663),\n",
       "  ('understood lifestyle', 0.2624),\n",
       "  ('associated reduced', 0.2435),\n",
       "  ('health copyright', 0.2293),\n",
       "  ('antioxidants omega', 0.2268),\n",
       "  ('food', 0.2013),\n",
       "  ('important role', 0.199),\n",
       "  ('review evidence', 0.19),\n",
       "  ('cognitive function', 0.1681),\n",
       "  ('disease little', 0.1627),\n",
       "  ('physical', 0.1421),\n",
       "  ('components', 0.1233),\n",
       "  ('generally recognised', 0.1204),\n",
       "  ('brain modulation', 0.1097),\n",
       "  ('provide model', 0.1048),\n",
       "  ('healthy', 0.1007),\n",
       "  ('indicates multiple', 0.1006),\n",
       "  ('little research', 0.0943),\n",
       "  ('investigating benefits', 0.0935),\n",
       "  ('research investigated', 0.0918),\n",
       "  ('high level', 0.0901),\n",
       "  ('synergistic actions', 0.0746),\n",
       "  ('2013', 0.0554),\n",
       "  ('need human', 0.0352),\n",
       "  ('reflected', 0.0318),\n",
       "  ('work', 0.0207),\n",
       "  ('people', 0.0097),\n",
       "  ('drawing studies', -0.0022),\n",
       "  ('rights reserved', -0.0188),\n",
       "  ('investigating isolation', -0.0288),\n",
       "  ('elsevier', -0.1142)],\n",
       " 'MED-1506': [('intake obesity', 0.4824),\n",
       "  ('cognitive impairment', 0.4634),\n",
       "  ('obesity alzheimer', 0.4618),\n",
       "  ('western diet', 0.4506),\n",
       "  ('neurobiological changes', 0.4406),\n",
       "  ('hippocampus paper', 0.4219),\n",
       "  ('changes hippocampus', 0.4045),\n",
       "  ('ability dietary', 0.4009),\n",
       "  ('associated cognitive', 0.3964),\n",
       "  ('carbohydrate intake', 0.3958),\n",
       "  ('saturated fats', 0.3892),\n",
       "  ('diet consumption', 0.3847),\n",
       "  ('memory inhibition', 0.3702),\n",
       "  ('memory functions', 0.3573),\n",
       "  ('integrity hippocampus', 0.354),\n",
       "  ('alzheimer disease', 0.3534),\n",
       "  ('simple carbohydrates', 0.3331),\n",
       "  ('components impair', 0.3312),\n",
       "  ('intake correlated', 0.3175),\n",
       "  ('impairment specific', 0.3145),\n",
       "  ('fat simple', 0.305),\n",
       "  ('modern western', 0.2638),\n",
       "  ('consumption contributes', 0.2528),\n",
       "  ('considers evidence', 0.2122),\n",
       "  ('components modern', 0.2122),\n",
       "  ('research showing', 0.1918),\n",
       "  ('paper summarizes', 0.1894),\n",
       "  ('inhibition critical', 0.1862),\n",
       "  ('emphasis learning', 0.1808),\n",
       "  ('consuming energy', 0.1738),\n",
       "  ('critical ability', 0.1697),\n",
       "  ('model described', 0.1614),\n",
       "  ('environmental cues', 0.1579),\n",
       "  ('solely caloric', 0.1507),\n",
       "  ('described proposing', 0.148),\n",
       "  ('disease present', 0.1422),\n",
       "  ('development excessive', 0.1415),\n",
       "  ('functions dependent', 0.1373),\n",
       "  ('interfering type', 0.1319),\n",
       "  ('saturated', 0.1252),\n",
       "  ('primary components', 0.1206),\n",
       "  ('changes', 0.0919),\n",
       "  ('linked', 0.0839),\n",
       "  ('contributes', 0.0776),\n",
       "  ('ability animals', 0.0699),\n",
       "  ('need', 0.0491),\n",
       "  ('integrity', 0.0362),\n",
       "  ('excess driven', 0.0136),\n",
       "  ('animals refrain', -0.006),\n",
       "  ('refrain responding', -0.0116)],\n",
       " 'MED-1507': [('curcumin exercise', 0.5589),\n",
       "  ('aging curcumin', 0.5499),\n",
       "  ('anti oxidative', 0.5103),\n",
       "  ('vascular aging', 0.4619),\n",
       "  ('decline endothelial', 0.4578),\n",
       "  ('groups curcumin', 0.4524),\n",
       "  ('anti inflammatory', 0.3945),\n",
       "  ('aging associated', 0.3847),\n",
       "  ('risk cardiovascular', 0.3681),\n",
       "  ('effect vascular', 0.343),\n",
       "  ('dietary adjustment', 0.3231),\n",
       "  ('oxidative effects', 0.3212),\n",
       "  ('function postmenopausal', 0.2942),\n",
       "  ('exercise groups', 0.2855),\n",
       "  ('turmeric', 0.2833),\n",
       "  ('mediated dilation', 0.2781),\n",
       "  ('particularly aerobic', 0.2768),\n",
       "  ('control exercise', 0.2734),\n",
       "  ('improve age', 0.2713),\n",
       "  ('indicator endothelial', 0.2697),\n",
       "  ('declines', 0.2455),\n",
       "  ('modification particularly', 0.2304),\n",
       "  ('known anti', 0.2141),\n",
       "  ('lifestyle', 0.2027),\n",
       "  ('effects investigated', 0.1977),\n",
       "  ('potentially improve', 0.1844),\n",
       "  ('intervention flow', 0.1797),\n",
       "  ('training weeks', 0.1401),\n",
       "  ('baseline flow', 0.138),\n",
       "  ('increase flow', 0.1349),\n",
       "  ('associated increased', 0.1333),\n",
       "  ('orally weeks', 0.1257),\n",
       "  ('group ingested', 0.1243),\n",
       "  ('favorable effect', 0.1199),\n",
       "  ('mediated', 0.1148),\n",
       "  ('groups changes', 0.1122),\n",
       "  ('major component', 0.0988),\n",
       "  ('underwent moderate', 0.0967),\n",
       "  ('disease', 0.0777),\n",
       "  ('control group', 0.0757),\n",
       "  ('variables detected', 0.0724),\n",
       "  ('orally', 0.0532),\n",
       "  ('women total', 0.0379),\n",
       "  ('function copyright', 0.0314),\n",
       "  ('significantly equally', 0.016),\n",
       "  ('2012 elsevier', 0.0156),\n",
       "  ('total 32', 0.0134),\n",
       "  ('rights reserved', -0.0007),\n",
       "  ('difference', -0.0095),\n",
       "  ('known', -0.0292)],\n",
       " 'MED-1508': [('obesity analyses', 0.4926),\n",
       "  ('improve metabolic', 0.4505),\n",
       "  ('physical activity', 0.414),\n",
       "  ('reduced physical', 0.4119),\n",
       "  ('sitting activity', 0.3923),\n",
       "  ('metabolic consequences', 0.387),\n",
       "  ('supports reducing', 0.3793),\n",
       "  ('cancer society', 0.3225),\n",
       "  ('relation mortality', 0.3166),\n",
       "  ('associated total', 0.3051),\n",
       "  ('95 ci', 0.3011),\n",
       "  ('mass index', 0.2981),\n",
       "  ('time spent', 0.2683),\n",
       "  ('public health', 0.258),\n",
       "  ('smoking body', 0.2338),\n",
       "  ('24 metabolic', 0.2258),\n",
       "  ('evidence supports', 0.2178),\n",
       "  ('sitting regardless', 0.2098),\n",
       "  ('cardiovascular', 0.1976),\n",
       "  ('examine leisure', 0.1907),\n",
       "  ('923 deaths', 0.1863),\n",
       "  ('body', 0.1859),\n",
       "  ('adults enrolled', 0.1761),\n",
       "  ('48 95', 0.1723),\n",
       "  ('prospective study', 0.1637),\n",
       "  ('adjustment', 0.1488),\n",
       "  ('authors identified', 0.1473),\n",
       "  ('met hours', 0.1392),\n",
       "  ('ci 70', 0.1276),\n",
       "  ('disease free', 0.1258),\n",
       "  ('risk 34', 0.1191),\n",
       "  ('compared', 0.1117),\n",
       "  ('women disease', 0.1091),\n",
       "  ('307 deaths', 0.1076),\n",
       "  ('14 year', 0.0994),\n",
       "  ('society examine', 0.0971),\n",
       "  ('associations strongest', 0.086),\n",
       "  ('65 men', 0.0812),\n",
       "  ('17', 0.0798),\n",
       "  ('440 men', 0.0781),\n",
       "  ('american', 0.0664),\n",
       "  ('vs hours', 0.0623),\n",
       "  ('messages include', 0.0598),\n",
       "  ('week', 0.0593),\n",
       "  ('identified 11', 0.0592),\n",
       "  ('conducted large', 0.0574),\n",
       "  ('20 women', 0.0549),\n",
       "  ('queried questionnaire', 0.0523),\n",
       "  ('epidemic', 0.0434),\n",
       "  ('53', 0.0083)],\n",
       " 'MED-1509': [('interpretation sedentary', 0.5073),\n",
       "  ('meta analysis', 0.425),\n",
       "  ('databases searched', 0.392),\n",
       "  ('conducted systematic', 0.3713),\n",
       "  ('cis extracted', 0.3343),\n",
       "  ('diabetes cardiovascular', 0.3339),\n",
       "  ('studies 16', 0.3221),\n",
       "  ('sitting behaviours', 0.3165),\n",
       "  ('mortality methods', 0.3118),\n",
       "  ('new studies', 0.3098),\n",
       "  ('participants studies', 0.3085),\n",
       "  ('time health', 0.3078),\n",
       "  ('included rr', 0.2993),\n",
       "  ('sectional included', 0.2844),\n",
       "  ('modern society', 0.2579),\n",
       "  ('prospective studies', 0.2562),\n",
       "  ('effects model', 0.2549),\n",
       "  ('95 cis', 0.2451),\n",
       "  ('aims hypothesis', 0.2424),\n",
       "  ('indicate variance', 0.2395),\n",
       "  ('time compared', 0.2336),\n",
       "  ('cochrane', 0.2333),\n",
       "  ('reviewers data', 0.2189),\n",
       "  ('intervals significant', 0.2101),\n",
       "  ('conclusions interpretation', 0.1997),\n",
       "  ('terms related', 0.1989),\n",
       "  ('examine association', 0.1924),\n",
       "  ('random effects', 0.1834),\n",
       "  ('bayesian predictive', 0.159),\n",
       "  ('rr 12', 0.1584),\n",
       "  ('outcomes cross', 0.1542),\n",
       "  ('adjusted baseline', 0.1494),\n",
       "  ('disease', 0.1483),\n",
       "  ('risk cause', 0.1381),\n",
       "  ('data', 0.1205),\n",
       "  ('quality', 0.1193),\n",
       "  ('lowest associated', 0.1063),\n",
       "  ('03', 0.0938),\n",
       "  ('577 participants', 0.0759),\n",
       "  ('associated increased', 0.0727),\n",
       "  ('24 90', 0.0687),\n",
       "  ('results eighteen', 0.06),\n",
       "  ('14', 0.055),\n",
       "  ('library', 0.0375),\n",
       "  ('36', 0.0242),\n",
       "  ('moderate high', 0.0202),\n",
       "  ('future', 0.015),\n",
       "  ('ubiquitous', 0.0116),\n",
       "  ('hr 49', 0.0012),\n",
       "  ('61', -0.0105)],\n",
       " 'MED-1510': [('men group', 0.4572),\n",
       "  ('preceded recumbency', 0.4008),\n",
       "  ('sitting hemodynamic', 0.4006),\n",
       "  ('70 min', 0.3913),\n",
       "  ('prolonged sitting', 0.3886),\n",
       "  ('group sitting', 0.3764),\n",
       "  ('min sitting', 0.3663),\n",
       "  ('hemodynamic responses', 0.3593),\n",
       "  ('similar sitting', 0.3473),\n",
       "  ('sitting preceded', 0.3338),\n",
       "  ('previous posture', 0.3318),\n",
       "  ('underwent quiet', 0.3219),\n",
       "  ('vs 5th', 0.2796),\n",
       "  ('30 min', 0.2793),\n",
       "  ('pooling decrease', 0.2768),\n",
       "  ('plethysmography group', 0.2767),\n",
       "  ('group showed', 0.2731),\n",
       "  ('mmhg respectively', 0.2705),\n",
       "  ('min standing', 0.2676),\n",
       "  ('effects prolonged', 0.2663),\n",
       "  ('peripheral resistance', 0.2618),\n",
       "  ('stroke volume', 0.2535),\n",
       "  ('maintained previously', 0.2381),\n",
       "  ('compensated increase', 0.2374),\n",
       "  ('reduction', 0.2329),\n",
       "  ('regardless posture', 0.2284),\n",
       "  ('underwent', 0.2218),\n",
       "  ('assessed position', 0.22),\n",
       "  ('gravitational', 0.2142),\n",
       "  ('measured impedance', 0.1861),\n",
       "  ('20 walking', 0.1792),\n",
       "  ('changes', 0.165),\n",
       "  ('responses assessed', 0.1636),\n",
       "  ('mean', 0.1634),\n",
       "  ('respectively minor', 0.1606),\n",
       "  ('diastolic', 0.1456),\n",
       "  ('comparison control', 0.1426),\n",
       "  ('pooling thigh', 0.1319),\n",
       "  ('13', 0.1222),\n",
       "  ('young', 0.1215),\n",
       "  ('blood', 0.1163),\n",
       "  ('changes heart', 0.1156),\n",
       "  ('cardiac output', 0.1061),\n",
       "  ('pooling 17', 0.0986),\n",
       "  ('results necessary', 0.0965),\n",
       "  ('main effect', 0.082),\n",
       "  ('vs', 0.082),\n",
       "  ('flow', 0.0795),\n",
       "  ('calf bf', 0.0757),\n",
       "  ('1st', 0.0023)],\n",
       " 'MED-1511': [('confounders sedentary', 0.6115),\n",
       "  ('prolonged sedentary', 0.5371),\n",
       "  ('cardio metabolic', 0.4613),\n",
       "  ('metabolic inflammatory', 0.4042),\n",
       "  ('cardiovascular disease', 0.381),\n",
       "  ('waist circumference', 0.3702),\n",
       "  ('breaking sedentary', 0.3573),\n",
       "  ('mortality study', 0.3452),\n",
       "  ('examined associations', 0.3372),\n",
       "  ('vigorous exercise', 0.3259),\n",
       "  ('associations prolonged', 0.3134),\n",
       "  ('ethnicity differences', 0.2771),\n",
       "  ('biomarkers age', 0.273),\n",
       "  ('breaks interruptions', 0.2631),\n",
       "  ('trends', 0.2623),\n",
       "  ('meaningful differences', 0.2588),\n",
       "  ('protein triglycerides', 0.2558),\n",
       "  ('time cardio', 0.2552),\n",
       "  ('sectional analyses', 0.2456),\n",
       "  ('breaks hdl', 0.2288),\n",
       "  ('developed economies', 0.2258),\n",
       "  ('cholesterol race', 0.2178),\n",
       "  ('insulin homa', 0.2122),\n",
       "  ('risk profile', 0.1997),\n",
       "  ('conclusion population', 0.1918),\n",
       "  ('findings suggest', 0.1825),\n",
       "  ('time ubiquitous', 0.1787),\n",
       "  ('objectively assessed', 0.1703),\n",
       "  ('reactive protein', 0.1642),\n",
       "  ('nutrition examination', 0.1618),\n",
       "  ('actigraph accelerometer', 0.1481),\n",
       "  ('methods', 0.1464),\n",
       "  ('counts minute', 0.1386),\n",
       "  ('20 years', 0.1368),\n",
       "  ('detrimental', 0.1356),\n",
       "  ('varied', 0.1284),\n",
       "  ('national health', 0.1075),\n",
       "  ('years 2003', 0.103),\n",
       "  ('limited evidence', 0.0991),\n",
       "  ('4757 participants', 0.0948),\n",
       "  ('beneficially associated', 0.0833),\n",
       "  ('premature', 0.08),\n",
       "  ('including moderate', 0.0789),\n",
       "  ('mexican americans', 0.0688),\n",
       "  ('whites null', 0.0637),\n",
       "  ('sex', 0.0513),\n",
       "  ('100 counts', 0.0163),\n",
       "  ('independent', -0.0048),\n",
       "  ('communications', -0.007),\n",
       "  ('2005 06', -0.0295)],\n",
       " 'MED-1512': [('effects curcumin', 0.5657),\n",
       "  ('lifestyle modification', 0.4634),\n",
       "  ('intervention postmenopausal', 0.3395),\n",
       "  ('bp augmentation', 0.3362),\n",
       "  ('increase cardiovascular', 0.3357),\n",
       "  ('potential therapeutic', 0.3326),\n",
       "  ('ingestion reduce', 0.3246),\n",
       "  ('effective preventing', 0.3147),\n",
       "  ('including cancer', 0.3125),\n",
       "  ('treatment exercise', 0.2874),\n",
       "  ('combined treatment', 0.2841),\n",
       "  ('interventions brachial', 0.2835),\n",
       "  ('cancer alzheimer', 0.2724),\n",
       "  ('sbp significantly', 0.2722),\n",
       "  ('various diseases', 0.2598),\n",
       "  ('groups interventions', 0.254),\n",
       "  ('suggest regular', 0.2533),\n",
       "  ('pills 150', 0.2471),\n",
       "  ('diferuloylmethane', 0.2414),\n",
       "  ('age related', 0.2234),\n",
       "  ('decreases combined', 0.2186),\n",
       "  ('risks potential', 0.2171),\n",
       "  ('combined daily', 0.2006),\n",
       "  ('hr corrected', 0.2005),\n",
       "  ('regular endurance', 0.175),\n",
       "  ('mg day', 0.1723),\n",
       "  ('baseline hemodynamic', 0.1721),\n",
       "  ('lowers age', 0.1628),\n",
       "  ('interventions placebo', 0.1572),\n",
       "  ('administered weeks', 0.145),\n",
       "  ('extent monotherapy', 0.1314),\n",
       "  ('ingestion 12', 0.1257),\n",
       "  ('aortic blood', 0.1228),\n",
       "  ('controlled parallel', 0.1208),\n",
       "  ('background', 0.1185),\n",
       "  ('tested central', 0.118),\n",
       "  ('physical', 0.1117),\n",
       "  ('manner methods', 0.098),\n",
       "  ('significant differences', 0.0974),\n",
       "  ('women using', 0.0946),\n",
       "  ('group 05', 0.0858),\n",
       "  ('11 exercise', 0.0798),\n",
       "  ('greater extent', 0.0684),\n",
       "  ('pulse', 0.0664),\n",
       "  ('aix index', 0.0564),\n",
       "  ('left ventricular', 0.0531),\n",
       "  ('aim pilot', 0.045),\n",
       "  ('afterload evaluated', -0.0007),\n",
       "  ('wave analysis', -0.003),\n",
       "  ('tonometrically measured', -0.0366)],\n",
       " 'MED-1513': [('metabolic health', 0.4795),\n",
       "  ('compromise metabolic', 0.4766),\n",
       "  ('sedentary time', 0.4387),\n",
       "  ('sitting prolonged', 0.4362),\n",
       "  ('prolonged periods', 0.4162),\n",
       "  ('deleterious associations', 0.3728),\n",
       "  ('physical activity', 0.3557),\n",
       "  ('studies deleterious', 0.3505),\n",
       "  ('metabolic', 0.3502),\n",
       "  ('sitting time', 0.3416),\n",
       "  ('mortality risk', 0.3148),\n",
       "  ('activity guidelines', 0.2986),\n",
       "  ('sitting automobiles', 0.2904),\n",
       "  ('tv time', 0.2888),\n",
       "  ('health tv', 0.2877),\n",
       "  ('measurement studies', 0.2863),\n",
       "  ('breaking sedentary', 0.278),\n",
       "  ('behavioral studies', 0.2775),\n",
       "  ('studies intervention', 0.2757),\n",
       "  ('premature mortality', 0.2725),\n",
       "  ('deleterious', 0.2657),\n",
       "  ('prospective studies', 0.2527),\n",
       "  ('studies required', 0.2484),\n",
       "  ('based behavioral', 0.2425),\n",
       "  ('guidelines sitting', 0.2406),\n",
       "  ('risk evidence', 0.2323),\n",
       "  ('automobiles increase', 0.2263),\n",
       "  ('time time', 0.22),\n",
       "  ('periods compromise', 0.2188),\n",
       "  ('beneficial sitting', 0.2069),\n",
       "  ('health', 0.2027),\n",
       "  ('time objective', 0.1999),\n",
       "  ('increase premature', 0.1997),\n",
       "  ('periods', 0.1846),\n",
       "  ('time beneficial', 0.1787),\n",
       "  ('associations', 0.1726),\n",
       "  ('trials population', 0.1609),\n",
       "  ('population based', 0.1595),\n",
       "  ('physical', 0.1526),\n",
       "  ('activity', 0.1493),\n",
       "  ('evidence', 0.1302),\n",
       "  ('adults meet', 0.1284),\n",
       "  ('associations breaking', 0.1264),\n",
       "  ('based', 0.1064),\n",
       "  ('intervention', 0.1054),\n",
       "  ('meet physical', 0.1019),\n",
       "  ('measurement', 0.0852),\n",
       "  ('required', 0.0223),\n",
       "  ('objective', -0.0048),\n",
       "  ('meet', -0.0567)],\n",
       " 'MED-1514': [('sedentary time', 0.6813),\n",
       "  ('markers metabolic', 0.4672),\n",
       "  ('increased breaks', 0.4528),\n",
       "  ('lifestyle study', 0.4473),\n",
       "  ('obesity abnormal', 0.4052),\n",
       "  ('movement time', 0.3909),\n",
       "  ('avoiding prolonged', 0.3589),\n",
       "  ('circumference resting', 0.3303),\n",
       "  ('time biological', 0.3253),\n",
       "  ('026 bmi', 0.3108),\n",
       "  ('break fasting', 0.2939),\n",
       "  ('effects total', 0.2772),\n",
       "  ('uninterrupted periods', 0.2577),\n",
       "  ('counts min', 0.2527),\n",
       "  ('objectively measured', 0.2404),\n",
       "  ('waist', 0.2345),\n",
       "  ('examined association', 0.2343),\n",
       "  ('findings suggest', 0.2328),\n",
       "  ('weight height', 0.232),\n",
       "  ('moderate vigorous', 0.2311),\n",
       "  ('triglycerides hdl', 0.2299),\n",
       "  ('complementary physical', 0.2271),\n",
       "  ('cross sectional', 0.2216),\n",
       "  ('syndrome', 0.2215),\n",
       "  ('95 ci', 0.2179),\n",
       "  ('glucose beta', 0.2137),\n",
       "  ('regarding breaking', 0.2128),\n",
       "  ('accumulated important', 0.198),\n",
       "  ('design methods', 0.1894),\n",
       "  ('absence body', 0.1883),\n",
       "  ('accelerometer counts', 0.1773),\n",
       "  ('beta 16', 0.1718),\n",
       "  ('168 mean', 0.1696),\n",
       "  ('years', 0.1645),\n",
       "  ('days interruption', 0.1363),\n",
       "  ('mean age', 0.1328),\n",
       "  ('evidence importance', 0.1323),\n",
       "  ('primarily sitting', 0.1282),\n",
       "  ('australian diabetes', 0.128),\n",
       "  ('029', 0.1158),\n",
       "  ('waking hours', 0.1092),\n",
       "  ('matlab used', 0.1025),\n",
       "  ('suggest new', 0.0987),\n",
       "  ('pressure measured', 0.0953),\n",
       "  ('public health', 0.0865),\n",
       "  ('2005', 0.079),\n",
       "  ('53 years', 0.0684),\n",
       "  ('100 considered', 0.0605),\n",
       "  ('recruited 2004', 0.0221),\n",
       "  ('seven consecutive', 0.0112)],\n",
       " 'MED-1515': [('sedentary behaviour', 0.5083),\n",
       "  ('postprandial lipaemia', 0.4732),\n",
       "  ('lipaemia reduced', 0.4289),\n",
       "  ('participants aged', 0.3659),\n",
       "  ('participants rested', 0.3658),\n",
       "  ('normolipidaemic japanese', 0.3632),\n",
       "  ('015 postprandial', 0.3557),\n",
       "  ('trial participants', 0.3146),\n",
       "  ('walking compared', 0.3146),\n",
       "  ('test meals', 0.3069),\n",
       "  ('15 participants', 0.306),\n",
       "  ('affect health', 0.2999),\n",
       "  ('serum triacylglycerol', 0.2773),\n",
       "  ('japanese men', 0.2583),\n",
       "  ('overall physical', 0.2556),\n",
       "  ('compared effects', 0.2543),\n",
       "  ('fasted state', 0.2442),\n",
       "  ('health irrespective', 0.2398),\n",
       "  ('long periods', 0.2308),\n",
       "  ('heart rate', 0.2104),\n",
       "  ('mean sd', 0.2093),\n",
       "  ('approximately 60', 0.2066),\n",
       "  ('levels study', 0.2003),\n",
       "  ('behaviour adversely', 0.1938),\n",
       "  ('briskly 30', 0.1876),\n",
       "  ('breakfast', 0.1851),\n",
       "  ('lunch venous', 0.1694),\n",
       "  ('sitting control', 0.1674),\n",
       "  ('min approximately', 0.1639),\n",
       "  ('random', 0.1552),\n",
       "  ('healthy', 0.155),\n",
       "  ('years mean', 0.1371),\n",
       "  ('consumed', 0.1368),\n",
       "  ('45', 0.1296),\n",
       "  ('anova 015', 0.1234),\n",
       "  ('standing reduced', 0.1093),\n",
       "  ('sitting standing', 0.1073),\n",
       "  ('state', 0.106),\n",
       "  ('samples collected', 0.0873),\n",
       "  ('vs time', 0.0821),\n",
       "  ('18 lower', 0.0817),\n",
       "  ('afternoon', 0.0778),\n",
       "  ('aged 26', 0.0742),\n",
       "  ('area', 0.0539),\n",
       "  ('men georg', 0.0463),\n",
       "  ('stuttgart new', 0.0386),\n",
       "  ('york', 0.038),\n",
       "  ('verlag kg', 0.038),\n",
       "  ('stood', 0.0318),\n",
       "  ('thieme', 0.0056)],\n",
       " 'MED-1516': [('summary sedentary', 0.5594),\n",
       "  ('acvd sedentary', 0.5005),\n",
       "  ('pursuits sedentary', 0.4457),\n",
       "  ('effects inactivity', 0.4061),\n",
       "  ('cardiovascular disease', 0.3678),\n",
       "  ('adults children', 0.342),\n",
       "  ('activity lower', 0.3304),\n",
       "  ('modifiable life', 0.2962),\n",
       "  ('metabolic function', 0.2874),\n",
       "  ('impaired insulin', 0.2721),\n",
       "  ('atherosclerotic', 0.2676),\n",
       "  ('acvd specifically', 0.2606),\n",
       "  ('component etiology', 0.2525),\n",
       "  ('mechanisms suggests', 0.2492),\n",
       "  ('activity defined', 0.2304),\n",
       "  ('distinct physiological', 0.2273),\n",
       "  ('muscular activity', 0.2256),\n",
       "  ('proposed protective', 0.2227),\n",
       "  ('mean shear', 0.2149),\n",
       "  ('children spend', 0.2128),\n",
       "  ('promotes reduced', 0.208),\n",
       "  ('lower extremities', 0.2034),\n",
       "  ('endothelial function', 0.1938),\n",
       "  ('increased oxidative', 0.1905),\n",
       "  ('arterial pressure', 0.1854),\n",
       "  ('half waking', 0.1835),\n",
       "  ('use sitting', 0.1775),\n",
       "  ('classic markers', 0.1715),\n",
       "  ('study effects', 0.152),\n",
       "  ('disease', 0.1511),\n",
       "  ('stress sufficient', 0.149),\n",
       "  ('future directions', 0.1397),\n",
       "  ('reduced bioavailability', 0.1391),\n",
       "  ('low mean', 0.1381),\n",
       "  ('behavior promotes', 0.1314),\n",
       "  ('attenuated presence', 0.1291),\n",
       "  ('summary', 0.1182),\n",
       "  ('deforms', 0.1173),\n",
       "  ('segments resulting', 0.1116),\n",
       "  ('evidence demonstrates', 0.1093),\n",
       "  ('pursuits', 0.1056),\n",
       "  ('sensitivity impaired', 0.0902),\n",
       "  ('ss induced', 0.0893),\n",
       "  ('augments mean', 0.0808),\n",
       "  ('style', 0.0577),\n",
       "  ('furthers use', 0.0434),\n",
       "  ('flow increases', 0.0343),\n",
       "  ('leg blood', 0.0233),\n",
       "  ('nitric', -0.0116),\n",
       "  ('pooling calf', -0.0243)],\n",
       " 'MED-1517': [('interrupting sedentary', 0.5493),\n",
       "  ('background sedentary', 0.508),\n",
       "  ('breaks postprandial', 0.4919),\n",
       "  ('prolonged sitting', 0.4636),\n",
       "  ('sitting intervention', 0.4368),\n",
       "  ('factor cardiometabolic', 0.4307),\n",
       "  ('activity intervention', 0.3863),\n",
       "  ('compared prolonged', 0.3841),\n",
       "  ('plasma triglyceride', 0.3833),\n",
       "  ('metabolism design', 0.3722),\n",
       "  ('min sitting', 0.3636),\n",
       "  ('participants consumed', 0.3538),\n",
       "  ('activity decreasing', 0.3191),\n",
       "  ('breaks conclusion', 0.3141),\n",
       "  ('sitting regular', 0.3048),\n",
       "  ('adults trial', 0.304),\n",
       "  ('insulinemia healthy', 0.3027),\n",
       "  ('meal replacement', 0.299),\n",
       "  ('95 ci', 0.2717),\n",
       "  ('crossover study', 0.2473),\n",
       "  ('differed interventions', 0.2453),\n",
       "  ('18 mmol', 0.2241),\n",
       "  ('effective continuous', 0.2205),\n",
       "  ('design seventy', 0.2173),\n",
       "  ('glucose iauc', 0.2171),\n",
       "  ('behavior risk', 0.2152),\n",
       "  ('beverage 60', 0.209),\n",
       "  ('023 physical', 0.2055),\n",
       "  ('effects', 0.2007),\n",
       "  ('activity plasma', 0.1938),\n",
       "  ('sitting 542', 0.187),\n",
       "  ('lowered values', 0.1801),\n",
       "  ('objective compared', 0.1713),\n",
       "  ('trials registry', 0.1696),\n",
       "  ('disease regularly', 0.1684),\n",
       "  ('values mmol', 0.1648),\n",
       "  ('weight', 0.1644),\n",
       "  ('ci 506', 0.1351),\n",
       "  ('actrn12610000953033', 0.1225),\n",
       "  ('overall 001', 0.1167),\n",
       "  ('values 866', 0.1103),\n",
       "  ('ci 10', 0.1102),\n",
       "  ('involved walking', 0.1095),\n",
       "  ('participated', 0.1002),\n",
       "  ('904', 0.0784),\n",
       "  ('179', 0.0758),\n",
       "  ('26 mmol', 0.0279),\n",
       "  ('240 420', 0.0123),\n",
       "  ('1227 iu', 0.0076),\n",
       "  ('zealand', -0.0153)],\n",
       " 'MED-1518': [('treadmill desks', 0.6035),\n",
       "  ('obesity treadmill', 0.4308),\n",
       "  ('increase employee', 0.3908),\n",
       "  ('desk replaced', 0.3775),\n",
       "  ('sedentariness associated', 0.3705),\n",
       "  ('sedentary jobs', 0.2885),\n",
       "  ('increased daily', 0.2875),\n",
       "  ('office workers', 0.2838),\n",
       "  ('intervention subjects', 0.2724),\n",
       "  ('work performance', 0.2668),\n",
       "  ('decrease daily', 0.2597),\n",
       "  ('accelerometers work', 0.226),\n",
       "  ('promote physical', 0.2253),\n",
       "  ('walking', 0.214),\n",
       "  ('day 001', 0.2099),\n",
       "  ('05', 0.2071),\n",
       "  ('improve health', 0.2036),\n",
       "  ('methods hypothesis', 0.2021),\n",
       "  ('obesity society', 0.2001),\n",
       "  ('jobs 87', 0.1854),\n",
       "  ('speed design', 0.1827),\n",
       "  ('employees 36', 0.178),\n",
       "  ('change significantly', 0.1618),\n",
       "  ('kg 15', 0.1588),\n",
       "  ('chair based', 0.1564),\n",
       "  ('020 75', 0.1473),\n",
       "  ('altered', 0.1451),\n",
       "  ('802', 0.1415),\n",
       "  ('measured baseline', 0.1343),\n",
       "  ('activity summation', 0.1339),\n",
       "  ('deployment associated', 0.1287),\n",
       "  ('lean', 0.124),\n",
       "  ('min day', 0.1137),\n",
       "  ('kg 03', 0.1086),\n",
       "  ('conclusions access', 0.0971),\n",
       "  ('27 kg', 0.0806),\n",
       "  ('84 min', 0.0755),\n",
       "  ('lost kg', 0.0716),\n",
       "  ('months 978', 0.0609),\n",
       "  ('compared traditional', 0.0598),\n",
       "  ('weight 22', 0.0549),\n",
       "  ('238 au', 0.0534),\n",
       "  ('blood variables', 0.0497),\n",
       "  ('460 376', 0.048),\n",
       "  ('zero', 0.0217),\n",
       "  ('copyright', 0.0037),\n",
       "  ('standing', -0.005),\n",
       "  ('11 men', -0.0061),\n",
       "  ('greatest people', -0.0251),\n",
       "  ('months 205', -0.0476)],\n",
       " 'MED-1519': [('odor typing', 0.5664),\n",
       "  ('task odor', 0.5111),\n",
       "  ('typing performance', 0.5087),\n",
       "  ('peppermint odor', 0.4493),\n",
       "  ('odors associated', 0.425),\n",
       "  ('alphabetization participants', 0.4137),\n",
       "  ('significantly odor', 0.4103),\n",
       "  ('performance alphabetization', 0.4015),\n",
       "  ('typing duration', 0.4002),\n",
       "  ('task performance', 0.3879),\n",
       "  ('condition typing', 0.3532),\n",
       "  ('use peppermint', 0.3509),\n",
       "  ('memorization alphabetization', 0.3474),\n",
       "  ('significant differences', 0.3416),\n",
       "  ('alphabetization improved', 0.3339),\n",
       "  ('improved performance', 0.3328),\n",
       "  ('participants completed', 0.2985),\n",
       "  ('performance memorization', 0.2979),\n",
       "  ('investigated use', 0.2907),\n",
       "  ('associated enhanced', 0.2776),\n",
       "  ('results suggest', 0.2752),\n",
       "  ('gross speed', 0.2715),\n",
       "  ('results', 0.2688),\n",
       "  ('memorization results', 0.2579),\n",
       "  ('performance present', 0.2565),\n",
       "  ('indicated significant', 0.2537),\n",
       "  ('protocol', 0.2475),\n",
       "  ('differences gross', 0.2307),\n",
       "  ('focused task', 0.2245),\n",
       "  ('task increase', 0.2233),\n",
       "  ('analysis indicated', 0.2222),\n",
       "  ('general arousal', 0.2189),\n",
       "  ('significantly', 0.2054),\n",
       "  ('associated', 0.2045),\n",
       "  ('research indicates', 0.1928),\n",
       "  ('use', 0.1866),\n",
       "  ('present study', 0.1738),\n",
       "  ('speed net', 0.1719),\n",
       "  ('investigated', 0.1669),\n",
       "  ('attention participants', 0.1653),\n",
       "  ('indicates presence', 0.1556),\n",
       "  ('indicated', 0.1533),\n",
       "  ('duration', 0.1517),\n",
       "  ('accuracy', 0.1477),\n",
       "  ('previous research', 0.1404),\n",
       "  ('condition', 0.1125),\n",
       "  ('twice', 0.112),\n",
       "  ('promote', 0.1074),\n",
       "  ('promote general', 0.0699),\n",
       "  ('stay', -0.0835)],\n",
       " 'MED-1520': [('mint aroma', 0.5601),\n",
       "  ('researchers mint', 0.445),\n",
       "  ('aroma athletes', 0.4203),\n",
       "  ('effects exercise', 0.3516),\n",
       "  ('inflammatory antispasmodic', 0.2909),\n",
       "  ('used analgesic', 0.2773),\n",
       "  ('athletes investigated', 0.2734),\n",
       "  ('antioxidant', 0.2621),\n",
       "  ('natural herbs', 0.2616),\n",
       "  ('enhancing', 0.2531),\n",
       "  ('inhaling', 0.2291),\n",
       "  ('min 001', 0.2236),\n",
       "  ('vasoconstrictor effects', 0.2214),\n",
       "  ('students relaxation', 0.1991),\n",
       "  ('coaches researchers', 0.1636),\n",
       "  ('supplementation period', 0.1484),\n",
       "  ('lactate level', 0.1444),\n",
       "  ('results respiratory', 0.1428),\n",
       "  ('351 min', 0.1327),\n",
       "  ('plausible explanations', 0.131),\n",
       "  ('treadmill based', 0.1297),\n",
       "  ('capacity fvc', 0.1282),\n",
       "  ('84 001', 0.1252),\n",
       "  ('exhaustion 664', 0.1115),\n",
       "  ('ml peppermint', 0.1094),\n",
       "  ('heart rate', 0.1086),\n",
       "  ('background', 0.1053),\n",
       "  ('performance gas', 0.1045),\n",
       "  ('healthy male', 0.0984),\n",
       "  ('using bruce', 0.0774),\n",
       "  ('great desire', 0.0757),\n",
       "  ('experiment support', 0.0749),\n",
       "  ('brain oxygen', 0.058),\n",
       "  ('bronchial smooth', 0.0574),\n",
       "  ('16 vs', 0.0573),\n",
       "  ('work 78', 0.0529),\n",
       "  ('vco2 08', 0.0489),\n",
       "  ('concentration decrease', 0.0349),\n",
       "  ('oil days', 0.0322),\n",
       "  ('73 518', 0.028),\n",
       "  ('bottle mineral', 0.0196),\n",
       "  ('consumed 500', 0.0159),\n",
       "  ('24', 0.0096),\n",
       "  ('water containing', 0.0009),\n",
       "  ('containing 05', -0.0032),\n",
       "  ('significantly changed', -0.0035),\n",
       "  ('vs 139', -0.0099),\n",
       "  ('vs 03', -0.0256),\n",
       "  ('pif determined', -0.0425),\n",
       "  ('32', -0.0442)],\n",
       " 'MED-1521': [('herbal teas', 0.5394),\n",
       "  ('adverse effects', 0.3803),\n",
       "  ('men adverse', 0.3735),\n",
       "  ('mentha spicata', 0.369),\n",
       "  ('piperita testicular', 0.3572),\n",
       "  ('herbs male', 0.3431),\n",
       "  ('tubules effects', 0.343),\n",
       "  ('labiatae herbal', 0.3425),\n",
       "  ('total testosterone', 0.3059),\n",
       "  ('reproductive function', 0.2641),\n",
       "  ('hormone levels', 0.2584),\n",
       "  ('mentha', 0.2447),\n",
       "  ('tea 20', 0.2433),\n",
       "  ('testicular biopsy', 0.2334),\n",
       "  ('aware toxic', 0.2167),\n",
       "  ('complaints area', 0.2078),\n",
       "  ('histologic features', 0.1942),\n",
       "  ('beneficial effects', 0.1941),\n",
       "  ('study', 0.1829),\n",
       "  ('results follicle', 0.174),\n",
       "  ('conclusions despite', 0.1616),\n",
       "  ('luteinizing', 0.1576),\n",
       "  ('48 male', 0.1546),\n",
       "  ('commercial drinking', 0.1491),\n",
       "  ('levels decreased', 0.1439),\n",
       "  ('maturation arrest', 0.141),\n",
       "  ('spicata labiatae', 0.1314),\n",
       "  ('recommended dose', 0.1269),\n",
       "  ('function methods', 0.1168),\n",
       "  ('objectives justify', 0.1127),\n",
       "  ('group differences', 0.1104),\n",
       "  ('rats control', 0.0941),\n",
       "  ('major', 0.0904),\n",
       "  ('significant johnsen', 0.0857),\n",
       "  ('40', 0.0629),\n",
       "  ('male wistar', 0.0534),\n",
       "  ('digestion', 0.0527),\n",
       "  ('germ', 0.0495),\n",
       "  ('levels increased', 0.0476),\n",
       "  ('greater control', 0.0475),\n",
       "  ('different', 0.0453),\n",
       "  ('water', 0.0313),\n",
       "  ('cell aplasia', 0.0293),\n",
       "  ('scores significantly', 0.029),\n",
       "  ('tissue segmental', 0.02),\n",
       "  ('groups 12', 0.0123),\n",
       "  ('body weight', -0.0044),\n",
       "  ('200 250', -0.0201),\n",
       "  ('albino', -0.0429),\n",
       "  ('fashion recommended', -0.0536)],\n",
       " 'MED-1522': [('tea antiandrogenic', 0.5149),\n",
       "  ('ovarian syndrome', 0.4305),\n",
       "  ('spearmint antiandrogen', 0.4199),\n",
       "  ('females hirsutism', 0.3988),\n",
       "  ('pcos consequent', 0.3963),\n",
       "  ('spearmint tea', 0.3842),\n",
       "  ('relationship androgen', 0.379),\n",
       "  ('hormones follicular', 0.3616),\n",
       "  ('research turkey', 0.329),\n",
       "  ('polycystic ovarian', 0.3157),\n",
       "  ('hirsutism resolve', 0.3008),\n",
       "  ('tea 15', 0.2322),\n",
       "  ('reduced spearmint', 0.2302),\n",
       "  ('consequent elevated', 0.2248),\n",
       "  ('psychological problems', 0.2109),\n",
       "  ('associated clinically', 0.2016),\n",
       "  ('gonadotrophins checked', 0.1985),\n",
       "  ('study duration', 0.1747),\n",
       "  ('research undertaken', 0.1706),\n",
       "  ('potential use', 0.167),\n",
       "  ('placebo herbal', 0.1619),\n",
       "  ('significant cosmetic', 0.1517),\n",
       "  ('patient subjective', 0.1486),\n",
       "  ('alteration', 0.1392),\n",
       "  ('reduction self', 0.1186),\n",
       "  ('study serum', 0.1086),\n",
       "  ('hair', 0.1018),\n",
       "  ('long time', 0.09),\n",
       "  ('twice day', 0.0889),\n",
       "  ('group 05', 0.087),\n",
       "  ('resolve significant', 0.0854),\n",
       "  ('free total', 0.0748),\n",
       "  ('natural treatment', 0.0708),\n",
       "  ('practice relationship', 0.0675),\n",
       "  ('proposed preliminary', 0.0617),\n",
       "  ('longer future', 0.0587),\n",
       "  ('2009', 0.0519),\n",
       "  ('levels leads', 0.0513),\n",
       "  ('original studies', 0.0426),\n",
       "  ('does', 0.037),\n",
       "  ('centre', 0.0354),\n",
       "  ('volunteers randomized', 0.0297),\n",
       "  ('42 patients', 0.0215),\n",
       "  ('galwey score', 0.0161),\n",
       "  ('cell turnover', -0.0075),\n",
       "  ('30 days', -0.0161),\n",
       "  ('using ferriman', -0.0217),\n",
       "  ('john wiley', -0.0395),\n",
       "  ('dqli significantly', -0.1216),\n",
       "  ('12', -0.1446)],\n",
       " 'MED-1523': [('peppermint oil', 0.4538),\n",
       "  ('shock managed', 0.4019),\n",
       "  ('comatosed state', 0.3774),\n",
       "  ('oral peppermint', 0.3565),\n",
       "  ('came comatosed', 0.3201),\n",
       "  ('medicines near', 0.317),\n",
       "  ('vital parameters', 0.3094),\n",
       "  ('oral toxic', 0.3025),\n",
       "  ('mechanical ventilation', 0.2926),\n",
       "  ('oil easily', 0.292),\n",
       "  ('state shock', 0.282),\n",
       "  ('oil reported', 0.2799),\n",
       "  ('dose oral', 0.2783),\n",
       "  ('reported patient', 0.275),\n",
       "  ('constituent medicines', 0.2744),\n",
       "  ('oil dangerous', 0.2674),\n",
       "  ('ingestion oral', 0.2669),\n",
       "  ('warns ingestion', 0.2639),\n",
       "  ('toxic doses', 0.238),\n",
       "  ('patient', 0.2331),\n",
       "  ('vital', 0.2282),\n",
       "  ('normal hours', 0.22),\n",
       "  ('hours conscious', 0.214),\n",
       "  ('case ingestion', 0.2112),\n",
       "  ('fatal case', 0.2049),\n",
       "  ('ingestion', 0.1958),\n",
       "  ('dose', 0.1955),\n",
       "  ('reached normal', 0.1919),\n",
       "  ('conscious 24', 0.1841),\n",
       "  ('considered mild', 0.1786),\n",
       "  ('case report', 0.1759),\n",
       "  ('hours effects', 0.1674),\n",
       "  ('dangerous', 0.1672),\n",
       "  ('patient came', 0.159),\n",
       "  ('oral', 0.1564),\n",
       "  ('parameters reached', 0.1528),\n",
       "  ('conscious', 0.1449),\n",
       "  ('managed', 0.1417),\n",
       "  ('effects', 0.1207),\n",
       "  ('ionotropes vital', 0.1149),\n",
       "  ('considered', 0.1099),\n",
       "  ('warns', 0.1067),\n",
       "  ('reached', 0.1058),\n",
       "  ('state', 0.0945),\n",
       "  ('easily available', 0.0852),\n",
       "  ('mechanical', 0.0814),\n",
       "  ('report', 0.0703),\n",
       "  ('available constituent', 0.0433),\n",
       "  ('near', 0.0176),\n",
       "  ('came', 0.0059)],\n",
       " 'MED-1524': [('dance clubs', 0.534),\n",
       "  ('clubs differentiate', 0.4342),\n",
       "  ('unwanted odors', 0.424),\n",
       "  ('odors allow', 0.4204),\n",
       "  ('conducted dance', 0.4154),\n",
       "  ('clubs undesirable', 0.4088),\n",
       "  ('smoke noticeable', 0.4082),\n",
       "  ('prohibited restaurants', 0.4041),\n",
       "  ('bars clubs', 0.3869),\n",
       "  ('enhance dancing', 0.3831),\n",
       "  ('scents mask', 0.3529),\n",
       "  ('ambient scents', 0.3518),\n",
       "  ('smoking prohibited', 0.3494),\n",
       "  ('scent control', 0.3361),\n",
       "  ('masked cigarette', 0.3289),\n",
       "  ('differences scents', 0.3261),\n",
       "  ('pleasant ambient', 0.3065),\n",
       "  ('smells previously', 0.269),\n",
       "  ('prohibited', 0.2521),\n",
       "  ('opens opportunities', 0.2176),\n",
       "  ('activity improve', 0.2045),\n",
       "  ('bars', 0.1918),\n",
       "  ('significant differences', 0.1879),\n",
       "  ('visitors', 0.1819),\n",
       "  ('previously masked', 0.1815),\n",
       "  ('undesirable', 0.1749),\n",
       "  ('music mood', 0.1742),\n",
       "  ('restaurants', 0.1677),\n",
       "  ('environment', 0.1638),\n",
       "  ('allow competing', 0.1462),\n",
       "  ('mask', 0.1384),\n",
       "  ('using latin', 0.1318),\n",
       "  ('evening', 0.1247),\n",
       "  ('control', 0.1232),\n",
       "  ('differentiate', 0.1198),\n",
       "  ('significant', 0.1149),\n",
       "  ('shown enhance', 0.1133),\n",
       "  ('introducing', 0.1044),\n",
       "  ('square design', 0.1001),\n",
       "  ('conditions', 0.0787),\n",
       "  ('differentiate field', 0.0685),\n",
       "  ('improve evaluation', 0.0648),\n",
       "  ('allow', 0.0485),\n",
       "  ('study conducted', 0.0434),\n",
       "  ('design pre', 0.0367),\n",
       "  ('tested orange', 0.0296),\n",
       "  ('post measurements', 0.0256),\n",
       "  ('tested', -0.0068),\n",
       "  ('seawater', -0.0355),\n",
       "  ('seawater peppermint', -0.0979)],\n",
       " 'MED-1525': [('piperita labiatae', 0.548),\n",
       "  ('mentha piperita', 0.535),\n",
       "  ('mentha spicata', 0.5318),\n",
       "  ('spearmint peppermint', 0.4669),\n",
       "  ('spicata piperita', 0.4524),\n",
       "  ('spicata labiatae', 0.4348),\n",
       "  ('spearmint mentha', 0.4233),\n",
       "  ('labiatae grows', 0.4036),\n",
       "  ('known peppermint', 0.3923),\n",
       "  ('medicine flavoring', 0.367),\n",
       "  ('industry spicata', 0.3247),\n",
       "  ('isparta located', 0.2536),\n",
       "  ('effect herbal', 0.2514),\n",
       "  ('kinds illnesses', 0.2367),\n",
       "  ('flavoring industry', 0.202),\n",
       "  ('consumption tea', 0.1872),\n",
       "  ('grows', 0.1766),\n",
       "  ('various kinds', 0.1732),\n",
       "  ('anamas plateau', 0.1718),\n",
       "  ('yenithornarbademli town', 0.1699),\n",
       "  ('alternative antiandrogenic', 0.1214),\n",
       "  ('mild', 0.1205),\n",
       "  ('syndrome idiopathic', 0.116),\n",
       "  ('hirsutism included', 0.1026),\n",
       "  ('levels', 0.0948),\n",
       "  ('treatment', 0.0855),\n",
       "  ('stimulating', 0.0711),\n",
       "  ('studies needed', 0.0667),\n",
       "  ('sulphate levels', 0.0664),\n",
       "  ('used', 0.0567),\n",
       "  ('polycystic', 0.056),\n",
       "  ('thought consumption', 0.0552),\n",
       "  ('cup', 0.0487),\n",
       "  ('luteinizing', 0.0477),\n",
       "  ('caused diminished', 0.0421),\n",
       "  ('rats', 0.0398),\n",
       "  ('patients 12', 0.0227),\n",
       "  ('results availability', 0.0226),\n",
       "  ('southwest turkey', 0.0223),\n",
       "  ('wiley sons', 0.0137),\n",
       "  ('copyright', -0.0011),\n",
       "  ('twice day', -0.0046),\n",
       "  ('2007', -0.0137),\n",
       "  ('cycles', -0.0176),\n",
       "  ('female', -0.0239),\n",
       "  ('libido', -0.0288),\n",
       "  ('test reliability', -0.0326),\n",
       "  ('steeped', -0.0519),\n",
       "  ('town clinicians', -0.0521),\n",
       "  ('total testosterone', -0.0972)],\n",
       " 'MED-1526': [('exercise 36', 0.4283),\n",
       "  ('running vo2max', 0.4018),\n",
       "  ('peppermint odor', 0.4006),\n",
       "  ('intensive exercise', 0.3824),\n",
       "  ('physical performance', 0.3802),\n",
       "  ('time running', 0.3159),\n",
       "  ('maximum oxygen', 0.3102),\n",
       "  ('36 women', 0.2989),\n",
       "  ('heart rate', 0.2941),\n",
       "  ('women soccer', 0.2855),\n",
       "  ('indexes physical', 0.2767),\n",
       "  ('duration training', 0.2664),\n",
       "  ('think intensity', 0.2606),\n",
       "  ('study inhaling', 0.246),\n",
       "  ('running mhr', 0.2317),\n",
       "  ('effects', 0.2236),\n",
       "  ('ran treadmill', 0.2195),\n",
       "  ('acute intensive', 0.2134),\n",
       "  ('present study', 0.2102),\n",
       "  ('differences', 0.2069),\n",
       "  ('groups ran', 0.2031),\n",
       "  ('ve respiratory', 0.1996),\n",
       "  ('participating', 0.1918),\n",
       "  ('did significant', 0.1894),\n",
       "  ('odors did', 0.188),\n",
       "  ('minute', 0.1878),\n",
       "  ('performance tab', 0.1869),\n",
       "  ('determined anova', 0.1866),\n",
       "  ('purpose', 0.1763),\n",
       "  ('pulmonary indexes', 0.1754),\n",
       "  ('player chosen', 0.1715),\n",
       "  ('groups subjects', 0.1621),\n",
       "  ('gas', 0.1615),\n",
       "  ('subjects bmi', 0.1575),\n",
       "  ('mixture', 0.1529),\n",
       "  ('research randomly', 0.1509),\n",
       "  ('groups control', 0.1429),\n",
       "  ('differences 05', 0.1371),\n",
       "  ('ratio rer', 0.1334),\n",
       "  ('showed study', 0.1306),\n",
       "  ('analyzer', 0.1179),\n",
       "  ('referring results', 0.113),\n",
       "  ('bruce', 0.1075),\n",
       "  ('divided', 0.1002),\n",
       "  ('ethanol', 0.091),\n",
       "  ('aware similarity', 0.0787),\n",
       "  ('fragrant', 0.0546),\n",
       "  ('fig ref', 0.0285),\n",
       "  ('order aware', 0.0264),\n",
       "  ('ref 21', 0.0038)],\n",
       " 'MED-1527': [('mortality vegetarians', 0.5008),\n",
       "  ('mortality associations', 0.4964),\n",
       "  ('lifestyle confounders', 0.4505),\n",
       "  ('cohort study', 0.4282),\n",
       "  ('relevance vegetarian', 0.4107),\n",
       "  ('dietary guidance', 0.3888),\n",
       "  ('analysis cox', 0.3499),\n",
       "  ('study ahs', 0.3323),\n",
       "  ('evaluate association', 0.3323),\n",
       "  ('adventist health', 0.3321),\n",
       "  ('proportional hazards', 0.3258),\n",
       "  ('reduced mortality', 0.32),\n",
       "  ('adjusted hr', 0.3199),\n",
       "  ('compared nonvegetarians', 0.2879),\n",
       "  ('detected cardiovascular', 0.2636),\n",
       "  ('regression controlling', 0.2631),\n",
       "  ('american cohort', 0.259),\n",
       "  ('endocrine mortality', 0.2566),\n",
       "  ('noncardiovascular', 0.2492),\n",
       "  ('design prospective', 0.2458),\n",
       "  ('women conclusions', 0.2313),\n",
       "  ('large north', 0.2286),\n",
       "  ('cause specific', 0.2277),\n",
       "  ('important demographic', 0.226),\n",
       "  ('evidence suggests', 0.2194),\n",
       "  ('national death', 0.1985),\n",
       "  ('considered carefully', 0.1941),\n",
       "  ('00 pesco', 0.1732),\n",
       "  ('exclusions', 0.1691),\n",
       "  ('baseline quantitative', 0.1682),\n",
       "  ('participants remained', 0.1564),\n",
       "  ('mean follow', 0.1512),\n",
       "  ('main outcome', 0.1504),\n",
       "  ('recruited 2002', 0.1454),\n",
       "  ('combined vs', 0.1421),\n",
       "  ('frequency questionnaire', 0.1345),\n",
       "  ('vegan', 0.1345),\n",
       "  ('renal', 0.1345),\n",
       "  ('13 compared', 0.1337),\n",
       "  ('308 participants', 0.1198),\n",
       "  ('92 95', 0.1129),\n",
       "  ('2570 deaths', 0.1029),\n",
       "  ('years', 0.0909),\n",
       "  ('relationship established', 0.0863),\n",
       "  ('2009', 0.0483),\n",
       "  ('seventh day', 0.0332),\n",
       "  ('96 469', 0.026),\n",
       "  ('lacto ovo', 0.0033),\n",
       "  ('1000 person', -0.0195),\n",
       "  ('robust males', -0.0582)],\n",
       " 'MED-1528': [('vegetarian diet', 0.6314),\n",
       "  ('plenty vegetables', 0.575),\n",
       "  ('diet generally', 0.5473),\n",
       "  ('vegetarians vegetarians', 0.5287),\n",
       "  ('lower vegetarians', 0.5122),\n",
       "  ('vitamins fe³', 0.5087),\n",
       "  ('vegetables', 0.5078),\n",
       "  ('folic acid', 0.4996),\n",
       "  ('polyunsaturated', 0.4905),\n",
       "  ('zinc vitamin', 0.4805),\n",
       "  ('low intake', 0.4619),\n",
       "  ('pufa reduce', 0.4598),\n",
       "  ('appropriate vegetarians', 0.4512),\n",
       "  ('especially pufa', 0.4459),\n",
       "  ('phytochemicals antioxidants', 0.4414),\n",
       "  ('antioxidants fiber', 0.4288),\n",
       "  ('intake', 0.4231),\n",
       "  ('saturated fatty', 0.398),\n",
       "  ('rich phytochemicals', 0.3732),\n",
       "  ('fat', 0.3649),\n",
       "  ('fruits rich', 0.354),\n",
       "  ('cholesterol total', 0.319),\n",
       "  ('folic', 0.2957),\n",
       "  ('includes plenty', 0.2819),\n",
       "  ('generally includes', 0.2639),\n",
       "  ('omnivorous populations', 0.2215),\n",
       "  ('rich', 0.206),\n",
       "  ('acid sodium', 0.2009),\n",
       "  ('fiber magnesium', 0.2005),\n",
       "  ('low mortality', 0.1569),\n",
       "  ('lower', 0.1479),\n",
       "  ('2013 society', 0.1397),\n",
       "  ('homocysteine mean', 0.135),\n",
       "  ('diabetes significantly', 0.1307),\n",
       "  ('risk factors', 0.1164),\n",
       "  ('aggregability', 0.1032),\n",
       "  ('communicable diseases', 0.1013),\n",
       "  ('platelet volume', 0.0953),\n",
       "  ('carefully design', 0.0931),\n",
       "  ('non', 0.0892),\n",
       "  ('number', 0.0881),\n",
       "  ('chemical industry', 0.0859),\n",
       "  ('focusing', 0.0594),\n",
       "  ('significantly', 0.0379),\n",
       "  ('heart', 0.0308),\n",
       "  ('cancer type', 0.0292),\n",
       "  ('populations compared', 0.0244),\n",
       "  ('present data', 0.022),\n",
       "  ('increased plasma', 0.0106),\n",
       "  ('ischemic', -0.0301)],\n",
       " 'MED-1529': [('diet risk', 0.4019),\n",
       "  ('risk vegetarians', 0.391),\n",
       "  ('compared nonvegetarians', 0.3798),\n",
       "  ('ihd identified', 0.3418),\n",
       "  ('heart disease', 0.3239),\n",
       "  ('nutrition epic', 0.3235),\n",
       "  ('studies examined', 0.3145),\n",
       "  ('non hdl', 0.3138),\n",
       "  ('vegetarians lower', 0.3035),\n",
       "  ('scotland enrolled', 0.285),\n",
       "  ('44 561', 0.2741),\n",
       "  ('vegetarians 32', 0.2724),\n",
       "  ('risk factors', 0.2716),\n",
       "  ('bmi did', 0.2526),\n",
       "  ('study 34', 0.251),\n",
       "  ('did differ', 0.2448),\n",
       "  ('european prospective', 0.2401),\n",
       "  ('men women', 0.2357),\n",
       "  ('deaths compared', 0.2347),\n",
       "  ('nonfatal fatal', 0.2234),\n",
       "  ('proportional hazards', 0.2213),\n",
       "  ('differences non', 0.2173),\n",
       "  ('women living', 0.1887),\n",
       "  ('incident ischemic', 0.1877),\n",
       "  ('examine association', 0.1857),\n",
       "  ('baseline analysis', 0.147),\n",
       "  ('ci 60', 0.1444),\n",
       "  ('concentration 45', 0.1413),\n",
       "  ('probably mediated', 0.1403),\n",
       "  ('hospital admissions', 0.1395),\n",
       "  ('lower risk', 0.1376),\n",
       "  ('169 deaths', 0.1259),\n",
       "  ('design', 0.1231),\n",
       "  ('attenuated adjustment', 0.1201),\n",
       "  ('cancer', 0.114),\n",
       "  ('living', 0.1064),\n",
       "  ('systolic blood', 0.102),\n",
       "  ('previous', 0.1008),\n",
       "  ('sex age', 0.1),\n",
       "  ('hg', 0.0998),\n",
       "  ('status estimated', 0.0938),\n",
       "  ('smoking', 0.0852),\n",
       "  ('hr 68', 0.0753),\n",
       "  ('cox', 0.074),\n",
       "  ('cases matched', 0.0691),\n",
       "  ('oxford', 0.0498),\n",
       "  ('kg 95', 0.0497),\n",
       "  ('1235', 0.0489),\n",
       "  ('using multivariate', 0.0478),\n",
       "  ('average follow', 0.0331)],\n",
       " 'MED-1530': [('cohort studies', 0.5233),\n",
       "  ('mortality vegetarians', 0.4965),\n",
       "  ('searched cohort', 0.4882),\n",
       "  ('vegetarians compared', 0.4419),\n",
       "  ('studies examined', 0.4402),\n",
       "  ('cancer incidence', 0.4047),\n",
       "  ('investigate cardiovascular', 0.4014),\n",
       "  ('meta analysis', 0.3689),\n",
       "  ('examined mortality', 0.333),\n",
       "  ('inconclusive aims', 0.3181),\n",
       "  ('searched', 0.317),\n",
       "  ('nonvegetarians vegetarians', 0.3038),\n",
       "  ('lower cancer', 0.2678),\n",
       "  ('diseases rr', 0.2491),\n",
       "  ('mortality cerebrovascular', 0.2389),\n",
       "  ('medline embase', 0.2171),\n",
       "  ('published inception', 0.2138),\n",
       "  ('participants included', 0.1954),\n",
       "  ('background prospective', 0.1943),\n",
       "  ('analysis cause', 0.1937),\n",
       "  ('web science', 0.1908),\n",
       "  ('databases', 0.1889),\n",
       "  ('ci participants', 0.1844),\n",
       "  ('2011 studies', 0.1689),\n",
       "  ('results suggest', 0.1674),\n",
       "  ('14 12', 0.1487),\n",
       "  ('objective present', 0.1424),\n",
       "  ('compared', 0.1291),\n",
       "  ('seven studies', 0.1262),\n",
       "  ('2012 karger', 0.1163),\n",
       "  ('ci 54', 0.1144),\n",
       "  ('ischemic heart', 0.0962),\n",
       "  ('circulatory', 0.0888),\n",
       "  ('japan results', 0.069),\n",
       "  ('risk', 0.0671),\n",
       "  ('contained relative', 0.0551),\n",
       "  ('rr 82', 0.0483),\n",
       "  ('706 participants', 0.0482),\n",
       "  ('95', 0.0471),\n",
       "  ('29 overall', 0.0399),\n",
       "  ('total 124', 0.038),\n",
       "  ('california', 0.0361),\n",
       "  ('netherlands', 0.0341),\n",
       "  ('uk germany', 0.0159),\n",
       "  ('ag basel', 0.0125),\n",
       "  ('incidence 18', -0.0013),\n",
       "  ('usa', -0.0029),\n",
       "  ('observed 16', -0.0054),\n",
       "  ('06', -0.0246),\n",
       "  ('copyright', -0.0535)],\n",
       " 'MED-1531': [('cancer risk', 0.5067),\n",
       "  ('ecological studies', 0.4567),\n",
       "  ('environmental factors', 0.4073),\n",
       "  ('risk factors', 0.3938),\n",
       "  ('study used', 0.3915),\n",
       "  ('index smoking', 0.3675),\n",
       "  ('studies inversely', 0.3456),\n",
       "  ('modifying factors', 0.3413),\n",
       "  ('country ecological', 0.3267),\n",
       "  ('countries regression', 0.3124),\n",
       "  ('adjusted incidence', 0.3045),\n",
       "  ('cancers animal', 0.2759),\n",
       "  ('observational', 0.265),\n",
       "  ('guidance prevention', 0.2479),\n",
       "  ('11 cancers', 0.243),\n",
       "  ('157 countries', 0.2425),\n",
       "  ('doses results', 0.2271),\n",
       "  ('quality data', 0.2241),\n",
       "  ('rates 21', 0.2181),\n",
       "  ('alcohol consumption', 0.211),\n",
       "  ('researchers generally', 0.2036),\n",
       "  ('diet lack', 0.1967),\n",
       "  ('lung', 0.1904),\n",
       "  ('levels important', 0.1833),\n",
       "  ('respect dietary', 0.1798),\n",
       "  ('physical activity', 0.1668),\n",
       "  ('years types', 0.1657),\n",
       "  ('low serum', 0.1638),\n",
       "  ('25 hdyroxyvitamin', 0.1567),\n",
       "  ('strongly multiple', 0.1561),\n",
       "  ('direct correlation', 0.1519),\n",
       "  ('life expectancy', 0.1423),\n",
       "  ('inverse latitude', 0.1299),\n",
       "  ('single country', 0.1252),\n",
       "  ('data 2008', 0.1205),\n",
       "  ('time 15', 0.1202),\n",
       "  ('presence effect', 0.1193),\n",
       "  ('national', 0.1108),\n",
       "  ('poor', 0.11),\n",
       "  ('supply factors', 0.1075),\n",
       "  ('solar ultraviolet', 0.1072),\n",
       "  ('12 types', 0.1009),\n",
       "  ('lag time', 0.0987),\n",
       "  ('energy', 0.0956),\n",
       "  ('including capita', 0.0841),\n",
       "  ('different 87', 0.0831),\n",
       "  ('expectancy sweeteners', 0.0705),\n",
       "  ('gross domestic', 0.0626),\n",
       "  ('tended', 0.0424),\n",
       "  ('animal fat', 0.0274)],\n",
       " 'MED-1532': [('trends cancer', 0.4835),\n",
       "  ('asia studies', 0.446),\n",
       "  ('nutrition transition', 0.4311),\n",
       "  ('inception nutrition', 0.4058),\n",
       "  ('investigate trends', 0.3727),\n",
       "  ('countries breast', 0.3504),\n",
       "  ('increased intake', 0.3484),\n",
       "  ('health implications', 0.342),\n",
       "  ('trends mortality', 0.338),\n",
       "  ('fat', 0.3167),\n",
       "  ('increase mortality', 0.3159),\n",
       "  ('decades east', 0.3141),\n",
       "  ('westernized diet', 0.2964),\n",
       "  ('increase breast', 0.2812),\n",
       "  ('red meats', 0.2791),\n",
       "  ('countries regions', 0.2664),\n",
       "  ('japan changes', 0.2636),\n",
       "  ('striking changes', 0.2631),\n",
       "  ('characterized increased', 0.2523),\n",
       "  ('transition characterized', 0.2437),\n",
       "  ('energy', 0.1893),\n",
       "  ('1993 korea', 0.1866),\n",
       "  ('stomach china', 0.181),\n",
       "  ('korea 1985', 0.1784),\n",
       "  ('mortality 95', 0.1782),\n",
       "  ('regions striking', 0.1715),\n",
       "  ('1950', 0.1698),\n",
       "  ('study periods', 0.1562),\n",
       "  ('populations area', 0.1546),\n",
       "  ('1958 1993', 0.1377),\n",
       "  ('evaluated temporal', 0.1244),\n",
       "  ('attributable concurrent', 0.1199),\n",
       "  ('years', 0.1175),\n",
       "  ('annual percentage', 0.117),\n",
       "  ('investigate question', 0.1054),\n",
       "  ('hong kong', 0.1051),\n",
       "  ('interval period', 0.1047),\n",
       "  ('prostate esophagus', 0.1028),\n",
       "  ('colon', 0.1023),\n",
       "  ('decrease esophageal', 0.1018),\n",
       "  ('lagged 10', 0.0885),\n",
       "  ('systematically evaluated', 0.0854),\n",
       "  ('joinpoint regression', 0.0661),\n",
       "  ('1988 2000', 0.0614),\n",
       "  ('tremendous public', 0.05),\n",
       "  ('singapore 1963', 0.0236),\n",
       "  ('used', 0.0006),\n",
       "  ('animal', -0.0006),\n",
       "  ('confidence', -0.0043),\n",
       "  ('2006', -0.0622)],\n",
       " 'MED-1533': [('children dietary', 0.6855),\n",
       "  ('school snack', 0.6098),\n",
       "  ('cookies children', 0.6077),\n",
       "  ('energy intake', 0.5434),\n",
       "  ('libitum snacks', 0.5357),\n",
       "  ('compared snacks', 0.5291),\n",
       "  ('snack raisins', 0.4708),\n",
       "  ('intake prior', 0.468),\n",
       "  ('dried fruit', 0.4525),\n",
       "  ('food', 0.4384),\n",
       "  ('instructed eat', 0.4267),\n",
       "  ('calories raisins', 0.4116),\n",
       "  ('chips chocolate', 0.4052),\n",
       "  ('appetite measured', 0.3951),\n",
       "  ('institute food', 0.381),\n",
       "  ('snack apple', 0.3662),\n",
       "  ('cookies increased', 0.3476),\n",
       "  ('lunch', 0.3425),\n",
       "  ('children unknown', 0.3364),\n",
       "  ('dinner similar', 0.3253),\n",
       "  ('breakfast morning', 0.3085),\n",
       "  ('children examined', 0.3084),\n",
       "  ('lowered appetite', 0.2875),\n",
       "  ('potential school', 0.2636),\n",
       "  ('consumed', 0.2591),\n",
       "  ('percentile children', 0.2586),\n",
       "  ('compared grapes', 0.2454),\n",
       "  ('potato', 0.2338),\n",
       "  ('apart children', 0.2331),\n",
       "  ('comfortably appetite', 0.2317),\n",
       "  ('001 weight', 0.2063),\n",
       "  ('unknown effect', 0.1977),\n",
       "  ('wk apart', 0.1773),\n",
       "  ('11 old', 0.1754),\n",
       "  ('chips 75', 0.168),\n",
       "  ('15th 85th', 0.1628),\n",
       "  ('kilocalorie', 0.1334),\n",
       "  ('old 2013', 0.1092),\n",
       "  ('raisins potential', 0.1045),\n",
       "  ('cumulative', 0.0736),\n",
       "  ('randomly received', 0.0725),\n",
       "  ('important', 0.0694),\n",
       "  ('role dried', 0.0601),\n",
       "  ('separate weekdays', 0.048),\n",
       "  ('30', 0.0238),\n",
       "  ('expressed change', 0.008),\n",
       "  ('normal', -0.0171),\n",
       "  ('technologists', -0.0305),\n",
       "  ('received ad', -0.0346),\n",
       "  ('given standardized', -0.0379)],\n",
       " 'MED-1534': [('snacks containing', 0.7132),\n",
       "  ('snack meals', 0.706),\n",
       "  ('snacks findings', 0.6902),\n",
       "  ('realistic snacks', 0.6692),\n",
       "  ('different snack', 0.6492),\n",
       "  ('snack evoked', 0.5896),\n",
       "  ('snacks plasma', 0.5843),\n",
       "  ('meals similar', 0.5793),\n",
       "  ('subjects consumed', 0.5641),\n",
       "  ('snacks normal', 0.5615),\n",
       "  ('foods drinks', 0.5294),\n",
       "  ('peanut snack', 0.5245),\n",
       "  ('glucose levels', 0.5185),\n",
       "  ('suggest foods', 0.516),\n",
       "  ('foods raisins', 0.4985),\n",
       "  ('similar fat', 0.4811),\n",
       "  ('processed food', 0.4775),\n",
       "  ('responses food', 0.4733),\n",
       "  ('products chocolate', 0.4555),\n",
       "  ('fat total', 0.4223),\n",
       "  ('consumed different', 0.4222),\n",
       "  ('sugars stress', 0.416),\n",
       "  ('sugar evoke', 0.4145),\n",
       "  ('lower food', 0.3778),\n",
       "  ('drink crisps', 0.3757),\n",
       "  ('peanuts bananas', 0.3384),\n",
       "  ('insulin curve', 0.313),\n",
       "  ('coated candy', 0.2539),\n",
       "  ('healthy subjects', 0.2384),\n",
       "  ('total energy', 0.2143),\n",
       "  ('responses 10', 0.206),\n",
       "  ('normal responses', 0.2015),\n",
       "  ('added fiber', 0.1915),\n",
       "  ('manufactured products', 0.1598),\n",
       "  ('70 greater', 0.1436),\n",
       "  ('bar cola', 0.1351),\n",
       "  ('findings suggest', 0.1243),\n",
       "  ('overwhelm homeostatic', 0.123),\n",
       "  ('plasma', 0.117),\n",
       "  ('levels tended', 0.1147),\n",
       "  ('containing', 0.1132),\n",
       "  ('raisins', 0.1117),\n",
       "  ('subject pathological', 0.0982),\n",
       "  ('influenced physical', 0.0843),\n",
       "  ('evoked intermediate', 0.0768),\n",
       "  ('determine realistic', 0.056),\n",
       "  ('tended', 0.0443),\n",
       "  ('higher fall', 0.0334),\n",
       "  ('depleted', 0.0093),\n",
       "  ('state', -0.0155)],\n",
       " 'MED-1535': [('raisin snacks', 0.6032),\n",
       "  ('randomized snacks', 0.5886),\n",
       "  ('snacks glycemia', 0.5789),\n",
       "  ('036 snack', 0.5304),\n",
       "  ('raisins intake', 0.5279),\n",
       "  ('conventional snacks', 0.5248),\n",
       "  ('snacks 15', 0.496),\n",
       "  ('regular consumption', 0.4698),\n",
       "  ('weeks snacks', 0.456),\n",
       "  ('trial compared', 0.3975),\n",
       "  ('results fasting', 0.377),\n",
       "  ('intake processed', 0.3766),\n",
       "  ('intake 036', 0.3717),\n",
       "  ('eating', 0.3648),\n",
       "  ('cardiovascular risk', 0.3624),\n",
       "  ('affected intake', 0.3509),\n",
       "  ('raisins reduce', 0.341),\n",
       "  ('prandial glucose', 0.3388),\n",
       "  ('decreased glycated', 0.3369),\n",
       "  ('13 mg', 0.3143),\n",
       "  ('body weight', 0.3139),\n",
       "  ('women randomized', 0.2886),\n",
       "  ('hba1c', 0.2885),\n",
       "  ('12 weeks', 0.2848),\n",
       "  ('bp raisin', 0.2694),\n",
       "  ('conclusions regular', 0.2601),\n",
       "  ('compared times', 0.2308),\n",
       "  ('including bp', 0.2171),\n",
       "  ('reductions systolic', 0.2111),\n",
       "  ('performed baseline', 0.1921),\n",
       "  ('men women', 0.1921),\n",
       "  ('post prandial', 0.1857),\n",
       "  ('conventional', 0.1818),\n",
       "  ('times day', 0.1803),\n",
       "  ('15', 0.1497),\n",
       "  ('hemoglobin', 0.142),\n",
       "  ('mg dl', 0.1283),\n",
       "  ('materials methods', 0.1128),\n",
       "  ('change groups', 0.1054),\n",
       "  ('objective', 0.1002),\n",
       "  ('men', 0.0994),\n",
       "  ('plasma', 0.0992),\n",
       "  ('significantly affected', 0.0952),\n",
       "  ('levels significantly', 0.0772),\n",
       "  ('associated', 0.0492),\n",
       "  ('affect subject', 0.0352),\n",
       "  ('dbp', 0.0258),\n",
       "  ('015 001', -0.0014),\n",
       "  ('31', -0.0281),\n",
       "  ('10', -0.0846)],\n",
       " 'MED-1538': [('intake children', 0.64),\n",
       "  ('intake compared', 0.5301),\n",
       "  ('intake similar', 0.5014),\n",
       "  ('libitum consumption', 0.4768),\n",
       "  ('intake fi', 0.4501),\n",
       "  ('premeal snack', 0.4355),\n",
       "  ('cumulative intakes', 0.4216),\n",
       "  ('meal time', 0.416),\n",
       "  ('snacks 003', 0.4138),\n",
       "  ('caloric ad', 0.4137),\n",
       "  ('snack experiment', 0.4056),\n",
       "  ('intakes 015', 0.4041),\n",
       "  ('mix almonds', 0.3912),\n",
       "  ('fixed calorie', 0.3887),\n",
       "  ('calorie 150', 0.3847),\n",
       "  ('normal weight', 0.3546),\n",
       "  ('control food', 0.3325),\n",
       "  ('reduces meal', 0.3134),\n",
       "  ('13 boys', 0.312),\n",
       "  ('conclusion consumption', 0.2999),\n",
       "  ('later appetite', 0.2791),\n",
       "  ('water grapes', 0.2529),\n",
       "  ('fixed amounts', 0.238),\n",
       "  ('85th percentile', 0.2265),\n",
       "  ('treatments followed', 0.2223),\n",
       "  ('kcal experiment', 0.2205),\n",
       "  ('raisins compared', 0.2201),\n",
       "  ('water raisins', 0.219),\n",
       "  ('15 cumulative', 0.1935),\n",
       "  ('meal 30', 0.1919),\n",
       "  ('randomly received', 0.1701),\n",
       "  ('examined 11', 0.1586),\n",
       "  ('effect premeal', 0.1506),\n",
       "  ('reduced pizza', 0.1442),\n",
       "  ('percentile', 0.1369),\n",
       "  ('lower water', 0.1367),\n",
       "  ('year old', 0.1319),\n",
       "  ('fi measured', 0.1244),\n",
       "  ('min ad', 0.1123),\n",
       "  ('girls fixed', 0.0984),\n",
       "  ('similar', 0.098),\n",
       "  ('energy', 0.084),\n",
       "  ('resulted', 0.0824),\n",
       "  ('22 mixed', 0.0758),\n",
       "  ('26', 0.0675),\n",
       "  ('study', 0.0674),\n",
       "  ('higher cumulative', 0.0652),\n",
       "  ('037', 0.0586),\n",
       "  ('lead increased', 0.0428),\n",
       "  ('does', -0.0444)],\n",
       " 'MED-1540': [('vegetarians studied', 0.6023),\n",
       "  ('effects vegetarian', 0.5997),\n",
       "  ('health vegetarians', 0.5884),\n",
       "  ('vegetarians lower', 0.5681),\n",
       "  ('evidence vegetarians', 0.5678),\n",
       "  ('effects foods', 0.4897),\n",
       "  ('diets healthful', 0.4676),\n",
       "  ('studies evaluated', 0.4215),\n",
       "  ('avoided vegetarians', 0.415),\n",
       "  ('effects health', 0.4091),\n",
       "  ('foods preferred', 0.4088),\n",
       "  ('purpose review', 0.3174),\n",
       "  ('lower prevalence', 0.3072),\n",
       "  ('possible explanations', 0.2885),\n",
       "  ('low ldl', 0.2788),\n",
       "  ('obesity overall', 0.26),\n",
       "  ('cancer lower', 0.2445),\n",
       "  ('lower risk', 0.2417),\n",
       "  ('evidence risk', 0.2356),\n",
       "  ('look critically', 0.2211),\n",
       "  ('colorectal cancer', 0.2091),\n",
       "  ('rates coronary', 0.2055),\n",
       "  ('meat results', 0.1982),\n",
       "  ('prevalence', 0.1947),\n",
       "  ('cholesterol probable', 0.1922),\n",
       "  ('heart disease', 0.1853),\n",
       "  ('different types', 0.1799),\n",
       "  ('communities life', 0.1679),\n",
       "  ('descriptive subtypes', 0.1635),\n",
       "  ('disease largely', 0.1525),\n",
       "  ('chronic', 0.1505),\n",
       "  ('cancers convincing', 0.1483),\n",
       "  ('disagree needs', 0.1465),\n",
       "  ('results specific', 0.1421),\n",
       "  ('category broad', 0.1401),\n",
       "  ('needs', 0.1386),\n",
       "  ('overall', 0.1142),\n",
       "  ('rates hypertension', 0.1087),\n",
       "  ('preferred', 0.1022),\n",
       "  ('diabetes mellitus', 0.0999),\n",
       "  ('appear moderately', 0.0903),\n",
       "  ('understanding served', 0.0793),\n",
       "  ('experience effects', 0.0608),\n",
       "  ('greater results', 0.0456),\n",
       "  ('conflict convincing', 0.0369),\n",
       "  ('expectancy appears', 0.0329),\n",
       "  ('using label', 0.016),\n",
       "  ('served', 0.0008),\n",
       "  ('british', -0.0024),\n",
       "  ('dividing', -0.016)],\n",
       " 'MED-1541': [('vegetarians diabetes', 0.5751),\n",
       "  ('diabetes lower', 0.5453),\n",
       "  ('diabetes findings', 0.5413),\n",
       "  ('risk diabetes', 0.5294),\n",
       "  ('diabetes stronger', 0.427),\n",
       "  ('dietary factors', 0.4128),\n",
       "  ('diet reduces', 0.4092),\n",
       "  ('population vegetarians', 0.3786),\n",
       "  ('hypothesis vegetarian', 0.3612),\n",
       "  ('lower vegetarians', 0.3488),\n",
       "  ('vegetarians associations', 0.3386),\n",
       "  ('death adventists', 0.3204),\n",
       "  ('adventist populations', 0.3143),\n",
       "  ('weight selected', 0.2759),\n",
       "  ('reduces risk', 0.2754),\n",
       "  ('vegetarians non', 0.26),\n",
       "  ('identified 1960', 0.2382),\n",
       "  ('population 25', 0.2347),\n",
       "  ('1960 21', 0.2316),\n",
       "  ('prevalence self', 0.2198),\n",
       "  ('25 698', 0.2163),\n",
       "  ('years follow', 0.2145),\n",
       "  ('female adventist', 0.2111),\n",
       "  ('risk whites', 0.2056),\n",
       "  ('consumption apparently', 0.1854),\n",
       "  ('findings generated', 0.1581),\n",
       "  ('risk developing', 0.1495),\n",
       "  ('seventh day', 0.1435),\n",
       "  ('activity associations', 0.1386),\n",
       "  ('propose hypothesis', 0.1377),\n",
       "  ('substantially lower', 0.1344),\n",
       "  ('underlying contributing', 0.1322),\n",
       "  ('white', 0.1195),\n",
       "  ('approximately half', 0.1181),\n",
       "  ('cause death', 0.1143),\n",
       "  ('male adventist', 0.1137),\n",
       "  ('factors physical', 0.1119),\n",
       "  ('meat consumption', 0.1116),\n",
       "  ('populations', 0.089),\n",
       "  ('apparently confounding', 0.0767),\n",
       "  ('developing', 0.0673),\n",
       "  ('generated', 0.0647),\n",
       "  ('day', 0.0594),\n",
       "  ('698', 0.0473),\n",
       "  ('substantially', 0.0337),\n",
       "  ('follow', 0.0274),\n",
       "  ('reported', 0.0235),\n",
       "  ('males females', 0.0173),\n",
       "  ('adult', 0.0037),\n",
       "  ('non', -0.0181)],\n",
       " 'MED-1542': [('cv health', 0.5139),\n",
       "  ('adults prevalence', 0.4595),\n",
       "  ('concept cardiovascular', 0.421),\n",
       "  ('health behaviors', 0.4053),\n",
       "  ('american heart', 0.4037),\n",
       "  ('current prevalence', 0.3828),\n",
       "  ('poor cv', 0.3715),\n",
       "  ('515 adults', 0.3621),\n",
       "  ('estimates age', 0.2991),\n",
       "  ('bmi range', 0.2978),\n",
       "  ('national health', 0.2946),\n",
       "  ('prevalence poor', 0.282),\n",
       "  ('20 years', 0.2556),\n",
       "  ('index smoking', 0.2548),\n",
       "  ('range 60', 0.251),\n",
       "  ('impact goals', 0.2306),\n",
       "  ('efforts promote', 0.2097),\n",
       "  ('included 14', 0.2069),\n",
       "  ('surveys participants', 0.1981),\n",
       "  ('blood pressure', 0.1796),\n",
       "  ('sex race', 0.178),\n",
       "  ('2020 strategic', 0.1774),\n",
       "  ('new concept', 0.1689),\n",
       "  ('physical activity', 0.1516),\n",
       "  ('50', 0.1413),\n",
       "  ('64 years', 0.1389),\n",
       "  ('current', 0.1384),\n",
       "  ('populations', 0.1158),\n",
       "  ('stratified young', 0.1145),\n",
       "  ('levels range', 0.1133),\n",
       "  ('groups conclusions', 0.1124),\n",
       "  ('cholesterol fasting', 0.1107),\n",
       "  ('association', 0.1071),\n",
       "  ('monitored compared', 0.1049),\n",
       "  ('ethnicity published', 0.1048),\n",
       "  ('years middle', 0.1042),\n",
       "  ('published methods', 0.0899),\n",
       "  ('score prevalent', 0.0896),\n",
       "  ('disease', 0.087),\n",
       "  ('middle 40', 0.0734),\n",
       "  ('represent starting', 0.0684),\n",
       "  ('healthy', 0.0667),\n",
       "  ('31 42', 0.0633),\n",
       "  ('36 blood', 0.0583),\n",
       "  ('factors lowest', 0.029),\n",
       "  ('range 11', 0.0129),\n",
       "  ('90 ideal', 0.0123),\n",
       "  ('2008', -0.0139),\n",
       "  ('years 2003', -0.0216),\n",
       "  ('non', -0.0701)],\n",
       " 'MED-1543': [('behaviors physicians', 0.601),\n",
       "  ('physicians training', 0.5866),\n",
       "  ('counseling physicians', 0.5738),\n",
       "  ('patients behaviors', 0.5336),\n",
       "  ('diet physicians', 0.5104),\n",
       "  ('health behaviors', 0.4925),\n",
       "  ('counseling patients', 0.4621),\n",
       "  ('received trainees', 0.4186),\n",
       "  ('behaviors predictors', 0.4047),\n",
       "  ('better training', 0.3995),\n",
       "  ('physicians lack', 0.3846),\n",
       "  ('teaching hospital', 0.3597),\n",
       "  ('improve patient', 0.3536),\n",
       "  ('major teaching', 0.3417),\n",
       "  ('counseling exercise', 0.3358),\n",
       "  ('techniques improve', 0.3305),\n",
       "  ('surveyed regarding', 0.3289),\n",
       "  ('attendings confident', 0.3162),\n",
       "  ('self efficacy', 0.3098),\n",
       "  ('included provider', 0.3088),\n",
       "  ('behavior perceived', 0.2851),\n",
       "  ('related lifestyle', 0.2621),\n",
       "  ('healthy diet', 0.2158),\n",
       "  ('diet 70', 0.1952),\n",
       "  ('overweight reported', 0.1946),\n",
       "  ('total responses', 0.1913),\n",
       "  ('consume fast', 0.1875),\n",
       "  ('confidence frequency', 0.182),\n",
       "  ('goal research', 0.1762),\n",
       "  ('eighty total', 0.1737),\n",
       "  ('0001 regular', 0.1705),\n",
       "  ('vegetables attendings', 0.1676),\n",
       "  ('efficacy', 0.1542),\n",
       "  ('regarding personal', 0.1451),\n",
       "  ('lack confidence', 0.1446),\n",
       "  ('predictor strong', 0.1408),\n",
       "  ('consume fruits', 0.1356),\n",
       "  ('evaluate', 0.1252),\n",
       "  ('week 150', 0.1104),\n",
       "  ('change', 0.1098),\n",
       "  ('major', 0.1067),\n",
       "  ('reported adequate', 0.0746),\n",
       "  ('69 vs', 0.0741),\n",
       "  ('days week', 0.073),\n",
       "  ('36 0001', 0.0563),\n",
       "  ('compared', 0.043),\n",
       "  ('2010', 0.0385),\n",
       "  ('association', 0.0314),\n",
       "  ('minutes', 0.007),\n",
       "  ('wiley periodicals', 0.0046)],\n",
       " 'MED-1544': [('programs advantages', 0.5366),\n",
       "  ('intervention programs', 0.5049),\n",
       "  ('universal programs', 0.4836),\n",
       "  ('programs potential', 0.4743),\n",
       "  ('targeted programs', 0.4708),\n",
       "  ('programs absence', 0.4364),\n",
       "  ('disadvantages universal', 0.4295),\n",
       "  ('programs carried', 0.392),\n",
       "  ('advantages universal', 0.3833),\n",
       "  ('advantages disadvantages', 0.3515),\n",
       "  ('run disadvantages', 0.3361),\n",
       "  ('universal targeted', 0.3211),\n",
       "  ('disadvantages unappealing', 0.2958),\n",
       "  ('program run', 0.2911),\n",
       "  ('disorders optimal', 0.2871),\n",
       "  ('clinical programs', 0.2532),\n",
       "  ('strategies elements', 0.2419),\n",
       "  ('potential addressing', 0.2319),\n",
       "  ('absence labeling', 0.2154),\n",
       "  ('reduce immense', 0.2087),\n",
       "  ('stigmatization argument', 0.2053),\n",
       "  ('offs strategies', 0.2002),\n",
       "  ('efficient targeting', 0.1993),\n",
       "  ('greatest effect', 0.1989),\n",
       "  ('potentially efficient', 0.1943),\n",
       "  ('include difficulties', 0.1862),\n",
       "  ('politicians', 0.1837),\n",
       "  ('problems early', 0.1799),\n",
       "  ('unappealing public', 0.1563),\n",
       "  ('middle class', 0.1544),\n",
       "  ('outlines', 0.1489),\n",
       "  ('difficulties screening', 0.1473),\n",
       "  ('risk', 0.1386),\n",
       "  ('lowest risk', 0.1296),\n",
       "  ('inclusion', 0.1188),\n",
       "  ('possibility labeling', 0.1133),\n",
       "  ('psychiatric', 0.1131),\n",
       "  ('community', 0.0982),\n",
       "  ('article', 0.0793),\n",
       "  ('context civic', 0.0744),\n",
       "  ('change', 0.0294),\n",
       "  ('mix', 0.0281),\n",
       "  ('knowledge accumulates', 0.0173),\n",
       "  ('carried context', 0.0108),\n",
       "  ('immense burden', 0.0034),\n",
       "  ('suffering', 0.0028),\n",
       "  ('community trade', -0.0238),\n",
       "  ('child adolescent', -0.054),\n",
       "  ('accumulates', -0.0702),\n",
       "  ('forth needed', -0.0861)],\n",
       " 'MED-1545': [('smoking physicians', 0.7084),\n",
       "  ('physicians impact', 0.5765),\n",
       "  ('opinions physicians', 0.5391),\n",
       "  ('discussed smoking', 0.5176),\n",
       "  ('assisting smoking', 0.5077),\n",
       "  ('interactions patients', 0.4628),\n",
       "  ('physicians invited', 0.458),\n",
       "  ('cessation perceptions', 0.4579),\n",
       "  ('smokers agreed', 0.439),\n",
       "  ('physicians stop', 0.4326),\n",
       "  ('methodology physician', 0.4174),\n",
       "  ('improving health', 0.359),\n",
       "  ('assisting quitting', 0.354),\n",
       "  ('42 smokers', 0.3467),\n",
       "  ('patients relevant', 0.3404),\n",
       "  ('4473 physicians', 0.3171),\n",
       "  ('practitioners adopt', 0.3074),\n",
       "  ('perceptions', 0.2984),\n",
       "  ('001 barriers', 0.2761),\n",
       "  ('specific strategies', 0.2741),\n",
       "  ('participated survey', 0.2532),\n",
       "  ('clinical', 0.2526),\n",
       "  ('implications need', 0.25),\n",
       "  ('examined association', 0.2404),\n",
       "  ('status beliefs', 0.1978),\n",
       "  ('non smoking', 0.1882),\n",
       "  ('discussed', 0.1788),\n",
       "  ('impact interactions', 0.1744),\n",
       "  ('general family', 0.1709),\n",
       "  ('self', 0.1525),\n",
       "  ('motivate', 0.1414),\n",
       "  ('saw stress', 0.1274),\n",
       "  ('2836 63', 0.1155),\n",
       "  ('reported results', 0.0904),\n",
       "  ('vs 82', 0.0869),\n",
       "  ('visit 45', 0.068),\n",
       "  ('telephone face', 0.0624),\n",
       "  ('22 001', 0.0533),\n",
       "  ('lack', 0.0514),\n",
       "  ('using convenience', 0.043),\n",
       "  ('countries', 0.041),\n",
       "  ('biggest step', 0.0315),\n",
       "  ('28 vs', 0.0217),\n",
       "  ('16 vs', 0.0202),\n",
       "  ('existed', 0.0096),\n",
       "  ('significantly fewer', -0.0285),\n",
       "  ('willpower', -0.0324),\n",
       "  ('34 001', -0.0352),\n",
       "  ('vs 10', -0.0472),\n",
       "  ('1200', -0.0476)],\n",
       " 'MED-1546': [('cardiovascular health', 0.5711),\n",
       "  ('construct cardiovascular', 0.4378),\n",
       "  ('health subgroups', 0.4301),\n",
       "  ('components aha', 0.4297),\n",
       "  ('heart association', 0.4188),\n",
       "  ('aha 2020', 0.3698),\n",
       "  ('health new', 0.357),\n",
       "  ('ideal health', 0.344),\n",
       "  ('new construct', 0.274),\n",
       "  ('community based', 0.2681),\n",
       "  ('study population', 0.265),\n",
       "  ('population comprehensive', 0.2524),\n",
       "  ('impact goals', 0.2504),\n",
       "  ('interventions developed', 0.2491),\n",
       "  ('based populations', 0.249),\n",
       "  ('prevalence ideal', 0.2451),\n",
       "  ('defined american', 0.2386),\n",
       "  ('applicability construct', 0.1947),\n",
       "  ('age income', 0.1896),\n",
       "  ('interval ci', 0.1785),\n",
       "  ('background', 0.1745),\n",
       "  ('59 years', 0.1716),\n",
       "  ('34 001', 0.154),\n",
       "  ('interaction race', 0.1473),\n",
       "  ('adjustment sex', 0.127),\n",
       "  ('developed support', 0.1221),\n",
       "  ('components whites', 0.1218),\n",
       "  ('index evaluated', 0.1175),\n",
       "  ('years', 0.1102),\n",
       "  ('distributions components', 0.1037),\n",
       "  ('27 components', 0.0996),\n",
       "  ('66 female', 0.0934),\n",
       "  ('reported methods', 0.0925),\n",
       "  ('participants mean', 0.0878),\n",
       "  ('thirty subjects', 0.0814),\n",
       "  ('odds ratio', 0.0813),\n",
       "  ('attainment', 0.0691),\n",
       "  ('years 44', 0.0577),\n",
       "  ('vs 001', 0.0543),\n",
       "  ('blacks significantly', 0.0541),\n",
       "  ('significantly', 0.0508),\n",
       "  ('individual', 0.0381),\n",
       "  ('18 95', 0.0365),\n",
       "  ('met components', 0.0306),\n",
       "  ('10 participants', 0.0164),\n",
       "  ('concentrating', 0.0131),\n",
       "  ('1933', 0.0074),\n",
       "  ('fewer ideal', -0.0086),\n",
       "  ('low middle', -0.012),\n",
       "  ('82', -0.0168)],\n",
       " 'MED-1548': [('recommendations goals', 0.5646),\n",
       "  ('metrics cardiovascular', 0.5518),\n",
       "  ('current guideline', 0.5252),\n",
       "  ('improve cardiovascular', 0.4998),\n",
       "  ('strategic planning', 0.4893),\n",
       "  ('committee strategic', 0.4652),\n",
       "  ('impact goal', 0.4535),\n",
       "  ('task force', 0.4128),\n",
       "  ('concept supported', 0.4013),\n",
       "  ('public health', 0.4001),\n",
       "  ('developed 2020', 0.3644),\n",
       "  ('prevention decade', 0.3598),\n",
       "  ('heart association', 0.3573),\n",
       "  ('organization', 0.3537),\n",
       "  ('ideal metrics', 0.3466),\n",
       "  ('mortality committee', 0.3106),\n",
       "  ('new concept', 0.3076),\n",
       "  ('document details', 0.3071),\n",
       "  ('improve', 0.3039),\n",
       "  ('define achievement', 0.3029),\n",
       "  ('promotion disease', 0.3002),\n",
       "  ('charged defining', 0.2986),\n",
       "  ('factors', 0.2789),\n",
       "  ('advocacy programs', 0.2707),\n",
       "  ('needed monitor', 0.2677),\n",
       "  ('use levels', 0.2529),\n",
       "  ('diet consistent', 0.2445),\n",
       "  ('population defined', 0.2384),\n",
       "  ('reducing deaths', 0.2324),\n",
       "  ('research clinical', 0.219),\n",
       "  ('supported literature', 0.2143),\n",
       "  ('mm hg', 0.2134),\n",
       "  ('force american', 0.2094),\n",
       "  ('mass index', 0.2081),\n",
       "  ('details procedures', 0.2077),\n",
       "  ('changing prevalence', 0.1966),\n",
       "  ('disease stroke', 0.1927),\n",
       "  ('levels children', 0.1779),\n",
       "  ('blood glucose', 0.1733),\n",
       "  ('index 25', 0.1698),\n",
       "  ('pressure 120', 0.1674),\n",
       "  ('physical activity', 0.163),\n",
       "  ('total cholesterol', 0.1517),\n",
       "  ('100', 0.1473),\n",
       "  ('20 reducing', 0.1344),\n",
       "  ('defined poor', 0.1332),\n",
       "  ('entire range', 0.1282),\n",
       "  ('80 mm', 0.036),\n",
       "  ('nonsmoking', -0.0038),\n",
       "  ('untreated blood', -0.0379)],\n",
       " 'MED-1549': [('lifestyle modification', 0.5008),\n",
       "  ('jnc vii', 0.4286),\n",
       "  ('committee prevention', 0.4106),\n",
       "  ('recommending jnc', 0.4068),\n",
       "  ('recommending patients', 0.3997),\n",
       "  ('blood pressure', 0.3978),\n",
       "  ('guidelines methods', 0.3894),\n",
       "  ('physician behavior', 0.3889),\n",
       "  ('pressure objective', 0.3695),\n",
       "  ('vii lifestyle', 0.3613),\n",
       "  ('health issues', 0.3549),\n",
       "  ('pharmacologic treatment', 0.3496),\n",
       "  ('interventions greater', 0.3323),\n",
       "  ('primary care', 0.3258),\n",
       "  ('patients exercised', 0.2951),\n",
       "  ('recommendations nonsmoking', 0.2817),\n",
       "  ('patients high', 0.281),\n",
       "  ('probability recommending', 0.2642),\n",
       "  ('attitudes behaviors', 0.2479),\n",
       "  ('27 exercised', 0.2355),\n",
       "  ('66 lifestyle', 0.224),\n",
       "  ('limit use', 0.2092),\n",
       "  ('determine association', 0.2013),\n",
       "  ('report joint', 0.1913),\n",
       "  ('detection evaluation', 0.1889),\n",
       "  ('web based', 0.1733),\n",
       "  ('68 male', 0.1699),\n",
       "  ('objective study', 0.1681),\n",
       "  ('designed provide', 0.1674),\n",
       "  ('national', 0.1629),\n",
       "  ('behavior smoked', 0.1573),\n",
       "  ('use conclusions', 0.1529),\n",
       "  ('94 collectively', 0.1491),\n",
       "  ('attain maintain', 0.1434),\n",
       "  ('diet 92', 0.1347),\n",
       "  ('days week', 0.1303),\n",
       "  ('patients eat', 0.1173),\n",
       "  ('results respondents', 0.1117),\n",
       "  ('alcohol 75', 0.1051),\n",
       "  ('healthy', 0.1048),\n",
       "  ('thousand primary', 0.0984),\n",
       "  ('45 years', 0.0844),\n",
       "  ('average age', 0.0801),\n",
       "  ('ate cups', 0.0541),\n",
       "  ('various', 0.0523),\n",
       "  ('personal', 0.0504),\n",
       "  ('fruits vegetables', 0.0076),\n",
       "  ('docstyles 2010', 0.0066),\n",
       "  ('male regards', 0.0025),\n",
       "  ('salt 96', -0.0039)],\n",
       " 'MED-1551': [('diet weeks', 0.488),\n",
       "  ('control diet', 0.4463),\n",
       "  ('vegetarians studied', 0.4407),\n",
       "  ('controlled trial', 0.4358),\n",
       "  ('diet followed', 0.4274),\n",
       "  ('week control', 0.4196),\n",
       "  ('vegetarian diet', 0.4077),\n",
       "  ('usual vegetarian', 0.3926),\n",
       "  ('eating control', 0.3854),\n",
       "  ('strict vegetarians', 0.3826),\n",
       "  ('followed weeks', 0.3573),\n",
       "  ('diet plasma', 0.3439),\n",
       "  ('meat eating', 0.3096),\n",
       "  ('end meat', 0.2726),\n",
       "  ('total cholesterol', 0.2578),\n",
       "  ('isocalorically', 0.2483),\n",
       "  ('lipid bp', 0.2425),\n",
       "  ('period usual', 0.2415),\n",
       "  ('beef plasma', 0.2389),\n",
       "  ('density lipoprotein', 0.2204),\n",
       "  ('normal limits', 0.2134),\n",
       "  ('study plasma', 0.2123),\n",
       "  ('effect consumption', 0.2077),\n",
       "  ('controlled', 0.2011),\n",
       "  ('study suggests', 0.1985),\n",
       "  ('studied prospectively', 0.1943),\n",
       "  ('21 strict', 0.1938),\n",
       "  ('excretions normal', 0.1922),\n",
       "  ('bp showed', 0.1917),\n",
       "  ('250', 0.1907),\n",
       "  ('followed', 0.1774),\n",
       "  ('cholesterol did', 0.1602),\n",
       "  ('total', 0.1587),\n",
       "  ('prostaglandin levels', 0.1506),\n",
       "  ('daily', 0.1496),\n",
       "  ('limits did', 0.1446),\n",
       "  ('major', 0.1418),\n",
       "  ('values', 0.1201),\n",
       "  ('major changes', 0.1191),\n",
       "  ('high', 0.1139),\n",
       "  ('period systolic', 0.0997),\n",
       "  ('kallikrein', 0.0908),\n",
       "  ('added', 0.0821),\n",
       "  ('significantly 19', 0.071),\n",
       "  ('values diastolic', 0.0688),\n",
       "  ('blood', 0.0669),\n",
       "  ('epinephrine', 0.0628),\n",
       "  ('did', 0.0343),\n",
       "  ('adverse effect', 0.0225),\n",
       "  ('rose', -0.0106)],\n",
       " 'MED-1552': [('dietary experiments', 0.5668),\n",
       "  ('dietary fatty', 0.5559),\n",
       "  ('saturated fats', 0.5061),\n",
       "  ('analysis metabolic', 0.4897),\n",
       "  ('fats complex', 0.4851),\n",
       "  ('cholesterol design', 0.4766),\n",
       "  ('diets healthy', 0.4745),\n",
       "  ('total cholesterol', 0.4688),\n",
       "  ('monounsaturated fats', 0.4553),\n",
       "  ('calories resulted', 0.4433),\n",
       "  ('studies solid', 0.4245),\n",
       "  ('cholesterol 13', 0.4093),\n",
       "  ('studies', 0.4041),\n",
       "  ('lipoprotein high', 0.3854),\n",
       "  ('subjects 395', 0.3848),\n",
       "  ('meta analysis', 0.3536),\n",
       "  ('experiments median', 0.335),\n",
       "  ('results isocaloric', 0.3265),\n",
       "  ('acids', 0.3225),\n",
       "  ('ward studies', 0.322),\n",
       "  ('complex carbohydrates', 0.3186),\n",
       "  ('effect total', 0.3186),\n",
       "  ('solid food', 0.3043),\n",
       "  ('concentrations', 0.2707),\n",
       "  ('volunteers subjects', 0.2501),\n",
       "  ('129 groups', 0.2459),\n",
       "  ('quantitative importance', 0.2377),\n",
       "  ('individuals results', 0.2107),\n",
       "  ('mmol similar', 0.2047),\n",
       "  ('conclusions typical', 0.1995),\n",
       "  ('13 02', 0.197),\n",
       "  ('05 mmol', 0.1856),\n",
       "  ('objective determine', 0.1696),\n",
       "  ('10 dietary', 0.1681),\n",
       "  ('healthy', 0.1674),\n",
       "  ('200 mg', 0.1628),\n",
       "  ('52 se', 0.1626),\n",
       "  ('produced significant', 0.154),\n",
       "  ('replacement saturated', 0.1527),\n",
       "  ('15', 0.138),\n",
       "  ('falling 36', 0.13),\n",
       "  ('replacing 60', 0.1297),\n",
       "  ('mg day', 0.1297),\n",
       "  ('decreased blood', 0.1283),\n",
       "  ('fifths reduction', 0.1267),\n",
       "  ('typical british', 0.0862),\n",
       "  ('avoiding', 0.0714),\n",
       "  ('low density', 0.0631),\n",
       "  ('11', 0.026),\n",
       "  ('duration month', 0.0226)],\n",
       " 'MED-1553': [('attitudes nutrition', 0.6693),\n",
       "  ('nutrition communications', 0.6185),\n",
       "  ('communicating dietary', 0.6023),\n",
       "  ('diet issues', 0.5903),\n",
       "  ('dietary guideline', 0.5607),\n",
       "  ('health knowledge', 0.5603),\n",
       "  ('food information', 0.5421),\n",
       "  ('dietitians using', 0.5303),\n",
       "  ('foods promotes', 0.506),\n",
       "  ('eating healthful', 0.4848),\n",
       "  ('worry foods', 0.4723),\n",
       "  ('international food', 0.4383),\n",
       "  ('consumer attitudes', 0.4254),\n",
       "  ('fat consistent', 0.3933),\n",
       "  ('translate healthful', 0.3933),\n",
       "  ('guidelines americans', 0.382),\n",
       "  ('good health', 0.3362),\n",
       "  ('implement recommendation', 0.3184),\n",
       "  ('fat address', 0.314),\n",
       "  ('information council', 0.3023),\n",
       "  ('effective messages', 0.3015),\n",
       "  ('counseling situations', 0.2968),\n",
       "  ('better understand', 0.2921),\n",
       "  ('ific conducted', 0.2791),\n",
       "  ('information propels', 0.2735),\n",
       "  ('intake new', 0.2639),\n",
       "  ('motivates behavior', 0.2527),\n",
       "  ('issues emerged', 0.245),\n",
       "  ('personal choices', 0.2433),\n",
       "  ('consumers using', 0.2376),\n",
       "  ('using focus', 0.2267),\n",
       "  ('national', 0.2254),\n",
       "  ('general', 0.2251),\n",
       "  ('common sense', 0.2211),\n",
       "  ('cholesterol moderate', 0.2185),\n",
       "  ('inclusion 2000', 0.2111),\n",
       "  ('need', 0.2079),\n",
       "  ('developing meaningful', 0.2039),\n",
       "  ('knowledge does', 0.1975),\n",
       "  ('guilt worry', 0.1972),\n",
       "  ('action appeals', 0.1884),\n",
       "  ('empowerment', 0.1156),\n",
       "  ('regimen reduces', 0.1063),\n",
       "  ('language', 0.1012),\n",
       "  ('interviews 1998', 0.0956),\n",
       "  ('allows flexibility', 0.0833),\n",
       "  ('results research', 0.08),\n",
       "  ('propels', 0.0669),\n",
       "  ('groups', 0.0587),\n",
       "  ('using telephone', 0.0565)],\n",
       " 'MED-1554': [('fat interventions', 0.5995),\n",
       "  ('reduction dietary', 0.562),\n",
       "  ('total cholesterol', 0.5125),\n",
       "  ('risk trials', 0.4081),\n",
       "  ('especially statins', 0.3993),\n",
       "  ('significant reductions', 0.3896),\n",
       "  ('cochrane groups', 0.3849),\n",
       "  ('studies included', 0.3825),\n",
       "  ('dietary saturated', 0.3403),\n",
       "  ('intervention months', 0.3361),\n",
       "  ('potentially important', 0.3099),\n",
       "  ('protection cardiovascular', 0.308),\n",
       "  ('improve total', 0.3069),\n",
       "  ('risk factors', 0.3061),\n",
       "  ('95 ci', 0.3018),\n",
       "  ('86 12', 0.2575),\n",
       "  ('sensitivity analysis', 0.2546),\n",
       "  ('mortality rate', 0.2305),\n",
       "  ('inclusion decisions', 0.2233),\n",
       "  ('unavailable rationed', 0.2203),\n",
       "  ('statins unavailable', 0.2194),\n",
       "  ('systematic', 0.2004),\n",
       "  ('used main', 0.1984),\n",
       "  ('trials longer', 0.1975),\n",
       "  ('cvrct registry', 0.1913),\n",
       "  ('advice', 0.1871),\n",
       "  ('objectives aim', 0.1846),\n",
       "  ('effects positive', 0.1781),\n",
       "  ('years lifestyle', 0.1769),\n",
       "  ('variety effects', 0.1716),\n",
       "  ('regression funnel', 0.165),\n",
       "  ('seven studies', 0.1627),\n",
       "  ('medline embase', 0.1506),\n",
       "  ('disagreement resolved', 0.149),\n",
       "  ('registers', 0.125),\n",
       "  ('replacement unsaturates', 0.1116),\n",
       "  ('biographies', 0.1049),\n",
       "  ('include permanent', 0.1011),\n",
       "  ('known experts', 0.1007),\n",
       "  ('population groups', 0.0929),\n",
       "  ('1998 sigle', 0.0916),\n",
       "  ('exclusively omega', 0.0916),\n",
       "  ('events appeared', 0.0829),\n",
       "  ('healthy adult', 0.0777),\n",
       "  ('high low', 0.068),\n",
       "  ('30 901', 0.0599),\n",
       "  ('party data', 0.0393),\n",
       "  ('included 40', 0.0337),\n",
       "  ('arms', 0.0027),\n",
       "  ('field', -0.0058)],\n",
       " 'MED-1555': [('confounding results', 0.5661),\n",
       "  ('confounding', 0.5028),\n",
       "  ('certain variances', 0.4682),\n",
       "  ('serum cholesterol', 0.4352),\n",
       "  ('epidemiologic observations', 0.4266),\n",
       "  ('cholesterol paper', 0.4175),\n",
       "  ('effect correlation', 0.4149),\n",
       "  ('results uncontrolled', 0.4035),\n",
       "  ('uncontrolled conditions', 0.3993),\n",
       "  ('variances sufficiently', 0.3955),\n",
       "  ('undermine validity', 0.3765),\n",
       "  ('conditions epidemiologic', 0.3687),\n",
       "  ('correlation coefficients', 0.3564),\n",
       "  ('authors using', 0.286),\n",
       "  ('coefficients close', 0.2825),\n",
       "  ('diet serum', 0.2731),\n",
       "  ('coefficients', 0.27),\n",
       "  ('referring empirical', 0.2678),\n",
       "  ('observations sufficient', 0.2663),\n",
       "  ('relationship diet', 0.2519),\n",
       "  ('sufficient undermine', 0.2452),\n",
       "  ('validity', 0.2439),\n",
       "  ('mathematical model', 0.2355),\n",
       "  ('investigation relationship', 0.2301),\n",
       "  ('data certain', 0.228),\n",
       "  ('data cross', 0.2201),\n",
       "  ('model referring', 0.2116),\n",
       "  ('sectional designs', 0.2013),\n",
       "  ('study', 0.1941),\n",
       "  ('effect', 0.1919),\n",
       "  ('studying relationship', 0.1866),\n",
       "  ('cross sectional', 0.1853),\n",
       "  ('cause', 0.1713),\n",
       "  ('results', 0.1695),\n",
       "  ('actual data', 0.167),\n",
       "  ('designs', 0.1579),\n",
       "  ('data', 0.1468),\n",
       "  ('paper', 0.1406),\n",
       "  ('suitable studying', 0.1347),\n",
       "  ('serum', 0.12),\n",
       "  ('great cause', 0.1065),\n",
       "  ('close zero', 0.1044),\n",
       "  ('respect investigation', 0.0973),\n",
       "  ('conditions', 0.0933),\n",
       "  ('sufficiently', 0.0844),\n",
       "  ('using', 0.0824),\n",
       "  ('zero expected', 0.0713),\n",
       "  ('referring', 0.0351),\n",
       "  ('close', 0.0254),\n",
       "  ('expected', 0.0201)],\n",
       " 'MED-1556': [('saturated fat', 0.499),\n",
       "  ('estimates chd', 0.422),\n",
       "  ('studies identified', 0.3996),\n",
       "  ('reduction dietary', 0.3912),\n",
       "  ('improve cardiovascular', 0.354),\n",
       "  ('risk coronary', 0.3532),\n",
       "  ('22 chd', 0.3263),\n",
       "  ('effects model', 0.3083),\n",
       "  ('replace saturated', 0.3017),\n",
       "  ('cvd pooled', 0.3015),\n",
       "  ('95 cvd', 0.2931),\n",
       "  ('specific nutrients', 0.2861),\n",
       "  ('stroke intake', 0.2667),\n",
       "  ('association dietary', 0.2644),\n",
       "  ('relative risk', 0.2636),\n",
       "  ('significant evidence', 0.2636),\n",
       "  ('health objective', 0.257),\n",
       "  ('analysis summarize', 0.237),\n",
       "  ('estimates compared', 0.2352),\n",
       "  ('related association', 0.2142),\n",
       "  ('meta', 0.2099),\n",
       "  ('prospective epidemiologic', 0.2077),\n",
       "  ('searching medline', 0.2049),\n",
       "  ('results 23', 0.185),\n",
       "  ('secondary referencing', 0.1757),\n",
       "  ('showed significant', 0.1685),\n",
       "  ('62', 0.1647),\n",
       "  ('study random', 0.1526),\n",
       "  ('background', 0.1507),\n",
       "  ('347 747', 0.1298),\n",
       "  ('sex study', 0.1286),\n",
       "  ('stroke 00', 0.1285),\n",
       "  ('data needed', 0.1178),\n",
       "  ('19', 0.1134),\n",
       "  ('did change', 0.1132),\n",
       "  ('heart', 0.1041),\n",
       "  ('intake 07', 0.0973),\n",
       "  ('disease', 0.0962),\n",
       "  ('quality', 0.0953),\n",
       "  ('inclusion', 0.0907),\n",
       "  ('associated increased', 0.0802),\n",
       "  ('006 developed', 0.079),\n",
       "  ('consideration age', 0.072),\n",
       "  ('generally thought', 0.0704),\n",
       "  ('composite', 0.0574),\n",
       "  ('concluding', 0.0521),\n",
       "  ('used replace', 0.0343),\n",
       "  ('05 11', 0.023),\n",
       "  ('subjects', -0.0014),\n",
       "  ('extreme quantiles', -0.0017)],\n",
       " 'MED-1557': [('pufa intakes', 0.5679),\n",
       "  ('population intakes', 0.5592),\n",
       "  ('dietary surveys', 0.5401),\n",
       "  ('countries fatty', 0.513),\n",
       "  ('fao methods', 0.4772),\n",
       "  ('total fat', 0.4673),\n",
       "  ('recommendations food', 0.44),\n",
       "  ('world health', 0.416),\n",
       "  ('different countries', 0.4154),\n",
       "  ('review data', 0.4071),\n",
       "  ('surveys population', 0.3652),\n",
       "  ('compare recommendations', 0.364),\n",
       "  ('intake ranged', 0.3582),\n",
       "  ('studies published', 0.3482),\n",
       "  ('seven countries', 0.3146),\n",
       "  ('united nations', 0.3145),\n",
       "  ('provided data', 0.3078),\n",
       "  ('lower intakes', 0.3001),\n",
       "  ('relation sfa', 0.2965),\n",
       "  ('acid intake', 0.2726),\n",
       "  ('levels recommended', 0.2572),\n",
       "  ('40 countries', 0.2482),\n",
       "  ('aim systematically', 0.2465),\n",
       "  ('sfa 20', 0.2344),\n",
       "  ('countries 50', 0.2252),\n",
       "  ('diseases relation', 0.2155),\n",
       "  ('agriculture organization', 0.2082),\n",
       "  ('national', 0.2053),\n",
       "  ('percent energy', 0.2046),\n",
       "  ('intakes 10', 0.2042),\n",
       "  ('conclusions', 0.1894),\n",
       "  ('populations accompanied', 0.1845),\n",
       "  ('correlated total', 0.1786),\n",
       "  ('intake 76', 0.1715),\n",
       "  ('medline', 0.1687),\n",
       "  ('intake 18', 0.1584),\n",
       "  ('health institutes', 0.1502),\n",
       "  ('recommended preventing', 0.1491),\n",
       "  ('web science', 0.148),\n",
       "  ('1995 searched', 0.1349),\n",
       "  ('majority population', 0.1025),\n",
       "  ('saturated', 0.1014),\n",
       "  ('25', 0.0976),\n",
       "  ('11 mean', 0.0724),\n",
       "  ('does', 0.0634),\n",
       "  ('ranged', 0.0317),\n",
       "  ('46 percent', 0.0305),\n",
       "  ('coronary', 0.0242),\n",
       "  ('adults does', 0.008),\n",
       "  ('03 84', -0.0005)],\n",
       " 'MED-1558': [('recommendations fat', 0.6215),\n",
       "  ('dietary guidelines', 0.5684),\n",
       "  ('dietary reference', 0.5313),\n",
       "  ('examine dietary', 0.5225),\n",
       "  ('saturated fats', 0.4908),\n",
       "  ('fatty acids', 0.4882),\n",
       "  ('recommendations analyzed', 0.4765),\n",
       "  ('nutritional objectives', 0.4728),\n",
       "  ('trans fats', 0.4304),\n",
       "  ('systematic review', 0.4079),\n",
       "  ('acids literature', 0.3815),\n",
       "  ('cholesterol intake', 0.367),\n",
       "  ('recommendations vary', 0.362),\n",
       "  ('intake share', 0.3586),\n",
       "  ('intake paper', 0.3476),\n",
       "  ('databases search', 0.2913),\n",
       "  ('1980s', 0.2873),\n",
       "  ('included reported', 0.2792),\n",
       "  ('health disease', 0.2723),\n",
       "  ('standard approach', 0.2547),\n",
       "  ('gaps research', 0.2419),\n",
       "  ('provide advice', 0.2412),\n",
       "  ('background information', 0.2349),\n",
       "  ('deriving nutrient', 0.2322),\n",
       "  ('regarding levels', 0.2051),\n",
       "  ('bodies organizations', 0.1973),\n",
       "  ('information process', 0.1957),\n",
       "  ('vary countries', 0.1945),\n",
       "  ('sets include', 0.1937),\n",
       "  ('reports documents', 0.1907),\n",
       "  ('regarding total', 0.1877),\n",
       "  ('type evidence', 0.1874),\n",
       "  ('regarding specific', 0.1786),\n",
       "  ('similar figures', 0.1705),\n",
       "  ('attracted research', 0.1682),\n",
       "  ('regular updates', 0.1672),\n",
       "  ('analyzed', 0.1667),\n",
       "  ('paper different', 0.1413),\n",
       "  ('saturated', 0.1264),\n",
       "  ('selected base', 0.1262),\n",
       "  ('despite efforts', 0.1223),\n",
       "  ('development', 0.1016),\n",
       "  ('recent', 0.0995),\n",
       "  ('contribute enhance', 0.077),\n",
       "  ('public', 0.0504),\n",
       "  ('ranked regular', 0.0492),\n",
       "  ('grey', 0.047),\n",
       "  ('concerned remain', 0.0232),\n",
       "  ('followed', 0.0107),\n",
       "  ('remain transparent', -0.0242)],\n",
       " 'MED-1559': [('guidelines cancer', 0.6325),\n",
       "  ('cancer survivors', 0.5742),\n",
       "  ('female cancer', 0.5238),\n",
       "  ('0001 cancer', 0.4422),\n",
       "  ('guidelines body', 0.4387),\n",
       "  ('women health', 0.4367),\n",
       "  ('prevention recommendations', 0.394),\n",
       "  ('survivors decrease', 0.3855),\n",
       "  ('world cancer', 0.3852),\n",
       "  ('research wcrf', 0.3683),\n",
       "  ('lower mortality', 0.3663),\n",
       "  ('adherence scores', 0.3617),\n",
       "  ('survivors methods', 0.3488),\n",
       "  ('aicr', 0.297),\n",
       "  ('specific mortality', 0.2859),\n",
       "  ('017 participants', 0.285),\n",
       "  ('lowest adherence', 0.28),\n",
       "  ('dietary recommendations', 0.2737),\n",
       "  ('association lower', 0.2656),\n",
       "  ('iowa women', 0.2586),\n",
       "  ('health study', 0.2485),\n",
       "  ('study confirmed', 0.2421),\n",
       "  ('95 ci', 0.2414),\n",
       "  ('2009 017', 0.2367),\n",
       "  ('healthy lifestyle', 0.2257),\n",
       "  ('background 2007', 0.217),\n",
       "  ('2004 follow', 0.214),\n",
       "  ('participants', 0.2122),\n",
       "  ('184 cardiovascular', 0.2041),\n",
       "  ('2002 completed', 0.1838),\n",
       "  ('physical activity', 0.1804),\n",
       "  ('94 meeting', 0.177),\n",
       "  ('cardiovascular disease', 0.1734),\n",
       "  ('follow questionnaire', 0.1525),\n",
       "  ('body weight', 0.1511),\n",
       "  ('67 95', 0.1437),\n",
       "  ('ptrend 03', 0.1424),\n",
       "  ('impact older', 0.119),\n",
       "  ('recommendation strongest', 0.1168),\n",
       "  ('145 compared', 0.1162),\n",
       "  ('institute', 0.1137),\n",
       "  ('encourage', 0.0967),\n",
       "  ('components', 0.0769),\n",
       "  ('compared total', 0.0703),\n",
       "  ('assigning points', 0.0479),\n",
       "  ('diagnosis', 0.0278),\n",
       "  ('world', 0.022),\n",
       "  ('fund', 0.0109),\n",
       "  ('hr', 0.0058),\n",
       "  ('cause 461', 0.0014)],\n",
       " 'MED-1560': [('aha cardiovascular', 0.5592),\n",
       "  ('aric study', 0.4746),\n",
       "  ('incidence aha', 0.4687),\n",
       "  ('health metrics', 0.4597),\n",
       "  ('ideal health', 0.4147),\n",
       "  ('incident cancers', 0.3974),\n",
       "  ('cox regression', 0.3765),\n",
       "  ('adherence seven', 0.3729),\n",
       "  ('aha 2020', 0.3724),\n",
       "  ('meeting goals', 0.3638),\n",
       "  ('atherosclerosis risk', 0.3613),\n",
       "  ('cancer advocacy', 0.3383),\n",
       "  ('calculate hazard', 0.3325),\n",
       "  ('hospital surveillance', 0.3136),\n",
       "  ('study 17', 0.3112),\n",
       "  ('risk communities', 0.3097),\n",
       "  ('ideal levels', 0.3015),\n",
       "  ('incidence excluding', 0.2962),\n",
       "  ('classify participants', 0.2917),\n",
       "  ('included analysis', 0.2786),\n",
       "  ('prevalence', 0.2722),\n",
       "  ('defined concept', 0.2554),\n",
       "  ('achieve reductions', 0.2539),\n",
       "  ('heart', 0.2489),\n",
       "  ('strategic impact', 0.2429),\n",
       "  ('significant trend', 0.2405),\n",
       "  ('association number', 0.2373),\n",
       "  ('background american', 0.2337),\n",
       "  ('promotion 2020', 0.2186),\n",
       "  ('advocacy groups', 0.1992),\n",
       "  ('chronic', 0.1967),\n",
       "  ('follow methods', 0.1951),\n",
       "  ('19 years', 0.1922),\n",
       "  ('surveillance 2880', 0.1875),\n",
       "  ('registries', 0.1842),\n",
       "  ('13', 0.1804),\n",
       "  ('years follow', 0.171),\n",
       "  ('according', 0.1619),\n",
       "  ('measurements used', 0.1596),\n",
       "  ('aha continue', 0.1556),\n",
       "  ('03 conclusions', 0.1435),\n",
       "  ('non melanoma', 0.1357),\n",
       "  ('0001', 0.1267),\n",
       "  ('population 51', 0.1204),\n",
       "  ('smoking removed', 0.1152),\n",
       "  ('association attenuated', 0.1148),\n",
       "  ('exclusions missing', 0.1127),\n",
       "  ('having 25', 0.0674),\n",
       "  ('graded inverse', 0.0581),\n",
       "  ('2006 captured', -0.0125)],\n",
       " 'MED-1563': [('lifestyle factors', 0.4808),\n",
       "  ('studies selected', 0.4608),\n",
       "  ('behaviors mortality', 0.4244),\n",
       "  ('mortality systematically', 0.4163),\n",
       "  ('evidence combined', 0.3738),\n",
       "  ('mortality compared', 0.3606),\n",
       "  ('combined effects', 0.3563),\n",
       "  ('sensitivity analyses', 0.3483),\n",
       "  ('prospective studies', 0.348),\n",
       "  ('factors meta', 0.3468),\n",
       "  ('factors cause', 0.3302),\n",
       "  ('analyses conducted', 0.3),\n",
       "  ('single factors', 0.297),\n",
       "  ('searched medline', 0.2808),\n",
       "  ('known impact', 0.274),\n",
       "  ('21 studies', 0.2737),\n",
       "  ('global health', 0.2735),\n",
       "  ('factors obesity', 0.2717),\n",
       "  ('factors current', 0.2712),\n",
       "  ('2012 prospective', 0.2414),\n",
       "  ('mean effect', 0.2346),\n",
       "  ('associated reduction', 0.2302),\n",
       "  ('15 included', 0.2262),\n",
       "  ('conducted explore', 0.2099),\n",
       "  ('included', 0.1963),\n",
       "  ('risks', 0.1908),\n",
       "  ('health somed', 0.1883),\n",
       "  ('follow 13', 0.1823),\n",
       "  ('studies 18', 0.1801),\n",
       "  ('physical activity', 0.1717),\n",
       "  ('compiled method', 0.1691),\n",
       "  ('objective', 0.1656),\n",
       "  ('diet', 0.1565),\n",
       "  ('smoking', 0.1559),\n",
       "  ('risk 66', 0.1494),\n",
       "  ('comprised 531', 0.1323),\n",
       "  ('cohorts', 0.1249),\n",
       "  ('published elsevier', 0.1187),\n",
       "  ('73 conclusion', 0.1151),\n",
       "  ('24 years', 0.1129),\n",
       "  ('years relative', 0.0982),\n",
       "  ('adherence', 0.0965),\n",
       "  ('alcohol', 0.0862),\n",
       "  ('proportionate', 0.066),\n",
       "  ('higher number', 0.0354),\n",
       "  ('interval 58', 0.0155),\n",
       "  ('804 people', 0.0106),\n",
       "  ('95 confidence', -0.0155),\n",
       "  ('healthy', -0.0294),\n",
       "  ('copyright', -0.0435)],\n",
       " 'MED-1564': [('released recommendations', 0.5288),\n",
       "  ('wcrf aicr', 0.4759),\n",
       "  ('specific cancers', 0.4713),\n",
       "  ('prevention recommendations', 0.445),\n",
       "  ('world cancer', 0.4103),\n",
       "  ('cancer research', 0.3954),\n",
       "  ('cancers 899', 0.3558),\n",
       "  ('body fatness', 0.3249),\n",
       "  ('diet aimed', 0.3188),\n",
       "  ('fund wcrf', 0.3063),\n",
       "  ('surveillance epidemiology', 0.2871),\n",
       "  ('including breast', 0.287),\n",
       "  ('risk suggested', 0.2836),\n",
       "  ('vitamins', 0.2836),\n",
       "  ('lifestyle vital', 0.2663),\n",
       "  ('physical activity', 0.2573),\n",
       "  ('increased adherence', 0.2562),\n",
       "  ('preventing common', 0.2372),\n",
       "  ('foods red', 0.2336),\n",
       "  ('background 2007', 0.2328),\n",
       "  ('participants included', 0.2194),\n",
       "  ('examined association', 0.2107),\n",
       "  ('limited information', 0.1989),\n",
       "  ('hr meeting', 0.1862),\n",
       "  ('methods operationalized', 0.1771),\n",
       "  ('western washington', 0.1694),\n",
       "  ('001 conclusions', 0.1609),\n",
       "  ('research fund', 0.1584),\n",
       "  ('women ages', 0.1469),\n",
       "  ('american institute', 0.1425),\n",
       "  ('reduced 60', 0.142),\n",
       "  ('38 95', 0.1416),\n",
       "  ('compared met', 0.1398),\n",
       "  ('cohort', 0.133),\n",
       "  ('post menopausal', 0.1261),\n",
       "  ('association invasive', 0.1255),\n",
       "  ('impact increased', 0.1127),\n",
       "  ('76 years', 0.1114),\n",
       "  ('substantially reduce', 0.1113),\n",
       "  ('vital', 0.1096),\n",
       "  ('processed meats', 0.0997),\n",
       "  ('alcohol hr', 0.0974),\n",
       "  ('65 ptrend', 0.0849),\n",
       "  ('baseline 2000', 0.0718),\n",
       "  ('database results', 0.0578),\n",
       "  ('ci 25', 0.055),\n",
       "  ('included 30', 0.0541),\n",
       "  ('plant', -0.0248),\n",
       "  ('ages 50', -0.0446),\n",
       "  ('removed individual', -0.069)],\n",
       " 'MED-1565': [('wcrf aicr', 0.5862),\n",
       "  ('countries wcrf', 0.5217),\n",
       "  ('cancer research', 0.5021),\n",
       "  ('cancer nutrition', 0.4975),\n",
       "  ('world cancer', 0.4832),\n",
       "  ('fund wcrf', 0.4411),\n",
       "  ('recommendations significantly', 0.4001),\n",
       "  ('prevention basis', 0.3988),\n",
       "  ('recommendations associations', 0.3748),\n",
       "  ('evidence objective', 0.3664),\n",
       "  ('2007 world', 0.3428),\n",
       "  ('95 ci', 0.3427),\n",
       "  ('lifestyle information', 0.3199),\n",
       "  ('disease conclusion', 0.3058),\n",
       "  ('deaths identified', 0.2805),\n",
       "  ('greater concordance', 0.2772),\n",
       "  ('european prospective', 0.2719),\n",
       "  ('design current', 0.271),\n",
       "  ('activity weight', 0.2649),\n",
       "  ('study suggest', 0.257),\n",
       "  ('comprehensive collection', 0.2451),\n",
       "  ('countries enrolled', 0.2411),\n",
       "  ('body fatness', 0.232),\n",
       "  ('significantly associated', 0.23),\n",
       "  ('respiratory disease', 0.2193),\n",
       "  ('increase longevity', 0.21),\n",
       "  ('research fund', 0.1947),\n",
       "  ('american institute', 0.1841),\n",
       "  ('breastfeeding score', 0.1815),\n",
       "  ('included 378', 0.1773),\n",
       "  ('risks total', 0.1665),\n",
       "  ('864 participants', 0.1624),\n",
       "  ('ci 59', 0.1623),\n",
       "  ('compared participants', 0.1602),\n",
       "  ('using cox', 0.1598),\n",
       "  ('lower hazard', 0.1559),\n",
       "  ('scores indicated', 0.1559),\n",
       "  ('inverse associations', 0.1393),\n",
       "  ('1998 dietary', 0.1281),\n",
       "  ('median follow', 0.1076),\n",
       "  ('circulatory', 0.1063),\n",
       "  ('constructed higher', 0.0942),\n",
       "  ('75 compared', 0.0836),\n",
       "  ('plus', 0.0782),\n",
       "  ('women', 0.0678),\n",
       "  ('drinks promote', 0.0619),\n",
       "  ('time 12', 0.0586),\n",
       "  ('23 828', 0.0542),\n",
       "  ('men regarding', -0.0019),\n",
       "  ('animal', -0.058)],\n",
       " 'MED-1567': [('adventists lower', 0.5442),\n",
       "  ('baptists low', 0.4975),\n",
       "  ('baptists discourage', 0.4774),\n",
       "  ('lower cancer', 0.4489),\n",
       "  ('adventists baptists', 0.4148),\n",
       "  ('adventists consume', 0.4096),\n",
       "  ('cancer risks', 0.3658),\n",
       "  ('alcohol tobacco', 0.3399),\n",
       "  ('cancers buccal', 0.326),\n",
       "  ('decreased general', 0.2875),\n",
       "  ('cervix decreased', 0.2772),\n",
       "  ('lifestyle', 0.2763),\n",
       "  ('women incidences', 0.2612),\n",
       "  ('2008 cancer', 0.237),\n",
       "  ('low differences', 0.2167),\n",
       "  ('risks individuals', 0.2017),\n",
       "  ('adhere lacto', 0.1992),\n",
       "  ('health recommendations', 0.1977),\n",
       "  ('women 85', 0.1961),\n",
       "  ('cis cohort', 0.1838),\n",
       "  ('72 women', 0.1779),\n",
       "  ('cancer 1943', 0.1763),\n",
       "  ('american seventh', 0.1761),\n",
       "  ('pork adhere', 0.1739),\n",
       "  ('general population', 0.1648),\n",
       "  ('methods followed', 0.1435),\n",
       "  ('sirs 95', 0.1276),\n",
       "  ('benefits compliance', 0.1259),\n",
       "  ('changes population', 0.1128),\n",
       "  ('ovo vegetarian', 0.1115),\n",
       "  ('ci 60', 0.0985),\n",
       "  ('stomach', 0.0937),\n",
       "  ('cox', 0.0891),\n",
       "  ('80 91', 0.0754),\n",
       "  ('11 580', 0.0649),\n",
       "  ('mortality', 0.0584),\n",
       "  ('cavity lung', 0.0581),\n",
       "  ('different compared', 0.0524),\n",
       "  ('confidence', 0.0482),\n",
       "  ('danish population', 0.0407),\n",
       "  ('ratios sirs', 0.0373),\n",
       "  ('registry contains', 0.0366),\n",
       "  ('study investigated', 0.0237),\n",
       "  ('2012 elsevier', 0.0223),\n",
       "  ('men 33', 0.0128),\n",
       "  ('individuals copyright', 0.012),\n",
       "  ('20 13', 0.005),\n",
       "  ('22 49', -0.0198),\n",
       "  ('contains', -0.0244),\n",
       "  ('sir 66', -0.0471)],\n",
       " 'MED-1568': [('ciguatoxins', 0.5483),\n",
       "  ('contaminated ciguatoxins', 0.5429),\n",
       "  ('ciguatoxins new', 0.5353),\n",
       "  ('associated ciguatera', 0.5216),\n",
       "  ('july312012 ciguatera', 0.5192),\n",
       "  ('ciguatera common', 0.4971),\n",
       "  ('ciguatera particular', 0.4845),\n",
       "  ('food poisoning', 0.4099),\n",
       "  ('consumption fish', 0.3891),\n",
       "  ('fish contaminated', 0.3767),\n",
       "  ('emboj 2012', 0.3723),\n",
       "  ('1038 emboj', 0.3432),\n",
       "  ('poisoning occurring', 0.3046),\n",
       "  ('al 2012', 0.2672),\n",
       "  ('online july312012', 0.2521),\n",
       "  ('occurring consumption', 0.2232),\n",
       "  ('3795 3808', 0.2196),\n",
       "  ('19 3795', 0.2092),\n",
       "  ('2012 31', 0.2073),\n",
       "  ('detection noxious', 0.2017),\n",
       "  ('embo', 0.1837),\n",
       "  ('forms food', 0.1589),\n",
       "  ('contaminated', 0.139),\n",
       "  ('et al', 0.1386),\n",
       "  ('implicated detection', 0.1355),\n",
       "  ('neurons express', 0.1217),\n",
       "  ('underlie altered', 0.1195),\n",
       "  ('noxious cold', 0.117),\n",
       "  ('common', 0.1155),\n",
       "  ('1038', 0.1147),\n",
       "  ('doi 10', 0.1143),\n",
       "  ('channel implicated', 0.1002),\n",
       "  ('vetter et', 0.0943),\n",
       "  ('19', 0.0925),\n",
       "  ('207', 0.0863),\n",
       "  ('reveals', 0.0682),\n",
       "  ('published', 0.0597),\n",
       "  ('new work', 0.0425),\n",
       "  ('particular', 0.0424),\n",
       "  ('forms', 0.0409),\n",
       "  ('temperature sensation', 0.0402),\n",
       "  ('reveals key', 0.039),\n",
       "  ('trpa1 ion', 0.0332),\n",
       "  ('online', 0.0288),\n",
       "  ('sensory', 0.0283),\n",
       "  ('occurring', 0.025),\n",
       "  ('express', 0.0062),\n",
       "  ('molecular', -0.0125),\n",
       "  ('players', -0.0199),\n",
       "  ('act', -0.0288)],\n",
       " 'MED-1569': [('ciguatera toxin', 0.5365),\n",
       "  ('toxin ciguatera', 0.5235),\n",
       "  ('toxin mechanisms', 0.5033),\n",
       "  ('ciguatera fish', 0.4563),\n",
       "  ('poisoned ciguatera', 0.4499),\n",
       "  ('fish toxin', 0.4444),\n",
       "  ('toxin patients', 0.4443),\n",
       "  ('toxin predisposed', 0.4356),\n",
       "  ('mechanism toxin', 0.4283),\n",
       "  ('toxin', 0.4246),\n",
       "  ('represent toxin', 0.398),\n",
       "  ('diseases suggested', 0.3617),\n",
       "  ('ciguatera', 0.3588),\n",
       "  ('polymyositis subsequently', 0.3517),\n",
       "  ('poisoned', 0.3517),\n",
       "  ('severely poisoned', 0.3448),\n",
       "  ('suggested causal', 0.3395),\n",
       "  ('proved polymyositis', 0.3312),\n",
       "  ('causal relationship', 0.3304),\n",
       "  ('diseases', 0.3061),\n",
       "  ('contracting diseases', 0.288),\n",
       "  ('muscle inflammation', 0.2777),\n",
       "  ('mechanisms action', 0.2548),\n",
       "  ('inflammation', 0.2517),\n",
       "  ('subsequently developed', 0.2481),\n",
       "  ('unlikelihood coincidence', 0.237),\n",
       "  ('fish', 0.2369),\n",
       "  ('developed patients', 0.2288),\n",
       "  ('severely', 0.2216),\n",
       "  ('courses unlikelihood', 0.2205),\n",
       "  ('mechanisms', 0.2021),\n",
       "  ('suggest mechanism', 0.2014),\n",
       "  ('coincidence', 0.2003),\n",
       "  ('patients severely', 0.192),\n",
       "  ('coincidence contracting', 0.1552),\n",
       "  ('clinical courses', 0.1498),\n",
       "  ('predisposed', 0.146),\n",
       "  ('biopsy proved', 0.1337),\n",
       "  ('predisposed muscle', 0.1325),\n",
       "  ('prove relationship', 0.1225),\n",
       "  ('clinical', 0.1204),\n",
       "  ('suggested', 0.1127),\n",
       "  ('developed', 0.1123),\n",
       "  ('relationship', 0.0956),\n",
       "  ('patients', 0.089),\n",
       "  ('action represent', 0.0799),\n",
       "  ('contracting', 0.0731),\n",
       "  ('muscle', 0.066),\n",
       "  ('prove', 0.0634),\n",
       "  ('represent', 0.0463)],\n",
       " 'MED-1570': [('causes ciguatera', 0.6137),\n",
       "  ('severe toxicity', 0.5738),\n",
       "  ('cumulative symptoms', 0.4908),\n",
       "  ('human poisoning', 0.478),\n",
       "  ('seafood disease', 0.4682),\n",
       "  ('toxicus tropical', 0.4326),\n",
       "  ('gastrointestinal neurological', 0.3556),\n",
       "  ('gambierdiscus toxicus', 0.3522),\n",
       "  ('toxins known', 0.3515),\n",
       "  ('finfish cause', 0.3104),\n",
       "  ('undergo oxidative', 0.3047),\n",
       "  ('caused consumption', 0.3035),\n",
       "  ('sewage eutrophication', 0.3032),\n",
       "  ('misdiagnosed lipid', 0.2937),\n",
       "  ('health problem', 0.2722),\n",
       "  ('disturbances cases', 0.2607),\n",
       "  ('ctx causes', 0.2547),\n",
       "  ('paralysis', 0.2506),\n",
       "  ('environmental factors', 0.2506),\n",
       "  ('symptoms persist', 0.2382),\n",
       "  ('instability worldwide', 0.2316),\n",
       "  ('microg kg', 0.2204),\n",
       "  ('unpredictable patchy', 0.22),\n",
       "  ('global warming', 0.2103),\n",
       "  ('dinoflagellate lives', 0.1911),\n",
       "  ('earthquakes hurricanes', 0.1867),\n",
       "  ('metabolism pass', 0.1841),\n",
       "  ('dead coral', 0.1735),\n",
       "  ('cardiovascular', 0.171),\n",
       "  ('exposed end', 0.1701),\n",
       "  ('chain carnivorous', 0.1683),\n",
       "  ('fish remains', 0.1417),\n",
       "  ('smell normal', 0.1235),\n",
       "  ('presence bloom', 0.1184),\n",
       "  ('lives', 0.1182),\n",
       "  ('bleaching', 0.1114),\n",
       "  ('certain subtropical', 0.1058),\n",
       "  ('main caribbean', 0.1032),\n",
       "  ('membrane excitability', 0.0977),\n",
       "  ('use marine', 0.089),\n",
       "  ('strong association', 0.0858),\n",
       "  ('pacific indian', 0.0804),\n",
       "  ('strains produce', 0.0637),\n",
       "  ('400 species', 0.0596),\n",
       "  ('management future', 0.0531),\n",
       "  ('production unknown', 0.0429),\n",
       "  ('small number', 0.0354),\n",
       "  ('exported areas', 0.0229),\n",
       "  ('activate sodium', 0.0109),\n",
       "  ('soluble polyether', -0.0042)],\n",
       " 'MED-1571': [('ciguatera outbreaks', 0.5337),\n",
       "  ('ichtyosarcotoxic outbreaks', 0.525),\n",
       "  ('caused ciguatera', 0.4779),\n",
       "  ('1994 ciguatera', 0.4611),\n",
       "  ('outbreaks represented', 0.4143),\n",
       "  ('estimated 78', 0.4102),\n",
       "  ('incidence rate', 0.3007),\n",
       "  ('50 outbreaks', 0.2936),\n",
       "  ('477 people', 0.2606),\n",
       "  ('total cases', 0.2443),\n",
       "  ('78 10', 0.2368),\n",
       "  ('island réunion', 0.2316),\n",
       "  ('poisoning', 0.2262),\n",
       "  ('symptoms caused', 0.2119),\n",
       "  ('recorded island', 0.2112),\n",
       "  ('ocean 1986', 0.2085),\n",
       "  ('commonly incriminated', 0.2068),\n",
       "  ('poisoning 16', 0.1988),\n",
       "  ('1986 1994', 0.1841),\n",
       "  ('symptoms hallucinatory', 0.1788),\n",
       "  ('cases', 0.1571),\n",
       "  ('residents symptoms', 0.1551),\n",
       "  ('caused', 0.1526),\n",
       "  ('reported pacific', 0.141),\n",
       "  ('people recorded', 0.1336),\n",
       "  ('incriminated accounting', 0.1143),\n",
       "  ('rate estimated', 0.1075),\n",
       "  ('patients serranidae', 0.1054),\n",
       "  ('caribbean', 0.0981),\n",
       "  ('including species', 0.0941),\n",
       "  ('fish', 0.0926),\n",
       "  ('islands additional', 0.0875),\n",
       "  ('000 residents', 0.0861),\n",
       "  ('reported', 0.0832),\n",
       "  ('16 patients', 0.0831),\n",
       "  ('ocean', 0.081),\n",
       "  ('represented', 0.0358),\n",
       "  ('great commercial', 0.0337),\n",
       "  ('indian', 0.0325),\n",
       "  ('commonly', 0.0315),\n",
       "  ('000', 0.029),\n",
       "  ('great', 0.025),\n",
       "  ('including', 0.017),\n",
       "  ('people', 0.016),\n",
       "  ('value commonly', 0.011),\n",
       "  ('different', 0.0),\n",
       "  ('annual', -0.0056),\n",
       "  ('sw', -0.0375),\n",
       "  ('10', -0.0455),\n",
       "  ('patients', -0.0793)],\n",
       " 'MED-1572': [('ciguatera fish', 0.6669),\n",
       "  ('cases ciguatera', 0.5735),\n",
       "  ('toxins symptoms', 0.5711),\n",
       "  ('fish poisoning', 0.5478),\n",
       "  ('poisoning results', 0.5335),\n",
       "  ('variety toxins', 0.4408),\n",
       "  ('symptoms vary', 0.3875),\n",
       "  ('gastrointestinal neurologic', 0.3713),\n",
       "  ('carnivorous fish', 0.3675),\n",
       "  ('dinoflagellates signs', 0.3639),\n",
       "  ('bioconcentration variety', 0.3509),\n",
       "  ('fish review', 0.3361),\n",
       "  ('symptoms persist', 0.3245),\n",
       "  ('neurologic complaints', 0.3215),\n",
       "  ('epidemics common', 0.3196),\n",
       "  ('signs symptoms', 0.3003),\n",
       "  ('involve ingestion', 0.2942),\n",
       "  ('isolated fish', 0.2624),\n",
       "  ('cases reported', 0.2602),\n",
       "  ('coasts usually', 0.2046),\n",
       "  ('complaints beginning', 0.2034),\n",
       "  ('vary widely', 0.1882),\n",
       "  ('produced marine', 0.1842),\n",
       "  ('large carnivorous', 0.1696),\n",
       "  ('common', 0.1632),\n",
       "  ('common tropical', 0.1579),\n",
       "  ('months years', 0.1286),\n",
       "  ('results', 0.1224),\n",
       "  ('caught', 0.1189),\n",
       "  ('widely usually', 0.11),\n",
       "  ('containing', 0.095),\n",
       "  ('states', 0.0944),\n",
       "  ('mexico', 0.0939),\n",
       "  ('tropical subtropical', 0.083),\n",
       "  ('literature', 0.0814),\n",
       "  ('persist', 0.08),\n",
       "  ('southern california', 0.0787),\n",
       "  ('usually involve', 0.0785),\n",
       "  ('presents', 0.0774),\n",
       "  ('successfully tracked', 0.0589),\n",
       "  ('services', 0.0424),\n",
       "  ('large', 0.0394),\n",
       "  ('department health', 0.0384),\n",
       "  ('beginning shortly', 0.0263),\n",
       "  ('reported united', 0.0126),\n",
       "  ('area hospitals', 0.0075),\n",
       "  ('25 cases', 0.0016),\n",
       "  ('services isolated', -0.0054),\n",
       "  ('area', -0.0143),\n",
       "  ('baja', -0.0366)],\n",
       " 'MED-1573': [('fish poisonings', 0.6047),\n",
       "  ('ciguatera fish', 0.5961),\n",
       "  ('poisonings outbreak', 0.4913),\n",
       "  ('ciguatera scombroid', 0.3959),\n",
       "  ('poison control', 0.3727),\n",
       "  ('intoxication illuminates', 0.3447),\n",
       "  ('data foodborne', 0.3438),\n",
       "  ('scombroid fish', 0.3312),\n",
       "  ('common causes', 0.3167),\n",
       "  ('outbreaks involving', 0.311),\n",
       "  ('underreporting underdiagnosis', 0.3068),\n",
       "  ('health impact', 0.2964),\n",
       "  ('number illnesses', 0.2886),\n",
       "  ('systems underestimate', 0.2811),\n",
       "  ('impact objectives', 0.2716),\n",
       "  ('2007 poison', 0.2612),\n",
       "  ('seafood', 0.2449),\n",
       "  ('ill persons', 0.2368),\n",
       "  ('reported surveillance', 0.2335),\n",
       "  ('exposure', 0.2128),\n",
       "  ('hospitalizations deaths', 0.1956),\n",
       "  ('model inputs', 0.1891),\n",
       "  ('objectives study', 0.1755),\n",
       "  ('systems', 0.1587),\n",
       "  ('problem efforts', 0.1555),\n",
       "  ('improve assessments', 0.1464),\n",
       "  ('states existing', 0.143),\n",
       "  ('center data', 0.1386),\n",
       "  ('estimated 15', 0.1317),\n",
       "  ('education reduce', 0.1279),\n",
       "  ('using statistical', 0.1107),\n",
       "  ('literature', 0.105),\n",
       "  ('200 exposure', 0.0958),\n",
       "  ('npds 2005', 0.0954),\n",
       "  ('resulting 343', 0.0854),\n",
       "  ('deaths 90', 0.0818),\n",
       "  ('overall human', 0.0592),\n",
       "  ('fdoss 2000', 0.0589),\n",
       "  ('annually resulting', 0.0311),\n",
       "  ('americans reported', 0.0307),\n",
       "  ('cri 4140', 0.0266),\n",
       "  ('credible', 0.0219),\n",
       "  ('60 108', 0.0147),\n",
       "  ('public', 0.0143),\n",
       "  ('2009', 0.0134),\n",
       "  ('558', 0.0117),\n",
       "  ('national', 0.0113),\n",
       "  ('496', -0.0126),\n",
       "  ('128', -0.0241),\n",
       "  ('162', -0.0444)],\n",
       " 'MED-1574': [('intestinal dysbiosis', 0.6462),\n",
       "  ('microbiome influenced', 0.5849),\n",
       "  ('gut microbes', 0.5667),\n",
       "  ('crohn disease', 0.5562),\n",
       "  ('increased bacterial', 0.5018),\n",
       "  ('forming biofilms', 0.4852),\n",
       "  ('intestinal epithelial', 0.4528),\n",
       "  ('cd patients', 0.4378),\n",
       "  ('coli aiec', 0.4319),\n",
       "  ('multiple coli', 0.426),\n",
       "  ('linked bacteria', 0.4112),\n",
       "  ('uniquely ileum', 0.3633),\n",
       "  ('mucosa associated', 0.3522),\n",
       "  ('influenced environmental', 0.3341),\n",
       "  ('strains disease', 0.3271),\n",
       "  ('contribute disease', 0.2971),\n",
       "  ('strains promoted', 0.2916),\n",
       "  ('disorders', 0.2671),\n",
       "  ('increased incidence', 0.237),\n",
       "  ('frequently isolated', 0.2305),\n",
       "  ('evidenced altered', 0.227),\n",
       "  ('phenotypes maltodextrin', 0.2212),\n",
       "  ('mdx polysaccharide', 0.2196),\n",
       "  ('diets parallels', 0.2104),\n",
       "  ('consumption polysaccharides', 0.1939),\n",
       "  ('characteristics host', 0.1884),\n",
       "  ('emulsifiers stabilizers', 0.1816),\n",
       "  ('strain lf82', 0.1715),\n",
       "  ('invasive', 0.1704),\n",
       "  ('composition characteristics', 0.151),\n",
       "  ('formation multiple', 0.1508),\n",
       "  ('induced type', 0.1483),\n",
       "  ('hydrolysis markedly', 0.1417),\n",
       "  ('pili', 0.1364),\n",
       "  ('chain length', 0.1306),\n",
       "  ('cell monolayers', 0.1272),\n",
       "  ('prevalence malx', 0.112),\n",
       "  ('findings demonstrate', 0.1099),\n",
       "  ('expression required', 0.0937),\n",
       "  ('panel adhesiveness', 0.0845),\n",
       "  ('cellular receptor', 0.0719),\n",
       "  ('agents linked', 0.0613),\n",
       "  ('determine food', 0.058),\n",
       "  ('century study', 0.0544),\n",
       "  ('ceacam6 suggesting', 0.0505),\n",
       "  ('suggesting novel', 0.0142),\n",
       "  ('bulking agents', 0.0084),\n",
       "  ('ubiquitous', 0.0063),\n",
       "  ('20th century', -0.0031),\n",
       "  ('mechanism western', -0.0866)],\n",
       " 'MED-1575': [('impaired crohn', 0.5888),\n",
       "  ('barrier dysfunction', 0.5386),\n",
       "  ('intestinal barrier', 0.5274),\n",
       "  ('epithelial lesions', 0.4867),\n",
       "  ('tight junctions', 0.468),\n",
       "  ('active ulcerative', 0.4567),\n",
       "  ('colon patients', 0.4209),\n",
       "  ('colitis inducible', 0.3865),\n",
       "  ('chambers barrier', 0.339),\n",
       "  ('conductance scanning', 0.3326),\n",
       "  ('claudin downregulated', 0.3246),\n",
       "  ('underlying cellular', 0.3169),\n",
       "  ('studied ussing', 0.3134),\n",
       "  ('pore forming', 0.309),\n",
       "  ('occludin sealing', 0.3062),\n",
       "  ('methods biopsy', 0.2746),\n",
       "  ('disease compared', 0.2529),\n",
       "  ('structure analysed', 0.2413),\n",
       "  ('impedance analysis', 0.2316),\n",
       "  ('proteins investigated', 0.2262),\n",
       "  ('scanning microscopy', 0.2249),\n",
       "  ('dysfunction mild', 0.2015),\n",
       "  ('apoptosis analysed', 0.1986),\n",
       "  ('specimens sigmoid', 0.1968),\n",
       "  ('function indicated', 0.1851),\n",
       "  ('background', 0.1778),\n",
       "  ('disease remission', 0.1769),\n",
       "  ('contrast', 0.1733),\n",
       "  ('conductivity focal', 0.1729),\n",
       "  ('discontinuous', 0.1659),\n",
       "  ('redistribution sealing', 0.1652),\n",
       "  ('transferase', 0.1485),\n",
       "  ('results patients', 0.1345),\n",
       "  ('microerosions did', 0.13),\n",
       "  ('changes', 0.1291),\n",
       "  ('resistance', 0.1205),\n",
       "  ('special attention', 0.1172),\n",
       "  ('instead freeze', 0.1109),\n",
       "  ('lead altered', 0.1072),\n",
       "  ('sd control', 0.1071),\n",
       "  ('end labelling', 0.0863),\n",
       "  ('14 15', 0.0814),\n",
       "  ('necrosis factor', 0.0778),\n",
       "  ('deoxynucleotidyl transferase', 0.0731),\n",
       "  ('11 12', 0.0646),\n",
       "  ('electron', 0.0581),\n",
       "  ('strongly upregulated', 0.0474),\n",
       "  ('unchanged', 0.045),\n",
       "  ('second source', 0.0043),\n",
       "  ('phenylindole', -0.0628)],\n",
       " 'MED-1576': [('diet ibd', 0.6587),\n",
       "  ('ibd increasing', 0.6526),\n",
       "  ('ibd risk', 0.6158),\n",
       "  ('inflammatory bowel', 0.5522),\n",
       "  ('609 ibd', 0.493),\n",
       "  ('increasing dietary', 0.436),\n",
       "  ('ulcerative colitis', 0.4233),\n",
       "  ('crohn disease', 0.4187),\n",
       "  ('association diet', 0.4154),\n",
       "  ('intake associated', 0.4089),\n",
       "  ('western diet', 0.4025),\n",
       "  ('dietary fiber', 0.331),\n",
       "  ('high fat', 0.2878),\n",
       "  ('uc risk', 0.2689),\n",
       "  ('illness', 0.2667),\n",
       "  ('studies identified', 0.2594),\n",
       "  ('evaluated association', 0.2569),\n",
       "  ('associated increased', 0.2512),\n",
       "  ('decreased uc', 0.2418),\n",
       "  ('vegetable intake', 0.2309),\n",
       "  ('protein food', 0.2256),\n",
       "  ('total polyunsaturated', 0.224),\n",
       "  ('negative association', 0.2201),\n",
       "  ('using guideline', 0.2175),\n",
       "  ('objectives incidence', 0.2132),\n",
       "  ('subsequent cd', 0.211),\n",
       "  ('340 ulcerative', 0.1955),\n",
       "  ('protein low', 0.1604),\n",
       "  ('omega', 0.1557),\n",
       "  ('meats risk', 0.1479),\n",
       "  ('acids', 0.1477),\n",
       "  ('performed systematic', 0.1404),\n",
       "  ('mono disaccharides', 0.1369),\n",
       "  ('included encompassing', 0.1227),\n",
       "  ('spread western', 0.1091),\n",
       "  ('manual searches', 0.1089),\n",
       "  ('000 controls', 0.1011),\n",
       "  ('structured keyword', 0.098),\n",
       "  ('groups fruits', 0.066),\n",
       "  ('patients', 0.0614),\n",
       "  ('fiber', 0.0585),\n",
       "  ('diagnosis eligible', 0.0484),\n",
       "  ('decreased risk', 0.0361),\n",
       "  ('nineteen studies', 0.0127),\n",
       "  ('encompassing 609', -0.0011),\n",
       "  ('conclusions', -0.0124),\n",
       "  ('google', -0.0794),\n",
       "  ('positive', -0.0832),\n",
       "  ('scholar', -0.0908),\n",
       "  ('patients 269', -0.1062)],\n",
       " 'MED-1577': [('pml risk', 0.6682),\n",
       "  ('leukoencephalopathy pml', 0.6644),\n",
       "  ('pml therapies', 0.6623),\n",
       "  ('virus pml', 0.6431),\n",
       "  ('pml rare', 0.6099),\n",
       "  ('increased pml', 0.5628),\n",
       "  ('pml multiple', 0.5606),\n",
       "  ('development pml', 0.5543),\n",
       "  ('people pml', 0.51),\n",
       "  ('demyelinating disorder', 0.4514),\n",
       "  ('multifocal leukoencephalopathy', 0.4462),\n",
       "  ('jc virus', 0.3912),\n",
       "  ('immunosuppression acquired', 0.3636),\n",
       "  ('therapies mechanism', 0.3086),\n",
       "  ('antibodies natalizumab', 0.2985),\n",
       "  ('progressive multifocal', 0.2915),\n",
       "  ('disorder latent', 0.2878),\n",
       "  ('proposed pathogenesis', 0.2869),\n",
       "  ('disorder recently', 0.2792),\n",
       "  ('ubiquitous polyomavirus', 0.2767),\n",
       "  ('different pharmacological', 0.2663),\n",
       "  ('mycophenolate mofetil', 0.2634),\n",
       "  ('syndrome common', 0.245),\n",
       "  ('associated underlying', 0.2222),\n",
       "  ('rare cases', 0.2203),\n",
       "  ('virus', 0.1989),\n",
       "  ('caused ubiquitous', 0.1737),\n",
       "  ('devastating', 0.1483),\n",
       "  ('review focuses', 0.1479),\n",
       "  ('predispose people', 0.1375),\n",
       "  ('conditions rituximab', 0.1321),\n",
       "  ('immune', 0.1277),\n",
       "  ('recently different', 0.1236),\n",
       "  ('deficiency', 0.1213),\n",
       "  ('monoclonal', 0.1154),\n",
       "  ('greater prevalence', 0.1141),\n",
       "  ('multiple', 0.1118),\n",
       "  ('suggest potential', 0.1045),\n",
       "  ('observed unlike', 0.0996),\n",
       "  ('brain', 0.0977),\n",
       "  ('existing conditions', 0.0954),\n",
       "  ('increasing risk', 0.095),\n",
       "  ('progressive', 0.0947),\n",
       "  ('drug initiation', 0.0889),\n",
       "  ('focuses risks', 0.0529),\n",
       "  ('classes', 0.0355),\n",
       "  ('interval time', 0.0201),\n",
       "  ('provided new', 0.0089),\n",
       "  ('agents uniquely', -0.0096),\n",
       "  ('pre', -0.0266)],\n",
       " 'MED-1578': [('crohn disease', 0.6815),\n",
       "  ('disease childhood', 0.5062),\n",
       "  ('nutrition een', 0.4328),\n",
       "  ('affect microbiome', 0.418),\n",
       "  ('exclusive enteral', 0.4031),\n",
       "  ('layer intestinal', 0.4014),\n",
       "  ('removal dietary', 0.4004),\n",
       "  ('een therapy', 0.3891),\n",
       "  ('disease remarkable', 0.3786),\n",
       "  ('normal diet', 0.3747),\n",
       "  ('pathogenesis environmental', 0.3621),\n",
       "  ('therapy need', 0.3426),\n",
       "  ('childhood effective', 0.3424),\n",
       "  ('gut 2014', 0.3413),\n",
       "  ('translocation pathobionts', 0.3394),\n",
       "  ('exclusivity een', 0.3288),\n",
       "  ('bacterial clearance', 0.3054),\n",
       "  ('cycle dietary', 0.3017),\n",
       "  ('complex inherited', 0.2886),\n",
       "  ('fiber diets', 0.2839),\n",
       "  ('inflammation', 0.2814),\n",
       "  ('exclusion normal', 0.2791),\n",
       "  ('interventions act', 0.2652),\n",
       "  ('genetic microbial', 0.2557),\n",
       "  ('involved development', 0.2522),\n",
       "  ('disorder unknown', 0.2302),\n",
       "  ('maltodextrin', 0.229),\n",
       "  ('adherence', 0.2216),\n",
       "  ('composition decrease', 0.2139),\n",
       "  ('defect leading', 0.2005),\n",
       "  ('gliadin', 0.1974),\n",
       "  ('termination vicious', 0.1924),\n",
       "  ('epidemiological data', 0.1899),\n",
       "  ('emulsifiers', 0.1893),\n",
       "  ('review', 0.1869),\n",
       "  ('nontraditional', 0.1842),\n",
       "  ('animal fat', 0.1651),\n",
       "  ('success principle', 0.1468),\n",
       "  ('mucous', 0.1437),\n",
       "  ('able cause', 0.142),\n",
       "  ('promote', 0.1295),\n",
       "  ('animal models', 0.1281),\n",
       "  ('localized acquired', 0.1247),\n",
       "  ('cell', 0.1151),\n",
       "  ('promote restitution', 0.1048),\n",
       "  ('2014 karger', 0.0965),\n",
       "  ('traditional', 0.0816),\n",
       "  ('high sugar', 0.0794),\n",
       "  ('low fiber', 0.0568),\n",
       "  ('basel', 0.051)],\n",
       " 'MED-1579': [('crohn disease', 0.6407),\n",
       "  ('autoimmune disorder', 0.4601),\n",
       "  ('cure crohn', 0.457),\n",
       "  ('chronic inflammation', 0.3721),\n",
       "  ('disease result', 0.348),\n",
       "  ('disorder affects', 0.2683),\n",
       "  ('disease aid', 0.258),\n",
       "  ('genetic link', 0.2514),\n",
       "  ('inflammation alleviating', 0.2505),\n",
       "  ('growth impairment', 0.248),\n",
       "  ('funded research', 0.2441),\n",
       "  ('pediatric patients', 0.2377),\n",
       "  ('etiology', 0.2343),\n",
       "  ('americans etiology', 0.2232),\n",
       "  ('afflicted patients', 0.2206),\n",
       "  ('research suggested', 0.2144),\n",
       "  ('mechanisms inducing', 0.1961),\n",
       "  ('seeks chronicle', 0.1848),\n",
       "  ('future treatment', 0.1842),\n",
       "  ('required clinical', 0.1711),\n",
       "  ('affects nearly', 0.1655),\n",
       "  ('disease completely', 0.157),\n",
       "  ('understanding potential', 0.1498),\n",
       "  ('government', 0.1455),\n",
       "  ('options patients', 0.1392),\n",
       "  ('cellular mechanistic', 0.138),\n",
       "  ('efficacy review', 0.1329),\n",
       "  ('alpha integrin', 0.1313),\n",
       "  ('reducing chronic', 0.1285),\n",
       "  ('treatment crown', 0.1279),\n",
       "  ('seeks', 0.1139),\n",
       "  ('inhibitor tnf', 0.1055),\n",
       "  ('leukocytes required', 0.1021),\n",
       "  ('inducing apoptosis', 0.0978),\n",
       "  ('known cure', 0.0947),\n",
       "  ('number treatment', 0.0778),\n",
       "  ('current', 0.0742),\n",
       "  ('shed light', 0.0732),\n",
       "  ('published', 0.0611),\n",
       "  ('conducted alternative', 0.0492),\n",
       "  ('patients reducing', 0.0452),\n",
       "  ('link currently', 0.0376),\n",
       "  ('quality life', 0.0367),\n",
       "  ('nearly million', 0.0032),\n",
       "  ('increase', -0.0239),\n",
       "  ('drug shed', -0.0299),\n",
       "  ('rights', -0.0331),\n",
       "  ('copyright 2013', -0.0381),\n",
       "  ('understand exactly', -0.0382),\n",
       "  ('elsevier rights', -0.0492)],\n",
       " 'MED-1580': [('crohn disease', 0.6149),\n",
       "  ('disease coli', 0.4555),\n",
       "  ('patches colonic', 0.4395),\n",
       "  ('impact dietary', 0.404),\n",
       "  ('typical diet', 0.3609),\n",
       "  ('food emulsifiers', 0.3489),\n",
       "  ('coli fold', 0.348),\n",
       "  ('bacterial invasion', 0.3231),\n",
       "  ('fibres food', 0.3206),\n",
       "  ('mucosa', 0.2996),\n",
       "  ('human peyer', 0.296),\n",
       "  ('disease common', 0.2898),\n",
       "  ('plantain broccoli', 0.2891),\n",
       "  ('low fibre', 0.2714),\n",
       "  ('caco2 cl1', 0.2511),\n",
       "  ('patches reduced', 0.2298),\n",
       "  ('starch polysaccharide', 0.2243),\n",
       "  ('primary lesions', 0.2174),\n",
       "  ('nsp significant', 0.1977),\n",
       "  ('monocultures 15', 0.175),\n",
       "  ('control isolates', 0.1674),\n",
       "  ('developed nations', 0.1486),\n",
       "  ('assess effects', 0.1436),\n",
       "  ('mounted ussing', 0.1418),\n",
       "  ('lymphoid follicles', 0.1347),\n",
       "  ('conclusions translocation', 0.1298),\n",
       "  ('plant', 0.1264),\n",
       "  ('background', 0.115),\n",
       "  ('polysorbate', 0.0966),\n",
       "  ('monolayers generated', 0.0918),\n",
       "  ('cells compared', 0.0908),\n",
       "  ('59', 0.0902),\n",
       "  ('01 apple', 0.0822),\n",
       "  ('effect soluble', 0.0808),\n",
       "  ('leek', 0.0787),\n",
       "  ('electron microscopy', 0.0725),\n",
       "  ('05 higher', 0.0708),\n",
       "  ('concentrations increased', 0.0625),\n",
       "  ('ml range', 0.0603),\n",
       "  ('cells mg', 0.0382),\n",
       "  ('non', 0.0378),\n",
       "  ('fold iqr', 0.0281),\n",
       "  ('overlie', 0.021),\n",
       "  ('chambers results', 0.0094),\n",
       "  ('high processed', 0.0089),\n",
       "  ('80 vol', -0.0091),\n",
       "  ('45', -0.0106),\n",
       "  ('parent', -0.0235),\n",
       "  ('iqr 21', -0.0345),\n",
       "  ('32', -0.0419)],\n",
       " 'MED-1581': [('crohn disease', 0.6868),\n",
       "  ('pathogenesis cd', 0.6005),\n",
       "  ('inflammatory disease', 0.5437),\n",
       "  ('disease affects', 0.521),\n",
       "  ('gut microbes', 0.4601),\n",
       "  ('entire gastrointestinal', 0.4154),\n",
       "  ('organs cd', 0.4124),\n",
       "  ('intestinal organs', 0.4122),\n",
       "  ('disease life', 0.4021),\n",
       "  ('factors gut', 0.388),\n",
       "  ('disease lead', 0.377),\n",
       "  ('cd holistic', 0.3415),\n",
       "  ('idiopathic inflammatory', 0.3378),\n",
       "  ('involved pathogenesis', 0.3283),\n",
       "  ('complex interactions', 0.3215),\n",
       "  ('mysteries cd', 0.319),\n",
       "  ('especially mucosal', 0.3185),\n",
       "  ('immune host', 0.2965),\n",
       "  ('research pathogenetic', 0.2946),\n",
       "  ('affects entire', 0.2902),\n",
       "  ('curing disease', 0.2868),\n",
       "  ('decades research', 0.2701),\n",
       "  ('affects', 0.2676),\n",
       "  ('immunity led', 0.247),\n",
       "  ('pathways different', 0.2442),\n",
       "  ('microbes genetic', 0.2338),\n",
       "  ('genetic background', 0.2338),\n",
       "  ('integrating research', 0.23),\n",
       "  ('biologic agents', 0.2225),\n",
       "  ('global approach', 0.1975),\n",
       "  ('targeting multiple', 0.1962),\n",
       "  ('host decades', 0.1776),\n",
       "  ('environmental', 0.1609),\n",
       "  ('tract occasionally', 0.1497),\n",
       "  ('aid unravelling', 0.1334),\n",
       "  ('led development', 0.1309),\n",
       "  ('treatment', 0.1294),\n",
       "  ('steps integrating', 0.1266),\n",
       "  ('probably evolve', 0.114),\n",
       "  ('components especially', 0.1113),\n",
       "  ('background', 0.0953),\n",
       "  ('curing', 0.077),\n",
       "  ('thought result', 0.0657),\n",
       "  ('long', 0.0513),\n",
       "  ('developing novel', 0.0272),\n",
       "  ('2014 elsevier', 0.0269),\n",
       "  ('improved dramatically', 0.0034),\n",
       "  ('extra', 0.0028),\n",
       "  ('far away', -0.0112),\n",
       "  ('copyright', -0.0349)],\n",
       " 'MED-1582': [('dietary fiber', 0.547),\n",
       "  ('diseases crohn', 0.3626),\n",
       "  ('dietary information', 0.3503),\n",
       "  ('examined associations', 0.3222),\n",
       "  ('associations long', 0.3101),\n",
       "  ('term intake', 0.3084),\n",
       "  ('risk inflammatory', 0.3014),\n",
       "  ('ulcerative', 0.2456),\n",
       "  ('bowel', 0.2377),\n",
       "  ('background aims', 0.2338),\n",
       "  ('17 intake', 0.2309),\n",
       "  ('studies needed', 0.2285),\n",
       "  ('women followed', 0.2232),\n",
       "  ('confounders used', 0.1989),\n",
       "  ('participated nurses', 0.1885),\n",
       "  ('health', 0.1838),\n",
       "  ('legumes', 0.1701),\n",
       "  ('energy adjusted', 0.1701),\n",
       "  ('frequency questionnaire', 0.1646),\n",
       "  ('uc confirmed', 0.1607),\n",
       "  ('mechanisms mediate', 0.1574),\n",
       "  ('776 women', 0.1505),\n",
       "  ('cereals', 0.1497),\n",
       "  ('sources appeared', 0.1304),\n",
       "  ('lower risk', 0.1247),\n",
       "  ('confidence interval', 0.121),\n",
       "  ('review medical', 0.1115),\n",
       "  ('incidence 10', 0.109),\n",
       "  ('82 95', 0.1069),\n",
       "  ('did modify', 0.1032),\n",
       "  ('cd multivariate', 0.1024),\n",
       "  ('derived fruits', 0.1006),\n",
       "  ('data 170', 0.0936),\n",
       "  ('incident cases', 0.0924),\n",
       "  ('prospectively', 0.0768),\n",
       "  ('24 day', 0.0752),\n",
       "  ('aims increased', 0.0573),\n",
       "  ('records cox', 0.053),\n",
       "  ('hrs results', 0.0408),\n",
       "  ('000 person', 0.0385),\n",
       "  ('analyzed data', 0.0362),\n",
       "  ('appeared significantly', 0.031),\n",
       "  ('40', 0.0249),\n",
       "  ('338 cases', 0.0179),\n",
       "  ('quintile median', 0.0172),\n",
       "  ('425 person', 0.014),\n",
       "  ('59', 0.0117),\n",
       "  ('26 participated', 0.0035),\n",
       "  ('person compared', -0.0318),\n",
       "  ('self', -0.0529)],\n",
       " 'MED-1584': [('twin pregnancies', 0.637),\n",
       "  ('morbidity twins', 0.5194),\n",
       "  ('complication twin', 0.5092),\n",
       "  ('twin transfusion', 0.4867),\n",
       "  ('pregnancies significant', 0.4687),\n",
       "  ('perinatal complications', 0.4466),\n",
       "  ('complications higher', 0.4056),\n",
       "  ('proportion maternities', 0.3952),\n",
       "  ('management twin', 0.3944),\n",
       "  ('preterm delivery', 0.3886),\n",
       "  ('weeks gestation', 0.3801),\n",
       "  ('chorionicity', 0.3636),\n",
       "  ('twins prompt', 0.3583),\n",
       "  ('risk fetal', 0.3503),\n",
       "  ('mortality intrapartum', 0.349),\n",
       "  ('pregnancy chapter', 0.3286),\n",
       "  ('mortality morbidity', 0.292),\n",
       "  ('neonatal facilities', 0.2752),\n",
       "  ('maternal', 0.2524),\n",
       "  ('technology increases', 0.2219),\n",
       "  ('mortality dichorionic', 0.2186),\n",
       "  ('better outcomes', 0.2074),\n",
       "  ('syndrome ttts', 0.2067),\n",
       "  ('assisted reproductive', 0.2025),\n",
       "  ('advances assisted', 0.196),\n",
       "  ('higher rate', 0.1772),\n",
       "  ('particularly monochorionic', 0.1754),\n",
       "  ('transfusion', 0.1606),\n",
       "  ('outcomes ultrasonography', 0.1504),\n",
       "  ('1980s', 0.1452),\n",
       "  ('older women', 0.1443),\n",
       "  ('incidence', 0.1396),\n",
       "  ('weeks', 0.1253),\n",
       "  ('setting anaesthetic', 0.125),\n",
       "  ('singleton', 0.1027),\n",
       "  ('significant proportion', 0.0998),\n",
       "  ('mode delivery', 0.0991),\n",
       "  ('therapeutic intervention', 0.085),\n",
       "  ('early diagnosis', 0.0797),\n",
       "  ('contributed', 0.0731),\n",
       "  ('management hospital', 0.0638),\n",
       "  ('recent', 0.0621),\n",
       "  ('particular focus', 0.0384),\n",
       "  ('tool management', 0.0274),\n",
       "  ('necessary reduce', 0.0156),\n",
       "  ('summarises topics', -0.0028),\n",
       "  ('steep', -0.012),\n",
       "  ('led', -0.0353),\n",
       "  ('viability', -0.059),\n",
       "  ('24', -0.0703)],\n",
       " 'MED-1585': [('pregnancy complications', 0.6137),\n",
       "  ('twin gestation', 0.6068),\n",
       "  ('maternal risks', 0.603),\n",
       "  ('risks mother', 0.5623),\n",
       "  ('gestation increased', 0.5353),\n",
       "  ('including preeclampsia', 0.4985),\n",
       "  ('increased risks', 0.4951),\n",
       "  ('incidence twin', 0.4604),\n",
       "  ('gestation', 0.4385),\n",
       "  ('certain pregnancy', 0.4384),\n",
       "  ('consider maternal', 0.4378),\n",
       "  ('complications likely', 0.4026),\n",
       "  ('counseling pregnancies', 0.4013),\n",
       "  ('maternal monitoring', 0.3861),\n",
       "  ('disorders antepartum', 0.3845),\n",
       "  ('hypertensive disorders', 0.346),\n",
       "  ('multiples compared', 0.3421),\n",
       "  ('preterm labor', 0.3417),\n",
       "  ('pregnancies copyright', 0.3401),\n",
       "  ('antepartum intrapartum', 0.34),\n",
       "  ('close maternal', 0.3394),\n",
       "  ('twins benefit', 0.3295),\n",
       "  ('mother', 0.3141),\n",
       "  ('deficiencies cesarean', 0.3074),\n",
       "  ('abnormal bleeding', 0.3032),\n",
       "  ('intrapartum', 0.2857),\n",
       "  ('hemorrhage women', 0.2853),\n",
       "  ('women carrying', 0.2369),\n",
       "  ('postpartum periods', 0.2322),\n",
       "  ('labor abnormal', 0.2092),\n",
       "  ('disorders', 0.2003),\n",
       "  ('singleton', 0.1983),\n",
       "  ('increases important', 0.1933),\n",
       "  ('important consider', 0.1826),\n",
       "  ('associated carrying', 0.1771),\n",
       "  ('nutritional deficiencies', 0.1748),\n",
       "  ('incidence', 0.1638),\n",
       "  ('hospitalization', 0.1581),\n",
       "  ('delivery', 0.1222),\n",
       "  ('early education', 0.1205),\n",
       "  ('physical therapy', 0.0966),\n",
       "  ('likely occur', 0.0927),\n",
       "  ('copyright 2012', 0.089),\n",
       "  ('monitoring', 0.0769),\n",
       "  ('periods', 0.0518),\n",
       "  ('issues close', 0.0369),\n",
       "  ('sessions', 0.0162),\n",
       "  ('benefit', -0.0139),\n",
       "  ('rights', -0.04),\n",
       "  ('elsevier rights', -0.0644)],\n",
       " 'MED-1586': [('pregnancy care', 0.6765),\n",
       "  ('multiple pregnancy', 0.6464),\n",
       "  ('pregnancy early', 0.62),\n",
       "  ('women pregnant', 0.558),\n",
       "  ('risks infants', 0.5562),\n",
       "  ('screening fetal', 0.5541),\n",
       "  ('pregnant child', 0.5418),\n",
       "  ('fetal anomalies', 0.5353),\n",
       "  ('pregnancy limited', 0.527),\n",
       "  ('women complications', 0.5169),\n",
       "  ('early prenatal', 0.5147),\n",
       "  ('chorionicity', 0.5135),\n",
       "  ('management preterm', 0.4998),\n",
       "  ('including monoamniotic', 0.4935),\n",
       "  ('infants women', 0.4924),\n",
       "  ('fetal death', 0.4577),\n",
       "  ('care women', 0.4419),\n",
       "  ('mode birth', 0.4336),\n",
       "  ('care require', 0.415),\n",
       "  ('complications multiple', 0.3661),\n",
       "  ('women multiple', 0.3635),\n",
       "  ('greater risks', 0.3348),\n",
       "  ('number embryos', 0.3326),\n",
       "  ('single intrauterine', 0.3307),\n",
       "  ('avoiding multiple', 0.3141),\n",
       "  ('screening', 0.3087),\n",
       "  ('growth restriction', 0.3009),\n",
       "  ('twin twin', 0.2676),\n",
       "  ('anomalies later', 0.2627),\n",
       "  ('syndrome care', 0.2518),\n",
       "  ('focus avoiding', 0.2518),\n",
       "  ('assisted reproductive', 0.2259),\n",
       "  ('transfusion syndrome', 0.2221),\n",
       "  ('treatment', 0.2182),\n",
       "  ('focusing presentation', 0.2179),\n",
       "  ('clinics better', 0.2076),\n",
       "  ('optimal timing', 0.2064),\n",
       "  ('pre', 0.1604),\n",
       "  ('centres determining', 0.1582),\n",
       "  ('face greater', 0.1578),\n",
       "  ('including using', 0.1576),\n",
       "  ('require better', 0.1499),\n",
       "  ('controlled trials', 0.1296),\n",
       "  ('following single', 0.1162),\n",
       "  ('benefits specialised', 0.0852),\n",
       "  ('prediction management', 0.0828),\n",
       "  ('quality information', 0.0716),\n",
       "  ('limited', 0.0672),\n",
       "  ('current', -0.0127),\n",
       "  ('transferred', -0.0311)],\n",
       " 'MED-1587': [('diets twinning', 0.5199),\n",
       "  ('increased twinning', 0.4813),\n",
       "  ('elevated cows', 0.4723),\n",
       "  ('twinning genotypes', 0.4397),\n",
       "  ('multiple pregnancies', 0.4283),\n",
       "  ('cows selected', 0.4195),\n",
       "  ('design insulin', 0.4037),\n",
       "  ('effect diet', 0.4015),\n",
       "  ('igf women', 0.4005),\n",
       "  ('dizygotic twinning', 0.3998),\n",
       "  ('including dairy', 0.3954),\n",
       "  ('pregnancies ovarian', 0.3602),\n",
       "  ('level igf', 0.3491),\n",
       "  ('heredity rates', 0.3486),\n",
       "  ('biochemical effect', 0.3436),\n",
       "  ('given cattle', 0.3074),\n",
       "  ('animal products', 0.2689),\n",
       "  ('content milk', 0.2688),\n",
       "  ('products elevated', 0.2679),\n",
       "  ('rates monozygotic', 0.2656),\n",
       "  ('hormone given', 0.2627),\n",
       "  ('favoring elevated', 0.2589),\n",
       "  ('examined correlated', 0.2558),\n",
       "  ('genotypes favoring', 0.2489),\n",
       "  ('model dizygotic', 0.2434),\n",
       "  ('demonstrated increased', 0.2333),\n",
       "  ('women examined', 0.2256),\n",
       "  ('particular effect', 0.2186),\n",
       "  ('multiple', 0.2144),\n",
       "  ('birthing particular', 0.2132),\n",
       "  ('study design', 0.2033),\n",
       "  ('agents influence', 0.1984),\n",
       "  ('exclude dairy', 0.1888),\n",
       "  ('rate effect', 0.1703),\n",
       "  ('like growth', 0.159),\n",
       "  ('singleton versus', 0.1575),\n",
       "  ('conclusion results', 0.1495),\n",
       "  ('objective evaluate', 0.1411),\n",
       "  ('level', 0.1383),\n",
       "  ('stimulation', 0.1353),\n",
       "  ('appear', 0.1281),\n",
       "  ('vegetarians', 0.1244),\n",
       "  ('proposed', 0.1198),\n",
       "  ('vegan women', 0.1193),\n",
       "  ('enhance chances', 0.1166),\n",
       "  ('prior history', 0.087),\n",
       "  ('fifth', 0.0859),\n",
       "  ('especially areas', 0.05),\n",
       "  ('omnivores conclusion', 0.0428),\n",
       "  ('reported support', 0.0211)],\n",
       " 'MED-1588': [('multiple pregnancies', 0.6195),\n",
       "  ('pregnancy rates', 0.5163),\n",
       "  ('triplet pregnancies', 0.4997),\n",
       "  ('embryos significantly', 0.4359),\n",
       "  ('pregnancy reduction', 0.4338),\n",
       "  ('maximize pregnancy', 0.4153),\n",
       "  ('adverse maternal', 0.3961),\n",
       "  ('morbidity sevenfold', 0.3935),\n",
       "  ('rates maternal', 0.3932),\n",
       "  ('pregnancies solution', 0.3886),\n",
       "  ('perinatal mortality', 0.3822),\n",
       "  ('vitro fertilization', 0.3534),\n",
       "  ('assisted conception', 0.3338),\n",
       "  ('morbidity', 0.3221),\n",
       "  ('multifetal', 0.3095),\n",
       "  ('triplets cerebral', 0.287),\n",
       "  ('embryo cryopreservation', 0.2774),\n",
       "  ('single embryo', 0.271),\n",
       "  ('developments blastocyst', 0.2662),\n",
       "  ('aneuploidy', 0.2631),\n",
       "  ('greater multiple', 0.2564),\n",
       "  ('twins sixfold', 0.2506),\n",
       "  ('conception misconceived', 0.2465),\n",
       "  ('limiting embryo', 0.2464),\n",
       "  ('rates twin', 0.2281),\n",
       "  ('palsy rates', 0.2235),\n",
       "  ('rates increasing', 0.2175),\n",
       "  ('mortality rates', 0.2124),\n",
       "  ('singletons', 0.2077),\n",
       "  ('reproductive', 0.2011),\n",
       "  ('pre implantation', 0.2002),\n",
       "  ('rates fourfold', 0.1895),\n",
       "  ('high order', 0.1732),\n",
       "  ('reduce adverse', 0.1611),\n",
       "  ('vitro', 0.1557),\n",
       "  ('new developments', 0.1555),\n",
       "  ('outcome assisted', 0.1469),\n",
       "  ('home baby', 0.146),\n",
       "  ('patients', 0.1265),\n",
       "  ('primary prevention', 0.116),\n",
       "  ('rates remain', 0.1153),\n",
       "  ('rates secondary', 0.0875),\n",
       "  ('significantly', 0.0755),\n",
       "  ('maximize', 0.0706),\n",
       "  ('transferring', 0.0672),\n",
       "  ('techniques', 0.0605),\n",
       "  ('presented chapter', 0.0449),\n",
       "  ('acceptable', 0.0313),\n",
       "  ('overwhelming evidence', -0.0136),\n",
       "  ('exclusion allow', -0.0258)],\n",
       " 'MED-1592': [('seven estrogen', 0.5903),\n",
       "  ('estrogen contribution', 0.5669),\n",
       "  ('total estrogen', 0.5376),\n",
       "  ('natural estrogen', 0.5066),\n",
       "  ('desorption estrogen', 0.502),\n",
       "  ('estrone detected', 0.4898),\n",
       "  ('hormones trace', 0.4701),\n",
       "  ('17β', 0.4594),\n",
       "  ('concentrations environment', 0.4187),\n",
       "  ('hormones natural', 0.3815),\n",
       "  ('biosolids manures', 0.3367),\n",
       "  ('environment reported', 0.3329),\n",
       "  ('experiments simulated', 0.2611),\n",
       "  ('ecosystem study', 0.2603),\n",
       "  ('desorption experiments', 0.257),\n",
       "  ('trace concentrations', 0.2564),\n",
       "  ('adverse effects', 0.2357),\n",
       "  ('sources reported', 0.227),\n",
       "  ('natural environment', 0.2119),\n",
       "  ('compost', 0.2078),\n",
       "  ('study municipal', 0.207),\n",
       "  ('researchers growing', 0.1859),\n",
       "  ('waste', 0.1854),\n",
       "  ('detected sampled', 0.1843),\n",
       "  ('examined', 0.1834),\n",
       "  ('growing concern', 0.1792),\n",
       "  ('significant load', 0.1643),\n",
       "  ('estimate total', 0.1635),\n",
       "  ('reported animal', 0.1628),\n",
       "  ('detected smc', 0.1302),\n",
       "  ('laboratory', 0.1269),\n",
       "  ('significant', 0.1263),\n",
       "  ('potential low', 0.1221),\n",
       "  ('using', 0.1186),\n",
       "  ('solid', 0.1159),\n",
       "  ('contribution different', 0.1081),\n",
       "  ('dihydroequilin', 0.0995),\n",
       "  ('presence', 0.094),\n",
       "  ('462 ng', 0.0744),\n",
       "  ('28 ng', 0.0686),\n",
       "  ('spent mushroom', 0.0612),\n",
       "  ('poultry', 0.0609),\n",
       "  ('ranging', 0.0593),\n",
       "  ('using deionized', 0.0512),\n",
       "  ('ng', 0.0429),\n",
       "  ('cow', 0.0368),\n",
       "  ('milli aqueous', 0.0238),\n",
       "  ('water', 0.0173),\n",
       "  ('dry', 0.0087),\n",
       "  ('cm spent', -0.0011)],\n",
       " 'MED-1593': [('randomized soya', 0.5042),\n",
       "  ('bean1 participants', 0.4303),\n",
       "  ('analysed oestrone', 0.422),\n",
       "  ('hormonal pathways', 0.3603),\n",
       "  ('dietary recalls', 0.3568),\n",
       "  ('metabolites measured', 0.3403),\n",
       "  ('design intervention', 0.3397),\n",
       "  ('high meat', 0.3318),\n",
       "  ('diets increase', 0.3295),\n",
       "  ('vegetarians 235', 0.3253),\n",
       "  ('cancer risk', 0.3154),\n",
       "  ('analysis compared', 0.2978),\n",
       "  ('repeated measures', 0.284),\n",
       "  ('confounders results', 0.2766),\n",
       "  ('increase breast', 0.2742),\n",
       "  ('strengthened associations', 0.273),\n",
       "  ('24 dietary', 0.2572),\n",
       "  ('reported consuming', 0.2481),\n",
       "  ('included', 0.243),\n",
       "  ('participants completed', 0.2351),\n",
       "  ('samples 13', 0.2348),\n",
       "  ('daily women', 0.227),\n",
       "  ('hypothesis high', 0.2256),\n",
       "  ('premenopausal healthy', 0.2229),\n",
       "  ('200 pmol', 0.2183),\n",
       "  ('272 participants', 0.2182),\n",
       "  ('limitations study', 0.2163),\n",
       "  ('years serum', 0.2162),\n",
       "  ('pg ml', 0.2056),\n",
       "  ('140 154', 0.2031),\n",
       "  ('non vegetarians', 0.202),\n",
       "  ('luteal phase', 0.1868),\n",
       "  ('using ria', 0.1841),\n",
       "  ('pescatarians', 0.1753),\n",
       "  ('consuming 20', 0.1751),\n",
       "  ('larger populations', 0.1597),\n",
       "  ('status adjusted', 0.1543),\n",
       "  ('seven unannounced', 0.1519),\n",
       "  ('did differ', 0.1475),\n",
       "  ('compute square', 0.1374),\n",
       "  ('e₁ 85', 0.1292),\n",
       "  ('thirty', 0.1262),\n",
       "  ('need confirmation', 0.1058),\n",
       "  ('235 non', 0.0999),\n",
       "  ('poultry 10', 0.0812),\n",
       "  ('red', 0.0764),\n",
       "  ('lower levels', 0.0642),\n",
       "  ('fish', 0.0571),\n",
       "  ('sum urinary', 0.0413),\n",
       "  ('donated blood', 0.0163)],\n",
       " 'MED-1594': [('estrogens estrone', 0.807),\n",
       "  ('synthetic estrogens', 0.7782),\n",
       "  ('estrogens excreted', 0.7697),\n",
       "  ('animals estrogens', 0.7521),\n",
       "  ('source estrogens', 0.7168),\n",
       "  ('estrogens 17alpha', 0.707),\n",
       "  ('estrogens critically', 0.6584),\n",
       "  ('pollution estrogens', 0.6462),\n",
       "  ('estradiol e2beta', 0.6324),\n",
       "  ('estriol e3', 0.6306),\n",
       "  ('sex hormones', 0.5817),\n",
       "  ('animal hormones', 0.5547),\n",
       "  ('ethinylestradiol', 0.5509),\n",
       "  ('degradation hormones', 0.4732),\n",
       "  ('17beta', 0.4659),\n",
       "  ('produce endocrine', 0.463),\n",
       "  ('hormones transfer', 0.4406),\n",
       "  ('ee2 used', 0.4236),\n",
       "  ('natural sex', 0.3856),\n",
       "  ('e3 natural', 0.3392),\n",
       "  ('humans animals', 0.3),\n",
       "  ('used contraception', 0.2809),\n",
       "  ('compounds able', 0.2757),\n",
       "  ('addition synthetic', 0.2718),\n",
       "  ('e1', 0.2322),\n",
       "  ('elimination rates', 0.2251),\n",
       "  ('produced humans', 0.2214),\n",
       "  ('levels humans', 0.1967),\n",
       "  ('feces reaching', 0.1727),\n",
       "  ('living organisms', 0.1661),\n",
       "  ('high concentrations', 0.1617),\n",
       "  ('environment pollution', 0.1365),\n",
       "  ('stps', 0.1316),\n",
       "  ('plants', 0.128),\n",
       "  ('parameters hydraulic', 0.1266),\n",
       "  ('disposal units', 0.1219),\n",
       "  ('pathways included', 0.121),\n",
       "  ('metabolic', 0.1207),\n",
       "  ('90 different', 0.0976),\n",
       "  ('review existing', 0.063),\n",
       "  ('nanogram liter', 0.0616),\n",
       "  ('times', 0.0601),\n",
       "  ('soil purpose', 0.0527),\n",
       "  ('borne', 0.044),\n",
       "  ('depends type', 0.0376),\n",
       "  ('spread land', 0.0358),\n",
       "  ('knowledge fate', 0.0352),\n",
       "  ('different treatment', 0.0317),\n",
       "  ('important source', 0.0246),\n",
       "  ('significance health', 0.021)],\n",
       " 'MED-1595': [('intakes hormones', 0.6616),\n",
       "  ('steroid hormones', 0.6518),\n",
       "  ('hormones work', 0.6341),\n",
       "  ('exogenous steroids', 0.6039),\n",
       "  ('steroids presence', 0.5961),\n",
       "  ('endogenous steroid', 0.5692),\n",
       "  ('sex hormones', 0.5166),\n",
       "  ('androstenedione', 0.4413),\n",
       "  ('estrone', 0.3819),\n",
       "  ('humans endogenous', 0.3812),\n",
       "  ('p₅ progesterone', 0.3753),\n",
       "  ('illnesses humans', 0.3437),\n",
       "  ('dehydroepiandrosterone dhea', 0.3375),\n",
       "  ('pregnenolone', 0.3192),\n",
       "  ('metabolic', 0.3051),\n",
       "  ('daily intakes', 0.2886),\n",
       "  ('products influence', 0.2811),\n",
       "  ('avoid metabolic', 0.2749),\n",
       "  ('dairy products', 0.2551),\n",
       "  ('existence differences', 0.2478),\n",
       "  ('reported exogenous', 0.238),\n",
       "  ('harmony body', 0.2142),\n",
       "  ('problems bovine', 0.2046),\n",
       "  ('hydroxylamine derivatisation', 0.1992),\n",
       "  ('quantification sex', 0.1948),\n",
       "  ('disequilibrium', 0.1929),\n",
       "  ('animal origin', 0.1695),\n",
       "  ('influence', 0.1679),\n",
       "  ('cows statistically', 0.1665),\n",
       "  ('origin unavoidable', 0.1494),\n",
       "  ('health', 0.1471),\n",
       "  ('environment', 0.1445),\n",
       "  ('calculations', 0.1398),\n",
       "  ('pregnant non', 0.1285),\n",
       "  ('mass spectrometry', 0.1245),\n",
       "  ('food animal', 0.1202),\n",
       "  ('samples existence', 0.1165),\n",
       "  ('occur naturally', 0.1127),\n",
       "  ('development important', 0.1126),\n",
       "  ('particular concern', 0.1111),\n",
       "  ('existing published', 0.0984),\n",
       "  ('status maintained', 0.0937),\n",
       "  ('data concluded', 0.0924),\n",
       "  ('revision', 0.0835),\n",
       "  ('considerable quantities', 0.0745),\n",
       "  ('maximum daily', 0.0602),\n",
       "  ('basing', 0.0598),\n",
       "  ('applied real', 0.0312),\n",
       "  ('connected human', 0.0308),\n",
       "  ('raw milk', 0.0074)],\n",
       " 'MED-1596': [('concerns estrogenic', 0.5684),\n",
       "  ('estrogenicity waterways', 0.5661),\n",
       "  ('exposure ocs', 0.5296),\n",
       "  ('feminization aquatic', 0.5193),\n",
       "  ('estrogens drinking', 0.5085),\n",
       "  ('ocs wastewater', 0.5012),\n",
       "  ('chemicals estrogenicity', 0.4842),\n",
       "  ('contraceptives ocs', 0.4803),\n",
       "  ('ocs drinking', 0.4709),\n",
       "  ('chemicals water', 0.4214),\n",
       "  ('synthetic estrogens', 0.3956),\n",
       "  ('reproductive problems', 0.3918),\n",
       "  ('potential chemicals', 0.3915),\n",
       "  ('concerns exposure', 0.3855),\n",
       "  ('feminization oral', 0.3814),\n",
       "  ('aquatic animals', 0.3762),\n",
       "  ('wastewater raises', 0.3381),\n",
       "  ('drinking water', 0.3377),\n",
       "  ('compounds environment', 0.3285),\n",
       "  ('waterways estimates', 0.3195),\n",
       "  ('water emphasis', 0.3188),\n",
       "  ('exposure synthetic', 0.2802),\n",
       "  ('human reproductive', 0.2484),\n",
       "  ('drinking', 0.2344),\n",
       "  ('compounds', 0.2222),\n",
       "  ('problems', 0.215),\n",
       "  ('includes discussion', 0.2001),\n",
       "  ('reduce levels', 0.1991),\n",
       "  ('better understand', 0.1767),\n",
       "  ('reviews literature', 0.1726),\n",
       "  ('environment possibilities', 0.1648),\n",
       "  ('public perception', 0.1603),\n",
       "  ('provides recommendations', 0.1275),\n",
       "  ('various sources', 0.1171),\n",
       "  ('estimates risk', 0.1131),\n",
       "  ('strategies better', 0.1127),\n",
       "  ('animals raised', 0.1108),\n",
       "  ('various agricultural', 0.1101),\n",
       "  ('human health', 0.108),\n",
       "  ('surface source', 0.0915),\n",
       "  ('raises', 0.0899),\n",
       "  ('recent observed', 0.083),\n",
       "  ('emphasis active', 0.0633),\n",
       "  ('municipal sources', 0.0534),\n",
       "  ('industrial', 0.0499),\n",
       "  ('supply', 0.033),\n",
       "  ('reach', 0.0213),\n",
       "  ('human', 0.0198),\n",
       "  ('molecule comes', -0.0004),\n",
       "  ('negligible paper', -0.0713)],\n",
       " 'MED-1597': [('estrogens environment', 0.6648),\n",
       "  ('compared exposures', 0.4363),\n",
       "  ('dietary exposure', 0.3763),\n",
       "  ('exposure total', 0.3674),\n",
       "  ('water conclusions', 0.3403),\n",
       "  ('water intakes', 0.3078),\n",
       "  ('affect wildlife', 0.3012),\n",
       "  ('child exposures', 0.2909),\n",
       "  ('effects', 0.2771),\n",
       "  ('lower exposure', 0.2761),\n",
       "  ('environment raised', 0.2735),\n",
       "  ('predict concentrations', 0.2686),\n",
       "  ('raised concerns', 0.2508),\n",
       "  ('occurring sources', 0.2386),\n",
       "  ('methods used', 0.2117),\n",
       "  ('present drinking', 0.2011),\n",
       "  ('levels naturally', 0.1912),\n",
       "  ('margins safety', 0.1601),\n",
       "  ('conclusions consistently', 0.157),\n",
       "  ('humans objectives', 0.1559),\n",
       "  ('000 times', 0.1534),\n",
       "  ('135 17', 0.1456),\n",
       "  ('moes', 0.1427),\n",
       "  ('background detection', 0.1403),\n",
       "  ('transport evaluation', 0.1309),\n",
       "  ('daily', 0.1287),\n",
       "  ('comparisons individual', 0.125),\n",
       "  ('residents including', 0.1239),\n",
       "  ('prescribed total', 0.1213),\n",
       "  ('pharmaceutical assessment', 0.1211),\n",
       "  ('range 28', 0.1181),\n",
       "  ('phate model', 0.1125),\n",
       "  ('children adults', 0.1086),\n",
       "  ('sensitive', 0.0989),\n",
       "  ('recent years', 0.0967),\n",
       "  ('subpopulations', 0.0904),\n",
       "  ('united states', 0.0868),\n",
       "  ('adi used', 0.0715),\n",
       "  ('used moss', 0.0713),\n",
       "  ('independently derived', 0.0691),\n",
       "  ('120 total', 0.0675),\n",
       "  ('large', 0.0654),\n",
       "  ('150 times', 0.063),\n",
       "  ('larger smaller', 0.043),\n",
       "  ('combined default', 0.0384),\n",
       "  ('730', 0.035),\n",
       "  ('milk', 0.0332),\n",
       "  ('480', 0.0272),\n",
       "  ('acceptable', -0.0026),\n",
       "  ('young', -0.0246)],\n",
       " 'MED-1598': [('smoke ths', 0.6755),\n",
       "  ('secondhand smoke', 0.6007),\n",
       "  ('thirdhand smoke', 0.5813),\n",
       "  ('threat smokers', 0.5249),\n",
       "  ('toxic ths', 0.4935),\n",
       "  ('prolonged exposure', 0.4543),\n",
       "  ('smoking remains', 0.4321),\n",
       "  ('tobacco specific', 0.4283),\n",
       "  ('chronic obstructive', 0.3626),\n",
       "  ('directly inhaled', 0.3333),\n",
       "  ('risk developing', 0.3018),\n",
       "  ('lung skin', 0.2968),\n",
       "  ('shs intrinsically', 0.2522),\n",
       "  ('specific carcinogen', 0.252),\n",
       "  ('children exposed', 0.2262),\n",
       "  ('contributor cardiovascular', 0.2251),\n",
       "  ('nonsmokers alike', 0.2247),\n",
       "  ('inflammatory cytokines', 0.2113),\n",
       "  ('new threat', 0.208),\n",
       "  ('behavioral problems', 0.2005),\n",
       "  ('ths leads', 0.1981),\n",
       "  ('investigate effects', 0.1981),\n",
       "  ('discovered thirdhand', 0.1923),\n",
       "  ('alike secondhand', 0.1726),\n",
       "  ('lipid levels', 0.167),\n",
       "  ('significant health', 0.1668),\n",
       "  ('surfaces ages', 0.1602),\n",
       "  ('severe neurological', 0.1482),\n",
       "  ('model exposed', 0.1413),\n",
       "  ('ths potential', 0.1397),\n",
       "  ('fibrosis implications', 0.1388),\n",
       "  ('systems excrete', 0.1065),\n",
       "  ('workers', 0.1013),\n",
       "  ('multiple organ', 0.1002),\n",
       "  ('time progressively', 0.0987),\n",
       "  ('tests ths', 0.0985),\n",
       "  ('stimulates excess', 0.096),\n",
       "  ('combined emerging', 0.0925),\n",
       "  ('policies prevent', 0.0886),\n",
       "  ('hyperactive data', 0.0832),\n",
       "  ('alcoholic', 0.0807),\n",
       "  ('characteristics poor', 0.0802),\n",
       "  ('children spouses', 0.0726),\n",
       "  ('levels non', 0.0719),\n",
       "  ('humans inform', 0.0486),\n",
       "  ('mice', 0.0426),\n",
       "  ('remains', 0.0353),\n",
       "  ('wounded skin', 0.0329),\n",
       "  ('biomarker similar', 0.0266),\n",
       "  ('involuntary', 0.0178)],\n",
       " 'MED-1599': [('smoke ths', 0.5522),\n",
       "  ('residual tobacco', 0.4874),\n",
       "  ('risks exposure', 0.4832),\n",
       "  ('thirdhand smoke', 0.4771),\n",
       "  ('ths exposure', 0.4726),\n",
       "  ('cancer risks', 0.4602),\n",
       "  ('passive inhalation', 0.4458),\n",
       "  ('environmental health', 0.4263),\n",
       "  ('exposure carcinogen', 0.4236),\n",
       "  ('non smokers', 0.401),\n",
       "  ('population exposed', 0.4005),\n",
       "  ('gases particles', 0.3872),\n",
       "  ('measured smoker', 0.387),\n",
       "  ('toxicological', 0.37),\n",
       "  ('exposed residual', 0.368),\n",
       "  ('consequences ths', 0.3182),\n",
       "  ('smokers homes', 0.3136),\n",
       "  ('specific nitrosamines', 0.2824),\n",
       "  ('particularly children', 0.2743),\n",
       "  ('future environmental', 0.268),\n",
       "  ('house dust', 0.241),\n",
       "  ('uncertain considered', 0.2316),\n",
       "  ('public health', 0.222),\n",
       "  ('composition estimated', 0.1865),\n",
       "  ('ths potential', 0.1787),\n",
       "  ('study estimate', 0.1773),\n",
       "  ('observed levels', 0.1484),\n",
       "  ('surfaces', 0.1425),\n",
       "  ('tsnas measured', 0.1413),\n",
       "  ('thirdhand', 0.1386),\n",
       "  ('dietary ingestion', 0.1367),\n",
       "  ('usepa 77', 0.1221),\n",
       "  ('age', 0.1185),\n",
       "  ('maximum risk', 0.1171),\n",
       "  ('dermal', 0.115),\n",
       "  ('strong evidence', 0.1099),\n",
       "  ('64 non', 0.1034),\n",
       "  ('applying recent', 0.1031),\n",
       "  ('stage 6years', 0.0902),\n",
       "  ('severe long', 0.0759),\n",
       "  ('group', 0.0619),\n",
       "  ('life', 0.0518),\n",
       "  ('excess', 0.0492),\n",
       "  ('samples homes', 0.0455),\n",
       "  ('sensitive selective', 0.039),\n",
       "  ('thousand population', 0.0362),\n",
       "  ('policies copyright', 0.0289),\n",
       "  ('settled', -0.0014),\n",
       "  ('2014', -0.0167),\n",
       "  ('elsevier rights', -0.0458)],\n",
       " 'MED-1600': [('celery concentrates', 0.485),\n",
       "  ('curing processes', 0.447),\n",
       "  ('processed meats', 0.4417),\n",
       "  ('ingredients processes', 0.428),\n",
       "  ('processes designed', 0.3936),\n",
       "  ('nitrate reducing', 0.393),\n",
       "  ('processes natural', 0.3856),\n",
       "  ('organic processed', 0.3775),\n",
       "  ('natural ingredients', 0.3771),\n",
       "  ('starter culture', 0.3387),\n",
       "  ('improved product', 0.3153),\n",
       "  ('nitrite suppliers', 0.3033),\n",
       "  ('natural organic', 0.3033),\n",
       "  ('variety ingredients', 0.294),\n",
       "  ('preservatives microbiological', 0.291),\n",
       "  ('reducing starter', 0.2858),\n",
       "  ('effects improved', 0.2793),\n",
       "  ('advances resulted', 0.2775),\n",
       "  ('microbiological', 0.2618),\n",
       "  ('requirements natural', 0.2509),\n",
       "  ('ongoing development', 0.2361),\n",
       "  ('combined', 0.231),\n",
       "  ('antimicrobial effects', 0.2201),\n",
       "  ('regulatory requirements', 0.2199),\n",
       "  ('culture subsequent', 0.2177),\n",
       "  ('concentrates high', 0.216),\n",
       "  ('product safety', 0.2061),\n",
       "  ('processed', 0.205),\n",
       "  ('past 10years', 0.2009),\n",
       "  ('converted', 0.1808),\n",
       "  ('utilized', 0.1792),\n",
       "  ('developed concerning', 0.1655),\n",
       "  ('resulted', 0.153),\n",
       "  ('suppliers', 0.1474),\n",
       "  ('wide variety', 0.1461),\n",
       "  ('designed', 0.1369),\n",
       "  ('effects', 0.1206),\n",
       "  ('consumer demand', 0.1155),\n",
       "  ('past', 0.1098),\n",
       "  ('concerning reduced', 0.102),\n",
       "  ('designed meet', 0.0938),\n",
       "  ('elsevier rights', 0.0937),\n",
       "  ('concentration', 0.088),\n",
       "  ('initially', 0.0874),\n",
       "  ('provide supplementary', 0.0709),\n",
       "  ('copyright 2012', 0.0651),\n",
       "  ('questions developed', 0.0643),\n",
       "  ('content', 0.0445),\n",
       "  ('reserved', -0.0011),\n",
       "  ('safety copyright', -0.0062)],\n",
       " 'MED-1601': [('nitrate antimicrobials', 0.4651),\n",
       "  ('nitrite objective', 0.4119),\n",
       "  ('residual nitrite', 0.39),\n",
       "  ('products pathogens', 0.3848),\n",
       "  ('organic products', 0.3843),\n",
       "  ('processed meat', 0.3704),\n",
       "  ('food regulations', 0.3698),\n",
       "  ('antimicrobials processed', 0.3328),\n",
       "  ('nitrate significantly', 0.3305),\n",
       "  ('regulations preclude', 0.3086),\n",
       "  ('processors begun', 0.2642),\n",
       "  ('pathogens water', 0.2527),\n",
       "  ('varied products', 0.2368),\n",
       "  ('preclude use', 0.222),\n",
       "  ('reactions cured', 0.2164),\n",
       "  ('perfringens', 0.215),\n",
       "  ('chemical characteristics', 0.2129),\n",
       "  ('use natural', 0.203),\n",
       "  ('characteristics sodium', 0.202),\n",
       "  ('turbinado sugar', 0.1903),\n",
       "  ('juice powder', 0.1656),\n",
       "  ('cured commercial', 0.1552),\n",
       "  ('intrinsic factors', 0.152),\n",
       "  ('begun use', 0.1438),\n",
       "  ('listeria', 0.1433),\n",
       "  ('traditionally', 0.1299),\n",
       "  ('moisture protein', 0.1205),\n",
       "  ('affect clostridium', 0.1184),\n",
       "  ('pigment residual', 0.117),\n",
       "  ('products copyright', 0.1156),\n",
       "  ('sea', 0.1153),\n",
       "  ('celery juice', 0.114),\n",
       "  ('salt turbinado', 0.1062),\n",
       "  ('processed', 0.106),\n",
       "  ('significantly', 0.0946),\n",
       "  ('bacon correlations', 0.0769),\n",
       "  ('concentration product', 0.0636),\n",
       "  ('sources', 0.0632),\n",
       "  ('growth varied', 0.0631),\n",
       "  ('common', 0.0614),\n",
       "  ('study compare', 0.0522),\n",
       "  ('powder', 0.0506),\n",
       "  ('rights', 0.0462),\n",
       "  ('significantly correlated', 0.0364),\n",
       "  ('specific', 0.0304),\n",
       "  ('elsevier rights', 0.0273),\n",
       "  ('frankfurters hams', 0.0176),\n",
       "  ('physio', 0.0121),\n",
       "  ('affect', 0.0062),\n",
       "  ('2012', -0.0402)],\n",
       " 'MED-1602': [('nitrate intake', 0.6161),\n",
       "  ('nitroso compounds', 0.5894),\n",
       "  ('quintile nitrite', 0.5263),\n",
       "  ('carcinogens prospectively', 0.3313),\n",
       "  ('animal carcinogens', 0.31),\n",
       "  ('intake overall', 0.2886),\n",
       "  ('investigated association', 0.2832),\n",
       "  ('foods precursors', 0.2738),\n",
       "  ('aarp diet', 0.2713),\n",
       "  ('adenocarcinoma risk', 0.2701),\n",
       "  ('renal cell', 0.216),\n",
       "  ('risk total', 0.2095),\n",
       "  ('processed meats', 0.2034),\n",
       "  ('total rcc', 0.2024),\n",
       "  ('subtype hr', 0.1857),\n",
       "  ('compounds known', 0.1813),\n",
       "  ('intake animal', 0.1796),\n",
       "  ('plant sources', 0.1788),\n",
       "  ('sources compared', 0.1756),\n",
       "  ('findings suggest', 0.174),\n",
       "  ('health study', 0.1726),\n",
       "  ('subtypes nih', 0.1636),\n",
       "  ('841', 0.1575),\n",
       "  ('115 papillary', 0.1538),\n",
       "  ('regression used', 0.1529),\n",
       "  ('cis results', 0.1462),\n",
       "  ('histological', 0.1454),\n",
       "  ('quintile increased', 0.1422),\n",
       "  ('particularly clear', 0.1358),\n",
       "  ('compared lowest', 0.117),\n",
       "  ('follow years', 0.1085),\n",
       "  ('participants', 0.1039),\n",
       "  ('prospectively', 0.1029),\n",
       "  ('frequency questionnaire', 0.1021),\n",
       "  ('cox', 0.101),\n",
       "  ('background', 0.0943),\n",
       "  ('overall conclusion', 0.0932),\n",
       "  ('76 hr', 0.0829),\n",
       "  ('cell subtype', 0.0791),\n",
       "  ('present', 0.066),\n",
       "  ('34 36', 0.0645),\n",
       "  ('124 item', 0.06),\n",
       "  ('identified 1816', 0.0429),\n",
       "  ('10', 0.0307),\n",
       "  ('33 95', 0.0268),\n",
       "  ('proportional', 0.0198),\n",
       "  ('potential human', 0.0145),\n",
       "  ('cases 498', 0.002),\n",
       "  ('hr 68', -0.0107),\n",
       "  ('25 27', -0.0194)],\n",
       " 'MED-1603': [('smoke undergoes', 0.6948),\n",
       "  ('nitrosamines cigarette', 0.5955),\n",
       "  ('secondhand cigarette', 0.5897),\n",
       "  ('contribute smoking', 0.5589),\n",
       "  ('pahs nicotine', 0.5131),\n",
       "  ('tobacco specific', 0.469),\n",
       "  ('accumulation carcinogens', 0.4428),\n",
       "  ('mainstream cigarette', 0.4336),\n",
       "  ('higher aerosol', 0.4157),\n",
       "  ('62 pahs', 0.4117),\n",
       "  ('nitrosamines dermal', 0.3841),\n",
       "  ('absorption inhalation', 0.3399),\n",
       "  ('exposure', 0.3283),\n",
       "  ('contaminated dust', 0.3275),\n",
       "  ('cotinine', 0.3249),\n",
       "  ('72 nicotine', 0.3128),\n",
       "  ('undergo chemical', 0.3056),\n",
       "  ('polycyclic aromatic', 0.2993),\n",
       "  ('hydrocarbons', 0.2983),\n",
       "  ('effects 60', 0.2805),\n",
       "  ('min aging', 0.2464),\n",
       "  ('secondhand', 0.2426),\n",
       "  ('indoor surfaces', 0.2187),\n",
       "  ('surfaces desorb', 0.2026),\n",
       "  ('undergoes numerous', 0.202),\n",
       "  ('ages objectives', 0.1991),\n",
       "  ('air exchange', 0.1928),\n",
       "  ('growing body', 0.187),\n",
       "  ('changes released', 0.186),\n",
       "  ('80 methylnitrosamino', 0.1829),\n",
       "  ('evidence shows', 0.1517),\n",
       "  ('generated sidestream', 0.1411),\n",
       "  ('methods generated', 0.1387),\n",
       "  ('background', 0.1286),\n",
       "  ('measured sorption', 0.1278),\n",
       "  ('conditioned filtered', 0.1259),\n",
       "  ('mass losses', 0.1183),\n",
       "  ('attributable', 0.1143),\n",
       "  ('butanone', 0.1097),\n",
       "  ('16', 0.1013),\n",
       "  ('test effects', 0.0993),\n",
       "  ('reactor results', 0.0821),\n",
       "  ('morbidity mortality', 0.0639),\n",
       "  ('cloth 10', 0.0468),\n",
       "  ('79', 0.0418),\n",
       "  ('machine diluted', 0.0323),\n",
       "  ('normal residential', 0.0252),\n",
       "  ('places deposit', 0.0229),\n",
       "  ('nnk extraction', 0.0126),\n",
       "  ('public', -0.003)],\n",
       " 'MED-1604': [('studies rr', 0.5493),\n",
       "  ('studies retrieved', 0.546),\n",
       "  ('meta analysis', 0.5388),\n",
       "  ('conflicting results', 0.4942),\n",
       "  ('searches review', 0.4814),\n",
       "  ('studies association', 0.4737),\n",
       "  ('publication bias', 0.4415),\n",
       "  ('calculated heterogeneity', 0.4337),\n",
       "  ('studies researches', 0.3998),\n",
       "  ('potential association', 0.3695),\n",
       "  ('vegetables consumption', 0.3486),\n",
       "  ('stratified analyses', 0.3438),\n",
       "  ('effect cruciferous', 0.334),\n",
       "  ('relative risks', 0.3333),\n",
       "  ('bias evaluated', 0.3154),\n",
       "  ('researches need', 0.3098),\n",
       "  ('control studies', 0.3086),\n",
       "  ('references summary', 0.2979),\n",
       "  ('meta', 0.2664),\n",
       "  ('illustrated conflicting', 0.2627),\n",
       "  ('cell carcinoma', 0.2597),\n",
       "  ('consumption risk', 0.2593),\n",
       "  ('prospective studies', 0.2399),\n",
       "  ('rr 96', 0.2229),\n",
       "  ('retrieved computerized', 0.2151),\n",
       "  ('95 confidence', 0.1986),\n",
       "  ('previous cohort', 0.192),\n",
       "  ('subgroup case', 0.1919),\n",
       "  ('ci 60', 0.1678),\n",
       "  ('renal', 0.1616),\n",
       "  ('case control', 0.1538),\n",
       "  ('rr 69', 0.1439),\n",
       "  ('83 subgroup', 0.1323),\n",
       "  ('vs lowest', 0.1309),\n",
       "  ('findings supported', 0.1297),\n",
       "  ('78 cohort', 0.1295),\n",
       "  ('demonstrate potential', 0.1272),\n",
       "  ('included significantly', 0.1216),\n",
       "  ('limited', 0.1117),\n",
       "  ('publication', 0.1066),\n",
       "  ('interval', 0.1015),\n",
       "  ('significantly decreased', 0.0998),\n",
       "  ('observed overall', 0.0746),\n",
       "  ('ci highest', 0.0659),\n",
       "  ('vs', 0.0646),\n",
       "  ('clarify protective', 0.0628),\n",
       "  ('results far', 0.051),\n",
       "  ('conducted better', 0.0351),\n",
       "  ('designed', -0.0146),\n",
       "  ('71 21', -0.0407)],\n",
       " 'MED-1605': [('prevention tobacco', 0.6216),\n",
       "  ('specific nitrosamines', 0.5865),\n",
       "  ('nitrosamines methylnitrosamino', 0.5504),\n",
       "  ('nitrosonornicotine nnn', 0.5351),\n",
       "  ('tobacco nnk', 0.501),\n",
       "  ('carcinogenic tobacco', 0.48),\n",
       "  ('regulation carcinogenic', 0.4772),\n",
       "  ('reduction carcinogens', 0.4479),\n",
       "  ('family smoking', 0.4206),\n",
       "  ('immediate regulation', 0.3781),\n",
       "  ('powerful carcinogens', 0.3564),\n",
       "  ('prevention nnk', 0.3475),\n",
       "  ('smokers exposed', 0.3306),\n",
       "  ('marketed cigarettes', 0.3297),\n",
       "  ('pyridyl butanone', 0.3144),\n",
       "  ('nnn products', 0.271),\n",
       "  ('non smokers', 0.2597),\n",
       "  ('drug administration', 0.2551),\n",
       "  ('control factors', 0.2539),\n",
       "  ('smoke highest', 0.2518),\n",
       "  ('power regulate', 0.2411),\n",
       "  ('act gives', 0.2287),\n",
       "  ('influence', 0.205),\n",
       "  ('metabolite nnal', 0.2049),\n",
       "  ('nnn powerful', 0.1938),\n",
       "  ('non', 0.1691),\n",
       "  ('commentary calls', 0.1507),\n",
       "  ('administration power', 0.1447),\n",
       "  ('ppb', 0.1438),\n",
       "  ('100 ppb', 0.1433),\n",
       "  ('fold reduction', 0.1247),\n",
       "  ('states', 0.1183),\n",
       "  ('international agency', 0.111),\n",
       "  ('approximate 15', 0.1097),\n",
       "  ('research cancer', 0.1022),\n",
       "  ('family', 0.0909),\n",
       "  ('gives food', 0.0852),\n",
       "  ('exposed', 0.0817),\n",
       "  ('strong', 0.0799),\n",
       "  ('secondhand', 0.0658),\n",
       "  ('urine', 0.0587),\n",
       "  ('logical path', 0.0579),\n",
       "  ('mainstream', 0.0537),\n",
       "  ('proportional amounts', 0.0415),\n",
       "  ('virtually', 0.0386),\n",
       "  ('laboratory animals', 0.0203),\n",
       "  ('processing methods', 0.0174),\n",
       "  ('choice', 0.0048),\n",
       "  ('blend agricultural', -0.0029),\n",
       "  ('20 fold', -0.0353)],\n",
       " 'MED-1606': [('intake rcc', 0.5168),\n",
       "  ('prevent cancer', 0.4956),\n",
       "  ('diet lifestyle', 0.443),\n",
       "  ('fiber intake', 0.4396),\n",
       "  ('obesity hypertension', 0.423),\n",
       "  ('associated renal', 0.3829),\n",
       "  ('chronic conditions', 0.3553),\n",
       "  ('plant foods', 0.3464),\n",
       "  ('005 intakes', 0.3359),\n",
       "  ('history diabetes', 0.3073),\n",
       "  ('conditions associated', 0.2906),\n",
       "  ('cell carcinoma', 0.2524),\n",
       "  ('cruciferous', 0.2417),\n",
       "  ('participants smoked', 0.2394),\n",
       "  ('role etiology', 0.2374),\n",
       "  ('95 cis', 0.2286),\n",
       "  ('health study', 0.2203),\n",
       "  ('women comprehensively', 0.2084),\n",
       "  ('cohort men', 0.2031),\n",
       "  ('significant 15', 0.2019),\n",
       "  ('refined grain', 0.1996),\n",
       "  ('quintiles compared', 0.1958),\n",
       "  ('participants', 0.1849),\n",
       "  ('multivariable cox', 0.1848),\n",
       "  ('risk design', 0.1825),\n",
       "  ('kg m2', 0.1783),\n",
       "  ('based fiber', 0.1676),\n",
       "  ('positively associated', 0.1673),\n",
       "  ('inverse association', 0.1564),\n",
       "  ('trial registered', 0.1453),\n",
       "  ('objective large', 0.1407),\n",
       "  ('trend 04', 0.1301),\n",
       "  ('ci 02', 0.1292),\n",
       "  ('body', 0.1268),\n",
       "  ('years follow', 0.123),\n",
       "  ('gov nct00340015', 0.1173),\n",
       "  ('medical', 0.1127),\n",
       "  ('nih aarp', 0.1115),\n",
       "  ('39 trend', 0.109),\n",
       "  ('conclusions', 0.1044),\n",
       "  ('demographics', 0.1038),\n",
       "  ('rich', 0.097),\n",
       "  ('hrs', 0.0854),\n",
       "  ('identified 1816', 0.0445),\n",
       "  ('20 lower', 0.0422),\n",
       "  ('491 841', 0.032),\n",
       "  ('completed self', 0.0204),\n",
       "  ('16 18', 0.0014),\n",
       "  ('did report', -0.0074),\n",
       "  ('30 did', -0.0418)],\n",
       " 'MED-1607': [('sodium intake', 0.5286),\n",
       "  ('intake rcc', 0.4882),\n",
       "  ('related hypertension', 0.4281),\n",
       "  ('factor renal', 0.4099),\n",
       "  ('fluid intake', 0.407),\n",
       "  ('lifestyle assessed', 0.3945),\n",
       "  ('cohort study', 0.3907),\n",
       "  ('increased rcc', 0.3779),\n",
       "  ('sodium low', 0.3687),\n",
       "  ('rcc methods', 0.3671),\n",
       "  ('intake potential', 0.352),\n",
       "  ('852 participants', 0.3325),\n",
       "  ('nlcs', 0.315),\n",
       "  ('cancer', 0.3129),\n",
       "  ('120 852', 0.306),\n",
       "  ('intake increased', 0.2994),\n",
       "  ('risk trend', 0.2895),\n",
       "  ('included 120', 0.2718),\n",
       "  ('diet', 0.2686),\n",
       "  ('assessed questionnaires', 0.2668),\n",
       "  ('methods netherlands', 0.2631),\n",
       "  ('trend 03', 0.2481),\n",
       "  ('intake did', 0.242),\n",
       "  ('study', 0.2395),\n",
       "  ('485 rcc', 0.2292),\n",
       "  ('independent risk', 0.2287),\n",
       "  ('potassium', 0.2106),\n",
       "  ('participants aged', 0.2074),\n",
       "  ('participants', 0.1997),\n",
       "  ('baseline', 0.1978),\n",
       "  ('design included', 0.1961),\n",
       "  ('available analyses', 0.1931),\n",
       "  ('results', 0.1871),\n",
       "  ('assessed', 0.1785),\n",
       "  ('subcohort members', 0.1779),\n",
       "  ('aged 55', 0.1771),\n",
       "  ('years follow', 0.1707),\n",
       "  ('cases', 0.162),\n",
       "  ('02 conclusion', 0.1561),\n",
       "  ('particularly fluid', 0.1458),\n",
       "  ('background', 0.1387),\n",
       "  ('69 years', 0.1082),\n",
       "  ('follow', 0.1061),\n",
       "  ('cell', 0.1003),\n",
       "  ('questionnaires 17', 0.0898),\n",
       "  ('high', 0.0755),\n",
       "  ('4438', 0.0695),\n",
       "  ('interaction', 0.0641),\n",
       "  ('consumption low', 0.058),\n",
       "  ('members available', 0.0564)],\n",
       " 'MED-1609': [('hcf diets', 0.6428),\n",
       "  ('diet glucose', 0.6247),\n",
       "  ('hepatic glucose', 0.5598),\n",
       "  ('diets insulin', 0.5289),\n",
       "  ('2h2 glucose', 0.5123),\n",
       "  ('diet diet', 0.4959),\n",
       "  ('glucose measured', 0.4901),\n",
       "  ('high carbohydrate', 0.4854),\n",
       "  ('extra alimentary', 0.4679),\n",
       "  ('diets improve', 0.4678),\n",
       "  ('triglyceride concentrations', 0.4549),\n",
       "  ('individuals fasting', 0.4522),\n",
       "  ('min diet', 0.4492),\n",
       "  ('employing euglycemic', 0.4461),\n",
       "  ('diet 02', 0.4447),\n",
       "  ('02 hcf', 0.3936),\n",
       "  ('insulin 66', 0.387),\n",
       "  ('serum cholesterol', 0.3786),\n",
       "  ('unchanged diet', 0.3571),\n",
       "  ('28 hcf', 0.348),\n",
       "  ('lowered fasting', 0.3412),\n",
       "  ('measured 12', 0.3212),\n",
       "  ('clamp hepatic', 0.2877),\n",
       "  ('kg', 0.2524),\n",
       "  ('effects high', 0.2487),\n",
       "  ('concentrations basal', 0.2307),\n",
       "  ('mmol 01', 0.2192),\n",
       "  ('examine extra', 0.2125),\n",
       "  ('healthy young', 0.2056),\n",
       "  ('elderly individuals', 0.2022),\n",
       "  ('employing 2h2', 0.2021),\n",
       "  ('hgo unchanged', 0.1887),\n",
       "  ('disposal rates', 0.1853),\n",
       "  ('fiber', 0.1655),\n",
       "  ('increased 18', 0.165),\n",
       "  ('pmol', 0.1576),\n",
       "  ('66 49', 0.1508),\n",
       "  ('52', 0.1503),\n",
       "  ('individuals 15', 0.1337),\n",
       "  ('enhanced peripheral', 0.1334),\n",
       "  ('economy enhanced', 0.131),\n",
       "  ('78 mumol', 0.1284),\n",
       "  ('80 20', 0.1244),\n",
       "  ('21', 0.1071),\n",
       "  ('23 87', 0.1071),\n",
       "  ('sensitivity', 0.0938),\n",
       "  ('serum', 0.0857),\n",
       "  ('rates', 0.0764),\n",
       "  ('decreased 17', 0.0645),\n",
       "  ('mediated', 0.0388)],\n",
       " 'MED-1610': [('test meals', 0.5146),\n",
       "  ('ratings hunger', 0.4709),\n",
       "  ('meals significant', 0.4674),\n",
       "  ('meal matched', 0.4664),\n",
       "  ('energy intake', 0.4428),\n",
       "  ('containing breakfast', 0.4421),\n",
       "  ('fasting', 0.4381),\n",
       "  ('meat groups', 0.4259),\n",
       "  ('menopausal women', 0.3971),\n",
       "  ('profile food', 0.3931),\n",
       "  ('meals pork', 0.3843),\n",
       "  ('glucose study', 0.3695),\n",
       "  ('hormones insulin', 0.3667),\n",
       "  ('acute satiety', 0.3446),\n",
       "  ('macronutrient profile', 0.3271),\n",
       "  ('women attended', 0.325),\n",
       "  ('hormones compared', 0.3089),\n",
       "  ('cck ghrelin', 0.3039),\n",
       "  ('consumed subsequent', 0.3002),\n",
       "  ('design thirty', 0.2922),\n",
       "  ('subjects', 0.2915),\n",
       "  ('release appetite', 0.2906),\n",
       "  ('protein content', 0.2815),\n",
       "  ('min period', 0.2538),\n",
       "  ('centre test', 0.2504),\n",
       "  ('palatability appearance', 0.2397),\n",
       "  ('matched energy', 0.2379),\n",
       "  ('related intestinal', 0.2301),\n",
       "  ('study design', 0.2298),\n",
       "  ('rest', 0.2122),\n",
       "  ('days consume', 0.2116),\n",
       "  ('non smoking', 0.1954),\n",
       "  ('pre', 0.1949),\n",
       "  ('attended research', 0.1937),\n",
       "  ('compared using', 0.1839),\n",
       "  ('kj', 0.1707),\n",
       "  ('regulatory', 0.1574),\n",
       "  ('chicken acute', 0.1473),\n",
       "  ('effects different', 0.1254),\n",
       "  ('positions', 0.1089),\n",
       "  ('buffet', 0.1071),\n",
       "  ('027 levels', 0.105),\n",
       "  ('containing', 0.1018),\n",
       "  ('did', 0.0823),\n",
       "  ('rights reserved', 0.0766),\n",
       "  ('180', 0.0623),\n",
       "  ('vas ratings', 0.0449),\n",
       "  ('pyy response', -0.0027),\n",
       "  ('subsequent ad', -0.0133),\n",
       "  ('2010 elsevier', -0.0328)],\n",
       " 'MED-1611': [('diabetes cancer', 0.6713),\n",
       "  ('diabetes increases', 0.6365),\n",
       "  ('interactions diabetes', 0.5709),\n",
       "  ('suggest diabetes', 0.5511),\n",
       "  ('mellitus associated', 0.5107),\n",
       "  ('cancer meta', 0.4643),\n",
       "  ('increase cancer', 0.4564),\n",
       "  ('risk cancer', 0.4433),\n",
       "  ('insulin resistance', 0.443),\n",
       "  ('including obesity', 0.427),\n",
       "  ('specific cancers', 0.4132),\n",
       "  ('hyperglycemia promote', 0.4093),\n",
       "  ('total cancer', 0.3653),\n",
       "  ('meta analyses', 0.3594),\n",
       "  ('increases risks', 0.3211),\n",
       "  ('diabetes modest', 0.3051),\n",
       "  ('instance metformin', 0.3032),\n",
       "  ('pancreas decreases', 0.2895),\n",
       "  ('potential anticancer', 0.2816),\n",
       "  ('carcinogenesis', 0.2772),\n",
       "  ('risk prostate', 0.2677),\n",
       "  ('designed studies', 0.2569),\n",
       "  ('body evidence', 0.2557),\n",
       "  ('data suggest', 0.2552),\n",
       "  ('breast', 0.2396),\n",
       "  ('global epidemic', 0.2311),\n",
       "  ('growing body', 0.2101),\n",
       "  ('frequently proposed', 0.2011),\n",
       "  ('endometrium bladder', 0.1837),\n",
       "  ('risk translate', 0.1821),\n",
       "  ('liver colorectum', 0.1733),\n",
       "  ('burden current', 0.1713),\n",
       "  ('decreases risk', 0.169),\n",
       "  ('addition facets', 0.1639),\n",
       "  ('insights underscore', 0.1603),\n",
       "  ('need clinical', 0.146),\n",
       "  ('facets lifestyle', 0.1382),\n",
       "  ('sensitizer reportedly', 0.135),\n",
       "  ('proposed hypothesis', 0.1171),\n",
       "  ('complex', 0.1125),\n",
       "  ('better designed', 0.0947),\n",
       "  ('site specific', 0.0915),\n",
       "  ('smoking', 0.0822),\n",
       "  ('interactions', 0.0716),\n",
       "  ('treatment', 0.0709),\n",
       "  ('lack exercise', 0.0488),\n",
       "  ('light exploding', 0.0246),\n",
       "  ('attention better', 0.0235),\n",
       "  ('resistance secondary', 0.0165),\n",
       "  ('substantial socioeconomic', -0.0011)],\n",
       " 'MED-1612': [('protein glucose', 0.6264),\n",
       "  ('protein meals', 0.6071),\n",
       "  ('meal reduced', 0.5751),\n",
       "  ('plasma glucose', 0.5639),\n",
       "  ('meal plasma', 0.5495),\n",
       "  ('glucose modestly', 0.5415),\n",
       "  ('insulin response', 0.5411),\n",
       "  ('meal following', 0.517),\n",
       "  ('meal random', 0.4963),\n",
       "  ('50 glucose', 0.4866),\n",
       "  ('different meal', 0.4837),\n",
       "  ('declined insulin', 0.4763),\n",
       "  ('diabetic subjects', 0.4564),\n",
       "  ('amounts protein', 0.4414),\n",
       "  ('second glucose', 0.4251),\n",
       "  ('ii diabetic', 0.3669),\n",
       "  ('reduced 34', 0.361),\n",
       "  ('greater protein', 0.3574),\n",
       "  ('increase insulin', 0.3403),\n",
       "  ('indicate protein', 0.3343),\n",
       "  ('single meal', 0.3186),\n",
       "  ('subsequently subjects', 0.28),\n",
       "  ('meals apart', 0.273),\n",
       "  ('given 50', 0.2727),\n",
       "  ('33 meal', 0.2682),\n",
       "  ('reduced large', 0.26),\n",
       "  ('reduce plasma', 0.2535),\n",
       "  ('sequence plasma', 0.2508),\n",
       "  ('determined subsequent', 0.2356),\n",
       "  ('amounts', 0.2264),\n",
       "  ('protein single', 0.2221),\n",
       "  ('baseline following', 0.2131),\n",
       "  ('data indicate', 0.1897),\n",
       "  ('stable declined', 0.1771),\n",
       "  ('35 83', 0.1753),\n",
       "  ('ml respectively', 0.1738),\n",
       "  ('type ii', 0.1724),\n",
       "  ('type', 0.1426),\n",
       "  ('modestly greater', 0.1277),\n",
       "  ('given 247', 0.1207),\n",
       "  ('area response', 0.113),\n",
       "  ('different', 0.1068),\n",
       "  ('rise type', 0.0975),\n",
       "  ('97', 0.0952),\n",
       "  ('concentration remained', 0.0863),\n",
       "  ('secretion', 0.0815),\n",
       "  ('microu', 0.0604),\n",
       "  ('19 microu', 0.0299),\n",
       "  ('large', 0.0249),\n",
       "  ('stable', -0.0116)],\n",
       " 'MED-1613': [('taiwanese vegetarians', 0.6213),\n",
       "  ('diets hormonal', 0.4641),\n",
       "  ('lactovegetarians', 0.4412),\n",
       "  ('lipid glycaemic', 0.4407),\n",
       "  ('vegetarian diets', 0.4232),\n",
       "  ('taiwan aged', 0.3832),\n",
       "  ('healthy female', 0.3739),\n",
       "  ('groups bmi', 0.3303),\n",
       "  ('ninety healthy', 0.33),\n",
       "  ('recruited hualien', 0.3248),\n",
       "  ('nutrients', 0.3135),\n",
       "  ('fasting insulin', 0.2978),\n",
       "  ('homeostasis model', 0.2913),\n",
       "  ('fat', 0.2834),\n",
       "  ('female adults', 0.2811),\n",
       "  ('effects habitual', 0.2778),\n",
       "  ('stimulating hormone', 0.2769),\n",
       "  ('levels triiodothyronine', 0.2658),\n",
       "  ('diet lower', 0.259),\n",
       "  ('glucose mean', 0.2406),\n",
       "  ('different groups', 0.2383),\n",
       "  ('secretion lipid', 0.2218),\n",
       "  ('consumed energy', 0.2094),\n",
       "  ('pmol plasma', 0.1947),\n",
       "  ('t4 ratio', 0.1885),\n",
       "  ('median 35', 0.1881),\n",
       "  ('50 pmol', 0.1851),\n",
       "  ('measured blood', 0.1839),\n",
       "  ('beta cell', 0.1582),\n",
       "  ('did omnivores', 0.1545),\n",
       "  ('years buddhist', 0.14),\n",
       "  ('45 years', 0.1399),\n",
       "  ('levels higher', 0.1358),\n",
       "  ('05 mmol', 0.13),\n",
       "  ('smaller waist', 0.1284),\n",
       "  ('56 beta', 0.1263),\n",
       "  ('present study', 0.1171),\n",
       "  ('aged 31', 0.1137),\n",
       "  ('showed similar', 0.0993),\n",
       "  ('18 15', 0.0884),\n",
       "  ('mean se', 0.0512),\n",
       "  ('observed young', 0.0293),\n",
       "  ('resistance contributed', 0.0277),\n",
       "  ('control', 0.0275),\n",
       "  ('independent predictors', 0.0187),\n",
       "  ('method significantly', 0.002),\n",
       "  ('free', -0.0057),\n",
       "  ('partially responsible', -0.0185),\n",
       "  ('sensitivity did', -0.0386),\n",
       "  ('median 10', -0.0975)],\n",
       " 'MED-1614': [('insulin sensitivity', 0.5003),\n",
       "  ('vegetarians insulin', 0.4988),\n",
       "  ('volunteers vegetarian', 0.4958),\n",
       "  ('glucose levels', 0.4673),\n",
       "  ('chinese vegetarians', 0.4566),\n",
       "  ('healthy volunteers', 0.4562),\n",
       "  ('normal fasting', 0.4114),\n",
       "  ('tests lipid', 0.396),\n",
       "  ('vegetarians omnivores', 0.3651),\n",
       "  ('included 36', 0.3063),\n",
       "  ('groups tested', 0.3022),\n",
       "  ('difference groups', 0.2709),\n",
       "  ('diet sspg', 0.2701),\n",
       "  ('compared steady', 0.2619),\n",
       "  ('suppression test', 0.2419),\n",
       "  ('17 normal', 0.2377),\n",
       "  ('function tests', 0.2344),\n",
       "  ('homeostasis model', 0.2336),\n",
       "  ('study included', 0.2152),\n",
       "  ('subjects younger', 0.2068),\n",
       "  ('secretion index', 0.2029),\n",
       "  ('chinese', 0.2014),\n",
       "  ('18 vs', 0.2009),\n",
       "  ('017 conclusions', 0.1871),\n",
       "  ('sex blood', 0.181),\n",
       "  ('indices different', 0.1733),\n",
       "  ('vs 58', 0.17),\n",
       "  ('participant', 0.1684),\n",
       "  ('aim compare', 0.1667),\n",
       "  ('beta groups', 0.1611),\n",
       "  ('sensitivity appeared', 0.1583),\n",
       "  ('159 31', 0.1456),\n",
       "  ('blood pressure', 0.1424),\n",
       "  ('counterparts', 0.1396),\n",
       "  ('19 microu', 0.1312),\n",
       "  ('sspg 541', 0.1228),\n",
       "  ('cell function', 0.1197),\n",
       "  ('vs 02', 0.1177),\n",
       "  ('75 mg', 0.1175),\n",
       "  ('uric acid', 0.1132),\n",
       "  ('profiles', 0.1102),\n",
       "  ('78 07', 0.089),\n",
       "  ('correlation', 0.0844),\n",
       "  ('264', 0.0809),\n",
       "  ('higher serum', 0.0776),\n",
       "  ('state plasma', 0.0751),\n",
       "  ('homa', 0.0357),\n",
       "  ('clear', -0.0088),\n",
       "  ('10 vs', -0.0504),\n",
       "  ('mean 105', -0.058)],\n",
       " 'MED-1615': [('hypertension hypertriglyceridemia', 0.5922),\n",
       "  ('diabetic patients', 0.5231),\n",
       "  ('group niddm', 0.5098),\n",
       "  ('mellitus', 0.4926),\n",
       "  ('hyperinsulinemia', 0.4868),\n",
       "  ('insulin resistant', 0.4672),\n",
       "  ('risk factors', 0.4512),\n",
       "  ('obesity independent', 0.4264),\n",
       "  ('blood pressure', 0.4235),\n",
       "  ('week dietary', 0.4199),\n",
       "  ('program obese', 0.419),\n",
       "  ('13 insulin', 0.4074),\n",
       "  ('artery disease', 0.4072),\n",
       "  ('triglycerides', 0.3919),\n",
       "  ('exercise program', 0.3855),\n",
       "  ('overweight overweight', 0.3765),\n",
       "  ('insulin equal', 0.3276),\n",
       "  ('mass index', 0.3024),\n",
       "  ('weight loss', 0.3019),\n",
       "  ('normal fasting', 0.2967),\n",
       "  ('factors patients', 0.2965),\n",
       "  ('coronary', 0.2826),\n",
       "  ('index patients', 0.2645),\n",
       "  ('mg dl', 0.2494),\n",
       "  ('investigated effects', 0.2485),\n",
       "  ('disease person', 0.2364),\n",
       "  ('kg m2', 0.2243),\n",
       "  ('intensive', 0.2224),\n",
       "  ('83 132', 0.1896),\n",
       "  ('353', 0.1553),\n",
       "  ('indicating normalization', 0.148),\n",
       "  ('person study', 0.1428),\n",
       "  ('resistant persons', 0.1416),\n",
       "  ('body', 0.1335),\n",
       "  ('subjects achieving', 0.128),\n",
       "  ('decreases risk', 0.1212),\n",
       "  ('blood', 0.1055),\n",
       "  ('divided', 0.1002),\n",
       "  ('m2 significant', 0.0978),\n",
       "  ('requisite', 0.0951),\n",
       "  ('hg', 0.0942),\n",
       "  ('40 15', 0.0928),\n",
       "  ('76 196', 0.0763),\n",
       "  ('non', 0.0754),\n",
       "  ('greater 30', 0.0678),\n",
       "  ('abstract truncated', 0.0569),\n",
       "  ('250 words', 0.0381),\n",
       "  ('71 mm', 0.0343),\n",
       "  ('group 17', 0.0185),\n",
       "  ('10 microu', 0.0068)],\n",
       " 'MED-1616': [('vlckd diet', 0.645),\n",
       "  ('energy diet', 0.4912),\n",
       "  ('low fat', 0.4777),\n",
       "  ('management obesity', 0.4584),\n",
       "  ('ketogenic', 0.4342),\n",
       "  ('carbohydrates achieve', 0.4295),\n",
       "  ('vlckd alternative', 0.397),\n",
       "  ('50 carbohydrates', 0.3644),\n",
       "  ('restricted energy', 0.3608),\n",
       "  ('patients ldl', 0.3571),\n",
       "  ('insulin hba1c', 0.3417),\n",
       "  ('hdl cholesterol', 0.3337),\n",
       "  ('restrictions randomised', 0.3221),\n",
       "  ('bodyweight secondary', 0.308),\n",
       "  ('cardiovascular risk', 0.2975),\n",
       "  ('greater weight', 0.2952),\n",
       "  ('lfd longterm', 0.2556),\n",
       "  ('diet 30', 0.2499),\n",
       "  ('mmol 1257', 0.2457),\n",
       "  ('04 mmol', 0.2438),\n",
       "  ('trials assigned', 0.2351),\n",
       "  ('12 mmol', 0.2104),\n",
       "  ('95 ci', 0.2101),\n",
       "  ('term body', 0.1912),\n",
       "  ('outcomes tag', 0.19),\n",
       "  ('protein levels', 0.1845),\n",
       "  ('assigned conventional', 0.178),\n",
       "  ('achieve better', 0.1678),\n",
       "  ('loss assigned', 0.1667),\n",
       "  ('patients diastolic', 0.1565),\n",
       "  ('difference 20', 0.1538),\n",
       "  ('thirteen studies', 0.153),\n",
       "  ('1415 patients', 0.1511),\n",
       "  ('exclusion criteria', 0.1468),\n",
       "  ('levels total', 0.1295),\n",
       "  ('management compared', 0.1251),\n",
       "  ('analysis aimed', 0.1249),\n",
       "  ('grey literature', 0.1199),\n",
       "  ('ci 06', 0.1121),\n",
       "  ('reactive', 0.1111),\n",
       "  ('17 kg', 0.0996),\n",
       "  ('language', 0.0734),\n",
       "  ('months follow', 0.0717),\n",
       "  ('scopus lilacs', 0.0713),\n",
       "  ('investigate individuals', 0.0701),\n",
       "  ('gov', 0.0518),\n",
       "  ('21 43', 0.0388),\n",
       "  ('1298', 0.0282),\n",
       "  ('adults', -0.0166),\n",
       "  ('sciencedirect', -0.0414)],\n",
       " 'MED-1617': [('dietary modification', 0.5723),\n",
       "  ('daniel fast', 0.4457),\n",
       "  ('improved metabolic', 0.4326),\n",
       "  ('mandated reduction', 0.4068),\n",
       "  ('guidelines provided', 0.3484),\n",
       "  ('cardiovascular disease', 0.3078),\n",
       "  ('improve markers', 0.2841),\n",
       "  ('cholesterol 171', 0.2723),\n",
       "  ('dl total', 0.2715),\n",
       "  ('total kilocalorie', 0.2645),\n",
       "  ('long term', 0.2522),\n",
       "  ('satiety following', 0.2495),\n",
       "  ('individuals limiting', 0.2321),\n",
       "  ('panel insulin', 0.2283),\n",
       "  ('performing strenuous', 0.2198),\n",
       "  ('based biblical', 0.2091),\n",
       "  ('maintain hdl', 0.2087),\n",
       "  ('preservatives inclusive', 0.2025),\n",
       "  ('vs 76', 0.1964),\n",
       "  ('ir reactive', 0.1939),\n",
       "  ('multiple differences', 0.1903),\n",
       "  ('crp 15', 0.1889),\n",
       "  ('nitrogen creatinine', 0.1883),\n",
       "  ('background', 0.1868),\n",
       "  ('compliance mood', 0.1858),\n",
       "  ('subjects day', 0.1815),\n",
       "  ('intake 2185', 0.1811),\n",
       "  ('anthropometric variable', 0.1725),\n",
       "  ('sbp 114', 0.1667),\n",
       "  ('randomized studies', 0.1649),\n",
       "  ('expected multiple', 0.1647),\n",
       "  ('day 22', 0.1587),\n",
       "  ('women improves', 0.1537),\n",
       "  ('week prepare', 0.1353),\n",
       "  ('vs 60', 0.1336),\n",
       "  ('rate blood', 0.1336),\n",
       "  ('10 point', 0.1211),\n",
       "  ('health sf', 0.1137),\n",
       "  ('tolerated men', 0.1132),\n",
       "  ('24 vs', 0.1002),\n",
       "  ('reported 12', 0.0929),\n",
       "  ('07 58', 0.0918),\n",
       "  ('35 yrs', 0.0769),\n",
       "  ('meaningful albeit', 0.0749),\n",
       "  ('yrs completed', 0.0647),\n",
       "  ('43 mmhg', 0.0611),\n",
       "  ('nuts seeds', 0.0533),\n",
       "  ('legumes', 0.0518),\n",
       "  ('19 mg', 0.0491),\n",
       "  ('devoid animal', -0.0245)],\n",
       " 'MED-1618': [('dietary regimens', 0.5183),\n",
       "  ('diet induced', 0.5091),\n",
       "  ('diets plasma', 0.5086),\n",
       "  ('diets enriched', 0.5082),\n",
       "  ('50 protein', 0.4638),\n",
       "  ('diets 12', 0.447),\n",
       "  ('daily protein', 0.4248),\n",
       "  ('dheas increased', 0.4097),\n",
       "  ('igf insulin', 0.3824),\n",
       "  ('plasma levels', 0.3771),\n",
       "  ('balanced randomized', 0.337),\n",
       "  ('crossover trial', 0.3271),\n",
       "  ('male volunteers', 0.2987),\n",
       "  ('collected fasting', 0.2739),\n",
       "  ('diet 20', 0.2687),\n",
       "  ('peptide excretion', 0.2621),\n",
       "  ('dheas remained', 0.2502),\n",
       "  ('manipulations endogenous', 0.2324),\n",
       "  ('basic', 0.2301),\n",
       "  ('increase daily', 0.2293),\n",
       "  ('performed healthy', 0.227),\n",
       "  ('glucuronide did', 0.2228),\n",
       "  ('hours approximately', 0.2071),\n",
       "  ('effect moderate', 0.2064),\n",
       "  ('12 13', 0.2046),\n",
       "  ('secretion produced', 0.1944),\n",
       "  ('methionine methionine', 0.1894),\n",
       "  ('androstanediol', 0.1836),\n",
       "  ('strictly controlled', 0.1809),\n",
       "  ('growth', 0.1764),\n",
       "  ('significant changes', 0.1731),\n",
       "  ('hot acid', 0.1729),\n",
       "  ('reflected renal', 0.1706),\n",
       "  ('enriched 32', 0.1584),\n",
       "  ('nonprotein source', 0.1551),\n",
       "  ('cleaved testosterone', 0.1335),\n",
       "  ('doubled', 0.1321),\n",
       "  ('respectively results', 0.1289),\n",
       "  ('conjugates 3alpha', 0.1287),\n",
       "  ('end day', 0.1234),\n",
       "  ('urine samples', 0.114),\n",
       "  ('24 hour', 0.0997),\n",
       "  ('contained', 0.0869),\n",
       "  ('10 mmol', 0.0753),\n",
       "  ('increments 01', 0.0733),\n",
       "  ('availability reflected', 0.0644),\n",
       "  ('sulfate control', 0.0442),\n",
       "  ('did', 0.0433),\n",
       "  ('nmol versus', 0.0195),\n",
       "  ('unaffected considering', -0.0029)],\n",
       " 'MED-1619': [('diet prevention', 0.6436),\n",
       "  ('vegetarians glucose', 0.5196),\n",
       "  ('glycemic index', 0.5184),\n",
       "  ('glucose minimal', 0.5078),\n",
       "  ('different nutritional', 0.5002),\n",
       "  ('lower vegetarians', 0.4955),\n",
       "  ('fasting concentrations', 0.4781),\n",
       "  ('fats', 0.4637),\n",
       "  ('rich carbohydrates', 0.447),\n",
       "  ('metabolic syndrome', 0.4324),\n",
       "  ('duration vegetarianism', 0.4225),\n",
       "  ('diabetes crucial', 0.3756),\n",
       "  ('subjects insulin', 0.3711),\n",
       "  ('consumption grain', 0.3633),\n",
       "  ('habits correlated', 0.3247),\n",
       "  ('normal weight', 0.3095),\n",
       "  ('fiber content', 0.3056),\n",
       "  ('cardiovascular', 0.2661),\n",
       "  ('crucial components', 0.2496),\n",
       "  ('sensitivity protective', 0.2403),\n",
       "  ('barley conclusion', 0.2359),\n",
       "  ('low values', 0.2214),\n",
       "  ('associated flat', 0.2104),\n",
       "  ('post prandial', 0.2088),\n",
       "  ('ovo vegetarians', 0.206),\n",
       "  ('mass index', 0.2003),\n",
       "  ('proteins similar', 0.176),\n",
       "  ('07 mmol', 0.1726),\n",
       "  ('beneficial effect', 0.1689),\n",
       "  ('traditional western', 0.168),\n",
       "  ('general population', 0.1629),\n",
       "  ('95 long', 0.1603),\n",
       "  ('term lacto', 0.1567),\n",
       "  ('products pulses', 0.1551),\n",
       "  ('secretion maintenance', 0.1541),\n",
       "  ('homa values', 0.1338),\n",
       "  ('25 kg', 0.1319),\n",
       "  ('ir', 0.1303),\n",
       "  ('aim study', 0.1244),\n",
       "  ('abnormality predictor', 0.1215),\n",
       "  ('10 years', 0.0925),\n",
       "  ('continued later', 0.0847),\n",
       "  ('vs 59', 0.0817),\n",
       "  ('rises blood', 0.0703),\n",
       "  ('non', 0.0679),\n",
       "  ('index 18', 0.0647),\n",
       "  ('results age', 0.0619),\n",
       "  ('term frequent', 0.0571),\n",
       "  ('64 years', 0.0272),\n",
       "  ('vs 32', -0.0366)],\n",
       " 'MED-1620': [('diet prohibits', 0.5581),\n",
       "  ('fast dietary', 0.5446),\n",
       "  ('daniel fast', 0.417),\n",
       "  ('sweeteners flavorings', 0.3546),\n",
       "  ('ldl certain', 0.3367),\n",
       "  ('significant reductions', 0.3258),\n",
       "  ('supplementation effect', 0.3212),\n",
       "  ('variety cardiometabolic', 0.3177),\n",
       "  ('vs fasting', 0.3137),\n",
       "  ('glucose 101', 0.3091),\n",
       "  ('oil day', 0.2831),\n",
       "  ('vegan', 0.2815),\n",
       "  ('plan 21', 0.2801),\n",
       "  ('improves variety', 0.2688),\n",
       "  ('days improvements', 0.263),\n",
       "  ('hyperlipidemic blood', 0.2621),\n",
       "  ('preservatives', 0.2479),\n",
       "  ('improve blood', 0.2418),\n",
       "  ('diabetic', 0.231),\n",
       "  ('systolic bp', 0.1927),\n",
       "  ('day placebo', 0.191),\n",
       "  ('coconut oil', 0.1896),\n",
       "  ('74 kg', 0.1872),\n",
       "  ('alcohol following', 0.1796),\n",
       "  ('animal products', 0.1701),\n",
       "  ('110 mm', 0.1653),\n",
       "  ('homeostasis model', 0.1514),\n",
       "  ('lower hdl', 0.1464),\n",
       "  ('certain markers', 0.1452),\n",
       "  ('conclusion following', 0.1438),\n",
       "  ('measure 05', 0.1434),\n",
       "  ('oxidative', 0.1412),\n",
       "  ('refined', 0.1188),\n",
       "  ('govnct01378767', 0.1173),\n",
       "  ('bmi normal', 0.1037),\n",
       "  ('80 mg', 0.08),\n",
       "  ('white flour', 0.071),\n",
       "  ('ir 06', 0.0688),\n",
       "  ('59', 0.0656),\n",
       "  ('resistance homa', 0.0562),\n",
       "  ('92', 0.0437),\n",
       "  ('μu ml', 0.0426),\n",
       "  ('12 men', 0.0409),\n",
       "  ('vs 40', 0.0399),\n",
       "  ('unaffected krill', 0.0369),\n",
       "  ('30', 0.0265),\n",
       "  ('27 women', 0.0196),\n",
       "  ('group collapsed', 0.0028),\n",
       "  ('little', -0.0071),\n",
       "  ('heterogeneous respect', -0.0634)],\n",
       " 'MED-1621': [('coffee risk', 0.564),\n",
       "  ('coffee tea', 0.4951),\n",
       "  ('beverages limitations', 0.3849),\n",
       "  ('studies concern', 0.3814),\n",
       "  ('cox models', 0.3541),\n",
       "  ('tea overall', 0.3304),\n",
       "  ('conflicting evidence', 0.3237),\n",
       "  ('covariates studied', 0.3233),\n",
       "  ('concern persists', 0.3056),\n",
       "  ('adjusted analyses', 0.2916),\n",
       "  ('risk cup', 0.2876),\n",
       "  ('studied relations', 0.28),\n",
       "  ('prior studies', 0.2571),\n",
       "  ('deaths slightly', 0.2445),\n",
       "  ('heavier cups', 0.2363),\n",
       "  ('limitations', 0.2145),\n",
       "  ('relative risk', 0.2102),\n",
       "  ('risk liver', 0.2045),\n",
       "  ('notably cirrhosis', 0.1955),\n",
       "  ('increases coronary', 0.1917),\n",
       "  ('major causes', 0.1817),\n",
       "  ('lower risk', 0.1802),\n",
       "  ('intake relative', 0.176),\n",
       "  ('overall relation', 0.1715),\n",
       "  ('mortality deaths', 0.1637),\n",
       "  ('versus nondrinkers', 0.1337),\n",
       "  ('confidence interval', 0.1293),\n",
       "  ('128 934', 0.1204),\n",
       "  ('persists using', 0.1156),\n",
       "  ('risk acute', 0.1145),\n",
       "  ('models', 0.1102),\n",
       "  ('balanced unexplained', 0.1005),\n",
       "  ('infarction heavier', 0.0967),\n",
       "  ('widespread use', 0.0846),\n",
       "  ('persons 4501', 0.0821),\n",
       "  ('96 00', 0.0681),\n",
       "  ('95', 0.0635),\n",
       "  ('users relative', 0.0629),\n",
       "  ('89 use', 0.0502),\n",
       "  ('00 major', 0.0328),\n",
       "  ('progressively', 0.0239),\n",
       "  ('versus', 0.0169),\n",
       "  ('myocardial', 0.0111),\n",
       "  ('conclude', 0.0077),\n",
       "  ('disease', 0.0076),\n",
       "  ('01 relative', -0.0097),\n",
       "  ('suicide', -0.0166),\n",
       "  ('day 77', -0.0195),\n",
       "  ('conditions notably', -0.0287),\n",
       "  ('day', -0.049)],\n",
       " 'MED-1622': [('caffeine consumption', 0.4918),\n",
       "  ('coffee assessed', 0.4877),\n",
       "  ('health study', 0.354),\n",
       "  ('coffee 77', 0.3342),\n",
       "  ('men women', 0.3236),\n",
       "  ('rrs pooled', 0.3142),\n",
       "  ('men enrolled', 0.2577),\n",
       "  ('cohort specific', 0.2419),\n",
       "  ('study hpfs', 0.2356),\n",
       "  ('300 mg', 0.221),\n",
       "  ('increment cups', 0.2209),\n",
       "  ('63 93', 0.2179),\n",
       "  ('data 43', 0.2154),\n",
       "  ('methods accessed', 0.212),\n",
       "  ('nurses health', 0.2073),\n",
       "  ('599 men', 0.1967),\n",
       "  ('effect models', 0.1961),\n",
       "  ('compared consuming', 0.1922),\n",
       "  ('estimated cox', 0.1835),\n",
       "  ('results documented', 0.1821),\n",
       "  ('suicide 75', 0.1788),\n",
       "  ('suicide compared', 0.1645),\n",
       "  ('820 women', 0.1515),\n",
       "  ('ii 1993', 0.1514),\n",
       "  ('55 38', 0.1369),\n",
       "  ('review', 0.1279),\n",
       "  ('2008 73', 0.1226),\n",
       "  ('multivariate adjusted', 0.1198),\n",
       "  ('277 deaths', 0.1105),\n",
       "  ('frequency questionnaires', 0.1029),\n",
       "  ('deaths', 0.1006),\n",
       "  ('1988', 0.0995),\n",
       "  ('2007 consumption', 0.0973),\n",
       "  ('objective', 0.0931),\n",
       "  ('determined physician', 0.0914),\n",
       "  ('lower risk', 0.0865),\n",
       "  ('ml pooled', 0.0859),\n",
       "  ('follow', 0.0847),\n",
       "  ('assessed years', 0.0736),\n",
       "  ('mg', 0.0722),\n",
       "  ('trend 001', 0.0677),\n",
       "  ('nhs 1992', 0.0646),\n",
       "  ('decaffeinated', 0.0642),\n",
       "  ('interval ci', 0.0607),\n",
       "  ('certificates multivariate', 0.0543),\n",
       "  ('large scale', 0.0529),\n",
       "  ('support association', 0.0203),\n",
       "  ('oz 237', -0.0012),\n",
       "  ('week', -0.0205),\n",
       "  ('using random', -0.0268)],\n",
       " 'MED-1623': [('aspartame consumption', 0.6864),\n",
       "  ('aspartame potentiates', 0.5966),\n",
       "  ('phenylalanine aspartame', 0.5957),\n",
       "  ('artificial sweetener', 0.4771),\n",
       "  ('phenylalanyl methyl', 0.4395),\n",
       "  ('phenylalanine neurotoxic', 0.3823),\n",
       "  ('equimolar phenylalanine', 0.3455),\n",
       "  ('elevations plasma', 0.3295),\n",
       "  ('beverages large', 0.3247),\n",
       "  ('additives modified', 0.3104),\n",
       "  ('americans', 0.3079),\n",
       "  ('anecdotal reports', 0.2878),\n",
       "  ('doses elevate', 0.2757),\n",
       "  ('adverse reactions', 0.2739),\n",
       "  ('monoamine neurotransmitters', 0.2689),\n",
       "  ('seizures inhaled', 0.2518),\n",
       "  ('behavioral reactions', 0.2479),\n",
       "  ('ester consumed', 0.233),\n",
       "  ('consumed primarily', 0.218),\n",
       "  ('synthesis inhibitory', 0.2058),\n",
       "  ('affect synthesis', 0.2043),\n",
       "  ('administration epileptogenic', 0.1969),\n",
       "  ('shock regulations', 0.1943),\n",
       "  ('plasma probably', 0.1913),\n",
       "  ('people suffer', 0.1791),\n",
       "  ('levels tyrosine', 0.1783),\n",
       "  ('valine blocks', 0.1736),\n",
       "  ('pentylenetetrazole enhanced', 0.1667),\n",
       "  ('methyl ester', 0.1643),\n",
       "  ('drug', 0.1589),\n",
       "  ('causing significant', 0.1465),\n",
       "  ('simulated equimolar', 0.1388),\n",
       "  ('levels', 0.1365),\n",
       "  ('enhanced effect', 0.1245),\n",
       "  ('sale food', 0.1237),\n",
       "  ('inhaled', 0.123),\n",
       "  ('neurologic effects', 0.1222),\n",
       "  ('humans frequency', 0.0983),\n",
       "  ('inhaled fluorothyl', 0.092),\n",
       "  ('suggest people', 0.0727),\n",
       "  ('large number', 0.0723),\n",
       "  ('simulated', 0.0493),\n",
       "  ('conceiveably', 0.0459),\n",
       "  ('electroconvulsive', 0.0284),\n",
       "  ('entry brain', 0.0246),\n",
       "  ('association', 0.0146),\n",
       "  ('mice', 0.003),\n",
       "  ('safety research', -0.0115),\n",
       "  ('conduct mandated', -0.0576),\n",
       "  ('blocked concurrent', -0.0589)],\n",
       " 'MED-1624': [('effects aspartame', 0.6646),\n",
       "  ('sweetener aspartame', 0.6065),\n",
       "  ('aspartame long', 0.5521),\n",
       "  ('50 aspartic', 0.4785),\n",
       "  ('asparagines', 0.4267),\n",
       "  ('nervous glutamate', 0.3453),\n",
       "  ('sweetener', 0.3343),\n",
       "  ('phenylalanine 50', 0.3271),\n",
       "  ('neurotransmitter regulation', 0.3271),\n",
       "  ('acid thought', 0.3186),\n",
       "  ('glutamine formed', 0.2973),\n",
       "  ('dopamine aim', 0.2788),\n",
       "  ('include norepinephrine', 0.278),\n",
       "  ('behavioural disturbances', 0.2703),\n",
       "  ('toxic derivatives', 0.2685),\n",
       "  ('diketopiperazine', 0.2327),\n",
       "  ('acid 40', 0.2221),\n",
       "  ('use artificial', 0.2129),\n",
       "  ('disorders dsm', 0.211),\n",
       "  ('formate excreted', 0.2105),\n",
       "  ('ingestion involved', 0.1982),\n",
       "  ('thought play', 0.192),\n",
       "  ('neurological effects', 0.1838),\n",
       "  ('propose excessive', 0.1739),\n",
       "  ('brain concentrations', 0.1434),\n",
       "  ('methanol forms', 0.1398),\n",
       "  ('forms 10', 0.1315),\n",
       "  ('2000 compromised', 0.1258),\n",
       "  ('emotional functioning', 0.1214),\n",
       "  ('long contemplated', 0.1144),\n",
       "  ('concerned negative', 0.1083),\n",
       "  ('insomnia', 0.0988),\n",
       "  ('cellular effects', 0.0978),\n",
       "  ('plays important', 0.0975),\n",
       "  ('various researchers', 0.0946),\n",
       "  ('rise formaldehyde', 0.0934),\n",
       "  ('compromised learning', 0.0652),\n",
       "  ('sensitive individuals', 0.0643),\n",
       "  ('previously reported', 0.0613),\n",
       "  ('product', 0.0579),\n",
       "  ('converted body', 0.0552),\n",
       "  ('pathogenesis certain', 0.0515),\n",
       "  ('excitatory', 0.0413),\n",
       "  ('accredited changes', 0.0018),\n",
       "  ('iv tr', -0.0047),\n",
       "  ('discuss direct', -0.0074),\n",
       "  ('changes regional', -0.01),\n",
       "  ('aim study', -0.0113),\n",
       "  ('number highly', -0.0394),\n",
       "  ('broken', -0.0589)],\n",
       " 'MED-1625': [('consume sugar', 0.6983),\n",
       "  ('excessive sugar', 0.6781),\n",
       "  ('sugar inseparable', 0.6707),\n",
       "  ('sugar substitutes', 0.6454),\n",
       "  ('sweeteners cause', 0.6149),\n",
       "  ('artificial sweeteners', 0.5145),\n",
       "  ('sweetened', 0.493),\n",
       "  ('sweetener safety', 0.4484),\n",
       "  ('inseparable food', 0.421),\n",
       "  ('consume', 0.3093),\n",
       "  ('taste usually', 0.3014),\n",
       "  ('health controversy', 0.2444),\n",
       "  ('controversial suggestions', 0.2433),\n",
       "  ('substances conclusions', 0.2257),\n",
       "  ('diseases artificial', 0.2232),\n",
       "  ('suggestions excessive', 0.2134),\n",
       "  ('degenerative diseases', 0.2025),\n",
       "  ('waistline controversial', 0.1953),\n",
       "  ('conditions unsafe', 0.1921),\n",
       "  ('substitutes', 0.1849),\n",
       "  ('consumers', 0.1826),\n",
       "  ('perceived benefits', 0.1749),\n",
       "  ('carried substances', 0.1748),\n",
       "  ('weight gain', 0.1605),\n",
       "  ('effects including', 0.1603),\n",
       "  ('products continue', 0.1589),\n",
       "  ('teeth', 0.1493),\n",
       "  ('opposing results', 0.1396),\n",
       "  ('energy', 0.1387),\n",
       "  ('views issue', 0.1217),\n",
       "  ('kind health', 0.1177),\n",
       "  ('carcinogenicity', 0.1101),\n",
       "  ('supporting studies', 0.1098),\n",
       "  ('issue artificial', 0.1089),\n",
       "  ('bladder cancer', 0.0858),\n",
       "  ('widely referenced', 0.059),\n",
       "  ('scientists divided', 0.0588),\n",
       "  ('play important', 0.0368),\n",
       "  ('dose scientists', 0.0326),\n",
       "  ('humans large', 0.0313),\n",
       "  ('duplicates effect', 0.0313),\n",
       "  ('cause', 0.0229),\n",
       "  ('brain tumors', 0.0189),\n",
       "  ('aims explore', 0.0112),\n",
       "  ('dismissed review', -0.0024),\n",
       "  ('noted humans', -0.0024),\n",
       "  ('animal', -0.0131),\n",
       "  ('ranging safe', -0.0158),\n",
       "  ('scientific lay', -0.0165),\n",
       "  ('attract', -0.0958)],\n",
       " 'MED-1626': [('depression individuals', 0.4981),\n",
       "  ('mood disorders', 0.4724),\n",
       "  ('effects aspartame', 0.4492),\n",
       "  ('depression similar', 0.3975),\n",
       "  ('study severity', 0.3759),\n",
       "  ('disorders particularly', 0.3676),\n",
       "  ('adverse effects', 0.3612),\n",
       "  ('completed study', 0.3324),\n",
       "  ('psychiatric history', 0.321),\n",
       "  ('depression crossover', 0.3116),\n",
       "  ('halted institutional', 0.3022),\n",
       "  ('aspartame 30', 0.2975),\n",
       "  ('severity symptoms', 0.2961),\n",
       "  ('vulnerable adverse', 0.2794),\n",
       "  ('study designed', 0.2741),\n",
       "  ('aspartame placebo', 0.2538),\n",
       "  ('review board', 0.2396),\n",
       "  ('reactions group', 0.2363),\n",
       "  ('40 patients', 0.2333),\n",
       "  ('effects', 0.2211),\n",
       "  ('placebo days', 0.2187),\n",
       "  ('13 individuals', 0.2148),\n",
       "  ('protocol required', 0.2079),\n",
       "  ('group patients', 0.2047),\n",
       "  ('small significant', 0.1975),\n",
       "  ('mood', 0.1942),\n",
       "  ('individuals completed', 0.1914),\n",
       "  ('patients history', 0.1875),\n",
       "  ('recruitment', 0.1783),\n",
       "  ('ascertain individuals', 0.1749),\n",
       "  ('days despite', 0.1675),\n",
       "  ('population discouraged', 0.1637),\n",
       "  ('project', 0.163),\n",
       "  ('number individuals', 0.1622),\n",
       "  ('institutional', 0.1579),\n",
       "  ('subjects', 0.1576),\n",
       "  ('sensitive', 0.1521),\n",
       "  ('use population', 0.1458),\n",
       "  ('mg kg', 0.1365),\n",
       "  ('30', 0.1325),\n",
       "  ('total', 0.1226),\n",
       "  ('sweetener use', 0.121),\n",
       "  ('history conclude', 0.1196),\n",
       "  ('unipolar', 0.117),\n",
       "  ('similar', 0.1005),\n",
       "  ('significant difference', 0.0884),\n",
       "  ('day', 0.0752),\n",
       "  ('received', 0.0702),\n",
       "  ('crossover', 0.0373),\n",
       "  ('artificial', 0.0296)],\n",
       " 'MED-1627': [('beverages assessed', 0.584),\n",
       "  ('analyses drinkers', 0.5625),\n",
       "  ('soft drinks', 0.456),\n",
       "  ('reported depression', 0.4186),\n",
       "  ('nondrinkers drinking', 0.411),\n",
       "  ('drinking coffee', 0.3908),\n",
       "  ('frequent consumption', 0.3674),\n",
       "  ('cups day', 0.359),\n",
       "  ('drinks 25', 0.3421),\n",
       "  ('drinks 91', 0.3371),\n",
       "  ('alcoholic', 0.3051),\n",
       "  ('associations observed', 0.2737),\n",
       "  ('1995 1996', 0.273),\n",
       "  ('95 ci', 0.2708),\n",
       "  ('odds ratios', 0.2699),\n",
       "  ('92 diet', 0.2411),\n",
       "  ('iced tea', 0.2366),\n",
       "  ('consumed non', 0.2225),\n",
       "  ('risks frequent', 0.2191),\n",
       "  ('artificial sweeteners', 0.2015),\n",
       "  ('65 fruit', 0.1977),\n",
       "  ('94 83', 0.195),\n",
       "  ('important health', 0.1877),\n",
       "  ('stratified analyses', 0.1713),\n",
       "  ('study', 0.1705),\n",
       "  ('15', 0.1618),\n",
       "  ('associated lower', 0.1487),\n",
       "  ('various types', 0.1429),\n",
       "  ('consequences prospectively', 0.1277),\n",
       "  ('03 45', 0.1276),\n",
       "  ('2000 263', 0.1238),\n",
       "  ('41 diet', 0.1123),\n",
       "  ('null associations', 0.1111),\n",
       "  ('finally compared', 0.1066),\n",
       "  ('38', 0.1062),\n",
       "  ('ci derived', 0.106),\n",
       "  ('day 30', 0.0921),\n",
       "  ('cans', 0.0904),\n",
       "  ('trend 0001', 0.0897),\n",
       "  ('nih aarp', 0.0807),\n",
       "  ('22 03', 0.0807),\n",
       "  ('17', 0.0739),\n",
       "  ('honey', 0.0684),\n",
       "  ('versus regular', 0.0653),\n",
       "  ('derived multivariate', 0.0647),\n",
       "  ('older adults', 0.0609),\n",
       "  ('relation self', 0.0093),\n",
       "  ('soft', -0.0026),\n",
       "  ('higher', -0.01),\n",
       "  ('10', -0.0439)],\n",
       " 'MED-1628': [('implicated coffee', 0.6156),\n",
       "  ('coffee drinking', 0.6056),\n",
       "  ('coffee drinkers', 0.5839),\n",
       "  ('daily coffee', 0.5561),\n",
       "  ('heavy coffee', 0.4933),\n",
       "  ('coffee', 0.4876),\n",
       "  ('213 suicides', 0.4233),\n",
       "  ('drinkers cups', 0.374),\n",
       "  ('drinking possible', 0.3448),\n",
       "  ('drinking shaped', 0.3307),\n",
       "  ('cups day', 0.3253),\n",
       "  ('drinkers', 0.3148),\n",
       "  ('moderate drinkers', 0.3124),\n",
       "  ('cox model', 0.3081),\n",
       "  ('years 213', 0.2993),\n",
       "  ('suicides committed', 0.2641),\n",
       "  ('potential covariates', 0.2566),\n",
       "  ('43 166', 0.2396),\n",
       "  ('suicide followed', 0.2309),\n",
       "  ('suicide using', 0.2264),\n",
       "  ('risk suicide', 0.2221),\n",
       "  ('cox', 0.2068),\n",
       "  ('committed', 0.1899),\n",
       "  ('association risk', 0.1892),\n",
       "  ('166 subjects', 0.183),\n",
       "  ('followed 43', 0.178),\n",
       "  ('research implicated', 0.1723),\n",
       "  ('possible protective', 0.1648),\n",
       "  ('14 years', 0.1583),\n",
       "  ('covariates heavy', 0.1418),\n",
       "  ('committed daily', 0.1258),\n",
       "  ('compared moderate', 0.117),\n",
       "  ('controlled', 0.1127),\n",
       "  ('implicated', 0.1059),\n",
       "  ('followed', 0.0917),\n",
       "  ('possible', 0.0868),\n",
       "  ('earlier research', 0.0803),\n",
       "  ('day risk', 0.0793),\n",
       "  ('mean', 0.0741),\n",
       "  ('suicide 58', 0.0728),\n",
       "  ('shaped association', 0.0702),\n",
       "  ('using', 0.0682),\n",
       "  ('compared', 0.0662),\n",
       "  ('subjects mean', 0.0655),\n",
       "  ('shaped', 0.0602),\n",
       "  ('model', 0.0439),\n",
       "  ('higher', 0.0412),\n",
       "  ('years', 0.0135),\n",
       "  ('58 higher', 0.0129),\n",
       "  ('earlier', -0.0093)],\n",
       " 'MED-1630': [('aspartame consumption', 0.6592),\n",
       "  ('low aspartame', 0.569),\n",
       "  ('aspartame remains', 0.5479),\n",
       "  ('artificial sweetener', 0.4656),\n",
       "  ('food additives', 0.4381),\n",
       "  ('daily intake', 0.4267),\n",
       "  ('diets examined', 0.3903),\n",
       "  ('adults consumed', 0.3902),\n",
       "  ('consuming food', 0.3535),\n",
       "  ('controversial food', 0.3367),\n",
       "  ('additives mixed', 0.3316),\n",
       "  ('depression scales', 0.2891),\n",
       "  ('neurobehavioral effects', 0.2481),\n",
       "  ('warranted consuming', 0.2467),\n",
       "  ('mixed evidence', 0.2382),\n",
       "  ('25 mg', 0.2352),\n",
       "  ('consuming high', 0.2293),\n",
       "  ('healthy adults', 0.2243),\n",
       "  ('acceptable daily', 0.2095),\n",
       "  ('days low', 0.2059),\n",
       "  ('products affect', 0.2059),\n",
       "  ('kg body', 0.1945),\n",
       "  ('use artificial', 0.1934),\n",
       "  ('participants irritable', 0.1772),\n",
       "  ('consumption did', 0.1725),\n",
       "  ('consumed study', 0.1691),\n",
       "  ('scales cognitive', 0.1669),\n",
       "  ('10 mg', 0.1524),\n",
       "  ('remains controversial', 0.1322),\n",
       "  ('widespread use', 0.1268),\n",
       "  ('week washout', 0.1252),\n",
       "  ('remains', 0.1089),\n",
       "  ('memory spatial', 0.1082),\n",
       "  ('despite widespread', 0.1049),\n",
       "  ('mood exhibited', 0.1048),\n",
       "  ('differences', 0.0983),\n",
       "  ('measures included', 0.0846),\n",
       "  ('performed worse', 0.0608),\n",
       "  ('level', 0.0478),\n",
       "  ('did influence', 0.0473),\n",
       "  ('headache measures', 0.0456),\n",
       "  ('containing', 0.0409),\n",
       "  ('health 2014', 0.04),\n",
       "  ('consideration warranted', 0.0277),\n",
       "  ('level 40', 0.0259),\n",
       "  ('tested maximum', 0.0122),\n",
       "  ('orientation tests', -0.0239),\n",
       "  ('50', -0.0289),\n",
       "  ('wiley periodicals', -0.0528),\n",
       "  ('working', -0.0843)],\n",
       " 'MED-1631': [('coffee studies', 0.5839),\n",
       "  ('caffeine consumption', 0.5543),\n",
       "  ('women consuming', 0.3839),\n",
       "  ('739 women', 0.3471),\n",
       "  ('antidepressant use', 0.3462),\n",
       "  ('free depressive', 0.3366),\n",
       "  ('usual caffeinated', 0.3351),\n",
       "  ('consumption depression', 0.3251),\n",
       "  ('consumption investigations', 0.3076),\n",
       "  ('beverages obtained', 0.3057),\n",
       "  ('compared women', 0.2996),\n",
       "  ('cups 80', 0.2907),\n",
       "  ('cup wk', 0.2614),\n",
       "  ('scarce methods', 0.2609),\n",
       "  ('studies analyzed', 0.2565),\n",
       "  ('63 years', 0.2325),\n",
       "  ('75', 0.2236),\n",
       "  ('ci 64', 0.2006),\n",
       "  ('consumption year', 0.1921),\n",
       "  ('stimulant', 0.1863),\n",
       "  ('symptoms', 0.1858),\n",
       "  ('baseline 1996', 0.1803),\n",
       "  ('methods total', 0.1746),\n",
       "  ('550 mg', 0.153),\n",
       "  ('risk scarce', 0.1495),\n",
       "  ('95 confidence', 0.1483),\n",
       "  ('68', 0.1483),\n",
       "  ('total 50', 0.1446),\n",
       "  ('computed cumulative', 0.142),\n",
       "  ('100 mg', 0.1415),\n",
       "  ('used central', 0.1036),\n",
       "  ('investigations needed', 0.102),\n",
       "  ('99 trend', 0.0983),\n",
       "  ('validated questionnaires', 0.097),\n",
       "  ('prospectively followed', 0.0945),\n",
       "  ('607 incident', 0.0941),\n",
       "  ('applied clinical', 0.0912),\n",
       "  ('models results', 0.0908),\n",
       "  ('conclusions large', 0.0788),\n",
       "  ('mg vs', 0.0724),\n",
       "  ('cox proportional', 0.0636),\n",
       "  ('wk multivariate', 0.0627),\n",
       "  ('world widely', 0.0622),\n",
       "  ('decreases increasing', 0.0602),\n",
       "  ('use relative', 0.0589),\n",
       "  ('1980 2002', 0.0547),\n",
       "  ('decaffeinated', 0.0522),\n",
       "  ('latency applied', 0.0445),\n",
       "  ('mean age', 0.0431),\n",
       "  ('contribute', -0.0175)],\n",
       " 'MED-1634': [('disease registries', 0.5587),\n",
       "  ('data standardization', 0.5183),\n",
       "  ('registries task', 0.4887),\n",
       "  ('registries', 0.4638),\n",
       "  ('inventory cardiovascular', 0.4441),\n",
       "  ('standardization', 0.4192),\n",
       "  ('cardiovascular disease', 0.3823),\n",
       "  ('esc create', 0.3336),\n",
       "  ('task force', 0.295),\n",
       "  ('cardiovascular', 0.2925),\n",
       "  ('esc', 0.2439),\n",
       "  ('create inventory', 0.2059),\n",
       "  ('force data', 0.183),\n",
       "  ('data', 0.1772),\n",
       "  ('inventory', 0.1497),\n",
       "  ('create', 0.1401),\n",
       "  ('disease', 0.0954),\n",
       "  ('force', 0.0467),\n",
       "  ('task', 0.039)],\n",
       " 'MED-1635': [('effects tea', 0.5826),\n",
       "  ('endothelial function', 0.4398),\n",
       "  ('reduced risk', 0.3742),\n",
       "  ('intervention studies', 0.3281),\n",
       "  ('overall effect', 0.3236),\n",
       "  ('mediated dilation', 0.3047),\n",
       "  ('performed meta', 0.2949),\n",
       "  ('cardiovascular events', 0.2913),\n",
       "  ('direct effects', 0.2736),\n",
       "  ('brachial artery', 0.2685),\n",
       "  ('including stroke', 0.2574),\n",
       "  ('drinkers', 0.2486),\n",
       "  ('treatment characteristics', 0.2477),\n",
       "  ('total studies', 0.2468),\n",
       "  ('fmd intake', 0.2381),\n",
       "  ('study arms', 0.231),\n",
       "  ('provide mechanistic', 0.2106),\n",
       "  ('heterogeneity studies', 0.207),\n",
       "  ('consumption associated', 0.2013),\n",
       "  ('suggested associated', 0.198),\n",
       "  ('95', 0.1856),\n",
       "  ('disease including', 0.1829),\n",
       "  ('model used', 0.1725),\n",
       "  ('bias conclusion', 0.172),\n",
       "  ('experimental variable', 0.1609),\n",
       "  ('explained cuff', 0.1436),\n",
       "  ('ci value', 0.1415),\n",
       "  ('objective', 0.1369),\n",
       "  ('embase chemical', 0.1345),\n",
       "  ('flow', 0.1149),\n",
       "  ('various subject', 0.1048),\n",
       "  ('median', 0.1028),\n",
       "  ('position distal', 0.098),\n",
       "  ('included 15', 0.0978),\n",
       "  ('cups relative', 0.0923),\n",
       "  ('controlled human', 0.0761),\n",
       "  ('baseline conditions', 0.0737),\n",
       "  ('biosis', 0.0732),\n",
       "  ('variable placebo', 0.0625),\n",
       "  ('40 compared', 0.0587),\n",
       "  ('searching', 0.0579),\n",
       "  ('vs', 0.0569),\n",
       "  ('2009', 0.0565),\n",
       "  ('march', 0.0547),\n",
       "  ('presence', 0.05),\n",
       "  ('missing data', 0.0443),\n",
       "  ('substantially enhances', 0.0426),\n",
       "  ('groups', 0.0043),\n",
       "  ('daily', -0.0044),\n",
       "  ('500 ml', -0.0267)],\n",
       " 'MED-1636': [('trials coffee', 0.5705),\n",
       "  ('published trials', 0.475),\n",
       "  ('trials caffeinated', 0.462),\n",
       "  ('hyperlipidemia trials', 0.4286),\n",
       "  ('filtered coffee', 0.4042),\n",
       "  ('total cholesterol', 0.4018),\n",
       "  ('literature published', 0.3909),\n",
       "  ('medline search', 0.3838),\n",
       "  ('studies', 0.3785),\n",
       "  ('bibliography review', 0.3774),\n",
       "  ('pooling results', 0.3492),\n",
       "  ('reviewers', 0.3446),\n",
       "  ('14 published', 0.3275),\n",
       "  ('review consultations', 0.3221),\n",
       "  ('studies patients', 0.3104),\n",
       "  ('standardized protocol', 0.2949),\n",
       "  ('information abstracted', 0.2924),\n",
       "  ('levels studies', 0.2921),\n",
       "  ('effects estimated', 0.2652),\n",
       "  ('hyperlipidemia', 0.263),\n",
       "  ('caffeinated', 0.2589),\n",
       "  ('drinking associated', 0.2502),\n",
       "  ('individual trials', 0.2427),\n",
       "  ('search english', 0.2395),\n",
       "  ('greater studies', 0.2369),\n",
       "  ('1998 bibliography', 0.2358),\n",
       "  ('language literature', 0.2331),\n",
       "  ('experts performed', 0.2264),\n",
       "  ('consumption information', 0.2264),\n",
       "  ('using filtered', 0.2024),\n",
       "  ('total variance', 0.1928),\n",
       "  ('dose response', 0.1911),\n",
       "  ('published prior', 0.19),\n",
       "  ('lipids', 0.1699),\n",
       "  ('performed identify', 0.1688),\n",
       "  ('model treatment', 0.1492),\n",
       "  ('results inverse', 0.1395),\n",
       "  ('december 1998', 0.1367),\n",
       "  ('response relation', 0.1283),\n",
       "  ('weighting', 0.1209),\n",
       "  ('using', 0.1162),\n",
       "  ('results individual', 0.0953),\n",
       "  ('associated increased', 0.0842),\n",
       "  ('identified 01', 0.0812),\n",
       "  ('little increase', 0.0723),\n",
       "  ('consumption unfiltered', 0.0491),\n",
       "  ('random', 0.0323),\n",
       "  ('increase serum', 0.0236),\n",
       "  ('boiled', 0.0203),\n",
       "  ('independently', 0.0127)],\n",
       " 'MED-1637': [('effects tea', 0.5734),\n",
       "  ('tea coronary', 0.5711),\n",
       "  ('black tea', 0.5142),\n",
       "  ('caffeine coronary', 0.439),\n",
       "  ('echocardiography ttde', 0.3134),\n",
       "  ('studies suggest', 0.3114),\n",
       "  ('coronary artery', 0.311),\n",
       "  ('epidemiologic studies', 0.3086),\n",
       "  ('cardiovascular events', 0.301),\n",
       "  ('crossover study', 0.2828),\n",
       "  ('evaluate effects', 0.2825),\n",
       "  ('beverage consumption', 0.2687),\n",
       "  ('decreases risk', 0.2667),\n",
       "  ('purpose study', 0.2557),\n",
       "  ('effect interaction', 0.2532),\n",
       "  ('consumption decreases', 0.1986),\n",
       "  ('ttde double', 0.197),\n",
       "  ('infusion ttde', 0.19),\n",
       "  ('using transthoracic', 0.1884),\n",
       "  ('consumption 001', 0.1859),\n",
       "  ('double blind', 0.1747),\n",
       "  ('consumption data', 0.168),\n",
       "  ('group black', 0.16),\n",
       "  ('reserve cfvr', 0.1589),\n",
       "  ('circulation purpose', 0.1571),\n",
       "  ('08 002', 0.1504),\n",
       "  ('flow velocity', 0.1467),\n",
       "  ('consumption improves', 0.1428),\n",
       "  ('conducted compare', 0.1357),\n",
       "  ('18', 0.131),\n",
       "  ('vs 04', 0.1213),\n",
       "  ('baseline hyperemia', 0.1051),\n",
       "  ('function determined', 0.0976),\n",
       "  ('type group', 0.0944),\n",
       "  ('significantly', 0.0898),\n",
       "  ('examining', 0.0897),\n",
       "  ('data divided', 0.0846),\n",
       "  ('variance showed', 0.0821),\n",
       "  ('way', 0.0737),\n",
       "  ('defined ratio', 0.0698),\n",
       "  ('clinical report', 0.0536),\n",
       "  ('vs 0001', 0.0502),\n",
       "  ('volunteers conducted', 0.0447),\n",
       "  ('vs', 0.0398),\n",
       "  ('adenosine', 0.0374),\n",
       "  ('larger', 0.0218),\n",
       "  ('triphosphate', 0.0095),\n",
       "  ('10 healthy', -0.0536),\n",
       "  ('left anterior', -0.0921),\n",
       "  ('male', -0.1082)],\n",
       " 'MED-1638': [('caffeine endothelial', 0.6068),\n",
       "  ('cells ecs', 0.5838),\n",
       "  ('reendothelialization caffeine', 0.5774),\n",
       "  ('endothelial progenitor', 0.5708),\n",
       "  ('epcs mature', 0.5164),\n",
       "  ('endothelial repair', 0.5114),\n",
       "  ('ecs patients', 0.5097),\n",
       "  ('improved endothelial', 0.4953),\n",
       "  ('endothelial damage', 0.4524),\n",
       "  ('prerequisite endothelial', 0.4434),\n",
       "  ('challenged reendothelialization', 0.3838),\n",
       "  ('reendothelialization ampk', 0.3559),\n",
       "  ('epcs decaffeinated', 0.3395),\n",
       "  ('ecs depleted', 0.3336),\n",
       "  ('patients coronary', 0.3282),\n",
       "  ('physiologically relevant', 0.3158),\n",
       "  ('cells', 0.2942),\n",
       "  ('migration human', 0.287),\n",
       "  ('artery disease', 0.2695),\n",
       "  ('denudation carotid', 0.2384),\n",
       "  ('decaffeinated coffee', 0.2171),\n",
       "  ('conclusions results', 0.1938),\n",
       "  ('did migrate', 0.1937),\n",
       "  ('concentrations 50', 0.1924),\n",
       "  ('micromol 23', 0.1906),\n",
       "  ('mature', 0.1816),\n",
       "  ('role mitochondria', 0.1764),\n",
       "  ('patient derived', 0.1636),\n",
       "  ('model improved', 0.1462),\n",
       "  ('damage methods', 0.1414),\n",
       "  ('repair', 0.1414),\n",
       "  ('significant increase', 0.1409),\n",
       "  ('denuding injury', 0.1408),\n",
       "  ('100 micromol', 0.1263),\n",
       "  ('cad', 0.1257),\n",
       "  ('suggesting beneficial', 0.1227),\n",
       "  ('activity patient', 0.1118),\n",
       "  ('objective', 0.1094),\n",
       "  ('capacity', 0.1021),\n",
       "  ('bone marrow', 0.1004),\n",
       "  ('animals transplantation', 0.0981),\n",
       "  ('induces', 0.0936),\n",
       "  ('treatment', 0.0785),\n",
       "  ('coinciding', 0.0706),\n",
       "  ('mouse model', 0.0667),\n",
       "  ('10 days', 0.0659),\n",
       "  ('dna did', 0.0509),\n",
       "  ('reduced ampk', 0.0231),\n",
       "  ('difference', 0.0043),\n",
       "  ('wild type', -0.0511)],\n",
       " 'MED-1639': [('caffeine ingestion', 0.5276),\n",
       "  ('coffee widely', 0.4549),\n",
       "  ('comparisons aspirin', 0.3728),\n",
       "  ('dyslipidemic smoked', 0.3588),\n",
       "  ('impact cardiovascular', 0.3382),\n",
       "  ('compared controls', 0.3298),\n",
       "  ('subjects cad', 0.3192),\n",
       "  ('artery disease', 0.3152),\n",
       "  ('beverage impact', 0.305),\n",
       "  ('statins significantly', 0.2766),\n",
       "  ('hypertensive obese', 0.2733),\n",
       "  ('baseline fmd', 0.2613),\n",
       "  ('fmd patients', 0.2428),\n",
       "  ('plasma markers', 0.2334),\n",
       "  ('participants underwent', 0.2129),\n",
       "  ('fmd nitroglycerin', 0.2031),\n",
       "  ('discontinuation medications', 0.1835),\n",
       "  ('clopidogrel angiotensin', 0.1817),\n",
       "  ('reactive protein', 0.1803),\n",
       "  ('pharmacologically active', 0.1797),\n",
       "  ('placebo hour', 0.1791),\n",
       "  ('inflammation copyright', 0.1788),\n",
       "  ('controversial', 0.1613),\n",
       "  ('fmd 40', 0.1594),\n",
       "  ('capsules', 0.1593),\n",
       "  ('explore effect', 0.1567),\n",
       "  ('common patients', 0.1558),\n",
       "  ('flow mediated', 0.1525),\n",
       "  ('assessed brachial', 0.1457),\n",
       "  ('fasting', 0.1442),\n",
       "  ('mg 001', 0.1414),\n",
       "  ('separate mornings', 0.1343),\n",
       "  ('dilation', 0.1223),\n",
       "  ('converting enzyme', 0.1069),\n",
       "  ('01 comparisons', 0.1053),\n",
       "  ('gender', 0.1047),\n",
       "  ('ntg patients', 0.1046),\n",
       "  ('200 mg', 0.0941),\n",
       "  ('resolution ultrasound', 0.0924),\n",
       "  ('significantly decreased', 0.0921),\n",
       "  ('conclusion acute', 0.0895),\n",
       "  ('week weeks', 0.0722),\n",
       "  ('prospectively assessed', 0.0709),\n",
       "  ('vs 18', 0.0421),\n",
       "  ('widely used', 0.0383),\n",
       "  ('12 hours', 0.0371),\n",
       "  ('using high', 0.0316),\n",
       "  ('vs 14', -0.0163),\n",
       "  ('rights reserved', -0.0266),\n",
       "  ('2011 elsevier', -0.0344)],\n",
       " 'MED-1640': [('coffee drinkers', 0.6534),\n",
       "  ('caffeine studied', 0.5629),\n",
       "  ('coffee widely', 0.5285),\n",
       "  ('decaffeinated coffee', 0.4445),\n",
       "  ('active beverages', 0.4353),\n",
       "  ('caffeine separate', 0.4259),\n",
       "  ('07 caffeinated', 0.4218),\n",
       "  ('drinkers endothelial', 0.4),\n",
       "  ('ingestion cup', 0.3724),\n",
       "  ('17 healthy', 0.2978),\n",
       "  ('min ingestion', 0.2905),\n",
       "  ('healthy individuals', 0.2461),\n",
       "  ('young adults', 0.2413),\n",
       "  ('pharmacologically active', 0.2207),\n",
       "  ('120 min', 0.2195),\n",
       "  ('endothelial function', 0.2158),\n",
       "  ('min 001', 0.1854),\n",
       "  ('baseline fmd', 0.1852),\n",
       "  ('study designed', 0.1793),\n",
       "  ('consumed time', 0.1774),\n",
       "  ('significant effect', 0.1592),\n",
       "  ('fmd 78', 0.1571),\n",
       "  ('60 min', 0.156),\n",
       "  ('001 adverse', 0.1403),\n",
       "  ('men regular', 0.137),\n",
       "  ('widely used', 0.1367),\n",
       "  ('young', 0.1362),\n",
       "  ('90', 0.1336),\n",
       "  ('separate sessions', 0.1288),\n",
       "  ('non heavy', 0.1145),\n",
       "  ('baseline 30', 0.1126),\n",
       "  ('fmd decaffeinated', 0.1062),\n",
       "  ('flow', 0.0968),\n",
       "  ('80 mg', 0.096),\n",
       "  ('single', 0.0946),\n",
       "  ('evaluate acute', 0.0932),\n",
       "  ('12', 0.0813),\n",
       "  ('values', 0.0784),\n",
       "  ('exerts', 0.0695),\n",
       "  ('lasting', 0.0631),\n",
       "  ('mg', 0.0621),\n",
       "  ('24 21', 0.0616),\n",
       "  ('performance', 0.059),\n",
       "  ('composite', 0.0538),\n",
       "  ('44 57', 0.0497),\n",
       "  ('dilatation', 0.0193),\n",
       "  ('different 021', 0.0055),\n",
       "  ('respectively ns', -0.0247),\n",
       "  ('led decline', -0.0353),\n",
       "  ('blind cross', -0.0409)],\n",
       " 'MED-1641': [('coffee myocardial', 0.6228),\n",
       "  ('background caffeine', 0.607),\n",
       "  ('mbf coronary', 0.4478),\n",
       "  ('caffeine decreased', 0.4414),\n",
       "  ('effect myocardial', 0.3925),\n",
       "  ('15o labelled', 0.3074),\n",
       "  ('mbf assessed', 0.3004),\n",
       "  ('impairs exercise', 0.2842),\n",
       "  ('repeated minutes', 0.277),\n",
       "  ('perfusion reserve', 0.2538),\n",
       "  ('artery disease', 0.2477),\n",
       "  ('pharmacologically active', 0.2428),\n",
       "  ('corresponding cups', 0.24),\n",
       "  ('baseline cad', 0.2325),\n",
       "  ('aim', 0.2083),\n",
       "  ('subtended stenotic', 0.2054),\n",
       "  ('mpr decreased', 0.2037),\n",
       "  ('labelled h2o', 0.1941),\n",
       "  ('assess acute', 0.1915),\n",
       "  ('widely unknown', 0.182),\n",
       "  ('patients 15', 0.1796),\n",
       "  ('bicycle', 0.1699),\n",
       "  ('mg', 0.168),\n",
       "  ('stress divided', 0.1609),\n",
       "  ('patients mpr', 0.1567),\n",
       "  ('hyperaemic', 0.146),\n",
       "  ('flow', 0.1381),\n",
       "  ('emission tomography', 0.1342),\n",
       "  ('78', 0.1282),\n",
       "  ('rest resting', 0.1181),\n",
       "  ('widely consumed', 0.1176),\n",
       "  ('methodology principal', 0.1152),\n",
       "  ('18 05', 0.1089),\n",
       "  ('calculated ratio', 0.0957),\n",
       "  ('subtended', 0.068),\n",
       "  ('segments 01', 0.0671),\n",
       "  ('200 mg', 0.0662),\n",
       "  ('mean age', 0.0625),\n",
       "  ('segments 90', 0.0564),\n",
       "  ('oral', 0.0531),\n",
       "  ('matched controls', 0.0405),\n",
       "  ('25', 0.0382),\n",
       "  ('30 001', 0.0296),\n",
       "  ('groups', 0.0215),\n",
       "  ('56 vs', 0.0045),\n",
       "  ('70 vs', -0.0016),\n",
       "  ('vs 02', -0.01),\n",
       "  ('61 years', -0.0166),\n",
       "  ('remote 40', -0.027),\n",
       "  ('13 years', -0.0272)],\n",
       " 'MED-1642': [('decaffeinated coffee', 0.6029),\n",
       "  ('coffee subjects', 0.5797),\n",
       "  ('blunted caffeine', 0.5783),\n",
       "  ('coffee endothelial', 0.5663),\n",
       "  ('caffeine unfavorably', 0.5006),\n",
       "  ('caffeinated', 0.3972),\n",
       "  ('contain antioxidant', 0.3751),\n",
       "  ('effects blunted', 0.3715),\n",
       "  ('ingestion cups', 0.3625),\n",
       "  ('affect cardiovascular', 0.3545),\n",
       "  ('mediated dilation', 0.3456),\n",
       "  ('lower cup', 0.3032),\n",
       "  ('substances effects', 0.2858),\n",
       "  ('endothelial function', 0.2857),\n",
       "  ('dc min', 0.2835),\n",
       "  ('decaffeinated espresso', 0.2714),\n",
       "  ('investigate effects', 0.2696),\n",
       "  ('effect blood', 0.2595),\n",
       "  ('fmd subjects', 0.252),\n",
       "  ('background objectives', 0.2342),\n",
       "  ('compared consumption', 0.2337),\n",
       "  ('chronic use', 0.2267),\n",
       "  ('did differ', 0.2153),\n",
       "  ('dose dependent', 0.2015),\n",
       "  ('treatment effect', 0.1901),\n",
       "  ('subjects methods', 0.1839),\n",
       "  ('function studies', 0.1797),\n",
       "  ('investigate acute', 0.1663),\n",
       "  ('conclusions present', 0.1654),\n",
       "  ('crossover study', 0.1585),\n",
       "  ('measures analysis', 0.1493),\n",
       "  ('mediated', 0.1352),\n",
       "  ('study demonstrated', 0.1272),\n",
       "  ('italian espresso', 0.1256),\n",
       "  ('measured brachial', 0.1255),\n",
       "  ('studies needed', 0.1253),\n",
       "  ('diseases', 0.1253),\n",
       "  ('hour following', 0.1194),\n",
       "  ('group baseline', 0.1125),\n",
       "  ('min 60', 0.0946),\n",
       "  ('known contain', 0.0831),\n",
       "  ('single blind', 0.0766),\n",
       "  ('increased mean', 0.0682),\n",
       "  ('men women', 0.0663),\n",
       "  ('15 men', 0.0639),\n",
       "  ('nonobese', 0.061),\n",
       "  ('037 time', 0.0581),\n",
       "  ('especially respect', 0.0476),\n",
       "  ('basal heart', 0.0406),\n",
       "  ('10 001', 0.019)],\n",
       " 'MED-1643': [('endothelial function', 0.4745),\n",
       "  ('subjects studied', 0.4245),\n",
       "  ('brachial artery', 0.4162),\n",
       "  ('reactive hyperaemia', 0.3815),\n",
       "  ('resting blood', 0.3624),\n",
       "  ('haemodynamic', 0.3584),\n",
       "  ('wine parameters', 0.3555),\n",
       "  ('known cardiovascular', 0.3405),\n",
       "  ('healthy subjects', 0.3367),\n",
       "  ('subjects drank', 0.3351),\n",
       "  ('12 healthy', 0.3149),\n",
       "  ('dilated blood', 0.3032),\n",
       "  ('ultrasound used', 0.3022),\n",
       "  ('alcohol brachial', 0.2939),\n",
       "  ('forearm cuff', 0.2885),\n",
       "  ('heart rate', 0.2813),\n",
       "  ('artery increased', 0.2794),\n",
       "  ('unchanged flow', 0.2788),\n",
       "  ('risk factors', 0.278),\n",
       "  ('250 ml', 0.2649),\n",
       "  ('antioxidant qualities', 0.248),\n",
       "  ('qualities red', 0.2392),\n",
       "  ('parameters unchanged', 0.2217),\n",
       "  ('diameter resting', 0.2129),\n",
       "  ('finished drinking', 0.206),\n",
       "  ('effect flow', 0.2006),\n",
       "  ('occlusion', 0.1834),\n",
       "  ('function methods', 0.1809),\n",
       "  ('dilatation did', 0.1793),\n",
       "  ('according randomized', 0.1734),\n",
       "  ('examine acute', 0.1702),\n",
       "  ('subjects 40', 0.1652),\n",
       "  ('aims', 0.1627),\n",
       "  ('plasma', 0.158),\n",
       "  ('10 min', 0.1388),\n",
       "  ('results high', 0.1362),\n",
       "  ('conclusion ingestion', 0.114),\n",
       "  ('society cardiology', 0.107),\n",
       "  ('60 min', 0.1049),\n",
       "  ('measured 30', 0.1045),\n",
       "  ('time week', 0.1035),\n",
       "  ('changes concealed', 0.1009),\n",
       "  ('2000 european', 0.1006),\n",
       "  ('did', 0.0777),\n",
       "  ('used measure', 0.0691),\n",
       "  ('higher 05', 0.0688),\n",
       "  ('cross', 0.0543),\n",
       "  ('increased changes', 0.0465),\n",
       "  ('second time', 0.0411),\n",
       "  ('years', 0.0134)],\n",
       " 'MED-1645': [('tea cardiovascular', 0.5567),\n",
       "  ('tea beneficial', 0.53),\n",
       "  ('black tea', 0.4922),\n",
       "  ('tea brachial', 0.4469),\n",
       "  ('endothelial function', 0.439),\n",
       "  ('tea 69', 0.4031),\n",
       "  ('artery reactivity', 0.3351),\n",
       "  ('assessed fmd', 0.2881),\n",
       "  ('associated decreased', 0.2862),\n",
       "  ('related coronary', 0.2844),\n",
       "  ('brachial artery', 0.2835),\n",
       "  ('antioxidative capacity', 0.27),\n",
       "  ('factors smoking', 0.2537),\n",
       "  ('caffeine contained', 0.2304),\n",
       "  ('flow mediated', 0.2218),\n",
       "  ('reactivity defined', 0.2055),\n",
       "  ('consumption associated', 0.1798),\n",
       "  ('plasma oxidative', 0.1683),\n",
       "  ('intervention results', 0.1603),\n",
       "  ('background', 0.1554),\n",
       "  ('resting hyperemic', 0.1504),\n",
       "  ('min afterward', 0.1491),\n",
       "  ('studied', 0.1454),\n",
       "  ('black', 0.1415),\n",
       "  ('measured baseline', 0.14),\n",
       "  ('years cardiovascular', 0.1397),\n",
       "  ('took green', 0.1359),\n",
       "  ('risk flow', 0.1333),\n",
       "  ('beneficial', 0.1158),\n",
       "  ('total plasma', 0.1121),\n",
       "  ('mediated', 0.1109),\n",
       "  ('dilatation', 0.0994),\n",
       "  ('did change', 0.0844),\n",
       "  ('il 1b', 0.0824),\n",
       "  ('predictor', 0.0809),\n",
       "  ('water', 0.0658),\n",
       "  ('02 did', 0.0638),\n",
       "  ('125', 0.0637),\n",
       "  ('defined design', 0.0614),\n",
       "  ('status stress', 0.0549),\n",
       "  ('occasions took', 0.0373),\n",
       "  ('72 peak', 0.0351),\n",
       "  ('capacity total', 0.035),\n",
       "  ('function independent', 0.0264),\n",
       "  ('contained', 0.0183),\n",
       "  ('14 healthy', -0.0091),\n",
       "  ('individuals age', -0.0257),\n",
       "  ('50 separate', -0.0293),\n",
       "  ('30 90', -0.0334),\n",
       "  ('increased significantly', -0.0835)],\n",
       " 'MED-1646': [('beverage guidance', 0.7382),\n",
       "  ('beverages panel', 0.6675),\n",
       "  ('literature beverages', 0.5406),\n",
       "  ('guidance panel', 0.5102),\n",
       "  ('panel initiated', 0.5064),\n",
       "  ('soy beverages', 0.3831),\n",
       "  ('author panel', 0.3686),\n",
       "  ('improve health', 0.3559),\n",
       "  ('needs followed', 0.3293),\n",
       "  ('consumption patterns', 0.31),\n",
       "  ('provide', 0.2902),\n",
       "  ('systematically review', 0.2893),\n",
       "  ('deeper dialog', 0.2882),\n",
       "  ('alcohol sports', 0.2693),\n",
       "  ('sweetened', 0.2608),\n",
       "  ('nutrient contents', 0.2528),\n",
       "  ('categories', 0.251),\n",
       "  ('value based', 0.2473),\n",
       "  ('water ranked', 0.2432),\n",
       "  ('community overall', 0.2404),\n",
       "  ('calories precedence', 0.2374),\n",
       "  ('contents related', 0.2365),\n",
       "  ('consumer additional', 0.2274),\n",
       "  ('intake 150', 0.2273),\n",
       "  ('scientific community', 0.2242),\n",
       "  ('potential change', 0.2165),\n",
       "  ('risks', 0.1963),\n",
       "  ('assembled', 0.1923),\n",
       "  ('coffee', 0.1676),\n",
       "  ('low fat', 0.1496),\n",
       "  ('poor', 0.1399),\n",
       "  ('fruit vegetable', 0.1373),\n",
       "  ('different age', 0.137),\n",
       "  ('united states', 0.1309),\n",
       "  ('kcal different', 0.1306),\n",
       "  ('occurred approximately', 0.1275),\n",
       "  ('daily', 0.1195),\n",
       "  ('followed decreasing', 0.11),\n",
       "  ('lowest highest', 0.1078),\n",
       "  ('noncalorically', 0.103),\n",
       "  ('milk', 0.0915),\n",
       "  ('obesity increased', 0.0789),\n",
       "  ('skim', 0.0701),\n",
       "  ('sex groups', 0.0694),\n",
       "  ('relative', 0.0499),\n",
       "  ('ranked preferred', 0.0479),\n",
       "  ('past decades', 0.0414),\n",
       "  ('300', 0.0386),\n",
       "  ('states great', 0.0261),\n",
       "  ('approximately 50', -0.0031)],\n",
       " 'MED-1647': [('tea consumption', 0.5244),\n",
       "  ('endothelial dysfunction', 0.4532),\n",
       "  ('antioxidant flavonoids', 0.3849),\n",
       "  ('decreases cardiovascular', 0.3716),\n",
       "  ('reverses endothelial', 0.3647),\n",
       "  ('studies suggest', 0.3),\n",
       "  ('effect 001', 0.2801),\n",
       "  ('intake decreased', 0.2757),\n",
       "  ('cardiovascular risk', 0.275),\n",
       "  ('dysfunction patients', 0.2487),\n",
       "  ('disease consume', 0.2479),\n",
       "  ('dose caffeine', 0.2357),\n",
       "  ('oxidative', 0.2314),\n",
       "  ('consumption conclusions', 0.2251),\n",
       "  ('background epidemiological', 0.2233),\n",
       "  ('weeks vasomotor', 0.2169),\n",
       "  ('intervention vascular', 0.2141),\n",
       "  ('mediated dilation', 0.2121),\n",
       "  ('nitroglycerin induced', 0.2116),\n",
       "  ('remain undefined', 0.2046),\n",
       "  ('water effect', 0.1973),\n",
       "  ('mechanisms benefit', 0.1959),\n",
       "  ('term effects', 0.1931),\n",
       "  ('proven coronary', 0.1903),\n",
       "  ('consumption improved', 0.1862),\n",
       "  ('partly explain', 0.1804),\n",
       "  ('66 patients', 0.1794),\n",
       "  ('artery consumption', 0.1788),\n",
       "  ('dependent flow', 0.1769),\n",
       "  ('endothelium independent', 0.1701),\n",
       "  ('randomized', 0.1509),\n",
       "  ('disease finding', 0.145),\n",
       "  ('patients completed', 0.1443),\n",
       "  ('equivalent oral', 0.1338),\n",
       "  ('consume black', 0.1207),\n",
       "  ('baseline intervention', 0.1155),\n",
       "  ('measures anova', 0.1119),\n",
       "  ('ultrasound patients', 0.1063),\n",
       "  ('protocol technically', 0.0984),\n",
       "  ('measurements short', 0.0968),\n",
       "  ('brachial', 0.083),\n",
       "  ('consumption 900', 0.078),\n",
       "  ('association', 0.0749),\n",
       "  ('examined hours', 0.0705),\n",
       "  ('long', 0.0394),\n",
       "  ('200 mg', 0.0337),\n",
       "  ('crossover', 0.0224),\n",
       "  ('450 ml', 0.0218),\n",
       "  ('contains', 0.0154),\n",
       "  ('plasma', -0.0071)],\n",
       " 'MED-1648': [('effects coffee', 0.6618),\n",
       "  ('espresso coffee', 0.5698),\n",
       "  ('coffee different', 0.542),\n",
       "  ('caffeine antioxidant', 0.5213),\n",
       "  ('caffeinated decaffeinated', 0.4344),\n",
       "  ('observed caffeinated', 0.41),\n",
       "  ('antioxidant activity', 0.3874),\n",
       "  ('oxidant capacity', 0.3693),\n",
       "  ('coffee 50', 0.3233),\n",
       "  ('impact cardiovascular', 0.3062),\n",
       "  ('dpph caffeinated', 0.3052),\n",
       "  ('endothelial function', 0.3006),\n",
       "  ('controversy exists', 0.2894),\n",
       "  ('decaffeinated espresso', 0.2847),\n",
       "  ('mediated dilation', 0.247),\n",
       "  ('effects observed', 0.24),\n",
       "  ('consumed adults', 0.2299),\n",
       "  ('understand chronic', 0.1983),\n",
       "  ('epidemiological studies', 0.1939),\n",
       "  ('adults western', 0.1935),\n",
       "  ('using flow', 0.1916),\n",
       "  ('consumption health', 0.1644),\n",
       "  ('brachial artery', 0.1639),\n",
       "  ('largely consumed', 0.163),\n",
       "  ('increased fmd', 0.1591),\n",
       "  ('unfavourable effects', 0.1382),\n",
       "  ('subjects measured', 0.1362),\n",
       "  ('02 vs', 0.1298),\n",
       "  ('higher anti', 0.1214),\n",
       "  ('substances terms', 0.1208),\n",
       "  ('different acute', 0.1002),\n",
       "  ('slightly', 0.0782),\n",
       "  ('activity', 0.0582),\n",
       "  ('clinical', 0.053),\n",
       "  ('terms free', 0.051),\n",
       "  ('stable radical', 0.0509),\n",
       "  ('mediated', 0.0508),\n",
       "  ('countries', 0.0424),\n",
       "  ('needed understand', 0.0343),\n",
       "  ('μl 001', 0.0235),\n",
       "  ('radical diphenyl', 0.0151),\n",
       "  ('hydrazyl 50', -0.0049),\n",
       "  ('responsible increased', -0.0118),\n",
       "  ('03 μl', -0.0168),\n",
       "  ('capacity', -0.0194),\n",
       "  ('exists', -0.0237),\n",
       "  ('dpph 13', -0.0272),\n",
       "  ('function healthy', -0.0386),\n",
       "  ('picryl', -0.045),\n",
       "  ('vs 30', -0.0928)],\n",
       " 'MED-1649': [('chronic coffee', 0.4526),\n",
       "  ('controversial endothelial', 0.3667),\n",
       "  ('examined association', 0.3473),\n",
       "  ('cardiovascular disease', 0.3108),\n",
       "  ('consumption endothelium', 0.2893),\n",
       "  ('remains controversial', 0.2791),\n",
       "  ('142 elderly', 0.2782),\n",
       "  ('association chronic', 0.2683),\n",
       "  ('ikaria study', 0.2624),\n",
       "  ('included study', 0.2351),\n",
       "  ('evaluated ultrasound', 0.2069),\n",
       "  ('compared consuming', 0.1972),\n",
       "  ('beverages', 0.1922),\n",
       "  ('subjects aged', 0.1921),\n",
       "  ('flow mediated', 0.1856),\n",
       "  ('72', 0.1668),\n",
       "  ('032 subjects', 0.1646),\n",
       "  ('disease remains', 0.1545),\n",
       "  ('objective', 0.1497),\n",
       "  ('examined', 0.1412),\n",
       "  ('function associated', 0.1325),\n",
       "  ('low 33', 0.1137),\n",
       "  ('200 450', 0.1079),\n",
       "  ('mainly boiled', 0.105),\n",
       "  ('aged 66', 0.1013),\n",
       "  ('risk', 0.0986),\n",
       "  ('moderate', 0.0953),\n",
       "  ('connection', 0.0922),\n",
       "  ('types', 0.0853),\n",
       "  ('fmd compared', 0.0844),\n",
       "  ('conclusions', 0.084),\n",
       "  ('mainly', 0.0785),\n",
       "  ('inhabitants island', 0.0765),\n",
       "  ('48 moderate', 0.0725),\n",
       "  ('ml day', 0.0705),\n",
       "  ('health', 0.0669),\n",
       "  ('vs high', 0.0658),\n",
       "  ('consumption linear', 0.0587),\n",
       "  ('study 87', 0.0582),\n",
       "  ('frequency questionnaire', 0.0505),\n",
       "  ('years', 0.0372),\n",
       "  ('13', 0.0223),\n",
       "  ('nutrition vascular', 0.0185),\n",
       "  ('dilation', 0.0019),\n",
       "  ('40', -0.0177),\n",
       "  ('subjects providing', -0.018),\n",
       "  ('39 09', -0.042),\n",
       "  ('91 years', -0.0545),\n",
       "  ('greek type', -0.0569),\n",
       "  ('providing new', -0.0901)],\n",
       " 'MED-1650': [('eating undermined', 0.5575),\n",
       "  ('obesity', 0.4871),\n",
       "  ('prevalence obesity', 0.476),\n",
       "  ('foods global', 0.4211),\n",
       "  ('undermined ubiquity', 0.4156),\n",
       "  ('dense foods', 0.3635),\n",
       "  ('eating', 0.3533),\n",
       "  ('healthy eating', 0.3208),\n",
       "  ('foods', 0.3177),\n",
       "  ('global strategy', 0.2892),\n",
       "  ('undermined', 0.2836),\n",
       "  ('campaigns promote', 0.2748),\n",
       "  ('abstract campaigns', 0.2448),\n",
       "  ('promote healthy', 0.2382),\n",
       "  ('rising prevalence', 0.2227),\n",
       "  ('campaigns', 0.2217),\n",
       "  ('global', 0.2108),\n",
       "  ('strategy needed', 0.2103),\n",
       "  ('prevalence', 0.1602),\n",
       "  ('needed tackle', 0.1456),\n",
       "  ('processed energy', 0.1442),\n",
       "  ('energy dense', 0.1429),\n",
       "  ('tackle rising', 0.0789),\n",
       "  ('energy', 0.0751),\n",
       "  ('ubiquity processed', 0.0698),\n",
       "  ('dense', 0.0667),\n",
       "  ('strategy', 0.0589),\n",
       "  ('tackle', 0.0523),\n",
       "  ('short abstract', 0.0479),\n",
       "  ('promote', 0.0341),\n",
       "  ('healthy', 0.0179),\n",
       "  ('ubiquity', 0.0137),\n",
       "  ('abstract', 0.0104),\n",
       "  ('needed', 0.0042),\n",
       "  ('short', -0.0151),\n",
       "  ('rising', -0.0364),\n",
       "  ('processed', -0.0373)],\n",
       " 'MED-1651': [('candy consumption', 0.5886),\n",
       "  ('nhanes adults', 0.3941),\n",
       "  ('consumption health', 0.3621),\n",
       "  ('chocolate', 0.3496),\n",
       "  ('consumption previous', 0.3494),\n",
       "  ('measures adiposity', 0.3483),\n",
       "  ('reduced intake', 0.3465),\n",
       "  ('lack associations', 0.337),\n",
       "  ('waist', 0.3282),\n",
       "  ('fatty acids', 0.3229),\n",
       "  ('consumption does', 0.321),\n",
       "  ('background limited', 0.3021),\n",
       "  ('cardiovascular risk', 0.2964),\n",
       "  ('cholesterol 001', 0.2964),\n",
       "  ('overweight dieting', 0.2833),\n",
       "  ('categorized infrequent', 0.2528),\n",
       "  ('obesity untoward', 0.2413),\n",
       "  ('covariates potential', 0.2401),\n",
       "  ('adjusted age', 0.2363),\n",
       "  ('months weight', 0.2161),\n",
       "  ('regarding impact', 0.2141),\n",
       "  ('added sugars', 0.2079),\n",
       "  ('ethnicity additional', 0.2009),\n",
       "  ('factors despite', 0.1985),\n",
       "  ('longitudinal studies', 0.1904),\n",
       "  ('2003 2006', 0.1873),\n",
       "  ('associations typical', 0.1817),\n",
       "  ('intakes protein', 0.1701),\n",
       "  ('previous 12', 0.1608),\n",
       "  ('moderate', 0.1523),\n",
       "  ('examination surveys', 0.1479),\n",
       "  ('sectional', 0.1316),\n",
       "  ('combined frequency', 0.131),\n",
       "  ('available regarding', 0.1226),\n",
       "  ('weights used', 0.1173),\n",
       "  ('consumers based', 0.1085),\n",
       "  ('states methods', 0.1026),\n",
       "  ('sex race', 0.1014),\n",
       "  ('united states', 0.0977),\n",
       "  ('logistic regression', 0.0622),\n",
       "  ('generalizable population', 0.059),\n",
       "  ('elevated skinfold', 0.0508),\n",
       "  ('saturated', 0.0491),\n",
       "  ('blood', 0.0436),\n",
       "  ('05', 0.0351),\n",
       "  ('does', 0.0277),\n",
       "  ('concluded', -0.0182),\n",
       "  ('professional', -0.0244),\n",
       "  ('month eo', -0.0266),\n",
       "  ('higher energy', -0.0558)],\n",
       " 'MED-1655': [('treatment hypertension', 0.4633),\n",
       "  ('began treat', 0.4086),\n",
       "  ('radical diet', 0.3462),\n",
       "  ('radical therapy', 0.346),\n",
       "  ('reduction blood', 0.3401),\n",
       "  ('enabled regain', 0.3055),\n",
       "  ('scientist duke', 0.3038),\n",
       "  ('refugee physician', 0.2973),\n",
       "  ('german refugee', 0.2956),\n",
       "  ('disease reversal', 0.2623),\n",
       "  ('largely vegetarian', 0.2603),\n",
       "  ('pressure rapid', 0.2561),\n",
       "  ('experienced physicians', 0.2363),\n",
       "  ('results dramatic', 0.231),\n",
       "  ('patients able', 0.2266),\n",
       "  ('1940', 0.2265),\n",
       "  ('kidney excretory', 0.2131),\n",
       "  ('drugs features', 0.2091),\n",
       "  ('effective ordinary', 0.2013),\n",
       "  ('papilledema', 0.1967),\n",
       "  ('function removing', 0.1797),\n",
       "  ('patient produced', 0.1747),\n",
       "  ('advent effective', 0.1741),\n",
       "  ('vasculopathy accelerated', 0.1723),\n",
       "  ('functions effective', 0.1713),\n",
       "  ('scientist', 0.1643),\n",
       "  ('congestive', 0.1619),\n",
       "  ('rice fruit', 0.1567),\n",
       "  ('protein burden', 0.1523),\n",
       "  ('therapy controversial', 0.1451),\n",
       "  ('tolerable', 0.1434),\n",
       "  ('slowly guided', 0.1373),\n",
       "  ('low fat', 0.1319),\n",
       "  ('fatal disease', 0.1135),\n",
       "  ('based theory', 0.1129),\n",
       "  ('manifestations previously', 0.1059),\n",
       "  ('paper reviews', 0.102),\n",
       "  ('follow regime', 0.0966),\n",
       "  ('metabolic functions', 0.095),\n",
       "  ('rights reserved', 0.0851),\n",
       "  ('known important', 0.0824),\n",
       "  ('normalization', 0.0804),\n",
       "  ('consisting white', 0.0548),\n",
       "  ('ecg', 0.0293),\n",
       "  ('fame', 0.0239),\n",
       "  ('decline popularity', 0.0195),\n",
       "  ('university', 0.0042),\n",
       "  ('superior current', 0.0021),\n",
       "  ('state permanently', 0.0004),\n",
       "  ('months', -0.0459)],\n",
       " 'MED-1656': [('prevalence lbp', 0.5772),\n",
       "  ('lbp children', 0.5098),\n",
       "  ('investigation prevalence', 0.4244),\n",
       "  ('research studies', 0.3939),\n",
       "  ('population studies', 0.3691),\n",
       "  ('methodologically poor', 0.3194),\n",
       "  ('low pain', 0.2747),\n",
       "  ('public health', 0.2736),\n",
       "  ('13 studies', 0.2666),\n",
       "  ('lifetime prevalence', 0.2623),\n",
       "  ('studies 336', 0.262),\n",
       "  ('lilacs cinahl', 0.2487),\n",
       "  ('poor', 0.225),\n",
       "  ('improve methodological', 0.2171),\n",
       "  ('children adolescents', 0.212),\n",
       "  ('need improve', 0.2097),\n",
       "  ('studies 177', 0.2091),\n",
       "  ('10 studies', 0.2041),\n",
       "  ('analyses results', 0.1928),\n",
       "  ('studies 120', 0.1913),\n",
       "  ('medline pedro', 0.1844),\n",
       "  ('regarding definition', 0.1621),\n",
       "  ('search period', 0.1466),\n",
       "  ('dependence problems', 0.1366),\n",
       "  ('random effects', 0.1349),\n",
       "  ('12 months', 0.1345),\n",
       "  ('concern recent', 0.1335),\n",
       "  ('95 ci', 0.1269),\n",
       "  ('59 articles', 0.1229),\n",
       "  ('publication year', 0.1201),\n",
       "  ('great variability', 0.1128),\n",
       "  ('124 247', 0.1083),\n",
       "  ('carry statistical', 0.1003),\n",
       "  ('459 lifetime', 0.0876),\n",
       "  ('carried different', 0.0869),\n",
       "  ('participants samples', 0.0856),\n",
       "  ('quality', 0.0735),\n",
       "  ('years considerable', 0.0725),\n",
       "  ('order avoid', 0.0632),\n",
       "  ('significant relationship', 0.0438),\n",
       "  ('common', 0.0423),\n",
       "  ('rates oldest', 0.0366),\n",
       "  ('rates separate', 0.0241),\n",
       "  ('extended april', 0.0108),\n",
       "  ('18', 0.0099),\n",
       "  ('2011', 0.0029),\n",
       "  ('means meta', 0.0001),\n",
       "  ('web knowledge', -0.0043),\n",
       "  ('moderator', -0.0468),\n",
       "  ('obtained 30', -0.0498)],\n",
       " 'MED-1657': [('lumbar arteries', 0.5569),\n",
       "  ('vascular diseases', 0.4792),\n",
       "  ('prevalence arterial', 0.4192),\n",
       "  ('postmortem aortograms', 0.3815),\n",
       "  ('001 stenotic', 0.3751),\n",
       "  ('narrowed arteries', 0.3564),\n",
       "  ('artery evaluated', 0.3497),\n",
       "  ('arteries common', 0.3443),\n",
       "  ('diseases', 0.3241),\n",
       "  ('atheromatous lesions', 0.3202),\n",
       "  ('evaluated 140', 0.2843),\n",
       "  ('spine relation', 0.2812),\n",
       "  ('study prevalence', 0.2678),\n",
       "  ('coronary', 0.2633),\n",
       "  ('lumbar middle', 0.2379),\n",
       "  ('chronic low', 0.22),\n",
       "  ('orifices', 0.2053),\n",
       "  ('necropsies subjects', 0.2023),\n",
       "  ('chronic pain', 0.1951),\n",
       "  ('subjects occluded', 0.1928),\n",
       "  ('35 men', 0.1775),\n",
       "  ('95 confidence', 0.1772),\n",
       "  ('routine medicolegal', 0.1508),\n",
       "  ('lesions adult', 0.1445),\n",
       "  ('sacral', 0.1416),\n",
       "  ('common subjects', 0.1381),\n",
       "  ('years women', 0.1379),\n",
       "  ('adjusted age', 0.1281),\n",
       "  ('life findings', 0.1169),\n",
       "  ('001 conclusions', 0.1084),\n",
       "  ('odds ratio', 0.1033),\n",
       "  ('ranging 16', 0.1012),\n",
       "  ('intervals', 0.0933),\n",
       "  ('years earlier', 0.0868),\n",
       "  ('followed fourth', 0.081),\n",
       "  ('59', 0.0802),\n",
       "  ('interviewed', 0.0794),\n",
       "  ('changes seen', 0.0725),\n",
       "  ('history close', 0.0702),\n",
       "  ('likely suffered', 0.0658),\n",
       "  ('results 22', 0.0646),\n",
       "  ('information low', 0.0639),\n",
       "  ('50 years', 0.0621),\n",
       "  ('men 20', 0.0577),\n",
       "  ('sex', 0.0223),\n",
       "  ('life obliteration', 0.0151),\n",
       "  ('17 38', 0.0072),\n",
       "  ('pairs', -0.0301),\n",
       "  ('months longer', -0.0653),\n",
       "  ('supplying', -0.0735)],\n",
       " 'MED-1658': [('images lumbar', 0.4631),\n",
       "  ('weighted images', 0.4321),\n",
       "  ('t2 weighted', 0.3985),\n",
       "  ('values intervertebral', 0.3816),\n",
       "  ('adc calculations', 0.3355),\n",
       "  ('resonance angiography', 0.3186),\n",
       "  ('diffusion coefficient', 0.307),\n",
       "  ('determined dimensional', 0.3011),\n",
       "  ('arteries evaluated', 0.2998),\n",
       "  ('independently radiologists', 0.2992),\n",
       "  ('degeneration materials', 0.2973),\n",
       "  ('spine obtained', 0.2895),\n",
       "  ('disks association', 0.2801),\n",
       "  ('analysis groups', 0.254),\n",
       "  ('68 years', 0.2313),\n",
       "  ('asymptomatic volunteers', 0.2195),\n",
       "  ('materials methods', 0.2177),\n",
       "  ('obtained 37', 0.2156),\n",
       "  ('status diffusion', 0.2147),\n",
       "  ('aged 22', 0.2119),\n",
       "  ('level analyzed', 0.2096),\n",
       "  ('intensities selected', 0.2069),\n",
       "  ('comparison', 0.1957),\n",
       "  ('evaluate correlation', 0.1934),\n",
       "  ('values 01', 0.1925),\n",
       "  ('significant results', 0.1738),\n",
       "  ('software values', 0.165),\n",
       "  ('98', 0.1588),\n",
       "  ('important role', 0.1532),\n",
       "  ('magnetic', 0.148),\n",
       "  ('sagittal', 0.1443),\n",
       "  ('groups scheffé', 0.1404),\n",
       "  ('associated decreased', 0.1362),\n",
       "  ('impaired flow', 0.1279),\n",
       "  ('significant severely', 0.1257),\n",
       "  ('average signal', 0.1146),\n",
       "  ('selected region', 0.1112),\n",
       "  ('normal', 0.111),\n",
       "  ('performed corresponding', 0.1079),\n",
       "  ('aged', 0.1034),\n",
       "  ('severely degenerated', 0.1014),\n",
       "  ('narrowing', 0.0999),\n",
       "  ('pairs total', 0.0916),\n",
       "  ('multiple', 0.0742),\n",
       "  ('higher degrees', 0.0622),\n",
       "  ('hoc', 0.0579),\n",
       "  ('196 degree', 0.0577),\n",
       "  ('years apparent', 0.0442),\n",
       "  ('time flight', 0.0354),\n",
       "  ('play', -0.0947)],\n",
       " 'MED-1659': [('histologic disc', 0.6343),\n",
       "  ('histologic changes', 0.5607),\n",
       "  ('disc aging', 0.4461),\n",
       "  ('alterations observed', 0.401),\n",
       "  ('morphologic framework', 0.3976),\n",
       "  ('degeneration 0001', 0.3919),\n",
       "  ('tissue breakdown', 0.3583),\n",
       "  ('comprehensive microscopic', 0.3514),\n",
       "  ('variable assessments', 0.3492),\n",
       "  ('250 histologic', 0.3467),\n",
       "  ('objectives investigate', 0.3435),\n",
       "  ('classification applied', 0.3386),\n",
       "  ('semiquantitative analyses', 0.327),\n",
       "  ('human lumbar', 0.3262),\n",
       "  ('favor histology', 0.2929),\n",
       "  ('temporospatial variations', 0.2912),\n",
       "  ('grade', 0.2786),\n",
       "  ('kappa values', 0.2776),\n",
       "  ('molecular biologic', 0.2757),\n",
       "  ('specimens regions', 0.2725),\n",
       "  ('methods', 0.2667),\n",
       "  ('changes diminished', 0.2495),\n",
       "  ('supply intervertebral', 0.2469),\n",
       "  ('11 histologic', 0.2453),\n",
       "  ('evidence detrimental', 0.2435),\n",
       "  ('included development', 0.2236),\n",
       "  ('applied cadaveric', 0.2193),\n",
       "  ('factors leading', 0.2063),\n",
       "  ('levels regions', 0.2017),\n",
       "  ('decade appears', 0.1932),\n",
       "  ('reference standard', 0.1859),\n",
       "  ('nucleus pulposus', 0.1851),\n",
       "  ('comprehensively age', 0.1832),\n",
       "  ('surgical', 0.1774),\n",
       "  ('reliance traditional', 0.1771),\n",
       "  ('analyses 20', 0.1742),\n",
       "  ('tested terms', 0.1715),\n",
       "  ('caution', 0.1512),\n",
       "  ('motion segment', 0.1489),\n",
       "  ('substantial data', 0.1363),\n",
       "  ('independent raters', 0.1293),\n",
       "  ('total 180', 0.1144),\n",
       "  ('44 deceased', 0.1084),\n",
       "  ('premature', 0.1012),\n",
       "  ('groups practicable', 0.0999),\n",
       "  ('88 years', 0.0926),\n",
       "  ('half', 0.0905),\n",
       "  ('moderate excellent', 0.0643),\n",
       "  ('individuals fetal', 0.046),\n",
       "  ('scatter', 0.0221)],\n",
       " 'MED-1660': [('atherosclerosis sciatica', 0.6111),\n",
       "  ('sciatica women', 0.4763),\n",
       "  ('objectives atherosclerosis', 0.4578),\n",
       "  ('treated hyperlipidemia', 0.3971),\n",
       "  ('men hyperlipidemia', 0.3782),\n",
       "  ('lipid levels', 0.3628),\n",
       "  ('lumbar region', 0.3413),\n",
       "  ('cholesterol high', 0.3081),\n",
       "  ('ldl', 0.3055),\n",
       "  ('sciatica 89', 0.3001),\n",
       "  ('arteries supplying', 0.2888),\n",
       "  ('intervertebral disc', 0.2854),\n",
       "  ('hdl associated', 0.2787),\n",
       "  ('possible confounders', 0.2701),\n",
       "  ('interviewed examined', 0.2605),\n",
       "  ('women associations', 0.2594),\n",
       "  ('results prevalence', 0.236),\n",
       "  ('8028 finns', 0.2226),\n",
       "  ('study described', 0.1997),\n",
       "  ('bmi exercise', 0.1984),\n",
       "  ('aged', 0.1792),\n",
       "  ('similar analyses', 0.176),\n",
       "  ('pharmacologically treated', 0.1643),\n",
       "  ('assessed physician', 0.1623),\n",
       "  ('smoking heavy', 0.1454),\n",
       "  ('comparison men', 0.1406),\n",
       "  ('degeneration', 0.1383),\n",
       "  ('region suggested', 0.135),\n",
       "  ('levels', 0.1332),\n",
       "  ('68', 0.1327),\n",
       "  ('30 years', 0.1321),\n",
       "  ('education', 0.13),\n",
       "  ('men 71', 0.1276),\n",
       "  ('associated total', 0.1212),\n",
       "  ('serum', 0.1206),\n",
       "  ('55 adjusted', 0.1049),\n",
       "  ('physical work', 0.0979),\n",
       "  ('nationally representative', 0.079),\n",
       "  ('hypothesis', 0.0687),\n",
       "  ('74 sample', 0.0625),\n",
       "  ('high vs', 0.0576),\n",
       "  ('01 04', 0.0551),\n",
       "  ('leading', 0.0466),\n",
       "  ('preset criteria', 0.0417),\n",
       "  ('middle tertile', 0.0354),\n",
       "  ('28 95', 0.0249),\n",
       "  ('supplying', -0.006),\n",
       "  ('lowest', -0.0149),\n",
       "  ('12', -0.0333),\n",
       "  ('ci', -0.0346)],\n",
       " 'MED-1661': [('degeneration grades', 0.5035),\n",
       "  ('disc degeneration', 0.4456),\n",
       "  ('intervertebral discs', 0.4445),\n",
       "  ('discs lumbar', 0.4332),\n",
       "  ('discs ages', 0.4179),\n",
       "  ('discs degenerated', 0.4167),\n",
       "  ('discs showed', 0.4104),\n",
       "  ('showed degeneration', 0.4072),\n",
       "  ('macroscopic disc', 0.3743),\n",
       "  ('authors correlated', 0.3661),\n",
       "  ('cadavers ages', 0.3579),\n",
       "  ('radiographic data', 0.3551),\n",
       "  ('discs 273', 0.3385),\n",
       "  ('16 published', 0.3381),\n",
       "  ('reports authors', 0.3368),\n",
       "  ('level discs', 0.3267),\n",
       "  ('published reports', 0.3117),\n",
       "  ('macroscopic findings', 0.307),\n",
       "  ('273 cadavers', 0.3005),\n",
       "  ('600 lumbar', 0.2908),\n",
       "  ('ages significantly', 0.2799),\n",
       "  ('female discs', 0.2762),\n",
       "  ('grades', 0.2741),\n",
       "  ('96 years', 0.2544),\n",
       "  ('sex spine', 0.2478),\n",
       "  ('earlier degeneration', 0.2465),\n",
       "  ('male discs', 0.2438),\n",
       "  ('spine level', 0.225),\n",
       "  ('epidemiologic studies', 0.1941),\n",
       "  ('studies calculations', 0.1924),\n",
       "  ('decades average', 0.192),\n",
       "  ('findings', 0.1811),\n",
       "  ('findings corroborate', 0.1706),\n",
       "  ('degenerated female', 0.1677),\n",
       "  ('using data', 0.1649),\n",
       "  ('l4 level', 0.1345),\n",
       "  ('seventh decades', 0.1314),\n",
       "  ('l5 l3', 0.1272),\n",
       "  ('higher mechanical', 0.1071),\n",
       "  ('stress combined', 0.0626),\n",
       "  ('sixth', 0.0571),\n",
       "  ('pathways', 0.0559),\n",
       "  ('second fifth', 0.0444),\n",
       "  ('responsible', 0.0217),\n",
       "  ('showed', 0.0144),\n",
       "  ('nutritional', 0.0094),\n",
       "  ('combined', -0.008),\n",
       "  ('average', -0.0185),\n",
       "  ('longer', -0.0945),\n",
       "  ('male', -0.0968)],\n",
       " 'MED-1663': [('arteries lumbar', 0.5875),\n",
       "  ('spine cholesterol', 0.5494),\n",
       "  ('data atherosclerosis', 0.4937),\n",
       "  ('occluded arteries', 0.4313),\n",
       "  ('cholesterol scored', 0.3873),\n",
       "  ('aorta usually', 0.3626),\n",
       "  ('spine result', 0.3488),\n",
       "  ('prevalence occluded', 0.317),\n",
       "  ('evaluate occlusion', 0.3147),\n",
       "  ('wall abdominal', 0.3034),\n",
       "  ('symptoms patients', 0.2817),\n",
       "  ('significant disc', 0.2762),\n",
       "  ('study design', 0.2614),\n",
       "  ('neurogenic symptoms', 0.2374),\n",
       "  ('035 patients', 0.2345),\n",
       "  ('levels associated', 0.2258),\n",
       "  ('severe pain', 0.2239),\n",
       "  ('background data', 0.2202),\n",
       "  ('orifices', 0.21),\n",
       "  ('degeneration methods', 0.2077),\n",
       "  ('lower pain', 0.2054),\n",
       "  ('used results', 0.2043),\n",
       "  ('sectional analysis', 0.1964),\n",
       "  ('mr images', 0.1959),\n",
       "  ('blood tests', 0.1953),\n",
       "  ('develops ostia', 0.1803),\n",
       "  ('bifurcation obliterate', 0.1772),\n",
       "  ('women significant', 0.1766),\n",
       "  ('low outcome', 0.1757),\n",
       "  ('causes ischemia', 0.1745),\n",
       "  ('analysis feeding', 0.1589),\n",
       "  ('root compression', 0.155),\n",
       "  ('cross', 0.1367),\n",
       "  ('age group', 0.1334),\n",
       "  ('51 patients', 0.1294),\n",
       "  ('long term', 0.122),\n",
       "  ('middle sacral', 0.12),\n",
       "  ('14', 0.1047),\n",
       "  ('material 62', 0.0986),\n",
       "  ('56 years', 0.0985),\n",
       "  ('times subjects', 0.0927),\n",
       "  ('nass', 0.0404),\n",
       "  ('normal serum', 0.0334),\n",
       "  ('did complain', 0.0039),\n",
       "  ('men 11', 0.0001),\n",
       "  ('instrument', -0.0057),\n",
       "  ('70 years', -0.0078),\n",
       "  ('37 men', -0.0098),\n",
       "  ('group finnish', -0.0248),\n",
       "  ('scored higher', -0.0394)],\n",
       " 'MED-1664': [('disc degeneration', 0.6402),\n",
       "  ('intervertebral disc', 0.6154),\n",
       "  ('shows degenerative', 0.5732),\n",
       "  ('disc cartilaginous', 0.5523),\n",
       "  ('degenerative ageing', 0.5382),\n",
       "  ('degeneration pain', 0.5036),\n",
       "  ('intervertebral', 0.4868),\n",
       "  ('articular cartilage', 0.4483),\n",
       "  ('cartilage biochemistry', 0.4306),\n",
       "  ('resembles articular', 0.4083),\n",
       "  ('cartilaginous structure', 0.4076),\n",
       "  ('disc', 0.3911),\n",
       "  ('association disc', 0.3687),\n",
       "  ('degeneration', 0.3678),\n",
       "  ('connective tissue', 0.3657),\n",
       "  ('ageing changes', 0.3458),\n",
       "  ('conservative commonly', 0.3063),\n",
       "  ('diagnosis treatments', 0.284),\n",
       "  ('important clinically', 0.2744),\n",
       "  ('pain', 0.26),\n",
       "  ('current treatments', 0.247),\n",
       "  ('better diagnosis', 0.2464),\n",
       "  ('structure resembles', 0.2444),\n",
       "  ('therapy considered', 0.2444),\n",
       "  ('treatments predominantly', 0.2194),\n",
       "  ('tissue', 0.2164),\n",
       "  ('changes earlier', 0.208),\n",
       "  ('biological approaches', 0.2053),\n",
       "  ('clearly different', 0.2019),\n",
       "  ('biochemistry morphologically', 0.1759),\n",
       "  ('surgical cases', 0.1682),\n",
       "  ('body', 0.1552),\n",
       "  ('approaches allow', 0.1401),\n",
       "  ('believed important', 0.1377),\n",
       "  ('does connective', 0.1347),\n",
       "  ('clinically association', 0.1338),\n",
       "  ('genetic', 0.1168),\n",
       "  ('allow better', 0.1135),\n",
       "  ('current', 0.1134),\n",
       "  ('treatments future', 0.1096),\n",
       "  ('developments', 0.1079),\n",
       "  ('different shows', 0.083),\n",
       "  ('considered', 0.0796),\n",
       "  ('commonly', 0.0677),\n",
       "  ('considered inadequate', 0.0577),\n",
       "  ('new', 0.0547),\n",
       "  ('earlier does', 0.0223),\n",
       "  ('morphologically clearly', 0.0055),\n",
       "  ('inadequate new', -0.0036),\n",
       "  ('cases clear', -0.0626)],\n",
       " 'MED-1665': [('ivd diseases', 0.5064),\n",
       "  ('factors atherosclerosis', 0.4746),\n",
       "  ('heart disease', 0.3753),\n",
       "  ('disease obesity', 0.3714),\n",
       "  ('poor vascularized', 0.3519),\n",
       "  ('risk factors', 0.3498),\n",
       "  ('diseases increased', 0.317),\n",
       "  ('degeneration association', 0.3027),\n",
       "  ('supply intervertebral', 0.2907),\n",
       "  ('higher triglyceride', 0.2584),\n",
       "  ('herniated lumbar', 0.2525),\n",
       "  ('cholesterol concentration', 0.2524),\n",
       "  ('disease', 0.2311),\n",
       "  ('risk dying', 0.2176),\n",
       "  ('tobacco', 0.2084),\n",
       "  ('causative factor', 0.2079),\n",
       "  ('ischaemic', 0.2012),\n",
       "  ('prevention management', 0.1911),\n",
       "  ('meniscal tear', 0.1808),\n",
       "  ('disc examined', 0.1713),\n",
       "  ('blood supply', 0.1697),\n",
       "  ('insufficient', 0.1469),\n",
       "  ('115 men', 0.1454),\n",
       "  ('supply poor', 0.1388),\n",
       "  ('men 54', 0.1315),\n",
       "  ('factors holds', 0.1217),\n",
       "  ('concentration 01', 0.1158),\n",
       "  ('control study', 0.1112),\n",
       "  ('examined fasting', 0.1096),\n",
       "  ('groups patients', 0.1092),\n",
       "  ('59 years', 0.0971),\n",
       "  ('new approaches', 0.0898),\n",
       "  ('02 total', 0.0879),\n",
       "  ('384 subjects', 0.0802),\n",
       "  ('serum levels', 0.0718),\n",
       "  ('gender', 0.0624),\n",
       "  ('mean age', 0.0605),\n",
       "  ('surgery symptomatic', 0.0531),\n",
       "  ('showed statistically', 0.0403),\n",
       "  ('comparing', 0.0401),\n",
       "  ('range 26', 0.0152),\n",
       "  ('subjects operated', 0.015),\n",
       "  ('play role', 0.014),\n",
       "  ('women', 0.0135),\n",
       "  ('consecutive', 0.0103),\n",
       "  ('86 underwent', -0.0027),\n",
       "  ('frequency matched', -0.0135),\n",
       "  ('extracted', -0.0163),\n",
       "  ('operated institution', -0.0211),\n",
       "  ('holds promise', -0.1241)],\n",
       " 'MED-1666': [('disc nutrition', 0.6561),\n",
       "  ('avascular disc', 0.4724),\n",
       "  ('movement disc', 0.4502),\n",
       "  ('supply disc', 0.4431),\n",
       "  ('literature disc', 0.4251),\n",
       "  ('acid disc', 0.4185),\n",
       "  ('transport nutrients', 0.4138),\n",
       "  ('degeneration summary', 0.3969),\n",
       "  ('disc vitro', 0.3824),\n",
       "  ('disc blood', 0.3799),\n",
       "  ('nutrition objectives', 0.368),\n",
       "  ('loss nutrient', 0.3207),\n",
       "  ('essential cellular', 0.3056),\n",
       "  ('background data', 0.2971),\n",
       "  ('studies examined', 0.2831),\n",
       "  ('glucose concentrations', 0.2421),\n",
       "  ('acid concentrations', 0.2398),\n",
       "  ('oxygen', 0.2341),\n",
       "  ('design', 0.2337),\n",
       "  ('summarize information', 0.2334),\n",
       "  ('depend balance', 0.2222),\n",
       "  ('cells', 0.2213),\n",
       "  ('margins supply', 0.2076),\n",
       "  ('diffusion convective', 0.2072),\n",
       "  ('nucleus', 0.1978),\n",
       "  ('matrix degradation', 0.194),\n",
       "  ('remove metabolic', 0.1915),\n",
       "  ('factors affecting', 0.1868),\n",
       "  ('wastes lactic', 0.1844),\n",
       "  ('fall critical', 0.1812),\n",
       "  ('calcification block', 0.1803),\n",
       "  ('studies solute', 0.1797),\n",
       "  ('lead cell', 0.1629),\n",
       "  ('activity viability', 0.1606),\n",
       "  ('blood vessels', 0.1592),\n",
       "  ('induced fluid', 0.1549),\n",
       "  ('influence transport', 0.141),\n",
       "  ('subchondral', 0.1155),\n",
       "  ('demand increases', 0.1127),\n",
       "  ('production', 0.1121),\n",
       "  ('bone endplate', 0.0907),\n",
       "  ('results small', 0.0782),\n",
       "  ('animal human', 0.0745),\n",
       "  ('concentrations greatest', 0.0637),\n",
       "  ('calcifies', 0.0618),\n",
       "  ('fail changes', 0.0608),\n",
       "  ('increases conclusions', 0.056),\n",
       "  ('lowest center', 0.0507),\n",
       "  ('sclerosis', 0.0308),\n",
       "  ('virtually entirely', 0.0214)],\n",
       " 'MED-1667': [('chronic low', 0.4557),\n",
       "  ('pain 23', 0.4424),\n",
       "  ('low pain', 0.4415),\n",
       "  ('pain management', 0.376),\n",
       "  ('disabled low', 0.3676),\n",
       "  ('prevalence low', 0.3449),\n",
       "  ('health problem', 0.3323),\n",
       "  ('pain mechanical', 0.313),\n",
       "  ('specific low', 0.3037),\n",
       "  ('problem worldwide', 0.2993),\n",
       "  ('prevalence chronic', 0.2629),\n",
       "  ('low patient', 0.2542),\n",
       "  ('treatments low', 0.2541),\n",
       "  ('population disabled', 0.2512),\n",
       "  ('restricted mechanism', 0.2341),\n",
       "  ('12 population', 0.2153),\n",
       "  ('lifting carrying', 0.2068),\n",
       "  ('self management', 0.2063),\n",
       "  ('mechanical factors', 0.1797),\n",
       "  ('prevalence', 0.1552),\n",
       "  ('diagnosis restricted', 0.1534),\n",
       "  ('worldwide lifetime', 0.1521),\n",
       "  ('treatments unclear', 0.1489),\n",
       "  ('avoided copyright', 0.1406),\n",
       "  ('problem', 0.1373),\n",
       "  ('overtreatment avoided', 0.1359),\n",
       "  ('pathogenic role', 0.1295),\n",
       "  ('support recommended', 0.1268),\n",
       "  ('factors', 0.1198),\n",
       "  ('population', 0.1136),\n",
       "  ('non specific', 0.1112),\n",
       "  ('guidelines use', 0.1081),\n",
       "  ('management appropriate', 0.1072),\n",
       "  ('probably major', 0.0851),\n",
       "  ('high 84', 0.0722),\n",
       "  ('surgery overtreatment', 0.0718),\n",
       "  ('major public', 0.0667),\n",
       "  ('effect sizes', 0.0612),\n",
       "  ('copyright 2012', 0.0583),\n",
       "  ('history taking', 0.0533),\n",
       "  ('taking clinical', 0.0531),\n",
       "  ('reported', 0.0485),\n",
       "  ('imaging diagnosis', 0.0395),\n",
       "  ('copyright', 0.0377),\n",
       "  ('11', 0.0345),\n",
       "  ('genetic', 0.0133),\n",
       "  ('constitution important', 0.0113),\n",
       "  ('preferences', 0.0031),\n",
       "  ('use', -0.0299),\n",
       "  ('elsevier rights', -0.0592)],\n",
       " 'MED-1668': [('diffusion lumbar', 0.5449),\n",
       "  ('diffusion contrast', 0.5051),\n",
       "  ('diffusion noninvasively', 0.4676),\n",
       "  ('altered diffusion', 0.4595),\n",
       "  ('study diffusion', 0.4422),\n",
       "  ('degeneration diffusion', 0.4318),\n",
       "  ('disc degeneration', 0.3935),\n",
       "  ('intervertebral discs', 0.3897),\n",
       "  ('atherosclerosis lumbar', 0.3774),\n",
       "  ('nutrition intervertebral', 0.361),\n",
       "  ('diffusion decreased', 0.3603),\n",
       "  ('diffusion remains', 0.3506),\n",
       "  ('arteries diffusion', 0.3265),\n",
       "  ('discs noninvasive', 0.3243),\n",
       "  ('pathway disc', 0.3101),\n",
       "  ('mri emerged', 0.3039),\n",
       "  ('postcontrast', 0.26),\n",
       "  ('designed studies', 0.2164),\n",
       "  ('paucity reliable', 0.2105),\n",
       "  ('slow process', 0.1921),\n",
       "  ('used document', 0.1738),\n",
       "  ('posture atherosclerosis', 0.1711),\n",
       "  ('humans vivo', 0.1695),\n",
       "  ('knowledge methodology', 0.1693),\n",
       "  ('studies shown', 0.161),\n",
       "  ('nutrition review', 0.1603),\n",
       "  ('methods', 0.157),\n",
       "  ('focuses current', 0.1147),\n",
       "  ('altered', 0.1048),\n",
       "  ('future technique', 0.0945),\n",
       "  ('noninvasively', 0.0935),\n",
       "  ('poorly', 0.0886),\n",
       "  ('factors influence', 0.0803),\n",
       "  ('wiley liss', 0.067),\n",
       "  ('reliable tool', 0.0615),\n",
       "  ('24 hours', 0.0599),\n",
       "  ('controls', 0.0568),\n",
       "  ('main structure', 0.0525),\n",
       "  ('process endplate', 0.0492),\n",
       "  ('loading', 0.0323),\n",
       "  ('applications', 0.0292),\n",
       "  ('breaks', 0.0248),\n",
       "  ('hours designed', 0.0154),\n",
       "  ('years', 0.0127),\n",
       "  ('remains', 0.0098),\n",
       "  ('safe used', -0.0074),\n",
       "  ('2007', -0.0381),\n",
       "  ('emerged powerful', -0.0692),\n",
       "  ('common', -0.0779),\n",
       "  ('smoking', -0.1003)],\n",
       " 'MED-1669': [('fructose intake', 0.7142),\n",
       "  ('frequency obesity', 0.463),\n",
       "  ('metabolic syndrome', 0.4562),\n",
       "  ('sugars randomized', 0.4413),\n",
       "  ('carbohydrates reduce', 0.4256),\n",
       "  ('obese subjects', 0.3757),\n",
       "  ('diet vs', 0.3618),\n",
       "  ('excessive intake', 0.3571),\n",
       "  ('resistance uric', 0.3398),\n",
       "  ('weight loss', 0.2985),\n",
       "  ('pressure lipid', 0.2861),\n",
       "  ('insulin', 0.2643),\n",
       "  ('proposed causes', 0.2427),\n",
       "  ('kg intervention', 0.2296),\n",
       "  ('randomized compare', 0.2281),\n",
       "  ('131 patients', 0.2246),\n",
       "  ('energy restricted', 0.2153),\n",
       "  ('important therapeutic', 0.1856),\n",
       "  ('cal diets', 0.182),\n",
       "  ('products containing', 0.1678),\n",
       "  ('natural fruit', 0.152),\n",
       "  ('achievement energy', 0.1478),\n",
       "  ('molecule quality', 0.1447),\n",
       "  ('absorbed compared', 0.1395),\n",
       "  ('0016 compared', 0.1375),\n",
       "  ('diet 20', 0.1353),\n",
       "  ('study addressed', 0.1268),\n",
       "  ('receive 1500', 0.1261),\n",
       "  ('reduce features', 0.1178),\n",
       "  ('outcomes 78', 0.116),\n",
       "  ('life scores', 0.1129),\n",
       "  ('loss achievement', 0.1104),\n",
       "  ('participants women', 0.109),\n",
       "  ('1800 2000', 0.1053),\n",
       "  ('acid soluble', 0.0981),\n",
       "  ('32 kg', 0.0972),\n",
       "  ('included secondary', 0.0938),\n",
       "  ('intercellular adhesion', 0.0873),\n",
       "  ('supplements 50', 0.0856),\n",
       "  ('ability excessive', 0.0808),\n",
       "  ('70 compared', 0.0758),\n",
       "  ('term effects', 0.0709),\n",
       "  ('group 19', 0.0634),\n",
       "  ('represent', 0.0452),\n",
       "  ('differently', 0.0427),\n",
       "  ('mounting date', 0.0396),\n",
       "  ('mean age', 0.0394),\n",
       "  ('according sex', 0.0041),\n",
       "  ('2011 elsevier', -0.0569),\n",
       "  ('rights reserved', -0.0651)],\n",
       " 'MED-1670': [('strawberry apple', 0.5281),\n",
       "  ('inhibition strawberry', 0.51),\n",
       "  ('inhibition uptake', 0.4679),\n",
       "  ('tannins ppts', 0.4156),\n",
       "  ('polyphenols phenolic', 0.3934),\n",
       "  ('inhibit glucose', 0.376),\n",
       "  ('transporters', 0.3412),\n",
       "  ('sglt1 extracts', 0.3298),\n",
       "  ('extract inhibition', 0.3298),\n",
       "  ('intestinal cell', 0.2988),\n",
       "  ('uptake apical', 0.2769),\n",
       "  ('using caco', 0.2715),\n",
       "  ('respectively inhibitory', 0.2692),\n",
       "  ('containing glucose', 0.2498),\n",
       "  ('cell monolayers', 0.2353),\n",
       "  ('active sodium', 0.2313),\n",
       "  ('tested quercetin', 0.2305),\n",
       "  ('glut2 facilitated', 0.2195),\n",
       "  ('kinetic analysis', 0.2044),\n",
       "  ('basolateral transport', 0.2037),\n",
       "  ('lumen', 0.2012),\n",
       "  ('ppts tested', 0.1912),\n",
       "  ('pelargonidin', 0.1891),\n",
       "  ('apparent results', 0.1786),\n",
       "  ('acids', 0.1763),\n",
       "  ('transport non', 0.1527),\n",
       "  ('constituent', 0.1282),\n",
       "  ('caffeoylquinic', 0.1253),\n",
       "  ('investigated using', 0.1215),\n",
       "  ('competitive based', 0.12),\n",
       "  ('changes', 0.0904),\n",
       "  ('802 μm', 0.0885),\n",
       "  ('μm phloridzin', 0.0841),\n",
       "  ('2010', 0.0816),\n",
       "  ('wiley', 0.0772),\n",
       "  ('μm contributed', 0.071),\n",
       "  ('conditions', 0.0516),\n",
       "  ('12 respectively', 0.0315),\n",
       "  ('mixed type', 0.0287),\n",
       "  ('copyright', 0.028),\n",
       "  ('ic₅₀ 146', 0.0276),\n",
       "  ('facilitated exit', 0.0256),\n",
       "  ('ic₅₀ 31', 0.0194),\n",
       "  ('rhamnoside', 0.0061),\n",
       "  ('kgaa weinheim', -0.0034),\n",
       "  ('vch', -0.0098),\n",
       "  ('2570', -0.0121),\n",
       "  ('26 total', -0.0132),\n",
       "  ('free', -0.0561),\n",
       "  ('52', -0.0723)],\n",
       " 'MED-1671': [('sucrose berries', 0.6519),\n",
       "  ('berries reduce', 0.496),\n",
       "  ('berries nectars', 0.4952),\n",
       "  ('sucrose suppress', 0.4885),\n",
       "  ('available carbohydrate', 0.4772),\n",
       "  ('consumed berry', 0.4076),\n",
       "  ('reduced glucose', 0.4067),\n",
       "  ('ingestion', 0.4043),\n",
       "  ('metabolic responses', 0.3867),\n",
       "  ('natural sugars', 0.3797),\n",
       "  ('hypoglycemic', 0.344),\n",
       "  ('suppress postprandial', 0.3333),\n",
       "  ('improved glycemic', 0.3269),\n",
       "  ('insulin concentrations', 0.3162),\n",
       "  ('high postprandial', 0.2898),\n",
       "  ('slower absorption', 0.2814),\n",
       "  ('nigrum lingonberries', 0.2748),\n",
       "  ('meals natural', 0.2662),\n",
       "  ('study consumed', 0.2455),\n",
       "  ('nectars optimize', 0.2369),\n",
       "  ('free fatty', 0.2276),\n",
       "  ('digestion', 0.2206),\n",
       "  ('ribes', 0.2022),\n",
       "  ('investigated effects', 0.1998),\n",
       "  ('conclusions blackcurrants', 0.1884),\n",
       "  ('30 min', 0.149),\n",
       "  ('humans limited', 0.14),\n",
       "  ('acid rebound', 0.13),\n",
       "  ('higher content', 0.1216),\n",
       "  ('background', 0.1189),\n",
       "  ('water used', 0.1184),\n",
       "  ('vaccinium vitis', 0.1173),\n",
       "  ('150', 0.1166),\n",
       "  ('blood samples', 0.1166),\n",
       "  ('served purées', 0.1047),\n",
       "  ('responses design', 0.0983),\n",
       "  ('despite', 0.0836),\n",
       "  ('min results', 0.0808),\n",
       "  ('evidence humans', 0.0736),\n",
       "  ('second hour', 0.0689),\n",
       "  ('induced late', 0.0622),\n",
       "  ('collected 15', 0.0613),\n",
       "  ('used reference', 0.0613),\n",
       "  ('women participated', 0.0597),\n",
       "  ('35 added', 0.0438),\n",
       "  ('significantly improved', 0.0369),\n",
       "  ('optimize', 0.0192),\n",
       "  ('idaea', -0.0003),\n",
       "  ('crossover', -0.0131),\n",
       "  ('compensatory free', -0.0214)],\n",
       " 'MED-1672': [('fructose intake', 0.6801),\n",
       "  ('high fructose', 0.674),\n",
       "  ('added sugars', 0.6351),\n",
       "  ('sugars distinct', 0.5751),\n",
       "  ('sugar sucrose', 0.5445),\n",
       "  ('caloric intake', 0.5193),\n",
       "  ('fructose corn', 0.5177),\n",
       "  ('sucrose high', 0.5086),\n",
       "  ('intake increases', 0.4909),\n",
       "  ('table sugar', 0.4888),\n",
       "  ('excessive caloric', 0.4683),\n",
       "  ('fat accumulation', 0.4574),\n",
       "  ('obesity provides', 0.3966),\n",
       "  ('intracellular atp', 0.3782),\n",
       "  ('syndrome diabetes', 0.3693),\n",
       "  ('syrup increased', 0.3422),\n",
       "  ('food matter', 0.3308),\n",
       "  ('induced uric', 0.3103),\n",
       "  ('metabolism accounts', 0.3096),\n",
       "  ('energy content', 0.3059),\n",
       "  ('risk metabolic', 0.3049),\n",
       "  ('just calorie', 0.303),\n",
       "  ('stress stimulates', 0.2821),\n",
       "  ('intake studies', 0.2818),\n",
       "  ('corn syrup', 0.2815),\n",
       "  ('nucleotide turnover', 0.2781),\n",
       "  ('dogma calorie', 0.2684),\n",
       "  ('acid generation', 0.2538),\n",
       "  ('oxidative stress', 0.249),\n",
       "  ('increased dramatically', 0.2348),\n",
       "  ('increases risk', 0.2161),\n",
       "  ('dramatically years', 0.21),\n",
       "  ('therapies important', 0.2005),\n",
       "  ('generation causes', 0.191),\n",
       "  ('component added', 0.1829),\n",
       "  ('provides new', 0.1633),\n",
       "  ('accumulation independent', 0.1507),\n",
       "  ('causes mitochondrial', 0.1423),\n",
       "  ('table', 0.1364),\n",
       "  ('insights pathogenesis', 0.1341),\n",
       "  ('depletion', 0.0951),\n",
       "  ('hypothesis unique', 0.0756),\n",
       "  ('studies challenge', 0.0697),\n",
       "  ('stimulates', 0.0548),\n",
       "  ('content discovery', 0.0274),\n",
       "  ('recent', 0.0223),\n",
       "  ('long', 0.0031),\n",
       "  ('correlates closely', 0.0026),\n",
       "  ('causal', -0.0204),\n",
       "  ('standing dogma', -0.0673)],\n",
       " 'MED-1673': [('polyphenols intestinal', 0.4944),\n",
       "  ('polyphenols inhibited', 0.4909),\n",
       "  ('dietary polyphenols', 0.4584),\n",
       "  ('intestinal glucose', 0.457),\n",
       "  ('uptake glycosides', 0.4483),\n",
       "  ('non glycosylated', 0.4214),\n",
       "  ('inhibited glucose', 0.4093),\n",
       "  ('glycosides non', 0.4037),\n",
       "  ('glycosylated dietary', 0.4008),\n",
       "  ('glycosides inhibit', 0.3869),\n",
       "  ('polyphenols aglycones', 0.3856),\n",
       "  ('glucose non', 0.3828),\n",
       "  ('glucose uptake', 0.3809),\n",
       "  ('intestinal cells', 0.3767),\n",
       "  ('uptake cells', 0.3654),\n",
       "  ('caco intestinal', 0.3645),\n",
       "  ('aglycones inhibit', 0.3579),\n",
       "  ('classes dietary', 0.3466),\n",
       "  ('inhibited flavonoid', 0.3458),\n",
       "  ('cells sodium', 0.3441),\n",
       "  ('acids ineffective', 0.3426),\n",
       "  ('cells glucose', 0.34),\n",
       "  ('glycosides phenolic', 0.3389),\n",
       "  ('polarised caco', 0.3353),\n",
       "  ('uptake investigated', 0.3258),\n",
       "  ('aglycones non', 0.32),\n",
       "  ('facilitated glucose', 0.3005),\n",
       "  ('sodium free', 0.3),\n",
       "  ('acids effect', 0.2997),\n",
       "  ('conditions aglycones', 0.283),\n",
       "  ('effective transporters', 0.2721),\n",
       "  ('conditions inhibited', 0.2465),\n",
       "  ('flavonoid', 0.1953),\n",
       "  ('steric hindrance', 0.1852),\n",
       "  ('caco', 0.1756),\n",
       "  ('free conditions', 0.1428),\n",
       "  ('epigallochatechingallate epichatechingallate', 0.138),\n",
       "  ('cells', 0.1366),\n",
       "  ('inhibit active', 0.1316),\n",
       "  ('using polarised', 0.1223),\n",
       "  ('ineffective data', 0.1189),\n",
       "  ('dependent conditions', 0.1082),\n",
       "  ('active transport', 0.0928),\n",
       "  ('different classes', 0.087),\n",
       "  ('effect different', 0.0747),\n",
       "  ('data suggest', 0.0669),\n",
       "  ('facilitated', 0.042),\n",
       "  ('investigated', 0.0182),\n",
       "  ('appear exert', -0.0274),\n",
       "  ('using', -0.0297)],\n",
       " 'MED-1674': [('atkins diet', 0.5468),\n",
       "  ('diet traditional', 0.5287),\n",
       "  ('commonality diets', 0.4899),\n",
       "  ('low fat', 0.4728),\n",
       "  ('diets eliminate', 0.4508),\n",
       "  ('carbohydrate', 0.4404),\n",
       "  ('calories different', 0.432),\n",
       "  ('fructose unlike', 0.4141),\n",
       "  ('weight loss', 0.3992),\n",
       "  ('glucose hypercaloric', 0.3813),\n",
       "  ('sugar synthetic', 0.3628),\n",
       "  ('nutritionists ages', 0.3533),\n",
       "  ('sucrose table', 0.3477),\n",
       "  ('eliminate monosaccharide', 0.3459),\n",
       "  ('chronic metabolic', 0.3361),\n",
       "  ('fat work', 0.3313),\n",
       "  ('paralleling obesity', 0.3214),\n",
       "  ('consumption', 0.3084),\n",
       "  ('particularly sweet', 0.3075),\n",
       "  ('starch', 0.3016),\n",
       "  ('vilified nutritionists', 0.2952),\n",
       "  ('syrup consist', 0.2306),\n",
       "  ('health effects', 0.2206),\n",
       "  ('metabolized', 0.218),\n",
       "  ('novo lipogenesis', 0.2003),\n",
       "  ('loss commonality', 0.1784),\n",
       "  ('traditional', 0.1763),\n",
       "  ('aging promotes', 0.1729),\n",
       "  ('japanese', 0.159),\n",
       "  ('hedonic analogies', 0.1519),\n",
       "  ('metabolic cousin', 0.1404),\n",
       "  ('alcohol buzz', 0.134),\n",
       "  ('fruit does', 0.1233),\n",
       "  ('promotes changes', 0.119),\n",
       "  ('hepatic mitochondrial', 0.1139),\n",
       "  ('oxygen species', 0.108),\n",
       "  ('depression experienced', 0.0984),\n",
       "  ('species formation', 0.0982),\n",
       "  ('consist molecules', 0.09),\n",
       "  ('changes brain', 0.0574),\n",
       "  ('worldwide', 0.0377),\n",
       "  ('distinction', 0.0332),\n",
       "  ('overwhelm', 0.0104),\n",
       "  ('synthetic sister', -0.0024),\n",
       "  ('state intermediary', -0.0152),\n",
       "  ('usually high', -0.0227),\n",
       "  ('index generates', -0.023),\n",
       "  ('drives', -0.0451),\n",
       "  ('acute neuronal', -0.0491),\n",
       "  ('does', -0.0562)],\n",
       " 'MED-1675': [('fructose intake', 0.6488),\n",
       "  ('metabolic factors', 0.5436),\n",
       "  ('graded steatosis', 0.4803),\n",
       "  ('fibrosis association', 0.4614),\n",
       "  ('liver disease', 0.426),\n",
       "  ('alcoholic steatohepatitis', 0.4144),\n",
       "  ('intake severity', 0.3998),\n",
       "  ('aims unhealthy', 0.3967),\n",
       "  ('hepatitis g1', 0.3953),\n",
       "  ('fatty', 0.3859),\n",
       "  ('genotype chronic', 0.3613),\n",
       "  ('patients food', 0.3059),\n",
       "  ('alterations severity', 0.2748),\n",
       "  ('diet 001', 0.2746),\n",
       "  ('02 hypercaloric', 0.2689),\n",
       "  ('risk factor', 0.2635),\n",
       "  ('alcoholic', 0.2196),\n",
       "  ('biopsies scored', 0.2176),\n",
       "  ('patients g1', 0.2059),\n",
       "  ('tested association', 0.1999),\n",
       "  ('cervical lipohypertrophy', 0.189),\n",
       "  ('01 fruit', 0.1876),\n",
       "  ('features nash', 0.1835),\n",
       "  ('chc tested', 0.1808),\n",
       "  ('study', 0.177),\n",
       "  ('circumference wc', 0.1764),\n",
       "  ('severe necroinflammatory', 0.1763),\n",
       "  ('2g respectively', 0.1694),\n",
       "  ('intake 147', 0.1582),\n",
       "  ('2013 european', 0.1506),\n",
       "  ('18 7g', 0.1359),\n",
       "  ('significantly higher', 0.1199),\n",
       "  ('hip ratio', 0.1146),\n",
       "  ('scheuer classification', 0.0993),\n",
       "  ('f3 reported', 0.0874),\n",
       "  ('older age', 0.084),\n",
       "  ('20 features', 0.0754),\n",
       "  ('34 multivariate', 0.0753),\n",
       "  ('total industrial', 0.0745),\n",
       "  ('homa assessed', 0.066),\n",
       "  ('257 003', 0.0658),\n",
       "  ('ci 004', 0.0658),\n",
       "  ('12 vs', 0.0543),\n",
       "  ('computed database', 0.0482),\n",
       "  ('bedossa classification', 0.04),\n",
       "  ('activity 325', 0.0367),\n",
       "  ('logistic', 0.027),\n",
       "  ('conclusions daily', 0.0132),\n",
       "  ('rights', -0.0042),\n",
       "  ('non', -0.0193)],\n",
       " 'MED-1676': [('starch suppress', 0.57),\n",
       "  ('reduced postprandial', 0.5626),\n",
       "  ('absorption starch', 0.5425),\n",
       "  ('meal studies', 0.5219),\n",
       "  ('suppress postprandial', 0.4852),\n",
       "  ('berries insulin', 0.4843),\n",
       "  ('postprandial glycemia', 0.481),\n",
       "  ('improved postprandial', 0.4775),\n",
       "  ('insulin responses', 0.4741),\n",
       "  ('reduced berries', 0.4695),\n",
       "  ('rb postprandial', 0.451),\n",
       "  ('lower insulin', 0.4489),\n",
       "  ('glucose metabolism', 0.436),\n",
       "  ('chokeberries study', 0.4345),\n",
       "  ('rye bread', 0.4248),\n",
       "  ('wb consumed', 0.3876),\n",
       "  ('profile breads', 0.3788),\n",
       "  ('compared wb', 0.3456),\n",
       "  ('white wheat', 0.3078),\n",
       "  ('responses rye', 0.3029),\n",
       "  ('studies suggest', 0.2949),\n",
       "  ('digestion', 0.2943),\n",
       "  ('polyphenol', 0.2932),\n",
       "  ('studies consumed', 0.2746),\n",
       "  ('strawberries', 0.2405),\n",
       "  ('bilberries cranberries', 0.2301),\n",
       "  ('mixture consumed', 0.2237),\n",
       "  ('reduced', 0.2232),\n",
       "  ('reference study', 0.2042),\n",
       "  ('humans limited', 0.1987),\n",
       "  ('limited investigated', 0.1967),\n",
       "  ('150', 0.1868),\n",
       "  ('36 berry', 0.1813),\n",
       "  ('lingonberries', 0.1774),\n",
       "  ('randomized controlled', 0.1677),\n",
       "  ('lower vitro', 0.1614),\n",
       "  ('responses healthy', 0.1409),\n",
       "  ('evidence humans', 0.1235),\n",
       "  ('slightly', 0.1156),\n",
       "  ('females', 0.0906),\n",
       "  ('rich', 0.0891),\n",
       "  ('38', 0.0781),\n",
       "  ('crossover', 0.0467),\n",
       "  ('rb 19', 0.0402),\n",
       "  ('served', 0.0398),\n",
       "  ('maintenance normal', 0.0324),\n",
       "  ('13', 0.0242),\n",
       "  ('blackcurrants', 0.0039),\n",
       "  ('20 participated', 0.0038),\n",
       "  ('induces', -0.0369)],\n",
       " 'MED-1677': [('lifestyle factors', 0.5569),\n",
       "  ('cohort study', 0.4254),\n",
       "  ('health study', 0.4217),\n",
       "  ('risk coronary', 0.4131),\n",
       "  ('study diet', 0.4059),\n",
       "  ('men health', 0.3489),\n",
       "  ('factors associated', 0.3341),\n",
       "  ('associated reduced', 0.3232),\n",
       "  ('adherence low', 0.3231),\n",
       "  ('diabetes', 0.3103),\n",
       "  ('combination healthy', 0.3045),\n",
       "  ('total cardiovascular', 0.2948),\n",
       "  ('diseases beneficial', 0.2894),\n",
       "  ('stroke prevented', 0.2874),\n",
       "  ('prevention', 0.2866),\n",
       "  ('study 43', 0.2791),\n",
       "  ('nurses health', 0.2704),\n",
       "  ('chronic', 0.2666),\n",
       "  ('95 ci', 0.2514),\n",
       "  ('685 men', 0.2167),\n",
       "  ('243 women', 0.2124),\n",
       "  ('disease little', 0.2031),\n",
       "  ('study 71', 0.1985),\n",
       "  ('smoking body', 0.1977),\n",
       "  ('mass index', 0.1888),\n",
       "  ('75 ischemic', 0.1771),\n",
       "  ('853', 0.1766),\n",
       "  ('prevented conclusions', 0.1728),\n",
       "  ('women 15g', 0.1649),\n",
       "  ('alcohol modestly', 0.1627),\n",
       "  ('activity consuming', 0.1489),\n",
       "  ('impact multiple', 0.1426),\n",
       "  ('58 total', 0.1321),\n",
       "  ('40 ischemic', 0.1279),\n",
       "  ('ci 12', 0.125),\n",
       "  ('1559', 0.1141),\n",
       "  ('little known', 0.1096),\n",
       "  ('updated self', 0.1045),\n",
       "  ('600', 0.1036),\n",
       "  ('cases attributable', 0.0992),\n",
       "  ('36 total', 0.0965),\n",
       "  ('994', 0.0856),\n",
       "  ('161', 0.0851),\n",
       "  ('day moderate', 0.0847),\n",
       "  ('men relative', 0.0645),\n",
       "  ('questionnaires defined', 0.0644),\n",
       "  ('278 hemorrhagic', 0.0564),\n",
       "  ('25 kg', 0.0141),\n",
       "  ('18', 0.0021),\n",
       "  ('10', -0.0326)],\n",
       " 'MED-1678': [('lifestyle factors', 0.4451),\n",
       "  ('mi women', 0.4427),\n",
       "  ('mammography cohort', 0.4407),\n",
       "  ('women low', 0.4339),\n",
       "  ('women preventable', 0.4312),\n",
       "  ('identified dietary', 0.3729),\n",
       "  ('mi low', 0.3581),\n",
       "  ('prevention myocardial', 0.3265),\n",
       "  ('postmenopausal', 0.3189),\n",
       "  ('preventable consuming', 0.3174),\n",
       "  ('background limited', 0.2969),\n",
       "  ('24 444', 0.2725),\n",
       "  ('associated decreased', 0.2699),\n",
       "  ('smoking maintaining', 0.2487),\n",
       "  ('compared findings', 0.2298),\n",
       "  ('diagnosed cancer', 0.228),\n",
       "  ('patterns healthy', 0.2238),\n",
       "  ('intake vegetables', 0.2209),\n",
       "  ('nonsmoking', 0.2109),\n",
       "  ('cardiovascular disease', 0.2097),\n",
       "  ('mis study', 0.2012),\n",
       "  ('population based', 0.1976),\n",
       "  ('exercise results', 0.1889),\n",
       "  ('mellitus', 0.1834),\n",
       "  ('cohort free', 0.1797),\n",
       "  ('benefit combining', 0.1696),\n",
       "  ('healthy alcohol', 0.1649),\n",
       "  ('significantly associated', 0.1542),\n",
       "  ('swedish', 0.1486),\n",
       "  ('moderate amounts', 0.1461),\n",
       "  ('factor analysis', 0.1423),\n",
       "  ('risk behavior', 0.1401),\n",
       "  ('hip ratio', 0.1395),\n",
       "  ('waist', 0.1365),\n",
       "  ('95 confidence', 0.1312),\n",
       "  ('interval 72', 0.1181),\n",
       "  ('active 40', 0.1132),\n",
       "  ('fruit grains', 0.107),\n",
       "  ('fish legumes', 0.0992),\n",
       "  ('75th percentile', 0.0992),\n",
       "  ('bicycling', 0.0981),\n",
       "  ('years follow', 0.0942),\n",
       "  ('308 cases', 0.0825),\n",
       "  ('baseline september', 0.0824),\n",
       "  ('77 mis', 0.0816),\n",
       "  ('15', 0.076),\n",
       "  ('data available', 0.0749),\n",
       "  ('walking', 0.0677),\n",
       "  ('years 151', 0.0589),\n",
       "  ('hour weekly', 0.0337)],\n",
       " 'MED-1679': [('lifestyle factors', 0.54),\n",
       "  ('improving lipids', 0.5156),\n",
       "  ('chd risk', 0.4916),\n",
       "  ('eating prudent', 0.4773),\n",
       "  ('chd avoided', 0.4646),\n",
       "  ('reduce coronary', 0.4629),\n",
       "  ('adherence modifiable', 0.4106),\n",
       "  ('managing weight', 0.3961),\n",
       "  ('hypercholesterolemia 57', 0.3885),\n",
       "  ('risk factors', 0.3777),\n",
       "  ('coronary events', 0.3562),\n",
       "  ('risk improving', 0.3378),\n",
       "  ('blood pressure', 0.3122),\n",
       "  ('avoided adherence', 0.3056),\n",
       "  ('men preventable', 0.2964),\n",
       "  ('diet score', 0.2909),\n",
       "  ('health professionals', 0.2866),\n",
       "  ('background healthy', 0.2515),\n",
       "  ('low risk', 0.2461),\n",
       "  ('smoking body', 0.2396),\n",
       "  ('nonfatal', 0.2294),\n",
       "  ('taking medications', 0.2197),\n",
       "  ('changes follow', 0.2151),\n",
       "  ('exercising', 0.2128),\n",
       "  ('hazards models', 0.2061),\n",
       "  ('moderate alcohol', 0.1889),\n",
       "  ('middle aged', 0.1841),\n",
       "  ('factors burden', 0.1761),\n",
       "  ('75 years', 0.1715),\n",
       "  ('prospectively monitored', 0.15),\n",
       "  ('95 confidence', 0.1458),\n",
       "  ('multivariate adjusted', 0.1434),\n",
       "  ('43 lower', 0.141),\n",
       "  ('1986 lifestyle', 0.1181),\n",
       "  ('updated self', 0.1111),\n",
       "  ('30 40', 0.1099),\n",
       "  ('13', 0.1),\n",
       "  ('kg m2', 0.083),\n",
       "  ('16 years', 0.0825),\n",
       "  ('25 kg', 0.0753),\n",
       "  ('847 men', 0.0736),\n",
       "  ('did make', 0.0731),\n",
       "  ('conclusions majority', 0.0722),\n",
       "  ('disease', 0.0708),\n",
       "  ('cox', 0.0621),\n",
       "  ('additional', 0.0572),\n",
       "  ('proportional', 0.0465),\n",
       "  ('2183 incident', 0.0254),\n",
       "  ('questionnaires low', 0.0248),\n",
       "  ('19 compared', 0.013)],\n",
       " 'MED-1680': [('risk coronary', 0.4076),\n",
       "  ('factors largely', 0.3026),\n",
       "  ('disease regions', 0.2955),\n",
       "  ('income countries', 0.2766),\n",
       "  ('study acute', 0.2666),\n",
       "  ('global burden', 0.2597),\n",
       "  ('low income', 0.2575),\n",
       "  ('countries knowledge', 0.2437),\n",
       "  ('infarction 0001', 0.2432),\n",
       "  ('potential prevent', 0.2373),\n",
       "  ('background 80', 0.2113),\n",
       "  ('psychosocial factors', 0.2073),\n",
       "  ('hypertension 91', 0.199),\n",
       "  ('alcohol associations', 0.1956),\n",
       "  ('smoking history', 0.1955),\n",
       "  ('young regions', 0.1921),\n",
       "  ('largely derived', 0.1881),\n",
       "  ('apolipoproteins apo', 0.1865),\n",
       "  ('population attributable', 0.1864),\n",
       "  ('waist hip', 0.1613),\n",
       "  ('13 lack', 0.1545),\n",
       "  ('cis association', 0.1498),\n",
       "  ('dietary patterns', 0.145),\n",
       "  ('standardised case', 0.1416),\n",
       "  ('94 women', 0.1321),\n",
       "  ('odds ratios', 0.122),\n",
       "  ('14820 controls', 0.1206),\n",
       "  ('17 diabetes', 0.1169),\n",
       "  ('methods', 0.114),\n",
       "  ('current vs', 0.1104),\n",
       "  ('women old', 0.1076),\n",
       "  ('factors 03', 0.0922),\n",
       "  ('world unknown', 0.089),\n",
       "  ('premature cases', 0.082),\n",
       "  ('quintiles vs', 0.0812),\n",
       "  ('significantly related', 0.0806),\n",
       "  ('37', 0.08),\n",
       "  ('enrolled relation', 0.0599),\n",
       "  ('continent 15152', 0.0581),\n",
       "  ('physical activity', 0.0442),\n",
       "  ('25 vs', 0.0378),\n",
       "  ('interpretation abnormal', 0.0317),\n",
       "  ('inhabited', 0.0095),\n",
       "  ('62 middle', -0.001),\n",
       "  ('sexes ages', -0.0013),\n",
       "  ('32 daily', -0.0081),\n",
       "  ('12 significantly', -0.0245),\n",
       "  ('blood', -0.0434),\n",
       "  ('raised', -0.0475),\n",
       "  ('noted men', -0.0659)],\n",
       " 'MED-1681': [('diabetes adjustment', 0.4845),\n",
       "  ('diabetes lack', 0.4774),\n",
       "  ('dietary lifestyle', 0.4013),\n",
       "  ('cohort women', 0.3876),\n",
       "  ('nurses 1980', 0.3838),\n",
       "  ('previous studies', 0.3767),\n",
       "  ('941 female', 0.3588),\n",
       "  ('conclusions findings', 0.324),\n",
       "  ('cardiovascular disease', 0.2725),\n",
       "  ('cancer base', 0.2644),\n",
       "  ('lack exercise', 0.2433),\n",
       "  ('obesity single', 0.243),\n",
       "  ('methods followed', 0.2406),\n",
       "  ('25 diet', 0.2385),\n",
       "  ('periodically low', 0.2286),\n",
       "  ('factors largely', 0.2283),\n",
       "  ('updated periodically', 0.2106),\n",
       "  ('trans fat', 0.2061),\n",
       "  ('1996', 0.2054),\n",
       "  ('interval 83', 0.2028),\n",
       "  ('smoking consumption', 0.2014),\n",
       "  ('variables bodymass', 0.1847),\n",
       "  ('years follow', 0.1799),\n",
       "  ('prevented adoption', 0.1728),\n",
       "  ('combined effects', 0.1625),\n",
       "  ('healthier', 0.1615),\n",
       "  ('compared rest', 0.1565),\n",
       "  ('background', 0.1564),\n",
       "  ('did conform', 0.1559),\n",
       "  ('risk group', 0.1499),\n",
       "  ('examined individual', 0.1267),\n",
       "  ('free diagnosed', 0.1212),\n",
       "  ('use associated', 0.1194),\n",
       "  ('interval 05', 0.1164),\n",
       "  ('line information', 0.1091),\n",
       "  ('largely unknown', 0.1068),\n",
       "  ('day current', 0.1032),\n",
       "  ('index compared', 0.0999),\n",
       "  ('support hypothesis', 0.0979),\n",
       "  ('half drink', 0.0959),\n",
       "  ('relation type', 0.0806),\n",
       "  ('kilograms divided', 0.0782),\n",
       "  ('blood', 0.0754),\n",
       "  ('new', 0.0542),\n",
       "  ('17 total', 0.0533),\n",
       "  ('square', 0.0118),\n",
       "  ('high cereal', 0.0089),\n",
       "  ('vigorous', -0.0119),\n",
       "  ('fiber', -0.0249),\n",
       "  ('documented 3300', -0.0529)],\n",
       " 'MED-1682': [('supplementation trials', 0.4867),\n",
       "  ('vitamins consequence', 0.4113),\n",
       "  ('vitamin increased', 0.3791),\n",
       "  ('effects diets', 0.3758),\n",
       "  ('background health', 0.3548),\n",
       "  ('oxidative status', 0.3508),\n",
       "  ('fruits vegetables', 0.3337),\n",
       "  ('isolated antioxidants', 0.3268),\n",
       "  ('plasma triglycerides', 0.3162),\n",
       "  ('chronic disease', 0.3056),\n",
       "  ('effect biomarkers', 0.2993),\n",
       "  ('consumption strengthens', 0.2869),\n",
       "  ('carotenoids ferric', 0.271),\n",
       "  ('effects dna', 0.2636),\n",
       "  ('decreased kiwifruit', 0.2596),\n",
       "  ('consumption malondialdehyde', 0.2587),\n",
       "  ('h2o2 induced', 0.2261),\n",
       "  ('actinidia chinensis', 0.2238),\n",
       "  ('plasma levels', 0.2154),\n",
       "  ('kiwifruit actinidia', 0.2098),\n",
       "  ('human intervention', 0.1738),\n",
       "  ('trials isolated', 0.1684),\n",
       "  ('reducing activity', 0.1577),\n",
       "  ('positive effects', 0.1564),\n",
       "  ('emphasis', 0.1518),\n",
       "  ('cross study', 0.1462),\n",
       "  ('lesions modification', 0.1422),\n",
       "  ('shifted foods', 0.1387),\n",
       "  ('methods carried', 0.1347),\n",
       "  ('prevention shifted', 0.1338),\n",
       "  ('did resistance', 0.13),\n",
       "  ('frap measured', 0.1287),\n",
       "  ('generally replicated', 0.1134),\n",
       "  ('healthy volunteers', 0.1073),\n",
       "  ('oxidation lymphocyte', 0.0984),\n",
       "  ('aggregation hypothesis', 0.0954),\n",
       "  ('affected', 0.0932),\n",
       "  ('comet assay', 0.088),\n",
       "  ('lasting weeks', 0.0719),\n",
       "  ('conclusion golden', 0.0484),\n",
       "  ('measure specific', 0.041),\n",
       "  ('endogenous', 0.0409),\n",
       "  ('blood', 0.0382),\n",
       "  ('pyrimidine', 0.0341),\n",
       "  ('day', 0.0338),\n",
       "  ('allowed estimation', 0.0249),\n",
       "  ('base excision', 0.0186),\n",
       "  ('products', 0.0146),\n",
       "  ('stability', -0.0015),\n",
       "  ('carried human', -0.0032)],\n",
       " 'MED-1683': [('platelets atherogenesis', 0.7819),\n",
       "  ('platelets involved', 0.7635),\n",
       "  ('activated platelets', 0.754),\n",
       "  ('platelets endothelial', 0.7277),\n",
       "  ('interaction platelets', 0.7157),\n",
       "  ('platelet function', 0.6924),\n",
       "  ('platelets unite', 0.6729),\n",
       "  ('cells platelets', 0.6574),\n",
       "  ('effect platelet', 0.6417),\n",
       "  ('inhibition platelet', 0.551),\n",
       "  ('platelets resting', 0.5502),\n",
       "  ('activated endothelium', 0.5388),\n",
       "  ('platelet anti', 0.5297),\n",
       "  ('thrombotic process', 0.5119),\n",
       "  ('achieved antiplatelet', 0.4831),\n",
       "  ('process atherogenesis', 0.4797),\n",
       "  ('endothelial protection', 0.4508),\n",
       "  ('involved arterial', 0.4081),\n",
       "  ('prevention atherothrombosis', 0.4023),\n",
       "  ('role inflammatory', 0.3207),\n",
       "  ('tomatoes platelet', 0.3134),\n",
       "  ('intact endothelial', 0.3067),\n",
       "  ('aggregation contribute', 0.2994),\n",
       "  ('function adhesion', 0.2854),\n",
       "  ('cardiovascular morbidity', 0.256),\n",
       "  ('mechanisms action', 0.2526),\n",
       "  ('anti aggregation', 0.2481),\n",
       "  ('resting adhere', 0.2296),\n",
       "  ('cells', 0.2041),\n",
       "  ('activated', 0.182),\n",
       "  ('recent years', 0.1566),\n",
       "  ('beginning interaction', 0.1283),\n",
       "  ('context inhibition', 0.1217),\n",
       "  ('contribute prevention', 0.1135),\n",
       "  ('play active', 0.107),\n",
       "  ('agents public', 0.1061),\n",
       "  ('beneficial effects', 0.0938),\n",
       "  ('unite intact', 0.0863),\n",
       "  ('shown exert', 0.0776),\n",
       "  ('level primary', 0.0755),\n",
       "  ('health article', 0.0752),\n",
       "  ('discusses involvement', 0.0598),\n",
       "  ('occurs manners', 0.0583),\n",
       "  ('leading', 0.0474),\n",
       "  ('healthy diet', 0.0287),\n",
       "  ('briefly discusses', 0.0284),\n",
       "  ('morbidity achieved', 0.0255),\n",
       "  ('consumption', 0.0168),\n",
       "  ('solanum lycopersicum', -0.0775),\n",
       "  ('stands', -0.0815)],\n",
       " 'MED-1685': [('tomato extract', 0.5861),\n",
       "  ('fruits tested', 0.4738),\n",
       "  ('juice inhibited', 0.3962),\n",
       "  ('apple little', 0.3245),\n",
       "  ('100 juice', 0.3081),\n",
       "  ('compounds inhibit', 0.2726),\n",
       "  ('inhibited adp', 0.2521),\n",
       "  ('strawberry pear', 0.245),\n",
       "  ('tested vitro', 0.2404),\n",
       "  ('platelet compounds', 0.2402),\n",
       "  ('inhibit thrombin', 0.2266),\n",
       "  ('acid induced', 0.2232),\n",
       "  ('unlike aspirin', 0.2031),\n",
       "  ('water soluble', 0.1943),\n",
       "  ('contained adenosine', 0.1858),\n",
       "  ('extract', 0.1855),\n",
       "  ('fluid seeds', 0.1698),\n",
       "  ('20 50', 0.1599),\n",
       "  ('followed grapefruit', 0.1485),\n",
       "  ('collagen induced', 0.1447),\n",
       "  ('completely abolished', 0.1262),\n",
       "  ('contains potent', 0.1223),\n",
       "  ('contain anti', 0.1185),\n",
       "  ('studies indicated', 0.117),\n",
       "  ('consuming', 0.1108),\n",
       "  ('unaffected results', 0.1084),\n",
       "  ('arachidonic acid', 0.1064),\n",
       "  ('fractionated peaks', 0.1057),\n",
       "  ('remained', 0.0956),\n",
       "  ('induced aggregation', 0.0943),\n",
       "  ('using gel', 0.086),\n",
       "  ('little activity', 0.0842),\n",
       "  ('70', 0.0839),\n",
       "  ('cardiovascular disease', 0.0737),\n",
       "  ('stable concentrated', 0.0611),\n",
       "  ('yellow', 0.0607),\n",
       "  ('xg supernatant', 0.0476),\n",
       "  ('reversed phase', 0.0412),\n",
       "  ('biogel', 0.0384),\n",
       "  ('mass', 0.0348),\n",
       "  ('synthesis similar', 0.0333),\n",
       "  ('spectroscopy studies', 0.0312),\n",
       "  ('column activity', 0.0252),\n",
       "  ('highest', 0.0231),\n",
       "  ('mw 1000', -0.0021),\n",
       "  ('f2 obtained', -0.0069),\n",
       "  ('110 000', -0.0079),\n",
       "  ('da', -0.0283),\n",
       "  ('cytidine deamination', -0.0296),\n",
       "  ('therapeutic regime', -0.0305)],\n",
       " 'MED-1686': [('cardiovascular antioxidant', 0.6075),\n",
       "  ('vegetables cardiovascular', 0.6064),\n",
       "  ('affect cardiovascular', 0.5061),\n",
       "  ('fruit vegetables', 0.4782),\n",
       "  ('vegetable components', 0.4668),\n",
       "  ('prevention cardiovascular', 0.4305),\n",
       "  ('lowering cardiovascular', 0.4189),\n",
       "  ('dietary means', 0.4121),\n",
       "  ('effects consumption', 0.4008),\n",
       "  ('beneficial effects', 0.3979),\n",
       "  ('mechanisms actions', 0.3691),\n",
       "  ('present fruits', 0.3447),\n",
       "  ('components affect', 0.3434),\n",
       "  ('understood compounds', 0.3302),\n",
       "  ('oxidation mechanisms', 0.3298),\n",
       "  ('protect lipoproteins', 0.3246),\n",
       "  ('risk factors', 0.2995),\n",
       "  ('mechanisms reducing', 0.2961),\n",
       "  ('nonantioxidant ways', 0.2953),\n",
       "  ('disease consumption', 0.2932),\n",
       "  ('preventive therapeutic', 0.2875),\n",
       "  ('lipids', 0.287),\n",
       "  ('effects', 0.2747),\n",
       "  ('vascular cells', 0.2575),\n",
       "  ('studies suggest', 0.237),\n",
       "  ('factors kiwifruit', 0.2144),\n",
       "  ('blood pressure', 0.2092),\n",
       "  ('human health', 0.1969),\n",
       "  ('factors relevance', 0.1929),\n",
       "  ('reducing plasma', 0.1921),\n",
       "  ('ways', 0.1583),\n",
       "  ('relevance lowering', 0.1526),\n",
       "  ('platelet hyperactivity', 0.1441),\n",
       "  ('protect', 0.1312),\n",
       "  ('days lowers', 0.1266),\n",
       "  ('human volunteers', 0.1126),\n",
       "  ('blood', 0.0779),\n",
       "  ('pressure human', 0.075),\n",
       "  ('levels high', 0.0748),\n",
       "  ('emerging data', 0.0704),\n",
       "  ('day', 0.0663),\n",
       "  ('28', 0.0577),\n",
       "  ('function', 0.0531),\n",
       "  ('strategy favorably', 0.051),\n",
       "  ('provide new', 0.043),\n",
       "  ('present', 0.0424),\n",
       "  ('rights reserved', 0.0413),\n",
       "  ('discussed copyright', -0.0022),\n",
       "  ('2013 elsevier', -0.0141),\n",
       "  ('individually concert', -0.0581)],\n",
       " 'MED-1687': [('herbs inhibit', 0.5021),\n",
       "  ('extract herbs', 0.4917),\n",
       "  ('28 herbs', 0.416),\n",
       "  ('extracts', 0.37),\n",
       "  ('potent anti', 0.3613),\n",
       "  ('inhibited thromboxane', 0.3609),\n",
       "  ('nutriceuticals investigated', 0.3598),\n",
       "  ('anti platelet', 0.3597),\n",
       "  ('garlic onion', 0.3403),\n",
       "  ('effect aqueous', 0.3351),\n",
       "  ('05 herbs', 0.3214),\n",
       "  ('properties inhibitory', 0.3045),\n",
       "  ('alfalfa inhibited', 0.2833),\n",
       "  ('potent inhibitor', 0.2729),\n",
       "  ('levels platelets', 0.2529),\n",
       "  ('acid thrombin', 0.2502),\n",
       "  ('arachidonic', 0.2419),\n",
       "  ('onion exhibited', 0.2413),\n",
       "  ('exhibited significant', 0.2247),\n",
       "  ('45 inhibition', 0.2221),\n",
       "  ('camomile 30', 0.2218),\n",
       "  ('vitro investigated', 0.2158),\n",
       "  ('actions mediated', 0.2155),\n",
       "  ('different mechanisms', 0.213),\n",
       "  ('investigated 28', 0.2109),\n",
       "  ('blood aggregation', 0.2042),\n",
       "  ('aggregation 84', 0.199),\n",
       "  ('camomile nettle', 0.1929),\n",
       "  ('alfalfa fresh', 0.1885),\n",
       "  ('acid', 0.174),\n",
       "  ('inhibitor 66', 0.162),\n",
       "  ('aggregation contrast', 0.1561),\n",
       "  ('synthesis', 0.1514),\n",
       "  ('35 respectively', 0.1495),\n",
       "  ('30 compared', 0.1483),\n",
       "  ('nm 005', 0.1342),\n",
       "  ('increased cgmp', 0.1243),\n",
       "  ('compared control', 0.1236),\n",
       "  ('control', 0.1086),\n",
       "  ('data indicate', 0.0939),\n",
       "  ('65 60', 0.0914),\n",
       "  ('increased', 0.0747),\n",
       "  ('respectively compared', 0.0671),\n",
       "  ('adp', 0.0557),\n",
       "  ('23 nm', 0.0271),\n",
       "  ('human', 0.0225),\n",
       "  ('collagen followed', 0.0193),\n",
       "  ('b2', -0.0007),\n",
       "  ('52', -0.0028),\n",
       "  ('fresh', -0.019)],\n",
       " 'MED-1688': [('extracts tomatoes', 0.6253),\n",
       "  ('aqueous extracts', 0.4111),\n",
       "  ('vivo platelet', 0.3315),\n",
       "  ('antiplatelet activities', 0.3177),\n",
       "  ('extract equivalent', 0.3076),\n",
       "  ('significant effects', 0.2684),\n",
       "  ('control supplements', 0.2645),\n",
       "  ('blinded placebo', 0.2564),\n",
       "  ('reducing platelet', 0.2558),\n",
       "  ('active components', 0.251),\n",
       "  ('background aqueous', 0.235),\n",
       "  ('reactive protein', 0.2265),\n",
       "  ('dose response', 0.2204),\n",
       "  ('study conducted', 0.214),\n",
       "  ('thrombotic', 0.2064),\n",
       "  ('functional food', 0.2042),\n",
       "  ('2te 001', 0.1959),\n",
       "  ('ex vivo', 0.1938),\n",
       "  ('cardiovascular disease', 0.1886),\n",
       "  ('vitro previously', 0.1836),\n",
       "  ('design randomized', 0.1833),\n",
       "  ('homocysteine', 0.1777),\n",
       "  ('evaluate suitability', 0.1753),\n",
       "  ('human subjects', 0.173),\n",
       "  ('stimulation inhibition', 0.1712),\n",
       "  ('double', 0.1684),\n",
       "  ('disease reducing', 0.1606),\n",
       "  ('function measured', 0.1593),\n",
       "  ('micromol adp', 0.1531),\n",
       "  ('001 mg', 0.1528),\n",
       "  ('objective objective', 0.1384),\n",
       "  ('dose 21', 0.1361),\n",
       "  ('agonist', 0.1349),\n",
       "  ('measured consumption', 0.1291),\n",
       "  ('primary prevention', 0.1287),\n",
       "  ('reductions ex', 0.1207),\n",
       "  ('alter', 0.1169),\n",
       "  ('aggregation induced', 0.1104),\n",
       "  ('changes baseline', 0.1104),\n",
       "  ('14 007', 0.0887),\n",
       "  ('healthy human', 0.0754),\n",
       "  ('low levels', 0.069),\n",
       "  ('highest plasma', 0.0665),\n",
       "  ('mg collagen', 0.0514),\n",
       "  ('display range', 0.0407),\n",
       "  ('controlled crossover', 0.0398),\n",
       "  ('6te high', 0.0283),\n",
       "  ('conducted 90', 0.0126),\n",
       "  ('05', 0.0038),\n",
       "  ('12', -0.0484)],\n",
       " 'MED-1689': [('processed tomatoes', 0.6747),\n",
       "  ('effect tomato', 0.6157),\n",
       "  ('red tomatoes', 0.4761),\n",
       "  ('vegetables', 0.4304),\n",
       "  ('consumption fruits', 0.4241),\n",
       "  ('processed foods', 0.3594),\n",
       "  ('includes thermal', 0.3074),\n",
       "  ('phenolic profile', 0.2973),\n",
       "  ('industrial processing', 0.2796),\n",
       "  ('different extracts', 0.2631),\n",
       "  ('products inhibit', 0.2431),\n",
       "  ('chlorogenic caffeic', 0.2196),\n",
       "  ('regular consumption', 0.2187),\n",
       "  ('juice', 0.2083),\n",
       "  ('antithrombotic activity', 0.2053),\n",
       "  ('cardiovascular', 0.2037),\n",
       "  ('shown beneficial', 0.1979),\n",
       "  ('ferulic', 0.1938),\n",
       "  ('terms reducing', 0.188),\n",
       "  ('assessed effect', 0.1876),\n",
       "  ('sauce', 0.1855),\n",
       "  ('based products', 0.1828),\n",
       "  ('ingredient adding', 0.1826),\n",
       "  ('diseases industrial', 0.1691),\n",
       "  ('conclusions processed', 0.1661),\n",
       "  ('treatments', 0.1649),\n",
       "  ('acid different', 0.1558),\n",
       "  ('extracts platelet', 0.1385),\n",
       "  ('collagen thrombin', 0.1348),\n",
       "  ('health benefiting', 0.1332),\n",
       "  ('little known', 0.131),\n",
       "  ('hplc analysis', 0.1253),\n",
       "  ('compounds selected', 0.1249),\n",
       "  ('extent pomace', 0.1144),\n",
       "  ('used functional', 0.1083),\n",
       "  ('background', 0.1067),\n",
       "  ('fresh ones', 0.0955),\n",
       "  ('induced adenosine', 0.0776),\n",
       "  ('inhibited platelet', 0.0692),\n",
       "  ('vivo model', 0.0588),\n",
       "  ('peptide arachidonic', 0.0542),\n",
       "  ('ketchup', 0.0429),\n",
       "  ('higher content', 0.0343),\n",
       "  ('diphosphate', 0.0336),\n",
       "  ('results natural', 0.0226),\n",
       "  ('trap', 0.0097),\n",
       "  ('presents best', -0.0172),\n",
       "  ('aggregation induced', -0.0547),\n",
       "  ('coumaric', -0.0562),\n",
       "  ('red', -0.0589)],\n",
       " 'MED-1690': [('tomato extracts', 0.5832),\n",
       "  ('extracts inhibit', 0.4517),\n",
       "  ('antithrombotic agents', 0.4288),\n",
       "  ('reported cardioprotective', 0.4073),\n",
       "  ('mechanisms action', 0.3301),\n",
       "  ('extract onset', 0.292),\n",
       "  ('known active', 0.2903),\n",
       "  ('modulation platelet', 0.2816),\n",
       "  ('duration antiplatelet', 0.2719),\n",
       "  ('inhibition glycoprotein', 0.2688),\n",
       "  ('observed effects', 0.2681),\n",
       "  ('components isolated', 0.248),\n",
       "  ('cardiovascular disease', 0.2401),\n",
       "  ('objectives study', 0.2286),\n",
       "  ('20 suboptimal', 0.2252),\n",
       "  ('collagen thrombin', 0.2132),\n",
       "  ('vivo efficacy', 0.2012),\n",
       "  ('effects persisted', 0.1989),\n",
       "  ('baseline platelet', 0.1989),\n",
       "  ('aggregation vitro', 0.191),\n",
       "  ('little known', 0.1892),\n",
       "  ('agents influence', 0.1728),\n",
       "  ('primary prevention', 0.17),\n",
       "  ('conclusions ingestion', 0.1694),\n",
       "  ('disease previous', 0.1575),\n",
       "  ('affected conclusions', 0.1525),\n",
       "  ('humans design', 0.142),\n",
       "  ('background natural', 0.1385),\n",
       "  ('potentially', 0.1382),\n",
       "  ('significantly affects', 0.1368),\n",
       "  ('appears linked', 0.1365),\n",
       "  ('function potential', 0.1351),\n",
       "  ('experimentation', 0.135),\n",
       "  ('001', 0.1321),\n",
       "  ('time', 0.1307),\n",
       "  ('supplement drink', 0.1291),\n",
       "  ('human subjects', 0.1257),\n",
       "  ('optimal adp', 0.1255),\n",
       "  ('secretory mechanisms', 0.0982),\n",
       "  ('arachidonate', 0.0861),\n",
       "  ('23 determine', 0.0749),\n",
       "  ('reports showed', 0.0716),\n",
       "  ('carried cannulated', 0.0657),\n",
       "  ('activity significantly', 0.0588),\n",
       "  ('12 coagulation', 0.0557),\n",
       "  ('concentrations 03', 0.0427),\n",
       "  ('equivalent', 0.014),\n",
       "  ('iib iiia', 0.0034),\n",
       "  ('human', -0.0049),\n",
       "  ('healthy', -0.0205)],\n",
       " 'MED-1691': [('increased prothrombotic', 0.7574),\n",
       "  ('prothrombotic tendency', 0.7096),\n",
       "  ('thromboembolism platelet', 0.6564),\n",
       "  ('determining prothrombotic', 0.6267),\n",
       "  ('reduce prothrombotic', 0.6139),\n",
       "  ('thrombotic diseases', 0.5724),\n",
       "  ('platelet aggregation', 0.5461),\n",
       "  ('risk thrombosis', 0.5211),\n",
       "  ('including bleeding', 0.464),\n",
       "  ('aspirin heparin', 0.4546),\n",
       "  ('cardiovascular disease', 0.4174),\n",
       "  ('supplements platelet', 0.4067),\n",
       "  ('major risk', 0.3844),\n",
       "  ('warfarin able', 0.3787),\n",
       "  ('pharmaceutical agents', 0.3746),\n",
       "  ('aggregation risk', 0.3739),\n",
       "  ('heart attacks', 0.3604),\n",
       "  ('decreasing platelet', 0.3564),\n",
       "  ('bleeding diet', 0.3363),\n",
       "  ('diseases influence', 0.3055),\n",
       "  ('term drug', 0.2988),\n",
       "  ('lipid levels', 0.29),\n",
       "  ('disorders probably', 0.2623),\n",
       "  ('factor development', 0.2588),\n",
       "  ('strokes venous', 0.2494),\n",
       "  ('various mechanisms', 0.2239),\n",
       "  ('development heart', 0.1971),\n",
       "  ('levels essential', 0.1913),\n",
       "  ('influence treatment', 0.1773),\n",
       "  ('attacks', 0.1721),\n",
       "  ('supplements', 0.1697),\n",
       "  ('review role', 0.1643),\n",
       "  ('modifying individual', 0.1547),\n",
       "  ('long term', 0.1533),\n",
       "  ('increased', 0.1409),\n",
       "  ('able reduce', 0.1362),\n",
       "  ('probably important', 0.1297),\n",
       "  ('medical publishers', 0.1296),\n",
       "  ('activation', 0.1277),\n",
       "  ('state major', 0.1184),\n",
       "  ('nutrient nonnutrient', 0.1161),\n",
       "  ('attenuating future', 0.1102),\n",
       "  ('tendency', 0.093),\n",
       "  ('serum', 0.086),\n",
       "  ('effective', 0.0509),\n",
       "  ('play', 0.0203),\n",
       "  ('recognized significantly', 0.0136),\n",
       "  ('provides date', -0.0148),\n",
       "  ('thieme', -0.0335),\n",
       "  ('produce variety', -0.0457)],\n",
       " 'MED-1693': [('nutrients tomatoes', 0.684),\n",
       "  ('tomatoes second', 0.6375),\n",
       "  ('increased lycopene', 0.4406),\n",
       "  ('consumed vegetable', 0.4188),\n",
       "  ('beta carotene', 0.3612),\n",
       "  ('flavonoids', 0.3024),\n",
       "  ('include nutrients', 0.2926),\n",
       "  ('cardiovascular disease', 0.2921),\n",
       "  ('vitamin processing', 0.277),\n",
       "  ('western world', 0.2561),\n",
       "  ('cardioprotective functions', 0.2545),\n",
       "  ('consumption antioxidant', 0.2482),\n",
       "  ('widely consumed', 0.2295),\n",
       "  ('affect bioavailability', 0.2278),\n",
       "  ('diet believed', 0.2112),\n",
       "  ('genesis atherosclerosis', 0.2099),\n",
       "  ('complex role', 0.208),\n",
       "  ('risk consumption', 0.1966),\n",
       "  ('second produced', 0.1953),\n",
       "  ('vivo epidemiological', 0.1926),\n",
       "  ('disease leading', 0.1858),\n",
       "  ('effects widely', 0.1853),\n",
       "  ('protect lipoproteins', 0.171),\n",
       "  ('cholesterol', 0.169),\n",
       "  ('nutrients homogenization', 0.1664),\n",
       "  ('folate potassium', 0.1638),\n",
       "  ('homocysteine platelet', 0.1525),\n",
       "  ('cells oxidation', 0.148),\n",
       "  ('variety maturity', 0.1331),\n",
       "  ('produced consumed', 0.1251),\n",
       "  ('content affected', 0.1067),\n",
       "  ('associated theoretical', 0.1017),\n",
       "  ('significant loss', 0.0997),\n",
       "  ('leads increased', 0.0945),\n",
       "  ('studies associate', 0.0838),\n",
       "  ('oil processed', 0.0824),\n",
       "  ('hypothesis supported', 0.0812),\n",
       "  ('blood pressure', 0.0654),\n",
       "  ('nationwide rich', 0.0645),\n",
       "  ('processes', 0.0473),\n",
       "  ('year round', 0.0377),\n",
       "  ('vascular cells', 0.0318),\n",
       "  ('believed play', 0.0099),\n",
       "  ('heat', 0.0065),\n",
       "  ('significantly', 0.0038),\n",
       "  ('functions provided', -0.0034),\n",
       "  ('vitro limited', -0.0148),\n",
       "  ('treatment incorporation', -0.0183),\n",
       "  ('individually concert', -0.026),\n",
       "  ('low density', -0.0895)],\n",
       " 'MED-1695': [('antioxidants components', 0.6617),\n",
       "  ('polyphenols beneficial', 0.5855),\n",
       "  ('vegetables explained', 0.5061),\n",
       "  ('known cardioprotective', 0.498),\n",
       "  ('nutrients function', 0.487),\n",
       "  ('beneficial cardiovascular', 0.4637),\n",
       "  ('vitamin vitamin', 0.4297),\n",
       "  ('protect lipoproteins', 0.4133),\n",
       "  ('effects fruits', 0.4065),\n",
       "  ('kiwi fruit', 0.3301),\n",
       "  ('indicate consuming', 0.3301),\n",
       "  ('blood triglycerides', 0.3266),\n",
       "  ('mechanisms reducing', 0.3221),\n",
       "  ('lipid', 0.3187),\n",
       "  ('addition consumption', 0.3167),\n",
       "  ('thought beneficial', 0.2977),\n",
       "  ('disease beneficial', 0.2925),\n",
       "  ('components contained', 0.2865),\n",
       "  ('fruit lowered', 0.2707),\n",
       "  ('mechanisms', 0.2615),\n",
       "  ('atherosclerotic disease', 0.2526),\n",
       "  ('effects observed', 0.2391),\n",
       "  ('activity medications', 0.2329),\n",
       "  ('oxidation', 0.2004),\n",
       "  ('controls', 0.1966),\n",
       "  ('reduces incidence', 0.1853),\n",
       "  ('vascular cells', 0.1781),\n",
       "  ('modulated platelet', 0.1586),\n",
       "  ('severity disease', 0.1281),\n",
       "  ('high amounts', 0.1273),\n",
       "  ('activity plasma', 0.1255),\n",
       "  ('05 effects', 0.1238),\n",
       "  ('levels data', 0.1209),\n",
       "  ('28 days', 0.1153),\n",
       "  ('function individually', 0.1133),\n",
       "  ('day', 0.1107),\n",
       "  ('volunteers randomized', 0.1042),\n",
       "  ('collagen', 0.0905),\n",
       "  ('15 compared', 0.0892),\n",
       "  ('development', 0.0844),\n",
       "  ('case cholesterol', 0.0834),\n",
       "  ('compared', 0.0748),\n",
       "  ('study report', 0.0723),\n",
       "  ('concert protect', 0.0421),\n",
       "  ('little known', 0.0389),\n",
       "  ('aggregation', 0.0267),\n",
       "  ('response', 0.0181),\n",
       "  ('human', 0.004),\n",
       "  ('adp 18', -0.0095),\n",
       "  ('cross', -0.0127)],\n",
       " 'MED-1696': [('platelet function', 0.6181),\n",
       "  ('pap aggregometer', 0.4454),\n",
       "  ('prp tests', 0.4423),\n",
       "  ('tests normal', 0.4125),\n",
       "  ('tests intra', 0.3994),\n",
       "  ('64 healthy', 0.3906),\n",
       "  ('function testing', 0.3847),\n",
       "  ('adults tested', 0.3613),\n",
       "  ('aggregometer bd', 0.3558),\n",
       "  ('wb tests', 0.3366),\n",
       "  ('using methods', 0.3174),\n",
       "  ('blood draw', 0.314),\n",
       "  ('aggregometer cl', 0.3041),\n",
       "  ('bio data', 0.3012),\n",
       "  ('intra individual', 0.27),\n",
       "  ('intervals using', 0.2682),\n",
       "  ('variability', 0.2589),\n",
       "  ('tested occasions', 0.2567),\n",
       "  ('tests gender', 0.2459),\n",
       "  ('analyzer mp', 0.2422),\n",
       "  ('week intervals', 0.2396),\n",
       "  ('agg abnormality', 0.2345),\n",
       "  ('summary assess', 0.2279),\n",
       "  ('bd prp', 0.2222),\n",
       "  ('aggregation', 0.211),\n",
       "  ('subjects suggesting', 0.1839),\n",
       "  ('exposures aberrant', 0.1713),\n",
       "  ('patients', 0.1667),\n",
       "  ('food medication', 0.1658),\n",
       "  ('wb epinephrine', 0.1643),\n",
       "  ('lumi aggregometer', 0.1587),\n",
       "  ('caution interpreting', 0.1563),\n",
       "  ('ristocetin', 0.1387),\n",
       "  ('chrono log', 0.1359),\n",
       "  ('28 cl', 0.1258),\n",
       "  ('agg collagen', 0.1245),\n",
       "  ('free specimens', 0.1153),\n",
       "  ('0001 specimens', 0.092),\n",
       "  ('atp release', 0.0918),\n",
       "  ('prior', 0.0881),\n",
       "  ('rich plasma', 0.0691),\n",
       "  ('reduced males', 0.0633),\n",
       "  ('drug free', 0.0559),\n",
       "  ('0035', 0.0439),\n",
       "  ('flavonoid', 0.0251),\n",
       "  ('young', 0.0128),\n",
       "  ('prp 15', -0.0009),\n",
       "  ('blacks', -0.0152),\n",
       "  ('seen 21', -0.0285),\n",
       "  ('rel significantly', -0.0705)],\n",
       " 'MED-1697': [('tomato compounds', 0.6427),\n",
       "  ('fresh tomato', 0.593),\n",
       "  ('hybrid tomato', 0.5826),\n",
       "  ('intake fruits', 0.4297),\n",
       "  ('vegetables context', 0.4169),\n",
       "  ('solanum lycopersicum', 0.3969),\n",
       "  ('cardiovascular disease', 0.2942),\n",
       "  ('healthy eating', 0.2545),\n",
       "  ('solanum', 0.2442),\n",
       "  ('daily intake', 0.2245),\n",
       "  ('agro industrial', 0.2218),\n",
       "  ('vitro significant', 0.2165),\n",
       "  ('worldwide healthy', 0.2032),\n",
       "  ('day prolonged', 0.1937),\n",
       "  ('platelet aggregation', 0.1704),\n",
       "  ('safeguards especially', 0.1697),\n",
       "  ('sun', 0.153),\n",
       "  ('pomace assessed', 0.149),\n",
       "  ('9997', 0.1367),\n",
       "  ('day studies', 0.1354),\n",
       "  ('consumption', 0.1342),\n",
       "  ('compounds caused', 0.1179),\n",
       "  ('process did', 0.1167),\n",
       "  ('paste product', 0.1162),\n",
       "  ('410', 0.116),\n",
       "  ('differences antiplatelet', 0.1093),\n",
       "  ('context shown', 0.094),\n",
       "  ('hybrids furthermore', 0.0931),\n",
       "  ('bleeding time', 0.0861),\n",
       "  ('present study', 0.065),\n",
       "  ('leading cause', 0.0613),\n",
       "  ('significant differences', 0.0591),\n",
       "  ('observed fresh', 0.0522),\n",
       "  ('9665 7709', 0.052),\n",
       "  ('ex vivo', 0.0493),\n",
       "  ('regimen', 0.0466),\n",
       "  ('kg', 0.0286),\n",
       "  ('time rats', 0.0223),\n",
       "  ('death worldwide', 0.0198),\n",
       "  ('indicate', 0.0067),\n",
       "  ('data obtained', 0.0067),\n",
       "  ('did affect', 0.0018),\n",
       "  ('derivatives', -0.0098),\n",
       "  ('activity observed', -0.0118),\n",
       "  ('apt', -0.0239),\n",
       "  ('9888 bos', -0.0376),\n",
       "  ('presents', -0.0469),\n",
       "  ('hmx', -0.0571),\n",
       "  ('time reduced', -0.0618),\n",
       "  ('ab3', -0.1084)],\n",
       " 'MED-1699': [('mediterranean diet', 0.5059),\n",
       "  ('dementia methods', 0.4254),\n",
       "  ('studies included', 0.4132),\n",
       "  ('narrative reviews', 0.3359),\n",
       "  ('diet associated', 0.3292),\n",
       "  ('adherence helps', 0.3271),\n",
       "  ('dementia long', 0.2944),\n",
       "  ('reference lists', 0.2879),\n",
       "  ('examined association', 0.286),\n",
       "  ('disease 12', 0.2823),\n",
       "  ('related diseases', 0.2766),\n",
       "  ('medline published', 0.275),\n",
       "  ('observational studies', 0.2692),\n",
       "  ('alzheimer disease', 0.2631),\n",
       "  ('quality assessment', 0.2586),\n",
       "  ('review 11', 0.2491),\n",
       "  ('journal contents', 0.2451),\n",
       "  ('decline reduced', 0.2285),\n",
       "  ('conducted systematic', 0.2276),\n",
       "  ('2012 reference', 0.2267),\n",
       "  ('reduced risk', 0.2216),\n",
       "  ('websites searched', 0.2194),\n",
       "  ('databases including', 0.2155),\n",
       "  ('despite methodological', 0.1976),\n",
       "  ('trial identified', 0.1835),\n",
       "  ('results mild', 0.1773),\n",
       "  ('heterogeneity limited', 0.1771),\n",
       "  ('slower cognitive', 0.1699),\n",
       "  ('inconsistent conclusions', 0.1646),\n",
       "  ('impairment inconsistent', 0.163),\n",
       "  ('score cognitive', 0.1614),\n",
       "  ('data extraction', 0.1509),\n",
       "  ('consistent pattern', 0.1259),\n",
       "  ('using predefined', 0.1232),\n",
       "  ('establish improved', 0.114),\n",
       "  ('cohorts despite', 0.1125),\n",
       "  ('reviewers using', 0.1071),\n",
       "  ('related', 0.1003),\n",
       "  ('background', 0.0963),\n",
       "  ('prevent', 0.0902),\n",
       "  ('long term', 0.0745),\n",
       "  ('electronic', 0.0694),\n",
       "  ('power studies', 0.0546),\n",
       "  ('various age', 0.0224),\n",
       "  ('useful clarify', 0.0018),\n",
       "  ('january', 0.0013),\n",
       "  ('performed independently', -0.0147),\n",
       "  ('vascular', -0.0196),\n",
       "  ('unique', -0.0945),\n",
       "  ('seven unique', -0.1156)],\n",
       " 'MED-1700': [('fat intakes', 0.5673),\n",
       "  ('dietary assessment', 0.4459),\n",
       "  ('older participants', 0.4293),\n",
       "  ('unsaturated pufa', 0.3758),\n",
       "  ('women health', 0.3648),\n",
       "  ('post dietary', 0.3642),\n",
       "  ('cognitive aging', 0.359),\n",
       "  ('mufa total', 0.3327),\n",
       "  ('higher sfa', 0.2891),\n",
       "  ('fas', 0.2823),\n",
       "  ('adjusted differences', 0.2806),\n",
       "  ('acids', 0.2677),\n",
       "  ('change healthy', 0.2627),\n",
       "  ('memory 56', 0.2201),\n",
       "  ('lowest sfa', 0.22),\n",
       "  ('general cognition', 0.2173),\n",
       "  ('community', 0.2157),\n",
       "  ('tests recall', 0.215),\n",
       "  ('late life', 0.2141),\n",
       "  ('recall used', 0.2099),\n",
       "  ('used analyses', 0.2071),\n",
       "  ('study related', 0.2039),\n",
       "  ('different consumption', 0.2016),\n",
       "  ('semantic fluency', 0.1993),\n",
       "  ('65', 0.1831),\n",
       "  ('methods 183', 0.1788),\n",
       "  ('04 61', 0.1704),\n",
       "  ('memory linear', 0.1642),\n",
       "  ('levels', 0.1634),\n",
       "  ('trend 008', 0.1627),\n",
       "  ('types total', 0.1625),\n",
       "  ('58 global', 0.1614),\n",
       "  ('serial cognitive', 0.1427),\n",
       "  ('better global', 0.1384),\n",
       "  ('quintiles multivariable', 0.137),\n",
       "  ('95 confidence', 0.1366),\n",
       "  ('related better', 0.1342),\n",
       "  ('cognition 52', 0.1299),\n",
       "  ('associated worse', 0.1221),\n",
       "  ('conducted years', 0.1209),\n",
       "  ('saturated', 0.1118),\n",
       "  ('odds ratio', 0.0811),\n",
       "  ('trajectories different', 0.0754),\n",
       "  ('88 verbal', 0.0752),\n",
       "  ('primary outcomes', 0.0551),\n",
       "  ('profiles logistic', 0.0454),\n",
       "  ('total poly', 0.0426),\n",
       "  ('appeared influence', 0.0301),\n",
       "  ('mono', 0.0123),\n",
       "  ('10', -0.048)],\n",
       " 'MED-1701': [('strawberries preventing', 0.5298),\n",
       "  ('effect strawberries', 0.5213),\n",
       "  ('strawberries unclear', 0.4596),\n",
       "  ('antithrombotic diet', 0.4591),\n",
       "  ('strawberry extract', 0.4212),\n",
       "  ('antithrombotic activity', 0.3922),\n",
       "  ('prevention platelet', 0.3902),\n",
       "  ('cardiovascular disease', 0.3731),\n",
       "  ('disease prevention', 0.3302),\n",
       "  ('habits including', 0.2966),\n",
       "  ('contribute prevention', 0.2917),\n",
       "  ('diet fruit', 0.2798),\n",
       "  ('platelet aggregation', 0.2595),\n",
       "  ('protective effects', 0.2589),\n",
       "  ('healthy eating', 0.2504),\n",
       "  ('thrombosis effect', 0.2445),\n",
       "  ('scd40l rantes', 0.2165),\n",
       "  ('inhibited platelet', 0.2102),\n",
       "  ('vegetables contribute', 0.2017),\n",
       "  ('1β levels', 0.1883),\n",
       "  ('factor arterial', 0.1864),\n",
       "  ('novel anti', 0.1825),\n",
       "  ('inflammatory effects', 0.1809),\n",
       "  ('preventing', 0.1664),\n",
       "  ('aggregation suggests', 0.154),\n",
       "  ('disorders inhibiting', 0.1501),\n",
       "  ('including regular', 0.1425),\n",
       "  ('unclear aim', 0.1424),\n",
       "  ('study systematically', 0.1382),\n",
       "  ('function critical', 0.1341),\n",
       "  ('arachidonic acid', 0.1217),\n",
       "  ('countries', 0.1084),\n",
       "  ('significantly decreased', 0.1055),\n",
       "  ('levels', 0.0948),\n",
       "  ('high priority', 0.0902),\n",
       "  ('sp selectin', 0.0851),\n",
       "  ('disease', 0.0821),\n",
       "  ('rantes', 0.0782),\n",
       "  ('acid concentrations', 0.0701),\n",
       "  ('related', 0.0658),\n",
       "  ('adp', 0.0653),\n",
       "  ('extract concentration', 0.0645),\n",
       "  ('action', 0.0534),\n",
       "  ('concentration dependently', 0.0377),\n",
       "  ('healthy', 0.0333),\n",
       "  ('formation', 0.0142),\n",
       "  ('significantly', 0.0046),\n",
       "  ('ml inhibited', -0.0115),\n",
       "  ('novel', -0.0453),\n",
       "  ('dependently mg', -0.1093)],\n",
       " 'MED-1702': [('medi mortality', 0.5325),\n",
       "  ('medi adherence', 0.5084),\n",
       "  ('diet medi', 0.44),\n",
       "  ('additional medi', 0.4085),\n",
       "  ('mediterranean diet', 0.3929),\n",
       "  ('lowest medi', 0.3768),\n",
       "  ('association medi', 0.2857),\n",
       "  ('mortality ad', 0.2835),\n",
       "  ('mass index', 0.2611),\n",
       "  ('ad patients', 0.2568),\n",
       "  ('disease course', 0.256),\n",
       "  ('lower mortality', 0.2549),\n",
       "  ('risk alzheimer', 0.2486),\n",
       "  ('adherence tertiles', 0.2348),\n",
       "  ('192 community', 0.209),\n",
       "  ('models compared', 0.2013),\n",
       "  ('adjusted period', 0.1797),\n",
       "  ('cox models', 0.1745),\n",
       "  ('remained significant', 0.1664),\n",
       "  ('gradual reduction', 0.15),\n",
       "  ('affect risk', 0.1414),\n",
       "  ('prospectively followed', 0.1407),\n",
       "  ('95', 0.1355),\n",
       "  ('dose response', 0.1325),\n",
       "  ('examine association', 0.1315),\n",
       "  ('survival subjects', 0.1265),\n",
       "  ('unadjusted models', 0.1183),\n",
       "  ('years longer', 0.1154),\n",
       "  ('44 died', 0.115),\n",
       "  ('course outcomes', 0.1131),\n",
       "  ('13 years', 0.1112),\n",
       "  ('patients lowest', 0.101),\n",
       "  ('investigated objectives', 0.084),\n",
       "  ('based individuals', 0.0758),\n",
       "  ('covariates 76', 0.0744),\n",
       "  ('trend 003', 0.0676),\n",
       "  ('background previously', 0.0482),\n",
       "  ('methods total', 0.0464),\n",
       "  ('smoking body', 0.0404),\n",
       "  ('apoe', 0.0324),\n",
       "  ('38 09', 0.0063),\n",
       "  ('york diagnosed', 0.0055),\n",
       "  ('main', 0.0046),\n",
       "  ('fertile middle', -0.0058),\n",
       "  ('eighty patients', -0.0195),\n",
       "  ('10', -0.02),\n",
       "  ('ci 69', -0.035),\n",
       "  ('scale higher', -0.0558),\n",
       "  ('ethnicity education', -0.0628),\n",
       "  ('risk 27', -0.0698)],\n",
       " 'MED-1703': [('ad prevalence', 0.5339),\n",
       "  ('modifiable ad', 0.4655),\n",
       "  ('ad worldwide', 0.4485),\n",
       "  ('33 million', 0.3835),\n",
       "  ('individuals alzheimer', 0.3747),\n",
       "  ('risk factors', 0.3672),\n",
       "  ('seven risk', 0.3397),\n",
       "  ('factors diabetes', 0.3256),\n",
       "  ('summarize evidence', 0.3208),\n",
       "  ('reduction ad', 0.279),\n",
       "  ('factors contributed', 0.2501),\n",
       "  ('17 million', 0.2437),\n",
       "  ('smoking depression', 0.237),\n",
       "  ('projected impact', 0.2347),\n",
       "  ('factor number', 0.2298),\n",
       "  ('million cases', 0.2265),\n",
       "  ('prevalence expected', 0.2254),\n",
       "  ('million individuals', 0.2187),\n",
       "  ('prevent million', 0.2174),\n",
       "  ('disease', 0.2157),\n",
       "  ('half ad', 0.2154),\n",
       "  ('obesity', 0.2069),\n",
       "  ('worldwide factors', 0.1958),\n",
       "  ('expected triple', 0.1758),\n",
       "  ('modifiable', 0.1685),\n",
       "  ('depression low', 0.1681),\n",
       "  ('life hypertension', 0.165),\n",
       "  ('40 years', 0.1632),\n",
       "  ('educational', 0.1625),\n",
       "  ('calculating population', 0.1578),\n",
       "  ('years', 0.1537),\n",
       "  ('factor reductions', 0.1528),\n",
       "  ('10 25', 0.141),\n",
       "  ('inactivity', 0.1121),\n",
       "  ('cases potentially', 0.1078),\n",
       "  ('million 10', 0.1068),\n",
       "  ('mid life', 0.1063),\n",
       "  ('low educational', 0.101),\n",
       "  ('goal', 0.0914),\n",
       "  ('percent', 0.0897),\n",
       "  ('currently approximately', 0.0885),\n",
       "  ('potentially', 0.0575),\n",
       "  ('000', 0.0543),\n",
       "  ('attributable given', 0.0254),\n",
       "  ('pars percent', 0.0159),\n",
       "  ('individuals', -0.0116),\n",
       "  ('contributed half', -0.0139),\n",
       "  ('492', -0.0308),\n",
       "  ('184', -0.0638),\n",
       "  ('physical', -0.0738)],\n",
       " 'MED-1704': [('alzheimer disease', 0.6053),\n",
       "  ('cognitive loss', 0.5145),\n",
       "  ('risk ad', 0.4433),\n",
       "  ('perturbed cognitive', 0.3905),\n",
       "  ('sporadic ad', 0.3871),\n",
       "  ('ad tests', 0.3631),\n",
       "  ('disease progress', 0.3279),\n",
       "  ('require research', 0.2814),\n",
       "  ('cerebrovasacular abnormalities', 0.2725),\n",
       "  ('abilities dead', 0.2647),\n",
       "  ('neuronal networks', 0.26),\n",
       "  ('neuroimaging tests', 0.2495),\n",
       "  ('deterioration allows', 0.2477),\n",
       "  ('disorder', 0.2337),\n",
       "  ('irreversibly damaged', 0.2331),\n",
       "  ('cerebrovascular risk', 0.2293),\n",
       "  ('curb disorder', 0.2238),\n",
       "  ('efforts funding', 0.2143),\n",
       "  ('disorder cure', 0.2137),\n",
       "  ('treatment evidence', 0.2072),\n",
       "  ('cognitively intact', 0.1815),\n",
       "  ('abnormalities long', 0.1781),\n",
       "  ('preventive measures', 0.1723),\n",
       "  ('intervention attenuate', 0.165),\n",
       "  ('costs', 0.1559),\n",
       "  ('screening effort', 0.1497),\n",
       "  ('pinpoint cause', 0.1412),\n",
       "  ('ad realistic', 0.1343),\n",
       "  ('cause abi', 0.1342),\n",
       "  ('reduces hospice', 0.1238),\n",
       "  ('proposed carotid', 0.1217),\n",
       "  ('appears unlikely', 0.1133),\n",
       "  ('possible reconstruct', 0.1116),\n",
       "  ('rising incidence', 0.0999),\n",
       "  ('previously proposed', 0.0974),\n",
       "  ('effective non', 0.0959),\n",
       "  ('factors sporadic', 0.0636),\n",
       "  ('stratagem', 0.0564),\n",
       "  ('partial success', 0.0561),\n",
       "  ('tests asymptomatic', 0.0481),\n",
       "  ('doctor visits', 0.0342),\n",
       "  ('invasive', 0.0297),\n",
       "  ('echocardiography ankle', 0.0232),\n",
       "  ('repeated', -0.0089),\n",
       "  ('intellectual identity', -0.0294),\n",
       "  ('individuals mass', -0.0428),\n",
       "  ('stay', -0.0642),\n",
       "  ('brachail index', -0.0689),\n",
       "  ('simple perform', -0.0775),\n",
       "  ('host', -0.1324)],\n",
       " 'MED-1705': [('lowering alzheimer', 0.5247),\n",
       "  ('sporadic ad', 0.4976),\n",
       "  ('alzheimer disease', 0.4946),\n",
       "  ('archive 73', 0.3678),\n",
       "  ('little clinical', 0.3303),\n",
       "  ('research papers', 0.3142),\n",
       "  ('interventions needed', 0.2985),\n",
       "  ('stress neurodegeneration', 0.2969),\n",
       "  ('published decades', 0.288),\n",
       "  ('review', 0.2838),\n",
       "  ('aging pathobiological', 0.2741),\n",
       "  ('ad multifactorial', 0.2549),\n",
       "  ('ad 2012', 0.2445),\n",
       "  ('ad help', 0.2343),\n",
       "  ('dramatic lowering', 0.2253),\n",
       "  ('prevention proactive', 0.2194),\n",
       "  ('special issue', 0.2171),\n",
       "  ('archive', 0.216),\n",
       "  ('disease', 0.2134),\n",
       "  ('based evidence', 0.2121),\n",
       "  ('avoid review', 0.2045),\n",
       "  ('progress relative', 0.1981),\n",
       "  ('molecular biology', 0.1906),\n",
       "  ('oxidants reviewed', 0.1604),\n",
       "  ('generate chronic', 0.152),\n",
       "  ('medical decisions', 0.1352),\n",
       "  ('applied therapeutic', 0.1342),\n",
       "  ('spotlights strategic', 0.1301),\n",
       "  ('people sporadic', 0.1289),\n",
       "  ('vascular risk', 0.1252),\n",
       "  ('despite', 0.1226),\n",
       "  ('assess modify', 0.0941),\n",
       "  ('mental activity', 0.0935),\n",
       "  ('hypoperfusion cbh', 0.0882),\n",
       "  ('trace metals', 0.0873),\n",
       "  ('prevalence main', 0.0805),\n",
       "  ('healthy diet', 0.0795),\n",
       "  ('tandem pillars', 0.0777),\n",
       "  ('factors generate', 0.0746),\n",
       "  ('control incipient', 0.0612),\n",
       "  ('appears involve', 0.0604),\n",
       "  ('turning point', 0.048),\n",
       "  ('modulation biofactors', 0.0367),\n",
       "  ('union biochemistry', 0.0358),\n",
       "  ('lipids', 0.0304),\n",
       "  ('copyright', -0.0009),\n",
       "  ('cbh advanced', -0.003),\n",
       "  ('coupled physical', -0.0302),\n",
       "  ('kindled', -0.0624),\n",
       "  ('mounting', -0.0881)],\n",
       " 'MED-1706': [('glycemic index', 0.6327),\n",
       "  ('significance glycemic', 0.6096),\n",
       "  ('effects glycemic', 0.5797),\n",
       "  ('glycemic', 0.5353),\n",
       "  ('classifying carbohydrate', 0.4893),\n",
       "  ('carbohydrate containing', 0.4472),\n",
       "  ('food scientific', 0.4142),\n",
       "  ('index relevance', 0.3743),\n",
       "  ('diabetes', 0.3706),\n",
       "  ('index proposed', 0.3589),\n",
       "  ('treating obesity', 0.3577),\n",
       "  ('diet', 0.3539),\n",
       "  ('physiological effects', 0.3487),\n",
       "  ('purpose review', 0.3456),\n",
       "  ('obesity diabetes', 0.3424),\n",
       "  ('clinical significance', 0.3403),\n",
       "  ('diet books', 0.3378),\n",
       "  ('examine physiological', 0.3321),\n",
       "  ('popular diet', 0.3178),\n",
       "  ('relevance effects', 0.3171),\n",
       "  ('review examine', 0.315),\n",
       "  ('proposed 1981', 0.3084),\n",
       "  ('topic clinical', 0.3075),\n",
       "  ('published topic', 0.3068),\n",
       "  ('obesity', 0.3046),\n",
       "  ('scientific articles', 0.3016),\n",
       "  ('diabetes cardiovascular', 0.3007),\n",
       "  ('subject debate', 0.2689),\n",
       "  ('containing food', 0.2659),\n",
       "  ('articles', 0.2592),\n",
       "  ('alternative classifying', 0.2492),\n",
       "  ('significance', 0.2373),\n",
       "  ('scientific', 0.2365),\n",
       "  ('index remains', 0.2233),\n",
       "  ('topic', 0.2167),\n",
       "  ('cardiovascular disease', 0.2098),\n",
       "  ('purpose', 0.201),\n",
       "  ('disease', 0.1803),\n",
       "  ('subject', 0.1761),\n",
       "  ('proposed', 0.1752),\n",
       "  ('effects', 0.1667),\n",
       "  ('remains subject', 0.1571),\n",
       "  ('books published', 0.1474),\n",
       "  ('effects preventing', 0.1394),\n",
       "  ('treating', 0.126),\n",
       "  ('alternative', 0.1223),\n",
       "  ('numerous', 0.1171),\n",
       "  ('preventing treating', 0.1058),\n",
       "  ('numerous popular', 0.08),\n",
       "  ('containing', 0.0558)],\n",
       " 'MED-1707': [('dietary sugar', 0.6455),\n",
       "  ('diabetes counterpoint', 0.4771),\n",
       "  ('reducing intake', 0.4324),\n",
       "  ('reconsider consumption', 0.4231),\n",
       "  ('sweetened', 0.4228),\n",
       "  ('health problems', 0.4206),\n",
       "  ('disease drinking', 0.3991),\n",
       "  ('foods beverages', 0.3964),\n",
       "  ('health nutrition', 0.3794),\n",
       "  ('dietary surveys', 0.3746),\n",
       "  ('opinion review', 0.3456),\n",
       "  ('drinks increased', 0.3431),\n",
       "  ('consumption calorie', 0.3273),\n",
       "  ('problems point', 0.3188),\n",
       "  ('growing concern', 0.314),\n",
       "  ('obesity metabolic', 0.3042),\n",
       "  ('need reconsider', 0.303),\n",
       "  ('understand changes', 0.2717),\n",
       "  ('contribution drs', 0.2697),\n",
       "  ('kahn sievenpiper', 0.2675),\n",
       "  ('related risk', 0.2529),\n",
       "  ('drs kahn', 0.2519),\n",
       "  ('recent studies', 0.2425),\n",
       "  ('cardiovascular disease', 0.2385),\n",
       "  ('relationship consumption', 0.2301),\n",
       "  ('narrative presented', 0.2253),\n",
       "  ('consumption meta', 0.2168),\n",
       "  ('drinking 16', 0.2092),\n",
       "  ('provide defense', 0.1981),\n",
       "  ('homescan data', 0.1762),\n",
       "  ('suggest gene', 0.1721),\n",
       "  ('role epidemic', 0.1651),\n",
       "  ('date need', 0.1601),\n",
       "  ('75', 0.1512),\n",
       "  ('culprit data', 0.1489),\n",
       "  ('examination survey', 0.1318),\n",
       "  ('ounce ssbs', 0.1309),\n",
       "  ('shown lowering', 0.1242),\n",
       "  ('department agriculture', 0.1224),\n",
       "  ('analyses randomized', 0.1175),\n",
       "  ('children adults', 0.1082),\n",
       "  ('contain', 0.1079),\n",
       "  ('data national', 0.1048),\n",
       "  ('soft', 0.0941),\n",
       "  ('based growing', 0.0899),\n",
       "  ('purchases used', 0.0856),\n",
       "  ('liver', 0.0486),\n",
       "  ('years', 0.0412),\n",
       "  ('day months', 0.0152),\n",
       "  ('increased fivefold', 0.0068)],\n",
       " 'MED-1708': [('consumption sugars', 0.6014),\n",
       "  ('22 teaspoons', 0.4791),\n",
       "  ('americans 22', 0.4614),\n",
       "  ('sugars 2001', 0.4453),\n",
       "  ('calories day', 0.3907),\n",
       "  ('2005 dietary', 0.3888),\n",
       "  ('americans diets', 0.3809),\n",
       "  ('sweetened', 0.3566),\n",
       "  ('contributing overconsumption', 0.3521),\n",
       "  ('higher intake', 0.3218),\n",
       "  ('355 calories', 0.3215),\n",
       "  ('guidelines intake', 0.2999),\n",
       "  ('discretionary calories', 0.2795),\n",
       "  ('obesity cardiovascular', 0.2733),\n",
       "  ('energy needs', 0.27),\n",
       "  ('metabolic abnormalities', 0.2671),\n",
       "  ('heightened concerns', 0.2639),\n",
       "  ('beverages primary', 0.2624),\n",
       "  ('adverse effects', 0.2284),\n",
       "  ('lower intake', 0.2089),\n",
       "  ('nutrients trial', 0.1978),\n",
       "  ('average daily', 0.1973),\n",
       "  ('indicate excessive', 0.183),\n",
       "  ('worldwide', 0.1799),\n",
       "  ('allowance american', 0.1752),\n",
       "  ('recommends reductions', 0.1727),\n",
       "  ('disease heightened', 0.153),\n",
       "  ('shortfalls', 0.1401),\n",
       "  ('100 calories', 0.1366),\n",
       "  ('studies indicates', 0.1287),\n",
       "  ('health conditions', 0.1217),\n",
       "  ('greatly exceeds', 0.1141),\n",
       "  ('pandemic', 0.1106),\n",
       "  ('prudent upper', 0.1061),\n",
       "  ('view considerations', 0.1048),\n",
       "  ('association recommends', 0.104),\n",
       "  ('national', 0.087),\n",
       "  ('source added', 0.083),\n",
       "  ('added 76', 0.0608),\n",
       "  ('limited evidence', 0.0569),\n",
       "  ('day 1970', 0.0488),\n",
       "  ('2001 2004', 0.0402),\n",
       "  ('survey data', 0.0286),\n",
       "  ('women', 0.024),\n",
       "  ('linked', 0.0114),\n",
       "  ('body', 0.006),\n",
       "  ('19 added', 0.001),\n",
       "  ('men 150', -0.0237),\n",
       "  ('half', -0.0614),\n",
       "  ('soft', -0.0721)],\n",
       " 'MED-1709': [('dietary sugar', 0.6038),\n",
       "  ('diabetes sugar', 0.5388),\n",
       "  ('diabetes counterpoint', 0.4939),\n",
       "  ('ingesting sugar', 0.4771),\n",
       "  ('added sugar', 0.4767),\n",
       "  ('evidence dietary', 0.4704),\n",
       "  ('reconsider consumption', 0.4418),\n",
       "  ('sugar unique', 0.4248),\n",
       "  ('opinion review', 0.3964),\n",
       "  ('concern obesity', 0.3948),\n",
       "  ('need reconsider', 0.3789),\n",
       "  ('obesity diabetes', 0.3779),\n",
       "  ('consumption dietary', 0.3649),\n",
       "  ('dietary added', 0.3629),\n",
       "  ('drs bray', 0.3332),\n",
       "  ('counterpoint narrative', 0.3321),\n",
       "  ('suggest need', 0.3241),\n",
       "  ('bray popkin', 0.3178),\n",
       "  ('calories development', 0.2976),\n",
       "  ('review data', 0.2878),\n",
       "  ('concern', 0.2847),\n",
       "  ('popkin provide', 0.2659),\n",
       "  ('consumption', 0.2582),\n",
       "  ('nutritional essential', 0.2525),\n",
       "  ('food wish', 0.2342),\n",
       "  ('narrative drs', 0.221),\n",
       "  ('wish reduce', 0.2185),\n",
       "  ('preceding point', 0.1976),\n",
       "  ('unique detrimental', 0.1747),\n",
       "  ('reduce energy', 0.1712),\n",
       "  ('convincing evidence', 0.1693),\n",
       "  ('appears contribute', 0.1688),\n",
       "  ('ingesting', 0.1602),\n",
       "  ('argue', 0.1601),\n",
       "  ('portend clinical', 0.1548),\n",
       "  ('start', 0.1447),\n",
       "  ('impact', 0.1237),\n",
       "  ('based', 0.1235),\n",
       "  ('based growing', 0.1087),\n",
       "  ('relative source', 0.0965),\n",
       "  ('energy property', 0.0815),\n",
       "  ('highly palatable', 0.075),\n",
       "  ('development', 0.0545),\n",
       "  ('clear', 0.0389),\n",
       "  ('data', 0.0341),\n",
       "  ('purely', 0.0261),\n",
       "  ('type', 0.021),\n",
       "  ('property appears', -0.0537),\n",
       "  ('doing does', -0.0636),\n",
       "  ('highly', -0.0768)],\n",
       " 'MED-1710': [('sugar intake', 0.6411),\n",
       "  ('sweetened beverage', 0.5164),\n",
       "  ('drinks increased', 0.4777),\n",
       "  ('primarily beverages', 0.4563),\n",
       "  ('sugar 50', 0.4245),\n",
       "  ('current diet', 0.4004),\n",
       "  ('reduction intake', 0.3821),\n",
       "  ('calories increase', 0.3709),\n",
       "  ('fructose increases', 0.3589),\n",
       "  ('consumption', 0.3589),\n",
       "  ('health concerns', 0.3246),\n",
       "  ('food suggesting', 0.3173),\n",
       "  ('load intake', 0.3079),\n",
       "  ('syrup', 0.2873),\n",
       "  ('calorie free', 0.2792),\n",
       "  ('increased 40', 0.2705),\n",
       "  ('acid worsening', 0.2584),\n",
       "  ('lipids contributing', 0.2549),\n",
       "  ('states increased', 0.2451),\n",
       "  ('nonalcoholic fatty', 0.2386),\n",
       "  ('united states', 0.231),\n",
       "  ('metabolized primarily', 0.2277),\n",
       "  ('consumed hazardous', 0.2267),\n",
       "  ('production uric', 0.2214),\n",
       "  ('amounts currently', 0.2043),\n",
       "  ('containing soft', 0.2036),\n",
       "  ('risk obesity', 0.1979),\n",
       "  ('liver gout', 0.1978),\n",
       "  ('diabetes cardiovascular', 0.1952),\n",
       "  ('concerns raised', 0.192),\n",
       "  ('revolution health', 0.1718),\n",
       "  ('american', 0.1599),\n",
       "  ('shown risk', 0.127),\n",
       "  ('phosphate transferred', 0.1222),\n",
       "  ('atp decreases', 0.114),\n",
       "  ('makes easy', 0.1077),\n",
       "  ('1950 2000', 0.1),\n",
       "  ('just 50', 0.0938),\n",
       "  ('meta analyses', 0.0905),\n",
       "  ('blood', 0.0854),\n",
       "  ('syndrome related', 0.0675),\n",
       "  ('body', 0.0591),\n",
       "  ('review just', 0.0582),\n",
       "  ('versus low', 0.0037),\n",
       "  ('high', -0.0244),\n",
       "  ('taken', -0.0387),\n",
       "  ('disease men', -0.0396),\n",
       "  ('tissue muscle', -0.061),\n",
       "  ('fold', -0.0707),\n",
       "  ('does', -0.1262)],\n",
       " 'MED-1711': [('nsclc figitumumab', 0.6789),\n",
       "  ('igf 1r', 0.4996),\n",
       "  ('total igf', 0.4569),\n",
       "  ('objectives insulin', 0.4194),\n",
       "  ('figitumumab 20', 0.4185),\n",
       "  ('advanced nsclc', 0.4086),\n",
       "  ('biomarkers antitumor', 0.3524),\n",
       "  ('cancer', 0.3424),\n",
       "  ('dose level', 0.3094),\n",
       "  ('numerous tumor', 0.304),\n",
       "  ('gov nct00603538', 0.284),\n",
       "  ('igg2 monoclonal', 0.2649),\n",
       "  ('carboplatin area', 0.2591),\n",
       "  ('mg m2', 0.2474),\n",
       "  ('paclitaxel 200', 0.2351),\n",
       "  ('area curve', 0.232),\n",
       "  ('escalation study', 0.2298),\n",
       "  ('like growth', 0.2238),\n",
       "  ('tolerated chemotherapy', 0.22),\n",
       "  ('evaluable patients', 0.1917),\n",
       "  ('pharmacokinetics biomarkers', 0.19),\n",
       "  ('factor', 0.1728),\n",
       "  ('open label', 0.1714),\n",
       "  ('kg combination', 0.1696),\n",
       "  ('methods phase', 0.1646),\n",
       "  ('cell lung', 0.1593),\n",
       "  ('therapy', 0.1588),\n",
       "  ('intravenously day', 0.1554),\n",
       "  ('binding protein', 0.1532),\n",
       "  ('concentrations increased', 0.1488),\n",
       "  ('approximate fold', 0.1464),\n",
       "  ('implicated pathogenesis', 0.1463),\n",
       "  ('types including', 0.1406),\n",
       "  ('serum total', 0.1382),\n",
       "  ('dependent relationship', 0.1321),\n",
       "  ('cycle cycles', 0.1283),\n",
       "  ('assessed safety', 0.1278),\n",
       "  ('summary objectives', 0.1227),\n",
       "  ('signaling', 0.1174),\n",
       "  ('gov', 0.1142),\n",
       "  ('proportional manner', 0.1024),\n",
       "  ('naïve advanced', 0.0888),\n",
       "  ('non small', 0.0861),\n",
       "  ('supported', 0.0859),\n",
       "  ('10', 0.0755),\n",
       "  ('patients 19', 0.0664),\n",
       "  ('demonstrated seven', 0.0477),\n",
       "  ('fully human', 0.0447),\n",
       "  ('day 21', 0.0242),\n",
       "  ('japanese', 0.0123)],\n",
       " 'MED-1712': [('slows cancer', 0.5482),\n",
       "  ('lowering igf', 0.5408),\n",
       "  ('lowered dietary', 0.4947),\n",
       "  ('dietary effects', 0.4661),\n",
       "  ('reduction caloric', 0.4635),\n",
       "  ('cancer deaths', 0.4332),\n",
       "  ('cancer insulin', 0.4151),\n",
       "  ('progression decreased', 0.3605),\n",
       "  ('central slowing', 0.3478),\n",
       "  ('tumorigenesis mechanisms', 0.3449),\n",
       "  ('reduction multifaceted', 0.3246),\n",
       "  ('weight rates', 0.3232),\n",
       "  ('changes body', 0.2844),\n",
       "  ('deaths western', 0.2823),\n",
       "  ('modulated tumor', 0.2805),\n",
       "  ('ascertain lowering', 0.2693),\n",
       "  ('rats igf', 0.2662),\n",
       "  ('hypothesis igf', 0.2627),\n",
       "  ('mechanisms protective', 0.2556),\n",
       "  ('restriction dr', 0.2395),\n",
       "  ('supplementation abrogates', 0.2379),\n",
       "  ('dr neoplastic', 0.232),\n",
       "  ('rodents major', 0.2256),\n",
       "  ('mechanistic study', 0.2238),\n",
       "  ('urothelial preneoplasia', 0.2233),\n",
       "  ('minipumps tumor', 0.2153),\n",
       "  ('carcinogen cresidine', 0.1975),\n",
       "  ('deficient mice', 0.1902),\n",
       "  ('heterozygous p53', 0.1843),\n",
       "  ('modulates cell', 0.1601),\n",
       "  ('favoring apoptosis', 0.1359),\n",
       "  ('world factors', 0.1258),\n",
       "  ('foci conclusion', 0.1256),\n",
       "  ('divided groups', 0.1235),\n",
       "  ('administered osmotic', 0.0986),\n",
       "  ('depend', 0.0934),\n",
       "  ('bladder', 0.0696),\n",
       "  ('multifaceted growth', 0.0656),\n",
       "  ('libitum 20', 0.0654),\n",
       "  ('24 dr', 0.0591),\n",
       "  ('compared', 0.0494),\n",
       "  ('fold', 0.048),\n",
       "  ('stage', 0.0464),\n",
       "  ('dr ad', 0.0422),\n",
       "  ('major contribution', 0.0349),\n",
       "  ('using recombinant', 0.0323),\n",
       "  ('hyperplastic foci', 0.0281),\n",
       "  ('serum', -0.0002),\n",
       "  ('10 times', -0.0091),\n",
       "  ('completely restored', -0.0601)],\n",
       " 'MED-1714': [('cancer risk', 0.613),\n",
       "  ('cancer low', 0.5419),\n",
       "  ('lifestyles associated', 0.4653),\n",
       "  ('diets obesity', 0.4556),\n",
       "  ('decreased adiposity', 0.4007),\n",
       "  ('associated low', 0.372),\n",
       "  ('background western', 0.363),\n",
       "  ('conclusions exercise', 0.3601),\n",
       "  ('diet runner', 0.3471),\n",
       "  ('protein lower', 0.3445),\n",
       "  ('growth factors', 0.3371),\n",
       "  ('protein intake', 0.327),\n",
       "  ('hormones leptin', 0.3225),\n",
       "  ('sedentary subjects', 0.3223),\n",
       "  ('intake endurance', 0.3208),\n",
       "  ('increased risk', 0.3038),\n",
       "  ('mechanisms responsible', 0.294),\n",
       "  ('training decreased', 0.2861),\n",
       "  ('background', 0.257),\n",
       "  ('intake additional', 0.2371),\n",
       "  ('igf binding', 0.2345),\n",
       "  ('mass index', 0.2324),\n",
       "  ('reactive protein', 0.2244),\n",
       "  ('subjects eating', 0.2168),\n",
       "  ('term consumption', 0.2126),\n",
       "  ('objective hypothesized', 0.2087),\n",
       "  ('body', 0.2055),\n",
       "  ('additional protective', 0.1962),\n",
       "  ('linked increased', 0.1952),\n",
       "  ('kg m2', 0.1877),\n",
       "  ('ng ml', 0.1869),\n",
       "  ('sex hormone', 0.1574),\n",
       "  ('044', 0.1517),\n",
       "  ('group 139', 0.1513),\n",
       "  ('long', 0.1485),\n",
       "  ('binding globulin', 0.1373),\n",
       "  ('group 05', 0.133),\n",
       "  ('concentration ratio', 0.1231),\n",
       "  ('177', 0.1197),\n",
       "  ('201 42', 0.1192),\n",
       "  ('design plasma', 0.1159),\n",
       "  ('insulin free', 0.1059),\n",
       "  ('033 01', 0.1055),\n",
       "  ('risk clear', 0.083),\n",
       "  ('matched', 0.0743),\n",
       "  ('21 groups', 0.0714),\n",
       "  ('circulating', 0.0533),\n",
       "  ('age 53', 0.0205),\n",
       "  ('sd age', -0.0029),\n",
       "  ('26 005', -0.0125)],\n",
       " 'MED-1715': [('calorie restriction', 0.4479),\n",
       "  ('cr decreases', 0.4347),\n",
       "  ('cancer slows', 0.3937),\n",
       "  ('reduced protein', 0.3915),\n",
       "  ('mutations insulin', 0.383),\n",
       "  ('anti aging', 0.3571),\n",
       "  ('decreases serum', 0.3413),\n",
       "  ('aging rodents', 0.336),\n",
       "  ('malnutrition did', 0.333),\n",
       "  ('individuals reducing', 0.3298),\n",
       "  ('cr studies', 0.3296),\n",
       "  ('change igf', 0.3261),\n",
       "  ('igf 194', 0.3155),\n",
       "  ('restricted individuals', 0.3079),\n",
       "  ('protects cancer', 0.3043),\n",
       "  ('aging dietary', 0.304),\n",
       "  ('does reduce', 0.2688),\n",
       "  ('function mutations', 0.263),\n",
       "  ('40 protects', 0.2489),\n",
       "  ('kg body', 0.2467),\n",
       "  ('nutrition circulating', 0.2432),\n",
       "  ('health span', 0.2411),\n",
       "  ('interventions', 0.2278),\n",
       "  ('signaling pathway', 0.2066),\n",
       "  ('component anticancer', 0.1977),\n",
       "  ('ratio levels', 0.1841),\n",
       "  ('95 kg', 0.1782),\n",
       "  ('intake key', 0.1771),\n",
       "  ('term effects', 0.17),\n",
       "  ('lower moderately', 0.1476),\n",
       "  ('species', 0.1279),\n",
       "  ('studies years', 0.126),\n",
       "  ('ml findings', 0.11),\n",
       "  ('report data', 0.1061),\n",
       "  ('weeks', 0.0983),\n",
       "  ('maximal lifespan', 0.0977),\n",
       "  ('did change', 0.095),\n",
       "  ('concentrations significantly', 0.0833),\n",
       "  ('humans contrast', 0.083),\n",
       "  ('humans unknown', 0.0763),\n",
       "  ('humans suggest', 0.0726),\n",
       "  ('key determinant', 0.0705),\n",
       "  ('total free', 0.06),\n",
       "  ('volunteers practicing', 0.0378),\n",
       "  ('showing severe', 0.0335),\n",
       "  ('152 ng', 0.0097),\n",
       "  ('data long', 0.0086),\n",
       "  ('unlike', 0.0067),\n",
       "  ('67 kg', 0.0066),\n",
       "  ('circulating', -0.0024)],\n",
       " 'MED-1716': [('obesity diabetes', 0.7125),\n",
       "  ('progression obesity', 0.6464),\n",
       "  ('hyperinsulinaemia cancer', 0.6296),\n",
       "  ('individuals diabetes', 0.5495),\n",
       "  ('metabolic syndrome', 0.5493),\n",
       "  ('insulin receptor', 0.5244),\n",
       "  ('mellitus type', 0.5212),\n",
       "  ('progression insulin', 0.5154),\n",
       "  ('contribute diabetes', 0.4999),\n",
       "  ('arise obese', 0.4579),\n",
       "  ('cancer risk', 0.4384),\n",
       "  ('diabetes finally', 0.4165),\n",
       "  ('adipose tissue', 0.3978),\n",
       "  ('type metabolic', 0.3867),\n",
       "  ('endocrine effects', 0.3744),\n",
       "  ('increase risk', 0.3684),\n",
       "  ('igf interacts', 0.3675),\n",
       "  ('cancers acknowledged', 0.3485),\n",
       "  ('factors progression', 0.3046),\n",
       "  ('visceral mammary', 0.3019),\n",
       "  ('epidemic', 0.2965),\n",
       "  ('high concentrations', 0.2945),\n",
       "  ('epidemiological biochemical', 0.281),\n",
       "  ('increased steroid', 0.2794),\n",
       "  ('morbidly', 0.2781),\n",
       "  ('effects exacerbated', 0.2732),\n",
       "  ('world progression', 0.2539),\n",
       "  ('like growth', 0.2492),\n",
       "  ('significant associated', 0.2346),\n",
       "  ('novel drugs', 0.2341),\n",
       "  ('developed world', 0.2274),\n",
       "  ('review molecular', 0.2173),\n",
       "  ('syndrome recognised', 0.2106),\n",
       "  ('proportions developed', 0.2017),\n",
       "  ('endogenous therapeutic', 0.1918),\n",
       "  ('significant paracrine', 0.186),\n",
       "  ('differently isoforms', 0.1645),\n",
       "  ('signal transduction', 0.1633),\n",
       "  ('major human', 0.1259),\n",
       "  ('target', 0.124),\n",
       "  ('basis involvement', 0.1131),\n",
       "  ('informed patient', 0.0916),\n",
       "  ('structural studies', 0.0881),\n",
       "  ('elucidate ligands', 0.0854),\n",
       "  ('trial effective', 0.0793),\n",
       "  ('protagonists contribute', 0.0763),\n",
       "  ('reached', 0.0512),\n",
       "  ('stratification implemented', 0.0507),\n",
       "  ('production', 0.0483),\n",
       "  ('interacts differently', 0.025)],\n",
       " 'MED-1717': [('associations bmi', 0.6113),\n",
       "  ('obesity cancer', 0.5187),\n",
       "  ('mass index', 0.4926),\n",
       "  ('adult cancers', 0.4607),\n",
       "  ('excess bodyweight', 0.4507),\n",
       "  ('0001 cancers', 0.4345),\n",
       "  ('meta regressions', 0.3851),\n",
       "  ('increased risk', 0.3726),\n",
       "  ('epidemiological observations', 0.3587),\n",
       "  ('systematic review', 0.3572),\n",
       "  ('stronger associations', 0.3379),\n",
       "  ('mechanisms link', 0.3091),\n",
       "  ('20 cancer', 0.3041),\n",
       "  ('postmenopausal breast', 0.2744),\n",
       "  ('multiple myeloma', 0.2743),\n",
       "  ('estimates determine', 0.264),\n",
       "  ('oesophageal adenocarcinoma', 0.2548),\n",
       "  ('investigate differences', 0.2508),\n",
       "  ('body', 0.2469),\n",
       "  ('assess strength', 0.2342),\n",
       "  ('2007 searched', 0.2314),\n",
       "  ('embase', 0.2264),\n",
       "  ('02 colon', 0.2228),\n",
       "  ('associated kg', 0.2193),\n",
       "  ('different sites', 0.2182),\n",
       "  ('studies incident', 0.2157),\n",
       "  ('populations increased', 0.2148),\n",
       "  ('interpretation increased', 0.2074),\n",
       "  ('datasets 141', 0.203),\n",
       "  ('exploration biological', 0.2011),\n",
       "  ('background', 0.1841),\n",
       "  ('types did', 0.1713),\n",
       "  ('thyroid 33', 0.1664),\n",
       "  ('identify prospective', 0.1658),\n",
       "  ('region recorded', 0.16),\n",
       "  ('men women', 0.1341),\n",
       "  ('m2', 0.101),\n",
       "  ('sex ethnic', 0.0982),\n",
       "  ('pacific region', 0.0953),\n",
       "  ('leukaemia', 0.0933),\n",
       "  ('including 282', 0.0847),\n",
       "  ('cases men', 0.0844),\n",
       "  ('52 0001', 0.084),\n",
       "  ('non hodgkin', 0.0785),\n",
       "  ('america europe', 0.0729),\n",
       "  ('1966', 0.0566),\n",
       "  ('59', 0.0481),\n",
       "  ('random', 0.0125),\n",
       "  ('weaker positive', -0.0062),\n",
       "  ('generally similar', -0.0222)],\n",
       " 'MED-1718': [('cancer obesity', 0.6164),\n",
       "  ('links obesity', 0.5543),\n",
       "  ('obesity main', 0.5382),\n",
       "  ('20 increased', 0.5053),\n",
       "  ('world cancer', 0.4545),\n",
       "  ('research cancer', 0.3986),\n",
       "  ('susceptibility cancer', 0.389),\n",
       "  ('malignancies influenced', 0.3801),\n",
       "  ('weight change', 0.3609),\n",
       "  ('chronic inflammation', 0.3355),\n",
       "  ('increased risk', 0.2769),\n",
       "  ('adipokines various', 0.2406),\n",
       "  ('colorectal', 0.2336),\n",
       "  ('international agency', 0.2313),\n",
       "  ('multiple myeloma', 0.2277),\n",
       "  ('malignancies leukemia', 0.2204),\n",
       "  ('growth factor', 0.2116),\n",
       "  ('fund wcrf', 0.2057),\n",
       "  ('malignant melanoma', 0.193),\n",
       "  ('thyroid tumours', 0.1911),\n",
       "  ('agency research', 0.1863),\n",
       "  ('induced hypoxia', 0.1802),\n",
       "  ('influenced diet', 0.1793),\n",
       "  ('postmenopausal', 0.1682),\n",
       "  ('insulin insulin', 0.1677),\n",
       "  ('physical activity', 0.1675),\n",
       "  ('induced', 0.165),\n",
       "  ('candidate mechanisms', 0.1613),\n",
       "  ('methods prevention', 0.153),\n",
       "  ('breast', 0.1518),\n",
       "  ('strongest evidence', 0.1407),\n",
       "  ('links', 0.1347),\n",
       "  ('main', 0.1275),\n",
       "  ('endometrial esophageal', 0.1186),\n",
       "  ('oxidative', 0.116),\n",
       "  ('activity reports', 0.1076),\n",
       "  ('stress crosstalk', 0.1055),\n",
       "  ('prostate renal', 0.0992),\n",
       "  ('shared genetic', 0.0795),\n",
       "  ('cases caused', 0.0783),\n",
       "  ('types', 0.0777),\n",
       "  ('stromal cells', 0.0771),\n",
       "  ('develop novel', 0.0558),\n",
       "  ('treatment understand', 0.0501),\n",
       "  ('sex steroids', 0.0492),\n",
       "  ('functional defeat', 0.0477),\n",
       "  ('hodgkin', 0.017),\n",
       "  ('migrating', 0.0011),\n",
       "  ('potential producers', -0.0185),\n",
       "  ('non', -0.1103)],\n",
       " 'MED-1719': [('prevalence malignancies', 0.5671),\n",
       "  ('congenital igf', 0.5187),\n",
       "  ('defects igf', 0.5132),\n",
       "  ('occurs tumors', 0.5042),\n",
       "  ('development cancer', 0.5029),\n",
       "  ('igf deficiency', 0.4722),\n",
       "  ('results igf', 0.4354),\n",
       "  ('wilms tumor', 0.4272),\n",
       "  ('history malignancy', 0.4128),\n",
       "  ('patients cancer', 0.406),\n",
       "  ('malignancy conclusions', 0.4043),\n",
       "  ('overexpression igf', 0.3986),\n",
       "  ('tumor neuroblastoma', 0.3718),\n",
       "  ('patients congenital', 0.3694),\n",
       "  ('childhood osteosarcoma', 0.3431),\n",
       "  ('diagnosed childhood', 0.3151),\n",
       "  ('adults breast', 0.2987),\n",
       "  ('diagnosed', 0.2796),\n",
       "  ('receptor defects', 0.2774),\n",
       "  ('factor development', 0.2671),\n",
       "  ('breast', 0.2527),\n",
       "  ('prostate cancer', 0.2357),\n",
       "  ('deficient patients', 0.2323),\n",
       "  ('patients', 0.232),\n",
       "  ('cancer 24', 0.2248),\n",
       "  ('defects', 0.2223),\n",
       "  ('establish prevalence', 0.2184),\n",
       "  ('second degree', 0.209),\n",
       "  ('222 patients', 0.1992),\n",
       "  ('overexpression', 0.1962),\n",
       "  ('338 second', 0.1814),\n",
       "  ('gene deletion', 0.1807),\n",
       "  ('aim study', 0.1791),\n",
       "  ('surveyed', 0.171),\n",
       "  ('colon', 0.163),\n",
       "  ('states', 0.157),\n",
       "  ('syndrome', 0.1567),\n",
       "  ('degree', 0.137),\n",
       "  ('ghrh receptor', 0.1357),\n",
       "  ('conclusions', 0.1265),\n",
       "  ('acts protecting', 0.1199),\n",
       "  ('ovaries', 0.1184),\n",
       "  ('degree relatives', 0.1108),\n",
       "  ('acts', 0.0992),\n",
       "  ('subjects', 0.0892),\n",
       "  ('laron syndrome', 0.0882),\n",
       "  ('establish', 0.0703),\n",
       "  ('members history', 0.0376),\n",
       "  ('24 family', 0.0281),\n",
       "  ('resistance', -0.002)],\n",
       " 'MED-1720': [('igf associated', 0.6458),\n",
       "  ('cancer igfbp', 0.6211),\n",
       "  ('tumour development', 0.4435),\n",
       "  ('background insulin', 0.4373),\n",
       "  ('cancer study', 0.3472),\n",
       "  ('dose response', 0.305),\n",
       "  ('premenopausal breast', 0.2664),\n",
       "  ('main binding', 0.2547),\n",
       "  ('blood concentrations', 0.2527),\n",
       "  ('95 ci', 0.2418),\n",
       "  ('like growth', 0.2296),\n",
       "  ('cohorts association', 0.2267),\n",
       "  ('associated increased', 0.2183),\n",
       "  ('risk prevention', 0.2117),\n",
       "  ('meta regression', 0.2082),\n",
       "  ('modulate cell', 0.2069),\n",
       "  ('development circulating', 0.1991),\n",
       "  ('colorectal', 0.1921),\n",
       "  ('survival thought', 0.1891),\n",
       "  ('background', 0.1885),\n",
       "  ('slopes obtained', 0.1865),\n",
       "  ('included', 0.1803),\n",
       "  ('ratios different', 0.1769),\n",
       "  ('01 27', 0.1714),\n",
       "  ('associated decreased', 0.1713),\n",
       "  ('major implications', 0.1701),\n",
       "  ('comparing 75th', 0.1679),\n",
       "  ('need standardised', 0.1676),\n",
       "  ('protein', 0.1644),\n",
       "  ('different exposure', 0.1626),\n",
       "  ('prostate', 0.1582),\n",
       "  ('ci 14', 0.1568),\n",
       "  ('normalised percentile', 0.1543),\n",
       "  ('controls high', 0.1526),\n",
       "  ('epidemiological observations', 0.1506),\n",
       "  ('sites laboratory', 0.1422),\n",
       "  ('scale findings', 0.1401),\n",
       "  ('vary sites', 0.1285),\n",
       "  ('log odds', 0.1254),\n",
       "  ('relating natural', 0.124),\n",
       "  ('nested', 0.1228),\n",
       "  ('cases 7137', 0.1168),\n",
       "  ('percentile 49', 0.1106),\n",
       "  ('08 high', 0.0879),\n",
       "  ('methods did', 0.0834),\n",
       "  ('65', 0.0781),\n",
       "  ('modest vary', 0.0682),\n",
       "  ('lung', 0.0342),\n",
       "  ('3609 cases', 0.0324),\n",
       "  ('standard case', 0.0224)],\n",
       " 'MED-1721': [('cancer incidence', 0.5831),\n",
       "  ('prospective cohort', 0.4171),\n",
       "  ('incidence endometrial', 0.3797),\n",
       "  ('women recruited', 0.3662),\n",
       "  ('mortality design', 0.3404),\n",
       "  ('14 breast', 0.3265),\n",
       "  ('million uk', 0.3082),\n",
       "  ('adjusted age', 0.3056),\n",
       "  ('mass index', 0.2912),\n",
       "  ('parity smoking', 0.2879),\n",
       "  ('overweight obese', 0.2812),\n",
       "  ('2001 followed', 0.2758),\n",
       "  ('years menopause', 0.2749),\n",
       "  ('27 cancers', 0.2549),\n",
       "  ('according body', 0.2466),\n",
       "  ('lymphoma 17', 0.2457),\n",
       "  ('trend relative', 0.2404),\n",
       "  ('use hormone', 0.2395),\n",
       "  ('61 05', 0.2352),\n",
       "  ('participants million', 0.2322),\n",
       "  ('49 colorectal', 0.2131),\n",
       "  ('modifiable risk', 0.2121),\n",
       "  ('multiple myeloma', 0.2072),\n",
       "  ('examine relation', 0.2043),\n",
       "  ('interval 62', 0.2024),\n",
       "  ('kg m2', 0.2015),\n",
       "  ('65 pancreatic', 0.2004),\n",
       "  ('conclusions increasing', 0.1973),\n",
       "  ('45 037', 0.1957),\n",
       "  ('similar incidence', 0.1904),\n",
       "  ('physical activity', 0.1865),\n",
       "  ('64 1996', 0.1861),\n",
       "  ('203 deaths', 0.1853),\n",
       "  ('oesophagus 38', 0.1787),\n",
       "  ('geographical region', 0.1666),\n",
       "  ('specific types', 0.1622),\n",
       "  ('leukaemia', 0.1617),\n",
       "  ('main', 0.1529),\n",
       "  ('socioeconomic status', 0.1527),\n",
       "  ('95 confidence', 0.1504),\n",
       "  ('40', 0.1143),\n",
       "  ('factor half', 0.1133),\n",
       "  ('non hodgkin', 0.1127),\n",
       "  ('03 34', 0.1099),\n",
       "  ('therapy results', 0.1002),\n",
       "  ('6000 annually', 0.0987),\n",
       "  ('alcohol intake', 0.0932),\n",
       "  ('kidney', 0.0733),\n",
       "  ('differed significantly', 0.0392),\n",
       "  ('10 units', -0.0338)],\n",
       " 'MED-1722': [('igf tumor', 0.58),\n",
       "  ('hallmarks cancer', 0.555),\n",
       "  ('risk cancers', 0.5258),\n",
       "  ('growth factors', 0.5233),\n",
       "  ('cancer uncontrolled', 0.468),\n",
       "  ('malignancy provides', 0.4628),\n",
       "  ('tumor type', 0.453),\n",
       "  ('relationship cancer', 0.4451),\n",
       "  ('novo malignancies', 0.4349),\n",
       "  ('work cancers', 0.4092),\n",
       "  ('uncontrolled proliferation', 0.3923),\n",
       "  ('overexpression growth', 0.3901),\n",
       "  ('malignancies 50', 0.3646),\n",
       "  ('mechanisms hallmarks', 0.3588),\n",
       "  ('metastasis disease', 0.3562),\n",
       "  ('children cancer', 0.3482),\n",
       "  ('colon breast', 0.3343),\n",
       "  ('proliferation mounting', 0.3304),\n",
       "  ('receptors common', 0.2703),\n",
       "  ('malignancies healthy', 0.2615),\n",
       "  ('investigated association', 0.252),\n",
       "  ('mounting evidence', 0.2286),\n",
       "  ('different disease', 0.2232),\n",
       "  ('controls age', 0.2053),\n",
       "  ('prostate', 0.1949),\n",
       "  ('studies investigated', 0.1933),\n",
       "  ('serum level', 0.1921),\n",
       "  ('larger populations', 0.1747),\n",
       "  ('group patients', 0.1673),\n",
       "  ('prevalent', 0.1648),\n",
       "  ('progression', 0.1598),\n",
       "  ('gender association', 0.1572),\n",
       "  ('type stage', 0.1532),\n",
       "  ('results showed', 0.1531),\n",
       "  ('significantly higher', 0.1496),\n",
       "  ('used identify', 0.1372),\n",
       "  ('suggests', 0.1243),\n",
       "  ('assess relationship', 0.1231),\n",
       "  ('using elisa', 0.1184),\n",
       "  ('standards estimation', 0.0924),\n",
       "  ('carried', 0.0916),\n",
       "  ('showed children', 0.0884),\n",
       "  ('lung', 0.0806),\n",
       "  ('benefit preventive', 0.072),\n",
       "  ('novo', 0.0711),\n",
       "  ('mounting', 0.0516),\n",
       "  ('routine work', 0.0395),\n",
       "  ('according local', 0.0348),\n",
       "  ('100 children', 0.0293),\n",
       "  ('small number', -0.0371)],\n",
       " 'MED-1723': [('diet mechanisms', 0.5072),\n",
       "  ('vegan diet', 0.3861),\n",
       "  ('cancers asian', 0.3633),\n",
       "  ('lower rates', 0.3406),\n",
       "  ('concentration diet', 0.3121),\n",
       "  ('lower circulating', 0.2887),\n",
       "  ('compared meat', 0.2765),\n",
       "  ('level insulin', 0.2684),\n",
       "  ('eating', 0.2667),\n",
       "  ('partial correlation', 0.257),\n",
       "  ('vegetarians 0006', 0.2478),\n",
       "  ('factor igf', 0.2469),\n",
       "  ('intake protein', 0.2469),\n",
       "  ('differences igfbp', 0.2437),\n",
       "  ('countries partly', 0.2423),\n",
       "  ('suggest plant', 0.2173),\n",
       "  ('sectional study', 0.2117),\n",
       "  ('mechanisms', 0.2084),\n",
       "  ('vegan women', 0.2083),\n",
       "  ('concentration 13', 0.2011),\n",
       "  ('data suggest', 0.1955),\n",
       "  ('unknown aim', 0.1862),\n",
       "  ('significant differences', 0.1738),\n",
       "  ('study determine', 0.1563),\n",
       "  ('women compared', 0.1469),\n",
       "  ('005', 0.1446),\n",
       "  ('lacto', 0.1253),\n",
       "  ('western', 0.117),\n",
       "  ('aim cross', 0.1156),\n",
       "  ('eaters 101', 0.1098),\n",
       "  ('binding globulin', 0.1091),\n",
       "  ('mean serum', 0.1009),\n",
       "  ('protein', 0.0964),\n",
       "  ('levels total', 0.0861),\n",
       "  ('groups', 0.0819),\n",
       "  ('explained', 0.0758),\n",
       "  ('sex hormone', 0.0737),\n",
       "  ('like growth', 0.072),\n",
       "  ('0008', 0.0422),\n",
       "  ('70 years', 0.0373),\n",
       "  ('92', 0.0216),\n",
       "  ('20 40', 0.0214),\n",
       "  ('27 0001', 0.0208),\n",
       "  ('292 british', 0.0144),\n",
       "  ('acids positively', 0.0066),\n",
       "  ('rich essential', 0.0054),\n",
       "  ('ages', 0.0049),\n",
       "  ('circulating', -0.0083),\n",
       "  ('compared 99', -0.0099),\n",
       "  ('ovo', -0.0204)],\n",
       " 'MED-1724': [('reduction igf', 0.5079),\n",
       "  ('restriction lifespans', 0.4443),\n",
       "  ('characteristic rodents', 0.4114),\n",
       "  ('igf promotes', 0.4009),\n",
       "  ('aging regulation', 0.3575),\n",
       "  ('dietary measures', 0.3169),\n",
       "  ('increased reduction', 0.2954),\n",
       "  ('low fat', 0.2782),\n",
       "  ('lifespan increased', 0.2645),\n",
       "  ('diseases regimens', 0.2636),\n",
       "  ('dogs', 0.253),\n",
       "  ('mammals fact', 0.2404),\n",
       "  ('hepatic synthesis', 0.2324),\n",
       "  ('useful retardation', 0.2321),\n",
       "  ('pro longevity', 0.2251),\n",
       "  ('pacesetter', 0.2157),\n",
       "  ('suppressants agents', 0.2147),\n",
       "  ('insulin', 0.2147),\n",
       "  ('levels link', 0.2056),\n",
       "  ('practical measures', 0.1992),\n",
       "  ('activity slow', 0.1876),\n",
       "  ('restriction advisable', 0.1791),\n",
       "  ('weight', 0.1778),\n",
       "  ('exercise training', 0.1773),\n",
       "  ('sensitizers appetite', 0.1737),\n",
       "  ('inversely proportional', 0.1603),\n",
       "  ('lignans oral', 0.1584),\n",
       "  ('risk common', 0.1554),\n",
       "  ('worms flies', 0.1523),\n",
       "  ('wide range', 0.1476),\n",
       "  ('appears evolutionarily', 0.1449),\n",
       "  ('combining approaches', 0.1399),\n",
       "  ('evidence consistent', 0.1388),\n",
       "  ('mutations signaling', 0.1308),\n",
       "  ('breeds', 0.1307),\n",
       "  ('production nitric', 0.1269),\n",
       "  ('role induction', 0.1263),\n",
       "  ('health additional', 0.1183),\n",
       "  ('agents flax', 0.0921),\n",
       "  ('estrogen tamoxifen', 0.09),\n",
       "  ('soluble fiber', 0.087),\n",
       "  ('intermediates homologous', 0.0858),\n",
       "  ('promotes endothelial', 0.0831),\n",
       "  ('plays key', 0.0624),\n",
       "  ('systemic', 0.0553),\n",
       "  ('tend', 0.0539),\n",
       "  ('notably salt', 0.0442),\n",
       "  ('vegan', 0.0217),\n",
       "  ('measures stroke', -0.0064),\n",
       "  ('sexual maturity', -0.0398)],\n",
       " 'MED-1725': [('pesticide exposures', 0.5172),\n",
       "  ('47 pesticides', 0.5132),\n",
       "  ('studies nhl', 0.4023),\n",
       "  ('including organophosphate', 0.3898),\n",
       "  ('analysis 47', 0.3236),\n",
       "  ('pooled data', 0.3066),\n",
       "  ('carcinogenic', 0.3027),\n",
       "  ('studies', 0.2959),\n",
       "  ('3417 allowed', 0.289),\n",
       "  ('risk exposure', 0.2835),\n",
       "  ('methods 1980s', 0.2799),\n",
       "  ('exposure increasing', 0.2725),\n",
       "  ('incidence including', 0.2504),\n",
       "  ('institute conducted', 0.2474),\n",
       "  ('specific effects', 0.2471),\n",
       "  ('farming', 0.2438),\n",
       "  ('allowed analysis', 0.2406),\n",
       "  ('herbicides', 0.238),\n",
       "  ('national cancer', 0.2328),\n",
       "  ('reported use', 0.2299),\n",
       "  ('results reported', 0.219),\n",
       "  ('adjusting estimates', 0.207),\n",
       "  ('chlorate subanalysis', 0.2057),\n",
       "  ('subanalysis potentially', 0.1868),\n",
       "  ('potential confounding', 0.173),\n",
       "  ('trend risk', 0.1665),\n",
       "  ('prespecified variance', 0.158),\n",
       "  ('insecticides chlordane', 0.1562),\n",
       "  ('positive trend', 0.1554),\n",
       "  ('multiple', 0.1505),\n",
       "  ('case control', 0.1428),\n",
       "  ('model', 0.1328),\n",
       "  ('large sample', 0.1136),\n",
       "  ('copper', 0.1118),\n",
       "  ('simultaneously controlling', 0.1113),\n",
       "  ('used examine', 0.1035),\n",
       "  ('men large', 0.1007),\n",
       "  ('dieldrin', 0.0977),\n",
       "  ('stable results', 0.0617),\n",
       "  ('numbers conclusion', 0.0597),\n",
       "  ('united states', 0.0559),\n",
       "  ('acetoarsenite', 0.0246),\n",
       "  ('atrazine', 0.0239),\n",
       "  ('important accurately', 0.0073),\n",
       "  ('sodium', -0.0031),\n",
       "  ('glyphosate', -0.0145),\n",
       "  ('midwestern', -0.0232),\n",
       "  ('fonofos', -0.0324),\n",
       "  ('individual', -0.0654),\n",
       "  ('coumaphos', -0.0687)],\n",
       " 'MED-1726': [('pesticides used', 0.6443),\n",
       "  ('pesticides norm', 0.4965),\n",
       "  ('insecticides tested', 0.4843),\n",
       "  ('fungicides measured', 0.4594),\n",
       "  ('formulations contain', 0.4262),\n",
       "  ('mixtures tested', 0.4183),\n",
       "  ('called inerts', 0.4111),\n",
       "  ('adjuvants kept', 0.394),\n",
       "  ('calculated toxicity', 0.3399),\n",
       "  ('environmental exposures', 0.3294),\n",
       "  ('toxic herbicides', 0.3208),\n",
       "  ('concentrations', 0.3161),\n",
       "  ('followed herbicides', 0.3088),\n",
       "  ('principles major', 0.2986),\n",
       "  ('pirimicarb', 0.2556),\n",
       "  ('imidacloprid acetamiprid', 0.2481),\n",
       "  ('agricultural dilutions', 0.2342),\n",
       "  ('ingredient', 0.2319),\n",
       "  ('concentrations 300', 0.2107),\n",
       "  ('caspases', 0.1968),\n",
       "  ('isoproturon', 0.188),\n",
       "  ('used world', 0.1866),\n",
       "  ('tested tested', 0.1828),\n",
       "  ('acceptable daily', 0.1759),\n",
       "  ('activities', 0.156),\n",
       "  ('reflect relevant', 0.1482),\n",
       "  ('manufacturing companies', 0.1479),\n",
       "  ('tebuconazole epoxiconazole', 0.1442),\n",
       "  ('roundup toxic', 0.1429),\n",
       "  ('types despite', 0.1323),\n",
       "  ('plus declared', 0.1258),\n",
       "  ('confidential called', 0.1124),\n",
       "  ('hek293 jeg3', 0.1109),\n",
       "  ('declared active', 0.1073),\n",
       "  ('glyphosate', 0.1055),\n",
       "  ('membrane degradations', 0.0967),\n",
       "  ('lower', 0.0679),\n",
       "  ('chronic', 0.0663),\n",
       "  ('challenge relevance', 0.0656),\n",
       "  ('profiles cell', 0.0644),\n",
       "  ('norm calculated', 0.0634),\n",
       "  ('constitute respectively', 0.0611),\n",
       "  ('prochloraz constitute', 0.0538),\n",
       "  ('measured mitochondrial', 0.0508),\n",
       "  ('thousand', 0.0442),\n",
       "  ('lines', 0.0325),\n",
       "  ('benign reputation', 0.0278),\n",
       "  ('600 times', 0.0274),\n",
       "  ('comparing', 0.0226),\n",
       "  ('lines hepg2', 0.0071)],\n",
       " 'MED-1728': [('exposure glyphosate', 0.5439),\n",
       "  ('glyphosate widely', 0.5343),\n",
       "  ('spectrum herbicide', 0.3965),\n",
       "  ('carcinogenicity studies', 0.3766),\n",
       "  ('recommended exposure', 0.3555),\n",
       "  ('environmental protection', 0.319),\n",
       "  ('type pesticide', 0.3069),\n",
       "  ('regulatory agencies', 0.2966),\n",
       "  ('protection agency', 0.2962),\n",
       "  ('glyphosate seven', 0.2943),\n",
       "  ('risks humans', 0.2762),\n",
       "  ('cancer risks', 0.2734),\n",
       "  ('use crops', 0.254),\n",
       "  ('biomonitoring data', 0.2424),\n",
       "  ('generic', 0.2329),\n",
       "  ('non food', 0.2085),\n",
       "  ('rats mice', 0.1968),\n",
       "  ('lead exposure', 0.1868),\n",
       "  ('broad spectrum', 0.1704),\n",
       "  ('potential based', 0.1602),\n",
       "  ('use multiple', 0.1413),\n",
       "  ('widely considered', 0.1328),\n",
       "  ('cancer adults', 0.1257),\n",
       "  ('studies indicate', 0.1205),\n",
       "  ('misclassification recommended', 0.1162),\n",
       "  ('site specific', 0.1159),\n",
       "  ('positive associations', 0.1143),\n",
       "  ('consistent pattern', 0.1067),\n",
       "  ('authorities scientific', 0.1044),\n",
       "  ('algorithms validated', 0.1038),\n",
       "  ('literature evaluate', 0.0997),\n",
       "  ('total cancer', 0.0971),\n",
       "  ('united states', 0.093),\n",
       "  ('examined association', 0.0896),\n",
       "  ('multiple food', 0.0839),\n",
       "  ('assessments', 0.0801),\n",
       "  ('studies fourteen', 0.0775),\n",
       "  ('world registered', 0.0651),\n",
       "  ('control', 0.0569),\n",
       "  ('primarily results', 0.0541),\n",
       "  ('children site', 0.042),\n",
       "  ('reserved', 0.0166),\n",
       "  ('cohort', -0.0029),\n",
       "  ('underscore importance', -0.0151),\n",
       "  ('elsevier rights', -0.0246),\n",
       "  ('incorporate duration', -0.0261),\n",
       "  ('bodies', -0.0356),\n",
       "  ('copyright 2012', -0.0367),\n",
       "  ('case', -0.0411),\n",
       "  ('data copyright', -0.0734)],\n",
       " 'MED-1729': [('birth defects', 0.4592),\n",
       "  ('families rrv', 0.3821),\n",
       "  ('695 families', 0.3691),\n",
       "  ('male births', 0.3596),\n",
       "  ('rrv minnesota', 0.354),\n",
       "  ('children residents', 0.3257),\n",
       "  ('exposure categories', 0.3244),\n",
       "  ('effects clustered', 0.3212),\n",
       "  ('532 children', 0.3165),\n",
       "  ('1989 1991', 0.3094),\n",
       "  ('male pesticide', 0.2831),\n",
       "  ('regions state', 0.2723),\n",
       "  ('conceptions spring', 0.2689),\n",
       "  ('disorders years', 0.261),\n",
       "  ('highest risk', 0.2518),\n",
       "  ('neurobehavioral developmental', 0.2414),\n",
       "  ('defects confirmed', 0.2345),\n",
       "  ('births 25', 0.2149),\n",
       "  ('adverse neurologic', 0.2095),\n",
       "  ('higher major', 0.2031),\n",
       "  ('glyphosate yielded', 0.1997),\n",
       "  ('sectional study', 0.1961),\n",
       "  ('75 specific', 0.1933),\n",
       "  ('red river', 0.1908),\n",
       "  ('different reproductive', 0.1683),\n",
       "  ('medical records', 0.1659),\n",
       "  ('total reported', 0.1632),\n",
       "  ('year life', 0.1592),\n",
       "  ('resulted significantly', 0.1552),\n",
       "  ('factor determination', 0.1514),\n",
       "  ('born applicator', 0.1448),\n",
       "  ('follow mendelian', 0.1411),\n",
       "  ('usa significantly', 0.1346),\n",
       "  ('parent reported', 0.1322),\n",
       "  ('agricultural regions', 0.1253),\n",
       "  ('detailed examination', 0.1253),\n",
       "  ('valley', 0.1244),\n",
       "  ('studies needed', 0.1238),\n",
       "  ('ci use', 0.1043),\n",
       "  ('sex children', 0.1007),\n",
       "  ('exclusive fungicides', 0.0873),\n",
       "  ('kinships defined', 0.0865),\n",
       "  ('000 83', 0.0852),\n",
       "  ('exceed male', 0.0759),\n",
       "  ('contributed', 0.0347),\n",
       "  ('significantly lower', 0.0344),\n",
       "  ('season vs', 0.0274),\n",
       "  ('pattern remaining', -0.0113),\n",
       "  ('47 000', -0.0357),\n",
       "  ('normal female', -0.1275)],\n",
       " 'MED-1730': [('exposure glyphosate', 0.6424),\n",
       "  ('glyphosate non', 0.5709),\n",
       "  ('recommended pesticide', 0.5029),\n",
       "  ('herbicide use', 0.4392),\n",
       "  ('evaluate exposure', 0.4371),\n",
       "  ('environmental protection', 0.4365),\n",
       "  ('agency epa', 0.3946),\n",
       "  ('risks humans', 0.3713),\n",
       "  ('biomonitoring studies', 0.3578),\n",
       "  ('potential health', 0.3422),\n",
       "  ('disease exposure', 0.3247),\n",
       "  ('crops examine', 0.3177),\n",
       "  ('review evidence', 0.3151),\n",
       "  ('regulatory agencies', 0.3119),\n",
       "  ('non cancer', 0.31),\n",
       "  ('broad spectrum', 0.2313),\n",
       "  ('associations indicating', 0.2295),\n",
       "  ('food non', 0.2129),\n",
       "  ('endpoints including', 0.2119),\n",
       "  ('use multiple', 0.1914),\n",
       "  ('causally non', 0.1832),\n",
       "  ('reproductive developmental', 0.1767),\n",
       "  ('cancer outcomes', 0.171),\n",
       "  ('associations weak', 0.1604),\n",
       "  ('issues related', 0.1551),\n",
       "  ('humans searched', 0.1477),\n",
       "  ('comprehensive discussion', 0.1477),\n",
       "  ('parkinson', 0.1453),\n",
       "  ('allow comprehensive', 0.1401),\n",
       "  ('developed validated', 0.1367),\n",
       "  ('multiple food', 0.1264),\n",
       "  ('respiratory', 0.1256),\n",
       "  ('united states', 0.1185),\n",
       "  ('pattern positive', 0.1183),\n",
       "  ('world registered', 0.1029),\n",
       "  ('evaluated variety', 0.1007),\n",
       "  ('misclassification cohort', 0.0991),\n",
       "  ('specific', 0.0952),\n",
       "  ('algorithms', 0.095),\n",
       "  ('control', 0.089),\n",
       "  ('different accurate', 0.075),\n",
       "  ('outcomes rheumatoid', 0.0737),\n",
       "  ('diabetes', 0.062),\n",
       "  ('thyroid', 0.0592),\n",
       "  ('sectional studies', 0.0512),\n",
       "  ('myocardial infarction', 0.0237),\n",
       "  ('cross', 0.0073),\n",
       "  ('elsevier rights', -0.0018),\n",
       "  ('copyright 2011', -0.009),\n",
       "  ('copyright', -0.0141)],\n",
       " 'MED-1731': [('glysh toxicity', 0.5403),\n",
       "  ('uncommon poisoning', 0.5112),\n",
       "  ('herbicide deaths', 0.4916),\n",
       "  ('poisoning report', 0.4876),\n",
       "  ('glyphosate surfactant', 0.4667),\n",
       "  ('toxicity proposed', 0.4487),\n",
       "  ('toxic deaths', 0.4421),\n",
       "  ('deaths occurred', 0.4143),\n",
       "  ('suicidal ingestion', 0.4104),\n",
       "  ('surfactant herbicide', 0.4087),\n",
       "  ('toxicity uncommon', 0.4021),\n",
       "  ('poisoning aggressive', 0.3942),\n",
       "  ('toxicity refractory', 0.3822),\n",
       "  ('minimally toxic', 0.3725),\n",
       "  ('treatment deaths', 0.3639),\n",
       "  ('nature poisoning', 0.3497),\n",
       "  ('following suicidal', 0.3493),\n",
       "  ('report fatalities', 0.3474),\n",
       "  ('ingestion severe', 0.3246),\n",
       "  ('refractory intensive', 0.32),\n",
       "  ('assessing severity', 0.3025),\n",
       "  ('proposed treatment', 0.2766),\n",
       "  ('poor outcome', 0.2756),\n",
       "  ('occurred despite', 0.2608),\n",
       "  ('review', 0.247),\n",
       "  ('existing literature', 0.2444),\n",
       "  ('acidosis', 0.2336),\n",
       "  ('organophosphate', 0.2231),\n",
       "  ('metabolic', 0.1973),\n",
       "  ('regarded minimally', 0.1829),\n",
       "  ('discussed', 0.1746),\n",
       "  ('reported following', 0.1725),\n",
       "  ('clinical guide', 0.1677),\n",
       "  ('series analysed', 0.16),\n",
       "  ('intensive supportive', 0.1433),\n",
       "  ('hyperkalaemia portends', 0.1415),\n",
       "  ('oedema', 0.1286),\n",
       "  ('containing carbon', 0.097),\n",
       "  ('phosphorus moiety', 0.088),\n",
       "  ('early recognition', 0.0767),\n",
       "  ('outcome containing', 0.0582),\n",
       "  ('moiety', 0.0579),\n",
       "  ('triad pulmonary', 0.0575),\n",
       "  ('aggressive', 0.0346),\n",
       "  ('context', 0.0316),\n",
       "  ('portends poor', 0.0166),\n",
       "  ('exhibit', -0.0286),\n",
       "  ('traditionally', -0.0517),\n",
       "  ('does', -0.0553),\n",
       "  ('portends', -0.1122)],\n",
       " 'MED-1732': [('effects glyphosate', 0.6475),\n",
       "  ('glyphosate estrogen', 0.6159),\n",
       "  ('pure glyphosate', 0.5112),\n",
       "  ('endocrine disruptor', 0.4213),\n",
       "  ('pesticides recent', 0.4027),\n",
       "  ('genistein', 0.3977),\n",
       "  ('herbicides widely', 0.3843),\n",
       "  ('low environmentally', 0.377),\n",
       "  ('toxic pesticides', 0.373),\n",
       "  ('environmentally relevant', 0.3549),\n",
       "  ('inhibited estrogen', 0.3331),\n",
       "  ('effects human', 0.3103),\n",
       "  ('contamination soybeans', 0.3056),\n",
       "  ('effects pure', 0.3023),\n",
       "  ('focuses effects', 0.2864),\n",
       "  ('relevant concentrations', 0.2734),\n",
       "  ('mediated ers', 0.2732),\n",
       "  ('potential adverse', 0.2722),\n",
       "  ('altered erα', 0.271),\n",
       "  ('possessed estrogenic', 0.258),\n",
       "  ('recent studies', 0.2364),\n",
       "  ('proliferative concentrations', 0.2348),\n",
       "  ('mediated transcriptional', 0.2306),\n",
       "  ('additive effects', 0.2149),\n",
       "  ('based', 0.1971),\n",
       "  ('showed potential', 0.1952),\n",
       "  ('contamination', 0.1922),\n",
       "  ('active ingredient', 0.1877),\n",
       "  ('response element', 0.1797),\n",
       "  ('hormone independent', 0.1628),\n",
       "  ('antagonist ici', 0.1541),\n",
       "  ('182780', 0.1512),\n",
       "  ('results indicated', 0.1418),\n",
       "  ('expressions', 0.1285),\n",
       "  ('cultivation results', 0.116),\n",
       "  ('fold control', 0.1064),\n",
       "  ('health', 0.1045),\n",
       "  ('widely', 0.0938),\n",
       "  ('10', 0.0847),\n",
       "  ('cells activation', 0.0803),\n",
       "  ('withdrawal condition', 0.0789),\n",
       "  ('mda', 0.0755),\n",
       "  ('rights reserved', 0.0692),\n",
       "  ('elsevier', 0.0616),\n",
       "  ('mb231', 0.0554),\n",
       "  ('breast cancer', 0.0496),\n",
       "  ('need animal', 0.0451),\n",
       "  ('kbluc cells', 0.0249),\n",
       "  ('13 fold', -0.0386),\n",
       "  ('t47d cells', -0.0413)],\n",
       " 'MED-1733': [('glysh intoxication', 0.5883),\n",
       "  ('herbicide glysh', 0.5863),\n",
       "  ('herbicide intoxicated', 0.5022),\n",
       "  ('glyphosate surfactant', 0.5021),\n",
       "  ('injection glysh', 0.4513),\n",
       "  ('intramuscular glysh', 0.4388),\n",
       "  ('surfactant herbicide', 0.3807),\n",
       "  ('ingestion inhalation', 0.3593),\n",
       "  ('intoxicated cases', 0.3298),\n",
       "  ('toxicity', 0.3284),\n",
       "  ('poisoning different', 0.2881),\n",
       "  ('injection case', 0.2527),\n",
       "  ('skin exposure', 0.2209),\n",
       "  ('used non', 0.1857),\n",
       "  ('intramuscular injection', 0.1828),\n",
       "  ('punctures', 0.1567),\n",
       "  ('ill defined', 0.1443),\n",
       "  ('syndrome develop', 0.1393),\n",
       "  ('introduction', 0.1392),\n",
       "  ('forearm needle', 0.1051),\n",
       "  ('scan revealed', 0.1037),\n",
       "  ('rhabdomyolysis compartment', 0.1007),\n",
       "  ('discussion mechanism', 0.0951),\n",
       "  ('disclosed painful', 0.0942),\n",
       "  ('42 year', 0.0848),\n",
       "  ('ml', 0.0839),\n",
       "  ('woman came', 0.0777),\n",
       "  ('present case', 0.0771),\n",
       "  ('care', 0.0755),\n",
       "  ('monitoring acute', 0.0652),\n",
       "  ('emergency', 0.0606),\n",
       "  ('widely used', 0.0566),\n",
       "  ('physical examination', 0.0447),\n",
       "  ('upper limb', 0.041),\n",
       "  ('subcutaneous tissue', 0.0367),\n",
       "  ('different oral', 0.0365),\n",
       "  ('areas heterogeneous', 0.0254),\n",
       "  ('selective', 0.0137),\n",
       "  ('lateral aspect', 0.0125),\n",
       "  ('department complaining', 0.0121),\n",
       "  ('play', 0.0033),\n",
       "  ('15 previously', 0.0016),\n",
       "  ('tissue posterior', -0.0067),\n",
       "  ('important role', -0.014),\n",
       "  ('high density', -0.0149),\n",
       "  ('old', -0.0178),\n",
       "  ('taken', -0.0268),\n",
       "  ('year', -0.0617),\n",
       "  ('rapidly contribute', -0.0689),\n",
       "  ('12 performed', -0.0932)],\n",
       " 'MED-1736': [('glyphosate herbicide', 0.5761),\n",
       "  ('herbicide effects', 0.5751),\n",
       "  ('toxicity related', 0.4137),\n",
       "  ('kill weeds', 0.3885),\n",
       "  ('disturbances reproductive', 0.3556),\n",
       "  ('aromatase', 0.3543),\n",
       "  ('weeds agricultural', 0.3342),\n",
       "  ('reduction testosterone', 0.3227),\n",
       "  ('morphology decreased', 0.3207),\n",
       "  ('rats reproductive', 0.3005),\n",
       "  ('disruptor vivo', 0.2865),\n",
       "  ('dose dependent', 0.2853),\n",
       "  ('manner reduced', 0.2834),\n",
       "  ('estradiol levels', 0.2781),\n",
       "  ('hormonal production', 0.2706),\n",
       "  ('synthesis studies', 0.259),\n",
       "  ('related inhibition', 0.2431),\n",
       "  ('corticosterone morphology', 0.2256),\n",
       "  ('non agricultural', 0.2184),\n",
       "  ('lower treated', 0.2024),\n",
       "  ('landscapes', 0.1908),\n",
       "  ('decreased significantly', 0.1841),\n",
       "  ('development', 0.1811),\n",
       "  ('enzyme causes', 0.1802),\n",
       "  ('semineferous tubules', 0.1762),\n",
       "  ('treated groups', 0.1672),\n",
       "  ('prepubertal', 0.1607),\n",
       "  ('star protein', 0.1574),\n",
       "  ('exposure performed', 0.1509),\n",
       "  ('69', 0.1267),\n",
       "  ('controls differences', 0.1178),\n",
       "  ('levels detected', 0.1176),\n",
       "  ('significantly changed', 0.1003),\n",
       "  ('dl mg', 0.0969),\n",
       "  ('kg 116', 0.0941),\n",
       "  ('94', 0.0887),\n",
       "  ('14 ng', 0.0778),\n",
       "  ('wistar rats', 0.0768),\n",
       "  ('groups 001', 0.0676),\n",
       "  ('observed relative', 0.0562),\n",
       "  ('epithelium', 0.0517),\n",
       "  ('microm difference', 0.0474),\n",
       "  ('diameter observed', 0.0421),\n",
       "  ('kg 130', 0.0218),\n",
       "  ('suggest commercial', -0.0005),\n",
       "  ('widely used', -0.0077),\n",
       "  ('85 microm', -0.0169),\n",
       "  ('microm 250', -0.0223),\n",
       "  ('increased luminal', -0.0452),\n",
       "  ('12', -0.0502)],\n",
       " 'MED-1737': [('major herbicide', 0.4957),\n",
       "  ('modified plants', 0.421),\n",
       "  ('dose dependent', 0.362),\n",
       "  ('endocrine disruption', 0.358),\n",
       "  ('reveal xenobiotic', 0.3378),\n",
       "  ('cytotoxic potentially', 0.3271),\n",
       "  ('cell lines', 0.317),\n",
       "  ('human reproduction', 0.2974),\n",
       "  ('roundup demonstrated', 0.2882),\n",
       "  ('pollutants', 0.2555),\n",
       "  ('conditions embryonic', 0.2552),\n",
       "  ('formulations appear', 0.221),\n",
       "  ('extracts furthermore', 0.2199),\n",
       "  ('bioforce human', 0.218),\n",
       "  ('placental ones', 0.217),\n",
       "  ('confirmed different', 0.2161),\n",
       "  ('acidity dose', 0.2145),\n",
       "  ('species', 0.2078),\n",
       "  ('glyphosate acts', 0.1917),\n",
       "  ('cells normal', 0.1711),\n",
       "  ('24', 0.1683),\n",
       "  ('293', 0.168),\n",
       "  ('affect human', 0.1671),\n",
       "  ('tolerate tested', 0.1651),\n",
       "  ('aromatase independently', 0.1606),\n",
       "  ('used worldwide', 0.1573),\n",
       "  ('synergistic effect', 0.1552),\n",
       "  ('times sensitive', 0.1496),\n",
       "  ('case contamination', 0.1468),\n",
       "  ('days later', 0.144),\n",
       "  ('microsomal', 0.1319),\n",
       "  ('kidney equine', 0.1254),\n",
       "  ('jeg3 cells', 0.1239),\n",
       "  ('partial inactivator', 0.1234),\n",
       "  ('short term', 0.1144),\n",
       "  ('agriculture 21', 0.1096),\n",
       "  ('adjuvants', 0.1041),\n",
       "  ('non', 0.0866),\n",
       "  ('efficient', 0.0799),\n",
       "  ('testicular', 0.0784),\n",
       "  ('compounds 27', 0.078),\n",
       "  ('acts directly', 0.072),\n",
       "  ('free medium', 0.0649),\n",
       "  ('ld 50', 0.0616),\n",
       "  ('taken data', 0.0567),\n",
       "  ('appear underestimated', 0.0473),\n",
       "  ('72 presence', 0.0391),\n",
       "  ('210 microm', 0.0258),\n",
       "  ('human fresh', 0.0188),\n",
       "  ('06 containing', 0.0088)],\n",
       " 'MED-1738': [('glyphosate exposure', 0.6222),\n",
       "  ('toxicity observed', 0.3992),\n",
       "  ('effects environmentally', 0.3738),\n",
       "  ('used herbicide', 0.3715),\n",
       "  ('human exposure', 0.3675),\n",
       "  ('reproductive effects', 0.3665),\n",
       "  ('various adverse', 0.3133),\n",
       "  ('pathway plants', 0.3091),\n",
       "  ('plants animals', 0.2875),\n",
       "  ('targets shikimate', 0.2849),\n",
       "  ('possible developmental', 0.2801),\n",
       "  ('reference dose', 0.2418),\n",
       "  ('concentrations humans', 0.2382),\n",
       "  ('metabolic', 0.2377),\n",
       "  ('health developing', 0.2335),\n",
       "  ('agency epa', 0.2252),\n",
       "  ('present formulations', 0.2232),\n",
       "  ('studies used', 0.2169),\n",
       "  ('consistent effects', 0.213),\n",
       "  ('studies mechanisms', 0.2124),\n",
       "  ('relative safety', 0.2032),\n",
       "  ('available biomonitoring', 0.2009),\n",
       "  ('animals despite', 0.193),\n",
       "  ('despite relative', 0.1925),\n",
       "  ('mg kg', 0.1786),\n",
       "  ('action related', 0.176),\n",
       "  ('problems alleged', 0.163),\n",
       "  ('surfactants', 0.1557),\n",
       "  ('humans animals', 0.1519),\n",
       "  ('reviewed evaluation', 0.149),\n",
       "  ('offspring furthermore', 0.1442),\n",
       "  ('potential human', 0.1407),\n",
       "  ('normal application', 0.137),\n",
       "  ('literature shows', 0.1364),\n",
       "  ('practices furthermore', 0.1194),\n",
       "  ('targets', 0.1062),\n",
       "  ('evidence linking', 0.101),\n",
       "  ('working', 0.0926),\n",
       "  ('low human', 0.0794),\n",
       "  ('epidemiological animal', 0.0703),\n",
       "  ('fold', 0.0633),\n",
       "  ('1993 conclusion', 0.05),\n",
       "  ('widely used', 0.05),\n",
       "  ('plausible', 0.0418),\n",
       "  ('database', 0.0262),\n",
       "  ('directly', -0.0024),\n",
       "  ('data strongly', -0.0205),\n",
       "  ('solid', -0.0235),\n",
       "  ('oral', -0.0451),\n",
       "  ('humans 500', -0.0472)],\n",
       " 'MED-1739': [('glyphosate 36', 0.5388),\n",
       "  ('testis glyphosate', 0.4723),\n",
       "  ('roundup exposure', 0.4335),\n",
       "  ('induces oxidative', 0.4309),\n",
       "  ('commercial pesticide', 0.4241),\n",
       "  ('testis pesticide', 0.3835),\n",
       "  ('gsh increased', 0.3808),\n",
       "  ('basis toxicity', 0.3772),\n",
       "  ('reduced glutathione', 0.3651),\n",
       "  ('prepubertal rat', 0.3547),\n",
       "  ('endocrine disruptor', 0.3219),\n",
       "  ('roundup decreased', 0.3118),\n",
       "  ('disruption spermatogenesis', 0.3048),\n",
       "  ('acid reactive', 0.3031),\n",
       "  ('activated protein', 0.292),\n",
       "  ('min induces', 0.2824),\n",
       "  ('30 min', 0.27),\n",
       "  ('exposure low', 0.2698),\n",
       "  ('signaling misregulation', 0.266),\n",
       "  ('ca overload', 0.2554),\n",
       "  ('ascorbic acid', 0.2528),\n",
       "  ('doses', 0.2488),\n",
       "  ('concentration opening', 0.245),\n",
       "  ('cell death', 0.2423),\n",
       "  ('ppm increased', 0.2414),\n",
       "  ('toxicity remains', 0.2366),\n",
       "  ('trolox', 0.2348),\n",
       "  ('molecular basis', 0.2277),\n",
       "  ('pathways leading', 0.2264),\n",
       "  ('fertility copyright', 0.215),\n",
       "  ('response endoplasmic', 0.2125),\n",
       "  ('tbars protein', 0.2105),\n",
       "  ('increased 45', 0.2014),\n",
       "  ('p38mapk', 0.2006),\n",
       "  ('results acute', 0.1937),\n",
       "  ('defenses contribute', 0.1922),\n",
       "  ('ryanodine receptors', 0.1825),\n",
       "  ('glucose phosphate', 0.1823),\n",
       "  ('sertoli cell', 0.173),\n",
       "  ('glutamyltransferase catalase', 0.1596),\n",
       "  ('ppm 036', 0.1495),\n",
       "  ('voltage dependent', 0.1438),\n",
       "  ('species', 0.1327),\n",
       "  ('primary', 0.1311),\n",
       "  ('peroxidase', 0.1143),\n",
       "  ('play role', 0.1121),\n",
       "  ('events prevented', 0.1023),\n",
       "  ('male', 0.0946),\n",
       "  ('elsevier rights', 0.0457),\n",
       "  ('clarified', 0.0275)],\n",
       " 'MED-1740': [('pesticide roundup', 0.5435),\n",
       "  ('roundup glyphosate', 0.4982),\n",
       "  ('urchin embryos', 0.4782),\n",
       "  ('roundup affects', 0.437),\n",
       "  ('chemicals studied', 0.4184),\n",
       "  ('development roundup', 0.4129),\n",
       "  ('concentration roundup', 0.4064),\n",
       "  ('health risk', 0.3741),\n",
       "  ('cycle regulation', 0.3714),\n",
       "  ('embryos', 0.3519),\n",
       "  ('fertilization appropriate', 0.3505),\n",
       "  ('regulation', 0.3417),\n",
       "  ('transcription roundup', 0.3279),\n",
       "  ('sea urchin', 0.3217),\n",
       "  ('environmental', 0.3014),\n",
       "  ('synthetic', 0.2696),\n",
       "  ('induced using', 0.2674),\n",
       "  ('regulates universally', 0.2664),\n",
       "  ('universally phase', 0.253),\n",
       "  ('global protein', 0.2512),\n",
       "  ('affects cell', 0.2497),\n",
       "  ('regulator results', 0.2489),\n",
       "  ('studied effect', 0.2472),\n",
       "  ('cleavage sea', 0.2444),\n",
       "  ('considering universality', 0.2395),\n",
       "  ('glyphosate ineffective', 0.2384),\n",
       "  ('model used', 0.2304),\n",
       "  ('rate preventing', 0.2235),\n",
       "  ('early', 0.222),\n",
       "  ('divisions', 0.2091),\n",
       "  ('delaying activation', 0.208),\n",
       "  ('subthreshold concentration', 0.2047),\n",
       "  ('vivo', 0.2025),\n",
       "  ('widely used', 0.194),\n",
       "  ('question safety', 0.19),\n",
       "  ('assess human', 0.1873),\n",
       "  ('judged cytologically', 0.1846),\n",
       "  ('kinetic cell', 0.1667),\n",
       "  ('species', 0.165),\n",
       "  ('summary', 0.1613),\n",
       "  ('products considering', 0.1573),\n",
       "  ('complex', 0.141),\n",
       "  ('analyzed cdk1', 0.139),\n",
       "  ('inhibited global', 0.1306),\n",
       "  ('interference', 0.1301),\n",
       "  ('indicating synergy', 0.13),\n",
       "  ('lethal involved', 0.125),\n",
       "  ('10 mm', 0.0764),\n",
       "  ('increasing', 0.068),\n",
       "  ('mm presence', 0.0084)],\n",
       " 'MED-1741': [('glyphosate contaminant', 0.6175),\n",
       "  ('roundup glyphosate', 0.607),\n",
       "  ('glyphosate pregnancy', 0.5679),\n",
       "  ('roundup toxic', 0.4677),\n",
       "  ('bioavailability bioaccumulation', 0.4555),\n",
       "  ('based herbicide', 0.4507),\n",
       "  ('toxic effects', 0.3941),\n",
       "  ('pregnancy problems', 0.3848),\n",
       "  ('modified plants', 0.3799),\n",
       "  ('residues enter', 0.3793),\n",
       "  ('roundup formulation', 0.3682),\n",
       "  ('agricultural use', 0.346),\n",
       "  ('tolerate residues', 0.3444),\n",
       "  ('contaminant', 0.3219),\n",
       "  ('use effect', 0.2992),\n",
       "  ('contaminant rivers', 0.2985),\n",
       "  ('hr concentrations', 0.2964),\n",
       "  ('genetically', 0.2945),\n",
       "  ('rivers agricultural', 0.2917),\n",
       "  ('lower agricultural', 0.2645),\n",
       "  ('enzyme effects', 0.2583),\n",
       "  ('concentrations lower', 0.2544),\n",
       "  ('nontoxic', 0.2318),\n",
       "  ('levels interacts', 0.2273),\n",
       "  ('facilitated roundup', 0.2207),\n",
       "  ('synthesis', 0.2046),\n",
       "  ('tested effects', 0.1997),\n",
       "  ('mammals', 0.1925),\n",
       "  ('disrupts aromatase', 0.18),\n",
       "  ('workers', 0.1793),\n",
       "  ('modified', 0.165),\n",
       "  ('increases concentration', 0.1606),\n",
       "  ('human placental', 0.1593),\n",
       "  ('estrogen', 0.1557),\n",
       "  ('problems mechanism', 0.1291),\n",
       "  ('adjuvants enhances', 0.1261),\n",
       "  ('mrna levels', 0.1241),\n",
       "  ('ingredient tested', 0.1238),\n",
       "  ('action', 0.1238),\n",
       "  ('microsomes cell', 0.1028),\n",
       "  ('human', 0.0966),\n",
       "  ('worldwide including', 0.0722),\n",
       "  ('enter food', 0.0683),\n",
       "  ('interacts active', 0.0599),\n",
       "  ('site purified', 0.0276),\n",
       "  ('questioned', -0.0029),\n",
       "  ('cells 18', -0.0068),\n",
       "  ('jeg3 cells', -0.0148),\n",
       "  ('surprisingly', -0.0227),\n",
       "  ('chain', -0.0239)],\n",
       " 'MED-1743': [('soybeans contained', 0.6356),\n",
       "  ('soy gm', 0.5545),\n",
       "  ('31 soybean', 0.5227),\n",
       "  ('characterise soy', 0.5211),\n",
       "  ('agrochemicals using', 0.4631),\n",
       "  ('soybeans exception', 0.4608),\n",
       "  ('pesticides 31', 0.4082),\n",
       "  ('unmodified soy', 0.3922),\n",
       "  ('nutritional profile', 0.3533),\n",
       "  ('residues herbicides', 0.3376),\n",
       "  ('including residues', 0.3314),\n",
       "  ('iowa usa', 0.3309),\n",
       "  ('genetically modified', 0.3186),\n",
       "  ('total protein', 0.3013),\n",
       "  ('acids', 0.299),\n",
       "  ('total saturated', 0.2662),\n",
       "  ('elemental variables', 0.2577),\n",
       "  ('samples grouped', 0.2522),\n",
       "  ('cultivation regime', 0.2519),\n",
       "  ('compositional characteristics', 0.2511),\n",
       "  ('glyphosate ampa', 0.2503),\n",
       "  ('different categories', 0.2443),\n",
       "  ('batches contained', 0.2417),\n",
       "  ('kg respectively', 0.2272),\n",
       "  ('profile sugars', 0.2233),\n",
       "  ('2013', 0.1979),\n",
       "  ('fat', 0.187),\n",
       "  ('mean mg', 0.1846),\n",
       "  ('article describes', 0.1754),\n",
       "  ('conventional organic', 0.1719),\n",
       "  ('using 35', 0.1673),\n",
       "  ('maltose significantly', 0.1648),\n",
       "  ('substantial non', 0.1642),\n",
       "  ('zinc fibre', 0.1622),\n",
       "  ('regime iii', 0.1592),\n",
       "  ('sucrose', 0.1428),\n",
       "  ('omega', 0.1347),\n",
       "  ('discriminate gm', 0.1303),\n",
       "  ('iii unmodified', 0.1288),\n",
       "  ('market', 0.1057),\n",
       "  ('contained high', 0.0977),\n",
       "  ('usa', 0.0974),\n",
       "  ('sample able', 0.0957),\n",
       "  ('showed healthiest', 0.0779),\n",
       "  ('published elsevier', 0.077),\n",
       "  ('significantly', 0.074),\n",
       "  ('ii', 0.0712),\n",
       "  ('rights reserved', 0.06),\n",
       "  ('tolerant', 0.0262),\n",
       "  ('equivalence', 0.0201)],\n",
       " 'MED-1744': [('ges patents', 0.5058),\n",
       "  ('seeds ges', 0.5049),\n",
       "  ('ges designed', 0.4419),\n",
       "  ('resist herbicides', 0.4208),\n",
       "  ('nearby ges', 0.419),\n",
       "  ('weeds extinction', 0.4146),\n",
       "  ('weeds', 0.4127),\n",
       "  ('herbicides letting', 0.4009),\n",
       "  ('farmers use', 0.3854),\n",
       "  ('use chemicals', 0.3789),\n",
       "  ('engineered seeds', 0.3432),\n",
       "  ('ges cause', 0.3239),\n",
       "  ('ge technology', 0.2786),\n",
       "  ('developing nations', 0.2503),\n",
       "  ('costs developing', 0.2204),\n",
       "  ('cultivars', 0.1917),\n",
       "  ('labor costs', 0.19),\n",
       "  ('unemployment resistant', 0.1851),\n",
       "  ('genetically', 0.1737),\n",
       "  ('surveys ge', 0.171),\n",
       "  ('policies paper', 0.1707),\n",
       "  ('food shortages', 0.1698),\n",
       "  ('shortages unemployment', 0.1682),\n",
       "  ('designed resist', 0.1679),\n",
       "  ('technology outlines', 0.1612),\n",
       "  ('patents reasonable', 0.1467),\n",
       "  ('volunteers drift', 0.1419),\n",
       "  ('eighty percent', 0.1383),\n",
       "  ('policies revised', 0.1366),\n",
       "  ('resistant', 0.1147),\n",
       "  ('implementing', 0.1067),\n",
       "  ('ethical constraints', 0.0867),\n",
       "  ('conclusions', 0.0784),\n",
       "  ('concrete suggestions', 0.0752),\n",
       "  ('percent commercial', 0.0705),\n",
       "  ('paper argues', 0.0494),\n",
       "  ('rights argues', 0.045),\n",
       "  ('extinction native', 0.0438),\n",
       "  ('classic account', 0.0268),\n",
       "  ('provides', 0.0175),\n",
       "  ('key objection', 0.0112),\n",
       "  ('locke classic', 0.0022),\n",
       "  ('cut', 0.0001),\n",
       "  ('key', -0.0115),\n",
       "  ('current', -0.0303),\n",
       "  ('provides concrete', -0.0623),\n",
       "  ('letting', -0.0777),\n",
       "  ('john', -0.1044),\n",
       "  ('account property', -0.1116),\n",
       "  ('constraints answering', -0.1178)],\n",
       " 'MED-1745': [('soybean compositional', 0.5091),\n",
       "  ('romania 2005', 0.4139),\n",
       "  ('soybean 40', 0.4137),\n",
       "  ('nutritious conventional', 0.3631),\n",
       "  ('glyphosate tolerant', 0.3409),\n",
       "  ('carbohydrates calculation', 0.3244),\n",
       "  ('animal feed', 0.3161),\n",
       "  ('safe nutritious', 0.3101),\n",
       "  ('trials compositional', 0.2977),\n",
       "  ('grown romania', 0.2927),\n",
       "  ('field trials', 0.2903),\n",
       "  ('comparative safety', 0.2903),\n",
       "  ('fiber forage', 0.2848),\n",
       "  ('amino', 0.2759),\n",
       "  ('compared conventional', 0.2734),\n",
       "  ('acids fatty', 0.2705),\n",
       "  ('tolerance interval', 0.2666),\n",
       "  ('varieties', 0.2631),\n",
       "  ('compositional variability', 0.2602),\n",
       "  ('assessed roundup', 0.2545),\n",
       "  ('compositionally equivalent', 0.2367),\n",
       "  ('comparisons history', 0.2347),\n",
       "  ('analyses performed', 0.2332),\n",
       "  ('components assessed', 0.232),\n",
       "  ('measure proximates', 0.2312),\n",
       "  ('40 compared', 0.2247),\n",
       "  ('grown', 0.218),\n",
       "  ('biochemical', 0.218),\n",
       "  ('program samples', 0.2096),\n",
       "  ('phytic acid', 0.1942),\n",
       "  ('collected replicated', 0.1863),\n",
       "  ('safe use', 0.1821),\n",
       "  ('moisture', 0.1802),\n",
       "  ('isoflavones raffinose', 0.1748),\n",
       "  ('common', 0.1736),\n",
       "  ('ash protein', 0.1718),\n",
       "  ('control published', 0.16),\n",
       "  ('marketplace comparisons', 0.1536),\n",
       "  ('performed measure', 0.1528),\n",
       "  ('feed human', 0.147),\n",
       "  ('published range', 0.1464),\n",
       "  ('30', 0.1359),\n",
       "  ('lectin grain', 0.1348),\n",
       "  ('conclusion', 0.1155),\n",
       "  ('acid trypsin', 0.1101),\n",
       "  ('animal', 0.0888),\n",
       "  ('calculating 99', 0.0739),\n",
       "  ('ready', 0.0705),\n",
       "  ('population traditional', 0.0556),\n",
       "  ('stachyose', -0.0613)],\n",
       " 'MED-1746': [('herbicide resistance', 0.6255),\n",
       "  ('modified crops', 0.6001),\n",
       "  ('rendered herbicide', 0.5255),\n",
       "  ('residues crops', 0.5079),\n",
       "  ('crops rapidly', 0.4861),\n",
       "  ('genetically modified', 0.4578),\n",
       "  ('transgenic genetically', 0.4487),\n",
       "  ('1990s crops', 0.4466),\n",
       "  ('crops article', 0.4281),\n",
       "  ('including resistance', 0.384),\n",
       "  ('residues formed', 0.3256),\n",
       "  ('lacking herbicide', 0.3131),\n",
       "  ('main categories', 0.2969),\n",
       "  ('inhibitors bromoxynil', 0.2856),\n",
       "  ('envisaged modification', 0.2708),\n",
       "  ('impact residue', 0.2701),\n",
       "  ('reviewed topics', 0.2635),\n",
       "  ('glufosinate glyphosate', 0.2532),\n",
       "  ('considered molecular', 0.2493),\n",
       "  ('inhibitors', 0.2457),\n",
       "  ('resistance acetolactate', 0.2443),\n",
       "  ('chemical industry', 0.234),\n",
       "  ('mid 1990s', 0.2273),\n",
       "  ('increased introduction', 0.2185),\n",
       "  ('combinations', 0.2116),\n",
       "  ('nature levels', 0.2107),\n",
       "  ('definitions mrls', 0.1986),\n",
       "  ('general', 0.1966),\n",
       "  ('harmonisation recommended', 0.1861),\n",
       "  ('global area', 0.1733),\n",
       "  ('article main', 0.1688),\n",
       "  ('conclusions drawn', 0.1557),\n",
       "  ('codex', 0.1416),\n",
       "  ('limits', 0.1226),\n",
       "  ('covered', 0.1161),\n",
       "  ('mechanism underlying', 0.1112),\n",
       "  ('synthase', 0.0977),\n",
       "  ('profile level', 0.0925),\n",
       "  ('introduction mid', 0.0893),\n",
       "  ('recommended copyright', 0.0868),\n",
       "  ('rapidly', 0.0778),\n",
       "  ('alimentarius', 0.0642),\n",
       "  ('definition maximum', 0.0642),\n",
       "  ('mrls lacking', 0.0472),\n",
       "  ('drawn', 0.0156),\n",
       "  ('society', 0.0124),\n",
       "  ('authorities', 0.0004),\n",
       "  ('case case', -0.022),\n",
       "  ('commission national', -0.0304),\n",
       "  ('copyright 2011', -0.0408)],\n",
       " 'MED-1747': [('syphilis study', 0.4889),\n",
       "  ('low participation', 0.4454),\n",
       "  ('research studies', 0.3805),\n",
       "  ('study participation', 0.377),\n",
       "  ('low income', 0.3401),\n",
       "  ('low biomedical', 0.2931),\n",
       "  ('minorities particularly', 0.2722),\n",
       "  ('participation rates', 0.2698),\n",
       "  ('telephone survey', 0.26),\n",
       "  ('tuskegee significant', 0.253),\n",
       "  ('area low', 0.2382),\n",
       "  ('public health', 0.2092),\n",
       "  ('253 latinos', 0.2086),\n",
       "  ('investigate associations', 0.2085),\n",
       "  ('results indicate', 0.2061),\n",
       "  ('behavioral study', 0.1921),\n",
       "  ('suggest factors', 0.1892),\n",
       "  ('theories respondents', 0.1763),\n",
       "  ('usphs', 0.1586),\n",
       "  ('investigate', 0.1558),\n",
       "  ('data random', 0.1469),\n",
       "  ('use data', 0.1296),\n",
       "  ('knowledge', 0.1159),\n",
       "  ('reason relatively', 0.1091),\n",
       "  ('theories african', 0.1051),\n",
       "  ('actually explored', 0.1008),\n",
       "  ('conspiracy theories', 0.0977),\n",
       "  ('survey 510', 0.0976),\n",
       "  ('important', 0.0951),\n",
       "  ('households', 0.0892),\n",
       "  ('rates', 0.0873),\n",
       "  ('endorse hiv', 0.0842),\n",
       "  ('aids', 0.0828),\n",
       "  ('possibility use', 0.0779),\n",
       "  ('18 45', 0.0686),\n",
       "  ('years', 0.0634),\n",
       "  ('americans biomedical', 0.0502),\n",
       "  ('income predominantly', 0.0501),\n",
       "  ('reported heard', 0.0483),\n",
       "  ('significant predictor', 0.0434),\n",
       "  ('94', 0.0285),\n",
       "  ('los angeles', 0.0214),\n",
       "  ('digit dial', 0.0175),\n",
       "  ('sst 72', 0.0083),\n",
       "  ('segregated', 0.001),\n",
       "  ('important accounting', -0.0069),\n",
       "  ('inner city', -0.0099),\n",
       "  ('race', -0.0328),\n",
       "  ('drawn area', -0.0351),\n",
       "  ('principal', -0.0507)],\n",
       " 'MED-1748': [('circulatory digestion', 0.5327),\n",
       "  ('macromolecules consumed', 0.4897),\n",
       "  ('digestion proteins', 0.4509),\n",
       "  ('bloodstream considered', 0.4191),\n",
       "  ('world digestive', 0.4148),\n",
       "  ('body circulation', 0.383),\n",
       "  ('large macromolecules', 0.3491),\n",
       "  ('meal derived', 0.3304),\n",
       "  ('environment separated', 0.3232),\n",
       "  ('proteins', 0.3178),\n",
       "  ('parts body', 0.3105),\n",
       "  ('amino acids', 0.3046),\n",
       "  ('genes avoid', 0.2958),\n",
       "  ('absorbed complex', 0.2935),\n",
       "  ('food pass', 0.2832),\n",
       "  ('plasma samples', 0.2758),\n",
       "  ('nucleic acids', 0.2757),\n",
       "  ('small constituents', 0.2751),\n",
       "  ('dna thought', 0.2477),\n",
       "  ('consumed', 0.2404),\n",
       "  ('thought degraded', 0.2388),\n",
       "  ('non plasma', 0.2322),\n",
       "  ('distribution plasma', 0.2165),\n",
       "  ('human samples', 0.1728),\n",
       "  ('avoid degradation', 0.1605),\n",
       "  ('world', 0.1515),\n",
       "  ('fragments', 0.1468),\n",
       "  ('process distributed', 0.1407),\n",
       "  ('evidence meal', 0.1268),\n",
       "  ('concentration shows', 0.1205),\n",
       "  ('based analysis', 0.1079),\n",
       "  ('mechanism', 0.1037),\n",
       "  ('degradation unknown', 0.1009),\n",
       "  ('complete genes', 0.0998),\n",
       "  ('tract according', 0.098),\n",
       "  ('plant', 0.0971),\n",
       "  ('enter human', 0.0915),\n",
       "  ('sample free', 0.0862),\n",
       "  ('control', 0.056),\n",
       "  ('outside', 0.054),\n",
       "  ('higher human', 0.0409),\n",
       "  ('independent studies', 0.0284),\n",
       "  ('log normal', 0.027),\n",
       "  ('1000 human', 0.026),\n",
       "  ('relative', 0.0253),\n",
       "  ('standard paradigm', 0.0228),\n",
       "  ('cord', 0.0121),\n",
       "  ('carry', 0.0019),\n",
       "  ('shows surprisingly', -0.0127),\n",
       "  ('directly', -0.0185)],\n",
       " 'MED-1749': [('pesticides associated', 0.639),\n",
       "  ('gluf insecticides', 0.5481),\n",
       "  ('insecticides bacterial', 0.4615),\n",
       "  ('tolerate herbicides', 0.4543),\n",
       "  ('exposure determine', 0.4038),\n",
       "  ('glyp gluphosinate', 0.385),\n",
       "  ('gluf metabolite', 0.3662),\n",
       "  ('pagmf engineered', 0.3473),\n",
       "  ('foods pagmf', 0.3431),\n",
       "  ('placental toxicities', 0.3406),\n",
       "  ('metabolite aminomethyl', 0.3264),\n",
       "  ('methylphosphinicopropionic', 0.3154),\n",
       "  ('reproductive toxicology', 0.315),\n",
       "  ('modified foods', 0.3087),\n",
       "  ('genetically', 0.3056),\n",
       "  ('maternal fetal', 0.287),\n",
       "  ('toxin detected', 0.2665),\n",
       "  ('fetuses npw', 0.2504),\n",
       "  ('levels', 0.2502),\n",
       "  ('pregnant', 0.2486),\n",
       "  ('nutrition utero', 0.2393),\n",
       "  ('phosphoric', 0.2358),\n",
       "  ('bacillus thuringiensis', 0.2293),\n",
       "  ('modified', 0.2128),\n",
       "  ('paving', 0.2037),\n",
       "  ('toxicities copyright', 0.2023),\n",
       "  ('cry1ab protein', 0.1945),\n",
       "  ('bacterial', 0.1892),\n",
       "  ('engineered', 0.1866),\n",
       "  ('protein', 0.1798),\n",
       "  ('ampa', 0.1601),\n",
       "  ('including', 0.1516),\n",
       "  ('serum mppa', 0.1441),\n",
       "  ('field reproductive', 0.1357),\n",
       "  ('toxin eastern', 0.1308),\n",
       "  ('nonpregnant women', 0.1249),\n",
       "  ('tolerate', 0.122),\n",
       "  ('detected', 0.1175),\n",
       "  ('study reveal', 0.1113),\n",
       "  ('correlation', 0.0926),\n",
       "  ('pw', 0.083),\n",
       "  ('new field', 0.0727),\n",
       "  ('npw studied', 0.0689),\n",
       "  ('bt aim', 0.0456),\n",
       "  ('rights reserved', 0.0184),\n",
       "  ('thirty', 0.0026),\n",
       "  ('townships', -0.03),\n",
       "  ('2011 elsevier', -0.037),\n",
       "  ('canada blood', -0.0629),\n",
       "  ('presence circulating', -0.0713)],\n",
       " 'MED-1750': [('discovery myostatin', 0.5892),\n",
       "  ('mouse decade', 0.506),\n",
       "  ('myostatin null', 0.4798),\n",
       "  ('muscling mice', 0.4778),\n",
       "  ('mighty mouse', 0.4108),\n",
       "  ('mice livestock', 0.3805),\n",
       "  ('muscling', 0.312),\n",
       "  ('livestock recently', 0.2252),\n",
       "  ('research impacted', 0.2196),\n",
       "  ('nonmuscle', 0.2131),\n",
       "  ('growth means', 0.2043),\n",
       "  ('biomedical fields', 0.1916),\n",
       "  ('adaptive molecular', 0.1751),\n",
       "  ('models particularly', 0.1706),\n",
       "  ('null genotype', 0.1686),\n",
       "  ('effects improve', 0.1674),\n",
       "  ('decade ago', 0.1594),\n",
       "  ('treatment muscle', 0.1512),\n",
       "  ('inhibitory effects', 0.142),\n",
       "  ('basic applied', 0.14),\n",
       "  ('produces double', 0.1385),\n",
       "  ('effects agricultural', 0.1349),\n",
       "  ('ago spurred', 0.131),\n",
       "  ('use different', 0.1276),\n",
       "  ('mammals somewhat', 0.1136),\n",
       "  ('recently described', 0.1091),\n",
       "  ('genotype produces', 0.1087),\n",
       "  ('cardiac', 0.1082),\n",
       "  ('vertebrate models', 0.1031),\n",
       "  ('skeletal', 0.1026),\n",
       "  ('adipocytes brain', 0.0988),\n",
       "  ('impacted popular', 0.0906),\n",
       "  ('multiple actively', 0.0853),\n",
       "  ('provides unique', 0.0825),\n",
       "  ('influence tissues', 0.0805),\n",
       "  ('particularly fish', 0.079),\n",
       "  ('actively diversifying', 0.0748),\n",
       "  ('child field', 0.0683),\n",
       "  ('limited', 0.0676),\n",
       "  ('duplication events', 0.0572),\n",
       "  ('settings', 0.051),\n",
       "  ('production retention', 0.0352),\n",
       "  ('clinic farm', 0.0295),\n",
       "  ('means surprising', 0.029),\n",
       "  ('disorders comparative', 0.0253),\n",
       "  ('confusing genome', -0.0004),\n",
       "  ('se additionally', -0.0013),\n",
       "  ('extrapolating', -0.0299),\n",
       "  ('opportunity study', -0.0377),\n",
       "  ('conserved neutralizing', -0.0622)],\n",
       " 'MED-1751': [('conspiracy theories', 0.5418),\n",
       "  ('predictors beliefs', 0.4862),\n",
       "  ('literature conspiracy', 0.4618),\n",
       "  ('people cynical', 0.4362),\n",
       "  ('sceptical', 0.4333),\n",
       "  ('companies beliefs', 0.4126),\n",
       "  ('theories discussed', 0.4019),\n",
       "  ('commercial conspiracy', 0.3581),\n",
       "  ('banks alcohol', 0.3556),\n",
       "  ('variance beliefs', 0.3301),\n",
       "  ('believed commercial', 0.3175),\n",
       "  ('literature', 0.3058),\n",
       "  ('general beliefs', 0.2933),\n",
       "  ('advertising tricks', 0.2875),\n",
       "  ('beliefs sorted', 0.2818),\n",
       "  ('regressions', 0.272),\n",
       "  ('british sample', 0.2525),\n",
       "  ('study examined', 0.2491),\n",
       "  ('variables explained', 0.2344),\n",
       "  ('tobacco companies', 0.2304),\n",
       "  ('300 women', 0.215),\n",
       "  ('people religious', 0.1937),\n",
       "  ('implications findings', 0.1932),\n",
       "  ('tactics', 0.1873),\n",
       "  ('like banks', 0.1852),\n",
       "  ('women men', 0.1742),\n",
       "  ('individual difference', 0.1669),\n",
       "  ('organisations like', 0.1645),\n",
       "  ('experience believed', 0.1582),\n",
       "  ('wing pessimistic', 0.1499),\n",
       "  ('showed people', 0.1446),\n",
       "  ('categorise', 0.1374),\n",
       "  ('results showed', 0.1304),\n",
       "  ('scale suggested', 0.1232),\n",
       "  ('discussed limitations', 0.1213),\n",
       "  ('labelled sneakiness', 0.1185),\n",
       "  ('wealthy neurotic', 0.1165),\n",
       "  ('difference variables', 0.1112),\n",
       "  ('demographic', 0.111),\n",
       "  ('self defined', 0.0801),\n",
       "  ('suppression prevention', 0.0789),\n",
       "  ('men results', 0.0496),\n",
       "  ('explained relatively', 0.0407),\n",
       "  ('little variance', 0.0406),\n",
       "  ('general', -0.0096),\n",
       "  ('drug', -0.0215),\n",
       "  ('change rules', -0.0301),\n",
       "  ('high alpha', -0.0367),\n",
       "  ('open experience', -0.0455),\n",
       "  ('left wing', -0.0667)],\n",
       " 'MED-1752': [('murine tgf', 0.6126),\n",
       "  ('tgf beta', 0.5703),\n",
       "  ('gdf gene', 0.4419),\n",
       "  ('mice gdf', 0.4374),\n",
       "  ('new murine', 0.411),\n",
       "  ('embryogenesis gdf', 0.4077),\n",
       "  ('growth factor', 0.4068),\n",
       "  ('superfamily encompasses', 0.3472),\n",
       "  ('gene targeting', 0.3394),\n",
       "  ('beta family', 0.3384),\n",
       "  ('disrupted gdf', 0.3144),\n",
       "  ('differentiation factors', 0.3062),\n",
       "  ('transforming growth', 0.295),\n",
       "  ('regulating embryonic', 0.2875),\n",
       "  ('targeting mice', 0.2694),\n",
       "  ('tissue homeostasis', 0.2536),\n",
       "  ('mutant animals', 0.2489),\n",
       "  ('determine biological', 0.2419),\n",
       "  ('development maintaining', 0.2413),\n",
       "  ('adult animals', 0.2288),\n",
       "  ('important roles', 0.2236),\n",
       "  ('developing adult', 0.1999),\n",
       "  ('factors playing', 0.1962),\n",
       "  ('function', 0.1928),\n",
       "  ('animals significantly', 0.1921),\n",
       "  ('gdf null', 0.1614),\n",
       "  ('identified new', 0.1549),\n",
       "  ('using degenerate', 0.1512),\n",
       "  ('muscles mutant', 0.1494),\n",
       "  ('results suggest', 0.1451),\n",
       "  ('hyperplasia', 0.1338),\n",
       "  ('polymerase chain', 0.131),\n",
       "  ('different', 0.128),\n",
       "  ('compartment developing', 0.1238),\n",
       "  ('widespread', 0.1192),\n",
       "  ('expression restricted', 0.1127),\n",
       "  ('later stages', 0.1079),\n",
       "  ('regulator', 0.1003),\n",
       "  ('myotome compartment', 0.0866),\n",
       "  ('significantly', 0.0859),\n",
       "  ('somites', 0.0806),\n",
       "  ('wild type', 0.0803),\n",
       "  ('increase skeletal', 0.0795),\n",
       "  ('group', 0.0792),\n",
       "  ('mass appears', 0.0723),\n",
       "  ('reaction identified', 0.0548),\n",
       "  ('weigh times', 0.0503),\n",
       "  ('specifically negative', 0.0334),\n",
       "  ('family member', 0.0293),\n",
       "  ('body', 0.0175)],\n",
       " 'MED-1753': [('gmo conflict', 0.4928),\n",
       "  ('debate gm', 0.4317),\n",
       "  ('animal biotechnology', 0.4287),\n",
       "  ('gm animal', 0.4136),\n",
       "  ('focusing eu', 0.3625),\n",
       "  ('conflict debate', 0.3523),\n",
       "  ('regulatory landscape', 0.3454),\n",
       "  ('animal future', 0.3435),\n",
       "  ('eu usa', 0.3412),\n",
       "  ('response regulatory', 0.3356),\n",
       "  ('debate', 0.3247),\n",
       "  ('response increased', 0.314),\n",
       "  ('history gmo', 0.312),\n",
       "  ('international levels', 0.2918),\n",
       "  ('regional international', 0.2641),\n",
       "  ('consequent implications', 0.2623),\n",
       "  ('gm', 0.2413),\n",
       "  ('conflict', 0.239),\n",
       "  ('red gm', 0.2385),\n",
       "  ('response', 0.2299),\n",
       "  ('level response', 0.2275),\n",
       "  ('cultural values', 0.2257),\n",
       "  ('multi level', 0.2176),\n",
       "  ('biotechnology copyright', 0.2168),\n",
       "  ('usa article', 0.2082),\n",
       "  ('regional', 0.1966),\n",
       "  ('animal', 0.1915),\n",
       "  ('landscape associated', 0.1834),\n",
       "  ('national', 0.1795),\n",
       "  ('implications commercialization', 0.1753),\n",
       "  ('increased role', 0.1745),\n",
       "  ('article examines', 0.1718),\n",
       "  ('groups consequent', 0.1701),\n",
       "  ('contribution', 0.1177),\n",
       "  ('commercialization green', 0.1123),\n",
       "  ('consequent', 0.1075),\n",
       "  ('levels focusing', 0.0998),\n",
       "  ('multi', 0.0988),\n",
       "  ('range', 0.0876),\n",
       "  ('likely form', 0.0859),\n",
       "  ('role', 0.0799),\n",
       "  ('published', 0.0704),\n",
       "  ('future', 0.0698),\n",
       "  ('associated', 0.0656),\n",
       "  ('values', 0.0621),\n",
       "  ('dependent', 0.0126),\n",
       "  ('new existing', 0.0098),\n",
       "  ('given history', 0.0018),\n",
       "  ('copyright 2012', -0.0029),\n",
       "  ('published elsevier', -0.012)],\n",
       " 'MED-1754': [('conspiracist ideation', 0.6262),\n",
       "  ('rejection science', 0.5076),\n",
       "  ('blogs conspiracist', 0.5061),\n",
       "  ('ideation rejection', 0.4815),\n",
       "  ('counterfactual thinking', 0.4771),\n",
       "  ('conspiratorial content', 0.4323),\n",
       "  ('rejection climate', 0.428),\n",
       "  ('scientific propositions', 0.3862),\n",
       "  ('climate blogs', 0.3847),\n",
       "  ('climate science', 0.3618),\n",
       "  ('role conspiracist', 0.3583),\n",
       "  ('hypotheses emerged', 0.3245),\n",
       "  ('scholarly interpretations', 0.3229),\n",
       "  ('science alternative', 0.3161),\n",
       "  ('implicated rejection', 0.303),\n",
       "  ('questioned validity', 0.3018),\n",
       "  ('content counterfactual', 0.301),\n",
       "  ('ideation repeatedly', 0.2679),\n",
       "  ('blogosphere response', 0.2588),\n",
       "  ('sparse recent', 0.2148),\n",
       "  ('smoking hiv', 0.1988),\n",
       "  ('repeatedly implicated', 0.196),\n",
       "  ('lung cancer', 0.1945),\n",
       "  ('paper conclusions', 0.1921),\n",
       "  ('possible role', 0.1643),\n",
       "  ('study involving', 0.1591),\n",
       "  ('thinking', 0.1544),\n",
       "  ('publication', 0.1489),\n",
       "  ('empirical evidence', 0.1269),\n",
       "  ('actors authors', 0.1247),\n",
       "  ('article analyses', 0.1045),\n",
       "  ('emerged response', 0.0871),\n",
       "  ('al press', 0.0811),\n",
       "  ('lewandowsky et', 0.0801),\n",
       "  ('aids', 0.0757),\n",
       "  ('narrowly focused', 0.0745),\n",
       "  ('et al', 0.0664),\n",
       "  ('log12 questioned', 0.055),\n",
       "  ('using', 0.0495),\n",
       "  ('executives', 0.0464),\n",
       "  ('link', 0.0213),\n",
       "  ('scope', 0.0186),\n",
       "  ('overall pattern', -0.0134),\n",
       "  ('established criteria', -0.025),\n",
       "  ('media organization', -0.0341),\n",
       "  ('involving visitors', -0.0354),\n",
       "  ('advanced future', -0.045),\n",
       "  ('university', -0.0574),\n",
       "  ('australian government', -0.0885),\n",
       "  ('grew', -0.1596)],\n",
       " 'MED-1755': [('mrsa poultry', 0.6142),\n",
       "  ('tested mrsa', 0.4897),\n",
       "  ('transmission mrsa', 0.4589),\n",
       "  ('staphylococcus aureus', 0.4402),\n",
       "  ('methicillin resistant', 0.4249),\n",
       "  ('poultry farms', 0.4102),\n",
       "  ('occurrence livestock', 0.3835),\n",
       "  ('farms investigated', 0.3729),\n",
       "  ('resistant bacteria', 0.3709),\n",
       "  ('emission microorganisms', 0.3685),\n",
       "  ('farms emission', 0.3229),\n",
       "  ('bacteria', 0.3193),\n",
       "  ('types isolates', 0.2748),\n",
       "  ('farms fatting', 0.254),\n",
       "  ('investigated occurrence', 0.207),\n",
       "  ('54 broiler', 0.202),\n",
       "  ('controversially discussed', 0.1882),\n",
       "  ('especially resistant', 0.1585),\n",
       "  ('issue study', 0.1536),\n",
       "  ('limited data', 0.1479),\n",
       "  ('inside outside', 0.1474),\n",
       "  ('data issue', 0.142),\n",
       "  ('surroundings ambient', 0.1374),\n",
       "  ('outside previously', 0.1349),\n",
       "  ('associated la', 0.1012),\n",
       "  ('surfaces different', 0.0956),\n",
       "  ('broiler 62', 0.0852),\n",
       "  ('swabs ground', 0.0841),\n",
       "  ('longitudinal study', 0.0795),\n",
       "  ('ground surface', 0.0762),\n",
       "  ('collected animals', 0.0739),\n",
       "  ('downwind 44', 0.0732),\n",
       "  ('detections levels', 0.0719),\n",
       "  ('originating', 0.0618),\n",
       "  ('discussed far', 0.0591),\n",
       "  ('tested', 0.059),\n",
       "  ('levels 50', 0.0556),\n",
       "  ('44 turkey', 0.0476),\n",
       "  ('inside barns', 0.043),\n",
       "  ('possible', 0.039),\n",
       "  ('spa types', 0.0213),\n",
       "  ('public', 0.0127),\n",
       "  ('period samples', 0.0122),\n",
       "  ('sectional', -0.0003),\n",
       "  ('positive', -0.0134),\n",
       "  ('distances', -0.0297),\n",
       "  ('air boot', -0.0385),\n",
       "  ('carried', -0.0474),\n",
       "  ('germany', -0.0658),\n",
       "  ('77 samples', -0.1281)],\n",
       " 'MED-1757': [('pig barns', 0.495),\n",
       "  ('pigs floor', 0.4665),\n",
       "  ('positive pig', 0.4053),\n",
       "  ('season pigs', 0.3968),\n",
       "  ('samples upwind', 0.3715),\n",
       "  ('samples taken', 0.3647),\n",
       "  ('animals floor', 0.3325),\n",
       "  ('14 cfu', 0.3306),\n",
       "  ('year samples', 0.3261),\n",
       "  ('la mrsa', 0.3214),\n",
       "  ('cfu', 0.3054),\n",
       "  ('characterize contamination', 0.2953),\n",
       "  ('spa typing', 0.2848),\n",
       "  ('positive soil', 0.283),\n",
       "  ('commercial livestock', 0.2733),\n",
       "  ('isolated animals', 0.2725),\n",
       "  ('staphylococcus', 0.2678),\n",
       "  ('concentrations 11', 0.2606),\n",
       "  ('barns statistical', 0.2545),\n",
       "  ('distances 50', 0.2467),\n",
       "  ('619 cfu', 0.2435),\n",
       "  ('results regular', 0.2424),\n",
       "  ('east germany', 0.2344),\n",
       "  ('taken days', 0.226),\n",
       "  ('150 upwind', 0.2183),\n",
       "  ('types inside', 0.1986),\n",
       "  ('detected', 0.1796),\n",
       "  ('deposition', 0.1794),\n",
       "  ('sporadically significantly', 0.1783),\n",
       "  ('distances outside', 0.1724),\n",
       "  ('low concentrations', 0.1714),\n",
       "  ('samples negative', 0.1711),\n",
       "  ('inside outside', 0.1699),\n",
       "  ('showing range', 0.1621),\n",
       "  ('observed proportions', 0.1597),\n",
       "  ('different', 0.154),\n",
       "  ('statistical differences', 0.1539),\n",
       "  ('downwind', 0.1312),\n",
       "  ('seasons', 0.1243),\n",
       "  ('significantly', 0.1199),\n",
       "  ('m3 distances', 0.1198),\n",
       "  ('ambient air', 0.1177),\n",
       "  ('median', 0.0968),\n",
       "  ('method suitable', 0.0944),\n",
       "  ('boot', 0.0809),\n",
       "  ('strongly influenced', 0.0598),\n",
       "  ('300 positive', 0.0425),\n",
       "  ('north', 0.0335),\n",
       "  ('identity', -0.0013),\n",
       "  ('transmission', -0.0074)],\n",
       " 'MED-1759': [('mrsa farm', 0.6684),\n",
       "  ('genes mrsa', 0.6167),\n",
       "  ('aureus', 0.49),\n",
       "  ('st398 lineage', 0.4515),\n",
       "  ('high livestock', 0.433),\n",
       "  ('associated methicillin', 0.4216),\n",
       "  ('pigs animals', 0.4043),\n",
       "  ('st1 strains', 0.3888),\n",
       "  ('infections infections', 0.355),\n",
       "  ('isolate categorized', 0.3492),\n",
       "  ('typing mlst', 0.3354),\n",
       "  ('clones frequent', 0.3174),\n",
       "  ('origin strains', 0.2998),\n",
       "  ('sccmec typing', 0.2853),\n",
       "  ('workers strains', 0.272),\n",
       "  ('farming methods', 0.2705),\n",
       "  ('colonize population', 0.2676),\n",
       "  ('leukocidin genes', 0.2386),\n",
       "  ('t899 isolates', 0.2311),\n",
       "  ('hospital origin', 0.2237),\n",
       "  ('multilocus sequence', 0.2185),\n",
       "  ('categorized la', 0.2149),\n",
       "  ('animals emerged', 0.1911),\n",
       "  ('europe new', 0.1906),\n",
       "  ('st8 conclusions', 0.1876),\n",
       "  ('nasal swabs', 0.1864),\n",
       "  ('otitis externa', 0.1808),\n",
       "  ('typing spa', 0.1734),\n",
       "  ('area lombardy', 0.1651),\n",
       "  ('sequence type', 0.1614),\n",
       "  ('pvl positive', 0.1592),\n",
       "  ('areas high', 0.1278),\n",
       "  ('molecular characterization', 0.1163),\n",
       "  ('risk factor', 0.1161),\n",
       "  ('resistant', 0.1084),\n",
       "  ('aim study', 0.0987),\n",
       "  ('panton', 0.0966),\n",
       "  ('acquired', 0.0891),\n",
       "  ('belonged different', 0.0851),\n",
       "  ('2010 879', 0.0716),\n",
       "  ('emerged central', 0.0657),\n",
       "  ('methods period', 0.0472),\n",
       "  ('typical ca', 0.0463),\n",
       "  ('march april', 0.0327),\n",
       "  ('soft', 0.0053),\n",
       "  ('rarely produce', 0.0015),\n",
       "  ('february 2011', -0.0326),\n",
       "  ('negative categorized', -0.0353),\n",
       "  ('italian', -0.0408),\n",
       "  ('cai 17', -0.1886)],\n",
       " 'MED-1760': [('children tasted', 0.6432),\n",
       "  ('branding children', 0.5425),\n",
       "  ('branding foods', 0.4812),\n",
       "  ('tastes foods', 0.4746),\n",
       "  ('tasted pairs', 0.4577),\n",
       "  ('children participants', 0.4252),\n",
       "  ('exposures young', 0.4197),\n",
       "  ('food comparisons', 0.416),\n",
       "  ('setting preschools', 0.4131),\n",
       "  ('children ate', 0.4127),\n",
       "  ('identical foods', 0.4111),\n",
       "  ('children testing', 0.4091),\n",
       "  ('source taste', 0.3567),\n",
       "  ('income children', 0.3547),\n",
       "  ('unbranded packaging', 0.352),\n",
       "  ('beverages packaging', 0.3225),\n",
       "  ('age years', 0.3168),\n",
       "  ('influence branding', 0.316),\n",
       "  ('eating behaviors', 0.3121),\n",
       "  ('perceptions', 0.2822),\n",
       "  ('packaging asked', 0.2682),\n",
       "  ('samples used', 0.2648),\n",
       "  ('preference results', 0.264),\n",
       "  ('effects cumulative', 0.2631),\n",
       "  ('marketed', 0.2409),\n",
       "  ('food mcdonald', 0.2388),\n",
       "  ('television sets', 0.2285),\n",
       "  ('sets', 0.2265),\n",
       "  ('pairs identical', 0.1975),\n",
       "  ('design experimental', 0.1877),\n",
       "  ('homes', 0.1693),\n",
       "  ('testing influence', 0.1611),\n",
       "  ('behaviors', 0.1606),\n",
       "  ('findings consistent', 0.159),\n",
       "  ('regulate marketing', 0.1411),\n",
       "  ('interquartile', 0.141),\n",
       "  ('real world', 0.132),\n",
       "  ('zero 001', 0.1288),\n",
       "  ('20 interquartile', 0.1248),\n",
       "  ('measures summary', 0.1241),\n",
       "  ('main exposure', 0.108),\n",
       "  ('37 45', 0.1024),\n",
       "  ('sd', 0.0693),\n",
       "  ('heavily', 0.0617),\n",
       "  ('low income', 0.0427),\n",
       "  ('00 80', 0.0259),\n",
       "  ('moderator', 0.0142),\n",
       "  ('ranging', 0.0006),\n",
       "  ('better', -0.01),\n",
       "  ('analysis significantly', -0.0302)],\n",
       " 'MED-1761': [('restaurants hospitals', 0.6426),\n",
       "  ('prevalence hospitals', 0.5682),\n",
       "  ('hospitals purchased', 0.532),\n",
       "  ('hospitals conclusions', 0.5185),\n",
       "  ('food hospital', 0.51),\n",
       "  ('children hospital', 0.4731),\n",
       "  ('evaluate hospital', 0.4705),\n",
       "  ('restaurant prevalence', 0.4675),\n",
       "  ('restaurant children', 0.4605),\n",
       "  ('pediatric residency', 0.3858),\n",
       "  ('residencies evaluate', 0.3704),\n",
       "  ('residencies fast', 0.3635),\n",
       "  ('hospital 33', 0.3574),\n",
       "  ('analyzed fast', 0.2816),\n",
       "  ('purchase fast', 0.2711),\n",
       "  ('programs regarding', 0.2695),\n",
       "  ('objectives study', 0.267),\n",
       "  ('surveys analyzed', 0.2665),\n",
       "  ('food methods', 0.2546),\n",
       "  ('mcdonald restaurant', 0.2309),\n",
       "  ('bought food', 0.222),\n",
       "  ('environment affects', 0.2108),\n",
       "  ('significantly increased', 0.1994),\n",
       "  ('prevalence', 0.1975),\n",
       "  ('hospital 22', 0.1946),\n",
       "  ('affects purchase', 0.19),\n",
       "  ('14', 0.1624),\n",
       "  ('conclusions', 0.1605),\n",
       "  ('determine attitudes', 0.1599),\n",
       "  ('site', 0.147),\n",
       "  ('consumption', 0.1394),\n",
       "  ('regression analysis', 0.1243),\n",
       "  ('surveyed adults', 0.1213),\n",
       "  ('95 fast', 0.117),\n",
       "  ('financially respondents', 0.103),\n",
       "  ('higher rating', 0.1022),\n",
       "  ('results 200', 0.1013),\n",
       "  ('times likely', 0.0934),\n",
       "  ('respondents 56', 0.0923),\n",
       "  ('associated significantly', 0.0911),\n",
       "  ('outpatients belief', 0.0881),\n",
       "  ('branding sought', 0.0733),\n",
       "  ('healthier did', 0.0703),\n",
       "  ('visitors', 0.0695),\n",
       "  ('did', 0.0666),\n",
       "  ('logistic', 0.0602),\n",
       "  ('corporation supported', 0.0353),\n",
       "  ('53', 0.0338),\n",
       "  ('total 386', 0.0268),\n",
       "  ('common', 0.0033)],\n",
       " 'MED-1762': [('beef investigated', 0.4783),\n",
       "  ('meat intake', 0.4447),\n",
       "  ('administered cattle', 0.4287),\n",
       "  ('men eat', 0.3846),\n",
       "  ('hormone levels', 0.3741),\n",
       "  ('men methods', 0.37),\n",
       "  ('regarding reproductive', 0.3394),\n",
       "  ('steroids administered', 0.3164),\n",
       "  ('189 men', 0.3007),\n",
       "  ('states anabolic', 0.2899),\n",
       "  ('promotion concern', 0.2829),\n",
       "  ('men increasing', 0.2756),\n",
       "  ('quality parameters', 0.2506),\n",
       "  ('years diet', 0.2475),\n",
       "  ('biological effect', 0.2407),\n",
       "  ('sex', 0.2406),\n",
       "  ('sperm count', 0.238),\n",
       "  ('men abstinence', 0.2314),\n",
       "  ('validated food', 0.1974),\n",
       "  ('ref 95', 0.1865),\n",
       "  ('aged 18', 0.1786),\n",
       "  ('sectional associations', 0.1773),\n",
       "  ('samples obtained', 0.1711),\n",
       "  ('processed red', 0.137),\n",
       "  ('003 conclusions', 0.1281),\n",
       "  ('questionnaire used', 0.1273),\n",
       "  ('increasing quartiles', 0.1238),\n",
       "  ('investigated', 0.1211),\n",
       "  ('intake ejaculate', 0.1169),\n",
       "  ('united states', 0.109),\n",
       "  ('consequences practice', 0.1024),\n",
       "  ('volume test', 0.0999),\n",
       "  ('associated lower', 0.0929),\n",
       "  ('previously', 0.0896),\n",
       "  ('confounding abstinence', 0.0883),\n",
       "  ('population young', 0.0819),\n",
       "  ('association', 0.079),\n",
       "  ('relative', 0.047),\n",
       "  ('used linear', 0.0444),\n",
       "  ('22 years', 0.0443),\n",
       "  ('trend 01', 0.0311),\n",
       "  ('aged', 0.0261),\n",
       "  ('count adjusted', 0.0229),\n",
       "  ('67 37', 0.0218),\n",
       "  ('14 82', 0.0177),\n",
       "  ('differences total', 0.0148),\n",
       "  ('represents', 0.005),\n",
       "  ('strongest', 0.0021),\n",
       "  ('days driven', -0.0025),\n",
       "  ('202 million', -0.0837)],\n",
       " 'MED-1763': [('sex hormones', 0.6347),\n",
       "  ('incidences testis', 0.5867),\n",
       "  ('hormonal effects', 0.5837),\n",
       "  ('genital abnormalities', 0.5757),\n",
       "  ('disrupted sex', 0.5616),\n",
       "  ('literature sex', 0.4952),\n",
       "  ('steroid levels', 0.4934),\n",
       "  ('steroids children', 0.4562),\n",
       "  ('exogenous sex', 0.4394),\n",
       "  ('precocious puberty', 0.4284),\n",
       "  ('estradiol prepubertal', 0.4113),\n",
       "  ('changes hormone', 0.4064),\n",
       "  ('endocrine disruptors', 0.4022),\n",
       "  ('abnormalities', 0.3607),\n",
       "  ('cancers poorly', 0.3358),\n",
       "  ('trends', 0.3234),\n",
       "  ('breast prostate', 0.3184),\n",
       "  ('boys', 0.3127),\n",
       "  ('physiological roles', 0.2971),\n",
       "  ('children estimated', 0.2913),\n",
       "  ('roles childhood', 0.2845),\n",
       "  ('abnormalities newborn', 0.2737),\n",
       "  ('recent literature', 0.2612),\n",
       "  ('exposure fetuses', 0.261),\n",
       "  ('increasing incidences', 0.2392),\n",
       "  ('poorly understood', 0.2306),\n",
       "  ('development severe', 0.2263),\n",
       "  ('effects seen', 0.2145),\n",
       "  ('current detection', 0.2103),\n",
       "  ('assessments', 0.1913),\n",
       "  ('ii children', 0.1885),\n",
       "  ('circulating levels', 0.1834),\n",
       "  ('production rates', 0.1805),\n",
       "  ('development serum', 0.1576),\n",
       "  ('low levels', 0.1554),\n",
       "  ('role disrupted', 0.1511),\n",
       "  ('overestimated revised', 0.121),\n",
       "  ('caution taken', 0.1196),\n",
       "  ('girls', 0.1063),\n",
       "  ('drug administration', 0.0944),\n",
       "  ('exposed exogenous', 0.0867),\n",
       "  ('iv', 0.0819),\n",
       "  ('used risk', 0.0758),\n",
       "  ('adult life', 0.031),\n",
       "  ('daily', 0.0269),\n",
       "  ('extremely sensitive', 0.0211),\n",
       "  ('respond', 0.0025),\n",
       "  ('food', -0.0141),\n",
       "  ('play', -0.0391),\n",
       "  ('1999 used', -0.0407)],\n",
       " 'MED-1764': [('decline sperm', 0.4935),\n",
       "  ('semen parameters', 0.4237),\n",
       "  ('lifestyle factors', 0.3942),\n",
       "  ('lipid homeostasis', 0.384),\n",
       "  ('associated obesity', 0.372),\n",
       "  ('cohort study', 0.3003),\n",
       "  ('high lipids', 0.2981),\n",
       "  ('phospholipids', 0.2823),\n",
       "  ('men serum', 0.2772),\n",
       "  ('total cholesterol', 0.2647),\n",
       "  ('male fecundity', 0.2501),\n",
       "  ('body mass', 0.246),\n",
       "  ('associations baseline', 0.2368),\n",
       "  ('hyperlipidemia play', 0.2314),\n",
       "  ('fertility addition', 0.2305),\n",
       "  ('50 years', 0.2155),\n",
       "  ('effects models', 0.2029),\n",
       "  ('quality parameters', 0.1976),\n",
       "  ('contraception', 0.1957),\n",
       "  ('years appears', 0.1902),\n",
       "  ('homeostasis male', 0.187),\n",
       "  ('concentrations affect', 0.1739),\n",
       "  ('adjusted age', 0.1641),\n",
       "  ('objective population', 0.1617),\n",
       "  ('94 men', 0.1529),\n",
       "  ('association men', 0.1477),\n",
       "  ('couples desiring', 0.1476),\n",
       "  ('significantly lower', 0.1425),\n",
       "  ('morphology highlighting', 0.1359),\n",
       "  ('rising prevalence', 0.1355),\n",
       "  ('results suggest', 0.1254),\n",
       "  ('later linear', 0.113),\n",
       "  ('addition environmental', 0.1128),\n",
       "  ('intact acrosome', 0.0975),\n",
       "  ('count rates', 0.089),\n",
       "  ('perimeter results', 0.0846),\n",
       "  ('associated significantly', 0.0814),\n",
       "  ('race', 0.0741),\n",
       "  ('head morphology', 0.0704),\n",
       "  ('levels strongly', 0.0697),\n",
       "  ('discontinuing', 0.0479),\n",
       "  ('second sample', 0.0438),\n",
       "  ('important role', 0.0323),\n",
       "  ('appears parallel', 0.027),\n",
       "  ('mixed', 0.0076),\n",
       "  ('affect', -0.0309),\n",
       "  ('month later', -0.0494),\n",
       "  ('samples 77', -0.0593),\n",
       "  ('participant provided', -0.092),\n",
       "  ('free', -0.1279)],\n",
       " 'MED-1765': [('inhibition cholesterol', 0.5476),\n",
       "  ('hmg coa', 0.4622),\n",
       "  ('steroid hormones', 0.4361),\n",
       "  ('gonadal function', 0.4261),\n",
       "  ('spermatogenesis', 0.4077),\n",
       "  ('free testosterone', 0.3894),\n",
       "  ('simvastatin pravastatin', 0.3805),\n",
       "  ('reductase', 0.3667),\n",
       "  ('biosynthesis hydroxymethyl', 0.346),\n",
       "  ('iib hypercholesterolemia', 0.3288),\n",
       "  ('chorionic gonadotropin', 0.3069),\n",
       "  ('compare effects', 0.2954),\n",
       "  ('coenzyme', 0.2742),\n",
       "  ('hydroxymethyl glutaryl', 0.2725),\n",
       "  ('placebo lipid', 0.2665),\n",
       "  ('density lipoprotein', 0.2663),\n",
       "  ('theory adversely', 0.2597),\n",
       "  ('hormone fsh', 0.2481),\n",
       "  ('diet run', 0.2343),\n",
       "  ('lh sex', 0.2204),\n",
       "  ('concentration ejaculate', 0.2157),\n",
       "  ('index follicle', 0.2076),\n",
       "  ('double blind', 0.203),\n",
       "  ('shbg statistically', 0.1961),\n",
       "  ('decreased 24', 0.1793),\n",
       "  ('affect male', 0.1775),\n",
       "  ('binding globulin', 0.1568),\n",
       "  ('summary evidence', 0.1557),\n",
       "  ('basal levels', 0.1479),\n",
       "  ('active treatment', 0.1442),\n",
       "  ('159 male', 0.1436),\n",
       "  ('multiple parameters', 0.1432),\n",
       "  ('mg dl', 0.1422),\n",
       "  ('objective', 0.1376),\n",
       "  ('145 240', 0.1229),\n",
       "  ('groups change', 0.1176),\n",
       "  ('years type', 0.1123),\n",
       "  ('patients aged', 0.1095),\n",
       "  ('55 years', 0.1085),\n",
       "  ('30 34', 0.0842),\n",
       "  ('40 mg', 0.0833),\n",
       "  ('reserve', 0.0733),\n",
       "  ('randomly', 0.0662),\n",
       "  ('tolerated', 0.0523),\n",
       "  ('type iia', 0.0506),\n",
       "  ('production', 0.0467),\n",
       "  ('differences week', 0.0272),\n",
       "  ('mean total', 0.0194),\n",
       "  ('12 week', 0.017),\n",
       "  ('20', 0.0145)],\n",
       " 'MED-1766': [('abnormalities spermiograms', 0.4896),\n",
       "  ('lipid abnormalities', 0.4284),\n",
       "  ('hyperlipoproteinaemia control', 0.4076),\n",
       "  ('carried hyperlipoproteinaemic', 0.3947),\n",
       "  ('undertaken spermiogram', 0.3896),\n",
       "  ('male patients', 0.3838),\n",
       "  ('studied 19', 0.3392),\n",
       "  ('poor semen', 0.3324),\n",
       "  ('hormone levels', 0.3128),\n",
       "  ('44 infertile', 0.3029),\n",
       "  ('biochemical studies', 0.2993),\n",
       "  ('abnormalities common', 0.2966),\n",
       "  ('results studies', 0.2943),\n",
       "  ('mean lipid', 0.2941),\n",
       "  ('controls semen', 0.2931),\n",
       "  ('infertile men', 0.2801),\n",
       "  ('studies measurements', 0.2751),\n",
       "  ('healthy men', 0.2654),\n",
       "  ('men mean', 0.2621),\n",
       "  ('fsh levels', 0.2508),\n",
       "  ('abnormal values', 0.2479),\n",
       "  ('patients showed', 0.2337),\n",
       "  ('determinations normal', 0.2312),\n",
       "  ('associated poor', 0.2208),\n",
       "  ('determinations carried', 0.2128),\n",
       "  ('common azoospermic', 0.2109),\n",
       "  ('lower controls', 0.2073),\n",
       "  ('control group', 0.1981),\n",
       "  ('studied', 0.1911),\n",
       "  ('testicular level', 0.1824),\n",
       "  ('28 healthy', 0.1813),\n",
       "  ('44', 0.175),\n",
       "  ('plasma', 0.1604),\n",
       "  ('majority hormone', 0.1454),\n",
       "  ('volume seminal', 0.1308),\n",
       "  ('group', 0.1302),\n",
       "  ('values mainly', 0.1298),\n",
       "  ('profile showed', 0.1092),\n",
       "  ('tg associated', 0.1047),\n",
       "  ('control', 0.0967),\n",
       "  ('suggest high', 0.0885),\n",
       "  ('treatment undertaken', 0.088),\n",
       "  ('volume', 0.0777),\n",
       "  ('levels exert', 0.077),\n",
       "  ('quality higher', 0.0766),\n",
       "  ('correlation', 0.064),\n",
       "  ('primary', 0.0277),\n",
       "  ('mainly e2', 0.0198),\n",
       "  ('carried', -0.0063),\n",
       "  ('adverse direct', -0.0237)],\n",
       " 'MED-1768': [('estrogens particularly', 0.5916),\n",
       "  ('environmental compounds', 0.4078),\n",
       "  ('elevated milk', 0.3872),\n",
       "  ('70 estrogens', 0.3867),\n",
       "  ('concerned cows', 0.3688),\n",
       "  ('reproductive disorders', 0.3248),\n",
       "  ('human exposure', 0.3222),\n",
       "  ('dairy products', 0.2966),\n",
       "  ('role environmental', 0.2804),\n",
       "  ('major sources', 0.2425),\n",
       "  ('concern routes', 0.2163),\n",
       "  ('markedly elevated', 0.2144),\n",
       "  ('particularly concerned', 0.2085),\n",
       "  ('sources animal', 0.2038),\n",
       "  ('disorders source', 0.1951),\n",
       "  ('compounds', 0.1721),\n",
       "  ('levels', 0.1704),\n",
       "  ('reproductive', 0.1694),\n",
       "  ('usually fed', 0.1545),\n",
       "  ('heifers half', 0.145),\n",
       "  ('humans consume', 0.1357),\n",
       "  ('genetically improved', 0.1302),\n",
       "  ('years', 0.1129),\n",
       "  ('considerable amounts', 0.0888),\n",
       "  ('gestation hypothesize', 0.0823),\n",
       "  ('mixes various', 0.0812),\n",
       "  ('220 days', 0.0796),\n",
       "  ('routes human', 0.0788),\n",
       "  ('grass concentrates', 0.0765),\n",
       "  ('activity development', 0.0695),\n",
       "  ('major', 0.0693),\n",
       "  ('half pregnancy', 0.0623),\n",
       "  ('days', 0.0483),\n",
       "  ('protein', 0.0465),\n",
       "  ('modern', 0.0442),\n",
       "  ('lactate', 0.039),\n",
       "  ('holstein', 0.0368),\n",
       "  ('70', 0.0337),\n",
       "  ('male', 0.0287),\n",
       "  ('hypothesize', 0.021),\n",
       "  ('publishers', 0.0113),\n",
       "  ('contains', 0.0002),\n",
       "  ('products account', -0.0013),\n",
       "  ('obtained', -0.0097),\n",
       "  ('harcourt', -0.025),\n",
       "  ('account 60', -0.039),\n",
       "  ('consumed 100', -0.0418),\n",
       "  ('copyright 2001', -0.0532),\n",
       "  ('ago', -0.0541),\n",
       "  ('unlike', -0.1061)],\n",
       " 'MED-1770': [('oestradiol metabolites', 0.559),\n",
       "  ('oestrogenic growth', 0.5506),\n",
       "  ('oestrogens untreated', 0.3871),\n",
       "  ('reproductive functions', 0.3773),\n",
       "  ('17beta milk', 0.3306),\n",
       "  ('functions vertebrates', 0.3172),\n",
       "  ('receptor subtypes', 0.2877),\n",
       "  ('animal tissues', 0.2656),\n",
       "  ('cattle meat', 0.2475),\n",
       "  ('untreated cattle', 0.2301),\n",
       "  ('non reproductive', 0.2227),\n",
       "  ('theoretical', 0.2094),\n",
       "  ('available eggs', 0.1997),\n",
       "  ('maximum daily', 0.189),\n",
       "  ('functions require', 0.1866),\n",
       "  ('production rate', 0.1814),\n",
       "  ('husbandry observed', 0.1706),\n",
       "  ('increased factor', 0.1606),\n",
       "  ('containing growth', 0.1552),\n",
       "  ('metabolites cancer', 0.1511),\n",
       "  ('agents tmdi', 0.1452),\n",
       "  ('esters', 0.143),\n",
       "  ('pg ml', 0.1367),\n",
       "  ('observed pork', 0.136),\n",
       "  ('data available', 0.1348),\n",
       "  ('concentrations', 0.1347),\n",
       "  ('promoting agents', 0.1232),\n",
       "  ('consumption', 0.1204),\n",
       "  ('contain similar', 0.1056),\n",
       "  ('following use', 0.0938),\n",
       "  ('conjugates widely', 0.086),\n",
       "  ('present animal', 0.0827),\n",
       "  ('prepubertal', 0.0819),\n",
       "  ('ng following', 0.08),\n",
       "  ('poultry probably', 0.0771),\n",
       "  ('uncertainties residues', 0.0736),\n",
       "  ('examination', 0.0605),\n",
       "  ('widely', 0.0573),\n",
       "  ('performance mass', 0.0434),\n",
       "  ('single dosage', 0.0324),\n",
       "  ('good', 0.0249),\n",
       "  ('actual', 0.0142),\n",
       "  ('children role', 0.0093),\n",
       "  ('200 pg', -0.0001),\n",
       "  ('different cytoplasmic', -0.0029),\n",
       "  ('govern', -0.0049),\n",
       "  ('needs improved', -0.0321),\n",
       "  ('widely unknown', -0.033),\n",
       "  ('spectrometry needs', -0.0364),\n",
       "  ('agents limited', -0.0441)],\n",
       " 'MED-1771': [('66 unmarried', 0.4389),\n",
       "  ('ph sperm', 0.4371),\n",
       "  ('lower sperm', 0.3984),\n",
       "  ('sperm count', 0.3868),\n",
       "  ('semen analysis', 0.3568),\n",
       "  ('sperm', 0.3485),\n",
       "  ('66', 0.3285),\n",
       "  ('semen', 0.3247),\n",
       "  ('analysis 66', 0.3219),\n",
       "  ('medical students', 0.3047),\n",
       "  ('unmarried medical', 0.2913),\n",
       "  ('values liquefaction', 0.2708),\n",
       "  ('ph motility', 0.2658),\n",
       "  ('unmarried', 0.2658),\n",
       "  ('motility lower', 0.2576),\n",
       "  ('students', 0.2443),\n",
       "  ('higher liquefaction', 0.2442),\n",
       "  ('vegetarians difference', 0.2257),\n",
       "  ('significantly different', 0.2082),\n",
       "  ('abnormal forms', 0.2082),\n",
       "  ('non vegetarians', 0.1984),\n",
       "  ('difference dietary', 0.1911),\n",
       "  ('age group', 0.1847),\n",
       "  ('time ph', 0.1742),\n",
       "  ('reported values', 0.1696),\n",
       "  ('group 17', 0.1636),\n",
       "  ('different', 0.1604),\n",
       "  ('difference', 0.1523),\n",
       "  ('different non', 0.1491),\n",
       "  ('compared', 0.1462),\n",
       "  ('motility', 0.14),\n",
       "  ('count abnormal', 0.1386),\n",
       "  ('vegetarians vegetarians', 0.1286),\n",
       "  ('dietary proteins', 0.1271),\n",
       "  ('medical', 0.1242),\n",
       "  ('proteins', 0.1177),\n",
       "  ('17 21', 0.1141),\n",
       "  ('lower', 0.103),\n",
       "  ('forms observed', 0.1028),\n",
       "  ('group', 0.0892),\n",
       "  ('reported', 0.087),\n",
       "  ('years carried', 0.0751),\n",
       "  ('non', 0.0724),\n",
       "  ('carried higher', 0.059),\n",
       "  ('observed', 0.0581),\n",
       "  ('analysis', 0.0559),\n",
       "  ('higher', 0.0537),\n",
       "  ('count significantly', 0.0202),\n",
       "  ('significantly', 0.0185),\n",
       "  ('time', -0.0081)],\n",
       " 'MED-1773': [('decreased semen', 0.4848),\n",
       "  ('dairy inversely', 0.4437),\n",
       "  ('estrogens studies', 0.4059),\n",
       "  ('intake cheese', 0.3717),\n",
       "  ('low fat', 0.329),\n",
       "  ('studies suggested', 0.31),\n",
       "  ('putative secular', 0.2835),\n",
       "  ('assessed food', 0.2772),\n",
       "  ('05 limitations', 0.2624),\n",
       "  ('suggested environmental', 0.2605),\n",
       "  ('restrict intake', 0.2598),\n",
       "  ('significantly lower', 0.2576),\n",
       "  ('decline', 0.2437),\n",
       "  ('detrimental effects', 0.2347),\n",
       "  ('morphology ejaculate', 0.2229),\n",
       "  ('reproductive health', 0.2199),\n",
       "  ('quality parameters', 0.2041),\n",
       "  ('trend 004', 0.1884),\n",
       "  ('inference limited', 0.1761),\n",
       "  ('smoking status', 0.1758),\n",
       "  ('linear regression', 0.1691),\n",
       "  ('study question', 0.1443),\n",
       "  ('22 years', 0.1427),\n",
       "  ('type entrez', 0.1261),\n",
       "  ('conflicts declare', 0.1256),\n",
       "  ('sectional', 0.1253),\n",
       "  ('frequency questionnaire', 0.1233),\n",
       "  ('size duration', 0.1203),\n",
       "  ('difference 95', 0.1196),\n",
       "  ('dk046200 dk046200', 0.119),\n",
       "  ('187635970', 0.1061),\n",
       "  ('competing european', 0.0998),\n",
       "  ('0001 equivalent', 0.0941),\n",
       "  ('status body', 0.0939),\n",
       "  ('conducted 2009', 0.0915),\n",
       "  ('deer grant', 0.0583),\n",
       "  ('conventional', 0.0565),\n",
       "  ('association driven', 0.0562),\n",
       "  ('progressively motile', 0.048),\n",
       "  ('16 national', 0.0191),\n",
       "  ('aged 18', 0.0174),\n",
       "  ('men aged', 0.0123),\n",
       "  ('tv watching', 0.0049),\n",
       "  ('07 06', 0.0048),\n",
       "  ('national institutes', -0.0133),\n",
       "  ('attrs text', -0.0205),\n",
       "  ('grant p30', -0.0373),\n",
       "  ('university rochester', -0.0475),\n",
       "  ('trying children', -0.0598),\n",
       "  ('large amounts', -0.0692)],\n",
       " 'MED-1774': [('pollutants milk', 0.5497),\n",
       "  ('persistent bioaccumulative', 0.447),\n",
       "  ('measured 21', 0.4199),\n",
       "  ('lead concentrations', 0.3573),\n",
       "  ('concentrations ranged', 0.3364),\n",
       "  ('2001 levels', 0.3129),\n",
       "  ('intakes pathways', 0.3099),\n",
       "  ('fat ingestion', 0.2919),\n",
       "  ('assuming exposure', 0.2635),\n",
       "  ('pbt', 0.2632),\n",
       "  ('11 chemicals', 0.2572),\n",
       "  ('highest dietary', 0.2555),\n",
       "  ('dairy plants', 0.2471),\n",
       "  ('samples national', 0.2421),\n",
       "  ('14 pahs', 0.2414),\n",
       "  ('higher levels', 0.2293),\n",
       "  ('study measured', 0.2282),\n",
       "  ('detection limits', 0.2171),\n",
       "  ('cdf pcb', 0.203),\n",
       "  ('chlorobenzene pesticide', 0.1991),\n",
       "  ('supply', 0.1889),\n",
       "  ('collected 45', 0.1598),\n",
       "  ('22 94', 0.1591),\n",
       "  ('ranging 40', 0.1588),\n",
       "  ('ranging 630', 0.1585),\n",
       "  ('cadmium 06', 0.1573),\n",
       "  ('respectively total', 0.1558),\n",
       "  ('teqs vs', 0.1451),\n",
       "  ('150 870', 0.1422),\n",
       "  ('july 2000', 0.1397),\n",
       "  ('pg levels', 0.1259),\n",
       "  ('halogenated', 0.1164),\n",
       "  ('important understand', 0.1118),\n",
       "  ('micro day', 0.0981),\n",
       "  ('64', 0.0898),\n",
       "  ('averages computed', 0.0783),\n",
       "  ('organic groups', 0.073),\n",
       "  ('half values', 0.0611),\n",
       "  ('compounds compared', 0.0592),\n",
       "  ('seasonal', 0.0514),\n",
       "  ('average 360', 0.0481),\n",
       "  ('geographic differences', 0.0471),\n",
       "  ('overall decrease', 0.0431),\n",
       "  ('vs 30', 0.0404),\n",
       "  ('777 ng', 0.0391),\n",
       "  ('remained', 0.0205),\n",
       "  ('adult background', -0.0146),\n",
       "  ('nondairy pathways', -0.0242),\n",
       "  ('1996 difference', -0.0373),\n",
       "  ('south east', -0.0874)],\n",
       " 'MED-1775': [('antioxidants sperm', 0.695),\n",
       "  ('plasma antioxidant', 0.5511),\n",
       "  ('antioxidant reduced', 0.4986),\n",
       "  ('reduced sperm', 0.4697),\n",
       "  ('seminal plasma', 0.4568),\n",
       "  ('design semen', 0.447),\n",
       "  ('separate sperm', 0.4253),\n",
       "  ('measure ascorbate', 0.3335),\n",
       "  ('levels seminal', 0.3198),\n",
       "  ('thiols major', 0.3168),\n",
       "  ('men normozoospermic', 0.3104),\n",
       "  ('plasma fertile', 0.3096),\n",
       "  ('men design', 0.2998),\n",
       "  ('fertile infertile', 0.2972),\n",
       "  ('individuals ros', 0.2759),\n",
       "  ('groups tocopherol', 0.2709),\n",
       "  ('reactive oxygen', 0.2705),\n",
       "  ('contributor samples', 0.2607),\n",
       "  ('plasma significantly', 0.2602),\n",
       "  ('samples screened', 0.2468),\n",
       "  ('infertility center', 0.2354),\n",
       "  ('percoll gradient', 0.2167),\n",
       "  ('measure individual', 0.2084),\n",
       "  ('urate sulphydryl', 0.2051),\n",
       "  ('18 men', 0.2034),\n",
       "  ('concentrations measured', 0.1909),\n",
       "  ('male patients', 0.1898),\n",
       "  ('significantly reduced', 0.1455),\n",
       "  ('screened phorbol', 0.1391),\n",
       "  ('profiles main', 0.1118),\n",
       "  ('main outcome', 0.0979),\n",
       "  ('biochemistry', 0.0967),\n",
       "  ('groups', 0.0962),\n",
       "  ('wives ongoing', 0.0932),\n",
       "  ('activity setting', 0.0831),\n",
       "  ('fraction', 0.0687),\n",
       "  ('separate', 0.0676),\n",
       "  ('21 men', 0.0674),\n",
       "  ('setting departments', 0.0607),\n",
       "  ('obstetrics gynaecology', 0.0527),\n",
       "  ('species', 0.0514),\n",
       "  ('contributed', 0.0407),\n",
       "  ('total conclusion', 0.0121),\n",
       "  ('ester induced', 0.0094),\n",
       "  ('present contrast', 0.0046),\n",
       "  ('20', -0.0024),\n",
       "  ('queen', -0.0096),\n",
       "  ('twice', -0.0487),\n",
       "  ('university belfast', -0.0773),\n",
       "  ('ireland patient', -0.0954)],\n",
       " 'MED-1776': [('decline sperm', 0.5255),\n",
       "  ('results sperm', 0.4406),\n",
       "  ('regions decrease', 0.4096),\n",
       "  ('2005 studied', 0.3653),\n",
       "  ('concentration decreased', 0.357),\n",
       "  ('morphology decrease', 0.3482),\n",
       "  ('retrospective study', 0.3441),\n",
       "  ('france consistent', 0.3381),\n",
       "  ('sample men', 0.3371),\n",
       "  ('men close', 0.3273),\n",
       "  ('studied trends', 0.2828),\n",
       "  ('database study', 0.2752),\n",
       "  ('french metropolitan', 0.2738),\n",
       "  ('fivnat database', 0.2641),\n",
       "  ('population reported', 0.2323),\n",
       "  ('study sample', 0.2247),\n",
       "  ('reproductive technology', 0.2167),\n",
       "  ('total motility', 0.2145),\n",
       "  ('highest decrease', 0.2102),\n",
       "  ('trends adjusted', 0.2003),\n",
       "  ('sterile women', 0.1856),\n",
       "  ('compared overall', 0.1615),\n",
       "  ('general population', 0.1564),\n",
       "  ('endocrine disruptor', 0.1522),\n",
       "  ('concentration morphology', 0.1469),\n",
       "  ('regions showed', 0.1429),\n",
       "  ('partners', 0.1408),\n",
       "  ('pyrénées lowest', 0.1398),\n",
       "  ('used model', 0.1382),\n",
       "  ('1950s results', 0.1356),\n",
       "  ('carried recently', 0.1324),\n",
       "  ('blocked located', 0.126),\n",
       "  ('global change', 0.1074),\n",
       "  ('showed slight', 0.1014),\n",
       "  ('bourgogne showed', 0.0989),\n",
       "  ('spatio', 0.0913),\n",
       "  ('conclusion', 0.0879),\n",
       "  ('values consistently', 0.0875),\n",
       "  ('lifestyle hypothesis', 0.0824),\n",
       "  ('male', 0.0781),\n",
       "  ('1989', 0.0591),\n",
       "  ('tubes', 0.0496),\n",
       "  ('technology center', 0.0284),\n",
       "  ('midi', 0.0092),\n",
       "  ('metropolitan territory', 0.0063),\n",
       "  ('located assisted', -0.0123),\n",
       "  ('bayesian', -0.0484),\n",
       "  ('agricultural', -0.0667),\n",
       "  ('ubiquitary exposure', -0.0685),\n",
       "  ('aquitaine', -0.0723)],\n",
       " 'MED-1777': [('declining sperm', 0.6113),\n",
       "  ('worldwide decline', 0.5475),\n",
       "  ('evidence declining', 0.5048),\n",
       "  ('decline search', 0.396),\n",
       "  ('monitoring semen', 0.3687),\n",
       "  ('studies quality', 0.3201),\n",
       "  ('sperm production', 0.3065),\n",
       "  ('analyses retrospective', 0.3029),\n",
       "  ('trend studies', 0.3001),\n",
       "  ('medline embase', 0.2844),\n",
       "  ('environmental pollutants', 0.2686),\n",
       "  ('1985 2013', 0.2519),\n",
       "  ('systematically examined', 0.2392),\n",
       "  ('search engines', 0.2272),\n",
       "  ('secular trend', 0.2183),\n",
       "  ('disruptors temporal', 0.2181),\n",
       "  ('cochrane', 0.2119),\n",
       "  ('available evidence', 0.2035),\n",
       "  ('conducted researches', 0.1981),\n",
       "  ('identify epidemiologic', 0.1915),\n",
       "  ('geographic variations', 0.1757),\n",
       "  ('xenobiotics better', 0.1592),\n",
       "  ('main issues', 0.1553),\n",
       "  ('counts scientific', 0.1529),\n",
       "  ('quality laboratory', 0.1523),\n",
       "  ('published', 0.1459),\n",
       "  ('based meta', 0.1414),\n",
       "  ('library', 0.1404),\n",
       "  ('populations', 0.1215),\n",
       "  ('engines including', 0.1204),\n",
       "  ('counts hypothesis', 0.1091),\n",
       "  ('definition fecundity', 0.0997),\n",
       "  ('confirm worldwide', 0.0992),\n",
       "  ('monitoring', 0.098),\n",
       "  ('better definition', 0.0949),\n",
       "  ('comparability', 0.0914),\n",
       "  ('control confounding', 0.0809),\n",
       "  ('production assumptions', 0.0673),\n",
       "  ('complicate interpretation', 0.0555),\n",
       "  ('causative role', 0.0515),\n",
       "  ('endocrine', 0.0489),\n",
       "  ('subject', 0.0448),\n",
       "  ('need continuing', 0.0408),\n",
       "  ('different time', 0.0287),\n",
       "  ('difficult control', 0.0229),\n",
       "  ('scientific truth', 0.0209),\n",
       "  ('biosis', 0.0153),\n",
       "  ('concluded', 0.0135),\n",
       "  ('nature', 0.005),\n",
       "  ('prevailing', -0.0008)],\n",
       " 'MED-1778': [('semen parameters', 0.5424),\n",
       "  ('quartile intake', 0.3895),\n",
       "  ('lower sperm', 0.3747),\n",
       "  ('fat dairy', 0.3738),\n",
       "  ('intake positively', 0.36),\n",
       "  ('intake lower', 0.3446),\n",
       "  ('men lowest', 0.3346),\n",
       "  ('higher sperm', 0.311),\n",
       "  ('lowest tertile', 0.3023),\n",
       "  ('men interventions', 0.287),\n",
       "  ('servings day', 0.2758),\n",
       "  ('center fertility', 0.254),\n",
       "  ('concentration men', 0.2499),\n",
       "  ('ma patients', 0.2103),\n",
       "  ('men attending', 0.2094),\n",
       "  ('outcome measures', 0.2011),\n",
       "  ('motility cheese', 0.1918),\n",
       "  ('progressive motility', 0.1886),\n",
       "  ('54 servings', 0.1878),\n",
       "  ('155', 0.1837),\n",
       "  ('boston ma', 0.177),\n",
       "  ('results low', 0.1742),\n",
       "  ('morphology results', 0.1641),\n",
       "  ('measures total', 0.162),\n",
       "  ('14 percentage', 0.1601),\n",
       "  ('longitudinal', 0.1574),\n",
       "  ('highest quartile', 0.1507),\n",
       "  ('milk 30', 0.1433),\n",
       "  ('parameters design', 0.1408),\n",
       "  ('interventions main', 0.1389),\n",
       "  ('28 servings', 0.1368),\n",
       "  ('smokers group', 0.136),\n",
       "  ('study setting', 0.1359),\n",
       "  ('ci 75', 0.1316),\n",
       "  ('intake 22', 0.1219),\n",
       "  ('objective examine', 0.1209),\n",
       "  ('82 43', 0.1032),\n",
       "  ('findings suggest', 0.0965),\n",
       "  ('associations primarily', 0.0653),\n",
       "  ('count', 0.0614),\n",
       "  ('33 95', 0.0613),\n",
       "  ('primarily explained', 0.0607),\n",
       "  ('day conclusions', 0.0585),\n",
       "  ('units', 0.0561),\n",
       "  ('academic', 0.0527),\n",
       "  ('confidence interval', 0.0479),\n",
       "  ('past current', 0.0455),\n",
       "  ('medical', 0.0282),\n",
       "  ('17', 0.0097),\n",
       "  ('day 53', 0.0095)],\n",
       " 'MED-1779': [('infertility ros', 0.6021),\n",
       "  ('correlated infertility', 0.5302),\n",
       "  ('scores semen', 0.4762),\n",
       "  ('male infertility', 0.4439),\n",
       "  ('seminal fluid', 0.423),\n",
       "  ('oxidative stress', 0.4103),\n",
       "  ('measured ros', 0.3951),\n",
       "  ('infertility 13', 0.3459),\n",
       "  ('prostatitis 35', 0.3435),\n",
       "  ('total antioxidant', 0.3257),\n",
       "  ('remained infertile', 0.3056),\n",
       "  ('higher infertile', 0.3045),\n",
       "  ('discriminating fertile', 0.2656),\n",
       "  ('tac seminal', 0.2444),\n",
       "  ('reversals 65', 0.218),\n",
       "  ('factor diagnoses', 0.2086),\n",
       "  ('patients partners', 0.2063),\n",
       "  ('89 vasectomy', 0.1909),\n",
       "  ('oxygen species', 0.1823),\n",
       "  ('127 patients', 0.1806),\n",
       "  ('imbalance', 0.1788),\n",
       "  ('men especially', 0.1709),\n",
       "  ('fluid indicates', 0.1664),\n",
       "  ('patients remained', 0.1653),\n",
       "  ('strongly correlated', 0.1636),\n",
       "  ('se 25', 0.1629),\n",
       "  ('stress superior', 0.1531),\n",
       "  ('factor idiopathic', 0.1487),\n",
       "  ('varicocele varicocele', 0.1431),\n",
       "  ('scores failed', 0.1413),\n",
       "  ('scores', 0.1313),\n",
       "  ('controls significantly', 0.1289),\n",
       "  ('novel measure', 0.1242),\n",
       "  ('patients 56', 0.1171),\n",
       "  ('24 healthy', 0.1121),\n",
       "  ('patients significantly', 0.0958),\n",
       "  ('reactive', 0.0699),\n",
       "  ('groups', 0.0569),\n",
       "  ('28 idiopathic', 0.0567),\n",
       "  ('production', 0.0533),\n",
       "  ('measured', 0.0529),\n",
       "  ('15', 0.0462),\n",
       "  ('pregnancy significantly', 0.0337),\n",
       "  ('significantly lower', 0.021),\n",
       "  ('composite', 0.0119),\n",
       "  ('better', -0.0153),\n",
       "  ('47 13', -0.0219),\n",
       "  ('higher 39', -0.0313),\n",
       "  ('01', -0.0505),\n",
       "  ('80', -0.097)],\n",
       " 'MED-1780': [('deterioration spermatogenesis', 0.6175),\n",
       "  ('poor semen', 0.5393),\n",
       "  ('testicular cancer', 0.5102),\n",
       "  ('spermatogenesis couple', 0.4997),\n",
       "  ('semen quality', 0.4847),\n",
       "  ('reproductive impairment', 0.4665),\n",
       "  ('puzzle infertility', 0.4239),\n",
       "  ('declined recent', 0.4142),\n",
       "  ('alongside deterioration', 0.3246),\n",
       "  ('fertility increased', 0.3195),\n",
       "  ('recent decades', 0.3003),\n",
       "  ('spermatogenesis clear', 0.2759),\n",
       "  ('related problems', 0.2737),\n",
       "  ('endocrine disruption', 0.2684),\n",
       "  ('relationship genetics', 0.2665),\n",
       "  ('trend condition', 0.2577),\n",
       "  ('apparent inconsistency', 0.2492),\n",
       "  ('reproduction prone', 0.2479),\n",
       "  ('male reproductive', 0.2471),\n",
       "  ('couple', 0.2362),\n",
       "  ('cancer like', 0.2291),\n",
       "  ('pregnancy loss', 0.2241),\n",
       "  ('europe time', 0.2136),\n",
       "  ('pathways implicated', 0.1965),\n",
       "  ('zygote development', 0.1913),\n",
       "  ('possible exposures', 0.1907),\n",
       "  ('alternative pathogenesis', 0.1815),\n",
       "  ('implications offspring', 0.174),\n",
       "  ('populations north', 0.1734),\n",
       "  ('aneuploidy female', 0.1716),\n",
       "  ('discussed context', 0.1683),\n",
       "  ('descriptive epidemiology', 0.153),\n",
       "  ('social timescale', 0.1395),\n",
       "  ('quality appears', 0.1387),\n",
       "  ('standpoint poor', 0.1375),\n",
       "  ('western', 0.1374),\n",
       "  ('impossible evolutionary', 0.0956),\n",
       "  ('increased hypotheses', 0.0775),\n",
       "  ('mammalian species', 0.0757),\n",
       "  ('indicates currently', 0.0722),\n",
       "  ('indicates environmental', 0.0688),\n",
       "  ('historico social', 0.0639),\n",
       "  ('century', 0.0556),\n",
       "  ('health needs', 0.0494),\n",
       "  ('male mediated', 0.0163),\n",
       "  ('apparatus observed', -0.0144),\n",
       "  ('currently popular', -0.0179),\n",
       "  ('main', -0.028),\n",
       "  ('ago', -0.0286),\n",
       "  ('specificity originated', -0.0977)],\n",
       " 'MED-1781': [('semen variables', 0.4556),\n",
       "  ('study men', 0.4142),\n",
       "  ('lower sperm', 0.3806),\n",
       "  ('saturated fat', 0.3728),\n",
       "  ('total sperm', 0.3606),\n",
       "  ('danish men', 0.3447),\n",
       "  ('men lowest', 0.3381),\n",
       "  ('intake lower', 0.3096),\n",
       "  ('cardiovascular disease', 0.293),\n",
       "  ('quality intake', 0.2832),\n",
       "  ('exposure variables', 0.2711),\n",
       "  ('adjusted confounders', 0.2698),\n",
       "  ('quartile association', 0.2588),\n",
       "  ('study association', 0.2537),\n",
       "  ('fat conclusions', 0.2536),\n",
       "  ('reproductive health', 0.2509),\n",
       "  ('association dietary', 0.2467),\n",
       "  ('quality 701', 0.2438),\n",
       "  ('did men', 0.2324),\n",
       "  ('reduction saturated', 0.2295),\n",
       "  ('association men', 0.2143),\n",
       "  ('population design', 0.2119),\n",
       "  ('sectional', 0.2098),\n",
       "  ('count men', 0.1996),\n",
       "  ('comprising quantitative', 0.1685),\n",
       "  ('regression analyses', 0.1671),\n",
       "  ('cancer', 0.1657),\n",
       "  ('physical examination', 0.1532),\n",
       "  ('findings potentially', 0.1484),\n",
       "  ('infertile', 0.1465),\n",
       "  ('dose response', 0.1428),\n",
       "  ('61 lower', 0.1423),\n",
       "  ('fitness', 0.1235),\n",
       "  ('background', 0.123),\n",
       "  ('objective objective', 0.1199),\n",
       "  ('recruited examined', 0.1122),\n",
       "  ('multiple linear', 0.1102),\n",
       "  ('ci 64', 0.1086),\n",
       "  ('answered questionnaire', 0.1032),\n",
       "  ('past decades', 0.0976),\n",
       "  ('95', 0.0879),\n",
       "  ('sample underwent', 0.0725),\n",
       "  ('beneficial general', 0.0603),\n",
       "  ('concentration 41', 0.0467),\n",
       "  ('risk newly', 0.0376),\n",
       "  ('subnormal human', 0.0332),\n",
       "  ('public changes', -0.0077),\n",
       "  ('2008', -0.0144),\n",
       "  ('high frequency', -0.0397),\n",
       "  ('military service', -0.0484)],\n",
       " 'MED-1782': [('oxidative products', 0.5565),\n",
       "  ('mutagenic effect', 0.4743),\n",
       "  ('impact sperm', 0.4726),\n",
       "  ('sperm dna', 0.4448),\n",
       "  ('ros negative', 0.429),\n",
       "  ('decrease sperm', 0.4262),\n",
       "  ('dna fragmentation', 0.4105),\n",
       "  ('treatment antioxidant', 0.407),\n",
       "  ('male infertility', 0.375),\n",
       "  ('ros improve', 0.3196),\n",
       "  ('improve fertility', 0.3121),\n",
       "  ('dihydroxyguanosine', 0.3003),\n",
       "  ('degree sperm', 0.2948),\n",
       "  ('study dna', 0.2942),\n",
       "  ('negative impact', 0.2741),\n",
       "  ('protamines explain', 0.2582),\n",
       "  ('compound causes', 0.2281),\n",
       "  ('vitamins especially', 0.2193),\n",
       "  ('chromatin structure', 0.2192),\n",
       "  ('decrease formation', 0.1962),\n",
       "  ('improving male', 0.1793),\n",
       "  ('oxygen', 0.1765),\n",
       "  ('decondensation', 0.1751),\n",
       "  ('gene activity', 0.1704),\n",
       "  ('fragmentation index', 0.1646),\n",
       "  ('preimplantation development', 0.1552),\n",
       "  ('standard practice', 0.153),\n",
       "  ('paternal gene', 0.1526),\n",
       "  ('net interfering', 0.1523),\n",
       "  ('selenium', 0.1315),\n",
       "  ('disulphide bridges', 0.1156),\n",
       "  ('explain discrepancy', 0.104),\n",
       "  ('oral', 0.1004),\n",
       "  ('reactive', 0.0994),\n",
       "  ('magnitude 22', 0.0857),\n",
       "  ('structure assay', 0.0844),\n",
       "  ('0004 suggesting', 0.0783),\n",
       "  ('treatment led', 0.0737),\n",
       "  ('leading formation', 0.0609),\n",
       "  ('order magnitude', 0.0556),\n",
       "  ('species', 0.0508),\n",
       "  ('patient', 0.0499),\n",
       "  ('attempt', 0.047),\n",
       "  ('90 days', 0.0403),\n",
       "  ('measured using', 0.0355),\n",
       "  ('open cystin', 0.0203),\n",
       "  ('led unexpected', -0.0138),\n",
       "  ('aspect', -0.0184),\n",
       "  ('interchain', -0.025),\n",
       "  ('19 0004', -0.0546)],\n",
       " 'MED-1783': [('measures semen', 0.4995),\n",
       "  ('dietary antioxidant', 0.3979),\n",
       "  ('men carotenoid', 0.3763),\n",
       "  ('compared men', 0.371),\n",
       "  ('better sperm', 0.3709),\n",
       "  ('healthy males', 0.3638),\n",
       "  ('total sperm', 0.3604),\n",
       "  ('young men', 0.345),\n",
       "  ('concentration men', 0.3247),\n",
       "  ('normal sperm', 0.3205),\n",
       "  ('men lowest', 0.3151),\n",
       "  ('males design', 0.2687),\n",
       "  ('quartiles lycopene', 0.2519),\n",
       "  ('intake compared', 0.2482),\n",
       "  ('men highest', 0.2478),\n",
       "  ('quality young', 0.2186),\n",
       "  ('relationship vitamin', 0.1972),\n",
       "  ('increasing quartiles', 0.1933),\n",
       "  ('university college', 0.189),\n",
       "  ('patients 189', 0.1885),\n",
       "  ('percentages 95', 0.1805),\n",
       "  ('study setting', 0.1715),\n",
       "  ('rochester new', 0.1682),\n",
       "  ('motile count', 0.1639),\n",
       "  ('progressive motility', 0.1583),\n",
       "  ('lowest concentrations', 0.1482),\n",
       "  ('objective assess', 0.1455),\n",
       "  ('interventions', 0.1443),\n",
       "  ('main outcome', 0.1351),\n",
       "  ('volume total', 0.1326),\n",
       "  ('conclusions population', 0.1308),\n",
       "  ('intake 10', 0.1277),\n",
       "  ('sectional', 0.115),\n",
       "  ('morphology data', 0.1147),\n",
       "  ('area patients', 0.1098),\n",
       "  ('adjusted percentages', 0.1094),\n",
       "  ('similar results', 0.1039),\n",
       "  ('12 percentage', 0.1036),\n",
       "  ('observed lutein', 0.084),\n",
       "  ('having average', 0.0804),\n",
       "  ('units higher', 0.0667),\n",
       "  ('positively related', 0.0485),\n",
       "  ('aged', 0.0484),\n",
       "  ('better', 0.0382),\n",
       "  ('linear', 0.033),\n",
       "  ('second quartile', 0.028),\n",
       "  ('york area', 0.0172),\n",
       "  ('ci morphologically', 0.0122),\n",
       "  ('11', -0.0102),\n",
       "  ('non', -0.0187)],\n",
       " 'MED-1784': [('semen quality', 0.6025),\n",
       "  ('seminal oxidative', 0.5096),\n",
       "  ('results sperm', 0.4927),\n",
       "  ('infertility subjects', 0.4259),\n",
       "  ('elevated sperm', 0.4205),\n",
       "  ('138 men', 0.4059),\n",
       "  ('men categorized', 0.3976),\n",
       "  ('male infertility', 0.3969),\n",
       "  ('basis sperm', 0.3895),\n",
       "  ('oxidative stress', 0.3871),\n",
       "  ('declining semen', 0.3854),\n",
       "  ('stress markers', 0.3693),\n",
       "  ('determine seminal', 0.3655),\n",
       "  ('antioxidant capacity', 0.3458),\n",
       "  ('quality protective', 0.3126),\n",
       "  ('markers association', 0.2797),\n",
       "  ('peroxidation lpo', 0.2641),\n",
       "  ('factor male', 0.2479),\n",
       "  ('objectives determine', 0.2236),\n",
       "  ('count motility', 0.2124),\n",
       "  ('thiols positively', 0.2063),\n",
       "  ('relationship sod', 0.202),\n",
       "  ('methods', 0.1753),\n",
       "  ('major etiological', 0.1608),\n",
       "  ('subjects', 0.1599),\n",
       "  ('categorized basis', 0.1489),\n",
       "  ('samples obtained', 0.1304),\n",
       "  ('showed significant', 0.1263),\n",
       "  ('associated elevated', 0.1172),\n",
       "  ('enzymes increased', 0.1032),\n",
       "  ('carbonyls pc', 0.1022),\n",
       "  ('catalase', 0.0961),\n",
       "  ('attribute risk', 0.0891),\n",
       "  ('society', 0.0724),\n",
       "  ('conclusion insufficient', 0.06),\n",
       "  ('follows lipid', 0.0539),\n",
       "  ('acid determined', 0.0531),\n",
       "  ('normal morphology', 0.0458),\n",
       "  ('risk declining', 0.0451),\n",
       "  ('chemists published', 0.0427),\n",
       "  ('protein', 0.0418),\n",
       "  ('canadian society', 0.0406),\n",
       "  ('capacity', 0.0366),\n",
       "  ('positive relationship', 0.0317),\n",
       "  ('negative correlation', 0.0148),\n",
       "  ('elsevier rights', -0.0147),\n",
       "  ('ruled copyright', -0.0164),\n",
       "  ('progressive', -0.0342),\n",
       "  ('2010', -0.0556),\n",
       "  ('cat', -0.0781)],\n",
       " 'MED-1785': [('dietary intervention', 0.43),\n",
       "  ('men beneficially', 0.3984),\n",
       "  ('75 shelled', 0.3965),\n",
       "  ('hypothesis 75', 0.3762),\n",
       "  ('walnuts', 0.3464),\n",
       "  ('group consuming', 0.3262),\n",
       "  ('semen quality', 0.3204),\n",
       "  ('sperm fatty', 0.3047),\n",
       "  ('quality randomized', 0.2871),\n",
       "  ('beneficially affect', 0.2715),\n",
       "  ('conducted 117', 0.2697),\n",
       "  ('nuts', 0.2514),\n",
       "  ('healthy young', 0.2306),\n",
       "  ('included blood', 0.2267),\n",
       "  ('included', 0.216),\n",
       "  ('western style', 0.2156),\n",
       "  ('serum fa', 0.1988),\n",
       "  ('35 yr', 0.1872),\n",
       "  ('control group', 0.1809),\n",
       "  ('folate group', 0.1801),\n",
       "  ('linolenic', 0.1736),\n",
       "  ('assessors conducted', 0.1615),\n",
       "  ('secondary endpoints', 0.154),\n",
       "  ('trial single', 0.1509),\n",
       "  ('hormones', 0.1446),\n",
       "  ('profiles improved', 0.144),\n",
       "  ('baseline', 0.1359),\n",
       "  ('58 comparing', 0.1282),\n",
       "  ('omega 0007', 0.1177),\n",
       "  ('improvement conventional', 0.1087),\n",
       "  ('aneuploidy', 0.1071),\n",
       "  ('sex chromosome', 0.0997),\n",
       "  ('ala increased', 0.0969),\n",
       "  ('differences groups', 0.091),\n",
       "  ('12', 0.0806),\n",
       "  ('tested hypothesis', 0.0777),\n",
       "  ('vitality motility', 0.0748),\n",
       "  ('avoiding', 0.0731),\n",
       "  ('acid', 0.0687),\n",
       "  ('inversely correlated', 0.0601),\n",
       "  ('morphology change', 0.0503),\n",
       "  ('old routinely', 0.0443),\n",
       "  ('group increases', 0.0372),\n",
       "  ('nullisomy spearman', 0.036),\n",
       "  ('plant source', 0.0344),\n",
       "  ('parallel', 0.0254),\n",
       "  ('blind masking', 0.0247),\n",
       "  ('41 002', 0.0059),\n",
       "  ('009', -0.0231),\n",
       "  ('forms 04', -0.0517)],\n",
       " 'MED-1786': [('semen characteristics', 0.5549),\n",
       "  ('copenhagen sperm', 0.5214),\n",
       "  ('fertility status', 0.4927),\n",
       "  ('referred infertility', 0.46),\n",
       "  ('normal spermatozoa', 0.4171),\n",
       "  ('mortality men', 0.3655),\n",
       "  ('decreased sperm', 0.363),\n",
       "  ('men referred', 0.3468),\n",
       "  ('practitioners urologists', 0.3298),\n",
       "  ('men children', 0.3175),\n",
       "  ('registers hold', 0.303),\n",
       "  ('urologists 1963', 0.3005),\n",
       "  ('cancer causes', 0.2984),\n",
       "  ('men followed', 0.2506),\n",
       "  ('danish central', 0.238),\n",
       "  ('personal identification', 0.235),\n",
       "  ('male health', 0.2327),\n",
       "  ('mortality cohort', 0.2261),\n",
       "  ('studies examined', 0.2168),\n",
       "  ('compared age', 0.2077),\n",
       "  ('general practitioners', 0.1756),\n",
       "  ('biomarker overall', 0.1744),\n",
       "  ('mortality decreased', 0.1742),\n",
       "  ('quality fundamental', 0.1671),\n",
       "  ('trend 05', 0.1587),\n",
       "  ('information cases', 0.1521),\n",
       "  ('men good', 0.14),\n",
       "  ('standardized', 0.1356),\n",
       "  ('cause specific', 0.1333),\n",
       "  ('morphologically normal', 0.1314),\n",
       "  ('range diseases', 0.128),\n",
       "  ('linked', 0.1043),\n",
       "  ('percentages motile', 0.1003),\n",
       "  ('population', 0.0958),\n",
       "  ('social factors', 0.0943),\n",
       "  ('dose response', 0.0845),\n",
       "  ('analysis laboratory', 0.0738),\n",
       "  ('277 men', 0.0617),\n",
       "  ('ml percentages', 0.0527),\n",
       "  ('increased mortality', 0.0506),\n",
       "  ('censoring whichever', 0.0454),\n",
       "  ('volume increased', 0.0425),\n",
       "  ('manner', 0.0352),\n",
       "  ('azospermia', 0.0319),\n",
       "  ('43', 0.0277),\n",
       "  ('40 million', 0.0197),\n",
       "  ('occurred total', 0.0129),\n",
       "  ('solely lifestyle', -0.0066),\n",
       "  ('2001 unique', -0.0175),\n",
       "  ('followed december', -0.0901)],\n",
       " 'MED-1787': [('semen quality', 0.5624),\n",
       "  ('history infertility', 0.449),\n",
       "  ('men included', 0.4021),\n",
       "  ('male fertility', 0.3991),\n",
       "  ('947 men', 0.3825),\n",
       "  ('review publications', 0.3671),\n",
       "  ('50 years', 0.3666),\n",
       "  ('abnormalities testicular', 0.349),\n",
       "  ('years male', 0.3383),\n",
       "  ('medline', 0.3378),\n",
       "  ('decline sperm', 0.3112),\n",
       "  ('quality past', 0.309),\n",
       "  ('volume results', 0.2839),\n",
       "  ('0001 seminal', 0.2642),\n",
       "  ('quality changed', 0.2522),\n",
       "  ('gonadal function', 0.251),\n",
       "  ('61 papers', 0.2422),\n",
       "  ('incidence genitourinary', 0.2311),\n",
       "  ('subjects 14', 0.228),\n",
       "  ('reduction male', 0.2217),\n",
       "  ('current list', 0.2172),\n",
       "  ('factors effects', 0.2149),\n",
       "  ('index medicus', 0.2145),\n",
       "  ('means cumulated', 0.2121),\n",
       "  ('study showed', 0.2102),\n",
       "  ('years design', 0.2055),\n",
       "  ('1940', 0.2029),\n",
       "  ('selected', 0.2028),\n",
       "  ('main outcome', 0.1817),\n",
       "  ('ml 75', 0.1788),\n",
       "  ('history', 0.1758),\n",
       "  ('hypospadias', 0.1662),\n",
       "  ('pronounced decrease', 0.1625),\n",
       "  ('1930 1965', 0.1534),\n",
       "  ('possibly cryptorchidism', 0.1468),\n",
       "  ('correlated', 0.1306),\n",
       "  ('biological significance', 0.1225),\n",
       "  ('count 113', 0.089),\n",
       "  ('results linear', 0.0834),\n",
       "  ('production', 0.0821),\n",
       "  ('66', 0.0778),\n",
       "  ('published 1938', 0.0748),\n",
       "  ('platter database', 0.0722),\n",
       "  ('volume 40', 0.0508),\n",
       "  ('investigate', 0.0463),\n",
       "  ('cancer', 0.029),\n",
       "  ('1991', 0.0208),\n",
       "  ('10 ml', 0.0145),\n",
       "  ('027', -0.0489),\n",
       "  ('silver', -0.0512)],\n",
       " 'MED-1788': [('older men', 0.4477),\n",
       "  ('micronutrients reduce', 0.4147),\n",
       "  ('sperm dna', 0.3882),\n",
       "  ('intakes antioxidants', 0.3726),\n",
       "  ('men design', 0.3498),\n",
       "  ('age groups', 0.3455),\n",
       "  ('medical reproductive', 0.3173),\n",
       "  ('protect somatic', 0.2855),\n",
       "  ('genomic damage', 0.2853),\n",
       "  ('habits determined', 0.2828),\n",
       "  ('men raises', 0.2781),\n",
       "  ('factors including', 0.2686),\n",
       "  ('men lowest', 0.264),\n",
       "  ('sociodemographics', 0.2625),\n",
       "  ('design equalized', 0.2576),\n",
       "  ('intake similar', 0.2521),\n",
       "  ('occupational exposures', 0.242),\n",
       "  ('increased dietary', 0.2368),\n",
       "  ('nonsmoking', 0.2363),\n",
       "  ('groups setting', 0.2307),\n",
       "  ('question lifestyle', 0.2223),\n",
       "  ('zinc older', 0.2172),\n",
       "  ('similar findings', 0.2109),\n",
       "  ('neutral dna', 0.1971),\n",
       "  ('44 years', 0.1783),\n",
       "  ('setting national', 0.1744),\n",
       "  ('university', 0.1744),\n",
       "  ('benefit younger', 0.1744),\n",
       "  ('cells', 0.1743),\n",
       "  ('questionnaire ffq', 0.1686),\n",
       "  ('folate determined', 0.168),\n",
       "  ('group 22', 0.1679),\n",
       "  ('main outcome', 0.1655),\n",
       "  ('80 year', 0.161),\n",
       "  ('broader', 0.1605),\n",
       "  ('surveyed conclusion', 0.158),\n",
       "  ('measured alkaline', 0.1485),\n",
       "  ('electrophoresis', 0.1439),\n",
       "  ('comet men', 0.14),\n",
       "  ('modified', 0.1344),\n",
       "  ('patient nonclinical', 0.1338),\n",
       "  ('approximately 20', 0.1334),\n",
       "  ('16', 0.1315),\n",
       "  ('years did', 0.1293),\n",
       "  ('sectional', 0.101),\n",
       "  ('average daily', 0.1006),\n",
       "  ('2012', 0.0348),\n",
       "  ('damage copyright', 0.0313),\n",
       "  ('using 100', -0.0006),\n",
       "  ('published elsevier', -0.0067)],\n",
       " 'MED-1789': [('polyphenols epp', 0.7158),\n",
       "  ('dietary polyphenols', 0.5808),\n",
       "  ('epp intake', 0.5701),\n",
       "  ('nonextractable polyphenols', 0.495),\n",
       "  ('exclusively epp', 0.4866),\n",
       "  ('extracts nepp', 0.4802),\n",
       "  ('epp objective', 0.4276),\n",
       "  ('hydrolyzable pp', 0.4154),\n",
       "  ('pp intake', 0.4127),\n",
       "  ('contents epp', 0.3809),\n",
       "  ('compounds solubilized', 0.3462),\n",
       "  ('epp methanol', 0.3444),\n",
       "  ('scope dietary', 0.338),\n",
       "  ('residues studies', 0.3277),\n",
       "  ('acetone extracts', 0.3243),\n",
       "  ('pp divided', 0.3197),\n",
       "  ('diet 942', 0.2867),\n",
       "  ('proanthocyanidins pa', 0.2821),\n",
       "  ('non extractable', 0.2807),\n",
       "  ('residues cereals', 0.2618),\n",
       "  ('corresponding extraction', 0.2595),\n",
       "  ('organic', 0.259),\n",
       "  ('studies', 0.2453),\n",
       "  ('health effects', 0.2424),\n",
       "  ('physiological properties', 0.2409),\n",
       "  ('contents estimated', 0.2324),\n",
       "  ('acidic hydrolyzates', 0.2238),\n",
       "  ('vegetables nuts', 0.2201),\n",
       "  ('contributors total', 0.2001),\n",
       "  ('address exclusively', 0.1784),\n",
       "  ('results hplc', 0.173),\n",
       "  ('weight fruits', 0.1694),\n",
       "  ('ms analyses', 0.1661),\n",
       "  ('dry weight', 0.1654),\n",
       "  ('aqueous', 0.16),\n",
       "  ('conclusion non', 0.1423),\n",
       "  ('258 mg', 0.1372),\n",
       "  ('legumes', 0.1305),\n",
       "  ('pa ranged', 0.1116),\n",
       "  ('210 mg', 0.0864),\n",
       "  ('useful better', 0.08),\n",
       "  ('ranged 880', 0.0719),\n",
       "  ('746 mg', 0.0668),\n",
       "  ('determine actual', 0.064),\n",
       "  ('groups', 0.0635),\n",
       "  ('remain', 0.0549),\n",
       "  ('day person', 0.0389),\n",
       "  ('substantially higher', 0.0258),\n",
       "  ('person spanish', 0.0129),\n",
       "  ('1201', 0.0075)],\n",
       " 'MED-1790': [('fruit children', 0.4719),\n",
       "  ('sucrose consumption', 0.4709),\n",
       "  ('juice consumption', 0.4622),\n",
       "  ('change nutritional', 0.4071),\n",
       "  ('obesity preschool', 0.4027),\n",
       "  ('food', 0.3614),\n",
       "  ('children recommend', 0.3554),\n",
       "  ('childcare centers', 0.354),\n",
       "  ('food care', 0.3525),\n",
       "  ('quality foods', 0.351),\n",
       "  ('meal patterns', 0.3477),\n",
       "  ('consumption associated', 0.3376),\n",
       "  ('elimination fruit', 0.3363),\n",
       "  ('nutritional', 0.3316),\n",
       "  ('excessive fruit', 0.3243),\n",
       "  ('preschool children', 0.3037),\n",
       "  ('free kids', 0.2968),\n",
       "  ('act 2010', 0.2787),\n",
       "  ('obesity recent', 0.2762),\n",
       "  ('healthy hunger', 0.2598),\n",
       "  ('low income', 0.2494),\n",
       "  ('adult food', 0.245),\n",
       "  ('start centers', 0.2429),\n",
       "  ('kids act', 0.2183),\n",
       "  ('child', 0.216),\n",
       "  ('metabolic syndrome', 0.1937),\n",
       "  ('fiber commonly', 0.1846),\n",
       "  ('promote elimination', 0.1788),\n",
       "  ('care program', 0.1727),\n",
       "  ('syndrome liver', 0.1638),\n",
       "  ('income', 0.1469),\n",
       "  ('program manages', 0.1337),\n",
       "  ('centers excessive', 0.1256),\n",
       "  ('served low', 0.1083),\n",
       "  ('recommend', 0.1003),\n",
       "  ('agriculture', 0.0773),\n",
       "  ('free', 0.0771),\n",
       "  ('scientific evidence', 0.0764),\n",
       "  ('presents opportunity', 0.0711),\n",
       "  ('head start', 0.0679),\n",
       "  ('recent', 0.06),\n",
       "  ('syndrome', 0.0562),\n",
       "  ('increasing risk', 0.0463),\n",
       "  ('favor', 0.0265),\n",
       "  ('commonly present', 0.0239),\n",
       "  ('quality', 0.0233),\n",
       "  ('served', 0.016),\n",
       "  ('department', -0.0126),\n",
       "  ('patterns', -0.0177),\n",
       "  ('injury', -0.1282)],\n",
       " 'MED-1791': [('effects dietary', 0.465),\n",
       "  ('inconsistent studies', 0.4231),\n",
       "  ('supplementation', 0.4),\n",
       "  ('results calcium', 0.3605),\n",
       "  ('fructans prebiotics', 0.3502),\n",
       "  ('assess effects', 0.3315),\n",
       "  ('adolescents generally', 0.3256),\n",
       "  ('effect persists', 0.3115),\n",
       "  ('growth effects', 0.3101),\n",
       "  ('combination prebiotic', 0.2896),\n",
       "  ('mineral content', 0.2893),\n",
       "  ('enhances bone', 0.2846),\n",
       "  ('stable isotopes', 0.2622),\n",
       "  ('mineralization pubertal', 0.2555),\n",
       "  ('fok1 vitamin', 0.2524),\n",
       "  ('group bone', 0.2465),\n",
       "  ('term studies', 0.2458),\n",
       "  ('vitamin receptor', 0.2265),\n",
       "  ('group wk', 0.2179),\n",
       "  ('consumption', 0.2093),\n",
       "  ('increment body', 0.2076),\n",
       "  ('baseline wk', 0.1989),\n",
       "  ('absorption significantly', 0.1854),\n",
       "  ('maltodextrin placebo', 0.1805),\n",
       "  ('short long', 0.1767),\n",
       "  ('background', 0.1655),\n",
       "  ('gene polymorphisms', 0.1555),\n",
       "  ('polymerization inulin', 0.1533),\n",
       "  ('accretion', 0.1392),\n",
       "  ('use stable', 0.1361),\n",
       "  ('measured use', 0.1338),\n",
       "  ('conducted', 0.1211),\n",
       "  ('015 004', 0.1207),\n",
       "  ('35 16', 0.1154),\n",
       "  ('difference', 0.1123),\n",
       "  ('including specific', 0.1119),\n",
       "  ('receive mixed', 0.1007),\n",
       "  ('initial response', 0.0985),\n",
       "  ('objective objective', 0.0926),\n",
       "  ('long chain', 0.0916),\n",
       "  ('subjects ff', 0.0874),\n",
       "  ('daily', 0.0839),\n",
       "  ('group conclusion', 0.0746),\n",
       "  ('shown enhancement', 0.0734),\n",
       "  ('present', 0.0618),\n",
       "  ('interaction', 0.0387),\n",
       "  ('did control', 0.0163),\n",
       "  ('randomly', 0.0036),\n",
       "  ('03', -0.0137),\n",
       "  ('significantly increases', -0.0319)],\n",
       " 'MED-1792': [('fruit consumption', 0.604),\n",
       "  ('apple juices', 0.5351),\n",
       "  ('clear apple', 0.3957),\n",
       "  ('juices 500', 0.3939),\n",
       "  ('juice free', 0.3418),\n",
       "  ('decreased risk', 0.3354),\n",
       "  ('commonly consumed', 0.3127),\n",
       "  ('nutritional recommendations', 0.2947),\n",
       "  ('factors cvd', 0.2617),\n",
       "  ('potentially bioactive', 0.2595),\n",
       "  ('studies endorsed', 0.252),\n",
       "  ('assess effects', 0.226),\n",
       "  ('intervention significantly', 0.2125),\n",
       "  ('ml day', 0.1975),\n",
       "  ('health authorities', 0.1956),\n",
       "  ('campaigns', 0.1915),\n",
       "  ('trends lower', 0.1893),\n",
       "  ('polyphenols pectin', 0.1852),\n",
       "  ('necessary cholesterol', 0.1807),\n",
       "  ('pomace effect', 0.1676),\n",
       "  ('conclusions', 0.1632),\n",
       "  ('glass', 0.1616),\n",
       "  ('effect hdl', 0.1603),\n",
       "  ('pressure group', 0.1548),\n",
       "  ('microbiota markers', 0.1537),\n",
       "  ('glucose', 0.1531),\n",
       "  ('cause protection', 0.1438),\n",
       "  ('serving', 0.1336),\n",
       "  ('affecting common', 0.1163),\n",
       "  ('constituents segregate', 0.1149),\n",
       "  ('cohort', 0.1072),\n",
       "  ('conclude fibre', 0.1071),\n",
       "  ('550 day', 0.0966),\n",
       "  ('humans clear', 0.0965),\n",
       "  ('healthy humans', 0.0943),\n",
       "  ('crp composition', 0.0727),\n",
       "  ('concentrations increased', 0.0722),\n",
       "  ('waist hip', 0.0683),\n",
       "  ('total', 0.0634),\n",
       "  ('tag weight', 0.0607),\n",
       "  ('igf1 igfbp3', 0.0598),\n",
       "  ('wall components', 0.0513),\n",
       "  ('group 23', 0.0234),\n",
       "  ('crossover study', 0.0175),\n",
       "  ('intake hand', 0.0151),\n",
       "  ('weeks', 0.0077),\n",
       "  ('affected serum', 0.0073),\n",
       "  ('cloudy', 0.0008),\n",
       "  ('surrogate', -0.0408),\n",
       "  ('hs', -0.0427)],\n",
       " 'MED-1793': [('nonextractable polyphenols', 0.6059),\n",
       "  ('dietary polyphenols', 0.5772),\n",
       "  ('polyphenols nepp', 0.4958),\n",
       "  ('polyphenols extracted', 0.4884),\n",
       "  ('exclusively polyphenols', 0.4714),\n",
       "  ('polyphenols depend', 0.4399),\n",
       "  ('solvents ignored', 0.4306),\n",
       "  ('phenolic', 0.3847),\n",
       "  ('chemical approach', 0.3392),\n",
       "  ('compounds use', 0.333),\n",
       "  ('physiological approaches', 0.3254),\n",
       "  ('ignored biological', 0.3191),\n",
       "  ('plant foods', 0.3032),\n",
       "  ('research studies', 0.3019),\n",
       "  ('epidemiological studies', 0.3016),\n",
       "  ('foods organic', 0.2964),\n",
       "  ('extracted organic', 0.2864),\n",
       "  ('nutritional epidemiological', 0.2789),\n",
       "  ('chemical physiological', 0.2781),\n",
       "  ('solubility organic', 0.2532),\n",
       "  ('stressed literature', 0.2504),\n",
       "  ('extracted plant', 0.2411),\n",
       "  ('total dietary', 0.2347),\n",
       "  ('significant biological', 0.2327),\n",
       "  ('shown nonextractable', 0.232),\n",
       "  ('solvents paper', 0.2279),\n",
       "  ('field dietary', 0.2272),\n",
       "  ('nepp current', 0.2262),\n",
       "  ('studies shown', 0.2139),\n",
       "  ('bioavailability health', 0.2102),\n",
       "  ('different solubility', 0.1963),\n",
       "  ('related properties', 0.1929),\n",
       "  ('quantitative differences', 0.1866),\n",
       "  ('refer extractable', 0.1721),\n",
       "  ('approaches pointing', 0.1582),\n",
       "  ('focusing exclusively', 0.1571),\n",
       "  ('databases refer', 0.1536),\n",
       "  ('differences stressed', 0.1441),\n",
       "  ('qualitative', 0.1401),\n",
       "  ('intestinal fluids', 0.1346),\n",
       "  ('major total', 0.0931),\n",
       "  ('clarify concept', 0.0898),\n",
       "  ('recent', 0.0869),\n",
       "  ('use', 0.068),\n",
       "  ('proposed basis', 0.0588),\n",
       "  ('attention', 0.0276),\n",
       "  ('gap field', 0.016),\n",
       "  ('greater', -0.0175),\n",
       "  ('exhibit', -0.0504),\n",
       "  ('tries', -0.0637)],\n",
       " 'MED-1794': [('polysaccharides nsps', 0.6973),\n",
       "  ('polysaccharides dietary', 0.6561),\n",
       "  ('nonstarch polysaccharides', 0.6142),\n",
       "  ('dietary fiber', 0.4856),\n",
       "  ('nutritional impact', 0.437),\n",
       "  ('naturally foods', 0.4303),\n",
       "  ('laxatives soluble', 0.4014),\n",
       "  ('nsps escapes', 0.401),\n",
       "  ('small intestine', 0.3777),\n",
       "  ('offer prebiotic', 0.3697),\n",
       "  ('glucans lower', 0.3673),\n",
       "  ('acids scfas', 0.366),\n",
       "  ('hemicellulose effective', 0.3638),\n",
       "  ('microflora present', 0.3391),\n",
       "  ('bulk fermentibility', 0.306),\n",
       "  ('dispersibility viscosity', 0.3024),\n",
       "  ('various physiological', 0.2892),\n",
       "  ('biological properties', 0.2863),\n",
       "  ('beneficial colonic', 0.2771),\n",
       "  ('chain fatty', 0.2494),\n",
       "  ('bacteria offer', 0.2411),\n",
       "  ('implications humans', 0.231),\n",
       "  ('products promote', 0.2233),\n",
       "  ('nonstarch', 0.2215),\n",
       "  ('related diseases', 0.2109),\n",
       "  ('plasma cholesterol', 0.2101),\n",
       "  ('important health', 0.2083),\n",
       "  ('fiber', 0.206),\n",
       "  ('films coatings', 0.2008),\n",
       "  ('compounds correspond', 0.1999),\n",
       "  ('insoluble', 0.1792),\n",
       "  ('problems western', 0.1658),\n",
       "  ('fully understood', 0.1609),\n",
       "  ('different', 0.1556),\n",
       "  ('plasma', 0.1529),\n",
       "  ('promotes normal', 0.1518),\n",
       "  ('making kinds', 0.1364),\n",
       "  ('packaging wrapping', 0.1359),\n",
       "  ('therapeutic agent', 0.1344),\n",
       "  ('levels help', 0.1337),\n",
       "  ('needs studied', 0.105),\n",
       "  ('include coronary', 0.1048),\n",
       "  ('formation mineral', 0.0966),\n",
       "  ('age groups', 0.096),\n",
       "  ('countries emerging', 0.0896),\n",
       "  ('type diabetes', 0.0836),\n",
       "  ('proposed present', 0.0573),\n",
       "  ('affluence conditions', 0.0454),\n",
       "  ('major proportion', 0.0431),\n",
       "  ('escapes', 0.0372)],\n",
       " 'MED-1795': [('diabetes servings', 0.4713),\n",
       "  ('health study', 0.4606),\n",
       "  ('health professionals', 0.4528),\n",
       "  ('fruits pooled', 0.4418),\n",
       "  ('dietary risk', 0.3981),\n",
       "  ('cohorts conclusion', 0.3867),\n",
       "  ('participants developed', 0.3395),\n",
       "  ('105 women', 0.3338),\n",
       "  ('chronic diseases', 0.3216),\n",
       "  ('men health', 0.3185),\n",
       "  ('study setting', 0.2983),\n",
       "  ('nurses', 0.2892),\n",
       "  ('findings suggest', 0.2786),\n",
       "  ('consumption specific', 0.2783),\n",
       "  ('design prospective', 0.2724),\n",
       "  ('96 apples', 0.2584),\n",
       "  ('juice consumption', 0.2572),\n",
       "  ('1984 2008', 0.2555),\n",
       "  ('heterogeneity associations', 0.2545),\n",
       "  ('baseline studies', 0.2425),\n",
       "  ('83 blueberries', 0.2347),\n",
       "  ('198 participants', 0.2265),\n",
       "  ('associated higher', 0.2195),\n",
       "  ('grapefruit 97', 0.2099),\n",
       "  ('74 66', 0.2098),\n",
       "  ('173 men', 0.1998),\n",
       "  ('person years', 0.1962),\n",
       "  ('03 oranges', 0.1871),\n",
       "  ('79 01', 0.1743),\n",
       "  ('08 05', 0.1719),\n",
       "  ('apricots 99', 0.1716),\n",
       "  ('11 associations', 0.1678),\n",
       "  ('supplementary questionnaires', 0.1667),\n",
       "  ('02 peaches', 0.1576),\n",
       "  ('85', 0.1502),\n",
       "  ('bananas', 0.1502),\n",
       "  ('identified self', 0.1484),\n",
       "  ('measure incident', 0.1303),\n",
       "  ('week total', 0.1212),\n",
       "  ('united states', 0.1149),\n",
       "  ('differed significantly', 0.1108),\n",
       "  ('10 strawberries', 0.0974),\n",
       "  ('2009 36', 0.086),\n",
       "  ('follow 12', 0.0738),\n",
       "  ('confidence', 0.0687),\n",
       "  ('adjustment personal', 0.0671),\n",
       "  ('plums', 0.0646),\n",
       "  ('cantaloupe', 0.0643),\n",
       "  ('associated lower', 0.0369),\n",
       "  ('raisins', 0.0356)],\n",
       " 'MED-1796': [('ad36 obesity', 0.603),\n",
       "  ('influence ad36', 0.5342),\n",
       "  ('infection obesity', 0.445),\n",
       "  ('adenovirus', 0.4197),\n",
       "  ('studies including', 0.3582),\n",
       "  ('effects model', 0.3344),\n",
       "  ('metabolic markers', 0.321),\n",
       "  ('sensitivity analysis', 0.3105),\n",
       "  ('infection compared', 0.2978),\n",
       "  ('weight gain', 0.2839),\n",
       "  ('influences risk', 0.2648),\n",
       "  ('analysis confirm', 0.2615),\n",
       "  ('associated accumulation', 0.2475),\n",
       "  ('etiology human', 0.2399),\n",
       "  ('published 1951', 0.2331),\n",
       "  ('significant 95', 0.2248),\n",
       "  ('showed wmd', 0.214),\n",
       "  ('associated abnormal', 0.2046),\n",
       "  ('data extraction', 0.2037),\n",
       "  ('differences relation', 0.1959),\n",
       "  ('conclusion significance', 0.1931),\n",
       "  ('ci 01', 0.1838),\n",
       "  ('56 047', 0.1647),\n",
       "  ('meta', 0.1625),\n",
       "  ('visceral', 0.1553),\n",
       "  ('approaches management', 0.1552),\n",
       "  ('designed prospective', 0.154),\n",
       "  ('clarifying relationship', 0.1467),\n",
       "  ('cochrane', 0.1449),\n",
       "  ('analysis restricted', 0.1419),\n",
       "  ('reports original', 0.1393),\n",
       "  ('model 237', 0.132),\n",
       "  ('cross sectional', 0.1308),\n",
       "  ('cholesterol', 0.1303),\n",
       "  ('weighted mean', 0.1233),\n",
       "  ('64 hdl', 0.1164),\n",
       "  ('searched medline', 0.1147),\n",
       "  ('plays role', 0.1112),\n",
       "  ('pressure 25', 0.0945),\n",
       "  ('adults yielded', 0.092),\n",
       "  ('ors', 0.0825),\n",
       "  ('glucose 08', 0.0804),\n",
       "  ('lead effective', 0.0623),\n",
       "  ('009 increased', 0.0426),\n",
       "  ('18', 0.0319),\n",
       "  ('gain better', 0.0132),\n",
       "  ('using random', 0.0089),\n",
       "  ('22 2012', 0.0084),\n",
       "  ('library', -0.0443),\n",
       "  ('non', -0.0451)],\n",
       " 'MED-1797': [('chickens broilers', 0.5573),\n",
       "  ('chickens compared', 0.5115),\n",
       "  ('chicken orthologues', 0.4926),\n",
       "  ('snps significant', 0.4106),\n",
       "  ('analysed 53', 0.4037),\n",
       "  ('candidate genes', 0.3991),\n",
       "  ('selection meat', 0.3864),\n",
       "  ('lean chickens', 0.3269),\n",
       "  ('associated obesity', 0.3189),\n",
       "  ('birds extreme', 0.3047),\n",
       "  ('animal genetics', 0.3037),\n",
       "  ('searches identified', 0.3004),\n",
       "  ('quantitative genes', 0.2447),\n",
       "  ('mfge8 significant', 0.239),\n",
       "  ('backcross populations', 0.2321),\n",
       "  ('fat globule', 0.2267),\n",
       "  ('orthologues blast', 0.2132),\n",
       "  ('mckusick', 0.209),\n",
       "  ('levels abdominal', 0.1955),\n",
       "  ('genes adrenergic', 0.1814),\n",
       "  ('expression liver', 0.1783),\n",
       "  ('weight used', 0.1759),\n",
       "  ('genes 2011', 0.1753),\n",
       "  ('melanocortin', 0.1699),\n",
       "  ('foundation animal', 0.1678),\n",
       "  ('populations varying', 0.1618),\n",
       "  ('frequencies', 0.16),\n",
       "  ('growth accompanied', 0.1525),\n",
       "  ('significantly higher', 0.1506),\n",
       "  ('traits', 0.147),\n",
       "  ('pcr genes', 0.1445),\n",
       "  ('receptor mc5r', 0.1312),\n",
       "  ('afw adrb2', 0.098),\n",
       "  ('layers following', 0.0949),\n",
       "  ('afw body', 0.0947),\n",
       "  ('identified single', 0.0897),\n",
       "  ('deposition study', 0.0862),\n",
       "  ('international foundation', 0.0828),\n",
       "  ('kaufman syndrome', 0.0815),\n",
       "  ('compared', 0.0766),\n",
       "  ('individuals believe', 0.0746),\n",
       "  ('beta', 0.073),\n",
       "  ('nucleotide', 0.0558),\n",
       "  ('blast', 0.0407),\n",
       "  ('following candidate', 0.0393),\n",
       "  ('real', 0.0283),\n",
       "  ('2011 stichting', 0.0203),\n",
       "  ('lepr', 0.0183),\n",
       "  ('receptor surface', 0.0182),\n",
       "  ('mkks milk', -0.0174)],\n",
       " 'MED-1798': [('antibodies obesity', 0.5481),\n",
       "  ('development obesity', 0.5082),\n",
       "  ('fat accumulation', 0.4522),\n",
       "  ('infections various', 0.4213),\n",
       "  ('infection predisposition', 0.4187),\n",
       "  ('accumulation children', 0.4057),\n",
       "  ('pathogens lead', 0.3745),\n",
       "  ('possible vaccines', 0.3729),\n",
       "  ('genetic inheritance', 0.3616),\n",
       "  ('association childhood', 0.3456),\n",
       "  ('humans incidence', 0.3314),\n",
       "  ('alterations behavioural', 0.3169),\n",
       "  ('incidence seroconversion', 0.3028),\n",
       "  ('environmental causes', 0.2902),\n",
       "  ('important factors', 0.2619),\n",
       "  ('studies humans', 0.2518),\n",
       "  ('studied infectious', 0.2508),\n",
       "  ('lead overweight', 0.2463),\n",
       "  ('potential association', 0.2384),\n",
       "  ('persistent viral', 0.2337),\n",
       "  ('evidence suggests', 0.221),\n",
       "  ('disease progression', 0.2199),\n",
       "  ('endocrine', 0.2147),\n",
       "  ('raised questions', 0.1991),\n",
       "  ('36 antibodies', 0.1983),\n",
       "  ('suffer persistent', 0.1904),\n",
       "  ('animals humans', 0.1862),\n",
       "  ('studies needed', 0.1702),\n",
       "  ('children normal', 0.1657),\n",
       "  ('widely studied', 0.1651),\n",
       "  ('role adenovirus', 0.161),\n",
       "  ('humans potential', 0.1557),\n",
       "  ('significantly frequent', 0.1355),\n",
       "  ('results', 0.1351),\n",
       "  ('drugs', 0.1313),\n",
       "  ('subjects greater', 0.1234),\n",
       "  ('raised', 0.1225),\n",
       "  ('adults', 0.1177),\n",
       "  ('inhibiting disease', 0.1128),\n",
       "  ('literature concerning', 0.1032),\n",
       "  ('leading development', 0.0837),\n",
       "  ('experimental animal', 0.0829),\n",
       "  ('progression copyright', 0.0774),\n",
       "  ('answers reviewed', 0.0377),\n",
       "  ('easily susceptible', 0.0016),\n",
       "  ('rights reserved', -0.0006),\n",
       "  ('copyright 2012', -0.0082),\n",
       "  ('unrelated', -0.0804),\n",
       "  ('agent', -0.0841),\n",
       "  ('does play', -0.1111)],\n",
       " 'MED-1799': [('adenovirus ad', 0.5594),\n",
       "  ('adipogenic inducers', 0.4756),\n",
       "  ('rodent preadipocytes', 0.426),\n",
       "  ('inducers ad', 0.3803),\n",
       "  ('absence adipogenic', 0.3727),\n",
       "  ('compared ad', 0.3608),\n",
       "  ('differentiation lipid', 0.3322),\n",
       "  ('human obesity', 0.3296),\n",
       "  ('hasc adipocyte', 0.3272),\n",
       "  ('receptor fatty', 0.3048),\n",
       "  ('dna adipose', 0.3007),\n",
       "  ('state ad', 0.2389),\n",
       "  ('expression lipoprotein', 0.2343),\n",
       "  ('proliferator activated', 0.2231),\n",
       "  ('dose dependent', 0.2222),\n",
       "  ('rodent', 0.2171),\n",
       "  ('time viral', 0.2095),\n",
       "  ('differentiate compared', 0.2077),\n",
       "  ('presence osteogenic', 0.1941),\n",
       "  ('accumulation investigated', 0.1875),\n",
       "  ('36 significantly', 0.1833),\n",
       "  ('genes', 0.1824),\n",
       "  ('induced', 0.1824),\n",
       "  ('investigated vitro', 0.1764),\n",
       "  ('activated receptor', 0.1747),\n",
       "  ('assess role', 0.1711),\n",
       "  ('manner presence', 0.1707),\n",
       "  ('derived stem', 0.1677),\n",
       "  ('acid binding', 0.1658),\n",
       "  ('causatively correlatively', 0.1648),\n",
       "  ('commitment differentiation', 0.1636),\n",
       "  ('infection significantly', 0.1616),\n",
       "  ('linked animal', 0.1539),\n",
       "  ('cascade ccaat', 0.1419),\n",
       "  ('proof concept', 0.141),\n",
       "  ('unknown indirectly', 0.14),\n",
       "  ('enhancer binding', 0.1277),\n",
       "  ('potential', 0.1239),\n",
       "  ('dependent', 0.119),\n",
       "  ('subjects harboring', 0.112),\n",
       "  ('primary human', 0.1067),\n",
       "  ('lineage', 0.1014),\n",
       "  ('hasc showed', 0.0965),\n",
       "  ('fraction', 0.089),\n",
       "  ('supported increased', 0.0842),\n",
       "  ('stromal cells', 0.0641),\n",
       "  ('tissue natural', 0.0599),\n",
       "  ('negative counterparts', 0.0381),\n",
       "  ('dna negative', 0.0223),\n",
       "  ('greater ability', -0.0185)],\n",
       " 'MED-1800': [('adv36 infection', 0.5402),\n",
       "  ('human adenovirus', 0.4751),\n",
       "  ('obesity children', 0.3063),\n",
       "  ('increasing adipogenesis', 0.3063),\n",
       "  ('neutralization assay', 0.2877),\n",
       "  ('infection associated', 0.2819),\n",
       "  ('presence antibodies', 0.2291),\n",
       "  ('serum prevalence', 0.2054),\n",
       "  ('insulin sensitivity', 0.1939),\n",
       "  ('elisa 1946', 0.1825),\n",
       "  ('diabetic adults', 0.1791),\n",
       "  ('antilipid pharmacological', 0.1615),\n",
       "  ('mildly obese', 0.1557),\n",
       "  ('background experimental', 0.1516),\n",
       "  ('species results', 0.1428),\n",
       "  ('multiple animal', 0.1377),\n",
       "  ('previously associated', 0.1243),\n",
       "  ('characterized individuals', 0.1022),\n",
       "  ('italy association', 0.0956),\n",
       "  ('ir showed', 0.0902),\n",
       "  ('severe', 0.0874),\n",
       "  ('netherlands usa', 0.0841),\n",
       "  ('levels non', 0.0709),\n",
       "  ('natural human', 0.0709),\n",
       "  ('15 20', 0.0681),\n",
       "  ('sensitivity measured', 0.0675),\n",
       "  ('showed higher', 0.0431),\n",
       "  ('population', 0.0368),\n",
       "  ('korea', 0.0321),\n",
       "  ('using novel', 0.0296),\n",
       "  ('2009 paralleled', 0.0273),\n",
       "  ('biopsies associate', 0.0198),\n",
       "  ('including 424', 0.0165),\n",
       "  ('individuals fold', 0.0163),\n",
       "  ('control', 0.0159),\n",
       "  ('08 conclusion', 0.0138),\n",
       "  ('military personnel', 0.0098),\n",
       "  ('blood donors', 0.0061),\n",
       "  ('females compared', -0.0016),\n",
       "  ('positivity lean', -0.0135),\n",
       "  ('detected belgium', -0.0283),\n",
       "  ('homa', -0.0302),\n",
       "  ('89 anonymous', -0.035),\n",
       "  ('males statistically', -0.0477),\n",
       "  ('swedish individuals', -0.0538),\n",
       "  ('1522', -0.0558),\n",
       "  ('living', -0.0656),\n",
       "  ('muscle', -0.0688),\n",
       "  ('south', -0.071),\n",
       "  ('residing central', -0.084)],\n",
       " 'MED-1801': [('chicken fat', 0.5849),\n",
       "  ('meat poultry', 0.5794),\n",
       "  ('poultry instead', 0.5262),\n",
       "  ('function fatty', 0.4136),\n",
       "  ('broiler', 0.4072),\n",
       "  ('level meat', 0.3963),\n",
       "  ('usual birds', 0.3749),\n",
       "  ('recommended eating', 0.3655),\n",
       "  ('increase fat', 0.356),\n",
       "  ('instead lean', 0.3128),\n",
       "  ('birds dha', 0.3032),\n",
       "  ('setting food', 0.2424),\n",
       "  ('synthesized parent', 0.2309),\n",
       "  ('physicians british', 0.226),\n",
       "  ('objective 1976', 0.2241),\n",
       "  ('society recommended', 0.2167),\n",
       "  ('red', 0.2133),\n",
       "  ('situation changed', 0.2045),\n",
       "  ('docosapentaenoic acid', 0.1973),\n",
       "  ('acids especially', 0.1934),\n",
       "  ('protein illogical', 0.1903),\n",
       "  ('obesity epidemic', 0.1899),\n",
       "  ('previous analyses', 0.181),\n",
       "  ('cardiac', 0.176),\n",
       "  ('phospholipids higher', 0.156),\n",
       "  ('eggs', 0.152),\n",
       "  ('reviewed regard', 0.1473),\n",
       "  ('opposed recommendation', 0.1451),\n",
       "  ('energy compared', 0.1419),\n",
       "  ('england', 0.1371),\n",
       "  ('chain view', 0.1362),\n",
       "  ('royal college', 0.1331),\n",
       "  ('estimated emulsification', 0.1328),\n",
       "  ('implications animal', 0.1316),\n",
       "  ('husbandry needs', 0.1292),\n",
       "  ('farms', 0.1254),\n",
       "  ('content standard', 0.1174),\n",
       "  ('traditional', 0.0922),\n",
       "  ('striking increase', 0.0713),\n",
       "  ('snapshot data', 0.0663),\n",
       "  ('design samples', 0.0638),\n",
       "  ('sources long', 0.0455),\n",
       "  ('randomly', 0.0357),\n",
       "  ('football club', 0.0314),\n",
       "  ('2008', 0.0197),\n",
       "  ('welfare human', 0.018),\n",
       "  ('methanol extraction', 0.0055),\n",
       "  ('22 5n', -0.0088),\n",
       "  ('green', -0.0274),\n",
       "  ('sold supermarkets', -0.1107)],\n",
       " 'MED-1802': [('meat intake', 0.5655),\n",
       "  ('study dietary', 0.4174),\n",
       "  ('men bmi', 0.4095),\n",
       "  ('baseline bmi', 0.362),\n",
       "  ('body weight', 0.3579),\n",
       "  ('cohort study', 0.3443),\n",
       "  ('increase bmi', 0.3383),\n",
       "  ('differential bmi', 0.3313),\n",
       "  ('using ffq', 0.3168),\n",
       "  ('consumption body', 0.2947),\n",
       "  ('associations significant', 0.2736),\n",
       "  ('sectional differences', 0.2696),\n",
       "  ('higher intakes', 0.2468),\n",
       "  ('weight modulation', 0.2402),\n",
       "  ('men women', 0.2356),\n",
       "  ('confounders used', 0.2289),\n",
       "  ('limited assessed', 0.21),\n",
       "  ('effect modeling', 0.2028),\n",
       "  ('20 men', 0.1878),\n",
       "  ('change observed', 0.1877),\n",
       "  ('contradictory prospective', 0.1823),\n",
       "  ('stratified analyses', 0.1795),\n",
       "  ('pork minced', 0.1783),\n",
       "  ('2000 analyses', 0.1741),\n",
       "  ('14 60', 0.1685),\n",
       "  ('lower increase', 0.1679),\n",
       "  ('observed men', 0.1655),\n",
       "  ('hypotheses regarding', 0.1427),\n",
       "  ('categories daily', 0.13),\n",
       "  ('fish', 0.1269),\n",
       "  ('yielded mixed', 0.1232),\n",
       "  ('stratifying median', 0.122),\n",
       "  ('kg m²', 0.1206),\n",
       "  ('01 sexes', 0.1142),\n",
       "  ('cross', 0.1142),\n",
       "  ('lowest quintile', 0.112),\n",
       "  ('3902', 0.1051),\n",
       "  ('m² chicken', 0.0995),\n",
       "  ('remained', 0.0715),\n",
       "  ('69 netherlands', 0.0713),\n",
       "  ('36 kg', 0.0673),\n",
       "  ('aged', 0.0599),\n",
       "  ('1986 1992', 0.0559),\n",
       "  ('06', 0.0527),\n",
       "  ('m² 75', 0.0478),\n",
       "  ('red', 0.0344),\n",
       "  ('total fresh', 0.026),\n",
       "  ('47 kg', 0.0175),\n",
       "  ('self', -0.0009),\n",
       "  ('highest vs', -0.0296)],\n",
       " 'MED-1803': [('obesity management', 0.6307),\n",
       "  ('obesity infectious', 0.5706),\n",
       "  ('infections contribute', 0.5066),\n",
       "  ('obesity global', 0.5029),\n",
       "  ('microbes causatively', 0.4604),\n",
       "  ('declared obesity', 0.453),\n",
       "  ('linked obesity', 0.4433),\n",
       "  ('approaches microbes', 0.4322),\n",
       "  ('obesity animals', 0.4233),\n",
       "  ('infectobesity', 0.4062),\n",
       "  ('management approaches', 0.3919),\n",
       "  ('treatment strategies', 0.3802),\n",
       "  ('strategies mainly', 0.379),\n",
       "  ('different prevention', 0.3781),\n",
       "  ('candidate microbes', 0.3592),\n",
       "  ('public health', 0.3258),\n",
       "  ('beings infections', 0.316),\n",
       "  ('obesity entirely', 0.3141),\n",
       "  ('behavioural components', 0.3082),\n",
       "  ('understanding causative', 0.2788),\n",
       "  ('policies needed', 0.2643),\n",
       "  ('disorder', 0.2481),\n",
       "  ('experimental infection', 0.2452),\n",
       "  ('infectious origin', 0.2367),\n",
       "  ('epidemic', 0.2287),\n",
       "  ('importance effective', 0.1887),\n",
       "  ('factors', 0.1725),\n",
       "  ('global', 0.1674),\n",
       "  ('ethical reasons', 0.1113),\n",
       "  ('clinicians', 0.1066),\n",
       "  ('animals', 0.1064),\n",
       "  ('preclude experimental', 0.106),\n",
       "  ('contributions specific', 0.1),\n",
       "  ('mainly target', 0.0966),\n",
       "  ('adipogenic human', 0.0942),\n",
       "  ('alternative', 0.0928),\n",
       "  ('entirely different', 0.0899),\n",
       "  ('available information', 0.0863),\n",
       "  ('marginally effective', 0.08),\n",
       "  ('declared', 0.0656),\n",
       "  ('linked', 0.0503),\n",
       "  ('management copyright', 0.0457),\n",
       "  ('examine comprehensively', 0.0305),\n",
       "  ('adenovirus ad36', 0.0223),\n",
       "  ('used create', 0.022),\n",
       "  ('rights reserved', 0.0163),\n",
       "  ('origin potential', 0.0081),\n",
       "  ('address subtype', 0.006),\n",
       "  ('human', -0.0348),\n",
       "  ('2011 elsevier', -0.0369)],\n",
       " 'MED-1804': [('adv36 infection', 0.5396),\n",
       "  ('adenovirus 36', 0.5135),\n",
       "  ('prevalence adv36', 0.5115),\n",
       "  ('human adenovirus', 0.4976),\n",
       "  ('obesity research', 0.4457),\n",
       "  ('infection obese', 0.4424),\n",
       "  ('animals adv36', 0.4065),\n",
       "  ('virus causes', 0.3731),\n",
       "  ('obesity humans', 0.3723),\n",
       "  ('correlation adv36', 0.3637),\n",
       "  ('correlation obesity', 0.3627),\n",
       "  ('infection experimental', 0.3553),\n",
       "  ('consequences adv36', 0.3474),\n",
       "  ('infection people', 0.3425),\n",
       "  ('infection 30', 0.3171),\n",
       "  ('studies shown', 0.2868),\n",
       "  ('increase prevalence', 0.2695),\n",
       "  ('increasing evidence', 0.2686),\n",
       "  ('obese adult', 0.2684),\n",
       "  ('obesity children', 0.2657),\n",
       "  ('shown prevalence', 0.2629),\n",
       "  ('human studies', 0.2591),\n",
       "  ('animals people', 0.1879),\n",
       "  ('data animals', 0.1795),\n",
       "  ('prevalences consequences', 0.1758),\n",
       "  ('research needed', 0.1709),\n",
       "  ('vs adults', 0.1689),\n",
       "  ('demonstrated contrast', 0.1605),\n",
       "  ('age', 0.1523),\n",
       "  ('published', 0.1196),\n",
       "  ('non obese', 0.1009),\n",
       "  ('children increase', 0.0956),\n",
       "  ('data', 0.0953),\n",
       "  ('humans associated', 0.0829),\n",
       "  ('correlation', 0.0824),\n",
       "  ('total 559', 0.0809),\n",
       "  ('people suggests', 0.0803),\n",
       "  ('explanation apparently', 0.0783),\n",
       "  ('28 compared', 0.0674),\n",
       "  ('contributed worldwide', 0.0626),\n",
       "  ('vs', 0.0592),\n",
       "  ('groups geographic', 0.0535),\n",
       "  ('needed identify', 0.0316),\n",
       "  ('clear data', 0.0107),\n",
       "  ('contributed', 0.0075),\n",
       "  ('human', 0.005),\n",
       "  ('apparently robust', 0.0049),\n",
       "  ('10', -0.0087),\n",
       "  ('greater', -0.0125),\n",
       "  ('total', -0.0146)],\n",
       " 'MED-1806': [('ad36 infection', 0.5682),\n",
       "  ('adenovirus increases', 0.5303),\n",
       "  ('insulin ad36', 0.5271),\n",
       "  ('adiposity improves', 0.4567),\n",
       "  ('infections modulate', 0.3999),\n",
       "  ('obesity diabetes', 0.3937),\n",
       "  ('indices adiposity', 0.3892),\n",
       "  ('indices glycemic', 0.3479),\n",
       "  ('overweight bmi', 0.3079),\n",
       "  ('animal models', 0.268),\n",
       "  ('adults research', 0.2587),\n",
       "  ('infection cross', 0.2519),\n",
       "  ('weight group', 0.2227),\n",
       "  ('antibodies indices', 0.2218),\n",
       "  ('versus uninfected', 0.2076),\n",
       "  ('seropositive seronegative', 0.2016),\n",
       "  ('adjusted', 0.1943),\n",
       "  ('nondiabetic subjects', 0.1938),\n",
       "  ('sectionally associated', 0.1938),\n",
       "  ('metabolic', 0.1859),\n",
       "  ('study strengthens', 0.1762),\n",
       "  ('recognized factors', 0.1555),\n",
       "  ('baseline compared', 0.1485),\n",
       "  ('control humans', 0.1433),\n",
       "  ('effectively combat', 0.1397),\n",
       "  ('years past', 0.137),\n",
       "  ('design methods', 0.1296),\n",
       "  ('attenuates deterioration', 0.127),\n",
       "  ('bmi 30', 0.1191),\n",
       "  ('panoptically study', 0.1074),\n",
       "  ('25 kg', 0.1057),\n",
       "  ('control animal', 0.1044),\n",
       "  ('levels subgroup', 0.1035),\n",
       "  ('natural', 0.0952),\n",
       "  ('subjects showed', 0.0939),\n",
       "  ('multiple tests', 0.0925),\n",
       "  ('differences', 0.0763),\n",
       "  ('age sex', 0.0762),\n",
       "  ('raises possibility', 0.0702),\n",
       "  ('m2 longitudinally', 0.0651),\n",
       "  ('plausibility humans', 0.0639),\n",
       "  ('lower fasting', 0.0621),\n",
       "  ('kg m2', 0.0511),\n",
       "  ('performed conclusions', 0.0411),\n",
       "  ('14 greater', 0.0406),\n",
       "  ('hispanic men', 0.0205),\n",
       "  ('hoc presence', 0.0122),\n",
       "  ('women 400', 0.011),\n",
       "  ('human', -0.0198),\n",
       "  ('10', -0.0291)],\n",
       " 'MED-1807': [('dietary protein', 0.7055),\n",
       "  ('increase thermogenesis', 0.5382),\n",
       "  ('macronutrients beneficial', 0.5363),\n",
       "  ('weight gain', 0.5281),\n",
       "  ('attributable protein', 0.4816),\n",
       "  ('cancer nutrition', 0.458),\n",
       "  ('intakes total', 0.4473),\n",
       "  ('prevention weight', 0.4295),\n",
       "  ('higher intake', 0.4176),\n",
       "  ('satiety', 0.3884),\n",
       "  ('association intake', 0.371),\n",
       "  ('food', 0.3527),\n",
       "  ('especially meat', 0.332),\n",
       "  ('associations showed', 0.3208),\n",
       "  ('subgroups protein', 0.3148),\n",
       "  ('associations waist', 0.3039),\n",
       "  ('89 432', 0.2864),\n",
       "  ('anthropometrics', 0.2852),\n",
       "  ('positively associated', 0.2711),\n",
       "  ('estimates considered', 0.261),\n",
       "  ('multiple regression', 0.254),\n",
       "  ('european prospective', 0.2219),\n",
       "  ('wc methods', 0.2186),\n",
       "  ('poultry', 0.2037),\n",
       "  ('dairy sources', 0.1887),\n",
       "  ('considered justified', 0.1872),\n",
       "  ('associated lower', 0.1822),\n",
       "  ('time used', 0.1815),\n",
       "  ('study contrast', 0.1807),\n",
       "  ('sources changes', 0.177),\n",
       "  ('mainly attributable', 0.1737),\n",
       "  ('factors baseline', 0.1665),\n",
       "  ('plant', 0.164),\n",
       "  ('demographic lifestyle', 0.1609),\n",
       "  ('countries participating', 0.1579),\n",
       "  ('results higher', 0.15),\n",
       "  ('red processed', 0.1467),\n",
       "  ('associated long', 0.1254),\n",
       "  ('gain clear', 0.1238),\n",
       "  ('maintenance objective', 0.1158),\n",
       "  ('investigated', 0.1037),\n",
       "  ('centre specific', 0.0982),\n",
       "  ('cm year', 0.0931),\n",
       "  ('meta', 0.0926),\n",
       "  ('gain genders', 0.08),\n",
       "  ('obtain pooled', 0.073),\n",
       "  ('animal origin', 0.0651),\n",
       "  ('used random', 0.0543),\n",
       "  ('fish', 0.025),\n",
       "  ('men', 0.0196)],\n",
       " 'MED-1808': [('adenovirus 36', 0.5629),\n",
       "  ('human adenovirus', 0.4998),\n",
       "  ('obesity ad', 0.4689),\n",
       "  ('adipocytes ad', 0.4138),\n",
       "  ('induce obesity', 0.4119),\n",
       "  ('obese adults', 0.3876),\n",
       "  ('prevalence ad', 0.3824),\n",
       "  ('childhood obesity', 0.3551),\n",
       "  ('36 prevalence', 0.3458),\n",
       "  ('infection bmi', 0.3311),\n",
       "  ('lipogenic', 0.2948),\n",
       "  ('korean children', 0.2843),\n",
       "  ('effect viral', 0.2764),\n",
       "  ('type diabetes', 0.2705),\n",
       "  ('adults prevalence', 0.2504),\n",
       "  ('epidemic children', 0.2428),\n",
       "  ('infected versus', 0.238),\n",
       "  ('total 30', 0.2146),\n",
       "  ('age', 0.1963),\n",
       "  ('65 01', 0.1945),\n",
       "  ('enzymes host', 0.1863),\n",
       "  ('e4orf1 gene', 0.1569),\n",
       "  ('cm 05', 0.1545),\n",
       "  ('determine prevalence', 0.1545),\n",
       "  ('cardiovascular', 0.1515),\n",
       "  ('uninfected children', 0.1381),\n",
       "  ('thought', 0.1364),\n",
       "  ('objectives determine', 0.1238),\n",
       "  ('direct', 0.1223),\n",
       "  ('gene', 0.1208),\n",
       "  ('factors significantly', 0.117),\n",
       "  ('annual school', 0.1133),\n",
       "  ('01 waist', 0.1085),\n",
       "  ('25', 0.1065),\n",
       "  ('range years', 0.0741),\n",
       "  ('background human', 0.0731),\n",
       "  ('neutralization assay', 0.0707),\n",
       "  ('different conclusions', 0.0597),\n",
       "  ('played', 0.055),\n",
       "  ('serum', 0.0512),\n",
       "  ('age 14', 0.0504),\n",
       "  ('higher', 0.0472),\n",
       "  ('clinic visit', 0.0462),\n",
       "  ('70 negative', 0.0347),\n",
       "  ('subjects', 0.0208),\n",
       "  ('vs 90', 0.0054),\n",
       "  ('physical exam', -0.0082),\n",
       "  ('circumferences 96', -0.0127),\n",
       "  ('common', -0.0205),\n",
       "  ('59 significantly', -0.0394)],\n",
       " 'MED-1810': [('adiposity chickens', 0.5077),\n",
       "  ('chicken model', 0.5057),\n",
       "  ('chickens transmissibility', 0.4798),\n",
       "  ('human adenovirus', 0.4377),\n",
       "  ('lower ad', 0.345),\n",
       "  ('tg animals', 0.3193),\n",
       "  ('36 infection', 0.3188),\n",
       "  ('adiposity paradoxically', 0.299),\n",
       "  ('animals objective', 0.2862),\n",
       "  ('experiment groups', 0.284),\n",
       "  ('viral', 0.2615),\n",
       "  ('serum cholesterol', 0.2449),\n",
       "  ('fat separated', 0.2389),\n",
       "  ('model design', 0.2385),\n",
       "  ('groups inoculated', 0.2317),\n",
       "  ('tg significantly', 0.2043),\n",
       "  ('weeks post', 0.2018),\n",
       "  ('experiment demonstrated', 0.1998),\n",
       "  ('noted visceral', 0.1961),\n",
       "  ('sharing cage', 0.1855),\n",
       "  ('presence ad', 0.1768),\n",
       "  ('borne', 0.1766),\n",
       "  ('housed', 0.1719),\n",
       "  ('weighed results', 0.1585),\n",
       "  ('chol significantly', 0.1579),\n",
       "  ('previously reported', 0.1576),\n",
       "  ('intranasally', 0.1523),\n",
       "  ('infection transmitted', 0.15),\n",
       "  ('transmissibility', 0.1485),\n",
       "  ('wing veins', 0.1309),\n",
       "  ('drawn body', 0.127),\n",
       "  ('uninoculated', 0.1145),\n",
       "  ('control donors', 0.1121),\n",
       "  ('media control', 0.1107),\n",
       "  ('25 days', 0.1105),\n",
       "  ('concerns possibility', 0.109),\n",
       "  ('later groups', 0.1038),\n",
       "  ('16 blood', 0.095),\n",
       "  ('levels', 0.0849),\n",
       "  ('samples used', 0.0797),\n",
       "  ('isolated 12', 0.0702),\n",
       "  ('induces', 0.0679),\n",
       "  ('dna persisted', 0.0571),\n",
       "  ('conclusion seen', 0.0559),\n",
       "  ('selected randomly', 0.0393),\n",
       "  ('sacrifice', 0.0246),\n",
       "  ('days', 0.0213),\n",
       "  ('humans needs', -0.0245),\n",
       "  ('mates', -0.047),\n",
       "  ('receivers respectively', -0.0716)],\n",
       " 'MED-1811': [('curcumin theracurmin', 0.6713),\n",
       "  ('curcumin promising', 0.6276),\n",
       "  ('plasma curcumin', 0.5675),\n",
       "  ('promising anticancer', 0.3979),\n",
       "  ('bioavailability major', 0.3878),\n",
       "  ('poor bioavailability', 0.3836),\n",
       "  ('theracurmin cancer', 0.3773),\n",
       "  ('pharmacokinetics data', 0.3454),\n",
       "  ('preclinical studies', 0.344),\n",
       "  ('drug', 0.3267),\n",
       "  ('single administration', 0.3137),\n",
       "  ('efficacy', 0.2907),\n",
       "  ('orally administered', 0.2785),\n",
       "  ('starting dose', 0.2715),\n",
       "  ('chemotherapy', 0.2475),\n",
       "  ('administration months', 0.2282),\n",
       "  ('studies demonstrated', 0.2192),\n",
       "  ('obstacle clinical', 0.2127),\n",
       "  ('volunteers study', 0.1863),\n",
       "  ('concentrations', 0.1774),\n",
       "  ('repetitive systemic', 0.165),\n",
       "  ('patients failed', 0.1598),\n",
       "  ('179', 0.156),\n",
       "  ('safely escalated', 0.1446),\n",
       "  ('324 ng', 0.1374),\n",
       "  ('failed standard', 0.1355),\n",
       "  ('overcome problem', 0.1352),\n",
       "  ('patients safely', 0.1275),\n",
       "  ('reported high', 0.1237),\n",
       "  ('standard gemcitabine', 0.119),\n",
       "  ('background growing', 0.1104),\n",
       "  ('ng ml', 0.1047),\n",
       "  ('levels median', 0.0983),\n",
       "  ('evaluate safety', 0.0981),\n",
       "  ('achieved single', 0.0808),\n",
       "  ('developed new', 0.0768),\n",
       "  ('380', 0.0758),\n",
       "  ('based previous', 0.0717),\n",
       "  ('containing 200', 0.0696),\n",
       "  ('day standard', 0.0648),\n",
       "  ('contained', 0.048),\n",
       "  ('biliary tract', 0.0459),\n",
       "  ('healthy', 0.0455),\n",
       "  ('quality life', 0.0394),\n",
       "  ('activity cytokine', 0.0387),\n",
       "  ('unexpected adverse', 0.0119),\n",
       "  ('nf κb', -0.0009),\n",
       "  ('did', -0.0078),\n",
       "  ('440', -0.0193),\n",
       "  ('47 029', -0.0599)],\n",
       " 'MED-1812': [('studies foods', 0.5662),\n",
       "  ('diet pancreas', 0.4665),\n",
       "  ('risk dietary', 0.4499),\n",
       "  ('pancreatic cancer', 0.426),\n",
       "  ('nutrients suggested', 0.4059),\n",
       "  ('consumption vegetables', 0.388),\n",
       "  ('cancer risk', 0.3479),\n",
       "  ('consumption meat', 0.3387),\n",
       "  ('epidemiologic studies', 0.3332),\n",
       "  ('total fat', 0.3219),\n",
       "  ('associations diabetes', 0.2993),\n",
       "  ('comparisons limited', 0.2883),\n",
       "  ('egg coffee', 0.2654),\n",
       "  ('beans', 0.2509),\n",
       "  ('consumption raw', 0.2248),\n",
       "  ('control studies', 0.2189),\n",
       "  ('findings suggest', 0.2189),\n",
       "  ('increasing consumption', 0.2151),\n",
       "  ('abdominal', 0.208),\n",
       "  ('include ecologic', 0.2062),\n",
       "  ('associated decreased', 0.1988),\n",
       "  ('positive associations', 0.1976),\n",
       "  ('duodenal', 0.1926),\n",
       "  ('lentils peas', 0.1803),\n",
       "  ('sugar', 0.1754),\n",
       "  ('dried fruit', 0.1739),\n",
       "  ('butter', 0.1677),\n",
       "  ('1983 deaths', 0.1516),\n",
       "  ('animal protein', 0.1511),\n",
       "  ('various allergic', 0.1506),\n",
       "  ('habits medical', 0.1474),\n",
       "  ('tonsillectomy', 0.1407),\n",
       "  ('suggestive', 0.1349),\n",
       "  ('products furthermore', 0.133),\n",
       "  ('cigarette smoking', 0.1285),\n",
       "  ('72 men', 0.1257),\n",
       "  ('evaluated prospective', 0.1253),\n",
       "  ('prior history', 0.1188),\n",
       "  ('period compared', 0.118),\n",
       "  ('000 california', 0.0958),\n",
       "  ('whites', 0.0943),\n",
       "  ('content important', 0.093),\n",
       "  ('seventh day', 0.0791),\n",
       "  ('mortality ratio', 0.0735),\n",
       "  ('inhibitor content', 0.0576),\n",
       "  ('adventists', 0.0556),\n",
       "  ('90 women', 0.0497),\n",
       "  ('34 000', 0.0364),\n",
       "  ('1976', 0.0139),\n",
       "  ('attendant', -0.0098)],\n",
       " 'MED-1813': [('pancreatic cancer', 0.5715),\n",
       "  ('gemcitabine erlotinib', 0.5093),\n",
       "  ('cancer lethal', 0.4088),\n",
       "  ('toxicities observed', 0.3769),\n",
       "  ('curcumin tolerated', 0.372),\n",
       "  ('curcumin diferuloylmethane', 0.3692),\n",
       "  ('tumor regression', 0.3513),\n",
       "  ('cancer experimental', 0.3403),\n",
       "  ('approved therapies', 0.305),\n",
       "  ('10 patients', 0.267),\n",
       "  ('biological activity', 0.2558),\n",
       "  ('conclusions oral', 0.2489),\n",
       "  ('cyclooxygenase phosphorylated', 0.2298),\n",
       "  ('detectable drug', 0.2229),\n",
       "  ('bioavailability patients', 0.218),\n",
       "  ('daily disease', 0.2079),\n",
       "  ('design patients', 0.1949),\n",
       "  ('showed clinical', 0.1867),\n",
       "  ('factor kappab', 0.1805),\n",
       "  ('stable disease', 0.1673),\n",
       "  ('limited absorption', 0.1482),\n",
       "  ('lethal food', 0.1441),\n",
       "  ('patient brief', 0.1264),\n",
       "  ('il receptor', 0.1257),\n",
       "  ('evaluable response', 0.1227),\n",
       "  ('glucuronide sulfate', 0.1095),\n",
       "  ('plant derived', 0.1034),\n",
       "  ('potent nuclear', 0.1024),\n",
       "  ('purpose', 0.0913),\n",
       "  ('suggesting poor', 0.087),\n",
       "  ('constant weeks', 0.0857),\n",
       "  ('activity ongoing', 0.0681),\n",
       "  ('administration', 0.0523),\n",
       "  ('peaked', 0.0521),\n",
       "  ('mononuclear cell', 0.0414),\n",
       "  ('antagonists peripheral', 0.0394),\n",
       "  ('state levels', 0.0378),\n",
       "  ('ml remained', 0.0376),\n",
       "  ('73 accompanied', 0.03),\n",
       "  ('transducer activator', 0.0251),\n",
       "  ('conjugate forms', 0.0215),\n",
       "  ('transcription peripheral', 0.0207),\n",
       "  ('interpatient', 0.0179),\n",
       "  ('fold', 0.0158),\n",
       "  ('despite', 0.0149),\n",
       "  ('peaked 22', 0.0106),\n",
       "  ('18 months', -0.0165),\n",
       "  ('volunteers considerable', -0.0335),\n",
       "  ('months serum', -0.0352),\n",
       "  ('41 ng', -0.0865)],\n",
       " 'MED-1814': [('pancreatic cancer', 0.6459),\n",
       "  ('risk pancreatic', 0.6138),\n",
       "  ('cancer risk', 0.5073),\n",
       "  ('modifiable risk', 0.4165),\n",
       "  ('component analysis', 0.3742),\n",
       "  ('increased risk', 0.3274),\n",
       "  ('potato chips', 0.3083),\n",
       "  ('high fat', 0.307),\n",
       "  ('impact population', 0.3044),\n",
       "  ('logistic regression', 0.2959),\n",
       "  ('chronic diseases', 0.2944),\n",
       "  ('diseases consuming', 0.2902),\n",
       "  ('public health', 0.2633),\n",
       "  ('greater intake', 0.2495),\n",
       "  ('factors substantial', 0.2253),\n",
       "  ('processed meats', 0.2225),\n",
       "  ('based foods', 0.2143),\n",
       "  ('trend 04', 0.2132),\n",
       "  ('case control', 0.2073),\n",
       "  ('risk women', 0.207),\n",
       "  ('risk consistent', 0.2057),\n",
       "  ('poultry', 0.2009),\n",
       "  ('sugary beverages', 0.2008),\n",
       "  ('principal', 0.194),\n",
       "  ('diet lower', 0.1815),\n",
       "  ('pattern characterized', 0.1799),\n",
       "  ('008 associated', 0.1782),\n",
       "  ('1701 controls', 0.1737),\n",
       "  ('95 ci', 0.1728),\n",
       "  ('532 cases', 0.1706),\n",
       "  ('examine particular', 0.1694),\n",
       "  ('associated fold', 0.1577),\n",
       "  ('models examine', 0.1541),\n",
       "  ('factors prudent', 0.1506),\n",
       "  ('lethal identifying', 0.1496),\n",
       "  ('multivariable unconditional', 0.1445),\n",
       "  ('eggs refined', 0.1295),\n",
       "  ('fish', 0.1214),\n",
       "  ('90 trend', 0.1178),\n",
       "  ('intake red', 0.1078),\n",
       "  ('quintiles', 0.1041),\n",
       "  ('31 84', 0.0958),\n",
       "  ('plant based', 0.0936),\n",
       "  ('reduction', 0.0918),\n",
       "  ('dairy associated', 0.0903),\n",
       "  ('known', 0.0823),\n",
       "  ('western', 0.062),\n",
       "  ('upper', 0.0579),\n",
       "  ('women men', 0.0295),\n",
       "  ('approximate 50', 0.0229)],\n",
       " 'MED-1817': [('pancreatic cancer', 0.5514),\n",
       "  ('consumption pancreatic', 0.4853),\n",
       "  ('cancer risk', 0.4466),\n",
       "  ('cancer nutrition', 0.4338),\n",
       "  ('cancer fourth', 0.402),\n",
       "  ('fish consumption', 0.3933),\n",
       "  ('cancer european', 0.3912),\n",
       "  ('world cancer', 0.3397),\n",
       "  ('meat rr', 0.3253),\n",
       "  ('poultry consumption', 0.3027),\n",
       "  ('epic participants', 0.2972),\n",
       "  ('lifestyle etiology', 0.2796),\n",
       "  ('consumption tended', 0.2745),\n",
       "  ('14 processed', 0.2732),\n",
       "  ('contribution diet', 0.2683),\n",
       "  ('common cause', 0.2673),\n",
       "  ('10 european', 0.2542),\n",
       "  ('analysis 2008', 0.2457),\n",
       "  ('countries recruited', 0.2381),\n",
       "  ('included analysis', 0.2247),\n",
       "  ('prospective investigation', 0.2152),\n",
       "  ('death worldwide', 0.2139),\n",
       "  ('cis computed', 0.1958),\n",
       "  ('models consumption', 0.1942),\n",
       "  ('associated increased', 0.1898),\n",
       "  ('2012 uicc', 0.1871),\n",
       "  ('large geographical', 0.1834),\n",
       "  ('84 association', 0.1795),\n",
       "  ('total 477', 0.1736),\n",
       "  ('2008 865', 0.1724),\n",
       "  ('202 epic', 0.1705),\n",
       "  ('using multivariable', 0.1515),\n",
       "  ('risks rrs', 0.1422),\n",
       "  ('ci 71', 0.1366),\n",
       "  ('variation implies', 0.1268),\n",
       "  ('positive association', 0.1212),\n",
       "  ('2000 included', 0.1136),\n",
       "  ('rr 50', 0.1127),\n",
       "  ('hazard regression', 0.105),\n",
       "  ('day 72', 0.1045),\n",
       "  ('62 results', 0.0928),\n",
       "  ('research fund', 0.0781),\n",
       "  ('findings copyright', 0.063),\n",
       "  ('nonendocrine', 0.0543),\n",
       "  ('recruited 1992', 0.0484),\n",
       "  ('day 93', 0.0441),\n",
       "  ('observed calibrated', 0.0378),\n",
       "  ('cox', 0.0322),\n",
       "  ('finding contradicts', 0.0137),\n",
       "  ('previous', -0.0038)],\n",
       " 'MED-1818': [('nutrients pancreatic', 0.4785),\n",
       "  ('dietary patterns', 0.4333),\n",
       "  ('combinations foods', 0.42),\n",
       "  ('intake population', 0.3762),\n",
       "  ('cancer risk', 0.3173),\n",
       "  ('variance nutrient', 0.2902),\n",
       "  ('purpose data', 0.2877),\n",
       "  ('fruit vegetables', 0.2582),\n",
       "  ('emerged vitamins', 0.2582),\n",
       "  ('potentially associated', 0.2515),\n",
       "  ('factor analysis', 0.2398),\n",
       "  ('refined cereals', 0.2346),\n",
       "  ('derived italian', 0.2334),\n",
       "  ('high consumption', 0.2148),\n",
       "  ('28 major', 0.2098),\n",
       "  ('fiber starch', 0.2062),\n",
       "  ('allowing patterns', 0.2045),\n",
       "  ('frequency questionnaire', 0.2),\n",
       "  ('inverse association', 0.1979),\n",
       "  ('logistic regression', 0.1966),\n",
       "  ('positive associations', 0.1889),\n",
       "  ('consumption meat', 0.185),\n",
       "  ('adjusted sociodemographic', 0.1821),\n",
       "  ('cases controls', 0.1661),\n",
       "  ('sugars positively', 0.149),\n",
       "  ('add information', 0.1429),\n",
       "  ('rich explain', 0.1355),\n",
       "  ('products', 0.1275),\n",
       "  ('86 association', 0.1262),\n",
       "  ('principal', 0.1239),\n",
       "  ('used estimate', 0.1215),\n",
       "  ('ci 71', 0.1166),\n",
       "  ('78 conclusions', 0.1111),\n",
       "  ('non neoplastic', 0.0965),\n",
       "  ('products unsaturated', 0.0958),\n",
       "  ('population allowing', 0.0825),\n",
       "  ('326 incident', 0.0775),\n",
       "  ('lowest quartiles', 0.0774),\n",
       "  ('exploratory', 0.0732),\n",
       "  ('role combinations', 0.0623),\n",
       "  ('652 frequency', 0.0601),\n",
       "  ('hospital', 0.0353),\n",
       "  ('13 95', 0.0347),\n",
       "  ('35', 0.0286),\n",
       "  ('02', 0.0112),\n",
       "  ('confidence', -0.0025),\n",
       "  ('2013 elsevier', -0.0228),\n",
       "  ('associated copyright', -0.0258),\n",
       "  ('named animal', -0.079),\n",
       "  ('19 69', -0.0832)],\n",
       " 'MED-1819': [('combination gemcitabine', 0.6997),\n",
       "  ('gemcitabine turmeric', 0.661),\n",
       "  ('gemcitabine tf', 0.6452),\n",
       "  ('resistant gemcitabine', 0.6318),\n",
       "  ('cancer drug', 0.4863),\n",
       "  ('pancreatic carcinoma', 0.4452),\n",
       "  ('chemotherapeutic drugs', 0.4316),\n",
       "  ('investigated cytotoxic', 0.3801),\n",
       "  ('cytotoxicity curcumin', 0.3606),\n",
       "  ('synergistic ic90', 0.319),\n",
       "  ('effect combination', 0.2829),\n",
       "  ('respectively ic50', 0.2795),\n",
       "  ('superior cytotoxicity', 0.2779),\n",
       "  ('cancer', 0.2711),\n",
       "  ('cytotoxic bxpc3', 0.267),\n",
       "  ('extract turmeric', 0.2655),\n",
       "  ('tf synergistic', 0.2388),\n",
       "  ('used treatment', 0.2252),\n",
       "  ('drug widely', 0.1995),\n",
       "  ('cells resistant', 0.186),\n",
       "  ('48 pancreatic', 0.1843),\n",
       "  ('combination nuclear', 0.1725),\n",
       "  ('tf supercritical', 0.166),\n",
       "  ('values 050', 0.1545),\n",
       "  ('cell lines', 0.15),\n",
       "  ('single agent', 0.1428),\n",
       "  ('increased inhibitory', 0.1385),\n",
       "  ('050 183', 0.1297),\n",
       "  ('panc tf', 0.0998),\n",
       "  ('kappab activity', 0.0934),\n",
       "  ('hydroethanolic', 0.0927),\n",
       "  ('induced cell', 0.0919),\n",
       "  ('lower concentrations', 0.0898),\n",
       "  ('100 microg', 0.0848),\n",
       "  ('strong synergism', 0.0809),\n",
       "  ('ml combination', 0.0782),\n",
       "  ('index ci', 0.0746),\n",
       "  ('data showed', 0.0724),\n",
       "  ('22 microg', 0.0655),\n",
       "  ('significantly limited', 0.0524),\n",
       "  ('calcusyn analysis', 0.0324),\n",
       "  ('line 03', 0.0321),\n",
       "  ('signal transducer', 0.0288),\n",
       "  ('transcription', 0.0227),\n",
       "  ('value cell', 0.0221),\n",
       "  ('efficiency significantly', 0.0112),\n",
       "  ('death 96', 0.0019),\n",
       "  ('microg', -0.0057),\n",
       "  ('respectively superior', -0.0456),\n",
       "  ('ml 30', -0.0819)],\n",
       " 'MED-1820': [('significance gemcitabine', 0.5876),\n",
       "  ('erlotinib comparison', 0.445),\n",
       "  ('pancreatic cancer', 0.4328),\n",
       "  ('studies containing', 0.4033),\n",
       "  ('systematically searched', 0.3542),\n",
       "  ('relevant publications', 0.3518),\n",
       "  ('available evidences', 0.3476),\n",
       "  ('included data', 0.3454),\n",
       "  ('pubmed embase', 0.3362),\n",
       "  ('cancer methodology', 0.325),\n",
       "  ('cochrane', 0.3153),\n",
       "  ('principal findings', 0.3027),\n",
       "  ('library abstracts', 0.2919),\n",
       "  ('treatment conclusions', 0.2722),\n",
       "  ('aims comprehensively', 0.2534),\n",
       "  ('efficacy compared', 0.2534),\n",
       "  ('major conferences', 0.2468),\n",
       "  ('reporting objective', 0.2463),\n",
       "  ('using meta', 0.2438),\n",
       "  ('patients', 0.2171),\n",
       "  ('adverse events', 0.1986),\n",
       "  ('summarize currently', 0.1923),\n",
       "  ('treating advanced', 0.1883),\n",
       "  ('disease control', 0.1839),\n",
       "  ('survival rates', 0.181),\n",
       "  ('safety profile', 0.1787),\n",
       "  ('events included', 0.1669),\n",
       "  ('incidences total', 0.1598),\n",
       "  ('model data', 0.1496),\n",
       "  ('needed specific', 0.1355),\n",
       "  ('rash diarrhea', 0.1352),\n",
       "  ('robust results', 0.1342),\n",
       "  ('events leucopenia', 0.1141),\n",
       "  ('meaningful additive', 0.1135),\n",
       "  ('thrombocytopenia anaemia', 0.1097),\n",
       "  ('reported median', 0.1055),\n",
       "  ('12 months', 0.1024),\n",
       "  ('descriptively sixteen', 0.1017),\n",
       "  ('year', 0.0934),\n",
       "  ('25 83', 0.0925),\n",
       "  ('stomatitis', 0.0878),\n",
       "  ('progression free', 0.0729),\n",
       "  ('analyst', 0.0592),\n",
       "  ('liver injury', 0.0458),\n",
       "  ('308', 0.0297),\n",
       "  ('62 respectively', 0.025),\n",
       "  ('new option', 0.0072),\n",
       "  ('software random', -0.0262),\n",
       "  ('significantly longer', -0.0337),\n",
       "  ('months 20', -0.0778)],\n",
       " 'MED-1825': [('flax efficacy', 0.6032),\n",
       "  ('improving menopausal', 0.5012),\n",
       "  ('possess phytogestrogenic', 0.4175),\n",
       "  ('lignan linolenic', 0.362),\n",
       "  ('fiber content', 0.3121),\n",
       "  ('supplement', 0.3068),\n",
       "  ('food dietary', 0.3062),\n",
       "  ('anti inflammatory', 0.2838),\n",
       "  ('efficacy improving', 0.2782),\n",
       "  ('hormone modulating', 0.2608),\n",
       "  ('components possess', 0.2087),\n",
       "  ('effects hot', 0.1939),\n",
       "  ('symptomatology seen', 0.1938),\n",
       "  ('angiogenic activity', 0.1888),\n",
       "  ('better mental', 0.1726),\n",
       "  ('flashes cell', 0.1683),\n",
       "  ('included total', 0.168),\n",
       "  ('effects breast', 0.1658),\n",
       "  ('suggests associations', 0.161),\n",
       "  ('health aor', 0.1558),\n",
       "  ('interventional observational', 0.1533),\n",
       "  ('patients conclusions', 0.1525),\n",
       "  ('cytomorphology mammographic', 0.1414),\n",
       "  ('women living', 0.1384),\n",
       "  ('background', 0.1384),\n",
       "  ('doses 25', 0.1374),\n",
       "  ('studies nonsignificant', 0.1348),\n",
       "  ('cancer mortality', 0.132),\n",
       "  ('50 mg', 0.122),\n",
       "  ('amed inception', 0.1113),\n",
       "  ('embase cochrane', 0.1111),\n",
       "  ('compared placebo', 0.1093),\n",
       "  ('recurrence methods', 0.1071),\n",
       "  ('risk primary', 0.106),\n",
       "  ('05 decreased', 0.1049),\n",
       "  ('uncontrolled biomarker', 0.1012),\n",
       "  ('increased', 0.1005),\n",
       "  ('mg secoisolariciresinol', 0.0949),\n",
       "  ('adjusted', 0.0896),\n",
       "  ('her2', 0.0871),\n",
       "  ('january 2013', 0.085),\n",
       "  ('confidence interval', 0.0811),\n",
       "  ('aor 76', 0.0774),\n",
       "  ('apoptotic index', 0.0692),\n",
       "  ('diglycoside daily', 0.0556),\n",
       "  ('67 index', 0.0381),\n",
       "  ('known', -0.0069),\n",
       "  ('library amed', -0.0247),\n",
       "  ('1892', -0.0432),\n",
       "  ('10 studies', -0.0568)],\n",
       " 'MED-1826': [('flaxseed intake', 0.6871),\n",
       "  ('flaxseed breast', 0.6004),\n",
       "  ('flax bread', 0.4565),\n",
       "  ('women diet', 0.4177),\n",
       "  ('class phytoestrogens', 0.4116),\n",
       "  ('risk dietary', 0.3622),\n",
       "  ('women breast', 0.3316),\n",
       "  ('flax', 0.327),\n",
       "  ('health study', 0.3184),\n",
       "  ('women participated', 0.3183),\n",
       "  ('frequency questionnaire', 0.3182),\n",
       "  ('999 women', 0.2989),\n",
       "  ('cancer prevention', 0.2822),\n",
       "  ('methods food', 0.2786),\n",
       "  ('associations consumption', 0.2599),\n",
       "  ('lignans', 0.2549),\n",
       "  ('investigate associations', 0.2527),\n",
       "  ('control women', 0.2523),\n",
       "  ('measure consumption', 0.2358),\n",
       "  ('canadian study', 0.2311),\n",
       "  ('ontario women', 0.2301),\n",
       "  ('richest source', 0.1933),\n",
       "  ('consumed weekly', 0.1782),\n",
       "  ('bread', 0.1759),\n",
       "  ('study 2002', 0.1658),\n",
       "  ('confidence interval', 0.1619),\n",
       "  ('assessed results', 0.1557),\n",
       "  ('risk methods', 0.146),\n",
       "  ('odds ratio', 0.1407),\n",
       "  ('regression used', 0.1295),\n",
       "  ('confounding established', 0.127),\n",
       "  ('89 conclusions', 0.1147),\n",
       "  ('97 consumption', 0.1029),\n",
       "  ('370 healthy', 0.1004),\n",
       "  ('significant', 0.0988),\n",
       "  ('source', 0.0951),\n",
       "  ('knowledge', 0.0821),\n",
       "  ('modifiable', 0.0799),\n",
       "  ('82 95', 0.0797),\n",
       "  ('ci 69', 0.0744),\n",
       "  ('19 variables', 0.074),\n",
       "  ('2003 logistic', 0.0696),\n",
       "  ('class', 0.0411),\n",
       "  ('significant reduction', 0.0319),\n",
       "  ('finding public', 0.0317),\n",
       "  ('importance respect', 0.0293),\n",
       "  ('weekly 21', 0.0242),\n",
       "  ('suspected', 0.0211),\n",
       "  ('report association', 0.0184),\n",
       "  ('control', 0.0145)],\n",
       " 'MED-1827': [('actin cytoskeleton', 0.4649),\n",
       "  ('cell invasion', 0.4311),\n",
       "  ('lignan flax', 0.4293),\n",
       "  ('enterolactone inhibit', 0.3704),\n",
       "  ('adhesion cell', 0.3656),\n",
       "  ('filopodia lamellipodia', 0.3395),\n",
       "  ('mmp9 mmp11', 0.3351),\n",
       "  ('enterodiol human', 0.3312),\n",
       "  ('related metalloproteinases', 0.31),\n",
       "  ('cancer metastasis', 0.2977),\n",
       "  ('inhibit adhesion', 0.2925),\n",
       "  ('performed mcf', 0.2743),\n",
       "  ('motility evidenced', 0.2581),\n",
       "  ('mmp14 genes', 0.2318),\n",
       "  ('leading edges', 0.2304),\n",
       "  ('dietary intake', 0.2256),\n",
       "  ('breast', 0.2177),\n",
       "  ('structures polymerization', 0.2168),\n",
       "  ('mda mb231', 0.2109),\n",
       "  ('el affects', 0.2072),\n",
       "  ('lines results', 0.2039),\n",
       "  ('filaments', 0.2024),\n",
       "  ('significantly regulates', 0.2009),\n",
       "  ('involves multiple', 0.2),\n",
       "  ('cell lines', 0.1998),\n",
       "  ('vitro significantly', 0.1985),\n",
       "  ('process involves', 0.1966),\n",
       "  ('protrusion traction', 0.195),\n",
       "  ('confocal imaging', 0.1812),\n",
       "  ('significant alteration', 0.1689),\n",
       "  ('inhibition assay', 0.1621),\n",
       "  ('results supported', 0.1592),\n",
       "  ('generating mechanisms', 0.1499),\n",
       "  ('expressions significant', 0.1385),\n",
       "  ('matrix', 0.1381),\n",
       "  ('retraction regulating', 0.1296),\n",
       "  ('chain reaction', 0.1293),\n",
       "  ('gets converted', 0.1204),\n",
       "  ('gene', 0.1203),\n",
       "  ('conclusions suggest', 0.1174),\n",
       "  ('materials methods', 0.1087),\n",
       "  ('seed gets', 0.1036),\n",
       "  ('231', 0.1035),\n",
       "  ('migration', 0.1016),\n",
       "  ('documentation cell', 0.0998),\n",
       "  ('attributed ability', 0.0841),\n",
       "  ('significant anti', 0.0715),\n",
       "  ('affects normal', 0.0702),\n",
       "  ('deadhesion tail', 0.0505),\n",
       "  ('reverse transcriptase', 0.0324)],\n",
       " 'MED-1828': [('chromatography diphenols', 0.5789),\n",
       "  ('phytoestrogens plasma', 0.5701),\n",
       "  ('isoflavonoids plasma', 0.4877),\n",
       "  ('analyses compounds', 0.4548),\n",
       "  ('separated fractions', 0.427),\n",
       "  ('free compounds', 0.4058),\n",
       "  ('mono diglucuronides', 0.3928),\n",
       "  ('estrogen conjugates', 0.3917),\n",
       "  ('plasma analyses', 0.3742),\n",
       "  ('disulfates biologically', 0.372),\n",
       "  ('assay lignans', 0.3582),\n",
       "  ('hydrolysis fractions', 0.3555),\n",
       "  ('phase extraction', 0.3545),\n",
       "  ('desmethylangolensin', 0.3527),\n",
       "  ('standards compounds', 0.3394),\n",
       "  ('biologically active', 0.3332),\n",
       "  ('daidzein', 0.3227),\n",
       "  ('compounds vary', 0.3072),\n",
       "  ('genistein final', 0.3004),\n",
       "  ('concentrations individual', 0.2802),\n",
       "  ('gc ms', 0.2608),\n",
       "  ('biologically inactive', 0.2572),\n",
       "  ('pre postmenopausal', 0.2444),\n",
       "  ('quantitative method', 0.2437),\n",
       "  ('correlation plasma', 0.2143),\n",
       "  ('metabolism', 0.2049),\n",
       "  ('total enterolactone', 0.1931),\n",
       "  ('low nmol', 0.1929),\n",
       "  ('important findings', 0.1922),\n",
       "  ('highly specific', 0.1921),\n",
       "  ('deuterated internal', 0.1796),\n",
       "  ('solid phase', 0.1725),\n",
       "  ('using radioactive', 0.1601),\n",
       "  ('dilution gas', 0.1586),\n",
       "  ('women presented', 0.1464),\n",
       "  ('omnivorous vegetarian', 0.1258),\n",
       "  ('higher values', 0.1021),\n",
       "  ('urine', 0.0969),\n",
       "  ('ion exchange', 0.0935),\n",
       "  ('fraction good', 0.0851),\n",
       "  ('time important', 0.0804),\n",
       "  ('particularly vegan', 0.0649),\n",
       "  ('greatly subjects', 0.0577),\n",
       "  ('useful future', 0.0564),\n",
       "  ('procedure corrected', 0.0537),\n",
       "  ('mumol concluded', 0.0519),\n",
       "  ('losses', 0.0487),\n",
       "  ('measured matairesinol', 0.0333),\n",
       "  ('equol', 0.026),\n",
       "  ('21 25', 0.0127)],\n",
       " 'MED-1829': [('hormone exposures', 0.5487),\n",
       "  ('elucidate estrogen', 0.5487),\n",
       "  ('estradiol breast', 0.4779),\n",
       "  ('attenuated antiestrogen', 0.4717),\n",
       "  ('breast cancers', 0.46),\n",
       "  ('cancer prevention', 0.428),\n",
       "  ('steroid', 0.3913),\n",
       "  ('1ra breast', 0.3644),\n",
       "  ('il 1β', 0.3606),\n",
       "  ('unclear mechanisms', 0.3588),\n",
       "  ('introduction sex', 0.3542),\n",
       "  ('mechanisms diet', 0.3346),\n",
       "  ('intratumoral levels', 0.3321),\n",
       "  ('tamoxifen dietary', 0.317),\n",
       "  ('cytokine family', 0.3014),\n",
       "  ('altered il', 0.2922),\n",
       "  ('exposures', 0.2818),\n",
       "  ('strategy proinflammatory', 0.2799),\n",
       "  ('increases risk', 0.2643),\n",
       "  ('potential therapeutic', 0.263),\n",
       "  ('reduction mammoplasties', 0.2626),\n",
       "  ('objective study', 0.2607),\n",
       "  ('changes cellular', 0.257),\n",
       "  ('women various', 0.2562),\n",
       "  ('implicated', 0.2553),\n",
       "  ('mainly secreted', 0.2378),\n",
       "  ('1s suggesting', 0.2347),\n",
       "  ('endogenous inhibitor', 0.2222),\n",
       "  ('introduction', 0.2144),\n",
       "  ('levels affected', 0.2113),\n",
       "  ('progression il', 0.1919),\n",
       "  ('abdominal sc', 0.1752),\n",
       "  ('immunohistochemistry', 0.1461),\n",
       "  ('reduction', 0.1456),\n",
       "  ('surgery', 0.1454),\n",
       "  ('modifications increased', 0.1399),\n",
       "  ('tissue design', 0.1381),\n",
       "  ('significant negative', 0.1323),\n",
       "  ('did reveal', 0.1229),\n",
       "  ('target', 0.1176),\n",
       "  ('positive correlation', 0.0974),\n",
       "  ('cultured', 0.0848),\n",
       "  ('control', 0.0839),\n",
       "  ('family', 0.0692),\n",
       "  ('methods microdialysis', 0.0567),\n",
       "  ('ex vivo', 0.0517),\n",
       "  ('flaxseed', 0.0478),\n",
       "  ('normal human', 0.0348),\n",
       "  ('day resulted', 0.0223),\n",
       "  ('addition 25', 0.0032)],\n",
       " 'MED-1830': [('medications cognition', 0.5644),\n",
       "  ('used medications', 0.5454),\n",
       "  ('adults studies', 0.3851),\n",
       "  ('conflicting reports', 0.3278),\n",
       "  ('lack evidence', 0.3191),\n",
       "  ('assessments years', 0.3142),\n",
       "  ('baseline clinical', 0.3063),\n",
       "  ('regarding effects', 0.2916),\n",
       "  ('studies needed', 0.2834),\n",
       "  ('42 medications', 0.2746),\n",
       "  ('explored use', 0.2726),\n",
       "  ('models used', 0.255),\n",
       "  ('observational', 0.2519),\n",
       "  ('methods longitudinal', 0.2451),\n",
       "  ('alzheimer coordinating', 0.2438),\n",
       "  ('evidence based', 0.2434),\n",
       "  ('investigate mechanisms', 0.2258),\n",
       "  ('cohort used', 0.225),\n",
       "  ('participants aged', 0.2201),\n",
       "  ('declining psychometric', 0.2088),\n",
       "  ('used analysis', 0.2065),\n",
       "  ('cognitive performance', 0.1937),\n",
       "  ('change scores', 0.1753),\n",
       "  ('sertraline', 0.1721),\n",
       "  ('background', 0.1577),\n",
       "  ('maintained', 0.1545),\n",
       "  ('data set', 0.1493),\n",
       "  ('used test', 0.144),\n",
       "  ('difference 05', 0.1384),\n",
       "  ('average time', 0.132),\n",
       "  ('calcium vitamin', 0.1259),\n",
       "  ('differed participants', 0.123),\n",
       "  ('use 100', 0.121),\n",
       "  ('furosemide', 0.1104),\n",
       "  ('set participants', 0.0997),\n",
       "  ('performance bupropion', 0.0951),\n",
       "  ('oxybutynin', 0.0937),\n",
       "  ('collected september', 0.0879),\n",
       "  ('stopping continuing', 0.0853),\n",
       "  ('sulfate potassium', 0.082),\n",
       "  ('2011 maintained', 0.0728),\n",
       "  ('50 years', 0.0721),\n",
       "  ('nacc sample', 0.0639),\n",
       "  ('chloride flax', 0.0633),\n",
       "  ('naproxen', 0.059),\n",
       "  ('general linear', 0.0421),\n",
       "  ('normal 4414', 0.0275),\n",
       "  ('composite', 0.0188),\n",
       "  ('scores second', 0.0057),\n",
       "  ('ferrous', -0.0381)],\n",
       " 'MED-1831': [('beneficial pufas', 0.6671),\n",
       "  ('pufas supplements', 0.6552),\n",
       "  ('omega pufas', 0.6298),\n",
       "  ('pufas increasingly', 0.5814),\n",
       "  ('fish supplements', 0.5443),\n",
       "  ('polyunsaturated', 0.5265),\n",
       "  ('children dietary', 0.4819),\n",
       "  ('fish oil', 0.4772),\n",
       "  ('pcbs supplement', 0.4498),\n",
       "  ('supplementation', 0.4198),\n",
       "  ('pufas low', 0.4022),\n",
       "  ('exposures ingestion', 0.4011),\n",
       "  ('levels children', 0.3906),\n",
       "  ('omega', 0.3789),\n",
       "  ('oil used', 0.3311),\n",
       "  ('acids', 0.3155),\n",
       "  ('polychlorinated biphenyls', 0.3034),\n",
       "  ('concentrations 13', 0.2952),\n",
       "  ('health benefits', 0.2865),\n",
       "  ('supplements decrease', 0.2762),\n",
       "  ('supplement analysed', 0.2761),\n",
       "  ('trophic level', 0.2731),\n",
       "  ('cognitive development', 0.2546),\n",
       "  ('including enhancement', 0.2458),\n",
       "  ('significant levels', 0.2416),\n",
       "  ('variability fish', 0.2163),\n",
       "  ('suggestions', 0.2063),\n",
       "  ('powders assess', 0.1746),\n",
       "  ('congener', 0.174),\n",
       "  ('used indicators', 0.1667),\n",
       "  ('fresh', 0.1548),\n",
       "  ('content serving', 0.1442),\n",
       "  ('products studied', 0.1431),\n",
       "  ('popular largest', 0.1405),\n",
       "  ('values ranged', 0.1323),\n",
       "  ('distillation trophic', 0.1181),\n",
       "  ('used make', 0.1142),\n",
       "  ('increasingly', 0.11),\n",
       "  ('suite health', 0.0836),\n",
       "  ('daily basis', 0.0719),\n",
       "  ('study factors', 0.0622),\n",
       "  ('50 ng', 0.0512),\n",
       "  ('compared', 0.0456),\n",
       "  ('adult', 0.029),\n",
       "  ('molecular', 0.0245),\n",
       "  ('purification methods', 0.0205),\n",
       "  ('significantly lower', 0.0005),\n",
       "  ('previously reported', -0.0131),\n",
       "  ('ng', -0.0166),\n",
       "  ('counter', -0.0513)],\n",
       " 'MED-1832': [('dha 36', 0.5946),\n",
       "  ('fed infants', 0.5842),\n",
       "  ('preformed dha', 0.537),\n",
       "  ('formula fed', 0.5261),\n",
       "  ('supply docosahexaenoic', 0.5093),\n",
       "  ('supplementation term', 0.506),\n",
       "  ('arachidonic aid', 0.4719),\n",
       "  ('need dietary', 0.4535),\n",
       "  ('total fatty', 0.408),\n",
       "  ('term infant', 0.4073),\n",
       "  ('birth randomized', 0.368),\n",
       "  ('intake preformed', 0.353),\n",
       "  ('acid composition', 0.339),\n",
       "  ('tolerated diets', 0.327),\n",
       "  ('26 wk', 0.2646),\n",
       "  ('wk age', 0.2409),\n",
       "  ('human milk', 0.2298),\n",
       "  ('rbc lipid', 0.2275),\n",
       "  ('development reaches', 0.2087),\n",
       "  ('trial effects', 0.2072),\n",
       "  ('necessary optimal', 0.2041),\n",
       "  ('fed gold', 0.2021),\n",
       "  ('12 mo', 0.1961),\n",
       "  ('early', 0.1955),\n",
       "  ('supply', 0.1888),\n",
       "  ('red blood', 0.186),\n",
       "  ('35 total', 0.1858),\n",
       "  ('unsupplemented', 0.1782),\n",
       "  ('52 wk', 0.1734),\n",
       "  ('aa mo', 0.1697),\n",
       "  ('72 visual', 0.1691),\n",
       "  ('double', 0.164),\n",
       "  ('time points', 0.1279),\n",
       "  ('clear differences', 0.1211),\n",
       "  ('significantly', 0.1146),\n",
       "  ('enrolled', 0.1102),\n",
       "  ('healthy', 0.1078),\n",
       "  ('evoked potential', 0.0977),\n",
       "  ('life', 0.0852),\n",
       "  ('standard group', 0.0834),\n",
       "  ('exclusively breast', 0.0814),\n",
       "  ('looking acuity', 0.0807),\n",
       "  ('yields better', 0.0764),\n",
       "  ('forced choice', 0.0706),\n",
       "  ('composition sweep', 0.0658),\n",
       "  ('similar rates', 0.0473),\n",
       "  ('29 exclusively', 0.0281),\n",
       "  ('reaches plateau', -0.0098),\n",
       "  ('different human', -0.0167),\n",
       "  ('17', -0.1064)],\n",
       " 'MED-1833': [('intake cod', 0.5194),\n",
       "  ('vitamin contains', 0.4752),\n",
       "  ('oil daily', 0.4582),\n",
       "  ('liver oil', 0.4302),\n",
       "  ('1000 µg', 0.3608),\n",
       "  ('contains fat', 0.3449),\n",
       "  ('norway contained', 0.3009),\n",
       "  ('trøndelag health', 0.2992),\n",
       "  ('diseases objective', 0.2968),\n",
       "  ('conclusions intake', 0.2683),\n",
       "  ('contained high', 0.2416),\n",
       "  ('defined daily', 0.2352),\n",
       "  ('important source', 0.2305),\n",
       "  ('increased risks', 0.2238),\n",
       "  ('95', 0.2188),\n",
       "  ('study total', 0.2094),\n",
       "  ('development methods', 0.209),\n",
       "  ('chronic', 0.1936),\n",
       "  ('bmi subgroups', 0.1907),\n",
       "  ('reported new', 0.1884),\n",
       "  ('formula', 0.1868),\n",
       "  ('25 616', 0.1821),\n",
       "  ('objective investigate', 0.1763),\n",
       "  ('µg ml', 0.1668),\n",
       "  ('content significantly', 0.1641),\n",
       "  ('status associated', 0.1585),\n",
       "  ('activity education', 0.1571),\n",
       "  ('positive association', 0.1527),\n",
       "  ('3076 consumed', 0.1489),\n",
       "  ('soluble components', 0.1394),\n",
       "  ('current analysis', 0.1355),\n",
       "  ('asthma reported', 0.1287),\n",
       "  ('socio economic', 0.1244),\n",
       "  ('baseline incident', 0.1244),\n",
       "  ('1999', 0.1232),\n",
       "  ('year prior', 0.116),\n",
       "  ('11', 0.1126),\n",
       "  ('complete information', 0.1055),\n",
       "  ('follow results', 0.0952),\n",
       "  ('smoking physical', 0.0745),\n",
       "  ('ci 32', 0.0685),\n",
       "  ('528', 0.0523),\n",
       "  ('2006 2008', 0.0461),\n",
       "  ('women family', 0.0238),\n",
       "  ('17', 0.0234),\n",
       "  ('years sex', 0.0113),\n",
       "  ('men', 0.0035),\n",
       "  ('adult onset', -0.0001),\n",
       "  ('40 years', -0.0067),\n",
       "  ('subjects free', -0.009)],\n",
       " 'MED-1834': [('allergy australia', 0.5646),\n",
       "  ('increasing allergy', 0.4929),\n",
       "  ('sensitization plausible', 0.4251),\n",
       "  ('uvr vitamin', 0.3597),\n",
       "  ('latitudinal variation', 0.347),\n",
       "  ('daily temperature', 0.3455),\n",
       "  ('asthma greater', 0.3446),\n",
       "  ('climatic data', 0.3414),\n",
       "  ('radiation contributed', 0.2708),\n",
       "  ('variation prevalence', 0.262),\n",
       "  ('positive associations', 0.2562),\n",
       "  ('administered questionnaire', 0.2283),\n",
       "  ('including biologic', 0.2251),\n",
       "  ('suggest solar', 0.2159),\n",
       "  ('skin used', 0.205),\n",
       "  ('prevalence decreasing', 0.196),\n",
       "  ('measures childhood', 0.1942),\n",
       "  ('cumulative actinic', 0.1929),\n",
       "  ('aims study', 0.1869),\n",
       "  ('equator', 0.1865),\n",
       "  ('data linked', 0.1787),\n",
       "  ('population based', 0.1781),\n",
       "  ('damage inverse', 0.1776),\n",
       "  ('adjusted odds', 0.1756),\n",
       "  ('ci 01', 0.1722),\n",
       "  ('regions', 0.1692),\n",
       "  ('persist adjusting', 0.167),\n",
       "  ('hydroxyvitamin concentrations', 0.1586),\n",
       "  ('ages', 0.1506),\n",
       "  ('explanations including', 0.1453),\n",
       "  ('ranging', 0.1406),\n",
       "  ('examination', 0.1275),\n",
       "  ('analyzed 25', 0.1123),\n",
       "  ('63 oral', 0.1035),\n",
       "  ('stored serum', 0.0972),\n",
       "  ('evaluate parallel', 0.0953),\n",
       "  ('15 yr', 0.089),\n",
       "  ('greater time', 0.0886),\n",
       "  ('rubber casts', 0.085),\n",
       "  ('43 data', 0.0806),\n",
       "  ('winter ages', 0.0803),\n",
       "  ('supplementation cod', 0.0749),\n",
       "  ('controls took', 0.0674),\n",
       "  ('observations 2010', 0.0335),\n",
       "  ('postcodes', 0.0057),\n",
       "  ('john', 0.0044),\n",
       "  ('yr resident', -0.0142),\n",
       "  ('hayfever', -0.0183),\n",
       "  ('residential', -0.0209),\n",
       "  ('00 32', -0.0284)],\n",
       " 'MED-1836': [('manganese supplementation', 0.5528),\n",
       "  ('supplementation study', 0.4551),\n",
       "  ('changes mnsod', 0.4464),\n",
       "  ('124 supplementation', 0.4088),\n",
       "  ('lymphocyte mnsod', 0.3701),\n",
       "  ('mineral supplements', 0.3671),\n",
       "  ('women 124', 0.3131),\n",
       "  ('study subjects', 0.2972),\n",
       "  ('dietary factors', 0.2887),\n",
       "  ('47 women', 0.2812),\n",
       "  ('studied longitudinally', 0.2667),\n",
       "  ('indices iron', 0.2445),\n",
       "  ('dismutase', 0.2347),\n",
       "  ('received treatments', 0.2231),\n",
       "  ('women', 0.2229),\n",
       "  ('dependent superoxide', 0.2036),\n",
       "  ('evaluated changes', 0.1954),\n",
       "  ('changes urinary', 0.1914),\n",
       "  ('intake affected', 0.1899),\n",
       "  ('exposure humans', 0.1881),\n",
       "  ('studied', 0.1872),\n",
       "  ('treatments placebo', 0.1791),\n",
       "  ('status 47', 0.1709),\n",
       "  ('did confound', 0.1671),\n",
       "  ('excretion indices', 0.1626),\n",
       "  ('concentrations baseline', 0.1608),\n",
       "  ('menstrual cycle', 0.1589),\n",
       "  ('factors', 0.1533),\n",
       "  ('affected indices', 0.1268),\n",
       "  ('status oral', 0.1197),\n",
       "  ('work', 0.1164),\n",
       "  ('did', 0.111),\n",
       "  ('used serum', 0.1093),\n",
       "  ('daily', 0.1026),\n",
       "  ('status fat', 0.1024),\n",
       "  ('activity humans', 0.0989),\n",
       "  ('placebo 60', 0.0988),\n",
       "  ('resulted significant', 0.0965),\n",
       "  ('15 mg', 0.0954),\n",
       "  ('oral contraceptive', 0.0934),\n",
       "  ('monitor', 0.093),\n",
       "  ('cycle did', 0.093),\n",
       "  ('values changes', 0.0928),\n",
       "  ('stage', 0.0746),\n",
       "  ('mg', 0.0505),\n",
       "  ('significant increases', 0.0419),\n",
       "  ('dependent', 0.038),\n",
       "  ('received', 0.0359),\n",
       "  ('use', 0.0294),\n",
       "  ('increases lymphocyte', 0.0285)],\n",
       " 'MED-1837': [('mn diets', 0.6204),\n",
       "  ('mn deficiency', 0.5743),\n",
       "  ('mn compared', 0.4892),\n",
       "  ('manganese', 0.4854),\n",
       "  ('mn homeostasis', 0.4705),\n",
       "  ('women fed', 0.4271),\n",
       "  ('result mn', 0.3719),\n",
       "  ('wk subjects', 0.3534),\n",
       "  ('deficiency toxicity', 0.3501),\n",
       "  ('subjects consumed', 0.347),\n",
       "  ('determine diets', 0.3363),\n",
       "  ('fats affected', 0.3313),\n",
       "  ('metabolic function', 0.319),\n",
       "  ('range intakes', 0.2788),\n",
       "  ('potentially toxic', 0.255),\n",
       "  ('containing low', 0.2406),\n",
       "  ('half subjects', 0.2374),\n",
       "  ('administered regular', 0.2303),\n",
       "  ('women', 0.226),\n",
       "  ('containing 54', 0.2166),\n",
       "  ('mn 20', 0.2155),\n",
       "  ('mechanisms operate', 0.2058),\n",
       "  ('absorbed significantly', 0.1963),\n",
       "  ('western diet', 0.1941),\n",
       "  ('measures neuropsychological', 0.19),\n",
       "  ('enriched saturated', 0.1871),\n",
       "  ('encountered mixed', 0.1803),\n",
       "  ('affected psychologic', 0.165),\n",
       "  ('current study', 0.1596),\n",
       "  ('affected measures', 0.1582),\n",
       "  ('minimally affected', 0.1536),\n",
       "  ('oil meal', 0.1467),\n",
       "  ('maintain', 0.1429),\n",
       "  ('underwent body', 0.1148),\n",
       "  ('objectives', 0.1045),\n",
       "  ('function healthy', 0.0993),\n",
       "  ('crossover design', 0.091),\n",
       "  ('counting', 0.0898),\n",
       "  ('cocoa butter', 0.0797),\n",
       "  ('compared high', 0.0766),\n",
       "  ('half life', 0.0744),\n",
       "  ('neurological', 0.0744),\n",
       "  ('longer', 0.0694),\n",
       "  ('received 15', 0.0444),\n",
       "  ('adults', 0.0392),\n",
       "  ('blood draws', 0.0366),\n",
       "  ('did', 0.0284),\n",
       "  ('corn', 0.0268),\n",
       "  ('data efficient', -0.0189),\n",
       "  ('young', -0.0406)],\n",
       " 'MED-1838': [('digests infusions', 0.4165),\n",
       "  ('spectrometry icp', 0.4143),\n",
       "  ('metals identification', 0.4036),\n",
       "  ('spectroscopy faas', 0.3955),\n",
       "  ('zn ca', 0.3763),\n",
       "  ('concentrations al', 0.3571),\n",
       "  ('contributors food', 0.2928),\n",
       "  ('petals ca', 0.2885),\n",
       "  ('values cu', 0.2865),\n",
       "  ('hibiscus sabdariffa', 0.2724),\n",
       "  ('atomic absorption', 0.2694),\n",
       "  ('emission spectrometry', 0.262),\n",
       "  ('mg respectively', 0.2469),\n",
       "  ('herbs', 0.2276),\n",
       "  ('fe', 0.223),\n",
       "  ('chromatography ic', 0.2198),\n",
       "  ('significant content', 0.2161),\n",
       "  ('daily consumption', 0.2102),\n",
       "  ('transformation infusion', 0.1999),\n",
       "  ('detected prepared', 0.1872),\n",
       "  ('speciation', 0.1814),\n",
       "  ('al allowance', 0.1813),\n",
       "  ('ginkgo biloba', 0.1792),\n",
       "  ('accessible mn', 0.1719),\n",
       "  ('leachates carried', 0.1667),\n",
       "  ('topmost concentrations', 0.1623),\n",
       "  ('canina receptacles', 0.1544),\n",
       "  ('oes flame', 0.1528),\n",
       "  ('possible raw', 0.152),\n",
       "  ('excluded diet', 0.15),\n",
       "  ('sensitive individuals', 0.149),\n",
       "  ('panax ginseng', 0.1476),\n",
       "  ('humans total', 0.1456),\n",
       "  ('coupled plasma', 0.1344),\n",
       "  ('including pregnant', 0.1318),\n",
       "  ('months age', 0.1185),\n",
       "  ('study particular', 0.1123),\n",
       "  ('citratus', 0.109),\n",
       "  ('rosa', 0.0964),\n",
       "  ('women completely', 0.0922),\n",
       "  ('blood pressure', 0.0764),\n",
       "  ('aloe vera', 0.0665),\n",
       "  ('2013 elsevier', 0.0609),\n",
       "  ('adverse effect', 0.0433),\n",
       "  ('17 mg', 0.0402),\n",
       "  ('106 mg', 0.0331),\n",
       "  ('cymbopogon', 0.0298),\n",
       "  ('decoction identified', 0.0055),\n",
       "  ('copyright', -0.0113),\n",
       "  ('children chronic', -0.0561)],\n",
       " 'MED-1839': [('aluminium antacids', 0.6041),\n",
       "  ('tablets aluminium', 0.567),\n",
       "  ('doses aluminium', 0.5375),\n",
       "  ('excretion aluminium', 0.5341),\n",
       "  ('antacids tablets', 0.5101),\n",
       "  ('serum aluminium', 0.5059),\n",
       "  ('antacids ingested', 0.4789),\n",
       "  ('oral doses', 0.4275),\n",
       "  ('acid solution', 0.3807),\n",
       "  ('single doses', 0.3802),\n",
       "  ('absorbed single', 0.3757),\n",
       "  ('higher antacids', 0.3699),\n",
       "  ('antacid significant', 0.358),\n",
       "  ('aluminium 50', 0.3406),\n",
       "  ('mg tablet', 0.3173),\n",
       "  ('estimated absorption', 0.3146),\n",
       "  ('05 antacids', 0.3144),\n",
       "  ('seen tablets', 0.3135),\n",
       "  ('urinary excretion', 0.3081),\n",
       "  ('normal renal', 0.305),\n",
       "  ('following doses', 0.3038),\n",
       "  ('swallowed water', 0.2913),\n",
       "  ('increase serum', 0.2885),\n",
       "  ('serum concentration', 0.2881),\n",
       "  ('subjects', 0.2836),\n",
       "  ('concomitant ingestion', 0.2805),\n",
       "  ('subjects normal', 0.2659),\n",
       "  ('24 urinary', 0.2639),\n",
       "  ('juice citric', 0.2037),\n",
       "  ('244 mg', 0.1927),\n",
       "  ('001', 0.1867),\n",
       "  ('concentration seen', 0.1804),\n",
       "  ('water measurable', 0.18),\n",
       "  ('oral', 0.1785),\n",
       "  ('solution marked', 0.1688),\n",
       "  ('times', 0.1419),\n",
       "  ('significant', 0.1407),\n",
       "  ('single', 0.1348),\n",
       "  ('measurable quantities', 0.1274),\n",
       "  ('50 times', 0.1244),\n",
       "  ('content', 0.1188),\n",
       "  ('substantially enhanced', 0.1103),\n",
       "  ('higher', 0.1036),\n",
       "  ('function given', 0.1032),\n",
       "  ('respectively taken', 0.0848),\n",
       "  ('slight significant', 0.0786),\n",
       "  ('given different', 0.0758),\n",
       "  ('taken orange', 0.048),\n",
       "  ('chewed', 0.0172),\n",
       "  ('05', 0.0146)],\n",
       " 'MED-1840': [('mn intake', 0.6236),\n",
       "  ('mnsod investigated', 0.5881),\n",
       "  ('levels manganese', 0.545),\n",
       "  ('assessed mn', 0.4774),\n",
       "  ('enzymes tea', 0.4724),\n",
       "  ('plasma mn', 0.4527),\n",
       "  ('black tea', 0.4523),\n",
       "  ('tea blood', 0.3991),\n",
       "  ('blood mn', 0.3862),\n",
       "  ('intakes mean', 0.3588),\n",
       "  ('expression mn', 0.3434),\n",
       "  ('drinking major', 0.3337),\n",
       "  ('investigated markers', 0.3024),\n",
       "  ('mononuclear cell', 0.302),\n",
       "  ('non tea', 0.2998),\n",
       "  ('drinkers design', 0.2804),\n",
       "  ('levels leucocyte', 0.2802),\n",
       "  ('relationship dietary', 0.2486),\n",
       "  ('values mg', 0.2476),\n",
       "  ('subjects total', 0.2423),\n",
       "  ('major source', 0.2391),\n",
       "  ('levels black', 0.2332),\n",
       "  ('dependent superoxide', 0.2179),\n",
       "  ('levels quantitative', 0.1921),\n",
       "  ('objective', 0.1868),\n",
       "  ('enzymes fasting', 0.1741),\n",
       "  ('frequency questionnaire', 0.1736),\n",
       "  ('continuous analysis', 0.1526),\n",
       "  ('conclusions', 0.1452),\n",
       "  ('inversely parameters', 0.1276),\n",
       "  ('commonly exceed', 0.1165),\n",
       "  ('cytosolic', 0.1126),\n",
       "  ('college london', 0.108),\n",
       "  ('did differ', 0.1075),\n",
       "  ('mean range', 0.1059),\n",
       "  ('used', 0.1051),\n",
       "  ('aminopeptidase', 0.1027),\n",
       "  ('students king', 0.0932),\n",
       "  ('10 mg', 0.0908),\n",
       "  ('0001 non', 0.0883),\n",
       "  ('12', 0.083),\n",
       "  ('significantly lower', 0.0805),\n",
       "  ('day 28', 0.0786),\n",
       "  ('contains', 0.0744),\n",
       "  ('status', 0.0716),\n",
       "  ('email results', 0.0501),\n",
       "  ('staff students', 0.0467),\n",
       "  ('total 24', 0.0383),\n",
       "  ('20 depending', 0.0231),\n",
       "  ('cap setting', -0.1275)],\n",
       " 'MED-1841': [('men ingested', 0.5212),\n",
       "  ('digestion nitric', 0.4399),\n",
       "  ('dietary period', 0.4368),\n",
       "  ('sampled dietary', 0.4313),\n",
       "  ('daily meals', 0.4144),\n",
       "  ('ingestion al', 0.3975),\n",
       "  ('lemon juice', 0.3783),\n",
       "  ('meals seven', 0.3683),\n",
       "  ('healthy men', 0.3612),\n",
       "  ('periods citric', 0.3535),\n",
       "  ('digestion', 0.3444),\n",
       "  ('respectively ingestion', 0.3259),\n",
       "  ('seen ingestion', 0.3142),\n",
       "  ('nitric acid', 0.3117),\n",
       "  ('electrothermally digestion', 0.2951),\n",
       "  ('juice al', 0.2795),\n",
       "  ('acid resulted', 0.2785),\n",
       "  ('acid blood', 0.2738),\n",
       "  ('al concentrations', 0.2618),\n",
       "  ('men', 0.2601),\n",
       "  ('experimental periods', 0.235),\n",
       "  ('concentrations', 0.212),\n",
       "  ('healthy', 0.2119),\n",
       "  ('blood sampled', 0.1888),\n",
       "  ('micrograms al', 0.1818),\n",
       "  ('day experimental', 0.1775),\n",
       "  ('increase al', 0.169),\n",
       "  ('citrate complexes', 0.1658),\n",
       "  ('formation absorption', 0.1631),\n",
       "  ('sd micrograms', 0.1595),\n",
       "  ('12 sd', 0.1559),\n",
       "  ('analyzed electrothermally', 0.1435),\n",
       "  ('twice daily', 0.1377),\n",
       "  ('pretreatment values', 0.1345),\n",
       "  ('sampled', 0.132),\n",
       "  ('mean', 0.13),\n",
       "  ('resulted', 0.1202),\n",
       "  ('period analyzed', 0.1199),\n",
       "  ('day', 0.1053),\n",
       "  ('001', 0.0932),\n",
       "  ('increases mean', 0.0815),\n",
       "  ('highly significant', 0.0782),\n",
       "  ('complexes', 0.049),\n",
       "  ('compared', 0.0472),\n",
       "  ('moderate significant', 0.0357),\n",
       "  ('liter seen', 0.0347),\n",
       "  ('23', 0.0343),\n",
       "  ('pronounced', 0.0341),\n",
       "  ('probably owing', 0.0257),\n",
       "  ('oh', 0.004)],\n",
       " 'MED-1842': [('hypertension debilitating', 0.5643),\n",
       "  ('hypertension purpose', 0.5597),\n",
       "  ('essential hypertension', 0.5213),\n",
       "  ('hypertension consuming', 0.4879),\n",
       "  ('tea hibiscus', 0.4378),\n",
       "  ('blood pressure', 0.4265),\n",
       "  ('hypertension randomly', 0.3953),\n",
       "  ('study systolic', 0.3403),\n",
       "  ('sour tea', 0.3317),\n",
       "  ('elevated diastolic', 0.3279),\n",
       "  ('consuming drugs', 0.314),\n",
       "  ('tea lowering', 0.3046),\n",
       "  ('evaluate effect', 0.304),\n",
       "  ('elevated experimental', 0.2991),\n",
       "  ('effects chemical', 0.2916),\n",
       "  ('experimental control', 0.2723),\n",
       "  ('pressure extensive', 0.2681),\n",
       "  ('drugs excluded', 0.2614),\n",
       "  ('used treatment', 0.2552),\n",
       "  ('studies concerning', 0.2374),\n",
       "  ('purpose', 0.2224),\n",
       "  ('pressures measured', 0.2172),\n",
       "  ('end organ', 0.2127),\n",
       "  ('high', 0.2005),\n",
       "  ('effect sour', 0.199),\n",
       "  ('prevalence', 0.1907),\n",
       "  ('vitro', 0.1893),\n",
       "  ('age patients', 0.1741),\n",
       "  ('patients secondary', 0.1467),\n",
       "  ('statistical', 0.1463),\n",
       "  ('blood', 0.1452),\n",
       "  ('23 patients', 0.141),\n",
       "  ('subject needed', 0.1363),\n",
       "  ('15 days', 0.1345),\n",
       "  ('consuming', 0.1247),\n",
       "  ('moderate essential', 0.1214),\n",
       "  ('45 patients', 0.1174),\n",
       "  ('days beginning', 0.1149),\n",
       "  ('group 30', 0.1105),\n",
       "  ('difference', 0.0972),\n",
       "  ('age 52', 0.0949),\n",
       "  ('group 12', 0.0852),\n",
       "  ('public belief', 0.0832),\n",
       "  ('groups significant', 0.062),\n",
       "  ('sabdariffa essential', 0.0606),\n",
       "  ('randomly', 0.0246),\n",
       "  ('11 lowering', 0.0104),\n",
       "  ('70 female', -0.003),\n",
       "  ('male', -0.0719),\n",
       "  ('10 years', -0.106)],\n",
       " 'MED-1843': [('aluminium toxicity', 0.6527),\n",
       "  ('1970s aluminium', 0.4845),\n",
       "  ('toxicity investigated', 0.4262),\n",
       "  ('absorption unlikely', 0.337),\n",
       "  ('toxicity advisable', 0.3317),\n",
       "  ('renal failure', 0.3239),\n",
       "  ('exposure despite', 0.3128),\n",
       "  ('toxicant provoke', 0.3066),\n",
       "  ('renal osteomalacia', 0.2832),\n",
       "  ('implicated pathogenesis', 0.2618),\n",
       "  ('investigated countless', 0.2452),\n",
       "  ('early 1970s', 0.244),\n",
       "  ('effects', 0.2265),\n",
       "  ('involving bone', 0.2185),\n",
       "  ('encephalopathy time', 0.216),\n",
       "  ('binders', 0.2026),\n",
       "  ('disorders patients', 0.2015),\n",
       "  ('contaminated dialysis', 0.2011),\n",
       "  ('based phosphate', 0.1999),\n",
       "  ('ingestion considered', 0.1903),\n",
       "  ('oral exposure', 0.1874),\n",
       "  ('epidemiological', 0.1681),\n",
       "  ('papers published', 0.1607),\n",
       "  ('failure', 0.1542),\n",
       "  ('citrate containing', 0.1529),\n",
       "  ('clinical studies', 0.1511),\n",
       "  ('early', 0.1462),\n",
       "  ('gestational exposure', 0.1447),\n",
       "  ('chronic', 0.1446),\n",
       "  ('parenteral', 0.1331),\n",
       "  ('administration', 0.1265),\n",
       "  ('studies animal', 0.1202),\n",
       "  ('leaflets', 0.0999),\n",
       "  ('warnings', 0.0984),\n",
       "  ('subject commonly', 0.0977),\n",
       "  ('brain tissue', 0.0927),\n",
       "  ('induced infusion', 0.0824),\n",
       "  ('european', 0.0814),\n",
       "  ('antacids important', 0.0764),\n",
       "  ('quantitative point', 0.0695),\n",
       "  ('differences regarding', 0.0681),\n",
       "  ('facts patient', 0.0633),\n",
       "  ('source human', 0.0594),\n",
       "  ('containing pharmaceutical', 0.0531),\n",
       "  ('powerful neurological', 0.0497),\n",
       "  ('major concern', 0.0493),\n",
       "  ('otc substantial', 0.039),\n",
       "  ('humans', 0.0221),\n",
       "  ('receive information', 0.0066),\n",
       "  ('regard increased', 0.0013)],\n",
       " 'MED-1844': [('manganese total', 0.452),\n",
       "  ('nickel determined', 0.426),\n",
       "  ('total content', 0.3758),\n",
       "  ('absorption spectrometry', 0.3721),\n",
       "  ('tea green', 0.3631),\n",
       "  ('amounts iron', 0.3628),\n",
       "  ('micronutrient', 0.3592),\n",
       "  ('chromium', 0.3564),\n",
       "  ('dietary source', 0.3415),\n",
       "  ('tea 919micro29', 0.3366),\n",
       "  ('prepared subsamples', 0.3292),\n",
       "  ('infusions analyzed', 0.3133),\n",
       "  ('tannins content', 0.3022),\n",
       "  ('material prepared', 0.2818),\n",
       "  ('available leafy', 0.2807),\n",
       "  ('evaluated obtained', 0.2765),\n",
       "  ('aluminum 272', 0.2739),\n",
       "  ('source essential', 0.2557),\n",
       "  ('acid digestion', 0.2433),\n",
       "  ('leached copper', 0.2396),\n",
       "  ('better leaching', 0.2363),\n",
       "  ('93', 0.236),\n",
       "  ('levels', 0.2217),\n",
       "  ('atomic', 0.2138),\n",
       "  ('nitric', 0.1949),\n",
       "  ('mate electrothermal', 0.1812),\n",
       "  ('ilex paraguariensis', 0.1748),\n",
       "  ('respectively referred', 0.1735),\n",
       "  ('369', 0.1697),\n",
       "  ('greater amounts', 0.166),\n",
       "  ('liquor evaluated', 0.1549),\n",
       "  ('beverage', 0.153),\n",
       "  ('110 microg', 0.1512),\n",
       "  ('perchloric', 0.1353),\n",
       "  ('commercially available', 0.133),\n",
       "  ('759', 0.1282),\n",
       "  ('2223', 0.1264),\n",
       "  ('ground', 0.1196),\n",
       "  ('strongly related', 0.1191),\n",
       "  ('contained lower', 0.1178),\n",
       "  ('82 exception', 0.1101),\n",
       "  ('19', 0.0879),\n",
       "  ('run parallel', 0.0779),\n",
       "  ('case', 0.0644),\n",
       "  ('total 40', 0.0538),\n",
       "  ('31', 0.0428),\n",
       "  ('hibiscus sabdariffa', 0.0427),\n",
       "  ('referred black', 0.0377),\n",
       "  ('48', 0.0057),\n",
       "  ('microg respectively', 0.0035)],\n",
       " 'MED-1845': [('al diet', 0.4732),\n",
       "  ('concentrations al', 0.4494),\n",
       "  ('al tea', 0.4446),\n",
       "  ('diet mineral', 0.4219),\n",
       "  ('infusions plasma', 0.3544),\n",
       "  ('al mineral', 0.34),\n",
       "  ('healthy volunteers', 0.3101),\n",
       "  ('plasma samples', 0.3072),\n",
       "  ('al determined', 0.307),\n",
       "  ('samples collected', 0.3025),\n",
       "  ('plasma al', 0.3013),\n",
       "  ('compared consumption', 0.2953),\n",
       "  ('controlled aluminium', 0.295),\n",
       "  ('drinking tea', 0.2864),\n",
       "  ('lemon juice', 0.2813),\n",
       "  ('additives', 0.2712),\n",
       "  ('mineral water', 0.2594),\n",
       "  ('500 ml', 0.2542),\n",
       "  ('consumed', 0.2342),\n",
       "  ('ml', 0.2331),\n",
       "  ('absorption', 0.2288),\n",
       "  ('milk', 0.2285),\n",
       "  ('ml 70', 0.2127),\n",
       "  ('juice did', 0.2092),\n",
       "  ('significantly total', 0.1995),\n",
       "  ('spectrometry consumption', 0.192),\n",
       "  ('term drinking', 0.1763),\n",
       "  ('12', 0.1738),\n",
       "  ('spectrophotometry inductively', 0.1714),\n",
       "  ('results suggest', 0.1665),\n",
       "  ('design concentrations', 0.1649),\n",
       "  ('weight', 0.1622),\n",
       "  ('levels compared', 0.1608),\n",
       "  ('60 mg', 0.1606),\n",
       "  ('collected 24', 0.1357),\n",
       "  ('contribute significantly', 0.1183),\n",
       "  ('crossover design', 0.1181),\n",
       "  ('approximately 001', 0.1168),\n",
       "  ('furnace atomic', 0.104),\n",
       "  ('did increase', 0.0912),\n",
       "  ('controlled', 0.0794),\n",
       "  ('hr', 0.0779),\n",
       "  ('body burden', 0.0702),\n",
       "  ('way', 0.0529),\n",
       "  ('suggest', 0.0488),\n",
       "  ('did', 0.0423),\n",
       "  ('plasma emission', 0.033),\n",
       "  ('coupled', 0.0125),\n",
       "  ('short term', -0.0522),\n",
       "  ('graphite', -0.1173)],\n",
       " 'MED-1846': [('absorption iron', 0.4954),\n",
       "  ('juices varied', 0.451),\n",
       "  ('fruit absorption', 0.394),\n",
       "  ('mean fe', 0.3604),\n",
       "  ('absorptions different', 0.3465),\n",
       "  ('measured 234', 0.3272),\n",
       "  ('meal measured', 0.3263),\n",
       "  ('mg citric', 0.3028),\n",
       "  ('content rs', 0.3005),\n",
       "  ('absorption 126', 0.2826),\n",
       "  ('129 variation', 0.2795),\n",
       "  ('respectively corrected', 0.2613),\n",
       "  ('031 088', 0.2534),\n",
       "  ('women using', 0.246),\n",
       "  ('28 mg', 0.2407),\n",
       "  ('contained ascorbic', 0.2348),\n",
       "  ('acid 139', 0.232),\n",
       "  ('rice', 0.2305),\n",
       "  ('correlation fe', 0.2231),\n",
       "  ('utilization radioactive', 0.2129),\n",
       "  ('mangifera indica', 0.21),\n",
       "  ('750 mg', 0.1932),\n",
       "  ('values guava', 0.1904),\n",
       "  ('promoting effects', 0.1802),\n",
       "  ('parous indian', 0.1774),\n",
       "  ('strawberry fragaria', 0.1758),\n",
       "  ('malus', 0.1568),\n",
       "  ('vitis vinifera', 0.1516),\n",
       "  ('100 ml', 0.1495),\n",
       "  ('using erythrocyte', 0.1434),\n",
       "  ('cucumis', 0.1392),\n",
       "  ('apple', 0.1383),\n",
       "  ('water 33', 0.1329),\n",
       "  ('papaya markedly', 0.1311),\n",
       "  ('oryza sativa', 0.1297),\n",
       "  ('rs 70', 0.1267),\n",
       "  ('significantly better', 0.1207),\n",
       "  ('laboratory lemon', 0.1116),\n",
       "  ('geometric mean', 0.1112),\n",
       "  ('markedly increased', 0.095),\n",
       "  ('domestica rhubarb', 0.0931),\n",
       "  ('abstract truncated', 0.0883),\n",
       "  ('musa cavendishii', 0.0844),\n",
       "  ('psidium', 0.0821),\n",
       "  ('293', 0.0619),\n",
       "  ('values plum', 0.0598),\n",
       "  ('little effect', 0.0403),\n",
       "  ('communis cantaloup', 0.0384),\n",
       "  ('ananas', 0.0354),\n",
       "  ('persea', 0.0183)],\n",
       " 'MED-1847': [('speciation aluminium', 0.5869),\n",
       "  ('aluminium excretion', 0.5678),\n",
       "  ('al absorption', 0.4293),\n",
       "  ('infusion ph', 0.4109),\n",
       "  ('78 al', 0.4053),\n",
       "  ('infusion passed', 0.3285),\n",
       "  ('ultrafilters effect', 0.3266),\n",
       "  ('vitro speciation', 0.3209),\n",
       "  ('spectroscopic analysis', 0.3052),\n",
       "  ('addition gastric', 0.3028),\n",
       "  ('total urinary', 0.2956),\n",
       "  ('effluent evidence', 0.295),\n",
       "  ('ph studied', 0.291),\n",
       "  ('tea drinking', 0.2724),\n",
       "  ('ingested', 0.267),\n",
       "  ('excretion previously', 0.2455),\n",
       "  ('studied 78', 0.2275),\n",
       "  ('juice', 0.2227),\n",
       "  ('analysis ileostomy', 0.2222),\n",
       "  ('total', 0.2075),\n",
       "  ('assessed using', 0.196),\n",
       "  ('adjusted', 0.1857),\n",
       "  ('vivo measured', 0.1844),\n",
       "  ('molecular weight', 0.1842),\n",
       "  ('studied', 0.1797),\n",
       "  ('000', 0.1736),\n",
       "  ('resolution 1h', 0.1705),\n",
       "  ('results suggest', 0.1692),\n",
       "  ('effect', 0.1663),\n",
       "  ('derived', 0.1645),\n",
       "  ('increased 90', 0.1642),\n",
       "  ('using high', 0.1508),\n",
       "  ('incubate', 0.1502),\n",
       "  ('products', 0.1345),\n",
       "  ('potentially available', 0.1338),\n",
       "  ('3000 da', 0.1327),\n",
       "  ('da cut', 0.1318),\n",
       "  ('phenols vivo', 0.1237),\n",
       "  ('weight breakdown', 0.1088),\n",
       "  ('reduced approximately', 0.0979),\n",
       "  ('polyphenols low', 0.0853),\n",
       "  ('adding human', 0.0786),\n",
       "  ('black', 0.065),\n",
       "  ('misleading estimate', 0.0628),\n",
       "  ('magnetic', 0.0538),\n",
       "  ('nuclear', 0.035),\n",
       "  ('evidence low', 0.0313),\n",
       "  ('systemic', 0.0215),\n",
       "  ('30', 0.0137),\n",
       "  ('10 000', 0.0095)],\n",
       " 'MED-1848': [('64 aluminium', 0.508),\n",
       "  ('inhalation aluminium', 0.4819),\n",
       "  ('exposed workers', 0.4727),\n",
       "  ('standardised occupational', 0.4485),\n",
       "  ('32 unexposed', 0.3469),\n",
       "  ('potential confounders', 0.3363),\n",
       "  ('employees compared', 0.3325),\n",
       "  ('cognitive impairment', 0.3257),\n",
       "  ('effects tests', 0.265),\n",
       "  ('metals serum', 0.2615),\n",
       "  ('early neurotoxic', 0.2601),\n",
       "  ('northern italy', 0.2543),\n",
       "  ('control population', 0.2464),\n",
       "  ('investigation involved', 0.2453),\n",
       "  ('like pathologies', 0.2427),\n",
       "  ('internal al', 0.2353),\n",
       "  ('al copper', 0.2333),\n",
       "  ('methods', 0.2315),\n",
       "  ('functions assessed', 0.2296),\n",
       "  ('controls companies', 0.2224),\n",
       "  ('cross sectional', 0.2159),\n",
       "  ('disorder prelude', 0.2146),\n",
       "  ('population p300', 0.204),\n",
       "  ('lead authors', 0.1882),\n",
       "  ('attention exposure', 0.1833),\n",
       "  ('matched age', 0.1824),\n",
       "  ('economic status', 0.1714),\n",
       "  ('inhalation', 0.1682),\n",
       "  ('smoking habit', 0.1433),\n",
       "  ('detected pre', 0.1412),\n",
       "  ('auditory evoked', 0.1293),\n",
       "  ('assessed mini', 0.1261),\n",
       "  ('group', 0.1197),\n",
       "  ('micrograms cut', 0.1175),\n",
       "  ('foundry', 0.1149),\n",
       "  ('difference latency', 0.1113),\n",
       "  ('mild', 0.1102),\n",
       "  ('educational clinical', 0.1019),\n",
       "  ('drawing', 0.0953),\n",
       "  ('help prevent', 0.0918),\n",
       "  ('schooling years', 0.0905),\n",
       "  ('significantly higher', 0.0828),\n",
       "  ('ad ad', 0.0688),\n",
       "  ('raise question', 0.0669),\n",
       "  ('signs', 0.0577),\n",
       "  ('mn', 0.0434),\n",
       "  ('blood pressure', 0.0056),\n",
       "  ('alcohol coffee', -0.0056),\n",
       "  ('positive relationship', -0.0085),\n",
       "  ('considering 10', -0.0686)],\n",
       " 'MED-1849': [('ad neuropathology', 0.7312),\n",
       "  ('specificity alzheimer', 0.5638),\n",
       "  ('progression neurofibrillary', 0.5628),\n",
       "  ('neuropathology clinical', 0.5507),\n",
       "  ('neuroanatomic specificity', 0.5227),\n",
       "  ('neuropathology rapid', 0.5199),\n",
       "  ('prodromal phase', 0.3779),\n",
       "  ('pathology observed', 0.3649),\n",
       "  ('clues ad', 0.3543),\n",
       "  ('corticosubcortical connections', 0.3283),\n",
       "  ('imaging studies', 0.3063),\n",
       "  ('etiopathogenesis apparently', 0.2786),\n",
       "  ('neurotoxicity best', 0.2682),\n",
       "  ('progression accumulate', 0.2679),\n",
       "  ('accumulate neurons', 0.2603),\n",
       "  ('tangle', 0.2597),\n",
       "  ('vulnerable brain', 0.2576),\n",
       "  ('earlier studies', 0.2567),\n",
       "  ('mechanisms evolved', 0.2566),\n",
       "  ('ad mixed', 0.2261),\n",
       "  ('rise ad', 0.2256),\n",
       "  ('studies consistently', 0.2085),\n",
       "  ('infective agent', 0.2041),\n",
       "  ('spread defined', 0.1997),\n",
       "  ('confirmed', 0.1949),\n",
       "  ('old age', 0.1778),\n",
       "  ('decades long', 0.1584),\n",
       "  ('involves susceptibility', 0.152),\n",
       "  ('reviewed assess', 0.1475),\n",
       "  ('regions toxic', 0.1428),\n",
       "  ('general conclusions', 0.1392),\n",
       "  ('allowing aluminum', 0.1305),\n",
       "  ('profile agent', 0.1196),\n",
       "  ('agent slowly', 0.0994),\n",
       "  ('syndrome patients', 0.0991),\n",
       "  ('ferric iron', 0.0829),\n",
       "  ('magnetic', 0.0711),\n",
       "  ('gene', 0.0676),\n",
       "  ('treated drinking', 0.0644),\n",
       "  ('lysis chronic', 0.0543),\n",
       "  ('salts additives', 0.0386),\n",
       "  ('physical properties', 0.0285),\n",
       "  ('time major', 0.0141),\n",
       "  ('humans routinely', 0.0071),\n",
       "  ('normal plasma', 0.006),\n",
       "  ('sparing identical', -0.001),\n",
       "  ('processed foods', -0.0067),\n",
       "  ('fits', -0.0141),\n",
       "  ('non', -0.0161),\n",
       "  ('twin', -0.029)],\n",
       " 'MED-1850': [('al excretion', 0.5741),\n",
       "  ('al urine', 0.5366),\n",
       "  ('determination aluminum', 0.5031),\n",
       "  ('al tea', 0.5023),\n",
       "  ('excretion metal', 0.479),\n",
       "  ('consumed al', 0.4515),\n",
       "  ('significant urinary', 0.4087),\n",
       "  ('volunteers tea', 0.3991),\n",
       "  ('atomic absorption', 0.3953),\n",
       "  ('al contents', 0.3906),\n",
       "  ('urine verify', 0.3841),\n",
       "  ('al significant', 0.3719),\n",
       "  ('unique al', 0.357),\n",
       "  ('tea unique', 0.3525),\n",
       "  ('assisted acid', 0.3479),\n",
       "  ('applied determination', 0.3443),\n",
       "  ('free al', 0.3253),\n",
       "  ('digestion procedure', 0.3091),\n",
       "  ('change urinary', 0.3057),\n",
       "  ('furnace atomic', 0.2941),\n",
       "  ('fractions consumed', 0.2849),\n",
       "  ('transformation ligands', 0.2813),\n",
       "  ('body excreted', 0.2785),\n",
       "  ('drinking difference', 0.2759),\n",
       "  ('24', 0.2647),\n",
       "  ('al species', 0.26),\n",
       "  ('feces considered', 0.2373),\n",
       "  ('infusions did', 0.2372),\n",
       "  ('levels', 0.2199),\n",
       "  ('metal human', 0.197),\n",
       "  ('procedure coupled', 0.1962),\n",
       "  ('consumption oolong', 0.1952),\n",
       "  ('microwave assisted', 0.1924),\n",
       "  ('tract git', 0.191),\n",
       "  ('bile', 0.19),\n",
       "  ('did result', 0.1706),\n",
       "  ('findings indicated', 0.1696),\n",
       "  ('forms', 0.1619),\n",
       "  ('present food', 0.1579),\n",
       "  ('possibly owing', 0.1466),\n",
       "  ('long', 0.1352),\n",
       "  ('correlation', 0.1078),\n",
       "  ('volunteers', 0.106),\n",
       "  ('retained body', 0.0853),\n",
       "  ('correlation free', 0.0834),\n",
       "  ('unique', 0.0614),\n",
       "  ('big difference', 0.0563),\n",
       "  ('graphite furnace', 0.0376),\n",
       "  ('jin green', 0.0215),\n",
       "  ('black', -0.0009)],\n",
       " 'MED-1851': [('alzheimer disease', 0.588),\n",
       "  ('prevalent neurodegenerative', 0.4766),\n",
       "  ('functions aluminum', 0.4629),\n",
       "  ('al intoxication', 0.4477),\n",
       "  ('neurotoxic metal', 0.4346),\n",
       "  ('accumulation neurons', 0.4076),\n",
       "  ('bioavailable al', 0.3899),\n",
       "  ('metabolic errors', 0.3807),\n",
       "  ('brain highly', 0.3784),\n",
       "  ('elderly characterized', 0.374),\n",
       "  ('ad heavily', 0.3621),\n",
       "  ('ad misconceptions', 0.36),\n",
       "  ('reproduces neuropathological', 0.3363),\n",
       "  ('neural aberrations', 0.334),\n",
       "  ('neuronal loss', 0.3299),\n",
       "  ('higher cognitive', 0.3127),\n",
       "  ('damage excess', 0.2806),\n",
       "  ('highly compartmentalized', 0.2798),\n",
       "  ('hypothesis al', 0.2535),\n",
       "  ('brain barriers', 0.2449),\n",
       "  ('human exposure', 0.236),\n",
       "  ('organ exceptionally', 0.2041),\n",
       "  ('earth widely', 0.182),\n",
       "  ('pathogenesis', 0.1747),\n",
       "  ('misled scientists', 0.1708),\n",
       "  ('exceptionally susceptible', 0.158),\n",
       "  ('excreted body', 0.1525),\n",
       "  ('experimental evidence', 0.1501),\n",
       "  ('research reveals', 0.1483),\n",
       "  ('avoidable factor', 0.1362),\n",
       "  ('mechanisms actively', 0.1182),\n",
       "  ('demonstrated chronic', 0.1064),\n",
       "  ('incremental acquisition', 0.1024),\n",
       "  ('lifetime', 0.0882),\n",
       "  ('hallmarks', 0.0741),\n",
       "  ('built solid', 0.0705),\n",
       "  ('sequesters', 0.0651),\n",
       "  ('regarding significance', 0.0442),\n",
       "  ('significantly contributes', 0.0379),\n",
       "  ('human', 0.0375),\n",
       "  ('regional', 0.0374),\n",
       "  ('humans repeatedly', 0.0289),\n",
       "  ('evidence dismissed', 0.0255),\n",
       "  ('foci spite', 0.0213),\n",
       "  ('heavily disputed', 0.0164),\n",
       "  ('1911', 0.0107),\n",
       "  ('satisfied dietary', 0.0102),\n",
       "  ('needed produce', -0.003),\n",
       "  ('transport', -0.011),\n",
       "  ('favors selective', -0.0308)],\n",
       " 'MED-1852': [('al concentration', 0.5117),\n",
       "  ('aluminium migration', 0.4794),\n",
       "  ('cans aluminium', 0.4567),\n",
       "  ('aluminium al', 0.4132),\n",
       "  ('months aluminium', 0.4044),\n",
       "  ('tea increased', 0.4034),\n",
       "  ('mg seven', 0.3484),\n",
       "  ('analyses al', 0.3353),\n",
       "  ('tea study', 0.326),\n",
       "  ('date seven', 0.3237),\n",
       "  ('al migration', 0.3214),\n",
       "  ('mg beer', 0.3104),\n",
       "  ('increased mg', 0.2993),\n",
       "  ('cans beer', 0.2992),\n",
       "  ('canned tea', 0.2974),\n",
       "  ('migration tea', 0.2915),\n",
       "  ('seven months', 0.288),\n",
       "  ('beer tea', 0.2843),\n",
       "  ('migration cans', 0.2829),\n",
       "  ('time analyses', 0.2814),\n",
       "  ('severe al', 0.281),\n",
       "  ('increase 14', 0.2772),\n",
       "  ('concentration', 0.2708),\n",
       "  ('migration increase', 0.2631),\n",
       "  ('tea particularly', 0.2598),\n",
       "  ('al', 0.2587),\n",
       "  ('canned drinks', 0.2459),\n",
       "  ('mg tea', 0.2382),\n",
       "  ('increased', 0.2376),\n",
       "  ('performed till', 0.2365),\n",
       "  ('increase', 0.2339),\n",
       "  ('cans', 0.233),\n",
       "  ('14 mg', 0.224),\n",
       "  ('studied time', 0.222),\n",
       "  ('drinks performed', 0.2172),\n",
       "  ('till sell', 0.1955),\n",
       "  ('canned', 0.1809),\n",
       "  ('study included', 0.1734),\n",
       "  ('dented cans', 0.1664),\n",
       "  ('time', 0.1517),\n",
       "  ('sell date', 0.1477),\n",
       "  ('studied', 0.1271),\n",
       "  ('mg', 0.1166),\n",
       "  ('included', 0.1057),\n",
       "  ('particularly severe', 0.0981),\n",
       "  ('date', 0.0962),\n",
       "  ('performed', 0.0938),\n",
       "  ('months', 0.0095),\n",
       "  ('dented', -0.004),\n",
       "  ('particularly', -0.0111)],\n",
       " 'MED-1853': [('bag teas', 0.6674),\n",
       "  ('tea flavors', 0.6623),\n",
       "  ('teas methods', 0.6238),\n",
       "  ('brewed teas', 0.6184),\n",
       "  ('citrus tea', 0.5616),\n",
       "  ('teas 05', 0.5516),\n",
       "  ('tea 83', 0.4676),\n",
       "  ('differed tea', 0.4627),\n",
       "  ('teas refreshed', 0.4481),\n",
       "  ('beverages investigated', 0.4389),\n",
       "  ('brands brewed', 0.3765),\n",
       "  ('flavors tulsi', 0.3702),\n",
       "  ('yogi brands', 0.3692),\n",
       "  ('acidity fluoride', 0.3471),\n",
       "  ('measure ph', 0.3089),\n",
       "  ('methods bag', 0.2629),\n",
       "  ('physiochemical properties', 0.2549),\n",
       "  ('05 ph', 0.2477),\n",
       "  ('floral 25', 0.2403),\n",
       "  ('produced fruity', 0.2265),\n",
       "  ('boiling water', 0.2078),\n",
       "  ('concentrations differed', 0.2004),\n",
       "  ('tazo', 0.1955),\n",
       "  ('teeth painted', 0.192),\n",
       "  ('erosive potential', 0.187),\n",
       "  ('molars randomly', 0.1845),\n",
       "  ('purchased represent', 0.1827),\n",
       "  ('inversely titratable', 0.1679),\n",
       "  ('bigelow hyvee', 0.1653),\n",
       "  ('relationships', 0.1563),\n",
       "  ('measurements representative', 0.1457),\n",
       "  ('greater depths', 0.1455),\n",
       "  ('black green', 0.1382),\n",
       "  ('evaluated using', 0.1272),\n",
       "  ('ph 96', 0.1193),\n",
       "  ('way anova', 0.0991),\n",
       "  ('240 ml', 0.0947),\n",
       "  ('83 10', 0.093),\n",
       "  ('way', 0.0803),\n",
       "  ('minutes', 0.0798),\n",
       "  ('fingernail polish', 0.0752),\n",
       "  ('window soaked', 0.0704),\n",
       "  ('006 positively', 0.0701),\n",
       "  ('using microtome', 0.0503),\n",
       "  ('extracted human', 0.0449),\n",
       "  ('refreshed hours', 0.0284),\n",
       "  ('22 microm', 0.0244),\n",
       "  ('software differences', 0.0142),\n",
       "  ('polarized light', 0.0049),\n",
       "  ('pro plus', -0.0186)],\n",
       " 'MED-1857': [('periodontal parameters', 0.4843),\n",
       "  ('clinical study', 0.4152),\n",
       "  ('teeth vegetarians', 0.3703),\n",
       "  ('vegetarians versus', 0.3674),\n",
       "  ('sample size', 0.3334),\n",
       "  ('100 vegetarians', 0.3291),\n",
       "  ('lower probing', 0.2863),\n",
       "  ('total 200', 0.2499),\n",
       "  ('objectives investigations', 0.248),\n",
       "  ('probing 001', 0.242),\n",
       "  ('nutrition', 0.2377),\n",
       "  ('questionnaire applied', 0.2376),\n",
       "  ('ask patients', 0.2345),\n",
       "  ('hygiene index', 0.2341),\n",
       "  ('026', 0.2022),\n",
       "  ('rare', 0.1984),\n",
       "  ('methods total', 0.194),\n",
       "  ('subjects', 0.1921),\n",
       "  ('overall healthier', 0.1834),\n",
       "  ('smokers group', 0.1813),\n",
       "  ('mouth', 0.179),\n",
       "  ('possible correlations', 0.1711),\n",
       "  ('risk factors', 0.1626),\n",
       "  ('females 29', 0.1598),\n",
       "  ('case numbers', 0.1595),\n",
       "  ('depths 039', 0.1389),\n",
       "  ('screening index', 0.1381),\n",
       "  ('habits equally', 0.1273),\n",
       "  ('significance 05', 0.1235),\n",
       "  ('pocket', 0.1207),\n",
       "  ('bleeding', 0.1196),\n",
       "  ('life style', 0.119),\n",
       "  ('numbers aim', 0.1095),\n",
       "  ('conditions inflammation', 0.1042),\n",
       "  ('001 eroded', 0.1023),\n",
       "  ('whitney', 0.0982),\n",
       "  ('72 years', 0.097),\n",
       "  ('years non', 0.09),\n",
       "  ('characterized overall', 0.0892),\n",
       "  ('education statistical', 0.0869),\n",
       "  ('visited', 0.0806),\n",
       "  ('home care', 0.0753),\n",
       "  ('frequent conclusions', 0.0677),\n",
       "  ('age gender', 0.0539),\n",
       "  ('significantly missing', 0.0479),\n",
       "  ('45', 0.0477),\n",
       "  ('avoiding meat', 0.0015),\n",
       "  ('age 41', -0.0172),\n",
       "  ('respectively 10', -0.0209),\n",
       "  ('damage better', -0.027)],\n",
       " 'MED-1858': [('dental erosion', 0.6327),\n",
       "  ('disease dental', 0.5244),\n",
       "  ('acidic beverages', 0.512),\n",
       "  ('examples erosion', 0.4749),\n",
       "  ('erosion multifactorial', 0.4698),\n",
       "  ('damage dentition', 0.4678),\n",
       "  ('intake acidic', 0.4356),\n",
       "  ('influence drinking', 0.426),\n",
       "  ('beverages examples', 0.3868),\n",
       "  ('dentition including', 0.3724),\n",
       "  ('consumption causative', 0.3641),\n",
       "  ('dietary intake', 0.3539),\n",
       "  ('hard tissue', 0.349),\n",
       "  ('including reduction', 0.3448),\n",
       "  ('preventive measures', 0.3199),\n",
       "  ('minimize damage', 0.3152),\n",
       "  ('extrinsic sources', 0.3015),\n",
       "  ('majority dental', 0.2971),\n",
       "  ('carbonated', 0.2856),\n",
       "  ('multifactorial etiology', 0.2711),\n",
       "  ('vestibule versus', 0.2525),\n",
       "  ('disease', 0.2409),\n",
       "  ('article presents', 0.2148),\n",
       "  ('suggests implementing', 0.1953),\n",
       "  ('chronic', 0.1914),\n",
       "  ('damage inflicted', 0.1864),\n",
       "  ('sources result', 0.1839),\n",
       "  ('cautions', 0.1777),\n",
       "  ('considered effective', 0.1771),\n",
       "  ('lesions demonstrated', 0.1712),\n",
       "  ('positioned labial', 0.1562),\n",
       "  ('evidence', 0.1517),\n",
       "  ('patterns influence', 0.1507),\n",
       "  ('involving clinical', 0.1494),\n",
       "  ('various', 0.1423),\n",
       "  ('versus cup', 0.1404),\n",
       "  ('means proposed', 0.1359),\n",
       "  ('radiographic features', 0.1204),\n",
       "  ('method view', 0.1169),\n",
       "  ('embody', 0.1117),\n",
       "  ('precise description', 0.1054),\n",
       "  ('utilizing straw', 0.1031),\n",
       "  ('course management', 0.1021),\n",
       "  ('formation', 0.101),\n",
       "  ('nonspecific terms', 0.076),\n",
       "  ('adoption', 0.0739),\n",
       "  ('view extensive', 0.0718),\n",
       "  ('measures', 0.0718),\n",
       "  ('term excessive', 0.0656),\n",
       "  ('offers', 0.0221)],\n",
       " 'MED-1859': [('processing variables', 0.4508),\n",
       "  ('cooked pork', 0.4488),\n",
       "  ('properties cooked', 0.4458),\n",
       "  ('physicochemical textural', 0.4099),\n",
       "  ('patties reduction', 0.4083),\n",
       "  ('values decreased', 0.4008),\n",
       "  ('levels ingredients', 0.3755),\n",
       "  ('reduction thickness', 0.3751),\n",
       "  ('ph values', 0.3245),\n",
       "  ('useful meat', 0.3238),\n",
       "  ('optimization study', 0.3172),\n",
       "  ('effect interactions', 0.3161),\n",
       "  ('decreased water', 0.3057),\n",
       "  ('interactions processing', 0.2964),\n",
       "  ('results', 0.2863),\n",
       "  ('quality score', 0.2795),\n",
       "  ('oil added', 0.2726),\n",
       "  ('variables', 0.2715),\n",
       "  ('20 physicochemical', 0.2647),\n",
       "  ('roselle extract', 0.2642),\n",
       "  ('sensory properties', 0.264),\n",
       "  ('rsm', 0.2616),\n",
       "  ('study useful', 0.2548),\n",
       "  ('using optimum', 0.2433),\n",
       "  ('added linear', 0.2422),\n",
       "  ('surface', 0.2409),\n",
       "  ('soybean oil', 0.2334),\n",
       "  ('product', 0.2332),\n",
       "  ('extract', 0.2132),\n",
       "  ('yield patties', 0.2112),\n",
       "  ('12', 0.2085),\n",
       "  ('copyright 2013', 0.2062),\n",
       "  ('hardness depended', 0.2059),\n",
       "  ('used investigate', 0.2004),\n",
       "  ('methodology used', 0.1998),\n",
       "  ('tenderness juiciness', 0.1738),\n",
       "  ('negative', 0.1515),\n",
       "  ('values patties', 0.1512),\n",
       "  ('color', 0.1491),\n",
       "  ('response', 0.1344),\n",
       "  ('diameter values', 0.1328),\n",
       "  ('depend', 0.124),\n",
       "  ('rights', 0.1205),\n",
       "  ('increased respectively', 0.0816),\n",
       "  ('elsevier rights', 0.0776),\n",
       "  ('42 observed', 0.0765),\n",
       "  ('01 preference', 0.0742),\n",
       "  ('capacity', 0.0649),\n",
       "  ('industry tends', 0.0348),\n",
       "  ('holding', -0.0066)],\n",
       " 'MED-1860': [('studies antihypertensive', 0.513),\n",
       "  ('antihyperlipidaemic medicines', 0.4377),\n",
       "  ('hypertension study', 0.4133),\n",
       "  ('st infusion', 0.4037),\n",
       "  ('tea st', 0.3812),\n",
       "  ('infusion diabetic', 0.3778),\n",
       "  ('consuming st', 0.3661),\n",
       "  ('blood pressure', 0.3651),\n",
       "  ('controlled trial', 0.3622),\n",
       "  ('sbp st', 0.354),\n",
       "  ('patients st', 0.3483),\n",
       "  ('black tea', 0.3452),\n",
       "  ('study patients', 0.329),\n",
       "  ('bt infusion', 0.3011),\n",
       "  ('instructed drink', 0.2977),\n",
       "  ('medicines', 0.2955),\n",
       "  ('mild hypertension', 0.2758),\n",
       "  ('double blind', 0.2539),\n",
       "  ('study 112', 0.2508),\n",
       "  ('carried diabetic', 0.2248),\n",
       "  ('mean diastolic', 0.2247),\n",
       "  ('patients randomly', 0.2245),\n",
       "  ('infusions times', 0.2181),\n",
       "  ('study mean', 0.2065),\n",
       "  ('beginning study', 0.2058),\n",
       "  ('month blood', 0.189),\n",
       "  ('conclusion consuming', 0.1709),\n",
       "  ('hibiscus sabdariffa', 0.1684),\n",
       "  ('sour', 0.1453),\n",
       "  ('period intervention', 0.139),\n",
       "  ('pp patients', 0.131),\n",
       "  ('mm hg', 0.1251),\n",
       "  ('002', 0.1122),\n",
       "  ('01 conclusion', 0.1012),\n",
       "  ('times day', 0.0976),\n",
       "  ('changed 118', 0.0801),\n",
       "  ('positive effects', 0.0797),\n",
       "  ('increased 41', 0.0753),\n",
       "  ('pulse', 0.0711),\n",
       "  ('127 mm', 0.0684),\n",
       "  ('15 30', 0.0668),\n",
       "  ('compare', 0.0605),\n",
       "  ('taking', 0.0558),\n",
       "  ('groups', 0.0416),\n",
       "  ('group decreased', 0.0098),\n",
       "  ('measure changed', 0.0007),\n",
       "  ('results similar', -0.0007),\n",
       "  ('34 mm', -0.001),\n",
       "  ('14', -0.0081),\n",
       "  ('black', -0.0261)],\n",
       " 'MED-1861': [('including hypertension', 0.53),\n",
       "  ('cochrane hypertension', 0.4956),\n",
       "  ('hibiscus treatment', 0.4794),\n",
       "  ('health problem', 0.3887),\n",
       "  ('hibiscus sabdariffa', 0.2963),\n",
       "  ('suggested treatment', 0.2765),\n",
       "  ('ace inhibitors', 0.271),\n",
       "  ('folk medicine', 0.2439),\n",
       "  ('global health', 0.2427),\n",
       "  ('hot', 0.2224),\n",
       "  ('significant mortality', 0.2189),\n",
       "  ('tea study', 0.2178),\n",
       "  ('sabdariffa treatment', 0.2096),\n",
       "  ('effectiveness safety', 0.2089),\n",
       "  ('studies compared', 0.2082),\n",
       "  ('medical databases', 0.2071),\n",
       "  ('pressure reduction', 0.2008),\n",
       "  ('cold drinks', 0.1914),\n",
       "  ('review', 0.1901),\n",
       "  ('problem significant', 0.1682),\n",
       "  ('plant', 0.1665),\n",
       "  ('inhibitors', 0.16),\n",
       "  ('lisinopril', 0.1407),\n",
       "  ('trials total', 0.119),\n",
       "  ('introduction', 0.1158),\n",
       "  ('blood', 0.1111),\n",
       "  ('compared captopril', 0.1109),\n",
       "  ('term poor', 0.1107),\n",
       "  ('embase', 0.1036),\n",
       "  ('cinahl', 0.0938),\n",
       "  ('conditions including', 0.0925),\n",
       "  ('jadad', 0.0908),\n",
       "  ('specialized', 0.0908),\n",
       "  ('objectives objectives', 0.0866),\n",
       "  ('addition use', 0.0676),\n",
       "  ('general engine', 0.0658),\n",
       "  ('provide reliable', 0.0547),\n",
       "  ('gmbh rights', 0.0507),\n",
       "  ('primary', 0.0475),\n",
       "  ('patients', 0.0412),\n",
       "  ('short', 0.0343),\n",
       "  ('extracted', 0.0341),\n",
       "  ('countries consumed', 0.0304),\n",
       "  ('total 390', 0.0184),\n",
       "  ('adults copyright', 0.0124),\n",
       "  ('international', 0.0101),\n",
       "  ('authors independently', -0.0061),\n",
       "  ('did meet', -0.0104),\n",
       "  ('black', -0.0558),\n",
       "  ('google january', -0.0708)],\n",
       " 'MED-1862': [('intervention effects', 0.5478),\n",
       "  ('premier trial', 0.4836),\n",
       "  ('hypertension 18', 0.456),\n",
       "  ('programs improve', 0.4453),\n",
       "  ('improve lifestyle', 0.4127),\n",
       "  ('stop hypertension', 0.3936),\n",
       "  ('compared advice', 0.36),\n",
       "  ('months persons', 0.3504),\n",
       "  ('established recommendations', 0.3277),\n",
       "  ('pressure objective', 0.2855),\n",
       "  ('arm randomized', 0.2775),\n",
       "  ('group reductions', 0.2762),\n",
       "  ('improve control', 0.2726),\n",
       "  ('modifications', 0.2568),\n",
       "  ('volunteers prehypertension', 0.2513),\n",
       "  ('background main', 0.2464),\n",
       "  ('cardiovascular disease', 0.2391),\n",
       "  ('lower blood', 0.2277),\n",
       "  ('multicomponent behavioral', 0.2176),\n",
       "  ('objective compare', 0.2118),\n",
       "  ('odds ratios', 0.2108),\n",
       "  ('mm hg', 0.2083),\n",
       "  ('accepted risk', 0.2078),\n",
       "  ('pressure 120', 0.2069),\n",
       "  ('statistically significantly', 0.196),\n",
       "  ('implemented long', 0.1917),\n",
       "  ('sodium intake', 0.1878),\n",
       "  ('chronic', 0.1829),\n",
       "  ('authors able', 0.1813),\n",
       "  ('ci 62', 0.1699),\n",
       "  ('design multicenter', 0.1573),\n",
       "  ('greater participants', 0.1549),\n",
       "  ('94 results', 0.1498),\n",
       "  ('showed comprehensive', 0.1492),\n",
       "  ('significant limitations', 0.1435),\n",
       "  ('patients', 0.1374),\n",
       "  ('centers coordinating', 0.1362),\n",
       "  ('159 mm', 0.1337),\n",
       "  ('time sample', 0.1275),\n",
       "  ('events limited', 0.1135),\n",
       "  ('status follow', 0.1123),\n",
       "  ('dash groups', 0.1019),\n",
       "  ('83', 0.0998),\n",
       "  ('exclusion criteria', 0.0946),\n",
       "  ('fiber mineral', 0.0822),\n",
       "  ('adult', 0.081),\n",
       "  ('nature cohort', 0.0807),\n",
       "  ('january 2000', 0.0384),\n",
       "  ('limit generalizability', 0.0173),\n",
       "  ('dairy', -0.0253)],\n",
       " 'MED-1863': [('diets bp', 0.4727),\n",
       "  ('studies examined', 0.4426),\n",
       "  ('diets lower', 0.3775),\n",
       "  ('examined association', 0.3693),\n",
       "  ('reducing bp', 0.3677),\n",
       "  ('association vegetarian', 0.3622),\n",
       "  ('synthesis data', 0.3379),\n",
       "  ('sources medline', 0.3072),\n",
       "  ('observational study', 0.3019),\n",
       "  ('controlled trial', 0.2861),\n",
       "  ('published english', 0.2849),\n",
       "  ('associated lower', 0.2764),\n",
       "  ('difference bp', 0.2627),\n",
       "  ('1946', 0.2528),\n",
       "  ('compared consumption', 0.2448),\n",
       "  ('95 ci', 0.2154),\n",
       "  ('exposure intervention', 0.2024),\n",
       "  ('design baseline', 0.1969),\n",
       "  ('web science', 0.1901),\n",
       "  ('604 participants', 0.1865),\n",
       "  ('importance previous', 0.1834),\n",
       "  ('random effects', 0.1809),\n",
       "  ('heterogeneity diastolic', 0.1804),\n",
       "  ('years consumption', 0.1784),\n",
       "  ('258', 0.173),\n",
       "  ('diets 32', 0.165),\n",
       "  ('older 20', 0.1618),\n",
       "  ('exclusion criteria', 0.1572),\n",
       "  ('43 heterogeneity', 0.1541),\n",
       "  ('nonpharmacologic means', 0.1454),\n",
       "  ('92 001', 0.1435),\n",
       "  ('age 44', 0.1392),\n",
       "  ('sources', 0.1349),\n",
       "  ('conduct systematic', 0.1272),\n",
       "  ('design addition', 0.1269),\n",
       "  ('compared', 0.1235),\n",
       "  ('model main', 0.1046),\n",
       "  ('data reliance', 0.0993),\n",
       "  ('relationship established', 0.0979),\n",
       "  ('use multiple', 0.092),\n",
       "  ('twin participants', 0.0781),\n",
       "  ('series', 0.0745),\n",
       "  ('001', 0.0595),\n",
       "  ('2013 respectively', 0.0463),\n",
       "  ('hg', 0.0441),\n",
       "  ('blood', 0.0414),\n",
       "  ('measures net', 0.0173),\n",
       "  ('omnivorous', -0.0093),\n",
       "  ('mean age', -0.0272),\n",
       "  ('311 participants', -0.0563)],\n",
       " 'MED-1864': [('effectiveness hibiscus', 0.4439),\n",
       "  ('hs treatment', 0.4329),\n",
       "  ('hs decoctions', 0.3865),\n",
       "  ('rcts showed', 0.3851),\n",
       "  ('considered phytochemicals', 0.3731),\n",
       "  ('evidence hs', 0.3413),\n",
       "  ('assessed review', 0.331),\n",
       "  ('associated cardiovascular', 0.3242),\n",
       "  ('responsible antihypertensive', 0.3189),\n",
       "  ('studies consistently', 0.3186),\n",
       "  ('effectiveness', 0.2982),\n",
       "  ('comprehensive approach', 0.2929),\n",
       "  ('human studies', 0.2856),\n",
       "  ('safety toxicity', 0.2833),\n",
       "  ('health benefit', 0.2621),\n",
       "  ('therapeutic', 0.255),\n",
       "  ('ethnomedical', 0.2463),\n",
       "  ('hs tea', 0.2425),\n",
       "  ('cholesterol hdl', 0.2423),\n",
       "  ('systolic blood', 0.2308),\n",
       "  ('mechanisms proposed', 0.2251),\n",
       "  ('disease assessed', 0.2204),\n",
       "  ('commonly used', 0.2118),\n",
       "  ('sabdariffa', 0.2017),\n",
       "  ('lisinopril total', 0.1986),\n",
       "  ('anticholesterol effects', 0.1931),\n",
       "  ('hepatic effects', 0.1873),\n",
       "  ('events effects', 0.1817),\n",
       "  ('models high', 0.1816),\n",
       "  ('infusions calyxes', 0.1699),\n",
       "  ('explain hypotensive', 0.1693),\n",
       "  ('electrolyte levels', 0.1666),\n",
       "  ('cases extract', 0.1576),\n",
       "  ('practices needed', 0.1572),\n",
       "  ('extract half', 0.1506),\n",
       "  ('interpreting', 0.1433),\n",
       "  ('impedes atherosclerosis', 0.1099),\n",
       "  ('levels animal', 0.1073),\n",
       "  ('oxidation', 0.1025),\n",
       "  ('needed provide', 0.0986),\n",
       "  ('ld50 ranging', 0.0912),\n",
       "  ('significantly lowered', 0.086),\n",
       "  ('daily consumption', 0.0764),\n",
       "  ('diabetic animal', 0.0553),\n",
       "  ('leaves used', 0.0421),\n",
       "  ('dependent', 0.0374),\n",
       "  ('did significantly', 0.0354),\n",
       "  ('10 countries', -0.0403),\n",
       "  ('adults pre', -0.043),\n",
       "  ('widespread public', -0.0718)],\n",
       " 'MED-1865': [('hibiscus tea', 0.5049),\n",
       "  ('tisane hibiscus', 0.4459),\n",
       "  ('tea blends', 0.4305),\n",
       "  ('hibiscus sabdariffa', 0.4295),\n",
       "  ('hibiscus treatment', 0.4122),\n",
       "  ('antihypertensive properties', 0.4076),\n",
       "  ('beverages antioxidant', 0.3966),\n",
       "  ('tea lowered', 0.3608),\n",
       "  ('sabdariffa ingredient', 0.3542),\n",
       "  ('demonstrated hypocholesterolemic', 0.3173),\n",
       "  ('tisane', 0.3116),\n",
       "  ('herbal', 0.2931),\n",
       "  ('effects observed', 0.2618),\n",
       "  ('lowering medications', 0.2439),\n",
       "  ('higher sbp', 0.2189),\n",
       "  ('treatment 421', 0.2067),\n",
       "  ('placebo beverage', 0.1815),\n",
       "  ('trial conducted', 0.1783),\n",
       "  ('blends', 0.1714),\n",
       "  ('effective component', 0.1681),\n",
       "  ('calyces demonstrated', 0.1652),\n",
       "  ('models extracts', 0.1648),\n",
       "  ('vitro', 0.1613),\n",
       "  ('medications 240', 0.1572),\n",
       "  ('incorporated diet', 0.1506),\n",
       "  ('diastolic', 0.1456),\n",
       "  ('consumption humans', 0.1373),\n",
       "  ('servings brewed', 0.1353),\n",
       "  ('054 participants', 0.1217),\n",
       "  ('mean arterial', 0.1081),\n",
       "  ('animal', 0.0948),\n",
       "  ('suggest', 0.0799),\n",
       "  ('hg 030', 0.0775),\n",
       "  ('taking blood', 0.0751),\n",
       "  ('010', 0.0734),\n",
       "  ('did differ', 0.071),\n",
       "  ('160 change', 0.0659),\n",
       "  ('weekly intervals', 0.064),\n",
       "  ('controlled', 0.0588),\n",
       "  ('vs', 0.0561),\n",
       "  ('age gender', 0.0533),\n",
       "  ('used measure', 0.051),\n",
       "  ('borderline', 0.0458),\n",
       "  ('conducted 65', 0.0431),\n",
       "  ('placebo 11', 0.0036),\n",
       "  ('baseline showed', 0.003),\n",
       "  ('adults prove', -0.012),\n",
       "  ('age 30', -0.0131),\n",
       "  ('blind', -0.0555),\n",
       "  ('people conditions', -0.0594)],\n",
       " 'MED-1866': [('polyphenols induced', 0.4287),\n",
       "  ('sabdariffa extract', 0.4002),\n",
       "  ('improved metabolism', 0.3944),\n",
       "  ('sabdariffa calices', 0.3819),\n",
       "  ('rats 125', 0.3657),\n",
       "  ('calices administered', 0.362),\n",
       "  ('patients metabolic', 0.3465),\n",
       "  ('extract improved', 0.3336),\n",
       "  ('antioxidant activities', 0.32),\n",
       "  ('polyphenols hibiscus', 0.3183),\n",
       "  ('syndrome 125', 0.2653),\n",
       "  ('cardiovascular risks', 0.2623),\n",
       "  ('administered patients', 0.2566),\n",
       "  ('dose daily', 0.2513),\n",
       "  ('kg day', 0.2436),\n",
       "  ('diuresis', 0.2336),\n",
       "  ('single dose', 0.2323),\n",
       "  ('blood pressure', 0.2297),\n",
       "  ('spontaneously hypertensive', 0.2289),\n",
       "  ('experimental group', 0.2184),\n",
       "  ('60 mg', 0.2121),\n",
       "  ('hibiscus sabdariffa', 0.2034),\n",
       "  ('effects explain', 0.198),\n",
       "  ('beneficial actions', 0.1925),\n",
       "  ('activities significantly', 0.1906),\n",
       "  ('humans rats', 0.187),\n",
       "  ('nutrition', 0.1864),\n",
       "  ('anti inflammatory', 0.1847),\n",
       "  ('induced favorable', 0.168),\n",
       "  ('displayed potent', 0.167),\n",
       "  ('wk 31', 0.1554),\n",
       "  ('inhibition angiotensin', 0.1441),\n",
       "  ('2014', 0.1399),\n",
       "  ('food research', 0.1303),\n",
       "  ('vch verlag', 0.1302),\n",
       "  ('converting enzyme', 0.1285),\n",
       "  ('pressure humans', 0.1261),\n",
       "  ('syndrome', 0.1213),\n",
       "  ('published wiley', 0.1149),\n",
       "  ('humans', 0.1098),\n",
       "  ('authors', 0.1012),\n",
       "  ('significantly reduced', 0.0792),\n",
       "  ('endothelial response', 0.0708),\n",
       "  ('important', 0.0683),\n",
       "  ('blood', 0.0484),\n",
       "  ('spontaneously', 0.0397),\n",
       "  ('considered management', 0.0361),\n",
       "  ('mg', 0.0321),\n",
       "  ('molecular', 0.0312),\n",
       "  ('dependent', -0.0338)],\n",
       " 'MED-1867': [('tea patients', 0.5403),\n",
       "  ('sour tea', 0.4918),\n",
       "  ('tea design', 0.4564),\n",
       "  ('black tea', 0.4402),\n",
       "  ('tea hibiscus', 0.4381),\n",
       "  ('diabetes compare', 0.4263),\n",
       "  ('tea bt', 0.4012),\n",
       "  ('hypoglycemic hypolipidemic', 0.3907),\n",
       "  ('sabdariffa hypoglycemic', 0.3638),\n",
       "  ('blood lipid', 0.3373),\n",
       "  ('total cholesterol', 0.3258),\n",
       "  ('instructed consume', 0.2833),\n",
       "  ('effect blood', 0.2724),\n",
       "  ('measures fasting', 0.2551),\n",
       "  ('sour', 0.2405),\n",
       "  ('benefit patients', 0.2251),\n",
       "  ('hibiscus sabdariffa', 0.2198),\n",
       "  ('metabolic', 0.2123),\n",
       "  ('disorders', 0.1883),\n",
       "  ('clinical trial', 0.1864),\n",
       "  ('patients suffering', 0.1809),\n",
       "  ('study showed', 0.1733),\n",
       "  ('outcome measures', 0.1638),\n",
       "  ('times day', 0.1606),\n",
       "  ('patients concluded', 0.1542),\n",
       "  ('samples taken', 0.1518),\n",
       "  ('group bt', 0.1466),\n",
       "  ('significant conclusions', 0.1424),\n",
       "  ('significantly 002', 0.1294),\n",
       "  ('objective present', 0.1282),\n",
       "  ('apo b100', 0.1195),\n",
       "  ('total', 0.1104),\n",
       "  ('beginning end', 0.0994),\n",
       "  ('decrease mean', 0.0954),\n",
       "  ('changes measures', 0.0929),\n",
       "  ('hdlc increased', 0.0814),\n",
       "  ('60 patients', 0.0675),\n",
       "  ('compare', 0.0641),\n",
       "  ('st significant', 0.0594),\n",
       "  ('design sequential', 0.0589),\n",
       "  ('st black', 0.0569),\n",
       "  ('taken', 0.051),\n",
       "  ('seen group', 0.0389),\n",
       "  ('month outcome', 0.0232),\n",
       "  ('apoproteins results', 0.0147),\n",
       "  ('increasing evidence', 0.0136),\n",
       "  ('a1', 0.0114),\n",
       "  ('randomly assigned', -0.0259),\n",
       "  ('mean high', -0.0329),\n",
       "  ('53', -0.0378)],\n",
       " 'MED-1868': [('steatosis hse', 0.5058),\n",
       "  ('associated obesity', 0.4556),\n",
       "  ('preventing obesity', 0.4268),\n",
       "  ('liver disease', 0.4038),\n",
       "  ('subjects bmi', 0.3808),\n",
       "  ('body fat', 0.3738),\n",
       "  ('polyphenols hse', 0.3622),\n",
       "  ('alcoholic fatty', 0.3582),\n",
       "  ('improved liver', 0.3568),\n",
       "  ('17 hse', 0.3485),\n",
       "  ('suggested hibiscus', 0.3414),\n",
       "  ('hse anatomic', 0.3308),\n",
       "  ('metabolic regulating', 0.3263),\n",
       "  ('potential study', 0.3246),\n",
       "  ('serum ffa', 0.3133),\n",
       "  ('hse improved', 0.3068),\n",
       "  ('clinical trial', 0.2859),\n",
       "  ('serum amylase', 0.2651),\n",
       "  ('waist hip', 0.259),\n",
       "  ('18 65', 0.2513),\n",
       "  ('showed consumption', 0.2513),\n",
       "  ('acids associated', 0.2448),\n",
       "  ('sabdariffa extracts', 0.2266),\n",
       "  ('abdominal', 0.2149),\n",
       "  ('lipase', 0.2128),\n",
       "  ('diversity diseases', 0.2056),\n",
       "  ('improved illness', 0.1995),\n",
       "  ('extracts', 0.199),\n",
       "  ('12 weeks', 0.1934),\n",
       "  ('anatomic changes', 0.1861),\n",
       "  ('confirm effect', 0.1845),\n",
       "  ('act adjuvant', 0.1657),\n",
       "  ('non alcoholic', 0.1599),\n",
       "  ('alteration serum', 0.159),\n",
       "  ('27 aged', 0.158),\n",
       "  ('reduced body', 0.1534),\n",
       "  ('effect mainly', 0.1518),\n",
       "  ('tolerated adverse', 0.1411),\n",
       "  ('analysis showed', 0.1322),\n",
       "  ('disease previous', 0.132),\n",
       "  ('suggested', 0.1298),\n",
       "  ('composition', 0.1128),\n",
       "  ('groups respectively', 0.1091),\n",
       "  ('protecting potential', 0.1026),\n",
       "  ('obviously high', 0.0939),\n",
       "  ('19 groups', 0.0899),\n",
       "  ('branched chain', 0.0774),\n",
       "  ('weeks data', 0.0687),\n",
       "  ('divided control', 0.0588),\n",
       "  ('free', -0.0453)],\n",
       " 'MED-1869': [('protein intake', 0.5729),\n",
       "  ('hypertension months', 0.491),\n",
       "  ('protein months', 0.4897),\n",
       "  ('intake bp', 0.4756),\n",
       "  ('risk hypertension', 0.4605),\n",
       "  ('protein bp', 0.4369),\n",
       "  ('bp examined', 0.4366),\n",
       "  ('modifications bp', 0.427),\n",
       "  ('lifestyle modifications', 0.4091),\n",
       "  ('bp multivariable', 0.4053),\n",
       "  ('protein inversely', 0.3962),\n",
       "  ('protein useful', 0.3775),\n",
       "  ('association dietary', 0.3745),\n",
       "  ('associated reduction', 0.3418),\n",
       "  ('body weight', 0.3095),\n",
       "  ('associated systolic', 0.2799),\n",
       "  ('association protein', 0.2794),\n",
       "  ('significantly associated', 0.2774),\n",
       "  ('high intake', 0.2763),\n",
       "  ('linear regression', 0.268),\n",
       "  ('clinical studies', 0.2583),\n",
       "  ('data premier', 0.2546),\n",
       "  ('analyses month', 0.2424),\n",
       "  ('18 months', 0.2372),\n",
       "  ('conjunction research', 0.2258),\n",
       "  ('pressure', 0.2243),\n",
       "  ('effects multi', 0.2193),\n",
       "  ('beneficial effect', 0.1882),\n",
       "  ('indicate plant', 0.1846),\n",
       "  ('baseline', 0.1773),\n",
       "  ('waist', 0.1672),\n",
       "  ('analysed data', 0.1585),\n",
       "  ('trial 810', 0.1512),\n",
       "  ('independent change', 0.1452),\n",
       "  ('suggest high', 0.1448),\n",
       "  ('0866', 0.1433),\n",
       "  ('vegetables significantly', 0.1411),\n",
       "  ('sectional analyses', 0.1362),\n",
       "  ('results', 0.1307),\n",
       "  ('longitudinal', 0.1226),\n",
       "  ('prevent treat', 0.1205),\n",
       "  ('furthermore increased', 0.1163),\n",
       "  ('0096 respectively', 0.1156),\n",
       "  ('months 0797', 0.0966),\n",
       "  ('marginally', 0.0937),\n",
       "  ('0045', 0.0918),\n",
       "  ('blood', 0.0891),\n",
       "  ('0003 0157', 0.0548),\n",
       "  ('performed cross', 0.0476),\n",
       "  ('animal', 0.0147)],\n",
       " 'MED-1871': [('effect antihypertensive', 0.5619),\n",
       "  ('randomized clinical', 0.3675),\n",
       "  ('extract hibiscus', 0.3616),\n",
       "  ('differences bp', 0.3571),\n",
       "  ('treatment groups', 0.328),\n",
       "  ('captopril 50', 0.3193),\n",
       "  ('patients experimental', 0.3185),\n",
       "  ('effectiveness diastolic', 0.3157),\n",
       "  ('infusion prepared', 0.2989),\n",
       "  ('tolerability standardized', 0.2805),\n",
       "  ('subjects included', 0.2681),\n",
       "  ('end study', 0.263),\n",
       "  ('systolic', 0.2519),\n",
       "  ('hg experimental', 0.2306),\n",
       "  ('ninety subjects', 0.2299),\n",
       "  ('80 years', 0.2245),\n",
       "  ('relative hypotensive', 0.2217),\n",
       "  ('139', 0.2205),\n",
       "  ('prepared 10', 0.2202),\n",
       "  ('control group', 0.215),\n",
       "  ('100 treatments', 0.2134),\n",
       "  ('extract', 0.2069),\n",
       "  ('analysis included', 0.2045),\n",
       "  ('hibiscus sabdariffa', 0.2009),\n",
       "  ('weeks outcome', 0.194),\n",
       "  ('30', 0.1895),\n",
       "  ('electrolytes modification', 0.184),\n",
       "  ('non medical', 0.1722),\n",
       "  ('effectiveness 7895', 0.1682),\n",
       "  ('daily breakfast', 0.1647),\n",
       "  ('blood', 0.1629),\n",
       "  ('diagnosed', 0.1549),\n",
       "  ('anova 06', 0.1389),\n",
       "  ('36 patients', 0.1358),\n",
       "  ('respectively chi2', 0.1355),\n",
       "  ('able decrease', 0.1242),\n",
       "  ('month included', 0.1224),\n",
       "  ('compare', 0.1156),\n",
       "  ('73mm hg', 0.1154),\n",
       "  ('15 withdrew', 0.1037),\n",
       "  ('mg twice', 0.0994),\n",
       "  ('03', 0.0761),\n",
       "  ('560', 0.0754),\n",
       "  ('52mm hg', 0.0744),\n",
       "  ('group urinary', 0.0603),\n",
       "  ('day did', 0.0578),\n",
       "  ('dry calyx', 0.0513),\n",
       "  ('years', 0.0499),\n",
       "  ('25 mg', 0.0299),\n",
       "  ('anthocyanins content', 0.0194)],\n",
       " 'MED-1872': [('bp reduce', 0.6333),\n",
       "  ('bp dietary', 0.6331),\n",
       "  ('lifestyle recommendations', 0.5719),\n",
       "  ('dash diet', 0.5033),\n",
       "  ('antihypertensive medications', 0.5018),\n",
       "  ('diet lowers', 0.4762),\n",
       "  ('behavioral intervention', 0.4718),\n",
       "  ('optimal bp', 0.4375),\n",
       "  ('bp difference', 0.4317),\n",
       "  ('baseline hypertension', 0.4141),\n",
       "  ('compared advice', 0.367),\n",
       "  ('weight improved', 0.3648),\n",
       "  ('recommendations objective', 0.3607),\n",
       "  ('physical activity', 0.3499),\n",
       "  ('loss sodium', 0.3379),\n",
       "  ('changes lower', 0.3348),\n",
       "  ('interventions design', 0.3326),\n",
       "  ('cardiovascular disease', 0.3309),\n",
       "  ('group 12', 0.2989),\n",
       "  ('alcohol intake', 0.2975),\n",
       "  ('measures blood', 0.2897),\n",
       "  ('diastolic taking', 0.2627),\n",
       "  ('multicomponent behavioral', 0.2571),\n",
       "  ('approaches stop', 0.243),\n",
       "  ('120 159', 0.2423),\n",
       "  ('effects simultaneously', 0.2178),\n",
       "  ('mm hg', 0.2156),\n",
       "  ('context weight', 0.1914),\n",
       "  ('years 62', 0.1891),\n",
       "  ('change', 0.1614),\n",
       "  ('group 005', 0.1569),\n",
       "  ('risk', 0.1323),\n",
       "  ('individuals optimal', 0.1226),\n",
       "  ('38 prevalence', 0.1193),\n",
       "  ('43 compared', 0.1184),\n",
       "  ('gradients', 0.1169),\n",
       "  ('group 24', 0.1117),\n",
       "  ('95 mm', 0.105),\n",
       "  ('810 adults', 0.0998),\n",
       "  ('mean sd', 0.093),\n",
       "  ('net', 0.0834),\n",
       "  ('including stage', 0.0756),\n",
       "  ('268 established', 0.0503),\n",
       "  ('limited', 0.043),\n",
       "  ('2000 june', 0.0417),\n",
       "  ('vegetable', 0.0411),\n",
       "  ('women', 0.0326),\n",
       "  ('centers january', 0.0062),\n",
       "  ('30 established', 0.0019),\n",
       "  ('african american', -0.0142)],\n",
       " 'MED-1873': [('subcomponents macronutrients', 0.6792),\n",
       "  ('macronutrients saturated', 0.5899),\n",
       "  ('protein macronutrient', 0.5823),\n",
       "  ('fat intake', 0.5327),\n",
       "  ('intakes assessed', 0.5146),\n",
       "  ('confounders calorie', 0.4862),\n",
       "  ('changes dietary', 0.4796),\n",
       "  ('diet recalls', 0.4597),\n",
       "  ('fat months', 0.4238),\n",
       "  ('intake saturated', 0.4162),\n",
       "  ('contributing nutrient', 0.4092),\n",
       "  ('little research', 0.3682),\n",
       "  ('weight loss', 0.3543),\n",
       "  ('weight secondary', 0.3448),\n",
       "  ('fat animal', 0.3085),\n",
       "  ('impact subcomponents', 0.2922),\n",
       "  ('secondary observational', 0.2797),\n",
       "  ('finding composition', 0.2748),\n",
       "  ('24 diet', 0.2659),\n",
       "  ('body', 0.2539),\n",
       "  ('research examined', 0.2534),\n",
       "  ('marginally associated', 0.2349),\n",
       "  ('plant protein', 0.228),\n",
       "  ('furthermore little', 0.2185),\n",
       "  ('lifestyle', 0.213),\n",
       "  ('higher weight', 0.2004),\n",
       "  ('regression models', 0.1969),\n",
       "  ('absolute weight', 0.1949),\n",
       "  ('month intervention', 0.1683),\n",
       "  ('randomized clinical', 0.1658),\n",
       "  ('fitness monitored', 0.1617),\n",
       "  ('recalls baseline', 0.1533),\n",
       "  ('intervention predicts', 0.1363),\n",
       "  ('purpose report', 0.1264),\n",
       "  ('intensive', 0.124),\n",
       "  ('total', 0.1189),\n",
       "  ('blood pressure', 0.1173),\n",
       "  ('predicts lower', 0.1169),\n",
       "  ('impact animal', 0.1105),\n",
       "  ('069', 0.1032),\n",
       "  ('002', 0.0849),\n",
       "  ('maintenance', 0.0652),\n",
       "  ('sessions designed', 0.0556),\n",
       "  ('810 participants', 0.0536),\n",
       "  ('controlling potential', 0.0459),\n",
       "  ('18', 0.0393),\n",
       "  ('group individual', 0.0327),\n",
       "  ('designed help', 0.0255),\n",
       "  ('subsequent follow', 0.0108),\n",
       "  ('premier', -0.011)],\n",
       " 'MED-1874': [('shaped dietary', 0.5536),\n",
       "  ('humans diets', 0.5432),\n",
       "  ('plant sterols', 0.5281),\n",
       "  ('needs cholesterol', 0.5114),\n",
       "  ('lipids concentrations', 0.4726),\n",
       "  ('contemporary eating', 0.4364),\n",
       "  ('high intakes', 0.4273),\n",
       "  ('dietary fiber', 0.4266),\n",
       "  ('trans fatty', 0.4243),\n",
       "  ('hyperlipidemic subjects', 0.3983),\n",
       "  ('lifestyle especially', 0.3852),\n",
       "  ('diet reduced', 0.3801),\n",
       "  ('reductions ldl', 0.3661),\n",
       "  ('correct lipid', 0.3338),\n",
       "  ('polymorphisms conserved', 0.3313),\n",
       "  ('leafy vegetables', 0.3255),\n",
       "  ('supplementation modern', 0.322),\n",
       "  ('protein plant', 0.3184),\n",
       "  ('generation statins', 0.3137),\n",
       "  ('acids substrates', 0.2797),\n",
       "  ('consumption human', 0.2795),\n",
       "  ('phytochemicals low', 0.2782),\n",
       "  ('intakes viscous', 0.2736),\n",
       "  ('body needs', 0.266),\n",
       "  ('cardiovascular disease', 0.257),\n",
       "  ('soy almonds', 0.2526),\n",
       "  ('biosynthesis', 0.2324),\n",
       "  ('contemporary humans', 0.2023),\n",
       "  ('patterns reduce', 0.1987),\n",
       "  ('evolution tended', 0.1963),\n",
       "  ('medications furthermore', 0.1914),\n",
       "  ('fruit nuts', 0.1859),\n",
       "  ('levels result', 0.1759),\n",
       "  ('subjects components', 0.1578),\n",
       "  ('possible myocene', 0.1568),\n",
       "  ('produced similar', 0.1548),\n",
       "  ('reduce need', 0.1402),\n",
       "  ('margarine produced', 0.1353),\n",
       "  ('oat barley', 0.1135),\n",
       "  ('psyllium viscous', 0.1023),\n",
       "  ('different', 0.0947),\n",
       "  ('large quantities', 0.0945),\n",
       "  ('tended raise', 0.0839),\n",
       "  ('volunteers 30', 0.0561),\n",
       "  ('middle age', 0.0509),\n",
       "  ('normal range', 0.0283),\n",
       "  ('disease experimental', 0.0228),\n",
       "  ('blood', 0.0167),\n",
       "  ('believe', 0.0062),\n",
       "  ('man radically', -0.0099)],\n",
       " 'MED-1876': [('diabetogenic polymorphisms', 0.5536),\n",
       "  ('prediabetes t2d', 0.495),\n",
       "  ('intake grain', 0.4929),\n",
       "  ('genetic effect', 0.4392),\n",
       "  ('grain protects', 0.4362),\n",
       "  ('insulin sensitivity', 0.4339),\n",
       "  ('prediabetes se', 0.4021),\n",
       "  ('history diabetes', 0.3968),\n",
       "  ('higher intake', 0.3926),\n",
       "  ('associations significant', 0.3408),\n",
       "  ('relation intake', 0.3273),\n",
       "  ('blood pressure', 0.3211),\n",
       "  ('95 ci', 0.3176),\n",
       "  ('effect modification', 0.3123),\n",
       "  ('protects development', 0.2942),\n",
       "  ('96 risk', 0.2884),\n",
       "  ('study investigated', 0.2856),\n",
       "  ('associated reduced', 0.2842),\n",
       "  ('t2d women', 0.2832),\n",
       "  ('normal glucose', 0.2781),\n",
       "  ('impaired fasting', 0.2739),\n",
       "  ('gene design', 0.2518),\n",
       "  ('mechanisms likely', 0.2504),\n",
       "  ('intake undetectable', 0.2443),\n",
       "  ('physical activity', 0.2302),\n",
       "  ('family history', 0.221),\n",
       "  ('tolerance including', 0.2207),\n",
       "  ('risk developing', 0.2116),\n",
       "  ('ir impact', 0.2096),\n",
       "  ('background high', 0.2026),\n",
       "  ('possibly subject', 0.1957),\n",
       "  ('population based', 0.1932),\n",
       "  ('objectives prospective', 0.1826),\n",
       "  ('conclusions higher', 0.1756),\n",
       "  ('56 results', 0.1695),\n",
       "  ('smoking education', 0.1467),\n",
       "  ('harbored', 0.1283),\n",
       "  ('homa ir', 0.1281),\n",
       "  ('baseline data', 0.123),\n",
       "  ('ci 63', 0.118),\n",
       "  ('modifications tcf7l2', 0.1096),\n",
       "  ('94 men', 0.0973),\n",
       "  ('remained', 0.0671),\n",
       "  ('aged 35', 0.0667),\n",
       "  ('49', 0.0517),\n",
       "  ('tied', 0.0482),\n",
       "  ('men aged', 0.0461),\n",
       "  ('85 women', 0.0453),\n",
       "  ('40 80', 0.0167),\n",
       "  ('examined 10', -0.0123)],\n",
       " 'MED-1878': [('medicine quality', 0.4476),\n",
       "  ('providers research', 0.4044),\n",
       "  ('policymakers health', 0.3969),\n",
       "  ('improvements quality', 0.3812),\n",
       "  ('american health', 0.3387),\n",
       "  ('information systems', 0.3231),\n",
       "  ('causes quality', 0.2982),\n",
       "  ('clinicians regulators', 0.2934),\n",
       "  ('promote evidence', 0.2905),\n",
       "  ('current practices', 0.2855),\n",
       "  ('research findings', 0.2846),\n",
       "  ('reports raised', 0.2803),\n",
       "  ('doubts quality', 0.2742),\n",
       "  ('care explores', 0.2635),\n",
       "  ('approaches used', 0.2598),\n",
       "  ('complex systems', 0.2531),\n",
       "  ('accountability improvements', 0.2341),\n",
       "  ('america project', 0.2326),\n",
       "  ('change', 0.2273),\n",
       "  ('practices impede', 0.2273),\n",
       "  ('new rules', 0.2062),\n",
       "  ('chasm documents', 0.2061),\n",
       "  ('gap identifies', 0.2055),\n",
       "  ('findings technology', 0.2014),\n",
       "  ('makes urgent', 0.2009),\n",
       "  ('framework better', 0.1982),\n",
       "  ('documents causes', 0.1881),\n",
       "  ('available recent', 0.1809),\n",
       "  ('provides overarching', 0.1793),\n",
       "  ('excerpt second', 0.1792),\n",
       "  ('comprehensive volume', 0.1779),\n",
       "  ('organizations', 0.1726),\n",
       "  ('clinician', 0.1617),\n",
       "  ('academy sciences', 0.1612),\n",
       "  ('project today', 0.1593),\n",
       "  ('21st century', 0.1291),\n",
       "  ('better', 0.1235),\n",
       "  ('fundamental', 0.1233),\n",
       "  ('institute', 0.1224),\n",
       "  ('explores', 0.1057),\n",
       "  ('crossing quality', 0.1041),\n",
       "  ('performance expectations', 0.1026),\n",
       "  ('recommends sweeping', 0.0669),\n",
       "  ('inherent payment', 0.0563),\n",
       "  ('used', 0.0467),\n",
       "  ('relationships suggested', 0.0443),\n",
       "  ('committee offers', 0.0321),\n",
       "  ('10 new', 0.0201),\n",
       "  ('national', 0.0034),\n",
       "  ('rights reserved', -0.0424)],\n",
       " 'MED-1879': [('decrease adiponectin', 0.5039),\n",
       "  ('insulin sensitivity', 0.5008),\n",
       "  ('diabetes consumed', 0.4989),\n",
       "  ('hypothesis fasting', 0.4888),\n",
       "  ('obese individuals', 0.4663),\n",
       "  ('diabetes randomized', 0.4506),\n",
       "  ('fatty acid', 0.4473),\n",
       "  ('decreased glucose', 0.4466),\n",
       "  ('study overweight', 0.4459),\n",
       "  ('weeks glucose', 0.4211),\n",
       "  ('insulin improved', 0.4188),\n",
       "  ('differences flaxseed', 0.3783),\n",
       "  ('fructosamine high', 0.3502),\n",
       "  ('ir decreased', 0.3319),\n",
       "  ('women 25', 0.3183),\n",
       "  ('35 linolenic', 0.3087),\n",
       "  ('adiponectin high', 0.3046),\n",
       "  ('postmenopausal', 0.2424),\n",
       "  ('intake', 0.242),\n",
       "  ('26 012', 0.2308),\n",
       "  ('individuals pre', 0.227),\n",
       "  ('habitual', 0.2132),\n",
       "  ('consumed 13', 0.2078),\n",
       "  ('intervention compared', 0.2047),\n",
       "  ('study hypothesis', 0.2045),\n",
       "  ('reactive protein', 0.1944),\n",
       "  ('ala significantly', 0.1888),\n",
       "  ('12 weeks', 0.1823),\n",
       "  ('cross study', 0.1657),\n",
       "  ('interleukin', 0.1638),\n",
       "  ('036 013', 0.1437),\n",
       "  ('homa ir', 0.1351),\n",
       "  ('normalized percent', 0.1118),\n",
       "  ('16 mu', 0.1042),\n",
       "  ('paired tests', 0.094),\n",
       "  ('different treatment', 0.0872),\n",
       "  ('men', 0.0842),\n",
       "  ('000 periods', 0.0783),\n",
       "  ('period', 0.0599),\n",
       "  ('ground', 0.041),\n",
       "  ('model assessment', 0.0397),\n",
       "  ('51', 0.0393),\n",
       "  ('008', 0.033),\n",
       "  ('mg mean', 0.0298),\n",
       "  ('10', 0.0193),\n",
       "  ('20 04', -0.0049),\n",
       "  ('sem 22', -0.0137),\n",
       "  ('67 84', -0.0439),\n",
       "  ('copyright', -0.0487),\n",
       "  ('elsevier', -0.0837)],\n",
       " 'MED-1880': [('beans analysed', 0.5887),\n",
       "  ('legumes basés', 0.4864),\n",
       "  ('diet countries', 0.3924),\n",
       "  ('differences phenolic', 0.385),\n",
       "  ('nutritional value', 0.3484),\n",
       "  ('related cooking', 0.3387),\n",
       "  ('improves digestion', 0.3359),\n",
       "  ('phaseolus', 0.3019),\n",
       "  ('tolosana effect', 0.2875),\n",
       "  ('processes boiling', 0.2866),\n",
       "  ('vulgaris', 0.2767),\n",
       "  ('intestinal level', 0.2567),\n",
       "  ('mainly germinated', 0.2455),\n",
       "  ('cooking dark', 0.2371),\n",
       "  ('anthocyanins study', 0.2335),\n",
       "  ('properties related', 0.2199),\n",
       "  ('extracts', 0.2028),\n",
       "  ('method qualitative', 0.2008),\n",
       "  ('samples decrease', 0.1993),\n",
       "  ('analysed hplc', 0.198),\n",
       "  ('decrease antioxidant', 0.1969),\n",
       "  ('effects sample', 0.166),\n",
       "  ('health nowadays', 0.1554),\n",
       "  ('composition raw', 0.1554),\n",
       "  ('different', 0.1398),\n",
       "  ('especially rich', 0.1336),\n",
       "  ('cellular level', 0.1297),\n",
       "  ('nowadays studied', 0.127),\n",
       "  ('oxygen species', 0.1211),\n",
       "  ('work study', 0.1207),\n",
       "  ('antitumoral effects', 0.1168),\n",
       "  ('reactive', 0.1148),\n",
       "  ('influence processes', 0.108),\n",
       "  ('renal', 0.1012),\n",
       "  ('test neuroprotective', 0.0945),\n",
       "  ('astrocytes cultures', 0.0904),\n",
       "  ('lines', 0.081),\n",
       "  ('cultures 373', 0.0803),\n",
       "  ('maintaining', 0.0787),\n",
       "  ('activity mainly', 0.0671),\n",
       "  ('62 sulphorhodamine', 0.057),\n",
       "  ('uacc', 0.0333),\n",
       "  ('rights reserved', 0.027),\n",
       "  ('pad', 0.0249),\n",
       "  ('copyright 2012', 0.0128),\n",
       "  ('tk 10', 0.0055),\n",
       "  ('evaluated orac', -0.0035),\n",
       "  ('species release', -0.0082),\n",
       "  ('breast', -0.0416),\n",
       "  ('adenocarcinoma mcf', -0.1175)],\n",
       " 'MED-1881': [('cognitive decline', 0.5148),\n",
       "  ('elderly chinese', 0.4684),\n",
       "  ('studies cognitive', 0.4428),\n",
       "  ('intake cognitive', 0.4248),\n",
       "  ('decline illiterate', 0.4213),\n",
       "  ('habits declines', 0.4165),\n",
       "  ('older investigated', 0.4104),\n",
       "  ('dietary habits', 0.3895),\n",
       "  ('study chinese', 0.3807),\n",
       "  ('function mmse', 0.3322),\n",
       "  ('little research', 0.3187),\n",
       "  ('health longevity', 0.3089),\n",
       "  ('investigate association', 0.308),\n",
       "  ('aged 65', 0.2833),\n",
       "  ('thousand illiterate', 0.2793),\n",
       "  ('socio demographic', 0.2444),\n",
       "  ('research designed', 0.2358),\n",
       "  ('background despite', 0.2348),\n",
       "  ('status smoking', 0.1991),\n",
       "  ('persons assessed', 0.1966),\n",
       "  ('conducted population', 0.1904),\n",
       "  ('function influential', 0.1835),\n",
       "  ('included current', 0.1694),\n",
       "  ('control study', 0.1649),\n",
       "  ('objective', 0.155),\n",
       "  ('inversely associated', 0.147),\n",
       "  ('collected baseline', 0.1461),\n",
       "  ('residents', 0.1422),\n",
       "  ('financial status', 0.1391),\n",
       "  ('mmse 18', 0.1278),\n",
       "  ('2002 2005', 0.127),\n",
       "  ('vegetable adjusted', 0.123),\n",
       "  ('ninety elderly', 0.1147),\n",
       "  ('follow normal', 0.1118),\n",
       "  ('egg', 0.111),\n",
       "  ('important prevention', 0.11),\n",
       "  ('mini mental', 0.1088),\n",
       "  ('64', 0.1048),\n",
       "  ('marital status', 0.0964),\n",
       "  ('confidence intervals', 0.0926),\n",
       "  ('years', 0.0807),\n",
       "  ('nested', 0.0771),\n",
       "  ('revised', 0.0741),\n",
       "  ('sugar multivariate', 0.0684),\n",
       "  ('clhls', 0.0507),\n",
       "  ('legumes aor', 0.0395),\n",
       "  ('logistic', 0.0335),\n",
       "  ('fishes', 0.0333),\n",
       "  ('aor 78', 0.0129),\n",
       "  ('drinking tea', 0.0113)],\n",
       " 'MED-1882': [('treatment gemfibrozil', 0.5642),\n",
       "  ('reductions coronary', 0.4336),\n",
       "  ('lipid risk', 0.4294),\n",
       "  ('cholesterol measures', 0.4218),\n",
       "  ('measured ldl', 0.4133),\n",
       "  ('chd risk', 0.4063),\n",
       "  ('hdl particles', 0.3917),\n",
       "  ('risk reduction', 0.3456),\n",
       "  ('conventional lipoprotein', 0.3189),\n",
       "  ('measures help', 0.2545),\n",
       "  ('intervention trial', 0.2431),\n",
       "  ('mean particle', 0.2105),\n",
       "  ('nonfatal', 0.2049),\n",
       "  ('conclusions effects', 0.2032),\n",
       "  ('changes conventional', 0.2028),\n",
       "  ('benefit therapy', 0.2),\n",
       "  ('myocardial infarction', 0.1928),\n",
       "  ('partially explain', 0.1877),\n",
       "  ('95', 0.1851),\n",
       "  ('calculated adjusted', 0.1746),\n",
       "  ('odds ratios', 0.1716),\n",
       "  ('veterans affairs', 0.1693),\n",
       "  ('magnetic resonance', 0.1652),\n",
       "  ('experienced men', 0.1651),\n",
       "  ('subclasses provides', 0.1606),\n",
       "  ('levels', 0.16),\n",
       "  ('study 364', 0.1552),\n",
       "  ('size lowered', 0.1457),\n",
       "  ('treatment increased', 0.1413),\n",
       "  ('low density', 0.1345),\n",
       "  ('patients', 0.1276),\n",
       "  ('median follow', 0.1199),\n",
       "  ('baseline months', 0.1162),\n",
       "  ('hit examined', 0.1007),\n",
       "  ('disease', 0.0962),\n",
       "  ('predictors new', 0.0895),\n",
       "  ('sd increment', 0.085),\n",
       "  ('additional information', 0.0833),\n",
       "  ('matched controls', 0.0832),\n",
       "  ('prospective nested', 0.0609),\n",
       "  ('particles raising', 0.0595),\n",
       "  ('spectroscopy used', 0.0594),\n",
       "  ('ci 61', 0.0553),\n",
       "  ('plasma obtained', 0.0549),\n",
       "  ('12 47', 0.0503),\n",
       "  ('controls nuclear', 0.0341),\n",
       "  ('10 small', 0.0304),\n",
       "  ('reflected', 0.0061),\n",
       "  ('697', -0.0001),\n",
       "  ('affairs high', -0.0641)],\n",
       " 'MED-1884': [('dietary cholesterol', 0.6339),\n",
       "  ('cholesterol children', 0.584),\n",
       "  ('study dietary', 0.4594),\n",
       "  ('atherogenicity evaluated', 0.4271),\n",
       "  ('alterations ldl', 0.3863),\n",
       "  ('lipids', 0.3575),\n",
       "  ('hdl ratios', 0.3473),\n",
       "  ('criteria diabetes', 0.3413),\n",
       "  ('study effects', 0.3379),\n",
       "  ('elderly subjects', 0.323),\n",
       "  ('adults study', 0.2807),\n",
       "  ('exclusion criteria', 0.2797),\n",
       "  ('children young', 0.2792),\n",
       "  ('wk washout', 0.2553),\n",
       "  ('disease use', 0.237),\n",
       "  ('fat free', 0.237),\n",
       "  ('old exclusion', 0.2358),\n",
       "  ('60 old', 0.2357),\n",
       "  ('randomized crossover', 0.2338),\n",
       "  ('risk heart', 0.2206),\n",
       "  ('period subjects', 0.2197),\n",
       "  ('conjugated diene', 0.2092),\n",
       "  ('men women', 0.2072),\n",
       "  ('subjects contrast', 0.2036),\n",
       "  ('evaluated 42', 0.2033),\n",
       "  ('29 postmenopausal', 0.1949),\n",
       "  ('women egg', 0.1838),\n",
       "  ('previously evaluated', 0.1812),\n",
       "  ('inhibitors study', 0.1736),\n",
       "  ('concentration plasma', 0.1603),\n",
       "  ('did differ', 0.15),\n",
       "  ('ratios addition', 0.1483),\n",
       "  ('13 men', 0.1395),\n",
       "  ('measured parameters', 0.1326),\n",
       "  ('consume equivalent', 0.1229),\n",
       "  ('design', 0.1215),\n",
       "  ('population', 0.1172),\n",
       "  ('period varied', 0.1147),\n",
       "  ('oxidation', 0.1096),\n",
       "  ('responses', 0.0913),\n",
       "  ('alternate treatment', 0.0911),\n",
       "  ('use reductase', 0.0775),\n",
       "  ('healthy', 0.0747),\n",
       "  ('daily', 0.0702),\n",
       "  ('lag', 0.0427),\n",
       "  ('large', 0.04),\n",
       "  ('05', 0.039),\n",
       "  ('diameter increased', 0.0356),\n",
       "  ('sub mo', 0.0125),\n",
       "  ('001 men', -0.0068)],\n",
       " 'MED-1885': [('dietary cholesterol', 0.7087),\n",
       "  ('regarding cholesterol', 0.6787),\n",
       "  ('cholesterol challenges', 0.6604),\n",
       "  ('cholesterol reconsidered', 0.6375),\n",
       "  ('limit cholesterol', 0.6108),\n",
       "  ('ldl cholesterol', 0.5212),\n",
       "  ('current dietary', 0.5049),\n",
       "  ('cholesterol healthy', 0.5037),\n",
       "  ('limiting dietary', 0.4612),\n",
       "  ('risk chd', 0.4493),\n",
       "  ('icon dietary', 0.4391),\n",
       "  ('eggs icon', 0.3387),\n",
       "  ('maintenance ldl', 0.3281),\n",
       "  ('existing epidemiological', 0.3226),\n",
       "  ('guidelines existing', 0.3175),\n",
       "  ('recent findings', 0.2959),\n",
       "  ('purpose review', 0.2921),\n",
       "  ('clinical interventions', 0.2824),\n",
       "  ('300 mg', 0.2801),\n",
       "  ('population hdl', 0.2794),\n",
       "  ('restrictions regarding', 0.2341),\n",
       "  ('upper limit', 0.2197),\n",
       "  ('studies shown', 0.2159),\n",
       "  ('risk', 0.2102),\n",
       "  ('heart disease', 0.2066),\n",
       "  ('challenges support', 0.2043),\n",
       "  ('increase plasma', 0.1952),\n",
       "  ('european countries', 0.1758),\n",
       "  ('current', 0.1748),\n",
       "  ('beneficial effects', 0.1696),\n",
       "  ('canada new', 0.1612),\n",
       "  ('challenges increase', 0.1535),\n",
       "  ('mg day', 0.1529),\n",
       "  ('correlated increased', 0.1515),\n",
       "  ('reconsidered', 0.1428),\n",
       "  ('evidence coming', 0.1426),\n",
       "  ('perceived notion', 0.1247),\n",
       "  ('zealand korea', 0.1062),\n",
       "  ('healthy populations', 0.1018),\n",
       "  ('data clearly', 0.0943),\n",
       "  ('ratio key', 0.0903),\n",
       "  ('individuals recent', 0.0572),\n",
       "  ('utilizing different', 0.0542),\n",
       "  ('usa', 0.0344),\n",
       "  ('india upper', 0.0309),\n",
       "  ('lines', 0.0115),\n",
       "  ('presents', 0.0113),\n",
       "  ('led', 0.0095),\n",
       "  ('countries australia', -0.0101),\n",
       "  ('quarter population', -0.1071)],\n",
       " 'MED-1886': [('lipoproteins measured', 0.5153),\n",
       "  ('nmr spectroscopy', 0.4828),\n",
       "  ('vldlnmr size', 0.4029),\n",
       "  ('ldlnmr 51', 0.3912),\n",
       "  ('non hdl', 0.3885),\n",
       "  ('67 ldl', 0.3771),\n",
       "  ('spectroscopy measures', 0.3729),\n",
       "  ('standard lipids', 0.3684),\n",
       "  ('58 apolipoproteins', 0.3552),\n",
       "  ('79 hdlnmr', 0.3329),\n",
       "  ('healthy women', 0.3243),\n",
       "  ('cholesterol 74', 0.3096),\n",
       "  ('instead cholesterol', 0.2875),\n",
       "  ('background nuclear', 0.2849),\n",
       "  ('study', 0.2537),\n",
       "  ('27 673', 0.2458),\n",
       "  ('disease cvd', 0.2437),\n",
       "  ('21 54', 0.2212),\n",
       "  ('12 low', 0.2145),\n",
       "  ('results baseline', 0.2127),\n",
       "  ('015 11', 0.2036),\n",
       "  ('nri respectively', 0.1938),\n",
       "  ('ratio non', 0.1931),\n",
       "  ('intervals cis', 0.1875),\n",
       "  ('58 95', 0.1771),\n",
       "  ('size 37', 0.176),\n",
       "  ('resonance', 0.1723),\n",
       "  ('particles instead', 0.1676),\n",
       "  ('uncertain methods', 0.1641),\n",
       "  ('nanometers', 0.162),\n",
       "  ('ratios hrs', 0.1562),\n",
       "  ('risk prediction', 0.154),\n",
       "  ('factors net', 0.1524),\n",
       "  ('10 70', 0.1504),\n",
       "  ('content clinical', 0.1472),\n",
       "  ('reclassification improvement', 0.1432),\n",
       "  ('profiles evaluated', 0.1164),\n",
       "  ('measures comparable', 0.1092),\n",
       "  ('64', 0.1065),\n",
       "  ('42', 0.0997),\n",
       "  ('82 23', 0.079),\n",
       "  ('ratio 25', 0.074),\n",
       "  ('did addition', 0.0738),\n",
       "  ('years adjusting', 0.0705),\n",
       "  ('magnetic', 0.0703),\n",
       "  ('30', 0.068),\n",
       "  ('high density', 0.0591),\n",
       "  ('followed incident', 0.0515),\n",
       "  ('vs quintile', 0.049),\n",
       "  ('superior', -0.0478)],\n",
       " 'MED-1887': [('lipoprotein analysis', 0.6004),\n",
       "  ('subfractionation apolipoproteins', 0.5345),\n",
       "  ('focusing ldl', 0.4787),\n",
       "  ('biomarker evaluation', 0.4356),\n",
       "  ('cardiovascular outcomes', 0.429),\n",
       "  ('hdl particle', 0.4229),\n",
       "  ('cholesterol reduction', 0.4008),\n",
       "  ('lifestyle drug', 0.389),\n",
       "  ('risk patients', 0.3377),\n",
       "  ('guided strategies', 0.3242),\n",
       "  ('intensification statin', 0.324),\n",
       "  ('practitioners use', 0.3138),\n",
       "  ('cardiology', 0.3083),\n",
       "  ('individualizing therapies', 0.3067),\n",
       "  ('approach needs', 0.285),\n",
       "  ('subfractionation', 0.281),\n",
       "  ('analysis guided', 0.278),\n",
       "  ('fenofibrate', 0.2727),\n",
       "  ('better predicting', 0.2707),\n",
       "  ('targeting measures', 0.2615),\n",
       "  ('current standards', 0.2553),\n",
       "  ('tests incrementally', 0.2472),\n",
       "  ('recent randomized', 0.2336),\n",
       "  ('particle number', 0.2325),\n",
       "  ('needs research', 0.2272),\n",
       "  ('body evidence', 0.203),\n",
       "  ('low density', 0.1919),\n",
       "  ('use advanced', 0.1898),\n",
       "  ('costs approach', 0.1897),\n",
       "  ('adverse effects', 0.1853),\n",
       "  ('parameters specifically', 0.1775),\n",
       "  ('reduction intensification', 0.1699),\n",
       "  ('prevention unfortunately', 0.1649),\n",
       "  ('predicted traditional', 0.1579),\n",
       "  ('goal better', 0.1568),\n",
       "  ('2012 american', 0.1322),\n",
       "  ('contrast large', 0.121),\n",
       "  ('risk copyright', 0.1185),\n",
       "  ('foundation published', 0.117),\n",
       "  ('specifically niacin', 0.1057),\n",
       "  ('known alter', 0.0895),\n",
       "  ('published elsevier', 0.083),\n",
       "  ('lead increased', 0.0821),\n",
       "  ('supports', 0.0714),\n",
       "  ('rights reserved', 0.0569),\n",
       "  ('establish role', 0.0526),\n",
       "  ('remains', 0.0435),\n",
       "  ('events lead', 0.0311),\n",
       "  ('treated', 0.0245),\n",
       "  ('college', 0.0229)],\n",
       " 'MED-1888': [('phosphatidylcholine tmao', 0.5117),\n",
       "  ('dietary phosphatidylcholine', 0.504),\n",
       "  ('lecithin coronary', 0.3984),\n",
       "  ('metabolism dietary', 0.3942),\n",
       "  ('link intestinal', 0.3763),\n",
       "  ('metabolites detected', 0.364),\n",
       "  ('proatherosclerotic', 0.3587),\n",
       "  ('phosphatidylcholine challenge', 0.3353),\n",
       "  ('choline betaine', 0.3307),\n",
       "  ('metabolite trimethylamine', 0.31),\n",
       "  ('microbial', 0.3073),\n",
       "  ('studies animals', 0.2628),\n",
       "  ('shown mechanistic', 0.2237),\n",
       "  ('myocardial infarction', 0.2147),\n",
       "  ('disease production', 0.2146),\n",
       "  ('adverse cardiovascular', 0.2138),\n",
       "  ('001 elevated', 0.1938),\n",
       "  ('oxide', 0.178),\n",
       "  ('background recent', 0.1764),\n",
       "  ('investigated relationship', 0.1711),\n",
       "  ('antibiotics increased', 0.1638),\n",
       "  ('risk subgroups', 0.1606),\n",
       "  ('levels means', 0.1538),\n",
       "  ('001 lower', 0.1439),\n",
       "  ('mass spectrometry', 0.1426),\n",
       "  ('boiled', 0.1335),\n",
       "  ('angiography results', 0.1306),\n",
       "  ('methods quantified', 0.1212),\n",
       "  ('eggs', 0.1153),\n",
       "  ('isotopologue', 0.1043),\n",
       "  ('4007 patients', 0.0999),\n",
       "  ('confidence interval', 0.0931),\n",
       "  ('54', 0.0919),\n",
       "  ('oral', 0.0913),\n",
       "  ('deuterium d9', 0.0893),\n",
       "  ('suppressed administration', 0.0685),\n",
       "  ('markedly', 0.0664),\n",
       "  ('plasma urinary', 0.0579),\n",
       "  ('adjustment traditional', 0.0574),\n",
       "  ('28 001', 0.0566),\n",
       "  ('national institutes', 0.0533),\n",
       "  ('broad spectrum', 0.0461),\n",
       "  ('health', 0.045),\n",
       "  ('stroke years', 0.0365),\n",
       "  ('events funded', 0.0307),\n",
       "  ('healthy participants', 0.0085),\n",
       "  ('online tandem', 0.0),\n",
       "  ('undergoing elective', -0.0228),\n",
       "  ('means liquid', -0.0347),\n",
       "  ('reappeared withdrawal', -0.0403)],\n",
       " 'MED-1889': [('eggs consumption', 0.6327),\n",
       "  ('cholesterol intake', 0.4962),\n",
       "  ('hypercholesterolemia generally', 0.4728),\n",
       "  ('affected eggs', 0.4659),\n",
       "  ('atherogenic properties', 0.4406),\n",
       "  ('plasma fatty', 0.4099),\n",
       "  ('intake', 0.3738),\n",
       "  ('day meals', 0.3682),\n",
       "  ('triglycerides decreased', 0.3451),\n",
       "  ('ldl oxidation', 0.3256),\n",
       "  ('ions lipid', 0.2788),\n",
       "  ('apolipoproteins 100', 0.2698),\n",
       "  ('hdl derived', 0.2671),\n",
       "  ('plasma antioxidants', 0.2651),\n",
       "  ('weeks resulted', 0.2624),\n",
       "  ('increased plasma', 0.2536),\n",
       "  ('urea concentrations', 0.2503),\n",
       "  ('peroxidation increased', 0.2272),\n",
       "  ('generally restricted', 0.2261),\n",
       "  ('acids concentration', 0.225),\n",
       "  ('carotenoids significantly', 0.2169),\n",
       "  ('consumption comparison', 0.2161),\n",
       "  ('glucose', 0.2068),\n",
       "  ('alterations', 0.1646),\n",
       "  ('increased mg', 0.1606),\n",
       "  ('05 13', 0.159),\n",
       "  ('reduction significant', 0.1561),\n",
       "  ('baseline susceptibility', 0.1414),\n",
       "  ('study analyzed', 0.1336),\n",
       "  ('time required', 0.127),\n",
       "  ('resulted', 0.1258),\n",
       "  ('long period', 0.1247),\n",
       "  ('34 respectively', 0.1233),\n",
       "  ('populations', 0.1081),\n",
       "  ('properties contribute', 0.1078),\n",
       "  ('thiobarbituric', 0.1071),\n",
       "  ('01 kinetic', 0.0973),\n",
       "  ('reactive substance', 0.0891),\n",
       "  ('lag', 0.0775),\n",
       "  ('enhance progression', 0.0681),\n",
       "  ('low density', 0.0679),\n",
       "  ('microm', 0.0671),\n",
       "  ('decreased 11', 0.0418),\n",
       "  ('efflux', 0.0405),\n",
       "  ('774 macrophages', 0.0318),\n",
       "  ('elevation', 0.0257),\n",
       "  ('tbars', 0.0208),\n",
       "  ('azobis amidinopropane', 0.0161),\n",
       "  ('copper', -0.0057),\n",
       "  ('42', -0.0065)],\n",
       " 'MED-1890': [('eggs cholesterol', 0.5529),\n",
       "  ('effect egg', 0.4903),\n",
       "  ('effect dietary', 0.4529),\n",
       "  ('effect hdl', 0.4449),\n",
       "  ('studies identified', 0.4304),\n",
       "  ('limit cholesterol', 0.3367),\n",
       "  ('cholesterol increased', 0.3349),\n",
       "  ('diets differed', 0.3333),\n",
       "  ('review effect', 0.3272),\n",
       "  ('risk coronary', 0.3118),\n",
       "  ('background epidemiologic', 0.3021),\n",
       "  ('95 ci', 0.2733),\n",
       "  ('ldl', 0.2714),\n",
       "  ('consumption risk', 0.2654),\n",
       "  ('possible adverse', 0.2621),\n",
       "  ('intake', 0.2479),\n",
       "  ('heart disease', 0.2362),\n",
       "  ('reference lists', 0.2311),\n",
       "  ('mg dietary', 0.2013),\n",
       "  ('medline', 0.196),\n",
       "  ('reducing consumption', 0.189),\n",
       "  ('008 mmol', 0.1882),\n",
       "  ('fed 14', 0.1808),\n",
       "  ('disease possible', 0.1794),\n",
       "  ('control group', 0.1667),\n",
       "  ('foods valid', 0.1591),\n",
       "  ('concentrations reported', 0.1581),\n",
       "  ('recently published', 0.1529),\n",
       "  ('included crossover', 0.1465),\n",
       "  ('biological', 0.1343),\n",
       "  ('dl conclusions', 0.1217),\n",
       "  ('results', 0.1192),\n",
       "  ('lists addition', 0.1121),\n",
       "  ('objective objective', 0.1108),\n",
       "  ('rich', 0.1057),\n",
       "  ('subjects met', 0.1033),\n",
       "  ('1999', 0.0957),\n",
       "  ('005 010', 0.095),\n",
       "  ('parallel design', 0.0776),\n",
       "  ('556 subjects', 0.0769),\n",
       "  ('advice', 0.0722),\n",
       "  ('raises ratio', 0.0665),\n",
       "  ('favorable effect', 0.0657),\n",
       "  ('030 total', 0.0621),\n",
       "  ('offset', 0.0577),\n",
       "  ('065 mmol', 0.0523),\n",
       "  ('identified 17', 0.0481),\n",
       "  ('100 mg', 0.0334),\n",
       "  ('reported 222', -0.0071),\n",
       "  ('1974 june', -0.0457)],\n",
       " 'MED-1914': [('telomere erosion', 0.6117),\n",
       "  ('mortality telomere', 0.5303),\n",
       "  ('telomere length', 0.5168),\n",
       "  ('telomeres shorter', 0.4846),\n",
       "  ('life maltreatment', 0.481),\n",
       "  ('telomere discoveries', 0.478),\n",
       "  ('erosion dna', 0.4136),\n",
       "  ('negative effects', 0.4004),\n",
       "  ('exposure stress', 0.3978),\n",
       "  ('later life', 0.3824),\n",
       "  ('stress health', 0.3805),\n",
       "  ('changes dna', 0.379),\n",
       "  ('effects health', 0.3546),\n",
       "  ('childhood stress', 0.3376),\n",
       "  ('length correlates', 0.3292),\n",
       "  ('maltreatment exert', 0.3266),\n",
       "  ('suggests exposure', 0.3262),\n",
       "  ('stress accelerate', 0.3172),\n",
       "  ('problems later', 0.3158),\n",
       "  ('research suggests', 0.2924),\n",
       "  ('decades later', 0.2759),\n",
       "  ('health decades', 0.2689),\n",
       "  ('disease risk', 0.2444),\n",
       "  ('potential mechanism', 0.2355),\n",
       "  ('chronological age', 0.2324),\n",
       "  ('biological questions', 0.2295),\n",
       "  ('shorter', 0.1993),\n",
       "  ('experiences early', 0.1891),\n",
       "  ('correlates', 0.1888),\n",
       "  ('research directions', 0.1848),\n",
       "  ('biological', 0.1798),\n",
       "  ('changes', 0.1669),\n",
       "  ('mortality', 0.1649),\n",
       "  ('mechanistic methodological', 0.1589),\n",
       "  ('paper covers', 0.1247),\n",
       "  ('accelerate erosion', 0.1202),\n",
       "  ('monitoring', 0.1),\n",
       "  ('clinical applications', 0.0993),\n",
       "  ('linking', 0.0987),\n",
       "  ('lays new', 0.0941),\n",
       "  ('segments called', 0.094),\n",
       "  ('discoveries', 0.0772),\n",
       "  ('state science', 0.0524),\n",
       "  ('array', 0.0519),\n",
       "  ('current', 0.0455),\n",
       "  ('addressed', 0.0351),\n",
       "  ('answer lie', 0.0259),\n",
       "  ('basic', 0.0202),\n",
       "  ('translate', 0.0129),\n",
       "  ('exert', -0.0178)],\n",
       " 'MED-1915': [('work stress', 0.542),\n",
       "  ('psychological stress', 0.4708),\n",
       "  ('leukocyte telomeres', 0.4548),\n",
       "  ('exhaustion leukocyte', 0.4539),\n",
       "  ('working age', 0.4487),\n",
       "  ('aging investigated', 0.4082),\n",
       "  ('association exhaustion', 0.3937),\n",
       "  ('background psychological', 0.3589),\n",
       "  ('burnout inventory', 0.3152),\n",
       "  ('suggest work', 0.2814),\n",
       "  ('age population', 0.2713),\n",
       "  ('chromosomal ends', 0.2654),\n",
       "  ('indicator prolonged', 0.2568),\n",
       "  ('length using', 0.2321),\n",
       "  ('associated accelerated', 0.2306),\n",
       "  ('rate biological', 0.2303),\n",
       "  ('population health', 0.2245),\n",
       "  ('sample finnish', 0.2223),\n",
       "  ('cells methods', 0.2166),\n",
       "  ('2000 study', 0.215),\n",
       "  ('prospective study', 0.2018),\n",
       "  ('results adjustment', 0.1724),\n",
       "  ('individuals severe', 0.1676),\n",
       "  ('smoking body', 0.1558),\n",
       "  ('data suggest', 0.1506),\n",
       "  ('polymerase', 0.146),\n",
       "  ('64', 0.1342),\n",
       "  ('indicated shorter', 0.1319),\n",
       "  ('men women', 0.1303),\n",
       "  ('chain reaction', 0.1298),\n",
       "  ('protein complexes', 0.1276),\n",
       "  ('standard error', 0.1219),\n",
       "  ('hypothesis awaits', 0.1152),\n",
       "  ('remained', 0.1094),\n",
       "  ('socioeconomic', 0.108),\n",
       "  ('008 conclusions', 0.1032),\n",
       "  ('sample consisted', 0.1009),\n",
       "  ('assessed using', 0.0903),\n",
       "  ('inventory general', 0.0699),\n",
       "  ('difference', 0.0604),\n",
       "  ('mass index', 0.0477),\n",
       "  ('mean 016', 0.0407),\n",
       "  ('units', 0.0366),\n",
       "  ('aged 30', 0.0213),\n",
       "  ('average 043', 0.0106),\n",
       "  ('real time', 0.0047),\n",
       "  ('sex', -0.0293),\n",
       "  ('using maslach', -0.0587),\n",
       "  ('cap', -0.0803),\n",
       "  ('2911 men', -0.0937)],\n",
       " 'MED-1916': [('leukocyte telomere', 0.5433),\n",
       "  ('diseases leukocyte', 0.4829),\n",
       "  ('aging tested', 0.4082),\n",
       "  ('regular exercise', 0.399),\n",
       "  ('inactivity important', 0.3863),\n",
       "  ('lifestyle addition', 0.3507),\n",
       "  ('length age', 0.3485),\n",
       "  ('level leisure', 0.314),\n",
       "  ('ltls active', 0.3132),\n",
       "  ('longer active', 0.3102),\n",
       "  ('conclusions sedentary', 0.3033),\n",
       "  ('related diseases', 0.2871),\n",
       "  ('attrition rate', 0.285),\n",
       "  ('001 association', 0.2839),\n",
       "  ('antiaging effect', 0.2767),\n",
       "  ('confounders results', 0.2712),\n",
       "  ('hypothesis physical', 0.2642),\n",
       "  ('time past', 0.2581),\n",
       "  ('biological indicator', 0.2565),\n",
       "  ('body mass', 0.2548),\n",
       "  ('association remained', 0.2491),\n",
       "  ('activity work', 0.2419),\n",
       "  ('nucleotides longer', 0.2382),\n",
       "  ('background', 0.237),\n",
       "  ('associated increasing', 0.2264),\n",
       "  ('12 months', 0.215),\n",
       "  ('studied 2401', 0.2143),\n",
       "  ('subjects kilobases', 0.211),\n",
       "  ('smoking status', 0.201),\n",
       "  ('normal healthy', 0.1781),\n",
       "  ('index low', 0.1753),\n",
       "  ('dynamics', 0.1635),\n",
       "  ('important risk', 0.1596),\n",
       "  ('comprising 2152', 0.1484),\n",
       "  ('terminal restriction', 0.1455),\n",
       "  ('200 nucleotides', 0.1329),\n",
       "  ('adjusted', 0.1279),\n",
       "  ('88 nucleotides', 0.1009),\n",
       "  ('respectively 006', 0.1008),\n",
       "  ('03 conclusions', 0.0928),\n",
       "  ('socioeconomic', 0.0784),\n",
       "  ('white', 0.0641),\n",
       "  ('used clinicians', 0.0521),\n",
       "  ('sex body', 0.0473),\n",
       "  ('twin volunteers', 0.0423),\n",
       "  ('derived mean', 0.0394),\n",
       "  ('women', 0.0233),\n",
       "  ('men questionnaires', 0.0128),\n",
       "  ('discordant', -0.0403),\n",
       "  ('powerful message', -0.0605)],\n",
       " 'MED-1917': [('telomeres characteristics', 0.563),\n",
       "  ('shorter telomere', 0.4925),\n",
       "  ('atherosclerosis unclear', 0.4777),\n",
       "  ('cac sample', 0.4221),\n",
       "  ('aging shorter', 0.4007),\n",
       "  ('biologic aging', 0.3626),\n",
       "  ('subjects aged', 0.3429),\n",
       "  ('cac attenuated', 0.3359),\n",
       "  ('attenuated association', 0.3358),\n",
       "  ('length coronary', 0.3304),\n",
       "  ('controlling age', 0.2941),\n",
       "  ('healthy lifestyles', 0.251),\n",
       "  ('unclear healthy', 0.2492),\n",
       "  ('low social', 0.2345),\n",
       "  ('40 64', 0.2325),\n",
       "  ('previous diagnosis', 0.221),\n",
       "  ('years previous', 0.2201),\n",
       "  ('heart disease', 0.2132),\n",
       "  ('study suggest', 0.2028),\n",
       "  ('ethnicity', 0.192),\n",
       "  ('conversely subjects', 0.1865),\n",
       "  ('stroke diabetes', 0.178),\n",
       "  ('indicator biologic', 0.1734),\n",
       "  ('men women', 0.1674),\n",
       "  ('regression analyses', 0.1631),\n",
       "  ('framingham', 0.1526),\n",
       "  ('different longer', 0.1488),\n",
       "  ('cancer 318', 0.1416),\n",
       "  ('interval 61', 0.1375),\n",
       "  ('race', 0.1221),\n",
       "  ('interval 24', 0.1141),\n",
       "  ('consumption odds', 0.1074),\n",
       "  ('increased risk', 0.1001),\n",
       "  ('ratio 58', 0.0991),\n",
       "  ('37 stratification', 0.0969),\n",
       "  ('gender yielded', 0.0921),\n",
       "  ('rights reserved', 0.0897),\n",
       "  ('social support', 0.089),\n",
       "  ('20', 0.0883),\n",
       "  ('weight presence', 0.074),\n",
       "  ('95 confidence', 0.0671),\n",
       "  ('logistic', 0.0658),\n",
       "  ('yielded similar', 0.0591),\n",
       "  ('women fruit', 0.0522),\n",
       "  ('present', 0.0429),\n",
       "  ('relation having', 0.0379),\n",
       "  ('meat consumption', 0.0301),\n",
       "  ('vegetable', 0.0215),\n",
       "  ('75', 0.0163),\n",
       "  ('2010 elsevier', -0.013)],\n",
       " 'MED-1918': [('meditation decreases', 0.5109),\n",
       "  ('developed meditative', 0.4367),\n",
       "  ('decreases chronic', 0.4306),\n",
       "  ('link meditation', 0.4075),\n",
       "  ('viability decreases', 0.391),\n",
       "  ('decreased stress', 0.3797),\n",
       "  ('results telomerase', 0.3512),\n",
       "  ('implications telomere', 0.3452),\n",
       "  ('chronic psychological', 0.3349),\n",
       "  ('buddhist traditions', 0.3213),\n",
       "  ('longevity', 0.3179),\n",
       "  ('positive psychological', 0.3096),\n",
       "  ('traditions claim', 0.262),\n",
       "  ('retreat 05', 0.258),\n",
       "  ('related changes', 0.2307),\n",
       "  ('mindfulness did', 0.2208),\n",
       "  ('distress used', 0.2102),\n",
       "  ('did measure', 0.1949),\n",
       "  ('measure baseline', 0.1945),\n",
       "  ('practices used', 0.1785),\n",
       "  ('hypotheses tailed', 0.1739),\n",
       "  ('et al', 0.1549),\n",
       "  ('body mass', 0.1451),\n",
       "  ('control negative', 0.1442),\n",
       "  ('daily months', 0.1401),\n",
       "  ('neuroticism partially', 0.1277),\n",
       "  ('analyses indicated', 0.1265),\n",
       "  ('term cellular', 0.1236),\n",
       "  ('life influenced', 0.1212),\n",
       "  ('2004', 0.1052),\n",
       "  ('concentrative', 0.1016),\n",
       "  ('cutler 2009', 0.0936),\n",
       "  ('benevolent states', 0.0934),\n",
       "  ('used mediation', 0.0925),\n",
       "  ('cultivate', 0.0876),\n",
       "  ('activity significantly', 0.0795),\n",
       "  ('dalai lama', 0.0748),\n",
       "  ('compared wait', 0.0596),\n",
       "  ('2006', 0.059),\n",
       "  ('group 30', 0.0554),\n",
       "  ('indirectly copyright', 0.0424),\n",
       "  ('directly affects', 0.0355),\n",
       "  ('wallace', 0.0307),\n",
       "  ('contributors experience', 0.0285),\n",
       "  ('peripheral', 0.0192),\n",
       "  ('immune cell', 0.0125),\n",
       "  ('clear priori', 0.0037),\n",
       "  ('collected post', -0.0034),\n",
       "  ('2010 elsevier', -0.0042),\n",
       "  ('difference increases', -0.0079)],\n",
       " 'MED-1919': [('telomerases constitute', 0.7102),\n",
       "  ('mechanism telomerase', 0.6637),\n",
       "  ('partial telomerase', 0.6052),\n",
       "  ('defects telomere', 0.5811),\n",
       "  ('constrained telomerase', 0.5668),\n",
       "  ('telomere elongation', 0.4906),\n",
       "  ('telomeric dna', 0.454),\n",
       "  ('chromosomal shrinkage', 0.3222),\n",
       "  ('dna remains', 0.317),\n",
       "  ('specialized ribonucleoprotein', 0.3098),\n",
       "  ('dna template', 0.3002),\n",
       "  ('elongation unknown', 0.2924),\n",
       "  ('diseases aging', 0.2822),\n",
       "  ('template reused', 0.2773),\n",
       "  ('enzymes remediate', 0.2694),\n",
       "  ('replication', 0.2593),\n",
       "  ('remains elusive', 0.2404),\n",
       "  ('subunit ter', 0.2325),\n",
       "  ('time translation', 0.2097),\n",
       "  ('single stranded', 0.1994),\n",
       "  ('cancer despite', 0.1869),\n",
       "  ('cycles domain', 0.1843),\n",
       "  ('understanding roles', 0.1796),\n",
       "  ('conclude rna', 0.1749),\n",
       "  ('new insights', 0.1743),\n",
       "  ('mechanism processivity', 0.1696),\n",
       "  ('defects', 0.1695),\n",
       "  ('heteroduplex constrained', 0.1648),\n",
       "  ('modeling molecular', 0.1642),\n",
       "  ('repeated extension', 0.1596),\n",
       "  ('provides details', 0.1504),\n",
       "  ('base time', 0.1461),\n",
       "  ('regulation associated', 0.1443),\n",
       "  ('complete structure', 0.139),\n",
       "  ('despite significant', 0.1363),\n",
       "  ('active site', 0.1311),\n",
       "  ('group specialized', 0.113),\n",
       "  ('problem', 0.1045),\n",
       "  ('available experimental', 0.1033),\n",
       "  ('essential protein', 0.1026),\n",
       "  ('significant progress', 0.1023),\n",
       "  ('region human', 0.0979),\n",
       "  ('helix', 0.088),\n",
       "  ('application computational', 0.0768),\n",
       "  ('detection comparative', 0.0755),\n",
       "  ('length', 0.0745),\n",
       "  ('distant homology', 0.0702),\n",
       "  ('target rational', 0.0512),\n",
       "  ('double', 0.0395),\n",
       "  ('bind complementarily', -0.0168)],\n",
       " 'MED-1920': [('diabetes overweight', 0.6661),\n",
       "  ('diabetes approximately', 0.6633),\n",
       "  ('obesity related', 0.6488),\n",
       "  ('diabetes cardiovascular', 0.6063),\n",
       "  ('diabetes control', 0.5844),\n",
       "  ('ameliorate obesity', 0.5585),\n",
       "  ('diabetes 45', 0.518),\n",
       "  ('weight loss', 0.4979),\n",
       "  ('effectiveness diabetes', 0.4845),\n",
       "  ('metabolic abnormalities', 0.4797),\n",
       "  ('cardiovascular disease', 0.4702),\n",
       "  ('intensive weight', 0.4558),\n",
       "  ('mass index', 0.3186),\n",
       "  ('term weight', 0.311),\n",
       "  ('complications hospitalizations', 0.2996),\n",
       "  ('decreased caloric', 0.2857),\n",
       "  ('age body', 0.2632),\n",
       "  ('consequences intentional', 0.2394),\n",
       "  ('intake increased', 0.2282),\n",
       "  ('lifestyle', 0.2282),\n",
       "  ('physical activity', 0.2201),\n",
       "  ('control complications', 0.22),\n",
       "  ('high risk', 0.2119),\n",
       "  ('disease', 0.2074),\n",
       "  ('trial assess', 0.1709),\n",
       "  ('mortality', 0.1707),\n",
       "  ('intervention designed', 0.161),\n",
       "  ('years intensive', 0.1471),\n",
       "  ('kg randomized', 0.146),\n",
       "  ('quality life', 0.1455),\n",
       "  ('time incidence', 0.1395),\n",
       "  ('11 years', 0.124),\n",
       "  ('groups outcomes', 0.1222),\n",
       "  ('components', 0.1109),\n",
       "  ('compared control', 0.1012),\n",
       "  ('18 difference', 0.0999),\n",
       "  ('primary objective', 0.0947),\n",
       "  ('assess long', 0.0921),\n",
       "  ('loss shown', 0.0906),\n",
       "  ('achieve maintain', 0.0887),\n",
       "  ('contributors type', 0.0753),\n",
       "  ('ahead clinical', 0.072),\n",
       "  ('index 25', 0.0648),\n",
       "  ('short term', 0.0355),\n",
       "  ('support education', 0.0313),\n",
       "  ('provide 90', 0.0054),\n",
       "  ('5000 male', -0.0105),\n",
       "  ('74 years', -0.0171),\n",
       "  ('female participants', -0.0252),\n",
       "  ('male female', -0.0831)],\n",
       " 'MED-1921': [('dietary fats', 0.4723),\n",
       "  ('telomere length', 0.4468),\n",
       "  ('postmenopausal women', 0.3991),\n",
       "  ('peripheral leukocyte', 0.3567),\n",
       "  ('inflammatory responses', 0.309),\n",
       "  ('oxidative stress', 0.3089),\n",
       "  ('tl affecting', 0.3056),\n",
       "  ('women lowest', 0.2897),\n",
       "  ('significant associations', 0.2812),\n",
       "  ('aging', 0.2734),\n",
       "  ('foods peripheral', 0.2731),\n",
       "  ('reflected shortening', 0.2651),\n",
       "  ('compared participants', 0.2581),\n",
       "  ('affect biological', 0.2447),\n",
       "  ('inversely associated', 0.2257),\n",
       "  ('tls 95', 0.2233),\n",
       "  ('acids conclusion', 0.2064),\n",
       "  ('assessed questionnaire', 0.186),\n",
       "  ('total types', 0.185),\n",
       "  ('affecting levels', 0.1818),\n",
       "  ('trend 046', 0.1694),\n",
       "  ('reaction intake', 0.1616),\n",
       "  ('216 bp', 0.1589),\n",
       "  ('chain saturated', 0.1575),\n",
       "  ('suggest potential', 0.1556),\n",
       "  ('05 isoenergetic', 0.1549),\n",
       "  ('energy shorter', 0.1453),\n",
       "  ('046 lauric', 0.1363),\n",
       "  ('bp longer', 0.1309),\n",
       "  ('00 kb', 0.1219),\n",
       "  ('major sources', 0.1193),\n",
       "  ('apparently healthy', 0.1178),\n",
       "  ('smsfas rate', 0.1137),\n",
       "  ('4029', 0.1102),\n",
       "  ('process reflected', 0.0993),\n",
       "  ('examined direct', 0.0917),\n",
       "  ('substitution models', 0.0822),\n",
       "  ('quartile median', 0.082),\n",
       "  ('aliphatic tails', 0.0803),\n",
       "  ('24 kb', 0.0768),\n",
       "  ('13 kb', 0.0726),\n",
       "  ('participated', 0.0707),\n",
       "  ('health initiative', 0.0671),\n",
       "  ('carbons', 0.0568),\n",
       "  ('nonskim', 0.0447),\n",
       "  ('ci 03', 0.0424),\n",
       "  ('quantitative polymerase', 0.0372),\n",
       "  ('milk', 0.0227),\n",
       "  ('individual', 0.0129),\n",
       "  ('21', 0.0124)],\n",
       " 'MED-1922': [('stress telomeres', 0.7347),\n",
       "  ('disorders telomere', 0.6698),\n",
       "  ('telomere science', 0.6346),\n",
       "  ('telomere erosion', 0.6256),\n",
       "  ('lifespan telomere', 0.5979),\n",
       "  ('telomeres better', 0.5911),\n",
       "  ('telomeres early', 0.5144),\n",
       "  ('shorter telomere', 0.5051),\n",
       "  ('programming telomere', 0.5025),\n",
       "  ('field telomere', 0.461),\n",
       "  ('biology lifespan', 0.4475),\n",
       "  ('adult telomere', 0.4302),\n",
       "  ('shortening lifespan', 0.4291),\n",
       "  ('related aging', 0.4281),\n",
       "  ('lifespan inform', 0.4066),\n",
       "  ('times lifespan', 0.405),\n",
       "  ('stress accelerates', 0.3293),\n",
       "  ('biology linking', 0.3024),\n",
       "  ('decade growing', 0.2732),\n",
       "  ('studies suggest', 0.2696),\n",
       "  ('increased disease', 0.2692),\n",
       "  ('ver lifespan', 0.2486),\n",
       "  ('mortality emerging', 0.241),\n",
       "  ('understanding etiology', 0.2336),\n",
       "  ('highlight recent', 0.2212),\n",
       "  ('term consequences', 0.2174),\n",
       "  ('linking exposure', 0.196),\n",
       "  ('chronological', 0.1944),\n",
       "  ('length present', 0.1738),\n",
       "  ('life possibly', 0.1698),\n",
       "  ('various times', 0.1663),\n",
       "  ('shorter', 0.1639),\n",
       "  ('substrates stress', 0.1624),\n",
       "  ('processes diverse', 0.1564),\n",
       "  ('science opened', 0.1506),\n",
       "  ('mental illnesses', 0.1496),\n",
       "  ('diverse populations', 0.1399),\n",
       "  ('cellular', 0.1356),\n",
       "  ('erosion present', 0.1354),\n",
       "  ('stress newborn', 0.1263),\n",
       "  ('risk behaviors', 0.1214),\n",
       "  ('health', 0.1144),\n",
       "  ('past', 0.1116),\n",
       "  ('buffer negative', 0.0963),\n",
       "  ('developmental programming', 0.0922),\n",
       "  ('characterize relationship', 0.0603),\n",
       "  ('trauma', 0.059),\n",
       "  ('avenues', 0.0435),\n",
       "  ('better', -0.0473),\n",
       "  ('govern regulate', -0.052)],\n",
       " 'MED-1923': [('shorter telomeres', 0.6058),\n",
       "  ('telomeres linked', 0.5014),\n",
       "  ('longevity examined', 0.492),\n",
       "  ('longer telomere', 0.4878),\n",
       "  ('health longevity', 0.435),\n",
       "  ('aging shorter', 0.4254),\n",
       "  ('lifestyle behaviors', 0.4039),\n",
       "  ('longevity copyright', 0.402),\n",
       "  ('stress associated', 0.3455),\n",
       "  ('previous research', 0.3395),\n",
       "  ('linked chronic', 0.3094),\n",
       "  ('behaviors mitigate', 0.2948),\n",
       "  ('tradition utilizes', 0.2849),\n",
       "  ('depression limited', 0.2557),\n",
       "  ('associated longer', 0.2556),\n",
       "  ('differences age', 0.2486),\n",
       "  ('biomarker associated', 0.2424),\n",
       "  ('length serve', 0.2383),\n",
       "  ('trend level', 0.2381),\n",
       "  ('lower rates', 0.2378),\n",
       "  ('volunteering caregiving', 0.2271),\n",
       "  ('bmi past', 0.2234),\n",
       "  ('leukocytes', 0.2062),\n",
       "  ('007 remained', 0.199),\n",
       "  ('small sample', 0.1928),\n",
       "  ('experienced loving', 0.1927),\n",
       "  ('suggests link', 0.1925),\n",
       "  ('participants meditation', 0.1878),\n",
       "  ('individuals experienced', 0.1837),\n",
       "  ('warmth people', 0.1741),\n",
       "  ('group individuals', 0.1579),\n",
       "  ('effects', 0.139),\n",
       "  ('rtl controls', 0.1387),\n",
       "  ('083 women', 0.1142),\n",
       "  ('rights reserved', 0.0944),\n",
       "  ('dna', 0.0859),\n",
       "  ('used measure', 0.085),\n",
       "  ('education exposure', 0.0806),\n",
       "  ('examined relative', 0.0794),\n",
       "  ('offer intriguing', 0.0764),\n",
       "  ('2002 lkm', 0.0597),\n",
       "  ('buddhist tradition', 0.0527),\n",
       "  ('practitioners significantly', 0.0495),\n",
       "  ('utilizes focus', 0.0453),\n",
       "  ('unselfish kindness', 0.0389),\n",
       "  ('copyright 2013', 0.0297),\n",
       "  ('women alter', 0.0252),\n",
       "  ('venipuncture genomic', 0.022),\n",
       "  ('race', 0.0217),\n",
       "  ('cawthon', -0.0056)],\n",
       " 'MED-1924': [('cellular senescence', 0.6963),\n",
       "  ('aging cells', 0.59),\n",
       "  ('aged lymphocytes', 0.5199),\n",
       "  ('levels cellular', 0.3899),\n",
       "  ('cell division', 0.3738),\n",
       "  ('anti aging', 0.3546),\n",
       "  ('cells organisms', 0.3515),\n",
       "  ('including aged', 0.3497),\n",
       "  ('culture telomeres', 0.3386),\n",
       "  ('expression ink4a', 0.3373),\n",
       "  ('function organelles', 0.3347),\n",
       "  ('cancerous growth', 0.3318),\n",
       "  ('humans p16', 0.32),\n",
       "  ('excessive cell', 0.3151),\n",
       "  ('different lineages', 0.2992),\n",
       "  ('induction apoptosis', 0.2979),\n",
       "  ('literature undertaken', 0.2871),\n",
       "  ('acid metabolism', 0.2833),\n",
       "  ('cellular palmitate', 0.2786),\n",
       "  ('membranes alters', 0.2741),\n",
       "  ('activates p53', 0.2713),\n",
       "  ('causes', 0.2705),\n",
       "  ('alters leads', 0.268),\n",
       "  ('division disturbances', 0.2614),\n",
       "  ('suppresses cell', 0.2536),\n",
       "  ('accompanied physiological', 0.2387),\n",
       "  ('longevity likely', 0.2386),\n",
       "  ('evidence organism', 0.2227),\n",
       "  ('lymphocytes high', 0.2165),\n",
       "  ('common initiation', 0.2062),\n",
       "  ('protective cancer', 0.2026),\n",
       "  ('growth switching', 0.1992),\n",
       "  ('mutation allows', 0.199),\n",
       "  ('repression stearoyl', 0.1838),\n",
       "  ('state arf', 0.1791),\n",
       "  ('changes structure', 0.1744),\n",
       "  ('key length', 0.1658),\n",
       "  ('models accelerated', 0.1548),\n",
       "  ('including cessation', 0.1477),\n",
       "  ('delta', 0.1373),\n",
       "  ('especially regulation', 0.1315),\n",
       "  ('organisms share', 0.1275),\n",
       "  ('vivo vitro', 0.1187),\n",
       "  ('mice', 0.1107),\n",
       "  ('past', 0.1095),\n",
       "  ('shortened', 0.0751),\n",
       "  ('stimulates enzyme', 0.0423),\n",
       "  ('exhibit', 0.0088),\n",
       "  ('coa', -0.0108),\n",
       "  ('p19', -0.0326)],\n",
       " 'MED-1926': [('exercise telomere', 0.6374),\n",
       "  ('exercise postmenopausal', 0.5587),\n",
       "  ('length postmenopausal', 0.4572),\n",
       "  ('pbmcs postmenopausal', 0.4349),\n",
       "  ('typically estrogen', 0.4181),\n",
       "  ('reduce telomere', 0.4174),\n",
       "  ('length pbmcs', 0.3732),\n",
       "  ('reported women', 0.3622),\n",
       "  ('aerobic resistance', 0.3522),\n",
       "  ('mononuclear cells', 0.3469),\n",
       "  ('sedentary participants', 0.3341),\n",
       "  ('duration type', 0.3304),\n",
       "  ('conclusions habitual', 0.2807),\n",
       "  ('58', 0.2667),\n",
       "  ('age participants', 0.2572),\n",
       "  ('triglyceride levels', 0.243),\n",
       "  ('length 01', 0.2288),\n",
       "  ('methods experimental', 0.2252),\n",
       "  ('results inconsistent', 0.2202),\n",
       "  ('finding suggests', 0.2181),\n",
       "  ('adiponectin levels', 0.2076),\n",
       "  ('chosen study', 0.1967),\n",
       "  ('objective reported', 0.1898),\n",
       "  ('measured mitochondrial', 0.1774),\n",
       "  ('attrition', 0.1697),\n",
       "  ('biochemical tests', 0.1689),\n",
       "  ('multiple regression', 0.1687),\n",
       "  ('waist', 0.162),\n",
       "  ('index body', 0.1557),\n",
       "  ('84 years', 0.1535),\n",
       "  ('relationship', 0.1477),\n",
       "  ('cross sectional', 0.1418),\n",
       "  ('homeostasis model', 0.1418),\n",
       "  ('522 01', 0.1388),\n",
       "  ('dna', 0.1359),\n",
       "  ('benefit maintenance', 0.1282),\n",
       "  ('15 months', 0.1275),\n",
       "  ('favorably influence', 0.1066),\n",
       "  ('peripheral', 0.1065),\n",
       "  ('significantly lower', 0.1039),\n",
       "  ('blood pressure', 0.0991),\n",
       "  ('139 03', 0.0989),\n",
       "  ('healthy', 0.0887),\n",
       "  ('nonsmoking', 0.0881),\n",
       "  ('week 12', 0.0818),\n",
       "  ('times week', 0.081),\n",
       "  ('average 19', 0.0728),\n",
       "  ('significantly higher', 0.0698),\n",
       "  ('months serum', 0.0613),\n",
       "  ('minutes session', 0.0177)],\n",
       " 'MED-1928': [('affect telomeres', 0.6682),\n",
       "  ('role telomeres', 0.6535),\n",
       "  ('telomeres associated', 0.6504),\n",
       "  ('telomeres aging', 0.6481),\n",
       "  ('telomere length', 0.6303),\n",
       "  ('telomere shortening', 0.6061),\n",
       "  ('summary telomere', 0.589),\n",
       "  ('lifespan review', 0.5775),\n",
       "  ('telomeres leads', 0.5693),\n",
       "  ('longevity altering', 0.5149),\n",
       "  ('excessive telomere', 0.513),\n",
       "  ('shorter telomeres', 0.4989),\n",
       "  ('health longevity', 0.4762),\n",
       "  ('lifespan individual', 0.4364),\n",
       "  ('aging summarize', 0.4166),\n",
       "  ('shortening recent', 0.3842),\n",
       "  ('recent studies', 0.3789),\n",
       "  ('increased lifespan', 0.3728),\n",
       "  ('describes lifestyle', 0.3701),\n",
       "  ('shortening increased', 0.3625),\n",
       "  ('review highlights', 0.362),\n",
       "  ('length affected', 0.3593),\n",
       "  ('affect health', 0.3451),\n",
       "  ('shortens age', 0.3306),\n",
       "  ('age associated', 0.3026),\n",
       "  ('length purpose', 0.2877),\n",
       "  ('associated diseases', 0.2872),\n",
       "  ('senescence apoptosis', 0.2777),\n",
       "  ('poor survival', 0.2678),\n",
       "  ('potential reduce', 0.2633),\n",
       "  ('factors affect', 0.2412),\n",
       "  ('growing evidence', 0.2153),\n",
       "  ('prevent excessive', 0.1852),\n",
       "  ('diet', 0.1707),\n",
       "  ('decreased specific', 0.1588),\n",
       "  ('associated increased', 0.1584),\n",
       "  ('various', 0.1536),\n",
       "  ('somatic', 0.1502),\n",
       "  ('leads', 0.1432),\n",
       "  ('oncogenic transformation', 0.1388),\n",
       "  ('attrition', 0.1336),\n",
       "  ('progressive', 0.1187),\n",
       "  ('affect pace', 0.1054),\n",
       "  ('cells', 0.092),\n",
       "  ('describes', 0.0843),\n",
       "  ('delayed onset', 0.0833),\n",
       "  ('importance', 0.0732),\n",
       "  ('better choice', 0.004),\n",
       "  ('human', -0.0121),\n",
       "  ('activities great', -0.0325)],\n",
       " 'MED-1929': [('yogic meditation', 0.5605),\n",
       "  ('group meditation', 0.5105),\n",
       "  ('mental health', 0.3958),\n",
       "  ('practices family', 0.3928),\n",
       "  ('health cognitive', 0.3682),\n",
       "  ('family dementia', 0.3558),\n",
       "  ('caregivers mean', 0.3548),\n",
       "  ('symptoms improvement', 0.3385),\n",
       "  ('intervention results', 0.317),\n",
       "  ('brief daily', 0.3122),\n",
       "  ('improved mental', 0.3111),\n",
       "  ('levels depressive', 0.2925),\n",
       "  ('symptoms greater', 0.2699),\n",
       "  ('compared relaxation', 0.262),\n",
       "  ('60 years', 0.2203),\n",
       "  ('practicing', 0.2195),\n",
       "  ('mcs sf', 0.1976),\n",
       "  ('assessed baseline', 0.1883),\n",
       "  ('kirtan kriya', 0.1826),\n",
       "  ('10 randomized', 0.1779),\n",
       "  ('music 12', 0.1765),\n",
       "  ('methods thirty', 0.1634),\n",
       "  ('weeks', 0.1577),\n",
       "  ('summary', 0.1556),\n",
       "  ('participants showed', 0.1485),\n",
       "  ('study examined', 0.148),\n",
       "  ('stress induced', 0.1472),\n",
       "  ('rating scale', 0.1451),\n",
       "  ('group 65', 0.1447),\n",
       "  ('functioning compared', 0.1367),\n",
       "  ('52 participants', 0.1357),\n",
       "  ('years', 0.1298),\n",
       "  ('36', 0.1262),\n",
       "  ('group pp', 0.1236),\n",
       "  ('improvement telomerase', 0.1194),\n",
       "  ('cellular aging', 0.118),\n",
       "  ('old sd', 0.0965),\n",
       "  ('pmbc examined', 0.0853),\n",
       "  ('need', 0.0848),\n",
       "  ('05', 0.0844),\n",
       "  ('pre post', 0.0776),\n",
       "  ('pbmc', 0.0583),\n",
       "  ('activity peripheral', 0.0575),\n",
       "  ('significantly lower', 0.0514),\n",
       "  ('showed 43', 0.0482),\n",
       "  ('pilot', 0.0035),\n",
       "  ('composite', -0.0188),\n",
       "  ('confirmed larger', -0.0228),\n",
       "  ('hamilton', -0.046),\n",
       "  ('19 respectively', -0.0662)],\n",
       " 'MED-1930': [('ltl intakes', 0.5617),\n",
       "  ('telomere length', 0.4838),\n",
       "  ('shorter telomeres', 0.4781),\n",
       "  ('telomeres consuming', 0.4639),\n",
       "  ('ltl objective', 0.4219),\n",
       "  ('hypothesized intakes', 0.3699),\n",
       "  ('vegetable intake', 0.3502),\n",
       "  ('association dietary', 0.3256),\n",
       "  ('diseases studies', 0.3246),\n",
       "  ('studies assessed', 0.3224),\n",
       "  ('associated chronic', 0.3049),\n",
       "  ('inversely associated', 0.295),\n",
       "  ('cohort study', 0.2938),\n",
       "  ('assessed association', 0.2857),\n",
       "  ('hypothesis fat', 0.279),\n",
       "  ('length', 0.2648),\n",
       "  ('study elderly', 0.2615),\n",
       "  ('objective study', 0.2507),\n",
       "  ('sfa intake', 0.2323),\n",
       "  ('leukocyte', 0.2213),\n",
       "  ('adjusting age', 0.2133),\n",
       "  ('smoking', 0.1922),\n",
       "  ('physical activity', 0.1829),\n",
       "  ('waist hip', 0.1761),\n",
       "  ('lowest amounts', 0.1756),\n",
       "  ('women aged', 0.1725),\n",
       "  ('questionnaire results', 0.1675),\n",
       "  ('conclusions cross', 0.1614),\n",
       "  ('mass index', 0.1319),\n",
       "  ('sfas negatively', 0.13),\n",
       "  ('sectional', 0.13),\n",
       "  ('04 01', 0.1236),\n",
       "  ('significant effects', 0.1125),\n",
       "  ('positively associated', 0.0957),\n",
       "  ('years', 0.095),\n",
       "  ('05 men', 0.0947),\n",
       "  ('butter fruits', 0.0925),\n",
       "  ('polymerase chain', 0.0898),\n",
       "  ('years helsinki', 0.0841),\n",
       "  ('aged 57', 0.0762),\n",
       "  ('especially saturated', 0.0726),\n",
       "  ('subjects', 0.072),\n",
       "  ('educational attainment', 0.0674),\n",
       "  ('general support', 0.0489),\n",
       "  ('semiquantitative', 0.0408),\n",
       "  ('1942', 0.0373),\n",
       "  ('128', 0.0274),\n",
       "  ('70 years', 0.0091),\n",
       "  ('birth', 0.0054),\n",
       "  ('real time', -0.0404)],\n",
       " 'MED-1931': [('caregivers findings', 0.5543),\n",
       "  ('telomeres caregivers', 0.5457),\n",
       "  ('caregivers alzheimer', 0.516),\n",
       "  ('changes caregivers', 0.504),\n",
       "  ('lifespan caregivers', 0.4879),\n",
       "  ('attrition caregivers', 0.4751),\n",
       "  ('compared depressive', 0.42),\n",
       "  ('symptoms pbmc', 0.4099),\n",
       "  ('decline immune', 0.4028),\n",
       "  ('disease patients', 0.3738),\n",
       "  ('associated decline', 0.3679),\n",
       "  ('chronic stress', 0.356),\n",
       "  ('alzheimer disease', 0.3488),\n",
       "  ('symptoms significantly', 0.3168),\n",
       "  ('aging suggested', 0.3046),\n",
       "  ('demonstrate chronic', 0.2813),\n",
       "  ('changes cellular', 0.2784),\n",
       "  ('assess psychological', 0.2695),\n",
       "  ('immune regulatory', 0.2672),\n",
       "  ('associated altered', 0.2628),\n",
       "  ('cellular replicative', 0.2593),\n",
       "  ('82 individuals', 0.2543),\n",
       "  ('cells monocytes', 0.2462),\n",
       "  ('telomere loss', 0.2332),\n",
       "  ('telomerase activity', 0.2133),\n",
       "  ('function assess', 0.2077),\n",
       "  ('matched controls', 0.2014),\n",
       "  ('cells significantly', 0.1945),\n",
       "  ('patients endure', 0.1893),\n",
       "  ('findings demonstrate', 0.1769),\n",
       "  ('isolated cells', 0.1766),\n",
       "  ('cytokines tnf', 0.1685),\n",
       "  ('controls kb', 0.1624),\n",
       "  ('lower cell', 0.1399),\n",
       "  ('attempt cells', 0.1355),\n",
       "  ('vitro examined', 0.1125),\n",
       "  ('compared', 0.1071),\n",
       "  ('05 similar', 0.0937),\n",
       "  ('subsets', 0.0868),\n",
       "  ('gender matched', 0.059),\n",
       "  ('activation induced', 0.0583),\n",
       "  ('excessive loss', 0.0526),\n",
       "  ('unsuccessful', 0.0488),\n",
       "  ('showed basal', 0.0459),\n",
       "  ('shortening isolated', 0.0422),\n",
       "  ('41 age', 0.0127),\n",
       "  ('il 10', 0.0055),\n",
       "  ('compensate excessive', 0.0017),\n",
       "  ('pointing', -0.0177),\n",
       "  ('higher production', -0.0854)],\n",
       " 'MED-1932': [('stress telomere', 0.535),\n",
       "  ('linking stress', 0.4865),\n",
       "  ('life stressor', 0.4487),\n",
       "  ('effects childhood', 0.3761),\n",
       "  ('risk longitudinal', 0.3697),\n",
       "  ('previous studies', 0.346),\n",
       "  ('potential impact', 0.2937),\n",
       "  ('life disease', 0.2881),\n",
       "  ('mortality humans', 0.2851),\n",
       "  ('cellular aging', 0.2826),\n",
       "  ('victimization physical', 0.2745),\n",
       "  ('violence assessed', 0.2575),\n",
       "  ('exposures recruited', 0.2538),\n",
       "  ('linking cumulative', 0.252),\n",
       "  ('morbidity', 0.2489),\n",
       "  ('discovering mechanisms', 0.2399),\n",
       "  ('study repeated', 0.2266),\n",
       "  ('erosion relation', 0.2262),\n",
       "  ('socioeconomic', 0.2154),\n",
       "  ('maltreatment adult', 0.2034),\n",
       "  ('frequent bullying', 0.1884),\n",
       "  ('twin study', 0.1779),\n",
       "  ('years', 0.1665),\n",
       "  ('10 years', 0.158),\n",
       "  ('follow dna', 0.1549),\n",
       "  ('study nationally', 0.1506),\n",
       "  ('age baseline', 0.1456),\n",
       "  ('1995 birth', 0.14),\n",
       "  ('social welfare', 0.1337),\n",
       "  ('maintenance observed', 0.1307),\n",
       "  ('tested hypothesis', 0.1198),\n",
       "  ('known long', 0.1172),\n",
       "  ('052 021', 0.1059),\n",
       "  ('experienced kinds', 0.1026),\n",
       "  ('counterparts children', 0.0896),\n",
       "  ('late', 0.0886),\n",
       "  ('adjusting sex', 0.0839),\n",
       "  ('participants 236', 0.0734),\n",
       "  ('quantitative pcr', 0.0373),\n",
       "  ('numbers compared', 0.0303),\n",
       "  ('provides support', 0.0302),\n",
       "  ('1994', 0.0122),\n",
       "  ('single', 0.0055),\n",
       "  ('mediate', -0.009),\n",
       "  ('status body', -0.0165),\n",
       "  ('showed significantly', -0.028),\n",
       "  ('females', -0.0348),\n",
       "  ('major public', -0.0501),\n",
       "  ('49', -0.0623),\n",
       "  ('maternal domestic', -0.1009)],\n",
       " 'MED-1933': [('mechanisms stress', 0.636),\n",
       "  ('perceived stress', 0.6284),\n",
       "  ('psychological stress', 0.6214),\n",
       "  ('stress chronicity', 0.6137),\n",
       "  ('stress promote', 0.5909),\n",
       "  ('stress telomeres', 0.5333),\n",
       "  ('hypothesis stress', 0.4979),\n",
       "  ('impacts health', 0.4527),\n",
       "  ('stress women', 0.4288),\n",
       "  ('health modulating', 0.4202),\n",
       "  ('links chronic', 0.4098),\n",
       "  ('understanding cellular', 0.4041),\n",
       "  ('poor health', 0.3979),\n",
       "  ('higher oxidative', 0.3925),\n",
       "  ('diseases', 0.3796),\n",
       "  ('cardiovascular disease', 0.3727),\n",
       "  ('cell senescence', 0.3641),\n",
       "  ('psychological', 0.3612),\n",
       "  ('poorer immune', 0.3528),\n",
       "  ('numerous studies', 0.3377),\n",
       "  ('investigated hypothesis', 0.303),\n",
       "  ('aging compared', 0.3002),\n",
       "  ('remain elusive', 0.2941),\n",
       "  ('immune function', 0.2915),\n",
       "  ('low stress', 0.2696),\n",
       "  ('skin remain', 0.2587),\n",
       "  ('determinants cell', 0.2523),\n",
       "  ('including risk', 0.2387),\n",
       "  ('levels perceived', 0.2355),\n",
       "  ('gets skin', 0.2341),\n",
       "  ('significantly associated', 0.2286),\n",
       "  ('exact mechanisms', 0.2253),\n",
       "  ('implications', 0.1801),\n",
       "  ('longevity peripheral', 0.1797),\n",
       "  ('premenopausal women', 0.1666),\n",
       "  ('indices poor', 0.1652),\n",
       "  ('decade additional', 0.157),\n",
       "  ('cells healthy', 0.1529),\n",
       "  ('provide evidence', 0.1522),\n",
       "  ('additional', 0.1432),\n",
       "  ('mononuclear cells', 0.1313),\n",
       "  ('telomerase', 0.1301),\n",
       "  ('shorter telomere', 0.1238),\n",
       "  ('modulating rate', 0.108),\n",
       "  ('function', 0.0419),\n",
       "  ('blood', 0.0272),\n",
       "  ('length', 0.0157),\n",
       "  ('earlier onset', 0.0119),\n",
       "  ('known', -0.0126),\n",
       "  ('highest', -0.0929)],\n",
       " 'MED-1934': [('diet exercise', 0.4683),\n",
       "  ('postmenopausal women', 0.45),\n",
       "  ('exercise leukocyte', 0.4329),\n",
       "  ('aerobic exercise', 0.4267),\n",
       "  ('12 months', 0.4249),\n",
       "  ('weight loss', 0.4153),\n",
       "  ('length postmenopausal', 0.4142),\n",
       "  ('439 overweight', 0.388),\n",
       "  ('leukocyte telomere', 0.3825),\n",
       "  ('intervention group', 0.3723),\n",
       "  ('loss aerobic', 0.3524),\n",
       "  ('women 50', 0.3399),\n",
       "  ('change telomere', 0.3352),\n",
       "  ('fat change', 0.3275),\n",
       "  ('women design', 0.3261),\n",
       "  ('exercise 117', 0.3152),\n",
       "  ('overweight obese', 0.2847),\n",
       "  ('03 bmi', 0.2799),\n",
       "  ('isolated leukocytes', 0.2797),\n",
       "  ('months dna', 0.2659),\n",
       "  ('fasting blood', 0.2404),\n",
       "  ('methods 439', 0.2394),\n",
       "  ('results baseline', 0.2137),\n",
       "  ('75 randomized', 0.1937),\n",
       "  ('length measured', 0.183),\n",
       "  ('mean changes', 0.1813),\n",
       "  ('loss 118', 0.1792),\n",
       "  ('compared controls', 0.1769),\n",
       "  ('randomized', 0.1536),\n",
       "  ('objective investigate', 0.1463),\n",
       "  ('moderate vigorous', 0.1427),\n",
       "  ('chain reaction', 0.1417),\n",
       "  ('estimating equations', 0.1368),\n",
       "  ('body', 0.1317),\n",
       "  ('10 weight', 0.1308),\n",
       "  ('0001 significant', 0.1299),\n",
       "  ('associated age', 0.1288),\n",
       "  ('oxygen', 0.126),\n",
       "  ('uptake 11', 0.126),\n",
       "  ('intent treat', 0.1112),\n",
       "  ('47 0001', 0.1087),\n",
       "  ('45 mins', 0.0992),\n",
       "  ('dna extracted', 0.0977),\n",
       "  ('conclusions', 0.0927),\n",
       "  ('inversely correlated', 0.084),\n",
       "  ('positively associated', 0.0838),\n",
       "  ('days week', 0.0663),\n",
       "  ('detected', 0.0456),\n",
       "  ('reaction qpcr', 0.014),\n",
       "  ('generalized', 0.0015)],\n",
       " 'MED-1935': [('telomere dysfunction', 0.5813),\n",
       "  ('lymphocytes 56', 0.3849),\n",
       "  ('tl highlighted', 0.375),\n",
       "  ('micronutrients mean', 0.3425),\n",
       "  ('damage genome', 0.3424),\n",
       "  ('low dietary', 0.3286),\n",
       "  ('information dietary', 0.3161),\n",
       "  ('shortening physiological', 0.3007),\n",
       "  ('length', 0.2961),\n",
       "  ('distribution trfs', 0.2705),\n",
       "  ('antioxidants observed', 0.2693),\n",
       "  ('lead chromosome', 0.2688),\n",
       "  ('study extensive', 0.2598),\n",
       "  ('ageing 008', 0.2492),\n",
       "  ('physiological relevance', 0.2477),\n",
       "  ('short trfs', 0.2355),\n",
       "  ('restriction fragment', 0.225),\n",
       "  ('cells exposed', 0.2207),\n",
       "  ('recent evidences', 0.2134),\n",
       "  ('healthy subjects', 0.2106),\n",
       "  ('blocked micronucleus', 0.2057),\n",
       "  ('peripheral blood', 0.1956),\n",
       "  ('vegetables related', 0.1834),\n",
       "  ('smoking status', 0.1809),\n",
       "  ('analysis association', 0.18),\n",
       "  ('consumption daily', 0.1781),\n",
       "  ('htert genotype', 0.175),\n",
       "  ('ionising radiation', 0.1743),\n",
       "  ('dysfunction visualised', 0.1658),\n",
       "  ('observed subjects', 0.1614),\n",
       "  ('factors influence', 0.1612),\n",
       "  ('assessed terminal', 0.1522),\n",
       "  ('care taken', 0.1518),\n",
       "  ('analysed slight', 0.1509),\n",
       "  ('beta carotene', 0.1485),\n",
       "  ('03 observed', 0.1474),\n",
       "  ('compared incidence', 0.1451),\n",
       "  ('nucleoplasmic', 0.1447),\n",
       "  ('radiation care', 0.1425),\n",
       "  ('maintenance', 0.1341),\n",
       "  ('capability detect', 0.1194),\n",
       "  ('erosion related', 0.116),\n",
       "  ('associated increased', 0.114),\n",
       "  ('did result', 0.0962),\n",
       "  ('bridges npbs', 0.0672),\n",
       "  ('cytokinesis blocked', 0.0617),\n",
       "  ('kb relative', 0.0531),\n",
       "  ('unrelated', 0.0389),\n",
       "  ('vitro', 0.0346),\n",
       "  ('explore', 0.0221)],\n",
       " 'MED-1936': [('telomere erosion', 0.526),\n",
       "  ('vascular telomere', 0.4881),\n",
       "  ('mechanisms vasculoprotective', 0.456),\n",
       "  ('training telomere', 0.4322),\n",
       "  ('cellular senescence', 0.399),\n",
       "  ('exercising vascular', 0.3559),\n",
       "  ('underlying molecular', 0.3539),\n",
       "  ('endothelial apoptosis', 0.3427),\n",
       "  ('weeks exercise', 0.3173),\n",
       "  ('survival study', 0.3173),\n",
       "  ('studies showed', 0.2734),\n",
       "  ('increased telomerase', 0.2641),\n",
       "  ('proteins downregulation', 0.2634),\n",
       "  ('mice humans', 0.2573),\n",
       "  ('conclusions physical', 0.2495),\n",
       "  ('effects long', 0.2447),\n",
       "  ('running running', 0.2441),\n",
       "  ('protects stress', 0.2378),\n",
       "  ('isolated endurance', 0.2358),\n",
       "  ('middle aged', 0.2336),\n",
       "  ('regulators cell', 0.2237),\n",
       "  ('biology circulating', 0.2041),\n",
       "  ('cells compared', 0.2028),\n",
       "  ('leukocytes isolated', 0.2023),\n",
       "  ('sedentary controls', 0.1822),\n",
       "  ('untrained individuals', 0.1813),\n",
       "  ('inhibitors compared', 0.177),\n",
       "  ('track field', 0.1705),\n",
       "  ('background', 0.168),\n",
       "  ('athletes analyzed', 0.1646),\n",
       "  ('checkpoint kinase', 0.1464),\n",
       "  ('incompletely understood', 0.1461),\n",
       "  ('thoracic aorta', 0.146),\n",
       "  ('oxide synthase', 0.1421),\n",
       "  ('erosion central', 0.1366),\n",
       "  ('activity test', 0.134),\n",
       "  ('humans methods', 0.1222),\n",
       "  ('transgenic', 0.1199),\n",
       "  ('repeat binding', 0.1171),\n",
       "  ('analyzed peripheral', 0.1114),\n",
       "  ('p16 p53', 0.1058),\n",
       "  ('resistance', 0.1058),\n",
       "  ('reverse transcriptase', 0.1048),\n",
       "  ('c57', 0.0873),\n",
       "  ('lipopolysaccharide induced', 0.0665),\n",
       "  ('synergize', 0.0479),\n",
       "  ('exhibited', 0.0192),\n",
       "  ('randomized voluntary', 0.0128),\n",
       "  ('factor ku70', 0.0072),\n",
       "  ('bl6', -0.0781)],\n",
       " 'MED-1937': [('symptoms dementia', 0.4763),\n",
       "  ('patients alzheimer', 0.4099),\n",
       "  ('ad bpsd', 0.4017),\n",
       "  ('ad behavioral', 0.3836),\n",
       "  ('apathy patients', 0.3786),\n",
       "  ('behavioral symptoms', 0.3642),\n",
       "  ('recovering symptoms', 0.3557),\n",
       "  ('exacerbation bpsd', 0.3487),\n",
       "  ('patients suffer', 0.3178),\n",
       "  ('psychological symptoms', 0.3133),\n",
       "  ('symptoms burden', 0.3082),\n",
       "  ('patients exhibited', 0.2997),\n",
       "  ('medicine cognitive', 0.2874),\n",
       "  ('indian medicine', 0.2828),\n",
       "  ('exhibited irritability', 0.2726),\n",
       "  ('turmeric treatment', 0.2711),\n",
       "  ('acuity symptoms', 0.2656),\n",
       "  ('decline behavioral', 0.2476),\n",
       "  ('mini mental', 0.2433),\n",
       "  ('year treatment', 0.2363),\n",
       "  ('weeks treatment', 0.2317),\n",
       "  ('improvement behavioral', 0.2302),\n",
       "  ('improved remarkably', 0.2098),\n",
       "  ('mmse came', 0.208),\n",
       "  ('psychiatric inventory', 0.2007),\n",
       "  ('treatment traditional', 0.1934),\n",
       "  ('suffer urinary', 0.1873),\n",
       "  ('powder capsules', 0.1765),\n",
       "  ('incontinence wonderings', 0.1649),\n",
       "  ('disease', 0.1565),\n",
       "  ('burden caregivers', 0.1461),\n",
       "  ('present cases', 0.1305),\n",
       "  ('adverse reaction', 0.1265),\n",
       "  ('agitation', 0.0983),\n",
       "  ('decreased significantly', 0.0951),\n",
       "  ('recognize family', 0.0948),\n",
       "  ('score neuro', 0.0873),\n",
       "  ('laboratory data', 0.0689),\n",
       "  ('taking', 0.0664),\n",
       "  ('change seen', 0.0636),\n",
       "  ('came', 0.047),\n",
       "  ('total', 0.0344),\n",
       "  ('benefit use', 0.0235),\n",
       "  ('12 weeks', 0.0199),\n",
       "  ('prescribed', 0.0187),\n",
       "  ('30 cases', 0.0108),\n",
       "  ('brief questionnaire', -0.0099),\n",
       "  ('state examination', -0.0159),\n",
       "  ('started', -0.0208),\n",
       "  ('17', -0.049)],\n",
       " 'MED-1939': [('efficacy curcumin', 0.6095),\n",
       "  ('antioxidant anti', 0.4117),\n",
       "  ('plant curcuma', 0.398),\n",
       "  ('polyphenolic', 0.3654),\n",
       "  ('levels aβ1', 0.3557),\n",
       "  ('reduces pathology', 0.3359),\n",
       "  ('generate tolerability', 0.3342),\n",
       "  ('compound derived', 0.2478),\n",
       "  ('transgenic models', 0.2416),\n",
       "  ('evidence efficacy', 0.2356),\n",
       "  ('tau181 f2', 0.2352),\n",
       "  ('limited bioavailability', 0.2277),\n",
       "  ('promising candidate', 0.2183),\n",
       "  ('aggregation reduces', 0.2157),\n",
       "  ('clinical biomarker', 0.2137),\n",
       "  ('tests alzheimer', 0.2114),\n",
       "  ('subscale adas', 0.1932),\n",
       "  ('effects effects', 0.1819),\n",
       "  ('long lin', 0.1803),\n",
       "  ('low 32', 0.1667),\n",
       "  ('continued dose', 0.1653),\n",
       "  ('ad randomized', 0.1627),\n",
       "  ('measures levels', 0.1619),\n",
       "  ('beta', 0.1574),\n",
       "  ('purpose current', 0.151),\n",
       "  ('complex associated', 0.1448),\n",
       "  ('neuropsychiatric inventory', 0.1447),\n",
       "  ('treating human', 0.1402),\n",
       "  ('label extension', 0.1395),\n",
       "  ('symptoms unable', 0.137),\n",
       "  ('gastrointestinal symptoms', 0.1272),\n",
       "  ('ml conclusions', 0.1189),\n",
       "  ('f2 isoprostanes', 0.1094),\n",
       "  ('mean mini', 0.1057),\n",
       "  ('cerebrospinal fluid', 0.0954),\n",
       "  ('24 subjects', 0.0932),\n",
       "  ('identifier nct00099710', 0.0925),\n",
       "  ('persons mild', 0.092),\n",
       "  ('73 years', 0.0885),\n",
       "  ('worsened memory', 0.0784),\n",
       "  ('study activities', 0.0768),\n",
       "  ('receive placebo', 0.0734),\n",
       "  ('living adcs', 0.0724),\n",
       "  ('weeks weeks', 0.0716),\n",
       "  ('oral', 0.0711),\n",
       "  ('score 22', 0.0467),\n",
       "  ('completers 30', 0.041),\n",
       "  ('subject withdrew', 0.0326),\n",
       "  ('grams day', 0.0011),\n",
       "  ('gov', -0.0045)],\n",
       " 'MED-1941': [('alzheimer disease', 0.6246),\n",
       "  ('curcuminoids abeta', 0.5844),\n",
       "  ('pathogenesis ad', 0.5602),\n",
       "  ('amyloidosis ad', 0.5454),\n",
       "  ('abeta plaques', 0.5096),\n",
       "  ('ad patients', 0.4419),\n",
       "  ('clearance abeta', 0.4171),\n",
       "  ('abeta vitro', 0.4127),\n",
       "  ('phagocytosis amyloid', 0.3969),\n",
       "  ('macrophages curcuminoids', 0.3809),\n",
       "  ('amyloid beta', 0.3791),\n",
       "  ('ad difficult', 0.3746),\n",
       "  ('macrophages ad', 0.3478),\n",
       "  ('clearance amyloidosis', 0.3464),\n",
       "  ('defects phagocytosis', 0.326),\n",
       "  ('ignorance pathogenesis', 0.3191),\n",
       "  ('plaques natural', 0.2564),\n",
       "  ('difficult ignorance', 0.2118),\n",
       "  ('pathogenesis', 0.2109),\n",
       "  ('brain clearance', 0.1936),\n",
       "  ('macrophages clearance', 0.1801),\n",
       "  ('animal models', 0.1663),\n",
       "  ('untreated macrophages', 0.1464),\n",
       "  ('beta 42', 0.1409),\n",
       "  ('immune cells', 0.1353),\n",
       "  ('microscopy ad', 0.1314),\n",
       "  ('treatment immunomodulation', 0.1303),\n",
       "  ('enhanced brain', 0.1075),\n",
       "  ('intracellular compartment', 0.0898),\n",
       "  ('patients defects', 0.0701),\n",
       "  ('compartment treatment', 0.0647),\n",
       "  ('phalloidin', 0.063),\n",
       "  ('monocyte', 0.0607),\n",
       "  ('vitro measured', 0.0513),\n",
       "  ('innate', 0.0504),\n",
       "  ('binding untreated', 0.0492),\n",
       "  ('natural product', 0.049),\n",
       "  ('significantly lower', 0.0341),\n",
       "  ('uptake using', 0.0266),\n",
       "  ('cells', 0.0188),\n",
       "  ('fluorescence confocal', 0.0035),\n",
       "  ('baseline', 0.0021),\n",
       "  ('involved', -0.0015),\n",
       "  ('significantly 001', -0.0032),\n",
       "  ('localization', -0.0248),\n",
       "  ('comparison control', -0.0249),\n",
       "  ('081 increased', -0.028),\n",
       "  ('showed surface', -0.0444),\n",
       "  ('safe', -0.0584),\n",
       "  ('patients significantly', -0.059)],\n",
       " 'MED-1942': [('curcumin curry', 0.6482),\n",
       "  ('curry authors', 0.4706),\n",
       "  ('consumed curry', 0.4541),\n",
       "  ('curry spice', 0.4072),\n",
       "  ('elderly asians', 0.3814),\n",
       "  ('antioxidant', 0.3354),\n",
       "  ('antiinflammatory properties', 0.3304),\n",
       "  ('usual curry', 0.318),\n",
       "  ('epidemiologic evidence', 0.2995),\n",
       "  ('plaque burden', 0.2808),\n",
       "  ('cognitive function', 0.2751),\n",
       "  ('investigated association', 0.2649),\n",
       "  ('consumption level', 0.2635),\n",
       "  ('correlates mmse', 0.2388),\n",
       "  ('turmeric', 0.235),\n",
       "  ('rarely consumed', 0.2338),\n",
       "  ('evidence lacking', 0.2297),\n",
       "  ('based cohort', 0.2292),\n",
       "  ('asians confirmed', 0.2249),\n",
       "  ('future studies', 0.2094),\n",
       "  ('authors investigated', 0.2062),\n",
       "  ('reported tentative', 0.2019),\n",
       "  ('lacking authors', 0.2014),\n",
       "  ('beta amyloid', 0.195),\n",
       "  ('sociodemographic health', 0.1929),\n",
       "  ('behavioral correlates', 0.189),\n",
       "  ('2003', 0.1637),\n",
       "  ('reduce', 0.1587),\n",
       "  ('aged', 0.1511),\n",
       "  ('subjects', 0.1507),\n",
       "  ('spice', 0.1424),\n",
       "  ('authors', 0.1312),\n",
       "  ('compared mini', 0.1293),\n",
       "  ('mental', 0.1119),\n",
       "  ('burden experimental', 0.1027),\n",
       "  ('60 93', 0.1016),\n",
       "  ('categories regular', 0.0836),\n",
       "  ('association', 0.0834),\n",
       "  ('occasionally', 0.0577),\n",
       "  ('010 nondemented', 0.0511),\n",
       "  ('level', 0.0509),\n",
       "  ('possess potent', 0.0496),\n",
       "  ('years', 0.04),\n",
       "  ('future', 0.037),\n",
       "  ('account known', 0.0091),\n",
       "  ('taking', -0.0017),\n",
       "  ('state examination', -0.0082),\n",
       "  ('performance consumed', -0.0116),\n",
       "  ('scores did', -0.0327),\n",
       "  ('significantly better', -0.0383)],\n",
       " 'MED-1944': [('ad incidence', 0.5195),\n",
       "  ('staging dementia', 0.4108),\n",
       "  ('india compare', 0.3987),\n",
       "  ('standardized age', 0.3885),\n",
       "  ('based cohort', 0.387),\n",
       "  ('prospective epidemiologic', 0.3834),\n",
       "  ('subjects aged', 0.357),\n",
       "  ('overall incidence', 0.332),\n",
       "  ('disorders association', 0.3123),\n",
       "  ('ability screening', 0.3107),\n",
       "  ('study subjects', 0.3005),\n",
       "  ('disease related', 0.2969),\n",
       "  ('55 years', 0.2937),\n",
       "  ('repeated cognitive', 0.2834),\n",
       "  ('association criteria', 0.2672),\n",
       "  ('diagnostic statistical', 0.2606),\n",
       "  ('methods year', 0.2532),\n",
       "  ('reference population', 0.2523),\n",
       "  ('rates reported', 0.2509),\n",
       "  ('years substantially', 0.2411),\n",
       "  ('aged 65', 0.2398),\n",
       "  ('disorders stroke', 0.2385),\n",
       "  ('1990 census', 0.2379),\n",
       "  ('14 aged', 0.2353),\n",
       "  ('subcontinent appear', 0.2337),\n",
       "  ('objective determine', 0.2336),\n",
       "  ('95 ci', 0.2293),\n",
       "  ('cohort ballabgarh', 0.2269),\n",
       "  ('pennsylvania methods', 0.2195),\n",
       "  ('cdr', 0.2123),\n",
       "  ('results', 0.2102),\n",
       "  ('edition national', 0.2079),\n",
       "  ('duration follow', 0.2043),\n",
       "  ('disorders 4th', 0.1859),\n",
       "  ('confounders', 0.1815),\n",
       "  ('distribution', 0.1625),\n",
       "  ('years 1000', 0.1572),\n",
       "  ('institute neurological', 0.1379),\n",
       "  ('rural population', 0.1375),\n",
       "  ('cultural factors', 0.136),\n",
       "  ('valley conclusion', 0.1282),\n",
       "  ('scale', 0.1123),\n",
       "  ('population monongahela', 0.1045),\n",
       "  ('ci 84', 0.0823),\n",
       "  ('manual', 0.0736),\n",
       "  ('20', 0.0735),\n",
       "  ('suggest caution', 0.0592),\n",
       "  ('48', 0.0356),\n",
       "  ('lowest reported', 0.0152),\n",
       "  ('17', 0.0021)],\n",
       " 'MED-1947': [('efficacy curcumin', 0.6099),\n",
       "  ('curcumin administered', 0.597),\n",
       "  ('suggested curcumin', 0.541),\n",
       "  ('curcumin used', 0.5286),\n",
       "  ('pseudotumours curcumin', 0.5),\n",
       "  ('administered orally', 0.3759),\n",
       "  ('treatment patients', 0.3735),\n",
       "  ('drug treatment', 0.3511),\n",
       "  ('375 mg', 0.323),\n",
       "  ('patients completed', 0.3201),\n",
       "  ('efficacy', 0.3121),\n",
       "  ('curcuma', 0.2969),\n",
       "  ('completed study', 0.2946),\n",
       "  ('recurrence suggested', 0.2892),\n",
       "  ('patients followed', 0.2854),\n",
       "  ('rhizomes', 0.2805),\n",
       "  ('longa treatment', 0.2728),\n",
       "  ('treatment idiopathic', 0.2709),\n",
       "  ('active constituent', 0.2394),\n",
       "  ('persisted effect', 0.2352),\n",
       "  ('months patients', 0.2185),\n",
       "  ('time clinical', 0.1968),\n",
       "  ('administered', 0.1955),\n",
       "  ('patients suffering', 0.195),\n",
       "  ('mg times', 0.1854),\n",
       "  ('safe effective', 0.1831),\n",
       "  ('completely patient', 0.1821),\n",
       "  ('recovered', 0.1543),\n",
       "  ('wiley sons', 0.1528),\n",
       "  ('swelling regressed', 0.1521),\n",
       "  ('orbital', 0.1515),\n",
       "  ('present report', 0.1434),\n",
       "  ('idiopathic inflammatory', 0.1398),\n",
       "  ('sons', 0.1281),\n",
       "  ('noted patient', 0.1256),\n",
       "  ('period 22', 0.1175),\n",
       "  ('suggested', 0.1157),\n",
       "  ('swelling', 0.1147),\n",
       "  ('monthly intervals', 0.0662),\n",
       "  ('regressed completely', 0.0656),\n",
       "  ('times day', 0.065),\n",
       "  ('used', 0.0617),\n",
       "  ('pseudotumours', 0.0566),\n",
       "  ('john', 0.0395),\n",
       "  ('completely limitation', 0.0354),\n",
       "  ('intervals', 0.035),\n",
       "  ('copyright', 0.0198),\n",
       "  ('movement', 0.0066),\n",
       "  ('period years', -0.0024),\n",
       "  ('copyright 2000', -0.0411)],\n",
       " 'MED-1948': [('curcumin neuroprotective', 0.6469),\n",
       "  ('years curcumin', 0.543),\n",
       "  ('models curcumin', 0.5322),\n",
       "  ('curcumin prevent', 0.4946),\n",
       "  ('cardioprotective anti', 0.472),\n",
       "  ('carcinogenic hepatoprotective', 0.4316),\n",
       "  ('neuroprotective efficacy', 0.4303),\n",
       "  ('anti carcinogenic', 0.4077),\n",
       "  ('compounds target', 0.3098),\n",
       "  ('candidate nutraceutical', 0.2865),\n",
       "  ('recent studies', 0.2733),\n",
       "  ('thrombosuppressive', 0.27),\n",
       "  ('trials neurodegenerative', 0.2639),\n",
       "  ('elegans review', 0.2594),\n",
       "  ('lifespan', 0.2125),\n",
       "  ('prevent aging', 0.2059),\n",
       "  ('reported effective', 0.2031),\n",
       "  ('cellular proteins', 0.1949),\n",
       "  ('common risk', 0.1917),\n",
       "  ('toxicity low', 0.1898),\n",
       "  ('infectious properties', 0.1865),\n",
       "  ('improves healthspan', 0.1793),\n",
       "  ('review evidence', 0.1749),\n",
       "  ('kinds diseases', 0.1724),\n",
       "  ('homeostasis associated', 0.172),\n",
       "  ('animal models', 0.1695),\n",
       "  ('maintain protein', 0.1595),\n",
       "  ('potential mechanism', 0.1521),\n",
       "  ('prevent kinds', 0.1475),\n",
       "  ('vertebrate invertebrate', 0.1425),\n",
       "  ('cost suggests', 0.1391),\n",
       "  ('benefits associated', 0.122),\n",
       "  ('lead protein', 0.1196),\n",
       "  ('changes cellular', 0.1154),\n",
       "  ('recently', 0.1085),\n",
       "  ('characterized having', 0.1052),\n",
       "  ('caenorhabditis', 0.1026),\n",
       "  ('delaying', 0.0743),\n",
       "  ('general', 0.0714),\n",
       "  ('protein insolubility', 0.0701),\n",
       "  ('created considerable', 0.0583),\n",
       "  ('worthy', 0.0511),\n",
       "  ('arthritic', 0.0496),\n",
       "  ('variety', 0.0389),\n",
       "  ('excitement mainly', 0.0366),\n",
       "  ('help', 0.0291),\n",
       "  ('mainly lack', 0.0199),\n",
       "  ('conducted determine', 0.0051),\n",
       "  ('pre', 0.0003),\n",
       "  ('aggregation loss', -0.0108)],\n",
       " 'MED-1949': [('preterm infants', 0.576),\n",
       "  ('neonatal care', 0.558),\n",
       "  ('infants data', 0.5062),\n",
       "  ('diabetes young', 0.4853),\n",
       "  ('infants accumulating', 0.4758),\n",
       "  ('care thirties', 0.4545),\n",
       "  ('thirties age', 0.4105),\n",
       "  ('individuals born', 0.3722),\n",
       "  ('born small', 0.3621),\n",
       "  ('later cardiovascular', 0.3367),\n",
       "  ('modern care', 0.3284),\n",
       "  ('cardiometabolic disease', 0.3234),\n",
       "  ('cohorts small', 0.3233),\n",
       "  ('age incidence', 0.3),\n",
       "  ('care suggest', 0.2769),\n",
       "  ('public health', 0.2724),\n",
       "  ('adult cohorts', 0.2587),\n",
       "  ('reducing risk', 0.2512),\n",
       "  ('blood pressure', 0.2495),\n",
       "  ('modern pre', 0.2425),\n",
       "  ('prior introduction', 0.2195),\n",
       "  ('disease low', 0.2192),\n",
       "  ('impaired glucose', 0.2096),\n",
       "  ('regulation atherogenic', 0.199),\n",
       "  ('fruit milk', 0.1818),\n",
       "  ('regarding lifestyle', 0.1725),\n",
       "  ('including higher', 0.1684),\n",
       "  ('disease individuals', 0.1679),\n",
       "  ('lower lean', 0.1592),\n",
       "  ('increased risk', 0.1506),\n",
       "  ('intake', 0.143),\n",
       "  ('particular blood', 0.1322),\n",
       "  ('products intervention', 0.1245),\n",
       "  ('factors particular', 0.1151),\n",
       "  ('lipid', 0.1133),\n",
       "  ('2013', 0.1037),\n",
       "  ('individuals', 0.0941),\n",
       "  ('non conditioning', 0.0937),\n",
       "  ('conditioning physical', 0.091),\n",
       "  ('body', 0.0898),\n",
       "  ('experience', 0.0897),\n",
       "  ('level evidence', 0.0652),\n",
       "  ('mass impaired', 0.0647),\n",
       "  ('evidence increased', 0.0627),\n",
       "  ('data', 0.0529),\n",
       "  ('burden', 0.0496),\n",
       "  ('substantial potential', 0.0156),\n",
       "  ('elsevier rights', -0.0458),\n",
       "  ('implications copyright', -0.0587),\n",
       "  ('undertake', -0.0914)],\n",
       " 'MED-1950': [('infections pregnancy', 0.5526),\n",
       "  ('prebiotics investigated', 0.5395),\n",
       "  ('affect microbes', 0.4638),\n",
       "  ('infections', 0.4629),\n",
       "  ('food antimicrobial', 0.4539),\n",
       "  ('associations microbial', 0.4459),\n",
       "  ('studies associations', 0.3702),\n",
       "  ('association preterm', 0.3503),\n",
       "  ('food types', 0.3334),\n",
       "  ('conclusion intake', 0.296),\n",
       "  ('ptd contained', 0.2853),\n",
       "  ('associated spontaneous', 0.2824),\n",
       "  ('gestational weeks', 0.2604),\n",
       "  ('prelabor', 0.2499),\n",
       "  ('compounds', 0.2431),\n",
       "  ('reduce risk', 0.237),\n",
       "  ('components affect', 0.2288),\n",
       "  ('95 ci', 0.2267),\n",
       "  ('fruits especially', 0.2214),\n",
       "  ('investigated', 0.2213),\n",
       "  ('literature search', 0.2164),\n",
       "  ('onions intake', 0.2064),\n",
       "  ('types', 0.2056),\n",
       "  ('31 39', 0.1883),\n",
       "  ('alliums garlic', 0.1863),\n",
       "  ('dietary fibers', 0.1863),\n",
       "  ('pronounced risk', 0.1694),\n",
       "  ('ptd 37', 0.1658),\n",
       "  ('apricots prunes', 0.1591),\n",
       "  ('main', 0.1507),\n",
       "  ('888 women', 0.1479),\n",
       "  ('weeks 28', 0.1416),\n",
       "  ('delivery', 0.1408),\n",
       "  ('child cohort', 0.1375),\n",
       "  ('membranes pprom', 0.1357),\n",
       "  ('005 dried', 0.1355),\n",
       "  ('followed cooked', 0.1303),\n",
       "  ('ci 56', 0.1191),\n",
       "  ('especially raisins', 0.1185),\n",
       "  ('norwegian mother', 0.1079),\n",
       "  ('95 strongest', 0.1078),\n",
       "  ('intake 18', 0.1034),\n",
       "  ('25', 0.0625),\n",
       "  ('overall lower', 0.0579),\n",
       "  ('47', 0.0494),\n",
       "  ('pprom 74', 0.0458),\n",
       "  ('figs dates', 0.0444),\n",
       "  ('80', 0.042),\n",
       "  ('moba', 0.0252),\n",
       "  ('leek spring', -0.0291)],\n",
       " 'MED-1951': [('preterm lp', 0.6241),\n",
       "  ('lp births', 0.5708),\n",
       "  ('neonatal risk', 0.5276),\n",
       "  ('birth disruptive', 0.4745),\n",
       "  ('births result', 0.438),\n",
       "  ('lp delivery', 0.4028),\n",
       "  ('gestational age', 0.389),\n",
       "  ('birth 34', 0.3835),\n",
       "  ('complications combination', 0.3719),\n",
       "  ('principle fetal', 0.3655),\n",
       "  ('deficits lp', 0.3323),\n",
       "  ('public health', 0.2953),\n",
       "  ('moderate lp', 0.2912),\n",
       "  ('concern immature', 0.288),\n",
       "  ('term children', 0.2862),\n",
       "  ('36 weeks', 0.2765),\n",
       "  ('mortality', 0.2623),\n",
       "  ('adverse effects', 0.2455),\n",
       "  ('development occurs', 0.2419),\n",
       "  ('increases risk', 0.2344),\n",
       "  ('combination maternal', 0.2258),\n",
       "  ('disruptive impact', 0.2168),\n",
       "  ('nearly fourths', 0.2162),\n",
       "  ('children worse', 0.2121),\n",
       "  ('sizeable public', 0.1815),\n",
       "  ('disparate medical', 0.1738),\n",
       "  ('early data', 0.1687),\n",
       "  ('prospective longitudinal', 0.1682),\n",
       "  ('psychological outcomes', 0.1639),\n",
       "  ('delivery increases', 0.1561),\n",
       "  ('late', 0.1503),\n",
       "  ('making population', 0.1369),\n",
       "  ('overall outcome', 0.132),\n",
       "  ('neuropsychological profile', 0.1199),\n",
       "  ('critical', 0.1163),\n",
       "  ('weeks', 0.1125),\n",
       "  ('studies moderate', 0.102),\n",
       "  ('adolescence understudied', 0.099),\n",
       "  ('sizeable', 0.0955),\n",
       "  ('begun addressed', 0.089),\n",
       "  ('accounts nearly', 0.0885),\n",
       "  ('brain', 0.0839),\n",
       "  ('functioning better', 0.0622),\n",
       "  ('subtle intellectual', 0.0563),\n",
       "  ('reconsidered rapidly', 0.0462),\n",
       "  ('common methodology', 0.0353),\n",
       "  ('compared healthy', 0.0213),\n",
       "  ('day', 0.0049),\n",
       "  ('literature reinforces', -0.0106),\n",
       "  ('participants single', -0.0174)],\n",
       " 'MED-1952': [('neurodevelopmental', 0.478),\n",
       "  ('health disorders', 0.4368),\n",
       "  ('mental health', 0.4335),\n",
       "  ('disorders population', 0.4197),\n",
       "  ('health sequelae', 0.4125),\n",
       "  ('extremely preterm', 0.4026),\n",
       "  ('health outcomes', 0.3538),\n",
       "  ('sequelae extremely', 0.3376),\n",
       "  ('problems emotional', 0.3301),\n",
       "  ('lifespan studies', 0.3216),\n",
       "  ('studies provide', 0.3163),\n",
       "  ('interpreting studies', 0.3048),\n",
       "  ('review literature', 0.3046),\n",
       "  ('conducted preschool', 0.2836),\n",
       "  ('birth paper', 0.2797),\n",
       "  ('birth', 0.2532),\n",
       "  ('born extremely', 0.2469),\n",
       "  ('individuals born', 0.2426),\n",
       "  ('problems', 0.2374),\n",
       "  ('difficulties individuals', 0.2221),\n",
       "  ('origin mental', 0.2207),\n",
       "  ('relating mental', 0.2172),\n",
       "  ('adulthood continuity', 0.2015),\n",
       "  ('communicative problems', 0.1943),\n",
       "  ('outcomes point', 0.1917),\n",
       "  ('increased risk', 0.1889),\n",
       "  ('continuity outcomes', 0.1854),\n",
       "  ('growing long', 0.1755),\n",
       "  ('adolescence', 0.1683),\n",
       "  ('age', 0.1583),\n",
       "  ('school age', 0.1529),\n",
       "  ('key methodological', 0.1476),\n",
       "  ('years', 0.1471),\n",
       "  ('behavioural neuroimaging', 0.1374),\n",
       "  ('summarise contemporary', 0.1301),\n",
       "  ('inattention', 0.119),\n",
       "  ('provide evidence', 0.1119),\n",
       "  ('term', 0.1116),\n",
       "  ('carrying interpreting', 0.0868),\n",
       "  ('population', 0.0836),\n",
       "  ('considerations', 0.0768),\n",
       "  ('point increased', 0.0687),\n",
       "  ('2013 elsevier', 0.0681),\n",
       "  ('conducted', 0.0317),\n",
       "  ('copyright', 0.0245),\n",
       "  ('studies field', -0.0001),\n",
       "  ('extremely', -0.0044),\n",
       "  ('highlight', -0.005),\n",
       "  ('socio communicative', -0.0063),\n",
       "  ('behavioural', -0.0115)],\n",
       " 'MED-1953': [('garlic used', 0.6508),\n",
       "  ('recent garlic', 0.6364),\n",
       "  ('use garlic', 0.6248),\n",
       "  ('garlic wide', 0.5976),\n",
       "  ('garlic sulfur', 0.4897),\n",
       "  ('herbal alternatives', 0.4642),\n",
       "  ('medicinal properties', 0.4194),\n",
       "  ('used medicinal', 0.3998),\n",
       "  ('natural herbal', 0.3681),\n",
       "  ('beneficial effects', 0.3466),\n",
       "  ('research antimicrobial', 0.3207),\n",
       "  ('pharmacological investigations', 0.3189),\n",
       "  ('antiprotozoal beneficial', 0.3172),\n",
       "  ('actions antibacterial', 0.3071),\n",
       "  ('antiviral', 0.2862),\n",
       "  ('years investigations', 0.2718),\n",
       "  ('antifungal', 0.2691),\n",
       "  ('effects cardiovascular', 0.2641),\n",
       "  ('new drugs', 0.2632),\n",
       "  ('resurgence use', 0.2622),\n",
       "  ('wide spectrum', 0.2496),\n",
       "  ('thousands years', 0.2493),\n",
       "  ('alternatives brought', 0.2249),\n",
       "  ('forefront pharmacological', 0.2078),\n",
       "  ('investigations new', 0.2057),\n",
       "  ('spectrum actions', 0.2024),\n",
       "  ('properties thousands', 0.1945),\n",
       "  ('review aims', 0.1933),\n",
       "  ('use natural', 0.1835),\n",
       "  ('cardiovascular immune', 0.1512),\n",
       "  ('plants forefront', 0.1472),\n",
       "  ('investigations mode', 0.1463),\n",
       "  ('relatively recent', 0.1374),\n",
       "  ('effects', 0.1143),\n",
       "  ('chemistry provide', 0.1117),\n",
       "  ('systems resurgence', 0.1105),\n",
       "  ('basis research', 0.1012),\n",
       "  ('brought use', 0.0913),\n",
       "  ('aims address', 0.0865),\n",
       "  ('sulfur chemistry', 0.0768),\n",
       "  ('wide', 0.073),\n",
       "  ('discovered', 0.0683),\n",
       "  ('systems', 0.0643),\n",
       "  ('address historical', 0.058),\n",
       "  ('action relatively', 0.0578),\n",
       "  ('used', 0.055),\n",
       "  ('provide', 0.0415),\n",
       "  ('properties', 0.0299),\n",
       "  ('forefront', 0.0181),\n",
       "  ('mode', -0.03)],\n",
       " 'MED-1954': [('problems children', 0.551),\n",
       "  ('problems infancy', 0.5263),\n",
       "  ('problems preterm', 0.4887),\n",
       "  ('infancy preschool', 0.4442),\n",
       "  ('preterm school', 0.4215),\n",
       "  ('born children', 0.4104),\n",
       "  ('comparison children', 0.4069),\n",
       "  ('cohort studies', 0.4017),\n",
       "  ('papers preterm', 0.3816),\n",
       "  ('fourteen cohort', 0.3777),\n",
       "  ('perinatal social', 0.3642),\n",
       "  ('behaviour problems', 0.3634),\n",
       "  ('preterm low', 0.3556),\n",
       "  ('known studies', 0.3132),\n",
       "  ('birthweight moderately', 0.302),\n",
       "  ('child neurology', 0.2754),\n",
       "  ('studies behaviour', 0.2731),\n",
       "  ('age groups', 0.2711),\n",
       "  ('authors developmental', 0.2707),\n",
       "  ('problems term', 0.2534),\n",
       "  ('developmental medicine', 0.2419),\n",
       "  ('controlled poor', 0.2413),\n",
       "  ('comorbidity stability', 0.2368),\n",
       "  ('programmes', 0.2331),\n",
       "  ('psycinfo 2000', 0.2307),\n",
       "  ('born comparison', 0.2238),\n",
       "  ('school', 0.2081),\n",
       "  ('reviewed', 0.2037),\n",
       "  ('difficulties reduced', 0.201),\n",
       "  ('poor social', 0.2006),\n",
       "  ('published pubmed', 0.1781),\n",
       "  ('skills poor', 0.1615),\n",
       "  ('2000 2012', 0.156),\n",
       "  ('common', 0.1426),\n",
       "  ('social risk', 0.1416),\n",
       "  ('groups behaviour', 0.1346),\n",
       "  ('included follow', 0.116),\n",
       "  ('predictive later', 0.1122),\n",
       "  ('considered additional', 0.0991),\n",
       "  ('2013', 0.0981),\n",
       "  ('focus type', 0.0829),\n",
       "  ('interactive skills', 0.0815),\n",
       "  ('reduced attention', 0.0697),\n",
       "  ('low', 0.0696),\n",
       "  ('cognitive performance', 0.0579),\n",
       "  ('type occurrence', 0.0511),\n",
       "  ('self regulation', 0.0354),\n",
       "  ('age 5y', 0.0267),\n",
       "  ('relational', 0.0169),\n",
       "  ('mac keith', -0.009)],\n",
       " 'MED-1955': [('enrolment pregnancy', 0.497),\n",
       "  ('gestational weeks', 0.4847),\n",
       "  ('cohort study', 0.404),\n",
       "  ('norway 2002', 0.4007),\n",
       "  ('compared women', 0.391),\n",
       "  ('exists maternal', 0.3822),\n",
       "  ('dietary patterns', 0.3646),\n",
       "  ('women eat', 0.3606),\n",
       "  ('pregnancy lower', 0.3591),\n",
       "  ('previously preterm', 0.3417),\n",
       "  ('design prospective', 0.3101),\n",
       "  ('findings establish', 0.2971),\n",
       "  ('answered food', 0.2855),\n",
       "  ('frequency questionnaire', 0.2839),\n",
       "  ('singletons answered', 0.2804),\n",
       "  ('diabetes', 0.2778),\n",
       "  ('delivery design', 0.262),\n",
       "  ('weeks', 0.2604),\n",
       "  ('study setting', 0.2478),\n",
       "  ('fish results', 0.2354),\n",
       "  ('participants', 0.2304),\n",
       "  ('66 000', 0.2195),\n",
       "  ('objective examine', 0.2145),\n",
       "  ('2008 participants', 0.2021),\n",
       "  ('41', 0.1983),\n",
       "  ('balanced', 0.1969),\n",
       "  ('results adjustment', 0.1958),\n",
       "  ('information parity', 0.1832),\n",
       "  ('association exists', 0.177),\n",
       "  ('000', 0.1703),\n",
       "  ('main outcome', 0.1482),\n",
       "  ('potatoes', 0.1451),\n",
       "  ('pattern traditional', 0.1426),\n",
       "  ('meat products', 0.1312),\n",
       "  ('missing information', 0.1233),\n",
       "  ('bread western', 0.1223),\n",
       "  ('fibre rich', 0.1222),\n",
       "  ('water', 0.1171),\n",
       "  ('advice', 0.1148),\n",
       "  ('totally', 0.1057),\n",
       "  ('covariates high', 0.1057),\n",
       "  ('spontaneous', 0.1),\n",
       "  ('late', 0.0993),\n",
       "  ('95 confidence', 0.0962),\n",
       "  ('adhering', 0.0839),\n",
       "  ('lowest hazard', 0.0747),\n",
       "  ('excluding processed', 0.068),\n",
       "  ('80 97', 0.0676),\n",
       "  ('salty sweet', 0.0269),\n",
       "  ('junk', -0.0847)],\n",
       " 'MED-1956': [('tcdd fda', 0.5127),\n",
       "  ('fda terminated', 0.4705),\n",
       "  ('tetrachlorodibenzo', 0.4387),\n",
       "  ('dioxin', 0.4178),\n",
       "  ('fda collected', 0.3752),\n",
       "  ('food drug', 0.3721),\n",
       "  ('terminated use', 0.351),\n",
       "  ('clay mississippi', 0.3105),\n",
       "  ('reference toxic', 0.2916),\n",
       "  ('discovering nanogram', 0.2915),\n",
       "  ('mass spectrometry', 0.2902),\n",
       "  ('concentrations significantly', 0.2686),\n",
       "  ('using quadrupole', 0.2305),\n",
       "  ('use', 0.2063),\n",
       "  ('animal feed', 0.1977),\n",
       "  ('use ball', 0.1942),\n",
       "  ('fly ash', 0.1907),\n",
       "  ('assess levels', 0.1863),\n",
       "  ('gram concentrations', 0.1817),\n",
       "  ('catfish exposed', 0.1803),\n",
       "  ('fillet', 0.1738),\n",
       "  ('additive', 0.1683),\n",
       "  ('measured', 0.1681),\n",
       "  ('administration', 0.1662),\n",
       "  ('isomer pattern', 0.1607),\n",
       "  ('new method', 0.1604),\n",
       "  ('tilapia', 0.1572),\n",
       "  ('qistms measured', 0.1521),\n",
       "  ('eggs farm', 0.1481),\n",
       "  ('time mass', 0.1392),\n",
       "  ('samples chicken', 0.1361),\n",
       "  ('ion storage', 0.1127),\n",
       "  ('discovering', 0.1124),\n",
       "  ('samples', 0.1005),\n",
       "  ('ingredient 1950s', 0.0965),\n",
       "  ('affected areas', 0.0962),\n",
       "  ('concentration 12', 0.0892),\n",
       "  ('united states', 0.0857),\n",
       "  ('fat used', 0.0824),\n",
       "  ('20 egg', 0.0783),\n",
       "  ('wet weight', 0.0714),\n",
       "  ('differed', 0.0618),\n",
       "  ('significantly pg', 0.0582),\n",
       "  ('levels 42', 0.0481),\n",
       "  ('tandem', 0.017),\n",
       "  ('chick edema', 0.0143),\n",
       "  ('raised', -0.0135),\n",
       "  ('composites', -0.0162),\n",
       "  ('remaining continental', -0.0496),\n",
       "  ('46', -0.0723)],\n",
       " 'MED-1957': [('pcdfs soybean', 0.5382),\n",
       "  ('ingredients analyzed', 0.4878),\n",
       "  ('contaminated pcdds', 0.4667),\n",
       "  ('pcdfs ingredients', 0.4573),\n",
       "  ('soybean meal', 0.4287),\n",
       "  ('analyzed pcdds', 0.411),\n",
       "  ('highly contaminated', 0.3558),\n",
       "  ('especially toxic', 0.3512),\n",
       "  ('pcdds sigma', 0.337),\n",
       "  ('lipid', 0.3111),\n",
       "  ('feed', 0.3041),\n",
       "  ('combined catfish', 0.297),\n",
       "  ('congeners pg', 0.2833),\n",
       "  ('environmental sample', 0.2827),\n",
       "  ('meal ruled', 0.2811),\n",
       "  ('concentrations approximately', 0.271),\n",
       "  ('congener pattern', 0.2681),\n",
       "  ('meal highly', 0.2663),\n",
       "  ('toxic substituted', 0.2596),\n",
       "  ('pg fat', 0.2393),\n",
       "  ('substituted congeners', 0.2051),\n",
       "  ('sample technical', 0.1911),\n",
       "  ('meal 11', 0.1879),\n",
       "  ('weight', 0.1851),\n",
       "  ('analyzed', 0.1846),\n",
       "  ('sigma', 0.1769),\n",
       "  ('cdd teq', 0.1573),\n",
       "  ('lower congener', 0.1531),\n",
       "  ('product similar', 0.1525),\n",
       "  ('characteristics result', 0.1506),\n",
       "  ('sample', 0.1302),\n",
       "  ('dry weight', 0.124),\n",
       "  ('values', 0.1236),\n",
       "  ('370', 0.123),\n",
       "  ('lipid tetra', 0.1201),\n",
       "  ('aware environmental', 0.1185),\n",
       "  ('approximately times', 0.1162),\n",
       "  ('pattern', 0.1009),\n",
       "  ('combined', 0.0991),\n",
       "  ('ruled', 0.0988),\n",
       "  ('quite unique', 0.0959),\n",
       "  ('weight 576', 0.0888),\n",
       "  ('arkansas', 0.0884),\n",
       "  ('especially', 0.0772),\n",
       "  ('pg', 0.0722),\n",
       "  ('profile ratio', 0.0636),\n",
       "  ('times lower', 0.0545),\n",
       "  ('usa', 0.048),\n",
       "  ('formation', 0.0416),\n",
       "  ('result natural', 0.0403)],\n",
       " 'MED-1958': [('dioxins pcdds', 0.6313),\n",
       "  ('source polychlorinated', 0.4974),\n",
       "  ('meat teqs', 0.4455),\n",
       "  ('estimate intake', 0.4435),\n",
       "  ('tcdd kg', 0.437),\n",
       "  ('york tetrachlorodibenzo', 0.3862),\n",
       "  ('highly toxic', 0.3695),\n",
       "  ('food especially', 0.3282),\n",
       "  ('consumption rates', 0.301),\n",
       "  ('dairy products', 0.295),\n",
       "  ('milk fish', 0.2827),\n",
       "  ('ppt fish', 0.2574),\n",
       "  ('average daily', 0.2471),\n",
       "  ('kg day', 0.2433),\n",
       "  ('congener', 0.2418),\n",
       "  ('products ranged', 0.2317),\n",
       "  ('compounds general', 0.2247),\n",
       "  ('risk 10', 0.2145),\n",
       "  ('epa virtually', 0.2138),\n",
       "  ('industrial countries', 0.1803),\n",
       "  ('total', 0.1644),\n",
       "  ('samples', 0.1626),\n",
       "  ('day 70', 0.1511),\n",
       "  ('body', 0.1428),\n",
       "  ('dose 006', 0.1377),\n",
       "  ('analyses used', 0.136),\n",
       "  ('cancer risk', 0.1341),\n",
       "  ('samples supermarket', 0.1315),\n",
       "  ('13 ppt', 0.125),\n",
       "  ('virtually safe', 0.1125),\n",
       "  ('government agencies', 0.1106),\n",
       "  ('used european', 0.1043),\n",
       "  ('highly', 0.1023),\n",
       "  ('human breast', 0.0939),\n",
       "  ('using 1986', 0.0775),\n",
       "  ('wet', 0.0714),\n",
       "  ('limit', 0.0669),\n",
       "  ('ranged 02', 0.056),\n",
       "  ('year lifetime', 0.0499),\n",
       "  ('immediate source', 0.0484),\n",
       "  ('average 35', 0.0473),\n",
       "  ('04', 0.0457),\n",
       "  ('adult weighing', 0.0302),\n",
       "  ('used current', 0.0265),\n",
       "  ('192 pg', 0.0093),\n",
       "  ('infant', 0.0082),\n",
       "  ('life compared', -0.0081),\n",
       "  ('upstate new', -0.0125),\n",
       "  ('total 18', -0.0217),\n",
       "  ('american women', -0.0406)],\n",
       " 'MED-1959': [('pesticide data', 0.5301),\n",
       "  ('amounts polychlorinated', 0.4395),\n",
       "  ('1479 catfish', 0.4378),\n",
       "  ('pdps subset', 0.3619),\n",
       "  ('assess chemical', 0.3598),\n",
       "  ('2010 pdps', 0.3386),\n",
       "  ('residues foods', 0.3375),\n",
       "  ('products 1479', 0.3249),\n",
       "  ('analysed 17', 0.3116),\n",
       "  ('higher pcdf', 0.3017),\n",
       "  ('feeds investigate', 0.2978),\n",
       "  ('samples analysed', 0.2946),\n",
       "  ('concentrations resembled', 0.2905),\n",
       "  ('1991 department', 0.2724),\n",
       "  ('usda conducted', 0.268),\n",
       "  ('annual surveys', 0.2624),\n",
       "  ('administration usfda', 0.2288),\n",
       "  ('collected 2008', 0.2218),\n",
       "  ('domestically marketed', 0.2173),\n",
       "  ('products china', 0.213),\n",
       "  ('products clays', 0.2119),\n",
       "  ('food drug', 0.2103),\n",
       "  ('agricultural', 0.2094),\n",
       "  ('toxic', 0.2021),\n",
       "  ('unique measurable', 0.1937),\n",
       "  ('202 samples', 0.1788),\n",
       "  ('similarities pattern', 0.1648),\n",
       "  ('dioxins furans', 0.1546),\n",
       "  ('database examined', 0.1505),\n",
       "  ('critical control', 0.1502),\n",
       "  ('program', 0.1453),\n",
       "  ('produced', 0.1414),\n",
       "  ('supply', 0.1192),\n",
       "  ('congener', 0.1113),\n",
       "  ('fs kaolin', 0.1055),\n",
       "  ('taiwan comparison', 0.1032),\n",
       "  ('61 112', 0.101),\n",
       "  ('states source', 0.1008),\n",
       "  ('pattern dominant', 0.1006),\n",
       "  ('mined south', 0.0912),\n",
       "  ('animal', 0.0795),\n",
       "  ('marketing service', 0.0768),\n",
       "  ('times higher', 0.0633),\n",
       "  ('considered likely', 0.0631),\n",
       "  ('range', 0.0534),\n",
       "  ('definitively established', 0.0162),\n",
       "  ('anti caking', 0.0142),\n",
       "  ('50 times', 0.0085),\n",
       "  ('eastern', -0.0006),\n",
       "  ('fs entrance', -0.0949)],\n",
       " 'MED-1960': [('pcb catfish', 0.5974),\n",
       "  ('catfish fillets', 0.5506),\n",
       "  ('catfish compared', 0.4932),\n",
       "  ('catfish mississippi', 0.4637),\n",
       "  ('catfish nuggets', 0.4551),\n",
       "  ('pcdf ranged', 0.4481),\n",
       "  ('teq pcdd', 0.4463),\n",
       "  ('analyzed pcdd', 0.4355),\n",
       "  ('pcb teq', 0.4229),\n",
       "  ('pcb ranged', 0.4117),\n",
       "  ('pcb farm', 0.3825),\n",
       "  ('concentrations dioxin', 0.3653),\n",
       "  ('feed samples', 0.3506),\n",
       "  ('substituted pcdd', 0.3404),\n",
       "  ('lipid teq', 0.3161),\n",
       "  ('contained significant', 0.2982),\n",
       "  ('congeners present', 0.2917),\n",
       "  ('non dioxin', 0.2855),\n",
       "  ('high concentrations', 0.2704),\n",
       "  ('fillets', 0.2352),\n",
       "  ('substituted congeners', 0.2301),\n",
       "  ('total', 0.2144),\n",
       "  ('present samples', 0.193),\n",
       "  ('levels', 0.1897),\n",
       "  ('farm raised', 0.1881),\n",
       "  ('compared aquarium', 0.1789),\n",
       "  ('raised results', 0.1789),\n",
       "  ('results study', 0.1685),\n",
       "  ('sediment immunoreactive', 0.1681),\n",
       "  ('large number', 0.1624),\n",
       "  ('16 total', 0.1578),\n",
       "  ('based', 0.1358),\n",
       "  ('pond sediment', 0.1331),\n",
       "  ('number non', 0.1328),\n",
       "  ('major', 0.1273),\n",
       "  ('mississippi', 0.1244),\n",
       "  ('ranged', 0.1195),\n",
       "  ('cyp1a induction', 0.1154),\n",
       "  ('contributed', 0.1122),\n",
       "  ('source', 0.0979),\n",
       "  ('fold', 0.0966),\n",
       "  ('nuggets', 0.0952),\n",
       "  ('compared', 0.0916),\n",
       "  ('protein elevated', 0.0871),\n",
       "  ('like', 0.082),\n",
       "  ('45 pg', 0.0811),\n",
       "  ('alabama', 0.0748),\n",
       "  ('arkansas contained', 0.0586),\n",
       "  ('43', 0.0449),\n",
       "  ('appears', 0.0297)],\n",
       " 'MED-1961': [('dioxins foods', 0.6867),\n",
       "  ('exposure dioxins', 0.6626),\n",
       "  ('dioxins vulnerable', 0.6612),\n",
       "  ('dioxin intake', 0.6486),\n",
       "  ('reducing dioxin', 0.6169),\n",
       "  ('dietary exposure', 0.5524),\n",
       "  ('intake exposure', 0.5292),\n",
       "  ('reducing dietary', 0.528),\n",
       "  ('dietary intake', 0.4707),\n",
       "  ('contaminants food', 0.4611),\n",
       "  ('exposure reducing', 0.4605),\n",
       "  ('foods minimized', 0.4377),\n",
       "  ('contaminants', 0.4289),\n",
       "  ('compounds undesirable', 0.3944),\n",
       "  ('body burdens', 0.3862),\n",
       "  ('unintended contaminants', 0.3823),\n",
       "  ('reducing body', 0.3794),\n",
       "  ('intake major', 0.3633),\n",
       "  ('supply dietary', 0.3598),\n",
       "  ('consuming foods', 0.3383),\n",
       "  ('generations exposure', 0.311),\n",
       "  ('burdens', 0.3095),\n",
       "  ('products consuming', 0.2837),\n",
       "  ('route exposure', 0.2772),\n",
       "  ('dairy products', 0.2759),\n",
       "  ('recommended amounts', 0.2617),\n",
       "  ('lower fat', 0.258),\n",
       "  ('strategy reducing', 0.2489),\n",
       "  ('exposure maintaining', 0.2447),\n",
       "  ('related compounds', 0.2273),\n",
       "  ('burdens future', 0.2263),\n",
       "  ('good health', 0.1979),\n",
       "  ('fat versions', 0.1906),\n",
       "  ('vulnerable segments', 0.1892),\n",
       "  ('poultry dairy', 0.1375),\n",
       "  ('infants', 0.1311),\n",
       "  ('population pregnant', 0.1229),\n",
       "  ('including', 0.1219),\n",
       "  ('fish', 0.1183),\n",
       "  ('major route', 0.0892),\n",
       "  ('future', 0.0872),\n",
       "  ('goal', 0.0841),\n",
       "  ('young girls', 0.0838),\n",
       "  ('population', 0.0778),\n",
       "  ('meats', 0.0766),\n",
       "  ('versions', 0.0676),\n",
       "  ('young', 0.0598),\n",
       "  ('women', 0.0526),\n",
       "  ('amounts congruent', 0.0452),\n",
       "  ('selecting', 0.0038)],\n",
       " 'MED-1962': [('tissues chicken', 0.5258),\n",
       "  ('pcdfs determined', 0.5249),\n",
       "  ('fat values', 0.5055),\n",
       "  ('concentrations pcdds', 0.4957),\n",
       "  ('chicken fryers', 0.4911),\n",
       "  ('fat determination', 0.4887),\n",
       "  ('pcdds pcdfs', 0.4673),\n",
       "  ('furans pcdds', 0.4569),\n",
       "  ('pcdfs abdominal', 0.455),\n",
       "  ('abdominal fat', 0.4391),\n",
       "  ('edible tissues', 0.4035),\n",
       "  ('determined edible', 0.4029),\n",
       "  ('dioxins edible', 0.4001),\n",
       "  ('basis lipid', 0.3788),\n",
       "  ('dioxins furans', 0.3603),\n",
       "  ('values abdominal', 0.3525),\n",
       "  ('concentration dibenzo', 0.3381),\n",
       "  ('weight basis', 0.3311),\n",
       "  ('dioxins statistically', 0.3265),\n",
       "  ('concentrations', 0.305),\n",
       "  ('lipid adjusted', 0.3035),\n",
       "  ('adjusted concentrations', 0.2956),\n",
       "  ('tissues expressed', 0.2953),\n",
       "  ('edible', 0.2815),\n",
       "  ('concentrations individual', 0.2781),\n",
       "  ('presence compounds', 0.2764),\n",
       "  ('concentrations cl', 0.2722),\n",
       "  ('fryers compared', 0.266),\n",
       "  ('difference concentration', 0.2564),\n",
       "  ('basis tissue', 0.2545),\n",
       "  ('compared values', 0.2501),\n",
       "  ('compounds different', 0.25),\n",
       "  ('different tissues', 0.242),\n",
       "  ('presented weight', 0.2233),\n",
       "  ('furans', 0.2123),\n",
       "  ('use lipid', 0.2109),\n",
       "  ('tissues validates', 0.2048),\n",
       "  ('determined', 0.1723),\n",
       "  ('various', 0.1575),\n",
       "  ('validates', 0.1444),\n",
       "  ('adjusted basis', 0.131),\n",
       "  ('statistically different', 0.1172),\n",
       "  ('cl substituted', 0.1162),\n",
       "  ('difference', 0.0944),\n",
       "  ('expressed', 0.0878),\n",
       "  ('marked', 0.0638),\n",
       "  ('statistically', 0.0511),\n",
       "  ('presented', 0.0451),\n",
       "  ('use', 0.0228),\n",
       "  ('presence', -0.0107)],\n",
       " 'MED-1963': [('43 foodstuff', 0.5824),\n",
       "  ('levels meat', 0.4945),\n",
       "  ('analyzed 43', 0.475),\n",
       "  ('foodstuff samples', 0.4356),\n",
       "  ('meat 53', 0.4244),\n",
       "  ('samples lipid', 0.3745),\n",
       "  ('quantified 31', 0.3701),\n",
       "  ('concentrations pcdd', 0.3397),\n",
       "  ('teq dairy', 0.306),\n",
       "  ('study detected', 0.305),\n",
       "  ('congeners teq', 0.3019),\n",
       "  ('40 teq', 0.3015),\n",
       "  ('local supermarkets', 0.2633),\n",
       "  ('1994 analyzed', 0.2628),\n",
       "  ('42', 0.2483),\n",
       "  ('highest concentrations', 0.2475),\n",
       "  ('basis levels', 0.2247),\n",
       "  ('example milk', 0.2212),\n",
       "  ('cl4dd quantified', 0.2199),\n",
       "  ('10 27', 0.2197),\n",
       "  ('samples united', 0.2147),\n",
       "  ('countries levels', 0.2098),\n",
       "  ('catfish samples', 0.1984),\n",
       "  ('products', 0.1977),\n",
       "  ('quantified', 0.1868),\n",
       "  ('individual congeners', 0.1724),\n",
       "  ('teq unique', 0.1707),\n",
       "  ('states', 0.1659),\n",
       "  ('farm raised', 0.1499),\n",
       "  ('10 pg', 0.1438),\n",
       "  ('unique finding', 0.1437),\n",
       "  ('contained', 0.1399),\n",
       "  ('53', 0.1386),\n",
       "  ('metabolize non', 0.134),\n",
       "  ('industrialized countries', 0.1336),\n",
       "  ('difference contribution', 0.1301),\n",
       "  ('contained non', 0.124),\n",
       "  ('local', 0.1193),\n",
       "  ('states europe', 0.1168),\n",
       "  ('southern mississippi', 0.1158),\n",
       "  ('usa', 0.1135),\n",
       "  ('addition', 0.0991),\n",
       "  ('slightly lower', 0.098),\n",
       "  ('selectively eliminate', 0.0978),\n",
       "  ('raised', 0.0843),\n",
       "  ('contributes 16', 0.0413),\n",
       "  ('cl5df', 0.0385),\n",
       "  ('samples germany', 0.0175),\n",
       "  ('animals', 0.0149),\n",
       "  ('individual', -0.0103)],\n",
       " 'MED-1966': [('dietary cholesterol', 0.5596),\n",
       "  ('cholesterol meta', 0.5113),\n",
       "  ('cholesterol mathematical', 0.5029),\n",
       "  ('cholesterol 27', 0.4751),\n",
       "  ('cholesterol mmol', 0.4732),\n",
       "  ('effects dietary', 0.4412),\n",
       "  ('controlled diets', 0.403),\n",
       "  ('meta analysis', 0.3624),\n",
       "  ('provided 76', 0.3412),\n",
       "  ('responsiveness dietary', 0.3363),\n",
       "  ('studies controlled', 0.3358),\n",
       "  ('estimate effects', 0.3304),\n",
       "  ('27 studies', 0.3175),\n",
       "  ('supplied metabolic', 0.2782),\n",
       "  ('nonlinear regression', 0.2728),\n",
       "  ('changes serum', 0.2703),\n",
       "  ('fit data', 0.2558),\n",
       "  ('attempts estimate', 0.2535),\n",
       "  ('metabolic kitchen', 0.2523),\n",
       "  ('weighted number', 0.2456),\n",
       "  ('number subjects', 0.2373),\n",
       "  ('reported changes', 0.233),\n",
       "  ('prior studies', 0.2216),\n",
       "  ('subjects nonlinear', 0.2183),\n",
       "  ('previously included', 0.2119),\n",
       "  ('data points', 0.2112),\n",
       "  ('0136', 0.2078),\n",
       "  ('model mean', 0.2066),\n",
       "  ('analysis previously', 0.1941),\n",
       "  ('studies public', 0.189),\n",
       "  ('mathematical', 0.1738),\n",
       "  ('regression good', 0.1709),\n",
       "  ('mechanisms individual', 0.1663),\n",
       "  ('public health', 0.1629),\n",
       "  ('effects', 0.1584),\n",
       "  ('mmol chi', 0.1435),\n",
       "  ('given equation', 0.1423),\n",
       "  ('controlled', 0.1387),\n",
       "  ('possible reasons', 0.1297),\n",
       "  ('reasons hyperbolic', 0.1286),\n",
       "  ('617 observed', 0.1258),\n",
       "  ('baseline', 0.1168),\n",
       "  ('interpretation prior', 0.0839),\n",
       "  ('important', 0.0831),\n",
       "  ('shape relationship', 0.0795),\n",
       "  ('supplied', 0.0724),\n",
       "  ('issues discussed', 0.0538),\n",
       "  ('22 00384', 0.0319),\n",
       "  ('mg possible', 0.0208),\n",
       "  ('0005', -0.014)],\n",
       " 'MED-1968': [('dietary cholesterol', 0.5676),\n",
       "  ('changes normolipidemic', 0.5119),\n",
       "  ('lipoprotein changes', 0.5089),\n",
       "  ('test meals', 0.5038),\n",
       "  ('plasma lipid', 0.4818),\n",
       "  ('triglycerides decreased', 0.4638),\n",
       "  ('subjects fed', 0.4626),\n",
       "  ('compared fat', 0.4619),\n",
       "  ('fixed lipids', 0.4345),\n",
       "  ('meals random', 0.4267),\n",
       "  ('cholesterol 710', 0.4236),\n",
       "  ('lipids 45', 0.4193),\n",
       "  ('lipoproteins isolated', 0.4131),\n",
       "  ('amounts dietary', 0.4109),\n",
       "  ('ldl free', 0.4061),\n",
       "  ('lowered cholesteryl', 0.4045),\n",
       "  ('increased ldl', 0.395),\n",
       "  ('esters postprandially', 0.3923),\n",
       "  ('triglyceride rich', 0.3788),\n",
       "  ('meals raised', 0.3654),\n",
       "  ('altered postprandially', 0.33),\n",
       "  ('apob altered', 0.328),\n",
       "  ('density hdl', 0.3232),\n",
       "  ('meal did', 0.3132),\n",
       "  ('fasting post', 0.3095),\n",
       "  ('subjects subjects', 0.2799),\n",
       "  ('05 plasma', 0.2284),\n",
       "  ('increased ingesting', 0.2262),\n",
       "  ('insulin', 0.2218),\n",
       "  ('zero 140', 0.2216),\n",
       "  ('containing zero', 0.1915),\n",
       "  ('composition', 0.1758),\n",
       "  ('710 mg', 0.1735),\n",
       "  ('different test', 0.1695),\n",
       "  ('concentrations small', 0.1678),\n",
       "  ('did contain', 0.159),\n",
       "  ('dropped', 0.155),\n",
       "  ('highly enriched', 0.153),\n",
       "  ('blood samples', 0.1462),\n",
       "  ('components altered', 0.1412),\n",
       "  ('healthy', 0.1237),\n",
       "  ('responses', 0.1075),\n",
       "  ('determine effects', 0.1075),\n",
       "  ('order', 0.0977),\n",
       "  ('isolated compared', 0.0791),\n",
       "  ('large trls', 0.05),\n",
       "  ('comparable', 0.0171),\n",
       "  ('significantly', -0.0088),\n",
       "  ('hand', -0.0217),\n",
       "  ('providing 280', -0.0609)],\n",
       " 'MED-1977': [('colonization swine', 0.6153),\n",
       "  ('contamination pig', 0.5659),\n",
       "  ('contamination pork', 0.4118),\n",
       "  ('carcasses strains', 0.4011),\n",
       "  ('mrsa 15', 0.3932),\n",
       "  ('isolates confirmed', 0.3745),\n",
       "  ('resistant staphylococcus', 0.3727),\n",
       "  ('livestock associated', 0.3519),\n",
       "  ('infections year', 0.3511),\n",
       "  ('contamination local', 0.3305),\n",
       "  ('aureus la', 0.3176),\n",
       "  ('meat investigated', 0.3118),\n",
       "  ('carriage risk', 0.3038),\n",
       "  ('ivb strains', 0.3021),\n",
       "  ('sccmec spa', 0.3016),\n",
       "  ('investigated pfge', 0.2903),\n",
       "  ('levels 10', 0.28),\n",
       "  ('isolates t359', 0.2656),\n",
       "  ('farmers veterinarians', 0.2485),\n",
       "  ('workers strains', 0.2442),\n",
       "  ('previously reported', 0.2225),\n",
       "  ('recently slaughtered', 0.2196),\n",
       "  ('presence meca', 0.2178),\n",
       "  ('reported buffaloes', 0.2129),\n",
       "  ('data contamination', 0.2071),\n",
       "  ('butchers markets', 0.189),\n",
       "  ('salt cultured', 0.1888),\n",
       "  ('recently china', 0.1772),\n",
       "  ('europe', 0.1657),\n",
       "  ('bovine milk', 0.1586),\n",
       "  ('seventeen samples', 0.1554),\n",
       "  ('cc6 colonizing', 0.1535),\n",
       "  ('handling raw', 0.1331),\n",
       "  ('15 harbouring', 0.1303),\n",
       "  ('completed questionnaire', 0.1297),\n",
       "  ('america recently', 0.1229),\n",
       "  ('healthcare origin', 0.1227),\n",
       "  ('abattoir', 0.1172),\n",
       "  ('performed presence', 0.105),\n",
       "  ('blackwell verlag', 0.097),\n",
       "  ('retail', 0.096),\n",
       "  ('cut nasal', 0.0915),\n",
       "  ('washing hands', 0.0712),\n",
       "  ('cc97', 0.07),\n",
       "  ('general', 0.0662),\n",
       "  ('canada limited', 0.0563),\n",
       "  ('family', -0.0025),\n",
       "  ('collected 300', -0.0123),\n",
       "  ('heart infusion', -0.0558),\n",
       "  ('type ii', -0.0805)],\n",
       " 'MED-1978': [('swine manure', 0.5923),\n",
       "  ('fields livestock', 0.4731),\n",
       "  ('field manure', 0.4594),\n",
       "  ('antibiotics united', 0.4294),\n",
       "  ('80 antibiotics', 0.4178),\n",
       "  ('risk antibiotic', 0.3994),\n",
       "  ('resistant staphylococcus', 0.3799),\n",
       "  ('agriculture risk', 0.3767),\n",
       "  ('bacteria', 0.3515),\n",
       "  ('resistance genes', 0.3294),\n",
       "  ('feeds', 0.2844),\n",
       "  ('infection design', 0.257),\n",
       "  ('isolates patients', 0.2201),\n",
       "  ('management plans', 0.2009),\n",
       "  ('exposure significantly', 0.1688),\n",
       "  ('quartiles', 0.1641),\n",
       "  ('operations main', 0.1519),\n",
       "  ('veal industrial', 0.148),\n",
       "  ('2914 controls', 0.1424),\n",
       "  ('outcome measures', 0.1382),\n",
       "  ('seasonal', 0.1252),\n",
       "  ('application number', 0.1146),\n",
       "  ('spa types', 0.1083),\n",
       "  ('sold use', 0.1013),\n",
       "  ('factors highest', 0.1011),\n",
       "  ('united states', 0.0993),\n",
       "  ('status adjusted', 0.0922),\n",
       "  ('446', 0.0862),\n",
       "  ('patients 1539', 0.0853),\n",
       "  ('69', 0.0834),\n",
       "  ('frequency matched', 0.0784),\n",
       "  ('testing', 0.0746),\n",
       "  ('health records', 0.0735),\n",
       "  ('cc398 previously', 0.0725),\n",
       "  ('60', 0.0598),\n",
       "  ('95', 0.0583),\n",
       "  ('2010 incident', 0.0583),\n",
       "  ('randomly', 0.0531),\n",
       "  ('growing', 0.0348),\n",
       "  ('classified community', 0.0294),\n",
       "  ('study geisinger', 0.0233),\n",
       "  ('patients pennsylvania', 0.0132),\n",
       "  ('200', 0.012),\n",
       "  ('contains', 0.0051),\n",
       "  ('nested case', 0.0033),\n",
       "  ('using electronic', -0.0009),\n",
       "  ('weaker associations', -0.014),\n",
       "  ('1335', -0.0151),\n",
       "  ('31 unique', -0.024),\n",
       "  ('skin soft', -0.0462)],\n",
       " 'MED-1979': [('mrsa pig', 0.6612),\n",
       "  ('mrsa various', 0.5859),\n",
       "  ('reservoir mrsa', 0.5703),\n",
       "  ('mrsa carcasses', 0.5561),\n",
       "  ('mrsa pork', 0.547),\n",
       "  ('burden mrsa', 0.5326),\n",
       "  ('staphylococcus aureus', 0.5114),\n",
       "  ('methicillin resistant', 0.5098),\n",
       "  ('recontamination mrsa', 0.4907),\n",
       "  ('pig herds', 0.4568),\n",
       "  ('specifically livestock', 0.3438),\n",
       "  ('herds important', 0.2906),\n",
       "  ('high prevalence', 0.2486),\n",
       "  ('fecal contamination', 0.2326),\n",
       "  ('398 high', 0.2213),\n",
       "  ('frequent detection', 0.1881),\n",
       "  ('safety issue', 0.1841),\n",
       "  ('sequence type', 0.1836),\n",
       "  ('meat products', 0.1813),\n",
       "  ('issue recurrent', 0.1643),\n",
       "  ('facilities frequent', 0.1624),\n",
       "  ('types pork', 0.1567),\n",
       "  ('farm fork', 0.1548),\n",
       "  ('management', 0.1457),\n",
       "  ('reports documented', 0.1423),\n",
       "  ('increased', 0.1393),\n",
       "  ('worldwide presence', 0.1293),\n",
       "  ('public health', 0.128),\n",
       "  ('production chain', 0.1181),\n",
       "  ('important reservoir', 0.1067),\n",
       "  ('personal hygiene', 0.1063),\n",
       "  ('resistant', 0.1033),\n",
       "  ('process significantly', 0.0824),\n",
       "  ('underlying mechanisms', 0.0721),\n",
       "  ('decisive role', 0.0662),\n",
       "  ('revealed slaughter', 0.0656),\n",
       "  ('presence', 0.0431),\n",
       "  ('various', 0.0422),\n",
       "  ('scalding flaming', 0.0418),\n",
       "  ('avoiding recontamination', 0.039),\n",
       "  ('human handling', 0.0106),\n",
       "  ('occur surface', 0.0089),\n",
       "  ('primary', 0.0055),\n",
       "  ('current literature', -0.0073),\n",
       "  ('comprehensive', -0.0093),\n",
       "  ('food', -0.0108),\n",
       "  ('superficial heat', -0.0241),\n",
       "  ('plays', -0.0412),\n",
       "  ('minimized', -0.0598),\n",
       "  ('introduction transmission', -0.0696)],\n",
       " 'MED-1980': [('lactamases esbls', 0.7193),\n",
       "  ('esbls enterobacteriaceae', 0.6743),\n",
       "  ('test esbl', 0.6534),\n",
       "  ('esbl ndp', 0.6293),\n",
       "  ('esbls increasingly', 0.6284),\n",
       "  ('48 esbl', 0.6056),\n",
       "  ('enterobacteriaceae biochemical', 0.5899),\n",
       "  ('producers esbl', 0.5504),\n",
       "  ('cefotaxime hydrolysis', 0.5103),\n",
       "  ('detection cephalosporin', 0.4532),\n",
       "  ('strains producing', 0.4055),\n",
       "  ('blood cultures', 0.3956),\n",
       "  ('tazobactam positive', 0.327),\n",
       "  ('24 48', 0.2984),\n",
       "  ('vitro detection', 0.2973),\n",
       "  ('cultures showed', 0.2874),\n",
       "  ('rapid identification', 0.2829),\n",
       "  ('biochemical test', 0.2445),\n",
       "  ('infection control', 0.2306),\n",
       "  ('hydrolysis reversed', 0.2103),\n",
       "  ('ph indicator', 0.2066),\n",
       "  ('strains 215', 0.1759),\n",
       "  ('increasingly reported', 0.1752),\n",
       "  ('specificity 92', 0.1733),\n",
       "  ('acid formation', 0.1701),\n",
       "  ('extended spectrum', 0.1639),\n",
       "  ('producing clavulanic', 0.1482),\n",
       "  ('producers 16', 0.1451),\n",
       "  ('time consuming', 0.1412),\n",
       "  ('ndp nordmann', 0.1323),\n",
       "  ('evaluated spiked', 0.1319),\n",
       "  ('cost effective', 0.1282),\n",
       "  ('poirel test', 0.1198),\n",
       "  ('worldwide conventional', 0.1145),\n",
       "  ('nonproducers sensitivity', 0.088),\n",
       "  ('phenol', 0.0803),\n",
       "  ('inhibited extended', 0.0796),\n",
       "  ('activity evidenced', 0.0715),\n",
       "  ('ctx producers', 0.0687),\n",
       "  ('health care', 0.0685),\n",
       "  ('100 excellent', 0.068),\n",
       "  ('purposes particular', 0.052),\n",
       "  ('40', 0.0457),\n",
       "  ('remained', 0.0411),\n",
       "  ('dortet', 0.0331),\n",
       "  ('facility adapted', 0.0179),\n",
       "  ('consuming', 0.0041),\n",
       "  ('change red', -0.0368),\n",
       "  ('formation resulting', -0.0497),\n",
       "  ('yellow', -0.0685)],\n",
       " 'MED-1981': [('antibiotic resistance', 0.5808),\n",
       "  ('resistance interventions', 0.5253),\n",
       "  ('climate change', 0.449),\n",
       "  ('internationally antibiotics', 0.409),\n",
       "  ('bacterial infections', 0.4038),\n",
       "  ('interventions needed', 0.3887),\n",
       "  ('resistance major', 0.3798),\n",
       "  ('antibiotics paved', 0.3432),\n",
       "  ('societal developments', 0.3423),\n",
       "  ('causes consequences', 0.3365),\n",
       "  ('coordinated action', 0.3131),\n",
       "  ('medical societal', 0.3023),\n",
       "  ('health systems', 0.2997),\n",
       "  ('efforts different', 0.2932),\n",
       "  ('global situation', 0.2837),\n",
       "  ('behaviour levels', 0.2834),\n",
       "  ('systems achievements', 0.2504),\n",
       "  ('affect everybody', 0.2463),\n",
       "  ('setbacks medically', 0.245),\n",
       "  ('change evident', 0.2362),\n",
       "  ('similarities climate', 0.2198),\n",
       "  ('urgently needed', 0.2183),\n",
       "  ('chemotherapy today', 0.2099),\n",
       "  ('especially political', 0.2032),\n",
       "  ('years faced', 0.2027),\n",
       "  ('levels society', 0.1929),\n",
       "  ('infections just', 0.1908),\n",
       "  ('nationally', 0.1892),\n",
       "  ('faced dire', 0.1696),\n",
       "  ('challenge', 0.1683),\n",
       "  ('actions immediately', 0.1658),\n",
       "  ('major surgery', 0.1345),\n",
       "  ('socially', 0.1331),\n",
       "  ('complex include', 0.126),\n",
       "  ('treatment', 0.1126),\n",
       "  ('world similarities', 0.0966),\n",
       "  ('modern', 0.0918),\n",
       "  ('identify key', 0.0889),\n",
       "  ('real unprecedented', 0.0658),\n",
       "  ('rights reserved', 0.0476),\n",
       "  ('access effective', 0.0476),\n",
       "  ('paved way', 0.0362),\n",
       "  ('indispensible health', 0.023),\n",
       "  ('preterm babies', 0.0121),\n",
       "  ('organ transplantation', 0.0091),\n",
       "  ('largely absent', 0.0032),\n",
       "  ('2013 elsevier', -0.0082),\n",
       "  ('economically unless', -0.0111),\n",
       "  ('include human', -0.0142),\n",
       "  ('granted possible', -0.0384)],\n",
       " 'MED-1982': [('40 methicillin', 0.6155),\n",
       "  ('mrsa transmission', 0.6126),\n",
       "  ('mrsa', 0.5886),\n",
       "  ('source mrsa', 0.5756),\n",
       "  ('mrsa carriers', 0.5614),\n",
       "  ('aureus mrsa', 0.5553),\n",
       "  ('hand contamination', 0.5092),\n",
       "  ('staphylococcus aureus', 0.4765),\n",
       "  ('contaminated surfaces', 0.4645),\n",
       "  ('aureus', 0.4602),\n",
       "  ('staphylococcus', 0.4492),\n",
       "  ('contamination equally', 0.4286),\n",
       "  ('contamination', 0.426),\n",
       "  ('methicillin', 0.4236),\n",
       "  ('resistant staphylococcus', 0.4184),\n",
       "  ('rooms 40', 0.4175),\n",
       "  ('methicillin resistant', 0.4122),\n",
       "  ('study 40', 0.4059),\n",
       "  ('40 vs', 0.3556),\n",
       "  ('45 findings', 0.3305),\n",
       "  ('suggest contaminated', 0.3014),\n",
       "  ('environmental surfaces', 0.2839),\n",
       "  ('touched environmental', 0.2454),\n",
       "  ('examined skin', 0.2401),\n",
       "  ('carriers hand', 0.2194),\n",
       "  ('vs 45', 0.2181),\n",
       "  ('findings suggest', 0.211),\n",
       "  ('examined', 0.2092),\n",
       "  ('patient rooms', 0.2055),\n",
       "  ('study', 0.2051),\n",
       "  ('rooms', 0.2021),\n",
       "  ('surfaces important', 0.1899),\n",
       "  ('surfaces patient', 0.1864),\n",
       "  ('commonly touched', 0.1799),\n",
       "  ('commonly examined', 0.1759),\n",
       "  ('sites commonly', 0.1693),\n",
       "  ('carriers', 0.1653),\n",
       "  ('environmental', 0.1541),\n",
       "  ('likely contact', 0.1489),\n",
       "  ('hand', 0.1475),\n",
       "  ('skin', 0.1472),\n",
       "  ('important source', 0.1278),\n",
       "  ('vs', 0.1249),\n",
       "  ('resistant', 0.1015),\n",
       "  ('important', 0.0987),\n",
       "  ('commonly', 0.0872),\n",
       "  ('transmission', 0.0687),\n",
       "  ('equally likely', 0.0594),\n",
       "  ('patient', 0.0324),\n",
       "  ('suggest', 0.0015)],\n",
       " 'MED-1983': [('exposure mrsa', 0.6955),\n",
       "  ('resistant staphylococcus', 0.6019),\n",
       "  ('mixed mrsa', 0.5878),\n",
       "  ('methicillin resistant', 0.5864),\n",
       "  ('transfer mrsa', 0.5619),\n",
       "  ('staphylococcus', 0.544),\n",
       "  ('antibiotics isolated', 0.3915),\n",
       "  ('lactam antibiotics', 0.3909),\n",
       "  ('pathogen developed', 0.3283),\n",
       "  ('pork products', 0.3249),\n",
       "  ('retail meat', 0.3166),\n",
       "  ('sausage inoculated', 0.3043),\n",
       "  ('contaminated retail', 0.2807),\n",
       "  ('resistance beta', 0.2702),\n",
       "  ('strain mixed', 0.2432),\n",
       "  ('contact contaminated', 0.226),\n",
       "  ('loins bacon', 0.21),\n",
       "  ('low population', 0.2065),\n",
       "  ('developed resistance', 0.2017),\n",
       "  ('human exposure', 0.2014),\n",
       "  ('objectives study', 0.1942),\n",
       "  ('surfaces cell', 0.1937),\n",
       "  ('model used', 0.1586),\n",
       "  ('cell concentrations', 0.1543),\n",
       "  ('49 percentages', 0.1439),\n",
       "  ('culture', 0.1424),\n",
       "  ('skin model', 0.1265),\n",
       "  ('placing inoculated', 0.1218),\n",
       "  ('percentages ranged', 0.1217),\n",
       "  ('isolated', 0.1076),\n",
       "  ('product contact', 0.1043),\n",
       "  ('surface removing', 0.0959),\n",
       "  ('simulate transfer', 0.0913),\n",
       "  ('estimate potential', 0.0911),\n",
       "  ('range populations', 0.0858),\n",
       "  ('log vacuum', 0.084),\n",
       "  ('population numbers', 0.0757),\n",
       "  ('significant differences', 0.0728),\n",
       "  ('statistical', 0.0637),\n",
       "  ('normal packaging', 0.0583),\n",
       "  ('board ranged', 0.0537),\n",
       "  ('min secondary', 0.0439),\n",
       "  ('food', 0.0211),\n",
       "  ('stored weeks', 0.0044),\n",
       "  ('knife blades', -0.015),\n",
       "  ('36 secondary', -0.0215),\n",
       "  ('17 42', -0.0292),\n",
       "  ('26', -0.0327),\n",
       "  ('distribution primary', -0.0513),\n",
       "  ('fresh', -0.0797)],\n",
       " 'MED-1985': [('school diet', 0.5968),\n",
       "  ('california diet', 0.5252),\n",
       "  ('children consumed', 0.4971),\n",
       "  ('vegetarian children', 0.4627),\n",
       "  ('studied children', 0.4582),\n",
       "  ('diet subgroups', 0.4493),\n",
       "  ('adolescents balanced', 0.4408),\n",
       "  ('difference diet', 0.4244),\n",
       "  ('schools 427', 0.4062),\n",
       "  ('518 children', 0.3747),\n",
       "  ('adolescents southern', 0.3712),\n",
       "  ('extensive food', 0.3357),\n",
       "  ('adventist children', 0.3313),\n",
       "  ('children split', 0.3292),\n",
       "  ('southern california', 0.3058),\n",
       "  ('significantly consumption', 0.3033),\n",
       "  ('cm boys', 0.291),\n",
       "  ('age adjusted', 0.2891),\n",
       "  ('consuming classmates', 0.289),\n",
       "  ('height studied', 0.2749),\n",
       "  ('consumed meat', 0.26),\n",
       "  ('seventh day', 0.2588),\n",
       "  ('daily vegetarians', 0.2514),\n",
       "  ('socioeconomic factors', 0.2427),\n",
       "  ('years attending', 0.2419),\n",
       "  ('health statistics', 0.2386),\n",
       "  ('categories frequency', 0.2323),\n",
       "  ('1765 caucasian', 0.2254),\n",
       "  ('classmates cm', 0.224),\n",
       "  ('groups fruit', 0.2139),\n",
       "  ('443 major', 0.1993),\n",
       "  ('parental', 0.1966),\n",
       "  ('percent state', 0.1913),\n",
       "  ('national', 0.1893),\n",
       "  ('percentile', 0.1859),\n",
       "  ('50th percentile', 0.1741),\n",
       "  ('18 years', 0.1432),\n",
       "  ('results indicate', 0.1294),\n",
       "  ('girls', 0.1256),\n",
       "  ('determined extensive', 0.1255),\n",
       "  ('groups did', 0.1202),\n",
       "  ('differed significantly', 0.1103),\n",
       "  ('grow tall', 0.1048),\n",
       "  ('week week', 0.0902),\n",
       "  ('sample', 0.0882),\n",
       "  ('regression analysis', 0.0856),\n",
       "  ('92 percent', 0.0812),\n",
       "  ('state adventist', 0.0755),\n",
       "  ('materially adjusting', 0.0488),\n",
       "  ('did', -0.0252)],\n",
       " 'MED-1986': [('overweight adolescents', 0.6393),\n",
       "  ('overweight adulthood', 0.607),\n",
       "  ('overweight morbidity', 0.6014),\n",
       "  ('adolescence morbidity', 0.4758),\n",
       "  ('increased morbidity', 0.3417),\n",
       "  ('growth study', 0.3389),\n",
       "  ('mass index', 0.3284),\n",
       "  ('health effects', 0.3228),\n",
       "  ('adulthood conclusions', 0.3205),\n",
       "  ('atherosclerosis increased', 0.3096),\n",
       "  ('mortality causes', 0.2738),\n",
       "  ('history weight', 0.2702),\n",
       "  ('18 years', 0.2471),\n",
       "  ('adults associated', 0.2452),\n",
       "  ('harvard growth', 0.2439),\n",
       "  ('age sex', 0.241),\n",
       "  ('increased men', 0.2337),\n",
       "  ('heart disease', 0.227),\n",
       "  ('risk factors', 0.2263),\n",
       "  ('old participated', 0.1981),\n",
       "  ('percentiles subjects', 0.1965),\n",
       "  ('arthritis increased', 0.193),\n",
       "  ('years follow', 0.1868),\n",
       "  ('50th', 0.1813),\n",
       "  ('increased women', 0.1793),\n",
       "  ('weight 55', 0.1765),\n",
       "  ('long term', 0.1684),\n",
       "  ('body', 0.1441),\n",
       "  ('13', 0.1153),\n",
       "  ('1935', 0.1152),\n",
       "  ('national survey', 0.0991),\n",
       "  ('studied relation', 0.0921),\n",
       "  ('lean', 0.0907),\n",
       "  ('gout', 0.0827),\n",
       "  ('1988', 0.0815),\n",
       "  ('occasions greater', 0.0706),\n",
       "  ('colorectal cancer', 0.0643),\n",
       "  ('study 1922', 0.0565),\n",
       "  ('alive interviewed', 0.0532),\n",
       "  ('men 95', 0.0509),\n",
       "  ('capacity risk', 0.0426),\n",
       "  ('effects independent', 0.0345),\n",
       "  ('index 25th', 0.0296),\n",
       "  ('information medical', 0.0235),\n",
       "  ('broad range', 0.0215),\n",
       "  ('confidence interval', 0.0211),\n",
       "  ('powerful predictor', 0.0182),\n",
       "  ('interval 004', -0.0017),\n",
       "  ('known methods', -0.0045),\n",
       "  ('certificates results', -0.0477)],\n",
       " 'MED-1987': [('childhood obesity', 0.5936),\n",
       "  ('obesity increased', 0.555),\n",
       "  ('addressing hyperlipidemia', 0.5137),\n",
       "  ('diabetes association', 0.4696),\n",
       "  ('t2dm published', 0.4626),\n",
       "  ('comorbidities data', 0.3598),\n",
       "  ('global recommendations', 0.313),\n",
       "  ('objective decades', 0.3022),\n",
       "  ('statement cardiovascular', 0.2661),\n",
       "  ('variety health', 0.2584),\n",
       "  ('reporting prevalence', 0.255),\n",
       "  ('retinopathy case', 0.2487),\n",
       "  ('increased dramatically', 0.2469),\n",
       "  ('consulting epidemiologist', 0.238),\n",
       "  ('existing diagnosis', 0.2375),\n",
       "  ('describes procedures', 0.215),\n",
       "  ('primary research', 0.2105),\n",
       "  ('position statement', 0.1876),\n",
       "  ('microalbuminuria depression', 0.1864),\n",
       "  ('evidence cohort', 0.1861),\n",
       "  ('10 study', 0.1816),\n",
       "  ('behaviors studies', 0.1778),\n",
       "  ('social issues', 0.1761),\n",
       "  ('risks american', 0.1696),\n",
       "  ('regard screening', 0.1686),\n",
       "  ('nonmedical treatments', 0.1646),\n",
       "  ('provided supplemental', 0.1622),\n",
       "  ('inclusion divided', 0.161),\n",
       "  ('basis type', 0.1607),\n",
       "  ('included abstract', 0.1462),\n",
       "  ('thousands articles', 0.1445),\n",
       "  ('committee did', 0.1396),\n",
       "  ('provides depth', 0.1342),\n",
       "  ('adolescents provides', 0.1302),\n",
       "  ('north', 0.1214),\n",
       "  ('later life', 0.1214),\n",
       "  ('20 grade', 0.1198),\n",
       "  ('previously typically', 0.1113),\n",
       "  ('life technical', 0.1069),\n",
       "  ('studies adult', 0.0953),\n",
       "  ('series breakdown', 0.0919),\n",
       "  ('ushering', 0.0895),\n",
       "  ('35 years', 0.0877),\n",
       "  ('specific ethnic', 0.0866),\n",
       "  ('conflicting', 0.0725),\n",
       "  ('grade 32', 0.0573),\n",
       "  ('199', -0.006),\n",
       "  ('scarce available', -0.0154),\n",
       "  ('did independently', -0.0356),\n",
       "  ('26 retained', -0.06)],\n",
       " 'MED-1988': [('bullying behaviors', 0.6436),\n",
       "  ('effective bullies', 0.4549),\n",
       "  ('symptoms children', 0.4106),\n",
       "  ('pediatric oral', 0.3378),\n",
       "  ('oral health', 0.3174),\n",
       "  ('pediatricians identifying', 0.3171),\n",
       "  ('school based', 0.3098),\n",
       "  ('literature shows', 0.3018),\n",
       "  ('important topics', 0.2985),\n",
       "  ('common children', 0.2965),\n",
       "  ('young kindergarten', 0.293),\n",
       "  ('delineate problems', 0.2756),\n",
       "  ('behaviors common', 0.2733),\n",
       "  ('poor dental', 0.2703),\n",
       "  ('caries summary', 0.2593),\n",
       "  ('prevention', 0.2467),\n",
       "  ('studies delineated', 0.2336),\n",
       "  ('psychosomatic depressive', 0.2192),\n",
       "  ('health recent', 0.2136),\n",
       "  ('based programs', 0.1956),\n",
       "  ('screen prediabetic', 0.1904),\n",
       "  ('treatment guidelines', 0.1812),\n",
       "  ('purpose review', 0.1767),\n",
       "  ('including family', 0.1731),\n",
       "  ('victims recent', 0.153),\n",
       "  ('future research', 0.1458),\n",
       "  ('practitioners screen', 0.1456),\n",
       "  ('sealants', 0.1452),\n",
       "  ('morbidities', 0.1313),\n",
       "  ('summary', 0.13),\n",
       "  ('important role', 0.1124),\n",
       "  ('practice', 0.1065),\n",
       "  ('continued gaps', 0.1053),\n",
       "  ('emphasizes continued', 0.0908),\n",
       "  ('patients risk', 0.0898),\n",
       "  ('diet', 0.0821),\n",
       "  ('role office', 0.0815),\n",
       "  ('opportunities intervene', 0.0804),\n",
       "  ('strong association', 0.0725),\n",
       "  ('work provided', 0.0707),\n",
       "  ('involved', 0.0674),\n",
       "  ('avoid', 0.0641),\n",
       "  ('refined primary', 0.0604),\n",
       "  ('victim', 0.0564),\n",
       "  ('developing type', 0.0372),\n",
       "  ('delineated glucose', 0.0251),\n",
       "  ('earlier', 0.0141),\n",
       "  ('new models', 0.0022),\n",
       "  ('shows', 0.0021),\n",
       "  ('state hope', -0.018)],\n",
       " ...}"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "doc_keywords = pd.read_pickle(\"/home/guest/r12922050/GitHub/d2qplus/augmented-data/nfcorpus/keywords/candidate_keywords_scibert.pkl\")\n",
    "doc_keywords"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "e76b3602",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "d2qplus",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.21"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
